PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ruckrich, T; Steinle, A				Rueckrich, Thomas; Steinle, Alexander			Attenuated Natural Killer (NK) Cell Activation through C-type Lectin-like Receptor NKp80 Is Due to an Anomalous Hemi-immunoreceptor Tyrosine-based Activation Motif (HemITAM) with Impaired Syk Kinase Recruitment Capacity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELLS; IDENTIFICATION; DECTIN-1; CLEC-2; SUBSET; NKG2D; SPECIFICITY; MACROPHAGES; MECHANISMS; IMMUNITY	Cellular cytotoxicity is the hallmark of NK cells mediating both elimination of virus-infected or malignant cells, and modulation of immune responses. NK cytotoxicity is triggered upon ligation of various activating NK cell receptors. Among these is the C-type lectin-like receptor NKp80 which is encoded in the human Natural Killer Gene Complex (NKC) adjacent to its ligand, activation-induced C-type lectin (AICL). NKp80-AICL interaction promotes cytolysis of malignant myeloid cells, but also stimulates the mutual crosstalk between NK cells and monocytes. While many activating NK cell receptors pair with ITAM-bearing adaptors, we recently reported that NKp80 signals via a hemITAM-like sequence in its cytoplasmic domain. Here we molecularly dissect the NKp80 hemITAM and demonstrate that two non-consensus amino acids, in particular arginine 6, critically impair both hemITAM phosphorylation and Syk recruitment. Impaired Syk recruitment results in a substantial attenuation of cytotoxic responses upon NKp80 ligation. Reconstituting the hemITAM consensus or Syk overexpression resulted in robust NKp80-mediated responsiveness. Collectively, our data provide a molecular rationale for the restrained activation potential of NKp80 and illustrate how subtle alterations in signaling motifs determine subsequent cellular responses. They also suggest that non-consensus alterations in the NKp80 hemITAM, as commonly present among mammalian NKp80 sequences, may have evolved to dampen NKp80-mediated cytotoxic responses toward AICL-expressing cells.	[Rueckrich, Thomas; Steinle, Alexander] Goethe Univ Frankfurt, Inst Mol Med, D-60590 Frankfurt, Germany	Goethe University Frankfurt	Steinle, A (corresponding author), Goethe Univ Frankfurt, Inst Mol Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	alexander.steinle@kgu.de		Steinle, Alexander/0000-0001-5081-8503	German Research Council (DFG) [STE 828/6-1]	German Research Council (DFG)(German Research Foundation (DFG))	This work was supported by a grant of the German Research Council (DFG; STE 828/6-1) (to A. S.).	Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Biassoni R, 2005, J IMMUNOL, V174, P5695, DOI 10.4049/jimmunol.174.9.5695; Bryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005; Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Bryceson YT, 2011, J INNATE IMMUN, V3, P216, DOI 10.1159/000325265; Cerboni C, 2007, BLOOD, V110, P606, DOI 10.1182/blood-2006-10-052720; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Dennehy KM, 2011, J IMMUNOL, V186, P657, DOI 10.4049/jimmunol.0904117; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Hughes CE, 2010, BLOOD, V115, P2947, DOI 10.1182/blood-2009-08-237834; Huysamen C, 2008, J BIOL CHEM, V283, P16693, DOI 10.1074/jbc.M709923200; Kerrigan AM, 2011, TRENDS IMMUNOL, V32, P151, DOI 10.1016/j.it.2011.01.002; Kerrigan AM, 2010, IMMUNOL REV, V234, P335, DOI 10.1111/j.0105-2896.2009.00882.x; Kerrigan AM, 2009, J IMMUNOL, V182, P4150, DOI 10.4049/jimmunol.0802808; Kitamura T, 1998, INT J HEMATOL, V67, P351; Kuttruff S, 2009, BLOOD, V113, P358, DOI [10.1182/blood-2008-04-145615, 10.1182/blood-2008-03-145615]; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Mavilio D, 2005, BLOOD, V106, P1718, DOI 10.1182/blood-2004-12-4762; Poulin LF, 2012, BLOOD, V119, P6052, DOI 10.1182/blood-2012-01-406967; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Severin S, 2011, J BIOL CHEM, V286, P4107, DOI 10.1074/jbc.M110.167502; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Spreu J, 2010, P NATL ACAD SCI USA, V107, P5100, DOI 10.1073/pnas.0913108107; Tam YK, 1999, HUM GENE THER, V10, P1359, DOI 10.1089/10430349950018030; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Vitale M, 2001, EUR J IMMUNOL, V31, P233, DOI 10.1002/1521-4141(200101)31:1<233::AID-IMMU233>3.3.CO;2-W; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vogler I, 2011, J INNATE IMMUN, V3, P227, DOI 10.1159/000324112; Waldhauer I, 2008, ONCOGENE, V27, P5932, DOI 10.1038/onc.2008.267; Welte S, 2006, NAT IMMUNOL, V7, P1334, DOI 10.1038/ni1402; Zhang JG, 2012, IMMUNITY, V36, P646, DOI 10.1016/j.immuni.2012.03.009	35	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17725	17733		10.1074/jbc.M113.453548	http://dx.doi.org/10.1074/jbc.M113.453548			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23609447	Green Published, hybrid			2022-12-28	WOS:000320380600062
J	Fan, YX; Wong, L; Marino, MP; Ou, W; Shen, Y; Wu, WJ; Wong, KK; Reiser, J; Johnson, GR				Fan, Ying-Xin; Wong, Lily; Marino, Michael P.; Ou, Wu; Shen, Yi; Wu, Wen Jin; Wong, Kwok-Kin; Reiser, Jakob; Johnson, Gibbes R.			Acquired Substrate Preference for GAB1 Protein Bestows Transforming Activity to ERBB2 Kinase Lung Cancer Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; PHOSPHORYLATION SITES; DOCKING PROTEIN; EGFR MUTATIONS; ACTIVATION; RESISTANCE; DOMAIN; SPECIFICITY; GEFITINIB; MECHANISM	Activating mutations in the alpha C-beta 4 loop of the ERBB2 kinase domain, such as ERBB2(YVMA) and ERBB2(G776VC), have been identified in human lung cancers and found to drive tumor formation. Here we observe that the docking protein GAB1 is hyper-phosphorylated in carcinomas from transgenic mice and in cell lines expressing these ERBB2 cancer mutants. Using dominant negative GAB1 mutants lacking canonical tyrosine residues for SHP2 and PI3K interactions or lentiviral shRNA that targets GAB1, we demonstrate that GAB1 phosphorylation is required for ERBB2 mutant-induced cell signaling, cell transformation, and tumorigenesis. An enzyme kinetic analysis comparing ERBB2(YVMA) to wild type using physiologically relevant peptide substrates reveals that ERBB2(YVMA) kinase adopts a striking preference for GAB1 phosphorylation sites as evidenced by similar to 150-fold increases in the specificity constants (k(cat)/K-m) for several GAB1 peptides, and this change in substrate selectivity was predominantly attributed to the peptide binding affinities as reflected by the apparent K-m values. Furthermore, we demonstrate that ERBB2(YVMA) phosphorylates GAB1 protein similar to 70-fold faster than wild type ERBB2 in vitro. Notably, the mutation does not significantly alter the K-m for ATP or sensitivity to lapatinib, suggesting that, unlike EGFR lung cancer mutants, the ATP binding cleft of the kinase is not significantly changed. Taken together, our results indicate that the acquired substrate preference for GAB1 is critical for the ERBB2 mutant-induced oncogenesis.	[Fan, Ying-Xin; Wong, Lily; Johnson, Gibbes R.] US FDA, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA; [Marino, Michael P.; Ou, Wu; Reiser, Jakob] US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; [Shen, Yi; Wu, Wen Jin] US FDA, Div Monoclonal Antibodies, Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA; [Wong, Kwok-Kin] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Harvard University; Harvard Medical School	Fan, YX (corresponding author), US FDA, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bldg 29A,Rm 3B-20,8800 Rockville Pike, Bethesda, MD 20892 USA.	ying-xin.fan@fda.hhs.gov; gibbes.johnson@fda.hhs.gov		wong, kwok kin/0000-0001-6323-235X	NCI NIH HHS [R01 CA166480, P01 CA154303, R01 CA140594, R01 CA122794] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA166480, P01CA154303, R01CA140594, R01CA122794] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cunnick JM, 2000, J BIOL CHEM, V275, P13842, DOI 10.1074/jbc.275.18.13842; Cunnick JM, 2001, J BIOL CHEM, V276, P24380, DOI 10.1074/jbc.M010275200; Deb TB, 1998, J BIOL CHEM, V273, P16643, DOI 10.1074/jbc.273.27.16643; Fan YX, 2008, J BIOL CHEM, V283, P1588, DOI 10.1074/jbc.M708116200; Fan YX, 2005, BIOCHEM J, V392, P417, DOI 10.1042/BJ20051122; Fan YX, 2004, J BIOL CHEM, V279, P38143, DOI 10.1074/jbc.M405760200; Fan YX, 1996, BIOCHEM J, V315, P97, DOI 10.1042/bj3150097; Felici A, 2010, J CELL BIOCHEM, V111, P310, DOI 10.1002/jcb.22695; Gazdar AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/j.molmed.2004.08.008; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Hoeben A, 2013, INT J CANCER, V132, P1042, DOI 10.1002/ijc.27763; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Itoh M, 2000, MOL CELL BIOL, V20, P3695, DOI 10.1128/MCB.20.10.3695-3704.2000; Lehr S, 1999, BIOCHEMISTRY-US, V38, P151, DOI 10.1021/bi9818265; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; Mood K, 2006, MOL BIOL CELL, V17, P3717, DOI 10.1091/mbc.E06-03-0244; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Ou W, 2012, HUM GENE THER METHOD, V23, P137, DOI 10.1089/hgtb.2012.054; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Perera SA, 2009, P NATL ACAD SCI USA, V106, P474, DOI 10.1073/pnas.0808930106; Pluta K, 2005, J GENE MED, V7, P803, DOI 10.1002/jgm.712; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Qiu C, 2009, BIOCHEMISTRY-US, V48, P6624, DOI 10.1021/bi900755n; SEGATTO O, 1990, New Biologist, V2, P187; Sharial MSNM, 2012, ANN ONCOL, V23, P3007, DOI 10.1093/annonc/mds200; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Sithanandam G, 2005, AM J RESP CELL MOL, V33, P490, DOI 10.1165/rcmb.2005-0049OC; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Vu T, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00062; TSOU CL, 1993, SCIENCE, V262, P380, DOI 10.1126/science.8211158; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Yamasaki S, 2003, ONCOGENE, V22, P1546, DOI 10.1038/sj.onc.1206284; Yart A, 2003, CURR CANCER DRUG TAR, V3, P177, DOI 10.2174/1568009033481976; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	51	5	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16895	16904		10.1074/jbc.M112.434217	http://dx.doi.org/10.1074/jbc.M112.434217			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612964	Green Published, hybrid			2022-12-28	WOS:000320378900062
J	Maurya, IK; Thota, CK; Verma, SD; Sharma, J; Rawal, MK; Ravikumar, B; Sen, S; Chauhan, N; Lynn, AM; Chauhan, VS; Prasad, R				Maurya, Indresh Kumar; Thota, Chaitanya Kumar; Verma, Sachin Dev; Sharma, Jyotsna; Rawal, Manpreet Kaur; Ravikumar, Balaguru; Sen, Sobhan; Chauhan, Neeraj; Lynn, Andrew M.; Chauhan, Virander Singh; Prasad, Rajendra			RETRACTED: Rationally Designed Transmembrane Peptide Mimics of the Multidrug Transporter Protein Cdr1 Act as Antagonists to Selectively Block Drug Efflux and Chemosensitize Azole-resistant Clinical Isolates of Candida albicans (Retracted article. See vol. 295, pg. 3393, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							FLUCONAZOLE RESISTANCE; YEAST; CONTRIBUTE; DOMAIN	Drug-resistant pathogenic fungi use several families of membrane- embedded transporters to efflux antifungal drugs from the cells. The efflux pump Cdr1 (Candida drug resistance 1) belongs to the ATP-binding cassette (ABC) superfamily of transporters. Cdr1 is one of the most predominant mechanisms of multidrug resistance in azole-resistant (AR) clinical isolates of Candida albicans. Blocking drug efflux represents an attractive approach to combat the multidrug resistance of this opportunistic human pathogen. In this study, we rationally designed and synthesized transmembrane peptide mimics (TMPMs) of Cdr1 protein (Cdr1p) that correspond to each of the 12 transmembrane helices (TMHs) of the two transmembrane domains of the protein to target the primary structure of the Cdr1p. Several FITC-tagged TMPMs specifically bound to Cdr1p and blocked the efflux of entrapped fluorescent dyes from the AR (Gu5) isolate. These TMPMs did not affect the efflux of entrapped fluorescent dye from cells expressing the Cdr1p homologue Cdr2p or from cells expressing a non-ABC transporter Mdr1p. Notably, the time correlation of single photon counting fluorescence measurements confirmed the specific interaction of FITC-tagged TMPMs with their respective TMH. By using mutant variants of Cdr1p, we show that these TMPM antagonists contain the structural information necessary to target their respective TMHs of Cdr1p and specific binding sites that mediate the interactions between the mimics and its respective helix. Additionally, TMPMs that were devoid of any demonstrable hemolytic, cytotoxic, and antifungal activities chemosensitize AR clinical isolates and demonstrate synergy with drugs that further improved the therapeutic potential of fluconazole in vivo.	[Maurya, Indresh Kumar; Rawal, Manpreet Kaur; Prasad, Rajendra] Jawaharlal Nehru Univ, Sch Life Sci, Membrane Biol Lab, New Delhi 110067, India; [Verma, Sachin Dev; Sen, Sobhan] Jawaharlal Nehru Univ, Sch Phys Sci, New Delhi 110067, India; [Ravikumar, Balaguru; Lynn, Andrew M.] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India; [Thota, Chaitanya Kumar; Sharma, Jyotsna; Chauhan, Virander Singh] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India; [Chauhan, Neeraj] Univ Med & Dent New Jersey, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07103 USA	Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Rutgers State University New Brunswick; Rutgers State University Medical Center	Chauhan, VS (corresponding author), Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India.	virander@icgeb.res.in; rp47@mail.jnu.ac.in	Verma, Sachin Dev/N-2959-2014; Chauhan, Virander S./K-5276-2019; Verma, Sachin Dev/N-9066-2019; Sen, Sobhan/Q-7523-2019; Rawal, Manpreet Kaur/AAG-5799-2019; Verma, Sachin Dev/E-8164-2018	Verma, Sachin Dev/0000-0002-6312-9333; Verma, Sachin Dev/0000-0002-6312-9333; Verma, Sachin Dev/0000-0002-6312-9333; Sen, Sobhan/0000-0002-9047-3455; Maurya, DST-INSPIRE FACULTY, Dr. Indresh Kumar/0000-0002-2377-3693	Department of Biotechnology [BT/PR11158/BRB/10/640/2008]	Department of Biotechnology	This work was supported by grants from the Department of Biotechnology (Grants BT/PR11158/BRB/10/640/2008 (to R.P and V.S.).	Cannon RD, 2009, CLIN MICROBIOL REV, V22, P291, DOI 10.1128/CMR.00051-08; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Devauges V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044434; Dewan PC, 2009, BIOCHEMISTRY-US, V48, P5642, DOI 10.1021/bi900272r; Franz R, 1999, MYCOSES, V42, P453, DOI 10.1046/j.1439-0507.1999.00498.x; Franz R, 1998, ANTIMICROB AGENTS CH, V42, P3065, DOI 10.1128/AAC.42.12.3065; Gamarra S, 2010, ANTIMICROB AGENTS CH, V54, P1753, DOI 10.1128/AAC.01728-09; Gauthier C, 2003, ANTIMICROB AGENTS CH, V47, P1543, DOI 10.1128/AAC.47.5.1543-1554.2003; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Ivnitski-Steele I, 2009, ANAL BIOCHEM, V394, P87, DOI 10.1016/j.ab.2009.07.001; Jha S, 2003, BIOCHEMISTRY-US, V42, P10822, DOI 10.1021/bi0345900; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Klepser ME, 1998, ANTIMICROB AGENTS CH, V42, P1207, DOI 10.1128/AAC.42.5.1207; Larsson L., 1988, IMMUNOCYTOCHEMISTRY, P224; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; Maesaki S, 1999, J ANTIMICROB CHEMOTH, V44, P27, DOI 10.1093/jac/44.1.27; Mandal A, 2012, BIOCHEM J, V445, P313, DOI 10.1042/BJ20120190; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakamura K, 2001, ANTIMICROB AGENTS CH, V45, P3366, DOI 10.1128/AAC.45.12.3366-3374.2001; National Committee for Clinical Laboratory Standards, 1998, M38A NAT COMM CLIN L; Niimi K, 2012, MOL MICROBIOL, V85, P747, DOI 10.1111/j.1365-2958.2012.08140.x; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Paderu P, 2007, ANTIMICROB AGENTS CH, V51, P2253, DOI 10.1128/AAC.01536-06; Pathak S, 2011, ANTIMICROB AGENTS CH, V55, P2178, DOI 10.1128/AAC.01493-10; Pirovano W, 2008, BIOINFORMATICS, V24, P492, DOI 10.1093/bioinformatics/btm636; Poulsen BE, 2012, ANTIMICROB AGENTS CH, V56, P3911, DOI 10.1128/AAC.00158-12; Prasad R, 2012, ANNU REV MICROBIOL, V66, P39, DOI 10.1146/annurev-micro-092611-150111; Puri N, 2009, BBA-BIOMEMBRANES, V1788, P1752, DOI 10.1016/j.bbamem.2009.04.009; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Sharma M, 2011, ANTIMICROB AGENTS CH, V55, P4834, DOI 10.1128/AAC.00344-11; Sharma M, 2009, ANTIMICROB AGENTS CH, V53, P3256, DOI 10.1128/AAC.01497-08; Shin SY, 1999, J PEPT RES, V53, P82, DOI 10.1111/j.1399-3011.1999.tb01620.x; Shukla S, 2006, BIOCHEMISTRY-US, V45, P2425, DOI 10.1021/bi0519147; Shukla S, 2003, EUKARYOT CELL, V2, P1361, DOI 10.1128/EC.2.6.1361-1375.2003; Singh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019266; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Standards N., 1997, M27A NAT COMM CLIN L; Tarasova NI, 2005, J MED CHEM, V48, P3768, DOI 10.1021/jm049065t; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Yan YL, 2003, CURR OPIN CHEM BIOL, V7, P635, DOI 10.1016/j.cbpa.2003.08.017	41	33	33	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16775	16787		10.1074/jbc.M113.467159	http://dx.doi.org/10.1074/jbc.M113.467159			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23592791	hybrid, Green Published			2022-12-28	WOS:000320378900051
J	Qi, WT; Fitchev, PS; Cornwell, ML; Greenberg, J; Cabe, M; Weber, CR; Roy, HK; Crawford, SE; Savkovic, SD				Qi, Wentao; Fitchev, Philip S.; Cornwell, Mona L.; Greenberg, Jordan; Cabe, Maleen; Weber, Christopher R.; Roy, Hemant K.; Crawford, Susan E.; Savkovic, Suzana D.			FOXO3 Growth Inhibition of Colonic Cells Is Dependent on Intraepithelial Lipid Droplet Density	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; FORKHEAD TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; COLORECTAL-CANCER; PAT-PROTEINS; KAPPA-B; EXPRESSION; SIRT1; ACCUMULATION; DEACETYLASE	Forkhead transcription factor FOXO3 plays a critical role in suppressing tumor growth, in part, by increasing the cell cycle inhibitor p27kip1, and Foxo3 deficiency in mice results in marked colonic epithelial proliferation. Here, we show in Foxo3-deficient colonic epithelial cells a striking increase in intracytoplasmic lipid droplets (LDs), a dynamic organelle recently observed in human tumor tissue. Although the regulation and function of LDs in non-adipocytes is unclear, we hypothesize that the anti-proliferative effect of FOXO3 was dependent on lowering LD density, thus decreasing fuel energy in both normal and colon cancer cells. In mouse colonic tumors, we found an increased expression of LD coat protein PLIN2 compared with normal colonic epithelial cells. Stimulation of LD density in human colon cancer cells led to a PI3K-dependent loss of FOXO3 and a decrease in the negative regulator of lipid metabolism in Sirtuin6 (SIRT6). Foxo3 deficiency also led to a decrease in SIRT6, revealing the existence of LD and FOXO3 feedback regulation in colonic cells. In parallel, LD-dependent loss of FOXO3 led to its dissociation from the promoter and decreased expression of the cell cycle inhibitor p27kip1. Stimulation of LD density promoted proliferation in colon cancer cells, whereas silencing PLIN2 or overexpression of FOXO3 inhibited proliferation. Taken together, FOXO3and LDs might serve as new targets for therapeutic intervention of colon cancer.	[Qi, Wentao; Greenberg, Jordan; Cabe, Maleen; Roy, Hemant K.; Savkovic, Suzana D.] Northshore Univ HealthSyst Res Inst, Div Gastroenterol, Dept Med, Evanston, IL 60201 USA; [Fitchev, Philip S.; Cornwell, Mona L.; Crawford, Susan E.] St Louis Univ Sch Med, Dept Pathol, St Louis, MO 63104 USA; [Weber, Christopher R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	NorthShore University Health System; Saint Louis University; University of Chicago	Savkovic, SD (corresponding author), 1001 Univ Pl,Rm 304, Evanston, IL 60201 USA.	SSavkovic@northshore.org	Roy, Hemant/AAC-9096-2020	Weber, Christopher/0000-0002-2117-3184	National Institutes of Health [NIHR01-CA160809]; NIHR01-CA64239; Crohn's and Colitis Foundation of America [CCFA 1953]; Northshore University Health System; University of Chicago Collaborative Grant;  [K08DK088953]; NATIONAL CANCER INSTITUTE [R01CA064239, R01CA160809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061931, K08DK088953] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHR01-CA64239; Crohn's and Colitis Foundation of America; Northshore University Health System; University of Chicago Collaborative Grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants NIHR01-CA160809 (to S.D.S.) and NIHR01-CA64239 (to S.E.C.), Senior Investigator Award CCFA 1953 from the Crohn's and Colitis Foundation of America (to S.D.S.), and Northshore University Health System and University of Chicago Collaborative Grant (to S.D.S. and C.R.W.), and K08DK088953 (to C.R.W.).	Accioly MT, 2008, CANCER RES, V68, P1732, DOI 10.1158/0008-5472.CAN-07-1999; Arden KC, 2006, EXP GERONTOL, V41, P709, DOI 10.1016/j.exger.2006.05.015; Beller M, 2010, FEBS LETT, V584, P2176, DOI 10.1016/j.febslet.2010.03.022; Bozza PT, 2010, PROSTAG LEUKOTR ESS, V82, P243, DOI 10.1016/j.plefa.2010.02.005; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Ciaparrone M, 1998, CANCER RES, V58, P114; Delpuech O, 2007, MOL CELL BIOL, V27, P4917, DOI 10.1128/MCB.01789-06; Dugail I, 2007, CELL MOL LIFE SCI, V64, P2452, DOI 10.1007/s00018-007-7277-6; GOCZE PM, 1994, CYTOMETRY, V17, P151, DOI 10.1002/cyto.990170207; Greenberg AS, 2008, CELL METAB, V7, P472, DOI 10.1016/j.cmet.2008.05.005; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Gunter MJ, 2006, J NUTR BIOCHEM, V17, P145, DOI 10.1016/j.jnutbio.2005.06.011; Heid HW, 1998, CELL TISSUE RES, V294, P309, DOI 10.1007/s004410051181; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Hoogeboom D, 2008, J BIOL CHEM, V283, P9224, DOI 10.1074/jbc.M706638200; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang YN, 2012, GENE, V502, P87, DOI 10.1016/j.gene.2012.04.052; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kuhnlein RP, 2012, J LIPID RES, V53, P1430, DOI 10.1194/jlr.R024299; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Li JN, 2001, CANCER RES, V61, P1493; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Liu XY, 2011, P NATL ACAD SCI USA, V108, P1925, DOI 10.1073/pnas.1019619108; Londos C, 2005, BIOCHIMIE, V87, P45, DOI 10.1016/j.biochi.2004.12.010; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; McIntosh AL, 2012, AM J PHYSIOL-CELL PH, V303, pC728, DOI 10.1152/ajpcell.00448.2011; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Nosho K, 2009, MODERN PATHOL, V22, P922, DOI 10.1038/modpathol.2009.49; Phillips WA, 1998, CANCER, V83, P41, DOI 10.1002/(SICI)1097-0142(19980701)83:1<41::AID-CNCR6>3.0.CO;2-H; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Qi WT, 2011, AM J PHYSIOL-GASTR L, V300, pG264, DOI 10.1152/ajpgi.00416.2010; Rashid A, 1997, AM J PATHOL, V150, P201; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sapiro JM, 2009, J LIPID RES, V50, P1621, DOI 10.1194/jlr.M800614-JLR200; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Snoeks L, 2008, INFECT IMMUN, V76, P4677, DOI 10.1128/IAI.00227-08; Snoeks L, 2009, LAB INVEST, V89, P1053, DOI 10.1038/labinvest.2009.66; Straub BK, 2010, MODERN PATHOL, V23, P480, DOI 10.1038/modpathol.2009.191; Straub BK, 2008, HEPATOLOGY, V47, P1936, DOI 10.1002/hep.22268; Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061; Vereshchagina N, 2006, DEVELOPMENT, V133, P4731, DOI 10.1242/dev.02659; Wang SM, 1997, J CELL BIOCHEM, V67, P84, DOI 10.1002/(SICI)1097-4644(19971001)67:1<84::AID-JCB9>3.0.CO;2-S; WHITEHEAD RH, 1994, EPITHELIAL CELL BIOL, V3, P119; Wu MQ, 2012, MED ONCOL, V29, P3240, DOI 10.1007/s12032-012-0260-6; Yang JY, 2009, CLIN CANCER RES, V15, P752, DOI 10.1158/1078-0432.CCR-08-0124; You H, 2006, P NATL ACAD SCI USA, V103, P9051, DOI 10.1073/pnas.0600889103; Zhang KB, 2012, ENDOCRINOLOGY, V153, P631, DOI 10.1210/en.2011-1527; Zhou WB, 2003, CANCER RES, V63, P7330	54	41	43	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16274	16281		10.1074/jbc.M113.470617	http://dx.doi.org/10.1074/jbc.M113.470617			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23603907	Green Published, hybrid			2022-12-28	WOS:000320378900007
J	Santos, JS; Syeda, R; Montal, M				Santos, Jose S.; Syeda, Ruhma; Montal, Mauricio			Stabilization of the Conductive Conformation of a Voltage-gated K+ (Kv) Channel THE LID MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE INACTIVATION; SHAKER POTASSIUM CHANNELS; SELECTIVITY FILTER; MOLECULAR TEMPLATE; ION CONDUCTION; PORE MODULE; SLOW INACTIVATION; CRYSTAL-STRUCTURE; BLOCKING PEPTIDE; GATING CHARGE	Voltage-gated K+ (Kv) channels are molecular switches that sense membrane potential and in response open to allow K+ ions to diffuse out of the cell. In these proteins, sensor and pore belong to two distinct structural modules. We previously showed that the pore module alone is a robust yet dynamic structural unit in lipid membranes and that it senses potential and gates open to conduct K+ with unchanged fidelity. The implication is that the voltage sensitivity of K+ channels is not solely encoded in the sensor. Given that the coupling between sensor and pore remains elusive, we asked whether it is then possible to convert a pore module characterized by brief openings into a conductor with a prolonged lifetime in the open state. The strategy involves selected probes targeted to the filter gate of the channel aiming to modulate the probability of the channel being open assayed by single channel recordings from the sensorless pore module reconstituted in lipid bilayers. Here we show that the premature closing of the pore is bypassed by association of the filter gate with two novel open conformation stabilizers: an antidepressant and a peptide toxin known to act selectively on Kv channels. Such stabilization of the conductive conformation of the channel is faithfully mimicked by the covalent attachment of fluorescein at a cysteine residue selectively introduced near the filter gate. This modulation prolongs the occupancy of permeant ions at the gate. It is this longer embrace between ion and gate that we conjecture underlies the observed stabilization of the conductive conformation. This study provides a new way of thinking about gating.	[Santos, Jose S.; Syeda, Ruhma; Montal, Mauricio] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Montal, M (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mmontal@ucsd.edu			National Institutes of Health Grant [GM-49711]; University of California San Diego Grant [RK-174C]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049711] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Diego Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-49711 (to M. M.). This work was also supported by University of California San Diego Grant RK-174C (to M. M.).	Abenavoli A, 2009, J GEN PHYSIOL, V134, P219, DOI 10.1085/jgp.200910266; Ambriz-Rivas M, 2005, PFLUG ARCH EUR J PHY, V450, P255, DOI 10.1007/s00424-005-1411-9; Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; Armstrong Clay M, 2003, Sci STKE, V2003, pre10, DOI 10.1126/stke.2003.188.re10; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; Bayley H, 2008, MOL BIOSYST, V4, P1191, DOI 10.1039/b808893d; Berneche S, 2005, STRUCTURE, V13, P591, DOI 10.1016/j.str.2004.12.019; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; del Camino D, 2005, J GEN PHYSIOL, V126, P419, DOI 10.1085/jgp.200509385; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; FRENCH RJ, 1981, BIOPHYS J, V34, P271, DOI 10.1016/S0006-3495(81)84849-7; GOLDSTEIN SAN, 1992, BIOPHYS J, V62, P5, DOI 10.1016/S0006-3495(92)81760-5; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; GRISSMER S, 1989, BIOPHYS J, V55, P203, DOI 10.1016/S0006-3495(89)82793-6; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Kiss L, 1998, BIOPHYS J, V74, P1840, DOI 10.1016/S0006-3495(98)77894-4; Koch ED, 2004, BIOPHYS J, V86, P191, DOI 10.1016/S0006-3495(04)74096-5; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Loboda A, 2001, BIOPHYS J, V81, P905, DOI 10.1016/S0006-3495(01)75750-5; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Loots E, 2000, J GEN PHYSIOL, V116, P623, DOI 10.1085/jgp.116.5.623; Loots E, 1998, J GEN PHYSIOL, V112, P377, DOI 10.1085/jgp.112.4.377; Lundby A, 2006, J GEN PHYSIOL, V128, P293, DOI 10.1085/jgp.200609573; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MACKINNON R, 1988, NEURON, V1, P997, DOI 10.1016/0896-6273(88)90156-0; MATTESON DR, 1986, J GEN PHYSIOL, V87, P795, DOI 10.1085/jgp.87.5.795; MILLER C, 1995, NEURON, V15, P5, DOI 10.1016/0896-6273(95)90057-8; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Naranjo D, 1996, NEURON, V16, P123, DOI 10.1016/S0896-6273(00)80029-X; Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943; Ogielska EM, 1995, BIOPHYS J, V69, P2449, DOI 10.1016/S0006-3495(95)80114-1; PANYI G, 1995, BIOPHYS J, V69, P896, DOI 10.1016/S0006-3495(95)79963-5; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; PARK CS, 1992, BIOCHEMISTRY-US, V31, P7749, DOI 10.1021/bi00149a002; PARK CS, 1992, NEURON, V9, P307, DOI 10.1016/0896-6273(92)90169-E; Pathak M, 2005, J GEN PHYSIOL, V125, P57, DOI 10.1085/jgp.200409197; Patlak JB, 1999, J GEN PHYSIOL, V113, P385, DOI 10.1085/jgp.113.3.385; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Santos JS, 2006, J GEN PHYSIOL, V128, P283, DOI 10.1085/jgp.200609572; Santos JS, 2012, J BIOL CHEM, V287, P43063, DOI 10.1074/jbc.M112.415091; Santos JS, 2008, J GEN PHYSIOL, V132, P651, DOI 10.1085/jgp.200810077; Santos JS, 2004, MAGN RESON CHEM, V42, P105, DOI 10.1002/mrc.1327; Schmidt D, 2012, P NATL ACAD SCI USA, V109, P10352, DOI 10.1073/pnas.1204700109; Schoppa NE, 1998, J GEN PHYSIOL, V111, P271, DOI 10.1085/jgp.111.2.271; Schroeder I, 2007, J GEN PHYSIOL, V130, P83, DOI 10.1085/jgp.200709802; Seebohm G, 2003, J PHYSIOL-LONDON, V552, P369, DOI 10.1113/jphysiol.2003.046490; Shahidullah M, 2003, BIOPHYS J, V84, P928, DOI 10.1016/S0006-3495(03)74910-8; STOCKER M, 1994, P NATL ACAD SCI USA, V91, P9509, DOI 10.1073/pnas.91.20.9509; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0; Syeda R, 2012, P NATL ACAD SCI USA, V109, P16917, DOI 10.1073/pnas.1205592109; Thompson J, 2000, BIOPHYS J, V78, P2382, DOI 10.1016/S0006-3495(00)76782-8; Vaid M, 2009, CHANNELS, V3, P3, DOI 10.4161/chan.3.1.7369; Yohannan S, 2007, J MOL BIOL, V366, P806, DOI 10.1016/j.jmb.2006.11.081; Yu LP, 2005, BIOCHEMISTRY-US, V44, P15834, DOI 10.1021/bi051656d; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	73	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16619	16628		10.1074/jbc.M113.468728	http://dx.doi.org/10.1074/jbc.M113.468728			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23609443	hybrid, Green Published			2022-12-28	WOS:000320378900038
J	Basso, M; Pozzi, S; Tortarolo, M; Fiordaliso, F; Bisighini, C; Pasetto, L; Spaltro, G; Lidonnici, D; Gensano, F; Battaglia, E; Bendotti, C; Bonetto, V				Basso, Manuela; Pozzi, Silvia; Tortarolo, Massimo; Fiordaliso, Fabio; Bisighini, Cinzia; Pasetto, Laura; Spaltro, Gabriella; Lidonnici, Dario; Gensano, Francesco; Battaglia, Elisa; Bendotti, Caterina; Bonetto, Valentina			Mutant Copper-Zinc Superoxide Dismutase (SOD1) Induces Protein Secretion Pathway Alterations and Exosome Release in Astrocytes IMPLICATIONS FOR DISEASE SPREADING AND MOTOR NEURON PATHOLOGY IN AMYOTROPHIC LATERAL SCLEROSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE TRANSPORTER GLT-1; LATERAL-SCLEROSIS; SPINAL-CORD; CEREBROSPINAL-FLUID; MOUSE MODEL; ENDOPLASMIC-RETICULUM; NRF2 ACTIVATION; STRESS; EXPRESSION; INDUCTION	Amyotrophic lateral sclerosis is the most common motor neuron disease and is still incurable. The mechanisms leading to the selective motor neuron vulnerability are still not known. The interplay between motor neurons and astrocytes is crucial in the outcome of the disease. Weshow that mutant copper-zinc superoxide dismutase (SOD1) overexpression in primary astrocyte cultures is associated with decreased levels of proteins involved in secretory pathways. This is linked to a general reduction of total secreted proteins, except for specific enrichment in a number of proteins in the media, such as mutant SOD1 and valosin-containing protein (VCP)/p97. Because there was also an increase in exosome release, we can deduce that astrocytes expressing mutant SOD1 activate unconventional secretory pathways, possibly as a protective mechanism. This may help limit the formation of intracellular aggregates and overcome mutant SOD1 toxicity. We also found that astrocyte-derived exosomes efficiently transfer mutant SOD1 to spinal neurons and induce selective motor neuron death. We conclude that the expression of mutant SOD1 has a substantial impact on astrocyte protein secretion pathways, contributing to motor neuron pathology and disease spread.	[Basso, Manuela; Pozzi, Silvia; Pasetto, Laura; Bonetto, Valentina] IRCCS Ist Ric Farmacol Mario Negri, Dulbecco Telethon Inst, I-20156 Milan, Italy; [Tortarolo, Massimo; Spaltro, Gabriella; Lidonnici, Dario; Gensano, Francesco; Battaglia, Elisa; Bendotti, Caterina] IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, I-20156 Milan, Italy; [Fiordaliso, Fabio; Bisighini, Cinzia] IRCCS Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Bioimaging Unit, I-20156 Milan, Italy	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Bonetto, V (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Dulbecco Telethon Inst, Via La Masa 19, I-20156 Milan, Italy.	valentina.bonetto@marionegri.it	Bendotti, Caterina/AAB-2273-2020; Basso, Manuela/AAA-9147-2020; Fiordaliso, Fabio/AAA-7161-2020; Silvia, Pozzi/AAF-9396-2019; Pasetto, Laura/I-6911-2018; Bonetto, Valentina/ABB-6383-2020; Pasetto, Laura/ABG-3421-2020; Tortarolo, Massimo/AAA-8048-2020; Bonetto, Valentina/I-4694-2018	Bendotti, Caterina/0000-0003-1055-1271; Basso, Manuela/0000-0002-9278-8960; Fiordaliso, Fabio/0000-0002-0172-4030; Silvia, Pozzi/0000-0002-1500-8158; Pasetto, Laura/0000-0003-0319-4448; Bonetto, Valentina/0000-0003-0456-2054; Pasetto, Laura/0000-0003-0319-4448; Tortarolo, Massimo/0000-0003-3078-2341; Bonetto, Valentina/0000-0003-0456-2054; Lidonnici, Dario/0000-0003-3136-0327	Telethon Foundation [S01010, TCR08002]; Cariplo Foundation; Compagnia San Paolo Foundation; Aldo e Cele Dacco Foundation; European Community's Health Seventh Framework Programme [259867]; Leonardi Fellowship; Vialli and Mauro Foundation for Research and Sport	Telethon Foundation(Fondazione Telethon); Cariplo Foundation(Fondazione Cariplo); Compagnia San Paolo Foundation(Compagnia di San Paolo); Aldo e Cele Dacco Foundation; European Community's Health Seventh Framework Programme; Leonardi Fellowship; Vialli and Mauro Foundation for Research and Sport	This work was supported by the Telethon (Grants S01010 and TCR08002) (to V. B.), Cariplo (to V. B. and C. B.), Compagnia San Paolo (to V. B.), and Aldo e Cele Dacco Foundations (to V. B.) and the European Community's Health Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 259867 (to V. B. and C. B.).; Recipient of a Leonardi Fellowship. Present address: Burke Medical Research Institute, Weill Medical College, Cornell University, Ithaca, NY.; Recipient of a fellowship from the Vialli and Mauro Foundation for Research and Sport.	Abramzon Y., 2012, NEUROBIOL AGING, V33; Aebischer J, 2011, CELL DEATH DIFFER, V18, P754, DOI 10.1038/cdd.2010.143; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Basso M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008130; Bellingham SA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00124; Bendotti C, 2001, J NEUROCHEM, V79, P737, DOI 10.1046/j.1471-4159.2001.00572.x; Biasini E, 2006, PROTEOMICS, V6, P2823, DOI 10.1002/pmic.200500620; Casoni F, 2005, J BIOL CHEM, V280, P16295, DOI 10.1074/jbc.M413111200; Choi JS, 2010, ANIM CELLS SYST, V14, P1, DOI 10.1080/19768351003765145; Delcourt N, 2005, MOL CELL PROTEOMICS, V4, P1085, DOI 10.1074/mcp.M500040-MCP200; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Diaz-Amarilla P, 2011, P NATL ACAD SCI USA, V108, P18126, DOI 10.1073/pnas.1110689108; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; FOUNTOULAKIS M, 1992, J BIOCHEM BIOPH METH, V24, P265, DOI 10.1016/0165-022X(94)90078-7; Fujita K, 1998, BRAIN RES, V785, P31, DOI 10.1016/S0006-8993(97)00612-4; Gomes C, 2007, NEUROSCI LETT, V428, P43, DOI 10.1016/j.neulet.2007.09.024; Greco TM, 2010, J PROTEOME RES, V9, P2764, DOI 10.1021/pr100134n; Gros-Louis F, 2010, J NEUROCHEM, V113, P1188, DOI 10.1111/j.1471-4159.2010.06683.x; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Jacobsson J, 2001, BRAIN, V124, P1461, DOI 10.1093/brain/124.7.1461; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Keene SD, 2009, PROTEOMICS, V9, P768, DOI 10.1002/pmic.200800385; Lafon-Cazal M, 2003, J BIOL CHEM, V278, P24438, DOI 10.1074/jbc.M211980200; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Liu HN, 2012, J NEUROSCI, V32, P8791, DOI 10.1523/JNEUROSCI.5053-11.2012; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Massignan T, 2010, MOL CELL PROTEOMICS, V9, P611, DOI 10.1074/mcp.M900271-MCP200; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Migheli A, 1999, NEUROSCI LETT, V261, P25, DOI 10.1016/S0304-3940(98)01001-5; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Papadeas ST, 2011, P NATL ACAD SCI USA, V108, P17803, DOI 10.1073/pnas.1103141108; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Peviani M, 2012, J NEUROSCI METH, V205, P139, DOI 10.1016/j.jneumeth.2011.12.024; Piccirillo R, 2012, EMBO J, V31, P3334, DOI 10.1038/emboj.2012.178; Potokar M, 2007, TRAFFIC, V8, P12, DOI 10.1111/j.1600-0854.2006.00509.x; Ravits JM, 2009, NEUROLOGY, V73, P805, DOI 10.1212/WNL.0b013e3181b6bbbd; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Schneider A, 2013, CELL TISSUE RES, V352, P33, DOI 10.1007/s00441-012-1428-2; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tortarolo M, 2004, J NEUROCHEM, V88, P481, DOI 10.1046/j.1471-4159.2003.02208.x; Turner BJ, 2005, J NEUROSCI, V25, P108, DOI 10.1523/JNEUROSCI.4253-04.2005; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Vargas MR, 2006, J NEUROCHEM, V97, P687, DOI 10.1111/j.1471-4159.2006.03742.x; Verderio C, 2012, ANN NEUROL, V72, P610, DOI 10.1002/ana.23627; Wang GH, 2012, J BIOL CHEM, V287, P21384, DOI 10.1074/jbc.M112.340513; Wang LJ, 2011, HUM MOL GENET, V20, P286, DOI 10.1093/hmg/ddq463; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zetterstrom P, 2011, J NEUROCHEM, V117, P91, DOI 10.1111/j.1471-4159.2011.07177.x; Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919	65	163	166	3	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15699	15711		10.1074/jbc.M112.425066	http://dx.doi.org/10.1074/jbc.M112.425066			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23592792	Green Published, hybrid			2022-12-28	WOS:000319822300026
J	Wang, RX; Wang, JD; Paul, AM; Acharya, D; Bai, FW; Huang, FQ; Guo, YL				Wang, Ruoxing; Wang, Jundi; Paul, Amber M.; Acharya, Dhiraj; Bai, Fengwei; Huang, Faqing; Guo, Yan-Lin			Mouse Embryonic Stem Cells Are Deficient in Type I Interferon Expression in Response to Viral Infections and Double-stranded RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-3; PROTEIN-KINASE PKR; RIG-I; ENDOTHELIAL-CELLS; VIRUS-INFECTION; INNATE IMMUNITY; SELF-RENEWAL; MAP KINASE; ACTIVATION; MECHANISMS	Embryonic stem cells (ESCs) are considered to be a promising cell source for regenerative medicine because of their unlimited capacity for self-renewal and differentiation. However, little is known about the innate immunity in ESCs and ESC-derived cells. We investigated the responses of mouse (m) ESCs to three types of live viruses as follows: La Crosse virus, West Nile virus, and Sendai virus. Our results demonstrated mESCs were susceptible to viral infection, but they were unable to express type I interferons (IFN alpha and IFN beta, IFN alpha/beta), which differ from fibroblasts (10T1/2 cells) that robustly express IFN alpha/beta upon viral infections. The failure of mESCs to express IFN alpha/beta was further demonstrated by treatment with polyIC, a synthetic viral dsRNA analog that strongly induced IFN alpha/beta in 10T1/2 cells. Although polyIC transiently inhibited the transcription of pluripotency markers, the stem cell morphology was not significantly affected. However, polyIC can induce dsRNA-activated protein kinase in mESCs, and this activation resulted in a strong inhibition of cell proliferation. We conclude that the cytosolic receptor dsRNA-activated protein kinase is functional, but the mechanisms that mediate type I IFN expression are deficient in mESCs. This conclusion is further supported by the findings that the major viral RNA receptors are either expressed at very low levels (TLR3 and MDA5) or may not be active (retinoic acid-inducible gene I) in mESCs.	[Wang, Ruoxing; Wang, Jundi; Paul, Amber M.; Acharya, Dhiraj; Bai, Fengwei; Guo, Yan-Lin] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA; [Huang, Faqing] Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA	University of Southern Mississippi; University of Southern Mississippi	Guo, YL (corresponding author), Univ So Mississippi, Dept Biol Sci, 118 Coll Dr 5018, Hattiesburg, MS 39406 USA.	yanlin.guo@usm.edu		Paul, Amber/0000-0002-1657-3618	National Institutes of Health from NIGMS (Mississippi IDeA Network of Biomedical Research Excellence) [P20 GM103476]; Aubrey Lucas Endowment for Faculty Excellence Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS (Mississippi IDeA Network of Biomedical Research Excellence); Aubrey Lucas Endowment for Faculty Excellence Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P20 GM103476 from NIGMS (Mississippi IDeA Network of Biomedical Research Excellence). This work was also supported in part by an Aubrey Lucas Endowment for Faculty Excellence Award (to Y.-L. G.).	Amarante MK, 2010, INT REV IMMUNOL, V29, P557, DOI 10.3109/08830185.2010.525723; Bai FW, 2005, J INFECT DIS, V191, P1148, DOI 10.1086/428507; Balconi G, 2000, ARTERIOSCL THROM VAS, V20, P1443, DOI 10.1161/01.ATV.20.6.1443; Burdon T, 1999, CELLS TISSUES ORGANS, V165, P131, DOI 10.1159/000016693; Castelli JC, 1997, J EXP MED, V186, P967, DOI 10.1084/jem.186.6.967; Chakraborty S, 2009, DIFFERENTIATION, V78, P143, DOI 10.1016/j.diff.2009.05.006; Chen LL, 2010, CELL CYCLE, V9, P3552, DOI 10.4161/cc.9.17.12792; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Elbahesh H, 2011, VIROLOGY, V421, P51, DOI 10.1016/j.virol.2011.08.008; Foldes G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010501; Fortier ME, 2004, AM J PHYSIOL-REG I, V287, pR759, DOI 10.1152/ajpregu.00293.2004; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Glaser DE, 2011, J VASC RES, V48, P415, DOI 10.1159/000324752; Guo YL, 2007, DEV DYNAM, V236, P3383, DOI 10.1002/dvdy.21374; Guo YL, 2006, STEM CELLS DEV, V15, P655, DOI 10.1089/scd.2006.15.655; Guo YL, 2010, STEM CELLS DEV, V19, P1321, DOI 10.1089/scd.2009.0313; Haas AR, 2000, METH MOL B, V137, P383; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Prabhakar U, 2002, J IMMUNOL METHODS, V260, P207, DOI 10.1016/S0022-1759(01)00543-9; Rajan S, 2008, J CELL BIOCHEM, V105, P477, DOI 10.1002/jcb.21845; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Soldan SS, 2010, VIROLOGY, V404, P139, DOI 10.1016/j.virol.2010.04.012; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Streitenfeld H, 2003, J VIROL, V77, P5507, DOI 10.1128/JVI.77.9.5507-5511.2003; Takeuchi K, 2008, J VIROL, V82, P10102, DOI 10.1128/JVI.00599-08; Toumadje A, 2003, IN VITRO CELL DEV-AN, V39, P449; Verbruggen P, 2011, J BIOL CHEM, V286, P3681, DOI 10.1074/jbc.M110.154799; Vercammen E, 2008, CLIN MICROBIOL REV, V21, P13, DOI 10.1128/CMR.00022-07; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424; Wang RX, 2012, EXP CELL RES, V318, P2094, DOI 10.1016/j.yexcr.2012.05.017; Wash R, 2012, J GEN VIROL, V93, P2118, DOI 10.1099/vir.0.043406-0; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Ye JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020681; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200; Yu J, 2009, INFECT IMMUN, V77, P585, DOI 10.1128/IAI.01003-08; Yu L, 2010, J CELL MOL MED, V14, P2592, DOI 10.1111/j.1582-4934.2010.01127.x; Zampetaki A, 2006, BIOCHEM BIOPH RES CO, V347, P89, DOI 10.1016/j.bbrc.2006.06.055; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4	54	42	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15926	15936		10.1074/jbc.M112.421438	http://dx.doi.org/10.1074/jbc.M112.421438			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23580653	Green Published, hybrid			2022-12-28	WOS:000319822300045
J	Ihara, M; Hamamoto, S; Miyanoiri, Y; Takeda, M; Kainosho, M; Yabe, I; Uozumi, N; Yamashita, A				Ihara, Makoto; Hamamoto, Shin; Miyanoiri, Yohei; Takeda, Mitsuhiro; Kainosho, Masatsune; Yabe, Isamu; Uozumi, Nobuyuki; Yamashita, Atsuko			Molecular Bases of Multimodal Regulation of a Fungal Transient Receptor Potential (TRP) Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-EVOKED ACTIVATION; ION-CHANNEL; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; VACUOLAR MEMBRANE; CATION CHANNEL; COILED COILS; PATCH-CLAMP; YEAST; DOMAIN	Multimodal activation by various stimuli is a fundamental characteristic of TRP channels. We identified a fungal TRP channel, TRPGz, exhibiting activation by hyperosmolarity, temperature increase, cytosolic Ca2+ elevation, membrane potential, and H2O2 application, and thus it is expected to represent a prototypic multimodal TRP channel. TRPGz possesses a cytosolic C-terminal domain (CTD), primarily composed of intrinsically disordered regions with some regulatory modules, a putative coiled-coil region and a basic residue cluster. The CTD oligomerization mediated by the coiled-coil region is required for the hyperosmotic and temperature increase activations but not for the tetrameric channel formation or other activation modalities. In contrast, the basic cluster is responsible for general channel inhibition, by binding to phosphatidylinositol phosphates. The crystal structure of the presumed coiled-coil region revealed a tetrameric assembly in an offset spiral rather than a canonical coiled-coil. This structure underlies the observed moderate oligomerization affinity enabling the dynamic assembly and disassembly of the CTD during channel functions, which are compatible with the multimodal regulation mediated by each functional module.	[Ihara, Makoto; Yamashita, Atsuko] RIKEN SPring 8 Ctr, Struct Physiol Res Grp, Mol Signaling Res Team, Sayo, Hyogo 6795148, Japan; [Ihara, Makoto; Yamashita, Atsuko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Hamamoto, Shin; Uozumi, Nobuyuki] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan; [Miyanoiri, Yohei; Takeda, Mitsuhiro; Kainosho, Masatsune] Nagoya Univ, Grad Sch Sci, Struct Biol Res Ctr, Nagoya, Aichi 4648602, Japan; [Kainosho, Masatsune] Tokyo Metropolitan Univ, Ctr Prior Areas, Hachioji, Tokyo 1920397, Japan; [Yabe, Isamu] Tokyo Denki Univ, Dept Green & Sustainable Chem, Tokyo 1208551, Japan	RIKEN; Okayama University; Tohoku University; Nagoya University; Tokyo Metropolitan University; Tokyo Denki University	Yamashita, A (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	a_yama@pharm.okayama-u.ac.jp	Yamashita, Atsuko/H-5566-2017; Uozumi, Nobuyuki/AAG-3252-2019; Ihara, Makoto/Q-7204-2016	Yamashita, Atsuko/0000-0002-8001-4642; Miyanoiri, Yohei/0000-0001-6889-5160; Uozumi, Nobuyuki/0000-0003-4268-1126; Ihara, Makoto/0000-0002-6403-0781	Funding Program for Next Generation World-Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP); Targeted Proteins Research Program (TPRP) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; MEXT	Funding Program for Next Generation World-Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); Targeted Proteins Research Program (TPRP) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Funding Program for Next Generation World-Leading Researchers (NEXT Program) from the Japan Society for the Promotion of Science (JSPS), the Council for Science and Technology Policy (CSTP) (to A. Y.), and the Targeted Proteins Research Program (TPRP) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (to A. Y. and M. K.) and Grants-in-aid for Scientific Research from MEXT (to S. H. and N. U.).	Akada R, 2002, YEAST, V19, P17, DOI 10.1002/yea.797; Arbuzova A, 2000, BIOCHEMISTRY-US, V39, P10330, DOI 10.1021/bi001039j; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Batiza AF, 1996, J BIOL CHEM, V271, P23357, DOI 10.1074/jbc.271.38.23357; BERTL A, 1990, P NATL ACAD SCI USA, V87, P7824, DOI 10.1073/pnas.87.20.7824; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chang YM, 2010, FEBS LETT, V584, P2028, DOI 10.1016/j.febslet.2009.12.035; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Cvetkov TL, 2011, J BIOL CHEM, V286, P38168, DOI 10.1074/jbc.M111.288993; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; Desjardins AE, 2003, ANNU REV PHYTOPATHOL, V41, P177, DOI 10.1146/annurev.phyto.41.011703.115501; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Drummond A. J., 2011, GENEIOUS VERSION 5 3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujiwara Y, 2008, J MOL BIOL, V383, P854, DOI 10.1016/j.jmb.2008.08.059; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Guler AD, 2002, J NEUROSCI, V22, P6408; Hamamoto S, 2008, J BIOL CHEM, V283, P1911, DOI 10.1074/jbc.M708213200; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HARDIE RC, 1993, TRENDS NEUROSCI, V16, P371, DOI 10.1016/0166-2236(93)90095-4; Ihara M, 2011, ANAL BIOCHEM, V412, P217, DOI 10.1016/j.ab.2011.01.038; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2003, BIOPHYS J, V85, P2988, DOI 10.1016/S0006-3495(03)74719-5; Maruyama Y, 2007, J BIOL CHEM, V282, P36961, DOI 10.1074/jbc.M705694200; McCleverty CJ, 2006, PROTEIN SCI, V15, P2201, DOI 10.1110/ps.062357206; MILLHAUSER GL, 1988, P NATL ACAD SCI USA, V85, P1503, DOI 10.1073/pnas.85.5.1503; Mio K, 2007, J MOL BIOL, V367, P373, DOI 10.1016/j.jmb.2006.12.043; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Molland KL, 2012, BBA-PROTEINS PROTEOM, V1824, P413, DOI 10.1016/j.bbapap.2011.12.002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakanishi Y, 2003, J BIOCHEM, V134, P615, DOI 10.1093/jb/mvg184; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmer CP, 2001, P NATL ACAD SCI USA, V98, P7801, DOI 10.1073/pnas.141036198; Popa CV, 2010, FEBS J, V277, P4027, DOI 10.1111/j.1742-4658.2010.07794.x; RENTSCH D, 1995, FEBS LETT, V370, P264, DOI 10.1016/0014-5793(95)00853-2; Saimi Y, 2007, CURR TOP MEMBR, V58, P311, DOI 10.1016/S1063-5823(06)58012-3; Schindl R, 2007, BIOCHEM SOC T, V35, P84, DOI 10.1042/BST0350084; Shigematsu H, 2010, J BIOL CHEM, V285, P11210, DOI 10.1074/jbc.M109.090712; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Su ZW, 2007, P NATL ACAD SCI USA, V104, P19607, DOI 10.1073/pnas.0708584104; Su ZW, 2009, J MEMBRANE BIOL, V227, P141, DOI 10.1007/s00232-009-9153-9; Takahashi N, 2011, NAT CHEM BIOL, V7, P701, DOI [10.1038/NCHEMBIO.640, 10.1038/nchembio.640]; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WADA Y, 1987, J BIOL CHEM, V262, P17260; Walshaw J, 2003, J STRUCT BIOL, V144, P349, DOI 10.1016/j.jsb.2003.10.014; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yabe I, 1999, J BIOL CHEM, V274, P34903, DOI 10.1074/jbc.274.49.34903; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106; Zaccai NR, 2011, NAT CHEM BIOL, V7, P935, DOI [10.1038/nchembio.692, 10.1038/NCHEMBIO.692]; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou XL, 2005, EUR BIOPHYS J BIOPHY, V34, P413, DOI 10.1007/s00249-005-0465-0; Zhou XL, 2003, P NATL ACAD SCI USA, V100, P7105, DOI 10.1073/pnas.1230540100; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	77	12	12	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15303	15317		10.1074/jbc.M112.434795	http://dx.doi.org/10.1074/jbc.M112.434795			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23553631	Green Published, hybrid			2022-12-28	WOS:000319452100056
J	Ramer, MD; Suman, ES; Richter, H; Stanger, K; Spranger, M; Bieberstein, N; Duncker, BP				Ramer, Matthew D.; Suman, Evelyin S.; Richter, Hagen; Stanger, Karen; Spranger, Martina; Bieberstein, Nicole; Duncker, Bernard P.			Dbf4 and Cdc7 Proteins Promote DNA Replication through Interactions with Distinct Mcm2-7 Protein Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-PHASE; SACCHAROMYCES-CEREVISIAE; PHOSPHORYLATION; KINASE; HELICASE; COMPLEX; STRESS; OVEREXPRESSION; MAINTENANCE; RESISTANCE	The essential cell cycle target of the Dbf4/Cdc7 kinase (DDK) is the Mcm2-7 helicase complex. Although Mcm4 has been identified as the critical DDK phosphorylation target for DNA replication, it is not well understood which of the six Mcm2-7 subunits actually mediate(s) docking of this kinase complex. We systematically examined the interaction between each Mcm2-7 subunit with Dbf4 and Cdc7 through two-hybrid and co-immunoprecipitation analyses. Strikingly different binding patterns were observed, as Dbf4 interacted most strongly with Mcm2, whereas Cdc7 displayed association with both Mcm4 and Mcm5. We identified an N-terminal Mcm2 region required for interaction with Dbf4. Cells expressing either an Mcm2 mutant lacking this docking domain (Mcm2 Delta DDD) or an Mcm4 mutant lacking a previously identified DDK docking domain (Mcm4 Delta DDD) displayed modest DNA replication and growth defects. In contrast, combining these two mutations resulted in synthetic lethality, suggesting that Mcm2 and Mcm4 play overlapping roles in the association of DDK with MCM rings at replication origins. Consistent with this model, growth inhibition could be induced in Mcm4 Delta DDD cells through Mcm2 overexpression as a means of titrating the Dbf4-MCM ring interaction. This growth inhibition was exacerbated by exposing the cells to either hydroxyurea or methyl methanesulfonate, lending support for a DDK role in stabilizing or restarting replication forks under S phase checkpoint conditions. Finally, constitutive overexpression of each individual MCM subunit was examined, and genotoxic sensitivity was found to be specific to Mcm2 or Mcm4 overexpression, further pointing to the importance of the DDK-MCM ring interaction.	[Ramer, Matthew D.; Suman, Evelyin S.; Richter, Hagen; Stanger, Karen; Spranger, Martina; Bieberstein, Nicole; Duncker, Bernard P.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Duncker, BP (corresponding author), Univ Waterloo, Dept Biol, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.	bduncker@uwaterloo.ca	Bieberstein, Nicole/G-4406-2014	Duncker, Bernard/0000-0002-6055-9522	Natural Sciences and Engineering Research Council of Canada [RGPIN 238392]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant RGPIN 238392.	Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Baker SP, 2010, NAT CELL BIOL, V12, P294, DOI 10.1038/ncb2030; Bonte D, 2008, NEOPLASIA, V10, P920, DOI 10.1593/neo.08216; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Chen S, 2007, GENE DEV, V21, P2897, DOI 10.1101/gad.1596807; Chuang CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001110; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Francis LI, 2009, GENE DEV, V23, P643, DOI 10.1101/gad.1759609; Gonzalez MA, 2005, NAT REV CANCER, V5, P135, DOI 10.1038/nrc1548; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Harkins V, 2009, GENETICS, V183, P1269, DOI 10.1534/genetics.109.110155; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Hoang ML, 2007, MOL CELL BIOL, V27, P7594, DOI 10.1128/MCB.00997-07; Jones DR, 2010, CELL CYCLE, V9, P2018, DOI 10.4161/cc.9.10.11752; Lau KM, 2010, ONCOGENE, V29, P5475, DOI 10.1038/onc.2010.287; Liku ME, 2005, MOL BIOL CELL, V16, P5026, DOI 10.1091/mbc.E05-05-0412; Matthews LA, 2012, J BIOL CHEM, V287, P2378, DOI 10.1074/jbc.M111.233973; Nougarede R, 2000, MOL CELL BIOL, V20, P3795, DOI 10.1128/MCB.20.11.3795-3806.2000; Pasero P, 2000, CURR OPIN GENET DEV, V10, P178, DOI 10.1016/S0959-437X(00)00067-8; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Semple JW, 2006, EMBO J, V25, P5150, DOI 10.1038/sj.emboj.7601391; Semple JW, 2004, BIOTECHNOL ADV, V22, P621, DOI 10.1016/j.biotechadv.2004.06.001; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Shima N, 2007, NAT GENET, V39, P93, DOI 10.1038/ng1936; Stead BE, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-36; Stead BE, 2011, NUCLEIC ACIDS RES, V39, P6998, DOI 10.1093/nar/gkr371; Stead BE, 2009, J MOL BIOL, V391, P301, DOI 10.1016/j.jmb.2009.06.038; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Tsuji T, 2008, MOL CELL, V32, P862, DOI 10.1016/j.molcel.2008.12.005; Varrin AE, 2005, MOL CELL BIOL, V25, P7494, DOI 10.1128/MCB.25.17.7494-7504.2005; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108	38	33	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14926	14935		10.1074/jbc.M112.392910	http://dx.doi.org/10.1074/jbc.M112.392910			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23549044	Green Published, hybrid			2022-12-28	WOS:000319452100023
J	Sagare, AP; Bell, RD; Srivastava, A; Sengillo, JD; Singh, I; Nishida, Y; Chow, N; Zlokovic, BV				Sagare, Abhay P.; Bell, Robert D.; Srivastava, Alaka; Sengillo, Jesse D.; Singh, Itender; Nishida, Yoichiro; Chow, Nienwen; Zlokovic, Berislav V.			A Lipoprotein Receptor Cluster IV Mutant Preferentially Binds Amyloid-beta and Regulates Its Clearance from the Mouse Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURALLY-OCCURRING AUTOANTIBODIES; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; LIGAND-BINDING; LDL RECEPTOR; INTRAVENOUS IMMUNOGLOBULINS; HOMEOSTATIC MECHANISM; BARRIER PERMEABILITY; CYSTEINE-RICH; FACTOR-VIII	Soluble low density lipoprotein receptor-related protein-1 (sLRP1) binds similar to 70% of amyloid beta-peptide (A beta) in human plasma. In Alzheimer disease (AD) and individuals with mild cognitive impairment converting to AD, plasma sLRP1 levels are reduced and sLRP1 is oxidized, which results in diminished A beta peripheral binding and higher levels of free A beta in plasma. Experimental studies have shown that free circulating A beta re-enters the brain and that sLRP1 and/or its recombinant wild type cluster IV (WT-LRPIV) prevent A beta from entering the brain. Treatment of Alzheimer APPsw(+/0) mice with WT-LRPIV has been shown to reduce brain A beta pathology. In addition to A beta, LRPIV binds multiple ligands. To enhance LRPIV binding for A beta relative to other LRP1 ligands, we generated a library of LRPIV-derived fragments and full-length LRPIV variants with glycine replacing aspartic acid residues 3394, 3556, and 3674 in the calcium binding sites. Compared with WT-LRPIV, a lead LRPIV-D3674G mutant had 1.6- and 2.7-fold higher binding affinity for A beta 40 and A beta 42 in vitro, respectively, and a lower binding affinity for other LRP1 ligands (e.g. apolipoprotein E2, E3, and E4 (1.3-1.8-fold), tissue plasminogen activator (2.7-fold), matrix metalloproteinase-9 (4.1-fold), and Factor Xa (3.8-fold)). LRPIV-D3674G cleared mouse endogenous brain A beta 40 and A beta 42 25-27% better than WT-LRPIV. A 3-month subcutaneous treatment of APPsw(+/0) mice with LRPIV-D3674G (40 mu g/kg/day) reduced A beta 40 and A beta 42 levels in the hippocampus, cortex, and cerebrospinal fluid by 60-80% and improved cerebral blood flow responses and hippocampal function at 9 months of age. Thus, LRPIV-D3674G is an efficient new A beta clearance therapy.	[Sagare, Abhay P.; Sengillo, Jesse D.; Zlokovic, Berislav V.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Sagare, Abhay P.; Sengillo, Jesse D.; Zlokovic, Berislav V.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA; [Bell, Robert D.; Singh, Itender; Nishida, Yoichiro] Univ Rochester, Med Ctr, Ctr Neurodegenerat & Vasc Brain Disorders, Rochester, NY 14642 USA; [Srivastava, Alaka] ZZ Alztech, Rochester, NY 14642 USA	University of Southern California; University of Southern California; University of Rochester	Zlokovic, BV (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, 1501 San Pablo St,ZNI 101, Los Angeles, CA 90089 USA.	zlokovic@usc.edu	Sagare, Abhay/Y-3273-2019	Sagare, Abhay/0000-0002-8178-3785	National Institutes of Health [AG023084, NS034467]; ZZ Alztech (Rochester, NY); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034467, R01NS034467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023084, R01AG023084] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ZZ Alztech (Rochester, NY); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG023084 and NS034467. This work was also supported by ZZ Alztech (Rochester, NY). Berislav V. Zlokovic is the scientific founder of Socratech LLC, a startup biotechnology company with a mission to develop new therapeutic approaches for stroke and Alzheimer disease. Berislav V. Zlokovic is co-inventor on patents pertaining to use of sLRP fragments as a potential therapy for Alzheimer disease.	Andersen OM, 2000, BIOCHEMISTRY-US, V39, P10627, DOI 10.1021/bi000498h; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Atkins AR, 1998, BIOCHEMISTRY-US, V37, P1662, DOI 10.1021/bi972529n; Bach JP, 2012, ADV EXP MED BIOL, V750, P91, DOI 10.1007/978-1-4614-3461-0_7; Balakrishnan K, 2010, J ALZHEIMERS DIS, V20, P135, DOI 10.3233/JAD-2010-1353; Banks WA, 2003, NEUROSCIENCE, V121, P487, DOI 10.1016/S0306-4522(03)00474-3; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Blacklow SC, 1996, NAT STRUCT BIOL, V3, P758, DOI 10.1038/nsb0996-758; Britschgi M, 2009, P NATL ACAD SCI USA, V106, P12145, DOI 10.1073/pnas.0904866106; Croy JE, 2003, BIOCHEMISTRY-US, V42, P13049, DOI 10.1021/bi034752s; Deacon RMJ, 2009, BEHAV BRAIN RES, V200, P128, DOI 10.1016/j.bbr.2009.01.007; Deane R, 2005, J NEUROSCI, V25, P11495, DOI 10.1523/JNEUROSCI.3697-05.2005; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Deane R, 2012, J CLIN INVEST, V122, P1377, DOI 10.1172/JCI58642; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Dodel R, 2002, ANN NEUROL, V52, P253, DOI 10.1002/ana.10253; Dodel R, 2010, DRUGS, V70, P513, DOI 10.2165/11533070-000000000-00000; Donahue JE, 2006, ACTA NEUROPATHOL, V112, P405, DOI 10.1007/s00401-006-0115-3; Du Y, 2001, NEUROLOGY, V57, P801, DOI 10.1212/WNL.57.5.801; Galluzzi S, 2013, J NEUROL, V260, P640, DOI 10.1007/s00415-012-6694-0; Gregory JL, 2012, J NEUROPATH EXP NEUR, V71, P1009, DOI 10.1097/NEN.0b013e3182729845; Herrmann N, 2011, DRUGS, V71, P2031, DOI 10.2165/11595870-000000000-00000; HERZ J, 1991, J BIOL CHEM, V266, P21232; Hirko AC, 2007, MOL THER, V15, P1623, DOI 10.1038/sj.mt.6300253; Horn IR, 1997, J BIOL CHEM, V272, P13608, DOI 10.1074/jbc.272.21.13608; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Ito S, 2006, NEUROSCI RES, V56, P246, DOI 10.1016/j.neures.2006.07.006; Jaeger LB, 2009, J ALZHEIMERS DIS, V17, P553, DOI 10.3233/JAD-2009-1074; Kanekiyo T, 2012, J NEUROSCI, V32, P16458, DOI 10.1523/JNEUROSCI.3987-12.2012; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Klaver AC, 2010, INT IMMUNOPHARMACOL, V10, P115, DOI 10.1016/j.intimp.2009.10.005; Kou JH, 2011, J ALZHEIMERS DIS, V27, P23, DOI 10.3233/JAD-2011-110230; LEYTE A, 1989, BIOCHEM J, V263, P187, DOI 10.1042/bj2630187; Mackic JB, 2002, VASC PHARMACOL, V38, P303, DOI 10.1016/S1537-1891(02)00198-2; Mackic JB, 1998, J NEUROCHEM, V70, P210; Matsuoka Y, 2003, J NEUROSCI, V23, P29; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Meijer AB, 2007, BBA-PROTEINS PROTEOM, V1774, P714, DOI 10.1016/j.bbapap.2007.04.003; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; Obermoeller LM, 1997, J BIOL CHEM, V272, P10761; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; Qosa H, 2012, J ALZHEIMERS DIS, V31, P151, DOI 10.3233/JAD-2012-120319; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Relkin NR, 2009, NEUROBIOL AGING, V30, P1728, DOI 10.1016/j.neurobiolaging.2007.12.021; Sagare A, 2007, NAT MED, V13, P1029, DOI 10.1038/nm1635; Sagare AP, 2012, PHARMACOL THERAPEUT, V136, P94, DOI 10.1016/j.pharmthera.2012.07.008; Sagare AP, 2011, J ALZHEIMERS DIS, V24, P25, DOI 10.3233/JAD-2010-101248; Saido T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006379; Sehgal N, 2012, P NATL ACAD SCI USA, V109, P3510, DOI 10.1073/pnas.1112209109; Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shayan G, 2012, ELECTROPHORESIS, V33, P1975, DOI 10.1002/elps.201100660; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Szabo P, 2010, J NEUROIMMUNOL, V227, P167, DOI 10.1016/j.jneuroim.2010.06.010; Tamaki C, 2006, PHARM RES-DORDR, V23, P1407, DOI 10.1007/s11095-006-0208-7; Ujiie M, 2003, MICROCIRCULATION, V10, P463, DOI 10.1038/sj.mn.7800212; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; Westein E, 2002, J BIOL CHEM, V277, P2511, DOI 10.1074/jbc.M102293200; Wilcock DM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-115; Wu ZH, 2005, NAT MED, V11, P959, DOI 10.1038/nm1287; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Zlokovic BV, 2010, J NEUROCHEM, V115, P1077, DOI 10.1111/j.1471-4159.2010.07002.x; ZLOKOVIC BV, 1987, J NEUROCHEM, V49, P310, DOI 10.1111/j.1471-4159.1987.tb03431.x	71	30	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15154	15166		10.1074/jbc.M112.439570	http://dx.doi.org/10.1074/jbc.M112.439570			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23580652	Green Published, hybrid			2022-12-28	WOS:000319452100045
J	Gray, MJ; Wholey, WY; Parker, BW; Kim, M; Jakob, U				Gray, Michael J.; Wholey, Wei-Yun; Parker, Benjamin W.; Kim, Minwook; Jakob, Ursula			NemR Is a Bleach-sensing Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; GLYOXALASE I; METHYLGLYOXAL; PROTEIN; SYSTEM; KINETICS; SEQUENCE; SENSORS; MODEL; GENE	Hypochlorous acid (HOCl), the active component of household bleach, also functions as a powerful antimicrobial during the innate immune response. Despite its widespread use, surprisingly little is known about how cells sense or respond to HOCl. We now demonstrate that Escherichia coli NemR is a redox-regulated transcriptional repressor, which uses the oxidation status of HOCl-sensitive cysteine residues to respond to bleach and related reactive chlorine species. NemR controls bleach-mediated expression of two enzymes required for detoxification of reactive electrophiles: glyoxalase I and N-ethylmaleimide reductase. Both enzymes contribute to bacterial bleach survival. These results provide evidence that bleach resistance relies on the capacity of organisms to specifically sense reactive chlorine species and respond with the up-regulation of enzymes dedicated to detoxification of methylglyoxal and other reactive electrophiles.	Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Wholey, Wei-Yun; Jakob, Ursula] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jakob, U (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 830 N Univ Ave, Ann Arbor, MI 48109 USA.	ujakob@umich.edu		Gray, Michael/0000-0002-7112-4188	National Institutes of Health [R01-GM065318, R21-AI097893, T-32-GM007315]; National Research Service Award Fellowship [F32GM096613]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315, R01GM065318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM065318 and R21-AI097893 (to U. J.).; Supported by National Research Service Award Fellowship F32GM096613.; Supported by National Institutes of Health Training Grant T-32-GM007315.	Bae YS, 2010, TRENDS IMMUNOL, V31, P278, DOI 10.1016/j.it.2010.05.003; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Booth IR, 2003, BIOCHEM SOC T, V31, P1406; Chapman ALP, 2003, BIOCHEM J, V375, P33, DOI 10.1042/BJ20030685; Chi BK, 2013, ANTIOXID REDOX SIGN, V18, P1273, DOI 10.1089/ars.2012.4686; Chi BK, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009506; Crack JC, 2012, ANTIOXID REDOX SIGN, V17, P1215, DOI 10.1089/ars.2012.4511; Creasy DM, 2004, PROTEOMICS, V4, P1534, DOI 10.1002/pmic.200300744; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deborde M, 2008, WATER RES, V42, P13, DOI 10.1016/j.watres.2007.07.025; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gebendorfer KM, 2012, J BIOL CHEM, V287, P6892, DOI 10.1074/jbc.M111.287219; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; KELLUM MW, 1978, ANAL BIOCHEM, V85, P586, DOI 10.1016/0003-2697(78)90258-0; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; KOSOWER NS, 1995, METHOD ENZYMOL, V251, P123, DOI 10.1016/0076-6879(95)51116-4; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; MacLean MJ, 1998, MOL MICROBIOL, V27, P563, DOI 10.1046/j.1365-2958.1998.00701.x; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Mueller NJ, 2010, ADV SYNTH CATAL, V352, P387, DOI 10.1002/adsc.200900832; Nagl M, 2000, ANTIMICROB AGENTS CH, V44, P2507, DOI 10.1128/AAC.44.9.2507-2513.2000; Peskin AV, 2001, FREE RADICAL BIO MED, V30, P572, DOI 10.1016/S0891-5849(00)00506-2; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poelarends GJ, 2000, J BACTERIOL, V182, P2191, DOI 10.1128/JB.182.8.2191-2199.2000; Poole L. B., 2008, CURR PROTOC TOXICOL; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Rutala WA, 1997, CLIN MICROBIOL REV, V10, P597, DOI 10.1128/CMR.10.4.597; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spiro S, 2012, ANTIOXID REDOX SIGN, V17, P1264, DOI 10.1089/ars.2012.4533; Subedi KP, 2011, MOL MICROBIOL, V81, P926, DOI 10.1111/j.1365-2958.2011.07736.x; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Umezawa Y, 2008, J BACTERIOL, V190, P5890, DOI 10.1128/JB.00459-08; Vazquez-Torres A, 2012, ANTIOXID REDOX SIGN, V17, P1201, DOI 10.1089/ars.2012.4522; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Winterbourn CC, 2013, ANTIOXID REDOX SIGN, V18, P642, DOI 10.1089/ars.2012.4827	40	67	67	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13789	13798		10.1074/jbc.M113.454421	http://dx.doi.org/10.1074/jbc.M113.454421			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23536188	hybrid, Green Published			2022-12-28	WOS:000318850300060
J	Qin, WP; Sun, L; Cao, J; Peng, YZ; Collier, L; Wu, Y; Creasey, G; Li, JH; Qin, YW; Jarvis, J; Bauman, WA; Zaidi, M; Cardozo, C				Qin, Weiping; Sun, Li; Cao, Jay; Peng, Yuanzhen; Collier, Lauren; Wu, Yong; Creasey, Graham; Li, Jianhua; Qin, Yiwen; Jarvis, Jonathan; Bauman, William A.; Zaidi, Mone; Cardozo, Christopher			The Central Nervous System (CNS)-independent Anti-bone-resorptive Activity of Muscle Contraction and the Underlying Molecular and Cellular Signatures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL-CORD-INJURY; GENE-EXPRESSION; C-FOS; CELLS; DIFFERENTIATION; IMMOBILIZATION; DISEASE; OSTEOCLASTOGENESIS; STIMULATION; NANDROLONE	Muscle and bone work as a functional unit. Cellular and molecular mechanisms underlying effects of muscle activity on bone mass are largely unknown. Spinal cord injury (SCI) causes muscle paralysis and extensive sublesional bone loss and disrupts neural connections between the central nervous system (CNS) and bone. Muscle contraction elicited by electrical stimulation (ES) of nerves partially protects against SCI-related bone loss. Thus, application of ES after SCI provides an opportunity to study the effects of muscle activity on bone and roles of the CNS in this interaction, as well as the underlying mechanisms. Using a rat model of SCI, the effects on bone of ES-induced muscle contraction were characterized. The SCI-mediated increase in serum C-terminal telopeptide of type I collagen (CTX) was completely reversed by ES. In ex vivo bone marrow cell cultures, SCI increased the number of osteoclasts and their expression of mRNA for several osteoclast differentiation markers, whereas ES significantly reduced these changes; SCI decreased osteoblast numbers, but increased expression in these cells of receptor activator of NF-kappa B ligand (RANKL) mRNA, whereas ES increased expression of osteoprotegerin (OPG) and the OPG/RANKL ratio. A microarray analysis revealed that ES partially reversed SCI-induced alterations in expression of genes involved in signaling through Wnt, FSH, parathyroid hormone (PTH), oxytocin, and calcineurin/nuclear factor of activated T-cells (NFAT) pathways. ES mitigated SCI-mediated increases in mRNA levels for the Wnt inhibitors DKK1, sFRP2, and sclerostin in ex vivo cultured osteoblasts. Our results demonstrate an anti-bone-resorptive activity of muscle contraction by ES that develops rapidly and is independent of the CNS. The pathways involved, particularly Wnt signaling, suggest future strategies to minimize bone loss after immobilization.	[Qin, Weiping; Sun, Li; Peng, Yuanzhen; Li, Jianhua; Bauman, William A.; Zaidi, Mone; Cardozo, Christopher] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Bauman, William A.; Cardozo, Christopher] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA; [Sun, Li; Li, Jianhua; Zaidi, Mone] Mt Sinai Sch Med, Mt Sinai Bone Program, New York, NY 10029 USA; [Qin, Weiping; Peng, Yuanzhen; Collier, Lauren; Wu, Yong; Bauman, William A.; Cardozo, Christopher] James J Peters Vet Affairs Med Ctr, Natl Ctr Excellence Med Consequences Spinal Cord, Bronx, NY 10468 USA; [Cao, Jay] Res Serv, USDA, Human Nutr Res Ctr, Grand Forks, ND 58201 USA; [Creasey, Graham] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Creasey, Graham] Stanford Univ, Palo Alto, CA 94304 USA; [Qin, Yiwen] Chapin Sch, New York, NY 10028 USA; [Jarvis, Jonathan] Liverpool John Moores Univ, Sch Sport & Exercise Sci, Liverpool L3 3AF, Merseyside, England	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; United States Department of Agriculture (USDA); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Liverpool John Moores University	Qin, WP (corresponding author), James J Peters Vet Affairs Med Ctr, Ctr Excellence Med Consequences SCI, 130 W Kingsbridge Rd, Bronx, NY 10468 USA.	weiping.qin@mssm.edu; Chris.cardozo@mssm.edu	Cardozo, Christopher/R-6021-2019	Cardozo, Christopher/0000-0003-4013-2537	United States Veterans Health Administration, Rehabilitation Research and Development Service [B4162C, B4055X, B3347K]; United States Department of Defense [SC090504]; National Institutes of Health [AG23176, DK80459]; European Commission [QLG5-CT-2001-02191]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040132, R01AG023176] Funding Source: NIH RePORTER	United States Veterans Health Administration, Rehabilitation Research and Development Service; United States Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the United States Veterans Health Administration, Rehabilitation Research and Development Service Grants B4162C (to W. A. B.) and B4055X and B3347K (to C. C.), the United States Department of Defense Grant SC090504 (to W. Q.), National Institutes of Health Grants AG23176 and DK80459 (to M. Z.), and European Commission Project RISE Grant QLG5-CT-2001-02191 (to J. J.).	Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; Abreu E. L., 2012, ASBMR TOP M JUL 2012, DOI [10.1038/bonekey.2012.239, DOI 10.1038/B0NEKEY.2012.239]; Andersson O, 2006, EMBO REP, V7, P831, DOI 10.1038/sj.embor.7400752; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Basso N, 2005, BONE, V37, P370, DOI 10.1016/j.bone.2005.04.033; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Chantry AD, 2010, J BONE MINER RES, V25, P2357, DOI 10.1002/jbmr.142; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dudley-Javoroski S, 2008, J REHABIL RES DEV, V45, P283, DOI 10.1682/JRRD.2007.02.0031; Fujita M, 2001, CANCER RES, V61, P7722; Gaudio A, 2010, J CLIN ENDOCR METAB, V95, P2248, DOI 10.1210/jc.2010-0067; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hafer-Macko CE, 2005, STROKE, V36, P2021, DOI 10.1161/01.STR.0000177878.33559.fe; Hamrick MW, 2008, OSTEOPOROSIS INT, V19, P905, DOI 10.1007/s00198-007-0487-9; Heiland GR, 2010, ANN RHEUM DIS, V69, P2152, DOI 10.1136/ard.2010.132852; Jahn K, 2012, EUR CELLS MATER, V24, P197; Jiang SD, 2011, JOINT BONE SPINE, V78, P488, DOI 10.1016/j.jbspin.2010.12.005; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Kondo H, 2005, J BIOL CHEM, V280, P30192, DOI 10.1074/jbc.M504179200; Krassioukov AV, 2007, J REHABIL RES DEV, V44, P103, DOI 10.1682/JRRD.2005.10.0159; Kubota T, 2009, J BONE MINER METAB, V27, P265, DOI 10.1007/s00774-009-0064-8; Lang TF, 2006, J BONE MINER RES, V21, P1224, DOI 10.1359/JBMR.060509; LEPOLA V, 1993, CLIN ORTHOP RELAT R, P55; Leupin O, 2007, J BONE MINER RES, V22, P1957, DOI 10.1359/JBMR.070804; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Mo Chenglin, 2012, Recent Pat Biotechnol, V6, P223; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pearman AT, 1996, J BIOL CHEM, V271, P25715, DOI 10.1074/jbc.271.41.25715; Pinzone JJ, 2009, BLOOD, V113, P517, DOI 10.1182/blood-2008-03-145169; Qin WP, 2010, BIOCHEM BIOPH RES CO, V403, P473, DOI 10.1016/j.bbrc.2010.11.061; Qin WP, 2010, ANN NY ACAD SCI, V1211, P66, DOI 10.1111/j.1749-6632.2010.05806.x; Qin WP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-596; Qin Weiping, 2010, Curr Osteoporos Rep, V8, P212, DOI 10.1007/s11914-010-0029-9; Rittweger J, 2000, BONE, V27, P319, DOI 10.1016/S8756-3282(00)00327-6; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Ryan AS, 2011, STROKE, V42, P416, DOI 10.1161/STROKEAHA.110.602441; Sato S, 2007, NAT MED, V13, P1234, DOI 10.1038/nm1640; Schoenau E., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P232; SESSIONS ND, 1989, AM J PHYSIOL, V257, pE606, DOI 10.1152/ajpendo.1989.257.4.E606; Shahnazari M, 2012, CALCIFIED TISSUE INT, V91, P50, DOI 10.1007/s00223-012-9610-9; Sitara D, 2010, IMMUNOL REV, V233, P286, DOI 10.1111/j.0105-2896.2009.00849.x; Sun L, 2006, CELL, V125, P247, DOI 10.1016/j.cell.2006.01.051; Sun L., 2012, J SPINAL CO IN PRESS; Takahashi N, 2011, FRONT BIOSCI-LANDMRK, V16, P21, DOI 10.2741/3673; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tamma R, 2009, P NATL ACAD SCI USA, V106, P7149, DOI 10.1073/pnas.0901890106; Thomaidis V T, 1976, Acta Chir Scand Suppl, V467, P36; Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025; TUUKKANEN J, 1991, BONE, V12, P113, DOI 10.1016/8756-3282(91)90009-8; Wijenayaka AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025900; Wu Y, 2012, J NEUROTRAUM, V29, P1663, DOI 10.1089/neu.2011.2203; Wu Y, 2010, ENDOCRINOLOGY, V151, P1050, DOI 10.1210/en.2009-0530; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yasui T, 2011, J BONE MINER RES, V26, P1447, DOI 10.1002/jbmr.357; Yuan YA, 2011, INT J MOL MED, V27, P63, DOI 10.3892/ijmm.2010.560; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; ZHANG RW, 1995, J BONE MINER RES, V10, P415	62	46	48	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13511	13521		10.1074/jbc.M113.454892	http://dx.doi.org/10.1074/jbc.M113.454892			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23530032	Green Published, hybrid			2022-12-28	WOS:000318850300035
J	Tuz, K; Hsiao, YC; Juarez, O; Shi, BX; Harmon, EY; Phelps, IG; Lennartz, MR; Glass, IA; Doherty, D; Ferland, RJ				Tuz, Karina; Hsiao, Yi-Chun; Juarez, Oscar; Shi, Bingxing; Harmon, Erin Y.; Phelps, Ian G.; Lennartz, Michelle R.; Glass, Ian A.; Doherty, Dan; Ferland, Russell J.			The Joubert Syndrome-associated Missense Mutation (V443D) in the Abelson-helper Integration Site 1 (AHI1) Protein Alters Its Localization and Protein-Protein Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUNTINGTIN-ASSOCIATED PROTEIN-1; RETINAL DEGENERATION; RESPIRATORY-CHAIN; PRIMARY CILIUM; HAP1; GENE; CILIOPATHIES; MITOCHONDRIA; CILIOGENESIS; CEREBELLAR	Mutations in AHI1 cause Joubert syndrome (JBTS), a neuro-developmental ciliopathy, characterized by midbrain-hindbrain malformations and motor/cognitive deficits. Here, we show that primary cilia (PC) formation is decreased in fibroblasts from individuals with JBTS and AHI1 mutations. Most missense mutations in AHI1, causing JBTS, occur in known protein domains, however, a common V443D mutation in AHI1 is found in a region with no known protein motifs. We show that cells transfected with AHI1-V443D, or a new JBTS-causing mutation, AHI1-R351L, have aberrant localization of AHI1 at the basal bodies of PC and at cell-cell junctions, likely through decreased binding of mutant AHI1 to NPHP1 (another JBTS-causing protein). The AHI1-V443D mutation causes decreased AHI1 stability because there is a 50% reduction in AHI1-V443D protein levels compared with wild type AHI1. Huntingtin-associated protein-1 (Hap1) is a regulatory protein that binds Ahi1, and Hap1 knock-out mice have been reported to have JBTS-like phenotypes, suggesting a role for Hap1 in ciliogenesis. Fibroblasts and neurons with Hap1 deficiency form PC with normal growth factor-induced ciliary signaling, indicating that the Hap1 JBTS phenotype is likely not through effects at PC. These results also suggest that the binding of Ahi1 and Hap1 may not be critical for ciliary function. However, we show that HAP1 has decreased binding to AHI1-V443D indicating that this altered binding could be responsible for the JBTS-like phenotype through an unknown pathway. Thus, these JBTS-associated missense mutations alter their subcellular distribution and protein interactions, compromising functions of AHI1 in cell polarity and cilium-mediated signaling, thereby contributing to JBTS.	[Tuz, Karina; Hsiao, Yi-Chun; Ferland, Russell J.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Harmon, Erin Y.; Lennartz, Michelle R.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Ferland, Russell J.] Albany Med Coll, Dept Neurol, Albany, NY 12208 USA; [Hsiao, Yi-Chun; Juarez, Oscar; Shi, Bingxing; Ferland, Russell J.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Phelps, Ian G.; Glass, Ian A.; Doherty, Dan] Univ Washington, Dept Pediat, Div Med Genet, Seattle, WA 98195 USA; [Phelps, Ian G.; Glass, Ian A.; Doherty, Dan] Univ Washington, Dept Pediat, Div Dev Med, Seattle, WA 98195 USA; [Doherty, Dan] Seattle Childrens Hosp Res Inst, Ctr Integrat Brain Res, Seattle, WA 98105 USA	Albany Medical College; Albany Medical College; Albany Medical College; Rensselaer Polytechnic Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Ferland, RJ (corresponding author), Albany Med Coll, Ctr Neuropharmacol & Neurosci, 47 New Scotland Ave,MC 136, Albany, NY 12208 USA.	ferlanr@mail.amc.edu	Ferland, Russell/Q-6793-2019	Ferland, Russell/0000-0002-8044-2479; Juarez, Oscar/0000-0002-2915-8413; Tuz, Karina/0000-0002-1669-4612	National Institutes of Health [R01GM50821, R01NS064077, K01MH71801, R01NS064283]; March of Dimes Foundation [5-FY09-29]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH071801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064077, R01NS064283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM50821 (to M. R. L.), R01NS064077 (to D. D.), K01MH71801 and R01NS064283 (to R. J. F.) and March of Dimes Foundation Grant 5-FY09-29 (to R. J. F.).	Alvarez Retuerto AI, 2008, HUM MOL GENET, V17, P3887, DOI 10.1093/hmg/ddn291; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chan EYW, 2002, HUM MOL GENET, V11, P945, DOI 10.1093/hmg/11.8.945; Delous M, 2009, HUM MOL GENET, V18, P4711, DOI 10.1093/hmg/ddp434; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Doering JE, 2008, J COMP NEUROL, V511, P238, DOI 10.1002/cne.21824; Donaldson JC, 2002, J BIOL CHEM, V277, P29028, DOI 10.1074/jbc.M111697200; Eley L, 2008, KIDNEY INT, V74, P1139, DOI 10.1038/ki.2008.377; Eubel H, 2003, PLANT PHYSIOL, V133, P274, DOI 10.1104/pp.103.024620; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gutekunst CA, 1998, J NEUROSCI, V18, P7674, DOI 10.1523/jneurosci.18-19-07674.1998; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hsiao YC, 2009, HUM MOL GENET, V18, P3926, DOI 10.1093/hmg/ddp335; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Jiang XY, 2002, J VIROL, V76, P9046, DOI 10.1128/JVI.76.18.9046-9059.2002; Keryer G, 2011, J CLIN INVEST, V121, P4372, DOI 10.1172/JCI57552; Kroes HY, 2008, EUR J MED GENET, V51, P24, DOI 10.1016/j.ejmg.2007.10.001; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Li H, 2003, HUM MOL GENET, V12, P2021, DOI 10.1093/hmg/ddg218; Li SH, 2003, J NEUROSCI, V23, P6956; Li SH, 1998, J BIOL CHEM, V273, P19220, DOI 10.1074/jbc.273.30.19220; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Louie CM, 2010, NAT GENET, V42, P175, DOI 10.1038/ng.519; Metzger S, 2008, HUM MOL GENET, V17, P1137, DOI 10.1093/hmg/ddn003; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Parisi MA, 2009, AM J MED GENET C, V151C, P326, DOI 10.1002/ajmg.c.30229; Rong J, 2007, J NEUROSCI RES, V85, P3025, DOI 10.1002/jnr.21326; Schagger H, 2001, J BIOL CHEM, V276, P37861; Sheng G, 2008, J CLIN INVEST, V118, P2785, DOI 10.1172/JCI35339; Sheng GQ, 2006, NAT MED, V12, P526, DOI 10.1038/nm1382; Tory K, 2007, J AM SOC NEPHROL, V18, P1566, DOI 10.1681/ASN.2006101164; Westfall JE, 2010, J NEUROSCI, V30, P8759, DOI 10.1523/JNEUROSCI.5229-09.2010; Wolf MTF, 2011, PEDIATR NEPHROL, V26, P181, DOI 10.1007/s00467-010-1585-z; Wu LLY, 2009, CELL ADHES MIGR, V3, P71, DOI 10.4161/cam.3.1.7511; Wu Q, 2011, EUR J PHARMACOL, V660, P21, DOI 10.1016/j.ejphar.2010.10.110; Xu XS, 2010, P NATL ACAD SCI USA, V107, P19126, DOI 10.1073/pnas.1013032107	41	27	30	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13676	13694		10.1074/jbc.M112.420786	http://dx.doi.org/10.1074/jbc.M112.420786			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23532844	hybrid, Green Published			2022-12-28	WOS:000318850300051
J	Kabuta, T; Mitsui, T; Takahashi, M; Fujiwara, Y; Kabuta, C; Konya, C; Tsuchiya, Y; Hatanaka, Y; Uchida, K; Hohjoh, H; Wada, K				Kabuta, Tomohiro; Mitsui, Takeshi; Takahashi, Masaki; Fujiwara, Yuuki; Kabuta, Chihana; Konya, Chiho; Tsuchiya, Yukihiro; Hatanaka, Yusuke; Uchida, Kenko; Hohjoh, Hirohiko; Wada, Keiji			Ubiquitin C-terminal Hydrolase L1 (UCH-L1) Acts as a Novel Potentiator of Cyclin-dependent Kinases to Enhance Cell Proliferation Independently of Its Hydrolase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-PRODUCT 9.5; INSULIN-RECEPTOR SUBSTRATE-3; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; MUTANT UCH-L1; UCHL1 GENE; EXPRESSION; PGP9.5; CANCER; NEURON	Dysregulation of cell proliferation and the cell cycle are associated with various diseases, such as cancer. Cyclin-dependent kinases (CDKs) play central roles in cell proliferation and the cell cycle. Ubiquitin C-terminal hydrolase L1 (UCH-L1) is expressed in a restricted range of tissues, including the brain and numerous types of cancer. However, the molecular functions of UCH-L1 remain elusive. In this study, we found that UCH-L1 physically interacts with CDK1, CDK4, and CDK5, enhancing their kinase activity. Using several mutants of UCH-L1, we showed that this enhancement is dependent upon interaction levels between UCH-L1 and CDKs but is independent of the known ubiquitin-related functions of UCH-L1. Gain-and loss-of-function studies revealed that UCH-L1 enhances proliferation of multiple cell types, including human cancer cells. Inhibition of the interaction between UCH-L1 and cell cycle-associated CDK resulted in the abolishment of UCH-L1-induced enhancement of cell proliferation. RNA interference of UCH-L1 reduced the growth of human xenograft tumors in mice. We concluded that UCH-L1 is a novel regulator of the kinase activities of CDKs. We believe that our findings from this study will significantly contribute to our understanding of cell cycle-associated diseases.	[Kabuta, Tomohiro; Mitsui, Takeshi; Fujiwara, Yuuki; Kabuta, Chihana; Konya, Chiho; Tsuchiya, Yukihiro; Hatanaka, Yusuke; Wada, Keiji] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, Kodaira, Tokyo 1878502, Japan; [Takahashi, Masaki; Hohjoh, Hirohiko] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Pharmacol, Kodaira, Tokyo 1878502, Japan; [Mitsui, Takeshi; Fujiwara, Yuuki; Uchida, Kenko] Waseda Univ, Dept Elect Engn & Biosci, Shinjuku Ku, Tokyo 1698555, Japan	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; Waseda University	Kabuta, T (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Degenerat Neurol Dis, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.	kabuta@ncnp.go.jp	Wada, Keiji/AAV-1500-2021; Kabuta, Tomohiro/B-2948-2015	Kabuta, Tomohiro/0000-0002-3058-2596; Takahashi, Masaki/0000-0003-1190-2213; Fujiwara, Yuuki/0000-0003-1032-7755	Ministry of Health, Labour, and Welfare of Japan; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology, Japan; National Institute of Biomedical Innovation (NIBIO), Japan; Ministry of Health, Labour, and Welfare, Japan	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO), Japan(National Institute of Biomedical Innovation); Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants-in-aid for scientific research on nervous and mental disorders from the Ministry of Health, Labour, and Welfare of Japan (to T. K.); by grants-in-aid for young scientists (to T. K.) and grants-in-aid for scientific research (to K. W.) of the Japan Society for the Promotion of Science; by a Research grant in priority area research of the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to K. W.); by grants-in-aid for scientific research of the Ministry of Health, Labour, and Welfare, Japan (to K. W.) and the by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), Japan (to K. W.).	ALKATIB AM, 1995, CELL GROWTH DIFFER, V6, P211; Arendt T, 1996, NEUROREPORT, V7, P3047; Bilguvar K, 2013, P NATL ACAD SCI USA, V110, P3489, DOI 10.1073/pnas.1222732110; Busser J, 1998, J NEUROSCI, V18, P2801; Caballero OL, 2002, ONCOGENE, V21, P3003, DOI 10.1038/sj.onc.1205390; Fujiwara Y, 2013, AUTOPHAGY, V9, P403, DOI 10.4161/auto.23002; GIAMBANCO I, 1991, FEBS LETT, V290, P131, DOI 10.1016/0014-5793(91)81242-Z; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hibi K, 1999, AM J PATHOL, V155, P711, DOI 10.1016/S0002-9440(10)65169-3; Higashi S, 2010, NEUROCHEM INT, V57, P906, DOI 10.1016/j.neuint.2010.09.010; Higashi S, 2010, J NEUROCHEM, V115, P423, DOI 10.1111/j.1471-4159.2010.06930.x; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Hoozemans JJM, 2002, J NEUROPATH EXP NEUR, V61, P678, DOI 10.1093/jnen/61.8.678; Howell VM, 2009, J CLIN ENDOCR METAB, V94, P434, DOI 10.1210/jc.2008-1740; Hussain S, 2010, LEUKEMIA, V24, P1641, DOI 10.1038/leu.2010.138; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Kabuta T, 2002, J BIOL CHEM, V277, P6846, DOI 10.1074/jbc.M107058200; Kabuta T, 2008, J BIOL CHEM, V283, P23731, DOI 10.1074/jbc.M801918200; Kabuta T, 2008, HUM MOL GENET, V17, P1482, DOI 10.1093/hmg/ddn037; Kabuta T, 2006, J BIOL CHEM, V281, P30524, DOI 10.1074/jbc.M603337200; Kabuta T, 2010, BIOCHEM BIOPH RES CO, V394, P697, DOI 10.1016/j.bbrc.2010.03.054; Kabuta T, 2009, BIOCHEM BIOPH RES CO, V387, P121, DOI 10.1016/j.bbrc.2009.06.138; Kabuta T, 2008, BIOCHEM BIOPH RES CO, V377, P741, DOI 10.1016/j.bbrc.2008.09.106; Kabuta T, 2008, AUTOPHAGY, V4, P827, DOI 10.4161/auto.6560; Kagara I, 2008, J UROLOGY, V180, P343, DOI 10.1016/j.juro.2008.02.044; Kaminosono S, 2008, J NEUROSCI, V28, P8747, DOI 10.1523/JNEUROSCI.0973-08.2008; Kawauchi T, 2006, NAT CELL BIOL, V8, P17, DOI 10.1038/ncb1338; Kim HJ, 2009, ONCOGENE, V28, P117, DOI 10.1038/onc.2008.364; Kwon J, 2004, BIOL REPROD, V71, P515, DOI 10.1095/biolreprod.104.027565; Kwon J, 2003, EXP ANIM TOKYO, V52, P1, DOI 10.1538/expanim.52.1; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Mann DA, 1996, J NEUROCHEM, V66, P35; McShea A, 1997, AM J PATHOL, V150, P1933; Miyoshi Y, 2006, CANCER SCI, V97, P523, DOI 10.1111/j.1349-7006.2006.00202.x; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nagy Z, 1997, ACTA NEUROPATHOL, V93, P294, DOI 10.1007/s004010050617; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Nishikawa K, 2003, BIOCHEM BIOPH RES CO, V304, P176, DOI 10.1016/S0006-291X(03)00555-2; Okochi-Takada E, 2006, INT J CANCER, V119, P1338, DOI 10.1002/ijc.22025; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Otsuki T, 2004, BRIT J HAEMATOL, V127, P292, DOI 10.1111/j.1365-2141.2004.05205.x; Ovaa H, 2004, P NATL ACAD SCI USA, V101, P2253, DOI 10.1073/pnas.0308411100; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Sekiguchi S, 2006, AM J PATHOL, V169, P1722, DOI 10.2353/ajpath.2006.060301; Setsuie R, 2007, NEUROCHEM INT, V50, P119, DOI 10.1016/j.neuint.2006.07.015; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Takase T, 2003, HEPATO-GASTROENTEROL, V50, P1278; Tezel E, 2000, CLIN CANCER RES, V6, P4764; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Yamazaki T, 2002, CLIN CANCER RES, V8, P192; Yang Y, 2003, J NEUROSCI, V23, P2557	57	29	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12615	12626		10.1074/jbc.M112.435701	http://dx.doi.org/10.1074/jbc.M112.435701			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23543736	hybrid, Green Published			2022-12-28	WOS:000318555100020
J	Matos, PM; Marin, M; Ahn, B; Lam, W; Santos, NC; Melikyan, GB				Matos, Pedro M.; Marin, Mariana; Ahn, Byungwook; Lam, Wilbur; Santos, Nuno C.; Melikyan, Gregory B.			Anionic Lipids Are Required for Vesicular Stomatitis Virus G Protein-mediated Single Particle Fusion with Supported Lipid Bilayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL MEMBRANE-FUSION; PH-DEPENDENT FUSION; INFLUENZA HEMAGGLUTININ; CONFORMATIONAL-CHANGES; PLANAR MEMBRANES; PORE FORMATION; CELLS; GLYCOPROTEIN; ENDOCYTOSIS; ENTRY	Viral glycoproteins mediate fusion between viral and cellular membranes upon binding to cognate receptors and/or experiencing low pH. Although activation of viral glycoproteins is thought to be necessary and sufficient for fusion, accumulating evidence suggests that additional cellular factors, including lipids, can modulate the fusion process. Understanding the role of lipids in virus entry via endocytosis is impeded by poor accessibility and the highly diverse nature of endosomes. Here we imaged fusion of single retroviral particles pseudotyped with the vesicular stomatitis virus (VSV) G protein with dextran-supported lipid bilayers. Incorporation of diffusible fluorescent labels into the viral membrane and the viral interior enabled detection of the lipid mixing (hemifusion) and content transfer (full fusion) steps of VSV G-mediated fusion at low pH. Although single virus fusion with supported bilayers made of zwitterionic lipids could not be detected, inclusion of anionic lipids, phosphatidylserine, and bis(monoacylglycero) phosphate (BMP), greatly enhanced the efficiency of hemifusion and permitted full fusion. Importantly, lipid mixing always preceded the opening of a fusion pore, demonstrating that VSV G-mediated fusion proceeds through a long-lived hemifusion intermediate. Kinetic analysis of lipid and content transfer showed that the lags between lipid and content mixing defining the lifetime of a hemifusion intermediate were significantly shorter for BMP-containing compared with PS-containing bilayers. The strong fusion-enhancing effect of BMP, a late endosome-resident lipid, is consistent with the model that VSV initiates fusion in early endosomes but releases its core into the cytosol after reaching late endosomal compartments.	[Matos, Pedro M.; Marin, Mariana; Ahn, Byungwook; Lam, Wilbur; Melikyan, Gregory B.] Emory Univ, Sch Med, Dept Pediat, Emory Childrens Ctr, Atlanta, GA 30322 USA; [Matos, Pedro M.; Santos, Nuno C.] Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal; [Melikyan, Gregory B.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA	Emory University; Universidade de Lisboa; Children's Healthcare of Atlanta (CHOA)	Melikyan, GB (corresponding author), Emory Univ, Dept Pediat Infect Dis, 2015 Uppergate Dr, Atlanta, GA 30322 USA.	gmeliki@emory.edu	Matos, Pedro/B-4718-2010; Santos, Nuno/N-7248-2013	Matos, Pedro/0000-0002-8386-6613; Santos, Nuno/0000-0002-0580-0475	National Institutes of Health [R01 AI053668]; Fundacao para a Ciencia e Tecnologia, Ministerio da Educacao e Ciencia (FCT-MEC, Portugal) [PTDC/QUI-BIQ/104787/2008];  [SFRH/BD/42205/2007]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053668] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao para a Ciencia e Tecnologia, Ministerio da Educacao e Ciencia (FCT-MEC, Portugal); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI053668 (to G. B. M.). This work was also supported by Fundacao para a Ciencia e Tecnologia, Ministerio da Educacao e Ciencia (FCT-MEC, Portugal) Project Grant PTDC/QUI-BIQ/104787/2008 (to N. C. S.) and by Fellowship SFRH/BD/42205/2007 (to P. M. M.).	Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Albertini AAV, 2012, VIRUSES-BASEL, V4, P117, DOI 10.3390/v4010117; Backovic M, 2009, CURR OPIN STRUC BIOL, V19, P189, DOI 10.1016/j.sbi.2009.02.012; BLUMENTHAL R, 1987, J BIOL CHEM, V262, P13614; Bowen ME, 2004, BIOPHYS J, V87, P3569, DOI 10.1529/biophysj.104.048637; Brandenburg B, 2007, NAT REV MICROBIOL, V5, P197, DOI 10.1038/nrmicro1615; BRIAN AA, 1984, P NATL ACAD SCI-BIOL, V81, P6159, DOI 10.1073/pnas.81.19.6159; Carneiro FA, 2002, J VIROL, V76, P3756, DOI 10.1128/JVI.76.8.3756-3764.2002; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Coil DA, 2004, J VIROL, V78, P10920, DOI 10.1128/JVI.78.20.10920-10926.2004; Costello DA, 2012, ANAL CHEM, V84, P8480, DOI 10.1021/ac3006473; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; EIDELMAN O, 1984, J BIOL CHEM, V259, P4622; Fix M, 2004, P NATL ACAD SCI USA, V101, P7311, DOI 10.1073/pnas.0401779101; Floyd DL, 2008, P NATL ACAD SCI USA, V105, P15382, DOI 10.1073/pnas.0807771105; Fredericksen BL, 1996, VIROLOGY, V217, P49, DOI 10.1006/viro.1996.0092; GAUDIN Y, 1991, J VIROL, V65, P4853, DOI 10.1128/JVI.65.9.4853-4859.1991; Gaudin Y, 2000, Subcell Biochem, V34, P379; Ge P, 2010, SCIENCE, V327, P689, DOI 10.1126/science.1181766; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Jha NK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001260; Johannsdottir HK, 2009, J VIROL, V83, P440, DOI 10.1128/JVI.01864-08; Karasawa S, 2004, BIOCHEM J, V381, P307, DOI 10.1042/BJ20040321; Karatekin E, 2012, NAT PROTOC, V7, P903, DOI 10.1038/nprot.2012.019; Karatekin E, 2010, P NATL ACAD SCI USA, V107, P3517, DOI 10.1073/pnas.0914723107; Kenworthy Anne K., 2007, V398, P179, DOI 10.1007/978-1-59745-513-8_13; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Koch P, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-84; Kolokoltsov AA, 2007, J VIROL, V81, P7786, DOI 10.1128/JVI.02780-06; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Leidl K, 2008, BBA-MOL CELL BIOL L, V1781, P655, DOI 10.1016/j.bbalip.2008.07.008; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Libersou S, 2010, J CELL BIOL, V191, P199, DOI 10.1083/jcb.201006116; Luyet PP, 2008, TRAFFIC, V9, P2279, DOI 10.1111/j.1600-0854.2008.00820.x; Markosyan RM, 2005, MOL BIOL CELL, V16, P5502, DOI 10.1091/mbc.E05-06-0496; Markosyan RM, 2000, MOL BIOL CELL, V11, P1143, DOI 10.1091/mbc.11.4.1143; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Melikyan GB, 2005, P NATL ACAD SCI USA, V102, P8728, DOI 10.1073/pnas.0501864102; MELIKYAN GB, 1993, J GEN PHYSIOL, V102, P1131, DOI 10.1085/jgp.102.6.1131; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mire CE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000994; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Padilla-Parra S, 2012, P NATL ACAD SCI USA, V109, P17627, DOI 10.1073/pnas.1211714109; Padilla-Parra S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002694; PURI A, 1992, BIOCHEMISTRY-US, V31, P10108, DOI 10.1021/bi00156a034; PURI A, 1988, J BIOL CHEM, V263, P4749; Roche S, 2008, CELL MOL LIFE SCI, V65, P1716, DOI 10.1007/s00018-008-7534-3; Roth SL, 2011, FEBS LETT, V585, P865, DOI 10.1016/j.febslet.2011.02.015; SCHLEGEL R, 1983, CELL, V32, P639, DOI 10.1016/0092-8674(83)90483-X; SCHLEGEL R, 1983, BIOCHEM BIOPH RES CO, V114, P774, DOI 10.1016/0006-291X(83)90848-3; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Shokralla S, 1998, VIROLOGY, V242, P39, DOI 10.1006/viro.1997.8986; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Sieczkarski SB, 2002, J GEN VIROL, V83, P1535, DOI 10.1099/0022-1317-83-7-1535; Smith MB, 2011, BIOPHYS J, V101, P1794, DOI 10.1016/j.bpj.2011.09.007; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; SPRUCE AE, 1989, NATURE, V342, P555, DOI 10.1038/342555a0; SPRUCE AE, 1991, P NATL ACAD SCI USA, V88, P3623, DOI 10.1073/pnas.88.9.3623; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; Waheed AA, 2010, VIRUSES-BASEL, V2, P1146, DOI 10.3390/v2051146; Wessels L, 2007, BIOPHYS J, V93, P526, DOI 10.1529/biophysj.106.097485; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131	70	34	34	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12416	12425		10.1074/jbc.M113.462028	http://dx.doi.org/10.1074/jbc.M113.462028			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23493401	hybrid, Green Published			2022-12-28	WOS:000318555100001
J	Shi, DW; Lv, XD; Zhang, Z; Yang, XF; Zhou, ZC; Zhang, L; Zhao, Y				Shi, Dawei; Lv, Xiangdong; Zhang, Zhao; Yang, Xiaofeng; Zhou, Zhaocai; Zhang, Lei; Zhao, Yun			Smoothened Oligomerization/Higher Order Clustering in Lipid Rafts Is Essential for High Hedgehog Activity Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GCN4 LEUCINE-ZIPPER; REQUIRES PHOSPHORYLATION; SIGNAL-TRANSDUCTION; PROTEIN; FLUORESCENCE; DIMERIZATION	The Hedgehog (Hh) signaling pathway plays evolutionarily conserved roles in controlling embryonic development and tissue homeostasis, and its dysregulation has been implicated in many human diseases including congenital disorder and cancer. The Hh pathway has a unique signal reception system that includes two membrane proteins, the receptor Patched (Ptc) and the transducer Smoothened (Smo). In the Hh signaling cascade, Smo plays a critical role in controlling transduction of Hh gradient signal from the outside into the inside of cells. Although the Smo downstream signal transduction has been intensively studied, the mechanism by which Smo on the plasma membrane is regulated has not been fully understood. As a specific membrane structure of metazoan cells, lipid rafts act as a platform to regulate signal transduction by forming a nanoscale cluster through protein-protein or protein-lipid interactions. However, it remains largely unknown whether lipid rafts are also involved in the regulation of Hh signal transduction. Here, we show that Smo extracellular domain (N terminus) and transmembrane domains form oligomers/higher order clusters in response to Hh signal. Furthermore, we identify that lipid rafts on the plasma membrane are essential for high level activity of Smo during the Hh signal transduction. Finally, our observation suggests that oligomerization/higher order clustering of Smo C-terminal cytoplasmic tail (C-tail) is essential for the transduction of high level Hh signal. Collectively, our data support that in response to Hh gradient signals, Smo transduces high level Hh signal by forming oligomers/higher order clusters in the lipid rafts of cell plasma membrane.	[Shi, Dawei; Lv, Xiangdong; Zhang, Zhao; Yang, Xiaofeng; Zhou, Zhaocai; Zhang, Lei; Zhao, Yun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhang, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	rayzhang@sibcb.ac.cn; yunzhao@sibcb.ac.cn	Zhang, Zhao/S-2072-2016; Lv, Xiangdong/S-9034-2019	Zhang, Zhao/0000-0001-9345-3663; Lv, Xiangdong/0000-0001-5310-5816	National Basic Research Program 973 of China [2010CB912101, 2011CB943902, 2012CB945001]; National Natural Science Foundation of China [31171414, 31171394]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01010405, XDA01010406]; Shanghai Committee of Science and Technology [11JC14140000]	National Basic Research Program 973 of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by National Basic Research Program 973 of China Grants 2010CB912101, 2011CB943902, and 2012CB945001, the National Natural Science Foundation of China Grants 31171414 and 31171394, and the Strategic Priority Research Program of the Chinese Academy of Sciences Grants XDA01010405 and XDA01010406.; Supported by Shanghai Committee of Science and Technology Grant 11JC14140000.	Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; AVISSAR S, 1983, P NATL ACAD SCI-BIOL, V80, P156, DOI 10.1073/pnas.80.1.156; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Camp D, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-28; Carroll CE, 2012, DEVELOPMENT, V139, P612, DOI 10.1242/dev.075614; Carron C, 2003, J CELL SCI, V116, P2541, DOI 10.1242/jcs.00451; Centonze VE, 2003, METHOD ENZYMOL, V360, P542; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Polizio AH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002396; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Shi Q, 2011, DEVELOPMENT, V138, P4219, DOI 10.1242/dev.067959; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Smelkinson MG, 2006, CURR BIOL, V16, P110, DOI 10.1016/j.cub.2005.12.012; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Stulnig TM, 1998, J CELL BIOL, V143, P637, DOI 10.1083/jcb.143.3.637; Stulnig TM, 2001, J BIOL CHEM, V276, P37335, DOI 10.1074/jbc.M106193200; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Vogel Steven S, 2006, Sci STKE, V2006, pre2; Wilson CW, 2010, DEVELOPMENT, V137, P2079, DOI 10.1242/dev.045021; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Yao Y, 2009, CELL RES, V19, P497, DOI 10.1038/cr.2009.27; Zhang WS, 2005, DEV CELL, V8, P267, DOI 10.1016/j.devcel.2005.01.001; Zhang YY, 2011, CELL RES, V21, P1436, DOI 10.1038/cr.2011.136; Zhao Y, 2007, FLY, V1, P333, DOI 10.4161/fly.5570; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225	39	41	42	1	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12605	12614		10.1074/jbc.M112.399477	http://dx.doi.org/10.1074/jbc.M112.399477			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23532857	Green Published, hybrid			2022-12-28	WOS:000318555100019
J	Li, YK; Zhang, P; Wang, CC; Han, CF; Meng, J; Liu, XG; Xu, S; Li, N; Wang, QQ; Shi, XY; Cao, XT				Li, Yingke; Zhang, Peng; Wang, Chengcai; Han, Chaofeng; Meng, Jun; Liu, Xingguang; Xu, Sheng; Li, Nan; Wang, Qingqing; Shi, Xueyin; Cao, Xuetao			Immune Responsive Gene 1 (IRG1) Promotes Endotoxin Tolerance by Increasing A20 Expression in Macrophages through Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGGERED INFLAMMATORY RESPONSES; NEGATIVE REGULATION; RECEPTOR; ACTIVATION; PROTEIN; SEPSIS; DEGRADATION; RECOGNITION; RECRUITMENT; INDUCTION	Sepsis-associated immunosuppression (SAIS) is regarded as one of main causes for the death of septic patients at the late stage because of the decreased innate immunity with a more opportunistic infection. LPS-tolerized macrophages, which are re-challenged by LPS after prior exposure to LPS, are regarded as the common model of hypo-responsiveness for SAIS. However, the molecular mechanisms of endotoxin tolerance and SAIS remain to be fully elucidated. In addition, negative regulation of the Toll-like receptor (TLR)-triggered innate inflammatory response needs further investigation. Here we show that expression of immune responsive gene 1 (IRG1) was highly upregulated in the peripheral blood mononuclear cells of septic patients and in LPS-tolerized mouse macrophages. IRG1 significantly suppressed TLR-triggered production of proinflammatory cytokines TNF-alpha, IL-6, and IFN-beta in LPS-tolerized macrophages, with the elevated expression of reactive oxygen species (ROS) and A20. Moreover, ROS enhanced A20 expression by increasing the H3K4me3 modification of histone on the A20 promoter domain, and supplement of the ROS abrogated the IRG1 knockdown function in breaking endotoxin tolerance by increasing A20 expression. Our results demonstrate that inducible IRG1 promotes endotoxin tolerance by increasing A20 expression through ROS, indicating a new molecular mechanism regulating hypoinflammation of sepsis and endotoxin tolerance.	[Li, Yingke; Zhang, Peng; Han, Chaofeng; Liu, Xingguang; Xu, Sheng; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Li, Yingke; Zhang, Peng; Han, Chaofeng; Liu, Xingguang; Xu, Sheng; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Li, Yingke; Wang, Chengcai; Shi, Xueyin] Second Mil Med Univ, Changzheng Hosp, Dept Anesthesiol, Shanghai 200003, Peoples R China; [Meng, Jun; Wang, Qingqing; Cao, Xuetao] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China; [Cao, Xuetao] Chinese Acad Med Sci, Natl Key Lab Med Mol Biol, Beijing 100021, Peoples R China; [Cao, Xuetao] Chinese Acad Med Sci, Dept Immunol, Beijing 100021, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Zhejiang University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Shi, XY (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Anesthesiol, 415 Fengyang Rd, Shanghai 200003, Peoples R China.	shixueyin1128@yahoo.com.cn; caoxt@immunol.org		xu, sheng/0000-0002-9547-8052	National Key Basic Research Program of China [2013CB530503, 2012CB910202]; National Natural Science Foundation of China [81230074, 81123006, 31070789]; Key Project of the "Twelfth Five- year Plan" for Medical Science Development of PLA [BWS12J027]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the "Twelfth Five- year Plan" for Medical Science Development of PLA	This work was supported by National Key Basic Research Program of China Grants 2013CB530503 and 2012CB910202, National Natural Science Foundation of China Grants 81230074, 81123006, and 31070789, and the Key Project of the "Twelfth Five- year Plan" for Medical Science Development of PLA (BWS12J027).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Basler T, 2006, J LEUKOCYTE BIOL, V79, P628, DOI 10.1189/jlb.0905520; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; BrougHolub E, 1997, INFECT IMMUN, V65, P1139, DOI 10.1128/IAI.65.4.1139-1146.1997; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chen WL, 2013, CELL, V152, P467, DOI 10.1016/j.cell.2013.01.011; Cheon YP, 2003, ENDOCRINOLOGY, V144, P5623, DOI 10.1210/en.2003-0585; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Dangi A, 2012, J IMMUNOL, V188, P3667, DOI 10.4049/jimmunol.1102460; Degrandi D, 2009, J INTERF CYTOK RES, V29, P55, DOI 10.1089/jir.2008.0013; Fairfax BP, 2011, J IMMUNOL, V186, P3058, DOI 10.4049/jimmunol.1001791; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Foster SL, 2009, CLIN IMMUNOL, V130, P7, DOI 10.1016/j.clim.2008.08.015; FREUDENBERG MA, 1988, INFECT IMMUN, V56, P1352, DOI 10.1128/IAI.56.5.1352-1357.1988; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Hicks Peter, 2008, Crit Care Resusc, V10, P8; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; Ho PC, 2012, NAT IMMUNOL, V13, P379, DOI 10.1038/ni.2238; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; LEE CGL, 1994, J IMMUNOL, V152, P5758; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Liu J, 2012, CELL MOL IMMUNOL, V9, P197, DOI 10.1038/cmi.2012.12; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Pan HJ, 2012, J IMMUNOL, V188, P3658, DOI 10.4049/jimmunol.1102187; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Rodriguez N, 2007, PHYSIOL GENOMICS, V30, P134, DOI 10.1152/physiolgenomics.00011.2007; Shi SP, 2005, J IMMUNOL, V175, P3318, DOI 10.4049/jimmunol.175.5.3318; Spach KM, 2004, PHYSIOL GENOMICS, V18, P141, DOI 10.1152/physiolgenomics.00003.2004; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; Xu S, 2012, NAT IMMUNOL, V13, P551, DOI 10.1038/ni.2283; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	48	99	106	1	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16225	16234		10.1074/jbc.M113.454538	http://dx.doi.org/10.1074/jbc.M113.454538			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23609450	hybrid, Green Published			2022-12-28	WOS:000320378900003
J	Salama-Alber, O; Jobby, MK; Chitayat, S; Smith, SP; White, BA; Shimon, LJW; Lamed, R; Frolow, F; Bayer, EA				Salama-Alber, Orly; Jobby, Maroor K.; Chitayat, Seth; Smith, Steven P.; White, Bryan A.; Shimon, Linda J. W.; Lamed, Raphael; Frolow, Felix; Bayer, Edward A.			Atypical Cohesin-Dockerin Complex Responsible for Cell Surface Attachment of Cellulosomal Components BINDING FIDELITY, PROMISCUITY, AND STRUCTURAL BUTTRESSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY CHARACTERIZATION; CLOSTRIDIUM-THERMOCELLUM; RUMINOCOCCUS-FLAVEFACIENS; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; ANCHORING COHESIN; PROTEIN-STRUCTURE; GENE-CLUSTER; SYSTEM; MODE	The rumen bacterium Ruminococcus flavefaciens produces a highly organized multienzyme cellulosome complex that plays a key role in the degradation of plant cell wall polysaccharides, notably cellulose. The R. flavefaciens cellulosomal system is anchored to the bacterial cell wall through a relatively small ScaE scaffoldin subunit, which bears a single type IIIe cohesin responsible for the attachment of two major dockerin-containing scaffoldin proteins, ScaB and the cellulose-binding protein CttA. Although ScaB recruits the catalytic machinery onto the complex, CttA mediates attachment of the bacterial substrate via its two putative carbohydrate-binding modules. In an effort to understand the structural basis for assembly and cell surface attachment of the cellulosome in R. flavefaciens, we determined the crystal structure of the high affinity complex (Kd = 20.83 nM) between the cohesin module of ScaE (CohE) and its cognate X-dockerin (XDoc) modular dyad from CttA at 1.97-angstrom resolution. The structure reveals an atypical calcium-binding loop containing a 13-residue insert. The results further pinpoint two charged specificity-related residues on the surface of the cohesin module that are responsible for specific versus promiscuous cross-strain binding of the dockerin module. In addition, a combined functional role for the three enigmatic dockerin inserts was established whereby these extraneous segments serve as structural buttresses that reinforce the stalklike conformation of the X-module, thus segregating its tethered complement of cellulosomal components from the cell surface. The novel structure of the RfCohE-XDoc complex sheds light on divergent dockerin structure and function and provides insight into the specificity features of the type IIIe cohesin-dockerin interaction.	[Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Shimon, Linda J. W.] Weizmann Inst Sci, Dept Chem Serv, IL-76100 Rehovot, Israel; [Jobby, Maroor K.; Chitayat, Seth; Smith, Steven P.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Lamed, Raphael; Frolow, Felix] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Frolow, Felix] Tel Aviv Univ, George S Wise Fac Life Sci, Daniella Rich Inst Struct Biol, IL-69978 Tel Aviv, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Queens University - Canada; University of Illinois System; University of Illinois Urbana-Champaign; Tel Aviv University; Tel Aviv University	Frolow, F (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	mbfrolow@post.tau.ac.il; ed.bayer@weizmann.ac.il		Shimon, Linda/0000-0002-7861-9247; Smith, Steven/0000-0003-2710-4400	Israel Science Foundation (ISF) [293/08, 966/09]; Natural Sciences and Engineering Research Council of Canada [RGPIN 398508]; Sidney E. Frank Foundation through the ISF [24/11]; Alternative Energy Research in Israel in support of alternative energy research in Israel administered by the Israel Strategic Alternative Energy Foundation; Israeli Center of Research Excellence (I-CORE Center [152/11]; Israel Science Foundation; the United States-Israel Binational Science Foundation; Weizmann Institute of Science Alternative Energy Research Initiative and the Helmsley Foundation; Israel Ministry of Science	Israel Science Foundation (ISF)(Israel Science Foundation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Sidney E. Frank Foundation through the ISF; Alternative Energy Research in Israel in support of alternative energy research in Israel administered by the Israel Strategic Alternative Energy Foundation; Israeli Center of Research Excellence (I-CORE Center; Israel Science Foundation; the United States-Israel Binational Science Foundation; Weizmann Institute of Science Alternative Energy Research Initiative and the Helmsley Foundation; Israel Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel)	This work was supported in part by Israel Science Foundation (ISF) Grants 293/08 (to F. F.) and 966/09 (to E. A. B.); Natural Sciences and Engineering Research Council of Canada Grant RGPIN 398508 (to S. P. S.); Grant 24/11 from The Sidney E. Frank Foundation through the ISF (to R. L.); an F. Warren Hellman Grant for Alternative Energy Research in Israel in support of alternative energy research in Israel administered by the Israel Strategic Alternative Energy Foundation (to E. A. B.); the establishment of an Israeli Center of Research Excellence (I-CORE Center 152/11; to E. A. B.) managed by the Israel Science Foundation; the United States-Israel Binational Science Foundation, Jerusalem, Israel; the Weizmann Institute of Science Alternative Energy Research Initiative and the Helmsley Foundation; and a grant from the Israel Ministry of Science (to E. A. B. and R. L.).	Adams JJ, 2008, P NATL ACAD SCI USA, V105, P12194, DOI 10.1073/pnas.0803154105; Adams JJ, 2006, P NATL ACAD SCI USA, V103, P305, DOI 10.1073/pnas.0507109103; Adams JJ, 2005, ACTA CRYSTALLOGR F, V61, P46, DOI 10.1107/S1744309104025837; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alber O, 2008, ACTA CRYSTALLOGR F, V64, P77, DOI 10.1107/S1744309107067437; Alber O, 2009, PROTEINS, V77, P699, DOI 10.1002/prot.22483; Barak Y, 2005, J MOL RECOGNIT, V18, P491, DOI 10.1002/jmr.749; BAYER EA, 1983, J BACTERIOL, V156, P818, DOI 10.1128/JB.156.2.818-827.1983; Brulc JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025329; BRYANT MP, 1958, J BACTERIOL, V76, P529, DOI 10.1128/JB.76.5.529-537.1958; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Currie MA, 2012, J BIOL CHEM, V287, P26953, DOI 10.1074/jbc.M112.343897; Ding SY, 2012, SCIENCE, V338, P1055, DOI 10.1126/science.1227491; Ding SY, 2001, J BACTERIOL, V183, P1945, DOI 10.1128/JB.183.6.1945-1953.2001; FLINT HJ, 1989, APPL ENVIRON MICROB, V55, P1230, DOI 10.1128/AEM.55.5.1230-1233.1989; Flint HJ, 1997, TRENDS MICROBIOL, V5, P483, DOI 10.1016/S0966-842X(97)01159-1; Gefen G, 2012, P NATL ACAD SCI USA, V109, P10298, DOI 10.1073/pnas.1202747109; Himmel ME, 2009, CURR OPIN BIOTECH, V20, P316, DOI 10.1016/j.copbio.2009.05.005; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jindou S, 2008, FEMS MICROBIOL LETT, V285, P188, DOI 10.1111/j.1574-6968.2008.01234.x; Jindou S, 2006, J BACTERIOL, V188, P7971, DOI 10.1128/JB.00973-06; Julliand V, 1999, APPL ENVIRON MICROB, V65, P3738; Krause DO, 1999, MICROBIOL-UK, V145, P1797, DOI 10.1099/13500872-145-7-1797; LAMED R, 1983, J BACTERIOL, V156, P828, DOI 10.1128/JB.156.2.828-836.1983; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Morais S, 2012, MBIO, V3, DOI 10.1128/mBio.00508-12; Mosbah A, 2000, J MOL BIOL, V304, P201, DOI 10.1006/jmbi.2000.4192; Nataf Y, 2010, P NATL ACAD SCI USA, V107, P18646, DOI 10.1073/pnas.1012175107; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; Nelson KE, 2003, ENVIRON MICROBIOL, V5, P1212, DOI 10.1046/j.1462-2920.2003.00526.x; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pinheiro BA, 2008, J BIOL CHEM, V283, P18422, DOI 10.1074/jbc.M801533200; Pluvinage B, 2013, J MOL BIOL, V425, P334, DOI 10.1016/j.jmb.2012.11.005; Rincon MT, 2007, J BACTERIOL, V189, P4774, DOI 10.1128/JB.00143-07; Rincon MT, 2005, J BACTERIOL, V187, P7569, DOI 10.1128/JB.187.22.7569-7578.2005; Rincon MT, 2004, J BACTERIOL, V186, P2576, DOI 10.1128/JB.186.9.2576-2585.2004; Rincon MT, 2003, J BACTERIOL, V185, P703, DOI 10.1128/JB.185.3.703-713.2003; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Salama-Alber O, 2012, ACTA CRYSTALLOGR F, V68, P1116, DOI 10.1107/S1744309112033088; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shimon LJW, 1997, STRUCTURE, V5, P381, DOI 10.1016/S0969-2126(97)00195-0; Stahl SW, 2012, P NATL ACAD SCI USA, V109, P20431, DOI 10.1073/pnas.1211929109; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; WEDEKIND KJ, 1988, APPL ENVIRON MICROB, V54, P1530, DOI 10.1128/AEM.54.6.1530-1535.1988; Wojdyla JA, 2012, J MOL BIOL, V417, P79, DOI 10.1016/j.jmb.2012.01.019	49	28	28	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16827	16838		10.1074/jbc.M113.466672	http://dx.doi.org/10.1074/jbc.M113.466672			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23580648	Green Published, hybrid			2022-12-28	WOS:000320378900055
J	Sanz, S; Bandini, G; Ospina, D; Bernabeu, M; Marino, K; Fernandez-Becerra, C; Izquierdo, L				Sanz, Silvia; Bandini, Giulia; Ospina, Diego; Bernabeu, Maria; Marino, Karina; Fernandez-Becerra, Carmen; Izquierdo, Luis			Biosynthesis of GDP-fucose and Other Sugar Nucleotides in the Blood Stages of Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBOSPONDIN TYPE-1 REPEATS; ANCHORED MEMBRANE-PROTEINS; TRYPANOSOMA-BRUCEI; MALARIA PARASITES; INTRAERYTHROCYTIC STAGE; LEISHMANIA-MAJOR; IN-VITRO; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORS; GALACTOSE PYROPHOSPHORYLASE; LIQUID-CHROMATOGRAPHY	Carbohydrate structures play important roles in many biological processes, including cell adhesion, cell-cell communication, and host-pathogen interactions. Sugar nucleotides are activated forms of sugars used by the cell as donors for most glycosylation reactions. Using a liquid chromatography-tandem mass spectrometry-based method, we identified and quantified the pools of UDP-glucose, UDP-galactose, UDP-N-acetylglucosamine, GDP-mannose, and GDP-fucose in Plasmodium falciparum intraerythrocytic life stages. We assembled these data with the in silico functional reconstruction of the parasite metabolic pathways obtained from the P. falciparum annotated genome, exposing new active biosynthetic routes crucial for further glycosylation reactions. Fucose is a sugar present in glycoconjugates often associated with recognition and adhesion events. Thus, the GDP-fucose precursor is essential in a wide variety of organisms. P. falciparum presents homologues of GDP-mannose 4,6-dehydratase and GDP-L-fucose synthase enzymes that are active in vitro, indicating that most GDP-fucose is formed by a de novo pathway that involves the bioconversion of GDP-mannose. Homologues for enzymes involved in a fucose salvage pathway are apparently absent in the P. falciparum genome. This is in agreement with in vivo metabolic labeling experiments showing that fucose is not significantly incorporated by the parasite. Fluorescence microscopy of epitope-tagged versions of P. falciparum GDP-mannose 4,6-dehydratase and GDP-L-fucose synthase expressed in transgenic 3D7 parasites shows that these enzymes localize in the cytoplasm of P. falciparum during the intraerythrocytic developmental cycle. Although the function of fucose in the parasite is not known, the presence of GDP-fucose suggests that the metabolite may be used for further fucosylation reactions.	[Sanz, Silvia; Ospina, Diego; Bernabeu, Maria; Fernandez-Becerra, Carmen; Izquierdo, Luis] Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res, CEK, Barcelona 08036, Spain; [Bandini, Giulia; Marino, Karina] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Dundee	Izquierdo, L (corresponding author), Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res, CEK, 1A Planta,Rossello 149-153, Barcelona 08036, Spain.	luis.izquierdo@cresib.cat	Fernandez Becerra, Carmen/L-2069-2014; Bandini, Giulia/ABC-4413-2021; Izquierdo, Luis/L-9291-2015	Fernandez Becerra, Carmen/0000-0001-5154-0013; Izquierdo, Luis/0000-0002-3704-9874; Sanz Sender, Silvia/0000-0003-4334-3284; Ospina Loaiza, Diego Andres/0000-0001-6308-6364; Marino, Karina Valeria/0000-0002-0581-8640; Bernabeu, Maria/0000-0001-7212-6209; Bandini, Giulia/0000-0002-8885-3643	Spanish Ministry of Economy and Competitiveness [SAF2010-21069]; Catalan Government (Research and Universities Commission); Ramon y Cajal Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI115063] Funding Source: NIH RePORTER	Spanish Ministry of Economy and Competitiveness(Spanish Government); Catalan Government (Research and Universities Commission); Ramon y Cajal Program(Spanish Government); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Spanish Ministry of Economy and Competitiveness Grant SAF2010-21069 (to L. I).; Recipient of a travel fellowship from the Catalan Government (Research and Universities Commission) and support from the Ramon y Cajal Program and Grant SAF2010-21069 (Spanish Ministry of Economy and Competitiveness).	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Aoki K, 2010, ACTA CRYSTALLOGR F, V66, P333, DOI 10.1107/S1744309110001740; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Azzouz N, 2005, MOL BIOCHEM PARASIT, V142, P12, DOI 10.1016/j.molbiopara.2005.02.011; Azzouz Nahid, 2008, V446, P183, DOI 10.1007/978-1-60327-084-7_13; Banerjee S, 2007, P NATL ACAD SCI USA, V104, P11676, DOI 10.1073/pnas.0704862104; Bernabeu M, 2012, CELL MICROBIOL, V14, P386, DOI 10.1111/j.1462-5822.2011.01726.x; Bhowmick IP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-179; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bushkin GG, 2010, EUKARYOT CELL, V9, P228, DOI 10.1128/EC.00197-09; Crabb BS, 2004, METH MOL B, V270, P263; Damerow S, 2010, J BIOL CHEM, V285, P878, DOI 10.1074/jbc.M109.067223; DAYALDRAGER R, 1991, CARBOHYD RES, V209, pC5, DOI 10.1016/0008-6215(91)80172-J; Delorenzi M, 2002, INFECT IMMUN, V70, P4510, DOI 10.1128/IAI.70.8.4510-4522.2002; Di Girolamo F, 2008, PROTEOMICS, V8, P2500, DOI 10.1002/pmic.200700763; Dickmanns A, 2011, J MOL BIOL, V405, P461, DOI 10.1016/j.jmb.2010.10.057; DIECKMANNSCHUPPERT A, 1992, EUR J BIOCHEM, V205, P815, DOI 10.1111/j.1432-1033.1992.tb16846.x; DIECKMANNSCHUPPERT A, 1992, PARASITOL RES, V78, P416, DOI 10.1007/BF00931698; DIECKMANNSCHUPPERT A, 1993, EUR J BIOCHEM, V216, P779, DOI 10.1111/j.1432-1033.1993.tb18198.x; Doud MB, 2012, P NATL ACAD SCI USA, V109, P7817, DOI 10.1073/pnas.1205737109; Ekland EH, 2007, CURR OPIN MICROBIOL, V10, P363, DOI 10.1016/j.mib.2007.07.007; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GEARY TG, 1985, J PROTOZOOL, V32, P608, DOI 10.1111/j.1550-7408.1985.tb03087.x; GEROLD P, 1994, J BIOL CHEM, V269, P2597; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; Ginsburg H, 2006, TRENDS PARASITOL, V22, P238, DOI 10.1016/j.pt.2006.04.008; Gowda DC, 1997, J BIOL CHEM, V272, P6428, DOI 10.1074/jbc.272.10.6428; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Guinovart C, 2006, CURR MOL MED, V6, P137, DOI 10.2174/156652406776055131; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; ISSELBACHER KJ, 1958, J BIOL CHEM, V232, P429; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Izquierdo L, 2009, EUKARYOT CELL, V8, P230, DOI 10.1128/EC.00361-08; Kimura EA, 1996, J BIOL CHEM, V271, P14452, DOI 10.1074/jbc.271.24.14452; Kooij TWA, 2006, NAT REV MICROBIOL, V4, P344, DOI 10.1038/nrmicro1392; Kotake T, 2007, BIOSCI BIOTECH BIOCH, V71, P761, DOI 10.1271/bbb.60605; Kozma K, 2006, J BIOL CHEM, V281, P36742, DOI 10.1074/jbc.M605912200; Lamerz AC, 2010, GLYCOBIOLOGY, V20, P872, DOI 10.1093/glycob/cwq045; Leslie N, 2005, MOL GENET METAB, V85, P21, DOI 10.1016/j.ymgme.2005.01.004; Litterer LA, 2006, PLANT PHYSIOL BIOCH, V44, P171, DOI 10.1016/j.plaphy.2006.04.004; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Marechal E, 2002, EUKARYOT CELL, V1, P653, DOI 10.1128/EC.1.4.653-656.2002; Martin RE, 2009, MOL MICROBIOL, V74, P519, DOI 10.1111/j.1365-2958.2009.06863.x; Meissner M, 2007, APPL MICROBIOL BIOT, V75, P963, DOI 10.1007/s00253-007-0946-4; Mendonca-Previato L, 2005, CURR OPIN STRUC BIOL, V15, P499, DOI 10.1016/j.sbi.2005.08.011; Morahan BJ, 2009, TRENDS PARASITOL, V25, P77, DOI 10.1016/j.pt.2008.11.004; Nasir-ud-Din, 1992, Biochemical Society Transactions, V20, p388S; NASIRUDDIN, 1992, BIOCHEM INT, V27, P55; Olszewski KL, 2011, MOL BIOCHEM PARASIT, V175, P95, DOI 10.1016/j.molbiopara.2010.09.001; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Pabst M, 2010, ANAL CHEM, V82, P9782, DOI 10.1021/ac101975k; Pesce ER, 2008, INT J BIOCHEM CELL B, V40, P2914, DOI 10.1016/j.biocel.2008.06.011; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Rabina J, 2001, GLYCOCONJUGATE J, V18, P799, DOI 10.1023/A:1021107602535; Ramasamy R, 2012, EXP PARASITOL, V130, P314, DOI 10.1016/j.exppara.2012.02.017; Rhomberg S, 2006, FEBS J, V273, P2244, DOI 10.1111/j.1742-4658.2006.05239.x; Rosenthal PJ, 2002, CURR OPIN HEMATOL, V9, P140, DOI 10.1097/00062752-200203000-00010; ROTH E, 1990, BLOOD CELLS, V16, P453; Rovira-Graells N, 2012, GENOME RES, V22, P925, DOI 10.1101/gr.129692.111; Sakata T, 2007, MOL BIOSYST, V3, P841, DOI 10.1039/b703924g; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Sanders PR, 2006, INFECT IMMUN, V74, P4330, DOI 10.1128/IAI.00054-06; Song GJ, 2012, P NATL ACAD SCI USA, V109, P21420, DOI 10.1073/pnas.1218581109; Stoeckert CJ, 2006, TRENDS PARASITOL, V22, P543, DOI 10.1016/j.pt.2006.09.005; Sullivan FX, 1998, J BIOL CHEM, V273, P8193, DOI 10.1074/jbc.273.14.8193; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Tonetti M, 2003, J BIOL CHEM, V278, P21559, DOI 10.1074/jbc.M301543200; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Turnock DC, 2007, J BIOL CHEM, V282, P28853, DOI 10.1074/jbc.M704742200; Turnock DC, 2007, EUKARYOT CELL, V6, P1450, DOI 10.1128/EC.00175-07; von Itzstein M, 2008, TRENDS PARASITOL, V24, P210, DOI 10.1016/j.pt.2008.02.007; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Williams M, 2011, MOL BIOCHEM PARASIT, V180, P17, DOI 10.1016/j.molbiopara.2011.07.004; Woodrow CJ, 2000, P NATL ACAD SCI USA, V97, P9931, DOI 10.1073/pnas.170153097	77	29	32	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16506	16517		10.1074/jbc.M112.439828	http://dx.doi.org/10.1074/jbc.M112.439828			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23615908	Green Published, hybrid			2022-12-28	WOS:000320378900027
J	Kuda, O; Pietka, TA; Demianova, Z; Kudova, E; Cvacka, J; Kopecky, J; Abumrad, NA				Kuda, Ondrej; Pietka, Terri A.; Demianova, Zuzana; Kudova, Eva; Cvacka, Josef; Kopecky, Jan; Abumrad, Nada A.			Sulfo-N-succinimidyl Oleate (SSO) Inhibits Fatty Acid Uptake and Signaling for Intracellular Calcium via Binding CD36 Lysine 164	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAVENGER RECEPTOR CD36; CHEMICAL CROSS-LINKING; ADIPOSE-TISSUE; OXIDIZED PHOSPHOLIPIDS; DENSITY-LIPOPROTEIN; SERUM-ALBUMIN; PROTEIN; SITE; IDENTIFICATION; INFLAMMATION	FAT/CD36 is a multifunctional glycoprotein that facilitates long-chain fatty acid (FA) uptake by cardiomyocytes and adipocytes and uptake of oxidized low density lipoproteins (oxLDL) by macrophages. CD36 also mediates FA-induced signaling to increase intracellular calcium in various cell types. The membrane-impermeable sulfo-N-hydroxysuccinimidyl (NHS) ester of oleate (SSO) irreversibly binds CD36 and has been widely used to inhibit CD36-dependent FA uptake and signaling to calcium. The inhibition mechanism and whether SSO modification of CD36 involves the FA-binding site remain unexplored. CHO cells expressing human CD36 were SSO-treated, and the protein was pulled down, deglycosylated, and resolved by electrophoresis. The CD36 band was extracted from the gel and digested for analysis by mass spectrometry. NHS derivatives react with primary or secondary amines on proteins to yield stable amide or imide bonds. Two oleoylated peptides, found only in SSO-treated samples, were identified with high contribution and confidence scores as carrying oleate modification of Lys-164. Lysine 164 lies within a predicted CD36 binding domain for FA and oxLDL. CHO cells expressing CD36 with mutated Lys-164 had impaired CD36 function in FA uptake and FA-induced calcium release from the endoplasmic reticulum, supporting the importance of Lys-164 for both FA effects. Furthermore, consistent with the importance of Lys-164 for oxLDL binding, SSO inhibited oxLDL uptake by macrophages. In conclusion, SSO accesses Lys-164 in the FA-binding site on CD36, and initial modeling of this site is presented. The data suggest competition between FA and oxLDL for access to the CD36 binding pocket.	[Kuda, Ondrej; Kopecky, Jan] Acad Sci Czech Republ, Inst Physiol, Vvi, CR-14220 Prague 4, Czech Republic; [Pietka, Terri A.; Abumrad, Nada A.] Washington Univ, Sch Med, Ctr Human Nutr, Dept Med, St Louis, MO 63110 USA; [Pietka, Terri A.; Abumrad, Nada A.] Washington Univ, Sch Med, Ctr Human Nutr, Dept Cell Biol, St Louis, MO 63110 USA; [Demianova, Zuzana; Kudova, Eva; Cvacka, Josef] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, CR-16610 Prague 6, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Washington University (WUSTL); Washington University (WUSTL); Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Kuda, O (corresponding author), Acad Sci Czech Republ, Inst Physiol, Vvi, Videnska 1083, CR-14220 Prague 4, Czech Republic.	kuda@biomed.cas.cz	Kopecky, Jan/B-8244-2012; Cvačka, Josef/A-6126-2014; Kudova, Eva/B-3155-2012; Kuda, Ondrej/B-7990-2012	Kopecky, Jan/0000-0001-8072-2035; Cvačka, Josef/0000-0002-3590-9009; Kudova, Eva/0000-0001-7131-5948; Kuda, Ondrej/0000-0001-7034-4536; demianova, zuzana/0000-0003-2822-2177	National Institutes of Health [DK033301, DK60022, P01 HL057278]; Czech Science Foundation [13-04449P]; EC Project DIABAT [HEALTH-F2-2011-278373]; Academy of Sciences of the Czech Republic [RVO 61388963]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R01DK033301, R01DK060022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Czech Science Foundation(Grant Agency of the Czech Republic); EC Project DIABAT; Academy of Sciences of the Czech Republic(Czech Academy of Sciences); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK033301, DK60022, and P01 HL057278. This work was also supported by Czech Science Foundation Grant 13-04449P, EC Project DIABAT HEALTH-F2-2011-278373, and Academy of Sciences of the Czech Republic Grant RVO 61388963.	Abumrad NA, 2012, PHYSIOL REV, V92, P1061, DOI 10.1152/physrev.00019.2011; ASCH AS, 1993, SCIENCE, V262, P1436, DOI 10.1126/science.7504322; Baillie AGS, 1996, J MEMBRANE BIOL, V153, P75, DOI 10.1007/s002329900111; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; Berglund L, 1996, BBA-GENE STRUCT EXPR, V1309, P63, DOI 10.1016/S0167-4781(96)00143-1; Coort SLM, 2002, MOL CELL BIOCHEM, V239, P213, DOI 10.1023/A:1020539932353; Demers A, 2004, BIOCHEM J, V382, P417, DOI 10.1042/BJ20040036; Dramane G, 2012, J CLIN INVEST, V122, P2267, DOI 10.1172/JCI59953; Duttaroy A. K., 2004, CELLULAR PROTEINS TH, P3; El-Yassimi A, 2008, J BIOL CHEM, V283, P12949, DOI 10.1074/jbc.M707478200; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Falomir-Lockhart LJ, 2006, J BIOL CHEM, V281, P13979, DOI 10.1074/jbc.M511943200; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Gao DT, 2010, J BIOL CHEM, V285, P4447, DOI 10.1074/jbc.M109.082800; GEFFEN I, 1989, EMBO J, V8, P2855, DOI 10.1002/j.1460-2075.1989.tb08433.x; Ghosh A, 2011, BLOOD, V117, P6355, DOI 10.1182/blood-2011-02-338582; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Gros J, 1999, J CELL SCI, V112, P3791; HARE JF, 1991, P NATL ACAD SCI USA, V88, P5902, DOI 10.1073/pnas.88.13.5902; HARMON CM, 1991, J MEMBRANE BIOL, V121, P261, DOI 10.1007/BF01951559; HARMON CM, 1993, J MEMBRANE BIOL, V133, P43; Hirano K, 2003, TRENDS CARDIOVAS MED, V13, P136, DOI 10.1016/S1050-1738(03)00026-4; Hoosdally SJ, 2009, J BIOL CHEM, V284, P16277, DOI 10.1074/jbc.M109.007849; Huang BX, 2005, BIOCHEM J, V387, P695, DOI 10.1042/BJ20041624; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Kalkhof S, 2008, ANAL BIOANAL CHEM, V392, P305, DOI 10.1007/s00216-008-2231-5; Kar NS, 2008, J BIOL CHEM, V283, P8765, DOI 10.1074/jbc.M709195200; Kennedy DJ, 2011, CARDIOVASC RES, V89, P604, DOI 10.1093/cvr/cvq360; Kerkhoff C, 2001, BIOCHEMISTRY-US, V40, P241, DOI 10.1021/bi001791k; Koutsari C, 2012, DIABETES, V61, P329, DOI 10.2337/db11-0748; Koutsari C, 2011, DIABETES, V60, P2032, DOI 10.2337/db11-0154; Kuda O, 2011, J BIOL CHEM, V286, P17785, DOI 10.1074/jbc.M111.232975; Le Foll C, 2009, AM J PHYSIOL-REG I, V297, pR655, DOI 10.1152/ajpregu.00223.2009; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060; Love-Gregory L, 2011, CURR OPIN CLIN NUTR, V14, P527, DOI 10.1097/MCO.0b013e32834bbac9; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Navazo MDP, 1996, J BIOL CHEM, V271, P15381, DOI 10.1074/jbc.271.26.15381; Naville D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030686; Nicholls HT, 2011, DIABETES, V60, P1100, DOI 10.2337/db10-1353; NICHOLSON AC, 1995, ARTERIOSCL THROM VAS, V15, P269, DOI 10.1161/01.ATV.15.2.269; Pepino MY, 2012, J LIPID RES, V53, P561, DOI 10.1194/jlr.M021873; Pohl J, 2005, MOL BIOL CELL, V16, P24, DOI 10.1091/mbc.E04-07-0616; Rasmussen JT, 1998, EUR J BIOCHEM, V257, P488, DOI 10.1046/j.1432-1327.1998.2570488.x; REED RG, 1986, J BIOL CHEM, V261, P5619; Riquelme CA, 2011, SCIENCE, V334, P528, DOI 10.1126/science.1210558; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Smith J, 2008, WESTERN HUM REV, V62, P36; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Sundaresan S, 2013, FASEB J, V27, P1191, DOI 10.1096/fj.12-217703; Tao NB, 1996, J BIOL CHEM, V271, P22315, DOI 10.1074/jbc.271.37.22315; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; Xiong Y, 2012, J CELL BIOL, V198, P155, DOI 10.1083/jcb.201202056	57	89	96	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15547	15555		10.1074/jbc.M113.473298	http://dx.doi.org/10.1074/jbc.M113.473298			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23603908	Green Published, hybrid			2022-12-28	WOS:000319822300013
J	Voss, S; Hallstrom, T; Saleh, M; Burchhardt, G; Pribyl, T; Singh, B; Riesbeck, K; Zipfel, PF; Hammerschmidt, S				Voss, Sylvia; Hallstroem, Teresia; Saleh, Malek; Burchhardt, Gerhard; Pribyl, Thomas; Singh, Birendra; Riesbeck, Kristian; Zipfel, Peter F.; Hammerschmidt, Sven			The Choline-binding Protein PspC of Streptococcus pneumoniae Interacts with the C-terminal Heparin-binding Domain of Vitronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE PROTEIN; NASOPHARYNGEAL COLONIZATION; INTRASTRAIN VARIATION; MEDIATES ADHESION; ADHERENCE; FIBRONECTIN; VIRULENCE; RECEPTOR; INVASION; POLYSACCHARIDE	Adherence of Streptococcus pneumoniae is directly mediated by interactions of adhesins with eukaryotic cellular receptors or indirectly by exploiting matrix and serum proteins as molecular bridges. Pneumococci engage vitronectin, the human adhesive glycoprotein and complement inhibitor, to facilitate attachment to epithelial cells of the mucosal cavity, thereby modulating host cell signaling. In this study, we identified PspC as a vitronectin-binding protein interacting with the C-terminal heparin-binding domain of vitronectin. PspC is a multifunctional surface-exposed choline-binding protein displaying various adhesive properties. Vitronectin binding required the R domains in the mature PspC protein, which are also essential for the interaction with the ectodomain of the polymeric immunoglobulin receptor and secretory IgA. Consequently, secretory IgA competitively inhibited binding of vitronectin to purified PspC and to PspC-expressing pneumococci. In contrast, Factor H, which binds to the N-terminal part of mature PspC molecules, did not interfere with the PspC-vitronectin interaction. Using a series of vitronectin peptides, the C-terminal heparin-binding domain was shown to be essential for the interaction of soluble vitronectin with PspC. Binding experiments with immobilized vitronectin suggested a region N-terminal to the identified heparin-binding domain as an additional binding region for PspC, suggesting that soluble, immobilized, as well as cellularly bound vitronectin possesses different conformations. Finally, vitronectin bound to PspC was functionally active and inhibited the deposition of the terminal complement complex. In conclusion, this study identifies and characterizes (on the molecular level) the interaction between the pneumococcal adhesin PspC and the human glycoprotein vitronectin.	[Voss, Sylvia; Saleh, Malek; Burchhardt, Gerhard; Pribyl, Thomas; Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Gen, Dept Genet Microorganisms, D-17487 Greifswald, Germany; [Hallstroem, Teresia; Zipfel, Peter F.] Leibniz Inst Nat Product Res & Infect Biol, Hans Knoell Inst, Dept Infect Biol, D-07745 Jena, Germany; [Zipfel, Peter F.] Univ Jena, Inst Microbiol, D-07743 Jena, Germany; [Singh, Birendra; Riesbeck, Kristian] Lund Univ, Skane Univ Hosp, Dept Lab Med, SE-20502 Malmo, Sweden	Ernst Moritz Arndt Universitat Greifswald; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Lund University; Skane University Hospital	Hammerschmidt, S (corresponding author), Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Gen, Dept Genet Microorganisms, Friedrich Ludwig Jahn Str 15A, D-17487 Greifswald, Germany.	sven.hammerschmidt@uni-greifswald.de	Hammerschmidt, Sven/G-2598-2010; Singh, Birendra/H-3592-2011	Hammerschmidt, Sven/0000-0002-6382-6681; Riesbeck, Kristian/0000-0001-6274-6965; Singh, Birendra/0000-0002-7246-1442	Deutsche Forschungsgemeinschaft [DFG HA 3125/4-2, DFG-GRK840]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grants DFG HA 3125/4-2 and the DFG-GRK840 from the Deutsche Forschungsgemeinschaft (to S. H.).	Agarwal V, 2010, J BIOL CHEM, V285, P23484, DOI 10.1074/jbc.M110.142703; Anderton JM, 2007, MICROB PATHOGENESIS, V42, P225, DOI 10.1016/j.micpath.2007.02.003; Asmat TM, 2012, MICROBIOL-SGM, V158, P771, DOI 10.1099/mic.0.053603-0; Attali C, 2008, INFECT IMMUN, V76, P466, DOI 10.1128/IAI.01261-07; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Brooks-Walter A, 1999, INFECT IMMUN, V67, P6533; Cartwright K, 2002, EUR J PEDIATR, V161, P188, DOI 10.1007/s00431-001-0907-3; Chia ES, 2000, INFECT IMMUN, V68, P1864, DOI 10.1128/IAI.68.4.1864-1870.2000; Chillakuri CR, 2010, FEBS LETT, V584, P3287, DOI 10.1016/j.febslet.2010.06.023; Dave S, 2004, J IMMUNOL, V173, P471, DOI 10.4049/jimmunol.173.1.471; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; Elm C, 2004, J BIOL CHEM, V279, P6296, DOI 10.1074/jbc.M310528200; Gamez G, 2012, CURR DRUG TARGETS, V13, P323, DOI 10.2174/138945012799424697; GASSON MJ, 1983, J BACTERIOL, V154, P1; Habermann BF, 1993, CURR OPIN CELL BIOL, V5, P864, DOI 10.1016/0955-0674(93)90036-P; Hartel T, 2011, INFECT IMMUN, V79, P44, DOI 10.1128/IAI.00855-10; Hallstrom T, 2011, J INFECT DIS, V204, P1065, DOI 10.1093/infdis/jir459; Hallstrom T, 2009, J IMMUNOL, V183, P2593, DOI 10.4049/jimmunol.0803226; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hammerschmidt S, 1997, MOL MICROBIOL, V25, P1113, DOI 10.1046/j.1365-2958.1997.5391899.x; Hammerschmidt S, 2000, MOL MICROBIOL, V36, P726, DOI 10.1046/j.1365-2958.2000.01897.x; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Haupt K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000250; Hill DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045452; Hilleringmann M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000026; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Hyams C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024581; Hyams C, 2010, INFECT IMMUN, V78, P716, DOI 10.1128/IAI.01056-09; Iannelli F, 2002, GENE, V284, P63, DOI 10.1016/S0378-1119(01)00896-4; ICHIHARA Y, 1993, GENE, V130, P153, DOI 10.1016/0378-1119(93)90361-6; Janulczyk R, 2000, J BIOL CHEM, V275, P37257, DOI 10.1074/jbc.M004572200; Jensch I, 2010, MOL MICROBIOL, V77, P22, DOI 10.1111/j.1365-2958.2010.07189.x; Lin IH, 2012, GENOMICS, V100, P370, DOI 10.1016/j.ygeno.2012.08.001; LOWRANCE JH, 1988, INFECT IMMUN, V56, P2279, DOI 10.1128/IAI.56.9.2279-2285.1988; McNab R, 1996, INFECT IMMUN, V64, P4204, DOI 10.1128/IAI.64.10.4204-4210.1996; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Papasergi S, 2010, J BIOL CHEM, V285, P7517, DOI 10.1074/jbc.M109.062075; Petit CM, 2001, FEMS MICROBIOL LETT, V200, P229, DOI 10.1111/j.1574-6968.2001.tb10720.x; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; Preissner KT, 2011, SEMIN THROMB HEMOST, V37, P408, DOI 10.1055/s-0031-1276590; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; Romero-Steiner S, 2006, VACCINE, V24, P3224, DOI 10.1016/j.vaccine.2006.01.042; Rose L, 2008, J INFECT DIS, V198, P375, DOI 10.1086/589775; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Singh B, 2011, MOL MICROBIOL, V81, P80, DOI 10.1111/j.1365-2958.2011.07678.x; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Tellier MC, 2000, J IMMUNOL, V164, P3236, DOI 10.4049/jimmunol.164.6.3236; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Vengadesan K, 2011, PROTEIN SCI, V20, P759, DOI 10.1002/pro.613; Voss S, 2012, MOL ORAL MICROBIOL, V27, P246, DOI 10.1111/j.2041-1014.2012.00654.x; Weiser JN, 1996, INFECT IMMUN, V64, P2240, DOI 10.1128/IAI.64.6.2240-2245.1996; Weiser JN, 1999, INFECT IMMUN, V67, P3690, DOI 10.1128/IAI.67.7.3690-3692.1999; Yamaguchi M, 2008, J BIOL CHEM, V283, P36272, DOI 10.1074/jbc.M807087200; Yuste J, 2010, INFECT IMMUN, V78, P283, DOI 10.1128/IAI.00541-09; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4; Zipfel PF, 2008, VACCINE, V26, pI67, DOI 10.1016/j.vaccine.2008.11.015	62	56	58	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15614	15627		10.1074/jbc.M112.443507	http://dx.doi.org/10.1074/jbc.M112.443507			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23603906	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000319822300019
J	Shodai, A; Morimura, T; Ido, A; Uchida, T; Ayaki, T; Takahashi, R; Kitazawa, S; Suzuki, S; Shirouzu, M; Kigawa, T; Muto, Y; Yokoyama, S; Takahashi, R; Kitahara, R; Ito, H; Fujiwara, N; Urushitani, M				Shodai, Akemi; Morimura, Toshifumi; Ido, Akemi; Uchida, Tsukasa; Ayaki, Takashi; Takahashi, Rina; Kitazawa, Soichiro; Suzuki, Sakura; Shirouzu, Mikako; Kigawa, Takanori; Muto, Yutaka; Yokoyama, Shigeyuki; Takahashi, Ryosuke; Kitahara, Ryo; Ito, Hidefumi; Fujiwara, Noriko; Urushitani, Makoto			Aberrant Assembly of RNA Recognition Motif 1 Links to Pathogenic Conversion of TAR DNA-binding Protein of 43 kDa (TDP-43)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEAR FACTOR TDP-43; CYTOPLASMIC INCLUSIONS; TERMINAL FRAGMENTS; PRION PROTEIN; AGGREGATION; DEPLETION; MECHANISMS; MUTATIONS	Aggregation of TAR DNA-binding protein of 43 kDa (TDP-43) is a pathological signature of amyotrophic lateral sclerosis (ALS). Although accumulating evidence suggests the involvement of RNA recognition motifs (RRMs) in TDP-43 proteinopathy, it remains unclear how native TDP-43 is converted to pathogenic forms. To elucidate the role of homeostasis of RRM1 structure in ALS pathogenesis, conformations of RRM1 under high pressure were monitored by NMR. We first found that RRM1 was prone to aggregation and had three regions showing stable chemical shifts during misfolding. Moreover, mass spectrometric analysis of aggregated RRM1 revealed that one of the regions was located on protease-resistant beta-strands containing two cysteines (Cys-173 and Cys-175), indicating that this region served as a core assembly interface in RRM1 aggregation. Although a fraction of RRM1 aggregates comprised disulfide-bonded oligomers, the substitution of cysteine(s) to serine(s) (C/S) resulted in unexpected acceleration of amyloid fibrils of RRM1 and disulfide-independent aggregate formation of full-length TDP-43. Notably, TDP-43 aggregates with RRM1-C/S required the C terminus, and replicated cytopathologies of ALS, including mislocalization, impaired RNA splicing, ubiquitination, phosphorylation, and motor neuron toxicity. Furthermore, RRM1-C/S accentuated inclusions of familial ALS-linked TDP-43 mutants in the C terminus. The relevance of RRM1-C/S-induced TDP-43 aggregates in ALS pathogenesis was verified by immunolabeling of inclusions of ALS patients and cultured cells overexpressing the RRM1-C/S TDP-43 with antibody targeting misfolding-relevant regions. Our results indicate that cysteines in RRM1 crucially govern the conformation of TDP-43, and aberrant self-assembly of RRM1 at amyloidogenic regions contributes to pathogenic conversion of TDP-43 in ALS.	[Shodai, Akemi; Morimura, Toshifumi; Ido, Akemi; Uchida, Tsukasa; Urushitani, Makoto] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Otsu, Shiga 5202192, Japan; [Uchida, Tsukasa; Ayaki, Takashi; Takahashi, Ryosuke; Ito, Hidefumi] Kyoto Univ, Dept Neurol, Grad Sch Med, Kyoto 6068507, Japan; [Takahashi, Rina; Kitazawa, Soichiro; Kitahara, Ryo] Ritsumeikan Univ, Coll Pharmaceut Sci, Kusatsu 5258577, Japan; [Suzuki, Sakura; Shirouzu, Mikako; Kigawa, Takanori; Muto, Yutaka; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Ito, Hidefumi] Wakayama Med Univ, Dept Neurol, Grad Sch Med, Wakayama 6418510, Japan; [Fujiwara, Noriko] Hyogo Coll Med, Dept Biochem, Nishinomiya, Hyogo 6638501, Japan	Shiga University of Medical Science; Kyoto University; Ritsumeikan University; RIKEN; Wakayama Medical University; Hyogo College of Medicine	Urushitani, M (corresponding author), Shiga Univ Med Sci, Mol Neurosci Res Ctr, Otsu, Shiga 5202192, Japan.	uru@belle.shiga-med.ac.jp	Shirouzu, Mikako/A-6521-2016; Yokoyama, Shigeyuki/N-6911-2015; Kigawa, Takanori/A-7679-2010	Yokoyama, Shigeyuki/0000-0003-3133-7338; Kigawa, Takanori/0000-0003-0146-9719; Urushitani, Makoto/0000-0003-2773-9836	KAKENHI [23300131, 22659171]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [23111002]; Grant for Research on Neurodegenerative Diseases from Japan Health and Labor Science; Grants-in-Aid for Scientific Research [23370080, 23580417] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant for Research on Neurodegenerative Diseases from Japan Health and Labor Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI Grants 23300131 for Scientific Research (B) and 22659171 for Challenging Exploratory Research; Grant-in-aid for Scientific Research on Innovative Areas 23111002 from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); and a Grant for Research on Neurodegenerative Diseases from Japan Health and Labor Science.	Akasaka K, 2006, CHEM REV, V106, P1814, DOI 10.1021/cr040440z; Akhtar Mohd Waseem, 2012, Int J Cell Biol, V2012, P463756, DOI 10.1155/2012/463756; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ash PEA, 2010, HUM MOL GENET, V19, P3206, DOI 10.1093/hmg/ddq230; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Baloh RH, 2012, CURR OPIN NEUROL, V25, P701, DOI 10.1097/WCO.0b013e32835a269b; Bentmann E, 2012, J BIOL CHEM, V287, P23079, DOI 10.1074/jbc.M111.328757; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Budini M, 2012, J BIOL CHEM, V287, P7512, DOI 10.1074/jbc.M111.288720; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Caccamo A, 2012, AM J PATHOL, V180, P293, DOI 10.1016/j.ajpath.2011.09.022; Chang CK, 2012, BIOCHEM BIOPH RES CO, V425, P219, DOI 10.1016/j.bbrc.2012.07.071; Che MX, 2011, FASEB J, V25, P2344, DOI 10.1096/fj.10-174482; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Cohen TJ, 2011, TRENDS MOL MED, V17, P659, DOI 10.1016/j.molmed.2011.06.004; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; Gendron TF, 2010, NEUROPATH APPL NEURO, V36, P97, DOI [10.1111/j.1365-2990.2009.01060.x, 10.1111/j.1365-2990.2010.01060.x]; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Higashi S, 2013, J NEUROCHEM, V126, P288, DOI 10.1111/jnc.12194; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Iguchi Y, 2012, NEUROBIOL DIS, V45, P862, DOI 10.1016/j.nbd.2011.12.002; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kitahara R, 2006, J MOL BIOL, V363, P395, DOI 10.1016/j.jmb.2006.07.074; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Kuwata K, 2007, P NATL ACAD SCI USA, V104, P11921, DOI 10.1073/pnas.0702671104; Matusica D, 2008, J NEUROSCI RES, V86, P553, DOI 10.1002/jnr.21507; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2009, FEBS LETT, V583, P394, DOI 10.1016/j.febslet.2008.12.031; Pesiridis GS, 2011, J BIOL CHEM, V286, P18845, DOI 10.1074/jbc.M111.231118; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Shodai A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052776; Swarup V, 2011, J EXP MED, V208, P2429, DOI 10.1084/jem.20111313; Swarup V, 2011, BRAIN, V134, P2610, DOI 10.1093/brain/awr159; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Torrent J, 2006, BBA-PROTEINS PROTEOM, V1764, P546, DOI 10.1016/j.bbapap.2005.10.014; Urushitani M, 2010, J NEUROSCI RES, V88, P784, DOI 10.1002/jnr.22243; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Xiao SX, 2011, MOL CELL NEUROSCI, V47, P167, DOI 10.1016/j.mcn.2011.02.013; Zhang T, 2011, HUM MOL GENET, V20, P1952, DOI 10.1093/hmg/ddr076	45	49	50	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14886	14905		10.1074/jbc.M113.451849	http://dx.doi.org/10.1074/jbc.M113.451849			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23558684	hybrid, Green Published			2022-12-28	WOS:000319452100020
J	Rapsinski, GJ; Newman, TN; Oppong, GO; van Putten, JPM; Tukel, C				Rapsinski, Glenn J.; Newman, Tiffanny N.; Oppong, Gertrude O.; van Putten, Jos P. M.; Tukel, Cagla			CD14 Protein Acts as an Adaptor Molecule for the Immune Recognition of Salmonella Curli Fibers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; AMYLOID-BETA-PEPTIDE; ENTERICA SEROTYPE TYPHIMURIUM; CONGO-RED-BINDING; ESCHERICHIA-COLI; FIBRONECTIN-BINDING; ALZHEIMERS-DISEASE; MYCOBACTERIUM-TUBERCULOSIS; AGGREGATIVE FIMBRIAE; BACTERIAL FLAGELLIN	Amyloids, protein aggregates with a cross beta-sheet structure, contribute to inflammation in debilitating disorders, including Alzheimer's disease. Enteric bacteria also produce amyloids, termed curli, contributing to inflammation during infection. It has been demonstrated that curli and beta-amyloid are recognized by the immune system via the Toll-like receptor (TLR) 2/TLR1 complex. Here we investigated the role of CD14 in the immune recognition of bacterial amyloids. We used HeLa 57A cells, a human cervical cancer cell line containing a luciferase reporter gene under the control of an NF-kappa B promoter. When HeLa 57A cells were transiently transfected with combinations of human expression vectors containing genes for TLR2, TLR1, and CD14, membrane-bound CD14 enhanced NF-kappa B activation through the TLR2/TLR1 complex stimulated with curli fibers or recombinant CsgA, the curli major subunit. Similarly, soluble CD14 augmented the TLR2/TLR1 response to curli fibers in the absence of membrane-bound CD14. We further revealed that IL-6 and nitric oxide production were significantly higher by wild-type (C57BL/6) bone marrow-derived macrophages compared with TLR2-deficient or CD14-deficient bone marrow-derived macrophages when stimulated with curli fibers, recombinant CsgA, or synthetic CsgA peptide, CsgA-R4-5. Binding assays demonstrated that recombinant TLR2, TLR1, and CD14 bound purified curli fibers. Interestingly, CD14-curli interaction was specific to the fibrillar form of the amyloid, as demonstrated by using synthetic CsgA peptides proficient and deficient in fiber formation, respectively. Activation of the TLR2/TLR1/CD14 trimolecular complex by amyloids provides novel insights for innate immunity with implications for amyloid-associated diseases.	[Rapsinski, Glenn J.; Newman, Tiffanny N.; Oppong, Gertrude O.; Tukel, Cagla] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; [van Putten, Jos P. M.] Univ Utrecht, Dept Infect Dis & Immunol, NL-3584 CL Utrecht, Netherlands	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Utrecht University	Tukel, C (corresponding author), Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA.	ctukel@temple.edu		van Putten, Jos/0000-0002-4126-8172; Newman, Tiffanny/0000-0003-4129-5186	American Heart Association Scientist Development Grant [0835248N]; Pennsylvania Department of Health	American Heart Association Scientist Development Grant(American Heart Association); Pennsylvania Department of Health	This work was supported by American Heart Association Scientist Development Grant 0835248N and by a grant from the Pennsylvania Department of Health (to G. J. R.).	Aigelsreiter A, 2007, PATHOBIOLOGY, V74, P145, DOI 10.1159/000103374; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Alteri CJ, 2007, P NATL ACAD SCI USA, V104, P5145, DOI 10.1073/pnas.0602304104; Anas A, 2010, CRIT CARE, V14, DOI 10.1186/cc8850; Antao EM, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-22; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bate C, 2004, NEUROREPORT, V15, P1427, DOI 10.1097/01.wnr.0000132203.76836.16; Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111; Bian Z, 2000, J INFECT DIS, V181, P602, DOI 10.1086/315233; Bian Z, 2001, J INFECT DIS, V183, P612, DOI 10.1086/318528; Broersen K, 2011, PROTEIN ENG DES SEL, V24, P743, DOI 10.1093/protein/gzr020; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; Castillo GM, 2000, J NEUROSCI RES, V62, P451, DOI 10.1002/1097-4547(20001101)62:3<451::AID-JNR15>3.0.CO;2-F; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Collinson SK, 1996, J BACTERIOL, V178, P662, DOI 10.1128/jb.178.3.662-667.1996; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Dueholm MS, 2011, BIOCHEMISTRY-US, V50, P8281, DOI 10.1021/bi200967c; Fassbender K, 2004, FASEB J, V18, P203, DOI 10.1096/fj.03-0364fje; Gerstel U, 2003, RES MICROBIOL, V154, P659, DOI 10.1016/j.resmic.2003.08.005; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Goulter-Thorsen RM, 2011, APPL ENVIRON MICROB, V77, P7339, DOI 10.1128/AEM.00277-11; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Hammer ND, 2012, J MOL BIOL, V422, P376, DOI 10.1016/j.jmb.2012.05.043; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; HAZIOT A, 1988, J IMMUNOL, V141, P547; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Hetherington CJ, 1999, J IMMUNOL, V162, P503; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Humphries AD, 2003, MOL MICROBIOL, V48, P1357, DOI 10.1046/j.1365-2958.2003.03507.x; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Keestra AM, 2007, J IMMUNOL, V178, P7110, DOI 10.4049/jimmunol.178.11.7110; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x; Leonhardt RM, 2010, J BIOL CHEM, V285, P16166, DOI 10.1074/jbc.M109.097725; Letiembre M, 2009, NEUROBIOL AGING, V30, P759, DOI 10.1016/j.neurobiolaging.2007.08.018; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Liu SR, 2012, J IMMUNOL, V188, P1098, DOI 10.4049/jimmunol.1101121; Liu Y, 2005, BRAIN, V128, P1778, DOI 10.1093/brain/awh531; Low KB, 1999, NAT BIOTECHNOL, V17, P37, DOI 10.1038/5205; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Manukyan M, 2005, EUR J IMMUNOL, V35, P911, DOI 10.1002/eji.200425336; Mauclaire L, 2010, COLLOID SURFACE B, V76, P104, DOI 10.1016/j.colsurfb.2009.10.021; Miura T, 2002, J RAMAN SPECTROSC, V33, P530, DOI 10.1002/jrs.869; Mok KH, 2007, BIOCHEM BIOPH RES CO, V354, P1, DOI 10.1016/j.bbrc.2006.12.167; Moreno C, 2004, MICROBES INFECT, V6, P990, DOI 10.1016/j.micinf.2004.05.010; MORROW JF, 1981, P NATL ACAD SCI-BIOL, V78, P4718, DOI 10.1073/pnas.78.8.4718; Nakata T, 2006, CELL MICROBIOL, V8, P1899, DOI 10.1111/j.1462-5822.2006.00756.x; Nenninger AA, 2011, MOL MICROBIOL, V81, P486, DOI 10.1111/j.1365-2958.2011.07706.x; Nenninger AA, 2009, P NATL ACAD SCI USA, V106, P900, DOI 10.1073/pnas.0812143106; OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0; OLSEN A, 1993, MOL MICROBIOL, V7, P523, DOI 10.1111/j.1365-2958.1993.tb01143.x; Oppong GO, 2013, INFECT IMMUN, V81, P478, DOI 10.1128/IAI.00453-12; Pan Z, 2000, J BIOL CHEM, V275, P36430, DOI 10.1074/jbc.M003192200; Pfefferkorn CM, 2010, P NATL ACAD SCI USA, V107, P21447, DOI 10.1073/pnas.1006424107; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ranoa DRE, 2013, J BIOL CHEM, V288, P9729, DOI 10.1074/jbc.M113.453266; Reed-Geaghan EG, 2010, J NEUROSCI, V30, P15369, DOI 10.1523/JNEUROSCI.2637-10.2010; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Robinson LS, 2006, MOL MICROBIOL, V59, P870, DOI 10.1111/j.1365-2958.2005.04997.x; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Romling U, 2003, INT J MED MICROBIOL, V293, P273, DOI 10.1078/1438-4221-00268; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Schromm AB, 2010, INNATE IMMUN-LONDON, V16, P213, DOI 10.1177/1753425909339232; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; Shin DM, 2010, CELL MICROBIOL, V12, P1648, DOI 10.1111/j.1462-5822.2010.01497.x; Shu Q, 2012, P NATL ACAD SCI USA, V109, P6502, DOI 10.1073/pnas.1204161109; SJOBRING U, 1994, MOL MICROBIOL, V14, P443, DOI 10.1111/j.1365-2958.1994.tb02179.x; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Toyama BH, 2011, ANNU REV BIOCHEM, V80, P557, DOI 10.1146/annurev-biochem-090908-120656; Tucker HM, 2000, J NEUROSCI, V20, P3937; Tukel C, 2009, CELL HOST MICROBE, V6, P45, DOI 10.1016/j.chom.2009.05.020; Tukel C, 2005, MOL MICROBIOL, V58, P289, DOI 10.1111/j.1365-2958.2005.04825.x; Tukel C, 2010, CELL MICROBIOL, V12, P1495, DOI 10.1111/j.1462-5822.2010.01485.x; Udan MLD, 2008, J NEUROCHEM, V104, P524, DOI 10.1111/j.1471-4159.2007.05001.x; Wang X, 2008, J BIOL CHEM, V283, P21530, DOI 10.1074/jbc.M800466200; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yu WM, 1998, J IMMUNOL, V161, P4244; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; ZIEGLERHEITBROCK HWL, 1993, IMMUNOL TODAY, V14, P121, DOI 10.1016/0167-5699(93)90212-4	89	37	37	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14178	14188		10.1074/jbc.M112.447060	http://dx.doi.org/10.1074/jbc.M112.447060			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23548899	Green Published, hybrid			2022-12-28	WOS:000319253500022
J	Mattheij, NJA; Gilio, K; van Kruchten, R; Jobe, SM; Wieschhaus, AJ; Chishti, AH; Collins, P; Heemskerk, JWM; Cosemans, JMEM				Mattheij, Nadine J. A.; Gilio, Karen; van Kruchten, Roger; Jobe, Shawn M.; Wieschhaus, Adam J.; Chishti, Athar H.; Collins, Peter; Heemskerk, Johan W. M.; Cosemans, Judith M. E. M.			Dual Mechanism of Integrin alpha(IIb)beta(3) Closure in Procoagulant Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLSERINE EXPOSURE; THROMBUS FORMATION; CALPAIN CLEAVAGE; ACTIVATION; APOPTOSIS	Aggregation of platelets via activated integrin alpha(IIb)beta(3) is a prerequisite for thrombus formation. Phosphatidylserine-exposing platelets with a key role in the coagulation process disconnect from a thrombus by integrin inactivation via an unknown mechanism. Here we show that alpha(IIb)beta(3) inactivation in procoagulant platelets relies on a sustained high intracellular Ca2+, stimulating intracellular cleavage of the beta(3) chain, talin, and Src kinase. Inhibition of calpain activity abolished protein cleavage, but only partly suppressed alpha(IIb)beta(3) inactivation. Integrin alpha(IIb)beta(3) inactivation was unchanged in platelets from Capn1(-/-) mice, suggesting a role of the calpain-2 isoform. Scott syndrome platelets, lacking the transmembrane protein TMEM16F and having low phosphatidylserine exposure, displayed reduced alpha(IIb)beta(3) inactivation with the remaining activity fully dependent on calpain. In platelets from Ppif(-/-) mice, lacking mitochondrial permeability transition pore (mPTP) formation, agonist-induced phosphatidylserine exposure and alpha(IIb)beta(3) inactivation were reduced. Treatment of human platelets with cyclosporin A gave a similar phenotype. Together, these data point to a dual mechanism of alpha(IIb)beta(3) inactivation via calpain(-2) cleavage of integrin-associated proteins and via TMEM16F-dependent phospholipid scrambling with an assistant role of mPTP formation.	[Mattheij, Nadine J. A.; Gilio, Karen; van Kruchten, Roger; Heemskerk, Johan W. M.; Cosemans, Judith M. E. M.] Maastricht Univ, Dept Biochem, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Jobe, Shawn M.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Wieschhaus, Adam J.] Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA; [Wieschhaus, Adam J.; Chishti, Athar H.] Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Boston, MA 02111 USA; [Collins, Peter] Cardiff Univ, Sch Med, Dept Haematol, Arthur Bloom Haemophilia Ctr, Cardiff CF14 4YU, S Glam, Wales	Maastricht University; Emory University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Tufts University; Cardiff University	Heemskerk, JWM (corresponding author), Maastricht Univ, Dept Biochem CARIM, POB 616, NL-6200 MD Maastricht, Netherlands.	heemskerk@maastrichtuniversity.nl	Cosemans, Judith MEM/C-8161-2016; Heemskerk, Johan/AAM-8323-2021	Cosemans, Judith MEM/0000-0001-7429-0109; Heemskerk, Johan/0000-0002-2848-5121	Cardiovascular Centre, Maastricht; Center for Translational Molecular Medicine Innovative Coagulation Diagnostics (INCOAG); Netherlands Heart Foundation [2011T6]; National Institute of Health [HL089519]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089519] Funding Source: NIH RePORTER	Cardiovascular Centre, Maastricht; Center for Translational Molecular Medicine Innovative Coagulation Diagnostics (INCOAG); Netherlands Heart Foundation(Netherlands Heart Foundation); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Cardiovascular Centre, Maastricht, the Center for Translational Molecular Medicine Innovative Coagulation Diagnostics (INCOAG), and the Netherlands Heart Foundation grant 2011T6 (to J. M. E. M. C.) and National Institute of Health grant HL089519 (to A. H. C.).	Arachiche A, 2009, ARTERIOSCL THROM VAS, V29, P1883, DOI 10.1161/ATVBAHA.109.190926; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Berny MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010415; Castoldi E, 2011, BLOOD, V117, P4399, DOI 10.1182/blood-2011-01-332502; Cosemans JMEM, 2008, J THROMB HAEMOST, V6, P1253, DOI 10.1111/j.1538-7836.2008.03041.x; Cosemans JMEM, 2010, J THROMB HAEMOST, V8, P1797, DOI 10.1111/j.1538-7836.2010.03935.x; Cosemans JMEM, 2011, BLOOD, V117, P651, DOI 10.1182/blood-2010-01-262683; Dale GL, 2005, J THROMB HAEMOST, V3, P2185, DOI 10.1111/j.1538-7836.2005.01274.x; DU XP, 1995, J BIOL CHEM, V270, P26146, DOI 10.1074/jbc.270.44.26146; Dutt P, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-3; Fuse I, 2001, BRIT J HAEMATOL, V112, P603, DOI 10.1046/j.1365-2141.2001.02637.x; Gilio K, 2010, J BIOL CHEM, V285, P23629, DOI 10.1074/jbc.M110.108696; Gilio K, 2010, J BIOL CHEM, V285, P23408, DOI 10.1074/jbc.M110.136176; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Heemskerk JWM, 2013, J THROMB HAEMOST, V11, P2, DOI 10.1111/jth.12045; Heemskerk JWM, 2002, THROMB HAEMOSTASIS, V88, P186; Heemskerk JWM, 1997, EUR J BIOCHEM, V249, P547, DOI 10.1111/j.1432-1033.1997.00547.x; Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515; Jobe SM, 2008, BLOOD, V111, P1257, DOI 10.1182/blood-2007-05-092684; Jobe SM, 2005, BLOOD, V106, P4146, DOI 10.1182/blood-2005-03-1223; Kim C, J CELL BIOL, V197, P605; Kuchay SM, 2012, J THROMB HAEMOST, V10, P1120, DOI 10.1111/j.1538-7836.2012.04715.x; Kuchay SM, 2007, CURR OPIN HEMATOL, V14, P249, DOI 10.1097/MOH.0b013e3280ef68f8; Kuchay SM, 2007, MOL CELL BIOL, V27, P6038, DOI 10.1128/MCB.00522-07; Kulkarni S, 2004, J BIOL CHEM, V279, P30697, DOI 10.1074/jbc.M403559200; Leytin V, 2009, LAB INVEST, V89, P374, DOI 10.1038/labinvest.2009.13; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Munnix ICA, 2003, THROMB HAEMOSTASIS, V89, P687, DOI 10.1055/s-0037-1613576; Munnix ICA, 2007, ARTERIOSCL THROM VAS, V27, P2484, DOI 10.1161/ATVBAHA.107.151100; Munnix ICA, 2009, THROMB HAEMOSTASIS, V102, P1149, DOI 10.1160/TH09-05-0289; Naik MU, 2012, BLOOD, V119, P3352, DOI 10.1182/blood-2011-12-397398; Nieswandt B, 2009, J THROMB HAEMOST, V7, P206, DOI 10.1111/j.1538-7836.2009.03370.x; Pfaff M, 1999, FEBS LETT, V460, P17, DOI 10.1016/S0014-5793(99)01250-8; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Siljander PRM, 2004, BLOOD, V103, P1333, DOI 10.1182/blood-2003-03-00869; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; van der Meijden PEJ, 2008, FEBS J, V275, P371, DOI 10.1111/j.1742-4658.2007.06207.x; van Kruchten R, 2013, BLOOD, V121, P1850, DOI 10.1182/blood-2012-09-454314; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; Wolfs JLN, 2005, CELL MOL LIFE SCI, V62, P1514, DOI 10.1007/s00018-005-5099-y; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200	42	80	82	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13325	13336		10.1074/jbc.M112.428359	http://dx.doi.org/10.1074/jbc.M112.428359			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23519467	Green Published, hybrid			2022-12-28	WOS:000318850300018
J	Niu, YL; Xia, YS; Wang, SS; Li, JN; Niu, CY; Li, X; Zhao, YH; Xiong, HY; Li, Z; Lou, HQ; Cao, QH				Niu, Yanling; Xia, Yisui; Wang, Sishuo; Li, Jiani; Niu, Caoyuan; Li, Xiao; Zhao, Yuehui; Xiong, Huiyang; Li, Zhen; Lou, Huiqiang; Cao, Qinhong			A Prototypic Lysine Methyltransferase 4 from Archaea with Degenerate Sequence Specificity Methylates Chromatin Proteins Sul7d and Cren7 in Different Patterns	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3K79 METHYLATION; DIVERSE FUNCTIONS; DNA; DOT1; DOMAIN; YEAST; IDENTIFICATION; REPLICATION; COMPLEXES; BACTERIA	Histone methylation is one of the major epigenetic modifications even in early diverging unicellular eukaryotes. We show that a widespread lysine methyltransferase from Archaea (aKMT4), bears striking structural and functional resemblance to the core of distantly related eukaryotic KMT4/Dot1. aKMT4 methylates a set of various proteins, including the chromatin proteins Sul7d and Cren7, and RNA exosome components. Csl4- and Rrp4-exosome complexes are methylated in different patterns. aKMT4 can self-methylate intramolecularly and compete with other proteins for the methyl group. Automethylation is inhibited by suitable substrates or DNA in a concentration-dependent manner. The automethylated enzyme shows relatively compromised activity. aKMT4-8A mutant with abrogated automethylation shows a more than 150% increase in methylation of substrates, suggesting a possible mechanism to regulate methyltransferase activity. More interestingly, methylation of Sul7d, but not Cren7, by aKMT4 is significantly enhanced by DNA. MS/MS and kinetic analysis further suggest that aKMT4 methylates Sul7d in the chromatin context. These data provide a clue to the possible regulation of aKMT4 activity by the local chromatin environment, albeit as a promiscuous enzyme required for extensive and variegated lysine methylation in Sulfolobus. This study supports the prokaryotic origin model of eukaryotic histone modification enzymes and sheds light on regulation of archaeal chromatin.	[Niu, Yanling; Xia, Yisui; Wang, Sishuo; Li, Jiani; Niu, Caoyuan; Li, Xiao; Zhao, Yuehui; Xiong, Huiyang; Li, Zhen; Lou, Huiqiang; Cao, Qinhong] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Niu, Yanling; Xia, Yisui; Wang, Sishuo; Li, Jiani; Niu, Caoyuan; Li, Xiao; Zhao, Yuehui; Xiong, Huiyang; Li, Zhen; Lou, Huiqiang; Cao, Qinhong] China Agr Univ, Coll Biol Sci, Minist Agr, Key Lab Soil Microbiol, Beijing 100193, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs	Lou, HQ (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	lou@cau.edu.cn; caoqinhong@cau.edu.cn	Lou, Huiqiang/B-6287-2012; Wang, Sishuo/S-1993-2019	Lou, Huiqiang/0000-0003-4465-6186; Wang, Sishuo/0000-0002-7220-7305; Xia, Yisui/0000-0002-5576-2147; Wang, Sishuo/0000-0002-2695-7607	National Natural Science Foundation of China [31200052, 30970063, 31071095]; Program for New Century Excellent Talents in University of China; Chinese Universities Scientific Fund; Open Project Program of the State Key Laboratory of Microbial Resources; Scholarship Award for Excellent Doctoral Student; Ministry of Education	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); Chinese Universities Scientific Fund; Open Project Program of the State Key Laboratory of Microbial Resources; Scholarship Award for Excellent Doctoral Student; Ministry of Education	This work was supported by National Natural Science Foundation of China Grants 31200052 (to Q. C.) and 30970063 and 31071095 (to H. L.); the Program for New Century Excellent Talents in University of China (to H. L.); the Chinese Universities Scientific Fund; the Open Project Program of the State Key Laboratory of Microbial Resources; and the Scholarship Award for Excellent Doctoral Student granted by the Ministry of Education (to Y. N.).	Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; Aravind L, 2011, PROG MOL BIOL TRANSL, V101, P105, DOI 10.1016/B978-0-12-387685-0.00004-4; Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; BAUMANN H, 1994, NAT STRUCT BIOL, V1, P808, DOI 10.1038/nsb1194-808; Bell SD, 2002, SCIENCE, V296, P148, DOI 10.1126/science.1070506; Bell SD, 2010, BACTERIAL CHROMATIN, P205, DOI 10.1007/978-90-481-3473-1_10; Botting CH, 2010, ARCHAEA, V2010, DOI 10.1155/2010/106341; Buttner K, 2005, MOL CELL, V20, P461, DOI 10.1016/j.molcel.2005.10.018; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; CHOLI T, 1988, BIOCHIM BIOPHYS ACTA, V950, P193, DOI 10.1016/0167-4781(88)90011-5; Chu YD, 2012, J BACTERIOL, V194, P6917, DOI 10.1128/JB.01535-12; Contursi P, 2006, EXTREMOPHILES, V10, P615, DOI 10.1007/s00792-006-0017-2; Driessen RPC, 2013, NUCLEIC ACIDS RES, V41, P196, DOI 10.1093/nar/gks1053; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichler J, 2005, MICROBIOL MOL BIOL R, V69, P393, DOI 10.1128/MMBR.69.3.393-425.2005; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Forbes AJ, 2004, P NATL ACAD SCI USA, V101, P2678, DOI 10.1073/pnas.0306575101; Frederiks F, 2008, NAT STRUCT MOL BIOL, V15, P550, DOI 10.1038/nsmb.1432; Guo L, 2008, NUCLEIC ACIDS RES, V36, P1129, DOI 10.1093/nar/gkm1128; Guo L, 2011, J BACTERIOL, V193, P1672, DOI 10.1128/JB.01487-10; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; Lou HQ, 2004, J BIOL CHEM, V279, P127, DOI 10.1074/jbc.M309860200; Luijsterburg MS, 2008, CRIT REV BIOCHEM MOL, V43, P393, DOI [10.1080/10409230802528488, 10.1080/10409230802528488 ]; Manzur KL, 2005, FEBS LETT, V579, P3859, DOI 10.1016/j.febslet.2005.05.026; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Martino F, 2009, MOL CELL, V33, P323, DOI 10.1016/j.molcel.2009.01.009; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Myllykallio H, 2000, SCIENCE, V288, P2212, DOI 10.1126/science.288.5474.2212; Napoli A, 2002, NUCLEIC ACIDS RES, V30, P2656, DOI 10.1093/nar/gkf377; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Niu LF, 2007, EMBO REP, V8, P1190, DOI 10.1038/sj.embor.7401111; Reno ML, 2009, P NATL ACAD SCI USA, V106, P8605, DOI 10.1073/pnas.0808945106; Rossmann MP, 2011, MOL CELL, V42, P127, DOI 10.1016/j.molcel.2011.03.007; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sandman K, 2006, CURR OPIN MICROBIOL, V9, P520, DOI 10.1016/j.mib.2006.08.003; Sasin JM, 2004, NUCLEIC ACIDS RES, V32, pW586, DOI 10.1093/nar/gkh440; Sawada K, 2004, J BIOL CHEM, V279, P43296, DOI 10.1074/jbc.M405902200; Siddique A, 2011, FEBS J, V278, P2055, DOI 10.1111/j.1742-4658.2011.08121.x; Singer MS, 1998, GENETICS, V150, P613; Takahashi YH, 2011, MOL CELL, V42, P118, DOI 10.1016/j.molcel.2011.03.006; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Witharana C, 2012, BIOCHIMIE, V94, P1578, DOI 10.1016/j.biochi.2012.03.026; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Xu M, 2012, METHOD ENZYMOL, V512, P29, DOI 10.1016/B978-0-12-391940-3.00002-0; Zhou XF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-294	53	26	29	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13728	13740		10.1074/jbc.M113.452979	http://dx.doi.org/10.1074/jbc.M113.452979			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23530048	Green Published, hybrid			2022-12-28	WOS:000318850300055
J	Russo, SB; Tidhar, R; Futerman, AH; Cowart, LA				Russo, Sarah Brice; Tidhar, Rotem; Futerman, Anthony H.; Cowart, L. Ashley			Myristate-derived d16:0 Sphingolipids Constitute a Cardiac Sphingolipid Pool with Distinct Synthetic Routes and Functional Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN SERINE PALMITOYLTRANSFERASE; CELL-DEATH; CERAMIDE SYNTHASES; LONG-CHAIN; SPHINGOSINE; DIHYDROCERAMIDE; IDENTIFICATION; ACCUMULATION; SPECIFICITY; METABOLISM	The enzyme serine palmitoyltransferase (SPT) catalyzes the formation of the sphingoid base "backbone" from which all sphingolipids are derived. Previous studies have shown that inhibition of SPT ameliorates pathological cardiac outcomes in models of lipid overload, but the metabolites responsible for these phenotypes remain unidentified. Recent in vitro studies have shown that incorporation of the novel subunit SPTLC3 broadens the substrate specificity of SPT, allowing utilization of myristoyl-coenzyme A (CoA) in addition to its canonical substrate palmitoyl-CoA. However, the relevance of these findings in vivo has yet to be determined. The present study sought to determine whether myristate-derived d16 sphingolipids are represented among myocardial sphingolipids and, if so, whether their function and metabolic routes were distinct from those of palmitate-derived d18 sphingolipids. Data showed that d16: 0 sphingoid bases occurred in more than one-third of total dihydrosphingosine and dihydroceramides in myocardium, and a diet high in saturated fat promoted their de novo production. Intriguingly, d16-ceramides demonstrated highly limited N-acyl chain diversity, and in vitro enzyme activity assays showed that these bases were utilized preferentially to canonical bases by CerS1. Functional differences between myristate- and palmitate-derived sphingolipids were observed in that, unlike d18 sphingolipids and SPTLC2, d16 sphingolipids and SPTLC3 did not appear to contribute to myristate-induced autophagy, whereas only d16 sphingolipids promoted cell death and cleavage of poly(ADPribose) polymerase in cardiomyocytes. Thus, these results reveal a previously unappreciated component of cardiac sphingolipids with functional differences from canonical sphingolipids.	[Russo, Sarah Brice; Cowart, L. Ashley] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29403 USA; [Tidhar, Rotem; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Cowart, L. Ashley] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29403 USA	Medical University of South Carolina; Weizmann Institute of Science; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Cowart, LA (corresponding author), Med Univ S Carolina, Ralph H Johnson Vet Affairs Med Ctr, Dept Biochem & Mol Biol, 173 Ashley Ave,MSC509, Charleston, SC 29403 USA.	cowartl@musc.edu		Futerman, Anthony/0000-0003-0013-0115	National Institutes of Health (NIH), NIDDK [F30DK092125]; NIH [P30 CA138313, P20 RR017677]; NIH COBRE in Lipidomics and Pathobiology at MUSC; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK092125] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH COBRE in Lipidomics and Pathobiology at MUSC; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NIDDK, Grant F30DK092125 (to S. B. R.); NIH Grant P30 CA138313 (Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina (MUSC)); NIH Grant P20 RR017677 (Lipidomics Core in the South Carolina Lipidomics and Pathobiology Centers of Biomedical Research Excellence (COBRE), Department of Biochemistry, MUSC); and the NIH COBRE in Lipidomics and Pathobiology at MUSC (to L. A. C.). This work was also supported by a Merit Award from the Department of Veterans Affairs (to L. A. C.).	Baranowski M, 2011, ADV EXP MED BIOL, V721, P41, DOI 10.1007/978-1-4614-0650-1_3; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Brice SE, 2011, ADV EXP MED BIOL, V721, P1, DOI 10.1007/978-1-4614-0650-1_1; Bugger H, 2009, DIS MODEL MECH, V2, P454, DOI 10.1242/dmm.001941; Chiong M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.130; Cowart LA, 2009, TRENDS ENDOCRIN MET, V20, P34, DOI 10.1016/j.tem.2008.09.004; Cybulski LE, 2011, CURR PROTEIN PEPT SC, V12, P760; Dupuy F, 2011, LANGMUIR, V27, P3783, DOI 10.1021/la105011x; Dyntar D, 2001, DIABETES, V50, P2105, DOI 10.2337/diabetes.50.9.2105; El Bawab S, 2001, J BIOL CHEM, V276, P16758, DOI 10.1074/jbc.M009331200; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Goni FM, 2006, BBA-BIOMEMBRANES, V1758, P1902, DOI 10.1016/j.bbamem.2006.09.011; Goni FM, 2009, BBA-BIOMEMBRANES, V1788, P169, DOI 10.1016/j.bbamem.2008.09.002; Guha A, 2008, CURR OPIN CARDIOL, V23, P241, DOI 10.1097/HCO.0b013e3282fcc2fa; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Harmancey R, 2010, J LIPID RES, V51, P1380, DOI 10.1194/jlr.M001230; Harmon JM, 2013, J BIOL CHEM, V288, P10144, DOI 10.1074/jbc.M113.451526; Hicks AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000672; Holopainen JM, 2001, BIOPHYS J, V80, P765, DOI 10.1016/S0006-3495(01)76056-0; Hornemann T, 2007, BIOCHEM J, V405, P157, DOI 10.1042/BJ20070025; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; Hornemann T, 2009, J BIOL CHEM, V284, P26322, DOI 10.1074/jbc.M109.023192; Hu W, 2009, J LIPID RES, V50, P1852, DOI 10.1194/jlr.M800635-JLR200; Ibarguren M, 2010, BBA-BIOMEMBRANES, V1798, P59, DOI 10.1016/j.bbamem.2009.10.017; Igarashi J, 2008, CIRC RES, V102, P630, DOI 10.1161/CIRCRESAHA.108.173799; Jenkins GM, 2002, J BIOL CHEM, V277, P42572, DOI 10.1074/jbc.M207346200; KENT RL, 1989, AM J PHYSIOL, V257, pH1717, DOI 10.1152/ajpheart.1989.257.5.H1717; Knaapen MWM, 2001, CARDIOVASC RES, V51, P304, DOI 10.1016/S0008-6363(01)00290-5; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Lee SY, 2012, J BIOL CHEM, V287, P18429, DOI 10.1074/jbc.M111.296947; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Megha, 2007, BBA-BIOMEMBRANES, V1768, P2205, DOI 10.1016/j.bbamem.2007.05.007; MERRILL AH, 1985, J LIPID RES, V26, P617; MERRILL AH, 1984, J LIPID RES, V25, P185; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Mimeault M, 2002, FEBS LETT, V530, P9, DOI 10.1016/S0014-5793(02)03432-4; Mirkov S, 2012, METABOLISM, V61, P1523, DOI 10.1016/j.metabol.2012.05.004; Montes LR, 2002, J BIOL CHEM, V277, P11788, DOI 10.1074/jbc.M111568200; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; *NAT RES COUNC, 1985, NIH PUBL, V8523; Nishio M, 2004, J BIOL CHEM, V279, P33368, DOI 10.1074/jbc.M403816200; Novgorodov SA, 2011, J BIOL CHEM, V286, P25352, DOI 10.1074/jbc.M110.214866; Nybond S, 2005, BBA-BIOMEMBRANES, V1718, P61, DOI 10.1016/j.bbamem.2005.10.009; Nyholm TKM, 2010, BBA-BIOMEMBRANES, V1798, P1008, DOI 10.1016/j.bbamem.2009.12.025; Othman A, 2012, DIABETOLOGIA, V55, P421, DOI 10.1007/s00125-011-2384-1; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Rotstein NP, 2010, J LIPID RES, V51, P1247, DOI 10.1194/jlr.R003442; Russo SB, 2012, J CLIN INVEST, V122, P3919, DOI 10.1172/JCI63888; Senkal CE, 2007, MOL CANCER THER, V6, P712, DOI 10.1158/1535-7163.MCT-06-0558; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Sot J, 2005, BIOPHYS J, V88, P3368, DOI 10.1529/biophysj.104.057851; Sullards MC, 2007, METHOD ENZYMOL, V432, P83, DOI 10.1016/S0076-6879(07)32004-1; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; Tidhar R, 2012, J BIOL CHEM, V287, P3197, DOI 10.1074/jbc.M111.280271; van de Weijer T, 2011, CARDIOVASC RES, V92, P10, DOI 10.1093/cvr/cvr212; Wieder T, 1997, FEBS LETT, V411, P260, DOI 10.1016/S0014-5793(97)00717-5; WILLIAMS RD, 1986, J LIPID RES, V27, P763	63	48	48	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13397	13409		10.1074/jbc.M112.428185	http://dx.doi.org/10.1074/jbc.M112.428185			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23530041	Green Published, hybrid			2022-12-28	WOS:000318850300025
J	Barcus, CE; Keely, PJ; Eliceiri, KW; Schuler, LA				Barcus, Craig E.; Keely, Patricia J.; Eliceiri, Kevin W.; Schuler, Linda A.			Stiff Collagen Matrices Increase Tumorigenic Prolactin Signaling in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; EPITHELIAL-SPECIFIC DISRUPTION; EXTRACELLULAR-MATRIX; MAMMOGRAPHIC DENSITY; GENE-EXPRESSION; MAMMARY TUMORIGENESIS; INTEGRIN; RECEPTOR; STAT5; RISK	Clinically, circulating prolactin levels and density of the extracellular matrix (ECM) are individual risk factors for breast cancer. As tumors develop, the surrounding stroma responds with increased deposition and cross-linking of the collagen matrix (desmoplasia). In mouse models, prolactin promotes mammary carcinomas that resemble luminal breast cancers in women, and increased collagen density promotes tumor metastasis and progression. Although the contributions of the ECM to the physiologic actions of prolactin are increasingly understood, little is known about the functional relationship between the ECM and prolactin signaling in breast cancer. Here, we examined consequences of increased ECM stiffness on prolactin signals to luminal breast cancer cells in three-dimensional collagen I matrices in vitro. We showed that matrix stiffness potently regulates a switch in prolactin signals from physiologic to protumorigenic outcomes. Compliant matrices promoted physiological prolactin actions and activation of STAT5, whereas stiff matrices promoted protumorigenic outcomes, including increased matrix metalloproteinase-dependent invasion and collagen scaffold realignment. In stiff matrices, prolactin increased SRC family kinase-dependent phosphorylation of focal adhesion kinase (FAK) at tyrosine 925, FAK association with the mitogen-activated protein kinase mediator GRB2, and pERK1/2. Stiff matrices also increased co-localization of prolactin receptors and integrin-activated FAK, implicating altered spatial relationships. Together, these results demonstrate that ECM stiffness is a powerful regulator of the spectrum of prolactin signals and that stiff matrices and prolactin interact in a feed-forward loop in breast cancer progression. Our study is the first reported evidence of altered ECM-prolactin interactions in breast cancer, suggesting the potential for new therapeutic approaches.	[Barcus, Craig E.; Schuler, Linda A.] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53706 USA; [Keely, Patricia J.] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Barcus, Craig E.; Keely, Patricia J.; Schuler, Linda A.] Univ Wisconsin, Cellular & Mol Biol Program, Madison, WI 53706 USA; [Keely, Patricia J.; Eliceiri, Kevin W.; Schuler, Linda A.] Univ Wisconsin, Lab Cellular & Mol Biol, Madison, WI 53706 USA; [Keely, Patricia J.; Eliceiri, Kevin W.; Schuler, Linda A.] Univ Wisconsin, Lab Opt & Computat Instrumentat, Madison, WI 53706 USA; [Keely, Patricia J.; Eliceiri, Kevin W.; Schuler, Linda A.] Univ Wisconsin, Paul P Carbone Comprehens Canc Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Schuler, LA (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, 2015 Linden Dr, Madison, WI 53706 USA.	schulerl@svm.vetmed.wisc.edu	Eliceiri, Kevin/ABD-4516-2020	Eliceiri, Kevin/0000-0001-8678-670X; Barcus, Craig/0000-0001-9887-0503	National Institutes of Health [R01CA157675, R01CA142833, R01CA114462, R01CA136590]; Regenerative Biology Scholar's Award; Regenerative Biological Sciences Scholar's Award; Comparative Biosciences, University of Wisconsin School of Veterinary Medicine; NATIONAL CANCER INSTITUTE [R01CA157675, P30CA014520, R01CA136590, R01CA179556, R01CA114462, R01CA142833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Regenerative Biology Scholar's Award; Regenerative Biological Sciences Scholar's Award; Comparative Biosciences, University of Wisconsin School of Veterinary Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA157675 (to L. A. S.), R01CA142833 and R01CA114462 (to P. J. K.), and R01CA136590 (to the Laboratory for Optical and Computational Instrumentation). This work was also supported by a Regenerative Biology Scholar's Award and Biological Sciences Scholar's Award (to C. E. B.) and by Comparative Biosciences, University of Wisconsin School of Veterinary Medicine.	Acosta JJ, 2003, MOL ENDOCRINOL, V17, P2268, DOI 10.1210/me.2002-0422; Akhtar N, 2009, DEVELOPMENT, V136, P1019, DOI 10.1242/dev.028423; Akhtar N, 2006, J CELL BIOL, V173, P781, DOI 10.1083/jcb.200601059; Arendt LM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2819; Arendt LM, 2009, J ENDOCRINOL, V203, P99, DOI 10.1677/JOE-09-0221; Arendt LM, 2006, AM J PATHOL, V168, P1365, DOI 10.2353/ajpath.2006.050861; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Boateng LR, 2012, EUR J CELL BIOL, V91, P878, DOI 10.1016/j.ejcb.2012.06.003; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; Bremnes Y, 2007, INT J CANCER, V121, P2506, DOI 10.1002/ijc.22971; Brunton VG, 2005, CANCER RES, V65, P1335, DOI 10.1158/0008-5472.CAN-04-1949; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Canbay E, 1997, BIOCHEM J, V324, P231, DOI 10.1042/bj3240231; Carver KC, 2008, MOL CANCER RES, V6, P634, DOI 10.1158/1541-7786.MCR-07-2069; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Chan KT, 2009, J CELL BIOL, V185, P357, DOI 10.1083/jcb.200809110; Clevenger CV, 2003, ENDOCR REV, V24, P1, DOI 10.1210/er.2001-0036; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Cotarla I, 2004, INT J CANCER, V108, P665, DOI 10.1002/ijc.11619; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Du JY, 2012, J CELL PHYSIOL, V227, P1553, DOI 10.1002/jcp.22886; Fernandez I, 2010, J NEUROENDOCRINOL, V22, P771, DOI 10.1111/j.1365-2826.2010.02011.x; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Gass S, 2003, J MAMMARY GLAND BIOL, V8, P269, DOI 10.1023/B:JOMG.0000010029.85796.63; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gioni V, 2008, MOL CANCER RES, V6, P706, DOI 10.1158/1541-7786.MCR-07-0355; Greendale GA, 2007, BREAST CANCER RES TR, V105, P337, DOI 10.1007/s10549-006-9454-y; Gutzman JH, 2007, ONCOGENE, V26, P6341, DOI 10.1038/sj.onc.1210454; Gutzman JH, 2004, MOL ENDOCRINOL, V18, P3064, DOI 10.1210/me.2004-0187; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hennighausen L, 1997, J MAMMARY GLAND BIOL, V2, P365, DOI 10.1023/A:1026347313096; Ingman WV, 2006, DEV DYNAM, V235, P3222, DOI 10.1002/dvdy.20972; Jacobson EM, 2011, DISCOV MED, V11, P315; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Katz E, 2007, INT J BIOCHEM CELL B, V39, P715, DOI 10.1016/j.biocel.2006.11.004; Keely PJ, 2011, J MAMMARY GLAND BIOL, V16, P205, DOI 10.1007/s10911-011-9226-0; KEELY PJ, 1995, DIFFERENTIATION, V59, P1, DOI 10.1046/j.1432-0436.1995.5910001.x; KLEINER DE, 1994, ANAL BIOCHEM, V218, P325, DOI 10.1006/abio.1994.1186; Kohrmann A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-188; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Lahlou H, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2905; Li T, 2005, CANCER EPIDEM BIOMAR, V14, P343, DOI 10.1158/1055-9965.EPI-04-0490; Luo M, 2009, CANCER RES, V69, P466, DOI 10.1158/0008-5472.CAN-08-3078; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; Mohler W, 2003, METHODS, V29, P97, DOI 10.1016/S1046-2023(02)00292-X; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Mould AP, 1996, J BIOL CHEM, V271, P20365, DOI 10.1074/jbc.271.34.20365; Oakes SR, 2008, J MAMMARY GLAND BIOL, V13, P13, DOI 10.1007/s10911-008-9069-5; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Peck AR, 2011, J CLIN ONCOL, V29, P2448, DOI 10.1200/JCO.2010.30.3552; Piazza TM, 2009, MOL ENDOCRINOL, V23, P202, DOI 10.1210/me.2008-0341; PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349, DOI 10.1091/mbc.6.10.1349; Plotnikov A, 2008, CANCER RES, V68, P1354, DOI 10.1158/0008-5472.CAN-07-6094; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2008, AM J PATHOL, V173, P1551, DOI 10.2353/ajpath.2008.080308; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; SATO H, 1993, ONCOGENE, V8, P395; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHLAEPFER DD, 1994, NATURE, V372, P786; Schroeder MD, 2002, MOL ENDOCRINOL, V16, P45, DOI 10.1210/me.16.1.45; Singh J, 2002, ONCOGENE, V21, P1812, DOI 10.1038/sj.onc.1205252; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Sultan AS, 2005, ONCOGENE, V24, P746, DOI 10.1038/sj.onc.1208203; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Tworoger SS, 2008, J MAMMARY GLAND BIOL, V13, P41, DOI 10.1007/s10911-008-9063-y; Vachon CM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1829; Wagner KU, 2004, MOL CELL BIOL, V24, P5510, DOI 10.1128/MCB.24.12.5510-5520.2004; Walker RA, 2001, BREAST CANCER RES, V3, P143, DOI 10.1186/bcr287; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P569, DOI 10.1016/j.ceb.2012.06.010; Wozniak MA, 2005, BIOL PROCED ONLINE, V7, P144, DOI 10.1251/bpo112; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Xu C, 2012, BREAST CANCER RES TR, V134, P157, DOI 10.1007/s10549-012-1954-3; Yamashita H, 2006, ENDOCR-RELAT CANCER, V13, P885, DOI 10.1677/erc.1.01095	79	103	106	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12722	12732		10.1074/jbc.M112.447631	http://dx.doi.org/10.1074/jbc.M112.447631			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23530035	Green Published, hybrid			2022-12-28	WOS:000318555100029
J	Hix, LM; Karavitis, J; Khan, MW; Shi, YH; Khazaie, K; Zhang, M				Hix, Laura M.; Karavitis, John; Khan, Mohammad W.; Shi, Yihui H.; Khazaie, Khashayarsha; Zhang, Ming			Tumor STAT1 Transcription Factor Activity Enhances Breast Tumor Growth and Immune Suppression Mediated by Myeloid-derived Suppressor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; IFN-GAMMA; INFILTRATING LYMPHOCYTES; TARGETED DISRUPTION; MAMMARY CARCINOMAS; SIGNAL TRANSDUCER; ADAPTIVE IMMUNITY; NECROSIS-FACTOR; CANCER-CELLS; BEARING MICE	Previous studies had implicated the IFN-gamma transcription factor signal transducer and activator of transcription 1 (STAT1) as a tumor suppressor. However, accumulating evidence has correlated increased STAT1 activation with increased tumor progression in multiple types of cancer, including breast cancer. Indeed, we present evidence that tumor up-regulation of STAT1 activity in human and mouse mammary tumors correlates with increasing disease progression to invasive carcinoma. A microarray analysis comparing low aggressive TM40D and highly aggressive TM40D-MB mouse mammary carcinoma cells revealed significantly higher STAT1 activity in the TM40D-MB cells. Ectopic overexpression of constitutively active STAT1 in TM40D cells promoted mobilization of myeloid-derived suppressor cells (MDSCs) and inhibition of antitumor T cells, resulting in aggressive tumor growth in tumor-transplanted, immunocompetent mice. Conversely, gene knockdown of STAT1 in the metastatic TM40D-MB cells reversed these events and attenuated tumor progression. Importantly, we demonstrate that in human breast cancer, the presence of tumor STAT1 activity and tumor-recruited CD33(+) myeloid cells correlates with increasing disease progression from ductal carcinoma in situ to invasive carcinoma. We conclude that STAT1 activity in breast cancer cells is responsible for shaping an immunosuppressive tumor microenvironment, and inhibiting STAT1 activity is a promising immune therapeutic approach.	[Hix, Laura M.; Karavitis, John; Shi, Yihui H.; Zhang, Ming] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol, Chicago, IL 60611 USA; [Hix, Laura M.; Karavitis, John; Shi, Yihui H.; Zhang, Ming] Northwestern Univ, Feinberg Sch Med, Dept Biol Chem, Chicago, IL 60611 USA; [Hix, Laura M.; Karavitis, John; Khan, Mohammad W.; Shi, Yihui H.; Khazaie, Khashayarsha; Zhang, Ming] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Zhang, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol, Chicago, IL 60611 USA.	m-zhang@northwestern.edu			Department of Defense [W81XWH-10-1-0200, W81XWH-10-1-0685]; Susan G. Komen for the Cure Foundation [KG 080231]	Department of Defense(United States Department of Defense); Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation)	This work was supported by Department of Defense Predoctoral Fellowship W81XWH-10-1-0200 (to L. M. H.), Department of Defense Idea Award W81XWH-10-1-0685 (to K. K. and M. Z.), and Susan G. Komen for the Cure Foundation Grant KG 080231 (to M. Z.).	AALTOMAA S, 1992, EUR J CANCER, V28A, P859, DOI 10.1016/0959-8049(92)90134-N; Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; American Cancer Society Inc, BREAST CANC FACTS FI; Brooks B, 1997, INT J CANCER, V73, P690, DOI 10.1002/(SICI)1097-0215(19971127)73:5<690::AID-IJC13>3.0.CO;2-A; Buess M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r191; Bui JD, 2007, CURR OPIN IMMUNOL, V19, P203, DOI 10.1016/j.coi.2007.02.001; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Chan SR, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3100; Cheon EC, 2011, CANCER RES, V71, P1627, DOI 10.1158/0008-5472.CAN-10-1923; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Critchley-Thorne RJ, 2007, PLOS MED, V4, P897, DOI 10.1371/journal.pmed.0040176; de Prati AC, 2005, CURR MED CHEM, V12, P1819, DOI 10.2174/0929867054546645; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Demaria S, 2001, CLIN CANCER RES, V7, P3025; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gross S, 2008, IMMUNOL LETT, V116, P7, DOI 10.1016/j.imlet.2007.11.012; Handel-Fernandez ME, 2009, ANTICANCER RES, V29, P2051; Hix LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020702; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Karavitis J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046342; Kaur T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.63; Khazaie K, 2006, SEMIN CANCER BIOL, V16, P124, DOI 10.1016/j.semcancer.2005.11.006; Khodarev N, 2010, ONCOGENE, V29, P920, DOI 10.1038/onc.2009.391; Khodarev NN, 2007, CANCER RES, V67, P9214, DOI 10.1158/0008-5472.CAN-07-1019; Khodarev NN, 2012, CLIN CANCER RES, V18, P3015, DOI 10.1158/1078-0432.CCR-11-3225; Khodarev NN, 2004, P NATL ACAD SCI USA, V101, P1714, DOI 10.1073/pnas.0308102100; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kovacic B, 2006, CANCER CELL, V10, P77, DOI 10.1016/j.ccr.2006.05.025; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571; Li JN, 2007, J INTERF CYTOK RES, V27, P209, DOI 10.1089/jir.2006.0111; Li ZG, 2008, CLIN EXP METASTAS, V25, P389, DOI 10.1007/s10585-007-9117-3; Lin WJ, 2005, SHOCK, V24, P206, DOI 10.1097/01.shk.0000180074.69143.77; Lynch RA, 2007, CANCER RES, V67, P1254, DOI 10.1158/0008-5472.CAN-06-2439; Manavi M, 2007, GYNECOL ONCOL, V105, P418, DOI 10.1016/j.ygyno.2006.12.032; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Melani C, 2003, BLOOD, V102, P2138, DOI 10.1182/blood-2003-01-0190; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Mocellin S, 2005, CYTOKINE GROWTH F R, V16, P35, DOI 10.1016/j.cytogfr.2004.11.001; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Ochoa AC, 2007, CLIN CANCER RES, V13, p721S, DOI 10.1158/1078-0432.CCR-06-2197; Ohmori Y, 2001, J LEUKOCYTE BIOL, V69, P598; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Schultz J, 2010, CLIN EXP METASTAS, V27, P133, DOI 10.1007/s10585-010-9310-7; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shi HY, 2003, HISTOL HISTOPATHOL, V18, P201, DOI 10.14670/HH-18.201; Shi HY, 2001, CANCER RES, V61, P6945; Simons DL, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-52; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; TANAKA K, 1986, CANCER IMMUNOL IMMUN, V22, P37; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wang HY, 2007, CURR OPIN IMMUNOL, V19, P217, DOI 10.1016/j.coi.2007.02.004; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; Xuan YT, 2003, J MOL CELL CARDIOL, V35, P525, DOI 10.1016/S0022-2828(03)00076-2; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	64	92	93	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11676	11688		10.1074/jbc.M112.441402	http://dx.doi.org/10.1074/jbc.M112.441402			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486482	Green Published, hybrid			2022-12-28	WOS:000318157600006
J	Hennen, E; Safina, D; Haussmann, U; Worsdorfer, P; Edenhofer, F; Poetsch, A; Faissner, A				Hennen, Eva; Safina, Dina; Haussmann, Ute; Woersdoerfer, Philipp; Edenhofer, Frank; Poetsch, Ansgar; Faissner, Andreas			A LewisX Glycoprotein Screen Identifies the Low Density Lipoprotein Receptor-related Protein 1 (LRP1) as a Modulator of Oligodendrogenesis in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; SIGNALING PATHWAY; CRE RECOMBINASE; NEURAL DEVELOPMENT; NERVOUS-SYSTEM; PROLIFERATION; MIGRATION; KNOCKOUT; NEURONS; CNS	In the developing and adult CNS multipotent neural stem cells reside in distinct niches. Specific carbohydrates and glycoproteins are expressed in these niche microenvironments which are important regulators of stem cell maintenance and differentiation fate. LewisX (LeX), also known as stage-specific embryonic antigen-1 or CD15, is a defined carbohydrate moiety expressed in niche microenvironments of the developing and adult CNS. LeX-glycans are involved in stem cell proliferation, migration, and stemness. A few LeX carrier proteins are known, but a systematic analysis of the targets of LeX glycosylation in vivo has not been performed so far. Using LeX glycosylation as a biomarker we aimed to discover new glycoproteins with a potential functional relevance for CNS development. By immunoaffinity chromatography we enriched LeX glycoproteins from embryonic and postnatal mouse brains and used one-dimensional nLC-ESI-MS/MS for their identification. We could validate phosphacan, tenascin-C, and L1-CAM as major LeX carrier proteins present in vivo. Furthermore, we identified LRP1, a member of theLDLreceptor family, as a new LeX carrier protein expressed by mouse neural stem cells. Surprisingly, little is known about LRP1 function for neural stem cells. Thus, we generated Lrp1 knock-out neural stem cells by Cre-mediated recombination and investigated their properties. Here, we provide first evidence that LRP1 is necessary for the differentiation of neural stem cells toward oligodendrocytes. However, this function is independent of LeX glycosylation.	[Hennen, Eva; Safina, Dina; Faissner, Andreas] Ruhr Univ Bochum, Dept Cell Morphol & Mol Neurobiol, D-44780 Bochum, Germany; [Haussmann, Ute; Poetsch, Ansgar] Ruhr Univ Bochum, Dept Plant Biochem, D-44780 Bochum, Germany; [Woersdoerfer, Philipp; Edenhofer, Frank] Univ Bonn, Life & Brain Ctr, Inst Reconstruct Neurobiol, Stem Cell Engn Grp, D-53105 Bonn, Germany	Ruhr University Bochum; Ruhr University Bochum; University of Bonn	Faissner, A (corresponding author), Ruhr Univ Bochum, Dept Cell Morphol & Mol Neurobiol, Univ Str 150,NDEF 05-593, D-44780 Bochum, Germany.	andreas.faissner@rub.de	Faissner, Andreas/A-5314-2008; Poetsch, Ansgar/A-1862-2013; Edenhofer, Frank/ABG-9458-2020	Faissner, Andreas/0000-0002-2211-8259; Poetsch, Ansgar/0000-0002-7540-3475; Edenhofer, Frank/0000-0002-6489-714X; Worsdorfer, Philipp/0000-0003-3398-3229	German Research Foundation Deutsche Forschungsgemeinschaft Grants [Fa 159/16-1, ED79/1-2]; Federal Ministry of Education and Research Grant [BMBF 01GN0503]	German Research Foundation Deutsche Forschungsgemeinschaft Grants(German Research Foundation (DFG)); Federal Ministry of Education and Research Grant	This work was supported by the German Research Foundation Deutsche Forschungsgemeinschaft Grants Fa 159/16-1 (to A. F.) and ED79/1-2 (to F. E.) and by the Federal Ministry of Education and Research Grant BMBF 01GN0503 (to A. F.).	BAZIN H, 1984, J IMMUNOL METHODS, V66, P261, DOI 10.1016/0022-1759(84)90337-5; BU GJ, 1994, J BIOL CHEM, V269, P18521; Capela A, 2006, DEV BIOL, V291, P300, DOI 10.1016/j.ydbio.2005.12.030; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Czopka T, 2009, CELL TISSUE RES, V338, P161, DOI 10.1007/s00441-009-0868-9; FAISSNER A, 1990, NEURON, V5, P627, DOI 10.1016/0896-6273(90)90217-4; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Gan HT, 2011, J NEUROCHEM, V117, P565, DOI 10.1111/j.1471-4159.2011.07227.x; Gaultier A, 2009, J CELL SCI, V122, P1155, DOI 10.1242/jcs.040717; Haussmann U, 2012, J PROTEOMICS, V75, P2649, DOI 10.1016/j.jprot.2012.03.005; Hennen E, 2012, INT J BIOCHEM CELL B, V44, P830, DOI 10.1016/j.biocel.2012.02.019; Hennen E, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201095; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Li YL, 2009, FEBS LETT, V583, P703, DOI 10.1016/j.febslet.2009.01.013; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Lillis AP, 2005, J THROMB HAEMOST, V3, P1884, DOI 10.1111/j.1538-7836.2005.01371.x; Liu QA, 2010, J NEUROSCI, V30, P17068, DOI 10.1523/JNEUROSCI.4067-10.2010; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Meng H, 2010, J BIOL CHEM, V285, P23045, DOI 10.1074/jbc.M110.144634; Nolden L, 2006, NAT METHODS, V3, P461, DOI 10.1038/NMETH884; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Rohlmann A, 1996, NAT BIOTECHNOL, V14, P1562, DOI 10.1038/nbt1196-1562; Satomaa T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-42; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Streit A, 1996, J NEUROCHEM, V66, P834; STREIT A, 1993, J CELL BIOL, V120, P799, DOI 10.1083/jcb.120.3.799; Yagi H, 2012, J BIOL CHEM, V287, P24356, DOI 10.1074/jbc.M112.365643; Yanagisawa M, 2005, J NEUROCHEM, V95, P1311, DOI 10.1111/j.1471-4159.2005.03452.x; Yanagisawa M, 2007, GLYCOBIOLOGY, V17, p57R, DOI 10.1093/glycob/cwm018; Zilberberg A, 2004, J BIOL CHEM, V279, P17535, DOI 10.1074/jbc.M311292200	31	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16538	16545		10.1074/jbc.M112.419812	http://dx.doi.org/10.1074/jbc.M112.419812			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23615909	hybrid, Green Published			2022-12-28	WOS:000320378900030
J	Tian, SF; Yang, HH; Xiao, DP; Huang, YJ; He, GY; Ma, HR; Xia, F; Shi, XC				Tian, Shu-Feng; Yang, Han-Hua; Xiao, Dan-Ping; Huang, Yue-Jun; He, Gu-Yu; Ma, Hai-Ran; Xia, Fang; Shi, Xue-Chuan			Mechanisms of Neuroprotection from Hypoxia-Ischemia (HI) Brain Injury by Up-regulation of Cytoglobin (CYGB) in a Neonatal Rat Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; VERTEBRATE GLOBIN FAMILY; FOCAL CEREBRAL-ISCHEMIA; TERM SPATIAL MEMORY; OXIDATIVE STRESS; DNA-DAMAGE; CELL-DEATH; HEPATOCELLULAR-CARCINOMA; OVEREXPRESSION PROTECTS; ANAEROBIC CONDITIONS	This study was designed to investigate the expression profile of CYGB, its potential neuroprotective function, and underlying molecular mechanisms using a model of neonatal hypoxia-ischemia (HI) brain injury. Cygb mRNA and protein expression were evaluated within the first 36 h after the HI model was induced using RT-PCR and Western blotting. Cygb mRNA expression was increased at 18 h in a time-dependent manner, and its level of protein expression increased progressively in 24 h. To verify the neuroprotective effect of CYGB, a gene transfection technique was employed. Cygb cDNA and shRNA delivery adenovirus systems were established (Cygb-cDNA-ADV and Cygb-shRNA-ADV, respectively) and injected into the brains of 3-day-old rats 4 days before they were induced with HI treatment. Rats from different groups were euthanized 24 h post-HI, and brain samples were harvested. 2,3,5-Triphenyltetrazolium chloride, TUNEL, and Nissl staining indicated that an up-regulation of CYGB resulted in reduced acute brain injury. The superoxide dismutase level was found to be dependent on expression of CYGB. The Morris water maze test in 28-day-old rats demonstrated that CYGB expression was associated with improvement of long term cognitive impairment. Studies also demonstrated that CYGB can up-regulate mRNA and protein levels of VEGF and increase both the density and diameter of the microvessels but inhibits activation of caspase-2 and -3. Thus, this is the first in vivo study focusing on the neuroprotective role of CYGB. The reduction of neonatal HI injury by CYGB may be due in part to antioxidant and antiapoptotic mechanisms and by promoting angiogenesis.	[Tian, Shu-Feng; Yang, Han-Hua; Xiao, Dan-Ping; Huang, Yue-Jun; He, Gu-Yu; Ma, Hai-Ran; Xia, Fang; Shi, Xue-Chuan] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Pediat, Shantou 515041, Guangdong, Peoples R China	Shantou University	Shi, XC (corresponding author), Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Pediat, North Sect Dong Xia Rd, Shantou 515041, Guangdong, Peoples R China.	shixuechuan@126.com			Postgraduate Student Training Foundation of Shantou University Medical College Grant [LD0504510817]; Chinese National Natural Science Foundation for Young Investigators Grant [31140016]; Administration of Science and Technology Research of Guangdong Province, China [2010B031600282]	Postgraduate Student Training Foundation of Shantou University Medical College Grant; Chinese National Natural Science Foundation for Young Investigators Grant; Administration of Science and Technology Research of Guangdong Province, China	This work was supported by Postgraduate Student Training Foundation of Shantou University Medical College Grant LD0504510817. This work was also supported in part by Chinese National Natural Science Foundation for Young Investigators Grant 31140016 and Administration of Science and Technology Research of Guangdong Province, China, Grant 2010B031600282.	Avivi A, 2010, P NATL ACAD SCI USA, V107, P21570, DOI 10.1073/pnas.1015379107; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Bass JL, 2004, PEDIATRICS, V114, P805, DOI 10.1542/peds.2004-0227; Blum S, 1999, J NEUROSCI, V19, P3535; Bouchier-Hayes L, 2009, MOL CELL, V35, P830, DOI 10.1016/j.molcel.2009.07.023; Buttner F, 2009, BRAIN RES, V1252, P1, DOI 10.1016/j.brainres.2008.10.045; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Carlsson Y, 2011, ANN NEUROL, V70, P781, DOI 10.1002/ana.22431; Chen WQ, 2011, STROKE, V42, P764, DOI 10.1161/STROKEAHA.110.599118; Cheng Y, 1998, J CLIN INVEST, V101, P1992, DOI 10.1172/JCI2169; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; De Beuf A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/395785; du Plessis AJ, 2002, CURR OPIN NEUROL, V15, P151, DOI 10.1097/00019052-200204000-00005; Fang JY, 2011, RADIAT RES, V176, P198, DOI 10.1667/RR2517.1; Feng YZ, 2008, PEDIATR RES, V64, P370, DOI 10.1203/PDR.0b013e318180ebe6; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Ferriero DM, 2001, DEV NEUROSCI-BASEL, V23, P198, DOI 10.1159/000046143; Fordel E, 2004, IUBMB LIFE, V56, P681, DOI 10.1080/15216540500037406; Fordel E, 2004, BIOCHEM BIOPH RES CO, V319, P342, DOI 10.1016/j.bbrc.2004.05.010; Fordel E, 2007, GENE, V398, P114, DOI 10.1016/j.gene.2007.03.022; Fordel E, 2006, NEUROSCI LETT, V410, P146, DOI 10.1016/j.neulet.2006.09.027; Gardner AM, 2010, J BIOL CHEM, V285, P23850, DOI 10.1074/jbc.M110.132340; Geuens E, 2003, J BIOL CHEM, V278, P30417, DOI 10.1074/jbc.C300203200; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Greenberg DA, 2008, CURR OPIN PHARMACOL, V8, P20, DOI 10.1016/j.coph.2007.09.003; Greggio S, 2011, NEUROBIOL DIS, V44, P152, DOI 10.1016/j.nbd.2011.06.018; Guo X, 2007, BIOCHEM BIOPH RES CO, V364, P145, DOI 10.1016/j.bbrc.2007.09.108; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Halligan KE, 2009, J BIOL CHEM, V284, P8539, DOI 10.1074/jbc.M808231200; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Hebert AE, 2002, LEARN MEMORY, V9, P156, DOI 10.1101/lm.48502; Hodges NJ, 2008, MUTAGENESIS, V23, P293, DOI 10.1093/mutage/gen013; Hoogewijs D, 2012, MOL BIOL EVOL, V29, P1105, DOI 10.1093/molbev/msr246; Huang YJ, 2010, NEUROCHEM RES, V35, P1038, DOI 10.1007/s11064-010-0152-0; Jin K, 2001, NEUROSCIENCE, V108, P351, DOI 10.1016/S0306-4522(01)00154-3; Jin KL, 2002, J NEUROCHEM, V80, P119, DOI 10.1046/j.0022-3042.2001.00678.x; Jin KL, 2010, STROKE, V41, P557, DOI 10.1161/STROKEAHA.109.567149; Jones NM, 2004, J NEUROCHEM, V89, P157, DOI 10.1111/j.1471-4159.2004.02324.x; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; Li D, 2007, NEUROCHEM RES, V32, P1375, DOI 10.1007/s11064-007-9317-x; Li HT, 2012, J BIOL CHEM, V287, P36623, DOI 10.1074/jbc.M112.342378; Liu F, 2009, J NEUROSCI METH, V179, P1, DOI 10.1016/j.jneumeth.2008.12.028; Mammen PPA, 2006, J HISTOCHEM CYTOCHEM, V54, P1349, DOI 10.1369/jhc.6A7008.2006; Mimura I, 2010, AM J PHYSIOL-RENAL, V299, pF1120, DOI 10.1152/ajprenal.00145.2010; Nelson KB, 2004, LANCET NEUROL, V3, P150, DOI 10.1016/S1474-4422(04)00679-9; *NIH, 2011, NIH PUBLICATION, V8523; Nishi H, 2011, AM J PATHOL, V178, P128, DOI 10.1016/j.ajpath.2010.11.011; Pesce A, 2002, EMBO REP, V3, P1146, DOI 10.1093/embo-reports/kvf248; Petersen MG, 2008, J INORG BIOCHEM, V102, P1777, DOI 10.1016/j.jinorgbio.2008.05.008; Raida Z, 2012, BIOCHEM BIOPH RES CO, V424, P274, DOI 10.1016/j.bbrc.2012.06.105; Reeder BJ, 2011, BIOCHEM J, V434, P483, DOI 10.1042/BJ20101136; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Sagawa T, 2008, HEPATOLOGY, V48, P828, DOI 10.1002/hep.22420; Schmidt M, 2004, J BIOL CHEM, V279, P8063, DOI 10.1074/jbc.M310540200; Schulz JB, 1999, ANN NEUROL, V45, P421, DOI 10.1002/1531-8249(199904)45:4<421::AID-ANA2>3.0.CO;2-Q; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Shinozaki K, 2005, J VIROL, V79, P13705, DOI 10.1128/JVI.79.21.13705-13713.2005; Shivapurkar N, 2008, CANCER RES, V68, P7448, DOI 10.1158/0008-5472.CAN-08-0565; Singh S, 2009, J BIOL CHEM, V284, P10409, DOI 10.1074/jbc.M809572200; Stagner JI, 2005, TRANSPL P, V37, P3452, DOI 10.1016/j.transproceed.2005.10.001; Stagner JI, 2009, ISLETS, V1, P50, DOI 10.4161/isl.1.1.8936; Sugiura S, 2005, STROKE, V36, P859, DOI 10.1161/01.STR.0000158905.22871.95; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; Venis S, 2001, LANCET, V358, P2055, DOI 10.1016/S0140-6736(01)07148-3; Xinarianos G, 2006, HUM MOL GENET, V15, P2038, DOI 10.1093/hmg/ddl128; Xu JK, 2012, J BIOL CHEM, V287, P26200, DOI 10.1074/jbc.M112.349811; Xu R, 2006, MOL THER, V13, P1093, DOI 10.1016/j.ymthe.2005.11.027; Yu ZY, 2012, INT J MOL SCI, V13, P6995, DOI 10.3390/ijms13066995; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zheng FQ, 2009, ACTA PHARMACOL SIN, V30, P617, DOI 10.1038/aps.2009.33	79	40	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15988	16003		10.1074/jbc.M112.428789	http://dx.doi.org/10.1074/jbc.M112.428789			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23585565	Green Published, hybrid			2022-12-28	WOS:000319822300051
J	Zhao, B; Pan, BS; Shen, SW; Sun, X; Hou, ZZ; Yan, RQ; Sun, FY				Zhao, Bei; Pan, Bai-Shen; Shen, Su-Wen; Sun, Xiao; Hou, Zheng-Zhou; Yan, Riqiang; Sun, Feng-Yan			Diabetes-induced Central Neuritic Dystrophy and Cognitive Deficits Are Associated with the Formation of Oligomeric Reticulon-3 via Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; ALZHEIMERS-DISEASE; PROTEIN CARBONYLATION; PROTEASOME INHIBITION; POSTSTROKE DEMENTIA; RISK; DYSFUNCTION; DAMAGE; TAU; ACCUMULATION	Diabetes is a high risk factor to dementia. To investigate the molecular mechanism of diabetic dementia, we induced type 2 diabetes in rats and examined potential changes in their cognitive functions and the neural morphology of the brains. We found that the diabetic rats with an impairment of spatial learning and memory showed the occurrence of RTN3-immunoreactive dystrophic neurites in the cortex. Biochemical examinations revealed the increase of a high molecular weight form of RTN3 (HW-RTN3) in diabetic brains. The corresponding decrease of monomeric RTN3 was correlated with the reduction of its inhibitory effects on the activity of beta-secretase (BACE1), a key enzyme for generation of beta-amyloid peptides. The results from immunoprecipitation combined with protein carbonyl detection showed that carbonylated RTN3 was significantly higher in cortical tissues of diabetic rats compared with control rats, indicating that diabetes-induced oxidative stress led to RTN3 oxidative damage. In neuroblastoma SH-SY5Y cells, high glucose and/or H2O2 treatment significantly increased the amounts of carbonylated proteins and HW-RTN3, whereas monomeric RTN3 was reduced. Hence, we conclude that diabetes-induced cognitive deficits and central neuritic dystrophy are correlated with the formation of aggregated RTN3 via oxidative stress. We provided the first evidence that oxidative damage caused the formation of toxic RTN3 aggregates, which participated in the pathogenesis of central neuritic dystrophy in diabetic brain. Present findings may offer a new therapeutic strategy to prevent or reduce diabetic dementia.	[Zhao, Bei; Shen, Su-Wen; Sun, Xiao; Hou, Zheng-Zhou; Sun, Feng-Yan] Sch Basic Med Sci, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Zhao, Bei; Shen, Su-Wen; Sun, Xiao; Hou, Zheng-Zhou; Sun, Feng-Yan] Sch Basic Med Sci, Dept Neurobiol, Shanghai 200032, Peoples R China; [Pan, Bai-Shen] Fudan Univ, Shanghai Med Coll, Zhongshan Hosp, Lab Clin Biochem, Shanghai 200032, Peoples R China; [Yan, Riqiang] Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA; [Zhao, Bei; Shen, Su-Wen; Sun, Xiao; Hou, Zheng-Zhou; Sun, Feng-Yan] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China	Fudan University; Cleveland Clinic Foundation; Fudan University	Sun, FY (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Neurobiol, 138 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China.	fysun@shmu.edu.cn		Yan, Riqiang/0000-0001-7195-7617	National Institutes of Health [AG025493]; National Nature Science Foundation of China [81030020, J0730860, 30770660]; NATIONAL INSTITUTE ON AGING [R01AG025493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG025493 (to R. Y.). This work was supported in part by grants from National Nature Science Foundation of China Grants 81030020, J0730860, and 30770660 (to F.-Y. S.).	Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; CHENG KC, 1992, J BIOL CHEM, V267, P166; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Daviglus ML, 2010, ANN INTERN MED, V153, P176, DOI 10.7326/0003-4819-153-3-201008030-00260; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Ewers M, 2011, TRENDS NEUROSCI, V34, P430, DOI 10.1016/j.tins.2011.05.005; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Greene DA, 1999, EUR J PHARMACOL, V375, P217, DOI 10.1016/S0014-2999(99)00356-8; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hashimoto M, 2003, NEUROMOL MED, V4, P21, DOI 10.1385/NMM:4:1-2:21; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Hu XY, 2007, EMBO J, V26, P2755, DOI 10.1038/sj.emboj.7601707; Iwahashi J, 2002, BIOCHEM BIOPH RES CO, V293, P698, DOI 10.1016/S0006-291X(02)00282-6; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Karnezis T, 2004, NAT NEUROSCI, V7, P736, DOI 10.1038/nn1261; Lee MH, 2001, J NEUROCHEM, V78, P32, DOI 10.1046/j.1471-4159.2001.00416.x; Li ZG, 2007, DIABETES, V56, P1817, DOI 10.2337/db07-0171; Liu HM, 2010, NEUROSCI BULL, V26, P1, DOI 10.1007/s12264-010-0922-3; Lortz S, 2000, DIABETES, V49, P1123, DOI 10.2337/diabetes.49.7.1123; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murayama KS, 2006, EUR J NEUROSCI, V24, P1237, DOI 10.1111/j.1460-9568.2006.05005.x; Murray IVJ, 2011, EXP BIOL MED, V236, P772, DOI 10.1258/ebm.2011.010355; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Nelson PT, 2009, BBA-MOL BASIS DIS, V1792, P454, DOI 10.1016/j.bbadis.2008.08.005; O'Brien JT, 2011, J PSYCHOPHARMACOL, V25, P997, DOI 10.1177/0269881110387547; Oertle T, 2003, TRENDS CELL BIOL, V13, P187, DOI 10.1016/S0962-8924(03)00035-7; Parodi J, 2010, J BIOL CHEM, V285, P2506, DOI 10.1074/jbc.M109.030023; Powell SR, 2005, FREE RADICAL BIO MED, V38, P1093, DOI 10.1016/j.freeradbiomed.2005.01.003; Prior M, 2010, NEUROSCI BIOBEHAV R, V34, P1201, DOI 10.1016/j.neubiorev.2010.01.017; Schrijvers EMC, 2010, NEUROLOGY, V75, P1982, DOI 10.1212/WNL.0b013e3181ffe4f6; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SELKOE DJ, 1986, NEUROBIOL AGING, V7, P425, DOI 10.1016/0197-4580(86)90055-2; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shi Q, 2009, J NEUROSCI, V29, P9163, DOI 10.1523/JNEUROSCI.5741-08.2009; SPILLANTINI MG, 1990, P NATL ACAD SCI USA, V87, P3952, DOI 10.1073/pnas.87.10.3952; Sponne I, 2003, J BIOL CHEM, V278, P3437, DOI 10.1074/jbc.M206745200; Squier TC, 2001, EXP GERONTOL, V36, P1539, DOI 10.1016/S0531-5565(01)00139-5; Steiner P, 2004, J NEUROCHEM, V89, P569, DOI 10.1111/j.1471-4159.2004.02345.x; Tang BL, 2007, J NEUROCHEM, V100, P314, DOI 10.1111/j.1471-4159.2006.04215.x; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Threlkeld ZD, 2011, J ALZHEIMERS DIS, V27, P415, DOI 10.3233/JAD-2011-110206; Vincent AM, 2002, ANN NY ACAD SCI, V959, P368, DOI 10.1111/j.1749-6632.2002.tb02108.x; Wang W, 2009, EUR J PHARMACOL, V613, P19, DOI 10.1016/j.ejphar.2009.04.013; Xiong M, 2008, NEUROBIOL DIS, V32, P433, DOI 10.1016/j.nbd.2008.08.007; Xu WL, 2009, DIABETOLOGIA, V52, P1031, DOI 10.1007/s00125-009-1323-x; Yan R, 2006, CELL MOL LIFE SCI, V63, P877, DOI 10.1007/s00018-005-5338-2; Yang YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-234; Yankner BA, 1996, NAT MED, V2, P850, DOI 10.1038/nm0896-850; Zhang FL, 2003, EXP ANIM TOKYO, V52, P401, DOI 10.1538/expanim.52.401; Zhang T, 2009, NEUROSCIENCE, V161, P1045, DOI 10.1016/j.neuroscience.2009.04.032; Zhang T, 2010, NEUROCHEM INT, V56, P955, DOI 10.1016/j.neuint.2010.04.003; Zhang Y, 2010, J CEREBR BLOOD F MET, V30, P566, DOI 10.1038/jcbfm.2009.228	54	29	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15590	15599		10.1074/jbc.M112.440784	http://dx.doi.org/10.1074/jbc.M112.440784			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23592790	Green Published, hybrid			2022-12-28	WOS:000319822300017
J	de Morree, A; Flix, B; Bagaric, I; Wang, J; van den Boogaard, M; Moursel, LG; Frants, RR; Illa, I; Gallardo, E; Toes, R; van der Maarel, SM				de Morree, Antoine; Flix, Barbara; Bagaric, Ivana; Wang, Jun; van den Boogaard, Marlinde; Moursel, Laure Grand; Frants, Rune R.; Illa, Isabel; Gallardo, Eduard; Toes, Rene; van der Maarel, Silvere M.			Dysferlin Regulates Cell Adhesion in Human Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFICIENT MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; PROTEIN; INTEGRIN; EXPRESSION; MYOPATHY; PHAGOCYTOSIS; COMPLEX; ALPHA-V-BETA-3; REGENERATION	Dysferlin is mutated in a group of muscular dystrophies commonly referred to as dysferlinopathies. It is highly expressed in skeletal muscle, where it is important for sarcolemmal maintenance. Recent studies show that dysferlin is also expressed in monocytes. Moreover, muscle of dysferlinopathy patients is characterized by massive immune cell infiltrates, and dysferlin-negative monocytes were shown to be more aggressive and phagocytose more particles. This suggests that dysferlin deregulation in monocytes might contribute to disease progression, but the molecular mechanism is unclear. Here we show that dysferlin expression is increased with differentiation in human monocytes and the THP1 monocyte cell model. Freshly isolated monocytes of dysferlinopathy patients show deregulated expression of fibronectin and fibronectin-binding integrins, which is recapitulated by transient knockdown of dysferlin in THP1 cells. Dysferlin forms a protein complex with these integrins at the cell membrane, and its depletion impairs cell adhesion. Moreover, patient macrophages show altered adhesion and motility. These findings suggest that dysferlin is involved in regulating cellular interactions and provide new insight into dysferlin function in inflammatory cells.	[de Morree, Antoine; Bagaric, Ivana; van den Boogaard, Marlinde; Moursel, Laure Grand; Frants, Rune R.; van der Maarel, Silvere M.] Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands; [Wang, Jun; Toes, Rene] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2333 ZA Leiden, Netherlands; [Flix, Barbara; Illa, Isabel; Gallardo, Eduard] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Lab Neurol Expt, Serv Neurol, Bellaterra 08193, Spain; [Flix, Barbara; Illa, Isabel; Gallardo, Eduard] Univ Autonoma Barcelona, Inst Recerca, HSCSP, Bellaterra 08193, Spain; [Flix, Barbara; Illa, Isabel; Gallardo, Eduard] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Bellaterra 08193, Spain	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; CIBERNED	van der Maarel, SM (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	maarel@lumc.nl	Wang, Jun/B-2414-2009; Grand Moursel, Laure/H-7061-2018; Moursel, Laure Grand/M-4194-2019; ILLA, Isabel/AAD-1816-2019; van der Maarel, Silvere/X-3631-2018; Wang, Jun/AGJ-1311-2022	Wang, Jun/0000-0002-4458-3741; Grand Moursel, Laure/0000-0002-8696-7145; Moursel, Laure Grand/0000-0002-8696-7145; van der Maarel, Silvere/0000-0001-8103-711X; Wang, Jun/0000-0002-4458-3741; Gallardo, Eduard/0000-0002-3942-3436; Flix, Barbara/0000-0002-4731-7801; de Morree, Antoine/0000-0002-8316-4531; Toes, Rene/0000-0002-9618-6414	Jain Foundation	Jain Foundation	This work was supported by the Jain Foundation.	Anderson LVB, 1999, HUM MOL GENET, V8, P855, DOI 10.1093/hmg/8.5.855; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; BLYSTONE SD, 1994, J CELL BIOL, V127, P1129, DOI 10.1083/jcb.127.4.1129; Chattopadhyay N, 2003, J CELL BIOL, V163, P1351, DOI 10.1083/jcb.200306067; Chiu YH, 2009, HUM MOL GENET, V18, P1976, DOI 10.1093/hmg/ddp121; Davis DM, 2009, NAT REV IMMUNOL, V9, P543, DOI 10.1038/nri2602; De Luna N, 2007, NEUROMUSCULAR DISORD, V17, P69, DOI 10.1016/j.nmd.2006.09.006; De Luna N, 2004, J NEUROPATH EXP NEUR, V63, P1104, DOI 10.1093/jnen/63.10.1104; De Luna N, 2010, J NEUROPATH EXP NEUR, V69, P643, DOI 10.1097/NEN.0b013e3181e0d01c; de Morree A, 2012, FASEB J, V26, P93, DOI 10.1096/fj.11-187971; de Morree A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013854; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Gallardo E, 2001, NEUROLOGY, V57, P2136, DOI 10.1212/WNL.57.11.2136; Gallardo E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029061; Gottlieb A, 2000, J AM ACAD DERMATOL, V42, P428, DOI 10.1016/S0190-9622(00)90214-7; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Huang YC, 2005, EUR J HUM GENET, V13, P721, DOI 10.1038/sj.ejhg.5201414; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Illa I, 2001, ANN NEUROL, V49, P130, DOI 10.1002/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO;2-0; Imhof BA, 1997, EUR J IMMUNOL, V27, P3242, DOI 10.1002/eji.1830271223; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Jackson DY, 2002, CURR PHARM DESIGN, V8, P1229, DOI 10.2174/1381612023394737; Lostal W, 2010, HUM MOL GENET, V19, P1897, DOI 10.1093/hmg/ddq065; Matsuda C, 1999, NEUROLOGY, V53, P1119, DOI 10.1212/WNL.53.5.1119; Matsuda C, 2005, J NEUROPATH EXP NEUR, V64, P334, DOI 10.1093/jnen/64.4.334; Millay DP, 2009, AM J PATHOL, V175, P1817, DOI 10.2353/ajpath.2009.090107; Nagaraju K, 2008, AM J PATHOL, V172, P774, DOI 10.2353/ajpath.2008.070327; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raghavan S, 2003, DEV CELL, V5, P415, DOI 10.1016/S1534-5807(03)00261-2; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Rawat R, 2010, AM J PATHOL, V176, P2891, DOI 10.2353/ajpath.2010.090058; Roche JA, 2010, AM J PHYSIOL-CELL PH, V298, pC298, DOI 10.1152/ajpcell.00122.2009; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Salim C, 2009, GLIA, V57, P535, DOI 10.1002/glia.20782; Sharma A, 2010, ARTERIOSCL THROM VAS, V30, P2196, DOI 10.1161/ATVBAHA.110.208108; Thomas-Ecker S, 2007, P NATL ACAD SCI USA, V104, P5539, DOI 10.1073/pnas.0700732104; Vernon-Wilson EF, 2006, J LEUKOCYTE BIOL, V79, P1260, DOI 10.1189/jlb.1005571; Weerasinghe D, 1998, J CELL BIOL, V142, P595, DOI 10.1083/jcb.142.2.595; Xu W, 2006, BLOOD, V107, P4930, DOI 10.1182/blood-2005-10-4144	41	35	38	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14147	14157		10.1074/jbc.M112.448589	http://dx.doi.org/10.1074/jbc.M112.448589			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23558685	Green Published, hybrid			2022-12-28	WOS:000319253500019
J	Hartmann, A; Arroyo-Olarte, RD; Imkeller, K; Hegemann, P; Lucius, R; Gupta, N				Hartmann, Anne; Arroyo-Olarte, Ruben Dario; Imkeller, Katharina; Hegemann, Peter; Lucius, Richard; Gupta, Nishith			Optogenetic Modulation of an Adenylate Cyclase in Toxoplasma gondii Demonstrates a Requirement of the Parasite cAMP for Host-Cell Invasion and Stage Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRADYZOITE DIFFERENTIATION; MOLECULAR-MECHANISMS; GENE-EXPRESSION; TRANSCRIPTION; TACHYZOITE; DOMAINS; MALARIA; LEVEL	Successful infection and transmission of the obligate intracellular parasite Toxoplasma gondii depends on its ability to switch between fast-replicating tachyzoite (acute) and quiescent bradyzoite (chronic) stages. Induction of cAMP in the parasitized host cells has been proposed to influence parasite differentiation. It is not known whether the parasite or host cAMP is required to drive this phenomenon. Other putative roles of cAMP for the parasite biology also remain to be identified. Unequivocal research on cAMP-mediated signaling in such intertwined systems also requires a method for an efficient and spatial control of the cAMP pool in the pathogen or in the enclosing host cell. We have resolved these critical concerns by expressing a photoactivated adenylate cyclase that allows light-sensitive control of the parasite or host-cell cAMP. Using this method, we reveal multiple roles of the parasite-derived cAMP in host-cell invasion, stage-specific expression, and asexual differentiation. An optogenetic method provides many desired advantages such as: (i) rapid, transient, and efficient cAMP induction in extracellular/intracellular and acute/chronic stages; (ii) circumvention of the difficulties often faced in cultures, i. e. poor diffusion, premature degradation, steady activation, and/or pleiotropic effects of cAMP agonists and antagonists; (iii) genetically encoded enzyme expression, thus inheritable to the cell progeny; and (iv) conditional and spatiotemporal control of cAMP levels. Importantly, a successful optogenetic application in Toxoplasma also illustrates its wider utility to study cAMP-mediated signaling in other genetically amenable two-organism systems such as in symbiotic and pathogen-host models.	[Hartmann, Anne; Arroyo-Olarte, Ruben Dario; Imkeller, Katharina; Lucius, Richard; Gupta, Nishith] Humboldt Univ, Dept Mol Parasitol, D-10115 Berlin, Germany; [Hegemann, Peter] Humboldt Univ, Dept Expt Biophys, D-10115 Berlin, Germany	Humboldt University of Berlin; Humboldt University of Berlin	Gupta, N (corresponding author), Dept Mol Parasitol, Philippstr 13, D-10115 Berlin, Germany.	Gupta.Nishith@staff.hu-berlin.de	Arroyo-Olarte, Ruben D/AAW-3127-2021; Arroyo-Olarte, Ruben D/AAH-8939-2020	Arroyo-Olarte, Ruben D/0000-0002-8096-2423; Gupta, Nishith/0000-0003-1452-5126	German Research Foundation [SFB618, GRK1121]	German Research Foundation(German Research Foundation (DFG))	This work was supported by Grants SFB618 and GRK1121 from the German Research Foundation (to N. G. and R. L.).	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Baker DA, 2011, CELL MICROBIOL, V13, P331, DOI 10.1111/j.1462-5822.2010.01561.x; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Behnke MS, 2008, MOL MICROBIOL, V68, P1502, DOI 10.1111/j.1365-2958.2008.06249.x; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Cleary MD, 2002, EUKARYOT CELL, V1, P329, DOI 10.1128/EC.1.3.329-340.2002; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; da Silva MDF, 2008, MOL BIOSYST, V4, P824, DOI 10.1039/b800520f; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Dobrowolski JM, 1997, CELL MOTIL CYTOSKEL, V37, P253, DOI 10.1002/(SICI)1097-0169(1997)37:3&lt;253::AID-CM7&gt;3.0.CO;2-7; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; DUBREMETZ JF, 1985, EXP PARASITOL, V59, P24, DOI 10.1016/0014-4894(85)90053-0; Eaton MS, 2006, INT J PARASITOL, V36, P107, DOI 10.1016/j.ijpara.2005.08.014; Fox BA, 2011, EUKARYOT CELL, V10, P1193, DOI 10.1128/EC.00297-10; Gould MK, 2011, FEMS MICROBIOL REV, V35, P515, DOI 10.1111/j.1574-6976.2010.00262.x; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Kirkman LA, 2001, INFECT IMMUN, V69, P148, DOI 10.1128/IAI.69.1.148-153.2001; Leykauf K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000941; Linder JU, 2006, CELL MOL LIFE SCI, V63, P1736, DOI 10.1007/s00018-006-6072-0; Mccoy JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003066; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Ono T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000008; Radke JR, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-26; Ryu MH, 2010, J BIOL CHEM, V285, P41501, DOI 10.1074/jbc.M110.177600; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Singh U, 2002, MOL MICROBIOL, V44, P721, DOI 10.1046/j.1365-2958.2002.02903.x; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Sullivan WJ, 2012, FEMS MICROBIOL REV, V36, P717, DOI 10.1111/j.1574-6976.2011.00305.x; Torgerson PR, 2011, VET PARASITOL, V182, P79, DOI 10.1016/j.vetpar.2011.07.017; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Vandamme J, 2012, CELL SIGNAL, V24, P1610, DOI 10.1016/j.cellsig.2012.04.001; Walker R, 2013, MOL MICROBIOL, V87, P641, DOI 10.1111/mmi.12121; Zhang YW, 2001, INFECT IMMUN, V69, P501, DOI 10.1128/IAI.69.1.501-507.2001	38	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13705	13717		10.1074/jbc.M113.465583	http://dx.doi.org/10.1074/jbc.M113.465583			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23525100	hybrid, Green Published			2022-12-28	WOS:000318850300053
J	Horowitz, B; Sharf, R; Avital-Shacham, M; Pechkovsky, A; Kleinberger, T				Horowitz, Ben; Sharf, Rakefet; Avital-Shacham, Meirav; Pechkovsky, Antonina; Kleinberger, Tamar			Structure- and Modeling-based Identification of the Adenovirus E4orf4 Binding Site in the Protein Phosphatase 2A B55 alpha Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-DEATH; EVOLUTIONARY CONSERVATION; P53-INDEPENDENT APOPTOSIS; 3-DIMENSIONAL STRUCTURES; GROWTH ARREST; B-ALPHA; INTERACTS; ACTIVATION; CONSURF	The adenovirus E4orf4 protein regulates the progression of viral infection and when expressed outside the context of the virus it induces nonclassical, cancer cell-specific apoptosis. All E4orf4 functions known to date require an interaction between E4orf4 and protein phosphatase 2A (PP2A), which is mediated through PP2A regulatory B subunits. Specifically, an interaction with the B55 alpha subunit is required for induction of cell death by E4orf4. To gain a better insight into the E4orf4-PP2A interaction, mapping of the E4orf4 interaction site in PP2A-B55 alpha has been undertaken. To this end we used a combination of bioinformatics analyses of PP2A-B55 alpha and of E4orf4, which led to the prediction of E4orf4 binding sites on the surface of PP2A-B55 alpha. Mutation analysis, immunoprecipitation, and GST pulldown assays based on the theoretical predictions revealed that the E4orf4 binding site included the alpha 1 and alpha 2 helices described in the B55 alpha structure and involved at least three residues located in these helices facing each other. Loss of E4orf4 binding was accompanied by reduced contribution of the B55 alpha mutants to E4orf4-induced cell death. The identified E4orf4 binding domain lies above the previously described substrate binding site and does not overlap it, although its location could be consistent with direct or indirect effects on substrate binding. This work assigns for the first time a functional significance to the alpha 1, alpha 2 helices of B55 alpha, and we suggest that the binding site defined by these helices could also contribute to interactions between PP2A and some of its cellular regulators.	[Horowitz, Ben; Sharf, Rakefet; Avital-Shacham, Meirav; Pechkovsky, Antonina; Kleinberger, Tamar] Technion Israel Inst Technol, Fac Med, Dept Mol Microbiol, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Kleinberger, T (corresponding author), Technion Israel Inst Technol, Fac Med, Dept Mol Microbiol, IL-31096 Haifa, Israel.	tamark@tx.technion.ac.il			Israel Science Foundation [769/07]; Deutsche Forschungsgemeinschaft; Rappaport Family Institute for Research in the Medical Sciences	Israel Science Foundation(Israel Science Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Rappaport Family Institute for Research in the Medical Sciences	This work was supported by Israel Science Foundation Grant 769/07, by the Deutsche Forschungsgemeinschaft within the framework of The German-Israeli Project Cooperation (DIP), and by the Rappaport Family Institute for Research in the Medical Sciences.	Afifi R, 2001, J VIROL, V75, P4444, DOI 10.1128/JVI.75.9.4444-4447.2001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Ben-Israel H, 2002, FRONT BIOSCI-LANDMRK, V7, pD1369, DOI 10.2741/ben; Ben-Israel H, 2008, J VIROL, V82, P9381, DOI 10.1128/JVI.00791-08; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Bondesson M, 1996, J VIROL, V70, P3844, DOI 10.1128/JVI.70.6.3844-3851.1996; Brestovitsky A, 2012, JOVE-J VIS EXP, DOI 10.3791/4442; Brestovitsky A, 2011, NUCLEIC ACIDS RES, V39, P6414, DOI 10.1093/nar/gkr231; Champagne C, 2004, J BIOL CHEM, V279, P25905, DOI 10.1074/jbc.M400933200; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Eichhorn PJA, 2007, PLOS GENET, V3, P2381, DOI 10.1371/journal.pgen.0030218; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Kanopka A, 1998, NATURE, V393, P185, DOI 10.1038/30277; KLEINBERGER T, 1993, J VIROL, V67, P7556, DOI 10.1128/JVI.67.12.7556-7560.1993; KLEINBERGER T, 2004, PROG MOLEC, P245; Koren R, 2004, J BIOL CHEM, V279, P48598, DOI 10.1074/jbc.M409359200; Kornitzer D, 2001, J CELL BIOL, V154, P331, DOI 10.1083/jcb.200104104; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lavoie JN, 1998, J CELL BIOL, V140, P637, DOI 10.1083/jcb.140.3.637; Lavoie JN, 2000, J CELL BIOL, V150, P1037, DOI 10.1083/jcb.150.5.1037; Li S, 2009, ONCOGENE, V28, P390, DOI 10.1038/onc.2008.393; Li SY, 2009, J VIROL, V83, P8340, DOI 10.1128/JVI.00711-09; Livne A, 2001, J VIROL, V75, P789, DOI 10.1128/JVI.75.2.789-798.2001; Mannervik M, 1999, VIROLOGY, V256, P313, DOI 10.1006/viro.1999.9663; Maoz T, 2005, J BIOL CHEM, V280, P41270, DOI 10.1074/jbc.M507281200; Marcellus RC, 1998, J VIROL, V72, P7144, DOI 10.1128/JVI.72.9.7144-7153.1998; Marcellus RC, 2000, J VIROL, V74, P7869, DOI 10.1128/JVI.74.17.7869-7877.2000; Mashiach E, 2010, NUCLEIC ACIDS RES, V38, pW457, DOI 10.1093/nar/gkq373; Medghalchi S, 1997, VIROLOGY, V236, P8, DOI 10.1006/viro.1997.8737; MULLER U, 1992, J VIROL, V66, P5867; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Nilsson CE, 2001, EMBO J, V20, P864, DOI 10.1093/emboj/20.4.864; O'Shea C, 2005, EMBO J, V24, P1211, DOI 10.1038/sj.emboj.7600597; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roopchand DE, 2001, ONCOGENE, V20, P5279, DOI 10.1038/sj.onc.1204693; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Shtrichman R, 2000, ONCOGENE, V19, P3757, DOI 10.1038/sj.onc.1203705; Shtrichman R, 1999, P NATL ACAD SCI USA, V96, P10080, DOI 10.1073/pnas.96.18.10080; Shtrichman R, 1998, J VIROL, V72, P2975, DOI 10.1128/JVI.72.4.2975-2982.1998; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Zhang ZY, 2011, J VIROL, V85, P286, DOI 10.1128/JVI.01381-10	49	10	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13718	13727		10.1074/jbc.M112.343756	http://dx.doi.org/10.1074/jbc.M112.343756			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23530045	Green Published, hybrid			2022-12-28	WOS:000318850300054
J	Joseph, K; Kulik, L; Coughlin, B; Kunchithapautham, K; Bandyopadhyay, M; Thiel, S; Thielens, NM; Holers, VM; Rohrer, B				Joseph, Kusumam; Kulik, Liudmila; Coughlin, Beth; Kunchithapautham, Kannan; Bandyopadhyay, Mausumi; Thiel, Steffen; Thielens, Nicole M.; Holers, V. Michael; Rohrer, Baerbel			Oxidative Stress Sensitizes Retinal Pigmented Epithelial (RPE) Cells to Complement-mediated Injury in a Natural Antibody-, Lectin Pathway-, and Phospholipid Epitope-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CHOROIDAL NEOVASCULARIZATION; LIPID-PEROXIDATION PRODUCTS; MACULAR DEGENERATION AMD; MEMBRANE-ATTACK-COMPLEX; MANNOSE-BINDING LECTIN; FACTOR-H; ISCHEMIA/REPERFUSION INJURY; SERINE-PROTEASE; ALTERNATIVE PATHWAY; REPERFUSION INJURY	Uncontrolled activation of the alternative complement pathway (AP) is thought to be associated with age-related macular degeneration. Previously, we have shown that in retinal pigmented epithelial (RPE) monolayers, oxidative stress reduced complement inhibition on the cell surface, resulting in sublytic complement activation and loss of transepithelial resistance (TER), but the potential ligand and pathway involved are unknown. ARPE-19 cells were grown as monolayers on transwell plates, and sublytic complement activation was induced with H2O2 and normal human serum. TER deteriorated rapidly in H2O2-exposed monolayers upon adding normal human serum. Although the effect required AP activation, AP was not sufficient, because elimination of MASP, but not C1q, prevented TER reduction. Reconstitution experiments to unravel essential components of the lectin pathway (LP) showed that both ficolin and mannan-binding lectin can activate the LP through natural IgM antibodies (IgM-C2) that recognize phospholipid cell surface modifications on oxidatively stressed RPE cells. The same epitopes were found on human primary embryonic RPE monolayers. Likewise, mouse laser-induced choroidal neovascularization, an injury that involves LP activation, could be increased in antibody-deficient rag1(-/-) mice using the phospholipid-specific IgM-C2. In summary, using a combination of depletion and reconstitution strategies, we have shown that the LP is required to initiate the complement cascade following natural antibody recognition of neoepitopes, which is then further amplified by the AP. LP activation is triggered by IgM bound to phospholipids. Taken together, we have defined novel mechanisms of complement activation in oxidatively stressed RPE, linking molecular events involved in age-related macular degeneration, including the presence of natural antibodies and neoepitopes.	[Joseph, Kusumam; Coughlin, Beth; Kunchithapautham, Kannan; Bandyopadhyay, Mausumi; Rohrer, Baerbel] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Kulik, Liudmila; Holers, V. Michael] Univ Colorado, Hlth Sci Ctr, Dept Med, Aurora, CO 80045 USA; [Thiel, Steffen] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark; [Thielens, Nicole M.] Univ Grenoble 1, CNRS, Inst Biol Struct, UMR 5075 CEA, F-38027 Grenoble 1, France; [Rohrer, Baerbel] Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC 29401 USA	Medical University of South Carolina; University of Colorado System; University of Colorado Anschutz Medical Campus; Aarhus University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Rohrer, B (corresponding author), Med Univ S Carolina, Dept Ophthalmol, 167 Ashley Ave,SEI 511, Charleston, SC 29425 USA.	rohrer@musc.edu	Thielens, Nicole M/F-2512-2013	Thielens, Nicole M/0000-0002-7354-0302; Thiel, Steffen/0000-0002-4817-155X	National Institutes of Health Grant [R01EY019320, C06 RR015455]; Department of Veterans Affairs Grant [I01 RX000444]; Foundation Fighting Blindness; Research to Prevent Blindness, Inc. (New York); NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019320] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000444] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Grant(US Department of Veterans Affairs); Foundation Fighting Blindness(European Commission); Research to Prevent Blindness, Inc. (New York)(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant R01EY019320. This work was also supported by Department of Veterans Affairs Grant I01 RX000444, Foundation Fighting Blindness, and an unrestricted grant to the Medical University of South Carolina from Research to Prevent Blindness, Inc. (New York). Animal studies were conducted in a facility constructed with support from National Institutes of Health Grant C06 RR015455.	Ablonczy Z, 2007, EXP EYE RES, V85, P762, DOI 10.1016/j.exer.2007.08.010; Bailey TA, 2004, INVEST OPHTH VIS SCI, V45, P675, DOI 10.1167/iovs.03-0351; Banda NK, 2011, MOL IMMUNOL, V49, P281, DOI 10.1016/j.molimm.2011.08.021; Bandyopadhyay M, 2012, INVEST OPHTH VIS SCI, V53, P1953, DOI 10.1167/iovs.11-8638; Bergmann M, 2011, GRAEF ARCH CLIN EXP, V249, P1477, DOI 10.1007/s00417-011-1682-0; Bhutto I, 2012, MOL ASPECTS MED, V33, P295, DOI 10.1016/j.mam.2012.04.005; Bhutto IA, 2011, BRIT J OPHTHALMOL, V95, P1323, DOI 10.1136/bjo.2010.199216; Bora PS, 2005, J IMMUNOL, V174, P491, DOI 10.4049/jimmunol.174.1.491; Campa C, 2008, INVEST OPHTH VIS SCI, V49, P1178, DOI 10.1167/iovs.07-1194; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Dhillon B, 2010, INVEST OPHTH VIS SCI, V51, P5858, DOI 10.1167/iovs.09-5124; Ding JD, 2011, P NATL ACAD SCI USA, V108, pE279, DOI 10.1073/pnas.1100901108; Edwards Albert O., 2007, Angiogenesis, V10, P119, DOI 10.1007/s10456-007-9064-2; Elvington A, 2012, J IMMUNOL, V188, P1460, DOI 10.4049/jimmunol.1102132; Esparza-Gordillo J, 2004, IMMUNOGENETICS, V56, P77, DOI 10.1007/s00251-004-0660-7; Faro J, 2008, CLIN EXP IMMUNOL, V151, P275, DOI 10.1111/j.1365-2249.2007.03538.x; Fett AL, 2012, HISTOL HISTOPATHOL, V27, P357, DOI 10.14670/HH-27.357; Fleming SD, 2002, J IMMUNOL, V169, P2126, DOI 10.4049/jimmunol.169.4.2126; Fraser DA, 2009, J IMMUNOL, V183, P6175, DOI 10.4049/jimmunol.0902232; Frederiksen PD, 2005, SCAND J IMMUNOL, V62, P462, DOI 10.1111/j.1365-3083.2005.01685.x; Gounopoulos P, 2007, Minerva Cardioangiol, V55, P821; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Haas MS, 2010, CARDIOVASC RES, V87, P618, DOI 10.1093/cvr/cvq141; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Hakobyan S, 2008, INVEST OPHTH VIS SCI, V49, P1983, DOI 10.1167/iovs.07-1523; Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Issa PC, 2011, GRAEF ARCH CLIN EXP, V249, P163, DOI 10.1007/s00417-010-1568-6; Jarrett SG, 2012, MOL ASPECTS MED, V33, P399, DOI 10.1016/j.mam.2012.03.009; Jensenius JC, 2003, BIOCHEM SOC T, V31, P763, DOI 10.1042/BST0310763; Johnson LV, 2011, P NATL ACAD SCI USA, V108, P18277, DOI 10.1073/pnas.1109703108; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Kaemmerer E, 2007, INVEST OPHTH VIS SCI, V48, P1342, DOI 10.1167/iovs.06-0549; Kijlstra A, 2005, OCUL IMMUNOL INFLAMM, V13, P3, DOI 10.1080/09273940590909185; Krohne TU, 2010, EXP EYE RES, V90, P261, DOI 10.1016/j.exer.2009.10.014; Kulik L, 2009, J IMMUNOL, V182, P5363, DOI 10.4049/jimmunol.0803980; Kunchithapautham K, 2011, J BIOL CHEM, V286, P23717, DOI 10.1074/jbc.M110.214593; Lacroix M, 2009, J IMMUNOL, V182, P456, DOI 10.4049/jimmunol.182.1.456; Lommatzsch A, 2008, GRAEF ARCH CLIN EXP, V246, P803, DOI 10.1007/s00417-007-0749-4; McLeod DS, 2002, INVEST OPHTH VIS SCI, V43, P1986; Morohoshi K, 2012, EXP MOL PATHOL, V93, P193, DOI 10.1016/j.yexmp.2012.03.007; Morohoshi K, 2009, J AUTOIMMUN, V33, P247, DOI 10.1016/j.jaut.2009.09.003; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; National Advisory Eye Council, 1999, VIS RES NAT PLAN 199; Nowak JZ, 2006, PHARMACOL REP, V58, P353; Nowak M, 2003, EUR J OPHTHALMOL, V13, P281, DOI 10.1177/112067210301300307; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Rajagopalan R, 2009, IMMUNOL LETT, V123, P114, DOI 10.1016/j.imlet.2009.02.013; Rayborn ME, 2006, ADV EXP MED BIOL, V572, P75; Rohrer B, 2012, OXID STRESS APPL BAS, P47, DOI 10.1007/978-1-61779-606-7_2; Rohrer B, 2009, INVEST OPHTH VIS SCI, V50, P3056, DOI 10.1167/iovs.08-2222; Rohrer Barbel, 2011, Mol Immunol, V48, pe1, DOI 10.1016/j.molimm.2010.12.016; Rutar M, 2012, ADV EXP MED BIOL, V723, P31, DOI 10.1007/978-1-4614-0631-0_5; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; SNODDERLY DM, 1995, AM J CLIN NUTR, V62, P1448; Takahashi M, 2007, ADV EXP MED BIOL, V598, P93; Tan SM, 1996, BIOCHEM J, V319, P329, DOI 10.1042/bj3190329; Tateishi K, 2011, MICROBIOL IMMUNOL, V55, P817, DOI 10.1111/j.1348-0421.2011.00378.x; Thiel S, 2009, J IMMUNOL, V182, P2939, DOI 10.4049/jimmunol.0802053; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005304; Weiser MR, 1996, J EXP MED, V183, P2343, DOI 10.1084/jem.183.5.2343; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Zacho RM, 2012, J BIOL CHEM, V287, P8071, DOI 10.1074/jbc.M111.301044; Zarbin MA, 2010, RETINA-J RET VIT DIS, V30, P1350, DOI 10.1097/IAE.0b013e3181f57e30; Zeiss CJ, 2010, VET PATHOL, V47, P396, DOI 10.1177/0300985809359598; Zhang M, 2004, P NATL ACAD SCI USA, V101, P3886, DOI 10.1073/pnas.0400347101; Zhang M, 2006, J IMMUNOL, V177, P4727, DOI 10.4049/jimmunol.177.7.4727	69	50	52	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12753	12765		10.1074/jbc.M112.421891	http://dx.doi.org/10.1074/jbc.M112.421891			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23493397	hybrid, Green Published			2022-12-28	WOS:000318555100032
J	Tran, CM; Fujita, N; Huang, BL; Ong, JR; Lyons, KM; Shapiro, IM; Risbud, MV				Tran, Cassie M.; Fujita, Nobuyuki; Huang, Bau-Lin; Ong, Jessica R.; Lyons, Karen M.; Shapiro, Irving M.; Risbud, Makarand V.			Hypoxia-inducible Factor (HIF)-1 alpha and CCN2 Form a Regulatory Circuit in Hypoxic Nucleus Pulposus Cells CCN2 SUPPRESSES HIF-1 alpha LEVEL AND TRANSCRIPTIONAL ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-GROWTH-FACTOR; HUMAN INTERVERTEBRAL DISC; FACTOR EXPRESSION; FACTOR CTGF/CCN2; IN-VIVO; HIF-1-ALPHA; CTGF; BINDING; CHONDROCYTES; DEGRADATION	The objective of the study was to investigate if hypoxia-inducible factor (HIF)-1 alpha and connective tissue growth factor (CCN2) form a regulatory network in hypoxic nucleus pulposus (NP) cells. A decrease in CCN2 expression and proximal promoter activity was observed in NP cells after hypoxic culture. Analysis of both human and mouse CCN2 promoters using the JASPAR core database revealed the presence of putative hypoxia response elements. Transfection experiments showed that both promoter activities and CCN2 expression decreases in hypoxia in a HIF-1 alpha-dependent fashion. Interestingly, deletion analysis and mutation of the hypoxia responsive elements individually or in combination resulted in no change in promoter activity in response to hypoxia or in response to HIF-1 alpha, suggesting an indirect mode of regulation. Notably, silencing of endogenous CCN2 increased HIF-1 alpha levels and its target gene expression, suggesting a role for CCN2 in controlling basal HIF-1 alpha levels. On the other hand, treatment of cells with rCCN2 resulted in a decrease in the ability of HIF-1 alpha transactivating domain to recruit co-activators and diminished target gene expression. Last, knockdown of CCN2 in NP cells results in a significant decrease in GAG synthesis and expression of AGGRECAN and COLLAGENII. Immunohistochemical staining of intervertebral discs of Ccn2 null embryos shows a decrease in aggrecan. These findings reveal a negative feedback loop between CCN2 and HIF-1 alpha in NP cells and demonstrate a role for CCN2 in maintaining matrix homeostasis in this tissue.	[Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Risbud, Makarand V.] Thomas Jefferson Univ, Grad Program Cell & Dev Biol, Philadelphia, PA 19107 USA; [Fujita, Nobuyuki] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo 1088345, Japan; [Huang, Bau-Lin; Ong, Jessica R.; Lyons, Karen M.] Univ Calif Los Angeles, Dept Mol, Los Angeles, CA 90024 USA; [Huang, Bau-Lin; Ong, Jessica R.; Lyons, Karen M.] Univ Calif Los Angeles, Dept Cell & Dev Biol, Los Angeles, CA 90024 USA; [Huang, Bau-Lin; Ong, Jessica R.; Lyons, Karen M.] Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA 90024 USA	Jefferson University; Jefferson University; Keio University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Risbud, MV (corresponding author), Thomas Jefferson Univ, 1025 Walnut St,Suite 511 Coll Bldg, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu	Fujita, Nobuyuki/L-4800-2013; Huang, Bau-Lin/K-8317-2019; Huang, Bau-Lin/S-4133-2019	Huang, Bau-Lin/0000-0003-3747-6697; Ong, Jessica/0000-0001-5925-8047	National Institutes of Health [AR050087, AR055655, AR052686]; National Institute on Aging [F31AG038125]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055655, R01AR052686, R01AR050087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG038125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AR050087 and AR055655 ( to M. R.) and AR052686 ( to K. M. L.).; Supported by National Institute on Aging Grant F31AG038125.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Agrawal A, 2007, AM J PHYSIOL-CELL PH, V293, pC621, DOI 10.1152/ajpcell.00538.2006; Agrawal A, 2008, ARTHRITIS RHEUM-US, V58, P3798, DOI 10.1002/art.24073; Aoyama E, 2009, BIOCHEM J, V420, P413, DOI 10.1042/BJ20081991; Aryee DNT, 2010, CANCER RES, V70, P4015, DOI 10.1158/0008-5472.CAN-09-4333; Bartels EM, 1998, SPINE, V23, P1, DOI 10.1097/00007632-199801010-00001; Bennewith KL, 2009, CANCER RES, V69, P775, DOI 10.1158/0008-5472.CAN-08-0987; Braig S, 2011, BRIT J CANCER, V105, P231, DOI 10.1038/bjc.2011.226; Capparelli C, 2012, CELL CYCLE, V11, P2272, DOI 10.4161/cc.20717; Chang CC, 2006, JNCI-J NATL CANCER I, V98, P984, DOI 10.1093/jnci/djj242; Chiou MJ, 2006, BIOCHEM BIOPH RES CO, V349, P750, DOI 10.1016/j.bbrc.2006.08.095; Erwin WM, 2006, ARTHRITIS RHEUM-US, V54, P3859, DOI 10.1002/art.22258; Fujita N, 2012, J BONE MINER RES, V27, P401, DOI 10.1002/jbmr.538; Gao RP, 2004, J BIOL CHEM, V279, P8848, DOI 10.1074/jbc.M313204200; Gogate SS, 2012, J BONE MINER RES, V27, P1106, DOI 10.1002/jbmr.1571; Gogate SS, 2011, ARTHRITIS RHEUM-US, V63, P1950, DOI 10.1002/art.30342; Gupta S, 2000, KIDNEY INT, V58, P1389, DOI 10.1046/j.1523-1755.2000.00301.x; Hall-Glenn F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030562; HASSLER O, 1969, ACTA ORTHOP SCAND, V40, P765, DOI 10.3109/17453676908989540; Higgins DF, 2004, AM J PHYSIOL-RENAL, V287, pF1223, DOI 10.1152/ajprenal.00245.2004; Hong KH, 2006, CLIN EXP IMMUNOL, V146, P362, DOI 10.1111/j.1365-2249.2006.03199.x; Hoshijima M, 2006, FEBS LETT, V580, P1376, DOI 10.1016/j.febslet.2006.01.061; Huang BL, 2010, J BIOL CHEM, V285, P27702, DOI 10.1074/jbc.M110.108498; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Klappacher GW, 2002, CELL, V109, P169, DOI 10.1016/S0092-8674(02)00714-6; Kondo S, 2011, BIOCHEM BIOPH RES CO, V405, P382, DOI 10.1016/j.bbrc.2011.01.034; Kroening S, 2010, AM J PHYSIOL-RENAL, V298, pF796, DOI 10.1152/ajprenal.00528.2009; Lee CH, 2010, J CLIN INVEST, V120, P3340, DOI 10.1172/JCI43230; Leung VYL, 2009, J HISTOCHEM CYTOCHEM, V57, P249, DOI 10.1369/jhc.2008.952184; Nakerakanti SS, 2006, J BIOL CHEM, V281, P25259, DOI 10.1074/jbc.M600466200; Nishida T, 2007, J CELL COMMUN SIGNAL, V1, P45, DOI 10.1007/s12079-007-0005-z; Nishida T, 2009, BONE, V44, P24, DOI 10.1016/j.bone.2008.08.125; Oikawa M, 2001, BIOCHEM BIOPH RES CO, V289, P39, DOI 10.1006/bbrc.2001.5927; Ponticos M, 2009, ARTHRITIS RHEUM-US, V60, P2142, DOI 10.1002/art.24620; Rajpurohit R, 2002, CELL TISSUE RES, V308, P401, DOI 10.1007/s00441-002-0563-6; Rimon E, 2008, ENDOCRINOLOGY, V149, P2952, DOI 10.1210/en.2007-1099; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; RUDERT M, 1993, ACTA ORTHOP SCAND, V64, P37, DOI 10.3109/17453679308994524; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Shimo T, 2001, CANCER LETT, V174, P57, DOI 10.1016/S0304-3835(01)00683-8; Sivan SS, 2006, J BIOL CHEM, V281, P13009, DOI 10.1074/jbc.M600296200; Skubutyte R, 2010, ARTHRITIS RHEUM-US, V62, P2707, DOI 10.1002/art.27558; Sonnylal S, 2010, ARTHRITIS RHEUM-US, V62, P1523, DOI 10.1002/art.27382; Tong ZY, 2009, HEPATOLOGY, V50, P939, DOI 10.1002/hep.23102; Tran CM, 2010, ARTHRITIS RHEUM-US, V62, P1983, DOI 10.1002/art.27445; Zeng Y, 2007, J BONE MINER RES, V22, P1851, DOI 10.1359/JBMR.070620	47	38	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12654	12666		10.1074/jbc.M112.448860	http://dx.doi.org/10.1074/jbc.M112.448860			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23530034	Green Published, hybrid			2022-12-28	WOS:000318555100023
J	Cases, O; Perea-Gomez, A; Aguiar, DP; Nykjaer, A; Amsellem, S; Chandellier, J; Umbhauer, M; Cereghini, S; Madsen, M; Collignon, J; Verroust, P; Riou, JF; Creuzet, SE; Kozyraki, R				Cases, Olivier; Perea-Gomez, Aitana; Aguiar, Diego P.; Nykjaer, Anders; Amsellem, Sabine; Chandellier, Jacqueline; Umbhauer, Muriel; Cereghini, Silvia; Madsen, Mette; Collignon, Jerome; Verroust, Pierre; Riou, Jean-Francois; Creuzet, Sophie E.; Kozyraki, Renata			Cubilin, a High Affinity Receptor for Fibroblast Growth Factor 8, Is Required for Cell Survival in the Developing Vertebrate Head	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL CREST; MULTIPLE ROLES; PROTEIN; MEGALIN; EXPRESSION; FOREBRAIN; FGF8; ENDOCYTOSIS; SHH; TELENCEPHALON	Cubilin (Cubn) is a multiligand endocytic receptor critical for the intestinal absorption of vitamin B12 and renal protein reabsorption. During mouse development, Cubn is expressed in both embryonic and extra-embryonic tissues, and Cubn gene inactivation results in early embryo lethality most likely due to the impairment of the function of extra-embryonic Cubn. Here, we focus on the developmental role of Cubn expressed in the embryonic head. We report that Cubn is a novel, interspecies-conserved Fgf receptor. Epiblast-specific inactivation of Cubn in the mouse embryo as well as Cubn silencing in the anterior head of frog or the cephalic neural crest of chick embryos show that Cubn is required during early somite stages to convey survival signals in the developing vertebrate head. Surface plasmon resonance analysis reveals that fibroblast growth factor 8 (Fgf8), a key mediator of cell survival, migration, proliferation, and patterning in the developing head, is a high affinity ligand for Cubn. Cell uptake studies show that binding to Cubn is necessary for the phosphorylation of the Fgf signaling mediators MAPK and Smad1. Although Cubn may not form stable ternary complexes with Fgf receptors (FgfRs), it acts together with and/or is necessary for optimal FgfR activity. We propose that plasma membrane binding of Fgf8, and most likely of the Fgf8 family members Fgf17 and Fgf18, to Cubn improves Fgf ligand endocytosis and availability to FgfRs, thus modulating Fgf signaling activity.	[Cases, Olivier; Amsellem, Sabine; Chandellier, Jacqueline; Verroust, Pierre; Kozyraki, Renata] Univ Paris 06, CNRS, INSERM, Inst Vis,U968,UMR7210,UMRS968, F-75012 Paris, France; [Perea-Gomez, Aitana; Collignon, Jerome] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, Inst Jacques Monod,UMR7592, F-75205 Paris, France; [Aguiar, Diego P.; Creuzet, Sophie E.] CNRS, Inst Neurobiol Alfred Fessard, UPR3294, F-91198 Gif Sur Yvette, France; [Nykjaer, Anders] Univ Aarhus, Dept Biomed, Lundbeck Fdn Res Ctr MIND, DK-8000 Aarhus, Denmark; [Umbhauer, Muriel; Cereghini, Silvia; Riou, Jean-Francois] Univ Paris 07, CNRS, UMR7622, Lab Biol Dev, F-75252 Paris, France; [Madsen, Mette] Univ Aarhus, Dept Biomed, DK-8000 Aarhus, Denmark	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Aarhus University; Lundbeckfonden; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Aarhus University	Kozyraki, R (corresponding author), Univ Paris 06, CNRS, INSERM, Inst Vis,U968,UMR7210,UMRS968, 17 Rue Moreau, F-75012 Paris, France.	renata.kozyraki@inserm.fr	Creuzet, Sophie E/AGX-9442-2022; collignon, jerome/K-8148-2017; cases, olivier/G-4882-2017; Kozyraki, Renata/G-5321-2017	cases, olivier/0000-0002-5678-7362; Collignon, Jerome/0000-0002-1212-4006; Riou, jean-francois/0000-0003-3272-7901; Madsen, Mette/0000-0001-7241-6505; Perea-Gomez, Aitana/0000-0002-7788-038X; Umbhauer, Muriel/0000-0001-7419-8070; Kozyraki, Renata/0000-0001-9779-5898; Nykjaer, Anders/0000-0001-6422-6736	INSERM; CNRS; UPMC; EuReGene FP6 [GA5085, CNRS-ANR-BLAN-0153, CNRS-ANR-06-BLAN-0200]; GEF-LUC-Paris Ile de France; Novo Nordisk Foundation; Lundbeck Foundation; Fondation des Treilles	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); UPMC; EuReGene FP6(European Commission); GEF-LUC-Paris Ile de France; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Fondation des Treilles	This work was supported in part by INSERM, CNRS, UPMC, EuReGene FP6 Grant GA5085; CNRS-ANR-BLAN-0153, CNRS-ANR-06-BLAN-0200, the GEF-LUC-Paris Ile de France; the Novo Nordisk Foundation, and the Lundbeck Foundation.; Recipient of a fellowship from Fondation des Treilles.	Amsellem S, 2010, J AM SOC NEPHROL, V21, P1859, DOI 10.1681/ASN.2010050492; Anderson RM, 2006, DEV DYNAM, V235, P2507, DOI 10.1002/dvdy.20891; Assemat E, 2005, GENE EXPR PATTERNS, V6, P69, DOI 10.1016/j.modgep.2005.04.014; Assemat E, 2005, BIOL REPROD, V72, P1079, DOI 10.1095/biolreprod.104.036913; Bai CB, 2002, DEVELOPMENT, V129, P4753; Barth JL, 2001, TRENDS CARDIOVAS MED, V11, P26, DOI 10.1016/S1050-1738(01)00080-9; Christ A, 2012, DEV CELL, V22, P268, DOI 10.1016/j.devcel.2011.11.023; Colas A, 2008, DEV BIOL, V320, P351, DOI 10.1016/j.ydbio.2008.05.547; Creuzet S, 2004, P NATL ACAD SCI USA, V101, P4843, DOI 10.1073/pnas.0400869101; Creuzet SE, 2006, P NATL ACAD SCI USA, V103, P14033, DOI 10.1073/pnas.0605899103; Creuzet SE, 2009, P NATL ACAD SCI USA, V106, P15774, DOI 10.1073/pnas.0906072106; Eivers E, 2009, CYTOKINE GROWTH F R, V20, P357, DOI 10.1016/j.cytogfr.2009.10.017; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Franke B, 2009, BIRTH DEFECTS RES A, V85, P216, DOI 10.1002/bdra.20556; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Fyfe JC, 2004, BLOOD, V103, P1573, DOI 10.1182/blood-2003-08-2852; Geng X, 2008, DEV CELL, V15, P236, DOI 10.1016/j.devcel.2008.07.003; Geng X, 2009, J CLIN INVEST, V119, P1403, DOI 10.1172/JCI38937; Grasbeck R, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-17; Guillemot F, 2011, NEURON, V71, P574, DOI 10.1016/j.neuron.2011.08.002; Guo QX, 2010, DEV BIOL, V338, P183, DOI 10.1016/j.ydbio.2009.11.034; Gutin G, 2006, DEVELOPMENT, V133, P2937, DOI 10.1242/dev.02465; Hammad SM, 1999, P NATL ACAD SCI USA, V96, P10158, DOI 10.1073/pnas.96.18.10158; Hayashi Shigemi, 2002, Gene Expression Patterns, V2, P93, DOI 10.1016/S0925-4773(02)00292-7; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Hoch RV, 2009, SEMIN CELL DEV BIOL, V20, P378, DOI 10.1016/j.semcdb.2009.02.005; Itasaki N, 2010, DEV DYNAM, V239, P16, DOI 10.1002/dvdy.22009; Klingensmith J, 2010, AM J MED GENET C, V154C, P43, DOI 10.1002/ajmg.c.30256; Kozyraki R, 2001, P NATL ACAD SCI USA, V98, P12491, DOI 10.1073/pnas.211291398; Kozyraki R, 2007, CURR PHARM DESIGN, V13, P3038, DOI 10.2174/138161207782110507; Kozyraki R, 2013, BIOCHIMIE, V95, P1002, DOI 10.1016/j.biochi.2012.11.004; Kristiansen M, 1999, J BIOL CHEM, V274, P20540, DOI 10.1074/jbc.274.29.20540; Le Douarin NM, 2012, DEV BIOL, V366, P74, DOI 10.1016/j.ydbio.2012.01.007; LEPANSE S, 1995, EUR J CELL BIOL, V67, P120; Liu W, 2010, J CLIN INVEST, V120, P3568, DOI 10.1172/JCI43219; Lunn JS, 2007, DEV BIOL, V302, P536, DOI 10.1016/j.ydbio.2006.10.014; Mason I, 2007, NAT REV NEUROSCI, V8, P583, DOI 10.1038/nrn2189; Moestrup SK, 1998, J BIOL CHEM, V273, P5235, DOI 10.1074/jbc.273.9.5235; Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Nykjaer A, 2001, P NATL ACAD SCI USA, V98, P13895, DOI 10.1073/pnas.241516998; Ohkubo Y, 2002, NEUROSCIENCE, V111, P1, DOI 10.1016/S0306-4522(01)00616-9; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; Olsen SK, 2004, P NATL ACAD SCI USA, V101, P935, DOI 10.1073/pnas.0307287101; Paek H, 2009, DEVELOPMENT, V136, P2457, DOI 10.1242/dev.032656; Pangilinan F, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-62; Regad T, 2007, NAT CELL BIOL, V9, P531, DOI 10.1038/ncb1573; Reznichenko A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036512; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Sheng NY, 2010, P NATL ACAD SCI USA, V107, P18886, DOI 10.1073/pnas.1009244107; Shinya M, 2001, DEVELOPMENT, V128, P4153; Smith BT, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-30; Spoelgen R, 2005, DEVELOPMENT, V132, P405, DOI 10.1242/dev.01580; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Tomihara-Newberger C, 1998, DEV BIOL, V204, P34, DOI 10.1006/dbio.1998.9034; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Walshe J, 2000, MECH DEVELOP, V90, P103, DOI 10.1016/S0925-4773(99)00225-7; Zucker RM, 1998, CYTOMETRY, V33, P348, DOI 10.1002/(SICI)1097-0320(19981101)33:3<348::AID-CYTO9>3.0.CO;2-C	58	19	19	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16655	16670		10.1074/jbc.M113.451070	http://dx.doi.org/10.1074/jbc.M113.451070			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23592779	Green Published, hybrid			2022-12-28	WOS:000320378900041
J	Eckl, JM; Rutz, DA; Haslbeck, V; Zierer, BK; Reinstein, J; Richter, K				Eckl, Julia M.; Rutz, Daniel A.; Haslbeck, Veronika; Zierer, Bettina K.; Reinstein, Jochen; Richter, Klaus			Cdc37 (Cell Division Cycle 37) Restricts Hsp90 (Heat Shock Protein 90) Motility by Interaction with N-terminal and Middle Domain Binding Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE; CO-CHAPERONE; CONFORMATIONAL-CHANGES; ATPASE ACTIVITY; ACTIVATION; AHA1; IMMUNOPHILINS; DIMERIZATION; NUCLEOTIDE; COMPLEXES	The ATPase-driven dimeric molecular Hsp90 (heat shock protein 90) and its cofactor Cdc37 (cell division cycle 37 protein) are crucial to prevent the cellular depletion of many protein kinases. In complex with Hsp90, Cdc37 is thought to bind an important lid structure in the ATPase domain of Hsp90 and inhibit ATP turnover by Hsp90. As different interaction modes have been reported, we were interested in the interaction mechanism of Hsp90 and Cdc37. We find that Cdc37 can bind to one subunit of the Hsp90 dimer. The inhibition of the ATPase activity is caused by a reduction in the closing rate of Hsp90 without obviously bridging the two subunits or affecting nucleotide accessibility to the binding site. Although human Cdc37 binds to the N-terminal domain of Hsp90, nematodal Cdc37 preferentially interacts with the middle domain of CeHsp90 and hHsp90, exposing two Cdc37 interaction sites. A previously unreported site in CeCdc37 is utilized for the middle domain interaction. Dephosphorylation of CeCdc37 by the Hsp90-associated phosphatase PPH-5, a step required during the kinase activation process, proceeds normally, even if only the new interaction site is used. This shows that the second interaction site is also functionally relevant and highlights that Cdc37, similar to the Hsp90 cofactors Sti1 and Aha1, may utilize two different attachment sites to restrict the conformational freedom and the ATP turnover of Hsp90.	[Eckl, Julia M.; Rutz, Daniel A.; Haslbeck, Veronika; Zierer, Bettina K.; Richter, Klaus] Tech Univ Munich, Ctr Integrated Prot Sci Munchen, D-85747 Garching, Germany; [Eckl, Julia M.; Rutz, Daniel A.; Haslbeck, Veronika; Zierer, Bettina K.; Richter, Klaus] Tech Univ Munich, Dept Chem, D-85747 Garching, Germany; [Reinstein, Jochen] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany	Technical University of Munich; Technical University of Munich; Max Planck Society	Richter, K (corresponding author), Tech Univ Munich, Ctr Integrated Prot Sci Munchen, Lichtenbergstr 4, D-85747 Garching, Germany.	klaus.richter@ch.tum.de	Richter, Klaus/A-2673-2010	Richter, Klaus/0000-0002-8952-9642	Deutsche Forschungsgemeinschaft Grant [RI1873/1-2]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant RI1873/1-2 (to K. R.) and Fonds der Chemischen Industrie.	ASHBURNER M, 1979, CELL, V17, P241, DOI 10.1016/0092-8674(79)90150-8; Bandhakavi S, 2003, J BIOL CHEM, V278, P2829, DOI 10.1074/jbc.M206662200; Gaiser AM, 2010, J BIOL CHEM, V285, P40921, DOI 10.1074/jbc.M110.131086; Gaiser AM, 2009, J MOL BIOL, V391, P621, DOI 10.1016/j.jmb.2009.06.051; Galigniana MD, 2002, BIOCHEMISTRY-US, V41, P13602, DOI 10.1021/bi020399z; Haslbeck V, 2012, BBA-MOL CELL RES, V1823, P712, DOI 10.1016/j.bbamcr.2011.09.004; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee CT, 2012, EMBO J, V31, P1518, DOI 10.1038/emboj.2012.37; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Miyata Y, 2004, MOL CELL BIOL, V24, P4065, DOI 10.1128/MCB.24.9.4065-4074.2004; OwensGrillo JK, 1996, J BIOL CHEM, V271, P13468, DOI 10.1074/jbc.271.23.13468; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 2003, CURR CANCER DRUG TAR, V3, P301, DOI 10.2174/1568009033481877; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Richter K, 2003, J BIOL CHEM, V278, P10328, DOI 10.1074/jbc.M213094200; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; Richter K, 2008, J BIOL CHEM, V283, P17757, DOI 10.1074/jbc.M800540200; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Shao JY, 2003, J BIOL CHEM, V278, P38117, DOI 10.1074/jbc.C300330200; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Silverstein AM, 1998, J BIOL CHEM, V273, P20090, DOI 10.1074/jbc.273.32.20090; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Sreedhar AS, 2004, FEBS LETT, V562, P11; Sreeramulu S, 2009, J BIOL CHEM, V284, P3885, DOI 10.1074/jbc.M806715200; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; Sun L, 2012, BBA-MOL CELL RES, V1823, P1092, DOI 10.1016/j.bbamcr.2012.03.014; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; WALSH KH, 1989, J LAB CLIN MED, V114, P563; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Weikl T, 2000, J MOL BIOL, V303, P583, DOI 10.1006/jmbi.2000.4157; Zhang W, 2004, J MOL BIOL, V340, P891, DOI 10.1016/j.jmb.2004.05.007	43	25	31	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16032	16042		10.1074/jbc.M112.439257	http://dx.doi.org/10.1074/jbc.M112.439257			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23569206	hybrid, Green Published			2022-12-28	WOS:000319822300054
J	Gisch, N; Kohler, T; Ulmer, AJ; Muthing, J; Pribyl, T; Fischer, K; Lindner, B; Hammerschmidt, S; Zahringer, U				Gisch, Nicolas; Kohler, Thomas; Ulmer, Artur J.; Muething, Johannes; Pribyl, Thomas; Fischer, Kathleen; Lindner, Buko; Hammerschmidt, Sven; Zaehringer, Ulrich			Structural Reevaluation of Streptococcus pneumoniae Lipoteichoic Acid and New Insights into Its Immunostimulatory Potency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS; TEICHOIC-ACIDS; GROUP-B; GANGLIOSIDES; FORSSMAN; RECEPTOR; GLYCOSPHINGOLIPIDS; PRELIPOPROTEINS; BIOSYNTHESIS; RECOGNITION	Streptococcus pneumoniae is a Gram-positive human pathogen with a complex lipoteichoic acid (pnLTA) structure. Because the current structural model for pnLTA shows substantial inconsistencies, we reinvestigated purified and, more importantly, O-deacylated pnLTA, which is most suitable for NMR spectroscopy and electrospray ionization-MS spectrometry. We analyzed pnLTA of nonencapsulated pneumococcal strains D39 Delta cps and TIGR4 Delta cps, respectively. The data obtained allowed us to (re) define (i) the position and linkage of the repeating unit, (ii) the putative alpha-GalpNAc substitution at the ribitiol 5-phosphate (Rib-ol-5-P), and (iii) the length of (i. e. the number of repeating units in) the pnLTA chain. We here also describe for the first time that the terminal sugar residues in the pnLTA (Forssman disaccharide; alpha-D-GalpNAc-(1 -> 3)-beta-D-GalpNAc-(1 ->)), responsible for the cross-reactivity with anti-Forssman antigen antibodies, can be heterogeneous with respect to its degree of phosphorylcholine substitution in both O-6-positions. To assess the proinflammatory potency of pnLTA, we generated a (lipopeptide-free) Delta lgt mutant of strain D39 Delta cps, isolated its pnLTA, and showed that it is capable of inducing IL-6 release in human mononuclear cells, independent of TLR2 activation. This finding was quite in contrast to LTA of the Staphylococcus aureus SA113 Delta lgt mutant, which did not activate human mononuclear cells in our experiments. Remarkably, this is also contrary to various other reports showing a proinflammatory potency of S. aureus LTA. Taken together, our study refines the structure of pnLTA and indicates that pneumococcal and S. aureus LTAs differ not only in their structure but also in their bioactivity.	[Gisch, Nicolas; Lindner, Buko; Zaehringer, Ulrich] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Immunochem, D-23845 Borstel, Germany; [Ulmer, Artur J.] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Innate Immun, D-23845 Borstel, Germany; [Fischer, Kathleen] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Struct Biochem, D-23845 Borstel, Germany; [Fischer, Kathleen] German Ctr Lung Res, Airway Res Ctr North, D-23845 Borstel, Germany; [Kohler, Thomas; Pribyl, Thomas; Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Dept Genet Microorganisms, Interfac Inst Genet & Funct Gen, D-17487 Greifswald, Germany; [Muething, Johannes] Univ Munster, Inst Hyg, D-48149 Munster, Germany	Forschungszentrum Borstel; Forschungszentrum Borstel; Forschungszentrum Borstel; Ernst Moritz Arndt Universitat Greifswald; University of Munster	Gisch, N (corresponding author), Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Immunochem, Pk Allee 1-40, D-23845 Borstel, Germany.	ngisch@fz-borstel.de	Hammerschmidt, Sven/G-2598-2010	Hammerschmidt, Sven/0000-0002-6382-6681; Gisch, Nicolas/0000-0003-3260-5269	Deutsche Forschungsgemeinschaft [(ZA 149/6-1, HA 3125/2-1]; cluster of excellence "Inflammation at Interfaces"	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); cluster of excellence "Inflammation at Interfaces"	This work was supported by Deutsche Forschungsgemeinschaft (ZA 149/6-1 and HA 3125/2-1) and the cluster of excellence "Inflammation at Interfaces."	BEHR T, 1992, EUR J BIOCHEM, V207, P1063, DOI 10.1111/j.1432-1033.1992.tb17143.x; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; BETHKE U, 1986, J IMMUNOL METHODS, V89, P111, DOI 10.1016/0022-1759(86)90038-4; BETHKE U, 1987, J IMMUNOL, V138, P4329; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Bui NK, 2012, ANAL BIOCHEM, V421, P657, DOI 10.1016/j.ab.2011.11.026; COURTNEY HS, 1986, INFECT IMMUN, V51, P414, DOI 10.1128/IAI.51.2.414-418.1986; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Debarry J, 2007, J ALLERGY CLIN IMMUN, V119, P1514, DOI 10.1016/j.jaci.2007.03.023; Dehus O, 2011, IMMUNOBIOLOGY, V216, P24, DOI 10.1016/j.imbio.2010.03.008; Denapaite D, 2012, MICROB DRUG RESIST, V18, P344, DOI 10.1089/mdr.2012.0026; Draing C, 2006, J BIOL CHEM, V281, P33849, DOI 10.1074/jbc.M602676200; Elling L, 1999, GLYCOCONJUGATE J, V16, P327, DOI 10.1023/A:1007039825505; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; Fischer W, 1997, MICROB DRUG RESIST, V3, P309, DOI 10.1089/mdr.1997.3.309; FISCHER W, 1983, EUR J BIOCHEM, V133, P523, DOI 10.1111/j.1432-1033.1983.tb07495.x; FISCHER W, 1993, EUR J BIOCHEM, V215, P851, DOI 10.1111/j.1432-1033.1993.tb18102.x; FISCHER W, 2000, STREPTOCOCCUS PNEUMO, P155; Gamez G, 2012, CURR DRUG TARGETS, V13, P323, DOI 10.2174/138945012799424697; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Heissigerova H, 2003, GLYCOBIOLOGY, V13, P377, DOI 10.1093/glycob/cwg042; Henneke P, 2005, J IMMUNOL, V174, P6449, DOI 10.4049/jimmunol.174.10.6449; Houliston RS, 2009, GLYCOBIOLOGY, V19, P153, DOI 10.1093/glycob/cwn117; HUMMELL DS, 1985, INFECT IMMUN, V47, P384, DOI 10.1128/IAI.47.2.384-387.1985; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kinjo Y, 2011, NAT IMMUNOL, V12, P966, DOI 10.1038/ni.2096; KUNDU SK, 1978, J LIPID RES, V19, P390; LEDEEN RW, 1982, METHOD ENZYMOL, V83, P139; LOOS M, 1986, INFECT IMMUN, V53, P595, DOI 10.1128/IAI.53.3.595-599.1986; Lopez R, 2004, INT MICROBIOL, V7, P163; LOWRY OH, 1954, J BIOL CHEM, V207, P1; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Morath S, 2002, J EXP MED, V195, P1635, DOI 10.1084/jem.20020322; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Morr M, 2002, EUR J IMMUNOL, V32, P3337, DOI 10.1002/1521-4141(2002012)32:12<3337::AID-IMMU3337>3.0.CO;2-I; Muthing J, 2012, GLYCOBIOLOGY, V22, P849, DOI 10.1093/glycob/cws009; Pedersen CM, 2010, ANGEW CHEM INT EDIT, V49, P2585, DOI 10.1002/anie.200906163; Petit CM, 2001, FEMS MICROBIOL LETT, V200, P229, DOI 10.1111/j.1574-6968.2001.tb10720.x; Radin JN, 2005, INFECT IMMUN, V73, P7827, DOI 10.1128/IAI.73.12.7827-7835.2005; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; SAITO T, 1971, J LIPID RES, V12, P257; Schmidt RR, 2011, ORG BIOMOL CHEM, V9, P2040, DOI 10.1039/c0ob00794c; Seo HS, 2008, J BACTERIOL, V190, P2379, DOI 10.1128/JB.01795-07; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; UENO K, 1978, J LIPID RES, V19, P863; Voss S, 2012, MOL ORAL MICROBIOL, V27, P246, DOI 10.1111/j.2041-1014.2012.00654.x; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005	51	67	69	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15654	15667		10.1074/jbc.M112.446963	http://dx.doi.org/10.1074/jbc.M112.446963			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23603911	Green Published, hybrid			2022-12-28	WOS:000319822300022
J	Griffiths, AE; Rydkin, I; Fay, PJ				Griffiths, Amy E.; Rydkin, Ivan; Fay, Philip J.			Factor VIIIa A2 Subunit Shows a High Affinity Interaction with Factor IXa CONTRIBUTION OF A2 SUBUNIT RESIDUES 707-714 TO THE INTERACTION WITH FACTOR IXa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORCINE FACTOR-VIII; COAGULATION-FACTOR-VIII; FACTOR-X; A1/A3-C1-C2 DIMER; FACTOR XASE; A1 SUBUNIT; SITE; ACTIVATION; CLEAVAGE; RESIDUES-558-565	Factor (F) VIIIa forms a number of contacts with FIXa in assembling the FXase enzyme complex. Surface plasmon resonance was used to examine the interaction between immobilized biotinylated active site-modified FIXa, and FVIII and FVIIIa subunits. The FVIIIa A2 subunit bound FIXa with high affinity (K-d = 3.9 +/- 1.6 nM) that was similar to the A3C1C2 subunit (K-d = 3.6 +/- 0.6 nM). This approach was used to evaluate a series of baculovirus-expressed, isolated A2 domain (bA2) variants where alanine substitutions were made for individual residues within the sequence 707-714, the C-terminal region of A2 thought to be FIXa interactive. Three of six bA2 variants examined displayed 2- to 4-fold decreased affinity for FIXa as compared with WT bA2. The variant bA2 proteins were also tested in two reconstitution systems to determine activity and affinity parameters in forming FXase and FVIIIa. V-max values for all variants were similar to the WT values, indicating that these residues do not affect cofactor function. All variants showed substantially greater increases in apparent K-d relative to WT in reconstituting the FXase complex (8- to 26-fold) compared with reconstituting FVIIIa (1.3- to 6-fold) suggesting that the mutations altered interaction with FIXa. bA2 domain variants with Ala replacing Lys(707), Asp(712), and Lys(713) demonstrated the greatest increases in apparent K-d (17- to 26-fold). These results indicate a high affinity interaction between the FVIIIa A2 subunit and FIXa and show a contribution of several residues within the 707-714 sequence to this binding.	[Griffiths, Amy E.; Rydkin, Ivan; Fay, Philip J.] Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Fay, PJ (corresponding author), POB 712,601 Elm wood Ave, Rochester, NY 14642 USA.	Philip_Fay@urmc.rochester.edu			National Institutes of Health [NCRR 1S10 RR027241, HL76213, HL38199]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027241] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076213, R01HL038199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Lisa Regan of Bayer Corp. for the FVIII concentrate ( Kogenate) and Indu Jagannathan for helpful discussions and experimental contributions to the early stages of this study. The Biacore T100 was obtained from National Institutes of Health shared instrument Grant NCRR 1S10 RR027241.; This work was supported, in whole or in part, by National Institutes of Health Grants HL76213 and HL38199.	Bajaj SP, 2001, J BIOL CHEM, V276, P16302, DOI 10.1074/jbc.M011680200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DUFFY EJ, 1992, J BIOL CHEM, V267, P7821; Fay PJ, 1998, J BIOL CHEM, V273, P19049, DOI 10.1074/jbc.273.30.19049; Fay PJ, 2005, BLOOD REV, V19, P15, DOI 10.1016/j.blre.2004.02.003; FAY PJ, 1994, J BIOL CHEM, V269, P20522; Fay PJ, 1996, J BIOL CHEM, V271, P6027, DOI 10.1074/jbc.271.11.6027; FAY PJ, 1991, J BIOL CHEM, V266, P20139; FAY PJ, 1992, J BIOL CHEM, V267, P13246; FAY PJ, 1991, J BIOL CHEM, V266, P8957; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; Fay PJ, 2001, J BIOL CHEM, V276, P12434, DOI 10.1074/jbc.M009539200; Jagannathan I, 2009, J BIOL CHEM, V284, P32248, DOI 10.1074/jbc.M109.050781; Jenkins PV, 2004, BIOCHEMISTRY-US, V43, P5094, DOI 10.1021/bi036289p; Jenkins PV, 2002, BLOOD, V100, P501, DOI 10.1182/blood-2001-12-0361; Kolkman JA, 1999, BIOCHEM J, V339, P217, DOI 10.1042/0264-6021:3390217; LAMPHEAR BJ, 1992, J BIOL CHEM, V267, P3725; Lapan KA, 1997, J BIOL CHEM, V272, P2082; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; LOLLAR P, 1990, J BIOL CHEM, V265, P1688; LOLLAR P, 1984, BLOOD, V63, P1303; LOLLAR P, 1989, BIOCHEMISTRY-US, V28, P666, DOI 10.1021/bi00428a038; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; Plantier JL, 2010, J THROMB HAEMOST, V8, P286, DOI 10.1111/j.1538-7836.2009.03675.x; Rosenblum MEK, 2002, J BIOL CHEM, V277, P11664, DOI 10.1074/jbc.M200037200; Selvaraj SR, 2012, J THROMB HAEMOST, V10, P107, DOI 10.1111/j.1538-7836.2011.04545.x; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433	29	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15057	15064		10.1074/jbc.M113.456467	http://dx.doi.org/10.1074/jbc.M113.456467			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23580639	Green Published, hybrid			2022-12-28	WOS:000319452100035
J	Tavares, IA; Touma, D; Lynham, S; Troakes, C; Schober, M; Causevic, M; Garg, R; Noble, W; Killick, R; Bodi, I; Hanger, DP; Morris, JDH				Tavares, Ignatius A.; Touma, Dona; Lynham, Steven; Troakes, Claire; Schober, Megan; Causevic, Mirsada; Garg, Ritu; Noble, Wendy; Killick, Richard; Bodi, Istvan; Hanger, Diane P.; Morris, Jonathan D. H.			Prostate-derived Sterile 20-like Kinases (PSKs/TAOKs) Phosphorylate Tau Protein and Are Activated in Tangle-bearing Neurons in Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; N-TERMINAL KINASE; NEUROFIBRILLARY TANGLES; P21-ACTIVATED KINASES; MICROTUBULE-BINDING; STE20-LIKE KINASE; TRANSGENIC MICE; TAUOPATHIES; SITES; GSK-3-BETA	In Alzheimer disease (AD), the microtubule-associated protein tau is highly phosphorylated and aggregates into characteristic neurofibrillary tangles. Prostate-derived sterile 20-like kinases (PSKs/TAOKs) 1 and 2, members of the sterile 20 family of kinases, have been shown to regulate microtubule stability and organization. Here we show that tau is a good substrate for PSK1 and PSK2 phosphorylation with mass spectrometric analysis of phosphorylated tau revealing more than 40 tau residues as targets of these kinases. Notably, phosphorylated residues include motifs located within the microtubule-binding repeat domain on tau (Ser-262, Ser-324, and Ser-356), sites that are known to regulate tau-microtubule interactions. PSK catalytic activity is enhanced in the entorhinal cortex and hippocampus, areas of the brain that are most susceptible to Alzheimer pathology, in comparison with the cerebellum, which is relatively spared. Activated PSK is associated with neurofibrillary tangles, dystrophic neurites surrounding neuritic plaques, neuropil threads, and granulovacuolar degeneration bodies in AD brain. By contrast, activated PSKs and phosphorylated tau are rarely detectible in immunostained control human brain. Our results demonstrate that tau is a substrate for PSK and suggest that this family of kinases could contribute to the development of AD pathology and dementia.	[Tavares, Ignatius A.; Touma, Dona; Schober, Megan; Morris, Jonathan D. H.] Kings Coll London, Div Canc Studies, London SE1 1UL, England; [Lynham, Steven] Kings Coll London, Ctr Excellence Mass Spectrometry, London SE5 8AF, England; [Troakes, Claire] Kings Coll London, MRC, London Neurodegenerat Dis Brain Bank, London SE5 8AF, England; [Causevic, Mirsada; Killick, Richard] Kings Coll London, Dept Old Age Psychiat, Inst Psychiat, London SE5 8AF, England; [Noble, Wendy; Hanger, Diane P.] Kings Coll London, Dept Neurosci, Inst Psychiat, London SE5 8AF, England; [Garg, Ritu] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Bodi, Istvan] Kings Coll Hosp London, Inst Psychiat, Dept Clin Neurosci, London SE5 8AF, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Morris, JDH (corresponding author), Kings Coll London, Div Canc Studies, New Hunts House,Guys Campus, London SE1 1UL, England.	jonathan.morris@kcl.ac.uk	Hanger, Diane/C-5697-2009; Causevic, Mirsada/AAM-7423-2020; Noble, Wendy/C-3756-2009; Troakes, Claire/K-4346-2015; Bodi, Istvan/H-8092-2019	Hanger, Diane/0000-0002-3044-9816; Causevic, Mirsada/0000-0002-6099-6415; Noble, Wendy/0000-0002-7898-4295; Bodi, Istvan/0000-0002-2533-4758; Killick, Richard/0000-0002-8815-3436; Troakes, Claire/0000-0002-1790-7376; Lynham, Steven/0000-0003-3756-6430; Morris, Jonathan/0000-0002-3211-1798	Medical Research Council; Alzheimer's Association; British United Provident Association Limited; King's Medical Research Trust; MRC [G1100695] Funding Source: UKRI; Medical Research Council [G1100695] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Association(Alzheimer's Association); British United Provident Association Limited; King's Medical Research Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (to D. H. and W. N.), the Alzheimer's Association and British United Provident Association Limited (to R. K.), and the King's Medical Research Trust and a donation from Laura Price (to J. M.).	Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Biernat J, 1999, MOL BIOL CELL, V10, P727, DOI 10.1091/mbc.10.3.727; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Causevic M, 2010, NEUROSCI LETT, V485, P162, DOI 10.1016/j.neulet.2010.08.088; Chen Z, 1999, J BIOL CHEM, V274, P28803, DOI 10.1074/jbc.274.40.28803; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; Chung CW, 2001, NEUROBIOL DIS, V8, P162, DOI 10.1006/nbdi.2000.0335; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; de Anda FC, 2012, NAT NEUROSCI, V15, P1022, DOI 10.1038/nn.3141; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Deters N, 2008, EUR J NEUROSCI, V28, P137, DOI 10.1111/j.1460-9568.2008.06318.x; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; Drewes G, 1998, TRENDS BIOCHEM SCI, V23, P307, DOI 10.1016/S0968-0004(98)01245-6; Eswaran J, 2008, TRENDS BIOCHEM SCI, V33, P394, DOI 10.1016/j.tibs.2008.06.002; Ferrer I, 2002, ACTA NEUROPATHOL, V104, P583, DOI 10.1007/s00401-002-002-0587-8; Ferrer I, 2001, J NEURAL TRANSM, V108, P1397, DOI 10.1007/s007020100016; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Hanger Diane P, 2011, Int J Alzheimers Dis, V2011, P352805, DOI 10.4061/2011/352805; Hanger DP, 2010, BIOCHEM SOC T, V38, P1016, DOI 10.1042/BST0381016; Hanger DP, 2009, EXPERT REV NEUROTHER, V9, P1647, DOI 10.1586/ERN.09.104; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Harr SD, 1996, NEUROBIOL AGING, V17, P343, DOI 10.1016/0197-4580(96)00025-5; Hernandez F, 2007, CELL MOL LIFE SCI, V64, P2219, DOI 10.1007/s00018-007-7220-x; Hutchison M, 1998, J BIOL CHEM, V273, P28625, DOI 10.1074/jbc.273.44.28625; Kawakami F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030834; Kremer A, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00017; Kumar RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004582; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Leroy K, 2007, NEUROPATH APPL NEURO, V33, P43, DOI 10.1111/j.1365-2990.2006.00795.x; Liu T, 2010, J CELL SCI, V123, P2708, DOI 10.1242/jcs.068726; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matenia D, 2009, TRENDS BIOCHEM SCI, V34, P332, DOI 10.1016/j.tibs.2009.03.008; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Mitsopoulos C, 2003, J BIOL CHEM, V278, P18085, DOI 10.1074/jbc.M213064200; Moore TM, 2000, J BIOL CHEM, V275, P4311, DOI 10.1074/jbc.275.6.4311; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Raman M, 2007, EMBO J, V26, P2005, DOI 10.1038/sj.emboj.7601668; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Schneider A, 2008, NEUROTHERAPEUTICS, V5, P443, DOI 10.1016/j.nurt.2008.05.006; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Spittaels K, 2000, J BIOL CHEM, V275, P41340, DOI 10.1074/jbc.M006219200; Tassi E, 1999, J BIOL CHEM, V274, P33287, DOI 10.1074/jbc.274.47.33287; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Timm T, 2006, NEURODEGENER DIS, V3, P207, DOI 10.1159/000095258; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Timm T, 2008, J BIOL CHEM, V283, P18873, DOI 10.1074/jbc.M706596200; Vingtdeux V, 2011, ACTA NEUROPATHOL, V121, P337, DOI 10.1007/s00401-010-0759-x; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Wojtala RL, 2011, J BIOL CHEM, V286, P30161, DOI 10.1074/jbc.M111.228320; Zach S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013191; Zhou TJ, 2004, STRUCTURE, V12, P1891, DOI 10.1016/j.str.2004.07.021; Zihni C, 2006, J BIOL CHEM, V281, P7317, DOI 10.1074/jbc.M513769200; Zihni C, 2007, J BIOL CHEM, V282, P6484, DOI 10.1074/jbc.M608336200	62	39	40	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15418	15429		10.1074/jbc.M112.448183	http://dx.doi.org/10.1074/jbc.M112.448183			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23585562	Green Published, hybrid			2022-12-28	WOS:000319452100065
J	Toro, TB; Toth, JI; Petroski, MD				Toro, Tasha B.; Toth, Julia I.; Petroski, Matthew D.			The Cyclomodulin Cycle Inhibiting Factor (CIF) Alters Cullin Neddylation Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCF UBIQUITIN LIGASE; NEDD8-ACTIVATING ENZYME; RING LIGASES; NEDD8 DEAMIDATION; COP9 SIGNALOSOME; PROTEIN NEDD8; EFFECTOR; ACTIVATION; MECHANISM; FAMILY	The bacterial effector protein cycle inhibiting factor (CIF) converts glutamine 40 of NEDD8 to glutamate (Q40E), causing cytopathic effects and inhibiting cell proliferation. Although these have been attributed to blocking the functions of cullin-RING ubiquitin ligases, how CIF modulates NEDD8-dependent signaling is unclear. Here we use conditional NEDD8-dependent yeast to explore the effects of CIF on cullin neddylation. Although CIF causes cullin deneddylation and the generation of free NEDD8 Q40E, inhibiting the COP9 signalosome (CSN) allows Q40E to form only on NEDD8 attached to cullins. In the presence of the CSN, NEDD8 Q40E is removed from cullins more rapidly than NEDD8, leading to a decrease in steady-state cullin neddylation. As NEDD8 Q40E is competent for cullin conjugation in the absence of functional CSN and with overexpression of the NEDD8 ligase Dcn1, our data are consistent with NEDD8 deamidation causing enhanced deneddylation of cullins by the CSN. This leads to a dramatic change in the extent of activated cullin-RING ubiquitin ligases.	[Toro, Tasha B.; Toth, Julia I.; Petroski, Matthew D.] Sanford Burnham Med Res Inst, Signal Transduct Program, NCI Designated Canc Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Petroski, MD (corresponding author), Sanford Burnham Med Res Inst, Signal Transduct Program, NCI Designated Canc Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	petroski@sanfordburnham.org			NCI National Institutes of Health [5 T32 CA121949]; V Foundation for Cancer Research; American Cancer Society [RSG-11-224-01-DMC]; NATIONAL CANCER INSTITUTE [T32CA121949] Funding Source: NIH RePORTER	NCI National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); V Foundation for Cancer Research; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI National Institutes of Health Training Grant 5 T32 CA121949 (to T. B. T.). This work was also supported by institutional start-up funds (to M. D. P.), by a scholars award from the V Foundation for Cancer Research (to M. D. P.), and by American Cancer Society Research Scholars Grant RSG-11-224-01-DMC (to M. D. P.).	Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Boh BK, 2011, J MOL BIOL, V413, P430, DOI 10.1016/j.jmb.2011.08.030; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Crow A, 2012, P NATL ACAD SCI USA, V109, pE1830, DOI 10.1073/pnas.1112107109; Crow A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005582; Cui JX, 2010, SCIENCE, V329, P1215, DOI 10.1126/science.1193844; DeRycke J, 1997, INFECT IMMUN, V65, P2555, DOI 10.1128/IAI.65.7.2555-2563.1997; Deshaies RJ, 2010, SUBCELL BIOCHEM, V54, P41, DOI 10.1007/978-1-4419-6676-6_4; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Emberley ED, 2012, J BIOL CHEM, V287, P29679, DOI 10.1074/jbc.M112.352484; Enchev RI, 2012, CELL REPORTS, V2, P616, DOI 10.1016/j.celrep.2012.08.019; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hjerpe R, 2012, J MOL BIOL, V421, P27, DOI 10.1016/j.jmb.2012.05.013; Hjerpe R, 2012, BIOCHEM J, V441, P927, DOI 10.1042/BJ20111671; Hsu Y, 2008, J MOL BIOL, V384, P465, DOI 10.1016/j.jmb.2008.09.051; Jubelin G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001128; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Laplaza JM, 2004, BIOCHEM J, V377, P459, DOI 10.1042/BJ20030755; Leidecker O, 2012, CELL CYCLE, V11, P1142, DOI 10.4161/cc.11.6.19559; Liakopoulos D, 1999, P NATL ACAD SCI USA, V96, P5510, DOI 10.1073/pnas.96.10.5510; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Marches O, 2003, MOL MICROBIOL, V50, P1553, DOI 10.1046/j.1365-2958.2003.03821.x; Mathias N, 1996, MOL CELL BIOL, V16, P6634; Milhollen MA, 2012, CANCER CELL, V21, P388, DOI 10.1016/j.ccr.2012.02.009; Morikawa H, 2010, BIOCHEM BIOPH RES CO, V401, P268, DOI 10.1016/j.bbrc.2010.09.048; Nougayrede JP, 2001, INFECT IMMUN, V69, P6785, DOI 10.1128/IAI.69.11.6785-6795.2001; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petroski MD, 2006, MOL CELL, V24, P523, DOI 10.1016/j.molcel.2006.10.010; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Samba-Louaka A, 2009, INFECT IMMUN, V77, P5471, DOI 10.1128/IAI.00860-09; Samba-Louaka A, 2009, FUTURE MICROBIOL, V4, P867, DOI [10.2217/fmb.09.60, 10.2217/FMB.09.60]; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898; Soucy TA, 2009, CLIN CANCER RES, V15, P3912, DOI 10.1158/1078-0432.CCR-09-0343; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Taieb F, 2011, TOXINS, V3, P356, DOI 10.3390/toxins3040356; Toth JI, 2012, CELL REP, V1, P309, DOI 10.1016/j.celrep.2012.02.006; Wang M, 2011, EXPERT OPIN THER TAR, V15, P253, DOI 10.1517/14728222.2011.550877; Wee S, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-15; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Yao Q, 2012, P NATL ACAD SCI USA, V109, P20395, DOI 10.1073/pnas.1210831109; Yao Q, 2009, P NATL ACAD SCI USA, V106, P3716, DOI 10.1073/pnas.0900212106; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	58	12	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14716	14726		10.1074/jbc.M112.448258	http://dx.doi.org/10.1074/jbc.M112.448258			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23589306	Green Published, hybrid			2022-12-28	WOS:000319452100006
J	Amiya, E; Watanabe, M; Takeda, N; Saito, T; Shiga, T; Hosoya, Y; Nakao, T; Imai, Y; Manabe, I; Nagai, R; Komuro, I; Maemura, K				Amiya, Eisuke; Watanabe, Masafumi; Takeda, Norihiko; Saito, Tetsuya; Shiga, Taro; Hosoya, Yumiko; Nakao, Tomoko; Imai, Yasushi; Manabe, Ichiro; Nagai, Ryozo; Komuro, Issei; Maemura, Koji			Angiotensin II Impairs Endothelial Nitric-oxide Synthase Bioavailability under Free Cholesterol-enriched Conditions via Intracellular Free Cholesterol-rich Membrane Microdomains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; SMOOTH-MUSCLE-CELLS; HUMAN ATHEROSCLEROTIC LESIONS; LIPID RAFTS; IN-VITRO; DYSFUNCTION; ACTIVATION; CAVEOLIN-1; MICE; HYPERCHOLESTEROLEMIA	Vascular endothelial function is impaired in hypercholesterolemia partly because of injury by modified LDL. In addition to modified LDL, free cholesterol (FC) is thought to play an important role in the development of endothelial dysfunction, although the precise mechanisms remain to be elucidated. The aim of this study was to clarify the mechanisms of endothelial dysfunction induced by an FC-rich environment. Loading cultured human aortic endothelial cells with FC induced the formation of vesicular structures composed of FC-rich membranes. Raft proteins such as phospho-caveolin-1 (Tyr-14) and small GTPase Rac were accumulated toward FC-rich membranes around vesicular structures. In the presence of these vesicles, angiotensin II-induced production of reactive oxygen species (ROS) was considerably enhanced. This ROS shifted endothelial NOS(eNOS) toward vesicle membranes and vesicles with a FC-rich domain trafficked toward perinuclear late endosomes/lysosomes, which resulted in the deterioration of eNOS Ser-1177 phosphorylation and NO production. Angiotensin II-induced ROS decreased the bioavailability of eNOS under the FC-enriched condition.	[Amiya, Eisuke; Watanabe, Masafumi; Takeda, Norihiko; Saito, Tetsuya; Shiga, Taro; Hosoya, Yumiko; Nakao, Tomoko; Imai, Yasushi; Manabe, Ichiro; Nagai, Ryozo; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Nagai, Ryozo] Jichi Med Univ, Shimotsuke 3290498, Japan; [Komuro, Issei] Nagasaki Univ, Grad Sch Med, Dept Cardiovasc Med, Osaka 5650871, Japan; [Maemura, Koji] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cardiovasc Med, Nagasaki 8528102, Japan	University of Tokyo; Jichi Medical University; Nagasaki University; Nagasaki University	Maemura, K (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Cardiovasc Med, 1-7-1 Sakamoto, Nagasaki 8528102, Japan.	maemura@nagasaki-u.ac.jp	Amiya, Eisuke/O-4981-2019; Manabe, Ichiro/E-1529-2014; Manabe, Ichiro/AAE-5105-2021	Amiya, Eisuke/0000-0003-2810-8040; 	Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Council for Science and Technology Policy; Ministry of Education, Science, and Culture, Japan [19590853]; Takeda Science Foundation; Mitsubishi Pharma Research Foundation	Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy(Council for Science and Technology Policy (CSTP)); Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Pharma Research Foundation	This work was supported by grants from the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), initiated by the Council for Science and Technology Policy. This work was also supported by Grant-in-Aid for Scientific Research 19590853 from the Ministry of Education, Science, and Culture, Japan (to K. M.) and by funds from the Takeda Science Foundation (to K. M.) and the Mitsubishi Pharma Research Foundation (to K. M.).	Blair A, 1999, J BIOL CHEM, V274, P32512, DOI 10.1074/jbc.274.45.32512; Bodary PF, 2005, CIRCULATION, V111, P629, DOI 10.1161/01.CIR.0000154550.15963.80; Brown AJ, 2000, J LIPID RES, V41, P226; CHAO FF, 1988, AM J PATHOL, V131, P73; Chen WG, 2010, BIOCHEMISTRY-US, V49, P3129, DOI 10.1021/bi9016632; CONRAD PA, 1995, J CELL BIOL, V131, P1421, DOI 10.1083/jcb.131.6.1421; Cox DA, 1996, PHARMACOL REV, V48, P3; Cuddy LK, 2012, J NEUROSCI, V32, P5573, DOI 10.1523/JNEUROSCI.5235-11.2012; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Fang Y, 2006, CIRC RES, V98, P1064, DOI 10.1161/01.RES.0000218776.87842.43; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fernandes R, 2011, AM J PHYSIOL-CELL PH, V300, pC927, DOI 10.1152/ajpcell.00140.2010; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Grosheva I, 2009, ARTERIOSCL THROM VAS, V29, P1615, DOI 10.1161/ATVBAHA.109.191882; Hakala JK, 2003, ARTERIOSCL THROM VAS, V23, P1430, DOI 10.1161/01.ATV.0000077207.49221.06; Heare T, 2007, J INHERIT METAB DIS, V30, P79, DOI 10.1007/s10545-006-0473-y; Jin BY, 2009, P NATL ACAD SCI USA, V106, P17343, DOI 10.1073/pnas.0907409106; Jin S, 2008, ARTERIOSCL THROM VAS, V28, P485, DOI 10.1161/ATVBAHA.107.159772; KIM JA, 1991, J LIPID RES, V32, P1125; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; KRUTH HS, 1984, ATHEROSCLEROSIS, V51, P281, DOI 10.1016/0021-9150(84)90175-8; Landmesser U, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000129501.88485.1f; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lobysheva I, 2011, ARTERIOSCL THROM VAS, V31, P2098, DOI 10.1161/ATVBAHA.111.230623; Maron BA, 2012, CIRC J, V76, P2497, DOI 10.1253/circj.CJ-12-1207; MCGOOKEY DJ, 1983, J CELL BIOL, V96, P1273, DOI 10.1083/jcb.96.5.1273; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Morikage N, 2006, CIRC RES, V99, P299, DOI 10.1161/01.RES.0000235877.33682.e9; Paragh G, 1999, J LIPID RES, V40, P1728; Pietiainen VM, 2005, ANN MED, V37, P394, DOI 10.1080/07853890510011976; Porto A, 2006, FASEB J, V20, P2565, DOI 10.1096/fj.06-5867fje; Presley T, 2008, AM J PHYSIOL-CELL PH, V295, pC1281, DOI 10.1152/ajpcell.00550.2007; Pritchard KA, 2002, FREE RADICAL BIO MED, V33, P52, DOI 10.1016/S0891-5849(02)00851-1; Qin CB, 2006, ARTERIOSCL THROM VAS, V26, P372, DOI 10.1161/01.ATV.0000197848.67999.e1; Ravi K, 2004, P NATL ACAD SCI USA, V101, P2619, DOI 10.1073/pnas.0300464101; Robinson JM, 2001, HISTOCHEM CELL BIOL, V116, P119; Rombach SM, 2010, MOL GENET METAB, V99, P99, DOI 10.1016/j.ymgme.2009.10.004; Rong JX, 2003, P NATL ACAD SCI USA, V100, P13531, DOI 10.1073/pnas.1735526100; Sanchez FA, 2009, P NATL ACAD SCI USA, V106, P6849, DOI 10.1073/pnas.0812694106; Simionescu M, 2002, VASC PHARMACOL, V38, P275, DOI 10.1016/S1537-1891(02)00252-5; SIMIONESCU N, 1986, AM J PATHOL, V123, P109; Terasaka N, 2008, J CLIN INVEST, V118, P3701, DOI 10.1172/JCI35470; Yang BH, 2006, FASEB J, V20, P1501, DOI 10.1096/fj.05-5359fje; Zhang C, 2010, FREE RADICAL RES, V44, P831, DOI 10.3109/10715762.2010.485994; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026; Zuo L, 2005, ARTERIOSCL THROM VAS, V25, P1824, DOI 10.1161/01.ATV.0000175295.09607.18	48	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14497	14509		10.1074/jbc.M112.448522	http://dx.doi.org/10.1074/jbc.M112.448522			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23548909	Green Published, hybrid			2022-12-28	WOS:000319253500052
J	Lo, CY; Antonopoulos, A; Gupta, R; Qu, J; Dell, A; Haslam, SM; Neelamegham, S				Lo, Chi Y.; Antonopoulos, Aristotelis; Gupta, Rohitesh; Qu, Jun; Dell, Anne; Haslam, Stuart M.; Neelamegham, Sriram			Competition between Core-2 GlcNAc-transferase and ST6GalNAc-transferase Regulates the Synthesis of the Leukocyte Selectin Ligand on Human P-selectin Glycoprotein Ligand-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-GLYCAN BIOSYNTHESIS; PSGL-1 AMINO-TERMINUS; SIALYL-LEWIS-X; SUBSTRATE-SPECIFICITY; CELL-ADHESION; T-CELLS; BINDING; SIALYLTRANSFERASE; OLIGOSACCHARIDE; IDENTIFICATION	The binding of selectins to carbohydrate ligands expressed on leukocytes regulates immunity and inflammation. Among the human selectin ligands, the O-linked glycans at the N-terminus of the leukocyte cell-surface molecule P-selectin glycoprotein ligand-1 (PSGL-1, CD162) are important because they bind all selectins (L-, E-, and P-selectin) with high affinity under hydrodynamic shear conditions. Analysis of glycan microheterogeneity at this site is complicated by the presence of 72 additional potential O-linked glycosylation sites on this mucinous protein. To overcome this limitation, truncated forms of PSGL-1, called "PSGL-1 peptide probes," were developed. Ultra-high sensitivity mass spectrometry analysis of glycans released from such probes along with glycoproteomic analysis demonstrate the presence of both the sialyl Lewis-X (sLe(X)) and the di-sialylated T-antigen (NeuAc alpha 2,3Gal beta 1,3(NeuAc alpha 2,6)GalNAc) at the PSGL-1 N-terminus. Overexpression of glycoprotein-specific ST6GalNAc-transferases (ST6GalNAc1, -2, or -4) in human promyelocytic HL-60 cells altered glycan structures and cell adhesion properties. In particular, ST6GalNAc2 overexpression abrogated cell surface HECA-452/CLA expression, reduced the number of rolling leukocytes on P-and L-selectin-bearing substrates by similar to 85%, and increased median rolling velocity of remaining cells by 80-150%. Cell rolling on E-selectin was unaltered although the number of adherent cells was reduced by 60%. ST6GalNAc2 partially co-localizes in the Golgi with the core-2 beta (1,6)GlcNAc-transferase C2GnT-1. Overall, the data describe the glycan microheterogeneity at the PSGL-1 N-terminus. They suggest that a competition between ST6GalNAc2 and C2GnT-1 for the core-1/Gal beta 1,3GalNAc glycan may regulate leukocyte adhesion under fluid shear.	[Lo, Chi Y.; Gupta, Rohitesh; Neelamegham, Sriram] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA; [Qu, Jun] SUNY Buffalo, Buffalo, NY 14260 USA; [Qu, Jun; Neelamegham, Sriram] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14260 USA; [Antonopoulos, Aristotelis; Dell, Anne; Haslam, Stuart M.] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Dept Life Sci, London SW7 2AZ, England	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Imperial College London	Neelamegham, S (corresponding author), SUNY Buffalo, 906 Furnas Hall, Buffalo, NY 14260 USA.	neel@buffalo.edu		Neelamegham, Sriram/0000-0002-1371-8500; gupta, rohitesh/0000-0001-8515-5869	National Institutes of Health [HL63014, HL103411]; American Heart pre-doctoral fellowship; Biotechnology and Biological Sciences Research Council [B19088, BBF0083091]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103411, R01HL063014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM099607] Funding Source: NIH RePORTER; BBSRC [BB/F008309/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F008309/1] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart pre-doctoral fellowship(American Heart Association); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grants HL63014 and HL103411 (to S. N.). This work was also supported by an American Heart pre-doctoral fellowship (to C. Y. L.) and Biotechnology and Biological Sciences Research Council Grants B19088 and BBF0083091 (to A. D. and S. M. H.).	Aeed PA, 1998, GLYCOCONJUGATE J, V15, P975, DOI 10.1023/A:1006985825141; Afshar-Kharghan V, 2001, BLOOD, V97, P3306, DOI 10.1182/blood.V97.10.3306; AMANO J, 1988, J BIOL CHEM, V263, P1157; Babu P, 2009, GLYCOCONJUGATE J, V26, P975, DOI 10.1007/s10719-008-9146-4; Beauharnois ME, 2005, BIOCHEMISTRY-US, V44, P9507, DOI 10.1021/bi0507130; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Buffone A, 2013, J BIOL CHEM, V288, P1620, DOI 10.1074/jbc.M112.400929; Carlow DA, 2009, IMMUNOL REV, V230, P75, DOI 10.1111/j.1600-065X.2009.00797.x; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Ellies LG, 1998, IMMUNITY, V9, P881, DOI 10.1016/S1074-7613(00)80653-6; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895; Goetz DJ, 1997, J CELL BIOL, V137, P509, DOI 10.1083/jcb.137.2.509; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Hirata T, 2004, J BIOL CHEM, V279, P51775, DOI 10.1074/jbc.M409868200; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Jayakumar D, 2009, CYTOM PART A, V75A, P866, DOI 10.1002/cyto.a.20773; Julien S, 2007, J IMMUNOL, V179, P5701, DOI 10.4049/jimmunol.179.9.5701; Kono M, 2000, BIOCHEM BIOPH RES CO, V272, P94, DOI 10.1006/bbrc.2000.2745; Leon B, 2008, BLOOD, V111, P3126, DOI 10.1182/blood-2007-07-100610; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; Liu W, 1998, J BIOL CHEM, V273, P7078, DOI 10.1074/jbc.273.12.7078; Marathe DD, 2010, BLOOD, V115, P1303, DOI 10.1182/blood-2009-07-231480; Marathe DD, 2008, FASEB J, V22, P4154, DOI 10.1096/fj.07-104257; McEver RP, 1997, J CLIN INVEST, V100, P485, DOI 10.1172/JCI119556; Meng FY, 2001, NAT BIOTECHNOL, V19, P952, DOI 10.1038/nbt1001-952; MOORE KL, 1992, J CELL BIOL, V118, P445, DOI 10.1083/jcb.118.2.445; Orr SL, 2013, GLYCOBIOLOGY, V23, P363, DOI 10.1093/glycob/cws150; PATEL KD, 1995, J CLIN INVEST, V96, P1887, DOI 10.1172/JCI118234; Patil SA, 2012, ANAL BIOCHEM, V425, P135, DOI 10.1016/j.ab.2012.03.009; PAULSON JC, 1982, J BIOL CHEM, V257, P2734; PILLER F, 1988, J BIOL CHEM, V263, P15146; POUYANI T, 1995, CELL, V83, P333, DOI 10.1016/0092-8674(95)90174-4; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Rossi FMV, 2005, NAT IMMUNOL, V6, P626, DOI 10.1038/ni1203; SAKO D, 1995, CELL, V83, P323, DOI 10.1016/0092-8674(95)90173-6; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Skrincosky D, 1997, J BIOL CHEM, V272, P22695, DOI 10.1074/jbc.272.36.22695; Snapp KR, 2001, BLOOD, V97, P3806, DOI 10.1182/blood.V97.12.3806; Tsuchida A, 2005, J BIOCHEM, V138, P237, DOI 10.1093/jb/mvi124; VACHINO G, 1995, J BIOL CHEM, V270, P21966, DOI 10.1074/jbc.270.37.21966; Veerman KM, 2007, NAT IMMUNOL, V8, P532, DOI 10.1038/ni1456; VELDMAN GM, 1995, J BIOL CHEM, V270, P16470, DOI 10.1074/jbc.270.27.16470; Wagers AJ, 1998, J IMMUNOL, V160, P5122; Walcheck B, 2002, BLOOD, V99, P4063, DOI 10.1182/blood-2001-12-0265; Whitehouse C, 1997, J CELL BIOL, V137, P1229, DOI 10.1083/jcb.137.6.1229; Wilkins PP, 1996, J BIOL CHEM, V271, P18732, DOI 10.1074/jbc.271.31.18732; Xiao ZH, 2006, BIOPHYS J, V90, P2221, DOI 10.1529/biophysj.105.065789	49	33	34	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					13974	13987		10.1074/jbc.M113.463653	http://dx.doi.org/10.1074/jbc.M113.463653			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23548905	Green Published, hybrid			2022-12-28	WOS:000319253500005
J	Ordonez, H; Shuman, S				Ordonez, Heather; Shuman, Stewart			Mycobacterium smegmatis Lhr Is a DNA-dependent ATPase and a 3 '-to-5 ' DNA Translocase and Helicase That Prefers to Unwind 3 '-Tailed RNA:DNA Hybrids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; C VIRUS NS3; DISPLACE STREPTAVIDIN; MOTOR-NUCLEASE; SUPERFAMILY-II; BREAK REPAIR; TUBERCULOSIS; PROTEIN; ADNAB; UVRD1	We are interested in the distinctive roster of helicases of Mycobacterium, a genus of the phylum Actinobacteria that includes the human pathogen Mycobacterium tuberculosis and its avirulent relative Mycobacterium smegmatis. Here, we identify and characterize M. smegmatis Lhr as the exemplar of a novel clade of superfamily II helicases, by virtue of its biochemical specificities and signature domain organization. Lhr is a 1507-amino acid monomeric nucleic acid-dependent ATPase that uses the energy of ATP hydrolysis to drive unidirectional 3'-to-5' translocation along single strand DNA and to unwind duplexes en route. The ATPase is more active in the presence of calcium than magnesium. ATP hydrolysis is triggered by either single strand DNA or single strand RNA, yet the apparent affinity for a DNA activator is 11-fold higher than for an RNA strand of identical size and nucleobase sequence. Lhr is 8-fold better at unwinding an RNA: DNA hybrid than it is at displacing a DNA: DNA duplex of identical nucleobase sequence. The truncated derivative Lhr-(1-856) is an autonomous ATPase, 3'-to-5' translocase, and RNA: DNA helicase. Lhr-(1-856) is 100-fold better RNA: DNA helicase than DNA: DNA helicase. Lhr homologs are found in bacteria representing eight different phyla, being especially prevalent in Actinobacteria (including M. tuberculosis) and Proteobacteria (including Escherichia coli).	[Ordonez, Heather; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA.	shuman@ski.mskcc.org			National Institutes of Health [AI64693]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI64693.	Balasingham SV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036960; Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Biswas T, 2009, BIOCHEMISTRY-US, V48, P2839, DOI 10.1021/bi8022416; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Curti E, 2007, J BACTERIOL, V189, P1542, DOI 10.1128/JB.01421-06; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Guthlein C, 2009, J BACTERIOL, V191, P555, DOI 10.1128/JB.00216-08; Gupta R, 2011, MOL MICROBIOL, V79, P316, DOI 10.1111/j.1365-2958.2010.07463.x; Houghton J, 2012, J BACTERIOL, V194, P2916, DOI 10.1128/JB.06654-11; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; MATSON SW, 1989, P NATL ACAD SCI USA, V86, P4430, DOI 10.1073/pnas.86.12.4430; Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269; Morris PD, 2002, BIOCHEMISTRY-US, V41, P2372, DOI 10.1021/bi012058b; Olsen I, 2009, FEMS IMMUNOL MED MIC, V56, P151, DOI 10.1111/j.1574-695X.2009.00562.x; Ordonez H, 2012, NUCLEIC ACIDS RES, V40, P4604, DOI 10.1093/nar/gks046; Poterszman A, 1997, TRENDS BIOCHEM SCI, V22, P418, DOI 10.1016/S0968-0004(97)01124-9; Rand L, 2003, MOL MICROBIOL, V50, P1031, DOI 10.1046/j.1365-2958.2003.03765.x; REUVEN NB, 1995, J BACTERIOL, V177, P5393, DOI 10.1128/jb.177.19.5393-5400.1995; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sinha KM, 2008, BIOCHEMISTRY-US, V47, P9355, DOI 10.1021/bi800725q; Sinha KM, 2007, J BIOL CHEM, V282, P15114, DOI 10.1074/jbc.M701167200; Sinha KM, 2009, GENE DEV, V23, P1423, DOI 10.1101/gad.1805709; Sinha KM, 2009, BIOCHEMISTRY-US, V48, P4019, DOI 10.1021/bi900103d; Unciuleac MC, 2010, J BIOL CHEM, V285, P34319, DOI 10.1074/jbc.M110.162925; Unciuleac MC, 2010, J BIOL CHEM, V285, P2632, DOI 10.1074/jbc.M109.076133; Williams A, 2011, J BACTERIOL, V193, P4487, DOI 10.1128/JB.00302-11; Yakovleva L, 2012, NUCLEIC ACIDS RES, V40, P7465, DOI 10.1093/nar/gks417; Zegeye ED, 2012, MICROBIOL-SGM, V158, P1982, DOI 10.1099/mic.0.058693-0	29	16	17	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14125	14134		10.1074/jbc.M113.466854	http://dx.doi.org/10.1074/jbc.M113.466854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23549043	hybrid, Green Published			2022-12-28	WOS:000319253500017
J	Padmanabhan, A; Li, X; Bieberich, CJ				Padmanabhan, Achuth; Li, Xiang; Bieberich, Charles J.			Protein Kinase A Regulates MYC Protein through Transcriptional and Post-translational Mechanisms in a Catalytic Subunit Isoform-specific Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; TUMOR-SUPPRESSOR NKX3.1; CREB-BINDING PROTEIN; C-MYC; MESSENGER-RNA; GENE; DEGRADATION; ACTIVATION; DIFFERENTIATION; TRANSFORMATION	MYC levels are tightly regulated in cells, and deregulation is associated with many cancers. In this report, we describe the existence of a MYC-protein kinase A (PKA)-polo-like kinase 1 (PLK1) signaling loop in cells. We report that sequential MYC phosphorylation by PKA and PLK1 protects MYC from proteasome-mediated degradation. Interestingly, short term pan-PKA inhibition diminishes MYC level, whereas prolonged PKA catalytic subunit alpha (PKAC alpha) knockdown, but not PKA catalytic subunit beta (PKAC beta) knockdown, increases MYC. We show that the short term effect of pan-PKA inhibition on MYC is post-translational and the PKAC alpha-specific long term effect on MYC is transcriptional. These data also reveal distinct functional roles among PKA catalytic isoforms in MYC regulation. We attribute this effect to differential phosphorylation selectivity among PKA catalytic subunits, which we demonstrate for multiple substrates. Further, we also show that MYC up-regulates PKAC beta, transcriptionally forming a proximate positive feedback loop. These results establish PKA as a regulator of MYC and highlight the distinct biological roles of the different PKA catalytic subunits.	[Padmanabhan, Achuth; Li, Xiang; Bieberich, Charles J.] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA; [Bieberich, Charles J.] Univ Maryland, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore	Bieberich, CJ (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA.	bieberic@umbc.edu		Bieberich, Charles/0000-0002-9208-5077	National Institutes of Health [RCA155568A]; NATIONAL CANCER INSTITUTE [R21CA155568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RCA155568A (to C. J. B.).	Amarzguioui M, 2004, BIOTECHNIQUES, V36, P766, DOI 10.2144/04365BM03; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Baluchamy S, 2007, ONCOGENE, V26, P781, DOI 10.1038/sj.onc.1209825; Bernard Sandra, 2006, V42, P329, DOI 10.1007/004; CHAUDHARY D, 1995, BIOCHEMISTRY-US, V34, P3438, DOI 10.1021/bi00010a036; Dang CV, 1999, MOL CELL BIOL, V19, P1; DANI C, 1984, P NATL ACAD SCI-BIOL, V81, P7046, DOI 10.1073/pnas.81.22.7046; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Feo S, 2000, FEBS LETT, V473, P47, DOI 10.1016/S0014-5793(00)01494-0; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Guan B, 2008, J BIOL CHEM, V283, P4834, DOI 10.1074/jbc.M708630200; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Jiang GS, 2008, LEUKEMIA RES, V32, P297, DOI 10.1016/j.leukres.2007.06.021; Kolli S, 2001, P NATL ACAD SCI USA, V98, P4646, DOI 10.1073/pnas.081141998; Kvissel AK, 2007, CELL SIGNAL, V19, P401, DOI 10.1016/j.cellsig.2006.07.011; Lee CM, 1999, ONCOGENE, V18, P2997, DOI 10.1038/sj.onc.1202786; Lemm I, 2002, MOL CELL BIOL, V22, P3959, DOI 10.1128/MCB.22.12.3959-3969.2002; Li X, 2007, NAT METHODS, V4, P957, DOI 10.1038/NMETH1106; Li X, 2012, J PROTEOME RES, V11, P3637, DOI 10.1021/pr3000514; Liu J, 2004, FEBS LETT, V577, P175, DOI 10.1016/j.febslet.2004.09.079; Malempati S, 2006, LEUKEMIA, V20, P1572, DOI 10.1038/sj.leu.2404317; Padmanabhan A, 2013, J CELL BIOCHEM, V114, P1050, DOI 10.1002/jcb.24444; Popov N, 2010, NAT CELL BIOL, V12, P973, DOI 10.1038/ncb2104; Rajabi HN, 2005, J BIOL CHEM, V280, P361, DOI 10.1074/jbc.M408633200; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; RAMSAY GM, 1990, P NATL ACAD SCI USA, V87, P2102, DOI 10.1073/pnas.87.6.2102; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Su AI, 2001, CANCER RES, V61, P7388; Swope DL, 1996, J BIOL CHEM, V271, P28138, DOI 10.1074/jbc.271.45.28138; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wall M, 2008, BLOOD, V112, P2305, DOI 10.1182/blood-2007-09-111856; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wu KJ, 2002, ONCOGENE, V21, P7872, DOI 10.1038/sj.onc.1205986; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110	43	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14158	14169		10.1074/jbc.M112.432377	http://dx.doi.org/10.1074/jbc.M112.432377			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23504319	Green Published, hybrid			2022-12-28	WOS:000319253500020
J	Gastebois, A; Aimanianda, V; Bachellier-Bassi, S; Nesseir, A; Firon, A; Beauvais, A; Schmitt, C; England, P; Beau, R; Prevost, MC; d'Enfert, C; Latge, JP; Mouyna, I				Gastebois, Amandine; Aimanianda, Vishukumar; Bachellier-Bassi, Sophie; Nesseir, Audrey; Firon, Arnaud; Beauvais, Anne; Schmitt, Christine; England, Patrick; Beau, Remi; Prevost, Marie-Christine; d'Enfert, Christophe; Latge, Jean-Paul; Mouyna, Isabelle			SUN Proteins Belong to a Novel Family of beta-(1,3)-Glucan-modifying Enzymes Involved in Fungal Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL BIOGENESIS; MOTOR-LIKE DOMAIN; ASPERGILLUS-FUMIGATUS; CANDIDA-ALBICANS; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; BIOFILM FORMATION; BETA-GLUCOSIDASE; CHITIN SYNTHASES; GENE	In yeasts, the family of SUN proteins has been involved in cell wall biogenesis. Here, we report the characterization of SUN proteins in a filamentous fungus, Aspergillus fumigatus. The function of the two A. fumigatus SUN genes was investigated by combining reverse genetics and biochemistry. During conidial swelling and mycelial growth, the expression of AfSUN1 was strongly induced, whereas the expression of AfSUN2 was not detectable. Deletion of AfSUN1 negatively affected hyphal growth and conidiation. A closer examination of the morphological defects revealed swollen hyphae, leaky tips, intrahyphal growth, and double cell wall, suggesting that, like in yeast, AfSun1p is associated with cell wall biogenesis. In contrast to AfSUN1, deletion of AfSUN2 either in the parental strain or in the AfSUN1 single mutant strain did not affect colony and hyphal morphology. Biochemical characterization of the recombinant AfSun1p and Candida albicans Sun41p showed that both proteins had a unique hydrolysis pattern: acting on beta-(1,3)-oligomers from dimer up to insoluble beta-(1,3)-glucan. Referring to the CAZy database, it is clear that fungal SUN proteins represent a new family of glucan hydrolases (GH132) and play an important morphogenetic role in fungal cell wall biogenesis and septation.	[Gastebois, Amandine; Aimanianda, Vishukumar; Beauvais, Anne; Beau, Remi; Latge, Jean-Paul; Mouyna, Isabelle] Inst Pasteur, Unite Aspergillus, Dept Parasitol & Mycol, F-75015 Paris, France; [Bachellier-Bassi, Sophie; Nesseir, Audrey; Firon, Arnaud; d'Enfert, Christophe] Inst Pasteur, Unite Biol & Pathogenicite Fong, Dept Genomes & Genet, F-75015 Paris, France; [Bachellier-Bassi, Sophie; Nesseir, Audrey; Firon, Arnaud; d'Enfert, Christophe] INRA, USC2019, F-75015 Paris, France; [Schmitt, Christine; Prevost, Marie-Christine] Inst Pasteur, Dept Biol Cellulaire & Infect, F-75015 Paris, France; [England, Patrick] Inst Pasteur, Dept Biol Struct & Chim, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Latge, JP (corresponding author), Inst Pasteur, Unite Aspergillus, Dept Parasitol & Mycol, 25 Rue Dr Roux, F-75015 Paris, France.	jplatge@pasteur.fr	Mouyna, Isabelle/O-7697-2018; Beauvais, Anne/A-6358-2012; Bachellier-Bassi, Sophie/AAB-7981-2020; Aimanianda, Vishukumar/E-9204-2011; Latge, Jean Paul/C-9846-2014	Mouyna, Isabelle/0000-0003-3140-5927; Bachellier-Bassi, Sophie/0000-0003-3970-4825; Aimanianda, Vishukumar/0000-0001-5813-7497; ENGLAND, Patrick/0000-0001-6410-5918; d'Enfert, Christophe/0000-0002-6235-3886; FIRON, Arnaud/0000-0002-5323-5212	European Commission [MRTN-CT-2003-504148, PITN-GA-2008-214004]; European Science Foundation (ESF) Fuminomics; Partenariat Sanofi-aventis-Aviesan (ITMO Maladies Infectieuses, Sanofi Aventis Research & Development TSU ID (SAR&D) TSU ID/Sanofi-Pasteur); Agence Nationale de Recherches (ANR) [09-BLAN-0287]	European Commission(European CommissionEuropean Commission Joint Research Centre); European Science Foundation (ESF) Fuminomics(European Science Foundation (ESF)); Partenariat Sanofi-aventis-Aviesan (ITMO Maladies Infectieuses, Sanofi Aventis Research & Development TSU ID (SAR&D) TSU ID/Sanofi-Pasteur); Agence Nationale de Recherches (ANR)(French National Research Agency (ANR))	This work was supported by grants from the European Commission (Galar Fungail 2, MRTN-CT-2003-504148; FINSysB, PITN-GA-2008-214004) (to C. d. E.) and the European Science Foundation (ESF) Fuminomics, Partenariat Sanofi-aventis-Aviesan (ITMO Maladies Infectieuses, Sanofi Aventis Research & Development TSU ID (SAR&D) TSU ID/Sanofi-Pasteur), and Agence Nationale de Recherches (ANR) (Grant 09-BLAN-0287) (to J. P. L.).	Alonso-Nunez ML, 2005, MOL BIOL CELL, V16, P2003, DOI 10.1091/mbc.E04-06-0442; Bandara PDS, 1998, CURR GENET, V34, P259, DOI 10.1007/s002940050395; Camougrand N, 2004, FEMS YEAST RES, V5, P133, DOI 10.1016/j.femsyr.2004.05.001; Camougrand NM, 2000, ARCH BIOCHEM BIOPHYS, V375, P154, DOI 10.1006/abbi.1999.1655; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; DESAI NN, 1983, BIOCHEM J, V211, P273, DOI 10.1042/bj2110273; Diaz-Guerra TM, 2003, ANTIMICROB AGENTS CH, V47, P1120, DOI 10.1128/AAC.47.3.1120-1124.2003; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Firon A, 2007, MOL MICROBIOL, V66, P1256, DOI 10.1111/j.1365-2958.2007.06011.x; Fontaine T, 1997, J BACTERIOL, V179, P3154, DOI 10.1128/jb.179.10.3154-3163.1997; GIRARDIN H, 1993, J CLIN MICROBIOL, V31, P1547, DOI 10.1128/JCM.31.6.1547-1554.1993; Guyard C, 2002, J ANTIMICROB CHEMOTH, V49, P961, DOI 10.1093/jac/dkf040; Guyard C, 2002, YEAST, V19, P1127, DOI 10.1002/yea.898; Hiller E, 2007, EUKARYOT CELL, V6, P2056, DOI 10.1128/EC.00285-07; Jimenez-Ortigosa C, 2012, ANTIMICROB AGENTS CH, V56, P6121, DOI 10.1128/AAC.00752-12; Lamarre C, 2007, FUNGAL GENET BIOL, V44, P682, DOI 10.1016/j.fgb.2007.01.009; Lambou K, 2010, MOL MICROBIOL, V75, P910, DOI 10.1111/j.1365-2958.2009.07024.x; Martin-Cuadrado AB, 2008, MOL MICROBIOL, V69, P188, DOI 10.1111/j.1365-2958.2008.06275.x; Mishima Y, 2009, J BIOL CHEM, V284, P28687, DOI 10.1074/jbc.M109.034587; Mouassite M, 2000, YEAST, V16, P905, DOI 10.1002/1097-0061(200007)16:10<905::AID-YEA584>3.0.CO;2-1; Mouyna I, 2010, MOL MICROBIOL, V76, P1205, DOI 10.1111/j.1365-2958.2010.07164.x; Norice CT, 2007, EUKARYOT CELL, V6, P2046, DOI 10.1128/EC.00314-07; Omi K, 1999, BIOCHEM BIOPH RES CO, V262, P368, DOI 10.1006/bbrc.1999.1209; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; RAU U, 1992, J IND MICROBIOL, V9, P19, DOI 10.1007/BF01576364; Richie DL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000258; Ritch JJ, 2010, FEMS YEAST RES, V10, P168, DOI 10.1111/j.1567-1364.2009.00601.x; Roncero C, 2010, YEAST, V27, P521, DOI 10.1002/yea.1779; SANCHEZ M, 1993, APPL ENVIRON MICROB, V59, P2087; Sipiczki M, 2007, FEMS YEAST RES, V7, P761, DOI 10.1111/j.1567-1364.2007.00266.x; SKORY CD, 1995, APPL ENVIRON MICROB, V61, P518, DOI 10.1128/AEM.61.2.518-525.1995; Sorgo AG, 2010, YEAST, V27, P661, DOI 10.1002/yea.1775; Sosinska GJ, 2008, MICROBIOL-SGM, V154, P510, DOI 10.1099/mic.0.2007/012617-0; Takeshita N, 2006, MOL MICROBIOL, V59, P1380, DOI 10.1111/j.1365-2958.2006.05030.x; TRINCI APJ, 1973, PROTOPLASMA, V80, P57, DOI 10.1007/BF01666351; Wang HX, 2011, EUKARYOT CELL, V10, P72, DOI 10.1128/EC.00167-10; Wei Y, 2011, ACTA BIOCH BIOPH SIN, V43, P226, DOI 10.1093/abbs/gmr001; Weidner G, 1998, CURR GENET, V33, P378, DOI 10.1007/s002940050350; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Xu ZW, 2006, PROTEIN EXPRES PURIF, V47, P118, DOI 10.1016/j.pep.2005.11.025; Zverlov VV, 1997, MICROBIOL-SGM, V143, P3537, DOI 10.1099/00221287-143-11-3537	45	21	23	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13387	13396		10.1074/jbc.M112.440172	http://dx.doi.org/10.1074/jbc.M112.440172			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23508952	Green Published, hybrid			2022-12-28	WOS:000318850300024
J	Bu, LT; Crowley, MF; Himmel, ME; Beckham, GT				Bu, Lintao; Crowley, Michael F.; Himmel, Michael E.; Beckham, Gregg T.			Computational Investigation of the pH Dependence of Loop Flexibility and Catalytic Function in Glycoside Hydrolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULE; TRICHODERMA-REESEI; MOLECULAR-DYNAMICS; CELLOBIOHYDROLASE-I; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; PROCESSIVE CELLULASE; CELLULOMONAS-FIMI; ACTIVITY PROFILE; ENDOGLUCANASE I	Cellulase enzymes cleave glycosidic bonds in cellulose to produce cellobiose via either retaining or inverting hydrolysis mechanisms, which are significantly pH-dependent. Many fungal cellulases function optimally at pH similar to 5, and their activities decrease dramatically at higher or lower pH. To understand the molecular-level implications of pH in cellulase structure, we use a hybrid, solvent-based, constant pH molecular dynamics method combined with pH-based replica exchange to determine the pK(a) values of titratable residues of a glycoside hydrolase (GH) family 6 cellobiohydrolase (Cel6A) and a GH family 7 cellobiohydrolase (Cel7A) from the fungus Hypocrea jecorina. For both enzymes, we demonstrate that a bound substrate significantly affects the pK(a) values of the acid residues at the catalytic center. The calculated pK(a) values of catalytic residues confirm their proposed roles from structural studies and are consistent with the experimentally measured apparent pK(a) values. Additionally, GHs are known to impart a strained pucker conformation in carbohydrate substrates in active sites for catalysis, and results from free energy calculations combined with constant pH molecular dynamics suggest that the correct ring pucker is stable near the optimal pH for both Cel6A and Cel7A. Much longer molecular dynamics simulations of Cel6A and Cel7A with fixed protonation states based on the calculated pK(a) values suggest that pH affects the flexibility of tunnel loops, which likely affects processivity and substrate complexation. Taken together, this work demonstrates several molecular-level effects of pH on GH enzymes important for cellulose turnover in the biosphere and relevant to biomass conversion processes.	[Bu, Lintao; Beckham, Gregg T.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Crowley, Michael F.; Himmel, Michael E.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Beckham, Gregg T.] Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Colorado School of Mines	Bu, LT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, 1617 Cole Blvd,MS 3322, Golden, CO 80401 USA.	lintao.bu@nrel.gov; gregg.beckham@nrel.gov	crowley, michael F/A-4852-2013	crowley, michael F/0000-0001-5163-9398	United States Department of Energy Bioenergy Technologies Office; United States Department of Energy Office of Energy Efficiency and Renewable Energy [DE-AC36-08GO28308]; National Science Foundation TeraGrid Grant via Texas Advanced Computing Center Ranger Cluster [TG-MCB090159]; National Institute for Computational Sciences Kraken Cluster	United States Department of Energy Bioenergy Technologies Office(United States Department of Energy (DOE)); United States Department of Energy Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); National Science Foundation TeraGrid Grant via Texas Advanced Computing Center Ranger Cluster(National Science Foundation (NSF)); National Institute for Computational Sciences Kraken Cluster	This work was supported by the United States Department of Energy Bioenergy Technologies Office. Computational time for this research was provided by the National Renewable Energy Laboratory Computational Sciences Center supported by the United States Department of Energy Office of Energy Efficiency and Renewable Energy under Contract DE-AC36-08GO28308 and by National Science Foundation TeraGrid Grant TG-MCB090159 via the Texas Advanced Computing Center Ranger Cluster and the National Institute for Computational Sciences Kraken Cluster.	Barnett CB, 2010, J AM CHEM SOC, V132, P12800, DOI 10.1021/ja103766w; BARROWS SE, 1995, CARBOHYD RES, V276, P219, DOI 10.1016/0008-6215(95)00175-S; Becker D, 2001, BIOCHEM J, V356, P19, DOI 10.1042/0264-6021:3560019; Beckham GT, 2011, CURR OPIN BIOTECH, V22, P231, DOI 10.1016/j.copbio.2010.11.005; Beckham GT, 2010, BIOPHYS J, V99, P3773, DOI 10.1016/j.bpj.2010.10.032; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; Boer H, 2003, EUR J BIOCHEM, V270, P841, DOI 10.1046/j.1432-1033.2003.03431.x; Boisset C, 2000, APPL ENVIRON MICROB, V66, P1444, DOI 10.1128/AEM.66.4.1444-1452.2000; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bu LT, 2012, J BIOL CHEM, V287, P24807, DOI 10.1074/jbc.M112.365510; Bu LT, 2011, J BIOL CHEM, V286, P18161, DOI 10.1074/jbc.M110.212076; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Castaneda CA, 2009, PROTEINS, V77, P570, DOI 10.1002/prot.22470; CHANZY H, 1983, FEBS LETT, V153, P113, DOI 10.1016/0014-5793(83)80129-X; CHANZY H, 1985, FEBS LETT, V184, P285, DOI 10.1016/0014-5793(85)80623-2; Chen JH, 2006, J AM CHEM SOC, V128, P3728, DOI 10.1021/ja057216r; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Cockburn DW, 2011, PROTEIN ENG DES SEL, V24, P429, DOI 10.1093/protein/gzr004; Cockburn DW, 2010, BIOCHEMISTRY-US, V49, P2042, DOI 10.1021/bi1000596; Colussi F, 2012, EUR BIOPHYS J BIOPHY, V41, P89, DOI 10.1007/s00249-011-0762-8; Cox EG, 1939, NATURE, V143, P894, DOI 10.1038/143894b0; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; DAMUDE HG, 1995, BIOCHEMISTRY-US, V34, P2220, DOI 10.1021/bi00007a016; Damude HG, 1996, BIOCHEM J, V315, P467, DOI 10.1042/bj3150467; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; DURELL SR, 1994, J PHYS CHEM-US, V98, P2198, DOI 10.1021/j100059a038; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feig M, 2003, J PHYS CHEM B, V107, P2831, DOI 10.1021/jp027293y; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Herpoel-Gimbert I, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-18; Hill AD, 2007, J CHEM INF MODEL, V47, P1031, DOI 10.1021/ci600492e; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khandogin J, 2005, BIOPHYS J, V89, P141, DOI 10.1529/biophysj.105.061341; Khandogin J, 2006, BIOCHEMISTRY-US, V45, P9363, DOI 10.1021/bi060706r; KNOWLES JKC, 1988, J CHEM SOC CHEM COMM, P1401, DOI 10.1039/c39880001401; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; Koivula A, 1996, PROTEIN ENG, V9, P691, DOI 10.1093/protein/9.8.691; Kong XJ, 1996, J CHEM PHYS, V105, P2414, DOI 10.1063/1.472109; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Lee MS, 2004, PROTEINS, V56, P738, DOI 10.1002/prot.20128; Li JH, 2010, J PHYS CHEM B, V114, P15261, DOI 10.1021/jp1064177; Linder M, 1999, FEBS LETT, V447, P13, DOI 10.1016/S0014-5793(99)00253-7; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Momeni MH, 2013, J BIOL CHEM, V288, P5861, DOI 10.1074/jbc.M112.440891; Nimlos MR, 2012, J BIOL CHEM, V287, P20603, DOI 10.1074/jbc.M112.358184; Nina M, 1997, J PHYS CHEM B, V101, P5239, DOI 10.1021/jp970736r; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Payne CM, 2011, J BIOL CHEM, V286, P41028, DOI 10.1074/jbc.M111.297713; Pingali SV, 2011, J BIOL CHEM, V286, P32801, DOI 10.1074/jbc.M111.263004; Qin YQ, 2008, J BIOTECHNOL, V135, P190, DOI 10.1016/j.jbiotec.2008.03.016; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; REEVES RE, 1950, J AM CHEM SOC, V72, P1499, DOI 10.1021/ja01160a021; Rosgaard L, 2007, BIOTECHNOL PROGR, V23, P1270, DOI 10.1021/bp070329p; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schulein M, 1997, J BIOTECHNOL, V57, P71, DOI 10.1016/S0168-1656(97)00090-4; STAHLBERG J, 1993, BIOCHIM BIOPHYS ACTA, V1157, P107, DOI 10.1016/0304-4165(93)90085-M; Stahlberg J, 2001, J MOL BIOL, V305, P79, DOI 10.1006/jmbi.2000.4237; Stals I, 2004, GLYCOBIOLOGY, V14, P713, DOI 10.1093/glycob/cwh080; Sulzenbacher G, 1997, BIOCHEMISTRY-US, V36, P5902, DOI 10.1021/bi962963+; Sulzenbacher G, 1996, BIOCHEMISTRY-US, V35, P15280, DOI 10.1021/bi961946h; Swails JM, 2012, J CHEM THEORY COMPUT, V8, P4393, DOI 10.1021/ct300512h; Taylor CB, 2012, J BIOL CHEM, V287, P3147, DOI 10.1074/jbc.M111.270389; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Wallace JA, 2011, J CHEM THEORY COMPUT, V7, P2617, DOI 10.1021/ct200146j; Wohlfahrt G, 2003, BIOCHEMISTRY-US, V42, P10095, DOI 10.1021/bi034954o; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zou JY, 1999, STRUCTURE, V7, P1035, DOI 10.1016/S0969-2126(99)80171-3	80	28	28	0	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12175	12186		10.1074/jbc.M113.462465	http://dx.doi.org/10.1074/jbc.M113.462465			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504310	Green Published, hybrid			2022-12-28	WOS:000318157600049
J	Lomberk, G; Grzenda, A; Mathison, A; Escande, C; Zhang, JS; Calvo, E; Miller, LJ; Iovanna, J; Chini, EN; Fernandez-Zapico, ME; Urrutia, R				Lomberk, Gwen; Grzenda, Adrienne; Mathison, Angela; Escande, Carlos; Zhang, Jin-San; Calvo, Ezequiel; Miller, Laurence J.; Iovanna, Juan; Chini, Eduardo N.; Fernandez-Zapico, Martin E.; Urrutia, Raul			Kruppel-like Factor 11 Regulates the Expression of Metabolic Genes via an Evolutionarily Conserved Protein Interaction Domain Functionally Disrupted in Maturity Onset Diabetes of the Young	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; FINGER TRANSCRIPTION FACTOR; BETA-GAMMA-SUBUNITS; MONOAMINE-OXIDASE; CELL-GROWTH; RECEPTOR; IDENTIFICATION; BIOSYNTHESIS; SUPPRESSION; ACTIVATION	The function of Kruppel-like factor 11 (KLF11) in the regulation of metabolic pathways is conserved from flies to human. Alterations in KLF11 function result in maturity onset diabetes of the young 7 (MODY7) and neonatal diabetes; however, the mechanisms underlying the role of this protein in metabolic disorders remain unclear. Here, we investigated how the A347S genetic variant, present in MODY7 patients, modulates KLF11 transcriptional activity. A347S affects a previously identified transcriptional regulatory domain 3 (TRD3) for which co-regulators remain unknown. Structure-oriented sequence analyses described here predicted that the KLF11 TRD3 represents an evolutionarily conserved protein domain. Combined yeast two-hybrid and protein array experiments demonstrated that the TRD3 binds WD40, WWI, WWII, and SH3 domain-containing proteins. Using one of these proteins as a model, guanine nucleotide-binding protein beta 2 (G beta(2)), we investigated the functional consequences of KLF11 coupling to a TRD3 binding partner. Combined immunoprecipitation and biomolecular fluorescence complementation assays confirmed that activation of three different metabolic G protein-coupled receptors (beta-adrenergic, secretin, and cholecystokinin) induces translocation of G beta(2) to the nucleus where it directly binds KLF11 in a manner that is disrupted by the MODY7 A347S variant. Using genome-wide expression profiles, we identified metabolic gene networks impacted upon TRD3 disruption. Furthermore, A347S disrupted KLF11-mediated increases in basal insulin levels and promoter activity and blunted glucose-stimulated insulin secretion. Thus, this study characterizes a novel protein/protein interaction domain disrupted in a KLF gene variant that associates to MODY7, contributing to our understanding of gene regulation events in complex metabolic diseases.	[Lomberk, Gwen; Grzenda, Adrienne; Mathison, Angela; Urrutia, Raul] Mayo Clin, Lab Epigenet & Chromatin Dynam, Epigen Translat Program, Div Gastroenterol & Hepatol,Ctr Individualized Me, Rochester, MN 55905 USA; [Lomberk, Gwen; Grzenda, Adrienne; Mathison, Angela; Urrutia, Raul] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Escande, Carlos; Chini, Eduardo N.] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA; [Escande, Carlos; Chini, Eduardo N.] Mayo Clin, Kogod Aging Ctr, Rochester, MN 55905 USA; [Zhang, Jin-San; Fernandez-Zapico, Martin E.] Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Calvo, Ezequiel] CHUL Res Ctr, Mol Endocrinol & Oncol Res Ctr, Quebec City, PQ 61V 462, Canada; [Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA; [Iovanna, Juan] Aix Marseille Univ, CNRS UMR 7258, INSERM UMR 1068, Ctr Rech Carcerol Marseille, F-13288 Marseille, France; [Iovanna, Juan] Inst Paoli Calmettes Parc Sci& Technol Luminy, F-13288 Marseille, France	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Laval University; Mayo Clinic; Mayo Clinic Phoenix; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Fernandez-Zapico, ME (corresponding author), Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA.	fernandezzapico.martin@mayo.edu; urrutia.raul@mayo.edu	Lomberk, Gwen/AAL-8490-2020; Iovanna, Juan/M-9805-2017; Grzenda, Adrienne L/K-4421-2019	Lomberk, Gwen/0000-0001-5463-789X; Iovanna, Juan/0000-0003-1822-2237; Grzenda, Adrienne L/0000-0001-5952-6953; Mathison, Angela/0000-0002-6763-2710	National Institutes of Health [DK52913, T32-CA148073, CA102701, P30DK084567]; Mayo Foundation; Fraternal Order of Eagles; NATIONAL CANCER INSTITUTE [T32CA148073, P20CA102701, P50CA102701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913, R56DK052913, P30DK084567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; Fraternal Order of Eagles; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52913 (to R. U.), T32-CA148073 (to A. G.), CA102701 (to M. E. F.-Z.), and P30DK084567 (to the Mayo Clinic Center for Cell Signaling in Gastroenterology). This work was also supported by the Mayo Foundation and the Fraternal Order of Eagles (to G. L.).	AlNakkash L, 1996, INT J PANCREATOL, V19, P39; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bonnefond A, 2011, J BIOL CHEM, V286, P28414, DOI 10.1074/jbc.M110.215822; Bulow MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015171; Buttar NS, 2010, J BIOL CHEM, V285, P11433, DOI 10.1074/jbc.M109.077065; Cao S, 2005, J BIOL CHEM, V280, P1901, DOI 10.1074/jbc.M407941200; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Cheng ZJ, 2003, J BIOL CHEM, V278, P52972, DOI 10.1074/jbc.M310090200; Civelek M, 2011, NAT GENET, V43, P506, DOI 10.1038/ng.842; Conkright MD, 2001, J BIOL CHEM, V276, P29299, DOI 10.1074/jbc.M103670200; Cook T, 1999, J BIOL CHEM, V274, P29500, DOI 10.1074/jbc.274.41.29500; Daftary GS, 2012, J BIOL CHEM, V287, P7010, DOI 10.1074/jbc.M111.266007; Del Vecchio I, 2009, GENE, V430, P17, DOI 10.1016/j.gene.2008.10.005; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fernandez-Zapico ME, 2011, BIOCHEM J, V435, P529, DOI 10.1042/BJ20100773; Fernandez-Zapico ME, 2009, J BIOL CHEM, V284, P36482, DOI 10.1074/jbc.M109.028852; Freund C., 2008, V186, P407, DOI 10.1007/978-3-540-72843-6_17; Gebelein B, 1998, J CLIN INVEST, V102, P1911, DOI 10.1172/JCI1919; Grunewald M, 2012, J BIOL CHEM, V287, P24195, DOI 10.1074/jbc.M112.373936; Hodel AE, 2006, J BIOL CHEM, V281, P23545, DOI 10.1074/jbc.M601718200; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kino T, 2005, J CELL BIOL, V169, P885, DOI 10.1083/jcb.200409150; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Lomberk G, 2012, J BIOL CHEM, V287, P13026, DOI 10.1074/jbc.M112.342634; Mathison A, 2010, PANCREATOLOGY, V10, P505, DOI [10.1016/S1424-3903(10)80035-3, 10.1159/000320540]; Migliori V, 2012, EPIGENETICS-US, V7, P815, DOI 10.4161/epi.21140; Munoz-Descalzo S, 2005, DEV BIOL, V287, P168, DOI 10.1016/j.ydbio.2005.08.048; Munoz-Descalzo S, 2007, DEV GENES EVOL, V217, P289, DOI 10.1007/s00427-007-0144-5; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Ou XM, 2004, J BIOL CHEM, V279, P21021, DOI 10.1074/jbc.M312638200; Robitaille M, 2010, CELL SIGNAL, V22, P1254, DOI 10.1016/j.cellsig.2010.04.005; Ryden M, 2002, DIABETES, V51, P1601, DOI 10.2337/diabetes.51.5.1601; Seo S, 2012, J BIOL CHEM, V287, P12723, DOI 10.1074/jbc.M112.351395; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Smrcka AV, 2008, COMB CHEM HIGH T SCR, V11, P382, DOI 10.2174/138620708784534761; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; TALLMAN JF, 1977, P NATL ACAD SCI USA, V74, P873, DOI 10.1073/pnas.74.3.873; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Venuprasad K, 2008, NAT IMMUNOL, V9, P245, DOI 10.1038/ni1564; Vila JA, 2004, BIOPHYS J, V86, P731, DOI 10.1016/S0006-3495(04)74151-X; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; WANK SA, 1994, ANN NY ACAD SCI, V713, P49, DOI 10.1111/j.1749-6632.1994.tb44052.x; Weinstein LS, 2006, TRENDS PHARMACOL SCI, V27, P260, DOI 10.1016/j.tips.2006.03.005; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Yamamoto K, 2010, BIOCHEM BIOPH RES CO, V400, P175, DOI 10.1016/j.bbrc.2010.08.039; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001; Zhi X, 2012, AM J PATHOL, V180, P2452, DOI 10.1016/j.ajpath.2012.02.025	53	21	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17745	17758		10.1074/jbc.M112.434670	http://dx.doi.org/10.1074/jbc.M112.434670			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23589285	Green Published, hybrid			2022-12-28	WOS:000320380600064
J	Kugler, JE; Horsch, M; Huang, D; Furusawa, T; Rochman, M; Garrett, L; Becker, L; Bohla, A; Holter, SM; Prehn, C; Rathkolb, B; Racz, I; Aguilar-Pimentel, JA; Adler, T; Adamski, J; Beckers, J; Busch, DH; Eickelberg, O; Klopstock, T; Ollert, M; Stoger, T; Wolf, E; Wurst, W; Yildirim, AO; Zimmer, A; Gailus-Durner, V; Fuchs, H; de Angelis, MH; Garfinkel, B; Orly, J; Ovcharenko, I; Bustin, M				Kugler, Jamie E.; Horsch, Marion; Huang, Di; Furusawa, Takashi; Rochman, Mark; Garrett, Lillian; Becker, Lore; Bohla, Alexander; Hoelter, Sabine M.; Prehn, Cornelia; Rathkolb, Birgit; Racz, Ildiko; Aguilar-Pimentel, Juan Antonio; Adler, Thure; Adamski, Jerzy; Beckers, Johannes; Busch, Dirk H.; Eickelberg, Oliver; Klopstock, Thomas; Ollert, Markus; Stoeger, Tobias; Wolf, Eckhard; Wurst, Wolfgang; Yildirim, Ali Oender; Zimmer, Andreas; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe; Garfinkel, Benny; Orly, Joseph; Ovcharenko, Ivan; Bustin, Michael			High Mobility Group N Proteins Modulate the Fidelity of the Cellular Transcriptional Profile in a Tissue- and Variant-specific Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H1; BINDING-PROTEIN; CHROMOSOMAL-PROTEINS; CHROMATIN-STRUCTURE; IONIZING-RADIATION; TRIBBLES HOMOLOG; HMG PROTEINS; GENE; EXPRESSION; MOUSE	The nuclei of most vertebrate cells contain members of the high mobility group N (HMGN) protein family, which bind specifically to nucleosome core particles and affect chromatin structure and function, including transcription. Here, we study the biological role of this protein family by systematic analysis of phenotypes and tissue transcription profiles in mice lacking functional HMGN variants. Phenotypic analysis of Hmgn1(tm1/tm1), Hmgn3(tm1/tm1), and Hmgn5(tm1/tm1) mice and their wild type littermates with a battery of standardized tests uncovered variant-specific abnormalities. Gene expression analysis of four different tissues in each of the Hmgn(tm1/tm1) lines reveals very little overlap between genes affected by specific variants in different tissues. Pathway analysis reveals that loss of an HMGN variant subtly affects expression of numerous genes in specific biological processes. We conclude that within the biological framework of an entire organism, HMGNs modulate the fidelity of the cellular transcriptional profile in a tissue- and HMGN variant-specific manner.	[Kugler, Jamie E.; Furusawa, Takashi; Rochman, Mark; Bustin, Michael] NCI, Prot Sect, Lab Metab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Horsch, Marion; Becker, Lore; Prehn, Cornelia; Rathkolb, Birgit; Adler, Thure; Adamski, Jerzy; Beckers, Johannes; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Expt Genet, German Mouse Clin, D-85764 Neuherberg, Germany; [Huang, Di; Ovcharenko, Ivan] NIH, Computat Biol Branch, NCBI, Natl Lib Med, Bethesda, MD 20892 USA; [Adamski, Jerzy; Beckers, Johannes] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, D-85350 Freising Weihenstephan, Germany; [Garrett, Lillian; Hoelter, Sabine M.; Wurst, Wolfgang] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, German Mouse Clin, Neuherberg, Germany; [Becker, Lore; Klopstock, Thomas] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80539 Munich, Germany; [Bohla, Alexander; Eickelberg, Oliver; Stoeger, Tobias; Yildirim, Ali Oender] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Lung Biol & Dis, German Mouse Clin,Comprehens Pneumol Ctr, Neuherberg, Germany; [Rathkolb, Birgit; Wolf, Eckhard] Univ Munich, Gene Ctr, Munich, Germany; [Racz, Ildiko; Zimmer, Andreas] Univ Bonn, Inst Mol Psychiat, Bonn, Germany; [Aguilar-Pimentel, Juan Antonio] Tech Univ Munich, Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Ctr Allergy & Environm, Neuherberg, Germany; [Aguilar-Pimentel, Juan Antonio; Ollert, Markus] Tech Univ Munich, Biederstein, Dept Dermatol & Allergy, D-80290 Munich, Germany; [Aguilar-Pimentel, Juan Antonio; Ollert, Markus] Tech Univ Munich, Clin Res Div Mol & Clin Allergotoxicol, D-80290 Munich, Germany; [Adler, Thure; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany; [Klopstock, Thomas; de Angelis, Martin Hrabe] Tech Univ Munich, German Ctr Vertigo & Balance Disorders, D-80290 Munich, Germany; [Klopstock, Thomas; Wurst, Wolfgang] German Ctr Neurodegenerat Dis, Site Munich, Munich, Germany; [Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Wurst, Wolfgang] Tech Univ Munich, Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Neuherberg, Germany; [de Angelis, Martin Hrabe] German Ctr Diabet Res, Neuherberg, Germany; [Bohla, Alexander; Eickelberg, Oliver; Stoeger, Tobias; Yildirim, Ali Oender] German Ctr Lung Res, Munich, Germany; [Garfinkel, Benny; Orly, Joseph] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Bonn; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Hebrew University of Jerusalem	Bustin, M (corresponding author), NCI, Prot Sect, Lab Metab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	bustin@helix.nih.gov	Zimmer, Andreas/B-8357-2009; Bustin, Michael/G-6155-2015; Becker, Lore/E-3717-2010; Racz, I./C-3074-2009; Fuchs, Helmut/M-7347-2014; Gailus-Durner, Valerie/M-7337-2014; Becker, Lore/AAJ-1203-2020; Hölter, Sabine M./N-5868-2014; Garfinkel, Benny/AAF-2030-2020; Stöger, Tobias/M-9861-2014; Beckers, Johannes/K-7237-2012; de Angelis, Martin Hrabe/F-5531-2012	Racz, I./0000-0002-1549-3616; Fuchs, Helmut/0000-0002-5143-2677; Becker, Lore/0000-0002-6890-4984; Hölter, Sabine M./0000-0003-4878-5241; Garfinkel, Benny/0000-0002-2790-1349; Stöger, Tobias/0000-0002-2790-0389; Beckers, Johannes/0000-0001-7874-3822; de Angelis, Martin Hrabe/0000-0002-7898-2353; Yildirim, Ali Onder/0000-0003-1969-480X; Wolf, Eckhard/0000-0002-0430-9510; Prehn, Cornelia/0000-0002-1274-4715; Adamski, Jerzy/0000-0001-9259-0199; Ollert, Markus W./0000-0002-8055-0103; Rochman, Mark/0000-0002-0818-927X; Garrett, Lillian/0000-0003-4880-7076; Wurst, Wolfgang/0000-0003-4422-7410	National Institutes of Health grants from the Center for Cancer Research, NCI; Research Program of the National Library of Medicine; United States-Israeli Binational Foundation [2009326]; German Federal Ministry of Education and Research; German Center for Vertigo and Balance Disorders [01 EO 0901]; Infrafrontier [01KX1012]; Initiative and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Research in an Aging Society [HA-21]; National Genome Research Network-Plus [01GS0850, 01GS0851, 01GS0852, 01GS0853, 01GS0854, GS0868]; NATIONAL CANCER INSTITUTE [ZIABC011154] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM200881] Funding Source: NIH RePORTER	National Institutes of Health grants from the Center for Cancer Research, NCI; Research Program of the National Library of Medicine; United States-Israeli Binational Foundation(US-Israel Binational Science Foundation); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Center for Vertigo and Balance Disorders; Infrafrontier; Initiative and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Research in an Aging Society; National Genome Research Network-Plus; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported, in whole or in part, by National Institutes of Health grants from the Center for Cancer Research, NCI. This work was also supported by the Research Program of the National Library of Medicine; Grant 2009326 from the United States-Israeli Binational Foundation; German Federal Ministry of Education and Research to the German Center for Diabetes Research; German Center for Vertigo and Balance Disorders Grant 01 EO 0901, Infrafrontier Grant 01KX1012, and Initiative and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Research in an Aging Society Grant HA-21.; We thank Reinhard Seeliger, Anke Bettenbrock, Jan Einicke, Michael Farberbock, Ralf Fischer, Corinne Graf, Christine Hollauer, Elfi Holupirek, Maria Kugler, Soren Kundt, Simon Orth, Florian Schleicher, Ann-Elisabeth Schwarz, Nadine Senger, Yvonne Sonntag, Bettina Sperling, Alida Theil, and Anja Wohlbier, as well as the mouse embryonic fibroblasts animal caretaker team for expert technical assistance. The German Mouse Clinic was supported by National Genome Research Network-Plus Grants 01GS0850, 01GS0851, 01GS0852, 01GS0853, 01GS0854, and GS0868.	Abuhatzira L, 2011, J BIOL CHEM, V286, P42051, DOI 10.1074/jbc.M111.300541; Amano T, 2002, DEV DYNAM, V223, P526, DOI 10.1002/dvdy.10075; Arvey A, 2012, GENOME RES, V22, P1723, DOI 10.1101/gr.127712.111; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergboer JGM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032045; Berto G, 2007, J CELL SCI, V120, P1859, DOI 10.1242/jcs.000703; Bhan S, 2008, GENE, V414, P10, DOI 10.1016/j.gene.2008.01.025; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Birger Y, 2005, CANCER RES, V65, P6711, DOI 10.1158/0008-5472.CAN-05-0310; Birger Y, 2003, EMBO J, V22, P1665, DOI 10.1093/emboj/cdg142; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P152, DOI 10.1016/S0968-0004(00)01777-1; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Catez F, 2006, NAT STRUCT MOL BIOL, V13, P305, DOI 10.1038/nsmb1077; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; Catez F, 2010, BBA-GENE REGUL MECH, V1799, P15, DOI 10.1016/j.bbagrm.2009.11.001; Cejkova P, 2005, VIRCHOWS ARCH, V446, P416, DOI 10.1007/s00428-005-1214-6; Cuddapah S, 2011, MOL CELL BIOL, V31, P700, DOI 10.1128/MCB.00740-10; Dinu I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-242; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Fuchs H, 2009, CURR PHARM BIOTECHNO, V10, P236, DOI 10.2174/138920109787315051; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; Furusawa T, 2010, BBA-GENE REGUL MECH, V1799, P69, DOI 10.1016/j.bbagrm.2009.11.011; Gailus-Durner Valerie, 2009, V530, P463, DOI 10.1007/978-1-59745-471-1_25; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hashimoto H, 2010, NUCLEIC ACIDS RES, V38, P3533, DOI 10.1093/nar/gkq076; Hassan MI, 2008, MOL CANCER RES, V6, P892, DOI 10.1158/1541-7786.MCR-07-2195; Hock R, 1998, J CELL BIOL, V143, P1427, DOI 10.1083/jcb.143.6.1427; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Horsch M, 2008, PROTEOMICS, V8, P1248, DOI 10.1002/pmic.200700725; Ito Y, 2002, J HISTOCHEM CYTOCHEM, V50, P1273, DOI 10.1177/002215540205000914; Jolliffe I. T., 2002, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kato H, 2011, P NATL ACAD SCI USA, V108, P12283, DOI 10.1073/pnas.1105848108; Khochbin S, 2001, GENE, V271, P1, DOI 10.1016/S0378-1119(01)00495-4; Kim YC, 2009, NAT CELL BIOL, V11, P92, DOI 10.1038/ncb1817; Kurahashi T, 2010, J CELL BIOCHEM, V109, P49, DOI 10.1002/jcb.22377; Kusakabe M, 2010, INT J CANCER, V126, P1895, DOI 10.1002/ijc.24947; Lim JH, 2005, EMBO J, V24, P3038, DOI 10.1038/sj.emboj.7600768; Lim JH, 2004, MOL CELL, V15, P573, DOI 10.1016/j.molcel.2004.08.006; Lim JH, 2002, J BIOL CHEM, V277, P20774, DOI 10.1074/jbc.M200404200; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Mountjoy KG, 2010, BIOCHEM J, V428, P305, DOI 10.1042/BJ20091957; Novy M, 2005, MOL BIOL CELL, V16, P2181, DOI 10.1091/mbc.E04-11-0975; Ogawa R, 2008, DIS ESOPHAGUS, V21, P288, DOI 10.1111/j.1442-2050.2007.00759.x; Okamoto H, 2007, DIABETES, V56, P1350, DOI 10.2337/db06-1448; PASH J, 1990, P NATL ACAD SCI USA, V87, P3836, DOI 10.1073/pnas.87.10.3836; Postnikov Y, 2010, BBA-GENE REGUL MECH, V1799, P62, DOI 10.1016/j.bbagrm.2009.11.016; Postnikov YV, 2012, MOL CELL BIOL, V32, P1844, DOI 10.1128/MCB.06429-11; POSTNIKOV YV, 1995, J MOL BIOL, V252, P423, DOI 10.1006/jmbi.1995.0508; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; ROBERTS B, 1992, GENE, V121, P255, DOI 10.1016/0378-1119(92)90129-D; Rochman M, 2011, NUCLEIC ACIDS RES, V39, P4076, DOI 10.1093/nar/gkq1343; Rochman M, 2009, MOL CELL, V35, P642, DOI 10.1016/j.molcel.2009.07.002; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schmidt MHH, 2009, NAT CELL BIOL, V11, P873, DOI 10.1038/ncb1896; Schumacher T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035613; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Snape K, 2011, NAT GENET, V43, P527, DOI 10.1038/ng.822; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun M, 2002, MOL MED, V8, P655, DOI 10.1007/BF03402176; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ueda T, 2006, J BIOL CHEM, V281, P10182, DOI 10.1074/jbc.M600821200; Ueda T, 2008, MOL CELL BIOL, V28, P2872, DOI 10.1128/MCB.02181-07; Ueda T, 2009, MOL CELL BIOL, V29, P5264, DOI 10.1128/MCB.00526-09; West KL, 2001, J BIOL CHEM, V276, P25959, DOI 10.1074/jbc.M101692200	68	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16690	16703		10.1074/jbc.M113.463315	http://dx.doi.org/10.1074/jbc.M113.463315			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23620591	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000320378900044
J	Gao, XL; Wang, HZ; Yang, JJ; Chen, J; Jie, J; Li, LW; Zhang, YW; Liu, ZR				Gao, Xueliang; Wang, Haizhen; Yang, Jenny J.; Chen, Jing; Jie, Jiang; Li, Liangwei; Zhang, Yinwei; Liu, Zhi-Ren			Reciprocal Regulation of Protein Kinase and Pyruvate Kinase Activities of Pyruvate Kinase M2 by Growth Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P68 RNA HELICASE; GENE-TRANSCRIPTION; PHOSPHORYLATION; METABOLISM	Pyruvate kinase isoform M2 (PKM2) is an enzyme-catalyzing conversion of phosphoenolpyruvate to pyruvate in the glycolysis pathway. It was demonstrated that PKM2 interacts with tyrosine phosphopeptide, and the interaction with the tyrosine phosphopeptide affects the pyruvate kinase activity of PKM2. Our experiments suggest that PKM2 is also an active protein kinase (Gao, X., Wang, H., Yang, J. J., Liu, X., and Liu, Z. R. (2012) Mol. Cell 45, 598-609). We report here that growth signals reciprocally regulate the pyruvate kinase and protein kinase activities of PKM2 by different mechanisms. On the one hand, growth signals induce protein tyrosine phosphorylations. The tyrosine-phosphorylated protein(s) regulates the conversion of pyruvate kinase and protein kinase of PKM2 by directly interacting with PKM2. Binding of the tyrosyl-phosphorylated proteins at the fructose 1,6-bisphosphate-binding site converts the tetrameric PKM2 to a dimer. On the other hand, growth stimulations also lead to PKM2 phosphorylation, which consequently regulates the conversion of protein kinase and pyruvate kinase activities. Growth factor stimulations significantly increase the dimer/tetramer PKM2 ratio in cells and consequently activate the protein kinase activity of PKM2. Our study suggests that the conversion between the pyruvate kinase and protein kinase activities of PKM2 may be an important mechanism mediating the effects of growth signals in promoting cell proliferation.	[Gao, Xueliang; Wang, Haizhen; Li, Liangwei; Zhang, Yinwei; Liu, Zhi-Ren] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Yang, Jenny J.; Jie, Jiang] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Chen, Jing] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Emory University	Liu, ZR (corresponding author), Georgia State Univ, Dept Biol, Univ Plaza, Atlanta, GA 30303 USA.	zliu8@gsu.edu	jie, jie/HGT-7778-2022		National Institutes of Health Grant from NCI [CA118113]; Georgia Cancer Coalition; Molecular Basis of Disease fellowship, Georgia State University; NATIONAL CANCER INSTITUTE [R01CA118113] Funding Source: NIH RePORTER	National Institutes of Health Grant from NCI; Georgia Cancer Coalition; Molecular Basis of Disease fellowship, Georgia State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA118113 from NCI. This work was also supported by the Georgia Cancer Coalition (to Z. R. L.); Supported by a Molecular Basis of Disease fellowship, Georgia State University. Both authors contributed equally to this work.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; ASHIZAWA K, 1991, J BIOL CHEM, V266, P16842; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; ELBERS JRJ, 1991, CANCER-AM CANCER SOC, V67, P2552, DOI 10.1002/1097-0142(19910515)67:10<2552::AID-CNCR2820671027>3.0.CO;2-K; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; Hacker HJ, 1998, CARCINOGENESIS, V19, P99, DOI 10.1093/carcin/19.1.99; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2003, ANTICANCER RES, V23, P1149; Yang L, 2007, ONCOGENE, V26, P6082, DOI 10.1038/sj.onc.1210427; Yang LQ, 2007, J BIOL CHEM, V282, P16811, DOI 10.1074/jbc.M610488200; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Yang LQ, 2005, MOL CANCER RES, V3, P355, DOI 10.1158/1541-7786.MCR-05-0022; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Zwerschke W, 1999, P NATL ACAD SCI USA, V96, P1291, DOI 10.1073/pnas.96.4.1291	22	50	50	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15971	15979		10.1074/jbc.M112.448753	http://dx.doi.org/10.1074/jbc.M112.448753			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23576436	Green Published, hybrid			2022-12-28	WOS:000319822300049
J	Murray, TVA; Smyrnias, I; Shah, AM; Brewer, AC				Murray, Thomas V. A.; Smyrnias, Ioannis; Shah, Ajay M.; Brewer, Alison C.			NADPH Oxidase 4 Regulates Cardiomyocyte Differentiation via Redox Activation of c-Jun Protein and the cis-Regulation of GATA-4 Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; CARDIAC DIFFERENTIATION; DNA-BINDING; NOX4; EXPRESSION; REVEALS; AP-1; PHOSPHORYLATION; PROLIFERATION; INACTIVATION	NADPH oxidase 4 (Nox4) generates reactive oxygen species (ROS) that can modulate cellular phenotype and function in part through the redox modulation of the activity of transcription factors. We demonstrate here the potential of Nox4 to drive cardiomyocyte differentiation in pluripotent embryonal carcinoma cells, and we show that this involves the redox activation of c-Jun. This in turn acts to up-regulate GATA-4 expression, one of the earliest markers of cardiotypic differentiation, through a defined and highly conserved cis-acting motif within the GATA-4 promoter. These data therefore suggest a mechanism whereby ROS act in pluripotential cells in vivo to regulate the initial transcription of critical tissue-restricted determinant(s) of the cardiomyocyte phenotype, including GATA-4. The ROS-dependent activation, mediated by Nox4, of widely expressed redox-regulated transcription factors, such as c-Jun, is fundamental to this process.	[Murray, Thomas V. A.; Smyrnias, Ioannis; Shah, Ajay M.; Brewer, Alison C.] Kings Coll London, British Heart Fdn Ctr Res Excellence, Div Cardiovasc, London SE5 9NU, England	University of London; King's College London	Brewer, AC (corresponding author), Kings Coll London, British Heart Fdn Ctr Res Excellence, James Black Ctr, Div Cardiovasc, 125 Coldharbour Lane, London SE5 9NU, England.	alison.brewer@kcl.ac.uk		Smyrnias, Ioannis/0000-0001-6422-938X; Murray, Thomas/0000-0003-3019-2739; Brewer, Alison/0000-0002-1021-9888; Shah, Ajay/0000-0002-6547-0631	British Heart Foundation [PG/08/110/26228, RG/08/110/25922]; British Heart Foundation Centre of Excellence Award [2E/08/003]; British Heart Foundation [RG/08/011/25922] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation Centre of Excellence Award; British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Grants PG/08/110/26228 and RG/08/110/25922 and British Heart Foundation Centre of Excellence Award 2E/08/003.	Alexandrovich A, 2006, MECH DEVELOP, V123, P297, DOI 10.1016/j.mod.2006.02.002; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Anilkumar N, 2008, ARTERIOSCL THROM VAS, V28, P1347, DOI 10.1161/ATVBAHA.108.164277; ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Brewer A, 1999, J BIOL CHEM, V274, P38004, DOI 10.1074/jbc.274.53.38004; Brewer AC, 2005, STEM CELLS DEV, V14, P425, DOI 10.1089/scd.2005.14.425; Brewer AC, 2011, FREE RADICAL BIO MED, V51, P205, DOI 10.1016/j.freeradbiomed.2011.04.022; Brown CO, 2004, J BIOL CHEM, V279, P10659, DOI 10.1074/jbc.M301648200; Buggisch M, 2007, J CELL SCI, V120, P885, DOI 10.1242/jcs.03386; Buzek J, 2002, NUCLEIC ACIDS RES, V30, P2340, DOI 10.1093/nar/30.11.2340; Cave A, 2005, PHILOS T R SOC B, V360, P2327, DOI 10.1098/rstb.2005.1772; Cross JV, 2006, ANTIOXID REDOX SIGN, V8, P1819, DOI 10.1089/ars.2006.8.1819; DEGROOT RP, 1990, EMBO J, V9, P1831, DOI 10.1002/j.1460-2075.1990.tb08308.x; Ding L, 2008, STEM CELLS DEV, V17, P751, DOI 10.1089/scd.2007.0206; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Drenckhahn JD, 2011, DEV CELL, V21, P392, DOI 10.1016/j.devcel.2011.08.021; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Eriksson M, 2002, J BIOL CHEM, V277, P15992, DOI 10.1074/jbc.M107340200; Guittot SM, 2007, BIOL REPROD, V76, P85, DOI 10.1095/biolreprod.106.055137; Guittot SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008454; Haddad JJ, 2002, CELL SIGNAL, V14, P879, DOI 10.1016/S0898-6568(02)00053-0; HEIKINHEIMO M, 1994, DEV BIOL, V164, P361, DOI 10.1006/dbio.1994.1206; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hilfiker-Kleiner D, 2006, CARDIOVASC RES, V71, P108, DOI 10.1016/j.cardiores.2006.02.032; Humar M, 2007, INT J BIOCHEM CELL B, V39, P2278, DOI 10.1016/j.biocel.2007.06.013; Ishibashi T, 2011, BIOCHEM BIOPH RES CO, V413, P171, DOI 10.1016/j.bbrc.2011.08.036; JONES DH, 1991, BIOTECHNIQUES, V10, P62; Krijnen PAJ, 2003, J CLIN PATHOL, V56, P194, DOI 10.1136/jcp.56.3.194; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Lee YM, 2001, DEV DYNAM, V220, P175, DOI 10.1002/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Li J, 2006, MOL BIOL CELL, V17, P3978, DOI 10.1091/mbc.E05-06-0532; Lien CL, 1999, DEVELOPMENT, V126, P75; Luo L, 2012, FREE RADICAL BIO MED, V53, P1697, DOI 10.1016/j.freeradbiomed.2012.08.566; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Molkentin JD, 2000, DEV BIOL, V217, P301, DOI 10.1006/dbio.1999.9544; Ohara Y, 2006, BIOL PHARM BULL, V29, P410, DOI 10.1248/bpb.29.410; Patterson AJ, 2010, CURR MOL MED, V10, P653; Peterson JR, 2009, HYPERTENSION, V54, P1106, DOI 10.1161/HYPERTENSIONAHA.109.140087; Puceat M, 2003, MOL BIOL CELL, V14, P2781, DOI 10.1091/mbc.E02-09-0562; Raddatz E, 2011, AM J PHYSIOL-HEART C, V300, pH820, DOI 10.1152/ajpheart.00827.2010; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; Sauer H, 2000, FEBS LETT, V476, P218, DOI 10.1016/S0014-5793(00)01747-6; Schmelter M, 2006, FASEB J, V20, P1182, DOI 10.1096/fj.05-4723fje; Serena E, 2009, EXP CELL RES, V315, P3611, DOI 10.1016/j.yexcr.2009.08.015; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; Tanner JJ, 2011, ANTIOXID REDOX SIGN, V15, P77, DOI 10.1089/ars.2010.3611; Ufer C, 2010, ANTIOXID REDOX SIGN, V13, P833, DOI 10.1089/ars.2009.3044; van der Heyden MAG, 2003, CARDIOVASC RES, V58, P292, DOI 10.1016/S0008-6363(02)00771-X; Von Lohneysen K, 2008, J BIOL CHEM, V283, P35273, DOI 10.1074/jbc.M804200200; Xiao L, 2002, AM J PHYSIOL-CELL PH, V282, pC926, DOI 10.1152/ajpcell.00254.2001; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007; Zaffran S, 2002, CIRC RES, V91, P457, DOI 10.1161/01.RES.0000034152.74523.A8; Zhang M, 2010, P NATL ACAD SCI USA, V107, P18121, DOI 10.1073/pnas.1009700107; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057032; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013	62	38	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15745	15759		10.1074/jbc.M112.439844	http://dx.doi.org/10.1074/jbc.M112.439844			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23589292	hybrid, Green Published			2022-12-28	WOS:000319822300030
J	Qin, B; Gao, BW; Yu, J; Yuan, J; Lou, ZK				Qin, Bo; Gao, Bowen; Yu, Jia; Yuan, Jian; Lou, Zhenkun			Ataxia Telangiectasia-mutated- and Rad3-related Protein Regulates the DNA Damage-induced G(2)/M Checkpoint through the Aurora A Cofactor Bora Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE KINASE-1; TRCP-DEPENDENT DEGRADATION; PLK1; PHOSPHORYLATION; INHIBITION; MITOSIS; ATM	Polo-like kinase1 (Plk1) activation is inhibited in response to DNA damage, and this inhibition contributes to the activation of the G(2)/M checkpoint, although the molecular mechanism by which Plk1 is inhibited is not clear. Here we report that the DNA damage signaling pathway inhibits Plk1 activity through Bora. Following UV irradiation, ataxia telangiectasia-mutated-and Rad3-related protein phosphorylates Bora at Thr-501. The phosphorylated Thr-501 is subsequently recognized by the E3 ubiquitin ligase SCF-beta-TRCP, which targets Bora for degradation. The degradation of Bora compromises Plk1 activation and contributes to DNA damage-induced G(2) arrest. These findings shed new light on Plk1 regulation by the DNA damage response pathway.	[Qin, Bo; Gao, Bowen; Lou, Zhenkun] Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA; [Yu, Jia] Mayo Clin, Dept Pharmacol, Rochester, MN 55905 USA; [Yuan, Jian] Tongji Univ, East Hosp, Res Ctr Translat Med, Shanghai 200120, Peoples R China	Mayo Clinic; Mayo Clinic; Tongji University	Yuan, J (corresponding author), Tongji Univ, East Hosp, Res Ctr Translat Med, Shanghai 200120, Peoples R China.	yuanjian229@hotmail.com; lou.zhenkun@mayo.edu		Yuan, Jian/0000-0002-2801-8849	National Institutes of Health [CA130996, CA129344, CA148940]; Richard Schulze Family Foundation; National Basic Research Program of China 973 Program [2013CB530700]; National Natural Science Foundation of China [81222029, 31270806]; NATIONAL CANCER INSTITUTE [R01CA129344, R01CA130996, R01CA148940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard Schulze Family Foundation; National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA130996, CA129344, and CA148940 (to Z.L.). This work was also supported by the Richard Schulze Family Foundation, by National Basic Research Program of China 973 Program Grant 2013CB530700), and by National Natural Science Foundation of China Grants 81222029 and 31270806 (to J.Y.).	Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Chan EHY, 2008, CHROMOSOMA, V117, P457, DOI 10.1007/s00412-008-0165-5; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Kelm O, 2002, J BIOL CHEM, V277, P25247, DOI 10.1074/jbc.M202855200; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Qian YW, 1998, MOL CELL BIOL, V18, P4262, DOI 10.1128/MCB.18.7.4262; Sarkaria JN, 1999, CANCER RES, V59, P4375; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; Tsvetkov L, 2005, CELL CYCLE, V4, P166, DOI 10.4161/cc.4.1.1348; van Vugt MATM, 2001, J BIOL CHEM, V276, P41656, DOI 10.1074/jbc.M101831200; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Yoo HY, 2004, CELL, V117, P575, DOI 10.1016/S0092-8674(04)00417-9	19	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16139	16144		10.1074/jbc.M113.456780	http://dx.doi.org/10.1074/jbc.M113.456780			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23592782	hybrid, Green Published			2022-12-28	WOS:000319822300064
J	Ashpole, NM; Chawla, AR; Martin, MP; Brustovetsky, T; Brustovetsky, N; Hudmon, A				Ashpole, Nicole M.; Chawla, Aarti R.; Martin, Matthew P.; Brustovetsky, Tatiana; Brustovetsky, Nickolay; Hudmon, Andy			Loss of Calcium/Calmodulin-dependent Protein Kinase II Activity in Cortical Astrocytes Decreases Glutamate Uptake and Induces Neurotoxic Release of ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCITATORY AMINO-ACIDS; P2X(7) RECEPTORS; GLIAL-CELLS; HIPPOCAMPAL-NEURONS; P2Y(1) RECEPTOR; CALCIUM WAVES; RAT STRIATUM; EXPRESSION; ISCHEMIA; CAMKII	The extent of calcium/calmodulin-dependent protein kinase II (CaMKII) inactivation in the brain after ischemia correlates with the extent of damage. We have previously shown that a loss of CaMKII activity in neurons is detrimental to neuronal viability by inducing excitotoxic glutamate release. In the current study we extend these findings to show that the ability of astrocytes to buffer extracellular glutamate is reduced when CaMKII is inhibited. Furthermore, CaMKII inhibition in astrocytes is associated with the rapid onset of intracellular calcium oscillations. Surprisingly, this rapid calcium influx is blocked by the N-type calcium channel antagonist, omega-conotoxin. Although the function of N-type calcium channels within astrocytes is controversial, these voltage-gated calcium channels have been linked to calcium-dependent vesicular gliotransmitter release. When extracellular glutamate and ATP levels are measured after CaMKII inhibition within our enriched astrocyte cultures, no alterations in glutamate levels are observed, whereas ATP levels in the extracellular environment significantly increase. Extracellular ATP accumulation associated with CaMKII inhibition contributes both to calcium oscillations within astrocytes and ultimately cortical neuron toxicity. Thus, a loss of CaMKII signaling within astrocytes dysregulates glutamate uptake and supports ATP release, two processes that would compromise neuronal survival after ischemic/excitotoxic insults.	[Ashpole, Nicole M.; Chawla, Aarti R.; Martin, Matthew P.; Brustovetsky, Nickolay; Hudmon, Andy] Indiana Univ, Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Brustovetsky, Tatiana; Brustovetsky, Nickolay] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Hudmon, Andy] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Hudmon, A (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Stark Neurosci Res Inst, 950 W Walnut St,R2-480, Indianapolis, IN 46202 USA.	ahudmon@iupui.edu			National Institutes of Health [NS078171, NS078008]; Indiana State Department of Health, Spinal Cord Brain Injury [ISDH/A70-2-079607]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078008, R01NS078171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana State Department of Health, Spinal Cord Brain Injury; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS078171 (to A. H.) and NS078008 (N. B.). This work was also supported by the Indiana State Department of Health, Spinal Cord Brain Injury (ISDH/A70-2-079607) research grants (A. H.).	Anderson CM, 2000, GLIA, V32, P1; Anderson CM, 2004, J NEUROCHEM, V88, P246, DOI 10.1046/j.1471-4159.2003.02204.x; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Arbeloa J, 2012, NEUROBIOL DIS, V45, P954, DOI 10.1016/j.nbd.2011.12.014; ARONOWSKI J, 1992, J NEUROCHEM, V58, P1743, DOI 10.1111/j.1471-4159.1992.tb10049.x; Ashpole NM, 2012, J BIOL CHEM, V287, P8495, DOI 10.1074/jbc.M111.323915; Ashpole NM, 2011, MOL CELL NEUROSCI, V46, P720, DOI 10.1016/j.mcn.2011.02.003; BANKER GA, 1980, SCIENCE, V209, P809, DOI 10.1126/science.7403847; BARRES BA, 1991, J NEUROSCI, V11, P3685; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Bayer KU, 1999, MOL BRAIN RES, V70, P147, DOI 10.1016/S0169-328X(99)00131-X; Bowser DN, 2007, J GEN PHYSIOL, V129, P485, DOI 10.1085/jgp.200709780; Carter DS, 2006, J PHARMACOL EXP THER, V319, P1021, DOI 10.1124/jpet.106.110403; Centemeri C, 1997, BRIT J PHARMACOL, V121, P1700, DOI 10.1038/sj.bjp.0701293; Chao LH, 2010, NAT STRUCT MOL BIOL, V17, P264, DOI 10.1038/nsmb.1751; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; Cotrina ML, 2000, DEV BIOL, V228, P326, DOI 10.1006/dbio.2000.9948; Cotrina ML, 2000, J NEUROSCI, V20, P2835; D'ascenzo M, 2004, GLIA, V45, P354, DOI 10.1002/glia.10336; Dallas M, 2007, J NEUROSCI, V27, P3946, DOI 10.1523/JNEUROSCI.5030-06.2007; Dosemeci A, 2000, J NEUROSCI, V20, P3076, DOI 10.1523/JNEUROSCI.20-09-03076.2000; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Fan DL, 1999, J NEUROSCI RES, V57, P557, DOI 10.1002/(SICI)1097-4547(19990815)57:4<557::AID-JNR16>3.0.CO;2-I; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; Franke H, 2004, J NEUROPATH EXP NEUR, V63, P686, DOI 10.1093/jnen/63.7.686; Franke H, 2006, PHARMACOL THERAPEUT, V109, P297, DOI 10.1016/j.pharmthera.2005.06.002; Franke H, 2012, PURINERG SIGNAL, V8, P629, DOI 10.1007/s11302-012-9300-0; Gallagher CJ, 2003, J NEUROSCI, V23, P6728; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; HANSON SK, 1994, STROKE, V25, P466, DOI 10.1161/01.STR.25.2.466; Holtje M, 2008, J BIOL CHEM, V283, P9289, DOI 10.1074/jbc.M706499200; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Hudmon A, 1996, J BIOL CHEM, V271, P8800, DOI 10.1074/jbc.271.15.8800; Inoue K, 2007, J NEUROCHEM, V102, P1447, DOI 10.1111/j.1471-4159.2007.04824.x; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kajihara H, 2001, BRAIN RES, V909, P92, DOI 10.1016/S0006-8993(01)02640-3; Klug JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045323; Koles L, 2011, ADV PHARMACOL, V61, P441, DOI 10.1016/B978-0-12-385526-8.00014-X; KOLB SJ, 1995, J NEUROCHEM, V64, P2147; Kuboyama K, 2011, J CEREBR BLOOD F MET, V31, P1930, DOI 10.1038/jcbfm.2011.49; Lammer A, 2006, EUR J NEUROSCI, V23, P2824, DOI 10.1111/j.1460-9568.2006.04825.x; Lammer AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019983; LAI Y, 1986, P NATL ACAD SCI USA, V83, P4253, DOI 10.1073/pnas.83.12.4253; Latour I, 2003, GLIA, V41, P347, DOI 10.1002/glia.10162; Leon D, 2006, EUR J NEUROSCI, V23, P2999, DOI 10.1111/j.1460-9568.2006.04832.x; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Liu T, 2011, J NEUROSCI, V31, P10593, DOI 10.1523/JNEUROSCI.6401-10.2011; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; Mamedova LK, 2006, BIOCHEM PHARMACOL, V72, P1031, DOI 10.1016/j.bcp.2006.07.017; Matos M, 2008, NEUROSCIENCE, V156, P898, DOI 10.1016/j.neuroscience.2008.08.022; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCCARTHY KD, 1991, NEUROSCIENCE, V41, P325, DOI 10.1016/0306-4522(91)90330-Q; MCGUINNESS TL, 1985, J BIOL CHEM, V260, P1696; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; OUIMET CC, 1984, P NATL ACAD SCI-BIOL, V81, P5604, DOI 10.1073/pnas.81.17.5604; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; Parpura V, 2004, NEUROCHEM INT, V45, P259, DOI 10.1016/j.neuint.2003.12.011; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; Parpura V, 2010, BRAIN RES REV, V63, P83, DOI 10.1016/j.brainresrev.2009.11.008; Perego C, 2000, J NEUROCHEM, V75, P1076, DOI 10.1046/j.1471-4159.2000.0751076.x; Petito CK, 1998, J NEUROPATH EXP NEUR, V57, P231, DOI 10.1097/00005072-199803000-00004; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Phillis JW, 2000, BRAIN RES, V880, P224, DOI 10.1016/S0006-8993(00)02755-4; PHILLIS JW, 1994, NEUROCHEM RES, V19, P1125, DOI 10.1007/BF00965145; Pryazhnikov E, 2008, GLIA, V56, P38, DOI 10.1002/glia.20590; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Ryu JK, 2002, NEUROREPORT, V13, P1611, DOI 10.1097/00001756-200209160-00008; SAKAGAMI H, 1992, MOL BRAIN RES, V16, P20, DOI 10.1016/0169-328X(92)90189-I; SALTER MW, 1994, J NEUROSCI, V14, P1563, DOI 10.1523/JNEUROSCI.14-03-01563.1994; Schmidt-Kastner R, 2005, BRAIN RES, V1052, P28, DOI 10.1016/j.brainres.2005.06.018; Schulze-Lohoff E, 1998, AM J PHYSIOL-RENAL, V275, pF962, DOI 10.1152/ajprenal.1998.275.6.F962; SCHWORER CM, 1988, J BIOL CHEM, V263, P13486; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; Sellers LK, 2001, J BIOL CHEM, V276, P16379, DOI 10.1074/jbc.M006617200; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Sperlagh B, 2002, J NEUROCHEM, V81, P1196, DOI 10.1046/j.1471-4159.2002.00920.x; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Takahashi S, 1997, DEV BRAIN RES, V104, P111, DOI 10.1016/S0165-3806(97)00175-2; Takeuchi Y, 2000, J NEUROCHEM, V74, P2557, DOI 10.1046/j.1471-4159.2000.0742557.x; Tang QB, 2012, J NEUROSCI, V32, P11737, DOI 10.1523/JNEUROSCI.0983-12.2012; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Vest RS, 2010, J BIOL CHEM, V285, P20675, DOI 10.1074/jbc.M109.088617; Volonte C, 2003, CNS NEUROL DISORD-DR, V2, P403, DOI 10.2174/1568007033482643; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Waxham MN, 1996, J CEREBR BLOOD F MET, V16, P1, DOI 10.1097/00004647-199601000-00001; Yaguchi T, 2010, J CELL PHYSIOL, V225, P512, DOI 10.1002/jcp.22231; Yasuda K, 2011, GLIA, V59, P143, DOI 10.1002/glia.21083; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620; Zhou BY, 2004, MOL CELL NEUROSCI, V27, P296, DOI 10.1016/j.mcn.2004.07.003; Zhou Y, 2010, NEUROCHEM RES, V35, P2124, DOI 10.1007/s11064-010-0325-x	98	30	31	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14599	14611		10.1074/jbc.M113.466235	http://dx.doi.org/10.1074/jbc.M113.466235			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23543737	Green Published, hybrid			2022-12-28	WOS:000319253500060
J	Too, PHM; Erales, J; Simen, JD; Marjanovic, A; Coffino, P				Too, Priscilla Hiu-Mei; Erales, Jenny; Simen, Joana Danica; Marjanovic, Antonija; Coffino, Philip			Slippery Substrates Impair Function of a Bacterial Protease ATPase by Unbalancing Translocation versus Exit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEGRADE PROTEINS; KAPPA-B; CLPXP; INHIBITION; MECHANISM; CLPAP; COMPONENTS; STABILITY; SEQUENCES; CHAPERONE	ATP-dependent proteases engage, translocate, and unfold substrate proteins. A sequence with only Gly and Ala residues (glycine-alanine repeat; GAr) encoded by the Epstein-Barr virus of humans inhibits eukaryotic proteasome activity. It causes the ATPase translocase to slip on its protein track, stalling unfolding and interrupting degradation. The bacterial protease ClpXP is structurally simpler than the proteasome but has related elements: a regulatory ATPase complex (ClpX) and associated proteolytic chamber (ClpP). In this study, GAr sequences were found to impair ClpXP function much as in proteasomes. Stalling depended on interaction between a GAr and a suitably spaced and positioned folded domain resistant to mechanical unfolding. Persistent unfolding failure results in the interruption of degradation and the production of partial degradation products that include the resistant domain. The capacity of various sequences to cause unfolding failure was investigated. Among those tested, a GAr was most effective, implying that viral selection had optimized processivity failure. More generally, amino acids of simple shape and small size promoted unfolding failure. The ClpX ATPase is a homohexamer. Partial degradation products could exit the complex through transient gaps between the ClpX monomers or, alternatively, by backing out. Production of intermediates by diverse topological forms of the hexamer was shown to be similar, excluding lateral escape. In principle, a GAr could interrupt degradation because 1) the translocase thrusts forward less effectively or because 2) the translocase retains substrate less well when resetting between forward strokes. Kinetic analysis showed that the predominant effect was through the second of these mechanisms.	[Too, Priscilla Hiu-Mei; Erales, Jenny; Simen, Joana Danica; Marjanovic, Antonija; Coffino, Philip] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Coffino, P (corresponding author), 513 Parnassus Ave,Rm S-430, San Francisco, CA 94143 USA.	philip.coffino@ucsf.edu		Marjanovic, Antonija/0000-0003-1865-5673	National Institutes of Health [GM45335, GM097974]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097974, R01GM045335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM45335 (to P. C.) and GM097974 (to Sanford Simon, Rockefeller University).	Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Barkow SR, 2009, CHEM BIOL, V16, P605, DOI 10.1016/j.chembiol.2009.05.007; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0; Erales J, 2012, J BIOL CHEM, V287, P18535, DOI 10.1074/jbc.M112.357327; FALK K, 1995, J GEN VIROL, V76, P779, DOI 10.1099/0022-1317-76-4-779; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Glynn SE, 2012, NAT STRUCT MOL BIOL, V19, P616, DOI 10.1038/nsmb.2288; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Henderson A, 2011, J BIOL CHEM, V286, P17495, DOI 10.1074/jbc.M110.212027; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hoskins JR, 2002, P NATL ACAD SCI USA, V99, P11037, DOI 10.1073/pnas.172378899; Hoyt MA, 2006, EMBO J, V25, P1720, DOI 10.1038/sj.emboj.7601058; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; Jones JM, 1998, J BIOL CHEM, V273, P459, DOI 10.1074/jbc.273.1.459; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kenniston JA, 2005, P NATL ACAD SCI USA, V102, P1390, DOI 10.1073/pnas.0409634102; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Koga N, 2009, P NATL ACAD SCI USA, V106, P18237, DOI 10.1073/pnas.0904756106; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Leight ER, 2000, REV MED VIROL, V10, P83, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;83::AID-RMV262&gt;3.0.CO;2-T; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; Li HB, 2000, NAT STRUCT BIOL, V7, P1117; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Popp Maximilian Wei-Lin, 2009, Curr Protoc Protein Sci, VChapter 15, DOI 10.1002/0471140864.ps1503s56; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Sharipo A, 2001, FEBS LETT, V499, P137, DOI 10.1016/S0014-5793(01)02542-X; Sharipo A, 1998, NAT MED, V4, P939, DOI 10.1038/nm0898-939; Singh SK, 1999, BIOCHEMISTRY-US, V38, P14906, DOI 10.1021/bi991615f; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; VANGUNSTEREN WF, 1992, J MOL BIOL, V227, P389, DOI 10.1016/0022-2836(92)90895-Q; Yakhnin AV, 1998, PROTEIN EXPRES PURIF, V14, P382, DOI 10.1006/prep.1998.0981; Yin Y, 2003, SCIENCE, V301, P1371, DOI 10.1126/science.1088902; Zhang MS, 2004, J BIOL CHEM, V279, P20959, DOI 10.1074/jbc.M314043200; Zhang MS, 2004, J BIOL CHEM, V279, P8635, DOI 10.1074/jbc.M310449200; ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6	44	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13243	13257		10.1074/jbc.M113.452524	http://dx.doi.org/10.1074/jbc.M113.452524			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23530043	Green Published, hybrid			2022-12-28	WOS:000318850300011
J	Wang, HG; He, XP; Li, Q; Madison, RD; Moore, SD; McNamara, JO; Pitt, GS				Wang, Hong-Gang; He, Xiao Ping; Li, Qiang; Madison, Roger D.; Moore, Scott D.; McNamara, James O.; Pitt, Geoffrey S.			The Auxiliary Subunit KChIP2 Is an Essential Regulator of Homeostatic Excitability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPORAL-LOBE EPILEPSY; CA1 PYRAMIDAL NEURONS; ACTIVITY-DEPENDENT REGULATION; KV4.2 POTASSIUM CHANNELS; LONG-TERM POTENTIATION; TRANSCRIPTIONAL REPRESSOR; EXCITATORY SYNAPSES; KNOCKOUT MICE; GENE; MODULATION	The somatodendritic I-A (A-type) K+ current underlies neuronal excitability, and loss of I-A has been associated with the development of epilepsy. Whether any one of the four auxiliary potassium channel interacting proteins (KChIPs), KChIP1-KChIP4, in specific neuronal populations is critical for I-A is not known. Here we show that KChIP2, which is abundantly expressed in hippocampal pyramidal cells, is essential for I-A regulation in hippocampal neurons and that deletion of Kchip2 affects susceptibility to limbic seizures. The specific effects of Kchip2 deletion on I-A recorded from isolated hippocampal pyramidal neurons were a reduction in amplitude and shift in the V-1/2 for steady-state in activation to hyperpolarized potentials when compared with WT neurons. Consistent with the relative loss of I-A, hippocampal neurons from Kchip2(-/-) mice showed increased excitability. WT cultured neurons fired only occasional single action potentials, but the average spontaneous firing rate (spikes/s) was almost 10-fold greater in Kchip2(-/-) neurons. In slice preparations, spontaneous firing was detected in CA1 pyramidal neurons from Kchip2(-/-) mice but not from WT. Additionally, when seizures were induced by kindling, the number of stimulations required to evoke an initial class 4 or 5 seizure was decreased, and the average duration of electrographic seizures was longer in Kchip2(-/-) mice compared with WT controls. Together, these data demonstrate that the KChIP2 is essential for physiologic I-A modulation and homeostatic stability and that there is a lack of functional redundancy among the different KChIPs in hippocampal neurons.	[Wang, Hong-Gang; Pitt, Geoffrey S.] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Wang, Hong-Gang; Pitt, Geoffrey S.] Duke Univ, Ion Channel Res Unit, Med Ctr, Durham, NC 27710 USA; [He, Xiao Ping; Madison, Roger D.; Moore, Scott D.; McNamara, James O.; Pitt, Geoffrey S.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Li, Qiang; Moore, Scott D.] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA; [Li, Qiang; Madison, Roger D.] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC 27710 USA; [Li, Qiang; Madison, Roger D.; Moore, Scott D.] Durham Vet Affairs Med Ctr, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Pitt, GS (corresponding author), Duke Univ, Ion Channel Res Unit, Med Ctr, Box 103030, Durham, NC 27710 USA.	geoffrey.pitt@duke.edu	Pitt, Geoffrey/L-4927-2019	Pitt, Geoffrey/0000-0003-2246-0289	National Institutes of Health [R01 HL71165, R01 HL088089, R01NS056217]; Citizens United for Research in Epilepsy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071165, R01HL088089, T32HL007101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056217] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Citizens United for Research in Epilepsy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL71165 and R01 HL088089 (to G. S. P.) and R01NS056217 (to J. O. M.). This work was also supported by grant from Citizens United for Research in Epilepsy (to G. S. P.).	An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Andrasfalvy BK, 2008, J PHYSIOL-LONDON, V586, P3881, DOI 10.1113/jphysiol.2008.154336; Barclay J, 2001, J NEUROSCI, V21, P6095, DOI 10.1523/JNEUROSCI.21-16-06095.2001; Barnwell LFS, 2009, EPILEPSIA, V50, P1741, DOI 10.1111/j.1528-1167.2009.02086.x; BASARSKY TA, 1994, J NEUROSCI, V14, P6402; Bauer CS, 2010, CURR OPIN NEUROBIOL, V20, P563, DOI 10.1016/j.conb.2010.05.007; Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Bourdeau ML, 2007, J NEUROSCI, V27, P1942, DOI 10.1523/JNEUROSCI.3208-06.2007; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Carrion AM, 1999, NATURE, V398, P80, DOI 10.1038/18044; Castro PA, 2001, J NEUROSCI, V21, P6626, DOI 10.1523/JNEUROSCI.21-17-06626.2001; Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308; Chang MC, 2010, NAT NEUROSCI, V13, P1090, DOI 10.1038/nn.2621; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; He XP, 2010, J NEUROSCI, V30, P6188, DOI 10.1523/JNEUROSCI.5821-09.2010; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; Lilliehook C, 2003, J NEUROSCI, V23, P9097; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Marionneau C, 2012, J NEUROSCI, V32, P5716, DOI 10.1523/JNEUROSCI.6450-11.2012; Monaghan MM, 2008, NEUROSCIENCE, V156, P550, DOI 10.1016/j.neuroscience.2008.07.057; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Norris AJ, 2010, J NEUROSCI, V30, P13644, DOI 10.1523/JNEUROSCI.2487-10.2010; Patel SP, 2004, J PHYSIOL-LONDON, V557, P19, DOI 10.1113/jphysiol.2003.058172; Patino GA, 2011, J NEUROSCI, V31, P14577, DOI 10.1523/JNEUROSCI.0361-11.2011; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Singh B, 2006, NEUROBIOL DIS, V24, P245, DOI 10.1016/j.nbd.2006.07.001; Surges R, 2009, NAT REV NEUROL, V5, P492, DOI 10.1038/nrneurol.2009.118; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Thomsen MB, 2009, CIRC RES, V104, P1382, DOI 10.1161/CIRCRESAHA.109.196972; TSAUR ML, 1992, NEURON, V8, P1055, DOI 10.1016/0896-6273(92)90127-Y; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252	44	15	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13258	13268		10.1074/jbc.M112.434548	http://dx.doi.org/10.1074/jbc.M112.434548			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23536187	Green Published, hybrid			2022-12-28	WOS:000318850300012
J	Kohzuma, K; Dal Bosco, C; Meurer, J; Kramer, DM				Kohzuma, Kaori; Dal Bosco, Cristina; Meurer, Joerg; Kramer, David M.			Light- and Metabolism-related Regulation of the Chloroplast ATP Synthase Has Distinct Mechanisms and Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLING FACTOR ACTIVITY; CYCLIC ELECTRON FLOW; GAMMA-SUBUNIT; ARABIDOPSIS-THALIANA; INVERSE REGULATION; THIOL MODULATION; IN-VIVO; PHOTOSYNTHESIS; MUTATION; PLANTS	The chloroplast CF0-CF1-ATP synthase (ATP synthase) is activated in the light and inactivated in the dark by thioredoxin-mediated redox modulation of a disulfide bridge on its gamma subunit. The activity of the ATP synthase is also fine-tuned during steady-state photosynthesis in response to metabolic changes, e.g. altering CO2 levels to adjust the thylakoid proton gradient and thus the regulation of light harvesting and electron transfer. The mechanism of this fine-tuning is unknown. We test here the possibility that it also involves redox modulation. We found that modifying the Arabidopsis thaliana gamma subunit by mutating three highly conserved acidic amino acids, D211V, E212L, and E226L, resulted in a mutant, termed mothra, in which ATP synthase which lacked light-dark regulation had relatively small effects on maximal activity in vivo. In situ equilibrium redox titrations and thiol redox-sensitive labeling studies showed that the gamma subunit disulfide/sulfhydryl couple in the modified ATP synthase has a more reducing redox potential and thus remains predominantly oxidized under physiological conditions, implying that the highly conserved acidic residues in the gamma subunit influence thiol redox potential. In contrast to its altered light-dark regulation, mothra retained wild-type fine-tuning of ATP synthase activity in response to changes in ambient CO2 concentrations, indicating that the light-dark- and metabolic-related regulation occur through different mechanisms, possibly via small molecule allosteric effectors or covalent modification.	[Kohzuma, Kaori; Kramer, David M.] Michigan State Univ, MSU DOE Plant Res Lab, E Lansing, MI 48824 USA; [Dal Bosco, Cristina; Meurer, Joerg] Univ Munich, Dept Biol 1, D-82152 Planegg Martinsried, Germany; [Dal Bosco, Cristina] Univ Freiburg, Fac Biol, Inst Biol Bot 2, D-79104 Freiburg, Germany	Michigan State University; United States Department of Energy (DOE); University of Munich; University of Freiburg	Kramer, DM (corresponding author), Michigan State Univ, MSU DOE Plant Res Lab, 612 Wilson Rd,Rm S220, E Lansing, MI 48824 USA.	kramerd8@msu.edu	Kramer, David M/B-9588-2016; Meurer, Jörg/F-8479-2010; Kohzuma, Kaori/N-6161-2014	Kramer, David M/0000-0003-2181-6888; Meurer, Jörg/0000-0003-2973-9514; Dal Bosco, Cristina/0000-0002-0280-5369; Kohzuma, Kaori/0000-0003-3899-543X	United States Department of Energy, Office of Science, Basic Energy Sciences Program [DE-FG02-91ER20021]; Deutsche Forschungsgemeinschaft; Deutsche Forschungsgemeinschaft [SFB TR1]	United States Department of Energy, Office of Science, Basic Energy Sciences Program(United States Department of Energy (DOE)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by United States Department of Energy, Office of Science, Basic Energy Sciences Program DE-FG02-91ER20021 (to K. K. and D. M. K.), the Deutsche Forschungsgemeinschaft (to C. D. B.), and Deutsche Forschungsgemeinschaft (SFB TR1) (to J. M.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Avenson TJ, 2004, P NATL ACAD SCI USA, V101, P5530, DOI 10.1073/pnas.0401269101; Baker NR, 2007, PLANT CELL ENVIRON, V30, P1107, DOI 10.1111/j.1365-3040.2007.01680.x; Bunney TD, 2001, P NATL ACAD SCI USA, V98, P4249, DOI 10.1073/pnas.061437498; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CROSS RL, 1982, J BIOL CHEM, V257, P2874; Cruz JA, 2005, J EXP BOT, V56, P395, DOI 10.1093/jxb/eri022; Dal Bosco C, 2004, J BIOL CHEM, V279, P1060, DOI 10.1074/jbc.M308435200; del Riego G, 2006, PHOTOSYNTH RES, V89, P11, DOI 10.1007/s11120-006-9078-4; Evron Y, 2000, J BIOENERG BIOMEMBR, V32, P501, DOI 10.1023/A:1005669008974; GABRYS H, 1994, PLANT PHYSIOL, V104, P769, DOI 10.1104/pp.104.2.769; Groth G, 1999, PHYSIOL PLANTARUM, V106, P142, DOI 10.1034/j.1399-3054.1999.106120.x; Hisabori T, 2003, FEBS LETT, V545, P71, DOI 10.1016/S0014-5793(03)00395-8; Hisabori T, 2002, BBA-BIOENERGETICS, V1555, P140, DOI 10.1016/S0005-2728(02)00269-4; Hisabori T., 2013, ANTIOXID RE IN PRESS; Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9; JUNESCH U, 1987, BIOCHIM BIOPHYS ACTA, V893, P275, DOI 10.1016/0005-2728(87)90049-1; JUNESCH U, 1991, FEBS LETT, V294, P275, DOI 10.1016/0014-5793(91)81447-G; Kanazawa A, 2002, P NATL ACAD SCI USA, V99, P12789, DOI 10.1073/pnas.182427499; Kiirats O, 2010, PHOTOSYNTH RES, V105, P89, DOI 10.1007/s11120-010-9561-9; Kohzuma K, 2009, PLANT CELL ENVIRON, V32, P209, DOI 10.1111/j.1365-3040.2008.01912.x; Kohzuma K, 2012, P NATL ACAD SCI USA, V109, P3293, DOI 10.1073/pnas.1115728109; Konno H, 2000, BIOCHEM J, V352, P783, DOI 10.1042/0264-6021:3520783; Konno H, 2012, PLANT CELL PHYSIOL, V53, P626, DOI 10.1093/pcp/pcs018; KRAMER DM, 1990, PHOTOSYNTH RES, V26, P213, DOI 10.1007/BF00033134; KRAMER DM, 1989, BIOCHIM BIOPHYS ACTA, V976, P28, DOI 10.1016/S0005-2728(89)80186-0; Livingston AK, 2010, PLANT CELL ENVIRON, V33, P1779, DOI 10.1111/j.1365-3040.2010.02183.x; Livingston AK, 2010, PLANT CELL, V22, P221, DOI 10.1105/tpc.109.071084; MILLS JD, 1982, BIOCHIM BIOPHYS ACTA, V679, P75, DOI 10.1016/0005-2728(82)90257-2; Okuno D, 2011, J BIOCHEM, V149, P655, DOI 10.1093/jb/mvr049; ORT DR, 1992, ANNU REV PLANT PHYS, V43, P269, DOI 10.1146/annurev.pp.43.060192.001413; Reiland S, 2009, PLANT PHYSIOL, V150, P889, DOI 10.1104/pp.109.138677; Richter ML, 2005, J BIOENERG BIOMEMBR, V37, P467, DOI 10.1007/s10863-005-9493-9; Richter ML, 2004, PHOTOSYNTH RES, V79, P319, DOI 10.1023/B:PRES.0000017157.08098.36; Seelert H, 2003, J MOL BIOL, V333, P337, DOI 10.1016/j.jmb.2003.08.046; SHARKEY TD, 1989, PLANT PHYSIOL, V91, P679, DOI 10.1104/pp.91.2.679; SHARKEY TD, 1989, PLANT PHYSIOL, V90, P385, DOI 10.1104/pp.90.2.385; Takizawa K, 2008, PLANT CELL ENVIRON, V31, P235, DOI 10.1111/j.1365-3040.2007.01753.x; Takizawa K, 2007, BBA-BIOENERGETICS, V1767, P1233, DOI 10.1016/j.bbabio.2007.07.006; Ueoka-Nakanishi H, 2004, J BIOL CHEM, V279, P16272, DOI 10.1074/jbc.M400607200; Wu G, 2008, PHOTOSYNTH RES, V97, P185, DOI 10.1007/s11120-008-9315-0; Wu G, 2007, J BIOL CHEM, V282, P36782, DOI 10.1074/jbc.M707007200	42	36	36	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13156	13163		10.1074/jbc.M113.453225	http://dx.doi.org/10.1074/jbc.M113.453225			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23486473	hybrid, Green Published			2022-12-28	WOS:000318555100065
J	Lei, CQ; Zhang, Y; Xia, T; Jiang, LQ; Zhong, B; Shu, HB				Lei, Cao-Qi; Zhang, Yu; Xia, Tian; Jiang, Li-Qun; Zhong, Bo; Shu, Hong-Bing			FoxO1 Negatively Regulates Cellular Antiviral Response by Promoting Degradation of IRF3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; I INTERFERON; ADAPTER PROTEIN; TRANSCRIPTION FACTORS; ACTIVATION; PHOSPHORYLATION; UBIQUITINATION; IDENTIFICATION; RECOGNITION; MECHANISMS	Viral infection causes activation of the transcription factor IRF3, which is critical for production of type I interferons (IFNs) and innate antiviral immune response. How virus-induced type I IFN signaling is controlled is not fully understood. Here we identified the transcription factor FoxO1 as a negative regulator for virus-triggered IFN-beta induction. Overexpression of FoxO1 inhibited virus-triggered ISRE activation, IFN-beta induction as well as cellular antiviral response, whereas knockdown of FoxO1 had opposite effects. FoxO1 interacted with IRF3 in a viral infection-dependent manner and promoted K48-linked polyubiquitination and degradation of IRF3 in the cytosol. Furthermore, FoxO1-mediated degradation of IRF3 was independent of the known E3 ubiquitin ligases for IRF3, including RBCK1 and RAUL. Our findings thus suggest that FoxO1 negatively regulates cellular antiviral response by promoting IRF3 ubiquitination and degradation, providing a previously unknown mechanism for control of type I IFN induction and cellular antiviral response.	[Lei, Cao-Qi; Zhang, Yu; Xia, Tian; Jiang, Li-Qun; Zhong, Bo; Shu, Hong-Bing] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Shu, HB (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	shuh@whu.edu.cn			Chinese Ministry of Science and Technology [2012CB910201, 2010DFA31100]; National Science Foundation of China [91029302, 31130020, 31221061]; Chinese 111 project [B06018]; Ministry of Education of China	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 project(Ministry of Education, China - 111 Project); Ministry of Education of China(Ministry of Education, China)	This work was supported by grants from the Chinese Ministry of Science and Technology (2012CB910201, 2010DFA31100), the National Science Foundation of China (91029302, 31130020, and 31221061), the Chinese 111 project (B06018), and the academic award for excellent Ph.D. candidates funded by Ministry of Education of China.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; AU WC, 1995, P NATL ACAD SCI USA, V92, P11657, DOI 10.1073/pnas.92.25.11657; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Han KJ, 2004, J BIOL CHEM, V279, P15652, DOI 10.1074/jbc.M311629200; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kubota T, 2008, J BIOL CHEM, V283, P25660, DOI 10.1074/jbc.M804479200; Lei CQ, 2010, IMMUNITY, V33, P878, DOI 10.1016/j.immuni.2010.11.021; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Li Y, 2012, P NATL ACAD SCI USA, V109, P11770, DOI 10.1073/pnas.1203405109; Litvak V, 2012, NATURE, V490, P421, DOI 10.1038/nature11428; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ran Y, 2011, J MOL CELL BIOL, V3, P283, DOI 10.1093/jmcb/mjr020; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shi HX, 2010, MOL CELL BIOL, V30, P2424, DOI 10.1128/MCB.01466-09; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Wang YY, 2010, P NATL ACAD SCI USA, V107, P815, DOI 10.1073/pnas.0908967107; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	31	54	59	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12596	12604		10.1074/jbc.M112.444794	http://dx.doi.org/10.1074/jbc.M112.444794			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23532851	Green Published, hybrid			2022-12-28	WOS:000318555100018
J	Kim, SC; Guo, L; Wang, XM				Kim, Sang-Chul; Guo, Liang; Wang, Xuemin			Phosphatidic Acid Binds to Cytosolic Glyceraldehyde-3-phosphate Dehydrogenase and Promotes Its Cleavage in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT-STRESS-RESPONSE; PHOSPHOLIPASE-D; FUNCTIONAL DIVERSITY; SIGNAL-TRANSDUCTION; TOMATO CELLS; PROTEIN; DELTA; IDENTIFICATION; MODULATION; ACTIVATION	Phosphatidic acid (PA) is a class of lipid messengers involved in a variety of physiological processes. To understand how PA mediates cell functions in plants, we used a PA affinity membrane assay to isolate PA-binding proteins from Camelina sativa followed by mass spectrometric sequencing. A cytosolic glyceraldehyde-3-phosphate dehydrogenase (GAPC) was identified to bind to PA, and detailed analysis was carried out subsequently using GAPC1 and GAPC1 from Arabidopsis. The PA and GAPC binding was abolished by the cation zinc whereas oxidation of GAPCs promoted the PA binding. PA had little impact on the GAPC catalytic activity in vitro, but the PA treatment of Arabidopsis seedlings induced proteolytic cleavage of GAPC2 and inhibited Arabidopsis seedling growth. The extent of PA inhibition was greater in GAPC-overexpressing than wildtype seedlings, but the greater PA inhibition was abolished by application of zinc to the seedling. The PA treatment also reduced the expression of genes involved in PA synthesis and utilization, and the PA-reduced gene expression was partially recovered by zinc treatment. These data suggest that PA binds to oxidized GAPDH and promotes its cleavage and that the PA and GAPC interaction may provide a signaling link coordinating carbohydrate and lipid metabolism.	Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Wang, Xuemin] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	University of Missouri System; University of Missouri Saint Louis; Donald Danforth Plant Science Center	Wang, XM (corresponding author), Donald Danforth Plant Sci Ctr, 975 N Warson Rd, St Louis, MO 63132 USA.	wangxue@umsl.edu	Guo, Liang/AAW-4739-2021; Wang, Xuemin/M-2853-2013	Guo, Liang/0000-0001-7191-5062; wang, xuemin/0000-0002-6251-6745	Center for Advanced Biofuels Systems, an Energy Frontier Research Center; United States Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0001295]; National Science Foundation [0818740]	Center for Advanced Biofuels Systems, an Energy Frontier Research Center; United States Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	This work was supported primarily by the Center for Advanced Biofuels Systems, an Energy Frontier Research Center funded by the United States Department of Energy, Office of Science, Basic Energy Sciences, under Award DE-SC0001295 (lipid-protein interactions) and by National Science Foundation Award 0818740 (mutant isolation).	Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; Barr FA, 2000, CURR BIOL, V10, pR141, DOI 10.1016/S0960-9822(00)00326-2; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Cotelle V, 2000, EMBO J, V19, P2869, DOI 10.1093/emboj/19.12.2869; Demarse NA, 2009, J MOL BIOL, V394, P789, DOI 10.1016/j.jmb.2009.09.062; Dineley KE, 2003, J NEUROCHEM, V85, P563, DOI 10.1046/j.1471-4159.2003.01678.x; Gardiner J, 2003, PLANT CELL PHYSIOL, V44, P687, DOI 10.1093/pcp/pcg095; Guo L, 2012, PLANT CELL, V24, P2200, DOI 10.1105/tpc.111.094946; Guo L, 2011, J BIOL CHEM, V286, P13336, DOI 10.1074/jbc.M110.190892; Hara MR, 2006, BBA-MOL BASIS DIS, V1762, P502, DOI 10.1016/j.bbadis.2006.01.012; Harada N, 2007, J BIOL CHEM, V282, P22651, DOI 10.1074/jbc.M610724200; Himmelbach A, 2002, EMBO J, V21, P3029, DOI 10.1093/emboj/cdf316; Holtgrefe S, 2008, PHYSIOL PLANTARUM, V133, P211, DOI 10.1111/j.1399-3054.2008.01066.x; Hong YY, 2010, PLANT CELL ENVIRON, V33, P627, DOI 10.1111/j.1365-3040.2009.02087.x; Hutcheon C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-233; Jacob T, 1999, P NATL ACAD SCI USA, V96, P12192, DOI 10.1073/pnas.96.21.12192; Jost R, 2009, J BIOL CHEM, V284, P31962, DOI 10.1074/jbc.M109.022657; Katagiri T, 2001, PLANT J, V26, P595, DOI 10.1046/j.1365-313x.2001.01060.x; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li G, 2007, PLANT CELL, V19, P281, DOI 10.1105/tpc.106.041426; Li MY, 2009, BBA-MOL CELL BIOL L, V1791, P927, DOI 10.1016/j.bbalip.2009.02.017; Liu XL, 2001, PLANT CELL, V13, P1293, DOI 10.1105/tpc.13.6.1293; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; McLoughlin F, 2013, BIOCHEM J, V450, P573, DOI 10.1042/BJ20121639; Monteiro D, 2005, J EXP BOT, V56, P1665, DOI 10.1093/jxb/eri163; Munnik T, 2000, PLANT J, V22, P147, DOI 10.1046/j.1365-313x.2000.00725.x; Munnik T, 1995, PLANT CELL, V7, P2197, DOI 10.1105/tpc.7.12.2197; Ohashi Y, 2003, SCIENCE, V300, P1427, DOI 10.1126/science.1083695; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Potocky M, 2003, PLANTA, V217, P122, DOI 10.1007/s00425-002-0965-4; Raho N, 2011, J PLANT PHYSIOL, V168, P534, DOI 10.1016/j.jplph.2010.09.004; Rius SP, 2008, PLANT PHYSIOL, V148, P1655, DOI 10.1104/pp.108.128769; Ruelland E, 2002, PLANT PHYSIOL, V130, P999, DOI 10.1104/pp.006080; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Stevenson JM, 1998, J BIOL CHEM, V273, P22761, DOI 10.1074/jbc.273.35.22761; Testerink C, 2004, PLANT J, V39, P527, DOI 10.1111/j.1365-313X.2004.02152.x; Testerink C, 2011, J EXP BOT, V62, P2349, DOI 10.1093/jxb/err079; van der Luit AH, 2000, PLANT PHYSIOL, V123, P1507, DOI 10.1104/pp.123.4.1507; Wang Q, 1997, PROTOPLASMA, V198, P155, DOI 10.1007/BF01287564; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yu LJ, 2010, NEW PHYTOL, V188, P762, DOI 10.1111/j.1469-8137.2010.03422.x; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101; Zhang WH, 2003, PLANT CELL, V15, P2285, DOI 10.1105/tpc.013961; Zhang YY, 2009, PLANT CELL, V21, P2357, DOI 10.1105/tpc.108.062992; Zhou Y, 2008, MOL CANCER RES, V6, P1375, DOI 10.1158/1541-7786.MCR-07-2170	49	51	55	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11834	11844		10.1074/jbc.M112.427229	http://dx.doi.org/10.1074/jbc.M112.427229			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504314	Green Published, hybrid			2022-12-28	WOS:000318157600019
J	Tan, E; Rao, F; Pasunooti, S; Pham, TH; Soehano, I; Turner, MS; Liew, CW; Lescar, J; Pervushin, K; Liang, ZX				Tan, Edward; Rao, Feng; Pasunooti, Swathi; Thi Huong Pham; Soehano, Ishin; Turner, Mark S.; Liew, Chong Wai; Lescar, Julien; Pervushin, Konstantin; Liang, Zhao-Xun			Solution Structure of the PAS Domain of a Thermophilic YybT Protein Homolog Reveals a Potential Ligand-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-DI-AMP; CRYSTAL-STRUCTURE; SIGNAL-TRANSDUCTION; LACTOCOCCUS-LACTIS; OXYGEN SENSOR; BACILLUS-SUBTILIS; HISTIDINE KINASES; NMR-SPECTROSCOPY; MECHANISM; LIGHT	The Bacillus subtilis protein YybT (or GdpP) and its homologs were recently established as stress signaling proteins that exert their biological effect by degrading the bacterial messenger cyclic di-AMP. YybT homologs contain a small Per-ARNT-Sim (PAS) domain (similar to 80 amino acids) that can bind b-type heme with 1:1 stoichiometry despite the small size of the domain and the lack of a conserved heme iron-coordinating residue. We determined the solution structure of the PAS domain of GtYybT from Geobacillus thermodenitrificans by NMR spectroscopy to further probe its function. The solution structure confirms that PAS(GtYybT) adopts the characteristic PAS fold composed of a five-stranded antiparallel beta sheet and a few short alpha-helices. One alpha-helix and three central beta-strands of PAS(GtYybT) are noticeably shorter than those of the typical PAS domains. Despite the small size of the protein domain, a hydrophobic pocket is formed by the side chains of nonpolar residues stemming from the beta-strands and alpha-helices. A set of residues in the vicinity of the pocket and in the C-terminal region at the dimeric interface exhibits perturbed NMR parameters in the presence of heme or zinc protoporphyrin. Together, the results unveil a compact PAS domain with a potential ligand-binding pocket and reinforce the view that the PAS(YybT) domains function as regulatory domains in the modulation of cellular cyclic di-AMP concentration.	[Tan, Edward; Rao, Feng; Pasunooti, Swathi; Soehano, Ishin; Liew, Chong Wai; Lescar, Julien; Pervushin, Konstantin; Liang, Zhao-Xun] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 637551, Singapore; [Thi Huong Pham; Turner, Mark S.] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld 4072, Australia; [Turner, Mark S.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld 4072, Australia	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Queensland; University of Queensland	Pervushin, K (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, 60 Nanyang Dr, Singapore 637551, Singapore.	kpervushin@ntu.edu.sg; zxliang@ntu.edu.sg	RAO, FENG/G-4529-2011; Rao, Feng/AAD-4712-2019; Turner, Mark/L-3798-2013; Pervushin, Konstantin/AAJ-6580-2020; Turner, Mark/K-9365-2013; Liang, Zhao-Xun/A-2191-2011; Tan, Edward/W-8611-2019	RAO, FENG/0000-0002-6038-6406; Rao, Feng/0000-0002-6038-6406; Pervushin, Konstantin/0000-0002-6393-4340; Turner, Mark/0000-0003-2770-852X; Pham, Huong Thi/0000-0003-1769-6713; Liang, Zhao-Xun/0000-0002-3128-1330	Tier II Academic Research Council (ARC) grant, Ministry of Education (MOE) of the Republic of Singapore; Australian Research Council [LP1210282]; Dairy Innovation Australia Limited	Tier II Academic Research Council (ARC) grant, Ministry of Education (MOE) of the Republic of Singapore(Ministry of Education, Singapore); Australian Research Council(Australian Research Council); Dairy Innovation Australia Limited	This work was supported by a Tier II Academic Research Council (ARC) grant (to Z.-X.L.) from the Ministry of Education (MOE) of the Republic of Singapore and grants from the Australian Research Council (LP1210282) and Dairy Innovation Australia Limited (to M. S. T.).	Amezcua CA, 2002, STRUCTURE, V10, P1349, DOI 10.1016/S0969-2126(02)00857-2; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; BORGSTAHL GEO, 1995, BIOCHEMISTRY-US, V34, P6278, DOI 10.1021/bi00019a004; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burnside K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011071; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Card PB, 2005, J MOL BIOL, V353, P664, DOI 10.1016/j.jmb.2005.08.043; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Cheung J, 2008, J BIOL CHEM, V283, P30256, DOI 10.1074/jbc.M805253200; Cheung J, 2008, J BIOL CHEM, V283, P13762, DOI 10.1074/jbc.M710592200; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Erbel PJA, 2003, P NATL ACAD SCI USA, V100, P15504, DOI 10.1073/pnas.2533374100; GILLESGONZALEZ MA, 1994, BIOCHEMISTRY-US, V33, P8067, DOI 10.1021/bi00192a011; Gong WM, 1998, P NATL ACAD SCI USA, V95, P15177, DOI 10.1073/pnas.95.26.15177; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hilty C, 2004, CHEMBIOCHEM, V5, P467, DOI 10.1002/cbic.200300815; Jensen MR, 2006, MAGN RESON CHEM, V44, P294, DOI 10.1002/mrc.1771; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; Lee J, 2008, BIOCHEMISTRY-US, V47, P4051, DOI 10.1021/bi7021156; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Ma XL, 2008, J BIOL CHEM, V283, P1167, DOI 10.1074/jbc.M706218200; Miyatake H, 2000, J MOL BIOL, V301, P415, DOI 10.1006/jmbi.2000.3954; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Pedersen MB, 2008, J BACTERIOL, V190, P4903, DOI 10.1128/JB.00447-08; PETROS AM, 1990, BIOCHEMISTRY-US, V29, P10041, DOI 10.1021/bi00495a005; Pintacuda G, 2002, J AM CHEM SOC, V124, P372, DOI 10.1021/ja016985h; Pozzi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002626; Purcell EB, 2007, P NATL ACAD SCI USA, V104, P18241, DOI 10.1073/pnas.0705887104; Purcell EB, 2010, BIOCHEMISTRY-US, V49, P6761, DOI 10.1021/bi1006404; Qi YN, 2009, BIOCHEMISTRY-US, V48, P10275, DOI 10.1021/bi901121w; Rallu F, 2000, MOL MICROBIOL, V35, P517, DOI 10.1046/j.1365-2958.2000.01711.x; Rao F, 2011, J BACTERIOL, V193, P1543, DOI 10.1128/JB.01364-10; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Smith WM, 2012, APPL ENVIRON MICROB, V78, P7753, DOI 10.1128/AEM.02316-12; Soderback E, 1998, MOL MICROBIOL, V28, P179, DOI 10.1046/j.1365-2958.1998.00788.x; Swartz TE, 2007, SCIENCE, V317, P1090, DOI 10.1126/science.1144306; Tuckerman JR, 2009, BIOCHEMISTRY-US, V48, P9764, DOI 10.1021/bi901409g; Ukaegbu UE, 2006, BIOCHEMISTRY-US, V45, P10191, DOI 10.1021/bi060693h; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Zhou YF, 2008, J MOL BIOL, V383, P49, DOI 10.1016/j.jmb.2008.08.010; Zoltowski BD, 2011, BIOCHEMISTRY-US, V50, P4, DOI 10.1021/bi101665s; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	56	17	21	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11949	11959		10.1074/jbc.M112.437764	http://dx.doi.org/10.1074/jbc.M112.437764			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504327	Green Published, hybrid			2022-12-28	WOS:000318157600030
J	Wang, L; Suzuki, T				Wang, Li; Suzuki, Tadashi			Dual Functions for Cytosolic alpha-Mannosidase (Man2C1) ITS DOWN-REGULATION CAUSES MITOCHONDRIA-DEPENDENT APOPTOSIS INDEPENDENTLY OF ITS alpha-MANNOSIDASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; GENE-EXPRESSION; FREE OLIGOSACCHARIDES; PROTEASOME INHIBITOR; CANCER-CELLS; DEATH; DEGRADATION; MECHANISMS; ROLES; GLYCOSYLATION	Cytosolic alpha-mannosidase (Man2C1) trims free oligosaccharides in mammalian cells, and its down-regulation reportedly delays cancer growth by inducing mitotic arrest or apoptosis. However, the mechanism by which Man2C1 down-regulation induces apoptosis is unknown. Here, we demonstrated that silencing of Man2C1 via small hairpin RNAs induced mitochondria-dependent apoptosis in HeLa cells. Expression of CHOP (C/EBP homologous protein), a transcription factor critical to endoplasmic reticulum stress-induced apoptosis, was significantly up-regulated in Man2C1 knockdown cells. However, this enhanced CHOP expression was not caused by endoplasmic reticulum stress. Interestingly, Man2C1 catalytic activity was not required for this regulation of apoptosis; introduction of mutant, enzymatically inactive Man2C1 rescued apoptotic phenotypes of Man2C1 knockdown cells. These results show that Man2C1 has dual functions: one in glycan catabolism and another in apoptotic signaling.	[Wang, Li; Suzuki, Tadashi] RIKEN Global Res Cluster, RIKEN Max Planck Joint Res Ctr, Syst Glycobiol Res Grp, Glycometabolome Team, Wako, Saitama 3510198, Japan	RIKEN	Suzuki, T (corresponding author), RIKEN Global Res Cluster, RIKEN Max Planck Joint Res Ctr, Syst Glycobiol Res Grp, Glycometabolome Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tsuzuki_gm@riken.jp	Suzuki, Tadashi/I-4536-2014; Suzuki, Tadashi/AAX-5707-2021	Suzuki, Tadashi/0000-0003-1030-7631	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Foundation for Applied Enzymology	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Applied Enzymology	The work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and a research grant from Japan Foundation for Applied Enzymology (to T. S.).	Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Bernon C, 2011, GLYCOBIOLOGY, V21, P363, DOI 10.1093/glycob/cwq169; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Butters TD, 2009, GLYCOCONJUGATE J, V26, P1109, DOI 10.1007/s10719-009-9231-3; Chantret I, 2008, GLYCOBIOLOGY, V18, P210, DOI 10.1093/glycob/cwn003; Chantret I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011734; Funakoshi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010545; Funakoshi Y, 2009, BBA-GEN SUBJECTS, V1790, P81, DOI 10.1016/j.bbagen.2008.09.009; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hagberg H, 2009, J CHILD NEUROL, V24, P1141, DOI 10.1177/0883073809338212; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Han YH, 2010, ANTICANCER RES, V30, P879; He LZ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1309; Heeres JT, 2007, CURR OPIN CHEM BIOL, V11, P644, DOI 10.1016/j.cbpa.2007.08.038; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirayama H, 2010, J BIOL CHEM, V285, P12390, DOI 10.1074/jbc.M109.082081; Howard S, 1998, J BIOL CHEM, V273, P2067, DOI 10.1074/jbc.273.4.2067; Huang T, 2010, CANCER SCI, V101, P713, DOI 10.1111/j.1349-7006.2009.01421.x; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Kato A, 2011, J BIOCHEM, V149, P415, DOI 10.1093/jb/mvq153; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lozon TI, 2011, AM J PHYSIOL-LUNG C, V300, pL422, DOI 10.1152/ajplung.00166.2010; Maerz S, 2010, J BIOL CHEM, V285, P2326, DOI 10.1074/jbc.M109.045302; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703; Peric D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011675; Qu L, 2006, CELL RES, V16, P622, DOI 10.1038/sj.cr.7310065; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Saint-Pol A, 1999, J BIOL CHEM, V274, P13547, DOI 10.1074/jbc.274.19.13547; Sartorius U, 2001, CHEMBIOCHEM, V2, P20, DOI 10.1002/1439-7633(20010105)2:1<20::AID-CBIC20>3.3.CO;2-O; Skalet AH, 2005, J BIOL CHEM, V280, P39762, DOI 10.1074/jbc.M502640200; Suzuki T, 2002, P NATL ACAD SCI USA, V99, P9691, DOI 10.1073/pnas.152333599; Suzuki T, 2007, SEMIN CELL DEV BIOL, V18, P762, DOI 10.1016/j.semcdb.2007.09.010; Suzuki T, 2006, BIOCHEM J, V400, P33, DOI 10.1042/BJ20060945; Suzuki T, 2006, GLYCOCONJUGATE J, V23, P291, DOI 10.1007/s10719-006-6975-x; Suzuki T, 2009, TRENDS GLYCOSCI GLYC, V21, P219, DOI 10.4052/tigg.21.219; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tang QH, 2011, VIRUS GENES, V42, P355, DOI 10.1007/s11262-011-0582-z; Taniguchi N, 2006, CURR OPIN STRUC BIOL, V16, P561, DOI 10.1016/j.sbi.2006.08.011; Tian Y, 2008, CANCER SCI, V99, P2428, DOI 10.1111/j.1349-7006.2008.01019.x; Uddin M, 2011, DIS MARKERS, V30, P111, DOI [10.1155/2011/513659, 10.3233/DMA-2011-0750]; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Vleugels W, 2011, BIOCHIMIE, V93, P823, DOI 10.1016/j.biochi.2011.01.016; Xiang ZG, 2010, TRANSGENIC RES, V19, P67, DOI 10.1007/s11248-009-9299-3; Yue W, 2004, INT J CANCER, V108, P189, DOI 10.1002/ijc.11536	47	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11887	11896		10.1074/jbc.M112.425702	http://dx.doi.org/10.1074/jbc.M112.425702			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486476	Green Published, hybrid			2022-12-28	WOS:000318157600024
J	Zhang, FX; Wang, Y; Wang, L; Luo, X; Huang, K; Wang, C; Du, M; Liu, FM; Luo, T; Huang, D; Huang, K				Zhang, Fengxiao; Wang, Yan; Wang, Lin; Luo, Xi; Huang, Kun; Wang, Cheng; Du, Meng; Liu, Fangmei; Luo, Ting; Huang, Dan; Huang, Kai			Poly(ADP-ribose) Polymerase 1 Is a Key Regulator of Estrogen Receptor alpha-dependent Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTORS; POSTTRANSLATIONAL MODIFICATION; COACTIVATOR COMPLEX; CARDIAC FIBROBLASTS; PARP-1; EXPRESSION; ACTIVATION; PROTEIN; ACETYLATION; MODULATION	Activation of nuclear receptor estrogen receptor alpha (ER alpha) exerts cardiovascular protective effects by modulating the expression of ER alpha target genes. However, the underlying mechanism remains unclear. PARP1 is a ubiquitous multifunctional nuclear enzyme. In this study, we examined the interplay between PARP1 and ER alpha, and identified PARP1 as an important regulator of ER alpha-dependent transcription. We showed that PARP1 could directly bind to ER alpha, and ER alpha could be poly(ADP-ribosyl)ated by PARP1. Poly(ADP-ribosyl)ation increased ER alpha binding to estrogen response element (ERE) present in the promoter of target genes and promoted ER alpha-mediated gene transcription. Estradiol, the ligand of ER alpha, increased PARP enzymatic activity and enhanced poly(ADP-ribosyl) ation of ER alpha. Upon treatment with estradiol, ER alpha binding to ERE- and ER alpha dependent gene expression was dramatically increased in cultured vascular smooth muscle cells (VSMCs). Inhibition of PARP1 by PARP inhibitor or PARP1 siRNA decreased ER alpha binding to ERE and prevented ER alpha-dependent gene transcription in VSMCs. Further studies revealed that PARP1 served as an indispensible component for the formation of the ER alpha-ERE complex by directly interacting with ER alpha. Thus, our results identify PARP1 as a key regulator of ER alpha in controlling ER alpha transactivation.	[Zhang, Fengxiao; Wang, Yan; Luo, Xi; Huang, Kun; Wang, Cheng; Du, Meng; Liu, Fangmei; Luo, Ting; Huang, Dan; Huang, Kai] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiovasc Dis, Wuhan 430022, Peoples R China; [Zhang, Fengxiao; Huang, Dan; Huang, Kai] Huazhong Univ Sci & Technol, Clin Ctr Human Genom Res, Union Hosp, Wuhan 430022, Peoples R China; [Wang, Lin] Huazhong Univ Sci & Technol, Cent Lab, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Huang, D (corresponding author), HUST, Union Hosp, Dept Cardiovasc Dis, 1277 Jiefang Ave, Wuhan 430022, Peoples R China.	joy_huangdan@yahoo.com.cn; huangkai1@mail.hust.edu.cn		Zhang, Fengxiao/0000-0002-5109-4196; Fangmei, Liu/0000-0002-7430-4950	National Natural Science Foundation of China [30971245, 81170239, 81000112]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30971245 and 81170239, to K. H. and 81000112, to D.H.).	Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Ba XQ, 2010, J BIOL CHEM, V285, P11596, DOI 10.1074/jbc.M109.076984; Benecke A, 2000, EMBO REP, V1, P151, DOI 10.1093/embo-reports/kvd028; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Chen W, 2011, SEMIN CELL DEV BIOL, V22, P749, DOI 10.1016/j.semcdb.2011.07.026; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Glass CK, 2000, GENE DEV, V14, P121; Glidewell-Kenney C, 2005, MOL CELL ENDOCRINOL, V245, P53, DOI 10.1016/j.mce.2005.10.003; Huang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027123; Huang D, 2008, ARCH MED RES, V39, P775, DOI 10.1016/j.arcmed.2008.09.003; Huang D, 2009, J MOL CELL CARDIOL, V46, P25, DOI 10.1016/j.yjmcc.2008.10.019; Huang D, 2009, CARDIOVASC RES, V81, P98, DOI 10.1093/cvr/cvn264; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kotova E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000387; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Lalevee S, 2010, METHODS MOL BIOL, V647, P251, DOI 10.1007/978-1-60761-738-9_15; Lewis BA, 2003, J CELL SCI, V116, P3667, DOI 10.1242/jcs.00734; Li GH, 1999, CIRCULATION, V100, P1639, DOI 10.1161/01.CIR.100.15.1639; Lombardi M, 2008, J CELL BIOL, V182, P327, DOI 10.1083/jcb.200712125; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Miyamoto T, 1999, MOL CELL BIOL, V19, P2644; Paddock MN, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000428; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SIMONIN F, 1990, J BIOL CHEM, V265, P19249; Smirnov AN, 2002, BIOCHEMISTRY-MOSCOW+, V67, P957, DOI 10.1023/A:1020545200302; Taatjes DJ, 2004, MOL CELL, V14, P675, DOI 10.1016/j.molcel.2004.05.014; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Xu W, 2003, METHOD ENZYMOL, V364, P205; Zaniolo K, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-96	33	52	52	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11348	11357		10.1074/jbc.M112.429134	http://dx.doi.org/10.1074/jbc.M112.429134			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23493398	Green Published, hybrid			2022-12-28	WOS:000317915500037
J	Das, D; Lee, WS; Grant, JC; Chiu, HJ; Farr, CL; Vance, J; Klock, HE; Knuth, MW; Miller, MD; Elsliger, MA; Deacon, AM; Godzik, A; Lesley, SA; Kornfeld, S; Wilson, IA				Das, Debanu; Lee, Wang-Sik; Grant, Joanna C.; Chiu, Hsiu-Ju; Farr, Carol L.; Vance, Julie; Klock, Heath E.; Knuth, Mark W.; Miller, Mitchell D.; Elsliger, Marc-Andre; Deacon, Ashley M.; Godzik, Adam; Lesley, Scott A.; Kornfeld, Stuart; Wilson, Ian A.			Structure and Function of the DUF2233 Domain in Bacteria and in the Human Mannose 6-Phosphate Uncovering Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PROTEIN-STRUCTURE; EVOLUTIONARY CONSERVATION; DIFFRACTION DATA; CONSURF; BIOSYNTHESIS; VALIDATION; MUTATIONS; SEROGROUP; GENOMICS	DUF2233, a domain of unknown function (DUF), is present in many bacterial and several viral proteins and was also identified in the mammalian transmembrane glycoprotein N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase ("uncovering enzyme" (UCE)). We report the crystal structure of BACOVA_ 00430, a 315-residue protein from the human gut bacterium Bacteroides ovatus that is the first structural representative of the DUF2233 protein family. A notable feature of this structure is the presence of a surface cavity that is populated by residues that are highly conserved across the entire family. The crystal structure was used to model the luminal portion of human UCE (hUCE), which is involved in targeting of lysosomal enzymes. Mutational analysis of several residues in a highly conserved surface cavity of hUCE revealed that they are essential for function. The bacterial enzyme (BACOVA_ 00430) has similar to 1% of the catalytic activity of hUCE toward the substrate GlcNAc-P-mannose, the precursor of the Man-6-P lysosomal targeting signal. GlcNAc-1-P is a poor substrate for both enzymes. We conclude that, for at least a subset of proteins in this family, DUF2233 functions as a phosphodiester glycosidase.	[Das, Debanu; Grant, Joanna C.; Chiu, Hsiu-Ju; Farr, Carol L.; Vance, Julie; Klock, Heath E.; Knuth, Mark W.; Miller, Mitchell D.; Elsliger, Marc-Andre; Deacon, Ashley M.; Godzik, Adam; Lesley, Scott A.; Wilson, Ian A.] SLAC Natl Accelerator Lab, Joint Ctr Struct Genom, Menlo Pk, CA 94025 USA; [Das, Debanu; Chiu, Hsiu-Ju; Miller, Mitchell D.; Deacon, Ashley M.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Lee, Wang-Sik; Kornfeld, Stuart] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Grant, Joanna C.; Vance, Julie; Klock, Heath E.; Knuth, Mark W.; Lesley, Scott A.] Novartis Res Fdn, Genom Inst, Prot Sci Dept, San Diego, CA 92121 USA; [Farr, Carol L.; Elsliger, Marc-Andre; Lesley, Scott A.; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Godzik, Adam] Sanford Burnham Med Res Inst, Program Bioinformat & Syst Biol, La Jolla, CA 92037 USA; [Godzik, Adam] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Washington University (WUSTL); Novartis; Scripps Research Institute; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Kornfeld, S (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.	skornfel@dom.wustl.edu; wilson@scripps.edu	Godzik, Adam/AAW-1467-2020; Godzik, Adam/A-7279-2009	Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; Miller, Mitchell/0000-0003-1626-4943; Elsliger, Marc Andre/0000-0002-1989-7626	National Institutes of Health [R21DC011332]; NIGMS Protein Structure Initiative [U54 GM094586]; NATIONAL CANCER INSTITUTE [R37CA008759] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094586, P41GM103393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011332] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants R21DC011332 (to S. K.) and U54 GM094586 from the NIGMS Protein Structure Initiative (to the Joint Center for Structural Genomics). This work was carried out as part of the Protein Structure Initiative Biology Community Nominated Targets program.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boonen M, 2009, MOL BIOL CELL, V20, P4381, DOI 10.1091/mbc.E09-05-0398; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; Cormier Catherine Y., 2011, Journal of Structural and Functional Genomics, V12, P55, DOI 10.1007/s10969-011-9100-8; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Do H, 2002, J BIOL CHEM, V277, P29737, DOI 10.1074/jbc.M202369200; Elsliger MA, 2010, ACTA CRYSTALLOGR F, V66, P1137, DOI 10.1107/S1744309110038212; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Kang C, 2010, NEW ENGL J MED, V362, P677, DOI 10.1056/NEJMoa0902630; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kleywegt GJ, 2000, ACTA CRYSTALLOGR D, V56, P249, DOI 10.1107/S0907444999016364; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Kornfeld R, 1999, J BIOL CHEM, V274, P32778, DOI 10.1074/jbc.274.46.32778; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Lee WS, 2011, J BIOL CHEM, V286, P39786, DOI 10.1074/jbc.M111.295899; LELOIR LF, 1957, METHOD ENZYMOL, V3, P840, DOI 10.1016/S0076-6879(57)03459-X; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; MULLIS KG, 1992, ANAL BIOCHEM, V205, P200, DOI 10.1016/0003-2697(92)90424-6; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Rohrer J, 2001, MOL BIOL CELL, V12, P1623, DOI 10.1091/mbc.12.6.1623; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Santarsiero BD, 2002, J APPL CRYSTALLOGR, V35, P278, DOI 10.1107/S0021889802001474; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Swartley JS, 1998, J BACTERIOL, V180, P1533, DOI 10.1128/JB.180.6.1533-1539.1998; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tzeng YL, 2003, INFECT IMMUN, V71, P6712, DOI 10.1128/IAI.71.12.6712-6720.2003; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; VARKI A, 1981, J BIOL CHEM, V256, P9937; VARKI A, 1983, ARCH BIOCHEM BIOPHYS, V222, P145, DOI 10.1016/0003-9861(83)90511-8; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wei YQ, 2005, GLYCOCONJUGATE J, V22, P13, DOI 10.1007/s10719-005-0846-8; Weiss MS, 1997, J APPL CRYSTALLOGR, V30, P203, DOI 10.1107/S0021889897003907; Weiss MS, 1998, FEBS LETT, V423, P291, DOI 10.1016/S0014-5793(98)00098-2; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	58	6	7	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16789	16799		10.1074/jbc.M112.434977	http://dx.doi.org/10.1074/jbc.M112.434977			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23572527	Green Published, hybrid			2022-12-28	WOS:000320378900052
J	Sasaki, H; Toda, T; Furukawa, T; Mawatari, Y; Takaesu, R; Shimizu, M; Wada, R; Kato, D; Utsugi, T; Ohtsu, M; Murakami, Y				Sasaki, Hitoshi; Toda, Takanori; Furukawa, Toru; Mawatari, Yuki; Takaesu, Rika; Shimizu, Masashi; Wada, Ryohei; Kato, Dai; Utsugi, Takahiko; Ohtsu, Masaya; Murakami, Yasufumi			alpha-1,6-Fucosyltransferase (FUT8) Inhibits Hemoglobin Production during Differentiation of Murine and K562 Human Erythroleukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; MOUSE EMBRYOS LACKING; CDNA CLONE SET; ERYTHROID-DIFFERENTIATION; ERYTHROPOIETIN RECEPTOR; GENE-EXPRESSION; HEMATOPOIETIC-CELLS; INITIAL ANNOTATION; DOWN-REGULATION; DEFICIENT MICE	Erythropoiesis results from a complex combination of the expression of several transcription factor genes and cytokine signaling. However, the overall view of erythroid differentiation remains unclear. First, we screened for erythroid differentiation- related genes by comparing the expression profiles of high differentiation-inducible and low differentiation-inducible murine erythroleukemia cells. We identified that overexpression of alpha-1,6-fucosyltransferase (Fut8) inhibits hemoglobin production. FUT8 catalyzes the transfer of a fucose residue to N-linked oligosaccharides on glycoproteins via an alpha-1,6 linkage, leading to core fucosylation in mammals. Expression of Fut8 was down-regulated during chemically induced differentiation of murine erythroleukemia cells. Additionally, expression of Fut8 was positively regulated by c-Myc and c-Myb, which are known as suppressors of erythroid differentiation. Second, we found that FUT8 is the only fucosyltransferase family member that inhibits hemoglobin production. Functional analysis of FUT8 revealed that the donor substrate-binding domain and a flexible loop play essential roles in inhibition of hemoglobin production. This result clearly demonstrates that core fucosylation inhibits hemoglobin production. Third, FUT8 also inhibited hemoglobin production of human erythroleukemia K562 cells. Finally, a short hairpin RNA study showed that FUT8 down-regulation induced hemoglobin production and increase of transferrin receptor/ glycophorin A-positive cells in human erythroleukemia K562 cells. Our findings define FUT8 as a novel factor for hemoglobin production and demonstrate that core fucosylation plays an important role in erythroid differentiation.	[Sasaki, Hitoshi; Toda, Takanori; Furukawa, Toru; Mawatari, Yuki; Takaesu, Rika; Shimizu, Masashi; Wada, Ryohei; Kato, Dai; Ohtsu, Masaya; Murakami, Yasufumi] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Tokyo 1258585, Japan; [Sasaki, Hitoshi; Toda, Takanori; Furukawa, Toru; Mawatari, Yuki; Takaesu, Rika; Shimizu, Masashi; Wada, Ryohei; Utsugi, Takahiko; Murakami, Yasufumi] Tokyo Univ Sci, Genome & Drug Res Ctr, Chiba 2700101, Japan; [Utsugi, Takahiko; Murakami, Yasufumi] Bio Matrix Res Inc, Chiba 2700101, Japan	Tokyo University of Science; Tokyo University of Science	Murakami, Y (corresponding author), Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Katsushika Ku, 3-1,Niijyuku 6 Chome, Tokyo 1258585, Japan.	yasufumi@rs.noda.tus.ac.jp	Furukawa, Toru/AAF-5596-2021	Furukawa, Toru/0000-0002-1083-2324	Bio Matrix Research Inc.	Bio Matrix Research Inc.	This work was supported by Bio Matrix Research Inc.	ANDERSSON LC, 1979, NATURE, V278, P364, DOI 10.1038/278364a0; Athanasiou M, 2000, LEUKEMIA, V14, P439, DOI 10.1038/sj.leu.2401689; Athanasiou M, 1996, CELL GROWTH DIFFER, V7, P1525; Bany-Laszewicz U, 2004, CELL MOL BIOL LETT, V9, P145; Bartunek P, 2003, ONCOGENE, V22, P1927, DOI 10.1038/sj.onc.1206281; BENDAVID Y, 1990, P NATL ACAD SCI USA, V87, P1332, DOI 10.1073/pnas.87.4.1332; BURGER PE, 1994, BLOOD, V83, P1808; Di Pietro R, 2007, J CELL BIOCHEM, V100, P1070, DOI 10.1002/jcb.21106; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; FUJITA H, 1991, J BIOL CHEM, V266, P17494; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; FUKUDA Y, 1994, BLOOD, V83, P1662; Ghaffari S, 2001, BLOOD, V98, P2948, DOI 10.1182/blood.V98.10.2948; Ihara H, 2007, GLYCOBIOLOGY, V17, P455, DOI 10.1093/glycob/cwl079; IKAWA Y, 1976, GANN, V67, P767; Jayapal S, 2010, J BIOL CHEM, V285, P40252, DOI 10.1074/jbc.M110.181073; Kaneko K, 2009, FEBS J, V276, P1370, DOI 10.1111/j.1742-4658.2009.06878.x; KANEKOISHINO T, 1988, MOL CELL BIOL, V8, P5545, DOI 10.1128/MCB.8.12.5545; Kargul GJ, 2001, NAT GENET, V28, P17, DOI 10.1038/ng0501-17; Kieran MW, 1996, P NATL ACAD SCI USA, V93, P9126, DOI 10.1073/pnas.93.17.9126; Kumar MS, 2011, BLOOD, V118, P4666, DOI 10.1182/blood-2010-12-324715; LACHMAN HM, 1984, NATURE, V310, P592, DOI 10.1038/310592a0; Li W, 2008, GLYCOBIOLOGY, V18, P114, DOI 10.1093/glycob/cwm107; Lin CS, 1996, GENE DEV, V10, P154, DOI 10.1101/gad.10.2.154; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Ma B, 2006, GLYCOBIOLOGY, V16, p158R, DOI 10.1093/glycob/cwl040; MARKS PA, 1987, ANN NY ACAD SCI, V511, P246, DOI 10.1111/j.1749-6632.1987.tb36252.x; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ney PA, 2000, BLOOD, V96, P3675, DOI 10.1182/blood.V96.12.3675.h8003675_3675_3680; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pang CJ, 2012, MOL CELL BIOL, V32, P2628, DOI 10.1128/MCB.00104-12; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; RUTHERFORD T, 1981, P NATL ACAD SCI-BIOL, V78, P348, DOI 10.1073/pnas.78.1.348; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Siatecka M, 2011, BLOOD, V118, P2044, DOI 10.1182/blood-2011-03-331371; Starck J, 2003, MOL CELL BIOL, V23, P1390, DOI 10.1128/MCB.23.4.1390-1402.2003; Takahashi T, 2000, GLYCOBIOLOGY, V10, P503, DOI 10.1093/glycob/10.5.503; Tanaka TS, 2000, P NATL ACAD SCI USA, V97, P9127, DOI 10.1073/pnas.97.16.9127; TODOKORO K, 1988, P NATL ACAD SCI USA, V85, P8900, DOI 10.1073/pnas.85.23.8900; VanBuren V, 2002, GENOME RES, V12, P1999, DOI 10.1101/gr.633802; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Wojda U, 2002, BLOOD, V99, P3005, DOI 10.1182/blood.V99.8.3005.h8003005_3005_3013; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yamaguchi Y, 2000, GLYCOBIOLOGY, V10, P637, DOI 10.1093/glycob/10.6.637; YOSHIDA M, 1987, CANCER RES, V47, P3688; Zhao W, 2006, BLOOD, V107, P907, DOI 10.1182/blood-2005-06-2516	52	11	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16839	16847		10.1074/jbc.M113.459594	http://dx.doi.org/10.1074/jbc.M113.459594			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23609441	Green Published, hybrid			2022-12-28	WOS:000320378900056
J	Canto, I; Trejo, J				Canto, Isabel; Trejo, JoAnn			Palmitoylation of Protease-activated Receptor-1 Regulates Adaptor Protein Complex-2 and-3 Interaction with Tyrosine-based Motifs and Endocytic Sorting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBIN-RECEPTOR; CYTOPLASMIC TAIL; BETA-ARRESTINS; INTERNALIZATION; TRAFFICKING; PAR1; PHOSPHORYLATION; DESENSITIZATION; TERMINATION; ACYLATION	Protease-activated receptor-1 (PAR1) is a G protein-coupled receptor for the coagulant protease thrombin. Thrombin binds to and cleaves the N terminus of PAR1, generating a new N terminus that functions as a tethered ligand that cannot diffuse away. In addition to rapid desensitization, PAR1 trafficking is critical for the regulation of cellular responses. PAR1 displays constitutive and agonist-induced internalization. Constitutive internalization of unactivated PAR1 is mediated by the clathrin adaptor protein complex-2 (AP-2), which binds to a distal tyrosine-based motif localized within the C-terminal tail (C-tail) domain. Once internalized, PAR1 is sorted from endosomes to lysosomes via AP-3 interaction with a second C-tail tyrosine motif proximal to the transmembrane domain. However, the regulatory processes that control adaptor protein recognition of PAR1 C-tail tyrosine-based motifs are not known. Here, we report that palmitoylation of PAR1 is critical for regulating proper utilization of tyrosine-based motifs and endocytic sorting. We show that PAR1 is basally palmitoylated at highly conserved C-tail cysteines. A palmitoylation-deficient PAR1 mutant is competent to signal and exhibits a marked increase in constitutive internalization and lysosomal degradation compared with wild type receptor. Intriguingly, enhanced constitutive internalization of PAR1 is mediated by AP-2 and requires the proximal tyrosine-based motif rather than the distal tyrosine motif used by wild type receptor. Moreover, palmitoylation-deficient PAR1 displays increased degradation that is mediated by AP-3. These findings suggest that palmitoylation of PAR1 regulates appropriate utilization of tyrosine-based motifs by adaptor proteins and endocytic trafficking, processes that are critical for maintaining appropriate expression of PAR1 at the cell surface.	[Canto, Isabel] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Trejo, JoAnn] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Trejo, J (corresponding author), 9500 Gilman Dr,BSB Rm 3044A, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu		TREJO, JOANN/0000-0003-4405-6228	National Institutes of Health [GM090689]; University of California Tobacco-related Disease Research Program Dissertation Award [21DT-0096]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM090689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Tobacco-related Disease Research Program Dissertation Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM090689 (to J. T.).; Supported by an University of California Tobacco-related Disease Research Program Dissertation Award 21DT-0096.	Adams MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028018; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Booden MA, 2004, MOL CELL BIOL, V24, P1990, DOI 10.1128/MCB.24.5.1990-1999.2004; Botham A, 2011, BIOCHEM J, V438, P359, DOI 10.1042/BJ20101958; Chen B, 2011, J BIOL CHEM, V286, P40760, DOI 10.1074/jbc.M111.299776; Chen CH, 2004, J BIOL CHEM, V279, P10020, DOI 10.1074/jbc.M310590200; CHEN J, 1994, J BIOL CHEM, V269, P16041; Chini B, 2009, J MOL ENDOCRINOL, V42, P371, DOI 10.1677/JME-08-0114; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dores MR, 2012, MOL BIOL CELL, V23, P3612, DOI 10.1091/mbc.E12-03-0251; Dores MR, 2012, J CELL BIOL, V197, P407, DOI 10.1083/jcb.201110031; Dowal L, 2011, P NATL ACAD SCI USA, V108, P2951, DOI 10.1073/pnas.1014863108; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Fukushima Y, 2001, BBA-MOL CELL RES, V1539, P181, DOI 10.1016/S0167-4889(01)00104-5; Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259; Hayashi MK, 1997, ARCH BIOCHEM BIOPHYS, V340, P376, DOI 10.1006/abbi.1997.9906; HEIN L, 1994, J BIOL CHEM, V269, P27719; Holliday ND, 2003, BRIT J PHARMACOL, V139, P501, DOI 10.1038/sj.bjp.0705276; Iwanaga T, 2009, PROG LIPID RES, V48, P117, DOI 10.1016/j.plipres.2009.02.001; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kvachnina E, 2009, BBA-MOL CELL RES, V1793, P1646, DOI 10.1016/j.bbamcr.2009.08.008; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; MOFFETT S, 1993, EMBO J, V12, P349, DOI 10.1002/j.1460-2075.1993.tb05663.x; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Okamoto Y, 1997, J BIOL CHEM, V272, P21589, DOI 10.1074/jbc.272.34.21589; OVCHINNIKOV YA, 1988, FEBS LETT, V230, P1, DOI 10.1016/0014-5793(88)80628-8; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Papoucheva E, 2004, J BIOL CHEM, V279, P3280, DOI 10.1074/jbc.M308177200; Parent JL, 2001, J BIOL CHEM, V276, P7079, DOI 10.1074/jbc.M009375200; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; Percherancier Y, 2001, J BIOL CHEM, V276, P31936, DOI 10.1074/jbc.M104013200; Pizard A, 2001, BIOCHEMISTRY-US, V40, P15743, DOI 10.1021/bi011600t; Ponimaskin EG, 2002, J BIOL CHEM, V277, P2534, DOI 10.1074/jbc.M106529200; Reid HM, 2007, CELL SIGNAL, V19, P1056, DOI 10.1016/j.cellsig.2006.12.001; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; Soto AG, 2010, J BIOL CHEM, V285, P18781, DOI 10.1074/jbc.M110.111088; Sun BM, 2004, MOL BIOL CELL, V15, P1397, DOI 10.1091/mbc.E03-09-0682; Swift S, 2006, J BIOL CHEM, V281, P4109, DOI 10.1074/jbc.M509525200; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; Trejo J, 2000, J BIOL CHEM, V275, P31255, DOI 10.1074/jbc.M003770200; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Zuckerman DM, 2011, J BIOL CHEM, V286, P19014, DOI 10.1074/jbc.M110.189977	54	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15900	15912		10.1074/jbc.M113.469866	http://dx.doi.org/10.1074/jbc.M113.469866			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23580642	Green Published, hybrid			2022-12-28	WOS:000319822300043
J	Hong, XX; Carmichael, GG				Hong, Xiao-Xiao; Carmichael, Gordon G.			Innate Immunity in Pluripotent Human Cells ATTENUATED RESPONSE TO INTERFERON-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; PROTEIN-TYROSINE-PHOSPHATASE; ALPHA-INDUCED APOPTOSIS; CYTOKINE SIGNALING-1; PROMOTES SURVIVAL; MESSENGER-RNAS; SELF-RENEWAL; KAPPA-B; ACTIVATION; STAT3	Type I interferon (IFN-alpha/beta) binds to cell surface receptors IFNAR1 and IFNAR2 and triggers a signaling cascade that leads to the transcription of hundreds of IFN-stimulated genes. This response is a crucial component in innate immunity in that it establishes an "antiviral state" in cells and protects them against further damage. Previous work demonstrated that, compared with their differentiated counterparts, pluripotent human cells have a much weaker response to cytoplasmic double-stranded RNA(dsRNA) and are only able to produce a minimal amount of IFN-beta. Weshow here that human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) also exhibit an attenuated response to IFN-beta. Even though all known type I IFN signaling components are expressed in these cells, STAT1 phosphorylation is greatly diminished upon IFN-beta treatment. This attenuated response correlates with a high expression of suppressor of cytokine signaling 1 (SOCS1). Upon differentiation of hESCs into trophoblasts, cells acquire the ability to respond to IFN-beta, and this is accompanied by a significant induction of STAT1 phosphorylation as well as a decrease in SOCS1 expression. Furthermore, SOCS1 knockdown in hiPSCs enhances their ability to respond to IFN-beta. Taken together, our results suggest that an attenuated cellular response to type I IFNs may be a general feature of pluripotent human cells and that this is associated with high expression of SOCS1.	[Hong, Xiao-Xiao; Carmichael, Gordon G.] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA	University of Connecticut	Carmichael, GG (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, 400 Farmington Ave, Farmington, CT 06030 USA.	carmichael@nso2.uchc.edu			State of Connecticut under the Connecticut Stem Cell Research Grants Program	State of Connecticut under the Connecticut Stem Cell Research Grants Program	This work was supported by an Established Investigator award from the State of Connecticut under the Connecticut Stem Cell Research Grants Program (to G. G. C.).	Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Babon JJ, 2008, J MOL BIOL, V381, P928, DOI 10.1016/j.jmb.2008.06.038; Barca O, 2003, J NEUROIMMUNOL, V139, P155, DOI 10.1016/S0165-5728(03)00160-7; Brysha M, 2001, J BIOL CHEM, V276, P22086, DOI 10.1074/jbc.M102737200; Chen LL, 2010, CELL CYCLE, V9, P3552, DOI 10.4161/cc.9.17.12792; Chen LL, 2009, MOL CELL, V35, P467, DOI 10.1016/j.molcel.2009.06.027; Chin YE, 1997, MOL CELL BIOL, V17, P5328, DOI 10.1128/MCB.17.9.5328; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Dumitru R, 2012, MOL CELL, V46, P573, DOI 10.1016/j.molcel.2012.04.002; Fujimoto M, 2003, TRENDS IMMUNOL, V24, P659, DOI 10.1016/j.it.2003.10.008; Gao SM, 2013, EXP HEMATOL, V41, P261, DOI 10.1016/j.exphem.2012.10.012; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Ilangumaran S, 2004, SEMIN IMMUNOL, V16, P351, DOI 10.1016/j.smim.2004.08.015; Ilangumaran S, 2002, J IMMUNOL, V169, P5010, DOI 10.4049/jimmunol.169.9.5010; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Li YZ, 2005, J BIOL CHEM, V280, P10001, DOI 10.1074/jbc.M410972200; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Ma Y., 2012, CURR PROTOC STEM CEL; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 1996, J BIOL CHEM, V271, P278, DOI 10.1074/jbc.271.1.278; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Ruuth K, 2001, BIOCHEM BIOPH RES CO, V284, P583, DOI 10.1006/bbrc.2001.5025; Shultz LD, 1997, TRENDS BIOTECHNOL, V15, P302, DOI 10.1016/S0167-7799(97)01060-3; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Sironi JJ, 2004, J BIOL CHEM, V279, P4066, DOI 10.1074/jbc.M307774200; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Svoboda P, 2000, DEVELOPMENT, V127, P4147; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thyrell L, 2004, J BIOL CHEM, V279, P24152, DOI 10.1074/jbc.M312219200; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; UDDIN S, 1995, J BIOL CHEM, V270, P15938, DOI 10.1074/jbc.270.27.15938; Uddin S, 2000, BIOCHEM BIOPH RES CO, V270, P158, DOI 10.1006/bbrc.2000.2402; Wang YJ, 2000, MOL CELL BIOL, V20, P4505, DOI 10.1128/MCB.20.13.4505-4512.2000; WHYATT LM, 1993, MOL CELL BIOL, V13, P7971, DOI 10.1128/MCB.13.12.7971; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yang CL, 2001, J BIOL CHEM, V276, P47277, DOI 10.1074/jbc.M105396200; Yang L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r16; Zeng H, 2009, STEM CELLS, V27, P2435, DOI 10.1002/stem.192; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223	50	45	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16196	16205		10.1074/jbc.M112.435461	http://dx.doi.org/10.1074/jbc.M112.435461			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23599426	Green Published, hybrid			2022-12-28	WOS:000319822300070
J	Ravindran, S; Snee, PT; Ramachandran, A; George, A				Ravindran, Sriram; Snee, Preston T.; Ramachandran, Amsaveni; George, Anne			Acidic Domain in Dentin Phosphophoryn Facilitates Cellular Uptake IMPLICATIONS IN TARGETED PROTEIN DELIVERY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; SIALOPHOSPHOPROTEIN DSPP; MATRIX PROTEINS; GENE-EXPRESSION; TAT PROTEIN; ENDOCYTOSIS; PHOSPHORYLATION; SIALOPROTEIN; TRANSDUCTION; DISORDERS	Dentin phosphophoryn is nature's most acidic protein found predominantly in the dentin extracellular matrix. Its unique amino acid composition containing Asp-Ser (DS)-rich repeats makes it highly anionic. It has a low isoelectric point (pI 1.1) and, therefore, tends to be negatively charged at physiological pH. Phosphophoryn is normally associated with matrix mineralization as it can bind avidly to Ca2(+). It is well known that several macromolecules present in the extracellular matrix can be internalized and localized to specific intracellular compartments. In this study we demonstrate that dentin phosphophoryn (DPP) is internalized by several cell types via a non-conventional endocytic process. Utilizing a DSS polypeptide derived from DPP, we demonstrate the repetitive DSS-rich domain facilitates that endocytosis. As a proof-of-concept, we further demonstrate the use of this polypeptide as a protein delivery vehicle by delivering the osteoblast transcription factor Runx2 to the nucleus of mesenchymal cells. The functionality of the endocytosed Runx2 protein was demonstrated by performing gene expression analysis of Runx2 target genes. Nuclear localization was also demonstrated with the fusion protein DSS-Runx2 conjugated to quantum dots in two-and three-dimensional culture models in vitro and in vivo. Overall, we demonstrate that the DSS domain of DPP functions as a novel cell-penetrating peptide, and these findings demonstrate new opportunities for intracellular delivery of therapeutic proteins and cell tracking in vivo.	[Ravindran, Sriram; Ramachandran, Amsaveni; George, Anne] Univ Illinois, Dept Oral Biol, Brodie Tooth Dev Genet & Regenerat Med Res Lab, Chicago, IL 60612 USA; [Snee, Preston T.] Univ Illinois, Dept Chem, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	George, A (corresponding author), Univ Illinois, Dept Oral Biol, Brodie Tooth Dev Genet & Regenerat Med Res Lab, Chicago, IL 60612 USA.	anneg@uic.edu		Snee, Preston/0000-0002-6544-6826; GEORGE, ANNE/0000-0002-9008-7642	National Institutes of Health [DE 19633]; Brodie Endowment Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brodie Endowment Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE 19633. This work was also supported by the Brodie Endowment Fund.	ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; Delehanty JB, 2010, THER DELIV, V1, P411, DOI 10.4155/TDE.10.27; Eapen A, 2012, J BIOL CHEM, V287, P5211, DOI 10.1074/jbc.M111.290080; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; George A, 1999, CONNECT TISSUE RES, V40, P49, DOI 10.3109/03008209909005277; George A, 1996, J BIOL CHEM, V271, P32869, DOI 10.1074/jbc.271.51.32869; Hao JJ, 2004, BONE, V34, P921, DOI 10.1016/j.bone.2004.01.020; Hart PS, 2007, CELLS TISSUES ORGANS, V186, P70, DOI 10.1159/000102682; He G, 2005, J BIOL CHEM, V280, P33109, DOI 10.1074/jbc.M500159200; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; Jadlowiec J, 2004, J BIOL CHEM, V279, P53323, DOI 10.1074/jbc.M404934200; Jadlowiec JA, 2006, J BIOL CHEM, V281, P5341, DOI 10.1074/jbc.M506158200; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; MacDougall M, 1997, CYTOGENET CELL GENET, V79, P121, DOI 10.1159/000134697; MacDougall M, 2006, AM J MED GENET A, V140A, P2536, DOI 10.1002/ajmg.a.31359; MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Norkin LC, 2002, J VIROL, V76, P5156, DOI 10.1128/JVI.76.10.5156-5166.2002; Ravindran S, 2008, J BIOL CHEM, V283, P29658, DOI 10.1074/jbc.M800786200; Ravindran S, 2012, TISSUE ENG PT A, V18, P295, DOI [10.1089/ten.tea.2011.0136, 10.1089/ten.TEA.2011.0136]; SABSAY B, 1991, BIOCHEM J, V276, P699, DOI 10.1042/bj2760699; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; SFEIR C, 1995, J BONE MINER RES, V10, P607; Shen HY, 2009, ACS NANO, V3, P915, DOI 10.1021/nn800870r; Song YL, 2008, J MED GENET, V45, P457, DOI 10.1136/jmg.2007.056911; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; STETLERSTEVENSON WG, 1983, BIOCHEMISTRY-US, V22, P4326, DOI 10.1021/bi00287a025; Thotakura SR, 2000, J DENT RES, V79, P835, DOI 10.1177/00220345000790030901; VEIS A, 1988, CIBA F SYMP, V136, P161; Veis A, 1998, EUR J ORAL SCI, V106, P234, DOI 10.1111/j.1600-0722.1998.tb02181.x; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Yamakoshi Y, 2005, J BIOL CHEM, V280, P17472, DOI 10.1074/jbc.M413220200; Yamakoshi Y, 2008, J BIOL CHEM, V283, P14835, DOI 10.1074/jbc.M800633200; Yamakoshi Y, 2006, J BIOL CHEM, V281, P38235, DOI 10.1074/jbc.M607767200; Zhang X, 2011, CHEM COMMUN, V47, P3532, DOI 10.1039/c0cc04549g	38	22	23	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16098	16109		10.1074/jbc.M113.450585	http://dx.doi.org/10.1074/jbc.M113.450585			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23589294	Green Published, hybrid			2022-12-28	WOS:000319822300060
J	Than, A; Leow, MKS; Chen, P				Than, Aung; Leow, Melvin Khee-Shing; Chen, Peng			Control of Adipogenesis by the Autocrine Interplays between Angiotensin 1-7/Mas Receptor and Angiotensin II/AT(1) Receptor Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPROVES INSULIN-RESISTANCE; MITOTIC CLONAL EXPANSION; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; IN-VITRO; HUMAN PREADIPOCYTES; MOUSE ADIPOCYTES; GENE-EXPRESSION; GLUCOSE-UPTAKE; II RECEPTORS	Angiotensin II (AngII), a peptide hormone released by adipocytes, can be catabolized by adipose angiotensin-converting enzyme 2 (ACE2) to form Ang(1-7). Co-expression of AngII receptors (AT(1) and AT(2)) and Ang(1-7) receptors (Mas) in adipocytes implies the autocrine regulation of the local angiotensin system upon adipocyte functions, through yet unknown interactive mechanisms. In the present study, we reveal the adipogenic effects of Ang(1-7) through activation of Mas receptor and its subtle interplays with the antiadipogenic AngII-AT(1) signaling pathways. Specifically, in human and 3T3-L1 preadipocytes, Ang(1-7)-Mas signaling promotes adipogenesis via activation of PI3K/Akt and inhibition of MAPK kinase/ERK pathways, and Ang(1-7)-Mas antagonizes the antiadipogenic effect of AngII-AT(1) by inhibiting the AngII-AT(1)-triggered MAPK kinase/ERK pathway. The autocrine regulation of the AngII/AT(1)-ACE2Ang( 1-7)/Mas axis upon adipogenesis has also been revealed. This study suggests the importance of the local regulation of the delicately balanced angiotensin system upon adipogenesis and its potential as a novel therapeutic target for obesity and related metabolic disorders.	[Than, Aung; Chen, Peng] Nanyang Technol Univ, Div Bioengn, Singapore 637457, Singapore; [Leow, Melvin Khee-Shing] Brenner Ctr Mol Med, Singapore Inst Clin Sci, Singapore 117609, Singapore; [Leow, Melvin Khee-Shing] Endocrine & Diabet Tan Tock Seng Hosp, Singapore 308433, Singapore; [Leow, Melvin Khee-Shing] Duke NUS Grad Med Sch, Singapore 169857, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Tan Tock Seng Hospital; National University of Singapore	Chen, P (corresponding author), Nanyang Technol Univ, Div Bioengn, 70 Nanyang Dr, Singapore 637457, Singapore.	chenpeng@ntu.edu.sg	Leow, Melvin/H-3129-2019; Chen, Peng/G-6202-2010; Leow, Melvin/AAJ-1168-2020	Leow, Melvin/0000-0002-2837-5889; Chen, Peng/0000-0003-3730-1846; aung, than/0000-0003-1558-7310	Singapore Ministry of Health National Medical Research Council under EDG grant [NMRC/EDG/1048/2011]	Singapore Ministry of Health National Medical Research Council under EDG grant(Ministry of Health-SingaporeNational Medical Research Council, Singapore)	This work was supported by the Singapore Ministry of Health National Medical Research Council under its EDG grant (NMRC/EDG/1048/2011).	Adams M, 1997, J CLIN INVEST, V100, P3149, DOI 10.1172/JCI119870; Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Attie AD, 2009, J LIPID RES, V50, pS395, DOI 10.1194/jlr.R800057-JLR200; BLANKLEY CJ, 1991, J MED CHEM, V34, P3248, DOI 10.1021/jm00115a014; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Brucher R, 2007, OBESITY, V15, P1643, DOI 10.1038/oby.2007.196; Cassis LA, 2008, CURR HYPERTENS REP, V10, P93, DOI 10.1007/s11906-008-0019-9; Clarke NE, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/307315; Cleland SJ, 1996, HEART, V76, P7, DOI 10.1136/hrt.76.3_Suppl_3.7; Dal Rhee S, 2008, MOL CELL ENDOCRINOL, V294, P61, DOI 10.1016/j.mce.2008.08.018; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; Dang ZC, 2004, J CELL BIOCHEM, V92, P525, DOI 10.1002/jcb.20087; de Castro CH, 2005, HYPERTENSION, V46, P937, DOI 10.1161/01.HYP.0000175813.04375.8a; de Kloet AD, 2010, PHYSIOL BEHAV, V100, P525, DOI 10.1016/j.physbeh.2010.03.018; Dinh DT, 2001, CLIN SCI, V100, P481, DOI 10.1042/CS20000263; Engeli S, 1999, J HYPERTENS, V17, P555, DOI 10.1097/00004872-199917040-00014; Engeli S, 2000, HYPERTENSION, V35, P1270, DOI 10.1161/01.HYP.35.6.1270; Freedland Eric S, 2004, Nutr Metab (Lond), V1, P12, DOI 10.1186/1743-7075-1-12; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; Fruhbeck G, 1997, BIOCHEM BIOPH RES CO, V240, P590, DOI 10.1006/bbrc.1997.7716; Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200; Fuentes P, 2010, J ENDOCRINOL, V206, P75, DOI 10.1677/JOE-10-0049; Fujimoto M, 2004, FEBS LETT, V576, P492, DOI 10.1016/j.febslet.2004.09.027; Giani JF, 2007, AM J PHYSIOL-HEART C, V293, pH1154, DOI 10.1152/ajpheart.01395.2006; Giani JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE262, DOI 10.1152/ajpendo.90678.2008; Goossens GH, 2007, INT J OBESITY, V31, P382, DOI 10.1038/sj.ijo.0803388; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Guerre-Millo M, 2004, DIABETES METAB, V30, P13, DOI 10.1016/S1262-3636(07)70084-8; Gupte M, 2008, AM J PHYSIOL-REG I, V295, pR781, DOI 10.1152/ajpregu.00183.2008; Hashimoto T, 2009, J LIPID RES, V50, P602, DOI 10.1194/jlr.M800206-JLR200; He HB, 2010, HYPERTENSION, V55, P869, DOI 10.1161/HYPERTENSIONAHA.109.143958; Heffelfinger SC, 2007, CURR PHARM DESIGN, V13, P1215, DOI 10.2174/138161207780618858; Hemmrich K, 2005, DIFFERENTIATION, V73, P28, DOI 10.1111/j.1432-0436.2005.07301003.x; Henriksen EJ, 2001, HYPERTENSION, V38, P884, DOI 10.1161/hy1101.092970; Santos SHS, 2008, DIABETES, V57, P340, DOI 10.2337/db07-0953; Hung WW, 2011, CARDIOVASC DRUG THER, V25, P3, DOI 10.1007/s10557-010-6274-4; Hutley L, 2004, DIABETES, V53, P3097, DOI 10.2337/diabetes.53.12.3097; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Janke J, 2002, DIABETES, V51, P1699, DOI 10.2337/diabetes.51.6.1699; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Kakuma T, 2010, OBES RES CLIN PRACT, V4, pE145, DOI 10.1016/j.orcp.2009.12.003; Kalupahana NS, 2012, OBES REV, V13, P136, DOI 10.1111/j.1467-789X.2011.00942.x; Kalupahana NS, 2012, CRIT REV BIOCHEM MOL, V47, P379, DOI 10.3109/10409238.2012.694843; Karastergiou K, 2010, MOL CELL ENDOCRINOL, V318, P69, DOI 10.1016/j.mce.2009.11.011; Kramer BK, 1998, J CARDIOVASC PHARM, V31, P700, DOI 10.1097/00005344-199805000-00008; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Kurata A, 2006, KIDNEY INT, V70, P1717, DOI 10.1038/sj.ki.5001810; Laplante M, 2006, DIABETES, V55, P2771, DOI 10.2337/db06-0551; Lebovitz HE, 2005, DIABETES CARE, V28, P2322, DOI 10.2337/diacare.28.9.2322; Liu C, 2012, ACTA DIABETOL, V49, P291, DOI 10.1007/s00592-011-0348-z; Lowell BB, 1999, CELL, V99, P239, DOI 10.1016/S0092-8674(00)81654-2; Mallow H, 2000, HORM METAB RES, V32, P500, DOI 10.1055/s-2007-978676; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Oh YB, 2012, PEPTIDES, V37, P79, DOI 10.1016/j.peptides.2012.06.005; Olivares-Reyes JA, 2009, MOL CELL ENDOCRINOL, V302, P128, DOI 10.1016/j.mce.2008.12.011; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Peckett AJ, 2011, METABOLISM, V60, P1500, DOI 10.1016/j.metabol.2011.06.012; Poulos SP, 2010, EXP BIOL MED, V235, P1185, DOI 10.1258/ebm.2010.010063; Qiao LP, 2011, DIABETES, V60, P1519, DOI 10.2337/db10-1017; Qiu ZL, 2001, J BIOL CHEM, V276, P11988, DOI 10.1074/jbc.M011729200; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Ramracheya RD, 2006, DIABETOLOGIA, V49, P321, DOI 10.1007/s00125-005-0101-7; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; ROWE BP, 1995, REGUL PEPTIDES, V56, P139, DOI 10.1016/0167-0115(95)00010-9; Sakaue H, 1998, J BIOL CHEM, V273, P28945, DOI 10.1074/jbc.273.44.28945; Sampaio WO, 2007, HYPERTENSION, V49, P185, DOI 10.1161/01.HYP.0000251865.35728.2f; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; SANTOS RAS, 1994, BRAIN RES BULL, V35, P293, DOI 10.1016/0361-9230(94)90104-X; Santos RAS, 2013, J ENDOCRINOL, V216, pR1, DOI 10.1530/JOE-12-0341; Santos SHS, 2010, ARTERIOSCL THROM VAS, V30, P953, DOI 10.1161/ATVBAHA.109.200493; Sarzani R, 2008, INT J OBESITY, V32, P259, DOI 10.1038/sj.ijo.0803724; Schling P, 2002, NEWS PHYSIOL SCI, V17, P99, DOI 10.1152/nips.01349.2001; Schling P, 1999, INT J OBESITY, V23, P336, DOI 10.1038/sj.ijo.0800821; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Than A, 2012, MOL CELL ENDOCRINOL, V362, P227, DOI 10.1016/j.mce.2012.07.002; Than A, 2012, MOL CELL ENDOCRINOL, V351, P296, DOI 10.1016/j.mce.2012.01.005; Than A, 2011, MOL CELL ENDOCRINOL, V332, P261, DOI 10.1016/j.mce.2010.11.002; Thatcher S, 2009, MOL CELL ENDOCRINOL, V302, P111, DOI 10.1016/j.mce.2009.01.019; Tomlinson JJ, 2010, MOL ENDOCRINOL, V24, P104, DOI 10.1210/me.2009-0091; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200; Xu L, 2006, BBA-MOL CELL BIOL L, V1761, P434, DOI 10.1016/j.bbalip.2006.03.017; Ye F, 2011, J CELL BIOCHEM, V112, P3002, DOI 10.1002/jcb.23223; Ye F, 2010, J ENDOCRINOL, V206, P27, DOI 10.1677/JOE-10-0090; Zhu SM, 2011, MOL CELL BIOCHEM, V353, P305, DOI 10.1007/s11010-011-0799-0	87	44	46	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15520	15531		10.1074/jbc.M113.459792	http://dx.doi.org/10.1074/jbc.M113.459792			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23592774	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000319822300010
J	Ipenberg, I; Guttmann-Raviv, N; Khoury, HP; Kupershmit, I; Ayoub, N				Ipenberg, Inbal; Guttmann-Raviv, Noga; Khoury, Hanan P.; Kupershmit, Ilana; Ayoub, Nabieh			Heat Shock Protein 90 (Hsp90) Selectively Regulates the Stability of KDM4B/JMJD2B Histone Demethylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE METHYLATION; JMJD2 FAMILY; CHROMATIN; KINASE; CANCER; H3; CARCINOGENESIS; TRIMETHYLATION; PROLIFERATION; MOBILIZATION	The family of KDM4A-D histone demethylases selectively demethylates H3K9 and H3K36 and is implicated in key cellular processes including DNA damage response, transcription, cell cycle regulation, cellular differentiation, senescence, and carcinogenesis. Various human cancers exhibit elevated protein levels of KDM4A-D members, and their depletion impairs tumor formation, suggesting that their enhanced activity promotes carcinogenesis. However, the mechanisms regulating the KDM4 protein stability remain largely unknown. Here, we show that the molecular chaperon Hsp90 interacts with and stabilizes KDM4B protein. Pharmacological inhibition of Hsp90 with geldanamycin resulted in ubiquitin-dependent proteasomal degradation of KDM4B, but not of KDM4C, suggesting that the turnover of these demethylases is regulated by distinct mechanisms. This degradation was accompanied by increased methylation of H3K9. We further show that KDM4B is ubiquitinated on lysines 337 and 562; simultaneous substitution of these residues to arginine suppressed the geldanamycin-induced degradation of KDM4B, suggesting that the ubiquitination of Lys-337 and Lys-562 targets KDM4B for proteasomal degradation upon Hsp90 inhibition. These findings constitute a novel pathway by which Hsp90 activity alters the histone code via regulation of KDM4B stability. This pathway may prove a druggable target for the treatment of tumors driven by enhanced KDM4B activity.	[Ipenberg, Inbal; Guttmann-Raviv, Noga; Khoury, Hanan P.; Kupershmit, Ilana; Ayoub, Nabieh] Technion Israel Inst Technol, Dept Biol, IL-3200003 Haifa, Israel	Technion Israel Institute of Technology	Ayoub, N (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-3200003 Haifa, Israel.	ayoubn@technion.ac.il	Ayoub, Nabieh/AFK-5616-2022; Ayoub, Nabieh/AAG-4076-2022	Ayoub, Nabieh/0000-0002-9549-9929; 	Israel Cancer Research Fund (ICRF); Israel Science Foundation (ISF); Israel Cancer Association (ICA); H. Blechman Memorial Cancer Research Fund; Eliyahu Pen Research Fund	Israel Cancer Research Fund (ICRF); Israel Science Foundation (ISF)(Israel Science Foundation); Israel Cancer Association (ICA); H. Blechman Memorial Cancer Research Fund; Eliyahu Pen Research Fund	This work was supported by grants from the Israel Cancer Research Fund (ICRF), Israel Science Foundation (ISF), Israel Cancer Association (ICA), H. Blechman Memorial Cancer Research Fund, and Eliyahu Pen Research Fund.	Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Ayoub Nabieh, 2009, Curr Biol, V19, P1075, DOI 10.1016/j.cub.2009.05.057; Ayoub N, 2009, CELL CYCLE, V8, P2945; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Citri A, 2004, CELL CYCLE, V3, P51; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Holzbeierlein JM, 2010, CURR ONCOL REP, V12, P95, DOI 10.1007/s11912-010-0086-3; Ishimura A, 2009, BIOCHEM BIOPH RES CO, V389, P366, DOI 10.1016/j.bbrc.2009.08.155; Kawazu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017830; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Koga F, 2006, P NATL ACAD SCI USA, V103, P11318, DOI 10.1073/pnas.0604705103; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Li WJ, 2011, BIOCHEM BIOPH RES CO, V416, P372, DOI 10.1016/j.bbrc.2011.11.045; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Nagata Y, 1999, ONCOGENE, V18, P6037, DOI 10.1038/sj.onc.1202978; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Ruden DM, 2008, CURR GENOMICS, V9, P500, DOI 10.2174/138920208786241207; Sawarkar R, 2013, TRENDS CELL BIOL, V23, P193, DOI 10.1016/j.tcb.2012.11.007; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shin S, 2007, BIOCHEM BIOPH RES CO, V359, P742, DOI 10.1016/j.bbrc.2007.05.179; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Tan MKM, 2011, MOL CELL BIOL, V31, P3687, DOI 10.1128/MCB.05746-11; Tariq M, 2009, P NATL ACAD SCI USA, V106, P1157, DOI 10.1073/pnas.0809669106; Toyokawa G, 2011, CANCER PREV RES, V4, P2051, DOI 10.1158/1940-6207.CAPR-11-0290; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Van Rechem C, 2011, J BIOL CHEM, V286, P30462, DOI 10.1074/jbc.M111.273508; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028	36	24	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14681	14687		10.1074/jbc.C113.462770	http://dx.doi.org/10.1074/jbc.C113.462770			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23589305	hybrid, Green Published			2022-12-28	WOS:000319452100002
J	Kohno, H; Chen, Y; Kevany, BM; Pearlman, E; Miyagi, M; Maeda, T; Palczewski, K; Maeda, A				Kohno, Hideo; Chen, Yu; Kevany, Brian M.; Pearlman, Eric; Miyagi, Masaru; Maeda, Tadao; Palczewski, Krzysztof; Maeda, Akiko			Photoreceptor Proteins Initiate Microglial Activation via Toll-like Receptor 4 in Retinal Degeneration Mediated by All-trans-retinal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACULAR DEGENERATION; OXIDATIVE STRESS; MOUSE RETINA; EXTRACELLULAR HSP70; PIGMENT EPITHELIUM; ENDOGENOUS LIGANDS; APOPTOTIC CELLS; MICE; INFLAMMATION; DISEASE	Although several genetic and biochemical factors are associated with the pathogenesis of retinal degeneration, it has yet to be determined how these different impairments can cause similar degenerative phenotypes. Here, we report microglial/macrophage activation in both a Stargardt disease and age-related macular degeneration mouse model caused by delayed clearance of all-trans-retinal from the retina, and in a retinitis pigmentosa mouse model with impaired retinal pigment epithelium (RPE) phagocytosis. Mouse microglia displayed RPE cytotoxicity and increased production of inflammatory chemokines/cytokines, Ccl2, Il1b, and Tnf, after coincubation with ligands that activate innate immunity. Notably, phagocytosis of photoreceptor proteins increased the activation of microglia/macrophages and RPE cells isolated from model mice as well as wildtype mice. The mRNA levels of Tlr2 and Tlr4, which can recognize proteins as their ligands, were elevated in mice with retinal degeneration. Bone marrow-derived macrophages from Tlr4-deficient mice did not increase Ccl2 after coincubation with photoreceptor proteins. Tlr4(-/-) Abca4(-/-) Rdh8(-/-) mice displayed milder retinal degenerative phenotypes than Abca4(-/-) Rdh8(-/-) mice. Additionally, inactivation of microglia/macrophages by pharmacological approaches attenuated mouse retinal degeneration. This study demonstrates an important contribution of TLR4-mediated microglial activation by endogenous photoreceptor proteins in retinal inflammation that aggravates retinal cell death. This pathway is likely to represent an underlying common pathology in degenerative retinal disorders.	[Kohno, Hideo; Chen, Yu; Kevany, Brian M.; Miyagi, Masaru; Maeda, Tadao; Palczewski, Krzysztof; Maeda, Akiko] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Pearlman, Eric; Miyagi, Masaru; Maeda, Tadao; Maeda, Akiko] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Miyagi, Masaru] Case Western Reserve Univ, Ctr Prote, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Maeda, A (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	aam19@case.edu			National Institutes of Health [EY022658, EY019031, EY019880, EY009339, EY021126, EY11373]; Research to Prevent Blindness Foundation; Foundation Fighting Blindness; Fight for Sight; Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [K08EY019880, R01EY022658, P30EY011373, R24EY021126, R01EY009339, K08EY019031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Foundation Fighting Blindness(European Commission); Fight for Sight; Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY022658, EY019031, EY019880, EY009339, EY021126, and EY11373 and grants from the Research to Prevent Blindness Foundation, Foundation Fighting Blindness, Fight for Sight, and Ohio Lions Eye Research Foundation.	Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Bauer M, 2011, P NATL ACAD SCI USA, V108, P21105, DOI 10.1073/pnas.1111919109; Beltran WA, 2009, INVEST OPHTH VIS SCI, V50, P3985, DOI 10.1167/iovs.08-3364; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; Bruban J, 2011, NEUROBIOL DIS, V42, P55, DOI 10.1016/j.nbd.2011.01.004; Cai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021164; Chen HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002339; Chen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022818; Chen XH, 2011, J NEUROIMMUNOL, V235, P1, DOI 10.1016/j.jneuroim.2011.04.006; Cho YE, 2009, INVEST OPHTH VIS SCI, V50, P5614, DOI 10.1167/iovs.09-3688; Diemer T, 2008, ADV EXP MED BIOL, V613, P321, DOI 10.1007/978-0-387-74904-4_37; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Edwards AO, 2008, INVEST OPHTH VIS SCI, V49, P1652, DOI 10.1167/iovs.07-1378; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Fillpovic R, 2008, EXP NEUROL, V211, P41, DOI 10.1016/j.expneurol.2007.12.024; FISHEL S, 1988, FERTIL STERIL, V49, P108; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gu D, 2009, INVEST OPHTH VIS SCI, V50, P3482, DOI 10.1167/iovs.08-3111; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Haeseleer F, 2002, J BIOL CHEM, V277, P45537, DOI 10.1074/jbc.M208882200; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Ji KA, 2007, GLIA, V55, P1577, DOI 10.1002/glia.20571; Johnson AC, 2008, J BIOL CHEM, V283, P3988, DOI 10.1074/jbc.M707264200; Joly S, 2009, AM J PATHOL, V174, P2310, DOI 10.2353/ajpath.2009.090023; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Kadiyala CSR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015332; Kaur C, 2008, PROG RETIN EYE RES, V27, P622, DOI 10.1016/j.preteyeres.2008.09.003; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kleinman ME, 2012, MOL THER, V20, P101, DOI 10.1038/mt.2011.212; Ko MK, 2011, INVEST OPHTH VIS SCI, V52, P5824, DOI 10.1167/iovs.10-6357; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lavalette S, 2011, AM J PATHOL, V178, P2416, DOI 10.1016/j.ajpath.2011.01.013; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Lichtlen P, 2010, INVEST OPHTH VIS SCI, V51, P4738, DOI 10.1167/iovs.09-4890; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Ma WX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007945; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Maeda A, 2010, P NATL ACAD SCI USA, V107, P8428, DOI 10.1073/pnas.1000640107; Maeda A, 2009, INVEST OPHTH VIS SCI, V50, P5435, DOI 10.1167/iovs.09-3944; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Molday RS, 2010, PROG LIPID RES, V49, P476, DOI 10.1016/j.plipres.2010.07.002; Nandrot EF, 2010, ADV EXP MED BIOL, V664, P133, DOI 10.1007/978-1-4419-1399-9_16; Nussenblatt RB, 2007, AM J OPHTHALMOL, V144, P618, DOI 10.1016/j.ajo.2007.06.025; Owens T, 2009, CURR TOP MICROBIOL, V336, P105, DOI 10.1007/978-3-642-00549-7_6; Palczewski K, 2010, TRENDS PHARMACOL SCI, V31, P284, DOI 10.1016/j.tips.2010.03.001; Radu RA, 2011, J BIOL CHEM, V286, P18593, DOI 10.1074/jbc.M110.191866; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; Sasahara M, 2008, AM J PATHOL, V172, P1693, DOI 10.2353/ajpath.2008.080024; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Sen A, 2011, INVEST OPHTH VIS SCI, V52, P6940, DOI 10.1167/iovs.11-7834; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Shiose S, 2011, J BIOL CHEM, V286, P15543, DOI 10.1074/jbc.M111.228551; Sugita S, 2009, CANCER SCI, V100, P82, DOI 10.1111/j.1349-7006.2008.01008.x; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Theodossiadis PG, 2009, AM J OPHTHALMOL, V147, P825, DOI 10.1016/j.ajo.2008.12.004; Theriault JR, 2005, FEBS LETT, V579, P1951, DOI 10.1016/j.febslet.2005.02.046; Tou JS, 2004, FASEB J, V18, P1297, DOI 10.1096/fj.04-1862fje; Usui Y, 2008, EXP EYE RES, V86, P52, DOI 10.1016/j.exer.2007.09.007; van Rooijen N, 2002, J LIPOSOME RES, V12, P81, DOI 10.1081/LPR-120004780; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wang AL, 2005, NEUROCHEM INT, V47, P152, DOI 10.1016/j.neuint.2005.04.018; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Xu HP, 2008, AGING CELL, V7, P58, DOI 10.1111/j.1474-9726.2007.00351.x; Xu HP, 2007, INVEST OPHTH VIS SCI, V48, P1701, DOI 10.1167/iovs.06-0697; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Xu J, 2011, FASEB J, V25, P2221, DOI 10.1096/fj.10-178350; Yang ZL, 2008, NEW ENGL J MED, V359, P1456, DOI 10.1056/NEJMoa0802437; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yoshida A, 2003, LAB INVEST, V83, P1117, DOI 10.1097/01.LAB.0000082393.02727.B5; Zareparsi S, 2005, HUM MOL GENET, V14, P1449, DOI 10.1093/hmg/ddi154; Zhao L, 2011, AM J PATHOL, V179, P1265, DOI 10.1016/j.ajpath.2011.05.042; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	89	128	130	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15326	15341		10.1074/jbc.M112.448712	http://dx.doi.org/10.1074/jbc.M112.448712			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23572532	Green Published, hybrid			2022-12-28	WOS:000319452100058
J	Garcia-Arcos, I; Hiyama, Y; Drosatos, K; Bharadwaj, KG; Hu, YY; Son, NHP; O'Byrne, SM; Chang, CCL; Deckelbaum, RJ; Takahashi, M; Westerterp, M; Obunike, JC; Jiang, HF; Yagyu, H; Blaner, WS; Goldberg, IJ				Garcia-Arcos, Itsaso; Hiyama, Yaeko; Drosatos, Konstantinos; Bharadwaj, Kalyani G.; Hu, Yunying; Son, Ni Huiping; O'Byrne, Sheila M.; Chang, Chuchun L.; Deckelbaum, Richard J.; Takahashi, Manabu; Westerterp, Marit; Obunike, Joseph C.; Jiang, Hongfeng; Yagyu, Hiroaki; Blaner, William S.; Goldberg, Ira J.			Adipose-specific Lipoprotein Lipase Deficiency More Profoundly Affects Brown than White Fat Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; HIGH-DENSITY-LIPOPROTEIN; IN-VIVO; ACID COMPOSITION; SKELETAL-MUSCLE; GENE-EXPRESSION; TRANSGENIC MICE; PPAR-GAMMA; TISSUE; METABOLISM	Adipose fat storage is thought to require uptake of circulating triglyceride (TG)-derived fatty acids via lipoprotein lipase (LpL). To determine how LpL affects the biology of adipose tissue, we created adipose-specific LpL knock-out (ATLO) mice, and we compared them with whole body LpL knock-out mice rescued with muscle LpL expression (MCK/L0) and wild type (WT) mice. ATLO LpL mRNA and activity were reduced, respectively, 75 and 70% in gonadal adipose tissue (GAT), 90 and 80% in subcutaneous tissue, and 84 and 85% in brown adipose tissue (BAT). ATLO mice had increased plasma TG levels associated with reduced chylomicron TG uptake into BAT and lung. ATLO BAT, but not GAT, had altered TG composition. GAT from MCK/L0 was smaller and contained less polyunsaturated fatty acids in TG, although GAT from ATLO was normal unless LpL was overexpressed in muscle. High fat diet feeding led to less adipose in MCK/L0 mice but TG acyl composition in subcutaneous tissue and BAT reverted to that of WT. Therefore, adipocyte LpL in BAT modulates plasma lipoprotein clearance, and the greater metabolic activity of this depot makes its lipid composition more dependent on LpL-mediated uptake. Loss of adipose LpL reduces fat accumulation only if accompanied by greater LpL activity in muscle. These data support the role of LpL as the "gatekeeper" for tissue lipid distribution.	[Garcia-Arcos, Itsaso; Hiyama, Yaeko; Drosatos, Konstantinos; Bharadwaj, Kalyani G.; Hu, Yunying; Son, Ni Huiping; O'Byrne, Sheila M.; Westerterp, Marit; Jiang, Hongfeng; Blaner, William S.; Goldberg, Ira J.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Chang, Chuchun L.; Deckelbaum, Richard J.] Columbia Univ Coll Phys & Surg, Inst Human Nutr, New York, NY 10032 USA; [Takahashi, Manabu; Yagyu, Hiroaki] Jichii Univ, Dept Med, Mibu, Tochigi 3290498, Japan; [Westerterp, Marit] Univ Amsterdam, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Obunike, Joseph C.] CUNY, New York City Coll Technol, Dept Biol Sci, Brooklyn, NY 11201 USA	Columbia University; Columbia University; University of Amsterdam; City University of New York (CUNY) System	Goldberg, IJ (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, 630 W 168th St, New York, NY 10032 USA.	ijg3@columbia.edu	jiang, hongfeng/I-6188-2013; Drosatos, Konstantinos/H-9153-2013	Drosatos, Konstantinos/0000-0003-0903-834X; Garcia-Arcos, Itsaso/0000-0002-4190-3252; Westerterp, Marit/0000-0003-2230-1659	National Institutes of Health Grant from NHLBI [HL45095]; Basque Government [BFI09.241]; NWO VENI-Grant from The Netherlands Organization of Sciences [916.11.072]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007343, R01HL045095, K99HL112853, R01HL073029, R37HL045095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095684, P30DK026687, R01DK068437] Funding Source: NIH RePORTER	National Institutes of Health Grant from NHLBI; Basque Government(Basque Government); NWO VENI-Grant from The Netherlands Organization of Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant HL45095 from NHLBI (to I. J. G.).; Recipient of Postdoctoral Fellowship BFI09.241 from the Basque Government.; Supported by NWO VENI-Grant 916.11.072 from The Netherlands Organization of Sciences.	Augustus A, 2004, J BIOL CHEM, V279, P25050, DOI 10.1074/jbc.M401028200; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; BERGER GMB, 1986, METABOLISM, V35, P1054, DOI 10.1016/0026-0495(86)90043-0; Bharadwaj KG, 2010, J BIOL CHEM, V285, P37976, DOI 10.1074/jbc.M110.174458; BRUN LD, 1989, METABOLISM, V38, P1005, DOI 10.1016/0026-0495(89)90013-9; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chang CL, 2010, ARTERIOSCL THROM VAS, V30, P2510, DOI 10.1161/ATVBAHA.110.215848; Clugston RD, 2011, J LIPID RES, V52, P2021, DOI 10.1194/jlr.M017368; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Davies BSJ, 2008, MOL ENDOCRINOL, V22, P2496, DOI 10.1210/me.2008-0146; Drosatos K, 2007, J BIOL CHEM, V282, P19556, DOI 10.1074/jbc.M700986200; Duncan JG, 2010, CIRCULATION, V121, P426, DOI 10.1161/CIRCULATIONAHA.109.888735; Goldberg IJ, 1996, J LIPID RES, V37, P693; GREENWOOD MRC, 1985, INT J OBESITY, V9, P67; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; Haugen BR, 2004, ENDOCRINOLOGY, V145, P3679, DOI 10.1210/en.2003-1401; Hocquette JF, 1998, COMP BIOCHEM PHYS B, V121, P201, DOI 10.1016/S0305-0491(98)10090-1; JACOBSEN BK, 1983, AM J CLIN NUTR, V38, P906, DOI 10.1093/ajcn/38.6.906; Jensen MD, 2007, HORM METAB RES, V39, P722, DOI 10.1055/s-2007-990274; Kratky D, 2005, J CLIN INVEST, V115, P161, DOI 10.1172/JCI200515972; LevakFrank S, 1997, J BIOL CHEM, V272, P17182, DOI 10.1074/jbc.272.27.17182; LEVAKFRANK S, 1995, J CLIN INVEST, V96, P976, DOI 10.1172/JCI118145; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Liu L, 2011, J LIPID RES, V52, P732, DOI 10.1194/jlr.M011395; MacLaren R, 2008, J LIPID RES, V49, P308, DOI 10.1194/jlr.M700199-JLR200; Merkel M, 1998, J CLIN INVEST, V102, P893, DOI 10.1172/JCI2912; NILSSONEHLE P, 1976, J LIPID RES, V17, P536; O'Byrne SM, 2010, AM J PHYSIOL-ENDOC M, V298, pE862, DOI 10.1152/ajpendo.00491.2009; Olafsen T, 2010, J BIOL CHEM, V285, P39239, DOI 10.1074/jbc.M110.171041; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Palmer WK, 1998, ATHEROSCLEROSIS, V136, P115, DOI 10.1016/S0021-9150(97)00193-7; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; Swayne TC, 2009, METHODS MOL BIOL, V586, P171, DOI 10.1007/978-1-60761-376-3_9; Takahashi M, 2013, J LIPID RES, V54, P1124, DOI 10.1194/jlr.M035568; Tang QQ, 2004, BIOCHEM BIOPH RES CO, V318, P213, DOI 10.1016/j.bbrc.2004.04.017; Ullrich NFE, 2001, J INVEST MED, V49, P273; VANSTAVEREN WA, 1986, AM J EPIDEMIOL, V123, P455; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wagner EM, 2004, J LIPID RES, V45, P356, DOI 10.1194/jlr.M300293-JLR200; Wang H, 2009, DIABETES, V58, P116, DOI 10.2337/db07-1839; Wassef L, 2011, J BIOL CHEM, V286, P32198, DOI 10.1074/jbc.M111.253070; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000	46	48	49	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14046	14058		10.1074/jbc.M113.469270	http://dx.doi.org/10.1074/jbc.M113.469270			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23542081	hybrid, Green Published			2022-12-28	WOS:000319253500010
J	Gameiro, PA; Laviolette, LA; Kelleher, JK; Iliopoulos, O; Stephanopoulos, G				Gameiro, Paulo A.; Laviolette, Laura A.; Kelleher, Joanne K.; Iliopoulos, Othon; Stephanopoulos, Gregory			Cofactor Balance by Nicotinamide Nucleotide Transhydrogenase (NNT) Coordinates Reductive Carboxylation and Glucose Catabolism in the Tricarboxylic Acid (TCA) Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE DINUCLEOTIDE PHOSPHATE; MALATE-ASPARTATE SHUTTLE; ISOCITRATE DEHYDROGENASE; CELL-GROWTH; GLUTAMINE-METABOLISM; INSULIN-SECRETION; MALIC ENZYME; TUMOR-CELLS; REDOX STATE; RAT LIVER	Cancer and proliferating cells exhibit an increased demand for glutamine-derived carbons to support anabolic processes. In addition, reductive carboxylation of alpha-ketoglutarate by isocitrate dehydrogenase 1 (IDH1) and 2 (IDH2) was recently shown to be a major source of citrate synthesis from glutamine. The role of NAD(P)H/NAD(P)(+) cofactors in coordinating glucose and glutamine utilization in the tricarboxylic acid (TCA) cycle is not well understood, with the source(s) of NADPH for the reductive carboxylation reaction remaining unexplored. Nicotinamide nucleotide transhydrogenase (NNT) is a mitochondrial enzyme that transfers reducing equivalents from NADH to NADPH. Here, we show that knockdown of NNT inhibits the contribution of glutamine to the TCA cycle and activates glucose catabolism in SkMel5 melanoma cells. The increase in glucose oxidation partially occurred through pyruvate carboxylase and rendered NNT knockdown cells more sensitive to glucose deprivation. Importantly, knocking down NNT inhibits reductive carboxylation in SkMel5 and 786-O renal carcinoma cells. Overexpression of NNT is sufficient to stimulate glutamine oxidation and reductive carboxylation, whereas it inhibits glucose catabolism in the TCA cycle. These observations are supported by an impairment of the NAD(P) H/NAD(P)+ ratios. Our findings underscore the role of NNT in regulating central carbon metabolism via redox balance, calling for other mechanisms that coordinate substrate preference to maintain a functional TCA cycle.	[Gameiro, Paulo A.; Kelleher, Joanne K.; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Gameiro, Paulo A.; Laviolette, Laura A.; Iliopoulos, Othon] Massachusetts Gen Hosp Canc Ctr, Ctr Canc Res, Charlestown, MA 02129 USA; [Gameiro, Paulo A.; Laviolette, Laura A.; Iliopoulos, Othon] Massachusetts Gen Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02115 USA; [Laviolette, Laura A.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02139 USA; [Gameiro, Paulo A.] Univ Coimbra, Dept Life Sci, P-3004517 Coimbra, Portugal	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Universidade de Coimbra	Stephanopoulos, G (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	gregstep@mit.edu	Gameiro, Paulo A/AAD-9324-2021	Gameiro, Paulo A./0000-0001-8176-4237	Massachusetts General Hospital (MGH) ProtonBeam Federal Share Project; National Institutes of Health [R01 DK075850, R01 CA122591]; Astra-Zeneca; Foundation for Science and Technology (FCT), Portugal; NATIONAL CANCER INSTITUTE [R01CA160458, R01CA122591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075850] Funding Source: NIH RePORTER	Massachusetts General Hospital (MGH) ProtonBeam Federal Share Project; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Astra-Zeneca(AstraZeneca); Foundation for Science and Technology (FCT), Portugal(Portuguese Foundation for Science and Technology); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Ana M. Metelo for insights on the xenograft experiments, Eric L. Bell for help with the NNT cDNA plasmid, Taylor Murphy for help on extracellular flux analyses, Thomas Wasylenko for feedback on cofactor measurements, and Christian M. Metallo for scientific discussions. This work was also supported by the Massachusetts General Hospital (MGH) ProtonBeam Federal Share Project.; This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK075850 (to G.S.) and R01 CA122591 (to O.I.). This work was also supported by an Award from Astra-Zeneca (to O.I.) and the Foundation for Science and Technology (FCT), Portugal (to P.A.G.).	Alberts B, 2002, MOL BIOL CELL; Blinova K, 2005, BIOCHEMISTRY-US, V44, P2585, DOI 10.1021/bi0485124; BRAND K, 1985, BIOCHEM J, V228, P353, DOI 10.1042/bj2280353; CEDERBAU.AI, 1973, ARCH BIOCHEM BIOPHYS, V158, P763, DOI 10.1016/0003-9861(73)90571-7; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; DALZIEL K, 1968, BIOCHEM J, V110, P223, DOI 10.1042/bj1100223; Dang CV, 2010, CELL CYCLE, V9, P3884, DOI 10.4161/cc.9.19.13302; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; Filipp FV, 2012, PIGM CELL MELANOMA R, V25, P375, DOI 10.1111/j.1755-148X.2012.00989.x; FIRTH JD, 1994, P NATL ACAD SCI USA, V91, P6496, DOI 10.1073/pnas.91.14.6496; Freeman H, 2006, CELL METAB, V3, P35, DOI 10.1016/j.cmet.2005.10.008; Gameiro PA, 2013, CELL METAB, V17, P372, DOI 10.1016/j.cmet.2013.02.002; GREENHOUSE WVV, 1976, CANCER RES, V36, P1392; Kaadige MR, 2009, P NATL ACAD SCI USA, V106, P14878, DOI 10.1073/pnas.0901221106; KAUPPINEN RA, 1987, BIOCHIM BIOPHYS ACTA, V930, P173, DOI 10.1016/0167-4889(87)90029-2; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Leonardi R, 2012, J BIOL CHEM, V287, P14615, DOI 10.1074/jbc.C112.353946; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Meimaridou E, 2012, NAT GENET, V44, P740, DOI 10.1038/ng.2299; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; MORENOSANCHEZ R, 1990, BIOCHEM J, V268, P421, DOI 10.1042/bj2680421; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; NEWSHOLME EA, 1985, BIOSCIENCE REP, V5, P393, DOI 10.1007/BF01116556; Nicholson A, 2010, OBESITY, V18, P1902, DOI 10.1038/oby.2009.477; Parker N, 2009, BBA-BIOENERGETICS, V1787, P1451, DOI 10.1016/j.bbabio.2009.06.005; Ripoll VM, 2012, FASEB J, V26, P3550, DOI 10.1096/fj.11-199935; Rydstrom J, 2006, BBA-BIOENERGETICS, V1757, P721, DOI 10.1016/j.bbabio.2006.03.010; SAUER LA, 1980, J BIOL CHEM, V255, P3844; SAZANOV LA, 1994, FEBS LETT, V344, P109, DOI 10.1016/0014-5793(94)00370-X; Scott DA, 2011, J BIOL CHEM, V286, P42626, DOI 10.1074/jbc.M111.282046; Sheeran FL, 2010, BBA-BIOENERGETICS, V1797, P1138, DOI 10.1016/j.bbabio.2010.04.002; SIEBERT G, 1957, J BIOL CHEM, V226, P977; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Vizan P, 2005, CANCER RES, V65, P5512, DOI 10.1158/0008-5472.CAN-05-0074; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wong N, 2010, ENDOCRINOLOGY, V151, P96, DOI 10.1210/en.2009-0887; Yin F, 2012, BBA-BIOENERGETICS, V1817, P401, DOI 10.1016/j.bbabio.2011.12.004; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024	46	84	85	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12967	12977		10.1074/jbc.M112.396796	http://dx.doi.org/10.1074/jbc.M112.396796			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23504317	Green Published, hybrid			2022-12-28	WOS:000318555100050
J	McNeill, DR; Paramasivam, M; Baldwin, J; Huang, J; Vyjayanti, VN; Seidman, MM; Wilson, DM				McNeill, Daniel R.; Paramasivam, Manikandan; Baldwin, Jakita; Huang, Jing; Vyjayanti, Vaddadi N.; Seidman, Michael M.; Wilson, David M., III			NEIL1 Responds and Binds to Psoralen-induced DNA Interstrand Crosslinks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; DAMAGE RESPONSE; HUMAN-CELLS; GLYCOSYLASE; DISEASE; BIOLOGY; CANCER	Recent evidence suggests a role for base excision repair (BER) proteins in the response to DNA interstrand crosslinks, which block replication and transcription, and lead to cell death and genetic instability. Employing fluorescently tagged fusion proteins and laser microirradiation coupled with confocal microscopy, we observed that the endonuclease VIII-like DNA glycosylase, NEIL1, accumulates at sites of oxidative DNA damage, as well as trioxsalen (psoralen)-induced DNA interstrand crosslinks, but not to angelicin monoadducts. While recruitment to the oxidative DNA lesions was abrogated by the anti-oxidant N-acetylcysteine, this treatment did not alter the accumulation of NEIL1 at sites of interstrand crosslinks, suggesting distinct recognition mechanisms. Consistent with this conclusion, recruitment of the NEIL1 population variants, G83D, C136R, and E181K, to oxidative DNA damage and psoralen-induced interstrand crosslinks was differentially affected by the mutation. NEIL1 recruitment to psoralen crosslinks was independent of the nucleotide excision repair recognition factor, XPC. Knockdown of NEIL1 in LN428 glioblastoma cells resulted in enhanced recruitment of XPC, a more rapid removal of digoxigenin-tagged psoralen adducts, and decreased cellular sensitivity to trioxsalen plus UVA, implying that NEIL1 and BER may interfere with normal cellular processing of interstrand crosslinks. While exhibiting no enzymatic activity, purified NEIL1 protein bound stably to psoralen interstrand crosslink-containing synthetic oligonucleotide substrates in vitro. Our results indicate that NEIL1 recognizes specifically and distinctly interstrand crosslinks in DNA, and can obstruct the efficient removal of lethal crosslink adducts.	[McNeill, Daniel R.; Paramasivam, Manikandan; Huang, Jing; Vyjayanti, Vaddadi N.; Seidman, Michael M.; Wilson, David M., III] NIA, Lab Mol Gerontol, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA; [Baldwin, Jakita] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Northwestern University; Feinberg School of Medicine	Wilson, DM (corresponding author), NIA, Lab Mol Gerontol, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA.	wilsonda@mail.nih.gov	Huang, Jing/J-8282-2018; Wilson, David M/AAK-5409-2021	Huang, Jing/0000-0002-5494-378X; Wilson, David M/0000-0002-8945-0395	National Institutes of Health, National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000743, ZIAAG000746] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in whole by the Intramural Research Program at the National Institutes of Health, National Institute on Aging.	Allan JM, 1998, CANCER RES, V58, P3965; Chaisaingmongkol J, 2012, ONCOGENE, V31, P5108, DOI 10.1038/onc.2011.660; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Couve S, 2009, J BIOL CHEM, V284, P11963, DOI 10.1074/jbc.M900746200; Couve-Privat S, 2007, NUCLEIC ACIDS RES, V35, P5672, DOI 10.1093/nar/gkm592; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Engelward BP, 1996, EMBO J, V15, P945, DOI 10.1002/j.1460-2075.1996.tb00429.x; Forsbring M, 2009, CARCINOGENESIS, V30, P1147, DOI 10.1093/carcin/bgp118; Hoogstraten D, 2008, J CELL SCI, V121, P2850, DOI 10.1242/jcs.031708; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kothandapani A, 2011, J BIOL CHEM, V286, P14564, DOI 10.1074/jbc.M111.225375; Lai CF, 2008, ANAL CHEM, V80, P8790, DOI 10.1021/ac801520m; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Maor-Shoshani A, 2008, DNA REPAIR, V7, P1399, DOI 10.1016/j.dnarep.2008.04.017; Muniandy PA, 2010, CRIT REV BIOCHEM MOL, V45, P23, DOI 10.3109/10409230903501819; Muniandy PA, 2009, J BIOL CHEM, V284, P27908, DOI 10.1074/jbc.M109.029025; Roy LM, 2007, J BIOL CHEM, V282, P15790, DOI 10.1074/jbc.M610626200; Shinmura K, 2004, CARCINOGENESIS, V25, P2311, DOI 10.1093/carcin/bgh267; SPIELMANN HP, 1995, BIOCHEMISTRY-US, V34, P12937, DOI 10.1021/bi00040a004; Stone MP, 2011, CHEM BIODIVERS, V8, P1571, DOI 10.1002/cbdv.201100033; Thazhathveetil AK, 2007, BIOCONJUGATE CHEM, V18, P431, DOI 10.1021/bc060309t; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; Wilson DM, 2010, TRENDS BIOCHEM SCI, V35, P247, DOI 10.1016/j.tibs.2010.01.003	24	21	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12426	12436		10.1074/jbc.M113.456087	http://dx.doi.org/10.1074/jbc.M113.456087			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23508956	Green Published, hybrid			2022-12-28	WOS:000318555100002
J	Chen, J; Fu, R; Cui, Y; Li, YS; Pan, JR; Liu, JL; Luo, HS; Yin, JD; Li, DF; Cui, S				Chen, Juan; Fu, Rui; Cui, Yan; Li, Yu-shan; Pan, Ji-rong; Liu, Jia-li; Luo, Hao-shu; Yin, Jing-dong; Li, De-fa; Cui, Sheng			LIM-homeodomain Transcription Factor Isl-1 Mediates the Effect of Leptin on Insulin Secretion in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISLET BETA-CELLS; HIGH-FAT DIET; GENE-EXPRESSION; PANCREATIC-ISLETS; MESSENGER-RNA; DNA-BINDING; ENDOCRINE PANCREAS; DIABETES-MELLITUS; TERMINAL DOMAIN; DEFICIENT MICE	In addition to the well known regulating effects of leptin on energy balance and glucose homeostasis through the central nervous system, circulating leptin has a direct effect on pancreatic islet and insulin secretion through its receptor (OBRb). The LIM-homeodomain transcription factor Isl-1 is expressed in all classes of pancreatic endocrine cells and is involved in regulating both islet development and insulin secretion. Both OBRb and Isl-1 mutations result in obesity-related diabetes. However, the interactions and physiological significance of leptin and Isl-1 in pancreatic islets remain to be established. Here, we show that most of leptin target cells in pancreatic islets and NIT beta cells express Isl-1. Both in vivo and in vitro results demonstrate that leptin suppresses Isl-1 expression and insulin secretion in islet in physiological and pathophysiological conditions, e. g. high fat diet. This effect of leptin on insulin secretion is lost in leptin receptor-defective db/db and Isl-1-inducible knock-out mice. We conclude that the action of leptin on insulin secretion is at least partly mediated by Isl-1. Another new finding of this study is that Isl-1 acts as a direct downstream target of leptin signaling molecule STAT3 to influence the effect of leptin on insulin secretion, whereas inversely, insulin has feedback regulating effects on Isl-1 expression through JAK-STAT3 pathway. These findings are crucial for understanding the mechanisms regulating insulin secretion and metabolism in related diseases, such as obesity and type 2 diabetes.	[Chen, Juan; Fu, Rui; Li, Yu-shan; Pan, Ji-rong; Liu, Jia-li; Luo, Hao-shu; Cui, Sheng] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Cui, Yan] 306th Hosp PLA, Beijing 100101, Peoples R China; [Yin, Jing-dong; Li, De-fa] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100193, Peoples R China	China Agricultural University; China Agricultural University	Li, DF (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.	defali@public2.bta.net.cn; cuisheng@cau.edu.cn		Yin, Jingdong/0000-0003-4623-0568	National Basic Research Program of China [2012CB124702]; Natural Science Foundation of China [31172287, 30630011]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2012CB124702) and the Natural Science Foundation of China (31172287 and 30630011).	Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Barat-Houari M, 2002, DIABETES, V51, P1640, DOI 10.2337/diabetes.51.5.1640; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; Campbell SC, 1999, FEBS LETT, V463, P53, DOI 10.1016/S0014-5793(99)01584-7; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Du AP, 2009, DIABETES, V58, P2059, DOI 10.2337/db08-0987; Emilsson V, 1997, DIABETES, V46, P313, DOI 10.2337/diabetes.46.2.313; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Fruhbeck G, 1999, PHYSIOL RES, V48, P189; HAMAGUCHI K, 1991, DIABETES, V40, P842, DOI 10.2337/diabetes.40.7.842; Hao AJ, 2005, MOL BIOL CELL, V16, P1569, DOI 10.1091/mbc.e04-08-0664; Iacobazzi V, 2009, BIOCHEM BIOPH RES CO, V385, P220, DOI 10.1016/j.bbrc.2009.05.030; Johnson JD, 2006, DIABETES, V55, P2737, DOI 10.2337/db05-1455; Kataoka K, 2004, J MOL ENDOCRINOL, V32, P9, DOI 10.1677/jme.0.0320009; Kieffer TJ, 1997, DIABETES, V46, P1087, DOI 10.2337/diabetes.46.6.1087; KORANYI L, 1992, J CLIN INVEST, V89, P432, DOI 10.1172/JCI115602; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; LEONARD J, 1992, P NATL ACAD SCI USA, V89, P6247, DOI 10.1073/pnas.89.14.6247; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Lin X, 1998, J NUTR, V128, P1606, DOI 10.1093/jn/128.10.1606; Liu JX, 2011, J BIOL CHEM, V286, P15352, DOI 10.1074/jbc.M111.231670; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; May CL, 2010, ISLETS, V2, P121, DOI 10.4161/isl.2.2.10908; Morioka T, 2007, J CLIN INVEST, V117, P2860, DOI 10.1172/JCI30910; Morton NM, 1999, J MOL ENDOCRINOL, V22, P173, DOI 10.1677/jme.0.0220173; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Pallett AL, 1997, BIOCHEM BIOPH RES CO, V238, P267, DOI 10.1006/bbrc.1997.7274; Pande M, 2011, DIABETES, V60, P1981, DOI 10.2337/db10-1541; Sahu A, 2003, FRONT NEUROENDOCRIN, V24, P225, DOI 10.1016/j.yfrne.2003.10.001; Sander M, 2000, DEVELOPMENT, V127, P5533; Schisler JC, 2005, P NATL ACAD SCI USA, V102, P7297, DOI 10.1073/pnas.0502168102; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Seufert J, 2004, DIABETES, V53, pS152, DOI 10.2337/diabetes.53.2007.S152; Seufert J, 1999, J CLIN ENDOCR METAB, V84, P670, DOI 10.1210/jc.84.2.670; Shimomura H, 2000, DIABETES, V49, P1597, DOI 10.2337/diabetes.49.9.1597; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Stepanova OI, 2007, B EXP BIOL MED+, V144, P813, DOI 10.1007/s10517-007-0438-7; Sun YF, 2008, NAT NEUROSCI, V11, P1283, DOI 10.1038/nn.2209; Taylor DG, 2005, BIOCHEMISTRY-US, V44, P11269, DOI 10.1021/bi050821m; Townsend KL, 2008, ENDOCRINE, V33, P176, DOI 10.1007/s12020-008-9070-1; Watada H, 1996, DIABETES, V45, P1826, DOI 10.2337/diabetes.45.12.1826; Wu HL, 2011, J BIOTECHNOL, V151, P231, DOI 10.1016/j.jbiotec.2010.12.003; Wu YJ, 2010, ENDOCRINOLOGY, V151, P4787, DOI 10.1210/en.2010-0208; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yu J, 2007, MOL ENDOCRINOL, V21, P2775, DOI 10.1210/me.2006-0473; Zhang H, 2009, J MOL BIOL, V392, P566, DOI 10.1016/j.jmb.2009.07.036	50	11	12	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12395	12405		10.1074/jbc.M113.450536	http://dx.doi.org/10.1074/jbc.M113.450536			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504315	hybrid, Green Published			2022-12-28	WOS:000318157600070
J	Crescenzi, E; Raia, Z; Pacifico, F; Mellone, S; Moscato, F; Palumbo, G; Leonardi, A				Crescenzi, Elvira; Raia, Zelinda; Pacifico, Francesco; Mellone, Stefano; Moscato, Fortunato; Palumbo, Giuseppe; Leonardi, Antonio			Down-regulation of Wild-type p53-induced Phosphatase 1 (Wip1) Plays a Critical Role in Regulating Several p53-dependent Functions in Premature Senescent Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; MITOTIC CATASTROPHE; ANTICANCER DRUGS; CANCER-THERAPY; GROWTH ARREST; P53; EXPRESSION; DEATH; PPM1D; AMPLIFICATION	Premature or drug-induced senescence is a major cellular response to chemotherapy in solid tumors. The senescent phenotype develops slowly and is associated with chronic DNA damage response. We found that expression of wild-type p53induced phosphatase 1 (Wip1) is markedly down-regulated during persistent DNA damage and after drug release during the acquisition of the senescent phenotype in carcinoma cells. We demonstrate that down-regulation of Wip1 is required for maintenance of permanent G2 arrest. In fact, we show that forced expression of Wip1 in premature senescent tumor cells induces inappropriate re-initiation of mitosis, uncontrolled polyploid progression, and cell death by mitotic failure. Most of the effects of Wip1 may be attributed to it sability to dephosphorylate p53 at Ser15 and to inhibit DNA damage response. However, we also uncover a regulatory pathway whereby suppression of p53 Ser15 phosphorylation is associated with enhanced phosphorylation at Ser46, increased p53 protein levels, and induction of Noxa expression. On the whole, our data indicate that downregulation of Wip1 expression during premature senescence plays a pivotal role in regulating several p53-dependent aspects of the senescent phenotype.	[Crescenzi, Elvira; Pacifico, Francesco; Mellone, Stefano; Moscato, Fortunato] CNR, Ist Endocrinol & Oncol Sperimentale, I-80131 Naples, Italy; [Raia, Zelinda; Palumbo, Giuseppe; Leonardi, Antonio] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II	Leonardi, A (corresponding author), Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, Via S Pansini 5, I-80131 Naples, Italy.	leonardi@unina.it	leonardi, antonio/A-2887-2009; Pacifico, Francesco/AAX-3958-2020; Palumbo, Giuseppe/N-3136-2016	leonardi, antonio/0000-0001-8636-9623; Pacifico, Francesco/0000-0001-9563-3596; CRESCENZI, ELVIRA/0000-0002-9258-8053; Palumbo, Giuseppe/0000-0001-9380-8436	MIUR [2008CCPKRP]; Firb/Merit Grant [RBNE08YYBM_002]	MIUR(Ministry of Education, Universities and Research (MIUR)); Firb/Merit Grant	This work was supported by MIUR Grant 2008CCPKRP (to A.L.) and Firb/Merit Grant RBNE08YYBM_002 (to A.L. and G.P.).	Aylon Y, 2011, MOL ONCOL, V5, P315, DOI 10.1016/j.molonc.2011.07.007; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Cairney CJ, 2012, DRUG DISCOV TODAY, V17, P269, DOI 10.1016/j.drudis.2012.01.019; Castellino RC, 2008, J NEURO-ONCOL, V86, P245, DOI 10.1007/s11060-007-9470-8; Chang BD, 2002, P NATL ACAD SCI USA, V99, P389, DOI 10.1073/pnas.012602599; Chang BD, 1999, CANCER RES, V59, P3761; Choi J, 2000, GENOMICS, V64, P298, DOI 10.1006/geno.2000.6134; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Crescenzi E, 2011, ONCOGENE, V30, P2707, DOI 10.1038/onc.2011.1; Crescenzi E, 2008, CLIN CANCER RES, V14, P1877, DOI 10.1158/1078-0432.CCR-07-4298; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; de Bruin EC, 2008, CANCER TREAT REV, V34, P737, DOI 10.1016/j.ctrv.2008.07.001; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gire V, 1998, MOL CELL BIOL, V18, P1611, DOI 10.1128/MCB.18.3.1611; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hirasawa A, 2003, CLIN CANCER RES, V9, P1995; Kawabe T, 2004, MOL CANCER THER, V3, P513; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lee JS, 2009, STEM CELLS, V27, P1963, DOI 10.1002/stem.121; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; Lindqvist A, 2009, EMBO J, V28, P3196, DOI 10.1038/emboj.2009.246; Lowe J, 2012, FRONT BIOSCI-LANDMRK, V17, P1480, DOI 10.2741/3999; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu XB, 2008, CANCER METAST REV, V27, P123, DOI 10.1007/s10555-008-9127-x; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Mansilla S, 2006, CELL CYCLE, V5, P53, DOI 10.4161/cc.5.1.2267; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Mirzayans R, 2005, RADIAT RES, V163, P53, DOI 10.1667/RR3280; Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Puca R, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-85; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Seo YW, 2003, J BIOL CHEM, V278, P48292, DOI 10.1074/jbc.M308785200; Sluss HK, 2004, MOL CELL BIOL, V24, P976, DOI 10.1128/MCB.24.3.976-984.2004; te Poele RH, 2002, CANCER RES, V62, P1876; Ugalde AP, 2011, EMBO J, V30, P2219, DOI 10.1038/emboj.2011.124; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wang YC, 1999, ONCOGENE, V18, P2643, DOI 10.1038/sj.onc.1202632; Wang YC, 1998, ONCOGENE, V17, P1923, DOI 10.1038/sj.onc.1202113; Wu ZQ, 2002, MOL CELL BIOL, V22, P2441, DOI 10.1128/MCB.22.8.2441-2449.2002; Young ARJ, 2009, EMBO REP, V10, P228, DOI 10.1038/embor.2009.22	51	21	23	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16212	16224		10.1074/jbc.M112.435149	http://dx.doi.org/10.1074/jbc.M112.435149			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612976	Green Published, hybrid			2022-12-28	WOS:000320378900002
J	Gumataotao, N; Kuhn, ML; Hajnas, N; Holz, RC				Gumataotao, Natalie; Kuhn, Misty L.; Hajnas, Natalia; Holz, Richard C.			Identification of an Active Site-bound Nitrile Hydratase Intermediate through Single Turnover Stopped-flow Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONHEME IRON; CATALYTIC MECHANISM; ELECTRONIC-STRUCTURE; ESCHERICHIA-COLI; ACRYLONITRILE; EXPRESSION; SUBSTRATE; NHASE; OXIDE	Stopped-flow kinetic data were obtained for the iron-type nitrile hydratase from Rhodococcus equi TG328-2 (ReNHase) using methacrylonitrile as the substrate. Multiple turnover experiments suggest a three-step kinetic model that allows for the reversible binding of substrate, the presence of an intermediate, and the formation of product. Microscopic rate constants determined from these data are in good agreement with steady state data confirming that the stopped-flow method used was appropriate for the reaction. Single turnover stopped-flow experiments were used to identify catalytic intermediates. These data were globally fit confirming a three-step kinetic model. Independent absorption spectra acquired between 0.005 and 0.5 s of the reaction reveal a significant increase in absorbance at 375, 460, and 550 nm along with the hypsochromic shift of an Fe3+<- S ligand-to-metal charge transfer band from 700 to 650 nm. The observed UV-visible absorption bands for the Fe3+-nitrile intermediate species are similar to low spin Fe3+-enzyme and model complexes bound by NO or N-3(-). These data provide spectroscopic evidence for the direct coordination of the nitrile substrate to the nitrile hydratase active site low spin Fe3+ center.	[Gumataotao, Natalie; Kuhn, Misty L.; Hajnas, Natalia; Holz, Richard C.] Loyola Univ Chicago, Dept Chem & Biochem, Chicago, IL 60660 USA	Loyola University Chicago	Holz, RC (corresponding author), Loyola Univ Chicago, Dept Chem & Biochem, 1068 West Sheridan Rd, Chicago, IL 60660 USA.	rholz1@luc.edu			National Science Foundation [CHE-1058357]; American Chemical Society (ACS) Petroleum Research Fund [ACS PRF 50033-ND4]; Division Of Chemistry [1058396] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); American Chemical Society (ACS) Petroleum Research Fund(American Cancer SocietyAmerican Chemical Society); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the National Science Foundation Grant CHE-1058357 (to R. C. H.) and American Chemical Society (ACS) Petroleum Research Fund Grant ACS PRF 50033-ND4 (to R. C. H.).	Banerjee A, 2002, APPL MICROBIOL BIOT, V60, P33, DOI 10.1007/s00253-002-1062-0; Baxter J, 2006, ANTON LEEUW INT J G, V90, P1, DOI 10.1007/s10482-006-9057-y; Desai LV, 2004, DALTON T, P872, DOI 10.1039/b313380j; Dey A, 2006, J AM CHEM SOC, V128, P533, DOI 10.1021/ja0549695; Hashimoto K, 2008, J BIOL CHEM, V283, P36617, DOI 10.1074/jbc.M806577200; Hopmann KH, 2007, INORG CHEM, V46, P4850, DOI 10.1021/ic061894c; Johnson K. A., 1992, ENZYMES, V20, P1, DOI DOI 10.1016/S1874-6047(08)60019-0; Kennepohl P, 2005, INORG CHEM, V44, P1826, DOI 10.1021/ic0487068; Kovacs JA, 2004, CHEM REV, V104, P825, DOI 10.1021/cr020619e; Martinkova L, 2003, CURR ORG CHEM, V7, P1279, DOI 10.2174/1385272033486486; Mitra S, 2007, J BIOL CHEM, V282, P7397, DOI 10.1074/jbc.M604117200; Noguchi T, 1996, BIOCHEMISTRY-US, V35, P16777, DOI 10.1021/bi961562r; Padmakumar R, 1999, APPL BIOCHEM BIOTECH, V77-9, P671; Petrillo KL, 2005, APPL MICROBIOL BIOT, V67, P664, DOI 10.1007/s00253-004-1842-9; Piersma SR, 2000, J INORG BIOCHEM, V80, P283, DOI 10.1016/S0162-0134(00)00076-3; Prasad S, 2010, BIOTECHNOL ADV, V28, P725, DOI 10.1016/j.biotechadv.2010.05.020; Rao S, 2008, BIOCHEMISTRY-US, V47, P12057, DOI 10.1021/bi801623t; Rose MJ, 2010, INORG CHEM, V49, P1854, DOI 10.1021/ic902220a; Rzeznicka K, 2010, APPL MICROBIOL BIOT, V85, P1417, DOI 10.1007/s00253-009-2153-y; Segel I. H., 1993, ENZYME KINETICS BEHA, P18; SUGIURA Y, 1987, J AM CHEM SOC, V109, P5848, DOI 10.1021/ja00253a046; Tsujimura M, 2003, J AM CHEM SOC, V125, P11532, DOI 10.1021/ja035018z; Wegman MA, 2002, BIOTECHNOL BIOENG, V79, P356, DOI 10.1002/bit.10278; Yamanaka Y, 2010, J BIOL INORG CHEM, V15, P655, DOI 10.1007/s00775-010-0632-3	24	14	14	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15532	15536		10.1074/jbc.M112.398909	http://dx.doi.org/10.1074/jbc.M112.398909			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23589282	Green Published, hybrid			2022-12-28	WOS:000319822300011
J	Wijeyewickrema, LC; Tang, YQ; Tran, TP; Thompson, PE; Viljoen, JE; Coetzer, TH; Duncan, RC; Kass, I; Buckle, AM; Pike, RN				Wijeyewickrema, Lakshmi C.; Tang Yongqing; Tran, Thuy P.; Thompson, Phillip E.; Viljoen, Jacqueline E.; Coetzer, Theresa H.; Duncan, Renee C.; Kass, Itamar; Buckle, Ashley M.; Pike, Robert N.			Molecular Determinants of the Substrate Specificity of the Complement-initiating Protease, C1r	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE; CATALYTIC DOMAIN; ACTIVATION; IDENTIFICATION; ZYMOGEN; MASP-2; PHAGE	The serine protease, C1r, initiates activation of the classical pathway of complement, which is a crucial innate defense mechanism against pathogens and altered-self cells. C1r both autoactivates and subsequently cleaves and activates C1s. Because complement is implicated in many inflammatory diseases, an understanding of the interaction between C1r and its target substrates is required for the design of effective inhibitors of complement activation. Examination of the active site specificity of C1r using phage library technology revealed clear specificity for Gln at P2 and Ile at P1', which are found in these positions in physiological substrates of C1r. Removal of one or both of the Gln at P2 and Ile at P1' in the C1s substrate reduced the rate of C1r activation. Substituting a Gln residue into the P2 of the activation site of MASP-3, a protein with similar domain structure to C1s that is not normally cleaved by C1r, enabled efficient activation of this enzyme. Molecular dynamics simulations and structural modeling of the interaction of the C1s activation peptide with the active site of C1r revealed the molecular mechanisms that particularly underpin the specificity of the enzyme for the P2 Gln residue. The complement control protein domains of C1r also made important contributions to efficient activation of C1s by this enzyme, indicating that exosite interactions were also important. These data show that C1r specificity is well suited to its cleavage targets and that efficient cleavage of C1s is achieved through both active site and exosite contributions.	[Wijeyewickrema, Lakshmi C.; Tang Yongqing; Tran, Thuy P.; Duncan, Renee C.; Kass, Itamar; Buckle, Ashley M.; Pike, Robert N.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Thompson, Phillip E.] Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Viljoen, Jacqueline E.; Coetzer, Theresa H.] Univ KwaZulu Natal, Sch Life Sci, Dept Biochem, ZA-3209 Scottsville, South Africa	Monash University; University of Kwazulu Natal	Pike, RN (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	rob.pike@monash.edu	Coetzer, Theresa/AAE-6207-2019; Buckle, Ashley/P-8366-2016; Kass, Itamar/P-5724-2014; Coetzer, Theresa/AAM-9193-2021; Wijeyewickrema, Lakshmi/A-9676-2015	Coetzer, Theresa/0000-0003-0706-3808; Buckle, Ashley/0000-0003-2943-9044; Kass, Itamar/0000-0002-5368-937X; Wijeyewickrema, Lakshmi/0000-0001-6084-4887; Pike, Robert/0000-0002-2083-0269; Thompson, Philip/0000-0002-5910-7625	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a program grant from the National Health and Medical Research Council of Australia.	Arlaud GJ, 2002, MOL IMMUNOL, V39, P383, DOI 10.1016/S0161-5890(02)00143-8; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Budayova-Spano M, 2002, STRUCTURE, V10, P1509, DOI 10.1016/S0969-2126(02)00881-X; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Duncan RC, 2008, BIOCHIMIE, V90, P387, DOI 10.1016/j.biochi.2007.07.023; Duncan RC, 2012, J IMMUNOL, V189, P2365, DOI 10.4049/jimmunol.1201085; Duncan RC, 2012, MOL IMMUNOL, V49, P593, DOI 10.1016/j.molimm.2011.10.006; Eswar N, 2006, CURR PROTOC BIOINFOR, V5; FRANK MM, 1991, IMMUNOL TODAY, V12, P322, DOI 10.1016/0167-5699(91)90009-I; Gaboriaud C, 2007, IMMUNOBIOLOGY, V212, P279, DOI 10.1016/j.imbio.2006.11.007; Gal P, 2009, MOL IMMUNOL, V46, P2745, DOI 10.1016/j.molimm.2009.04.026; Goldring JPD, 2005, IMMUNOL INVEST, V34, P101, DOI 10.1081/IMM-200049537; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; Heinz TN, 2001, J CHEM PHYS, V115, P1125, DOI 10.1063/1.1379764; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Kardos J, 2001, J IMMUNOL, V167, P5202, DOI 10.4049/jimmunol.167.9.5202; Kerr FK, 2008, MOL IMMUNOL, V45, P670, DOI 10.1016/j.molimm.2007.07.008; Lacroix M, 2001, J BIOL CHEM, V276, P36233, DOI 10.1074/jbc.M105688200; MATTHEWS DJ, 1994, PROTEIN SCI, V3, P1197, DOI 10.1002/pro.5560030805; Mittl PRE, 1997, STRUCTURE, V5, P253, DOI 10.1016/S0969-2126(97)00183-4; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; de Cordoba SR, 2012, IMMUNOBIOLOGY, V217, P1034, DOI 10.1016/j.imbio.2012.07.021; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006	28	13	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15571	15580		10.1074/jbc.M113.451757	http://dx.doi.org/10.1074/jbc.M113.451757			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23589288	Green Published, hybrid			2022-12-28	WOS:000319822300015
J	Lamothe, SM; Zhang, ST				Lamothe, Shawn M.; Zhang, Shetuan			The Serum- and Glucocorticoid-inducible Kinases SGK1 and SGK3 Regulate hERG Channel Expression via Ubiquitin Ligase Nedd4-2 and GTPase Rab11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; I-KR; CARDIAC-ARRHYTHMIA; QT SYNDROME; GENE; TRAFFICKING; PROTEIN; UBIQUITYLATION; DEGRADATION; TRANSPORT	The hERG (human ether-a-go-go-related gene) encodes the alpha subunit of the rapidly activating delayed rectifier potassium channel (I-Kr). Dysfunction of hERG channels due to mutations or certain medications causes long QT syndrome, which can lead to fatal ventricular arrhythmias or sudden death. Although the abundance of hERG in the plasma membrane is a key determinant of hERG functionality, the mechanisms underlying its regulation are not well understood. In the present study, we demonstrated that overexpression of the stress-responsive serum- and glucocorticoid-inducible kinase (SGK) isoforms SGK1 and SGK3 increased the current and expression level of the membrane-localized mature proteins of hERG channels stably expressed in HEK 293 (hERG-HEK) cells. Furthermore, the synthetic glucocorticoid, dexamethasone, increased the current and abundance of mature ERG proteins in both hERG-HEK cells and neonatal cardiac myocytes through the enhancement of SGK1 but not SGK3 expression. We have previously shown that mature hERG channels are degraded by ubiquitin ligase Nedd4-2 via enhanced channel ubiquitination. Here, we showed that SGK1 or SGK3 overexpression increased Nedd4-2 phosphorylation, which is known to inhibit Nedd4-2 activity. Nonetheless, disruption of the Nedd4-2 binding site in hERG channels did not eliminate the SGK-induced increase in hERG expression. Additional disruption of Rab11 proteins led to a complete elimination of SGK-mediated increase in hERG expression. These results show that SGK enhances the expression level of mature hERG channels by inhibiting Nedd4-2 as well as by promoting Rab11-mediated hERG recycling.	[Lamothe, Shawn M.; Zhang, Shetuan] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Zhang, ST (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Botterell Hall,Rm 429,18 Stuart St, Kingston, ON K7L 3N6, Canada.	shetuan.zhang@queensu.ca		Zhang, Shetuan/0000-0002-2297-0193; Lamothe, Shawn/0000-0001-8722-2631	Canadian Institutes of Health Research Grant [MOP 72911]; Heart and Stroke Foundation of Ontario Grant [T 6612]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario Grant	This work was supported by Canadian Institutes of Health Research Grant MOP 72911 and Heart and Stroke Foundation of Ontario Grant T 6612 (to S. Z.).; Recipient of a Canadian Institutes of Health Research new investigator award. To whom correspondence should be addressed: Dept. of Biomedical and Molecular Sciences, Queen's University, Botterell Hall, Rm. 429, 18 Stuart St., Kingston, Ontario K7L 3N6, Canada. Tel.: 613-533-3348; Fax: 613533-6880; E-mail: shetuan.zhang@queensu.ca.	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Albesa M, 2011, J MOL CELL CARDIOL, V51, P90, DOI 10.1016/j.yjmcc.2011.03.015; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Best JM, 2011, AM J PHYSIOL-CELL PH, V300, pC1023, DOI 10.1152/ajpcell.00288.2010; Busjahn A, 2004, CELL PHYSIOL BIOCHEM, V14, P135, DOI 10.1159/000078105; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Flores SY, 2003, PFLUG ARCH EUR J PHY, V446, P334, DOI 10.1007/s00424-003-1027-x; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Guo J, 2012, J BIOL CHEM, V287, P33132, DOI 10.1074/jbc.M112.389643; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; KERN W, 1995, J APPL PHYSIOL, V79, P1461, DOI 10.1152/jappl.1995.79.5.1461; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Lane RD, 2005, PSYCHOSOM MED, V67, P359, DOI 10.1097/01.psy.0000160476.67536.41; Lang F, 2001, Sci STKE, V2001, pre17, DOI 10.1126/stke.2001.108.re17; Maier G, 2006, CELL PHYSIOL BIOCHEM, V18, P177, DOI 10.1159/000097666; Massaeli H, 2010, J BIOL CHEM, V285, P27259, DOI 10.1074/jbc.M110.124909; McEwen RK, 1999, J BIOL CHEM, V274, P33905, DOI 10.1074/jbc.274.48.33905; Mohrmann K, 1999, MOL MEMBR BIOL, V16, P81, DOI 10.1080/096876899294797; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Patel C, 2010, CIRC-ARRHYTHMIA ELEC, V3, P401, DOI 10.1161/CIRCEP.109.921056; Peal DS, 2011, CIRCULATION, V123, P23, DOI 10.1161/CIRCULATIONAHA.110.003731; Pearce D, 2001, TRENDS ENDOCRIN MET, V12, P341, DOI 10.1016/S1043-2760(01)00439-8; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Sanguinetti MC, 2005, TRENDS PHARMACOL SCI, V26, P119, DOI 10.1016/j.tips.2005.01.003; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SCHWARTZ PJ, 1993, CIRCULATION, V88, P782, DOI 10.1161/01.CIR.88.2.782; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Shallow H, 2011, BIOPHYS J, V100, P102; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; Uhlig M, 2005, MOL CELL ENDOCRINOL, V235, P1, DOI 10.1016/j.mce.2005.02.004; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; VINCENT GM, 1992, NEW ENGL J MED, V327, P846, DOI 10.1056/NEJM199209173271204; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Zhang ST, 2006, AM J PHYSIOL-HEART C, V290, pH1038, DOI 10.1152/ajpheart.00679.2005; Zhang YQ, 2006, AM J PHYSIOL-HEART C, V291, pH1446, DOI 10.1152/ajpheart.01356.2005; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	41	43	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15075	15084		10.1074/jbc.M113.453670	http://dx.doi.org/10.1074/jbc.M113.453670			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23589291	hybrid, Green Published			2022-12-28	WOS:000319452100037
J	Lin, XH; Yang, H; Zhang, HF; Zhou, LC; Guo, ZM				Lin, Xinghua; Yang, Hong; Zhang, Hongfeng; Zhou, LiChun; Guo, ZhongMao			A Novel Transcription Mechanism Activated by Ethanol INDUCTION OF Slc7a11 GENE EXPRESSION VIA INHIBITION OF THE DNA-BINDING ACTIVITY OF TRANSCRIPTIONAL REPRESSOR OCTAMER-BINDING TRANSCRIPTION FACTOR 1 (OCT-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE PERITONEAL-MACROPHAGES; CYSTINE TRANSPORT ACTIVITY; HEPATIC STELLATE CELLS; ARYL-HYDROCARBON RECEPTOR; OXIDATIVE STRESS; HUMAN-FIBROBLASTS; GENE-EXPRESSION; BACTERIAL LIPOPOLYSACCHARIDE; PLASMA-MEMBRANE; LIVER-DISEASE	Solute carrier family 7, member 11 (Slc7a11) is a plasma membrane cystine/glutamate exchanger that provides intracellular cystine to produce glutathione, a major cellular antioxidant. Oxidative and endoplasmic reticulum stresses up-regulate Slc7a11 expression by activation of nuclear factor erythroid 2-related factor 2 and transcription factor 4. This study examined the effect of ethanol on Slc7a11 expression and the underlying mechanism involved. Treatment of mouse hepatic stellate cells with ethanol significantly increased Slc7a11 mRNA and protein levels. Deletion of a 20-bp DNA sequence between -2044 to -2024 upstream of the transcription start site significantly increased basal activity and completely abolished the ethanol-induced activity of the Slc7a11 promoter. This deletion did not affect Slc7a11 promoter activity induced by oxidative or endoplasmic reticulum stress. DNA sequence analysis revealed a binding motif for octamer-binding transcription factor 1 (OCT-1) in the deleted fragment. Mutation of this OCT-1 binding motif resulted in a similar effect as the deletion experiment, i.e. it increased the basal promoter activity and abolished the response to ethanol. Ethanol exposure significantly inhibited OCT-1 binding to the Slc7a11 promoter region, although it did not alter OCT-1 mRNA and protein levels. OCT-1 reportedly functions as either a transcriptional enhancer or repressor, depending on the target genes. Results from this study suggest that OCT-1 functions as a repressor on the Slc7a11 promoter and that ethanol inhibits OCT-1 binding to the Slc7a11 promoter, thereby increasing Slc7a11 expression. Taken together, inhibition of the DNA binding activity of transcriptional repressor OCT-1 is a mechanism by which ethanol up-regulates Slc711 expression.	[Lin, Xinghua; Yang, Hong; Zhang, Hongfeng; Zhou, LiChun; Guo, ZhongMao] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA	Meharry Medical College	Guo, ZM (corresponding author), Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA.	zguo@mmc.edu			National Institutes of Health [SC1HL101431, U54RR026140, R01ES014471, R01HL089382]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089382, SC1HL101431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported, in whole or in part, by National Institutes of Health Grants SC1HL101431 and U54RR026140 (to H. Y.) and R01ES014471 and R01HL089382 (to Z. G.).	Andersen B, 2001, ENDOCR REV, V22, P2, DOI 10.1210/er.22.1.2; Baker DA, 2002, AMINO ACIDS, V23, P161, DOI 10.1007/s00726-001-0122-6; BANNAI S, 1989, J BIOL CHEM, V264, P18480; BANNAI S, 1984, J BIOL CHEM, V259, P2435; BANNAI S, 1986, J BIOL CHEM, V261, P2256; Bassi MT, 2001, PFLUG ARCH EUR J PHY, V442, P286, DOI 10.1007/s004240100537; Castilla R, 2004, ALCOHOL ALCOHOLISM, V39, P290, DOI 10.1093/alcalc/agh065; Chen G, 2008, J NEUROSCI RES, V86, P937, DOI 10.1002/jnr.21540; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Dong J, 2008, ANTIOXID REDOX SIGN, V10, P2023, DOI 10.1089/ars.2007.2019; Eng FJ, 2000, AM J PHYSIOL-GASTR L, V279, pG7, DOI 10.1152/ajpgi.2000.279.1.G7; Grenfell SJ, 1996, BIOCHEM J, V315, P889, DOI 10.1042/bj3150889; Gukovskaya AS, 2002, GASTROENTEROLOGY, V122, P106, DOI 10.1053/gast.2002.30302; Gyamfi MA, 2010, EXP BIOL MED, V235, P547, DOI 10.1258/ebm.2009.009249; Hardie DG., 1999, PROTEIN PHOSPHORYLAT; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Kakizawa T, 1999, J BIOL CHEM, V274, P19103, DOI 10.1074/jbc.274.27.19103; Kawada N, 1996, CELL TISSUE RES, V284, P341, DOI 10.1007/s004410050594; Kawada N, 2006, GUT, V55, P1073, DOI 10.1136/gut.2005.090449; Ke ZJ, 2011, ALCOHOL CLIN EXP RES, V35, P1574, DOI 10.1111/j.1530-0277.2011.01503.x; Kim YD, 2007, J OCCUP HEALTH, V49, P363, DOI 10.1539/joh.49.363; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; Liang YB, 1996, J NEUROCHEM, V67, P1352; Lim K, 2005, ONCOL REP, V14, P727; Magne L, 2011, J HEPATOL, V54, P729, DOI 10.1016/j.jhep.2010.07.023; MAKOWSKE M, 1982, J BIOL CHEM, V257, P5663; Mann DA, 2010, J HEPATOL, V52, P949, DOI 10.1016/j.jhep.2010.02.005; Mates JM, 2008, ARCH TOXICOL, V82, P273, DOI 10.1007/s00204-008-0304-z; MURPHY S, 1992, MOL CELL BIOL, V12, P3247, DOI 10.1128/MCB.12.7.3247; Mustonen H, 2007, AM J PHYSIOL-GASTR L, V292, pG1614, DOI 10.1152/ajpgi.00273.2006; Norkina O, 2007, J LEUKOCYTE BIOL, V82, P752, DOI 10.1189/jlb.0207099; Pochareddy S, 2012, ALCOHOL CLIN EXP RES, V36, P1021, DOI 10.1111/j.1530-0277.2011.01677.x; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; SAMBROOK T, 2001, MOL CLONING LAB MANU; Sasaki H, 2002, J BIOL CHEM, V277, P44765, DOI 10.1074/jbc.M208704200; Sato H, 2004, BIOCHEM BIOPH RES CO, V325, P109, DOI 10.1016/j.bbrc.2004.10.009; SATO H, 1995, BIOCHEM J, V310, P547, DOI 10.1042/bj3100547; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; SATO H, 1995, BIOCHEM BIOPH RES CO, V215, P154, DOI 10.1006/bbrc.1995.2446; Sato H, 2001, J BIOL CHEM, V276, P10407, DOI 10.1074/jbc.M007216200; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; SIVE HL, 1986, MOL CELL BIOL, V6, P3329, DOI 10.1128/MCB.6.10.3329; Strom AC, 1996, NUCLEIC ACIDS RES, V24, P1981, DOI 10.1093/nar/24.11.1981; Tang TA, 2010, FREE RADICAL BIO MED, V49, P487, DOI 10.1016/j.freeradbiomed.2010.05.007; Urtasun R, 2008, CLIN LIVER DIS, V12, P769, DOI 10.1016/j.cld.2008.07.005; Zhang HF, 2012, ALCOHOL CLIN EXP RES, V36, P1873, DOI 10.1111/j.1530-0277.2012.01787.x	47	21	22	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14815	14823		10.1074/jbc.M113.466565	http://dx.doi.org/10.1074/jbc.M113.466565			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23592778	hybrid, Green Published			2022-12-28	WOS:000319452100014
J	Nguyen, S; Jones, DC; Wyllie, S; Fairlamb, AH; Phillips, MA				Suong Nguyen; Jones, Deuan C.; Wyllie, Susan; Fairlamb, Alan H.; Phillips, Margaret A.			Allosteric Activation of Trypanosomatid Deoxyhypusine Synthase by a Catalytically Dead Paralog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTES TRANSLATION ELONGATION; BLOOD-STREAM FORMS; GENE-EXPRESSION; DRUG TARGET; AFRICAN TRYPANOSOMES; EF-P; BRUCEI; ENZYME; PROTEINS; KINETOPLASTIDS	Polyamine biosynthesis is a key drug target in African trypanosomes. The "resurrection drug" eflornithine (difluoromethylornithine), which is used clinically to treathuman African trypanosomiasis, inhibits the first step in polyamine (spermidine) biosynthesis, a highly regulated pathway in most eukaryotic cells. Previously, we showed that activity of a key trypanosomatid spermidine biosynthetic enzyme, S-adenosylmethionine decarboxylase, is regulated by heterodimer formation with a catalytically dead paralog (a prozyme). Here, we describe an expansion of this prozyme paradigm to the enzyme deoxyhypusine synthase, which is required for spermidine-dependent hypusine modification of a lysine residue in the essential translation factor eIF5A. Trypanosoma brucei encodes two deoxyhypusine synthase paralogs, one that is catalytically functional but grossly impaired, and the other is inactive. Co-expression in Escherichia coli results in heterotetramer formation with a 3000-fold increase in enzyme activity. This functional complex is also present in T. brucei, and conditional knock-out studies indicate that both DHS genes are essential for in vitro growth and infectivity in mice. The recurrent evolution of paralogous, catalytically dead enzyme-based activating mechanisms may be a consequence of the unusual gene expression in the parasites, which lack transcriptional regulation. Our results suggest that this mechanism may be more widely used by trypanosomatids to control enzyme activity and ultimately influence pathogenesis than currently appreciated.	[Suong Nguyen; Phillips, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Jones, Deuan C.; Wyllie, Susan; Fairlamb, Alan H.] Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Dundee DD1 5EH, Scotland	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Dundee	Phillips, MA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	margaret.phillips@UTSouthwestern.edu	Fairlamb, Alan/A-5272-2009; Wyllie, Susan/AAI-4430-2021	Fairlamb, Alan/0000-0001-5134-0329; Wyllie, Susan/0000-0001-8810-5605	National Institutes of Health [2R37 AI034432]; Welch Foundation [I-1257]; Wellcome Trust [079838, 083481]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R37 AI034432 (to M. A. P.). This work was also supported by Welch Foundation Grant I-1257 (to M. A. P.).; Wellcome Trust Principal Research Fellow supported by Wellcome Trust Grants 079838 and 083481.	Adrain C, 2012, NAT REV MOL CELL BIO, V13, P489, DOI 10.1038/nrm3392; Arakaki TL, 2008, MOL MICROBIOL, V68, P37, DOI 10.1111/j.1365-2958.2008.06131.x; Brenndorfer M, 2010, MOL BIOCHEM PARASIT, V172, P52, DOI 10.1016/j.molbiopara.2010.03.007; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Chawla B, 2010, J BIOL CHEM, V285, P453, DOI 10.1074/jbc.M109.048850; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; Force A, 1999, GENETICS, V151, P1531; Gunzl A, 2010, EUKARYOT CELL, V9, P1159, DOI 10.1128/EC.00113-10; HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2; Ivanov IP, 2010, J MOL EVOL, V70, P289, DOI 10.1007/s00239-010-9331-5; Ivanov IP, 2010, NUCLEIC ACIDS RES, V38, P353, DOI 10.1093/nar/gkp1037; JOE YA, 1995, J BIOL CHEM, V270, P22386, DOI 10.1074/jbc.270.38.22386; Jones DC, 2012, MOL MICROBIOL, V86, P51, DOI 10.1111/j.1365-2958.2012.08189.x; Kahana C, 2009, ESSAYS BIOCHEM, V46, P47, DOI [10.1042/BSE0460004, 10.1042/bse0460004]; Kramer S, 2012, MOL BIOCHEM PARASIT, V181, P61, DOI 10.1016/j.molbiopara.2011.10.002; LEE YB, 1995, J MED CHEM, V38, P3053, DOI 10.1021/jm00016a008; Li CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009942; Monnerat S, 2004, MOL BIOCHEM PARASIT, V134, P233, DOI 10.1016/j.molbiopara.2003.12.004; Nishimura K, 2012, AMINO ACIDS, V42, P703, DOI 10.1007/s00726-011-0986-z; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Pegg AE, 2011, METHODS MOL BIOL, V720, P3, DOI 10.1007/978-1-61779-034-8_1; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Pei BK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r51; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Sasaki K, 1996, FEBS LETT, V384, P151, DOI 10.1016/0014-5793(96)00310-9; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Sienkiewicz N, 2008, MOL MICROBIOL, V69, P520, DOI 10.1111/j.1365-2958.2008.06305.x; Sommer MN, 2004, J BIOMOL SCREEN, V9, P434, DOI 10.1177/1087057104264031; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Umland TC, 2004, J BIOL CHEM, V279, P28697, DOI 10.1074/jbc.M404095200; Willert E, 2012, TRENDS PARASITOL, V28, P66, DOI 10.1016/j.pt.2011.11.001; Willert EK, 2007, P NATL ACAD SCI USA, V104, P8275, DOI 10.1073/pnas.0701111104; Willert EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000183; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wolff EC, 2000, J BIOL CHEM, V275, P9170, DOI 10.1074/jbc.275.13.9170; Wolff EC, 2011, METHODS MOL BIOL, V720, P195, DOI 10.1007/978-1-61779-034-8_12; Wyllie S, 2009, MOL MICROBIOL, V74, P529, DOI 10.1111/j.1365-2958.2009.06761.x; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001	44	34	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15256	15267		10.1074/jbc.M113.461137	http://dx.doi.org/10.1074/jbc.M113.461137			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23525104	Green Published, hybrid			2022-12-28	WOS:000319452100052
J	Zhang, YX; Motamed, M; Seemann, J; Brown, MS; Goldstein, JL				Zhang, Yinxin; Motamed, Massoud; Seemann, Joachim; Brown, Michael S.; Goldstein, Joseph L.			Point Mutation in Luminal Loop 7 of Scap Protein Blocks Interaction with Loop 1 and Abolishes Movement to Golgi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLEAVAGE-ACTIVATING PROTEIN; ELEMENT-BINDING PROTEINS; STEROL-SENSING DOMAIN; ENDOPLASMIC-RETICULUM; CHOLESTEROL HOMEOSTASIS; COMPETITIVE INHIBITOR; REGULATED TRANSPORT; MEMBRANE-PROTEIN; COPII PROTEINS; ER MEMBRANES	Scap is a polytopic protein of the endoplasmic reticulum (ER) that controls cholesterol homeostasis by transporting sterol regulatory element-binding proteins (SREBPs) from the ER to the Golgi complex. Scap has eight transmembrane helices (TM) joined by four small hydrophilic loops and three large loops. Two of the large loops (Loops 1 and 7) are in the ER lumen, and the other large loop (Loop 6) faces the cytosol where it binds COPII proteins that initiate transport to Golgi. Cholesterol binding to Loop 1 alters the configuration of Loop 6, precluding COPII binding and preventing the exit of Scap from the ER. Here, we create a point mutation (Y640S) in luminal Loop 7 that prevents Scap movement to Golgi. Trypsin cleavage assays show that Loop 6 of Scap(Y640S) is always in the configuration that precludes COPII binding, even in the absence of cholesterol. When expressed separately by co-transfection, the NH2-terminal portion of Scap (containing TM helices 1-6, including Loop 1) binds to the COOH-terminal portion (containing TM helices 7-8 and Loop 7) as determined by co-immunoprecipitation. This binding does not occur when Loop 7 contains the Y640S mutation. Co-immunoprecipitation is also abolished by a point mutation in Loop 1 (Y234A) that also prevents Scap movement. These data suggest that Scap Loop 1 must interact with Loop 7 to maintain Loop 6 in the configuration that permits COPII binding. These results help explain the operation of Scap as a sterol sensor.	[Zhang, Yinxin; Motamed, Massoud; Brown, Michael S.; Goldstein, Joseph L.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Seemann, Joachim] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Brown, MS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	mike.brown@utsouthwestern.edu; joe.goldstein@utsouthwestern.edu	Zhang, Yinxin/I-9996-2019	Zhang, Yinxin/0000-0001-5909-3676	National Institutes of Health [HL20948, GM096070]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL20948 (to J. L. G. and M. S. B.) and GM096070 (to J. S.).	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Feramisco JD, 2005, P NATL ACAD SCI USA, V102, P3242, DOI 10.1073/pnas.0500206102; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Gong Y, 2006, CELL METAB, V3, P15, DOI 10.1016/j.cmet.2005.11.014; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Ikeda Y, 2009, J BIOL CHEM, V284, P34889, DOI 10.1074/jbc.M109.044875; KITA T, 1980, J CLIN INVEST, V66, P1094, DOI 10.1172/JCI109938; Motamed M, 2011, J BIOL CHEM, V286, P18002, DOI 10.1074/jbc.M111.238311; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Nohturfft A, 1998, P NATL ACAD SCI USA, V95, P12848, DOI 10.1073/pnas.95.22.12848; Nohturfft A, 1998, J BIOL CHEM, V273, P17243, DOI 10.1074/jbc.273.27.17243; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; Wei JH, 2009, NAT PROTOC, V4, P1653, DOI 10.1038/nprot.2009.160; Wei JH, 2009, J CELL BIOL, V184, P391, DOI 10.1083/jcb.200809090; Yabe D, 2002, P NATL ACAD SCI USA, V99, P16672, DOI 10.1073/pnas.262669399; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Yang T, 2000, J BIOL CHEM, V275, P29881, DOI 10.1074/jbc.M005439200; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3	32	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14059	14067		10.1074/jbc.M113.469528	http://dx.doi.org/10.1074/jbc.M113.469528			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23564452	hybrid, Green Published			2022-12-28	WOS:000319253500011
J	Gherasim, C; Lofgren, M; Banerjee, R				Gherasim, Carmen; Lofgren, Michael; Banerjee, Ruma			Navigating the B-12 Road: Assimilation, Delivery, and Disorders of Cobalamin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HUMAN METHIONINE SYNTHASE; METHYLMALONYL-COA MUTASE; COMMON POLYMORPHIC VARIANTS; COENZYME B-12; INTRINSIC-FACTOR; COMPLEMENTATION GROUP; CBLD DEFECT; ATP-COB(I)ALAMIN ADENOSYLTRANSFERASE; ACTIVATION PARAMETERS; REDUCTIVE ACTIVATION	The reactivity of the cobalt-carbon bond in cobalamins is the key to their chemical versatility, supporting both methyl transfer and isomerization reactions. During evolution of higher eukaryotes that utilize vitamin B-12, the high reactivity of the cofactor coupled with its low abundance pressured development of an efficient system for uptake, assimilation, and delivery of the cofactor to client B-12-dependent enzymes. Although most proteins suspected to be involved in B-12 trafficking were discovered by 2009, the recent identification of a new protein reveals that the quest for elucidating the intracellular B-12 highway is still far from complete. Herein, we review the biochemistry of cobalamin trafficking.	[Gherasim, Carmen; Lofgren, Michael; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu			National Institutes of Health [DK45776]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045776, R29DK045776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK45776. This is the fourth article in the Thematic Minireview Series on Metals in Biology 2013.	Aminoff M, 1999, NAT GENET, V21, P309, DOI 10.1038/6831; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Banerjee R, 2006, ACS CHEM BIOL, V1, P149, DOI 10.1021/cb6001174; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; BANERJEE RV, 1990, BIOCHEMISTRY-US, V29, P1129, DOI 10.1021/bi00457a005; Beedholm-Ebsen R, 2010, BLOOD, V115, P1632, DOI 10.1182/blood-2009-07-232587; Boal AK, 2009, CHEM REV, V109, P4760, DOI 10.1021/cr900104z; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; BROWN KL, 1984, J AM CHEM SOC, V106, P7894, DOI 10.1021/ja00337a043; Brown KL, 1999, J INORG BIOCHEM, V77, P185, DOI 10.1016/S0162-0134(99)00190-7; Chen LH, 1997, J BIOL CHEM, V272, P3628, DOI 10.1074/jbc.272.6.3628; Coelho D, 2008, NEW ENGL J MED, V358, P1454, DOI 10.1056/NEJMoa072200; Coelho D, 2012, NAT GENET, V44, P1152, DOI 10.1038/ng.2386; Deme JC, 2012, MOL GENET METAB, V107, P352, DOI 10.1016/j.ymgme.2012.07.001; Dempsey-Nunez L, 2012, MOL GENET METAB, V107, P363, DOI 10.1016/j.ymgme.2012.09.012; Dobson CM, 2002, HUM MOL GENET, V11, P3361, DOI 10.1093/hmg/11.26.3361; Dobson CM, 2002, P NATL ACAD SCI USA, V99, P15554, DOI 10.1073/pnas.242614799; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Fedosov SN, 2002, J BIOL CHEM, V277, P9989, DOI 10.1074/jbc.M111399200; Froese DS, 2012, BIOCHEMISTRY-US, V51, P5083, DOI 10.1021/bi300150y; Froese DS, 2010, J BIOL CHEM, V285, P38204, DOI 10.1074/jbc.M110.177717; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Gherasim C, 2013, BIOCHIMIE, V95, P1023, DOI 10.1016/j.biochi.2013.02.003; Gulati S, 1997, J BIOL CHEM, V272, P19171, DOI 10.1074/jbc.272.31.19171; Gulati S, 1996, HUM MOL GENET, V5, P1859, DOI 10.1093/hmg/5.12.1859; HALL CA, 1977, CLIN SCI MOL MED, V53, P453, DOI 10.1042/cs0530453; Hannibal L, 2009, MOL GENET METAB, V97, P260, DOI 10.1016/j.ymgme.2009.04.005; HODGKIN DC, 1956, NATURE, V178, P64, DOI 10.1038/178064a0; Hu YL, 2013, BBA-BIOENERGETICS, V1827, P1112, DOI 10.1016/j.bbabio.2012.12.001; Hubbard PA, 2007, J BIOL CHEM, V282, P31308, DOI 10.1074/jbc.M704850200; Kim J, 2008, P NATL ACAD SCI USA, V105, P14551, DOI 10.1073/pnas.0805989105; Kim J, 2009, J BIOL CHEM, V284, P33418, DOI 10.1074/jbc.M109.057877; KOLHOUSE JF, 1978, NEW ENGL J MED, V299, P785, DOI 10.1056/NEJM197810122991501; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; Koutmos M, 2011, J BIOL CHEM, V286, P29780, DOI 10.1074/jbc.M111.261370; Leal NA, 2004, J BIOL CHEM, V279, P47536, DOI 10.1074/jbc.M405449200; Leal NA, 2003, J BIOL CHEM, V278, P9227, DOI 10.1074/jbc.M212739200; Leclerc D, 1996, HUM MOL GENET, V5, P1867, DOI 10.1093/hmg/5.12.1867; Lerner-Ellis JP, 2006, NAT GENET, V38, P93, DOI 10.1038/ng1683; Lerner-Ellis JP, 2004, HUM MUTAT, V24, P509, DOI 10.1002/humu.20104; LEXA D, 1983, ACCOUNTS CHEM RES, V16, P235, DOI 10.1021/ar00091a001; LI N, 1995, BIOCHEM BIOPH RES CO, V208, P756, DOI 10.1006/bbrc.1995.1402; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lofgren M, 2011, BIOCHEMISTRY-US, V50, P5790, DOI 10.1021/bi2006306; Ludwig ML, 1997, ANNU REV BIOCHEM, V66, P269, DOI 10.1146/annurev.biochem.66.1.269; Lutsenko S, 2010, CURR OPIN CHEM BIOL, V14, P211, DOI 10.1016/j.cbpa.2010.01.003; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Matthews RG, 2008, CURR OPIN STRUC BIOL, V18, P658, DOI 10.1016/j.sbi.2008.11.005; Mera PE, 2010, APPL MICROBIOL BIOT, V88, P41, DOI 10.1007/s00253-010-2773-2; Mera PE, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.059485; Olteanu H, 2004, BIOCHEMISTRY-US, V43, P1988, DOI 10.1021/bi035910i; Olteanu H, 2002, BIOCHEMISTRY-US, V41, P13378, DOI 10.1021/bi020536s; Olteanu H, 2001, J BIOL CHEM, V276, P35558, DOI 10.1074/jbc.M103707200; Padovani D, 2008, NAT CHEM BIOL, V4, P194, DOI 10.1038/nchembio.67; Padovani D, 2006, BIOCHEMISTRY-US, V45, P9300, DOI 10.1021/bi0604532; Padovani D, 2006, J BIOL CHEM, V281, P17838, DOI 10.1074/jbc.M600047200; Padovani D, 2009, P NATL ACAD SCI USA, V106, P21567, DOI 10.1073/pnas.0908106106; Padovani D, 2009, BIOCHEMISTRY-US, V48, P5350, DOI 10.1021/bi900454s; Perez B, 2010, J INHERIT METAB DIS, V33, pS307, DOI 10.1007/s10545-010-9116-4; Quadros EV, 2010, BRIT J HAEMATOL, V148, P195, DOI 10.1111/j.1365-2141.2009.07937.x; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; Reddi AR, 2009, CHEM REV, V109, P4722, DOI 10.1021/cr900031u; ROSENBLATT DS, 1985, SCIENCE, V228, P1319, DOI 10.1126/science.4001945; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; Seetharam Bellur, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006422; SHEVELL MI, 1992, CAN J NEUROL SCI, V19, P472, DOI 10.1017/S0317167100041676; Stich TA, 2005, J AM CHEM SOC, V127, P7660, DOI 10.1021/ja050546r; Stucki M, 2012, HUM MOL GENET, V21, P1410, DOI 10.1093/hmg/ddr579; STUPPERICH E, 1991, EUR J BIOCHEM, V199, P299, DOI 10.1111/j.1432-1033.1991.tb16124.x; Suormala T, 2004, J BIOL CHEM, V279, P42742, DOI 10.1074/jbc.M407733200; Takahashi-Iniguez T, 2011, BIOCHEM BIOPH RES CO, V404, P443, DOI 10.1016/j.bbrc.2010.11.141; WADDINGTON MD, 1993, J AM CHEM SOC, V115, P4629, DOI 10.1021/ja00064a026; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; WATKINS D, 1989, AM J MED GENET, V34, P427, DOI 10.1002/ajmg.1320340320; Wolthers KR, 2003, BIOCHEMISTRY-US, V42, P3911, DOI 10.1021/bi027290b; Wuerges J, 2006, P NATL ACAD SCI USA, V103, P4386, DOI 10.1073/pnas.0509099103; Yamada K, 2006, P NATL ACAD SCI USA, V103, P9476, DOI 10.1073/pnas.0603694103; Yamanishi M, 2005, J AM CHEM SOC, V127, P526, DOI 10.1021/ja044365l; Yamanishi M, 2005, TRENDS BIOCHEM SCI, V30, P304, DOI 10.1016/j.tibs.2005.04.008	79	117	118	0	64	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13186	13193		10.1074/jbc.R113.458810	http://dx.doi.org/10.1074/jbc.R113.458810			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23539619	Green Published, hybrid			2022-12-28	WOS:000318850300005
J	Lai, FF; Madan, N; Ye, QQ; Duan, QM; Li, ZC; Wang, SM; Si, SY; Xie, ZJ				Lai, Fangfang; Madan, Namrata; Ye, Qiqi; Duan, Qiming; Li, Zhichuan; Wang, Shaomeng; Si, Shuyi; Xie, Zijian			Identification of a Mutant alpha 1 Na/K-ATPase That Pumps but Is Defective in Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-POTASSIUM PUMP; CARDIOTONIC STEROIDS; CRYSTAL-STRUCTURE; SRC; OUABAIN; EXPRESSION; BINDING; INHIBITOR; LLC-PK1; GROWTH	The alpha 1 Na/K-ATPase possesses both pumping and signaling functions. However, it has not been possible to study these functions independently in live cells. We have identified a 20-amino acid peptide (Ser-415 to Gln-434) (NaKtide) from the nucleotide binding domain of alpha 1 Na/K-ATPase that binds and inhibits Src in vitro. The N terminus of NaKtide adapts a helical structure. In vitro kinase assays showed that replacement of residues that contain a bulky side chain in the helical structure of NaKtide by alanine abolished the inhibitory effect of the peptide on Src. Similarly, disruption of helical structure by proline replacement, either single or in combination, reduced the inhibitory potency of NaKtide on Src. To identify mutant alpha 1 that retains normal pumping function but is defective in Src regulation, we transfected Na/K-ATPase alpha 1 knockdown PY-17 cells with expression vectors of wild type or mutant alpha 1 carrying Ala to Pro mutations in the region of NaKtide helical structure and generated several stable cell lines. We found that expression of either A416P or A420P or A425P mutant fully restored the alpha 1 content and consequently the pumping capacity of cells. However, in contrast to A416P, either A420P or A425P mutant was incapable of interacting and regulating cellular Src. Consequently, expression of these two mutants caused significant inhibition of ouabain-activated signal transduction and cell growth. Thus we have identified alpha 1 mutant that has normal pumping function but is defective in signal transduction.	[Lai, Fangfang; Madan, Namrata; Ye, Qiqi; Duan, Qiming; Li, Zhichuan; Xie, Zijian] Univ Toledo, Coll Med, Dept Physiol Pharmacol & Med, Toledo, OH 43614 USA; [Lai, Fangfang; Si, Shuyi] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China; [Lai, Fangfang; Si, Shuyi] Peking Union Med Coll, Beijing 100050, Peoples R China; [Wang, Shaomeng] Univ Michigan, Ctr Comprehens Canc, Dept Med Chem Internal Med & Pharmacol, Ann Arbor, MI 48109 USA	University System of Ohio; University of Toledo; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Michigan System; University of Michigan	Xie, ZJ (corresponding author), Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Mail Stop 1008,3000 Arlington Ave, Toledo, OH 43614 USA.	Zi-jian.Xie@utoledo.edu	Li, Zhichuan/Q-7379-2017; Duan, Qiming/I-1822-2019	Duan, Qiming/0000-0002-6204-3028; Wang, Shaomeng/0000-0002-8782-6950	National Institutes of Health [HL-109015]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-109015 (NHLBI).	Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Blanco G, 2005, SEMIN NEPHROL, V25, P292, DOI 10.1016/j.semnephrol.2005.03.004; Boxenbaum N, 1998, J BIOL CHEM, V273, P23086, DOI 10.1074/jbc.273.36.23086; Cai T, 2008, J CELL BIOL, V182, P1153, DOI 10.1083/jcb.200712022; Chen YL, 2009, J BIOL CHEM, V284, P14881, DOI 10.1074/jbc.M109.003574; Dostanic-Larson I, 2005, P NATL ACAD SCI USA, V102, P15845, DOI 10.1073/pnas.0507358102; Haas M, 2000, J BIOL CHEM, V275, P27832; HAMLYN JM, 1982, NATURE, V300, P650, DOI 10.1038/300650a0; Kawamoto SA, 2012, J MED CHEM, V55, P1137, DOI 10.1021/jm201125d; KELLY RA, 1989, AM J PHYSIOL, V256, pC937, DOI 10.1152/ajpcell.1989.256.5.C937; Kennedy DJ, 2006, HYPERTENSION, V47, P488, DOI 10.1161/01.HYP.0000202594.82271.92; Li JA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1043; Li ZC, 2011, J BIOL CHEM, V286, P32394, DOI 10.1074/jbc.M110.207597; Li ZC, 2009, J BIOL CHEM, V284, P21066, DOI 10.1074/jbc.M109.013821; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Liu J, 2002, KIDNEY INT, V62, P2118, DOI 10.1046/j.1523-1755.2002.00672.x; Liu J, 2004, KIDNEY INT, V66, P227, DOI 10.1111/j.1523-1755.2004.00723.x; Liu J, 2011, J BIOL CHEM, V286, P22806, DOI 10.1074/jbc.M111.246249; Loreaux EL, 2008, J AM SOC NEPHROL, V19, P1947, DOI 10.1681/ASN.2008020174; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Salanueva IJ, 2007, J CELL MOL MED, V11, P969, DOI 10.1111/j.1582-4934.2007.00109.x; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; Toustrup-Jensen M, 2003, J BIOL CHEM, V278, P38653, DOI 10.1074/jbc.M305521200; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; Ye QQ, 2013, J BIOL CHEM, V288, P5803, DOI 10.1074/jbc.M112.442608	32	47	51	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13295	13304		10.1074/jbc.M113.467381	http://dx.doi.org/10.1074/jbc.M113.467381			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23532853	hybrid, Green Published			2022-12-28	WOS:000318850300015
J	Liang, SY; Dai, JX; Hou, S; Su, LS; Zhang, DP; Guo, HZ; Hu, S; Wang, H; Rao, ZH; Guo, YJ; Lou, ZY				Liang, Shuaiyi; Dai, Jianxin; Hou, Sheng; Su, Lishu; Zhang, Dapeng; Guo, Huaizu; Hu, Shi; Wang, Hao; Rao, Zihe; Guo, Yajun; Lou, Zhiyong			Structural Basis for Treating Tumor Necrosis Factor alpha (TNF alpha)-associated Diseases with the Therapeutic Antibody Infliximab	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-ALPHA; CRYSTAL-STRUCTURE; RHEUMATOID-ARTHRITIS; RECEPTOR; BINDING; EFFICACY; COMPLEX; METAANALYSIS; SUPERFAMILY; RESISTANCE	Monoclonal antibody (mAb) drugs have been widely used for treating tumor necrosis factor alpha (TNF alpha)-related diseases for over 10 years. Although their action has been hypothesized to depend in part on their ability to bind precursor cell surface TNF alpha, the precise mechanism and the epitope bound on TNF alpha remain unclear. In the present work, we report the crystal structure of the infliximab Fab fragment in complex with TNF alpha at a resolution of 2.6 angstrom. The key features of the TNF alpha E-F loop region in this complex distinguish the interaction between infliximab and TNF alpha from other TNF-receptor structures, revealing the mechanism of TNF alpha inhibition by overlapping with the TNF alpha-receptor interface and indicating the crucial role of the E-F loop in the action of this therapeutic antibody. This structure also indicates the formation of an aggregated network for the activation of complement-dependent cytolysis and antibody-dependent cell-mediated cytotoxicity, which result in development of granulomatous infections through TNF alpha blockage. These results provide the first experimental model for the interaction of TNF alpha with therapeutic antibodies and offer useful information for antibody optimization by understanding the precise molecular mechanism of TNF alpha inhibition.	[Liang, Shuaiyi; Su, Lishu; Rao, Zihe; Lou, Zhiyong] Tsinghua Univ, Struct Biol Lab, Beijing 100084, Peoples R China; [Liang, Shuaiyi; Su, Lishu; Rao, Zihe; Lou, Zhiyong] Tsinghua Univ, Minist Educ, Lab Prot Sci, Sch Med, Beijing 100084, Peoples R China; [Dai, Jianxin; Hou, Sheng; Zhang, Dapeng; Guo, Huaizu; Hu, Shi; Wang, Hao; Guo, Yajun] Second Mil Med Univ, Int Joint Canc Inst, Shanghai 200433, Peoples R China; [Dai, Jianxin; Hou, Sheng; Zhang, Dapeng; Guo, Huaizu; Hu, Shi; Wang, Hao; Guo, Yajun] Natl Engn Res Ctr Antibody Med, Shanghai 201203, Peoples R China; [Dai, Jianxin; Hou, Sheng; Zhang, Dapeng; Guo, Huaizu; Hu, Shi; Wang, Hao; Guo, Yajun] Shanghai Key Lab Cell Engn & Antibody, Shanghai 201203, Peoples R China; [Dai, Jianxin; Hou, Sheng; Zhang, Dapeng; Guo, Huaizu; Hu, Shi; Wang, Hao; Guo, Yajun] Peoples Liberat Army Gen Hosp, Ctr Canc, PLA Postgrad Sch Med, Beijing 100853, Peoples R China	Tsinghua University; Tsinghua University; Naval Medical University; Chinese People's Liberation Army General Hospital	Guo, YJ (corresponding author), Second Mil Med Univ, Int Joint Canc Inst, Shanghai 200433, Peoples R China.	yjguo@smmu.edu.cn; louzy@xtal.tsinghua.edu.cn	Hu, Shi/A-2140-2015; Rao, Zihe/HCH-6944-2022	Hu, Shi/0000-0002-7905-4284; 	"973" Project [2010CB833600]; National Major Projects of China [2009ZX10004-304, 2009ZX09311-001]; National Natural Science Foundation of China [30830109]; Shanghai Leading Academic Discipline Project [B905]	"973" Project(National Basic Research Program of China); National Major Projects of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by "973" Project Grant 2010CB833600, National Major Projects of China Grants 2009ZX10004-304 and 2009ZX09311-001, National Natural Science Foundation of China Grant 30830109, and Shanghai Leading Academic Discipline Project Grant B905.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Alonso-Ruiz A, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-52; An ZQ, 2010, PROTEIN CELL, V1, P319, DOI 10.1007/s13238-010-0052-8; Bachmann F, 2010, SEMIN CUTAN MED SURG, V29, P35, DOI 10.1016/j.sder.2010.02.002; Baidoo L, 2005, AM J GASTROENTEROL, V100, P80, DOI 10.1111/j.1572-0241.2005.41716.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bernett MJ, 2010, J MOL BIOL, V396, P1474, DOI 10.1016/j.jmb.2009.12.046; Buch MH, 2004, ANN RHEUM DIS, V63, P1344, DOI 10.1136/ard.2003.014878; Byla P, 2010, J BIOL CHEM, V285, P12096, DOI 10.1074/jbc.M109.063305; Carter PH, 2001, P NATL ACAD SCI USA, V98, P11879, DOI 10.1073/pnas.211178398; Chan FKM, 2000, IMMUNITY, V13, P419, DOI 10.1016/S1074-7613(00)00041-8; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chiou HL, 1997, J GEN VIROL, V78, P2639, DOI 10.1099/0022-1317-78-10-2639; DeLano W.L, PYMOL MOL GRAPHICS S; ECK MJ, 1992, J BIOL CHEM, V267, P2119; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gupta AK, 2004, J CUTAN MED SURG, V8, P77, DOI 10.1177/120347540400800202; Hasegawa Akihiro, 2001, Mini-Reviews in Medicinal Chemistry, V1, P5, DOI 10.2174/1389557013407214; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kaymakcalan Z, 2009, CLIN IMMUNOL, V131, P308, DOI 10.1016/j.clim.2009.01.002; Kim MS, 2007, J MOL BIOL, V374, P1374, DOI 10.1016/j.jmb.2007.10.034; KNIGHT DM, 1993, MOL IMMUNOL, V30, P1443, DOI 10.1016/0161-5890(93)90106-L; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Le J, 1997, Methods of treating TNF-a-mediated Crohn's disease using chimeric anti-TNF antibodies, Patent No. [5,656,272, 5656272, US5656272]; Martin ACR, 1996, PROTEINS, V25, P130, DOI 10.1002/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.3.CO;2-Y; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Matthews N., 1987, LYMPHOKINES INTERFER; Mazza J, 2010, DERMATOL CLIN, V28, P559, DOI 10.1016/j.det.2010.03.009; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Moreland LW, 1999, J RHEUMATOL, V26, P7; Mukai Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000954; Mukai Y, 2009, J MOL BIOL, V385, P1221, DOI 10.1016/j.jmb.2008.11.053; Murali R, 2005, P NATL ACAD SCI USA, V102, P10970, DOI 10.1073/pnas.0504301102; NAISMITH JH, 1995, J BIOL CHEM, V270, P13303, DOI 10.1074/jbc.270.22.13303; Ono K, 2010, PROTEIN CELL, V1, P161, DOI 10.1007/s13238-010-0017-y; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palladino MA, 2003, NAT REV DRUG DISCOV, V2, P736, DOI 10.1038/nrd1175; PEREZ C, 1990, CELL, V63, P251, DOI 10.1016/0092-8674(90)90158-B; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Ricart E, 1999, GASTROENTEROLOGY, V117, P429, DOI 10.1053/gast.1999.0029900429; Scallon B, 2002, J PHARMACOL EXP THER, V301, P418, DOI 10.1124/jpet.301.2.418; SCALLON BJ, 1995, CYTOKINE, V7, P251, DOI 10.1006/cyto.1995.0029; Talbot C, 2005, COLORECTAL DIS, V7, P164, DOI 10.1111/j.1463-1318.2004.00749.x; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; van Horssen R, 2006, ONCOLOGIST, V11, P397, DOI 10.1634/theoncologist.11-4-397; Wiens A, 2010, PHARMACOTHERAPY, V30, P339, DOI 10.1592/phco.30.4.339; Yang ZR, 2009, NAT STRUCT MOL BIOL, V16, P1189, DOI 10.1038/nsmb.1683	54	65	77	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13799	13807		10.1074/jbc.M112.433961	http://dx.doi.org/10.1074/jbc.M112.433961			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23504311	hybrid, Green Published			2022-12-28	WOS:000318850300061
J	Nakamura, A; Tsukada, T; Auer, S; Furuta, T; Wada, M; Koivula, A; Igarashi, K; Samejima, M				Nakamura, Akihiko; Tsukada, Takeshi; Auer, Sanna; Furuta, Tadaomi; Wada, Masahisa; Koivula, Anu; Igarashi, Kiyohiko; Samejima, Masahiro			The Tryptophan Residue at the Active Site Tunnel Entrance of Trichoderma reesei Cellobiohydrolase Cel7A Is Important for Initiation of Degradation of Crystalline Cellulose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; PROCESSIVITY; HYDROLYSIS; KINETICS; DOMAINS; CLONING; ENZYME; CHAIN	The glycoside hydrolase family 7 cellobiohydrolase Cel7A from Trichoderma reesei is one of the best studied cellulases with the ability to degrade highly crystalline cellulose. The catalytic domain and the cellulose-binding domain (CBD) are both necessary for full activity on crystalline substrates. Our previous high-speed atomic force microscopy studies showed that mutation of Trp-40 at the entrance of the catalytic tunnel drastically decreases the ability to degrade crystalline cellulose. Here, we examined the activities of the WT enzyme and mutant W40A (with and without the CBD) for various substrates. Evaluation and comparison of the specific activities of the enzymes (WT, W40A, and the corresponding catalytic subunits (WTcat and W40A(cat))) adsorbed on crystalline cellulose indicated that Trp-40 is involved in recruiting individual substrate chains into the active site tunnel to initiate processive hydrolysis. This was supported by molecular dynamics simulation study, i.e. the reducing end glucose unit was effectively loaded into the active site of WTcat, but not into that of W40A(cat), when the simulation was started from subsite -7. However, when similar simulations were carried out starting from subsite -5, both enzymes held the substrate for 50 ns, indicating that the major difference between WTcat and W40A(cat) is the length of the free chain end of the substrate required to allow initiation of processive movements; this also reflects the difference between crystalline and amorphous celluloses. The CBD is important for enhancing the enzyme population on crystalline substrate, but it also decreases the specific activity of the adsorbed enzyme, possibly by attaching the enzyme to non-optimal places on the cellulose surface and/or hindering processive hydrolysis.	[Nakamura, Akihiko; Tsukada, Takeshi; Wada, Masahisa; Igarashi, Kiyohiko; Samejima, Masahiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo 1138657, Japan; [Tsukada, Takeshi; Auer, Sanna; Koivula, Anu] VTT Tech Res Ctr Finland, FI-02044 Espoo, VTT, Finland; [Furuta, Tadaomi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; [Wada, Masahisa] Kyung Hee Univ, Coll Life Sci, Dept Plant & Environm New Resources, Yongin 446701, Gyeonggi Do, South Korea	University of Tokyo; VTT Technical Research Center Finland; Tokyo Institute of Technology; Kyung Hee University	Koivula, A (corresponding author), VTT Tech Res Ctr Finland, FI-02044 Espoo, VTT, Finland.	anu.koivula@vtt.fi; amsam@mail.ecc.u-tokyo.ac.jp	Furuta, Tadaomi/D-5225-2015; Nakamura, Akihiko/U-1988-2019; Igarashi, Kiyohiko/E-6799-2016	Furuta, Tadaomi/0000-0003-4568-9043; Nakamura, Akihiko/0000-0003-0409-5759; Igarashi, Kiyohiko/0000-0001-5152-7177; Koivula, Anu/0000-0002-7600-5700	Japanese Ministry of Education, Culture, Sports, and Technology (MEXT) [24114008]; Japan Society for the Promotion of Science (JSPS) [24380089, 19688016, 21688023, 17780245, 257574, 08J07454]; Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [24114008] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Innovative Areas 24114008 from the Japanese Ministry of Education, Culture, Sports, and Technology (MEXT) (to K. I.); Grant-in-aid for Scientific Research (B) 24380089 and Grants-in-aid for Scientific Research for Young Scientists (A) 19688016, (A) 21688023, and (B) 17780245 (to K. I.) and Grant-in-aid for JSPS Fellows 257574 (to A. N.) and 08J07454 (to T. T.) from the Japan Society for the Promotion of Science (JSPS); and a grant from the Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST) (to K.I.)	ABUJA PM, 1988, EUR BIOPHYS J BIOPHY, V15, P339, DOI 10.1007/BF00254721; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Case D. A., 2021, AMBER 2022; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davies GJ, 1997, J BIOTECHNOL, V57, P91, DOI 10.1016/S0168-1656(97)00092-8; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; GhattyVenkataKrishna PK, 2013, BIOPHYS J, V104, P904, DOI 10.1016/j.bpj.2012.12.052; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Igarashi K, 2006, FEBS J, V273, P2869, DOI 10.1111/j.1742-4658.2006.05299.x; Igarashi K, 2012, METHOD ENZYMOL, V510, P169, DOI 10.1016/B978-0-12-415931-0.00009-4; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Ishiguro M, 2010, PLANT BIOTECHNOL, V27, P273, DOI 10.5511/plantbiotechnology.27.273; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; KLYOSOV AA, 1990, BIOCHEMISTRY-US, V29, P10577, DOI 10.1021/bi00499a001; Koivula A, 1998, FEBS LETT, V429, P341, DOI 10.1016/S0014-5793(98)00596-1; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; LINDER M, 1995, PROTEIN SCI, V4, P1056, DOI 10.1002/pro.5560040604; MACH RL, 1994, CURR GENET, V25, P567, DOI 10.1007/BF00351679; MargollesClark E, 1996, APPL ENVIRON MICROB, V62, P2145, DOI 10.1128/AEM.62.6.2145-2151.1996; Medve J, 1998, BIOTECHNOL BIOENG, V59, P621, DOI 10.1002/(SICI)1097-0290(19980905)59:5&lt;621::AID-BIT13&gt;3.0.CO;2-C; Mulakala C, 2005, PROTEINS, V60, P598, DOI 10.1002/prot.20547; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; QUIOCHO FA, 1986, ANNU REV BIOCHEM, V55, P287, DOI 10.1146/annurev.bi.55.070186.001443; Stahlberg J, 1996, J MOL BIOL, V264, P337, DOI 10.1006/jmbi.1996.0644; Suurnakki A, 2000, CELLULOSE, V7, P189, DOI 10.1023/A:1009280109519; Tenkanen M, 1997, J BIOTECHNOL, V57, P191, DOI 10.1016/S0168-1656(97)00099-0; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Voutilainen SP, 2008, BIOTECHNOL BIOENG, V101, P515, DOI 10.1002/bit.21940; Voutilainen SP, 2007, ENZYME MICROB TECH, V41, P234, DOI 10.1016/j.enzmictec.2007.01.015; Vyas NK, 1991, CURR OPIN STRUC BIOL, V1, P732, DOI 10.1016/0959-440X(91)90172-P; Wada M, 2001, J WOOD SCI, V47, P124, DOI 10.1007/BF00780560; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200	36	66	70	1	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13503	13510		10.1074/jbc.M113.452623	http://dx.doi.org/10.1074/jbc.M113.452623			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23532843	Green Published, hybrid			2022-12-28	WOS:000318850300034
J	Suzuki, J; Fujii, T; Imao, T; Ishihara, K; Kuba, H; Nagata, S				Suzuki, Jun; Fujii, Toshihiro; Imao, Takeshi; Ishihara, Kenji; Kuba, Hiroshi; Nagata, Shigekazu			Calcium-dependent Phospholipid Scramblase Activity of TMEM16 Protein Family Members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; PHOSPHATIDYLSERINE EXPOSURE; CHLORIDE CHANNELS; GNATHODIAPHYSEAL-DYSPLASIA; TRANSBILAYER MOVEMENT; CELLS; APOPTOSIS; EXPRESSION; MACROPHAGES; LYMPHOCYTES	Asymmetrical distribution of phospholipids between the inner and outer plasma membrane leaflets is disrupted in various biological processes. We recently identified TMEM16F, an eight-transmembrane protein, as a Ca2+-dependent phospholipid scramblase that exposes phosphatidylserine (PS) to the cell surface. In this study, we established a mouse lymphocyte cell line with a floxed allele in the TMEM16F gene. When TMEM16F was deleted, these cells failed to expose PS in response to Ca2+ ionophore, but PS exposure was elicited by Fas ligand treatment. We expressed other TMEM16 proteins in the TMEM16F(-/-) cells and found that not only TMEM16F, but also 16C, 16D, 16G, and 16J work as lipid scramblases with different preference to lipid substrates. On the other hand, a patch clamp analysis in 293T cells indicated that TMEM16A and 16B, but not other family members, acted as Ca2+-dependent Cl- channels. These results indicated that among 10 TMEM16 family members, 7 members could be divided into two subfamilies, Ca2+-dependent Cl- channels (16A and 16B) and Ca2+-dependent lipid scramblases (16C, 16D, 16F, 16G, and 16J).	[Suzuki, Jun; Fujii, Toshihiro; Imao, Takeshi; Ishihara, Kenji; Nagata, Shigekazu] Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Yoshida, Kyoto 6068501, Japan; [Suzuki, Jun; Fujii, Toshihiro; Nagata, Shigekazu] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kyoto 6068501, Japan; [Kuba, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Physiol, Sakyo Ku, Yoshida, Kyoto 6068501, Japan	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University	Nagata, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Yoshida Konoe, Kyoto 6068501, Japan.	snagata@mfour.med.kyoto-u.ac.jp	Kuba, Hiroshi/I-7519-2014; Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426	Ministry of Education, Science, Sports, and Culture in Japan; Naito Foundation; Nakajima Foundation; Grants-in-Aid for Scientific Research [25860162, 22000013] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Nakajima Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Ministry of Education, Science, Sports, and Culture in Japan and Research Grants from the Naito Foundation and Nakajima Foundation (to J. S.).	ADLER RR, 1995, BIOL REPROD, V53, P905, DOI 10.1095/biolreprod53.4.905; Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Basse F, 1996, J BIOL CHEM, V271, P17205, DOI 10.1074/jbc.271.29.17205; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Boas FE, 1998, P NATL ACAD SCI USA, V95, P3077, DOI 10.1073/pnas.95.6.3077; Bolduc V, 2010, AM J HUM GENET, V86, P213, DOI 10.1016/j.ajhg.2009.12.013; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Castoldi E, 2011, BLOOD, V117, P4399, DOI 10.1182/blood-2011-01-332502; Chen TY, 2008, PHYSIOL REV, V88, P351, DOI 10.1152/physrev.00058.2006; DELBUONO BJ, 1989, J CELL PHYSIOL, V138, P61, DOI 10.1002/jcp.1041380110; DIVE C, 1992, BIOCHIM BIOPHYS ACTA, V1133, P275, DOI 10.1016/0167-4889(92)90048-G; Duran C, 2012, AM J PHYSIOL-CELL PH, V302, pC482, DOI 10.1152/ajpcell.00140.2011; Duran C, 2011, ACTA PHARMACOL SIN, V32, P685, DOI 10.1038/aps.2011.48; Ehlen HWA, 2013, J BONE MINER RES, V28, P246, DOI 10.1002/jbmr.1751; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Fischer K, 2006, BLOOD, V108, P4094, DOI 10.1182/blood-2006-03-011742; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; Gadella BM, 2002, BIOL REPROD, V67, P340, DOI 10.1095/biolreprod67.1.340; Galietta LJV, 2009, BIOPHYS J, V97, P3047, DOI 10.1016/j.bpj.2009.09.024; Hampton MB, 1996, FEBS LETT, V399, P277, DOI 10.1016/S0014-5793(96)01341-5; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; Imo T, 2013, CELL DEATH DIFFER, V20, P343, DOI 10.1038/cdd.2012.149; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Kuba H, 2003, J PHYSIOL-LONDON, V552, P611, DOI 10.1113/jphysiol.2003.041574; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; Mizuta K, 2007, BIOCHEM BIOPH RES CO, V357, P126, DOI 10.1016/j.bbrc.2007.03.108; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murai K, 1998, P NATL ACAD SCI USA, V95, P3461, DOI 10.1073/pnas.95.7.3461; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; OGASAWARA J, 1995, J EXP MED, V181, P485, DOI 10.1084/jem.181.2.485; Oram JF, 2000, CURR OPIN LIPIDOL, V11, P253, DOI 10.1097/00041433-200006000-00005; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Sahu SK, 2007, ARCH BIOCHEM BIOPHYS, V462, P103, DOI 10.1016/j.abb.2007.04.002; Schoenwaelder SM, 2009, BLOOD, V114, P663, DOI 10.1182/blood-2009-01-200345; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Segawa K, 2011, P NATL ACAD SCI USA, V108, P19246, DOI 10.1073/pnas.1114799108; SESSIONS A, 1983, BIOCHIM BIOPHYS ACTA, V728, P103, DOI 10.1016/0005-2736(83)90442-X; Shiraishi T, 2004, BIOCHEM BIOPH RES CO, V322, P197, DOI 10.1016/j.bbrc.2004.07.098; Stowell SR, 2009, MOL BIOL CELL, V20, P1408, DOI 10.1091/mbc.E08-07-0786; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Tsutsumi S, 2004, AM J HUM GENET, V74, P1255, DOI 10.1086/421527; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vermeer S, 2010, AM J HUM GENET, V87, P813, DOI 10.1016/j.ajhg.2010.10.015; WATSON JD, 1989, J IMMUNOL, V143, P1215; Williamson P, 2001, BIOCHEMISTRY-US, V40, P8065, DOI 10.1021/bi001929z; Williamson P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000729; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964; Zhou QS, 2002, BLOOD, V99, P4030, DOI 10.1182/blood-2001-12-0271; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240; Zwaal RFA, 1998, BBA-REV BIOMEMBRANES, V1376, P433, DOI 10.1016/S0304-4157(98)00018-5	57	229	239	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13305	13316		10.1074/jbc.M113.457937	http://dx.doi.org/10.1074/jbc.M113.457937			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23532839	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000318850300016
J	Hoeferlin, LA; Fekry, B; Ogretmen, B; Krupenko, SA; Krupenko, NI				Hoeferlin, L. Alexis; Fekry, Baharan; Ogretmen, Besim; Krupenko, Sergey A.; Krupenko, Natalia I.			Folate Stress Induces Apoptosis via p53-dependent de Novo Ceramide Synthesis and Up-regulation of Ceramide Synthase 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE; SPHINGOLIPID METABOLISM; TNF-ALPHA; CANCER; P53; EXPRESSION; CELLS; DEFICIENCY; GENERATION	We have investigated the role of ceramide in the cellular adaptation to folate stress induced by Aldh1l1, the enzyme involved in the regulation of folate metabolism. Our previous studies demonstrated that Aldh1l1, similar to folate deficiency, evokes metabolic stress and causes apoptosis in cancer cells. Here we report that the expression of Aldh1l1 in A549 or HCT116 cells results in the elevation of C-16-ceramide and a transient up-regulation of ceramide synthase 6 (CerS6) mRNA and protein. Pretreatment with ceramide synthesis inhibitors myriocin and fumonisin B1 or siRNA silencing of CerS6 prevented C-16-ceramide accumulation and rescued cells supporting the role of CerS6/C-16-ceramide as effectors of Aldh1l1-induced apoptosis. The CerS6 activation by Aldh1l1 and increased ceramide generation were p53-dependent; this effect was ablated in p53-null cells. Furthermore, the expression of wild type p53 but not transcriptionally inactive R175H p53 mutant strongly elevated CerS6. Also, this dominant negative mutant prevented accumulation of CerS6 in response to Aldh1l1, indicating that CerS6 is a transcriptional target of p53. In support of this mechanism, bioinformatics analysis revealed the p53 binding site 3 kb downstream of the CerS6 transcription start. Interestingly, ceramide elevation in response to Aldh1l1 was inhibited by silencing of PUMA, a proapoptotic downstream effector of p53 whereas the transient expression of CerS6 elevated PUMA in a p53-dependent manner indicating reciprocal relationships between ceramide and p53/PUMA pathways. Importantly, folate withdrawal also induced CerS6/C-16-ceramide elevation accompanied by p53 accumulation. Overall, these novel findings link folate and de novo ceramide pathways in cellular stress response.	[Hoeferlin, L. Alexis; Fekry, Baharan; Ogretmen, Besim; Krupenko, Sergey A.; Krupenko, Natalia I.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Ogretmen, Besim; Krupenko, Sergey A.; Krupenko, Natalia I.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Krupenko, SA (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	krupenko@musc.edu; krupenkn@musc.edu	Fekry, Baharan/GLT-6510-2022	Fekry, Baharan/0000-0003-1218-4161; Hoeferlin, L. Alexis/0000-0001-7569-8712	National Institutes of Health [DK54388, CA095030, CA88932, CA97165, DE16572]; South Carolina Lipidomics and Pathobiology Center of Biomedical Research Excellence [P20 RR017677]; U.S. Department of Education Graduate Assistance in Areas of National Need Training [P200A100105]; Cancer Center Grant [P30 CA138313]; NATIONAL CANCER INSTITUTE [R01CA095030, R01CA173687, R01CA088932, P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Lipidomics and Pathobiology Center of Biomedical Research Excellence; U.S. Department of Education Graduate Assistance in Areas of National Need Training; Cancer Center Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work supported, in whole or in part, by National Institutes of Health Grants DK54388 and CA095030 (to S.A.K.). This work was also supported by the South Carolina Lipidomics and Pathobiology Center of Biomedical Research Excellence Grant P20 RR017677 (to N.I.K.) and the U.S. Department of Education Graduate Assistance in Areas of National Need Training Grant P200A100105 (to L.A.H.). The Flow Cytometry and Lipidomics Shared Resource Facilities were supported in part by Cancer Center Grant P30 CA138313 to the Hollings Cancer Center, Medical University of South Carolina.; Supported by the National Institutes of Health Grants CA88932, CA97165, and DE16572.	Anguera MC, 2006, J BIOL CHEM, V281, P18335, DOI 10.1074/jbc.M510623200; Aoyama M, 2008, J DERMATOL, V35, P33, DOI 10.1111/j.1346-8138.2007.00408.x; Bailey LB, 1999, J NUTR, V129, P779, DOI 10.1093/jn/129.4.779; Bedia C, 2011, ANTI-CANCER AGENT ME, V11, P844, DOI 10.2174/187152011797655131; Bertino JR, 2009, BEST PRACT RES CL HA, V22, P577, DOI 10.1016/j.beha.2009.09.004; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Bohnsack BL, 2004, ANNU REV NUTR, V24, P433, DOI 10.1146/annurev.nutr.23.011702.073203; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chen XQ, 2012, MED ONCOL, V29, P1843, DOI 10.1007/s12032-011-0075-x; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Chipuk JE, 2009, CELL CYCLE, V8, P2692, DOI 10.4161/cc.8.17.9412; CIFONE MG, 1994, J EXP MED, V180, P1547, DOI 10.1084/jem.180.4.1547; Dbaibo GS, 1998, J CLIN INVEST, V102, P329, DOI 10.1172/JCI1180; DBAIBO GS, 1993, J BIOL CHEM, V268, P17762; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Ghose S, 2009, MOL CANCER RES, V7, P99, DOI 10.1158/1541-7786.MCR-08-0309; Goldman ID, 2010, CURR OPIN INVEST DR, V11, P1409; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hoeferlin L Alexis, 2011, Genes Cancer, V2, P889, DOI 10.1177/1947601911432495; HORVATH A, 1994, EMBO J, V13, P3687, DOI 10.1002/j.1460-2075.1994.tb06678.x; JAYADEV S, 1995, J BIOL CHEM, V270, P2047, DOI 10.1074/jbc.270.5.2047; Jhaveri MS, 2001, MOL PHARMACOL, V60, P1288, DOI 10.1124/mol.60.6.1288; Katula KS, 2007, J NUTR BIOCHEM, V18, P541, DOI 10.1016/j.jnutbio.2006.11.002; KIM MY, 1991, J BIOL CHEM, V266, P484; Kim YI, 1997, AM J CLIN NUTR, V65, P46, DOI 10.1093/ajcn/65.1.46; Krupenko SA, 2002, CELL GROWTH DIFFER, V13, P227; Krupenko SA, 2009, CHEM-BIOL INTERACT, V178, P84, DOI 10.1016/j.cbi.2008.09.007; Laethem RM, 1998, BLOOD, V91, P4350, DOI 10.1182/blood.V91.11.4350.411k27_4350_4360; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Lavieu G, 2006, J BIOL CHEM, V281, P8518, DOI 10.1074/jbc.M506182200; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Li GM, 2003, J NUTR BIOCHEM, V14, P568, DOI 10.1016/S0955-2863(03)00115-3; Liu B, 1998, J BIOL CHEM, V273, P11313, DOI 10.1074/jbc.273.18.11313; Martinez-Borra J, 2012, ADV EXP MED BIOL, V738, P169, DOI 10.1007/978-1-4614-1680-7_11; Meyers-Needham M, 2012, EMBO MOL MED, V4, P78, DOI 10.1002/emmm.201100189; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Novgorodov SA, 2011, J BIOL CHEM, V286, P4644, DOI 10.1074/jbc.M110.164392; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Oleinik NV, 2007, ONCOGENE, V26, P7222, DOI 10.1038/sj.onc.1210526; Oleinik NV, 2010, ONCOGENE, V29, P6233, DOI 10.1038/onc.2010.356; Oleinik Natalia V, 2011, Genes Cancer, V2, P130, DOI 10.1177/1947601911405841; Oleinik NV, 2005, BIOCHEM J, V391, P503, DOI 10.1042/BJ20050533; Oleinik NV, 2003, MOL CANCER RES, V1, P577; Panjarian S, 2008, PROSTAG OTH LIPID M, V86, P41, DOI 10.1016/j.prostaglandins.2008.02.004; Perry DK, 2000, J BIOL CHEM, V275, P9078, DOI 10.1074/jbc.275.12.9078; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Rodriguez FJ, 2008, J NEUROPATH EXP NEUR, V67, P1194, DOI 10.1097/NEN.0b013e31818fbe1e; Sawada M, 2004, CELL DEATH DIFFER, V11, P997, DOI 10.1038/sj.cdd.4401438; Sawada N, 2000, CELL DEATH DIFFER, V7, P761, DOI 10.1038/sj.cdd.4400711; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Separovic D, 2012, ANTICANCER RES, V32, P753; Siskind LJ, 2010, J BIOL CHEM, V285, P11818, DOI 10.1074/jbc.M109.078121; Szak ST, 1999, J BIOL CHEM, V274, P3904, DOI 10.1074/jbc.274.6.3904; WANG E, 1991, J BIOL CHEM, V266, P14486; White-Gilbertson S, 2009, ONCOGENE, V28, P1132, DOI 10.1038/onc.2008.468; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Yu J, 2003, CANCER CELL, V4, P248, DOI 10.1016/S1535-6108(03)00249-6	63	51	51	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12880	12890		10.1074/jbc.M113.461798	http://dx.doi.org/10.1074/jbc.M113.461798			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23519469	hybrid, Green Published			2022-12-28	WOS:000318555100042
J	Leal, MC; Magnani, N; Villordo, S; Buslje, CM; Evelson, P; Castano, EM; Morelli, L				Leal, Maria C.; Magnani, Natalia; Villordo, Sergio; Marino Buslje, Cristina; Evelson, Pablo; Castano, Eduardo M.; Morelli, Laura			Transcriptional Regulation of Insulin-degrading Enzyme Modulates Mitochondrial Amyloid beta (A beta) Peptide Catabolism and Functionality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RESPIRATORY FACTOR-1; ALZHEIMERS-DISEASE; MAMMALIAN-CELLS; INDUCIBLE COACTIVATOR; CONVERTING ENZYME; OXIDATIVE STRESS; PROTEIN; DYSFUNCTION; GENE; BRAIN	Studies of post-mortem brains from Alzheimer disease patients suggest that oxidative damage induced by mitochondrial amyloid beta (mitA beta) accumulation is associated with mitochondrial dysfunction. However, the regulation of mitA beta metabolism is unknown. One of the proteases involved in mitA beta catabolism is the long insulin-degrading enzyme (IDE) isoform (IDE-Met(1)). However, the mechanisms of its expression are unknown, and its presence in brain is uncertain. We detected IDE-Met(1) in brain and showed that its expression is regulated by the mitochondrial biogenesis pathway (PGC-1 alpha/NRF-1). A strong positive correlation between PGC-1 alpha or NRF-1 and long IDE isoform transcripts was found in non-demented brains. This correlation was weaker in Alzheimer disease. In vitro inhibition of IDE increased mitA beta and impaired mitochondrial respiration. These changes were restored by inhibition of gamma-secretase or promotion of mitochondrial biogenesis. Our results suggest that IDE-Met(1) links the mitochondrial biogenesis pathway with mitA beta levels and organelle functionality.	[Leal, Maria C.; Villordo, Sergio; Marino Buslje, Cristina; Castano, Eduardo M.; Morelli, Laura] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, Fdn Inst Leloir, RA-1033 Buenos Aires, DF, Argentina; [Magnani, Natalia; Evelson, Pablo] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Quim Gen & Inorgan, RA-1113 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Buenos Aires	Morelli, L (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, Fdn Inst Leloir, Ave Patricias Argentinas 435,C1405BWE, RA-1033 Buenos Aires, DF, Argentina.	lmorelli@leloir.org.ar	Evelson, Pablo/J-1245-2014; Marino-Buslje, Cristina/J-7438-2019; Soriano, Vicente/O-5730-2018	Evelson, Pablo/0000-0001-7920-7968; Marino-Buslje, Cristina/0000-0002-6564-1920; Soriano, Vicente/0000-0002-4624-5199	Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET) [PIP693]; Florencio Fiorini Fundation; International Society for Neurochemistry-Committee for Aid and Education in Neurochemistry; John Simon Guggenheim Memorial Foundation; Alzheimer's Association [IIRG-11-205127]; United States Public Health Service [R24-MH 068855]; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH068855] Funding Source: NIH RePORTER	Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Florencio Fiorini Fundation; International Society for Neurochemistry-Committee for Aid and Education in Neurochemistry; John Simon Guggenheim Memorial Foundation; Alzheimer's Association(Alzheimer's Association); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET)-PIP693 and Florencio Fiorini Fundation (to L.M.), the International Society for Neurochemistry-Committee for Aid and Education in Neurochemistry (to M.C.L.), and the John Simon Guggenheim Memorial Foundation and Alzheimer's Association Grant IIRG-11-205127) (to E.M.C.).; We acknowledge Dr. Fernando Pitossi and Dr. Osvaldo Podhajcer (Fundacion Instituto Leloir) for providing personal equipment, technical assistance, and molecular reagents. We thank Leonardo Sganga for cooperation in the measurement of the mitochondrial mass by flow cytometry. The brain tissues were provided by the Harvard Brain Tissue Resource Center, which is supported in part by United States Public Health Service Grant R24-MH 068855.	Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Alikhani N, 2011, J ALZHEIMERS DIS, V27, P75, DOI 10.3233/JAD-2011-101716; Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Baar K, 2003, FASEB J, V17, P1666, DOI 10.1096/fj.03-0049com; Blass JP, 2000, ANN NY ACAD SCI, V924, P170; Boveris A, 1999, METHOD ENZYMOL, V301, P188; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Bulloj A, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-22; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Chan CB, 2006, BIOCHEM SOC T, V34, P802, DOI 10.1042/BST0340802; Chan CB, 2006, CURR DIABETES REV, V2, P271, DOI 10.2174/157339906777950660; Cho YM, 2005, DIABETOLOGIA, V48, P2033, DOI 10.1007/s00125-005-1855-7; Chowanadisai W, 2010, J BIOL CHEM, V285, P142, DOI 10.1074/jbc.M109.030130; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Cook DG, 2003, AM J PATHOL, V162, P313, DOI 10.1016/S0002-9440(10)63822-9; de la Monte SM, 2000, LAB INVEST, V80, P1323, DOI 10.1038/labinvest.3780140; Du J, 2009, BIOCHEM BIOPH RES CO, V383, P485, DOI 10.1016/j.bbrc.2009.04.047; Falkevall A, 2006, J BIOL CHEM, V281, P29096, DOI 10.1074/jbc.M602532200; Farris W, 2005, BIOCHEMISTRY-US, V44, P6513, DOI 10.1021/bi0476578; Fernandez-Gamba A, 2009, CURR PHARM DESIGN, V15, P3644, DOI 10.2174/138161209789271799; Fernandez-Gamba A, 2012, J NEUROCHEM, V121, P985, DOI 10.1111/j.1471-4159.2012.07742.x; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; GOLBUS J, 1990, EUR J IMMUNOL, V20, P1869, DOI 10.1002/eji.1830200836; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Izumi H, 2003, BIOCHEM J, V373, P713, DOI 10.1042/BJ20021902; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; KUO WL, 1993, ENDOCRINOLOGY, V132, P604, DOI 10.1210/en.132.2.604; Leal MC, 2012, BBA-MOL CELL RES, V1823, P227, DOI 10.1016/j.bbamcr.2011.09.014; Leissring MA, 2004, BIOCHEM J, V383, P439, DOI 10.1042/BJ20041081; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu Y, 2008, DIABETES, V57, P777, DOI 10.2337/db07-0008; Llovera RE, 2008, J BIOL CHEM, V283, P17039, DOI 10.1074/jbc.M706316200; Miners JS, 2010, BRAIN PATHOL, V20, P794, DOI 10.1111/j.1750-3639.2010.00375.x; Miners JS, 2009, J NEUROPATH EXP NEUR, V68, P902, DOI 10.1097/NEN.0b013e3181afe475; Morelli L, 2004, J BIOL CHEM, V279, P56004, DOI 10.1074/jbc.M407283200; Perera R, 2003, P NATL ACAD SCI USA, V100, P3641, DOI 10.1073/pnas.0737142100; Perez A, 2000, NEUROCHEM RES, V25, P247, DOI 10.1023/A:1007527721160; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Piantadosi CA, 2006, J BIOL CHEM, V281, P324, DOI 10.1074/jbc.M508805200; Prat MI, 2002, NEUROSCI LETT, V326, P9, DOI 10.1016/S0304-3940(02)00298-7; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Regev-Rudzki N, 2007, BIOESSAYS, V29, P772, DOI 10.1002/bies.20609; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x; Shinall H, 2005, BIOCHEMISTRY-US, V44, P15345, DOI 10.1021/bi050650l; Tanabe T, 2006, INTERNAL MED, V45, P1243, DOI 10.2169/internalmedicine.45.1759; Walls KC, 2012, J BIOL CHEM, V287, P30317, DOI 10.1074/jbc.M112.365890; Wang SQ, 2010, J NEUROCHEM, V115, P47, DOI 10.1111/j.1471-4159.2010.06899.x; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; WILSON V L, 1983, Science (Washington D C), V220, P1055, DOI 10.1126/science.6844925; Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042035; Zhao LX, 2004, J NEUROSCI, V24, P11120, DOI 10.1523/JNEUROSCI.2860-04.2004; Zhao Z, 2007, NEUROBIOL AGING, V28, P824, DOI 10.1016/j.neurobiolaging.2006.05.001; Zhu XW, 2006, J ALZHEIMERS DIS, V9, P147; Zuo XM, 2009, BRAIN RES, V1249, P1, DOI 10.1016/j.brainres.2008.10.034	60	27	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12920	12931		10.1074/jbc.M112.424820	http://dx.doi.org/10.1074/jbc.M112.424820			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23525105	Green Published, hybrid			2022-12-28	WOS:000318555100046
J	Philippe, M; Leger, T; Desvaux, R; Walch, L				Philippe, Monique; Leger, Thibaut; Desvaux, Raphaelle; Walch, Laurence			Discs Large 1 (Dlg1) Scaffolding Protein Participates with Clathrin and Adaptator Protein Complex 1 (AP-1) in Forming Weibel-Palade Bodies of Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; TRANS-GOLGI NETWORK; VONWILLEBRAND-FACTOR; HUMAN HOMOLOG; MYOSIN-VI; EPITHELIAL-CELLS; SAP97; POLARITY; MEMBRANE; ASSOCIATION	Weibel-Palade bodies (WPBs) are specific cigar-shaped granules that store von Willebrand factor (VWF) for its regulated secretion by endothelial cells. The first steps of the formation of these granules at the trans-Golgi network specifically require VWF aggregation and an external scaffolding complex that contains the adaptator protein complex 1 (AP-1) and clathrin. Discs large 1 (Dlg1) is generally considered to be a modular scaffolding protein implicated in the control of cell polarity in a large variety of cells by specific recruiting of receptors, channels, or signaling proteins to specialized zones of the plasma membrane. We propose here that in endothelial cells, Dlg1, in a complex with AP-1 and clathrin, participates in the biogenesis of WPBs. Supporting data show that Dlg1 colocalizes with microtubules, intermediate filaments, and Golgi markers. Tandem mass spectrometry experiments led to the identification of clathrin as an Dlg1-interacting partner. Interaction was confirmed by in situ proximity ligation assays. Furthermore, AP-1 and VWF immunoprecipitate and colocalize with Dlg1 in the juxtanuclear zone. Finally, Dlg1 depletion by siRNA duplexes disrupts trans-Golgi network morphology and WPB formation. Our results provide the first evidence for an unexpected role of Dlg1 in controlling the formation of specific secretory granules involved in VWF exocytosis in endothelial cells.	[Philippe, Monique; Walch, Laurence] Univ Paris 07, INSERM, U698, CHU X Bichat, F-75018 Paris, France; [Leger, Thibaut] Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR7592, F-75013 Paris, France; [Desvaux, Raphaelle] Univ Paris 05, Inst Fed Rech Necker Enfants Malad IFR9, F-75014 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Walch, L (corresponding author), Univ Paris 07, INSERM, U698, CHU X Bichat, 46 Rue Henri Huchard, F-75018 Paris, France.	laurence.walch@inserm.fr	Léger, Thibaut/GPP-5828-2022	Leger, Thibaut/0000-0002-6304-3433				Almeida CG, 2011, NAT CELL BIOL, V13, P779, DOI 10.1038/ncb2262; Blomback M, 2012, HAEMOPHILIA, V18, P141, DOI 10.1111/j.1365-2516.2012.02840.x; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Burgess J, 2011, MOL BIOL CELL, V22, P2094, DOI 10.1091/mbc.E11-01-0054; Carreno S, 2004, J CELL BIOL, V165, P781, DOI 10.1083/jcb.200403120; De Meyer SF, 2012, STROKE, V43, P599, DOI 10.1161/STROKEAHA.111.628867; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; FOX JEB, 1985, J CLIN INVEST, V76, P1673, DOI 10.1172/JCI112153; Gardoni F, 2007, J BIOL CHEM, V282, P28691, DOI 10.1074/jbc.M701899200; Giblin JP, 2008, BLOOD, V112, P957, DOI 10.1182/blood-2007-12-130740; Godreau D, 2003, J BIOL CHEM, V278, P47046, DOI 10.1074/jbc.M308463200; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; HORVAT R, 1986, J CELL BIOL, V102, P484, DOI 10.1083/jcb.102.2.484; Iden S, 2006, EMBO REP, V7, P1239, DOI 10.1038/sj.embor.7400819; Jeyifous O, 2009, NAT NEUROSCI, V12, P1011, DOI 10.1038/nn.2362; Laprise P, 2004, J BIOL CHEM, V279, P10157, DOI 10.1074/jbc.M309843200; Lui-Roberts WWY, 2005, J CELL BIOL, V170, P627, DOI 10.1083/jcb.200503054; Maiga O, 2011, FEBS J, V278, P2655, DOI 10.1111/j.1742-4658.2011.08192.x; Manneville JB, 2010, J CELL BIOL, V191, P585, DOI 10.1083/jcb.201002151; Metcalf DJ, 2008, J CELL SCI, V121, P19, DOI 10.1242/jcs.03494; Michaux G, 2004, TRAFFIC, V5, P69, DOI 10.1111/j.1600-0854.2004.00157.x; Michaux G, 2011, J THROMB HAEMOST, V9, P392, DOI 10.1111/j.1538-7836.2010.04138.x; Montgomery JM, 2004, CELL MOL LIFE SCI, V61, P911, DOI 10.1007/s00018-003-3364-5; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; MULLER WA, 1986, J CELL BIOL, V103, P2389, DOI 10.1083/jcb.103.6.2389; NAKACHE M, 1985, NATURE, V317, P75, DOI 10.1038/317075a0; Nash JE, 2010, J NEUROCHEM, V112, P677, DOI 10.1111/j.1471-4159.2009.06480.x; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Petri B, 2010, BLOOD, V116, P4712, DOI 10.1182/blood-2010-03-276311; Reuver SM, 1998, J CELL SCI, V111, P1071; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; SIMIONESCU N, 1981, J CELL BIOL, V90, P605, DOI 10.1083/jcb.90.3.605; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spiel AO, 2008, CIRCULATION, V117, P1449, DOI 10.1161/CIRCULATIONAHA.107.722827; SPORN LA, 1989, J CELL BIOL, V108, P1283, DOI 10.1083/jcb.108.4.1283; Stucke VM, 2007, MOL BIOL CELL, V18, P1744, DOI 10.1091/mbc.E06-11-0980; Tamaru S, 2005, BIOCHEM BIOPH RES CO, V332, P347, DOI 10.1016/j.bbrc.2005.04.127; TSCHOPP TB, 1974, J LAB CLIN MED, V83, P296; TURITTO VT, 1985, BLOOD, V65, P823; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; Warner CL, 2003, EMBO J, V22, P569, DOI 10.1093/emboj/cdg055; WEIBEL ER, 1964, J CELL BIOL, V23, P101, DOI 10.1083/jcb.23.1.101; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Wu HJ, 1998, J CELL SCI, V111, P2365	46	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13046	13056		10.1074/jbc.M112.441261	http://dx.doi.org/10.1074/jbc.M112.441261			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23532850	Green Published, hybrid			2022-12-28	WOS:000318555100056
J	Rao, S; Liu, XH; Freedman, BD; Behrens, EM				Rao, Sheila; Liu, Xiaohong; Freedman, Bruce D.; Behrens, Edward M.			Spleen Tyrosine Kinase (Syk)-dependent Calcium Signals Mediate Efficient CpG-induced Exocytosis of Tumor Necrosis Factor alpha (TNF alpha) in Innate Immune Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE-RECEPTORS; NF-KAPPA-B; CYTOKINE SECRETION; TGF-BETA; IN-VITRO; T-CELLS; SYK; MACROPHAGES; ACTIVATION; PHOSPHORYLATION	Pattern recognition receptors expressed by cells of the innate immune system initiate the immune response upon recognition of microbial products. Activation of pattern recognition receptors result in the production and release of proinflammatory cytokines, including TNF alpha and IL-6. Because these cytokines promote disparate effector cell responses, understanding the signaling pathways involved in their regulation is critical for directing the immune response. Using macrophages and dendritic cells deficient in spleen tyrosine kinase (Syk), we identified a novel pathway by which TNF alpha trafficking and secretion are regulated by Syk following stimulation with CpG DNA. In the absence of PLC gamma 2, a Syk substrate, or the calcium-responsive kinase calcium calmodulin kinase II, CpG-induced TNF alpha secretion was impaired. Forced calcium mobilization rescued the TNF alpha secretion defect in Syk-deficient cells. In contrast to its effect on TNF alpha, Syk deficiency did not affect IL-6 secretion, suggesting that Syk-dependent signals participate in differential sorting of cytokines, thus tailoring the cytokine response. Our data report a novel pathway for TNF alpha regulation and provide insight into non-transcriptional mechanisms for shaping cytokine responses.	[Rao, Sheila; Behrens, Edward M.] Childrens Hosp Philadelphia, Div Pediat Rheumatol, Philadelphia, PA 19104 USA; [Rao, Sheila; Behrens, Edward M.] Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA; [Liu, Xiaohong; Freedman, Bruce D.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	Behrens, EM (corresponding author), Childrens Hosp Philadelphia, Dept Pediat Rheumatol, 3615 Civ Ctr Blvd,ARC Rm 1102, Philadelphia, PA 19104 USA.	behrens@email.chop.edu			National Institutes of Health [K08-A179396]; Howard Hughes Medical Institute Early Career Physician Scientist Award; Arthritis Foundation Innovative Research Grant; Nancy Taylor Foundation for Chronic Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Early Career Physician Scientist Award; Arthritis Foundation Innovative Research Grant; Nancy Taylor Foundation for Chronic Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant K08-A179396 (to E. M. B.). This work was also supported by a Howard Hughes Medical Institute Early Career Physician Scientist Award, by an Arthritis Foundation Innovative Research Grant, and by the Nancy Taylor Foundation for Chronic Diseases.	Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Chaudhary A, 2007, IMMUNOL CELL BIOL, V85, P249, DOI 10.1038/sj.icb7100030; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Dearman RJ, 2009, IMMUNOLOGY, V126, P475, DOI 10.1111/j.1365-2567.2008.02922.x; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; El Gazzar MA, 2007, BBA-GEN SUBJECTS, V1770, P556, DOI 10.1016/j.bbagen.2007.01.002; El-Hage N, 2011, IMMUNOL INVEST, V40, P498, DOI 10.3109/08820139.2011.561904; Flavell RA, 2002, CURR TOP MICROBIOL, V266, P1; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; GEAHLEN RL, 1989, BIOCHEM BIOPH RES CO, V165, P241, DOI 10.1016/0006-291X(89)91060-7; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Griffith LC, 2004, J NEUROSCI, V24, P8394, DOI 10.1523/JNEUROSCI.3604-04.2004; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; Hilfiker S, 1999, J NEUROCHEM, V73, P921, DOI 10.1046/j.1471-4159.1999.0730921.x; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kulathu Y, 2008, EMBO J, V27, P1333, DOI 10.1038/emboj.2008.62; Law CL, 1996, MOL CELL BIOL, V16, P1305; Lin YC, 2010, MOL IMMUNOL, V47, P1569, DOI 10.1016/j.molimm.2010.01.008; Liu QH, 2002, J EXP MED, V196, P897, DOI 10.1084/jem.20020381; Liu XG, 2008, BLOOD, V112, P4961, DOI 10.1182/blood-2008-03-144022; Low PC, 2010, J CELL BIOL, V190, P1053, DOI 10.1083/jcb.201001028; Manderson AP, 2007, J CELL BIOL, V178, P57, DOI 10.1083/jcb.200612131; McVicar DW, 1998, J BIOL CHEM, V273, P32934, DOI 10.1074/jbc.273.49.32934; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; Murray RZ, 2005, SCIENCE, V310, P1492, DOI 10.1126/science.1120225; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Sanjuan MA, 2006, J CELL BIOL, V172, P1057, DOI 10.1083/jcb.200508058; Stow JL, 2009, IMMUNOBIOLOGY, V214, P601, DOI 10.1016/j.imbio.2008.11.005; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Van Ziffle JA, 2009, BLOOD, V114, P4871, DOI 10.1182/blood-2009-05-220806; VANZEE KJ, 1992, P NATL ACAD SCI USA, V89, P4845, DOI 10.1073/pnas.89.11.4845; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Verona M, 2000, J NEUROCHEM, V74, P209, DOI 10.1046/j.1471-4159.2000.0740209.x; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zhang X, 2009, IMMUNITY, V31, P761, DOI 10.1016/j.immuni.2009.09.016; Zhu PM, 2009, J BIOL CHEM, V284, P22878, DOI 10.1074/jbc.M109.018580	51	18	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12448	12458		10.1074/jbc.M113.454405	http://dx.doi.org/10.1074/jbc.M113.454405			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23515313	Green Published, hybrid			2022-12-28	WOS:000318555100004
J	Wang, YX; Ding, M; Chaudhari, S; Ding, YF; Yuan, J; Stankowska, D; He, SQ; Krishnamoorthy, R; Cunningham, JT; Ma, R				Wang, Yanxia; Ding, Min; Chaudhari, Sarika; Ding, Yanfeng; Yuan, Joseph; Stankowska, Dorota; He, Shaoqing; Krishnamoorthy, Raghu; Cunningham, Joseph T.; Ma, Rong			Nuclear Factor kappa B Mediates Suppression of Canonical Transient Receptor Potential 6 Expression by Reactive Oxygen Species and Protein Kinase C in Kidney Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULAR MESANGIAL CELLS; TUMOR-NECROSIS-FACTOR; TRPC6 CHANNEL; OXIDATIVE STRESS; DOWN-REGULATION; FACTOR-ALPHA; ACTIVATION; PHOSPHORYLATION; MECHANISM; PROLIFERATION	This study was carried out to explore the molecular mechanism for down-regulation of TRPC6 expression in the reactive oxygen species (ROS)/PKC signaling in kidney cells. In cultured human mesangial cells, H2O2 and TNF-alpha inhibited TRPC6 mRNA expression in a time-dependent manner. Inhibition of NF-kappa B reversed both H2O2-and phorbol 12-myristate 13-acetate (PMA)-induced decrease in TRPC6 protein expression. Activation of NF-kappa B by knocking down I kappa B alpha using siRNA could mimic the suppressive effect of ROS/PKC on TRPC6. a Ca2+ imaging study showed that activation and inhibition of NF-kappa B significantly decreased and increased the TRPC6-mediated Ca2+ entry, respectively. Further experiments showed that PMA, but not its inactive analog 4 alpha-phorbol 12, 13-didecanoate (4 alpha-PDD), caused phosphorylation of I kappa B alpha and stimulated the nuclear translocation of NF-kappa B p50 and p65 subunits. The PMA-dependent I kappa B alpha phosphorylation was significantly inhibited by Go6976. Electrophoretic mobility shift assay revealed that PMA stimulated DNA binding activity of NF-kappa B. Furthermore, specific knockdown of p65, but not p50, prevented an H2O2 inhibitory effect on TRPC6 protein expression, suggesting p65 as a predominant NF-kappa B subunit repressing TRPC6. In agreement with a major role of p65, chromatin immunoprecipitation assays showed that PMA treatment induced p65 binding to the TRPC6 promoter. Moreover, PMA treatment increased the association of p65 with histone deacetylase (HDAC) and decreased histone acetylation at the TRPC6 promoter. Consistently, knockdown of HDAC2 by siRNA or inhibition of HDAC with trichostatin A prevented a H2O2-induced decrease in TRPC6 mRNA and protein expressions, respectively. Taken together, our findings imply an important role of NF-kappa B in a negative regulation of TRPC6 expression at the gene transcription level in kidney cells.	[Wang, Yanxia; Ding, Min; Chaudhari, Sarika; Ding, Yanfeng; Yuan, Joseph; Cunningham, Joseph T.; Ma, Rong] Univ N Texas, Hlth Sci Ctr, Dept Integrat Physiol, Ft Worth, TX 76107 USA; [Wang, Yanxia; Ding, Min; Chaudhari, Sarika; Ding, Yanfeng; Yuan, Joseph; Cunningham, Joseph T.; Ma, Rong] Univ N Texas, Hlth Sci Ctr, Cardiovasc Res Inst, Ft Worth, TX 76107 USA; [Stankowska, Dorota; He, Shaoqing; Krishnamoorthy, Raghu] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Ma, R (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Integrat Physiol, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	rong.ma@unthsc.edu	ma, rong/GVU-3096-2022	Chaudhari, Sarika/0000-0002-2590-6365	National Institutes of Health [5 RO1 DK079968-01A2]; American Heart Association South Central Affiliate [11GRNT7560013]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association South Central Affiliate(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5 RO1 DK079968-01A2 (NIDDK; to R.M.). This work was also supported by American Heart Association South Central Affiliate Grant-in-aid 11GRNT7560013 (to R.M.).	Aarenstrup L, 2008, J INVEST DERMATOL, V128, P1095, DOI 10.1038/sj.jid.5701146; Abboud HE, 2012, EXP CELL RES, V318, P979, DOI 10.1016/j.yexcr.2012.02.025; Abramowitz J, 2009, FASEB J, V23, P297, DOI 10.1096/fj.08-119495; Banday AA, 2007, J AM SOC NEPHROL, V18, P1446, DOI 10.1681/ASN.2006121373; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; Bottero V, 2001, CANCER RES, V61, P7785; Bousquet SM, 2010, J BIOL CHEM, V285, P40534, DOI 10.1074/jbc.M110.160051; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Canty TG, 1999, CIRCULATION, V100, P361; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Chuang HC, 2011, NAT IMMUNOL, V12, P1113, DOI 10.1038/ni.2121; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Ding YF, 2011, J BIOL CHEM, V286, P31799, DOI 10.1074/jbc.M111.248344; Estacion M, 2004, J BIOL CHEM, V279, P22047, DOI 10.1074/jbc.M402320200; Freidkin I, 2010, AM J PHYSIOL-RENAL, V298, pF426, DOI 10.1152/ajprenal.00107.2009; Gastonguay AJ, 2012, CANCER BIOL THER, V13, P647, DOI 10.4161/cbt.20082; Ge RL, 2009, CANCER LETT, V283, P43, DOI 10.1016/j.canlet.2009.03.023; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Graham S, 2007, AM J PHYSIOL-RENAL, V293, pF1381, DOI 10.1152/ajprenal.00185.2007; Graham S, 2011, AM J PHYSIOL-CELL PH, V301, pC304, DOI 10.1152/ajpcell.00014.2011; Graham S, 2010, J BIOL CHEM, V285, P23464, DOI 10.1074/jbc.M109.093500; Hamid R, 2009, CIRCULATION, V119, P2297, DOI 10.1161/CIRCULATIONAHA.109.855197; Hayden MR, 2007, ANTIOXID REDOX SIGN, V9, P865, DOI 10.1089/ars.2007.1640; Hirano F, 1998, MOL CELL BIOL, V18, P1266, DOI 10.1128/MCB.18.3.1266; Hocherl K, 2010, AM J PHYSIOL-RENAL, V298, pF196, DOI 10.1152/ajprenal.90607.2008; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hong CY, 2003, MOL CELL BIOL, V23, P6000, DOI 10.1128/MCB.23.17.6000-6012.2003; Inoue R, 2009, CIRC RES, V104, P1399, DOI 10.1161/CIRCRESAHA.108.193227; Kanwar YS, 2005, NEPHRON EXP NEPHROL, V101, P100, DOI 10.1159/000087339; KASHGARIAN M, 1992, KIDNEY INT, V41, P524, DOI 10.1038/ki.1992.74; Kim JM, 2012, CELL PHYSIOL BIOCHEM, V30, P49, DOI 10.1159/000339045; KretzRemy C, 1996, J CELL BIOL, V133, P1083, DOI 10.1083/jcb.133.5.1083; Kume S, 2007, J BIOL CHEM, V282, P151, DOI 10.1074/jbc.M605904200; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Leuner K, 2007, FASEB J, V21, P4101, DOI 10.1096/fj.07-8110com; Lu XH, 2004, J CELL BIOCHEM, V92, P833, DOI 10.1002/jcb.20143; Mizuno N, 1999, MOL BRAIN RES, V64, P41, DOI 10.1016/S0169-328X(98)00296-4; Monet M, 2012, J BIOL CHEM, V287, P17672, DOI 10.1074/jbc.M112.341354; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Muller M, 2008, J BIOL CHEM, V283, P33942, DOI 10.1074/jbc.M801844200; Nicolls MR, 2007, ANTIOXID REDOX SIGN, V9, P879, DOI 10.1089/ars.2007.1631; Nishikori M, 2005, J CLIN EXP HEMATOP, V45, P15, DOI 10.3960/jslrt.45.15; Noh H, 2009, AM J PHYSIOL-RENAL, V297, pF729, DOI 10.1152/ajprenal.00086.2009; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Satou R, 2010, AM J PHYSIOL-CELL PH, V299, pC750, DOI 10.1152/ajpcell.00078.2010; Schlondorff D, 2009, J AM SOC NEPHROL, V20, P1179, DOI 10.1681/ASN.2008050549; Scindia YM, 2010, ADV DRUG DELIVER REV, V62, P1337, DOI 10.1016/j.addr.2010.08.011; Sel S, 2008, CLIN EXP ALLERGY, V38, P1548, DOI 10.1111/j.1365-2222.2008.03043.x; Shah SV, 2007, J AM SOC NEPHROL, V18, P16, DOI 10.1681/ASN.2006050500; Shen B, 2011, J BIOL CHEM, V286, P19439, DOI 10.1074/jbc.M110.210294; Shi XZ, 2003, GASTROENTEROLOGY, V124, P1369, DOI 10.1016/S0016-5085(03)00263-4; Sours S, 2006, AM J PHYSIOL-RENAL, V290, pF1507, DOI 10.1152/ajprenal.00268.2005; Sours-Brorhers S, 2009, EXP BIOL MED, V234, P673, DOI 10.3181/0809-RM-279; Stockand JD, 1998, PHYSIOL REV, V78, P723, DOI 10.1152/physrev.1998.78.3.723; Tsai KL, 2012, CELL BIOCHEM BIOPHYS, V62, P467, DOI 10.1007/s12013-011-9333-y; Weissmann N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1660; Winn MP, 2006, J AM SOC NEPHROL, V17, P378, DOI 10.1681/ASN.2005090962; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Yu Y, 2003, AM J PHYSIOL-CELL PH, V284, pC316, DOI 10.1152/ajpcell.00125.2002; Yu Y, 2009, CIRCULATION, V119, P2313, DOI 10.1161/CIRCULATIONAHA.108.782458; Yu ZT, 2002, J AM SOC NEPHROL, V13, P2009, DOI 10.1097/01.ASN.0000024253.59665.F1; Yu ZY, 2006, AM J PHYSIOL-RENAL, V290, pF496, DOI 10.1152/ajprenal.00316.2005; Zhu NL, 2007, GENE, V393, P70, DOI 10.1016/j.gene.2007.01.016	65	32	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12852	12865		10.1074/jbc.M112.410357	http://dx.doi.org/10.1074/jbc.M112.410357			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23525112	Green Published, hybrid			2022-12-28	WOS:000318555100040
J	Brown, DB; Muszynski, A; Salas, O; Speed, K; Carlson, RW				Brown, Dusty B.; Muszynski, Artur; Salas, Omar; Speed, Kacie; Carlson, Russell W.			Elucidation of the 3-O-Deacylase Gene, pagL, Required for the Removal of Primary beta-Hydroxy Fatty Acid from the Lipid A in the Nitrogen-fixing Endosymbiont Rhizobium etli CE3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL-CHARACTERIZATION; PSEUDOMONAS-AERUGINOSA; SALMONELLA-TYPHIMURIUM; LEGUME SYMBIOSIS; LIPOPOLYSACCHARIDES; BACTERIA; RECOGNITION; INFECTION; RESISTANCE; DEACYLASE	Until now, the gene responsible for the 3-O-deacylation of lipid A among nitrogen-fixing endosymbionts has not been characterized. Several Gram-negative animal pathogens such as Salmonella enterica, Pseudomonas aeruginosa, and Bordetella bronchiseptica contain an outer membrane 3-O-deacylase (PagL) that has been implicated in host immune evasion. The role of 3-O-deacylated lipid A among nitrogen-fixing endosymbionts, plant endophytes, and plant pathogens has not been studied. However, D'Haeze et al. (D'Haeze, W., Leoff, C., Freshour, G., Noel, K. D., and Carlson, R. W. (2007) J. Biol. Chem. 282, 17101-17113) reported that the lipopolysaccharide from Rhizobium etli CE3 bacteroids isolated from host bean root nodules contained exclusively tetraacylated lipid A that lacked a lipid A beta-hydroxymyristyl residue, an observation that is consistent with the possibility of PagL activity being important in symbiosis. A putative pagL gene was identified in the R. etli genome sequence. With this information, we created a pagL(-) mutant strain derived from R. etli CE3. Using mass spectrometry, we demonstrated that the mutant lacks 3-O-deacylated lipid A. The parent and mutant LPS were very similar as determined by gel electrophoresis and glycosyl composition analysis using gas chromatography/mass spectrometry. However, fatty acid analysis showed that the mutant lipid A contained larger amounts of beta-hydroxypentadecanoic acid than that of the parent. Furthermore, the mutant was adversely affected in establishing symbiosis with its host, Phaseolus vulgaris.	[Brown, Dusty B.; Muszynski, Artur; Salas, Omar; Speed, Kacie; Carlson, Russell W.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Carlson, RW (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	rcarlson@ccrc.uga.edu		Muszynski, Artur/0000-0003-3497-9977	National Institutes of Health [GM39583]; Department of Energy [DE-FG-02-09ER20097]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM39583 (to R. W. C.). This work was also supported by Department of Energy Grant DE-FG-02-09ER20097 to the Complex Carbohydrate Research Center.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ardissone S, 2011, J BACTERIOL, V193, P2218, DOI 10.1128/JB.01260-10; Basu SS, 1999, J BIOL CHEM, V274, P11150, DOI 10.1074/jbc.274.16.11150; BECKER A, 1995, GENE, V162, P37, DOI 10.1016/0378-1119(95)00313-U; Berezow AB, 2009, MICROB PATHOGENESIS, V47, P68, DOI 10.1016/j.micpath.2009.04.015; Beringer J. E., 1974, MICROBIOLOGY, V84, P188; BHAT UR, 1994, J BIOL CHEM, V269, P14402; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Brown DB, 2011, J BACTERIOL, V193, P4766, DOI 10.1128/JB.00392-11; Carlson RW, 2010, SUBCELL BIOCHEM, V53, P339, DOI 10.1007/978-90-481-9078-2_16; Coats SR, 2011, INFECT IMMUN, V79, P203, DOI 10.1128/IAI.00937-10; D'Haeze W, 2007, J BIOL CHEM, V282, P17101, DOI 10.1074/jbc.M611669200; Erbs G, 2010, SUBCELL BIOCHEM, V53, P387, DOI 10.1007/978-90-481-9078-2_17; FAHRAEUS G, 1957, J GEN MICROBIOL, V16, P374, DOI 10.1099/00221287-16-2-374; Ferguson GP, 2005, MOL MICROBIOL, V56, P68, DOI 10.1111/j.1365-2958.2005.04536.x; Forsberg LS, 1998, J BIOL CHEM, V273, P2747, DOI 10.1074/jbc.273.5.2747; Forsberg LS, 2000, J BIOL CHEM, V275, P18851, DOI 10.1074/jbc.M001090200; Fraysse N, 2003, EUR J BIOCHEM, V270, P1365, DOI 10.1046/j.1432-1033.2003.03492.x; Gudlavalleti SK, 2003, J BIOL CHEM, V278, P3957, DOI 10.1074/jbc.M210491200; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Kanistanon D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040024; KANNENBERG EL, 1998, RHIZOBIACEAE, P119; Kannenberg Elmar L., 1994, Trends in Microbiology, V2, P277, DOI 10.1016/0966-842X(94)90004-3; Kawasaki K, 2004, J BIOL CHEM, V279, P20044, DOI 10.1074/jbc.M401275200; Kawasaki K, 2007, J BACTERIOL, V189, P4911, DOI 10.1128/JB.00451-07; KITTELBERGER R, 1993, J BIOCHEM BIOPH METH, V26, P81, DOI 10.1016/0165-022X(93)90024-I; Lefebvre B, 2010, P NATL ACAD SCI USA, V107, P2343, DOI 10.1073/pnas.0913320107; LEHMAN LJ, 1990, GENE, V95, P143, DOI 10.1016/0378-1119(90)90426-R; Limpens E, 2005, P NATL ACAD SCI USA, V102, P10375, DOI 10.1073/pnas.0504284102; Manabe T, 2008, J BACTERIOL, V190, P5597, DOI 10.1128/JB.00587-08; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; NOEL KD, 1984, J BACTERIOL, V158, P148, DOI 10.1128/JB.158.1.148-155.1984; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; PHADNIS SH, 1987, J BIOSCIENCE, V12, P131, DOI 10.1007/BF02702964; Que NLS, 2000, J BIOL CHEM, V275, P28006; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; REUHS BL, 1993, J BACTERIOL, V175, P3570, DOI 10.1128/jb.175.11.3570-3580.1993; Rutten L, 2006, P NATL ACAD SCI USA, V103, P7071, DOI 10.1073/pnas.0509392103; RYAN JM, 1974, ARCH BIOCHEM BIOPHYS, V162, P530, DOI 10.1016/0003-9861(74)90213-6; Spaink HP, 2004, TRENDS MICROBIOL, V12, P201, DOI 10.1016/j.tim.2004.03.001; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; YORK WS, 1986, METHOD ENZYMOL, V118, P3	46	4	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12004	12013		10.1074/jbc.M113.470484	http://dx.doi.org/10.1074/jbc.M113.470484			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23511636	Green Published, hybrid			2022-12-28	WOS:000318157600034
J	Krishnan, H; Ochoa-Alvarez, JA; Shen, YQ; Nevel, E; Lakshminarayanan, M; Williams, MC; Ramirez, MI; Miller, WT; Goldberg, GS				Krishnan, Harini; Ochoa-Alvarez, Jhon A.; Shen, Yongquan; Nevel, Evan; Lakshminarayanan, Meenakshi; Williams, Mary C.; Ramirez, Maria I.; Miller, W. Todd; Goldberg, Gary S.			Serines in the Intracellular Tail of Podoplanin (PDPN) Regulate Cell Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP JUNCTIONAL COMMUNICATION; TRANSFORMED-CELLS; PLATELET-AGGREGATION; POSITIVE FIBROBLASTS; LUNG ADENOCARCINOMA; TUMOR PROGRESSION; EXPRESSION; INVASION; METASTASIS; CARCINOMAS	Podoplanin (PDPN) is a transmembrane receptor that affects the activities of Rho, ezrin, and other proteins to promote tumor cell motility, invasion, and metastasis. PDPN is found in many types of cancer and may serve as a tumor biomarker and chemotherapeutic target. The intracellular region of PDPN contains only two serines, and these are conserved in mammals including mice and humans. We generated cells from the embryos of homozygous null Pdpn knock-out mice to investigate the relevance of these serines to cell growth and migration on a clear (PDPN-free) background. We report here that one or both of these serines can be phosphorylated by PKA (protein kinase A). We also report that conversion of these serines to nonphosphorylatable alanine residues enhances cell migration, whereas their conversion to phosphomimetic aspartate residues decreases cell migration. These results indicate that PKA can phosphorylate PDPN to decrease cell migration. In addition, we report that PDPN expression in fibroblasts causes them to facilitate the motility and viability of neighboring melanoma cells in coculture. These findings shed new light on how PDPN promotes cell motility, its role in tumorigenesis, and its utility as a functionally relevant biomarker and chemotherapeutic target.	[Krishnan, Harini; Ochoa-Alvarez, Jhon A.; Shen, Yongquan; Goldberg, Gary S.] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Stratford, NJ 08084 USA; [Krishnan, Harini; Ochoa-Alvarez, Jhon A.; Shen, Yongquan; Goldberg, Gary S.] Univ Med & Dent New Jersey, Dept Mol Biol, Sch Osteopath Med, Stratford, NJ 08084 USA; [Lakshminarayanan, Meenakshi; Williams, Mary C.; Ramirez, Maria I.] Boston Univ, Sch Med, Ctr Pulm, Dept Med, Boston, MA 02118 USA; [Miller, W. Todd] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Boston University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Goldberg, GS (corresponding author), Univ Med & Dent New Jersey, Dept Mol Biol, 2 Med Ctr Dr, Stratford, NJ 08084 USA.	gary.goldberg@umdnj.edu	Krishnan, Harini/J-5632-2019	Krishnan, Harini/0000-0003-0286-0322; Ramirez, Maria Isabel/0000-0001-6294-4419	Research Foundation of University of Medicine and Dentistry of New Jersey (UMDNJ); Sentrimed; National Institutes of Health Grant [HL083034, CA58530]; NATIONAL CANCER INSTITUTE [R29CA058530, R01CA058530] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083034] Funding Source: NIH RePORTER	Research Foundation of University of Medicine and Dentistry of New Jersey (UMDNJ); Sentrimed; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded in part by grants from the Research Foundation of University of Medicine and Dentistry of New Jersey (UMDNJ) and Sentrimed (to G. S. G.) and National Institutes of Health Grant HL083034 (to M. I. R.) and CA58530 (to W. T. M.).	Alexander DB, 2004, CANCER RES, V64, P1347, DOI 10.1158/0008-5472.CAN-03-2558; Asano E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029338; Astarita JL, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00283; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Casnellie J. E., 1991, METHODS ENZYMOL, V200; Chandramohan V, 2013, INT J CANCER, V132, P2339, DOI 10.1002/ijc.27919; Cortez MA, 2010, GENE CHROMOSOME CANC, V49, P981, DOI 10.1002/gcc.20808; Durchdewald M, 2008, CANCER RES, V68, P6877, DOI 10.1158/0008-5472.CAN-08-0299; Funayama A, 2011, PATHOBIOLOGY, V78, P171, DOI 10.1159/000324926; Gandarillas A, 1997, MOL CARCINOGEN, V20, P10, DOI 10.1002/(SICI)1098-2744(199709)20:1<10::AID-MC3>3.0.CO;2-M; GOLDBERG GS, 1994, MOL CARCINOGEN, V11, P106, DOI 10.1002/mc.2940110208; Goldberg GS, 2003, J BIOL CHEM, V278, P46533, DOI 10.1074/jbc.M307526200; Honma M, 2012, J DERMATOL SCI, V65, P134, DOI 10.1016/j.jdermsci.2011.11.011; Hoshino A, 2011, CANCER RES, V71, P4769, DOI 10.1158/0008-5472.CAN-10-3228; Ito M, 2012, CHEST, V142, P151, DOI 10.1378/chest.11-2458; Ito S, 2012, BIOCHEM BIOPH RES CO, V422, P194, DOI 10.1016/j.bbrc.2012.04.158; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Kato Y, 2010, NUCL MED BIOL, V37, P785, DOI 10.1016/j.nucmedbio.2010.03.010; Kawase A, 2008, INT J CANCER, V123, P1053, DOI 10.1002/ijc.23611; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Krishnan Harini, 2012, Genes Cancer, V3, P426, DOI 10.1177/1947601912458583; Liang HH, 2007, AM J SURG PATHOL, V31, P304, DOI 10.1097/01.pas.0000213388.47913.f1; Martin-Villar E, 2005, INT J CANCER, V113, P899, DOI 10.1002/ijc.20656; Martin-Villar E, 2010, MOL BIOL CELL, V21, P4387, DOI 10.1091/mbc.E10-06-0489; Millien G, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-35; Mohammed RAA, 2007, AM J SURG PATHOL, V31, P1825, DOI 10.1097/PAS.0b013e31806841f6; Mumprecht V, 2009, J CELL MOL MED, V13, P1405, DOI 10.1111/j.1582-4934.2009.00834.x; Nakazawa Y, 2008, BLOOD, V112, P1730, DOI 10.1182/blood-2007-11-124693; NOSE K, 1990, CELL GROWTH DIFFER, V1, P511; Ochoa-Alvarez JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041845; Raica M, 2008, ANTICANCER RES, V28, P2997; Ramirez MI, 2003, DEV BIOL, V256, P61, DOI 10.1016/S0012-1606(02)00098-2; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Shen YQ, 2010, J BIOL CHEM, V285, P9649, DOI 10.1074/jbc.M109.047696; Shen YQ, 2006, CANCER RES, V66, P1543, DOI 10.1158/0008-5472.CAN-05-3152; Valiunas V, 2005, BIOCHEM BIOPH RES CO, V333, P174, DOI 10.1016/j.bbrc.2005.05.104; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Wicki A, 2007, BRIT J CANCER, V96, P1, DOI 10.1038/sj.bjc.6603518; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966	40	48	50	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12215	12221		10.1074/jbc.C112.446823	http://dx.doi.org/10.1074/jbc.C112.446823			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23530051	Green Published, hybrid			2022-12-28	WOS:000318157600053
J	Banerjee, A; Wu, Y; Banerjee, R; Li, Y; Yan, HG; Sharkey, TD				Banerjee, Aparajita; Wu, Yan; Banerjee, Rahul; Li, Yue; Yan, Honggao; Sharkey, Thomas D.			Feedback Inhibition of Deoxy-D-xylulose-5-phosphate Synthase Regulates the Methylerythritol 4-Phosphate Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1-DEOXY-D-XYLULOSE 5-PHOSPHATE SYNTHASE; NON-MEVALONATE PATHWAY; DEOXYXYLULOSE PHOSPHATE-PATHWAY; ISOPRENOID BIOSYNTHESIS; ISOPENTENYL DIPHOSPHATE; TERPENOID BIOSYNTHESIS; ESCHERICHIA-COLI; HIGHER-PLANTS; MEP PATHWAY; SYNECHOCOCCUS-LEOPOLIENSIS	The 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway leads to the biosynthesis of isopentenyl diphosphate (IDP) and dimethylallyl diphosphate (DMADP), the precursors for isoprene and higher isoprenoids. Isoprene has significant effects on atmospheric chemistry, whereas other isoprenoids have diverse roles ranging from various biological processes to applications in commercial uses. Understanding the metabolic regulation of the MEP pathway is important considering the numerous applications of this pathway. The 1-deoxy-D-xylulose-5-phosphate synthase (DXS) enzyme was cloned from Populus trichocarpa, and the recombinant protein (PtDXS) was purified from Escherichia coli. The steady-state kinetic parameters were measured by a coupled enzyme assay. An LC-MS/MS-based assay involving the direct quantification of the end product of the enzymatic reaction, 1-deoxy-D-xylulose 5-phosphate (DXP), was developed. The effect of different metabolites of the MEP pathway on PtDXS activity was tested. PtDXS was inhibited by IDP and DMADP. Both of these metabolites compete with thiamine pyrophosphate for binding with the enzyme. An atomic structural model of PtDXS in complex with thiamine pyrophosphate and Mg2+ was built by homology modeling and refined by molecular dynamics simulations. The refined structure was used to model the binding of IDP and DMADP and indicated that IDP and DMADP might bind with the enzyme in a manner very similar to the binding of thiamine pyrophosphate. The feedback inhibition of PtDXS by IDP and DMADP constitutes an important mechanism of metabolic regulation of the MEP pathway and indicates that thiamine pyrophosphate-dependent enzymes may often be affected by IDP and DMADP.	[Banerjee, Aparajita; Wu, Yan; Banerjee, Rahul; Li, Yue; Yan, Honggao; Sharkey, Thomas D.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Yan, HG (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	yanh@msu.edu; tsharkey@msu.edu	BANERJEE, RAHUL/Q-7260-2019; Sharkey, Thomas/ABF-1317-2020; Sharkey, Thomas D/B-4032-2009; Banerjee, Aparajita/ABC-8383-2020	BANERJEE, RAHUL/0000-0002-3547-4746; Sharkey, Thomas/0000-0002-4423-3223; Sharkey, Thomas D/0000-0002-4423-3223; Banerjee, Aparajita/0000-0001-5711-4998; Banerjee, Rahul/0000-0002-6681-1047	National Science Foundation [IOS-0950574, CHE-0957201]; Division Of Chemistry [0957201] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Science Foundation Grants IOS-0950574 (to T. D. S.) and CHE-0957201 (to H. Y.).	Adam P, 2002, P NATL ACAD SCI USA, V99, P12108, DOI 10.1073/pnas.182412599; Altincicek B, 2000, FEMS MICROBIOL LETT, V190, P329, DOI 10.1111/j.1574-6968.2000.tb09307.x; Altincicek B, 2002, FEBS LETT, V532, P437, DOI 10.1016/S0014-5793(02)03726-2; [Anonymous], 2008, AMBER 10; Argyrou A, 2004, BIOCHEMISTRY-US, V43, P4375, DOI 10.1021/bi049974k; Arigoni D, 1997, P NATL ACAD SCI USA, V94, P10600, DOI 10.1073/pnas.94.20.10600; Bailey AM, 2002, GLYCOBIOLOGY, V12, P813, DOI 10.1093/glycob/cwf100; Bitok JK, 2012, ACS CHEM BIOL, V7, P1702, DOI 10.1021/cb300243w; Bouvier F, 1998, PLANT PHYSIOL, V117, P1423, DOI 10.1104/pp.117.4.1423; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cordoba E, 2009, J EXP BOT, V60, P2933, DOI 10.1093/jxb/erp190; DellaPenna D, 2006, ANNU REV PLANT BIOL, V57, P711, DOI 10.1146/annurev.arplant.56.032604.144301; Dubey VS, 2003, J BIOSCIENCES, V28, P637, DOI 10.1007/BF02703339; Eisenreich W, 2004, CELL MOL LIFE SCI, V61, P1401, DOI 10.1007/s00018-004-3381-z; Eisenreich W, 1996, P NATL ACAD SCI USA, V93, P6431, DOI 10.1073/pnas.93.13.6431; Eisenreich W, 1998, CHEM BIOL, V5, pR221, DOI 10.1016/S1074-5521(98)90002-3; Enfissi EMA, 2005, PLANT BIOTECHNOL J, V3, P17, DOI 10.1111/j.1467-7652.2004.00091.x; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Estevez JM, 2001, J BIOL CHEM, V276, P22901, DOI 10.1074/jbc.M100854200; Eubanks LM, 2003, BIOCHEMISTRY-US, V42, P1140, DOI 10.1021/bi0205303; Feurle J, 1998, J CHROMATOGR A, V803, P111, DOI 10.1016/S0021-9673(97)01214-4; Gong YF, 2006, PLANTA MED, V72, P329, DOI 10.1055/s-2005-916234; Guevara-Garcia A, 2005, PLANT CELL, V17, P628, DOI 10.1105/tpc.104.028860; Hahn FM, 2001, J BACTERIOL, V183, P1, DOI 10.1128/JB.183.1.1-11.2001; Hale I, 2012, MEDCHEMCOMM, V3, P418, DOI 10.1039/c2md00298a; Han YS, 2003, J CHROMATOGR A, V986, P291, DOI 10.1016/S0021-9673(02)02016-2; Harker M, 1999, FEBS LETT, V448, P115, DOI 10.1016/S0014-5793(99)00360-9; HAWKINS CF, 1989, FEBS LETT, V255, P77, DOI 10.1016/0014-5793(89)81064-6; Hemmerlin A, 2003, J BIOL CHEM, V278, P26666, DOI 10.1074/jbc.M302526200; Hunter WN, 2007, J BIOL CHEM, V282, P21573, DOI 10.1074/jbc.R700005200; Kuzuyama T, 2000, J BACTERIOL, V182, P891, DOI 10.1128/JB.182.4.891-897.2000; Lange BM, 1998, P NATL ACAD SCI USA, V95, P2100, DOI 10.1073/pnas.95.5.2100; Li ZR, 2013, PLANT CELL ENVIRON, V36, P429, DOI 10.1111/j.1365-3040.2012.02584.x; Li ZR, 2011, PLANT PHYSIOL, V155, P1037, DOI 10.1104/pp.110.167551; Lichtenthaler HK, 1997, PHYSIOL PLANTARUM, V101, P643, DOI 10.1111/j.1399-3054.1997.tb01049.x; Lichtenthaler HK, 1997, FEBS LETT, V400, P271, DOI 10.1016/S0014-5793(96)01404-4; Lois LM, 2000, PLANT J, V22, P503, DOI 10.1046/j.1365-313x.2000.00764.x; Lois LM, 1998, P NATL ACAD SCI USA, V95, P2105, DOI 10.1073/pnas.95.5.2105; Matthews PD, 2000, APPL MICROBIOL BIOT, V53, P396, DOI 10.1007/s002530051632; Miller B, 2000, FEBS LETT, V481, P221, DOI 10.1016/S0014-5793(00)02014-7; Miller B, 1999, FEBS LETT, V460, P485, DOI 10.1016/S0014-5793(99)01397-6; Morris WL, 2006, J EXP BOT, V57, P3007, DOI 10.1093/jxb/erl061; Patel H, 2012, J AM CHEM SOC, V134, P18374, DOI 10.1021/ja307315u; Phillips MA, 2008, TRENDS PLANT SCI, V13, P619, DOI 10.1016/j.tplants.2008.09.003; Querol J, 2001, ANAL BIOCHEM, V296, P101, DOI 10.1006/abio.2001.5234; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Rodriguez-Concepcion Manuel, 2006, Phytochemistry Reviews, V5, P1, DOI 10.1007/s11101-005-3130-4; Rohdich F, 2003, P NATL ACAD SCI USA, V100, P1586, DOI 10.1073/pnas.0337742100; Rohdich F, 2002, P NATL ACAD SCI USA, V99, P1158, DOI 10.1073/pnas.032658999; Rohmer M, 1996, J AM CHEM SOC, V118, P2564, DOI 10.1021/ja9538344; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Schwender J, 1997, FEBS LETT, V414, P129, DOI 10.1016/S0014-5793(97)01002-8; Schwender J, 1996, BIOCHEM J, V316, P73, DOI 10.1042/bj3160073; Sharkey TD, 2008, ANN BOT-LONDON, V101, P5, DOI 10.1093/aob/mcm240; Sharkey TD, 2013, EVOLUTION, V67, P1026, DOI 10.1111/evo.12013; Shi GB, 2012, BIOORGAN MED CHEM, V20, P4303, DOI 10.1016/j.bmc.2012.05.060; Sprenger GA, 1997, P NATL ACAD SCI USA, V94, P12857, DOI 10.1073/pnas.94.24.12857; Takahashi S, 1998, PSYCHIAT CLIN NEUROS, V52, P1; Wanke M, 2001, ACTA BIOCHIM POL, V48, P663; Wiberley AE, 2009, PLANT CELL ENVIRON, V32, P939, DOI 10.1111/j.1365-3040.2009.01980.x; WINTER H, 1994, PLANTA, V193, P530, DOI 10.1007/BF02411558; Wolfertz M, 2004, PLANT PHYSIOL, V135, P1939, DOI 10.1104/pp.104.043737; Wolfertz M, 2003, PLANT CELL ENVIRON, V26, P1357, DOI 10.1046/j.0016-8025.2003.01059.x; Xiang S, 2007, J BIOL CHEM, V282, P2676, DOI 10.1074/jbc.M610235200; Zeidler JG, 1997, Z NATURFORSCH C, V52, P15	67	121	127	1	93	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16926	16936		10.1074/jbc.M113.464636	http://dx.doi.org/10.1074/jbc.M113.464636			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612965	Green Published, hybrid			2022-12-28	WOS:000320378900065
J	Mosbech, A; Lukas, C; Bekker-Jensen, S; Mailand, N				Mosbech, Anna; Lukas, Claudia; Bekker-Jensen, Simon; Mailand, Niels			The Deubiquitylating Enzyme USP44 Counteracts the DNA Double-strand Break Response Mediated by the RNF8 and RNF168 Ubiquitin Ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							53BP1 RECRUITMENT; DAMAGE; BRCA1; PROMOTES; UBIQUITYLATION; RECOGNITION; PROGRESSION; PATHWAY; SITES	Protein recruitment to DNA double-strand breaks (DSBs) relies on ubiquitylation of the surrounding chromatin by the RING finger ubiquitin ligases RNF8 and RNF168. Flux through this pathway is opposed by several deubiquitylating enzymes (DUBs), including OTUB1 and USP3. By analyzing the effect of individually overexpressing the majority of human DUBs on RNF8/RNF168-mediated 53BP1 retention at DSB sites, we found that USP44 and USP29 powerfully inhibited this response at the level of RNF168 accrual. Both USP44 and USP29 promoted efficient deubiquitylation of histone H2A, but unlike USP44, USP29 displayed nonspecific reactivity toward ubiquitylated substrates. Moreover, USP44 but not other H2A DUBs was recruited to RNF168-generated ubiquitylation products at DSB sites. Individual depletion of these DUBs only mildly enhanced accumulation of ubiquitin conjugates and 53BP1 at DSBs, suggesting considerable functional redundancy among cellular DUBs that restrict ubiquitin-dependent protein assembly at DSBs. Our findings implicate USP44 in negative regulation of the RNF8/RNF168 pathway and illustrate the usefulness of DUB overexpression screens for identification of antagonizers of ubiquitin-dependent cellular responses.	[Mosbech, Anna; Bekker-Jensen, Simon; Mailand, Niels] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Dept Dis Biol, Ubiquitin Signaling Grp, DK-2200 Copenhagen, Denmark; [Lukas, Claudia] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Dept Dis Biol, Chromosome Stabil & Dynam Grp, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Bekker-Jensen, S (corresponding author), Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Dept Dis Biol, Ubiquitin Signaling Grp, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	simon.bekker-jensen@cpr.ku.dk; niels.mailand@cpr.ku.dk		Lukas, Claudia/0000-0001-7169-6883; Bekker-Jensen, Simon/0000-0002-7308-4597	Novo Nordisk Foundation; Danish Medical Research Council; Danish Cancer Society; Lundbeck Foundation; Novo Nordisk Foundation Center for Protein Research [PI Niels Mailand] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation Center for Protein Research	This work was supported by grants from the Novo Nordisk Foundation, the Danish Medical Research Council, the Danish Cancer Society, and the Lundbeck Foundation.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Brooks CL, 2011, FEBS LETT, V585, P2803, DOI 10.1016/j.febslet.2011.05.022; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Butler LR, 2012, EMBO J, V31, P3918, DOI 10.1038/emboj.2012.232; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Fuchs G, 2012, MOL CELL, V46, P662, DOI 10.1016/j.molcel.2012.05.023; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pinato S, 2011, MOL CELL BIOL, V31, P118, DOI 10.1128/MCB.00818-10; Poulsen M, 2012, J CELL BIOL, V197, P189, DOI 10.1083/jcb.201109100; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Vissers JHA, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-8; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wu JX, 2009, MOL CELL BIOL, V29, P849, DOI 10.1128/MCB.01302-08; Zhang Y, 2012, J CLIN INVEST, V122, P4362, DOI 10.1172/JCI63084; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023389	42	98	100	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16579	16587		10.1074/jbc.M113.459917	http://dx.doi.org/10.1074/jbc.M113.459917			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23615962	Green Published, hybrid			2022-12-28	WOS:000320378900034
J	Ma, WS; Liu, YW; Ellison, N; Shen, JZ				Ma, Wanshu; Liu, Yiwei; Ellison, Nicholas; Shen, Jianzhong			Induction of C-X-C Chemokine Receptor Type 7 (CXCR7) Switches Stromal Cell-derived Factor-1 (SDF-1) Signaling and Phagocytic Activity in Macrophages Linked to Atherosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECRUITS BETA-ARRESTIN; MIGRATION; PROTEIN; EXPRESSION; ANTAGONIST; ASTROCYTES; MONOCYTE; SURVIVAL; LIGAND; CXCL12	The discovery of CXCR7 as a new receptor for SDF-1 places many previously described SDF-1 functions attributed to CXCR4 in question, though whether CXCR7 acts as a signaling or "decoy" receptor has been in debate. It is known that CXCR7 is not expressed in normal blood leukocytes; however, the potential role of leukocyte CXCR7 in disease states has not been addressed. The aim of this study was to determine the expression and function of macrophage CXCR7 linked to atherosclerosis. Here, we show that CXCR7 was detected in macrophage-positive area of aortic atheroma of ApoE-null mice, but not in healthy aorta. During monocyte differentiation to macrophages, CXCR7 was up-regulated at mRNA and protein levels, with more expression in M1 than in M2 phenotype. In addition, CXCR7 induction was associated with a SDF-1 signaling switch from the pro-survival ERK and AKT pathways in monocytes to the pro-inflammatory JNK and p38 pathways in macrophages. The latter effect was mimicked by a CXCR7-selective agonist TC14012 and abolished by siRNA knockdown of CXCR7. Furthermore, CXCR7 activation increased macrophage phagocytic activity, which was suppressed by CXCR7 siRNA silencing or by inhibiting either the JNK or p38 pathways, but was not affected by blocking CXCR4. Finally, activation of CXCR7 by I-TAC showed a similar signaling and phagocytic activity in macrophages with no detectable CXCR3. We conclude that CXCR7 is induced during monocyte-to-macrophage differentiation, which is required for SDF-1 and I-TAC signaling to JNK and p38 pathways, leading to enhanced macrophage phagocytosis, thus possibly contributing to atherogenesis.	[Ma, Wanshu; Liu, Yiwei; Ellison, Nicholas; Shen, Jianzhong] Auburn Univ, Harrison Sch Pharm, Dept Pharmacal Sci, Div Pharmacol, Auburn, AL 36849 USA	Auburn University System; Auburn University	Shen, JZ (corresponding author), Auburn Univ, Sch Pharm, Dept Pharmacal Sci, Div Pharmacol, Auburn, AL 36849 USA.	jzs0019@auburn.edu	Ma, Wanshu/J-2447-2019; Ma, Wanshu/A-5233-2018; ramapuram, jay/B-3425-2012; Shen, Jianzhong/AAH-8184-2019	Ma, Wanshu/0000-0001-7462-2759; Liu, Yiwei/0000-0002-9979-6269	New Faculty Startup Fund Auburn University; American Heart Association-National SDG Award [12SDG8850011]	New Faculty Startup Fund Auburn University; American Heart Association-National SDG Award(American Heart Association)	This study was supported by the New Faculty Startup Fund Auburn University (to J.S.) and the American Heart Association-National SDG Award 12SDG8850011 (to J.S.).	Abi-Younes S, 2000, CIRC RES, V86, P131, DOI 10.1161/01.RES.86.2.131; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Berahovich RD, 2010, IMMUNOL LETT, V133, P112, DOI 10.1016/j.imlet.2010.06.010; Berahovich RD, 2010, J IMMUNOL, V185, P5130, DOI 10.4049/jimmunol.1001660; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Damas JK, 2002, CIRCULATION, V106, P36, DOI 10.1161/01.CIR.0000020001.09990.90; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; DiPersio JF, 2009, J CLIN ONCOL, V27, P4767, DOI 10.1200/JCO.2008.20.7209; Fricker SP, 2008, EXPERT OPIN INV DRUG, V17, P1749, DOI 10.1517/13543784.17.11.1749 ; Gautier EL, 2009, ARTERIOSCL THROM VAS, V29, P1412, DOI 10.1161/ATVBAHA.108.180505; Gravel S, 2010, J BIOL CHEM, V285, P37939, DOI 10.1074/jbc.C110.147470; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Infantino S, 2006, J IMMUNOL, V176, P2197, DOI 10.4049/jimmunol.176.4.2197; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Moyer MW, 2010, NAT MED, V16, P150, DOI 10.1038/nm0210-150; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Odemis V, 2012, GLIA, V60, P372, DOI 10.1002/glia.22271; Odemis V, 2010, J CELL SCI, V123, P1081, DOI 10.1242/jcs.062810; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Schnoor M, 2009, J IMMUNOL METHODS, V344, P109, DOI 10.1016/j.jim.2009.03.014; Seeger FH, 2007, EUR HEART J, V28, P766, DOI 10.1093/eurheartj/ehl509; Shen JZ, 2010, CIRC RES, V106, P902, DOI 10.1161/CIRCRESAHA.109.198069; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Tarnowski M, 2010, EUR J HAEMATOL, V85, P472, DOI 10.1111/j.1600-0609.2010.01531.x; Tarnowski M, 2010, MOL CANCER RES, V8, P1, DOI 10.1158/1541-7786.MCR-09-0259; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Wang HS, 2012, BLOOD, V119, P465, DOI 10.1182/blood-2011-03-343608; Wei DS, 2012, ANN BIOMED ENG, V40, P1018, DOI 10.1007/s10439-011-0486-z; Xu QY, 2011, ATHEROSCLEROSIS, V219, P92, DOI 10.1016/j.atherosclerosis.2011.07.118; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; Zernecke A, 2008, CIRC RES, V102, P209, DOI 10.1161/CIRCRESAHA.107.160697	36	55	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15481	15494		10.1074/jbc.M112.445510	http://dx.doi.org/10.1074/jbc.M112.445510			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23599431	Green Published, hybrid			2022-12-28	WOS:000319822300007
J	Park, J; Rhee, S				Park, Jinseo; Rhee, Sangkee			Structural Basis for a Cofactor-dependent Oxidation Protection and Catalysis of Cyanobacterial Succinic Semialdehyde Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDEHYDE DEHYDROGENASE; HYDROGEN-PEROXIDE; FEATURES; LEAVES; DOMAIN; ADDUCT	Succinic semialdehyde dehydrogenase (SSADH) from cyanobacterium Synechococcus differs from other SSADHs in the gamma-aminobutyrate shunt. Synechococcus SSADH (SySSADH) is a TCA cycle enzyme and completes a 2-oxoglutarate dehydrogenase-deficient cyanobacterial TCA cycle through a detour metabolic pathway. SySSADH produces succinate in an NADP(+)-dependent manner with a single cysteine acting as the catalytic residue in the catalytic loop. Crystal structures of SySSADH were determined in their apo form, as a binary complex with NADP(+) and as a ternary complex with succinic semialdehyde and NADPH, providing details about the catalytic mechanism by revealing a covalent adduct of a cofactor with the catalytic cysteine in the binary complex and a proposed thiohemiacetal intermediate in the ternary complex. Further analyses showed that SySSADH is an oxidation-sensitive enzyme and that the formation of the NADP-cysteine adduct is a kinetically preferred event that protects the catalytic cysteine from H2O2-dependent oxidative stress. These structural and functional features of SySSADH provide a molecular basis for cofactor-dependent oxidation protection in 1-Cys SSADH, which is unique relative to other 2-Cys SSADHs employing a redox-dependent formation of a disulfide bridge.	[Park, Jinseo; Rhee, Sangkee] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Rhee, Sangkee] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul 151921, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Rhee, S (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biol, Seoul 151921, South Korea.	srheesnu@snu.ac.kr			Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), the Rural Development Administration [PJ008059]; National Research Foundation, the Ministry of Education, Science, and Technology, Republic of Korea [R11-2008-062-01002-0, 2010-0025883]	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), the Rural Development Administration; National Research Foundation, the Ministry of Education, Science, and Technology, Republic of Korea	This work was supported by a grant from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center no. PJ008059), the Rural Development Administration, the Rural Development Administration, and from the National Research Foundation (R11-2008-062-01002-0 and 2010-0025883), the Ministry of Education, Science, and Technology, Republic of Korea.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahn JW, 2010, BIOCHEM BIOPH RES CO, V392, P106, DOI 10.1016/j.bbrc.2010.01.014; [Anonymous], TRENDS PLANT SCI, V13, P14; Bouche N, 2003, P NATL ACAD SCI USA, V100, P6843, DOI 10.1073/pnas.1037532100; Busch KB, 1999, PLANT PHYSIOL, V121, P589, DOI 10.1104/pp.121.2.589; Cheeseman JM, 2006, J EXP BOT, V57, P2435, DOI 10.1093/jxb/erl004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; de Carvalho LPS, 2011, ARCH BIOCHEM BIOPHYS, V509, P90, DOI 10.1016/j.abb.2011.01.023; Di Costanzo L, 2007, J MOL BIOL, V366, P481, DOI 10.1016/j.jmb.2006.11.023; Diaz-Sanchez AG, 2011, BIOCHEM J, V439, P443, DOI 10.1042/BJ20110376; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GonzalezFlecha B, 1997, J BACTERIOL, V179, P382, DOI 10.1128/jb.179.2.382-388.1997; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Halliwell B, 2000, FEBS LETT, V486, P10, DOI 10.1016/S0014-5793(00)02197-9; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kim KJ, 2011, ANTIOXID REDOX SIGN, V15, P691, DOI 10.1089/ars.2010.3470; Kim YG, 2009, EMBO J, V28, P959, DOI 10.1038/emboj.2009.40; Kirch HH, 2004, TRENDS PLANT SCI, V9, P371, DOI 10.1016/j.tplants.2004.06.004; Langendorf CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009280; Malaspina Patrizia, 2009, Human Genomics, V3, P106; Munoz-Clares RA, 2011, CHEM-BIOL INTERACT, V191, P137, DOI 10.1016/j.cbi.2010.12.024; Munoz-Clares RA, 2010, ARCH BIOCHEM BIOPHYS, V493, P71, DOI 10.1016/j.abb.2009.09.006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perozich J, 1999, PROTEIN SCI, V8, P137, DOI 10.1110/ps.8.1.137; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Schneider BL, 2012, J BACTERIOL, V194, P4080, DOI 10.1128/JB.05063-11; Steinhauser D, 2012, TRENDS PLANT SCI, V17, P503, DOI 10.1016/j.tplants.2012.05.005; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; Toyokura K, 2011, PLANT CELL PHYSIOL, V52, P1340, DOI 10.1093/pcp/pcr079; Tsybovsky Y, 2007, BIOCHEMISTRY-US, V46, P2917, DOI 10.1021/bi0619573; Tsybovsky Y, 2011, J BIOL CHEM, V286, P23357, DOI 10.1074/jbc.M111.221069; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wymore T, 2007, BIOCHEMISTRY-US, V46, P9495, DOI 10.1021/bi700555g; Zhang SY, 2011, SCIENCE, V334, P1551, DOI 10.1126/science.1210858; Zheng HY, 2013, PROTEINS, V81, P1031, DOI 10.1002/prot.24227	35	18	21	4	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15760	15770		10.1074/jbc.M113.460428	http://dx.doi.org/10.1074/jbc.M113.460428			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23589281	hybrid, Green Published			2022-12-28	WOS:000319822300031
J	Caster, AH; Sztul, E; Kahn, RA				Caster, Amanda H.; Sztul, Elizabeth; Kahn, Richard A.			A Role for Cargo in Arf-dependent Adaptor Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; MANNOSE 6-PHOSPHATE RECEPTORS; ADP-RIBOSYLATION FACTOR-1; EAR HOMOLOGY DOMAIN; GGA PROTEINS; ENDOPLASMIC-RETICULUM; CELL-SURFACE; IN-VITRO; MEMBRANE-PROTEINS; GAMMA-ADAPTIN	Membrane traffic requires the specific concentration of protein cargos and exclusion of other proteins into nascent carriers. Critical components of this selectivity are the protein adaptors that bind to short, linear motifs in the cytoplasmic tails of transmembrane protein cargos and sequester them into nascent carriers. The recruitment of the adaptors is mediated by activated Arf GTPases, and the Arf-adaptor complexes mark sites of carrier formation. However, the nature of the signal(s) that initiates carrier biogenesis remains unknown. We examined the specificity and initial sites of recruitment of Arf-dependent adaptors (AP-1 and GGAs) in response to the Golgi or endosomal localization of specific cargo proteins (furin, mannose-6-phosphate receptor (M6PR), and M6PR lacking a C-terminal domain M6PR Delta C). We find that cargo promotes the recruitment of specific adaptors, suggesting that it is part of an upstream signaling event. Cargos do not promote adaptor recruitment to all compartments in which they reside, and thus additional factors regulate the cargo's ability to promote Arf activation and adaptor recruitment. We document that within a given compartment different cargos recruit different adaptors, suggesting that there is little or no free, activated Arf at the membrane and that Arf activation is spatially and temporally coupled to the cargo and the adaptor. Using temperature block, brefeldin A, and recovery from each, we found that the cytoplasmic tail of M6PR causes the recruitment of AP-1 and GGAs to recycling endosomes and not at the Golgi, as predicted by steady state staining profiles. These results are discussed with respect to the generation of novel models for cargo-dependent regulation of membrane traffic.	Emory Univ, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Sztul, Elizabeth] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Med Sch Birmingham, Birmingham, AL 35294 USA	Emory University; Emory University; University of Alabama System; University of Alabama Birmingham	Kahn, RA (corresponding author), Emory Univ, Dept Biochem, Rollins Res Ctr, 1510 Clifton Ave,Suite G-218, Atlanta, GA 30322 USA.	rkahn@emory.edu	Kahn, Richard/ABD-2666-2020	Kahn, Richard/0000-0002-0259-0601	National Institutes of Health Grant (NIGMS) [GM067226]; Imaging Core of the Emory Neuroscience NINDS Core Facilities Grant [P30NS055077]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077] Funding Source: NIH RePORTER	National Institutes of Health Grant (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Imaging Core of the Emory Neuroscience NINDS Core Facilities Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM067226 (NIGMS) and by Imaging Core of the Emory Neuroscience NINDS Core Facilities Grant P30NS055077.	Aguilar RC, 1997, J BIOL CHEM, V272, P27160, DOI 10.1074/jbc.272.43.27160; Aridor M, 2002, TRAFFIC, V3, P537, DOI 10.1034/j.1600-0854.2002.30804.x; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Calhoun BC, 1996, YALE J BIOL MED, V69, P1; Caster Amanda H, 2012, Cell Logist, V2, P176; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396; GEUZE HJ, 1988, J CELL BIOL, V107, P2491, DOI 10.1083/jcb.107.6.2491; Ghosh P, 2004, ARCH BIOCHEM BIOPHYS, V426, P225, DOI 10.1016/j.abb.2004.02.011; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Gravotta D, 2007, P NATL ACAD SCI USA, V104, P1564, DOI 10.1073/pnas.0610700104; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; Han JB, 2008, J CELL SCI, V121, P2217, DOI 10.1242/jcs.019745; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; Heilker R, 1996, EMBO J, V15, P2893, DOI 10.1002/j.1460-2075.1996.tb00650.x; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; Hirst J, 2007, TRAFFIC, V8, P594, DOI 10.1111/j.1600-0854.2007.00556.x; Hirst J, 2009, TRAFFIC, V10, P1696, DOI 10.1111/j.1600-0854.2009.00983.x; Honing S, 1996, EMBO J, V15, P5230, DOI 10.1002/j.1460-2075.1996.tb00908.x; Jacobsen L, 2002, FEBS LETT, V511, P155, DOI 10.1016/S0014-5793(01)03299-9; Jian XY, 2010, TRAFFIC, V11, P732, DOI 10.1111/j.1600-0854.2010.01054.x; Jones DH, 2000, J BIOL CHEM, V275, P13962, DOI 10.1074/jbc.C901019199; Karlsson K, 1998, J BIOL CHEM, V273, P18966, DOI 10.1074/jbc.273.30.18966; Klumperman J, 1998, J CELL BIOL, V141, P359, DOI 10.1083/jcb.141.2.359; Kuai J, 2002, METHOD ENZYMOL, V345, P359; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; Ladinsky MS, 2002, MOL BIOL CELL, V13, P2810, DOI 10.1091/mbc.01-12-0593; LEBORGNE R, 1993, J BIOL CHEM, V268, P22552; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Liu YZ, 2010, NAT STRUCT MOL BIOL, V17, P876, DOI 10.1038/nsmb.1853; LODISH HF, 1983, VIROLOGY, V125, P335, DOI 10.1016/0042-6822(83)90206-4; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; MARGOLIS B, 1994, J AM SOC NEPHROL, V5, P1288; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; McKay MM, 2004, TRAFFIC, V5, P102, DOI 10.1111/j.1600-0854.2004.00160.x; Medigeshi GR, 2003, TRAFFIC, V4, P802, DOI 10.1034/j.1600-0854.2003.00136.x; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; Montagnac G, 2011, CURR BIOL, V21, P574, DOI 10.1016/j.cub.2011.02.034; MOTTET G, 1986, J GEN VIROL, V67, P2029, DOI 10.1099/0022-1317-67-9-2029; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; Nakayama K, 2005, METHOD ENZYMOL, V404, P367, DOI 10.1016/S0076-6879(05)04032-2; North AJ, 2006, J CELL BIOL, V172, P9, DOI 10.1083/jcb.200507103; Odorizzi G, 1997, J CELL BIOL, V137, P1255, DOI 10.1083/jcb.137.6.1255; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; SARASTE J, 1984, CELL, V38, P535, DOI 10.1016/0092-8674(84)90508-7; SARASTE J, 1986, P NATL ACAD SCI USA, V83, P6425, DOI 10.1073/pnas.83.17.6425; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Sohn K, 1996, J CELL BIOL, V135, P1239, DOI 10.1083/jcb.135.5.1239; Takatsu H, 2000, BIOCHEM BIOPH RES CO, V271, P719, DOI 10.1006/bbrc.2000.2700; Takatsu H, 2001, J BIOL CHEM, V276, P28541, DOI 10.1074/jbc.C100218200; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Teuchert M, 1999, J BIOL CHEM, V274, P8199, DOI 10.1074/jbc.274.12.8199; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tikkanen R, 2000, TRAFFIC, V1, P631, DOI 10.1034/j.1600-0854.2000.010807.x; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; Valdivia RH, 2002, DEV CELL, V2, P283, DOI 10.1016/S1534-5807(02)00127-2; VALNES K, 1985, J HISTOCHEM CYTOCHEM, V33, P755, DOI 10.1177/33.8.3926864; Vieira SI, 2009, MOL CELL BIOCHEM, V328, P145, DOI 10.1007/s11010-009-0084-7; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5; Yoon HY, 2005, METHOD ENZYMOL, V404, P316, DOI 10.1016/S0076-6879(05)04028-0; Zhu YX, 1999, P NATL ACAD SCI USA, V96, P5013, DOI 10.1073/pnas.96.9.5013	85	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14788	14804		10.1074/jbc.M113.453621	http://dx.doi.org/10.1074/jbc.M113.453621			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23572528	hybrid, Green Published			2022-12-28	WOS:000319452100012
J	Lowey, S; Bretton, V; Gulick, J; Robbins, J; Trybus, KM				Lowey, Susan; Bretton, Vera; Gulick, James; Robbins, Jeffrey; Trybus, Kathleen M.			Transgenic Mouse alpha- and beta-Cardiac Myosins Containing the R403Q Mutation Show Isoform-dependent Transient Kinetic Differences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; HEAVY-CHAIN; SHORTENING VELOCITY; FUNCTIONAL DIVERSITY; MUSCLE; MOTOR; MECHANICS; RELEASE; MAMMALS; ACTIN	Familial hypertrophic cardiomyopathy (FHC) is a major cause of sudden cardiac death in young athletes. The discovery in 1990 that a point mutation at residue 403 (R403Q) in the beta-myosin heavy chain (MHC) caused a severe form of FHC was the first of many demonstrations linking FHC to mutations in muscle proteins. A mouse model for FHC has been widely used to study the mechanochemical properties of mutated cardiac myosin, but mouse hearts express alpha-MHC, whereas the ventricles of larger mammals express predominantly beta-MHC. To address the role of the isoform backbone on function, we generated a transgenic mouse in which the endogenous alpha-MHC was partially replaced with transgenically encoded beta-MHC or alpha-MHC. A His(6) tag was cloned at the N terminus, along with R403Q, to facilitate isolation of myosin subfragment 1 (S1). Stopped flow kinetics were used to measure the equilibrium constants and rates of nucleotide binding and release for the mouse S1 isoforms bound to actin. For the wild-type isoforms, we found that the affinity of MgADP for alpha-S1 (100 mu M) is similar to 4-fold weaker than for beta-S1 (25 mu M). Correspondingly, the MgADP release rate for alpha-S1 (350 s(-1)) is similar to 3-fold greater than for beta-S1 (120 s(-1)). Introducing the R403Q mutation caused only a minor reduction in kinetics for beta-S1, but R403Q in alpha-S1 caused the ADP release rate to increase by 20% (430 s(-1)). These transient kinetic studies on mouse cardiac myosins provide strong evidence that the functional impact of an FHC mutation on myosin depends on the isoform backbone.	[Lowey, Susan; Bretton, Vera; Trybus, Kathleen M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Gulick, James; Robbins, Jeffrey] Childrens Hosp Med Ctr, Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA	University of Vermont; Cincinnati Children's Hospital Medical Center	Lowey, S (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, HSRF 128, Burlington, VT 05405 USA.	susan.lowey@uvm.edu			National Institutes of Health [HL111847, AR053975, HL38113, HL110869, HL077101, HL049058]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077101, R21HL111847, P01HL110869, P01HL059408, R01HL038113, R29HL038113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053975] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL111847 and AR053975 (to S. L.), HL38113 and HL110869 (to K. M. T.), and HL077101 and HL049058 (to J. R.).	Alpert NR, 2002, AM J PHYSIOL-HEART C, V283, pH1446, DOI 10.1152/ajpheart.00274.2002; Bloemink MJ, 2011, SEMIN CELL DEV BIOL, V22, P961, DOI 10.1016/j.semcdb.2011.09.015; Canepari M, 2000, J MUSCLE RES CELL M, V21, P375, DOI 10.1023/A:1005640004495; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Cuda G, 1997, J MUSCLE RES CELL M, V18, P275, DOI 10.1023/A:1018613907574; CUDA G, 1993, J CLIN INVEST, V91, P2861, DOI 10.1172/JCI116530; Deacon JC, 2012, CELL MOL LIFE SCI, V69, P2261, DOI 10.1007/s00018-012-0927-3; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Keller DI, 2004, J MOL CELL CARDIOL, V36, P355, DOI 10.1016/j.yjmcc.2003.12.006; Krenz M, 2003, J BIOL CHEM, V278, P17466, DOI 10.1074/jbc.M210804200; LOMPRE AM, 1981, DEV BIOL, V84, P286, DOI 10.1016/0012-1606(81)90396-1; Lowey S, 2002, TRENDS CARDIOVAS MED, V12, P348, DOI 10.1016/S1050-1738(02)00181-0; Lowey S, 2008, J BIOL CHEM, V283, P20579, DOI 10.1074/jbc.M800554200; Malmqvist UP, 2004, BIOCHEMISTRY-US, V43, P15058, DOI 10.1021/bi0495329; Nyitrai M, 2006, J MOL BIOL, V355, P432, DOI 10.1016/j.jmb.2005.10.063; Palmiter KA, 2000, J MUSCLE RES CELL M, V21, P609, DOI 10.1023/A:1005678905119; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pellegrino MA, 2003, J PHYSIOL-LONDON, V546, P677, DOI 10.1113/jphysiol.2002.027375; Pereira JS, 2001, J BIOL CHEM, V276, P4409, DOI 10.1074/jbc.M006441200; Resnicow DI, 2010, P NATL ACAD SCI USA, V107, P1053, DOI 10.1073/pnas.0913527107; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; Srikakulam R, 1999, J BIOL CHEM, V274, P27265, DOI 10.1074/jbc.274.38.27265; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Tyska MJ, 2000, CIRC RES, V86, P737, DOI 10.1161/01.RES.86.7.737; Wang Q, 2003, J CELL SCI, V116, P4227, DOI 10.1242/jcs.00709; Wang Y, 2013, J MOL CELL CARDIOL, V54, P1, DOI 10.1016/j.yjmcc.2012.10.010; Weiss S, 2001, J BIOL CHEM, V276, P45902, DOI 10.1074/jbc.M107434200	29	28	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14780	14787		10.1074/jbc.M113.450668	http://dx.doi.org/10.1074/jbc.M113.450668			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23580644	hybrid, Green Published			2022-12-28	WOS:000319452100011
J	Chalfoun, NR; Grellet-Bournonville, CF; Martinez-Zamora, MG; Diaz-Perales, A; Castagnaro, AP; Diaz-Ricci, JC				Chalfoun, Nadia R.; Grellet-Bournonville, Carlos F.; Martinez-Zamora, Martin G.; Diaz-Perales, Araceli; Castagnaro, Atilio P.; Diaz-Ricci, Juan C.			Purification and Characterization of AsES Protein A SUBTILISIN SECRETED BY ACREMONIUM STRICTUM IS A NOVEL PLANT DEFENSE ELICITOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERSENSITIVE RESPONSE; NUCLEOTIDE-SEQUENCES; FUNGAL PROTEINASE; EFFECTOR PROTEINS; AVIRULENT STRAIN; PATHOGEN; RESISTANCE; GENE; COLLETOTRICHUM; EXPRESSION	In this work, the purification and characterization of an extracellular elicitor protein, designated AsES, produced by an avirulent isolate of the strawberry pathogen Acremonium strictum, are reported. The defense eliciting activity present in culture filtrates was recovered and purified by ultrafiltration (cutoff, 30 kDa), anionic exchange (Q-Sepharose, pH 7.5), and hydrophobic interaction (phenyl-Sepharose) chromatographies. Two-dimensional SDS-PAGE of the purified active fraction revealed a single spot of 34 kDa and pI 8.8. HPLC (C2/C18) and MS/MS analysis confirmed purification to homogeneity. Foliar spray with AsES provided a total systemic protection against anthracnose disease in strawberry, accompanied by the expression of defense-related genes (i.e. PR1 and Chi2-1). Accumulation of reactive oxygen species (e.g. H2O2 and O-2(radical anion)) and callose was also observed in Arabidopsis. By using degenerate primers designed from the partial amino acid sequences and rapid amplification reactions of cDNA ends, the complete AsES-coding cDNA of 1167 nucleotides was obtained. The deduced amino acid sequence showed significant identity with fungal serine proteinases of the subtilisin family, indicating that AsES is synthesized as a larger precursor containing a 15-residue secretory signal peptide and a 90-residue peptidase inhibitor I9 domain in addition to the 283-residue mature protein. AsES exhibited proteolytic activity in vitro, and its resistance eliciting activity was eliminated when inhibited with PMSF, suggesting that its proteolytic activity is required to induce the defense response. This is, to our knowledge, the first report of a fungal subtilisin that shows eliciting activity in plants. This finding could contribute to develop disease biocontrol strategies in plants by activating its innate immunity.	[Chalfoun, Nadia R.; Grellet-Bournonville, Carlos F.; Martinez-Zamora, Martin G.; Diaz-Ricci, Juan C.] Univ Nacl Tucuman, Fac Bioquim Quim & Farm, Inst Super Invest Biol, RA-4000 San Miguel De Tucuman, Tucuman, Argentina; [Chalfoun, Nadia R.; Grellet-Bournonville, Carlos F.; Martinez-Zamora, Martin G.; Diaz-Ricci, Juan C.] Univ Nacl Tucuman, Fac Bioquim Quim & Farm, Consejo Nacl Invest Cient & Tecn, RA-4000 San Miguel De Tucuman, Tucuman, Argentina; [Castagnaro, Atilio P.] Estn Expt Agroind Obispo Colombres, Secc Biotecnol, Las Talitas, Tucuman, Argentina; [Diaz-Perales, Araceli] Univ Politecn Madrid, Escuela Tecn Super Ingenieros Agronomos, Dept Biotecnol, Unidad Quim & Bioquim, E-28040 Madrid, Spain	Universidad Nacional de Tucuman; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman; Universidad Politecnica de Madrid	Diaz-Ricci, JC (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.	juan@fbqf.unt.edu.ar	Díaz-Perales, Araceli/D-8433-2016	Díaz-Perales, Araceli/0000-0002-1093-3627; Castagnaro, Atilio/0000-0002-1599-2255; Grellet Bournonville, Carlos Froilan/0000-0001-5990-9233	Consejo de Investigaciones de la Universidad Nacional de Tucuman Grant [26/D423]; Agencia Nacional de Promocion Cientifica y Tecnologica [BID PICT-2008-2105]	Consejo de Investigaciones de la Universidad Nacional de Tucuman Grant; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported in part by Consejo de Investigaciones de la Universidad Nacional de Tucuman Grant 26/D423 and Agencia Nacional de Promocion Cientifica y Tecnologica Grant BID PICT-2008-2105.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amil-Ruiz F, 2011, PLANT CELL PHYSIOL, V52, P1873, DOI 10.1093/pcp/pcr136; BASSE CW, 1993, J BIOL CHEM, V268, P14724; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bonas U, 2002, CURR OPIN MICROBIOL, V5, P44, DOI 10.1016/S1369-5274(02)00284-9; Bozso Z, 2005, J PHYTOPATHOL, V153, P596, DOI 10.1111/j.1439-0434.2005.01026.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunner F, 2002, EMBO J, V21, P6681, DOI 10.1093/emboj/cdf667; Chalfoun NR, 2011, BIOL CONTROL, V58, P319, DOI 10.1016/j.biocontrol.2011.05.007; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; DELP B R, 1980, Plant Disease, V64, P1071, DOI 10.1094/PD-64-1071; DeWit PJGM, 1997, TRENDS PLANT SCI, V2, P452, DOI 10.1016/S1360-1385(97)01139-4; DOKE N, 1983, PHYSIOL PLANT PATHOL, V23, P359, DOI 10.1016/0048-4059(83)90020-6; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FABRE E, 1991, J BIOL CHEM, V266, P3782; Freeman S, 1997, PHYTOPATHOLOGY, V87, P516, DOI 10.1094/PHYTO.1997.87.5.516; GORG A, 1987, ELECTROPHORESIS, V8, P122, DOI 10.1002/elps.1150080207; Grellet-Bournonville CF, 2012, PLANT PHYSIOL BIOCH, V54, P10, DOI 10.1016/j.plaphy.2012.01.019; GUNKEL FA, 1989, EUR J BIOCHEM, V179, P185, DOI 10.1111/j.1432-1033.1989.tb14539.x; Iandolino AB, 2004, PLANT MOL BIOL REP, V22, P269, DOI 10.1007/BF02773137; Ikram N, 2009, AFR J BIOTECHNOL, V8, P5867; ISOGAI T, 1991, AGR BIOL CHEM TOKYO, V55, P471, DOI 10.1080/00021369.1991.10870614; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jorge I, 2005, PROTEOMICS, V5, P222, DOI 10.1002/pmic.200400893; Kamoun S, 2007, CURR OPIN PLANT BIOL, V10, P358, DOI 10.1016/j.pbi.2007.04.017; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; KEEN NT, 1990, MOL PLANT MICROBE IN, V3, P112, DOI 10.1094/MPMI-3-112; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; LINDSTROM JT, 1994, PLANT PHYSIOL, V106, P7, DOI 10.1104/pp.106.1.7; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Liu CL, 2007, BIOCHEM BIOPH RES CO, V358, P356, DOI 10.1016/j.bbrc.2007.04.133; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Mamani A, 2012, MOL PLANT MICROBE IN, V25, P1430, DOI 10.1094/MPMI-12-11-0306; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Mateos FV, 1997, MOL PLANT MICROBE IN, V10, P1045, DOI 10.1094/MPMI.1997.10.9.1045; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Mikes V, 1998, BIOCHEM BIOPH RES CO, V245, P133, DOI 10.1006/bbrc.1998.8341; Moallaei H, 2006, MYCOPATHOLOGIA, V161, P369, DOI 10.1007/s11046-006-0019-8; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Olivieri F, 2002, EUR J PLANT PATHOL, V108, P63, DOI 10.1023/A:1013920929965; Orbach MJ, 2000, PLANT CELL, V12, P2019, DOI 10.1105/tpc.12.11.2019; Orsomando G, 2001, J BIOL CHEM, V276, P21578, DOI 10.1074/jbc.M101377200; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; SACKS W, 1995, MOL GEN GENET, V246, P45, DOI 10.1007/BF00290132; Salazar SM, 2007, EUR J PLANT PATHOL, V117, P109, DOI 10.1007/s10658-006-9075-7; Salazar SM, 2013, EUR J PLANT PATHOL, V135, P877, DOI 10.1007/s10658-012-0134-y; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Segrest JP, 1972, METHOD ENZYMOL, V28, P54, DOI DOI 10.1016/0076-6879(72)28007-7; SHARON A, 1993, PLANT PHYSIOL, V102, P1325, DOI 10.1104/pp.102.4.1325; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siezen RJ, 1997, PROTEIN SCI, V6, P501; SMITH BJ, 1990, PLANT DIS, V74, P69, DOI 10.1094/PD-74-0069; Sreedhar L, 1999, GENE, V235, P121, DOI 10.1016/S0378-1119(99)00201-2; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Takagi H, 2001, FEBS LETT, V508, P210, DOI 10.1016/S0014-5793(01)03053-8; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; VALENT B, 1994, RICE BLAST DISEASE, P111; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; van't Slot KAE, 2002, CRIT REV PLANT SCI, V21, P229, DOI 10.1080/0735-260291044223; Vellicce GR, 2006, TRANSGENIC RES, V15, P57, DOI 10.1007/s11248-005-2543-6; Wang B, 2009, MICROBIOL RES, V164, P665, DOI 10.1016/j.micres.2009.01.003; Yamaguchi Y, 2011, CURR OPIN PLANT BIOL, V14, P351, DOI 10.1016/j.pbi.2011.05.001; Yang JK, 2011, APPL MICROBIOL BIOT, V89, P1895, DOI 10.1007/s00253-010-3012-6; Yun MH, 2006, PLANT PHYSIOL, V141, P178, DOI 10.1104/pp.105.074542	72	35	37	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14098	14113		10.1074/jbc.M112.429423	http://dx.doi.org/10.1074/jbc.M112.429423			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23530047	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000319253500015
J	Kim, HS; Caswell, CC; Foreman, R; Roop, RM; Crosson, S				Kim, Hye-Sook; Caswell, Clayton C.; Foreman, Robert; Roop, R. Martin, II; Crosson, Sean			The Brucella abortus General Stress Response System Regulates Chronic Mammalian Infection and Is Controlled by Phosphorylation and Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGMA-FACTOR MIMICRY; 2-COMPONENT SYSTEM; BACILLUS-SUBTILIS; STRUCTURAL BASIS; VIRULENCE; PHYR; MELITENSIS; MODEL; IDENTIFICATION; RECOGNITION	Brucella spp. are adept at establishing a chronic infection in mammals. We demonstrate that core components of the alpha-proteobacterial general stress response (GSR) system, PhyR and sigma(E1), are required for Brucella abortus stress survival in vitro and maintenance of chronic murine infection in vivo. Delta phyR and Delta rpoE1 null mutants exhibit decreased survival under acute oxidative and acid stress but are not defective in infection of primary murine macrophages or in initial colonization of BALB/c mouse spleens. However, Delta phyR and Delta rpoE1 mutants are attenuated in spleens beginning 1 month postinfection. Thus, the B. abortus GSR system is dispensable for colonization but is required to maintain chronic infection. A genome-scale analysis of the B. abortus GSR regulon identified stress response genes previously linked to virulence and genes that affect immunomodulatory components of the cell envelope. These data support a model in which the GSR system affects both stress survival and the interface between B. abortus and the host immune system. We further demonstrate that PhyR proteolysis is a unique feature of GSR control in B. abortus. Proteolysis of PhyR provides a mechanism to avoid spurious PhyR protein interactions that inappropriately activate GSR-dependent transcription. We conclude that the B. abortus GSR system regulates acute stress adaptation and long term survival within a mammalian host and that PhyR proteolysis is a novel regulatory feature in B. abortus that ensures proper control of GSR transcription.	[Kim, Hye-Sook; Crosson, Sean] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Kim, Hye-Sook; Foreman, Robert; Crosson, Sean] Argonne Natl Lab, Howard Taylor Ricketts Lab, Argonne, IL 60439 USA; [Caswell, Clayton C.; Roop, R. Martin, II] E Carolina Univ, Sch Med, Dept Microbiol & Immunol, Greenville, NC 27834 USA; [Foreman, Robert; Crosson, Sean] Univ Chicago, Comm Microbiol, Chicago, IL 60637 USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of North Carolina; East Carolina University; University of Chicago	Crosson, S (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 E 57th St,GCIS W138, Chicago, IL 60637 USA.	scrosson@uchicago.edu	Crosson, Sean/AAE-2453-2022	Crosson, Sean/0000-0002-1727-322X	National Institutes of Health (NIH), NIAID, Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) Program (Region V "Great Lakes" RCE) [1U54AI057153]; NIH, NIAID [R01AI048499]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R01AI048499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIAID, Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) Program (Region V "Great Lakes" RCE); NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health (NIH), NIAID, Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) Program (Region V "Great Lakes" RCE; Grant 1U54AI057153) and NIH, NIAID, Grant R01AI048499.	Arenas GN, 2000, INFECT IMMUN, V68, P4255, DOI 10.1128/IAI.68.7.4255-4263.2000; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; Bastiat B, 2010, J BACTERIOL, V192, P2255, DOI 10.1128/JB.01666-09; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Campagne S, 2012, P NATL ACAD SCI USA, V109, pE1405, DOI 10.1073/pnas.1117003109; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Delory M, 2006, J BACTERIOL, V188, P7707, DOI 10.1128/JB.00644-06; Endley S, 2001, J BACTERIOL, V183, P2454, DOI 10.1128/JB.183.8.2454-2462.2001; Ferooz J, 2011, MICROBIOL-SGM, V157, P1263, DOI 10.1099/mic.0.044875-0; Fiebig A, 2010, MOL MICROBIOL, V77, P236, DOI 10.1111/j.1365-2958.2010.07207.x; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Foreman R, 2012, J BACTERIOL, V194, P3038, DOI 10.1128/JB.00182-12; Francez-Charlot A, 2009, P NATL ACAD SCI USA, V106, P3467, DOI 10.1073/pnas.0810291106; Fretin D, 2005, CELL MICROBIOL, V7, P687, DOI 10.1111/j.1462-5822.2005.00502.x; GERHARDT P, 1958, BACTERIOL REV, V22, P81, DOI 10.1128/MMBR.22.2.81-98.1958; Gorvel JP, 2002, VET MICROBIOL, V90, P281, DOI 10.1016/S0378-1135(02)00214-6; Gourion B, 2008, J BACTERIOL, V190, P1027, DOI 10.1128/JB.01483-07; Gourion B, 2009, MOL MICROBIOL, V73, P291, DOI 10.1111/j.1365-2958.2009.06769.x; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Herrou J, 2012, P NATL ACAD SCI USA, V109, pE1415, DOI 10.1073/pnas.1116887109; Herrou J, 2010, MOL MICROBIOL, V78, P290, DOI 10.1111/j.1365-2958.2010.07323.x; Castano MJ, 2009, J CLIN MICROBIOL, V47, P2084, DOI 10.1128/JCM.02159-08; Kaczmarczyk A, 2011, J BACTERIOL, V193, P6629, DOI 10.1128/JB.06006-11; Kohler S, 2003, TRENDS MICROBIOL, V11, P215, DOI 10.1016/S0966-842X(03)00078-7; Lourenco RF, 2011, MOL MICROBIOL, V80, P1598, DOI 10.1111/j.1365-2958.2011.07668.x; Moreno E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P315, DOI 10.1007/0-387-30745-1_17; Naroeni A, 2001, INFECT IMMUN, V69, P486, DOI 10.1128/IAI.69.1.486-493.2001; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; RIED JL, 1987, GENE, V57, P239, DOI 10.1016/0378-1119(87)90127-2; Robertson G. T., 2000, THESIS LOUISIANA STA; Roop RM, 2009, MED MICROBIOL IMMUN, V198, P221, DOI 10.1007/s00430-009-0123-8; Roop RM, 2004, MOL MICROBIOL, V52, P621, DOI 10.1111/j.1365-2958.2004.04017.x; Sangari FJ, 2007, INFECT IMMUN, V75, P774, DOI 10.1128/IAI.01244-06; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Solera J, 2010, INT J ANTIMICROB AG, V36, pS18, DOI 10.1016/j.ijantimicag.2010.06.015; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Steele KH, 2010, J BACTERIOL, V192, P4912, DOI 10.1128/JB.00231-10; Sun YH, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00047; Terwagne M, 2013, CELL MICROBIOL, V15, P942, DOI 10.1111/cmi.12088; Ugalde JE, 2000, INFECT IMMUN, V68, P5716, DOI 10.1128/IAI.68.10.5716-5723.2000; Ugalde JE, 2003, INFECT IMMUN, V71, P6264, DOI 10.1128/IAI.71.11.6264-6269.2003; Vemulapalli TH, 2006, INFECT IMMUN, V74, P183, DOI 10.1128/IAI.74.1.183-191.2006; Zhang Y, 2007, J BACTERIOL, V189, P7669, DOI 10.1128/JB.00745-07	44	47	48	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13906	13916		10.1074/jbc.M113.459305	http://dx.doi.org/10.1074/jbc.M113.459305			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23546883	Green Published, hybrid			2022-12-28	WOS:000318850300071
J	Van Itallie, CM; Aponte, A; Tietgens, AJ; Gucek, M; Fredriksson, K; Anderson, JM				Van Itallie, Christina M.; Aponte, Angel; Tietgens, Amber Jean; Gucek, Marjan; Fredriksson, Karin; Anderson, James Melvin			The N and C Termini of ZO-1 Are Surrounded by Distinct Proteins and Functional Protein Networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT JUNCTION PROTEIN; CELL-ADHESION SITES; PDZ DOMAIN; E-CADHERIN; SEQUENCE SIMILARITY; BINDING PROTEIN; GENE-PRODUCT; ACTIN; POLARITY; MEMBRANE	The proteins and functional protein networks of the tight junction remain incompletely defined. Among the currently known proteins are barrier-forming proteins like occludin and the claudin family; scaffolding proteins like ZO-1; and some cytoskeletal, signaling, and cell polarity proteins. To define a more complete list of proteins and infer their functional implications, we identified the proteins that are within molecular dimensions of ZO-1 by fusing biotin ligase to either its N or C terminus, expressing these fusion proteins in Madin-Darby canine kidney epithelial cells, and purifying and identifying the resulting biotinylated proteins by mass spectrometry. Of a predicted proteome of similar to 9000, we identified more than 400 proteins tagged by biotin ligase fused to ZO-1, with both identical and distinct proteins near the N- and C-terminal ends. Those proximal to the N terminus were enriched in transmembrane tight junction proteins, and those proximal to the C terminus were enriched in cytoskeletal proteins. We also identified many unexpected but easily rationalized proteins and verified partial colocalization of three of these proteins with ZO-1 as examples. In addition, functional networks of interacting proteins were tagged, such as the basolateral but not apical polarity network. These results provide a rich inventory of proteins and potential novel insights into functions and protein networks that should catalyze further understanding of tight junction biology. Unexpectedly, the technique demonstrates high spatial resolution, which could be generally applied to defining other subcellular protein compartmentalization.	[Van Itallie, Christina M.; Tietgens, Amber Jean; Fredriksson, Karin; Anderson, James Melvin] NHLBI, Lab Tight Junct Struct & Funct, NIH, Bethesda, MD 20892 USA; [Aponte, Angel; Gucek, Marjan] NHLBI, Prote Core Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Van Itallie, CM (corresponding author), NHLBI, NIH, Bldg 50,Rm 45425,50 South Dr, Bethesda, MD 20892 USA.	Christina.vanitallie@nih.gov		Anderson, James/0000-0003-2765-7996	National Institutes of Health Division of Intramural Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005903, ZIAHL006176] Funding Source: NIH RePORTER	National Institutes of Health Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institutes of Health Division of Intramural Research.	Akashi M, 2011, BIOCHEM BIOPH RES CO, V413, P224, DOI 10.1016/j.bbrc.2011.08.073; Anastas JN, 2012, ONCOGENE, V31, P3696, DOI 10.1038/onc.2011.528; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; ANDERSON JM, 1988, J CELL BIOL, V106, P1141, DOI 10.1083/jcb.106.4.1141; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; BUTZ S, 1994, FEBS LETT, V355, P195, DOI 10.1016/0014-5793(94)01205-9; Cao XW, 2012, CELL RES, V22, P793, DOI 10.1038/cr.2012.64; Chen XY, 2006, J CELL BIOL, V172, P671, DOI 10.1083/jcb.200510061; CITI S, 1988, NATURE, V333, P272, DOI 10.1038/333272a0; Citi S, 2012, ANN NY ACAD SCI, V1257, P125, DOI 10.1111/j.1749-6632.2012.06506.x; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Cohen D, 2004, J CELL BIOL, V164, P717, DOI 10.1083/jcb.200308104; Cohen D, 2011, J CELL BIOL, V192, P525, DOI 10.1083/jcb.201007002; Cong WL, 2010, CURR BIOL, V20, P1408, DOI 10.1016/j.cub.2010.06.024; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dorfel MJ, 2009, ANN NY ACAD SCI, V1165, P69, DOI 10.1111/j.1749-6632.2009.04043.x; Dupre-Crochet S, 2007, MOL CELL BIOL, V27, P3804, DOI 10.1128/MCB.01590-06; Ebnet K, 2000, J BIOL CHEM, V275, P27979; Elbert M, 2006, MOL BIOL CELL, V17, P3345, DOI 10.1091/mbc.E06-03-0193; Etournay R, 2007, J CELL SCI, V120, P2838, DOI 10.1242/jcs.002568; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Fanning AS, 2002, FASEB J, V16, P1835, DOI 10.1096/fj.02-0121fje; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fletcher SJ, 2012, BIOL CELL, V104, P238, DOI 10.1111/boc.201100004; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Gao L, 2002, GENE, V294, P99, DOI 10.1016/S0378-1119(02)00681-9; Giuliani C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000675; Gonzalez-Mariscal L, 2012, ANN NY ACAD SCI, V1257, P133, DOI 10.1111/j.1749-6632.2012.06537.x; GONZALEZMARISCAL L, 1985, J MEMBRANE BIOL, V86, P113, DOI 10.1007/BF01870778; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Hu JH, 2011, J BIOL CHEM, V286, P2261, DOI 10.1074/jbc.M110.157974; Huling JC, 2012, AM J PHYSIOL-RENAL, V302, pF401, DOI 10.1152/ajprenal.00457.2011; HULL BE, 1979, J CELL BIOL, V81, P67, DOI 10.1083/jcb.81.1.67; Ide N, 1999, ONCOGENE, V18, P7810, DOI 10.1038/sj.onc.1203153; Ikenouchi J, 2007, J CELL BIOL, V176, P779, DOI 10.1083/jcb.200612080; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Ivanov AI, 2010, AM J PATHOL, V176, P134, DOI 10.2353/ajpath.2010.090220; JESAITIS LA, 1994, J CELL BIOL, V124, P949, DOI 10.1083/jcb.124.6.949; Katoh M, 2004, INT J ONCOL, V25, P535; Katsube T, 1998, J BIOL CHEM, V273, P29672, DOI 10.1074/jbc.273.45.29672; Kim Y, 2002, GENES CELLS, V7, P413, DOI 10.1046/j.1365-2443.2002.00524.x; Langton PF, 2009, CURR BIOL, V19, P1969, DOI 10.1016/j.cub.2009.10.027; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Lee DBN, 2004, AM J PHYSIOL-RENAL, V287, pF481, DOI 10.1152/ajprenal.00175.2003; Lie PPY, 2009, FASEB J, V23, P2555, DOI 10.1096/fj.06-070573; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Luton F, 2004, MOL BIOL CELL, V15, P1134, DOI 10.1091/mbc.E03-10-0751; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Marx A, 2010, FASEB J, V24, P1637, DOI 10.1096/fj.09-148064; Matsuda M, 2008, EXP CELL RES, V314, P939, DOI 10.1016/j.yexcr.2007.11.009; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Murase K, 2012, MED MOL MORPHOL, V45, P22, DOI 10.1007/s00795-010-0537-9; Muthuswamy SK, 2012, ANNU REV CELL DEV BI, V28, P599, DOI 10.1146/annurev-cellbio-092910-154244; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Nethe M, 2012, J CELL SCI, V125, P3430, DOI 10.1242/jcs.100925; Ohnishi H, 2004, J BIOL CHEM, V279, P46014, DOI 10.1074/jbc.M402616200; Oka T, 2012, ONCOGENE, V31, P128, DOI 10.1038/onc.2011.216; Ooshio T, 2004, J BIOL CHEM, V279, P31365, DOI 10.1074/jbc.M401957200; Patrie KM, 2002, J BIOL CHEM, V277, P30183, DOI 10.1074/jbc.M203072200; Petit MM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-1; Rodgers LS, 2011, CYTOSKELETON, V68, P653, DOI 10.1002/cm.20547; Routhier EL, 2001, J BIOL CHEM, V276, P21670, DOI 10.1074/jbc.M101096200; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Salazar MA, 2003, J BIOL CHEM, V278, P49031, DOI 10.1074/jbc.M308104200; Sharma S, 2006, HUM MOL GENET, V15, P1972, DOI 10.1093/hmg/ddl120; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Sottocornola R, 2010, DEV CELL, V19, P126, DOI 10.1016/j.devcel.2010.06.003; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Stamatovic SM, 2012, MOL CELL BIOL, V32, P3414, DOI 10.1128/MCB.06678-11; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; Traweger A, 2008, P NATL ACAD SCI USA, V105, P10402, DOI 10.1073/pnas.0804102105; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Utepbergenov DI, 2006, J BIOL CHEM, V281, P24671, DOI 10.1074/jbc.M512820200; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; Walsh GS, 2011, DEVELOPMENT, V138, P3033, DOI 10.1242/dev.063842; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199; Yamazaki Y, 2008, BIOCHEMISTRY-US, V47, P5378, DOI 10.1021/bi8002567; Yap AS, 1998, J MEMBRANE BIOL, V163, P159, DOI 10.1007/s002329900380; Yates LL, 2013, DEV BIOL, V373, P267, DOI 10.1016/j.ydbio.2012.11.012; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	96	78	78	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13775	13788		10.1074/jbc.M113.466193	http://dx.doi.org/10.1074/jbc.M113.466193			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23553632	hybrid, Green Published			2022-12-28	WOS:000318850300059
J	Gouriou, Y; Bijlenga, P; Demaurex, N				Gouriou, Yves; Bijlenga, Philippe; Demaurex, Nicolas			Mitochondrial Ca2+ Uptake from Plasma Membrane Cav3.2 Protein Channels Contributes to Ischemic Toxicity in PC12 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; NA+/CA2+ EXCHANGER; CALCIUM UNIPORTER; NEURONAL DEATH; EXCITOTOXICITY; TRANSPORT; RESPONSES; ALPHA-1H; HYPOXIA; SIGNALS	T-type Ca2+ channel inhibitors protect hippocampal CA1 neurons from delayed death after global ischemia in rats, suggesting that Cav3.1, Cav3.2, or Cav3.3 channels generate cytotoxic Ca2+ elevations during anoxia. To test this hypothesis, we measured the Ca2+ concentration changes evoked by oxygen and glucose deprivation (OGD) in the cytosol and in the mitochondria of PC12 cells. OGD evoked long-lasting cytosolic Ca2+ elevations that were reduced by Cav3.2 inhibition (50 mu M Ni2+) and Cav3.1/Cav3.2 silencing and potentiated by Cav3.2 overexpression. The kinetics of the sustained cytosolic Ca2+ elevations occurring during OGD directly correlated to the extent of cell death measured 20 h after reoxygenation, which was decreased by Ni2+ and Cav3.1/Cav3.2 silencing and increased by Cav3.2 overexpression. Ni2+ and Cav3.1/Cav3.2 silencing delayed the decline of cellular ATP during OGD, consistent with a reduction in the Ca2+ load actively extruded by plasma membrane Ca2+ pumps. The cytosolic Ca2+ elevations were paralleled by mitochondrial Ca2+ elevations that were also increased by Cav3.2 overexpression and decreased by Ni2+ but not by Cav3.1/Cav3.2 silencing. Overexpression and silencing of the mitochondrial Ca2+ uniporter, the major mitochondrial Ca2+ uptake protein, revealed that the cytotoxicity was correlated to the amplitude of the mitochondrial, rather than the cytosolic, Ca2+ elevations. Selective activation of T-type Ca2+ channels evoked both cytosolic and mitochondrial Ca2+ elevations, but only the mitochondrial responses were reduced by Cav3.1/Cav3.2 silencing. We conclude that the opening of Cav3.2 channels during ischemia contribute to the entry of Ca2+ ions that are transmitted to mitochondria, resulting in a deleterious mitochondrial Ca2+ overload.	[Gouriou, Yves; Demaurex, Nicolas] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland; [Gouriou, Yves; Bijlenga, Philippe] Univ Geneva, Dept Fundamental Neurosci, CH-1211 Geneva 4, Switzerland; [Bijlenga, Philippe] Univ Geneva, Dept Clin Neurosci, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva; University of Geneva	Demaurex, N (corresponding author), Univ Geneva, Dept Cell Physiol & Metab, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.	Nicolas.Demaurex@unige.ch	Gouriou, Yves/ADY-8018-2022; Bijlenga, Philippe/S-1049-2016	Bijlenga, Philippe/0000-0002-3586-2757; Gouriou, Yves/0000-0003-2565-4935; Demaurex, Nicolas/0000-0002-9933-6772	Swiss National Foundation [310030B-133126]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Foundation Grant 310030B-133126 (to N. D.).	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Bancila M, 2011, FUND CLIN PHARMACOL, V25, P469, DOI 10.1111/j.1472-8206.2010.00879.x; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bijlenga P, 2000, P NATL ACAD SCI USA, V97, P7627, DOI 10.1073/pnas.97.13.7627; Bragadin M, 1997, J INORG BIOCHEM, V66, P227, DOI 10.1016/S0162-0134(96)00207-3; Cheng Yu Dennis, 2004, NeuroRx, V1, P36, DOI 10.1007/BF03206566; Czyz A, 2002, J NEUROCHEM, V83, P1321, DOI 10.1046/j.1471-4159.2002.01227.x; Davidson T, 2005, MOL CELL BIOCHEM, V279, P157, DOI 10.1007/s11010-005-8288-y; De Marchi U, 2011, J BIOL CHEM, V286, P32533, DOI 10.1074/jbc.M110.216044; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Del Toro R, 2003, J BIOL CHEM, V278, P22316, DOI 10.1074/jbc.M212576200; Demaurex N, 2009, BBA-BIOENERGETICS, V1787, P1383, DOI 10.1016/j.bbabio.2008.12.012; Demaurex N, 2009, NAT NEUROSCI, V12, P819, DOI 10.1038/nn0709-819; GARBER SS, 1989, J NEUROSCI, V9, P3976; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Gouriou Y, 2011, BIOCHIMIE, V93, P2060, DOI 10.1016/j.biochi.2011.08.001; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Illing AC, 2012, J BIOL CHEM, V287, P30485, DOI 10.1074/jbc.M112.364208; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Jeffs GJ, 2007, J CLIN NEUROSCI, V14, P507, DOI 10.1016/j.jocn.2006.07.013; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; Nicholls DG, 2009, BBA-BIOENERGETICS, V1787, P1416, DOI 10.1016/j.bbabio.2009.03.010; Nikonenko I, 2005, MOL PHARMACOL, V68, P84, DOI 10.1124/mol.104.010066; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pacher P, 2002, P NATL ACAD SCI USA, V99, P2380, DOI 10.1073/pnas.032423699; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Sattler R, 1998, J NEUROCHEM, V71, P2349; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Zhu WH, 1996, AM J PHYSIOL-CELL PH, V271, pC658, DOI 10.1152/ajpcell.1996.271.2.C658	39	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12459	12468		10.1074/jbc.M112.428128	http://dx.doi.org/10.1074/jbc.M112.428128			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23508951	Green Published, hybrid			2022-12-28	WOS:000318555100005
J	Qin, ZP; Fisher, GJ; Quan, TH				Qin, Zhaoping; Fisher, Gary J.; Quan, Taihao			Cysteine-rich Protein 61 (CCN1) Domain-specific Stimulation of Matrix Metalloproteinase-1 Expression through alpha V beta 3 Integrin in Human Skin Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE GROWTH-FACTOR; AGED HUMAN SKIN; ABERRANT COLLAGEN HOMEOSTASIS; VEIN ENDOTHELIAL-CELLS; IMMEDIATE-EARLY GENE; ULTRAVIOLET-IRRADIATION; IN-VIVO; NEGATIVE REGULATOR; CYR61; CANCER	Human skin largely comprises collagenous extracellular matrix. The hallmark of skin aging is fragmentation of collagen fibrils. Matrix metalloproteinases (MMPs) are largely responsible for collagen degradation. MMP-1, principally derived from dermal fibroblasts, is the major protease capable of initiating degradation of native fibrillar collagens. Presently, we report that CCN1, a secreted and extracellular matrix-associated protein, is elevated in aged human skin dermal fibroblasts in vivo and stimulates MMP-1 expression through functional interaction with alpha V beta 3 integrin in human dermal fibroblasts. CCN1 contains four conserved structural domains. Our results indicate that the three N-terminal domains (IGFBP, VWC, and TSP1), but not the C-terminal CT domain, are required for CCN1 to stimulate MMP-1 expression. This stimulation is dependent on interaction between the active structural domains and alpha V beta 3 integrin. The interaction of VWC domain with integrin alpha V beta 3 is necessary and requires functional cooperation with adjacent IGFBP and TSP1 domains to stimulate MMP-1 expression. Finally, induction of MMP-1 expression in dermal fibroblasts by CCN1 N-terminal domains resulted in fragmentation of type I collagen fibrils in a three-dimensional collagen lattice model. These data suggest that domain-specific interactions of CCN1 with alpha V beta 3 integrin contribute to human skin aging by stimulating MMP-1-mediated collagen fibril fragmentation.	[Qin, Zhaoping; Fisher, Gary J.; Quan, Taihao] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Quan, TH (corresponding author), Univ Michigan, Sch Med, Dept Dermatol, 1301 E Catherine,R6447, Ann Arbor, MI 48109 USA.	thquan@umich.edu		Quan, Taihao/0000-0002-0954-5109	National Institutes of Health [R01 ES014697, ES014697 30S1, AG019364, AG025186]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025186, R01AG019364] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES014697 and ES014697 30S1 (to T. Q.), AG019364 (to G. J. F. and T. Q.), and AG025186 (to G. J. F.).	Ashcroft GS, 1995, J ANAT, V87, P1; Brauchle M, 2000, EXP CELL RES, V258, P135, DOI 10.1006/excr.2000.4913; Brennan M, 2003, PHOTOCHEM PHOTOBIOL, V78, P43, DOI 10.1562/0031-8655(2003)078<0043:MMITMC>2.0.CO;2; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Campisi J, 2008, AGING CELL, V7, P281, DOI 10.1111/j.1474-9726.2008.00383.x; Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Fisher GJ, 2008, ARCH DERMATOL, V144, P666, DOI 10.1001/archderm.144.5.666; Fisher GJ, 2009, AM J PATHOL, V174, P101, DOI 10.2353/ajpath.2009.080599; Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; FISHER GJ, 1991, J CELL PHYSIOL, V146, P309, DOI 10.1002/jcp.1041460216; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Grzeszkiewicz TM, 2001, J BIOL CHEM, V276, P21943, DOI 10.1074/jbc.M100978200; GUTMAN A, 1990, EMBO J, V9, P2241, DOI 10.1002/j.1460-2075.1990.tb07394.x; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jin H, 2004, BRIT J CANCER, V90, P561, DOI 10.1038/sj.bjc.6601576; Kireeva ML, 1996, MOL CELL BIOL, V16, P1326; Kireeva ML, 1998, J BIOL CHEM, V273, P3090, DOI 10.1074/jbc.273.5.3090; Kudravi SA, 2000, IN VIVO, V14, P83; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200; LIU X, 1995, J CELL BIOL, V130, P227, DOI 10.1083/jcb.130.1.227; Menendez JA, 2003, ENDOCR-RELAT CANCER, V10, P141, DOI 10.1677/erc.0.0100141; Orringer JS, 2012, DERMATOL SURG, V38, P1668, DOI 10.1111/j.1524-4725.2012.02518.x; Pennica D, 1998, P NATL ACAD SCI USA, V95, P14717, DOI 10.1073/pnas.95.25.14717; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Planque N, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-15; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Quan T, 2002, J INVEST DERMATOL, V119, P499, DOI 10.1046/j.1523-1747.2002.01834.x; Quan TH, 2006, AM J PATHOL, V169, P482, DOI 10.2353/ajpath.2006.060128; Quan TH, 2013, J INVEST DERMATOL, V133, P1362, DOI 10.1038/jid.2012.509; Quan TH, 2012, J CELL BIOCHEM, V113, P3011, DOI 10.1002/jcb.24179; Quan TH, 2011, EXP DERMATOL, V20, P572, DOI 10.1111/j.1600-0625.2011.01278.x; Quan TH, 2010, J INVEST DERMATOL, V130, P1697, DOI 10.1038/jid.2010.29; Quan TH, 2009, J INVEST DERM SYMP P, V14, P20, DOI 10.1038/jidsymp.2009.8; Quan TH, 2002, J INVEST DERMATOL, V118, P402, DOI 10.1046/j.0022-202x.2001.01678.x; Quan TH, 2001, J BIOL CHEM, V276, P26349, DOI 10.1074/jbc.M010835200; Uitto J, 1998, J Investig Dermatol Symp Proc, V3, P41; Varani J, 2000, J INVEST DERMATOL, V114, P480, DOI 10.1046/j.1523-1747.2000.00902.x; Zhang R, 1998, MOL CELL BIOL, V18, P6131, DOI 10.1128/MCB.18.10.6131	43	24	24	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12386	12394		10.1074/jbc.M112.424358	http://dx.doi.org/10.1074/jbc.M112.424358			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504324	hybrid, Green Published			2022-12-28	WOS:000318157600069
J	Corriveau, M; Mullins, MR; Baus, D; Harris, ME; Taylor, DJ				Corriveau, Mark; Mullins, Michael R.; Baus, Diane; Harris, Michael E.; Taylor, Derek J.			Coordinated Interactions of Multiple POT1-TPP1 Proteins with Telomere DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; HUMAN POT1; HUMAN-CHROMOSOMES; LENGTH REGULATOR; END-PROTECTION; TPP1; COMPLEX; BINDING; TRF2; PROCESSIVITY	Telomeres are macromolecular nucleoprotein complexes that protect the ends of eukaryotic chromosomes from degradation, end-to-end fusion events, and from engaging the DNA damage response. However, the assembly of this essential DNA-protein complex is poorly understood. Telomere DNA consists of the repeated double-stranded sequence 5'-TTAGGG-3' in vertebrates, followed by a single-stranded DNA overhang with the same sequence. Both double-and single-stranded regions are coated with high specificity by telomere end-binding proteins, including POT1 and TPP1, that bind as a heterodimer to single-stranded telomeric DNA. Multiple POT1-TPP1 proteins must fully coat the single-stranded telomere DNA to form a functional telomere. To better understand the mechanism of multiple binding, we mutated or deleted the two guanosine nucleotides residing between adjacent POT1-TPP1 recognition sites in single-stranded telomere DNA that are not required for multiple POT1-TPP1 binding events. Circular dichroism demonstrated that spectra from the native telomere sequence are characteristic of a G-quadruplex secondary structure, whereas the altered telomere sequences were devoid of these signatures. The altered telomere strands, however, facilitated more cooperative loading of multiple POT1-TPP1 proteins compared with the wild-type telomere sequence. Finally, we show that a 48-nucleotide DNA with a telomere sequence is more susceptible to nuclease digestion when coated with POT1-TPP1 proteins than when it is left uncoated. Together, these data suggest that POT1-TPP1 binds telomeric DNA in a coordinated manner to facilitate assembly of the nucleoprotein complexes into a state that is more accessible to enzymatic activity.	[Corriveau, Mark; Mullins, Michael R.; Baus, Diane; Taylor, Derek J.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Harris, Michael E.; Taylor, Derek J.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Taylor, DJ (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	derek.taylor@case.edu			American Heart Association Scientist Development Grant [11SDB5580010]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056740] Funding Source: NIH RePORTER	American Heart Association Scientist Development Grant(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Scientist Development Grant 11SDB5580010 (to D. J. T.).	Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Baumann P, 2002, MOL CELL BIOL, V22, P8079, DOI 10.1128/MCB.22.22.8079-8087.2002; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Baumann P, 2010, FEBS LETT, V584, P3779, DOI 10.1016/j.febslet.2010.05.024; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Buczek P, 2006, J BIOL CHEM, V281, P40124, DOI 10.1074/jbc.M607749200; Choi KH, 2011, NUCLEIC ACIDS RES, V39, P9206, DOI 10.1093/nar/gkr665; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; GREIDER CW, 1991, MOL CELL BIOL, V11, P4572, DOI 10.1128/MCB.11.9.4572; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Horvath MP, 2011, CRIT REV BIOCHEM MOL, V46, P409, DOI 10.3109/10409238.2011.609295; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Huffman KE, 2000, J BIOL CHEM, V275, P19719, DOI 10.1074/jbc.M002843200; Kibe T, 2010, MOL CELL BIOL, V30, P1059, DOI 10.1128/MCB.01498-09; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Latrick CM, 2010, EMBO J, V29, P924, DOI 10.1038/emboj.2009.409; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lewis KA, 2012, STRUCTURE, V20, P28, DOI 10.1016/j.str.2011.10.017; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2004, J BIOL CHEM, V279, P13241, DOI 10.1074/jbc.M312309200; MANTELL LL, 1994, EMBO J, V13, P3211, DOI 10.1002/j.1460-2075.1994.tb06620.x; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Moser BA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000622; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Nandakumar J, 2012, NUCLEIC ACIDS RES, V40, P235, DOI 10.1093/nar/gkr721; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; Pinto AR, 2011, FRONT BIOSCI-LANDMRK, V16, P187, DOI 10.2741/3683; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; Taylor DJ, 2011, J MOL BIOL, V410, P10, DOI 10.1016/j.jmb.2011.04.049; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wang H, 2011, J BIOL CHEM, V286, P7479, DOI 10.1074/jbc.M110.205641; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Williams TL, 2010, J BIOL CHEM, V285, P35814, DOI 10.1074/jbc.M110.170167; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; WRIGHT WE, 1989, MOL CELL BIOL, V9, P3088, DOI 10.1128/MCB.9.7.3088; Wright WE, 1996, DEV GENET, V18, P173; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012	52	14	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16361	16370		10.1074/jbc.M113.471896	http://dx.doi.org/10.1074/jbc.M113.471896			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23616058	Green Published, hybrid			2022-12-28	WOS:000320378900014
J	D'Avanzo, N; Lee, SJ; Cheng, WWL; Nichols, CG				D'Avanzo, Nazzareno; Lee, Sun-Joo; Cheng, Wayland W. L.; Nichols, Colin G.			Energetics and Location of Phosphoinositide Binding in Human Kir2.1 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING K+ CHANNELS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CRYSTAL-STRUCTURE; STRUCTURAL DETERMINANTS; PIP2 REGULATION; ATP; ACTIVATION; SENSITIVITY; MODULATION; SPECIFICITIES	Kir2.1 channels are uniquely activated by phosphoinositide 4,5-bisphosphate (PI(4,5)P-2) and can be inhibited by other phosphoinositides (PIPs). Using biochemical and computational approaches, we assess PIP-channel interactions and distinguish residues that are energetically critical for binding from those that alter PIP sensitivity by shifting the open-closed equilibrium. Intriguingly, binding of each PIP is disrupted by a different subset of mutations. In silico ligand docking indicates that PIPs bind to two sites. The second minor site may correspond to the secondary anionic phospholipid site required for channel activation. However, 96-99% of PIP binding localizes to the first cluster, which corresponds to the general PI(4,5)P-2 binding location in recent Kir crystal structures. PIPs can encompass multiple orientations; each di- and triphosphorylated species binds with comparable energies and is favored over monophosphorylated PIPs. The data suggest that selective activation by PI(4,5)P-2 involves orientational specificity and that other PIPs inhibit this activation through direct competition.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	D'Avanzo, N (corresponding author), Univ Montreal, GEPROM, Montreal, PQ H3T 1J4, Canada.	nazzareno.d.avanzo@umontreal.ca; cnichols@wustl.edu		Cheng, Wayland/0000-0002-9529-9820	National Institutes of Health [HL54171, K99 HL112300-01]; American Heart Association Fellowship [13POST14660069]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL112300, R01HL054171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL54171 (to C. G. N.) and K99 HL112300-01 (to N. D.). This work was also supported by American Heart Association Fellowship 13POST14660069 (to S. J. L.).	Cheng WWL, 2011, BIOPHYS J, V100, P620, DOI 10.1016/j.bpj.2010.12.3724; Cheng WWL, 2009, J GEN PHYSIOL, V133, P295, DOI 10.1085/jgp.200810125; Cukras CA, 2002, J GEN PHYSIOL, V120, P437, DOI 10.1085/jgp.20028621; D'Avanzo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019393; D'Avanzo N, 2010, J BIOL CHEM, V285, P37129, DOI 10.1074/jbc.C110.186692; D'Avanzo N, 2010, PROTEIN EXPRES PURIF, V71, P115, DOI 10.1016/j.pep.2010.01.010; Donaldson MR, 2003, NEUROLOGY, V60, P1811, DOI 10.1212/01.WNL.0000072261.14060.47; Enkvetchakul D, 2005, J BIOL CHEM, V280, P35785, DOI 10.1074/jbc.C500355200; Eswar N., 2006, CURR PROT BIOINF, V15, P1, DOI [10.1002/0471250953.bi0506s15, DOI 10.1002/0471250953.BI0506S15]; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Haider S, 2007, EMBO J, V26, P3749, DOI 10.1038/sj.emboj.7601809; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Inanobe A, 2010, J BIOL CHEM, V285, P38517, DOI 10.1074/jbc.M110.161703; Jin TH, 2008, CHANNELS, V2, P19, DOI 10.4161/chan.2.1.5942; Leal-Pinto E, 2010, J BIOL CHEM, V285, P39790, DOI 10.1074/jbc.M110.151373; LEDERER WJ, 1989, J PHYSIOL-LONDON, V419, P193, DOI 10.1113/jphysiol.1989.sp017869; Leung YM, 2000, J BIOL CHEM, V275, P10182, DOI 10.1074/jbc.275.14.10182; Liou HH, 1999, P NATL ACAD SCI USA, V96, P5820, DOI 10.1073/pnas.96.10.5820; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lupyan D, 2010, BIOPHYS J, V98, P240, DOI 10.1016/j.bpj.2009.09.063; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Pegan S, 2006, BIOCHEMISTRY-US, V45, P8599, DOI 10.1021/bi060653d; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Savaresi SM, 2002, SIAM PROC S, P299; Schmidt MR, 2013, BIOCHEMISTRY-US, V52, P279, DOI 10.1021/bi301350s; Schulze D, 2003, J BIOL CHEM, V278, P10500, DOI 10.1074/jbc.M208413200; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; Stansfeld PJ, 2009, BIOCHEMISTRY-US, V48, P10926, DOI 10.1021/bi9013193; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Thomas AM, 2011, J BIOL CHEM, V286, P2088, DOI 10.1074/jbc.M110.153551; Thomas Alison M., 2008, V491, P103, DOI 10.1007/978-1-59745-526-8_8; Wang SZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1625; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Xie LH, 2008, J PHYSIOL-LONDON, V586, P1833, DOI 10.1113/jphysiol.2007.147868; Zeng WZ, 2002, AM J PHYSIOL-RENAL, V282, pF826, DOI 10.1152/ajprenal.00300.2001; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	45	31	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16726	16737		10.1074/jbc.M113.452540	http://dx.doi.org/10.1074/jbc.M113.452540			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23564459	hybrid, Green Published			2022-12-28	WOS:000320378900047
J	Wang, Y; Yu, HY; Shi, XL; Luo, ZP; Lin, DH; Huang, MD				Wang, Yu; Yu, Haiyang; Shi, Xiaoli; Luo, Zhipu; Lin, Donghai; Huang, Mingdong			Structural Mechanism of Ring-opening Reaction of Glucose by Human Serum Albumin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG BINDING-SITES; NONENZYMATIC GLYCOSYLATION; X-RAY; MASS-SPECTROMETRY; HEMOGLOBIN-A; GLYCATION; SPECIFICITY; PROTEINS; BOVINE; TIME	Glucose reacts with proteins nonenzymatically under physiological conditions. Such glycation is exacerbated in diabetic patients with high levels of blood sugar and induces various complications. Human albumin serum (HSA) is the most abundant protein in plasma and is glycated by glucose. The glycation sites on HSA remain controversial among different studies. Here, we report two protein crystal structures of HSA in complex with either glucose or fructose. These crystal structures reveal the presence of linear forms of sugar for both monosaccharides. The linear form of glucose forms a covalent bond to Lys-195 of HSA, but this is not the case for fructose. Based on these structures, we propose a mechanism for glucose ring opening involving both residues Lys-195 and Lys-199. These results provide mechanistic insights to understand the glucose ring-opening reaction and the glycation of proteins by monosaccharides.	[Wang, Yu; Shi, Xiaoli; Luo, Zhipu; Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China; [Wang, Yu; Yu, Haiyang; Shi, Xiaoli; Luo, Zhipu; Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, Danish Chinese Ctr Proteases & Canc, Fuzhou 350002, Fujian, Peoples R China; [Wang, Yu; Shi, Xiaoli; Luo, Zhipu; Huang, Mingdong] Chinese Acad Sci, Grad Sch, Beijing 10039, Peoples R China; [Yu, Haiyang] Fuzhou Univ, Dept Chem, Fuzhou 350002, Fujian, Peoples R China; [Lin, Donghai] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen 361005, Fujian, Peoples R China	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Chinese Academy of Sciences; Fuzhou University; Xiamen University	Huang, MD (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China.	mhuang@fjirsm.ac.cn	Luo, Zhipu/P-9168-2014; Huang, Mingdong/J-4278-2017	Huang, Mingdong/0000-0003-0085-9141	Natural Science Foundation of China [30800181, 21171167, 31161130356]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Natural Science Foundation of China (Grants 30800181, 21171167, and 31161130356).	Bai X, 2012, MOLECULES, V17, P8782, DOI 10.3390/molecules17088782; Barnaby OS, 2011, CLIN CHIM ACTA, V412, P1606, DOI 10.1016/j.cca.2011.05.012; Barnaby OS, 2011, CLIN CHIM ACTA, V412, P277, DOI 10.1016/j.cca.2010.10.018; Baynes J W, 1989, Prog Clin Biol Res, V304, P43; Bourdon E, 1999, FASEB J, V13, P233, DOI 10.1096/fasebj.13.2.233; BUNN HF, 1978, SCIENCE, V200, P21, DOI 10.1126/science.635569; BUNN HF, 1979, J BIOL CHEM, V254, P3892; BUNN HF, 1981, SCIENCE, V213, P222, DOI 10.1126/science.12192669; Curry S, 2009, DRUG METAB PHARMACOK, V24, P342, DOI 10.2133/dmpk.24.342; DAY JF, 1979, J BIOL CHEM, V254, P595; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DING A, 1993, P NATL ACAD SCI USA, V90, P3797, DOI 10.1073/pnas.90.9.3797; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Guo SH, 2009, BIOCHEM J, V423, P23, DOI 10.1042/BJ20090913; Haworth WN, 1929, J CHEM SOC, P2796, DOI 10.1039/jr9290002796; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Howard MJ, 2005, J BIOL CHEM, V280, P22582, DOI 10.1074/jbc.M501480200; IBERG N, 1986, J BIOL CHEM, V261, P3542; Johansen MB, 2006, GLYCOBIOLOGY, V16, P844, DOI 10.1093/glycob/cwl009; Joseph KS, 2011, J PHARMACEUT BIOMED, V54, P426, DOI 10.1016/j.jpba.2010.09.003; Kandagal PB, 2006, J PHARMACEUT BIOMED, V41, P393, DOI 10.1016/j.jpba.2005.11.037; KOENIG RJ, 1976, NEW ENGL J MED, V295, P417, DOI 10.1056/NEJM197608192950804; Kovalevsky AY, 2010, STRUCTURE, V18, P688, DOI 10.1016/j.str.2010.03.011; Lapolla A, 2004, J AM SOC MASS SPECTR, V15, P496, DOI 10.1016/j.jasms.2003.11.014; Lewis BE, 2006, J AM CHEM SOC, V128, P5049, DOI 10.1021/ja0573054; Lim PS, 2007, NEPHROLOGY, V12, P18, DOI 10.1111/j.1440-1797.2006.00745.x; Liu QY, 2012, J MASS SPECTROM, V47, P411, DOI 10.1002/jms.2037; Liyasova MS, 2010, BIOCHEM PHARMACOL, V79, P784, DOI 10.1016/j.bcp.2009.10.007; Lu M, 1998, J CLIN INVEST, V101, P1219, DOI 10.1172/JCI1277; Mendez DL, 2005, ARCH BIOCHEM BIOPHYS, V444, P92, DOI 10.1016/j.abb.2005.10.019; Moriyama Y, 1996, J PROTEIN CHEM, V15, P265, DOI 10.1007/BF01887115; Nasiri R, 2010, J BIOMOL STRUCT DYN, V28, P211, DOI 10.1080/07391102.2010.10507354; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peters T., 1995, ALL ALBUMIN BIOCH GE, P9, DOI [10.1016/B978-012552110-9/50004-0, DOI 10.1016/B978-012552110-9/50004-0]; Petitpas I, 2003, P NATL ACAD SCI USA, V100, P6440, DOI 10.1073/pnas.1137188100; Rondeau P, 2011, BIOCHIMIE, V93, P645, DOI 10.1016/j.biochi.2010.12.003; Schalkwijk CG, 2002, EUR J CLIN INVEST, V32, P500, DOI 10.1046/j.1365-2362.2002.01011.x; SHAKLAI N, 1984, J BIOL CHEM, V259, P3812; SHILTON BH, 1993, EUR J BIOCHEM, V215, P567, DOI 10.1111/j.1432-1033.1993.tb18067.x; Stefanowicz P, 2010, ANAL BIOCHEM, V400, P237, DOI 10.1016/j.ab.2010.02.011; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Wa C, 2007, CLIN CHIM ACTA, V385, P48, DOI 10.1016/j.cca.2007.06.011; Wang Y., 2013, IN PRESS; Wang Y, 2011, PROTEIN SCI, V20, P2095, DOI 10.1002/pro.749; Whitaker P, 2011, J IMMUNOL, V187, P200, DOI 10.4049/jimmunol.1100647; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamagishi S, 2003, INT J CLIN PHARM RES, V23, P129; Yang F, 2007, J STRUCT BIOL, V157, P348, DOI 10.1016/j.jsb.2006.08.015; Zhu LL, 2008, J STRUCT BIOL, V162, P40, DOI 10.1016/j.jsb.2007.12.004; Zhu YP, 2001, J ORG CHEM, V66, P6244, DOI 10.1021/jo010541m	53	84	86	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15980	15987		10.1074/jbc.M113.467027	http://dx.doi.org/10.1074/jbc.M113.467027			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23592780	Green Published, hybrid			2022-12-28	WOS:000319822300050
J	Chandrasekhar, K; Wang, JJ; Arjunan, P; Sax, M; Park, YH; Nemeria, NS; Kumaran, S; Song, JY; Jordan, F; Furey, W				Chandrasekhar, Krishnamoorthy; Wang, Junjie; Arjunan, Palaniappa; Sax, Martin; Park, Yun-Hee; Nemeria, Natalia S.; Kumaran, Sowmini; Song, Jaeyoung; Jordan, Frank; Furey, William			Insight to the Interaction of the Dihydrolipoamide Acetyltransferase (E2) Core with the Peripheral Components in the Escherichia coli Pyruvate Dehydrogenase Complex via Multifaceted Structural Approaches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REFINED CRYSTAL-STRUCTURE; LIPOAMIDE DEHYDROGENASE; MULTIENZYME COMPLEX; E1 SUBUNIT; AZOTOBACTER-VINELANDII; REDUCTIVE ACETYLATION; GLUTATHIONE-REDUCTASE; ANGSTROM RESOLUTION; HYDROGEN-EXCHANGE; MASS-SPECTROMETRY	Multifaceted structural approaches were undertaken to investigate interaction of the E2 component with E3 and E1 components from the Escherichia coli pyruvate dehydrogenase multienzyme complex (PDHc), as a representative of the PDHc from Gram-negative bacteria. The crystal structure of E3 at 2.5 angstrom resolution reveals similarity to other E3 structures and was an important starting point for understanding interaction surfaces between E3 and E2. Biochemical studies revealed that R129E-E2 and R150E-E2 substitutions in the peripheral subunit-binding domain (PSBD) of E2 greatly diminished PDHc activity, affected interactions with E3 and E1 components, and affected reductive acetylation of E2. Because crystal structures are unavailable for any complete E2-containing complexes, peptide-specific hydrogen/deuterium exchange mass spectrometry was used to identify loci of interactions between 3-lipoyl E2 and E3. Two peptides from the PSBD, including Arg-129, and three peptides from E3 displayed statistically significant reductions in deuterium uptake resulting from interaction between E3 and E2. Of the peptides identified on E3, two were from the catalytic site, and the third was from the interface domain, which for all known E3 structures is believed to interact with the PSBD. NMR clearly demonstrates that there is no change in the lipoyl domain structure on complexation with E3. This is the first instance where the entire wild-type E2 component was employed to understand interactions with E3. A model for PSBD-E3 binding was independently constructed and found to be consistent with the importance of Arg-129, as well as revealing other electrostatic interactions likely stabilizing this complex.	[Chandrasekhar, Krishnamoorthy; Arjunan, Palaniappa; Furey, William] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Sch Med, Pittsburgh, PA 15261 USA; [Sax, Martin; Furey, William] Vet Affairs Med Ctr, Pittsburgh, PA 15240 USA; [Wang, Junjie; Park, Yun-Hee; Nemeria, Natalia S.; Kumaran, Sowmini; Song, Jaeyoung; Jordan, Frank] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); Rutgers State University Newark; Rutgers State University New Brunswick	Jordan, F (corresponding author), Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA.	frjordan@rutgers.edu; fureyw@pitt.edu	Wang, Junjie/K-7509-2014	Wang, Junjie/0000-0002-0587-2209	National Institutes of Health [GM061791, GM050380]; Veterans Affairs Merit Review; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061791, R01GM050380] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM061791 (to W. F.) and GM050380 (to F. J.). This work was also supported by Veterans Affairs Merit Review (to W. F.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALI ST, 1990, BIOCHEM J, V271, P139, DOI 10.1042/bj2710139; Allen MD, 2005, FEBS J, V272, P259, DOI 10.1111/j.1432-1033.2004.04405.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arjunan P, 2002, BIOCHEMISTRY-US, V41, P5213, DOI 10.1021/bi0118557; Arjunan P, 2004, BIOCHEMISTRY-US, V43, P2405, DOI 10.1021/bi030200y; Arjunan P, 2006, J BIOL CHEM, V281, P15296, DOI 10.1074/jbc.M600656200; BLEILE DM, 1979, P NATL ACAD SCI USA, V76, P4385, DOI 10.1073/pnas.76.9.4385; BOYD DB, 1972, J AM CHEM SOC, V94, P8799, DOI 10.1021/ja00780a027; Brautigam CA, 2006, STRUCTURE, V14, P611, DOI 10.1016/j.str.2006.01.001; Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014; Brautigam CA, 2011, J BIOL CHEM, V286, P23476, DOI 10.1074/jbc.M110.202960; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Chandrasekhar K, 2006, ACTA CRYSTALLOGR D, V62, P1382, DOI 10.1107/S0907444906034408; Ciszak EM, 2006, J BIOL CHEM, V281, P648, DOI 10.1074/jbc.M507850200; DANSON MJ, 1984, BIOCHEM J, V218, P811, DOI 10.1042/bj2180811; DANSON MJ, 1987, BIOCHEM J, V243, P661, DOI 10.1042/bj2430661; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; delaSierra IL, 1997, J MOL BIOL, V269, P129, DOI 10.1006/jmbi.1997.1009; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faure M, 2000, EUR J BIOCHEM, V267, P2890, DOI 10.1046/j.1432-1033.2000.01330.x; GUEST JR, 1984, BIOCHEM SOC T, V12, P220, DOI 10.1042/bst0120220; Hamuro Y, 2008, RAPID COMMUN MASS SP, V22, P1041, DOI 10.1002/rcm.3467; Kale S, 2007, J BIOL CHEM, V282, P28106, DOI 10.1074/jbc.M704326200; Kavan D, 2011, INT J MASS SPECTROM, V302, P53, DOI 10.1016/j.ijms.2010.07.030; Keller R., 2004, COMPUTER AIDED RESON, V1; Keppel TR, 2011, J AM SOC MASS SPECTR, V22, P1472, DOI 10.1007/s13361-011-0152-6; Kim H, 2005, J BIOCHEM MOL BIOL, V38, P248; Knapp JE, 1998, J MOL BIOL, V280, P655, DOI 10.1006/jmbi.1998.1924; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; Mande SS, 1996, STRUCTURE, V4, P277, DOI 10.1016/S0969-2126(96)00032-9; MATTEVI A, 1992, SCIENCE, V255, P1544, DOI 10.1126/science.1549782; MATTEVI A, 1991, J MOL BIOL, V220, P975, DOI 10.1016/0022-2836(91)90367-F; MATTEVI A, 1992, PROTEINS, V13, P336, DOI 10.1002/prot.340130406; MATTEVI A, 1993, J MOL BIOL, V230, P1200, DOI 10.1006/jmbi.1993.1236; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MITTL PRE, 1994, PROTEIN SCI, V3, P799; Nakai T, 2008, J BIOCHEM, V143, P747, DOI 10.1093/jb/mvn033; Nambi S, 2012, J BIOL CHEM, V287, P18115, DOI 10.1074/jbc.M111.328112; Nemeria N, 1998, BIOCHEMISTRY-US, V37, P911, DOI 10.1021/bi9722251; Nemeria N, 2001, J BIOL CHEM, V276, P45969, DOI 10.1074/jbc.M104116200; Nemeria NS, 2010, J BIOL CHEM, V285, P11197, DOI 10.1074/jbc.M109.069179; OLIVER RM, 1982, ELECTRON MICROS, V2, P1; Park Y.-H., 2008, THESIS RUTGERS U; Park YH, 2004, BIOCHEMISTRY-US, V43, P14037, DOI 10.1021/bi049027b; Patel MS, 2003, BIOCHEM MOL BIOL EDU, V31, P5, DOI 10.1002/bmb.2003.494031010156; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Patel MS, 2009, J MOL CATAL B-ENZYM, V61, P2, DOI 10.1016/j.molcatb.2009.05.001; Perham RN, 1978, BIOCHEM SOC T, V6, P47, DOI 10.1042/bst0060047; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; PETTIT FH, 1967, P NATL ACAD SCI USA, V58, P1126, DOI 10.1073/pnas.58.3.1126; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Rajashankar KR, 2005, J BIOL CHEM, V280, P33977, DOI 10.1074/jbc.M507466200; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; RICE DW, 1984, J MOL BIOL, V174, P483, DOI 10.1016/0022-2836(84)90332-2; SCHIERBEEK AJ, 1989, J MOL BIOL, V206, P365, DOI 10.1016/0022-2836(89)90486-5; Song JY, 2012, BIOCHEMISTRY-US, V51, P2795, DOI 10.1021/bi201614n; STEIERT PS, 1990, J BACTERIOL, V172, P6142, DOI 10.1128/jb.172.10.6142-6144.1990; STEPHENS PE, 1983, EUR J BIOCHEM, V133, P481, DOI 10.1111/j.1432-1033.1983.tb07490.x; Toyoda T, 1998, J BIOCHEM-TOKYO, V123, P668; Wei W, 2003, PROTEIN EXPRES PURIF, V28, P140, DOI 10.1016/S1046-5928(02)00674-5; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1498, DOI 10.1016/j.jasms.2006.05.014; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; Yi JZ, 1996, J BIOL CHEM, V271, P33192, DOI 10.1074/jbc.271.52.33192; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	68	33	33	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15402	15417		10.1074/jbc.M113.466789	http://dx.doi.org/10.1074/jbc.M113.466789			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23580650	Green Published, hybrid			2022-12-28	WOS:000319452100064
J	Das, B; Cash, MN; Robinson, B; Kuhns, CS; Latchney, LR; Fallon, MA; Elliott, RW; Hand, AR; Culp, DJ				Das, Biswadip; Cash, Melanie N.; Robinson, Bently; Kuhns, Christopher S.; Latchney, Lisa R.; Fallon, Margaret A.; Elliott, Rosemary W.; Hand, Arthur R.; Culp, David J.			The sld Genetic Defect TWO INTRONIC CA REPEATS PROMOTE INSERTION OF THE SUBSEQUENT INTRON AND mRNA DECAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DECAY; EXOCRINE SECRETION; SUBLINGUAL GLANDS; INTRON RETENTION; HNRNP-L; EXPRESSION; GENOME; MUCINS; IDENTIFICATION; GLYCOPROTEINS	The autosomal recessive mutation, sld, attenuates mucous cell expression in murine sublingual glands with corresponding effects on mucin 19 (Muc19). We conducted a systematic study including genetic mapping, sequencing, and functional analyses to elucidate a mutation to explain the sld phenotype in neonatal mice. Genetic mapping and gene expression analyses localized the sld mutation within the gene Muc19/Smgc, specifically attenuating Muc19 transcripts, and Muc19 knock-out mice mimic the sld phenotype in neonates. Muc19 transcription is unaffected in sld mice, whereas mRNA stability is markedly decreased. Decreased mRNA stability is not due to a defect in 3'-end processing nor to sequence differences in Muc19 transcripts. Comparative sequencing of the Muc19/Smgc gene identified four candidate intronic mutations within the Muc19 coding region. Minigene splicing assays revealed a novel splicing event in which insertion of two additional repeats within a CA repeat region of intron 53 of the sld genome enhances retention of intron 54, decreasing the levels of correctly spliced transcripts. Moreover, pateamine A, an inhibitor of nonsense-mediated mRNA decay, inhibits degradation of aberrant Muc19 transcripts. The mutation in intron 53 thus enhances aberrant splicing leading to degradation of aberrant transcripts and decreased Muc19 message stability, consistent with the sld phenotype. We propose a working model of the unique splicing event enhanced by the mutation, as well as putative explanations for the gradual but limited increase in Muc19 glycoprotein expression and its restricted localization to subpopulations of mucous cells in sld mice during postnatal gland development.	[Das, Biswadip; Cash, Melanie N.; Robinson, Bently; Kuhns, Christopher S.; Culp, David J.] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Latchney, Lisa R.; Fallon, Margaret A.; Culp, David J.] Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA; [Elliott, Rosemary W.] New York State Dept Hlth, Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; [Hand, Arthur R.] Univ Connecticut, Ctr Hlth, Sch Dent Med, Dept Craniofacial Sci, Farmington, CT 06030 USA; [Hand, Arthur R.] Univ Connecticut, Ctr Hlth, Sch Dent Med, Dept Cell Biol, Farmington, CT 06030 USA	State University System of Florida; University of Florida; University of Rochester; Roswell Park Cancer Institute; University of Connecticut; University of Connecticut	Culp, DJ (corresponding author), Univ Florida, Coll Dent, Dept Oral Biol, 1395 Ctr Dr,POB 100424, Gainesville, FL 32610 USA.	dculp@dental.ufl.edu	Das, Biswadip/AAN-6505-2021; Cash, Melanie/AAT-3751-2020	Das, Biswadip/0000-0002-2839-2048; 	National Institutes of Health [DE014730, DE016509]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U24DE016509, R01DE014730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE014730 and DE016509 (to D. J. C.).	Amerongen AV, 2004, CARIES RES, V38, P247, DOI 10.1159/000077762; Bhide SA, 2009, CLIN ONCOL-UK, V21, P737, DOI 10.1016/j.clon.2009.09.002; BOGART BI, 1971, AM J ANAT, V132, P259, DOI 10.1002/aja.1001320210; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; BUTTIGLIONE M, 1995, MOL BRAIN RES, V29, P297, DOI 10.1016/0169-328X(94)00262-D; Cheli Y, 2006, BLOOD, V107, P4391, DOI 10.1182/blood-2005-12-4822; Chen Y, 2004, AM J RESP CELL MOL, V30, P155, DOI 10.1165/rcmb.2003-0103OC; Chiorini JA, 2009, J AUTOIMMUN, V33, P190, DOI 10.1016/j.jaut.2009.09.009; COUWENHOVEN RI, 1995, J DENT RES, V74, P196; Culp DJ, 2011, J DENT RES, V90, P1469, DOI 10.1177/0022034511422817; Culp DJ, 2004, PHYSIOL GENOMICS, V19, P303, DOI 10.1152/physiolgenomics.00161.2004; CULP DJ, 1993, AM J PHYSIOL, V265, pL260, DOI 10.1152/ajplung.1993.265.3.L260; Culp DJ, 1996, AM J PHYSIOL-CELL PH, V271, pC1963, DOI 10.1152/ajpcell.1996.271.6.C1963; Dang YJ, 2009, J BIOL CHEM, V284, P23613, DOI 10.1074/jbc.M109.009985; Das B, 2010, J HISTOCHEM CYTOCHEM, V58, P141, DOI 10.1369/jhc.2009.954891; Das B, 2009, J HISTOCHEM CYTOCHEM, V57, P383, DOI 10.1369/jhc.2008.952853; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fallon MA, 2003, PHYSIOL GENOMICS, V14, P95, DOI 10.1152/physiolgenomics.00151.2002; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; Garrett J. R., 1988, SALIVARY SYSTEM, P69; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; HAYASHI Y, 1988, AM J PATHOL, V132, P187; Heiner M, 2010, RNA BIOL, V7, P56, DOI 10.4161/rna.7.1.10402; House AE, 2006, NAT STRUCT MOL BIOL, V13, P937, DOI 10.1038/nsmb1149; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Hung LH, 2008, RNA, V14, P284, DOI 10.1261/rna.725208; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Kim JH, 2000, J MOL BIOL, V298, P395, DOI 10.1006/jmbi.2000.3687; Kojima A., 1988, MOUSE NEWS LETT, V80, P147; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Luo W, 2001, AM J PHYSIOL-CELL PH, V280, pC884, DOI 10.1152/ajpcell.2001.280.4.C884; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Sakabe NJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-59; Salles FJ, 1999, METH MOL B, V118, P441; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Sonesson M, 2008, ARCH ORAL BIOL, V53, P523, DOI 10.1016/j.archoralbio.2008.01.002; Soriano P, 1997, DEVELOPMENT, V124, P2691; Stamm S, 2000, DNA CELL BIOL, V19, P739, DOI 10.1089/104454900750058107; TABAK LA, 1995, ANNU REV PHYSIOL, V57, P547, DOI 10.1146/annurev.ph.57.030195.002555; Taudien S, 2000, TRENDS GENET, V16, P519, DOI 10.1016/S0168-9525(00)02127-2; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	45	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14742	14755		10.1074/jbc.M113.468645	http://dx.doi.org/10.1074/jbc.M113.468645			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23580649	Green Published, hybrid			2022-12-28	WOS:000319452100008
J	Tanaka, H; Akagi, K; Oneyama, C; Tanaka, M; Sasaki, Y; Kanou, T; Lee, YH; Yokogawa, D; Dobenecker, MW; Nakagawa, A; Okada, M; Ikegami, T				Tanaka, Hiroaki; Akagi, Ken-ichi; Oneyama, Chitose; Tanaka, Masakazu; Sasaki, Yuichi; Kanou, Takashi; Lee, Young-Ho; Yokogawa, Daisuke; Dobenecker, Marc-Werner; Nakagawa, Atsushi; Okada, Masato; Ikegami, Takahisa			Identification of a New Interaction Mode between the Src Homology 2 Domain of C-terminal Src Kinase (Csk) and Csk-binding Protein/Phosphoprotein Associated with Glycosphingolipid Microdomains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; AFFINITY PHOSPHOTYROSYL PEPTIDE; TRANSMEMBRANE ADAPTER PROTEIN; NMR CHEMICAL-SHIFTS; SH2 DOMAIN; CRYSTAL-STRUCTURES; FAMILY KINASES; SPECIFICITY; ACTIVATION; COMMUNICATION	Proteins with Src homology 2 (SH2) domains play major roles in tyrosine kinase signaling. Structures of many SH2 domains have been studied, and the regions involved in their interactions with ligands have been elucidated. However, these analyses have been performed using short peptides consisting of phosphotyrosine followed by a few amino acids, which are described as the canonical recognition sites. Here, we report the solution structure of the SH2 domain of C-terminal Src kinase (Csk) in complex with a longer phosphopeptide from the Csk-binding protein (Cbp). This structure, together with biochemical experiments, revealed the existence of a novel binding region in addition to the canonical phosphotyrosine 314-binding site of Cbp. Mutational analysis of this second region in cells showed that both canonical and novel binding sites are required for tumor suppression through the Cbp-Csk interaction. Furthermore, the data indicate an allosteric connection between Cbp binding and Csk activation that arises from residues in the beta B/beta C loop of the SH2 domain.	[Tanaka, Hiroaki; Tanaka, Masakazu; Sasaki, Yuichi; Lee, Young-Ho; Yokogawa, Daisuke; Nakagawa, Atsushi; Ikegami, Takahisa] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Akagi, Ken-ichi] Natl Inst Biomed Innovat, Osaka, Japan; [Oneyama, Chitose; Kanou, Takashi; Okada, Masato] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Dobenecker, Marc-Werner] Rockefeller Univ, Lab Immune Cell Epigenet & Signaling, New York, NY 10065 USA	Osaka University; National Institute of Health Sciences - Japan; Osaka University; Rockefeller University	Ikegami, T (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamada Oka, Suita, Osaka 5650871, Japan.	tiik@protein.osaka-u.ac.jp	Ikegami, Takahisa/I-9626-2017; Nakagawa, Atsushi/M-5731-2019; Nakagawa, Atsushi/D-4329-2009; Yokogawa, Daisuke/AAC-6929-2022	Ikegami, Takahisa/0000-0002-1429-1844; Nakagawa, Atsushi/0000-0002-1700-7861; Nakagawa, Atsushi/0000-0002-1700-7861; Yokogawa, Daisuke/0000-0002-7574-0965; AKAGI, Ken-ichi/0000-0002-7051-4598	Grants-in-Aid for Scientific Research [25870407] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Bae JH, 2009, CELL, V138, P514, DOI 10.1016/j.cell.2009.05.028; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Bradshaw JM, 2000, J MOL BIOL, V299, P521; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; CHOW LML, 1993, NATURE, V365, P156, DOI 10.1038/365156a0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEROME AE, 1990, J MAGN RESON, V88, P177, DOI 10.1016/0022-2364(90)90123-Q; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; ECK MJ, 1993, NATURE, V362, P87, DOI 10.1038/362087a0; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; GILSON MK, 1988, J COMPUT CHEM, V9, P327, DOI 10.1002/jcc.540090407; Goddard T. D., 1999, SPARKY 3; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Ia KK, 2010, GROWTH FACTORS, V28, P329, DOI 10.3109/08977194.2010.484424; Kanou T, 2011, MOL CANCER RES, V9, P103, DOI 10.1158/1541-7786.MCR-10-0340; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Ladbury JE, 2000, CHEM BIOL, V7, pR3, DOI 10.1016/S1074-5521(00)00067-3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE CH, 1994, STRUCTURE, V2, P423, DOI 10.1016/S0969-2126(00)00044-7; Lin XF, 2006, J MOL BIOL, V357, P1263, DOI 10.1016/j.jmb.2006.01.046; Lin XF, 2005, BIOCHEMISTRY-US, V44, P1561, DOI 10.1021/bi048142j; Lin Z, 2006, ANGEW CHEM INT EDIT, V45, P1960, DOI 10.1002/anie.200503558; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Mikkola ET, 2010, J MOL BIOL, V399, P618, DOI 10.1016/j.jmb.2010.04.045; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; NARULA SS, 1995, STRUCTURE, V3, P1061, DOI 10.1016/S0969-2126(01)00242-8; Ogawa A, 2002, J BIOL CHEM, V277, P14351, DOI 10.1074/jbc.C200086200; Ogura K, 1999, J MOL BIOL, V289, P439, DOI 10.1006/jmbi.1999.2792; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfrepper KI, 2001, EUR J IMMUNOL, V31, P1825, DOI 10.1002/1521-4141(200106)31:6<1825::AID-IMMU1825>3.0.CO;2-V; PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062; PICCIONE E, 1993, BIOCHEMISTRY-US, V32, P3197, DOI 10.1021/bi00064a001; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; SHAKA AJ, 1983, J MAGN RESON, V51, P169, DOI 10.1016/0022-2364(83)90117-8; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Songyang Zhou, 1995, Trends in Biochemical Sciences, V20, P470, DOI 10.1016/S0968-0004(00)89103-3; Takeuchi S, 2000, J BIOL CHEM, V275, P29183, DOI 10.1074/jbc.C000326200; Umitsu M, 2005, J BIOMOL NMR, V31, P365, DOI 10.1007/s10858-005-2450-4; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; Wang H, 2002, BIOCHEMISTRY-US, V41, P5453, DOI 10.1021/bi011914g; WIDER G, 1991, Journal of Biomolecular NMR, V1, P93, DOI 10.1007/BF01874572; Wong L, 2005, J MOL BIOL, V351, P131, DOI 10.1016/j.jmb.2005.05.042; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	54	8	10	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15240	15254		10.1074/jbc.M112.439075	http://dx.doi.org/10.1074/jbc.M112.439075			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23548896	Green Published, hybrid			2022-12-28	WOS:000319452100051
J	Gamez, B; Rodriguez-Carballo, E; Bartrons, R; Rosa, JL; Ventura, F				Gamez, Beatriz; Rodriguez-Carballo, Edgardo; Bartrons, Ramon; Luis Rosa, Jose; Ventura, Francesc			MicroRNA-322 (miR-322) and Its Target Protein Tob2 Modulate Osterix (Osx) mRNA Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION FACTOR; MUSCLE DIFFERENTIATION; UP-REGULATION; DEADENYLATION; EXPRESSION; MATURATION; MECHANISM; LINEAGE	Osteogenesis depends on a coordinated network of signals and transcription factors such as Runx2 and Osterix. Recent evidence indicates that microRNAs (miRNAs) act as important post-transcriptional regulators in a large number of processes, including osteoblast differentiation. In this study, we performed miRNA expression profiling and identified miR-322, a BMP-2-down-regulated miRNA, as a regulator of osteoblast differentiation. We report miR-322 gain- and loss-of-function experiments in C2C12 and MC3T3-E1 cells and primary cultures of murine bone marrow-derived mesenchymal stem cells. We demonstrate that overexpression of miR-322 enhances BMP-2 response, increasing the expression of Osx and other osteogenic genes. Furthermore, we identify Tob2 as a target of miR-322, and we characterize the specific Tob2 3'-UTR sequence bound by miR-322 by reporter assays. We demonstrate that Tob2 is a negative regulator of osteogenesis that binds and mediates degradation of Osx mRNA. Our results demonstrate a new molecular mechanism controlling osteogenesis through the specific miR-322/Tob2 regulation of specific target mRNAs. This regulatory circuit provides a clear example of a complex miRNA-transcription factor network for fine-tuning the osteoblast differentiation program.	Univ Barcelona, Dept Ciencies Fisiol 2, E-08907 Lhospitalet De Llobregat, Spain; Inst Invest Biomed Bellvitge IDIBELL, E-08907 Lhospitalet De Llobregat, Spain	University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Ventura, F (corresponding author), Univ Barcelona, IDIBELL, Dept Ciencies Fisiol 2, C Feixa Llarga S-N, E-08907 Lhospitalet De Llobregat, Spain.	fventura@ub.edu	Ventura, Francesc/ABG-2285-2020; Rosa, Jose Luis/K-6685-2014; Ventura, Francesc/K-9700-2014; Jurado Gamez, Bernabe/AAD-9681-2020	Ventura, Francesc/0000-0001-9673-9405; Rosa, Jose Luis/0000-0002-6161-5688; Ventura, Francesc/0000-0001-9673-9405; Rodriguez-Carballo, Eddie/0000-0003-4321-508X; Jurado Gamez, Bernabe/0000-0002-1608-1795; Bartrons, Ramon/0000-0001-9349-5847	Ministerio de Educacion y Ciencia [BFU2011-24254]; Fundacio La Marato de TV3; Instituto de Salud Carlos III Grant [RETIC RD06/0020]; L'Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007509, R01AI078962] Funding Source: NIH RePORTER	Ministerio de Educacion y Ciencia(Spanish Government); Fundacio La Marato de TV3; Instituto de Salud Carlos III Grant(Instituto de Salud Carlos III); L'Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by Ministerio de Educacion y Ciencia Grant BFU2011-24254, the Fundacio La Marato de TV3, and Instituto de Salud Carlos III Grant RETIC RD06/0020.; Recipient of a fellowship from L'Institut d'Investigacio Biomedica de Bellvitge (IDIBELL).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blahna MT, 2012, FEBS LETT, V586, P1906, DOI 10.1016/j.febslet.2012.01.041; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ezzeddine N, 2007, MOL CELL BIOL, V27, P7791, DOI 10.1128/MCB.01254-07; Ezzeddine N, 2012, MOL CELL BIOL, V32, P1089, DOI 10.1128/MCB.06370-11; Fang Y, 2005, AM J HUM GENET, V77, P807, DOI 10.1086/497438; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; Gaur T, 2010, DEV BIOL, V340, P10, DOI 10.1016/j.ydbio.2010.01.008; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hosoda N, 2011, EMBO J, V30, P1311, DOI 10.1038/emboj.2011.37; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Inose T, 2009, ANN SURG ONCOL, V16, P1704, DOI 10.1245/s10434-009-0443-3; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Ortuno MJ, 2010, J BIOL CHEM, V285, P31985, DOI 10.1074/jbc.M110.123612; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Lee MH, 1999, J CELL BIOCHEM, V73, P114, DOI 10.1002/(SICI)1097-4644(19990401)73:1<114::AID-JCB13>3.3.CO;2-D; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Lipchina I, 2011, GENE DEV, V25, P2173, DOI 10.1101/gad.17221311; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mauxion F, 2009, TRENDS BIOCHEM SCI, V34, P640, DOI 10.1016/j.tibs.2009.07.008; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Rodriguez-Carballo E, 2011, J BONE MINER RES, V26, P718, DOI 10.1002/jbmr.260; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Rydziel S, 2004, J BIOL CHEM, V279, P5397, DOI 10.1074/jbc.M311984200; Sarkar S, 2010, MOL BIOL CELL, V21, P2138, DOI 10.1091/mbc.E10-01-0062; Sato MM, 2009, BIOCHEM BIOPH RES CO, V383, P125, DOI 10.1016/j.bbrc.2009.03.142; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Susperregui ARG, 2011, MOL ENDOCRINOL, V25, P1006, DOI 10.1210/me.2010-0515; Taipaleenmaki H, 2012, EUR J ENDOCRINOL, V166, P359, DOI 10.1530/EJE-11-0646; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Usui M, 2004, P NATL ACAD SCI USA, V101, P6653, DOI 10.1073/pnas.0303093101; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Washio-Oikawa K, 2007, J BONE MINER RES, V22, P1217, DOI 10.1359/JBMR.070411; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Wu TT, 2012, J BIOL CHEM, V287, P7503, DOI 10.1074/jbc.M111.292722; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108	53	68	71	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14264	14275		10.1074/jbc.M112.432104	http://dx.doi.org/10.1074/jbc.M112.432104			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23564456	hybrid, Green Published			2022-12-28	WOS:000319253500031
J	Lorent, J; Le Duff, CS; Quetin-Leclercq, J; Mingeot-Leclercq, MP				Lorent, Joseph; Le Duff, Cecile S.; Quetin-Leclercq, Joelle; Mingeot-Leclercq, Marie-Paule			Induction of Highly Curved Structures in Relation to Membrane Permeabilization and Budding by the Triterpenoid Saponins, alpha- and delta-Hederin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIANT UNILAMELLAR VESICLES; PORE FORMATION; P-31 NMR; PHOSPHATIDYLCHOLINE LIPOSOMES; ANTIMICROBIAL PEPTIDES; PHOSPHOLIPID-BILAYERS; LAURDAN FLUORESCENCE; SHAPE TRANSITIONS; LIPID-BILAYERS; CHOLESTEROL	The interactions of triterpenoid monodesmosidic saponins, alpha-hederin and delta-hederin, with lipid membranes are involved in their permeabilizing effect. Unfortunately, the interactions of these saponins with lipid membranes are largely unknown, as are the roles of cholesterol or the branched sugar moieties (two for alpha-hederin and one for delta-hederin) on the aglycone backbone, hederagenin. The differences in sugar moieties are responsible for differences in the molecular shape of the saponins and the effects on membrane curvature that should be the most positive for alpha-hederin in a transbilayer direction. In large unilamellar vesicles and monocyte cells, we showed that membrane permeabilization was dependent on the presence of membrane cholesterol and saponin sugar chains, being largest for alpha-hederin and smallest for hederagenin. In the presence of cholesterol, alpha-hederin induced the formation of nonbilayer phases with a higher rate of Brownian tumbling or lateral diffusion. A reduction of Laurdan's generalized polarization in relation to change in order of the polar heads of phospholipids was observed. Using giant unilamellar vesicles, we visualized the formation of wrinkled borders, the decrease in liposome size, budding, and the formation of macroscopic pores. All these processes are highly dependent on the sugars linked to the aglycone, with alpha-hederin showing a greater ability to induce pore formation and delta-hederin being more efficient in inducing budding. Hederagenin induced intravesicular budding but no pore formation. Based on these results, a curvature-driven permeabilization mechanism dependent on the interaction between saponin and sterols and on the molecular shape of the saponin and its ability to induce local spontaneous curvature is proposed.	[Lorent, Joseph; Mingeot-Leclercq, Marie-Paule] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Lorent, Joseph; Quetin-Leclercq, Joelle] Catholic Univ Louvain, Louvain Drug Res Inst, B-1200 Brussels, Belgium; [Le Duff, Cecile S.] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain	Mingeot-Leclercq, MP (corresponding author), Catholic Univ Louvain, B-1200 Brussels, Belgium.	marie-paule.mingeot@uclouvain.be	Lorent, Joseph Helmuth/AAY-5423-2021	Lorent, Joseph Helmuth/0000-0002-7537-8521; Le Duff, Cecile S/0000-0003-3585-9491; Leclercq, Joelle/0000-0002-2278-6206				AKIYAMA T, 1980, BIOCHEMISTRY-US, V19, P1904, DOI 10.1021/bi00550a027; Allain JM, 2006, EUR PHYS J E, V20, P409, DOI 10.1140/epje/i2006-10030-4; Alves ID, 2008, BBA-GEN SUBJECTS, V1780, P948, DOI 10.1016/j.bbagen.2008.04.004; ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; Armah CN, 1999, BIOPHYS J, V76, P281, DOI 10.1016/S0006-3495(99)77196-1; BANGHAM AD, 1962, NATURE, V196, P952, DOI 10.1038/196952a0; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bensikaddour H, 2008, BBA-BIOMEMBRANES, V1778, P2535, DOI 10.1016/j.bbamem.2008.08.015; Cheng KH, 1999, BIOPHYS J, V77, P3108, DOI 10.1016/S0006-3495(99)77141-9; Choi JH, 2008, FOOD CHEM TOXICOL, V46, P3486, DOI 10.1016/j.fct.2008.08.026; CHONG PLG, 1993, BIOCHIM BIOPHYS ACTA, V1149, P260, DOI 10.1016/0005-2736(93)90209-I; Christian AE, 1997, J LIPID RES, V38, P2264; Chwalek M, 2006, BBA-GEN SUBJECTS, V1760, P1418, DOI 10.1016/j.bbagen.2006.05.004; CULLIS PR, 1976, BIOCHIM BIOPHYS ACTA, V426, P433, DOI 10.1016/0005-2736(76)90388-6; DANLOY S, 1994, PLANTA MED, V60, P45, DOI 10.1055/s-2006-959406; Domenech O, 2010, BBA-BIOMEMBRANES, V1798, P1876, DOI 10.1016/j.bbamem.2010.06.011; Domenech O, 2009, BBA-BIOMEMBRANES, V1788, P1832, DOI 10.1016/j.bbamem.2009.05.003; Francis G, 2002, BRIT J NUTR, V88, P587, DOI 10.1079/BJN2002725; Gauthier C, 2009, BIOORGAN MED CHEM, V17, P2002, DOI 10.1016/j.bmc.2009.01.022; Gayet L, 2005, BIOCHEMISTRY-US, V44, P4499, DOI 10.1021/bi048669w; Giraldo J, 2002, PHARMACOL THERAPEUT, V95, P21, DOI 10.1016/S0163-7258(02)00223-1; Hamada T, 2007, J PHYS CHEM B, V111, P10853, DOI 10.1021/jp075412+; HEINRICH V, 1993, PHYS REV E, V48, P3112, DOI 10.1103/PhysRevE.48.3112; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Huang JY, 1999, BIOPHYS J, V76, P2142, DOI 10.1016/S0006-3495(99)77369-8; ISRAELACHVILI JN, 1977, BIOCHIM BIOPHYS ACTA, V470, P185, DOI 10.1016/0005-2736(77)90099-2; Juhasz J, 2010, BIOCHEM J, V430, P415, DOI [10.1042/Bj20100516, 10.1042/BJ20100516]; Kaiser RD, 1998, BIOCHEMISTRY-US, V37, P8180, DOI 10.1021/bi980064a; Karatekin E, 2003, BIOPHYS J, V84, P1734, DOI 10.1016/S0006-3495(03)74981-9; KAS J, 1991, BIOPHYS J, V60, P825, DOI 10.1016/S0006-3495(91)82117-8; Kerdous R, 2011, BBA-BIOMEMBRANES, V1808, P2965, DOI 10.1016/j.bbamem.2011.08.002; Keukens EAJ, 1995, BBA-BIOMEMBRANES, V1240, P216, DOI 10.1016/0005-2736(95)00186-7; KING MD, 1989, BIOCHEMISTRY-US, V28, P5643, DOI 10.1021/bi00439a046; Kleinschmidt JH, 2002, BIOPHYS J, V83, P994, DOI 10.1016/S0006-3495(02)75225-9; Kumara SSM, 2001, PLANTA MED, V67, P29; Lee MT, 2008, P NATL ACAD SCI USA, V105, P5087, DOI 10.1073/pnas.0710625105; Lelkes P. I., 1984, LIPOSOME TECHNOLOGY, P225; LENTZ BR, 1993, CHEM PHYS LIPIDS, V64, P99, DOI 10.1016/0009-3084(93)90060-G; Li XX, 2005, BIOPHYS J, V88, P2577, DOI 10.1529/biophysj.104.049403; Lin F, 2010, J MOL MODEL, V16, P107, DOI 10.1007/s00894-009-0523-0; Lohner K, 1999, BBA-BIOMEMBRANES, V1462, P141, DOI 10.1016/S0005-2736(99)00204-7; Loura LMS, 1997, BIOPHYS J, V72, P2226, DOI 10.1016/S0006-3495(97)78866-0; Luckey M., 2008, STRUCTURAL BIOL BIOC, P13; MA JYC, 1985, J LIPID RES, V26, P735; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; MCLAUGHLIN AC, 1975, FEBS LETT, V57, P213, DOI 10.1016/0014-5793(75)80719-8; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; Nazari M, 2012, BIOPHYS J, V102, P498, DOI 10.1016/j.bpj.2011.12.029; NEZIL FA, 1992, BIOPHYS J, V61, P1413, DOI 10.1016/S0006-3495(92)81946-X; NISHIKAWA M, 1984, J BIOCHEM-TOKYO, V96, P1231, DOI 10.1093/oxfordjournals.jbchem.a134941; Palffy R, 2009, MOL MED, V15, P51, DOI 10.2119/molmed.2008.00087; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; PARASASSI T, 1995, BIOPHYS J, V68, P1895, DOI 10.1016/S0006-3495(95)80367-X; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; Praper T, 2011, J BIOL CHEM, V286, P2946, DOI 10.1074/jbc.M110.169417; Rog T, 2009, BBA-BIOMEMBRANES, V1788, P97, DOI 10.1016/j.bbamem.2008.08.022; Sakuma Y, 2010, BIOPHYS J, V99, P472, DOI 10.1016/j.bpj.2010.03.064; SERAS M, 1994, J COLLOID INTERF SCI, V167, P159, DOI 10.1006/jcis.1994.1344; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; SHINITZKY M, 1978, BIOCHIM BIOPHYS ACTA, V515, P367, DOI 10.1016/0304-4157(78)90010-2; Sieben A, 2009, BIOCHEMISTRY-US, V48, P3477, DOI 10.1021/bi802036b; Sudbrack TP, 2011, J PHYS CHEM B, V115, P269, DOI 10.1021/jp108653e; Swamy SMK, 2003, MOL CELL BIOCHEM, V245, P127, DOI 10.1023/A:1022807207948; Tamba Y, 2010, J PHYS CHEM B, V114, P12018, DOI 10.1021/jp104527y; Tanaka T, 2004, LANGMUIR, V20, P9526, DOI 10.1021/la049481g; Montero MT, 2006, LANGMUIR, V22, P7574, DOI 10.1021/la060633c; Todor I. N., 2012, Experimental Oncology, V34, P97; Valcarcel CA, 2001, BIOPHYS J, V80, P2761, DOI 10.1016/S0006-3495(01)76244-3; van der Haar A. W., 1912, ARCH PHARM, V250, P560; van Duyl BY, 2005, BIOCHEMISTRY-US, V44, P4526, DOI 10.1021/bi047937n; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; VANBAMBEKE F, 1993, EUR J PHARM-MOLEC PH, V247, P155, DOI 10.1016/0922-4106(93)90073-I; Venturoli D, 2005, AM J PHYSIOL-RENAL, V288, pF605, DOI 10.1152/ajprenal.00171.2004; Viseu MI, 2010, J COLLOID INTERF SCI, V351, P156, DOI 10.1016/j.jcis.2010.06.061; WASSLER M, 1987, BIOCHEM J, V247, P407, DOI 10.1042/bj2470407; WEINSTEIN JN, 1977, SCIENCE, V195, P489, DOI 10.1126/science.835007; Wesolowska O, 2009, ACTA BIOCHIM POL, V56, P33; Wustner D, 2007, CHEM PHYS LIPIDS, V146, P1, DOI 10.1016/j.chemphyslip.2006.12.004; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	79	48	49	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14000	14017		10.1074/jbc.M112.407635	http://dx.doi.org/10.1074/jbc.M112.407635			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23530040	Green Published, hybrid			2022-12-28	WOS:000319253500007
J	Pandey, MS; Baggenstoss, BA; Washburn, J; Harris, EN; Weigel, PH				Pandey, Madhu S.; Baggenstoss, Bruce A.; Washburn, Jennifer; Harris, Edward N.; Weigel, Paul H.			The Hyaluronan Receptor for Endocytosis (HARE) Activates NF-kappa B-mediated Gene Expression in Response to 40-400-kDa, but Not Smaller or Larger, Hyaluronans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEINS; CHONDROITIN SULFATE; TISSUE-INJURY; ACID; CLEARANCE; FRAGMENTS; IDENTIFICATION; PURIFICATION; DEGRADATION; METABOLISM	The hyaluronan (HA) receptor for endocytosis (HARE; Stabilin-2) binds and clears 14 different ligands, including HA and heparin, via clathrin-mediated endocytosis. HA binding to HARE stimulates ERK1/2 activation (Kyosseva, S. V., Harris, E. N., and Weigel, P. H. (2008) J. Biol. Chem. 283, 15047-15055). To assess a possible HA size dependence for signaling, we tested purified HA fractions of different weight-average molar mass and with narrow size distributions and Select-HA (TM) for stimulation of HARE-mediated gene expression using an NF-kappa B promoter-driven luciferase reporter system. Human HARE-mediated gene expression was stimulated in a dose-dependent manner with small HA (sHA) >40 kDa and intermediate HA (iHA) <400 kDa. The hyperbolic dose response saturated at 20-50 nM with an apparent K-m similar to 10 nM, identical to the K-d for HA-HARE binding. Activation was not detected with oligomeric HA (oHA), sHA <40 kDa, iHA >400 kDa, or large HA (IHA). Similar responses occurred with rat HARE. Activation by sHA-iHA was blocked by excess nonsignaling sHA, iHA, or IHA, deletion of the HA-binding LINK domain, or HA-blocking antibody. Endogenous NF-kappa B activation also occurred in the absence of luciferase plasmids, as assessed by degradation of I kappa B-alpha. ERK1/2 activation was also HA size-dependent. The results show that HA-HARE interactions stimulate NF-kappa B-activated gene expression and that HARE senses a narrow size range of HA degradation products. We propose a model in which optimal length HA binds multiple HARE proteins to allow cytoplasmic domain interactions that stimulate intracellular signaling. This HARE signaling system during continuous HA clearance could monitor the homeostasis of tissue biomatrix turnover throughout the body.	[Pandey, Madhu S.; Baggenstoss, Bruce A.; Washburn, Jennifer; Weigel, Paul H.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Med Glycobiol, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Harris, Edward N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Nebraska System; University of Nebraska Lincoln	Weigel, PH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Med Glycobiol, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA.	paul-weigel@ouhsc.edu		Washburn, Jennifer/0000-0002-0699-1162	National Institutes of Health from NIGMS [GM69961]; OCAST from the State of Oklahoma [HR10-074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069961] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OCAST from the State of Oklahoma; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM69961 from NIGMS. This work was also supported by OCAST Grant HR10-074 from the State of Oklahoma.	Abatangelo G., 2000, REDEFINING HYALURONA; Adair-Kirk TL, 2008, INT J BIOCHEM CELL B, V40, P1101, DOI 10.1016/j.biocel.2007.12.005; Anttila MA, 2000, CANCER RES, V60, P150; Baggenstoss BA, 2006, ANAL BIOCHEM, V352, P243, DOI 10.1016/j.ab.2006.01.019; Bollyky PL, 2007, J IMMUNOL, V179, P744, DOI 10.4049/jimmunol.179.2.744; Bourguignon LYW, 2011, CYTOSKELETON, V68, P671, DOI 10.1002/cm.20544; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANTOR JO, 1995, EXP LUNG RES, V21, P423, DOI 10.3109/01902149509023717; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; DeAngelis PL, 2008, CURR PHARM BIOTECHNO, V9, P246, DOI 10.2174/138920108785161550; Deed R, 1997, INT J CANCER, V71, P251, DOI 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J; DEUTSCH HF, 1957, J BIOL CHEM, V224, P767; Eberlein M, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-20; Elliott AL, 2005, ARTHRITIS RHEUM-US, V52, P105, DOI 10.1002/art.20724; ESTES JM, 1993, J PEDIATR SURG, V28, P1227, DOI 10.1016/S0022-3468(05)80303-3; Falkowski M, 2003, HISTOCHEM CELL BIOL, V120, P361, DOI 10.1007/s00418-003-0585-5; Fieber C, 2004, J CELL SCI, V117, P359, DOI 10.1242/jcs.00831; FRASER JRE, 1981, BIOCHEM J, V200, P415, DOI 10.1042/bj2000415; Fujii K, 1999, LAB INVEST, V79, P1439; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Goto M, 2001, CLIN EXP RHEUMATOL, V19, P377; Harris EN, 2007, J BIOL CHEM, V282, P2785, DOI 10.1074/jbc.M607787200; Harris EN, 2010, GLYCOBIOLOGY, V20, P991, DOI 10.1093/glycob/cwq057; Harris EN, 2004, J BIOL CHEM, V279, P36201, DOI 10.1074/jbc.M405322200; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jing W, 2004, J BIOL CHEM, V279, P42345, DOI 10.1074/jbc.M402744200; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Khaing ZZ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046033; Kim KW, 2007, IMMUNOL LETT, V110, P54, DOI 10.1016/j.imlet.2007.03.004; KNUDSON CB, 1993, FASEB J, V7, P1233, DOI 10.1096/fasebj.7.13.7691670; Kouvidi K, 2011, J BIOL CHEM, V286, P38509, DOI 10.1074/jbc.M111.275875; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Kyosseva SV, 2008, J BIOL CHEM, V283, P15047, DOI 10.1074/jbc.M709921200; Laurent T. C., 1996, IMMUNOL CELL BIOL, V74, pA1, DOI [10.1038/icb.1996.32, DOI 10.1038/ICB.1996.32]; Laurent T.C., 1991, DEGRADATION BIOACTIV, P249; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LAURENT TC, 1986, BIOCHEM J, V234, P653, DOI 10.1042/bj2340653; LEBEL L, 1994, EUR J CLIN INVEST, V24, P621, DOI 10.1111/j.1365-2362.1994.tb01114.x; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; MAPP PI, 1995, BRIT MED BULL, V51, P419, DOI 10.1093/oxfordjournals.bmb.a072970; MCGARY CT, 1989, BIOCHEM J, V257, P875, DOI 10.1042/bj2570875; Nakamura K, 2004, J GASTROENTEROL, V39, P346, DOI 10.1007/s00535-003-1301-x; Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6; Pandey MS, 2008, J BIOL CHEM, V283, P21453, DOI 10.1074/jbc.M800886200; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; Qian H, 2009, BIOCHEM BIOPH RES CO, V390, P883, DOI 10.1016/j.bbrc.2009.10.068; RAJA RH, 1984, ANAL BIOCHEM, V139, P168, DOI 10.1016/0003-2697(84)90402-0; SAMPSON PM, 1992, J CLIN INVEST, V90, P1492, DOI 10.1172/JCI116017; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Senftleben U, 2002, CRIT CARE MED, V30, pS18, DOI 10.1097/00003246-200201001-00003; SMEDSROD B, 1988, CELL TISSUE RES, V253, P39; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; TENGBLAD A, 1986, BIOCHEM J, V236, P521, DOI 10.1042/bj2360521; Termeer C, 2003, TRENDS IMMUNOL, V24, P112, DOI 10.1016/S1471-4906(03)00029-2; Toole BP, 1990, CURR OPIN CELL BIOL, V2, P839, DOI 10.1016/0955-0674(90)90081-O; Toole BP, 1997, J INTERN MED, V242, P35, DOI 10.1046/j.1365-2796.1997.00171.x; Weigel JA, 2003, J BIOL CHEM, V278, P9808, DOI 10.1074/jbc.M211462200; Weigel P. H., 2012, STRUCTURE FUNCTION B, P293; Weigel PH, 2012, GLYCOBIOLOGY, V22, P1302, DOI 10.1093/glycob/cws102; Weigel PH, 2002, BBA-GEN SUBJECTS, V1572, P341, DOI 10.1016/S0304-4165(02)00318-5; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; Zhou B, 1999, J BIOL CHEM, V274, P33831, DOI 10.1074/jbc.274.48.33831; Zhou B, 2003, GLYCOBIOLOGY, V13, P339, DOI 10.1093/glycob/cwg029; Zhou B, 2002, MOL BIOL CELL, V13, P2853, DOI 10.1091/mbc.02-03-0048; Zhou B, 2000, J BIOL CHEM, V275, P37733, DOI 10.1074/jbc.M003030200	68	46	48	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14068	14079		10.1074/jbc.M112.442889	http://dx.doi.org/10.1074/jbc.M112.442889			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23530033	hybrid, Green Published			2022-12-28	WOS:000319253500012
J	Wilson, CH; Indarto, D; Doucet, A; Pogson, LD; Pitman, MR; McNicholas, K; Menz, RI; Overall, CM; Abbott, CA				Wilson, Claire H.; Indarto, Dono; Doucet, Alain; Pogson, Lisa D.; Pitman, Melissa R.; McNicholas, Kym; Menz, R. Ian; Overall, Christopher M.; Abbott, Catherine A.			Identifying Natural Substrates for Dipeptidyl Peptidases 8 and 9 Using Terminal Amine Isotopic Labeling of Substrates (TAILS) Reveals in Vivo Roles in Cellular Homeostasis and Energy Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; STRESS GRANULES; IV; EXPRESSION; CALRETICULIN; ENZYMES; DIPEPTIDYL-PEPTIDASE-4; LOCALIZATION; ARGINYLATION; SPECIFICITY	Dipeptidyl peptidases (DP) 8 and 9 are homologous, cytoplasmic N-terminal post-proline-cleaving enzymes that are anti-targets for the development of DP4 (DPPIV/CD26) inhibitors for treating type II diabetes. To date, DP8 and DP9 have been implicated in immune responses and cancer biology, but their pathophysiological functions and substrate repertoire remain unknown. This study utilizes terminal amine isotopic labeling of substrates (TAILS), an N-terminal positional proteomic approach, for the discovery of in vivo DP8 and DP9 substrates. In vivo roles for DP8 and DP9 in cellular metabolism and homeostasis were revealed via the identification of more than 29 candidate natural substrates and pathways affected by DP8/DP9 overexpression. Cleavage of 14 substrates was investigated in vitro; 9/14 substrates for both DP8 and DP9 were confirmed by MALDI-TOF MS, including two of high confidence, calreticulin and adenylate kinase 2. Adenylate kinase 2 plays key roles in cellular energy and nucleotide homeostasis. These results demonstrate remarkable in vivo substrate overlap between DP8/DP9, suggesting compensatory roles for these enzymes. This work provides the first global investigation into DP8 and DP9 substrates, providing a number of leads for future investigations into the biological roles and significance of DP8 and DP9 in human health and disease.	[Wilson, Claire H.; Indarto, Dono; Pogson, Lisa D.; Pitman, Melissa R.; McNicholas, Kym; Menz, R. Ian; Abbott, Catherine A.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Indarto, Dono; Pogson, Lisa D.; Abbott, Catherine A.] Flinders Univ S Australia, Flinders Ctr Innovat Canc, Adelaide, SA 5001, Australia; [Wilson, Claire H.; Doucet, Alain; Overall, Christopher M.] Univ British Columbia, Dept Biochem, Vancouver, BC V6T 1Z3, Canada; [Wilson, Claire H.; Doucet, Alain; Overall, Christopher M.] Univ British Columbia, Dept Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Wilson, Claire H.; Doucet, Alain; Overall, Christopher M.] Univ British Columbia, Dept Oral Biol, Vancouver, BC V6T 1Z3, Canada; [Wilson, Claire H.; Doucet, Alain; Overall, Christopher M.] Univ British Columbia, Ctr Blood Res, Dept Med Sci, Vancouver, BC V6T 1Z3, Canada; [Wilson, Claire H.; Doucet, Alain; Overall, Christopher M.] Univ British Columbia, Fac Dent, Vancouver, BC V6T 1Z3, Canada	Flinders University South Australia; Flinders University South Australia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Overall, CM (corresponding author), Univ British Columbia, Ctr Blood Res, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	chris.overall@ubc.ca; cathy.abbott@flinders.edu.au	Abbott, Catherine A/A-9121-2008; Indarto, Dono/V-8219-2019	Abbott, Catherine A/0000-0001-8215-4406; Indarto, Dono/0000-0001-7420-5816; McNicholas, Kym/0000-0002-1556-8796; Pitman, Melissa/0000-0002-9587-3837	Canadian Institutes of Health Research Grant [MOP-37937]; Michael Smith Research Foundation (University of British Columbia Centre for Blood Research); Trevor Prescott Freemasons Memorial Scholarship (The Masonic Foundation, Australia); Flinders University Overseas Field Trip Grant; Flinders University Research Scholarship (Flinders University, Australia); Directorate General of Higher Education Ph.D. scholarship from the Indonesian Government; British Columbia Proteomics Network	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Michael Smith Research Foundation (University of British Columbia Centre for Blood Research); Trevor Prescott Freemasons Memorial Scholarship (The Masonic Foundation, Australia); Flinders University Overseas Field Trip Grant; Flinders University Research Scholarship (Flinders University, Australia); Directorate General of Higher Education Ph.D. scholarship from the Indonesian Government; British Columbia Proteomics Network	This work was supported in part by an anonymous philanthropic grant (to C. A. A.), Canadian Institutes of Health Research Grant MOP-37937 (to C. M. O.), an infrastructure grant from the Michael Smith Research Foundation (University of British Columbia Centre for Blood Research), and by the British Columbia Proteomics Network (to C. M. O.).; Supported by a Trevor Prescott Freemasons Memorial Scholarship (The Masonic Foundation, Australia), a Flinders University Overseas Field Trip Grant to visit the Overall Laboratory (February 2007 to August 2008), and a Flinders University Research Scholarship (Flinders University, Australia).; Employee of the Faculty of Medicine, Sebelas Maret University, Surakarta 57126, Indonesia. Supported by a Directorate General of Higher Education Ph.D. scholarship from the Indonesian Government.	Abbott CA, 2000, EUR J BIOCHEM, V267, P6140, DOI 10.1046/j.1432-1327.2000.01617.x; Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Ajami K, 2004, BBA-GENE STRUCT EXPR, V1679, P18, DOI 10.1016/j.bbaexp.2004.03.010; Ajami K, 2008, FEBS LETT, V582, P819, DOI 10.1016/j.febslet.2008.02.005; Ansorge S, 2009, CLIN CHEM LAB MED, V47, P253, DOI 10.1515/CCLM.2009.063; Bjelke JR, 2006, BIOCHEM J, V396, P391, DOI 10.1042/BJ20060079; Carpio MA, 2010, BIOCHEM J, V429, P63, DOI 10.1042/BJ20091953; Chen YS, 2004, PROTEIN EXPRES PURIF, V35, P142, DOI 10.1016/j.pep.2003.12.019; Decca MB, 2007, J BIOL CHEM, V282, P8237, DOI 10.1074/jbc.M608559200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Frerker N, 2007, PEPTIDES, V28, P257, DOI 10.1016/j.peptides.2006.09.027; Geiss-Friedlander R, 2009, J BIOL CHEM, V284, P27211, DOI 10.1074/jbc.M109.041871; Huth W, 2002, BIOCHEM J, V364, P275, DOI 10.1042/bj3640275; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Keller UAD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003512; Keller UAD, 2012, BIOL CHEM, V393, P1477, DOI 10.1515/hsz-2012-0269; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Lange PF, 2013, CURR OPIN CHEM BIOL, V17, P73, DOI 10.1016/j.cbpa.2012.11.025; Lange PF, 2011, NAT METHODS, V8, P703, DOI 10.1038/nmeth.1669; Lankas GR, 2005, DIABETES, V54, P2988, DOI 10.2337/diabetes.54.10.2988; Lee HJ, 2007, NAT CELL BIOL, V9, P1303, DOI 10.1038/ncb1650; Lee HJ, 2006, J BIOL CHEM, V281, P38653, DOI 10.1074/jbc.M603895200; Li XJ, 2003, ANAL CHEM, V75, P6648, DOI 10.1021/ac034633i; Lu CY, 2011, J BIOL CHEM, V286, P27494, DOI 10.1074/jbc.M111.224089; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Olsen C, 2002, GENE, V299, P185, DOI 10.1016/S0378-1119(02)01059-4; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Pitman MR, 2010, BIOL CHEM, V391, P959, DOI 10.1515/BC.2010.111; Prudova A, 2010, MOL CELL PROTEOMICS, V9, P894, DOI 10.1074/mcp.M000050-MCP201; Reinhold D, 2009, CLIN CHEM LAB MED, V47, P268, DOI 10.1515/CCLM.2009.062; Schade J, 2008, J HISTOCHEM CYTOCHEM, V56, P147, DOI 10.1369/jhc.7A7319.2007; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Schlauderer GJ, 1996, PROTEIN SCI, V5, P434; Stremenova J, 2010, INT J ONCOL, V36, P351, DOI 10.3892/ijo_00000506; Sulda ML, 2010, CANCER BIOL THER, V10, P180, DOI 10.4161/cbt.10.2.12168; Tang HK, 2009, ARCH BIOCHEM BIOPHYS, V485, P120, DOI 10.1016/j.abb.2009.02.015; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Wilson CH, 2012, INT J ONCOL, V41, P919, DOI 10.3892/ijo.2012.1522; Yazbeck R, 2010, INFLAMM BOWEL DIS, V16, P1340, DOI 10.1002/ibd.21241; Yazbeck R, 2009, TRENDS PHARMACOL SCI, V30, P600, DOI 10.1016/j.tips.2009.08.003; Yu DMT, 2006, FEBS J, V273, P2447, DOI 10.1111/j.1742-4658.2006.05253.x; Yu DMT, 2009, J HISTOCHEM CYTOCHEM, V57, P1025, DOI 10.1369/jhc.2009.953760	43	46	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					13936	13949		10.1074/jbc.M112.445841	http://dx.doi.org/10.1074/jbc.M112.445841			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23519473	Green Published, hybrid			2022-12-28	WOS:000319253500002
J	Cao, ZY; Hulsizer, S; Cui, YJ; Pretto, DL; Kim, KH; Hagerman, PJ; Tassone, F; Pessah, IN				Cao, Zhengyu; Hulsizer, Susan; Cui, Yanjun; Pretto, Dalyir L.; Kim, Kyung Ho; Hagerman, Paul J.; Tassone, Flora; Pessah, Isaac N.			Enhanced Asynchronous Ca2+ Oscillations Associated with Impaired Glutamate Transport in Cortical Astrocytes Expressing Fmr1 Gene Premutation Expansion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRAGILE-X-SYNDROME; CGG-REPEAT LENGTH; MOUSE MODEL; TREMOR/ATAXIA SYNDROME; MESSENGER-RNA; ACTIVATION; PLASTICITY; INVOLVEMENT; INDIVIDUALS; INCLUSIONS	Premutation CGG repeat expansions (55-200 CGG repeats; preCGG) within the fragile X mental retardation 1 (FMR1) gene can cause fragile X-associated tremor/ataxia syndrome. Defects in early neuronal migration and morphology, electrophysiological activity, and mitochondria trafficking have been described in a premutation mouse model, but whether preCGG mutations also affect astrocyte function remains unknown. PreCGG cortical astrocytes (similar to 170 CGG repeats) displayed 3-fold higher Fmr1 mRNA and 30% lower FMR1 protein (FMRP) when compared with WT. PreCGG astrocytes showed modest reductions in expression of glutamate (Glu) transporters GLT-1 and GLAST and attenuated Glu uptake (p<0.01). Consistent with astrocyte cultures in vitro, aged preCGG mice cerebral cortex also displayed reduced GLAST and GLT-1 expression. Approximately 65% of the WT and preCGG cortical astrocytes displayed spontaneous asynchronous Ca2+ oscillations. PreCGG astrocytes exhibited nearly 50% higher frequency of asynchronous Ca2+ oscillations (p < 0.01) than WT, a difference mimicked by chronic exposure of WT astrocytes to L-trans-pyrrolidine-2,4-dicarboxylic acid (L-trans-PDC) or by partial suppression of GLAST using siRNA interference. Acute challenge with Glu augmented the frequency of Ca2+ oscillations in both genotypes. Additionally, 10 mu M Glu elicited a sustained intracellular Ca2+ rise in a higher portion of preCGG astrocytes when compared with WT. Pharmacological studies showed that mGluR5, but not NMDA receptor, contributed to Glu hypersensitivity in preCGG astrocytes. These functional defects in preCGG astrocytes, especially in Glu signaling, may contribute to fragile X-associated tremor/ataxia syndrome neuropathology.	[Cao, Zhengyu; Hulsizer, Susan; Cui, Yanjun; Kim, Kyung Ho; Pessah, Isaac N.] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA; [Pretto, Dalyir L.; Hagerman, Paul J.; Tassone, Flora] Univ Calif Davis, Dept Biochem & Mol Med, Sch Med, Davis, CA 95616 USA; [Hagerman, Paul J.; Tassone, Flora; Pessah, Isaac N.] Univ Calif Davis, MIND Inst, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Cao, ZY (corresponding author), Univ Calif Davis, 1 Shields Ave, Davis, CA 95616 USA.	zcao@ucdavis.edu	Pessah, Isaac N/K-7985-2017	Pessah, Isaac N/0000-0002-8149-588X	National Institutes of Health [RC1 AG036022, 1R01 HD064817, P01ES011269]; United States Environmental Protection Agency [R833292, R829388, HD02274]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274, R01HD064817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC1AG036022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Environmental Protection Agency(United States Environmental Protection Agency); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RC1 AG036022 (to P. J. H. and I. N. P.), 1R01 HD064817 (to I. N. P.), and P01ES011269 (to I. N. P.). This work was also supported by the United States Environmental Protection Agency Grants R833292 and R829388 (to I. N. P.) and HD02274 (to F. T.).	Allen EG, 2004, HUM GENET, V114, P439, DOI 10.1007/s00439-004-1086-x; Amiri K, 2008, ARCH NEUROL-CHICAGO, V65, P19, DOI 10.1001/archneurol.2007.30; Arocena DG, 2005, HUM MOL GENET, V14, P3661, DOI 10.1093/hmg/ddi394; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Ben Achour S, 2010, NEURON GLIA BIOL, V6, P147, DOI 10.1017/S1740925X10000207; Berry-Kravis E, 2007, MOVEMENT DISORD, V22, P2018, DOI 10.1002/mds.21493; Bourgeois JA, 2009, J CLIN PSYCHIAT, V70, P852, DOI 10.4088/JCP.08m04476; Brouwer JR, 2008, PSYCHONEUROENDOCRINO, V33, P863, DOI 10.1016/j.psyneuen.2008.03.011; Brouwer JR, 2007, EXP CELL RES, V313, P244, DOI 10.1016/j.yexcr.2006.10.002; Brouwer JR, 2009, AM J MED GENET B, V150B, P782, DOI 10.1002/ajmg.b.30910; Brouwer JR, 2008, J NEUROCHEM, V107, P1671, DOI 10.1111/j.1471-4159.2008.05747.x; Cao ZY, 2012, TOXICOL SCI, V130, P362, DOI 10.1093/toxsci/kfs244; Cao ZY, 2012, HUM MOL GENET, V21, P2923, DOI 10.1093/hmg/dds118; Cao ZY, 2010, TOXICOL SCI, V114, P323, DOI 10.1093/toxsci/kfp312; Chen YC, 2010, HUM MOL GENET, V19, P196, DOI 10.1093/hmg/ddp479; Cunningham CL, 2011, HUM MOL GENET, V20, P64, DOI 10.1093/hmg/ddq432; Deng PY, 2011, J NEUROSCI, V31, P10971, DOI 10.1523/JNEUROSCI.2021-11.2011; Farzin F, 2006, J DEV BEHAV PEDIATR, V27, pS137, DOI 10.1097/00004703-200604002-00012; Goodlin-Jones BL, 2004, J DEV BEHAV PEDIATR, V25, P392, DOI 10.1097/00004703-200412000-00002; Greco CM, 2002, BRAIN, V125, P1760, DOI 10.1093/brain/awf184; Greco CM, 2006, BRAIN, V129, P243, DOI 10.1093/brain/awh683; Hagerman PJ, 2008, J MED GENET, V45, P498, DOI 10.1136/jmg.2008.059055; Hagerman R, 2011, J NEURODEV DISORD, V3, P211, DOI 10.1007/s11689-011-9084-5; Hagerman RJ, 2006, J DEV BEHAV PEDIATR, V27, P63, DOI 10.1097/00004703-200602000-00012; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hessl D, 2005, AM J MED GENET B, V139B, P115, DOI 10.1002/ajmg.b.30241; Higashimori H., 2013, HUM MOL GEN IN PRESS; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Hunsaker MR, 2012, HIPPOCAMPUS, V22, P2260, DOI 10.1002/hipo.22043; Iliff AJ, 2013, HUM MOL GENET, V22, P1180, DOI 10.1093/hmg/dds525; Iwahashi C, 2009, J MOL DIAGN, V11, P281, DOI 10.2353/jmoldx.2009.080118; Jacobs S, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-132; Jacobs S, 2010, J NEUROSCI, V30, P4508, DOI 10.1523/JNEUROSCI.5027-09.2010; Jacquemont S, 2004, AM J MENT RETARD, V109, P154, DOI 10.1352/0895-8017(2004)109<154:AIIWTF>2.0.CO;2; Jacquemont S, 2007, LANCET NEUROL, V6, P45, DOI 10.1016/S1474-4422(06)70676-7; Kaplan ES, 2012, J NEUROCHEM, V123, P613, DOI 10.1111/j.1471-4159.2012.07936.x; Koizumi S, 2003, P NATL ACAD SCI USA, V100, P11023, DOI 10.1073/pnas.1834448100; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Liu J, 2012, HUM MOL GENET, V21, P3795, DOI 10.1093/hmg/dds207; Maezawa I, 2010, J NEUROSCI, V30, P5346, DOI 10.1523/JNEUROSCI.5966-09.2010; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Padmashri R, 2008, NEUROSCIENCE, V151, P56, DOI 10.1016/j.neuroscience.2007.09.054; Potier B, 2010, AGING CELL, V9, P722, DOI 10.1111/j.1474-9726.2010.00593.x; Rodriguez-Revenga L, 2009, EUR J HUM GENET, V17, P1359, DOI 10.1038/ejhg.2009.51; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tassone F, 2007, AM J MED GENET B, V144B, P566, DOI 10.1002/ajmg.b.30482; Tassone Flora, 2004, RNA Biol, V1, P103, DOI 10.4161/rna.1.2.1035; Tessier CR, 2011, NEUROBIOL DIS, V41, P147, DOI 10.1016/j.nbd.2010.09.002; Wenzel HJ, 2010, BRAIN RES, V1318, P155, DOI 10.1016/j.brainres.2009.12.077; Willemsen R, 2003, HUM MOL GENET, V12, P949, DOI 10.1093/hmg/ddg114; Yuskaitis CJ, 2010, BBA-MOL BASIS DIS, V1802, P1006, DOI 10.1016/j.bbadis.2010.06.015; Zur Nieden R, 2006, CEREB CORTEX, V16, P676, DOI 10.1093/cercor/bhj013	55	32	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13831	13841		10.1074/jbc.M112.441055	http://dx.doi.org/10.1074/jbc.M112.441055			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23553633	Green Published, hybrid			2022-12-28	WOS:000318850300064
J	Farrugia, MA; Macomber, L; Hausinger, RP				Farrugia, Mark A.; Macomber, Lee; Hausinger, Robert P.			Biosynthesis of the Urease Metallocenter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							KLEBSIELLA-AEROGENES UREASE; HELICOBACTER-PYLORI UREASE; ALLELIC EXCHANGE MUTAGENESIS; ACCESSORY PROTEIN; CRYSTAL-STRUCTURE; NICKEL METALLOCENTER; BACILLUS-PASTEURII; GASTRIC PATHOGEN; BINDING PROTEIN; METAL-BINDING	Metalloenzymes often require elaborate metallocenter assembly systems to create functional active sites. The medically important dinuclear nickel enzyme urease provides an excellent model for studying metallocenter assembly. Nickel is inserted into the urease active site in a GTP-dependent process with the assistance of UreD/UreH, UreE, UreF, and UreG. These accessory proteins orchestrate apoprotein activation by delivering the appropriate metal, facilitating protein conformational changes, and possibly providing a requisite post-translational modification. The activation mechanism and roles of each accessory protein in urease maturation are the subject of ongoing studies, with the latest findings presented in this minireview.	[Farrugia, Mark A.; Hausinger, Robert P.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Macomber, Lee; Hausinger, Robert P.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Hausinger, RP (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	hausinge@msu.edu		Hausinger, Robert/0000-0002-3643-2054	National Institutes of Health [DK045686]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045686] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK045686 (to R. P. H.). This is the third article in the Thematic Minireview Series on Metals in Biology 2013.	Bacanamwo M, 2002, MOL GENET GENOMICS, V268, P525, DOI 10.1007/s00438-002-0769-z; Balasubramanian A, 2010, J MOL BIOL, V400, P274, DOI 10.1016/j.jmb.2010.05.009; Banaszak K, 2012, BIOCHEM J, V441, P1017, DOI 10.1042/BJ20111659; Bauerfeind P, 1996, INFECT IMMUN, V64, P2877, DOI 10.1128/IAI.64.7.2877-2880.1996; Bellucci M, 2009, BIOCHEM J, V422, P91, DOI 10.1042/BJ20090434; Benini S, 1999, STRUCTURE, V7, P205, DOI 10.1016/S0969-2126(99)80026-4; Benoit SL, 2012, BBA-GEN SUBJECTS, V1820, P1519, DOI 10.1016/j.bbagen.2012.06.002; Boer JL, 2012, BIOCHEMISTRY-US, V51, P2298, DOI 10.1021/bi3000897; Boer JL, 2010, BIOCHEMISTRY-US, V49, P5859, DOI 10.1021/bi1004987; Bosse JT, 2001, J BACTERIOL, V183, P1242, DOI 10.1128/JB.183.4.1242-1247.2001; Brayman TG, 1996, J BACTERIOL, V178, P5410, DOI 10.1128/jb.178.18.5410-5416.1996; Bremner JM, 1995, FERT RES, V42, P321, DOI 10.1007/BF00750524; Carlsson H, 2010, BIOINORG CHEM APPL, V2010, DOI 10.1155/2010/364891; Carter EL, 2012, J INORG BIOCHEM, V111, P195, DOI 10.1016/j.jinorgbio.2011.10.016; Carter EL, 2011, BIOCHEMISTRY-US, V50, P9296, DOI 10.1021/bi2011064; Carter EL, 2011, P NATL ACAD SCI USA, V108, P13095, DOI 10.1073/pnas.1106915108; Carter EL, 2010, J BACTERIOL, V192, P2294, DOI 10.1128/JB.01426-09; Carter EL, 2009, METALLOMICS, V1, P207, DOI 10.1039/b903311d; Chang ZZ, 2004, J BIOL CHEM, V279, P15305, DOI 10.1074/jbc.M312979200; Colpas GJ, 1999, BIOCHEMISTRY-US, V38, P4078, DOI 10.1021/bi982435t; CUSSAC V, 1992, J BACTERIOL, V174, P2466, DOI 10.1128/jb.174.8.2466-2473.1992; Davis GS, 2006, INFECT IMMUN, V74, P6811, DOI 10.1128/IAI.01188-06; DIXON NE, 1975, J AM CHEM SOC, V97, P4131, DOI 10.1021/ja00847a045; Estiu G, 2006, BIOCHEMISTRY-US, V45, P4429, DOI 10.1021/bi052020p; Estiu G, 2007, J PHYS CHEM B, V111, P10263, DOI 10.1021/jp072323o; Fong YH, 2011, J BIOL CHEM, V286, P43241, DOI 10.1074/jbc.M111.296830; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; Grossoehme NE, 2007, BIOCHEMISTRY-US, V46, P10506, DOI 10.1021/bi700171v; Ha NC, 2001, NAT STRUCT BIOL, V8, P505, DOI 10.1038/88563; Hendricks JK, 1997, J BACTERIOL, V179, P5892, DOI 10.1128/jb.179.18.5892-5902.1997; Higgins KA, 2012, BIOCHEMISTRY-US, V51, P7816, DOI 10.1021/bi300981m; JABRI E, 1995, SCIENCE, V268, P998, DOI 10.1126/science.7754395; Kaluarachchi H, 2010, NAT PROD REP, V27, P681, DOI 10.1039/b906688h; Kim JK, 2005, J BACTERIOL, V187, P7150, DOI 10.1128/JB.187.20.7150-7154.2005; Kim JK, 2006, J BACTERIOL, V188, P8413, DOI 10.1128/JB.01265-06; Kim KY, 1999, ARCH PHARM RES, V22, P274, DOI 10.1007/BF02976362; Krajewska B, 2009, J MOL CATAL B-ENZYM, V59, P9, DOI 10.1016/j.molcatb.2009.01.003; Lam R, 2010, PROTEINS, V78, P2839, DOI 10.1002/prot.22802; LEE MH, 1993, PROTEIN SCI, V2, P1042, DOI 10.1002/pro.5560020617; LEE MH, 1992, J BACTERIOL, V174, P4324, DOI 10.1128/JB.174.13.4324-4330.1992; Ligabue-Braun R, 2013, J BIOMOL STRUCT DYN, V31, P854, DOI 10.1080/07391102.2012.713782; MAEDA M, 1994, J BACTERIOL, V176, P432, DOI 10.1128/JB.176.2.432-442.1994; Martin-Diaconescu V, 2012, J BIOL INORG CHEM, V17, P353, DOI 10.1007/s00775-011-0857-9; Mehta N, 2003, MICROB PATHOGENESIS, V35, P229, DOI 10.1016/S0882-4010(03)00151-7; Mizuki T, 2004, BIOSCI BIOTECH BIOCH, V68, P397, DOI 10.1271/bbb.68.397; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; Moncrief MBC, 1996, J BACTERIOL, V178, P5417, DOI 10.1128/jb.178.18.5417-5421.1996; Moncrief MBC, 1997, J BACTERIOL, V179, P4081, DOI 10.1128/jb.179.13.4081-4086.1997; MULROONEY SB, 1990, J BACTERIOL, V172, P5837, DOI 10.1128/jb.172.10.5837-5843.1990; Mulrooney SB, 2003, FEMS MICROBIOL REV, V27, P239, DOI 10.1016/S0168-6445(03)00042-1; Musiani F, 2004, J INORG BIOCHEM, V98, P803, DOI 10.1016/j.jinorgbio.2003.12.012; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; O'Toole PW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-164; Olson JW, 2001, MOL MICROBIOL, V39, P176, DOI 10.1046/j.1365-2958.2001.02244.x; Park IS, 1996, BIOCHEMISTRY-US, V35, P5345, DOI 10.1021/bi952894j; PARK IS, 1994, P NATL ACAD SCI USA, V91, P3233, DOI 10.1073/pnas.91.8.3233; PARK IS, 1995, J BACTERIOL, V177, P1947, DOI 10.1128/jb.177.8.1947-1951.1995; PARK IS, 1995, SCIENCE, V267, P1156, DOI 10.1126/science.7855593; Pearson MA, 1997, BIOCHEMISTRY-US, V36, P8164, DOI 10.1021/bi970514j; Polacco JC, 2013, PLANT SCI, V199, P79, DOI 10.1016/j.plantsci.2012.10.010; Quiroz-Valenzuela S, 2008, ARCH BIOCHEM BIOPHYS, V480, P51, DOI 10.1016/j.abb.2008.09.004; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Real-Guerra R, 2012, PLANT MOL BIOL, V78, P461, DOI 10.1007/s11103-012-9878-1; Remaut H, 2001, J BIOL CHEM, V276, P49365, DOI 10.1074/jbc.M108304200; Rodionov DA, 2006, J BACTERIOL, V188, P317, DOI 10.1128/JB.188.1.317-327.2006; Salomone-Stagni M, 2007, PROTEINS, V68, P749, DOI 10.1002/prot.21472; Schauer K, 2007, MOL MICROBIOL, V63, P1054, DOI 10.1111/j.1365-2958.2006.05578.x; Scott DR, 2002, GASTROENTEROLOGY, V123, P187, DOI 10.1053/gast.2002.34218; Sebbane F, 2002, J BACTERIOL, V184, P5706, DOI 10.1128/JB.184.20.5706-5713.2002; Shi R, 2010, BIOCHEMISTRY-US, V49, P7080, DOI 10.1021/bi100372h; Song HK, 2001, J BIOL CHEM, V276, P49359, DOI 10.1074/jbc.M108619200; Soriano A, 1999, P NATL ACAD SCI USA, V96, P11140, DOI 10.1073/pnas.96.20.11140; Soriano A, 2000, BIOCHEMISTRY-US, V39, P12435, DOI 10.1021/bi001296o; Stingl K, 2008, MOL CELL PROTEOMICS, V7, P2429, DOI 10.1074/mcp.M800160-MCP200; Stoof J, 2008, ENVIRON MICROBIOL, V10, P2586, DOI 10.1111/j.1462-2920.2008.01681.x; Strugatsky D, 2013, NATURE, V493, P255, DOI 10.1038/nature11684; Sumner JB, 1926, J BIOL CHEM, V69, P435; Voland P, 2003, AM J PHYSIOL-GASTR L, V284, pG96, DOI 10.1152/ajpgi.00160.2002; Witte CP, 2011, PLANT SCI, V180, P431, DOI 10.1016/j.plantsci.2010.11.010; Wollers S, 2010, J BIOL CHEM, V285, P23329, DOI 10.1074/jbc.M110.127449; Zambelli B, 2005, J BIOL CHEM, V280, P4684, DOI 10.1074/jbc.M408483200; Zambelli B, 2009, PROTEINS, V74, P222, DOI 10.1002/prot.22205; Zambelli B, 2007, BIOCHEMISTRY-US, V46, P3171, DOI 10.1021/bi6024676; Zambelli B, 2012, MOL BIOSYST, V8, P220, DOI 10.1039/c1mb05227f; Zambelli B, 2011, ACCOUNTS CHEM RES, V44, P520, DOI 10.1021/ar200041k	85	81	86	1	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13178	13185		10.1074/jbc.R112.446526	http://dx.doi.org/10.1074/jbc.R112.446526			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23539618	Green Published, hybrid			2022-12-28	WOS:000318850300004
J	Ishii, TM; Kotlova, N; Tapsoba, F; Steinberg, SV				Ishii, Tetsu M.; Kotlova, Natalia; Tapsoba, Franck; Steinberg, Sergey V.			The Long D-stem of the Selenocysteine tRNA Provides Resilience at the Expense of Maximal Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; ESCHERICHIA-COLI; AMINO-ACID; DETERMINANTS; SECONDARY; FEATURES; KINASE; SERINE; LOOP	The D-stem of the selenocysteine tRNA (tRNA(Sec)) contains 2 additional base pairs, which replace tertiary interactions 8-14 and 15-48 universally present in all other cytosolic tRNAs. To study the role of these additional base pairs in the tRNA(Sec) function, we used the instant evolution approach. In vivo screening of six combinatorial gene libraries provided 158 functional variants of the Escherichia coli tRNA(Sec). Analysis of these variants showed that the additional base pairs in the D-stem were not required for the tRNA(Sec) function. Moreover, at lower temperatures, these base pairs notably harmed the tRNA(Sec) activity. However, at elevated temperatures, these base pairs became essential as they made the tRNA structure more stable. The alternative way to stabilize the structure through formation of the standard tertiary interactions was not an option for tRNA(Sec) variants, which suggests that the absence of these interactions and the resulting flexibility of the tertiary structure are essential for tRNA(Sec) function.	[Ishii, Tetsu M.; Kotlova, Natalia; Tapsoba, Franck; Steinberg, Sergey V.] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Steinberg, SV (corresponding author), Univ Montreal, Dept Biochem, Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	serguei.chteinberg@umontreal.ca						BARRETT EL, 1979, MOL GEN GENET, V177, P95, DOI 10.1007/BF00267258; BURKARD U, 1988, NUCLEIC ACIDS RES, V16, P11617, DOI 10.1093/nar/16.24.11617; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; Chiba S, 2010, MOL CELL, V39, P410, DOI 10.1016/j.molcel.2010.07.018; HEIDER J, 1992, EMBO J, V11, P3759, DOI 10.1002/j.1460-2075.1992.tb05461.x; Itoh Y, 2009, NUCLEIC ACIDS RES, V37, P6259, DOI 10.1093/nar/gkp648; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kotlova N, 2007, J MOL BIOL, V373, P462, DOI 10.1016/j.jmb.2007.07.058; Lee KS, 1997, J MOL BIOL, V269, P732, DOI 10.1006/jmbi.1997.1092; LEINFELDER W, 1988, NATURE, V331, P723, DOI 10.1038/331723a0; Palioura S, 2009, SCIENCE, V325, P321, DOI 10.1126/science.1173755; STURCHLER C, 1993, NUCLEIC ACIDS RES, V21, P1073, DOI 10.1093/nar/21.5.1073; Takahata M, 2008, J BIOCHEM, V143, P467, DOI 10.1093/jb/mvm247; Tormay P, 1996, MOL MICROBIOL, V21, P1253, DOI 10.1046/j.1365-2958.1996.881450.x; Turanov AA, 2011, ADV NUTR, V2, P122, DOI 10.3945/an.110.000265; WU XQ, 1994, EMBO J, V13, P241, DOI 10.1002/j.1460-2075.1994.tb06254.x; Yoshizawa S, 2009, BBA-GEN SUBJECTS, V1790, P1404, DOI 10.1016/j.bbagen.2009.03.010; Zagryadskaya EI, 2003, NUCLEIC ACIDS RES, V31, P3946, DOI 10.1093/nar/gkg448; ZINONI F, 1990, P NATL ACAD SCI USA, V87, P4660, DOI 10.1073/pnas.87.12.4660; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	20	5	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13337	13344		10.1074/jbc.M112.434704	http://dx.doi.org/10.1074/jbc.M112.434704			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23525102	Green Published, hybrid			2022-12-28	WOS:000318850300019
J	Li, YK; Wang, XR; Yue, P; Tao, H; Ramalingam, SS; Owonikoko, TK; Deng, XM; Wang, Y; Fu, HA; Khuri, FR; Sun, SY				Li, Yikun; Wang, Xuerong; Yue, Ping; Tao, Hui; Ramalingam, Suresh S.; Owonikoko, Taofeek K.; Deng, Xingming; Wang, Ya; Fu, Haian; Khuri, Fadlo R.; Sun, Shi-Yong			Protein Phosphatase 2A and DNA-dependent Protein Kinase Are Involved in Mediating Rapamycin-induced Akt Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG-CARCINOMA CELLS; STRAND BREAK REPAIR; MAMMALIAN TARGET; HYDROPHOBIC MOTIF; DAMAGE RESPONSE; MTOR INHIBITORS; CANCER-THERAPY; PK; ACTIVATION; SURVIVAL	Inhibition of mammalian target of rapamycin complex 1 (mTORC1), for example with rapamycin, increases Akt phosphorylation while inhibiting mTORC1 signaling. However, the underlying mechanisms have not been fully elucidated. The current study has uncovered a previously unknown mechanism underlying rapamycin-induced Akt phosphorylation involving protein phosphatase 2A (PP2A)-dependent DNA protein kinase (DNA-PK) activation. In several cancer cell lines, inhibition of PP2A with okadaic acid, fostriecin, small T antigen, or PP2A knockdown abrogated rapamycin-induced Akt phosphorylation, and rapamycin increased PP2A activity. Chemical inhibition of DNA-PK, knockdown or deficiency of DNA-PK catalytic subunit (DNA-PKcs), or knock-out of the DNA-PK component Ku86 inhibited rapamycin-induced Akt phosphorylation. Exposure of cancer cells to rapamycin increased DNA-PK activity, and gene silencing-mediated PP2A inhibition attenuated rapamycin-induced DNA-PK activity. Collectively these results suggest that rapamycin induces PP2A-dependent and DNA-PK-mediated Akt phosphorylation. Accordingly, simultaneous inhibition of mTOR and DNA-PK did not stimulate Akt activity and synergistically inhibited the growth of cancer cells both in vitro and in vivo. Thus, our findings also suggest a novel strategy to enhance mTOR-targeted cancer therapy by co-targeting DNA-PK.	[Li, Yikun; Wang, Xuerong; Yue, Ping; Tao, Hui; Ramalingam, Suresh S.; Owonikoko, Taofeek K.; Khuri, Fadlo R.; Sun, Shi-Yong] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Deng, Xingming; Wang, Ya] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Fu, Haian] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Fu, Haian] Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Sun, SY (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, 1365-C Clifton Rd,C3088, Atlanta, GA 30322 USA.	ssun@emory.edu	Khuri, Fadlo R./AAU-4942-2020; Ramalingam, Suresh/AAV-7478-2020	Khuri, Fadlo R./0000-0002-8638-7618; 	National Institutes of Health/NCI [R01 CA118450, R01 CA160522, P01 CA116676]; NATIONAL CANCER INSTITUTE [R01CA160522, K23CA164015, R01CA118450, P01CA116676] Funding Source: NIH RePORTER	National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health/NCI Grants R01 CA118450 (to S.-Y.S.), R01 CA160522 (to S.-Y.S.), and P01 CA116676 (Project 1 to F. R. K. and S.-Y.S.).	Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Bandhakavi S, 2010, MOL CELL PROTEOMICS, V9, P403, DOI 10.1074/mcp.M900326-MCP200; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Boehme KA, 2008, P NATL ACAD SCI USA, V105, P7785, DOI 10.1073/pnas.0703423105; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Bozulic L, 2009, CURR OPIN CELL BIOL, V21, P256, DOI 10.1016/j.ceb.2009.02.002; Chan DW, 1996, J BIOL CHEM, V271, P8936, DOI 10.1074/jbc.271.15.8936; Chen HH, 2011, RADIAT RES, V175, P214, DOI 10.1667/RR2323.1; Dennis PB, 1999, CURR OPIN GENET DEV, V9, P49, DOI 10.1016/S0959-437X(99)80007-0; Douglas P, 2001, J BIOL CHEM, V276, P18992, DOI 10.1074/jbc.M011703200; Dragoi AM, 2005, EMBO J, V24, P779, DOI 10.1038/sj.emboj.7600539; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Fielhaber JA, 2009, J BIOL CHEM, V284, P24341, DOI 10.1074/jbc.M109.033530; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hill R, 2010, CELL CYCLE, V9, P3460, DOI 10.4161/cc.9.17.13043; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Huang S, 2001, DRUG RESIST UPDATE, V4, P378, DOI 10.1054/drup.2002.0227; Hui L, 2005, J BIOL CHEM, V280, P35829, DOI 10.1074/jbc.M504192200; Huston E, 2008, P NATL ACAD SCI USA, V105, P12791, DOI 10.1073/pnas.0805167105; Inuzuka H, 2011, ONCOTARGET, V2, P239; Koul D, 2012, CLIN CANCER RES, V18, P184, DOI 10.1158/1078-0432.CCR-11-1558; Limson MV, 2010, TOXICOL SCI, V113, P77, DOI 10.1093/toxsci/kfp238; Lu DM, 2006, J BIOL CHEM, V281, P22799, DOI 10.1074/jbc.M603390200; Lucero H, 2003, J BIOL CHEM, V278, P22136, DOI 10.1074/jbc.M301579200; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Manning BD, 2003, BIOCHEM SOC T, V31, P573, DOI 10.1042/BST0310573; Meric-Bernstam F, 2012, CLIN CANCER RES, V18, P1777, DOI 10.1158/1078-0432.CCR-11-2123; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Park E, 2012, INT J ONCOL, V40, P1259, DOI 10.3892/ijo.2011.1290; Park J, 2009, J BIOL CHEM, V284, P6169, DOI 10.1074/jbc.C800210200; Quanz M, 2012, J BIOL CHEM, V287, P8803, DOI 10.1074/jbc.M111.320887; Santhanam A, 2004, EUKARYOT CELL, V3, P1261, DOI 10.1128/EC.3.5.1261-1271.2004; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Sun SY, 1999, ONCOGENE, V18, P2357, DOI 10.1038/sj.onc.1202543; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Sun SY, 1997, CANCER RES, V57, P4931; Surucu B, 2008, J BIOL CHEM, V283, P30025, DOI 10.1074/jbc.M803053200; Wang QH, 2009, NEOPLASIA, V11, P1012, DOI 10.1593/neo.09720; Wang XR, 2008, CANCER RES, V68, P7409, DOI 10.1158/0008-5472.CAN-08-1522; Wang XR, 2008, CANCER BIOL THER, V7, P1952, DOI 10.4161/cbt.7.12.6944; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Weterings E, 2007, J CELL BIOL, V179, P183, DOI 10.1083/jcb.200705106; Yorimitsu T, 2009, AUTOPHAGY, V5, P616, DOI 10.4161/auto.5.5.8091; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484	51	34	35	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13215	13224		10.1074/jbc.M113.463679	http://dx.doi.org/10.1074/jbc.M113.463679			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23536185	hybrid, Green Published			2022-12-28	WOS:000318850300008
J	Fassolari, M; Chemes, LB; Gallo, M; Smal, C; Sanchez, IE; de Prat-Gay, G				Fassolari, Marisol; Chemes, Lucia B.; Gallo, Mariana; Smal, Clara; Sanchez, Ignacio E.; de Prat-Gay, Gonzalo			Minute Time Scale Prolyl Isomerization Governs Antibody Recognition of an Intrinsically Disordered Immunodominant Epitope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PAPILLOMAVIRUS E7; RETINOBLASTOMA TUMOR-SUPPRESSOR; CONFORMATIONAL SELECTION; MOLECULAR RECOGNITION; ANTIGEN RECOGNITION; PROTEIN-FRAGMENTS; VIRAL ONCOPROTEIN; LINEAR MOTIFS; INDUCED FIT; T-CELL	Conformational rearrangements in antibody antigen recognition are essential events where kinetic discrimination of isomers expands the universe of combinations. We investigated the interaction mechanism of a monoclonal antibody, M1, raised against E7 from human papillomavirus, a prototypic viral oncoprotein and a model intrinsically disordered protein. The mapped 12-amino acid immunodominant epitope lies within a "hinge" region between the N-terminal intrinsically disordered and the C-terminal globular domains. Kinetic experiments show that despite being within an intrinsically disordered region, the hinge E7 epitope has at least two populations separated by a high energy barrier. Nuclear magnetic resonance traced the origin of this barrier to a very slow (t(1/2) similar to 4 min) trans-cis prolyl isomerization event involving changes in secondary structure. The less populated (10%) cis isomer is the binding-competent species, thus requiring the 90% of molecules in the trans configuration to isomerize before binding. The association rate for the cis isomer approaches 6 x 10(7) M-1 s(-1), a ceiling for antigen-antibody interactions. Mutagenesis experiments showed that Pro-41 in E7Ep was required for both binding and isomerization. After a slow postbinding unimolecular rearrangement, a consolidated complex with K-D = 1.2 x 10(-7) M is reached. Our results suggest that presentation of this viral epitope by the antigen-presenting cells would have to be "locked" in the cis conformation, in opposition to the most populated trans isomer, in order to select the specific antibody clone that goes through affinity and kinetic maturation.	[Fassolari, Marisol; Chemes, Lucia B.; de Prat-Gay, Gonzalo] IIBBA CONICET, Fdn Inst Leloir, Prot Struct Funct & Engn Lab, RA-1405 Buenos Aires, DF, Argentina; [Gallo, Mariana; Smal, Clara] IIBBA CONICET, Fdn Inst Leloir, NMR Lab, RA-1405 Buenos Aires, DF, Argentina; [Sanchez, Ignacio E.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Prot Physiol Lab, RA-1428 Buenos Aires, DF, Argentina; [Sanchez, Ignacio E.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, IQUIBICEN CONICET, RA-1428 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Buenos Aires; University of Buenos Aires	de Prat-Gay, G (corresponding author), Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.	gpg@leloir.org.ar		Prat Gay, Gonzalo/0000-0001-5748-6863; Sanchez, Ignacio Enrique/0000-0003-4284-9013; Gallo, Mariana/0000-0002-0022-4499; Chemes, Lucia Beatriz/0000-0003-0192-9906	Agencia Nacional de Promocion Cientifica y Tecnologica Grant [PICT2010-1052]; Instituto Nacional de Cancer, Argentina	Agencia Nacional de Promocion Cientifica y Tecnologica Grant; Instituto Nacional de Cancer, Argentina	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica Grant PICT2010-1052 (to I. E. S.) and Instituto Nacional de Cancer, Argentina, Basic Research Grant 2012-2014 (to G. P. G.).	Accardi L, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-17; Allcorn LC, 2002, BIOINFORMATICS, V18, P175, DOI 10.1093/bioinformatics/18.1.175; Alonso L. G., 2012, SMALL TUMOUR VIRUSES, P125; Alonso LG, 2002, BIOCHEMISTRY-US, V41, P10510, DOI 10.1021/bi025579n; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; Berger C, 1999, FEBS LETT, V450, P149, DOI 10.1016/S0014-5793(99)00458-5; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bosshard HR, 2001, NEWS PHYSIOL SCI, V16, P171; Cerutti M. L., INT J CANC, V130, P1813; Cerutti ML, 2006, BIOCHEMISTRY-US, V45, P15520, DOI 10.1021/bi0615184; Chemes LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047661; Chemes LB, 2012, J MOL BIOL, V422, P336, DOI 10.1016/j.jmb.2012.05.036; Chemes LB, 2011, J MOL BIOL, V412, P267, DOI 10.1016/j.jmb.2011.07.015; Chemes LB, 2010, FEBS J, V277, P973, DOI 10.1111/j.1742-4658.2009.07540.x; Choi UB, 2011, STRUCTURE, V19, P566, DOI 10.1016/j.str.2011.01.011; COMERFORD SA, 1991, J VIROL, V65, P4681, DOI 10.1128/JVI.65.9.4681-4690.1991; Dantur K, 2009, INT J CANCER, V125, P1902, DOI 10.1002/ijc.24579; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dogan J, 2012, J BIOL CHEM, V287, P34316, DOI 10.1074/jbc.M112.399436; DYSON HJ, 1995, FASEB J, V9, P37, DOI 10.1096/fasebj.9.1.7821757; Eckert B, 2005, NAT STRUCT MOL BIOL, V12, P619, DOI 10.1038/nsmb946; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Ferreiro DU, 2003, J MOL BIOL, V331, P89, DOI 10.1016/S0022-2836(03)00720-4; FOOTE J, 1991, NATURE, V352, P530, DOI 10.1038/352530a0; FOOTE J, 1994, P NATL ACAD SCI USA, V91, P10370, DOI 10.1073/pnas.91.22.10370; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; Galloway D A, 1992, IARC Sci Publ, P147; Garcia-Alai MM, 2007, BIOCHEMISTRY-US, V46, P10405, DOI 10.1021/bi7007917; GAY GD, 1994, BIOCHEMISTRY-US, V33, P7957, DOI 10.1021/bi00191a024; GAY GD, 1994, BIOCHEMISTRY-US, V33, P7964, DOI 10.1021/bi00191a025; Hans-Ulrich B., 2006, PAPILLOMAVIRUS RES N, P11; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P1684, DOI 10.1021/bi00459a003; Hung CF, 2008, EXPERT OPIN BIOL TH, V8, P421, DOI [10.1517/14712598.8.4.421, 10.1517/14712598.8.4.421 ]; James LC, 2005, P NATL ACAD SCI USA, V102, P12730, DOI 10.1073/pnas.0500909102; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KRCHNAK V, 1990, J GEN VIROL, V71, P2719, DOI 10.1099/0022-1317-71-11-2719; Leder L, 1995, BIOCHEMISTRY-US, V34, P16509, DOI 10.1021/bi00050a035; Liu X, 2006, J BIOL CHEM, V281, P578, DOI 10.1074/jbc.M508455200; LUND O, 2005, IMMUNOLOGICAL BIOINF, P69; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Munger K, 2001, ONCOGENE, V20, P7888, DOI 10.1038/sj.onc.1204860; Ohlenschlager O, 2006, ONCOGENE, V25, P5953, DOI 10.1038/sj.onc.1209584; Oldstone MBA, 1998, FASEB J, V12, P1255, DOI 10.1096/fasebj.12.13.1255; Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018; POLJAK RJ, 1972, NATURE-NEW BIOL, V235, P137, DOI 10.1038/newbio235137a0; Rajbhandari P, 2012, MOL CELL BIOL, V32, P445, DOI 10.1128/MCB.06073-11; Sarkar P, 2007, MOL CELL, V25, P413, DOI 10.1016/j.molcel.2007.01.004; Shen Y, 2010, J BIOMOL NMR, V46, P199, DOI 10.1007/s10858-009-9395-y; Sibille N., 2011, PROTEINS, DOI [10.1002/prot.23210, DOI 10.1002/PR0T.23210]; Smal C, 2009, BIOCHEMISTRY-US, V48, P11939, DOI 10.1021/bi901415k; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Tetin SY, 2003, ANAL BIOCHEM, V321, P183, DOI 10.1016/S0003-2697(03)00458-5; TINDLE RW, 1990, J GEN VIROL, V71, P1347, DOI 10.1099/0022-1317-71-6-1347; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tsikaris V, 1996, INT J PEPT PROT RES, V48, P319; Tugarinov V, 1999, NAT STRUCT BIOL, V6, P331; Uversky V. N., INT J BIOCH CELL BIO, V43, P1090; Uversky VN, 2006, J PROTEOME RES, V5, P1829, DOI 10.1021/pr0602388; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; WALTHO JP, 1989, FEBS LETT, V250, P400, DOI 10.1016/0014-5793(89)80764-1; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; Zeng Q, 2011, HUM GENE THER, V22, P809, DOI 10.1089/hum.2010.071	66	12	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13110	13123		10.1074/jbc.M112.444554	http://dx.doi.org/10.1074/jbc.M112.444554			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23504368	hybrid, Green Published			2022-12-28	WOS:000318555100061
J	Gupta, S; Purohit, P; Auerbach, A				Gupta, Shaweta; Purohit, Prasad; Auerbach, Anthony			Function of Interfacial Prolines at the Transmitter-binding Sites of the Neuromuscular Acetylcholine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYS-LOOP; GATING ISOMERIZATION; TRANSITION-STATE; PLAUSIBLE MODEL; CHANNEL; DYNAMICS; PROTEINS; NICOTINE; SUBUNIT; ENERGY	The neuromuscular acetylcholine (ACh) receptor has two conserved prolines in loop D of the complementary subunit at each of its two transmitter-binding sites (alpha-epsilon and alpha-delta). We used single-channel electrophysiology to estimate the energy changes caused by mutations of these prolines with regard to unliganded gating (Delta G(0)) and the affinity change for ACh that increases the open channel probability (Delta G(B)). The effects of mutations of ProD2 (epsilon Pro-121/delta Pro-123) were greater than those of its neighbor (epsilon Pro-120/delta Pro-122) and were greater at alpha-epsilon versus alpha-delta. The main consequence of the congenital myasthenic syndrome mutation epsilon ProD2-L was to impair the establishment of a high affinity for ACh and thus make Delta G(B) less favorable. At both binding sites, most ProD2 mutations decreased constitutive activity (increased Delta G(0)). LRYHQG and RL substitutions reduced substantially the net binding energy (made Delta G(B)(ACh) less favorable) by >= 2 kcal/mol at alpha-epsilon and alpha-delta, respectively. Mutant cycle analyses were used to estimate energy coupling between the two ProD2 residues and between each ProD2 and glycine residues (alpha Gly-147 and alpha Gly-153) on the primary (alpha subunit) side of each binding pocket. The distant binding site prolines interact weakly. ProD2 interacts strongly with alpha Gly-147 but only at alpha-epsilon and only when ACh is present. The results suggest that in the low to-high affinity change there is a concerted inter-subunit strain in the backbones at epsilon ProD2 and alpha Gly-147. It is possible to engineer receptors having a single functional binding site by using a alpha-epsilon or alpha-delta ProD2-R knock-out mutation. In adult-type ACh receptors, the energy from the affinity change for ACh is approximately the same at the two binding sites (approximately -5 kcal/mol).	[Gupta, Shaweta; Purohit, Prasad; Auerbach, Anthony] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Auerbach, A (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA.	auerbach@buffalo.edu			National Institutes of Health [NS-23513, NS-064969]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064969, R01NS023513, R56NS023513, R37NS023513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS-23513 and NS-064969.	Auerbach A, 2005, P NATL ACAD SCI USA, V102, P1408, DOI 10.1073/pnas.0406787102; Auerbach A., 2013, J MOL BIOL IN PRESS; Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; Bafna PA, 2009, J BIOL CHEM, V284, P8582, DOI 10.1074/jbc.M807152200; Cadugan DJ, 2007, BIOPHYS J, V93, P859, DOI 10.1529/biophysj.107.105171; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chakrapani S, 2003, J GEN PHYSIOL, V122, P521, DOI 10.1085/jgp.200308885; Christoph P, 2005, PFLUG ARCH EUR J PHY, V450, P178, DOI 10.1007/s00424-005-1387-5; Grosman C, 2001, P NATL ACAD SCI USA, V98, P14102, DOI 10.1073/pnas.251402498; Gupta S, 2011, BIOPHYS J, V100, P904, DOI 10.1016/j.bpj.2010.12.3739; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; Jadey S, 2013, J GEN PHYSIOL, V141, P95, DOI 10.1085/jgp.201210896; Jadey S, 2012, J GEN PHYSIOL, V140, P17, DOI 10.1085/jgp.201210801; Jadey SV, 2011, P NATL ACAD SCI USA, V108, P4328, DOI 10.1073/pnas.1016617108; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Jha A, 2010, BIOPHYS J, V98, P1840, DOI 10.1016/j.bpj.2010.01.025; KARLIN A, 1967, J THEOR BIOL, V16, P306, DOI 10.1016/0022-5193(67)90011-2; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Mitra A, 2004, STRUCTURE, V12, P1909, DOI 10.1016/j.str.2004.08.004; Mitra A, 2005, P NATL ACAD SCI USA, V102, P15069, DOI 10.1073/pnas.0505090102; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nayak TK, 2012, J GEN PHYSIOL, V139, P349, DOI 10.1085/jgp.201110752; Ohno K, 1996, NEURON, V17, P157, DOI 10.1016/S0896-6273(00)80289-5; Purohit P, 2007, J GEN PHYSIOL, V130, P569, DOI 10.1085/jgp.200709858; Purohit P, 2012, P NATL ACAD SCI USA, V109, P9384, DOI 10.1073/pnas.1203633109; Purohit P, 2011, MOL PHARMACOL, V79, P351, DOI 10.1124/mol.110.068767; Purohit P, 2010, J GEN PHYSIOL, V135, P321, DOI 10.1085/jgp.200910384; Purohit P, 2009, P NATL ACAD SCI USA, V106, P115, DOI 10.1073/pnas.0809272106; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Zhou M, 1999, P NATL ACAD SCI USA, V96, P10466, DOI 10.1073/pnas.96.18.10466	35	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12667	12679		10.1074/jbc.M112.443911	http://dx.doi.org/10.1074/jbc.M112.443911			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23519471	hybrid, Green Published			2022-12-28	WOS:000318555100024
J	Huang, Q; Wang, H; Perry, SW; Figueiredo-Pereira, ME				Huang, Qian; Wang, Hu; Perry, Seth W.; Figueiredo-Pereira, Maria E.			Negative Regulation of 26S Proteasome Stability via Calpain-mediated Cleavage of Rpn10 Subunit upon Mitochondrial Dysfunction in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-(4,5-DIMETHYLTHIAZOL-2-YL)-2,5-DIPHENYLTETRAZOLIUM BROMIDE MTT; OXIDATIVE-STRESS; ALZHEIMERS-DISEASE; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); NEURODEGENERATIVE DISEASE; ENDOGENOUS ELECTROPHILE; PROTEIN-DEGRADATION; CELLULAR-RESPONSES; UBIQUITIN; CELLS	Proteasomal and mitochondrial dysfunctions are implicated in chronic neurodegenerative diseases. To investigate the impact of mitochondrial impairment on the proteasome, we treated rat cerebral cortical neurons with oligomycin, antimycin, or rotenone, which inhibit different elements of the electron transport chain. Firstly, we observed a reduction in ubiquitinated proteins and E1 activity. Secondly, we established that 26S proteasomes are disassembled with a decline in activity. Thirdly, we show, to our knowledge for the first time, that calpain activation triggers the selective processing of the 26S proteasome subunit Rpn10. Other proteasome subunits tested were not affected. Calpain also cleaved caspase 3 to an inactive fragment, thus preventing apoptosis that is an energy-dependent cell death pathway. In addition, calpain cleaved the microtubule-associated protein Tau, a major component of neurofibrillary tangles in Alzheimer disease and other tauopathies. Fourthly, we detected a rise in 20S proteasome levels and activity. Finally, we show that both acute (16 h) and long term (up to 7 days) mitochondrial impairment led to down-regulation of ubiquitinated-proteins, 26S proteasome disassembly, and a rise in 20S proteasomes. We postulate that upon mitochondrial dysfunction, ATP depletion and calpain activation contribute to the demise of protein turnover by the ubiquitin/proteasome pathway. The concomitant rise in 20S proteasomes, which seem to degrade proteins in an unregulated and energy-independent manner, in the short term may carry out the turnover of randomly unfolded oxidized proteins. However, if chronic, it could lead to neurodegeneration as regulated protein degradation by the ubiquitin/proteasome pathway is essential for neuronal survival.	[Huang, Qian; Wang, Hu; Figueiredo-Pereira, Maria E.] CUNY, Dept Biol Sci, Hunter Coll, New York, NY 10065 USA; [Huang, Qian; Wang, Hu; Figueiredo-Pereira, Maria E.] CUNY, Grad Ctr, New York, NY 10065 USA; [Perry, Seth W.] Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; University of Rochester	Figueiredo-Pereira, ME (corresponding author), CUNY, Dept Biol Sci, Hunter Coll, 695 Pk Ave, New York, NY 10065 USA.	pereira@genectr.hunter.cuny.edu		Perry, Seth W/0000-0002-1503-6634	National Institutes of Health Grants, NIA [R01 AG028847]; NINDS [U54 NS041073]; National Institutes of Health Grant, National Center for Research Resources (NCRR) [G12 RR003037]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028847] Funding Source: NIH RePORTER	National Institutes of Health Grants, NIA; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health Grant, National Center for Research Resources (NCRR); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AG028847 (to M. E. F.-P.) from the NIA and U54 NS041073 (Specialized Neuroscience Research Programs (SNRP)) (to M. E. F.-P., head of sub-project) from the NINDS.; We thank Dr. L. Binder (Northwestern University, Chicago, IL) for the Tau C5 antibody. Hunter College, City University of New York was supported by National Institutes of Health Grant G12 RR003037 (to the Gene Center at Hunter College) from the National Center for Research Resources (NCRR).	Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924; Akude E, 2011, DIABETES, V60, P288, DOI 10.2337/db10-0818; Azzu V, 2008, BIOCHEM J, V413, P323, DOI 10.1042/BJ20080321; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Bedford L, 2009, AUTOPHAGY, V5, P224, DOI 10.4161/auto.5.2.7389; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; BREEUWER P, 1995, APPL ENVIRON MICROB, V61, P1614, DOI 10.1128/AEM.61.4.1614-1619.1995; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Chandra A, 2010, CURR GENET, V56, P543, DOI 10.1007/s00294-010-0321-3; Dasuri K, 2010, FREE RADICAL BIO MED, V49, P1290, DOI 10.1016/j.freeradbiomed.2010.07.014; Ding QX, 2006, ANTIOXID REDOX SIGN, V8, P163, DOI 10.1089/ars.2006.8.163; duVerle DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019035; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; Ferreira A, 2011, MOL MED, V17, P676, DOI 10.2119/molmed.2010.00220; Garg S, 2011, NEUROBIOL AGING, V32, P1, DOI 10.1016/j.neurobiolaging.2010.09.008; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Grimm S, 2011, FREE RADICAL RES, V45, P73, DOI 10.3109/10715762.2010.512040; Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020; HOYER S, 1992, MOL CHEM NEUROPATHOL, V16, P207, DOI 10.1007/BF03159971; Huang LS, 2005, J MOL BIOL, V351, P573, DOI 10.1016/j.jmb.2005.05.053; Huber N, 2009, HEPATOLOGY, V49, P1718, DOI 10.1002/hep.22840; JahngenHodge J, 1997, J BIOL CHEM, V272, P28218, DOI 10.1074/jbc.272.45.28218; Jha N, 2002, J NEUROCHEM, V80, P555, DOI 10.1046/j.0022-3042.2001.00009.x; Kastle M, 2011, BIOCHIMIE, V93, P1076, DOI 10.1016/j.biochi.2011.03.004; Kondo M, 2002, P NATL ACAD SCI USA, V99, P7367, DOI 10.1073/pnas.112212599; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Liu MC, 2011, ASN NEURO, V3, P25, DOI 10.1042/AN20100012; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; Liu YB, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-98; Liu Z, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0027887, 10.1371/journal.pone.0019001]; Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005; Mosconi L, 2008, ANN NY ACAD SCI, V1147, P180, DOI 10.1196/annals.1427.007; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Myeku N, 2011, METHODS MOL BIOL, V793, P273, DOI 10.1007/978-1-61779-328-8_18; Nam Y, 2007, J BIOMAT SCI-POLYM E, V18, P1091, DOI 10.1163/156856207781494430; Nicholls DG, 2008, ANN NY ACAD SCI, V1147, P53, DOI 10.1196/annals.1427.002; Oddo S, 2008, J CELL MOL MED, V12, P363, DOI 10.1111/j.1582-4934.2008.00276.x; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; PACIFICI RE, 1989, FREE RADICAL BIO MED, V7, P521, DOI 10.1016/0891-5849(89)90028-2; Papa L, 2008, APOPTOSIS, V13, P588, DOI 10.1007/s10495-008-0182-0; Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878; Reddy PH, 2007, ANTIOXID REDOX SIGN, V9, P1647, DOI 10.1089/ars.2007.1754; Rego AC, 2001, CELL DEATH DIFFER, V8, P995, DOI 10.1038/sj.cdd.4400916; Reinheckel T, 1998, BIOCHEM J, V335, P637, DOI 10.1042/bj3350637; Rinaldi T, 2002, GENE, V286, P43, DOI 10.1016/S0378-1119(01)00799-5; Sakata E, 2012, P NATL ACAD SCI USA, V109, P1479, DOI 10.1073/pnas.1119394109; Shang F, 2001, EXP EYE RES, V73, P229, DOI 10.1006/exer.2001.1029; Shang F, 2011, FREE RADICAL BIO MED, V51, P5, DOI 10.1016/j.freeradbiomed.2011.03.031; Shell JR, 2012, BIOCHEMISTRY-US, V51, P2258, DOI 10.1021/bi201573k; Shibata T, 2003, BIOCHEMISTRY-US, V42, P13960, DOI 10.1021/bi035215a; Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200; Sorimachi H, 2012, CARDIOVASC RES, V96, P11, DOI 10.1093/cvr/cvs157; Stadtman ER, 1998, DRUG METAB REV, V30, P225, DOI 10.3109/03602539808996310; Stranahan AM, 2012, NAT REV NEUROSCI, V13, P209, DOI 10.1038/nrn3151; Sullivan PG, 2004, J BIOL CHEM, V279, P20699, DOI 10.1074/jbc.M313579200; Sun XM, 2004, MOL CELL, V14, P81, DOI 10.1016/S1097-2765(04)00156-X; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Uchida K, 2008, CHEM RES TOXICOL, V21, P138, DOI 10.1021/tx700177j; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; VITALE M, 1993, HISTOCHEMISTRY, V100, P223, DOI 10.1007/BF00269095; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; WILK S, 1983, J NEUROCHEM, V40, P842, DOI 10.1111/j.1471-4159.1983.tb08056.x; Zhu XW, 2013, J ALZHEIMERS DIS, V33, pS253, DOI 10.3233/JAD-2012-129005; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	68	47	48	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12161	12174		10.1074/jbc.M113.464552	http://dx.doi.org/10.1074/jbc.M113.464552			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23508964	hybrid, Green Published			2022-12-28	WOS:000318157600048
J	Li, W; Rao, DK; Kaur, P				Li, Wen; Rao, Divya K.; Kaur, Parjit			Dual Role of the Metalloprotease FtsH in Biogenesis of the DrrAB Drug Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-LIKE ACTIVITY; ESCHERICHIA-COLI; AAA+ PROTEASES; PROTEIN; MEMBRANE; DISAGGREGATION; DEGRADATION; MACHINES; SECY	This study provides the first direct evidence for the dual role of the metalloprotease FtsH in membrane protein biogenesis. Using the physiological substrate DrrAB, it is shown that FtsH is not only responsible for proteolysis of unassembled DrrB protein but also plays a much broader role in biogenesis of the DrrAB complex. Previous studies showed that the stable expression of DrrB in the membrane depends on simultaneous expression of DrrA. Here we show that DrrB is proteolyzed by FtsH when it is expressed alone. Moreover, DrrA and DrrB proteins expressed together in a temperature-sensitive ftsH mutant strain of Escherichia coli were found to be nonfunctional due to their incorrect assembly. Simultaneous expression of wild-type FtsH in trans resulted in normal doxorubicin efflux. Strikingly, doxorubicin efflux could be restored in mutant cells irrespective of whether FtsH was expressed simultaneously with DrrAB or expressed after these proteins had already accumulated in an inactive conformation, thus providing crucial evidence for the ability of FtsH to refold the misassembled proteins. Complementation experiments also showed that the catalytic AAA domain of FtsH contains a chaperone-like activity, however, unlike wild-type FtsH, it was unable to restore function. Our results therefore show for the first time that FtsH contains the protease as well as refolding functions, and both the AAA and the proteolytic domains of FtsH are required for each of these activities.	[Li, Wen; Rao, Divya K.; Kaur, Parjit] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Kaur, P (corresponding author), 161 Jesse Hill Jr Dr, Atlanta, GA 30303 USA.	pkaur@gsu.edu			National Institutes of Health [RO1 GM51981-09]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Service Award RO1 GM51981-09 (to P. K.).	AKIYAMA Y, 1994, J BIOL CHEM, V269, P5218; Akiyama Y, 1996, J BIOL CHEM, V271, P31196, DOI 10.1074/jbc.271.49.31196; Akiyama Y, 2009, J BIOCHEM, V146, P449, DOI 10.1093/jb/mvp071; Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7; Asahara Y, 2000, J BIOCHEM, V127, P931, DOI 10.1093/oxfordjournals.jbchem.a022689; Chiba S, 2002, J BACTERIOL, V184, P4775, DOI 10.1128/JB.184.17.4775-4782.2002; Dougan DA, 2002, CELL MOL LIFE SCI, V59, P1607, DOI 10.1007/PL00012487; Gandlur SM, 2004, J BIOL CHEM, V279, P27799, DOI 10.1074/jbc.M402898200; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Kaur P, 1997, J BACTERIOL, V179, P569, DOI 10.1128/jb.179.3.569-575.1997; Kaur P, 1998, J BIOL CHEM, V273, P17933, DOI 10.1074/jbc.273.28.17933; KIHARA A, 1995, P NATL ACAD SCI USA, V92, P4532, DOI 10.1073/pnas.92.10.4532; Langer T, 2000, TRENDS BIOCHEM SCI, V25, P247, DOI 10.1016/S0968-0004(99)01541-8; Leonhard K, 1999, NATURE, V398, P348, DOI 10.1038/18704; MAURIZI MR, 1985, J BACTERIOL, V164, P1124, DOI 10.1128/JB.164.3.1124-1135.1985; Mogk A, 2008, BIOCHEM SOC T, V36, P120, DOI 10.1042/BST0360120; Pak M, 1999, J BIOL CHEM, V274, P19316, DOI 10.1074/jbc.274.27.19316; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Shirai Y, 1996, J BACTERIOL, V178, P1141, DOI 10.1128/jb.178.4.1141-1145.1996; Snider J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-216; Suzuki CK, 1997, TRENDS BIOCHEM SCI, V22, P118, DOI 10.1016/S0968-0004(97)01020-7; Truscott KN, 2010, BIOCHEM CELL BIOL, V88, P97, DOI [10.1139/O09-167, 10.1139/o09-167]; Weibezahn J, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-1; Zhang H, 2010, J BIOL CHEM, V285, P38324, DOI 10.1074/jbc.M110.131540	29	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11854	11864		10.1074/jbc.M112.441915	http://dx.doi.org/10.1074/jbc.M112.441915			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504316	Green Published, hybrid			2022-12-28	WOS:000318157600021
J	Ryzhakov, G; Teixeira, A; Saliba, D; Blazek, K; Muta, T; Ragoussis, J; Udalova, IA				Ryzhakov, Grigory; Teixeira, Ana; Saliba, David; Blazek, Katrina; Muta, Tatsushi; Ragoussis, Jiannis; Udalova, Irina A.			Cross-species Analysis Reveals Evolving and Conserved Features of the Nuclear Factor kappa B (NF-kappa B) Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEMATOSTELLA-VECTENSIS; TRANSCRIPTION FACTORS; SEA-ANEMONE; IMMUNE-SYSTEM; DNA; BINDING; ZETA; REPERTOIRE; ACTIVATION; COMPLEXITY	NF-kappa B is a key regulator of immune gene expression in metazoans. It is currently unclear what changes occurred in NF-kappa B during animal evolution and what features remained conserved. To address this question, we compared the biochemical and functional properties of NF-kappa B proteins derived from human and the starlet sea anemone (Nematostella vectensis) in 1) a high-throughput assay of in vitro preferences for DNA sequences, 2) ChIP analysis of in vivo recruitment to the promoters of target genes, 3) a LUMIER-assisted examination of interactions with cofactors, and 4) a transactivation assay. We observed a remarkable evolutionary conservation of the DNA binding preferences of the animal NF-kappa B orthologs. We also show that NF-kappa B dimerization properties, nuclear localization signals, and binding to cytosolic I kappa Bs are conserved. Surprisingly, the Bcl3-type nuclear I kappa B proteins functionally pair up only with NF-kappa B derived from their own species. The basis of the differential NF-kappa B recognition by I kappa B subfamilies is discussed.	[Ryzhakov, Grigory; Saliba, David; Blazek, Katrina; Udalova, Irina A.] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, London W6 8LH, England; [Teixeira, Ana; Ragoussis, Jiannis] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Muta, Tatsushi] Tohoku Univ, Lab Cell Recognit & Response, Dept Dev Biol & Neurosci, Grad Sch Life Sci, Sendai, Miyagi 9808577, Japan	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Tohoku University	Ryzhakov, G (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, 65 Aspenlea Rd, London W6 8LH, England.	grigory@ryzhakov.co.uk; irina.udalova@kennedy.ox.ac.uk	Ragoussis, Ioannis/AAD-9790-2022; Blazek, Katrina/AAU-6194-2020	Saliba, David/0000-0001-9523-0586; Blazek, Katrina/0000-0002-4439-4756; Udalova, Irina/0000-0002-6716-2528; Ragoussis, Ioannis/0000-0002-8515-0934	European Community [222008]; Wellcome Trust [090532/Z/09/Z, 075491/Z/04]; Medical Research Council [G0700818, G0501087] Funding Source: researchfish; MRC [G0700818, G0501087] Funding Source: UKRI	European Community(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by European Community Seventh Framework Programme FP7/2007-2013 under Grant 222008.; Supported by The Wellcome Trust Grants 090532/Z/09/Z and 075491/Z/04. Present address: McGill University and Genome Quebec Innovation Centre, 740 Docteur Penfield Avenue, Montreal (Quebec) H3A 0G1, Canada.	Augustin R, 2010, SEMIN IMMUNOL, V22, P54, DOI 10.1016/j.smim.2009.11.002; Bae S, 2009, J INVERTEBR PATHOL, V102, P79, DOI 10.1016/j.jip.2009.06.007; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; Darling JA, 2005, BIOESSAYS, V27, P211, DOI 10.1002/bies.20181; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Hetru C, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000232; Heusch M, 1999, ONCOGENE, V18, P6201, DOI 10.1038/sj.onc.1203022; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin L, 1996, MOL CELL BIOL, V16, P2248; LIN YC, 1995, P NATL ACAD SCI USA, V92, P552, DOI 10.1073/pnas.92.2.552; Manavalan B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015782; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Miller DJ, 2005, TRENDS GENET, V21, P536, DOI 10.1016/j.tig.2005.08.002; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Muta T, 2006, VITAM HORM, V74, P301, DOI 10.1016/S0083-6729(06)74012-2; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Palmer S, 2008, IMMUNOL RES, V42, P210, DOI 10.1007/s12026-008-8075-4; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ragoussis Jiannis, 2006, V338, P261; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schuhmann KM, 2011, J VIROL, V85, P3162, DOI 10.1128/JVI.02342-10; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Steele RE, 2011, TRENDS GENET, V27, P7, DOI 10.1016/j.tig.2010.10.002; Sullivan JC, 2007, DEV GENES EVOL, V217, P63, DOI 10.1007/s00427-006-0111-6; Sullivan JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007311; Trinh DV, 2008, J MOL BIOL, V379, P122, DOI 10.1016/j.jmb.2008.03.060; Udalova IA, 2002, P NATL ACAD SCI USA, V99, P8167, DOI 10.1073/pnas.102674699; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; Wolenski FS, 2011, MOL CELL BIOL, V31, P1076, DOI 10.1128/MCB.00927-10; Wong D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r70; Yamamoto Masahiro, 2008, Journal of Infection and Chemotherapy, V14, P265, DOI 10.1007/s10156-008-0619-y	38	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11546	11554		10.1074/jbc.M113.451153	http://dx.doi.org/10.1074/jbc.M113.451153			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23508954	Green Published, hybrid			2022-12-28	WOS:000317915500060
J	Zhu, H; Moriasi, CM; Zhang, M; Zhao, Y; Zou, MH				Zhu, Huaiping; Moriasi, Cate M.; Zhang, Miao; Zhao, Yu; Zou, Ming-Hui			Phosphorylation of Serine 399 in LKB1 Protein Short Form by Protein Kinase C xi Is Required for Its Nucleocytoplasmic Transport and Consequent AMP-activated Protein Kinase (AMPK) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEUTZ-JEGHERS-SYNDROME; TUMOR-SUPPRESSOR; ENDOTHELIAL-CELLS; GLUCOSE-TRANSPORT; SPLICE VARIANT; MUSCLE-CELLS; IN-VIVO; ZETA; POLARITY; GROWTH	Two splice variants of LKB1 exist: LKB1 long form (LKB1L) and LKB1 short form (LKB1S). In a previous study, we demonstrated that phosphorylation of Ser-428/431 (in LKB1L) by protein kinase C xi (PKC xi) was essential for LKB1-mediated activation of AMP-activated protein kinase (AMPK) in response to oxidants or metformin. Paradoxically, LKB1S also activates AMPK although it lacks Ser-428/431. Thus, we hypothesized that LKB1S contained additional phosphorylation sites important in AMPK activation. Truncation analysis and site-directed mutagenesis were used to identify putative PKC xi phosphorylation sites in LKB1S. Substitution of Ser-399 to alanine did not alter the activity of LKB1S, but abolished peroxynitrite-and metformin-induced activation of AMPK. Furthermore, the phosphomimetic mutation (S399D) increased the phosphorylation of AMPK and its downstream target phospho-acetyl-coenzyme A carboxylase (ACC). PKC xi-dependent phosphorylation of Ser-399 triggered nucleocytoplasmic translocation of LKB1S in response to metformin or peroxynitrite treatment. This effect was ablated by pharmacological and genetic inhibition of PKC xi, by inhibition of CRM1 activity and by substituting Ser-399 with alanine (S399A). Overexpression of PKC xi up-regulated metformin-mediated phosphorylation of both AMPK (Thr-172) and ACC (Ser-79), but the effect was ablated in the S399A mutant. We conclude that, similar to Ser-428/431 (in LKB1L), Ser-399 (in LKB1S) is a PKC xi-dependent phosphorylation site essential for nucleocytoplasmic export of LKB1S and consequent AMPK activation.	[Zhu, Huaiping; Moriasi, Cate M.; Zhang, Miao; Zhao, Yu; Zou, Ming-Hui] Univ Oklahoma Hlth Sci Ctr, Dept Med, Sect Mol Med, Oklahoma City, OK 73104 USA; [Zou, Ming-Hui] Univ Oklahoma Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zou, MH (corresponding author), Univ Oklahoma Hlth Sci Ctr, Dept Med, Sect Mol Med, BSEB 306A,941,Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	ming-hui-zou@ouhsc.edu			National Institutes of Health [HL079584, HL080499, HL074399, HL089920, HL096032, HL105157, HL110488]; American Diabetes Association; Warren Chair of the University of Oklahoma Health Sciences Center; National Established Investigator Award of the American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074399, R01HL080499, R01HL079584, R01HL089920, R01HL105157, R01HL096032, R01HL110488] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Warren Chair of the University of Oklahoma Health Sciences Center; National Established Investigator Award of the American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL079584, HL080499, HL074399, HL089920, HL096032, HL105157, and HL110488) (to M. H. Z.). This work was also supported by a Research Award from the American Diabetes Association and funds from the Warren Chair of the University of Oklahoma Health Sciences Center (to M. H. Z.).; A recipient of the National Established Investigator Award of the American Heart Association.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Boudeau J, 2003, FEBS LETT, V546, P159, DOI 10.1016/S0014-5793(03)00642-2; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Canto C, 2004, J BIOL CHEM, V279, P12260, DOI 10.1074/jbc.M308554200; Collins SP, 2000, BIOCHEM J, V345, P673, DOI 10.1042/0264-6021:3450673; Denison FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028306; Denison FC, 2009, J BIOL CHEM, V284, P67, DOI 10.1074/jbc.M806153200; Dorfman J, 2008, MOL BIOL CELL, V19, P1614, DOI 10.1091/mbc.E07-05-0454; Fogarty S, 2009, J BIOL CHEM, V284, P77, DOI 10.1074/jbc.M806152200; Forcet C, 2005, HUM MOL GENET, V14, P1283, DOI 10.1093/hmg/ddi139; Grifoni D, 2007, ONCOGENE, V26, P5960, DOI 10.1038/sj.onc.1210389; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; HUANG WD, 1994, P NATL ACAD SCI USA, V91, P8960, DOI 10.1073/pnas.91.19.8960; Jansen M, 2009, PHYSIOL REV, V89, P777, DOI 10.1152/physrev.00026.2008; Jishage K, 2002, P NATL ACAD SCI USA, V99, P8903, DOI 10.1073/pnas.122254599; Liu LZ, 2006, MOL BIOL CELL, V17, P2322, DOI 10.1091/mbc.E05-10-0969; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Mirouse V, 2011, FEBS LETT, V585, P981, DOI 10.1016/j.febslet.2010.12.025; Real E, 2007, J IMMUNOL, V179, P5649, DOI 10.4049/jimmunol.179.9.5649; Rowan A, 2000, J PATHOL, V192, P203; Sanchez-Cespedes M, 2007, ONCOGENE, V26, P7825, DOI 10.1038/sj.onc.1210594; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw Reuben J, 2008, Biochem J, V416, pe1, DOI 10.1042/BJ20082023; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Smith DP, 1999, HUM MOL GENET, V8, P1479, DOI 10.1093/hmg/8.8.1479; Song P, 2008, J BIOL CHEM, V283, P12446, DOI 10.1074/jbc.M708208200; Tiainen M, 2002, HUM MOL GENET, V11, P1497, DOI 10.1093/hmg/11.13.1497; Towler MC, 2008, BIOCHEM J, V416, P1, DOI 10.1042/BJ20081447; Vaahtomeri K, 2011, FEBS LETT, V585, P944, DOI 10.1016/j.febslet.2010.12.034; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Xie ZL, 2009, MOL CELL BIOL, V29, P3582, DOI 10.1128/MCB.01417-08; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	41	22	24	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16495	16505		10.1074/jbc.M112.443580	http://dx.doi.org/10.1074/jbc.M112.443580			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612973	Green Published, hybrid			2022-12-28	WOS:000320378900026
J	McAndrew, RP; Park, JI; Heins, RA; Reindl, W; Friedland, GD; D'haeseleer, P; Northen, T; Sale, KL; Simmons, BA; Adams, PD				McAndrew, Ryan P.; Park, Joshua I.; Heins, Richard A.; Reindl, Wolfgang; Friedland, Gregory D.; D'haeseleer, Patrik; Northen, Trent; Sale, Kenneth L.; Simmons, Blake A.; Adams, Paul D.			From Soil to Structure, a Novel Dimeric beta-Glucosidase Belonging to Glycoside Hydrolase Family 3 Isolated from Compost Using Metagenomic Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWITCHGRASS; REVEALS	A recent metagenomic analysis sequenced a switchgrass-adapted compost community to identify enzymes from microorganisms that were specifically adapted to switchgrass under thermophilic conditions. These enzymes are being examined as part of the pretreatment process for the production of "second-generation" biofuels. Among the enzymes discovered was JMB19063, a novel three-domain beta-glucosidase that belongs to the GH3 (glycoside hydrolase 3) family. Here, we report the structure of JMB19063 in complex with glucose and the catalytic variant D261N crystallized in the presence of cellopentaose. JMB19063 is first structure of a dimeric member of the GH3 family, and we demonstrate that dimerization is required for catalytic activity. Arg-587 and Phe-598 from the C-terminal domain of the opposing monomer are shown to interact with bound ligands in the D261N structure. Enzyme assays confirmed that these residues are absolutely essential for full catalytic activity.	[McAndrew, Ryan P.; Park, Joshua I.; Heins, Richard A.; Reindl, Wolfgang; Friedland, Gregory D.; D'haeseleer, Patrik; Northen, Trent; Sale, Kenneth L.; Simmons, Blake A.; Adams, Paul D.] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [McAndrew, Ryan P.; Reindl, Wolfgang; Adams, Paul D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Reindl, Wolfgang; D'haeseleer, Patrik; Northen, Trent] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Bioenergy GTL, Berkeley, CA 94720 USA; [Reindl, Wolfgang; D'haeseleer, Patrik; Northen, Trent] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Biol Struct, Berkeley, CA 94720 USA; [Park, Joshua I.; Heins, Richard A.; Friedland, Gregory D.; Sale, Kenneth L.] Sandia Natl Labs, Biomass Sci & Convers Technol Dept, Livermore, CA USA; [Simmons, Blake A.] Sandia Natl Labs, Energy Syst Dept, Livermore, CA USA; [Adams, Paul D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Sandia National Laboratories; University of California System; University of California Berkeley	Adams, PD (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	pdadams@lbl.gov	Adams, Paul David/A-1977-2013; Simmons, Blake/N-6022-2016	Adams, Paul David/0000-0001-9333-8219; Simmons, Blake/0000-0002-1332-1810; Northen, Trent/0000-0001-8404-3259				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Baran R, 2011, MOL BIOSYST, V7, P3200, DOI 10.1039/c1mb05196b; Bouton JH, 2007, CURR OPIN GENET DEV, V17, P553, DOI 10.1016/j.gde.2007.08.012; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li YK, 1999, ENZYME MICROB TECH, V24, P144, DOI 10.1016/S0141-0229(98)00095-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Northen TR, 2008, P NATL ACAD SCI USA, V105, P3678, DOI 10.1073/pnas.0712332105; Northen TR, 2007, NATURE, V449, P1033, DOI 10.1038/nature06195; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Park JI, 2011, BIORESOURCE TECHNOL, V102, P5988, DOI 10.1016/j.biortech.2011.02.036; Petkun S, 2010, ACTA CRYSTALLOGR D, V66, P33, DOI 10.1107/S0907444909043030; Plewczynski Dariusz, 2002, Appl Bioinformatics, V1, P223; Pozzo T, 2010, J MOL BIOL, V397, P724, DOI 10.1016/j.jmb.2010.01.072; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Reindl W, 2011, ENERG ENVIRON SCI, V4, P2884, DOI 10.1039/c1ee01112j; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; SHEWALE JG, 1982, INT J BIOCHEM, V14, P435, DOI 10.1016/0020-711X(82)90109-4; Shimon LJW, 2000, ACTA CRYSTALLOGR D, V56, P1560, DOI 10.1107/S0907444900012889; Simmons BA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-242; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Varghese JN, 1999, STRUCTURE, V7, P179, DOI 10.1016/S0969-2126(99)80024-0; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Yoshida E, 2010, BIOCHEM J, V431, P39, DOI 10.1042/BJ20100351	33	33	37	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14985	14992		10.1074/jbc.M113.458356	http://dx.doi.org/10.1074/jbc.M113.458356			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23580647	Green Published, hybrid			2022-12-28	WOS:000319452100028
J	de Diego, I; Veillard, FT; Guevara, T; Potempa, B; Sztukowska, M; Potempa, J; Gomis-Ruth, FX				de Diego, Inaki; Veillard, Florian T.; Guevara, Tibisay; Potempa, Barbara; Sztukowska, Maryta; Potempa, Jan; Xavier Gomis-Rueth, F.			Porphyromonas gingivalis Virulence Factor Gingipain RgpB Shows a Unique Zymogenic Mechanism for Cysteine Peptidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ACTIVE-SITE; ACTIVATION MECHANISM; STRUCTURE VALIDATION; PROCATHEPSIN B; PROTEASE; REVEALS; PROTEINASES; PROREGION; PROCASPASE-8	Zymogenicity is a regulatory mechanism that prevents inadequate catalytic activity in the wrong context. It plays a central role in maintaining microbial virulence factors in an inactive form inside the pathogen until secretion. Among these virulence factors is the cysteine peptidase gingipain B (RgpB), which is the major virulence factor secreted by the periodontopathogen Porphyromonas gingivalis that attacks host vasculature and defense proteins. The structure of the complex between soluble mature RgpB, consisting of a catalytic domain and an immunoglobulin superfamily domain, and its 205-residue N-terminal prodomain, the largest structurally characterized to date for a cysteine peptidase, reveals a novel fold for the prodomain that is distantly related to sugar-binding lectins. It attaches laterally to the catalytic domain through a large concave surface. The main determinant for latency is a surface "inhibitory loop," which approaches the active-site cleft of the enzyme on its non-primed side in a substrate-like manner. It inserts an arginine (Arg(126)) into the S-1 pocket, thus matching the substrate specificity of the enzyme. Downstream of Arg(126), the polypeptide leaves the cleft, thereby preventing cleavage. Moreover, the carbonyl group of Arg(126) establishes a very strong hydrogen bond with the co-catalytic histidine, His(440), pulling it away from the catalytic cysteine, Cys(473), and toward Glu(381), which probably plays a role in orienting the side chain of His(440) during catalysis. The present results provide the structural determinants of zymogenic inhibition of RgpB by way of a novel inhibitory mechanism for peptidases in general and open the field for the design of novel inhibitory strategies in the treatment of human periodontal disease.	[de Diego, Inaki; Guevara, Tibisay; Xavier Gomis-Rueth, F.] Spanish Res Council CSIC, Mol Biol Inst Barcelona, Proteolysis Lab, Barcelona 08028, Catalonia, Spain; [Veillard, Florian T.; Potempa, Barbara; Sztukowska, Maryta; Potempa, Jan] Univ Louisville, Sch Dent, Louisville, KY 40202 USA; [Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, PL-30387 Krakow, Poland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Louisville; Jagiellonian University	Potempa, J (corresponding author), Univ Louisville, Sch Dent, Louisville, KY 40202 USA.	jspote01@louisville.edu; xgrcri@ibmb.csic.es	de Diego Martinez, Iñaki/AAB-4712-2019; Potempa, Jan/AAA-6850-2021	de Diego Martinez, Iñaki/0000-0002-6156-4032; Veillard, Florian/0000-0003-1248-2396; Gomis-Ruth, F. Xavier/0000-0002-6848-6874; Guevara Puig, Tibisay/0000-0002-1366-8507; Potempa, Jan/0000-0002-3600-7461	ESRF; European agency (Polish Ministry of Science and Higher Education) [137/7.PR-EU/2011/2]; United States agency (Polish Ministry of Science and Higher Education) [137/7.PR-EU/2011/2]; Polish agency (Polish Ministry of Science and Higher Education) [137/7.PR-EU/2011/2]; Spanish agency (Polish Ministry of Science and Higher Education) [137/7.PR-EU/2011/2]; Catalan agency (Polish Ministry of Science and Higher Education) [137/7.PR-EU/2011/2]; Foundation for Polish Science TEAM Project [DPS/424-329/10]; National Institutes of Health from the NIDCR [DE 09761, DE 022597]; Polish National Science Center [2011/01/B/NZ6/00268, 2012/04/A/NZ1/00051]; European Union [FP7-HEALTH-F3-2009-223101, FP7-PEOPLE-2011-ITN-290246, FP7-HEALTH-2010-261460]; Spanish Ministry of Economy and Competitivity [BIO2009-10334, BFU2012-32862, CSD2006-00015]; Fundacio "La Marato de TV3" Grant [2009-100732]; Catalan National Government AGAUR Grant [2009SGR1036]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022597, R01DE009761] Funding Source: NIH RePORTER	ESRF; European agency (Polish Ministry of Science and Higher Education); United States agency (Polish Ministry of Science and Higher Education); Polish agency (Polish Ministry of Science and Higher Education); Spanish agency (Polish Ministry of Science and Higher Education); Catalan agency (Polish Ministry of Science and Higher Education); Foundation for Polish Science TEAM Project; National Institutes of Health from the NIDCR; Polish National Science Center; European Union(European Commission); Spanish Ministry of Economy and Competitivity(Spanish Government); Fundacio "La Marato de TV3" Grant; Catalan National Government AGAUR Grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We are grateful to the Automated Crystallography Platform for assistance during crystallization experiments. We acknowledge the help provided by local contacts at the ESRF synchrotron. Funding for data collection was provided in part by the ESRF.; This study was supported in part by grants from European, United States, Polish, Spanish, and Catalan agencies (Polish Ministry of Science and Higher Education Project 137/7.PR-EU/2011/2 (to J. P.); Foundation for Polish Science TEAM Project DPS/424-329/10 (to J. P.); National Institutes of Health Grants DE 09761 and DE 022597 from the NIDCR (both to J. P.); Polish National Science Center Grants 2011/01/B/NZ6/00268 and 2012/04/A/NZ1/00051 (both to J. P.); European Union Grants FP7-HEALTH-F3-2009-223101 "AntiPathoGN" (to F. X. G.-R.), FP7-HEALTH-2010-261460 "Gums&Joints" ( to J. P. and F. X. G.-R.), and FP7-PEOPLE-2011-ITN-290246 "RAPID" (to J. P. and F. X. G.-R.); Spanish Ministry of Economy and Competitivity Grants BIO2009-10334, BFU2012-32862, and CSD2006-00015 (all to F. X. G.-R.); Fundacio "La Marato de TV3" Grant 2009-100732 (to F. X. G.-R.); and Catalan National Government AGAUR Grant 2009SGR1036 ( to F. X. G.-R.)).	Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryan PN, 2002, CHEM REV, V102, P4805, DOI 10.1021/cr010190b; Carranza C., 1999, AFMB ACTIVITY REPORT, P89; Chai JJ, 2001, CELL, V107, P399, DOI 10.1016/S0092-8674(01)00544-X; Chen JM, 1998, FEBS LETT, V441, P361, DOI 10.1016/S0014-5793(98)01574-9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Cygler M, 1996, STRUCTURE, V4, P405, DOI 10.1016/S0969-2126(96)00046-9; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Eichinger A, 1999, EMBO J, V18, P5453, DOI 10.1093/emboj/18.20.5453; Elliott JM, 2009, J BIOL CHEM, V284, P6546, DOI 10.1074/jbc.M806121200; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Filipek R, 2004, BIOCHEMISTRY-US, V43, P14306, DOI 10.1021/bi048661m; Forsyth CM, 2004, J BIOL CHEM, V279, P7001, DOI 10.1074/jbc.M312472200; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Groves MR, 1996, STRUCTURE, V4, P1193, DOI 10.1016/S0969-2126(96)00127-X; Guarne A, 2000, J MOL BIOL, V302, P1227, DOI 10.1006/jmbi.2000.4115; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Holm L., 2006, CURR PROTOC BIOINFOR, V14, P551; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOLZER H, 1980, ANNU REV BIOCHEM, V49, P63, DOI 10.1146/annurev.bi.49.070180.000431; JANIN J, 1990, J BIOL CHEM, V265, P16027; Kabsch W., 2001, INT TABLES CRYSTALLO, P730, DOI [10.1107/97809553602060000001, DOI 10.1107/97809553602060000001]; Kagawa TF, 2000, P NATL ACAD SCI USA, V97, P2235, DOI 10.1073/pnas.040549997; Kaulmann G, 2006, PROTEIN SCI, V15, P2619, DOI 10.1110/ps.062401806; Keller N, 2009, STRUCTURE, V17, P438, DOI 10.1016/j.str.2008.12.019; Khan AR, 1998, PROTEIN SCI, V7, P815; LaLonde JM, 1999, BIOCHEMISTRY-US, V38, P862, DOI 10.1021/bi9822271; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Mallorqui-Fernandez N, 2008, J BIOL CHEM, V283, P2871, DOI 10.1074/jbc.M708481200; Marrero A, 2012, ANGEW CHEM INT EDIT, V51, P3340, DOI 10.1002/anie.201108015; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mikolajczyk J, 2003, J BIOL CHEM, V278, P10458, DOI 10.1074/jbc.M210564200; Mittl PRE, 2006, CURR OPIN STRUC BIOL, V16, P769, DOI 10.1016/j.sbi.2006.10.014; O'Brien-Simpson NM, 2001, INFECT IMMUN, V69, P7527, DOI 10.1128/IAI.69.12.7527-7534.2001; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Petersen PE, 2005, J PERIODONTOL, V76, P2187, DOI 10.1902/jop.2005.76.12.2187; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PIKE R, 1994, J BIOL CHEM, V269, P406; Podobnik M, 1997, J MOL BIOL, V271, P774, DOI 10.1006/jmbi.1997.1218; Potempa J, 1997, BIOL CHEM, V378, P223, DOI 10.1515/bchm.1997.378.3-4.223; Potempa J, 2005, MOL MICROBIOL, V57, P605, DOI 10.1111/j.1365-2958.2005.04714.x; Puente XS, 1997, BIOCHEM J, V322, P947, DOI 10.1042/bj3220947; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Riedl SJ, 2001, P NATL ACAD SCI USA, V98, P14790, DOI 10.1073/pnas.221580098; Roy S, 2012, ACTA CRYSTALLOGR D, V68, P1591, DOI 10.1107/S0907444912038607; Sanchez JF, 2006, J BIOL CHEM, V281, P20171, DOI 10.1074/jbc.M603452200; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schifferle RE, 1996, J ENDODONT, V22, P352, DOI 10.1016/S0099-2399(96)80216-0; Sivaraman J, 1999, PROTEIN SCI, V8, P283; Sivaraman J, 2000, J MOL BIOL, V295, P939, DOI 10.1006/jmbi.1999.3410; Skottrup PD, 2011, ANAL BIOCHEM, V415, P158, DOI 10.1016/j.ab.2011.04.015; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Tang YQ, 2011, ADV EXP MED BIOL, V712, P15, DOI 10.1007/978-1-4419-8414-2_2; TAO K, 1994, ARCH BIOCHEM BIOPHYS, V311, P19, DOI 10.1006/abbi.1994.1203; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; van Winkelhoff AJ, 2002, J CLIN PERIODONTOL, V29, P1023, DOI 10.1034/j.1600-051X.2002.291107.x; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Walters J, 2009, BIOCHEM J, V424, P335, DOI 10.1042/BJ20090825; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wiederanders B, 2003, ACTA BIOCHIM POL, V50, P691; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Yan N, 2006, J BIOL CHEM, V281, P8667, DOI 10.1074/jbc.M513232200; Yang HW, 2004, J PERIODONTOL, V75, P1077, DOI 10.1902/jop.2004.75.8.1077; Yilmaz Ozlem, 2008, Microbiology (Reading), V154, P2897, DOI 10.1099/mic.0.2008/021220-0; Yu JW, 2009, P NATL ACAD SCI USA, V106, P8169, DOI 10.1073/pnas.0812453106	73	27	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14287	14296		10.1074/jbc.M112.444927	http://dx.doi.org/10.1074/jbc.M112.444927			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23558682	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000319253500033
J	Jin, ES; Sherry, AD; Malloy, CR				Jin, Eunsook S.; Sherry, A. Dean; Malloy, Craig R.			Metabolism of Glycerol, Glucose, and Lactate in the Citric Acid Cycle Prior to Incorporation into Hepatic Acylglycerols	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TISSUE; IN-VIVO; PHOSPHOENOLPYRUVATE CARBOXYKINASE; GLYCERONEOGENESIS; PYRUVATE; HUMANS; LIVER; RAT	During hepatic lipogenesis, the glycerol backbone of acylglycerols originates from one of three sources: glucose, glycerol, or substrates passing through the citric acid cycle via glyceroneogenesis. The relative contribution of each substrate source to glycerol in rat liver acylglycerols was determined using C-13-enriched substrates and NMR. Animals received a fixed mixture of glucose, glycerol, and lactate; one group received [U-C-13(6)]glucose, another received [U-C-13(3)]glycerol, and the third received [U-C-13(3)]lactate. After 3 h, the livers were harvested to extract fats, and the glycerol moiety from hydrolyzed acylglycerols was analyzed by C-13 NMR. In either fed or fasted animals, glucose and glycerol provided the majority of the glycerol backbone carbons, whereas the contribution of lactate was small. In fed animals, glucose contributed > 50% of the total newly synthesized glycerol backbone, and 35% of this contribution occurred after glucose had passed through the citric acid cycle. By comparison, the glycerol contribution was similar to 40%, and of this, 17% of the exogenous glycerol passed first through the cycle. In fasted animals, exogenous glycerol became the major contributor to acylglycerols. The contribution from exogenous lactate did increase in fasted animals, but its overall contribution remained small. The contributions of glucose and glycerol that had passed through the citric acid cycle first increased in fasted animals from 35 to 71% for glucose and from 17 to 24% for glycerol. Thus, a substantial fraction from both substrate sources passed through the cycle prior to incorporation into the glycerol moiety of acylglycerols in the liver.	[Jin, Eunsook S.; Sherry, A. Dean; Malloy, Craig R.] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Jin, Eunsook S.; Malloy, Craig R.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Sherry, A. Dean; Malloy, Craig R.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Sherry, A. Dean] Univ Texas Dallas, Dept Chem, Richardson, TX 75080 USA; [Malloy, Craig R.] Vet Affairs North Texas Hlth Care Syst, Dallas, TX 75216 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Jin, ES (corresponding author), Adv Imaging Res Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eunsook.jin@utsouthwestern.edu	Sherry, Dean/P-2348-2018	Sherry, Dean/0000-0001-7150-8301; Malloy, Craig/0000-0001-5077-0642	National Institutes of Health [K01 DK078933, RR002584, EB015908, HL34557]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002584] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL034557, R01HL034557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398, K01DK078933] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K01 DK078933 (to E. S. J.), RR002584 and EB015908 (to C. R. M.), and HL34557 (to A. D. S.).	BALLARD FJ, 1967, J BIOL CHEM, V242, P2746; BALLY PR, 1960, J BIOL CHEM, V235, P333; Botion LM, 1998, METABOLISM, V47, P1217, DOI 10.1016/S0026-0495(98)90326-2; Chen JL, 2005, J BIOL CHEM, V280, P25396, DOI 10.1074/jbc.M413948200; Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573; Jin ES, 2009, AM J PHYSIOL-ENDOC M, V296, pE748, DOI 10.1152/ajpendo.90935.2008; Kalhan SC, 2008, METABOLISM, V57, P305, DOI 10.1016/j.metabol.2007.10.003; Kalhan SC, 2001, J BIOL CHEM, V276, P12928, DOI 10.1074/jbc.M006186200; MARGOLIS S, 1962, J BIOL CHEM, V237, P44; Nye CK, 2008, J BIOL CHEM, V283, P27565, DOI 10.1074/jbc.M804393200; RESHEF L, 1969, J BIOL CHEM, V244, P1994; Turner SM, 2003, AM J PHYSIOL-ENDOC M, V285, pE790, DOI 10.1152/ajpendo.00402.2002	12	18	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14488	14496		10.1074/jbc.M113.461947	http://dx.doi.org/10.1074/jbc.M113.461947			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23572519	Green Published, hybrid			2022-12-28	WOS:000319253500051
J	Malloy, MT; McIntosh, DJ; Walters, TS; Flores, A; Goodwin, JS; Arinze, IJ				Malloy, Melanie Theodore; McIntosh, Deneshia J.; Walters, Treniqka S.; Flores, Andrea; Goodwin, J. Shawn; Arinze, Ifeanyi J.			Trafficking of the Transcription Factor Nrf2 to Promyelocytic Leukemia-Nuclear Bodies IMPLICATIONS FOR DEGRADATION OF NRF2 IN THE NUCLEUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE; ANTIOXIDANT RESPONSE; OXIDATIVE STRESS; COVALENT MODIFICATION; SENSOR KEAP1; PROTEIN PML; RAR-ALPHA; SUMO; ACTIVATION; RNF4	Ubiquitylation of Nrf2 by the Keap1-Cullin3/RING box1 (Cul3-Rbx1) E3 ubiquitin ligase complex targets Nrf2 for proteasomal degradation in the cytoplasm and is an extensively studied mechanism for regulating the cellular level of Nrf2. Although mechanistic details are lacking, reports abound that Nrf2 can also be degraded in the nucleus. Here, we demonstrate that Nrf2 is a target for sumoylation by both SUMO-1 and SUMO-2. HepG2 cells treated with As2O3, which enhances attachment of SUMO-2/3 to target proteins, increased SUMO-2/3-modification (polysumoylation) of Nrf2. We show that Nrf2 traffics, in part, to promyelocytic leukemia-nuclear bodies (PML-NBs). Cell fractions harboring key components of PML-NBs did not contain biologically active Keap1 but contained modified Nrf2 as well as RING finger protein 4 (RNF4), a poly-SUMO-specific E3 ubiquitin ligase. Overexpression of wild-type RNF4, but not the catalytically inactive mutant, decreased the steady-state levels of Nrf2, measured in the PML-NB-enriched cell fraction. The proteasome inhibitor MG-132 interfered with this decrease, resulting in elevated levels of polysumoylated Nrf2 that was also ubiquitylated. Wild-type RNF4 accelerated the half-life (t(1/2)) of Nrf2, measured in PML-NB-enriched cell fractions. These results suggest that RNF4 mediates polyubiquitylation of polysumoylated Nrf2, leading to its subsequent degradation in PML-NBs. Overall, this work identifies Nrf2 as a target for sumoylation and provides a novel mechanism for its degradation in the nucleus, independent of Keap1.	Meharry Med Coll, Sch Med, Dept Neurosci & Pharmacol, Nashville, TN 37208 USA; [Goodwin, J. Shawn] Meharry Med Coll, Sch Med, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Arinze, Ifeanyi J.] Meharry Med Coll, Sch Med, Dept Physiol, Nashville, TN 37208 USA	Meharry Medical College; Meharry Medical College; Meharry Medical College	Arinze, IJ (corresponding author), Meharry Med Coll, Sch Med, Dept Physiol, Nashville, TN 37208 USA.	iarinze@mmc.edu			National Institutes of Health [SC1CA143985, 5T32HL007737, 2S21MD000104, 5T32 GM07628, U01NS041071, U54CA91408, U54RR026140, S10RR0254970]; Clinical and Translational Science Award from the National Center for Advancing Translational Sciences [ULITR000445]; National Institutes of Health RISE Grant [5R25GM059994]; Medical Scientist Training Program Grant [T32GM07347]; NATIONAL CANCER INSTITUTE [U54CA163069, SC1CA143985, U54CA091408] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025497, U54RR026140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347, R25GM059994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041071] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Award from the National Center for Advancing Translational Sciences; National Institutes of Health RISE Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants SC1CA143985. This work was also supported by Clinical and Translational Science Award ULITR000445 from the National Center for Advancing Translational Sciences.; Supported by National Institutes of Health RISE Grant 5R25GM059994 (to the School of Graduate Studies and Research, Meharry Medical College) and by Medical Scientist Training Program Grant T32GM07347 (to Vanderbilt University Medical School).; Supported by National Institutes of Health Grants 5T32HL007737 and 2S21MD000104.; Supported by National Institutes of Health Grant 5T32 GM07628.; Supported by National Institutes of Health RISE Grant 5R25GM059994.; We thank Dr. Angela Chen (National Sun Yat-Sen University, Kaohsiung, Taiwan) for providing us with expression plasmids for RFP-SUMO-1 and -2 and mutants thereof, Dr. Edward T. H. Yeh (University of Texas M. D. Anderson Cancer Center, Houston, TX) for providing us with expression plasmid for SENP1, and Dr. Ronald T. Hay (University of Dundee, Dundee, Scotland, UK) for providing us with expression plasmid for RNF4 and for mutant RNF4. We thank Dr. Michael L. Freeman and Dr. Sekhar Konjeti (Vanderbilt University) for guiding us on the purification of GST and GST-Nrf2. We thank Dr. Jianqi Yang and Azza Gasmelseed for their support and encouragement during the performance of this work. Confocal microscopy images were generated at the Meharry Medical College Morphology Core Laboratory, which is supported in part by National Institutes of Health Grants U01NS041071, U54CA91408, U54RR026140, and S10RR0254970.	Akileswaran L, 2001, J BIOL CHEM, V276, P17448, DOI 10.1074/jbc.M101171200; Aono J, 2003, BIOCHEM BIOPH RES CO, V305, P271, DOI 10.1016/S0006-291X(03)00728-9; Apopa PL, 2008, J BIOCHEM MOL TOXIC, V22, P63, DOI 10.1002/jbt.20212; Arinze IJ, 2005, J BIOL CHEM, V280, P9786, DOI 10.1074/jbc.M414006200; Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Bailey D, 2005, BIOCHEM J, V392, P271, DOI 10.1042/BJ20050873; Barchowsky A, 1999, FREE RADICAL BIO MED, V27, P1405, DOI 10.1016/S0891-5849(99)00186-0; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Chalkiadaki A, 2005, MOL CELL BIOL, V25, P5095, DOI 10.1128/MCB.25.12.5095-5105.2005; Chen A, 2006, J CELL BIOCHEM, V98, P895, DOI 10.1002/jcb.20703; Chowdhry S., 2012, ONCOGENE IN PRESS; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; de la Vega L, 2011, BBA-MOL CELL RES, V1813, P283, DOI 10.1016/j.bbamcr.2010.11.022; Duprez E, 1999, J CELL SCI, V112, P381; Eskiw CH, 2003, J CELL SCI, V116, P4455, DOI 10.1242/jcs.00758; Fabunmi RP, 2001, J CELL SCI, V114, P29; Flora SJS, 1999, CLIN EXP PHARMACOL P, V26, P865, DOI 10.1046/j.1440-1681.1999.03157.x; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Geoffroy MC, 2010, MOL BIOL CELL, V21, P4227, DOI 10.1091/mbc.E10-05-0449; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Hakli M, 2005, EXP CELL RES, V304, P224, DOI 10.1016/j.yexcr.2004.10.029; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; HE DC, 1990, J CELL BIOL, V110, P569, DOI 10.1083/jcb.110.3.569; He XQ, 2006, J BIOL CHEM, V281, P23620, DOI 10.1074/jbc.M604120200; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Jain AK, 2006, J BIOL CHEM, V281, P12132, DOI 10.1074/jbc.M511198200; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Katoh Y, 2005, ARCH BIOCHEM BIOPHYS, V433, P342, DOI 10.1016/j.abb.2004.10.012; Kawai Y, 2011, J BIOL CHEM, V286, P7629, DOI 10.1074/jbc.M110.208173; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Konstantinopoulos PA, 2011, CANCER RES, V71, P5081, DOI 10.1158/0008-5472.CAN-10-4668; Kurki S, 2003, J CELL SCI, V116, P3917, DOI 10.1242/jcs.00714; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lallemand-Breitenbach V., 2010, COLD SPRING HARBOR P, V2010; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lau A, 2013, ANTIOXID REDOX SIGN, V18, P91, DOI 10.1089/ars.2012.4754; Liew CW, 2010, BIOCHEM J, V431, P23, DOI 10.1042/BJ20100957; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Martin SF, 2008, PROTEIN SCI, V17, P777, DOI 10.1110/ps.073369608; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Melchior Frauke, 2009, J Cell Biol, V187, P586, DOI 10.1083/jcb.1875pi; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Moller A, 2003, CANCER RES, V63, P4310; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Negorev D, 2001, ONCOGENE, V20, P7234, DOI 10.1038/sj.onc.1204764; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Niture SK, 2009, J BIOL CHEM, V284, P13856, DOI 10.1074/jbc.M808084200; Papaiahgari S, 2004, J BIOL CHEM, V279, P42302, DOI 10.1074/jbc.M408275200; Percherancier Y, 2009, J BIOL CHEM, V284, P16595, DOI 10.1074/jbc.M109.006387; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Pi JB, 2002, ENVIRON HEALTH PERSP, V110, P331, DOI 10.1289/ehp.02110331; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Rachakonda G, 2008, CHEM RES TOXICOL, V21, P705, DOI 10.1021/tx700302s; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Rinaldo C, 2008, BBA-MOL CELL RES, V1783, P2124, DOI 10.1016/j.bbamcr.2008.06.006; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sakurai T, 2006, CHEM RES TOXICOL, V19, P1196, DOI 10.1021/tx0601105; Sharma P, 2010, J CELL SCI, V123, P1227, DOI 10.1242/jcs.060160; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Spector David L, 2006, Cell, V127, P1071, DOI 10.1016/j.cell.2006.11.026; St-Germain JR, 2008, EPIGENETICS-US, V3, P342, DOI 10.4161/epi.3.6.7203; Stanek D, 2004, J CELL BIOL, V166, P1015, DOI 10.1083/jcb.200405160; Sternsdorf T, 1997, J CELL BIOL, V139, P1621, DOI 10.1083/jcb.139.7.1621; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Sun Z, 2007, MOL CELL BIOL, V27, P6334, DOI 10.1128/MCB.00630-07; Sun Z, 2011, MOL CELL BIOL, V31, P1800, DOI 10.1128/MCB.05036-11; Sun Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006588; Sun Z, 2009, MOL CELL BIOL, V29, P2658, DOI 10.1128/MCB.01639-08; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Theodore M, 2008, J BIOL CHEM, V283, P8984, DOI 10.1074/jbc.M709040200; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Vertegaal ACO, 2004, J BIOL CHEM, V279, P33791, DOI 10.1074/jbc.M404201200; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Weisshaar SR, 2008, FEBS LETT, V582, P3174, DOI 10.1016/j.febslet.2008.08.008; Wu MM, 2001, ENVIRON HEALTH PERSP, V109, P1011, DOI 10.2307/3454955; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Yoo NJ, 2012, HISTOPATHOLOGY, V60, P943, DOI 10.1111/j.1365-2559.2012.04178.x; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zhao R, 2009, CURR OPIN GENET DEV, V19, P172, DOI 10.1016/j.gde.2009.02.007; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752	96	54	58	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14569	14583		10.1074/jbc.M112.437392	http://dx.doi.org/10.1074/jbc.M112.437392			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23543742	hybrid, Green Published			2022-12-28	WOS:000319253500058
J	Peskin, AV; Dickerhof, N; Poynton, RA; Paton, LN; Pace, PE; Hampton, MB; Winterbourn, CC				Peskin, Alexander V.; Dickerhof, Nina; Poynton, Rebecca A.; Paton, Louise N.; Pace, Paul E.; Hampton, Mark B.; Winterbourn, Christine C.			Hyperoxidation of Peroxiredoxins 2 and 3 RATE CONSTANTS FOR THE REACTIONS OF THE SULFENIC ACID OF THE PEROXIDATIC CYSTEINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SERUM-ALBUMIN; HYDROGEN-PEROXIDE; SULFINIC ACID; INACTIVATION; MECHANISM; KINETICS; PEROXYNITRITE; REACTIVITY; SULFIREDOXIN; OXIDATION	Typical 2-Cys peroxiredoxins (Prxs) react rapidly with H2O2 to form a sulfenic acid, which then condenses with the resolving cysteine of the adjacent Prx in the homodimer or reacts with another H2O2 to become hyperoxidized. Hyperoxidation inactivates the Prx and is implicated in cell signaling. Prxs vary in susceptibility to hyperoxidation. We determined rate constants for disulfide formation and hyperoxidation for human recombinant Prx2 and Prx3 by analyzing the relative proportions of hyperoxidized and dimeric products using mass spectrometry as a function of H2O2 concentration (in the absence of reductive cycling) and in competition with catalase at a fixed concentration of H2O2. This gave a second order rate constant for hyperoxidation of 12,000 M-1 s(-1) and a rate constant for disulfide formation of 2 s(-1) for Prx2. A similar hyperoxidation rate constant for Prx3 was measured, but its rate of disulfide formation was similar to 10-fold higher, making it is more resistant than Prx2 to hyperoxidation. There are two active sites within the homodimer, and at low H2O2 concentrations one site was hyperoxidized and the other present as a disulfide. Prx with two hyperoxidized sites formed progressively at higher H2O2 concentrations. Although the sulfenic acid forms of Prx2 and Prx3 are similar to 1000-fold less reactive with H2O2 than their active site thiols, they react several orders of magnitude faster than most reduced thiol proteins. This observation has important implications for understanding the mechanism of peroxide sensing in cells.	Univ Otago, Ctr Free Rad Res, Christchurch 8140, New Zealand; Univ Otago, Gravida Natl Ctr Growth & Dev, Christchurch 8140, New Zealand	University of Otago; University of Otago	Peskin, AV (corresponding author), Univ Otago Christchurch, Dept Pathol, Ctr Free Rad Res, POB 4345, Christchurch 8140, New Zealand.	alexander.peskin@otago.ac.nz	Hampton, Mark B/A-8490-2008; Peskin, alexander/R-6457-2019; Pace, Paul E/A-3104-2012	Hampton, Mark B/0000-0002-7349-3729; Pace, Paul E/0000-0003-1855-5760; Dickerhof, Nina/0000-0003-2269-4595; peskin, alexander/0000-0001-9890-6043; Paton, Louise N/0000-0002-7055-5170	Marsden Fund; Health Research Council of New Zealand	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was supported by the Marsden Fund and the Health Research Council of New Zealand.	Ashby MT, 2006, J PHARM SCI-US, V95, P15, DOI 10.1002/jps.20521; Bae SH, 2011, HEPATOLOGY, V53, P945, DOI 10.1002/hep.24104; Carballal S, 2003, BIOCHEMISTRY-US, V42, P9906, DOI 10.1021/bi027434m; CHANCE B, 1949, J BIOL CHEM, V180, P947; Cox AG, 2009, BIOCHEMISTRY-US, V48, P6495, DOI 10.1021/bi900558g; Cox AG, 2009, BIOCHEM J, V421, P51, DOI 10.1042/BJ20090242; Hall A, 2010, J MOL BIOL, V402, P194, DOI 10.1016/j.jmb.2010.07.022; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Hugo M, 2009, BIOCHEMISTRY-US, V48, P9416, DOI 10.1021/bi901221s; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Jeong W, 2012, FREE RADICAL BIO MED, V53, P447, DOI 10.1016/j.freeradbiomed.2012.05.020; Kil IS, 2012, MOL CELL, V46, P584, DOI 10.1016/j.molcel.2012.05.030; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Nagy P, 2013, ANTIOXID REDOX SIGN, V18, P1623, DOI 10.1089/ars.2012.4973; Nagy P, 2011, J BIOL CHEM, V286, P18048, DOI 10.1074/jbc.M111.232355; Neumann CA, 2009, CELL CYCLE, V8, P4072, DOI 10.4161/cc.8.24.10242; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Peskin AV, 2010, BIOCHEM J, V432, P313, DOI 10.1042/BJ20101156; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; Roussel X, 2009, J BIOL CHEM, V284, P33048, DOI 10.1074/jbc.M109.035352; Selles B, 2012, BIOCHEM J, V442, P369, DOI 10.1042/BJ20111378; Sohn J, 2003, BIOCHEMISTRY-US, V42, P10060, DOI 10.1021/bi0345081; Turell L, 2008, BIOCHEMISTRY-US, V47, P358, DOI 10.1021/bi701520y; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	30	111	115	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14170	14177		10.1074/jbc.M113.460881	http://dx.doi.org/10.1074/jbc.M113.460881			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23543738	hybrid, Green Published			2022-12-28	WOS:000319253500021
J	Zhang, WJ; Zhou, Q; Xu, W; Cai, YX; Yin, ZN; Gao, XM; Xiong, SD				Zhang, Weijuan; Zhou, Qian; Xu, Wei; Cai, Yanxing; Yin, Zhinan; Gao, Xiaoming; Xiong, Sidong			DNA-dependent Activator of Interferon-regulatory Factors (DAI) Promotes Lupus Nephritis by Activating the Calcium Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC CELLS; CYTOSOLIC DNA; I INTERFERON; IMMUNE-RESPONSES; DISEASE-ACTIVITY; INNATE IMMUNITY; MURINE LUPUS; ERYTHEMATOSUS; INDUCTION; MICE	DNA-dependent activator of interferon-regulatory factors (DAI) functions as a cytoplasmic DNA sensor that activates the innate immune system. We previously found that activated lymphocyte-derived self-apoptotic DNA (ALD-DNA) immunization led to pathological macrophage activation and M2b polarization, which could initiate and propagate murine lupus nephritis. However, the specificDNAsensor(s) as well as underlying molecular mechanisms involved in ALD-DNA-induced macrophage M2b polarization in systemic lupus erythematosus (SLE) disease remains unknown. In this study, we reported that DAI expression was significantly increased in SLE patients as well as in lupus mice. Gain-and loss-of-function studies revealed that DAI was involved in ALD-DNA-induced macrophage activation and M2b polarization. Moreover, ALD-DNA notably induced dimerization/oligomerization of DAI and consequently activation of nuclear factor kappa B (NF-kappa B) and interferon regulatory factor 3 (IRF3) signaling pathways via calcium signaling, resulting in macrophage activation and M2b polarization. More importantly, blockade of DAI in vivo or selective knockdown of DAI in macrophages could ameliorate SLE syndrome via blunting macrophage M2b polarization and inhibiting inflammatory response in lupus mice. Our results suggest that DAI could function as a DNA sensor and a regulator in ALD-DNA-induced macrophage M2b polarization and lupus nephritis, providing the possible molecular mechanisms involved in ALD-DNA-induced macrophage M2b polarization in SLE disease and making DAI as a potential therapeutic target for the treatment of SLE.	[Zhang, Weijuan; Zhou, Qian; Cai, Yanxing; Xiong, Sidong] Fudan Univ, Shanghai Med Coll, Inst Immunobiol, Shanghai 200032, Peoples R China; [Zhang, Weijuan; Zhou, Qian; Cai, Yanxing; Xiong, Sidong] Fudan Univ, Shanghai Med Coll, Dept Immunol, Shanghai 200032, Peoples R China; [Xu, Wei; Gao, Xiaoming; Xiong, Sidong] Soochow Univ, Inst Biol Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Peoples R China; [Xu, Wei; Gao, Xiaoming; Xiong, Sidong] Soochow Univ, Inst Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou 215123, Peoples R China; [Yin, Zhinan] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Fudan University; Fudan University; Soochow University - China; Soochow University - China; Nankai University	Xiong, SD (corresponding author), Fudan Univ, Shanghai Med Coll, Inst Immunobiol, 138 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China.	sdxiongfd@126.com	Zhang, Weijuan/Q-1645-2019	Zhang, Weijuan/0000-0003-3494-3114	National Natural Science Foundation of China [30890141, 31100629, 31270863, 81273300]; Major State Basic Research Development Program of China [2013CB530501]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT1075]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Shanghai STC [10JC1401400]; Postdoctoral Science Foundation of China [2012T50397]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Shanghai STC; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This work was supported by grants of National Natural Science Foundation of China Grants 30890141, 31100629, 31270863, and 81273300, Major State Basic Research Development Program of China Grant 2013CB530501, Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT, IRT1075), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Shanghai STC Grant 10JC1401400, and Postdoctoral Science Foundation of China Grant 2012T50397.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Amarzguioui M, 2006, NAT PROTOC, V1, P508, DOI 10.1038/nprot.2006.72; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bethunaickan R, 2011, J IMMUNOL, V186, P4994, DOI 10.4049/jimmunol.1003010; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Chen M, 2011, MOL IMMUNOL, V48, P1532, DOI 10.1016/j.molimm.2011.04.016; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Chung EY, 2006, CELL RES, V16, P154, DOI 10.1038/sj.cr.7310021; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Csiszar A, 2000, CLIN EXP IMMUNOL, V122, P464, DOI 10.1046/j.1365-2249.2000.01369.x; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Finke D, 2007, EUR J IMMUNOL, V37, P1702, DOI 10.1002/eji.200636719; Goubau D, 2010, NAT IMMUNOL, V11, P984, DOI 10.1038/ni1110-984; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hagiwara E, 1996, ARTHRITIS RHEUM, V39, P379, DOI 10.1002/art.1780390305; Hill GS, 2001, KIDNEY INT, V59, P304, DOI 10.1046/j.1523-1755.2001.00492.x; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; HOUSSIAU FA, 1995, LUPUS, V4, P393, DOI 10.1177/096120339500400510; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Iwata Y, 2012, J IMMUNOL, V188, P4568, DOI 10.4049/jimmunol.1102154; Jiang ZY, 2011, J IMMUNOL, V186, P1173, DOI 10.4049/jimmunol.1002342; Kaiser WJ, 2008, J IMMUNOL, V181, P6427, DOI 10.4049/jimmunol.181.9.6427; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; Lippmann J, 2008, CELL MICROBIOL, V10, P2579, DOI 10.1111/j.1462-5822.2008.01232.x; Liu HO, 2011, CANCER RES, V71, P7547, DOI 10.1158/0008-5472.CAN-11-2260; Liu XG, 2008, BLOOD, V112, P4961, DOI 10.1182/blood-2008-03-144022; Lladser A, 2011, MOL THER, V19, P594, DOI 10.1038/mt.2010.268; LLORENTE L, 1995, J EXP MED, V181, P839, DOI 10.1084/jem.181.3.839; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Mevorach D, 1998, J EXP MED, V188, P387, DOI 10.1084/jem.188.2.387; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Papatriantafyllou M, 2011, NAT REV IMMUNOL, V11, P569, DOI 10.1038/nri3057; Park YB, 1998, CLIN EXP RHEUMATOL, V16, P283; Qiao B, 2005, RHEUMATOLOGY, V44, P1108, DOI 10.1093/rheumatology/keh656; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; RIEBER M, 1989, BIOCHEM BIOPH RES CO, V159, P1441, DOI 10.1016/0006-291X(89)92271-7; Roszer T, 2011, J IMMUNOL, V186, P621, DOI 10.4049/jimmunol.1002230; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schiffer L, 2008, J IMMUNOL, V180, P1938, DOI 10.4049/jimmunol.180.3.1938; Sean Eardley K, 2005, KIDNEY INT, V68, P437, DOI 10.1111/j.1523-1755.2005.00422.x; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sutterwala FS, 1997, J EXP MED, V185, P1977, DOI 10.1084/jem.185.11.1977; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tano JY, 2011, BIOCHEM BIOPH RES CO, V407, P432, DOI 10.1016/j.bbrc.2011.03.048; TERADA K, 1992, BIOCHEM BIOPH RES CO, V183, P797, DOI 10.1016/0006-291X(92)90553-W; Triantafyllopoulou A, 2010, P NATL ACAD SCI USA, V107, P3012, DOI 10.1073/pnas.0914902107; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vinuesa CG, 2002, NATURE, V416, P595, DOI 10.1038/416595a; Wada T, 1996, KIDNEY INT, V49, P761, DOI 10.1038/ki.1996.105; Walport MJ, 2000, NAT GENET, V25, P135, DOI 10.1038/75963; Wang L, 2008, NAT IMMUNOL, V9, P186, DOI 10.1038/ni1548; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Wen ZK, 2007, RHEUMATOLOGY, V46, P1796, DOI 10.1093/rheumatology/kem275; Xu JJ, 2012, GASTROENTEROLOGY, V143, P199, DOI 10.1053/j.gastro.2012.03.053; Xu JJ, 2010, HEPATOLOGY, V52, P142, DOI 10.1002/hep.23613; Yanai H, 2009, CURR OPIN IMMUNOL, V21, P17, DOI 10.1016/j.coi.2009.01.005; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Zhang WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022659; Zhang WJ, 2011, J IMMUNOL, V187, P1764, DOI 10.4049/jimmunol.1002315; Zhang WJ, 2010, J IMMUNOL, V184, P6465, DOI 10.4049/jimmunol.0904016; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	71	39	39	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13534	13550		10.1074/jbc.M113.457218	http://dx.doi.org/10.1074/jbc.M113.457218			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23553627	Green Published, hybrid			2022-12-28	WOS:000318850300037
J	Samanta, S; Pursell, B; Mercurio, AM				Samanta, Sanjoy; Pursell, Bryan; Mercurio, Arthur M.			IMP3 Protein Promotes Chemoresistance in Breast Cancer Cells by Regulating Breast Cancer Resistance Protein (ABCG2) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; GROWTH; PROLIFERATION; CHEMOTHERAPY; MITOXANTRONE	IMP3, a member of a family of insulin-like growth factor II (IGF-II) mRNA-binding proteins (IMPs), is expressed preferentially in triple-negative breast cancers, which are resistant to many chemotherapeutics. However, the mechanisms by which it impacts breast cancer have not been elucidated. We hypothesized a role for IMP3 in chemoresistance based on these observations. Depletion of IMP3 expression in triple-negative breast cancer cells increased their sensitivity to doxorubicin and mitoxantrone significantly but not to taxol. Given that doxorubicin and mitoxantrone are effluxed by breast cancer resistance protein (BCRP), we assessed whether IMP3 regulates BCRP. The data obtained demonstrate that IMP3 binds to BCRP mRNA and regulates BCRP expression. These findings are significant because they provide insight into the mechanism by which IMP3 contributes to aggressive cancers, and they highlight the potential for targeting this mRNA-binding protein for the clinical management of cancer.	[Samanta, Sanjoy; Pursell, Bryan; Mercurio, Arthur M.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Mercurio, AM (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, LRB-408,364 Plantat St, Worcester, MA 01605 USA.	arthur.mercurio@umassmed.edu			National Institutes of Health [CA168464]; NATIONAL CANCER INSTITUTE [R01CA168464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA168464.	Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Griffiths Carrie L, 2012, J Pharm Pract, V25, P319, DOI 10.1177/0897190012442062; Hazlehurst LA, 1999, CANCER RES, V59, P1021; Ibrahim NK, 2000, ANN ONCOL, V11, P1597, DOI 10.1023/A:1008315312795; Ikeda K, 2011, DIAGN CYTOPATHOL, V39, P395, DOI 10.1002/dc.21398; Janiszewska M, 2012, GENE DEV, V26, P1926, DOI 10.1101/gad.188292.112; Jiang Z, 2006, LANCET ONCOL, V7, P556, DOI 10.1016/S1470-2045(06)70732-X; Liao BS, 2005, J BIOL CHEM, V280, P18517, DOI 10.1074/jbc.M500270200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mueller-Pillasch F, 1999, MECH DEVELOP, V88, P95, DOI 10.1016/S0925-4773(99)00160-4; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Petit T, 2003, ANN SURG ONCOL, V10, P369, DOI 10.1245/ASO.2003.07.015; Robey RW, 2003, BRIT J CANCER, V89, P1971, DOI 10.1038/sj.bjc.6601370; ROWINSKY EK, 1992, SEMIN ONCOL, V19, P646; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Walter O, 2009, HUM PATHOL, V40, P1528, DOI 10.1016/j.humpath.2009.05.005	17	47	49	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12569	12573		10.1074/jbc.C112.442319	http://dx.doi.org/10.1074/jbc.C112.442319			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23539627	Green Published, hybrid			2022-12-28	WOS:000318555100015
J	Nishii, K; Nakaseko, C; Jiang, MZ; Shimizu, N; Takeuchi, M; Schneider, WJ; Bujo, H				Nishii, Keigo; Nakaseko, Chiaki; Jiang, Meizi; Shimizu, Naomi; Takeuchi, Masahiro; Schneider, Wolfgang J.; Bujo, Hideaki			The Soluble Form of LR11 Protein Is a Regulator of Hypoxia-induced, Urokinase-type Plasminogen Activator Receptor (uPAR)-mediated Adhesion of Immature Hematological Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; SMOOTH-MUSCLE-CELLS; SCID-REPOPULATING CELLS; INDUCIBLE FACTOR-I; BONE-MARROW NICHE; FAMILY-MEMBER; OSTEOBLASTIC NICHE; ALZHEIMER-DISEASE; EXPRESSION; MIGRATION	A key property of hematopoietic stem and progenitor cells (HSPCs) regarding differentiation from the self-renewing quiescent to the proliferating stage is their adhesion to the bone marrow (BM) niche. An important molecule involved in proliferation and pool size of HSPCs in the BM is the hypoxia-induced urokinase-type plasminogen activator receptor (uPAR). Here, we show that the soluble form (sLR11) of LR11 (also called SorLA or SORL1) modulates the uPAR-mediated attachment of HSPCs under hypoxic conditions. Immunohistochemical and mRNA expression analyses revealed that hypoxia increased LR11 expression in hematological c-Kit(+) Lin(-) cells. In U937 cells, hypoxia induced a transient rise in LR11 transcription, production of cellular protein, and release of sLR11. Attachment to stromal cells of c-Kit(+) Lin(-) cells of lr11(-/-) mice was reduced by hypoxia much more than of lr11(+/+) animals. sLR11 induced the adhesion of U937 and c-Kit(+) Lin(-) cells to stromal cells. Cell attachment was increased by sLR11 and reduced in the presence of anti-uPAR antibodies. Furthermore, the fraction of uPAR co-immunoprecipitated with LR11 in membrane extracts of U937 cells was increased by hypoxia. CoCl2, a chemical inducer of HIF-1 alpha, enhanced the levels of LR11 and sLR11 in U937 cells. The decrease in hypoxia-induced attachment of HIF-1 alpha-knockdown cells was largely prevented by exogenously added sLR11. Finally, hypoxia induced HIF-1 alpha binding to a consensus binding site in the LR11 promoter. Thus, we conclude that sLR11 regulates the hypoxia-enhanced adhesion of HSPCs via an uPAR-mediated pathway that stabilizes the hematological pool size by controlling cell attachment to the BM niche.	[Nishii, Keigo; Jiang, Meizi; Bujo, Hideaki] Chiba Univ, Grad Sch Med, Dept Genome Res & Clin Applicat, Chiba 2608670, Japan; [Nakaseko, Chiaki; Shimizu, Naomi; Takeuchi, Masahiro] Chiba Univ Hosp, Dept Hematol, Chiba 2608670, Japan; [Shimizu, Naomi] Chiba Univ Hosp, Div Transfus Med & Cell Therapy, Chiba 2608670, Japan; [Schneider, Wolfgang J.] Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, A-1090 Vienna, Austria	Chiba University; Chiba University; Chiba University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Bujo, H (corresponding author), Chiba Univ, Grad Sch Med, Dept Genome Res & Clin Applicat, 1-8-1 Inohana, Chiba 2608670, Japan.	hbujo@faculty.chiba-u.jp		Takeuchi, Masahiro/0000-0003-2516-2199	Health and Labor Sciences Research Grants for Translational Research, Japan; Japanese Ministry of Education, Culture, Sports, Science, and Technology; Austrian Science Fund; Grants-in-Aid for Scientific Research [23591368, 24790907] Funding Source: KAKEN	Health and Labor Sciences Research Grants for Translational Research, Japan; Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Austrian Science Fund(Austrian Science Fund (FWF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Health and Labor Sciences Research Grants for Translational Research, Japan (to H. B.), and by grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (to H. B.).; Supported by grants from the Austrian Science Fund.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Bene MC, 2004, LEUKEMIA, V18, P394, DOI 10.1038/sj.leu.2403250; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Bradfute SB, 2005, EXP HEMATOL, V33, P836, DOI 10.1016/j.exphem.2005.04.001; Bujo H, 2006, ARTERIOSCL THROM VAS, V26, P1246, DOI 10.1161/01.ATV.0000219692.78477.17; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chow DC, 2001, BIOPHYS J, V81, P685, DOI 10.1016/S0006-3495(01)75733-5; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Driessen RL, 2003, EXP HEMATOL, V31, P1284, DOI 10.1016/j.exphem.2003.08.015; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Harrison JS, 2002, BLOOD, V99, P394, DOI 10.1182/blood.V99.1.394; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hermey G, 2006, BIOCHEM J, V395, P285, DOI 10.1042/BJ20051364; Hermitte F, 2006, STEM CELLS, V24, P65, DOI 10.1634/stemcells.2004-0351; Ikeuchi T, 2010, DEMENT GERIATR COGN, V30, P28, DOI 10.1159/000315539; Ivanovic Z, 2004, STEM CELLS, V22, P716, DOI 10.1634/stemcells.22-5-716; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Jiang M, 2008, J CLIN INVEST, V118, P2733, DOI 10.1172/JCI32381; Katayama K, 2004, FEBS LETT, V560, P178, DOI 10.1016/S0014-5793(04)00100-0; Kirito K, 2005, BLOOD, V105, P4258, DOI 10.1182/blood-2004-07-2712; Kong TQ, 2004, P NATL ACAD SCI USA, V101, P10440, DOI 10.1073/pnas.0401339101; Krishnamachary B, 2003, CANCER RES, V63, P1138; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Levesque JP, 2010, LEUKEMIA, V24, P1979, DOI 10.1038/leu.2010.214; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Matsuo M, 2009, CLIN CHEM, V55, P1801, DOI 10.1373/clinchem.2009.127027; Ohwaki K, 2007, ARTERIOSCL THROM VAS, V27, P1050, DOI 10.1161/ATVBAHA.106.137091; Papayannopoulou T, 1998, BLOOD, V91, P2231, DOI 10.1182/blood.V91.7.2231.2231_2231_2239; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Pedersen M, 2008, BIOCHEM BIOPH RES CO, V377, P98, DOI 10.1016/j.bbrc.2008.09.102; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Sakai S, 2012, CLIN CHIM ACTA, V413, P1542, DOI 10.1016/j.cca.2012.06.025; Shima H, 2010, EXP HEMATOL, V38, P1231, DOI 10.1016/j.exphem.2010.08.004; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Suzuki A, 1996, BLOOD, V87, P3550, DOI 10.1182/blood.V87.9.3550.bloodjournal8793550; Taira K, 2001, ARTERIOSCL THROM VAS, V21, P1501, DOI 10.1161/hq0901.094500; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tjwa M, 2009, J CLIN INVEST, V119, P1008, DOI 10.1172/JCI36010; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Willnow TE, 2008, NAT REV NEUROSCI, V9, P899, DOI 10.1038/nrn2516; Winning S, 2010, J IMMUNOL, V185, P1786, DOI 10.4049/jimmunol.0903244; Yamazaki H, 1996, J BIOL CHEM, V271, P24761, DOI 10.1074/jbc.271.40.24761; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang XM, 2000, EXP HEMATOL, V28, P1286, DOI 10.1016/S0301-472X(00)00539-7; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815; Zhu YJ, 2004, CIRC RES, V94, P752, DOI 10.1161/01.RES.0000120862.79154.0F; Zhu YJ, 2002, CIRCULATION, V105, P1830, DOI 10.1161/01.CIR.0000014413.91312.EF	54	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11877	11886		10.1074/jbc.M112.442491	http://dx.doi.org/10.1074/jbc.M112.442491			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486467	Green Published, hybrid			2022-12-28	WOS:000318157600023
J	Li, SH; Yang, ZH; Hu, J; Gordon, WC; Bazan, NG; Haas, AL; Bok, D; Jin, MH				Li, Songhua; Yang, Zhihui; Hu, Jane; Gordon, William C.; Bazan, Nicolas G.; Haas, Arthur L.; Bok, Dean; Jin, Minghao			Secretory Defect and Cytotoxicity THE POTENTIAL DISEASE MECHANISMS FOR THE RETINITIS PIGMENTOSA (RP)-ASSOCIATED INTERPHOTORECEPTOR RETINOID-BINDING PROTEIN (IRBP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-BINDING PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; PHYSIOLOGICALLY RELEVANT CARRIER; CARBONIC-ANHYDRASE-IV; DISULFIDE-ISOMERASE; ENDOPLASMIC-RETICULUM; ER-STRESS; GENE-EXPRESSION; MESSENGER-RNA; VISUAL CYCLE	Interphotoreceptor retinoid-binding protein (IRBP) secreted by photoreceptors plays a pivotal role in photoreceptor survival and function. Recently, a D1080N mutation in IRBP was found in patients with retinitis pigmentosa, a frequent cause of retinal degeneration. The molecular and cellular bases for pathogenicity of the mutation are unknown. Here, we show that the mutation abolishes secretion of IRBP and results in formation of insoluble high molecular weight complexes via disulfide bonds. Co-expression of protein disulfide isomerase A2 that regulates disulfide bond formation or introduction of double Cys-to-Ala substitutions at positions 304 and 1175 in D1080N IRBP promoted secretion of the mutated IRBP. D1080N IRBP was not transported to the Golgi apparatus, but accumulated in the endoplasmic reticulum (ER), bound with the ER-resident chaperone proteins such as BiP, protein disulfide isomerase, and heat shock proteins. Splicing of X-box-binding protein-1 mRNA, expression of activating transcription factor 4 (ATF4), and cleavage of ATF6 were significantly increased in cells expressing D1080N IRBP. Moreover, D1080N IRBP induced up-regulation and nuclear translocation of the C/EBP homologous protein, a proapoptotic transcription factor associated with the unfolded protein response. These results indicate that loss of normal function (nonsecretion) and gain of cytotoxic function (ER stress) are involved in the disease mechanisms of D1080N IRBP. Chemical chaperones and low temperature, which help proper folding of many mutated proteins, significantly rescued secretion of D1080N IRBP, suggesting that misfolding is the molecular basis for pathogenicity of D1080N substitution and that chemical chaperones are therapeutic candidates for the mutation-caused blinding disease.	[Li, Songhua; Yang, Zhihui; Gordon, William C.; Bazan, Nicolas G.; Jin, Minghao] Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA; [Li, Songhua; Yang, Zhihui; Gordon, William C.; Bazan, Nicolas G.; Jin, Minghao] Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA; [Haas, Arthur L.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Hu, Jane; Bok, Dean] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Hu, Jane; Bok, Dean] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Jin, MH (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA.	mjin@lsuhsc.edu	Bazan, Nicolas/AAN-4121-2020	Bazan, Nicolas/0000-0002-9243-5444	National Institutes of Health [R01 EY021208]; NATIONAL EYE INSTITUTE [R01EY021208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 EY021208 (to M. J.).	Bonapace G, 2004, P NATL ACAD SCI USA, V101, P12300, DOI 10.1073/pnas.0404764101; BORST DE, 1989, J BIOL CHEM, V264, P1115; BRIDGES CDB, 1984, VISION RES, V24, P1581, DOI 10.1016/0042-6989(84)90316-X; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Byerley LO, 2010, AGE, V32, P497, DOI 10.1007/s11357-010-9146-8; CARLSON A, 1992, BIOCHEMISTRY-US, V31, P9056, DOI 10.1021/bi00152a049; CARLSON SG, 1993, MOL CELL BIOL, V13, P4736, DOI 10.1128/MCB.13.8.4736; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; CROUCH RK, 1992, PHOTOCHEM PHOTOBIOL, V56, P251, DOI 10.1111/j.1751-1097.1992.tb02154.x; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; Datta R, 2009, P NATL ACAD SCI USA, V106, P3437, DOI 10.1073/pnas.0813178106; den Hollander AI, 2009, INVEST OPHTH VIS SCI, V50, P1864, DOI 10.1167/iovs.08-2497; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Duricka DL, 2012, BIOCHEM J, V441, P685, DOI 10.1042/BJ20111004; EISENFELD AJ, 1985, INVEST OPHTH VIS SCI, V26, P775; FONG SL, 1988, J BIOL CHEM, V263, P15330; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; Giodini A, 2008, EMBO J, V27, P201, DOI 10.1038/sj.emboj.7601941; GONZALEZFERNANDEZ F, 1984, J CELL BIOL, V99, P2092, DOI 10.1083/jcb.99.6.2092; GONZALEZFERNANDEZ F, 1990, J CELL BIOL, V111, P2775, DOI 10.1083/jcb.111.6.2775; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Haeri Mohammad, 2012, J Ophthalmic Vis Res, V7, P45; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Jin MH, 2007, J BIOL CHEM, V282, P20915, DOI 10.1074/jbc.M701432200; Jin MH, 2009, J NEUROSCI, V29, P1486, DOI 10.1523/JNEUROSCI.3882-08.2009; Langton KP, 2005, HUM MOL GENET, V14, P3579, DOI 10.1093/hmg/ddi385; Lin JH, 2010, ADV EXP MED BIOL, V664, P115, DOI 10.1007/978-1-4419-1399-9_14; LIOU GI, 1994, DEV BIOL, V161, P345, DOI 10.1006/dbio.1994.1036; LIOU GI, 1982, VISION RES, V22, P1457, DOI 10.1016/0042-6989(82)90210-3; Liou GI, 1998, J NEUROSCI, V18, P4511; Liu X, 1996, P NATL ACAD SCI USA, V93, P4554, DOI 10.1073/pnas.93.10.4554; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; Marmorstein LHY, 2002, P NATL ACAD SCI USA, V99, P13067, DOI 10.1073/pnas.202491599; Parker R, 2011, J NEUROSCI, V31, P4714, DOI 10.1523/JNEUROSCI.3722-10.2011; Parker RO, 2009, J NEUROSCI, V29, P4616, DOI 10.1523/JNEUROSCI.0063-09.2009; Primm TP, 1996, J BIOL CHEM, V271, P33664, DOI 10.1074/jbc.271.52.33664; Qtaishat NM, 2005, EXP EYE RES, V81, P455, DOI 10.1016/j.exer.2005.03.005; Ripps H, 2000, VISUAL NEUROSCI, V17, P97, DOI 10.1017/S095252380017110X; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Sideraki V, 2000, BIOCHEMISTRY-US, V39, P1180, DOI 10.1021/bi992246q; Surgucheva I, 2005, CELL MOL NEUROBIOL, V25, P1051, DOI 10.1007/s10571-005-8474-1; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; VANVEEN T, 1986, FEBS LETT, V208, P133, DOI 10.1016/0014-5793(86)81547-2; VANVEEN T, 1988, EXP EYE RES, V47, P291, DOI 10.1016/0014-4835(88)90012-7; Walker AK, 2010, BRAIN, V133, P105, DOI 10.1093/brain/awp267; Wisard J, 2011, INVEST OPHTH VIS SCI, V52, P5804, DOI 10.1167/iovs.10-7129; Wiszniewski W, 2005, HUM MOL GENET, V14, P2769, DOI 10.1093/hmg/ddi310; Wu QQ, 2007, BIOCHEMISTRY-US, V46, P8669, DOI 10.1021/bi7004619; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303; Zhao TJ, 2005, J BIOL CHEM, V280, P13470, DOI 10.1074/jbc.M413882200; Zhou ZH, 1999, HUM MOL GENET, V8, P2221, DOI 10.1093/hmg/8.12.2221; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	57	26	28	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11395	11406		10.1074/jbc.M112.418251	http://dx.doi.org/10.1074/jbc.M112.418251			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23486466	hybrid, Green Published			2022-12-28	WOS:000317915500042
J	Ehteshami, M; Nijhuis, M; Bernatchez, JA; Ablenas, CJ; McCormick, S; de Jong, D; Jochmans, D; Gotte, M				Ehteshami, Maryam; Nijhuis, Monique; Bernatchez, Jean A.; Ablenas, Christopher J.; McCormick, Suzanne; de Jong, Dorien; Jochmans, Dirk; Goette, Matthias			Formation of a Quaternary Complex of HIV-1 Reverse Transcriptase with a Nucleotide-competing Inhibitor and Its ATP Enhancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DEPENDENT PRIMER UNBLOCKING; DRUG-RESISTANCE; POLYMERASE TRANSLOCATION; DNA-POLYMERASE; ZIDOVUDINE RESISTANCE; MOLECULAR-MECHANISMS; ANALOG INHIBITORS; RATCHET MODEL; MUTATIONS	Nucleotide-competing reverse transcriptase inhibitors were shown to bind reversibly to the nucleotide-binding site of the reverse transcriptase (RT) enzyme of human immunodeficiency virus type 1 (HIV-1). Here, we show that the presence of ATP can enhance the inhibitory effects of the prototype compound INDOPY-1. We employed a combination of cell-free and cell-based assays to shed light on the underlying molecular mechanism. Binding studies and site-specific footprinting experiments demonstrate the existence of a stable quaternary complex with HIV-1 RT, its nucleic acid substrate, INDOPY-1, and ATP. The complex is frozen in the post-translocational state that usually accommodates the incoming nucleotide substrate. Structure-activity relationship studies show that both the base and the phosphate moieties of ATP are elements that play important roles in enhancing the inhibitory effects of INDOPY-1. In vitro susceptibility measurements with mutant viruses containing amino acid substitutions K70G, V75T, L228R, and K219R in the putative ATP binding pocket revealed unexpectedly a hypersusceptible phenotype with respect to INDOPY-1. The same mutational cluster was previously shown to reduce susceptibility to the pyrophosphate analog phosphonoformic acid. However, in the absence of INDOPY-1, ATP can bind and act as a pyrophosphate donor under conditions that favor formation of the pre-translocated RT complex. We therefore conclude that the mutant enzyme facilitates simultaneous binding of INDOPY-1 and ATP to the post-translocated complex. Based on these data, we propose a model in which the bound ATP traps the inhibitor, which, in turn, compromises its dissociation.	[Ehteshami, Maryam; McCormick, Suzanne; Goette, Matthias] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Bernatchez, Jean A.; Ablenas, Christopher J.; Goette, Matthias] McGill Univ, Dept Biochem, Montreal, PQ H3A 2B4, Canada; [Goette, Matthias] McGill Univ, Dept Med, Montreal, PQ H3A 2B4, Canada; [Nijhuis, Monique; de Jong, Dorien] Univ Med Ctr Utrecht, Dept Med Microbiol, NL-3584 CX Utrecht, Netherlands; [Jochmans, Dirk] Univ Louvain, Rega Inst Med Res, B-3000 Louvain, Belgium	McGill University; McGill University; McGill University; Utrecht University; Utrecht University Medical Center; KU Leuven	Gotte, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg D-6,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	matthias.gotte@mcgill.ca	JOCHMANS, DIRK/T-6223-2017	JOCHMANS, DIRK/0000-0002-9265-6028; Bernatchez, Jean/0000-0002-8309-1627	Canadian Institutes of Health Research, Tibotec; Netherlands Organisation for Scientific Research VIDI [91796349]; Canadian Institutes of Health Research doctoral research award; Fonds de la Recherche en Sante du Quebec; Canadian Institutes of Health Research Strategic Training Initiative in Chemical Biology	Canadian Institutes of Health Research, Tibotec(Canadian Institutes of Health Research (CIHR)); Netherlands Organisation for Scientific Research VIDI(Netherlands Organization for Scientific Research (NWO)); Canadian Institutes of Health Research doctoral research award(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research Strategic Training Initiative in Chemical Biology(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Canadian Institutes of Health Research, Tibotec, and Netherlands Organisation for Scientific Research VIDI Grant 91796349.; Recipient of a Canadian Institutes of Health Research doctoral research award. Present address: Dept. of Pediatrics, Emory University/Veterans Affairs Medical Hospital, Decatur, GA 30033.; Recipient of a doctoral training award from the Fonds de la Recherche en Sante du Quebec and supported by the Canadian Institutes of Health Research Strategic Training Initiative in Chemical Biology.; Recipient of a career award from the Fonds de la Recherche en Sante du Quebec. To whom correspondence should be addressed: McGill University, Dept. of Microbiology and Immunology, Duff Medical Bldg. (D-6), 3775 University St., Montreal, Quebec H3A 2B4, Canada. Tel.: 514-398-1365; Fax: 514-398-7052; E-mail: matthias.gotte@mcgill.ca.	ARTS EJ, 1994, J BIOL CHEM, V269, P14672; Auger A, 2011, J BIOL CHEM, V286, P29575, DOI 10.1074/jbc.M111.268235; Basavapathruni A, 2007, FASEB J, V21, P3795, DOI 10.1096/fj.07-8697rev; Boucher CAB, 1996, ANTIMICROB AGENTS CH, V40, P2404, DOI 10.1128/AAC.40.10.2404; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; Bradshaw D, 2007, ANTIMICROB AGENTS CH, V51, P4489, DOI 10.1128/AAC.00687-07; Cases-Gonzalez CE, 2000, J BIOL CHEM, V275, P19759, DOI 10.1074/jbc.M910361199; Cauchon E, 2011, J BIOMOL SCREEN, V16, P518, DOI 10.1177/1087057111402201; Ehteshami M, 2008, J BIOL CHEM, V283, P29904, DOI 10.1074/jbc.M804882200; Ehteshami M, 2008, AIDS REV, V10, P224; Feng JY, 1999, BIOCHEMISTRY-US, V38, P9440, DOI 10.1021/bi990709m; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; Gotte M, 2006, CURR PHARM DESIGN, V12, P1867, DOI 10.2174/138161206776873626; Goldschmidt V, 2004, INT J BIOCHEM CELL B, V36, P1687, DOI 10.1016/j.biocel.2004.02.028; Gotte M, 1999, J BIOL CHEM, V274, P11159, DOI 10.1074/jbc.274.16.11159; Gotte Matthias, 2004, Expert Rev Anti Infect Ther, V2, P707, DOI 10.1586/14789072.2.5.707; Hammond JL, 2001, ANTIMICROB AGENTS CH, V45, P1621, DOI 10.1128/AAC.45.6.1621-1628.2001; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Jochmans D, 2008, VIRUS RES, V134, P171, DOI 10.1016/j.virusres.2008.01.003; Jochmans D, 2006, J VIROL, V80, P12283, DOI 10.1128/JVI.00889-06; Kisic M, 2011, J BIOL CHEM, V286, P20615, DOI 10.1074/jbc.M111.226100; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Marchand B, 2004, INT J BIOCHEM CELL B, V36, P1823, DOI 10.1016/j.biocel.2004.02.029; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, ANTIMICROB AGENTS CH, V51, P2911, DOI 10.1128/AAC.00314-07; Marchand B, 2007, J BIOL CHEM, V282, P3337, DOI 10.1074/jbc.M607710200; Mathiesen S, 2007, ANTIVIR THER, V12, P335; MELLORS JW, 1995, ANTIMICROB AGENTS CH, V39, P1087, DOI 10.1128/AAC.39.5.1087; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Meyer PR, 2003, J VIROL, V77, P3871, DOI 10.1128/JVI.77.6.3871-3877.2003; Meyer PR, 2002, ANTIMICROB AGENTS CH, V46, P1540, DOI 10.1128/AAC.46.5.1540-1545.2002; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Ray AS, 2003, BIOCHEMISTRY-US, V42, P8831, DOI 10.1021/bi034435l; Sarafianos SG, 1999, CHEM BIOL, V6, pR137, DOI 10.1016/S1074-5521(99)80071-4; Sarafianos SG, 2003, J BIOL CHEM, V278, P16280, DOI 10.1074/jbc.M212911200; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Scarth B, 2011, J MOL BIOL, V405, P349, DOI 10.1016/j.jmb.2010.10.009; Sluis-Cremer N, 2008, VIRUS RES, V134, P147, DOI 10.1016/j.virusres.2008.01.002; Smith AJ, 2005, ANTIMICROB AGENTS CH, V49, P1761, DOI 10.1128/AAC.49.5.1761-1769.2005; TACHEDJIAN G, 1995, VIROLOGY, V212, P58, DOI 10.1006/viro.1995.1453; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; Tu XY, 2010, NAT STRUCT MOL BIOL, V17, P1202, DOI 10.1038/nsmb.1908; van Maarseveen NM, 2006, J VIROL METHODS, V133, P185, DOI 10.1016/j.jviromet.2005.11.008; Wainberg MA, 1996, AIDS, V10, pS3, DOI 10.1097/00002030-199612005-00002; Zahn KE, 2011, J BIOL CHEM, V286, P25246, DOI 10.1074/jbc.M111.248864; Zhang ZJ, 2006, ANTIMICROB AGENTS CH, V50, P2772, DOI 10.1128/AAC.00127-06	48	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17336	17346		10.1074/jbc.M112.433441	http://dx.doi.org/10.1074/jbc.M112.433441			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23598281	Green Published, hybrid			2022-12-28	WOS:000320380600027
J	Solomonson, M; Huesgen, PF; Wasney, GA; Watanabe, N; Gruninger, RJ; Prehna, G; Overall, CM; Strynadka, NCJ				Solomonson, Matthew; Huesgen, Pitter F.; Wasney, Gregory A.; Watanabe, Nobuhiko; Gruninger, Robert J.; Prehna, Gerd; Overall, Christopher M.; Strynadka, Natalie C. J.			Structure of the Mycosin-1 Protease from the Mycobacterial ESX-1 Protein Type VII Secretion System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBERCULOSIS; PE; PROLINE; PATHWAY; UNIQUE; PPE	Mycobacteria use specialized type VII (ESX) secretion systems to export proteins across their complex cell walls. Mycobacterium tuberculosis encodes five nonredundant ESX secretion systems, with ESX-1 being particularly important to disease progression. All ESX loci encode extracellular membrane-bound proteases called mycosins (MycP) that are essential to secretion and have been shown to be involved in processing of type VII-exported proteins. Here, we report the first x-ray crystallographic structure of MycP1(24-407) to 1.86 angstrom, defining a subtilisin-like fold with a unique N-terminal extension previously proposed to function as a propeptide for regulation of enzyme activity. The structure reveals that this N-terminal extension shows no structural similarity to previously characterized protease propeptides and instead wraps intimately around the catalytic domain where, tethered by a disulfide bond, it forms additional interactions with a unique extended loop that protrudes from the catalytic core. We also show MycP1 cleaves the ESX-1 secreted protein EspB from both M. tuberculosis and Mycobacterium smegmatis at a homologous cut site in vitro.	[Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	ncjs@mail.ubc.ca	Huesgen, Pitter/E-9246-2019	Huesgen, Pitter/0000-0002-0335-2242; Solomonson, Matthew/0000-0002-5344-9026; Prehna, Gerd/0000-0001-5539-7533	Canadian Institute of Health Research; Howard Hughes Medical Institute International Senior Scholar Program; University of British Columbia 4-year Ph.D. fellowship; Canadian Foundation of Innovation, the British Columbia Knowledge Development Fund	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute International Senior Scholar Program; University of British Columbia 4-year Ph.D. fellowship; Canadian Foundation of Innovation, the British Columbia Knowledge Development Fund	This work was supported in part by operating grants from the Canadian Institute of Health Research and the Howard Hughes Medical Institute International Senior Scholar Program.; Supported by a University of British Columbia 4-year Ph.D. fellowship.; We thank the staff at the Canadian Light Source beamline CMCF-1 for assistance with data collection, the Canadian Foundation of Innovation, the British Columbia Knowledge Development Fund for infrastructure funding, Marija Vuckovic for technical aid, and Julien Bergeron and Antonio Ruzzini for helpful discussion.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Brown GD, 2000, GENE, V254, P147, DOI 10.1016/S0378-1119(00)00277-8; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Converse SE, 2005, J BACTERIOL, V187, P1238, DOI 10.1128/JB.187.4.1238-1245.2005; Coros A, 2008, MOL MICROBIOL, V69, P794, DOI 10.1111/j.1365-2958.2008.06299.x; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Daleke MH, 2011, J BIOL CHEM, V286, P19024, DOI 10.1074/jbc.M110.204966; Dave JA, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-30; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Houben ENG, 2012, MOL MICROBIOL, V86, P472, DOI 10.1111/j.1365-2958.2012.08206.x; Khan AR, 1998, PROTEIN SCI, V7, P815; Larsson A. M., 2009, PROTEIN CRYSTALLIZAT, P137; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; McLaughlin B, 2007, PLOS PATHOG, V3, P1051, DOI 10.1371/journal.ppat.0030105; Millington KA, 2011, P NATL ACAD SCI USA, V108, P5730, DOI 10.1073/pnas.1015153108; Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SHINDE U, 1995, J MOL BIOL, V247, P390, DOI 10.1006/jmbi.1994.0147; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Vevodova J, 2010, STRUCTURE, V18, P744, DOI 10.1016/j.str.2010.03.008; Volkamer A, 2012, J CHEM INF MODEL, V52, P360, DOI 10.1021/ci200454v; Xu J, 2007, MOL MICROBIOL, V66, P787, DOI 10.1111/j.1365-2958.2007.05959.x; Zarrinpar A, 2000, NAT STRUCT BIOL, V7, P611, DOI 10.1038/77891	41	39	41	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17782	17790		10.1074/jbc.M113.462036	http://dx.doi.org/10.1074/jbc.M113.462036			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23620593	Green Published, hybrid			2022-12-28	WOS:000320380600067
J	Jha, KN; Coleman, AR; Wong, L; Salicioni, AM; Howcroft, E; Johnson, GR				Jha, Kula N.; Coleman, Alyssa R.; Wong, Lily; Salicioni, Ana M.; Howcroft, Elizabeth; Johnson, Gibbes R.			Heat Shock Protein 90 Functions to Stabilize and Activate the Testis-specific Serine/Threonine Kinases, a Family of Kinases Essential for Male Fertility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE MACHINERY; HSP90 FUNCTION; GERM-CELLS; IN-VIVO; DEGRADATION; MOUSE; GELDANAMYCIN; EXPRESSION; PROTEASOME; INHIBITOR	Spermiogenesis is characterized by a profound morphological differentiation of the haploid spermatid into spermatozoa. The testis-specific serine/ threonine kinases (TSSKs) comprise a family of post-meiotic kinases expressed in spermatids, are critical to spermiogenesis, and are required for male fertility in mammals. To explore the role of heat shock protein 90 (HSP90) in regulation of TSSKs, the stability and catalytic activity of epitope-tagged murine TSSKs were assessed in 293T and COS-7 cells. TSSK1, -2, -4, and -6 (small serine/threonine kinase) were all found to associate with HSP90, and pharmacological inhibition of HSP90 function using the highly specific drugs 17-AAG, SNX-5422, or NVP-AUY922 reduced TSSK protein levels in cells. The attenuation of HSP90 function abolished the catalytic activities of TSSK4 and -6 but did not significantly alter the specific activities of TSSK1 and -2. Inhibition of HSP90 resulted in increased TSSK ubiquitination and proteasomal degradation, indicating that HSP90 acts to control ubiquitin-mediated catabolism of the TSSKs. To study HSP90 and TSSKs in germ cells, a mouse primary spermatid culture model was developed and characterized. Using specific antibodies against murine TSSK2 and -6, it was demonstrated that HSP90 inhibition resulted in a marked decrease of the endogenous kinases in spermatids. Together, our findings demonstrate that HSP90 plays a broad and critical role in stabilization and activation of the TSSK family of protein kinases.	[Jha, Kula N.; Coleman, Alyssa R.; Wong, Lily; Howcroft, Elizabeth; Johnson, Gibbes R.] US FDA, Div Therapeut Prot, Ctr Drug Evaluat & Res, Bethesda, MD 20892 USA; [Salicioni, Ana M.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	US Food & Drug Administration (FDA); University of Massachusetts System; University of Massachusetts Amherst	Jha, KN (corresponding author), US FDA, Div Therapeut Prot, Ctr Drug Evaluat & Res, 29 Lincoln Dr,Bldg 29A,HFD 122, Bethesda, MD 20892 USA.	kula.jha@fda.hhs.gov; gibbes.johnson@fda.hhs.gov	Salicioni, Ana Maria/ABD-8384-2021	Salicioni, Ana Maria/0000-0002-8951-3587	A.R.C	A.R.C(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported in part by an appointment of A.R.C. to the ORISE Research Participation Program at the Center for Drug Evaluation and Research (CDER) administered by the Oak Ridge Institute for Science and Education through an agreement between the United States Department of Energy and CDER.	An WG, 2000, CELL GROWTH DIFFER, V11, P355; Baker MA, 2011, J PROTEOME RES, V10, P1004, DOI 10.1021/pr1007224; Baldo B, 2012, J BIOL CHEM, V287, P1406, DOI 10.1074/jbc.M111.294801; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; BLAGOSKLONNY MV, 1995, ONCOGENE, V11, P933; Bucko-Justyna M, 2005, FEBS J, V272, P6310, DOI 10.1111/j.1742-4658.2005.05018.x; Chandarlapaty S, 2008, CLIN CANCER RES, V14, P240, DOI 10.1158/1078-0432.CCR-07-1667; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Eddy EM, 1998, CURR TOP DEV BIOL, V37, P141; Ehrlich ES, 2009, P NATL ACAD SCI USA, V106, P20330, DOI 10.1073/pnas.0810571106; Escalier D, 2003, MOL REPROD DEV, V66, P190, DOI 10.1002/mrd.10346; Faresse N, 2010, AM J PHYSIOL-RENAL, V299, pF1462, DOI 10.1152/ajprenal.00285.2010; Grad I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015770; GRISWOLD MD, 1995, BIOL REPROD, V52, P211, DOI 10.1095/biolreprod52.2.211; Jha KN, 2010, J BIOL CHEM, V285, P35180, DOI 10.1074/jbc.M110.134767; KIERSZENBAUM AL, 1975, J CELL BIOL, V65, P258, DOI 10.1083/jcb.65.2.258; La Salle S, 2009, METHODS MOL BIOL, V558, P279, DOI 10.1007/978-1-60761-103-5_17; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Li YH, 2011, MOL HUM REPROD, V17, P42, DOI 10.1093/molehr/gaq071; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; Marubayashi S, 2010, J CLIN INVEST, V120, P3578, DOI 10.1172/JCI42442; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Ogurtsov AY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003599; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pedersen AG, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P226; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Rajan A, 2012, CLIN CANCER RES, V18, P2344, DOI 10.1158/1078-0432.CCR-11-2425; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Segnitz B, 1997, J BIOL CHEM, V272, P18694, DOI 10.1074/jbc.272.30.18694; Shang P, 2010, J CELL SCI, V123, P331, DOI 10.1242/jcs.059949; Sosnik J, 2009, J CELL SCI, V122, P2741, DOI 10.1242/jcs.047225; Spiridonov NA, 2005, MOL CELL BIOL, V25, P4250, DOI 10.1128/MCB.25.10.4250-4261.2005; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Tikhomirov O, 2000, J BIOL CHEM, V275, P26625, DOI 10.1074/jbc.M003114200; van de Kooij B, 2013, J BIOL CHEM, V288, P6617, DOI 10.1074/jbc.M112.448209; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; Xu BF, 2008, DEV BIOL, V319, P211, DOI 10.1016/j.ydbio.2008.03.047; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	46	27	27	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16308	16320		10.1074/jbc.M112.400978	http://dx.doi.org/10.1074/jbc.M112.400978			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23599433	Green Published, hybrid			2022-12-28	WOS:000320378900010
J	Poon, WW; Carlos, AJ; Aguilar, BL; Berchtold, NC; Kawano, CK; Zograbyan, V; Yaopruke, T; Shelanski, M; Cotman, CW				Poon, Wayne W.; Carlos, Anthony J.; Aguilar, Brittany L.; Berchtold, Nicole C.; Kawano, Crystal K.; Zograbyan, Vahe; Yaopruke, Tim; Shelanski, Michael; Cotman, Carl W.			beta-Amyloid (A beta) Oligomers Impair Brain-derived Neurotrophic Factor Retrograde Trafficking by Down-regulating Ubiquitin C-terminal Hydrolase, UCH-L1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; BDNF KNOCKOUT MICE; AXONAL-TRANSPORT; ALZHEIMERS-DISEASE; HIPPOCAMPAL-NEURONS; CORTICAL-NEURONS; TRANSGENIC MICE; DEGRADATION; EXPRESSION; PROTEASOME	We previously found that BDNF-dependent retrograde trafficking is impaired in AD transgenic mouse neurons. Utilizing a novel microfluidic culture chamber, we demonstrate that A beta oligomers compromise BDNF-mediated retrograde transport by impairing endosomal vesicle velocities, resulting in impaired downstream signaling driven by BDNF/TrkB, including ERK5 activation, and CREB-dependent gene regulation. Our data suggest that a key mechanism mediating the deficit involves ubiquitin C-terminal hydrolase L1 (UCH-L1), a deubiquitinating enzyme that functions to regulate cellular ubiquitin. A beta-induced deficits in BDNF trafficking and signaling are mimicked by LDN (an inhibitor of UCH-L1) and can be reversed by increasing cellular UCH-L1 levels, demonstrated here using a transducible TAT-UCH-L1 strategy. Finally, our data reveal that UCH-L1 mRNA levels are decreased in the hippocampi of AD brains. Taken together, our data implicate that UCH-L1 is important for regulating neurotrophin receptor sorting to signaling endosomes and supporting retrograde transport. Further, our results support the idea that in AD, A beta may downregulate UCH-L1 in the AD brain, which in turn impairs BDNF/TrkB-mediated retrograde signaling, compromising synaptic plasticity and neuronal survival.	[Poon, Wayne W.; Carlos, Anthony J.; Aguilar, Brittany L.; Berchtold, Nicole C.; Kawano, Crystal K.; Zograbyan, Vahe; Yaopruke, Tim; Cotman, Carl W.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92697 USA; [Shelanski, Michael] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Shelanski, Michael] Columbia Univ, Taub Inst, New York, NY 10032 USA	University of California System; University of California Irvine; Columbia University; Columbia University	Poon, WW (corresponding author), Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, 1259 Gillespie NRF, Irvine, CA 92697 USA.	wpoon@uci.edu		Aguilar, Brittany/0000-0002-9966-2834; Poon, Wayne/0000-0003-0625-3968	National Institutes of Health [AG016573, AG000538, AG00096]; NATIONAL INSTITUTE ON AGING [P01AG000538, P50AG016573, T32AG000096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG016573 and AG000538 (to C. W. C) and AG00096 (to A. J. C.).	Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; Alwan HAJ, 2003, J BIOL CHEM, V278, P35781, DOI 10.1074/jbc.M301326200; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Blurton-Jones M, 2004, J COMP NEUROL, V468, P347, DOI 10.1002/cne.10989; Cartier AE, 2009, J NEUROSCI, V29, P7857, DOI 10.1523/JNEUROSCI.1817-09.2009; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Causing CG, 1997, NEURON, V18, P257, DOI 10.1016/S0896-6273(00)80266-4; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cribbs DH, 1996, NEUROSCIENCE, V75, P173, DOI 10.1016/0306-4522(96)80001-P; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Devon RS, 2006, P NATL ACAD SCI USA, V103, P9595, DOI 10.1073/pnas.0510197103; ESCANDON E, 1994, J NEUROSCI, V14, P2054; Garzon DJ, 2007, J NEUROSCI, V27, P2628, DOI 10.1523/JNEUROSCI.5053-06.2007; Geetha T, 2008, TRAFFIC, V9, P1146, DOI 10.1111/j.1600-0854.2008.00751.x; Genoud C, 2004, J NEUROSCI, V24, P2394, DOI 10.1523/JNEUROSCI.4040-03.2004; Georgieva MV, 2011, J NEUROCHEM, V117, P479, DOI 10.1111/j.1471-4159.2011.07218.x; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Grimes ML, 1996, J NEUROSCI, V16, P7950; Guerreiro RJ, 2011, BIOCHEM SOC T, V39, P910, DOI 10.1042/BST0390910; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Heerssen HM, 2004, NAT NEUROSCI, V7, P596, DOI 10.1038/nn1242; Her LS, 2008, J NEUROSCI, V28, P13662, DOI 10.1523/JNEUROSCI.4144-08.2008; Hiruma H, 2003, J NEUROSCI, V23, P8967; Howe CL, 2004, J NEUROBIOL, V58, P207, DOI 10.1002/neu.10323; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Kim HJ, 2012, ACS CHEM NEUROSCI, V3, P433, DOI 10.1021/cn3000026; Kohara K, 2001, SCIENCE, V291, P2419, DOI 10.1126/science.1057415; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Lee S, 2011, J NEUROSCI, V31, P7817, DOI 10.1523/JNEUROSCI.6412-10.2011; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Martinez A, 1998, J NEUROSCI, V18, P7336; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; Moises T, 2009, BIOCHEM BIOPH RES CO, V387, P360, DOI 10.1016/j.bbrc.2009.07.032; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Park YY, 2010, J CELL SCI, V123, P619, DOI 10.1242/jcs.061481; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Philippidou P, 2011, P NATL ACAD SCI USA, V108, P852, DOI 10.1073/pnas.1015981108; Piper RC, 2011, TRENDS CELL BIOL, V21, P647, DOI 10.1016/j.tcb.2011.08.007; Poon WW, 2011, NEUROBIOL AGING, V32, P821, DOI 10.1016/j.neurobiolaging.2009.05.012; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Rui YF, 2006, J NEUROSCI, V26, P10480, DOI 10.1523/JNEUROSCI.3231-06.2006; Ryu KY, 2008, P NATL ACAD SCI USA, V105, P4016, DOI 10.1073/pnas.0800096105; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Tong LQ, 2004, J NEUROSCI, V24, P6799, DOI 10.1523/JNEUROSCI.5463-03.2004; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Valdez G, 2005, J NEUROSCI, V25, P5236, DOI 10.1523/JNEUROSCI.5104-04.2005; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang XL, 2010, NEURODEGENER DIS, V7, P56, DOI 10.1159/000283484; Watanabe T, 2012, J NEUROSCI, V32, P3352, DOI 10.1523/JNEUROSCI.5659-11.2012; Watson FL, 1999, J NEUROSCI, V19, P7889; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Xu BJ, 2000, NEURON, V26, P233, DOI 10.1016/S0896-6273(00)81153-8; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4	77	82	83	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16937	16948		10.1074/jbc.M113.463711	http://dx.doi.org/10.1074/jbc.M113.463711			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23599427	Green Published, hybrid			2022-12-28	WOS:000320378900066
J	Abrusan, G; Zhang, Y; Szilagyi, A				Abrusan, Gyoergy; Zhang, Yang; Szilagyi, Andras			Structure Prediction and Analysis of DNA Transposon and LINE Retrotransposon Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; NUCLEIC-ACID-BINDING; LTR-RETROTRANSPOSONS; HORIZONTAL TRANSFER; I-TASSER; ELEMENTS; EVOLUTION; DISORDER; DOMAIN; CONSTRAINT	Despite the considerable amount of research on transposable elements, no large-scale structural analyses of the TE proteome have been performed so far. We predicted the structures of hundreds of proteins from a representative set of DNA and LINE transposable elements and used the obtained structural data to provide the first general structural characterization of TE proteins and to estimate the frequency of TE domestication and horizontal transfer events. We show that 1) ORF1 and Gag proteins of retrotransposons contain high amounts of structural disorder; thus, despite their very low conservation, the presence of disordered regions and probably their chaperone function is conserved. 2) The distribution of SCOP classes in DNA transposons and LINEs indicates that the proteins of DNA transposons are more ancient, containing folds that already existed when the first cellular organisms appeared. 3) DNA transposon proteins have lower contact order than randomly selected reference proteins, indicating rapid folding, most likely to avoid protein aggregation. 4) Structure-based searches for TE homologs indicate that the overall frequency of TE domestication events is low, whereas we found a relatively high number of cases where horizontal transfer, frequently involving parasites, is the most likely explanation for the observed homology.	[Abrusan, Gyoergy] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, Synthet & Syst Biol Unit, H-6701 Szeged, Hungary; [Zhang, Yang] Univ Michigan, Sch Med, Dept Biol Chem, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Szilagyi, Andras] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, H-1113 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Michigan System; University of Michigan; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Abrusan, G (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, Synthet & Syst Biol Unit, Temesvari Krt 62, H-6701 Szeged, Hungary.	abrusan@brc.hu	Szilagyi, Andras/A-3561-2008	Szilagyi, Andras/0000-0002-1773-6861	Hungarian Scientific Research Fund OTKA [PD83571, K105415, NK77978]; National Science Foundation Career Award [DBI 0746198]; National Institute of General Medical Sciences [GM083107, GM084222]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083107, R01GM084222] Funding Source: NIH RePORTER	Hungarian Scientific Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Science Foundation Career Award(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Hungarian Scientific Research Fund OTKA Grants PD83571 (to G. A.) and K105415 and NK77978 (to A. S.), by the National Science Foundation Career Award DBI 0746198 (to Y.Z.), and the National Institute of General Medical Sciences Grants GM083107 and GM084222 (to Y.Z.).	Abrusan G, 2013, NUCLEIC ACIDS RES, V41, P3190, DOI 10.1093/nar/gkt011; Anbar AD, 2008, SCIENCE, V322, P1481, DOI 10.1126/science.1163100; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Anurag M, 2012, MOL BIOSYST, V8, P346, DOI 10.1039/c1mb05210a; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Bolton EC, 2002, MOL CELL, V9, P879, DOI 10.1016/S1097-2765(02)00495-1; Bondugula R, 2009, NUCLEIC ACIDS RES, V37, P452, DOI 10.1093/nar/gkn944; Britten R, 2006, P NATL ACAD SCI USA, V103, P1798, DOI 10.1073/pnas.0510007103; Brosius J, 2005, CYTOGENET GENOME RES, V110, P8, DOI 10.1159/000084934; Brown CJ, 2011, CURR OPIN STRUC BIOL, V21, P441, DOI 10.1016/j.sbi.2011.02.005; Caetano-Anolles G, 2009, BIOCHEM J, V417, P621, DOI 10.1042/BJ20082063; Callahan KE, 2012, NUCLEIC ACIDS RES, V40, P813, DOI 10.1093/nar/gkr728; Capy P, 1997, GENETICA, V100, P63, DOI 10.1023/A:1018300721953; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Drew K, 2011, GENOME RES, V21, P1981, DOI 10.1101/gr.121475.111; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dupont CL, 2010, P NATL ACAD SCI USA, V107, P10567, DOI 10.1073/pnas.0912491107; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Gilbert C, 2010, NATURE, V464, P1347, DOI 10.1038/nature08939; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Gruber M, 2006, J STRUCT BIOL, V155, P140, DOI 10.1016/j.jsb.2006.03.009; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; Januszyk K, 2007, J BIOL CHEM, V282, P24893, DOI 10.1074/jbc.M702023200; Ji HF, 2009, BIOESSAYS, V31, P975, DOI 10.1002/bies.200800201; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 2007, ANNU REV GENOM HUM G, V8, P241, DOI 10.1146/annurev.genom.8.080706.092416; Khazina E, 2011, NAT STRUCT MOL BIOL, V18, P1006, DOI 10.1038/nsmb.2097; Khazina E, 2009, P NATL ACAD SCI USA, V106, P731, DOI 10.1073/pnas.0809964106; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; Malmstrom L, 2007, PLOS BIOL, V5, P758, DOI 10.1371/journal.pbio.0050076; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martin SL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/45621; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Nakamura M, 2012, MOL CELL BIOL, V32, P458, DOI 10.1128/MCB.06162-11; Ni Jun, 2008, Briefings in Functional Genomics & Proteomics, V7, P444, DOI 10.1093/bfgp/eln049; Niwa T, 2009, P NATL ACAD SCI USA, V106, P4201, DOI 10.1073/pnas.0811922106; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Prlic A, 2000, PROTEIN ENG, V13, P545, DOI 10.1093/protein/13.8.545; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schaack S, 2010, TRENDS ECOL EVOL, V25, P537, DOI 10.1016/j.tree.2010.06.001; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Tompa P, 2010, BIOCHEM CELL BIOL, V88, P167, DOI [10.1139/O09-163, 10.1139/o09-163]; Tramontano A., 2006, PROTEIN STRUCTURE PR, P37; Wacey D, 2011, NAT GEOSCI, V4, P698, DOI 10.1038/NGEO1238; Wang ML, 2011, MOL BIOL EVOL, V28, P567, DOI 10.1093/molbev/msq232; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Yarrington RM, 2007, J VIROL, V81, P9004, DOI 10.1128/JVI.02502-06; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zdobnov EM, 2005, NUCLEIC ACIDS RES, V33, P946, DOI 10.1093/nar/gki236; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P2605, DOI 10.1073/pnas.0509379103; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002046	71	8	8	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16127	16138		10.1074/jbc.M113.451500	http://dx.doi.org/10.1074/jbc.M113.451500			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23530042	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000319822300063
J	Honda-Ogawa, M; Ogawa, T; Terao, Y; Sumitomo, T; Nakata, M; Ikebe, K; Maeda, Y; Kawabata, S				Honda-Ogawa, Mariko; Ogawa, Taiji; Terao, Yutaka; Sumitomo, Tomoko; Nakata, Masanobu; Ikebe, Kazunori; Maeda, Yoshinobu; Kawabata, Shigetada			Cysteine Proteinase from Streptococcus pyogenes Enables Evasion of Innate Immunity via Degradation of Complement Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRONECTIN-BINDING PROTEIN; EPITHELIAL-CELLS; SPEB; CONTRIBUTES; GENE; PATHOGENESIS; ACTIVATION; KALLIKREIN; ADHESION; ANTIGEN	Streptococcus pyogenes is an important human pathogen that causes invasive diseases such as necrotizing fasciitis, sepsis, and streptococcal toxic shock syndrome. We investigated the function of a major cysteine protease from S. pyogenes that affects the amount of C1-esterase inhibitor (C1-INH) and other complement factors and aimed to elucidate the mechanism involved in occurrence of streptococcal toxic shock syndrome from the aspect of the complement system. First, we revealed that culture supernatant of a given S. pyogenes strain and recombinant SpeB degraded the C1-INH. Then, we determined the N-terminal sequence of the C1-INH fragment degraded by recombinant SpeB. Interestingly, the region containing one of the identified cleavage sites is not present in patients with C1-INH deficiency. Scanning electron microscopy of the speB mutant incubated in human serum showed the abnormal superficial architecture and irregular oval structure. Furthermore, unlike the wild-type strain, that mutant strain showed lower survival capacity than normal as compared with heat-inactivated serum, whereas it had a significantly higher survival rate in serum without the C1-INH than in normal serum. Also, SpeB degraded multiple complement factors and the membrane attack complex. Flow cytometric analyses revealed deposition of C9, one of the components of membrane the attack complex, in greater amounts on the surface of the speB mutant, whereas lower amounts of C9 were bound to the wild-type strain surface. These results suggest that SpeB can interrupt the human complement system via degrading the C1-INH, thus enabling S. pyogenes to evade eradication in a hostile environment.	[Honda-Ogawa, Mariko; Ogawa, Taiji; Sumitomo, Tomoko; Nakata, Masanobu; Kawabata, Shigetada] Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Suita, Osaka 5650871, Japan; [Honda-Ogawa, Mariko; Ogawa, Taiji; Ikebe, Kazunori; Maeda, Yoshinobu] Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Suita, Osaka 5650871, Japan; [Terao, Yutaka] Niigata Univ, Grad Sch Med & Dent Sci, Div Microbiol & Infect Dis, Chuo Ku, Niigata 9518514, Japan	Osaka University; Osaka University; Niigata University	Terao, Y (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Microbiol & Infect Dis, Chuo Ku, 2-5274 Gakkocho Dori, Niigata 9518514, Japan.	terao@dent.niigata-u.ac.jp		Nakata, Masanobu/0000-0003-1686-5415; Ogawa, Taiji/0000-0001-8279-4040; Terao, Yutaka/0000-0002-4450-5583	Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [23592700, 24659812] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by grants-in-aid for scientific research (B), young scientists (B), and challenging exploratory research through the Japan Society for the Promotion of Science (JSPS).	BOHACH GA, 1988, INFECT IMMUN, V56, P1665, DOI 10.1128/IAI.56.6.1665-1667.1988; Bos IGA, 2003, J BIOL CHEM, V278, P29463, DOI 10.1074/jbc.M302977200; Brosnahan AJ, 2011, FEBS J, V278, P4649, DOI 10.1111/j.1742-4658.2011.08151.x; Castelli R, 2013, IMMUNOPHARM IMMUNOT, V35, P181, DOI 10.3109/08923973.2012.726627; CHEN CC, 1990, J BIOL CHEM, V265, P3161; Cockerill FR, 1998, CLIN INFECT DIS, V26, P1448, DOI 10.1086/516376; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Egesten A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004769; Eriksson A, 2003, INFECT IMMUN, V71, P211, DOI 10.1128/IAI.71.1.211-217.2003; Fiedler T, 2010, FUTURE MICROBIOL, V5, P1675, DOI [10.2217/fmb.10.128, 10.2217/FMB.10.128]; Fronhoffs S, 2000, INTENS CARE MED, V26, P1566, DOI 10.1007/s001340000654; Hidalgo-Grass C, 2004, LANCET, V363, P696, DOI 10.1016/S0140-6736(04)15643-2; Kunitomo E, 2008, MICROBES INFECT, V10, P414, DOI 10.1016/j.micinf.2008.01.003; LANCEFIELD RC, 1957, J EXP MED, V106, P525, DOI 10.1084/jem.106.4.525; Lappin E, 2009, LANCET INFECT DIS, V9, P281, DOI 10.1016/S1473-3099(09)70066-0; Muller-Eberhard H J, 1980, Adv Immunol, V29, P1, DOI 10.1016/S0065-2776(08)60042-5; Murakami J, 2002, EPIDEMIOL INFECT, V128, P397, DOI 10.1017/S0950268802006854; Ogawa T, 2011, MICROB PATHOGENESIS, V51, P58, DOI 10.1016/j.micpath.2011.03.009; Okamoto S, 2004, INFECT IMMUN, V72, P6068, DOI 10.1128/IAI.72.10.6068-6075.2004; PIXLEY RA, 1993, J CLIN INVEST, V91, P61, DOI 10.1172/JCI116201; SCHAPIRA M, 1982, J CLIN INVEST, V69, P1199, DOI 10.1172/JCI110557; Sim RB, 2004, BIOCHEM SOC T, V32, P21, DOI 10.1042/BST0320021; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Terao Y, 2002, J BIOL CHEM, V277, P47428, DOI 10.1074/jbc.M209133200; Terao Y, 2001, MOL MICROBIOL, V42, P75, DOI 10.1046/j.1365-2958.2001.02579.x; Terao Y, 2008, J BIOL CHEM, V283, P6253, DOI 10.1074/jbc.M704821200; Terao Y, 2006, J BIOL CHEM, V281, P14215, DOI 10.1074/jbc.M513408200; Tsao N, 2006, BIOCHEM BIOPH RES CO, V339, P779, DOI 10.1016/j.bbrc.2005.11.078; VANDERGRAAF F, 1983, J CLIN INVEST, V71, P149, DOI 10.1172/JCI110743; von Pawel-Rammingen U, 2003, CURR OPIN MICROBIOL, V6, P50, DOI 10.1016/S1369-5274(03)00003-1; Yamaguchi M, 2008, J BIOL CHEM, V283, P36272, DOI 10.1074/jbc.M807087200; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024	34	40	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15854	15864		10.1074/jbc.M113.469106	http://dx.doi.org/10.1074/jbc.M113.469106			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23589297	Green Published, hybrid			2022-12-28	WOS:000319822300039
J	Jain, P; Baranwal, S; Dong, SL; Struckhoff, AP; Worthylake, RA; Alahari, SK				Jain, Prachi; Baranwal, Somesh; Dong, Shengli; Struckhoff, Amanda P.; Worthylake, Rebecca A.; Alahari, Suresh K.			Integrin-binding Protein Nischarin Interacts with Tumor Suppressor Liver Kinase B1 (LKB1) to Regulate Cell Migration of Breast Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEUTZ-JEGHERS-SYNDROME; P21-ACTIVATED-KINASE-1 PAK1; DOWN-REGULATION; CANCER CELLS; LIM-KINASE; PHOSPHORYLATION; ACTIVATION; EXPRESSION; INVASION; POLARITY	Biallelic inactivation of LKB1, a serine/threonine kinase, has been detected in 30% of lung adenocarcinomas, and inhibition of breast tumor growth has been demonstrated. We have identified the tumor suppressor, Nischarin, as a novel binding partner of LKB1. Our mapping analysis shows that the N terminus of Nischarin interacts with amino acids 44-436 of LKB1. Time lapse microscopy and Transwell migration data show that the absence of both Nischarin and LKB1 from an invasive breast cancer cell line (MDA-MB-231) enhances migration as measured by increased distance and speed of migrating cells. Our data suggest that this is a result of elevated PAK1 and LIMK1 phosphorylation. Moreover, the absence of Nischarin and LKB1 increased tumor growth in vivo. Consistent with this, the percentage of S phase cells was increased, as demonstrated by flow cytometry and enhanced cyclin D1. The absence of Nischarin and LKB1 also led to a dramatic increase in the formation of lung metastases. Our studies, for the first time, demonstrate functional interaction between LKB1 and Nischarin to inhibit cell migration and breast tumor progression. Mechanistically, we show that these two proteins together regulate PAK-LIMK-Cofilin and cyclin D1/CDK4 pathways.	[Jain, Prachi; Baranwal, Somesh; Dong, Shengli; Alahari, Suresh K.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Stanley S Scott Canc Ctr,Sch Med, New Orleans, LA 70112 USA; [Struckhoff, Amanda P.; Worthylake, Rebecca A.] Louisiana State Univ, Hlth Sci Ctr, Dept Oral Biol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Alahari, SK (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Stanley S Scott Canc Ctr,Sch Med, New Orleans, LA 70112 USA.	salaha@lsuhsc.edu			National Institutes of Health [CA 115706]; Susan G. Komen Foundation [BCTR0600278]; Louisiana Cancer Research Consortium; NATIONAL CANCER INSTITUTE [R01CA115706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Louisiana Cancer Research Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA 115706. This work was also supported by Grant BCTR0600278 from the Susan G. Komen Foundation and funds from the Louisiana Cancer Research Consortium.	Alahari SK, 2004, EMBO J, V23, P2777, DOI 10.1038/sj.emboj.7600291; Alahari SK, 2003, EXP CELL RES, V288, P415, DOI 10.1016/S0014-4827(03)00233-7; Alahari SK, 2000, J CELL BIOL, V151, P1141, DOI 10.1083/jcb.151.6.1141; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Bagheri-Yarmand R, 2006, INT J CANCER, V118, P2703, DOI 10.1002/ijc.21650; Balasenthil S, 2004, J BIOL CHEM, V279, P1422, DOI 10.1074/jbc.M309937200; Baranwal S, 2011, J NATL CANCER I, V103, P1513, DOI 10.1093/jnci/djr350; Boardman LA, 1998, ANN INTERN MED, V128, P896, DOI 10.7326/0003-4819-128-11-199806010-00004; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Chen JD, 2000, CLIN GENET, V57, P394, DOI 10.1034/j.1399-0004.2000.570511.x; Chow SE, 2011, J CELL BIOCHEM, V112, P3459, DOI 10.1002/jcb.23277; Deguchi A, 2010, J BIOL CHEM, V285, P18283, DOI 10.1074/jbc.M109.079137; Deng WG, 2007, CANCER RES, V67, P709, DOI 10.1158/0008-5472.CAN-06-3463; Ding YM, 2008, MOL CELL BIOL, V28, P3742, DOI 10.1128/MCB.01832-07; Dong M, 2007, J CLIN INVEST, V117, P206, DOI 10.1172/JCI29293; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fenton H, 2006, APPL IMMUNOHISTO M M, V14, P146, DOI 10.1097/01.pai.0000176157.07908.20; Gao YJ, 2010, P NATL ACAD SCI USA, V107, P18892, DOI 10.1073/pnas.1004952107; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; Gu Y, 2012, ONCOGENE, V31, P469, DOI 10.1038/onc.2011.247; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Jain P, 2012, JOVE-J VIS EXP, DOI 10.3791/3585; JEGHERS H, 1949, NEW ENGL J MED, V241, P1031, DOI 10.1056/NEJM194912292412601; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kok K, 1997, ADV CANCER RES, V71, P27, DOI 10.1016/S0065-230X(08)60096-2; Kong HJ, 2003, MOL CANCER RES, V1, P948; McCarthy A, 2009, J PATHOL, V219, P306, DOI 10.1002/path.2599; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Scott KD, 2007, CANCER RES, V67, P5622, DOI 10.1158/0008-5472.CAN-07-0762; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Shen Z, 2002, CLIN CANCER RES, V8, P2085; Shorning BY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016209; Smith DP, 2001, HUM MOL GENET, V10, P2869, DOI 10.1093/hmg/10.25.2869; Stupack DG, 2000, IMMUNOL RES, V21, P83, DOI 10.1385/IR:21:2-3:83; Wang YF, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-84; Yoo LI, 2002, NAT REV CANCER, V2, P529, DOI 10.1038/nrc843; Zhang SM, 2008, CANCER RES, V68, P740, DOI 10.1158/0008-5472.CAN-07-2989; Zhong DS, 2008, CANCER RES, V68, P7270, DOI 10.1158/0008-5472.CAN-08-1484; Zhuang ZG, 2006, MOL CANCER RES, V4, P843, DOI 10.1158/1541-7786.MCR-06-0118	46	24	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15495	15509		10.1074/jbc.M112.418103	http://dx.doi.org/10.1074/jbc.M112.418103			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23572524	Green Published, hybrid			2022-12-28	WOS:000319822300008
J	Adler, JJ; Heller, BL; Bringman, LR; Ranahan, WP; Cocklin, RR; Goebl, MG; Oh, M; Lim, HS; Ingham, RJ; Wells, CD				Adler, Jacob J.; Heller, Brigitte L.; Bringman, Lauren R.; Ranahan, William P.; Cocklin, Ross R.; Goebl, Mark G.; Oh, Misook; Lim, Hyun-Suk; Ingham, Robert J.; Wells, Clark D.			Amot130 Adapts Atrophin-1 Interacting Protein 4 to Inhibit Yes-associated Protein Signaling and Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; WW DOMAINS; NEGATIVE REGULATOR; HIPPO PATHWAY; COILED-COIL; ANGIOMOTIN; ITCH; YAP; COMPLEX	The adaptor protein Amot130 scaffolds components of the Hippo pathway to promote the inhibition of cell growth. This study describes how Amot130 through binding and activating the ubiquitin ligase AIP4/Itch achieves these effects. AIP4 is found to bind and ubiquitinate Amot130 at residue Lys-481. This both stabilizes Amot130 and promotes its residence at the plasma membrane. Furthermore, Amot130 is shown to scaffold a complex containing overexpressed AIP4 and the transcriptional co-activator Yes-associated protein (YAP). Consequently, Amot130 promotes the ubiquitination of YAP by AIP4 and prevents AIP4 from binding to large tumor suppressor 1. Amot130 is found to reduce YAP stability. Importantly, Amot130 inhibition of YAP dependent transcription is reversed by AIP4 silencing, whereas Amot130 and AIP4 expression interdependently suppress cell growth. Thus, Amot130 repurposes AIP4 from its previously described role in degrading large tumor suppressor 1 to the inhibition of YAP and cell growth.	[Adler, Jacob J.; Heller, Brigitte L.; Bringman, Lauren R.; Ranahan, William P.; Cocklin, Ross R.; Goebl, Mark G.; Oh, Misook; Lim, Hyun-Suk; Wells, Clark D.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Ingham, Robert J.] Univ Alberta, Dept Med Microbiol & Immunol, Li Ka Shing Inst Virol, Edmonton, AB T6G 2E1, Canada	Indiana University System; Indiana University Bloomington; University of Alberta	Wells, CD (corresponding author), John D Van Nuys Med Sci Bldg,635 Barnhill Dr,Rm 4, Indianapolis, IN 46202 USA.	wells4@iupui.edu			National Institutes of Health/NCI Grant [R01CA151765]; Department of Defense Grant [W81XWH]; NATIONAL CANCER INSTITUTE [R01CA151765] Funding Source: NIH RePORTER	National Institutes of Health/NCI Grant; Department of Defense Grant(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health/NCI Grant R01CA151765 and Department of Defense Grant W81XWH (to C.D.W).	Aase K, 2007, GENE DEV, V21, P2055, DOI 10.1101/gad.432007; Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Azakir BA, 2010, FEBS J, V277, P1319, DOI 10.1111/j.1742-4658.2010.07562.x; Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Bratt A, 2002, GENE, V298, P69, DOI 10.1016/S0378-1119(02)00928-9; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Chong PA, 2010, P NATL ACAD SCI USA, V107, P18404, DOI 10.1073/pnas.1003023107; Colwill K, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-13; Ernkvist M, 2006, FEBS J, V273, P2000, DOI 10.1111/j.1742-4658.2006.05216.x; Gagne V, 2009, CELL MOTIL CYTOSKEL, V66, P754, DOI 10.1002/cm.20405; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Heller B, 2010, J BIOL CHEM, V285, P12308, DOI 10.1074/jbc.M109.096230; Ho KC, 2011, P NATL ACAD SCI USA, V108, P4870, DOI 10.1073/pnas.1101273108; Hooper C, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-72; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lee JH, 2011, J AM CHEM SOC, V133, P676, DOI 10.1021/ja108230s; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lobry C, 2007, P NATL ACAD SCI USA, V104, P908, DOI 10.1073/pnas.0606982104; Lott JS, 2002, BIOCHEM J, V361, P481, DOI 10.1042/0264-6021:3610481; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Ranahan WP, 2011, CANCER RES, V71, P2203, DOI 10.1158/0008-5472.CAN-10-1995; Rasband WS, 2011, IMAGEJ VERSION 1 44O; Rathinam C, 2011, NAT IMMUNOL, V12, P399, DOI 10.1038/ni.2021; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Salah Z, 2011, CANCER RES, V71, P2010, DOI 10.1158/0008-5472.CAN-10-3516; Scharschmidt E, 2004, MOL CELL BIOL, V24, P3860, DOI 10.1128/MCB.24.9.3860-3873.2004; Shimono A, 2003, CURR BIOL, V13, P613, DOI 10.1016/S0960-9822(03)00204-5; Skouloudaki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035735; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Vitolol MI, 2007, CANCER BIOL THER, V6, P856, DOI 10.4161/cbt.6.6.4241; Wang CJ, 2012, BIOCHEM J, V444, P279, DOI 10.1042/BJ20111983; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Webb C, 2011, BIOCHEMISTRY-US, V50, P3300, DOI 10.1021/bi2001888; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	52	44	46	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15181	15193		10.1074/jbc.M112.446534	http://dx.doi.org/10.1074/jbc.M112.446534			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23564455	Green Published, hybrid			2022-12-28	WOS:000319452100047
J	Balchin, D; Wallace, L; Dirr, HW				Balchin, David; Wallace, Louise; Dirr, Heini W.			S-Nitrosation of Glutathione Transferase P1-1 Is Controlled by the Conformation of a Dynamic Active Site Helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; INDUCED-FIT; NITROSYLATION; PI; NITROSOTHIOLS; MECHANISM; COMPLEX; NITROSOGLUTATHIONE; TRANSNITROSATION; CYSTEINE	S-Nitrosation is a post-translational modification of protein cysteine residues, which occurs in response to cellular oxidative stress. Although it is increasingly being linked to physiologically important processes, the molecular basis for protein regulation by this modification remains poorly understood. We used transient kinetic methods to determine a minimal mechanism for spontaneous S-nitrosoglutathione (GSNO)-mediated transnitrosation of human glutathione transferase (GST) P1-1, a major detoxification enzyme and key regulator of cell proliferation. Cys(47) of GSTP1-1 is S-nitrosated in two steps, with the chemical step limited by a pre-equilibrium between the open and closed conformations of helix alpha 2 at the active site. Cys(101), in contrast, is S-nitrosated in a single step but is subject to negative cooperativity due to steric hindrance at the dimer interface. Despite the presence of a GSNO binding site at the active site of GSTP1-1, isothermal titration calorimetry as well as nitrosation experiments using S-nitrosocysteine demonstrate that GSNO binding does not precede S-nitrosation of GSTP1-1. Kinetics experiments using the cellular reductant glutathione show that Cys(101)-NO is substantially more resistant to denitrosation than Cys(47)-NO, suggesting a potential role for Cys(101) in long term nitric oxide storage or transfer. These results constitute the first report of the molecular mechanism of spontaneous protein transnitrosation, providing insight into the post-translational control of GSTP1-1 as well as the process of protein transnitrosation in general.	[Balchin, David; Wallace, Louise; Dirr, Heini W.] Univ Witwatersrand, Sch Mol & Cell Biol, Prot Struct Funct Res Unit, Johannesburg, South Africa	University of Witwatersrand	Dirr, HW (corresponding author), Univ Witwatersrand, Sch Mol & Cell Biol, Prot Struct Funct Res Unit, Johannesburg, South Africa.	heinrich.dirr@wits.ac.za		Dirr, Heini/0000-0003-1455-7769; Balchin, David/0000-0002-5000-0995	University of the Witwatersrand; South African National Research Foundation [60810, 65510, 68898]; South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation [64788]	University of the Witwatersrand; South African National Research Foundation(National Research Foundation - South Africa); South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation	This work was supported by the University of the Witwatersrand, South African National Research Foundation Grants 60810, 65510, and 68898 and South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation Grant 64788.	Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Anand P, 2012, J MOL MED, V90, P233, DOI 10.1007/s00109-012-0878-z; Barglow KT, 2011, P NATL ACAD SCI USA, V108, pE600, DOI 10.1073/pnas.1110736108; Bell S, 2002, J MOL BIOL, V322, P917, DOI 10.1016/S0022-2836(02)00848-3; Beltran B, 2000, BRIT J PHARMACOL, V129, P953, DOI 10.1038/sj.bjp.0703147; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Caccuri AM, 1999, J BIOL CHEM, V274, P19276, DOI 10.1074/jbc.274.27.19276; Chang MS, 1999, PROTEIN EXPRES PURIF, V17, P443, DOI 10.1006/prep.1999.1149; Chen XC, 2001, J ORG CHEM, V66, P6064, DOI 10.1021/jo015658p; De Maria F, 2003, J BIOL CHEM, V278, P42283, DOI 10.1074/jbc.M305568200; Doulias PT, 2010, P NATL ACAD SCI USA, V107, P16958, DOI 10.1073/pnas.1008036107; Foster MW, 2009, P NATL ACAD SCI USA, V106, P18948, DOI 10.1073/pnas.0900729106; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; GASTON B, 1993, P NATL ACAD SCI USA, V90, P10957, DOI 10.1073/pnas.90.23.10957; Gildenhuys S, 2010, BIOCHEMISTRY-US, V49, P5074, DOI 10.1021/bi100552d; Goldstein S, 1996, J AM CHEM SOC, V118, P3419, DOI 10.1021/ja9536680; HART TW, 1985, TETRAHEDRON LETT, V26, P2013, DOI 10.1016/S0040-4039(00)98368-0; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hitchens TK, 2001, BIOCHEMISTRY-US, V40, P11660, DOI 10.1021/bi010909+; Hogg N, 1999, ANAL BIOCHEM, V272, P257, DOI 10.1006/abio.1999.4199; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; KONG KH, 1991, BIOCHEM BIOPH RES CO, V181, P748, DOI 10.1016/0006-291X(91)91254-A; Lee TY, 2012, BIOINFORMATICS, V28, P2293, DOI 10.1093/bioinformatics/bts436; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Lo Bello M, 2001, J BIOL CHEM, V276, P42138; LOBELLO M, 1993, J BIOL CHEM, V268, P19033; Madej E, 2008, FREE RADICAL BIO MED, V44, P2013, DOI 10.1016/j.freeradbiomed.2008.02.015; Marino SM, 2010, J MOL BIOL, V395, P844, DOI 10.1016/j.jmb.2009.10.042; Nuriel T, 2011, J PROTEOMICS, V74, P2300, DOI 10.1016/j.jprot.2011.05.032; Oakley AJ, 1998, BIOCHEMISTRY-US, V37, P9912, DOI 10.1021/bi980323w; Oakley AJ, 1997, J MOL BIOL, V274, P84, DOI 10.1006/jmbi.1997.1364; Paige JS, 2008, CHEM BIOL, V15, P1307, DOI 10.1016/j.chembiol.2008.10.013; Patel RP, 1999, J BIOL CHEM, V274, P15487, DOI 10.1074/jbc.274.22.15487; Ralat LA, 2008, ARCH BIOCHEM BIOPHYS, V474, P109, DOI 10.1016/j.abb.2008.02.043; RICCI G, 1995, J BIOL CHEM, V270, P1243, DOI 10.1074/jbc.270.3.1243; Ricci G, 1996, J BIOL CHEM, V271, P16187, DOI 10.1074/jbc.271.27.16187; Rossi R, 1997, ANAL BIOCHEM, V254, P215, DOI 10.1006/abio.1997.2424; Sarkar S, 2011, MOL CELL, V43, P19, DOI 10.1016/j.molcel.2011.04.029; Savidge TC, 2011, NAT MED, V17, P1136, DOI 10.1038/nm.2405; Seth D, 2011, CURR OPIN CHEM BIOL, V15, P129, DOI 10.1016/j.cbpa.2010.10.012; SEXTON DJ, 1994, PHOTOCHEM PHOTOBIOL, V59, P463, DOI 10.1111/j.1751-1097.1994.tb05065.x; Sinha V, 2010, ACS CHEM BIOL, V5, P667, DOI 10.1021/cb100054m; Tellez-Sanz R, 2006, PROTEIN SCI, V15, P1093, DOI 10.1110/ps.052055206; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Werbeck ND, 2009, BIOCHEMISTRY-US, V48, P7240, DOI 10.1021/bi900880c; Yap LP, 2010, METHOD ENZYMOL, V473, P137, DOI 10.1016/S0076-6879(10)73006-8	48	7	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14973	14984		10.1074/jbc.M113.462671	http://dx.doi.org/10.1074/jbc.M113.462671			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23572520	Green Published, hybrid			2022-12-28	WOS:000319452100027
J	Haeussler, DJ; Pimentel, DR; Hou, X; Burgoyne, JR; Cohen, RA; Bachschmid, MM				Haeussler, Dagmar J.; Pimentel, David R.; Hou, Xiuyun; Burgoyne, Joseph R.; Cohen, Richard A.; Bachschmid, Markus M.			Endomembrane H-Ras Controls Vascular Endothelial Growth Factor-induced Nitric-oxide Synthase-mediated Endothelial Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED ANGIOGENESIS; PLASMA-MEMBRANE; GOLGI-APPARATUS; PROTEIN-KINASE; NO SYNTHESIS; ACTIVATION; PATHWAYS; PHOSPHORYLATION; LOCALIZATION; INTEGRATION	We demonstrate for the first time that endomembrane-delimited H-Ras mediates VEGF-induced activation of endothelial nitric-oxide synthase (eNOS) and migratory response of human endothelial cells. Using thiol labeling strategies and immunofluorescent cell staining, we found that only 31% of total H-Ras is S-palmitoylated, tethering the small GTPase to the plasma membrane but leaving the function of the large majority of endomembrane-localized H-Ras unexplained. Knockdown of H-Ras blocked VEGF-induced PI3K-dependent Akt (Ser-473) and eNOS (Ser-1177) phosphorylation and nitric oxide-dependent cell migration, demonstrating the essential role of H-Ras. Activation of endogenous H-Ras led to recruitment and phosphorylation of eNOS at endomembranes. The loss of migratory response in cells lacking endogenous H-Ras was fully restored by modest overexpression of an endomembrane-delimited H-Ras palmitoylation mutant. These studies define a newly recognized role for endomembrane-localized H-Ras in mediating nitric oxide-dependent proangiogenic signaling.	[Haeussler, Dagmar J.; Hou, Xiuyun; Cohen, Richard A.; Bachschmid, Markus M.] Boston Univ, Sch Med, Vasc Biol Sect, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Pimentel, David R.] Boston Univ, Sch Med, Myocardial Biol Unit, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Burgoyne, Joseph R.] Kings Coll London, London SE1 7EH, England	Boston University; Boston University; University of London; King's College London	Bachschmid, MM (corresponding author), Boston Univ, Sch Med, Vasc Biol Sect, Whitaker Cardiovasc Inst, Boston, MA 02118 USA.	bach@bu.edu		Bachschmid, Markus Michael/0000-0002-0748-5528; Burgoyne, Joseph/0000-0001-7325-7382; Pimentel, David/0000-0002-0537-7195; /0000-0002-1070-6408	National Institutes of Health [PO1 HL 068758, R37 HL104017]; NHLBI [HHSN268201000031C]; Wellcome Trust [085483/Z/08/Z]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028178] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068758, R37HL104017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust(Wellcome TrustEuropean Commission); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL 068758, R37 HL104017, and NHLBI contract number HHSN268201000031C. This work was also supported by a Sir Henry Wellcome postdoctoral fellowship from the Wellcome Trust (Sponsor Reference 085483/Z/08/Z; to J. R. B.).	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Ahearn IM, 2011, MOL CELL, V41, P173, DOI 10.1016/j.molcel.2011.01.001; Bajaj A, 2010, CANCER RES, V70, P3803, DOI 10.1158/0008-5472.CAN-09-2648; Balla A, 2011, J BIOL CHEM, V286, P5319, DOI 10.1074/jbc.M110.176933; Belanis L, 2008, MOL BIOL CELL, V19, P1404, DOI 10.1091/mbc.E07-10-1053; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Cheng CM, 2011, MOL CELL BIOL, V31, P983, DOI 10.1128/MCB.00137-10; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; D'Angelo G, 1999, MOL ENDOCRINOL, V13, P692, DOI 10.1210/me.13.5.692; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Doanes AM, 1999, BIOCHEM BIOPH RES CO, V255, P545, DOI 10.1006/bbrc.1999.0227; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Evangelista AM, 2012, ANTIOXID REDOX SIGN, V17, P1099, DOI 10.1089/ars.2011.4022; Fulton D, 2004, J BIOL CHEM, V279, P30349, DOI 10.1074/jbc.M402155200; Gelinas DS, 2002, BRIT J PHARMACOL, V137, P1021, DOI 10.1038/sj.bjp.0704956; Gonzalez E, 2002, J BIOL CHEM, V277, P39554, DOI 10.1074/jbc.M207299200; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Haeussler DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023160; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Henis YI, 2009, MOL MEMBR BIOL, V26, P80, DOI 10.1080/09687680802649582; Hood JD, 2003, J CELL BIOL, V162, P933, DOI 10.1083/jcb.200304105; Iwakiri Y, 2006, P NATL ACAD SCI USA, V103, P19777, DOI 10.1073/pnas.0605907103; Jin T, 2012, CELL RES, V22, P661, DOI 10.1038/cr.2011.161; Jobin CM, 2003, BIOCHEMISTRY-US, V42, P11716, DOI 10.1021/bi035066w; Kawasaki K, 2003, MOL CELL BIOL, V23, P5726, DOI 10.1128/MCB.23.16.5726-5737.2003; Kawasaki K, 2008, J CELL BIOL, V181, P131, DOI 10.1083/jcb.200709127; Kim CK, 2010, MOL PHARMACOL, V78, P142, DOI 10.1124/mol.110.063586; Koika V, 2010, VASC PHARMACOL, V53, P215, DOI 10.1016/j.vph.2010.08.004; Kumar VB, 1999, ANAL BIOCHEM, V269, P17, DOI 10.1006/abio.1999.4013; Meadows KN, 2004, ONCOGENE, V23, P192, DOI 10.1038/sj.onc.1206921; Miura S, 2003, ARTERIOSCL THROM VAS, V23, P802, DOI 10.1161/01.ATV.0000066134.79956.58; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Rotblat B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011991; Serban D, 2008, CIRC RES, V102, P1350, DOI 10.1161/CIRCRESAHA.107.169664; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; WILLINGHAM MC, 1980, CELL, V19, P1005, DOI 10.1016/0092-8674(80)90091-4; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096; Zachary I, 2003, BIOCHEM SOC T, V31, P1171	47	9	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15380	15389		10.1074/jbc.M112.427765	http://dx.doi.org/10.1074/jbc.M112.427765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23548900	hybrid, Green Published			2022-12-28	WOS:000319452100062
J	Boutigny, S; Saini, A; Baidoo, EEK; Yeung, N; Keasling, JD; Butland, G				Boutigny, Sylvain; Saini, Avneesh; Baidoo, Edward E. K.; Yeung, Natasha; Keasling, Jay D.; Butland, Gareth			Physical and Functional Interactions of a Monothiol Glutaredoxin and an Iron Sulfur Cluster Carrier Protein with the Sulfur-donating Radical S-Adenosyl-L-methionine Enzyme MiaB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; TRANSFER-RNA; AZOTOBACTER-VINELANDII; 4FE-4S CLUSTERS; SAM ENZYMES; COMPLEXES; FORMS; NFUA; METHYLTHIOLATION; IDENTIFICATION	The biosynthesis of iron sulfur (FeS) clusters, their trafficking from initial assembly on scaffold proteins via carrier proteins to final incorporation into FeS apoproteins, is a highly coordinated process enabled by multiprotein systems encoded in iscRSUAh-scBAfdx and sufABCDSE operons in Escherichia coli. Although these systems are believed to encode all factors required for initial cluster assembly and transfer to FeS carrier proteins, accessory factors such as monothiol glutaredoxin, GrxD, and the FeS carrier protein NfuA are located outside of these defined systems. These factors have been suggested to function both as shuttle proteins acting to transfer clusters between scaffold and carrier proteins and in the final stages of FeS protein assembly by transferring clusters to client FeS apoproteins. Here we implicate both of these factors in client protein interactions. We demonstrate specific interactions between GrxD, NfuA, and the methylthiolase MiaB, a radical S-adenosyl-L-methionine-dependent enzyme involved in the maturation of a subset of tRNAs. We show that GrxD and NfuA physically interact with MiaB with affinities compatible with an in vivo function. We furthermore demonstrate that NfuA is able to transfer its cluster in vitro to MiaB, whereas GrxD is unable to do so. The relevance of these interactions was demonstrated by linking the activity of MiaB with GrxD and NfuA in vivo. We observe a severe defect in in vivo MiaB activity in cells lacking both GrxD and NfuA, suggesting that these proteins could play complementary roles in maturation and repair of MiaB.	[Boutigny, Sylvain; Saini, Avneesh; Yeung, Natasha; Butland, Gareth] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Baidoo, Edward E. K.; Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Baidoo, Edward E. K.; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA 94608 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI	Butland, G (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	gpbutland@lbl.gov	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088	National Institutes of Health from the NIGMS [GM088196]; Office of Science, of the United States Department of Energy through an E. O. Lawrence Fellowship [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088196] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science, of the United States Department of Energy through an E. O. Lawrence Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM088196 from the NIGMS. This work was also supported by the Director, Office of Science, of the United States Department of Energy under Contract DE-AC02-05CH11231 through an E. O. Lawrence Fellowship (to N. Y.).	Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; Atta M, 2012, BBA-PROTEINS PROTEOM, V1824, P1223, DOI 10.1016/j.bbapap.2011.11.007; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bandyopadhyay S, 2008, J BIOL CHEM, V283, P14092, DOI 10.1074/jbc.M709161200; Booker SJ, 2009, CURR OPIN CHEM BIOL, V13, P58, DOI 10.1016/j.cbpa.2009.02.036; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Esberg B, 1999, J BACTERIOL, V181, P7256, DOI 10.1128/JB.181.23.7256-7265.1999; Fontecave M, 2006, NAT CHEM BIOL, V2, P171, DOI 10.1038/nchembio0406-171; Gao-Sheridan HS, 1998, J BIOL CHEM, V273, P5514, DOI 10.1074/jbc.273.10.5514; Hernandez HL, 2007, BIOCHEMISTRY-US, V46, P5140, DOI 10.1021/bi7000449; Lanz ND, 2012, BBA-PROTEINS PROTEOM, V1824, P1196, DOI 10.1016/j.bbapap.2012.07.009; Layer G, 2007, J BIOL CHEM, V282, P13342, DOI 10.1074/jbc.M608555200; Lee KH, 2009, BIOCHEMISTRY-US, V48, P10162, DOI 10.1021/bi900939w; Li HR, 2012, BIOCHEMISTRY-US, V51, P1687, DOI 10.1021/bi2019089; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Mapolelo DT, 2013, DALTON T, V42, P3107, DOI 10.1039/c2dt32263c; Pierrel F, 2003, J BIOL CHEM, V278, P29515, DOI 10.1074/jbc.M301518200; Pierrel F, 2004, J BIOL CHEM, V279, P47555, DOI 10.1074/jbc.M408562200; Pierrel F, 2002, J BIOL CHEM, V277, P13367, DOI 10.1074/jbc.C100609200; Pinske C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031755; Pinske C, 2012, J BACTERIOL, V194, P346, DOI 10.1128/JB.06024-11; Py B, 2012, MOL MICROBIOL, V86, P155, DOI 10.1111/j.1365-2958.2012.08181.x; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Ranquet C, 2007, J BIOL CHEM, V282, P30442, DOI 10.1074/jbc.M702519200; Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019; Santos JM, 2002, MOL MICROBIOL, V45, P1729, DOI 10.1046/j.1365-2958.2002.03131.x; Shakamuri P, 2012, J AM CHEM SOC, V134, P15213, DOI 10.1021/ja306061x; Shepard EM, 2011, CURR OPIN CHEM BIOL, V15, P319, DOI 10.1016/j.cbpa.2011.02.012; Ugulava NB, 2003, BIOCHEMISTRY-US, V42, P2708, DOI 10.1021/bi0261084; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; Waller JC, 2012, J BACTERIOL, V194, P362, DOI 10.1128/JB.06226-11; Waller JC, 2010, P NATL ACAD SCI USA, V107, P10412, DOI 10.1073/pnas.0911586107; Yeung N, 2011, BIOCHEMISTRY-US, V50, P8957, DOI 10.1021/bi2008883	36	25	25	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14200	14211		10.1074/jbc.M113.460360	http://dx.doi.org/10.1074/jbc.M113.460360			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23543739	Green Published, hybrid			2022-12-28	WOS:000319253500024
J	Hall, JA; Yan, DL				Hall, Jason A.; Yan, Dalai			The Molecular Basis of K+ Exclusion by the Escherichia coli Ammonium Channel AmtB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY PROTEIN; TRANSPORTER AMT-1; CRYSTAL-STRUCTURE; MECHANISM; SUBSTRATE; BACTERIA; FAMILY; NITROGEN; DEPROTONATION; AMT/MEP/RH	Members of the Amt family of channels mediate the transport of ammonium. The form of ammonium, NH3 or NH4+, carried by these proteins remains controversial, and the mechanism by which they select against K+ ions is unclear. We describe here a set of Escherichia coli AmtB proteins carrying mutations at the conserved twin-histidine site within the conduction pore that have altered substrate specificity and now transport K+. Subsequent work established that AmtB-mediated K+ uptake occurred against a concentration gradient and was membrane potential-dependent. These findings indicate that the twin-histidine element serves as a filter to prevent K+ conduction and strongly support the notion that Amt proteins transport cations (NH4+ or, in mutant proteins, K+) rather than NH3 gas molecules through their conduction pores.	[Hall, Jason A.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Yan, Dalai] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	University of California System; University of California San Diego; Indiana University System; Indiana University Bloomington	Hall, JA (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jahall@ucsd.edu			National Institutes of Health [GM38361]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038361, R01GM038361] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM38361 (to Sydney Kustu).	Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Andrade SLA, 2007, MOL MEMBR BIOL, V24, P357, DOI 10.1080/09687680701388423; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BENDER RA, 1977, J BACTERIOL, V132, P100, DOI 10.1128/JB.132.1.100-105.1977; Blakey D, 2002, BIOCHEM J, V364, P527, DOI 10.1042/BJ20011761; Boeckstaens M, 2008, J BIOL CHEM, V283, P21362, DOI 10.1074/jbc.M801467200; Boogerd FC, 2011, FEBS LETT, V585, P23, DOI 10.1016/j.febslet.2010.11.055; Booth IR, 1999, NOVART FDN SYMP, V221, P19; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Bostick DL, 2007, PLOS COMPUT BIOL, V3, P231, DOI 10.1371/journal.pcbi.0030022; BOUSSIBA S, 1984, J BACTERIOL, V160, P204, DOI 10.1128/JB.160.1.204-210.1984; Capone D. G., 2000, MICROBIAL ECOLOGY OC, P455; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; Fong RN, 2007, P NATL ACAD SCI USA, V104, P18706, DOI 10.1073/pnas.0709267104; Gruswitz F, 2007, P NATL ACAD SCI USA, V104, P42, DOI 10.1073/pnas.0609796104; Gruswitz F, 2010, P NATL ACAD SCI USA, V107, P9638, DOI 10.1073/pnas.1003587107; Guether M, 2009, PLANT PHYSIOL, V150, P73, DOI 10.1104/pp.109.136390; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; Hall JA, 2011, P NATL ACAD SCI USA, V108, P13270, DOI 10.1073/pnas.1108451108; Inwood WB, 2009, GENETICS, V183, P1327, DOI 10.1534/genetics.109.103747; Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200; Javelle A, 2008, P NATL ACAD SCI USA, V105, P5040, DOI 10.1073/pnas.0711742105; Javelle A, 2007, J STRUCT BIOL, V159, P243, DOI 10.1016/S1047-8477(07)00165-7; Javelle A, 2006, J BIOL CHEM, V281, P39492, DOI 10.1074/jbc.M608325200; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Kim M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.46; KLEINER D, 1981, BIOCHIM BIOPHYS ACTA, V641, P138, DOI 10.1016/0005-2736(81)90577-0; Li X, 2007, P NATL ACAD SCI USA, V104, P19279, DOI 10.1073/pnas.0709710104; Lin YC, 2009, J PHYS CHEM B, V113, P4922, DOI 10.1021/jp810651m; Loque D, 2009, J BIOL CHEM, V284, P24988, DOI 10.1074/jbc.M109.020842; Ludewig U, 2006, TRANSFUS CLIN BIOL, V13, P111, DOI 10.1016/j.tracli.2006.02.012; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; Lupo D, 2007, P NATL ACAD SCI USA, V104, P19303, DOI 10.1073/pnas.0706563104; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; MILLERO FJ, 2006, CHEM OCEANOGR, P55; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Neuhauser B, 2009, FEBS LETT, V583, P2833, DOI 10.1016/j.febslet.2009.07.039; Nygaard TP, 2006, BIOPHYS J, V91, P4401, DOI 10.1529/biophysj.106.089714; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; RHOADS DB, 1976, J GEN PHYSIOL, V67, P325, DOI 10.1085/jgp.67.3.325; Sogaard R, 2009, PFLUG ARCH EUR J PHY, V458, P733, DOI 10.1007/s00424-009-0665-z; Soupene E, 1998, P NATL ACAD SCI USA, V95, P7030, DOI 10.1073/pnas.95.12.7030; Soupene E, 2003, J BACTERIOL, V185, P5611, DOI 10.1128/JB.185.18.5611-5626.2003; Ullmann RT, 2012, J PHYS CHEM B, V116, P9690, DOI 10.1021/jp305440f; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; WALTER A, 1986, J MEMBRANE BIOL, V90, P207, DOI 10.1007/BF01870127; Walter B, 2008, J BACTERIOL, V190, P2611, DOI 10.1128/JB.01896-07; Wang SH, 2012, J AM CHEM SOC, V134, P10419, DOI 10.1021/ja300129x; Yang HY, 2007, BIOPHYS J, V92, P877, DOI 10.1529/biophysj.106.090191; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101; Zimmer DP, 2000, P NATL ACAD SCI USA, V97, P14674, DOI 10.1073/pnas.97.26.14674	53	15	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14080	14086		10.1074/jbc.M113.457952	http://dx.doi.org/10.1074/jbc.M113.457952			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23546877	Green Published, hybrid			2022-12-28	WOS:000319253500013
J	Zimmerman, KA; Graham, LV; Pallero, MA; Murphy-Ullrich, JE				Zimmerman, Kurt A.; Graham, Lauren V.; Pallero, Manuel A.; Murphy-Ullrich, Joanne E.			Calreticulin Regulates Transforming Growth Factor-beta-stimulated Extracellular Matrix Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; FIBRONECTIN MESSENGER-RNAS; INDUCED PULMONARY-FIBROSIS; UNFOLDED PROTEIN RESPONSE; ALVEOLAR EPITHELIAL-CELLS; HUMAN DERMAL FIBROBLASTS; TGF-BETA; GENE-EXPRESSION; CA2+ INFLUX; LUNG FIBROBLASTS	Endoplasmic reticulum (ER) stress is an emerging factor in fibrotic disease, although precise mechanisms are not clear. Calreticulin (CRT) is an ER chaperone and regulator of Ca2+ signaling up-regulated by ER stress and in fibrotic tissues. Previously, we showed that ER CRT regulates type I collagen transcript, trafficking, secretion, and processing into the extracellular matrix (ECM). To determine the role of CRT in ECM regulation under fibrotic conditions, we asked whether CRT modified cellular responses to the pro-fibrotic cytokine, TGF-beta. These studies show that CRT-/- mouse embryonic fibroblasts (MEFs) and rat and human idiopathic pulmonary fibrosis lung fibroblasts with siRNA CRT knockdown had impaired TGF-beta stimulation of type I collagen and fibronectin. In contrast, fibroblasts with increased CRT expression had enhanced responses to TGF-beta. The lack of CRT does not impact canonical TGF-beta signaling as TGF-beta was able to stimulate Smad reporter activity in CRT-/- MEFs. CRT regulation of TGF-beta-stimulated Ca2(+) signaling is important for induction of ECM. CRT-/- MEFs failed to increase intracellular Ca2(+) levels in response to TGF-beta. NFAT activity is required for ECM stimulation by TGF-beta. In CRT-/- MEFs, TGF-beta stimulation of NFAT nuclear translocation and reporter activity is impaired. Importantly, CRT is required for TGF-beta stimulation of ECM under conditions of ER stress, as tunicamycin-induced ER stress was insufficient to induce ECM production in TGF-beta stimulated CRT-/- MEFs. Together, these data identify CRT-regulated Ca2+-dependent pathways as a critical molecular link between ER stress and TGF-beta fibrotic signaling.	[Zimmerman, Kurt A.; Graham, Lauren V.; Pallero, Manuel A.; Murphy-Ullrich, Joanne E.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Murphy-Ullrich, JE (corresponding author), Univ Alabama Birmingham, Dept Pathol, 668B Volker Hall,1720 2nd Ave S, Birmingham, AL 35294 USA.	murphy@uab.edu			National Institutes of Health [T32 HL007918, T32 GM008361, C06RR15490]; American Heart Association Innovation Grant [12IRG160008]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015490] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008361] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Innovation Grant(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 HL007918 (to K. A. Z.) and T32 GM008361 (to L. V. G.). This work was also supported by American Heart Association Innovation Grant 12IRG160008 (to J. M.-U.).; We thank Drs. Michal Opas (University of Toronto) and Dr. Marek Michalak (University of Alberta) for the generous gifts of L fibroblasts and CRT-/- MEFs and Dr. Victor Thannickal (University of Alabama at Birmingham) for the gift of human IPF lung fibroblasts. We thank Abbott Laboratories for the gift of A285222. We thank Dr. Majd Zayzafoon and Dr. John Chatham, Department of Pathology, University of Alabama at Birmingham for helpful discussions. We also thank Claire Gamlin for work on signaling studies on non-canonical TGF-beta pathways. We also thank Shawn Williams of the University of Alabama at Birmingham High Resolution Imaging Facility for assistance in acquiring confocal images. This work was performed in facilities supported by National Institutes of Health Grant C06RR15490.	Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Ayala P, 2012, EXP MOL PATHOL, V92, P97, DOI 10.1016/j.yexmp.2011.10.012; Baek HA, 2012, AM J RESP CELL MOL, V46, P731, DOI 10.1165/rcmb.2011-0121OC; BAKSH S, 1991, J BIOL CHEM, V266, P21458; Barker TH, 2004, EXP CELL RES, V295, P488, DOI 10.1016/j.yexcr.2004.01.026; BASTIANUTTO C, 1995, J CELL BIOL, V130, P847, DOI 10.1083/jcb.130.4.847; Beriault DR, 2011, ATHEROSCLEROSIS, V219, P134, DOI 10.1016/j.atherosclerosis.2011.07.108; Bowes AJ, 2009, AM J PATHOL, V174, P330, DOI 10.2353/ajpath.2009.080385; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; Cobbs SL, 2007, BIOCHEM BIOPH RES CO, V362, P288, DOI 10.1016/j.bbrc.2007.07.186; Coe H, 2009, GEN PHYSIOL BIOPHYS, V28, pF96; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Cui Y, 2011, INT J BIOCHEM CELL B, V43, P1122, DOI 10.1016/j.biocel.2011.04.005; Davidson JM, 1997, J BIOL CHEM, V272, P345, DOI 10.1074/jbc.272.1.345; DEDHAR S, 1994, NATURE, V367, P480, DOI 10.1038/367480a0; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Gooch JL, 2004, J BIOL CHEM, V279, P15561, DOI 10.1074/jbc.M308759200; Graham LV, 2010, J BIOL CHEM, V285, P7067, DOI 10.1074/jbc.M109.006841; Groenendyk J, 2004, MOL CELLS, V17, P383; Guo L, 2002, J BIOL CHEM, V277, P50776, DOI 10.1074/jbc.M209900200; Hagood JS, 2005, AM J PATHOL, V167, P365, DOI 10.1016/S0002-9440(10)62982-3; Hanafusa H, 1999, J BIOL CHEM, V274, P27161, DOI 10.1074/jbc.274.38.27161; Hattori K, 2007, MOL GENET METAB, V91, P285, DOI 10.1016/j.ymgme.2007.02.003; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; Herum KM, 2013, J MOL CELL CARDIOL, V54, P73, DOI 10.1016/j.yjmcc.2012.11.006; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; INAGAKI Y, 1994, J BIOL CHEM, V269, P14828; Ishiyama N, 1996, MOL CELL ENDOCRINOL, V117, P1, DOI 10.1016/0303-7207(95)03726-8; Isono M, 2002, BIOCHEM BIOPH RES CO, V296, P1356, DOI 10.1016/S0006-291X(02)02084-3; Janowski E, 2011, INT J BIOCHEM CELL B, V43, P1104, DOI 10.1016/j.biocel.2011.03.011; Jayaraman L, 2000, J BIOL CHEM, V275, P40710, DOI 10.1074/jbc.M005799200; Jia LY, 2008, AM J PHYSIOL-CELL PH, V294, pC47, DOI 10.1152/ajpcell.00019.2007; Junn E, 2000, J IMMUNOL, V165, P2190, DOI 10.4049/jimmunol.165.4.2190; Kassan M, 2012, ARTERIOSCL THROM VAS, V32, P1652, DOI 10.1161/ATVBAHA.112.249318; Kelsen SG, 2008, AM J RESP CELL MOL, V38, P541, DOI 10.1165/rcmb.2007-0221OC; Khan MI, 2009, ANTIOXID REDOX SIGN, V11, P2289, DOI [10.1089/ars.2009.2569, 10.1089/ARS.2009.2569]; Knee R, 2003, BIOCHEM BIOPH RES CO, V304, P661, DOI 10.1016/S0006-291X(03)00643-0; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Kurokawa M, 2009, EXP ANIM TOKYO, V58, P113, DOI 10.1538/expanim.58.113; Kypreou KP, 2008, PROTEOMICS, V8, P2407, DOI 10.1002/pmic.200700831; Lawson WE, 2011, P NATL ACAD SCI USA, V108, P10562, DOI 10.1073/pnas.1107559108; Lee GH, 2011, KOREAN J PHYSIOL PHA, V15, P345, DOI 10.4196/kjpp.2011.15.6.345; Lenna S, 2012, CURR OPIN RHEUMATOL, V24, P663, DOI 10.1097/BOR.0b013e3283588dbb; Lynch J, 2005, J CELL BIOL, V170, P37, DOI 10.1083/jcb.200412156; Lynch J, 2003, BIOCHEM BIOPH RES CO, V311, P1173, DOI 10.1016/j.bbrc.2003.08.040; McGowan TA, 2002, AM J PHYSIOL-RENAL, V282, pF910, DOI 10.1152/ajprenal.00252.2001; Mery L, 1996, J BIOL CHEM, V271, P9332, DOI 10.1074/jbc.271.16.9332; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Midwood KS, 2002, METHOD CELL BIOL, V69, P145, DOI 10.1016/S0091-679X(02)69011-9; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; MULDOON LL, 1988, J BIOL CHEM, V263, P18834; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; Nanney LB, 2008, AM J PATHOL, V173, P610, DOI 10.2353/ajpath.2008.071027; Nilsson-Berglund LM, 2010, ARTERIOSCL THROM VAS, V30, P218, DOI 10.1161/ATVBAHA.109.199299; Pallero MA, 2008, FASEB J, V22, P3968, DOI 10.1096/fj.07-104802; Pan CL, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S17; Papp S, 2008, EXP CELL RES, V314, P1313, DOI 10.1016/j.yexcr.2008.01.008; Papp S, 2007, J BIOL CHEM, V282, P16585, DOI 10.1074/jbc.M701011200; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Qi W, 2011, METABOLISM, V60, P594, DOI 10.1016/j.metabol.2010.07.021; RAGHOW R, 1987, J CLIN INVEST, V79, P1285, DOI 10.1172/JCI112950; Rishikof DC, 2004, J CELL BIOCHEM, V91, P740, DOI 10.1002/jcb.10742; Roberts AB, 1998, MINER ELECTROL METAB, V24, P111, DOI 10.1159/000057358; Sage AT, 2010, AM J PHYSIOL-ENDOC M, V298, pE499, DOI 10.1152/ajpendo.00507.2009; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; Srinivasan V, 2009, MOL CELL BIOCHEM, V328, P217, DOI 10.1007/s11010-009-0092-7; Sweetwyne MT, 2010, AM J PATHOL, V177, P1710, DOI 10.2353/ajpath.2010.090903; Tanaka KI, 2012, BIOCHEM BIOPH RES CO, V425, P818, DOI 10.1016/j.bbrc.2012.07.158; Tanjore H, 2011, J BIOL CHEM, V286, P30972, DOI 10.1074/jbc.M110.181164; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Tili E, 2010, BIOCHEM PHARMACOL, V80, P2057, DOI 10.1016/j.bcp.2010.07.003; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Torres-Gonzalez E, 2012, AM J RESP CELL MOL, V46, P748, DOI 10.1165/rcmb.2011-0224OC; Trevillyan JM, 2001, J BIOL CHEM, V276, P48118, DOI 10.1074/jbc.M107919200; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; Vonk LA, 2010, BIOCHEM CELL BIOL, V88, P539, DOI [10.1139/O09-174, 10.1139/o09-174]; Wang JQ, 2013, TOXICOL APPL PHARM, V266, P307, DOI 10.1016/j.taap.2012.11.007; Wrana JL, 2000, CELL, V100, P189, DOI 10.1016/S0092-8674(00)81556-1; Xu W, 2000, J BIOL CHEM, V275, P36676, DOI 10.1074/jbc.M002041200; Yang KL, 2008, BIOCHEM BIOPH RES CO, V365, P484, DOI 10.1016/j.bbrc.2007.10.203; Zhou Y, 2004, AM J PATHOL, V165, P659, DOI 10.1016/S0002-9440(10)63330-5	86	43	44	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14584	14598		10.1074/jbc.M112.447243	http://dx.doi.org/10.1074/jbc.M112.447243			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23564462	Green Published, hybrid			2022-12-28	WOS:000319253500059
J	Aquilina, JA; Shrestha, S; Morris, AM; Ecroyd, H				Aquilina, J. Andrew; Shrestha, Sudichhya; Morris, Amie M.; Ecroyd, Heath			Structural and Functional Aspects of Hetero-oligomers Formed by the Small Heat Shock Proteins alpha B-Crystallin and HSP27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRY REVEALS; CHAPERONE FUNCTION; SUBUNIT EXCHANGE; MOLECULAR CHAPERONES; A-CRYSTALLIN; QUATERNARY DYNAMICS; HUMAN-DISEASE; STATE NMR; PHOSPHORYLATION; POLYDISPERSITY	Small heat shock proteins (sHSPs) exist as large polydisperse species in which there is constant dynamic subunit exchange between oligomeric and dissociated forms. Their primary role in vivo is to bind destabilized proteins and prevent their misfolding and aggregation. alpha B-Crystallin (alpha B) and HSP27 are the two most widely distributed and most studied sHSPs in the human body. They are coexpressed in different tissues, where they are known to associate with each other to form hetero-oligomeric complexes. In this study, we aimed to determine how these two sHSPs interact to form hetero-oligomers in vitro and whether, by doing so, there is an increase in their chaperone activity and stability compared with their homo-oligomeric forms. Our results demonstrate that HSP27 and alpha B formed polydisperse hetero-oligomers in vitro, which had an average molecular mass that was intermediate of each of the homo-oligomers and which were more thermostable than alpha B, but less so than HSP27. The hetero-oligomer chaperone function was found to be equivalent to that of alpha B, with each being significantly better in preventing the amorphous aggregation of alpha-lactalbumin and the amyloid fibril formation of alpha-synuclein in comparison with HSP27. Using mass spectrometry to monitor subunit exchange over time, we found that HSP27 and alpha B exchanged subunits 23% faster than the reported rate for HSP27 and alpha A and almost twice that for alpha A and alpha B. This represents the first quantitative evaluation of alpha B/HSP27 subunit exchange, and the results are discussed in the broader context of regulation of function and cellular proteostasis.	[Aquilina, J. Andrew] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia	University of Wollongong; University of Wollongong	Aquilina, JA (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia.	aquilina@uow.edu.au; heathe@uow.edu.au	Aquilina, J. Andrew/A-5366-2013; Aquilina, John Andrew/AGF-4013-2022; Ecroyd, Heath/E-7140-2015	Ecroyd, Heath/0000-0001-7574-0044	National Health and Medical Research Council [514615]; Australian Research Council [FT110100586]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported in part by National Health and Medical Research Council Grant 514615 (to J. A. A.).; Recipient of Australian Research Council Future Fellowship FT110100586. To whom correspondence may be addressed. Tel.: 61-2-4221-3443; Fax: 61-2-4221-8130; E-mail: heathe@uow.edu.au.	Almeida-Souza L, 2010, J BIOL CHEM, V285, P12778, DOI 10.1074/jbc.M109.082644; Aquilina JA, 2005, J BIOL CHEM, V280, P14485, DOI 10.1074/jbc.M500135200; Aquilina JA, 2004, J BIOL CHEM, V279, P28675, DOI 10.1074/jbc.M403348200; Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Baldwin AJ, 2011, J MOL BIOL, V413, P297, DOI 10.1016/j.jmb.2011.07.016; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Bova MP, 2000, J BIOL CHEM, V275, P1035, DOI 10.1074/jbc.275.2.1035; Bova MP, 1997, J BIOL CHEM, V272, P29511, DOI 10.1074/jbc.272.47.29511; CASSIMAN JJ, 1981, CELL BIOL INT REP, V5, P901, DOI 10.1016/0309-1651(81)90205-8; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; Ecroyd H, 2007, BIOCHEM J, V401, P129, DOI 10.1042/BJ20060981; Fontaine JM, 2005, BIOCHEM BIOPH RES CO, V337, P1006, DOI 10.1016/j.bbrc.2005.09.148; Fu L, 2003, BIOCHEM BIOPH RES CO, V302, P710, DOI 10.1016/S0006-291X(03)00257-2; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; Haley DA, 2000, J MOL BIOL, V298, P261, DOI 10.1006/jmbi.2000.3657; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hayes D, 2009, J BIOL CHEM, V284, P18801, DOI 10.1074/jbc.M109.011353; Horwitz J, 1998, METHOD ENZYMOL, V290, P365, DOI 10.1016/S0076-6879(98)90032-5; Horwitz J, 2000, SEMIN CELL DEV BIOL, V11, P53, DOI 10.1006/scdb.1999.0351; Ito K, 2001, J BIOL CHEM, V276, P5346, DOI 10.1074/jbc.M009004200; Jehle S, 2010, NAT STRUCT MOL BIOL, V17, P1037, DOI 10.1038/nsmb.1891; Jehle S, 2009, J MOL BIOL, V385, P1481, DOI 10.1016/j.jmb.2008.10.097; KATO K, 1994, J BIOL CHEM, V269, P11274; KATO K, 1992, J BIOL CHEM, V267, P7718; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; McDonald ET, 2012, BIOCHEMISTRY-US, V51, P1257, DOI 10.1021/bi2017624; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Rekas A, 2004, J MOL BIOL, V340, P1167, DOI 10.1016/j.jmb.2004.05.054; Sakuma K, 1998, BBA-MOL BASIS DIS, V1406, P162, DOI 10.1016/S0925-4439(97)00094-X; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Sobott F, 2002, J BIOL CHEM, V277, P38921, DOI 10.1074/jbc.M206060200; Stamler R, 2005, J MOL BIOL, V353, P68, DOI 10.1016/j.jmb.2005.08.025; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Voisine C, 2010, NEUROBIOL DIS, V40, P12, DOI 10.1016/j.nbd.2010.05.007; ZANTEMA A, 1992, J BIOL CHEM, V267, P12936	48	53	55	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13602	13609		10.1074/jbc.M112.443812	http://dx.doi.org/10.1074/jbc.M112.443812			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23532854	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000318850300042
J	Cheng, C; Li, WG; Zhang, Z; Yoshimura, S; Hao, QY; Zhang, C; Wang, Z				Cheng, Cong; Li, Weiguang; Zhang, Zheng; Yoshimura, Shohei; Hao, Qinyu; Zhang, Chi; Wang, Zhao			MicroRNA-144 Is Regulated by Activator Protein-1 (AP-1) and Decreases Expression of Alzheimer Disease-related A Disintegrin and Metalloprotease 10 (ADAM10)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; ALPHA-SECRETASE ADAM10; C-JUN; BETA; NEURONS; BRAIN; FOS; TRANSCRIPTION; BINDING; GENES	Amyloid beta-peptide (A beta) accumulating in the brain of Alzheimer disease (AD) patients is believed to be the main pathophysiologcal cause of the disease. Proteolytic processing of the amyloid precursor protein by alpha-secretase ADAM10 (a disintegrin and metalloprotease 10) protects the brain from the production of the A beta. Meanwhile, dysregulation or aberrant expression of microRNAs (miRNAs) has been widely documented in AD patients. In this study, we demonstrated that overexpression of miR-144, which was previously reported to be increased in elderly primate brains and AD patients, significantly decreased activity of the luciferase reporter containing the ADAM10 3'-untranslated region (3'-UTR) and suppressed the ADAM10 protein level, whereas the miR-144 inhibitor led to an increase of the luciferase activity. The negative regulation caused by miR-144 was strictly dependent on the binding of the miRNA to its recognition element in the ADAM10 3'-UTR. Moreover, we also showed that activator protein-1 regulates the transcription of miR-144 and the up-regulation of miR-144 at least partially induces the suppression of the ADAM10 protein in the presence of A beta. In addition, we found that miR-451, a miRNA processed from a single gene locus with miR-144, is also involved in the regulation of ADAM10 expression. Taken together, our data therefore demonstrate miR-144/451 is a negative regulator of the ADAM10 protein and suggest a mechanistic role for miR-144/451 in AD pathogenesis.	[Cheng, Cong; Li, Weiguang; Zhang, Zheng; Hao, Qinyu; Zhang, Chi; Wang, Zhao] Tsinghua Univ, Sch Med, Minist Educ, Prot Sci Key Lab, Beijing 100084, Peoples R China; [Yoshimura, Shohei] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pharmacol, Okayama 7008558, Japan	Tsinghua University; Okayama University	Wang, Z (corresponding author), Tsinghua Univ, Sch Med, Minist Educ, Prot Sci Key Lab, Beijing 100084, Peoples R China.	zwang@tsinghua.edu.cn	Yoshimura, Shohei/HCI-7392-2022; zhang, zheng/HCH-9684-2022	Yoshimura, Shohei/0000-0001-8549-8941; Zhang, Chi/0000-0002-9188-6307	"J&J-Tsinghua Co-managed Fund"; Chinese National Basic Research Program (973 Project) [2007CB507406]	"J&J-Tsinghua Co-managed Fund"; Chinese National Basic Research Program (973 Project)(National Basic Research Program of China)	This work was supported by a grant from the "J&J-Tsinghua Co-managed Fund" and the Chinese National Basic Research Program (973 Project, No. 2007CB507406).	ANDERSON AJ, 1995, J NEUROCHEM, V65, P1487; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Augustin R, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-35; Bai SM, 2009, J BIOL CHEM, V284, P32015, DOI 10.1074/jbc.M109.016774; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein HG, 2003, J NEUROCYTOL, V32, P153, DOI 10.1023/B:NEUR.0000005600.61844.a6; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Boissonneault V, 2009, J BIOL CHEM, V284, P1971, DOI 10.1074/jbc.M807530200; Bozyczko-Coyne D, 2002, CNS NEUROL DISORD-DR, V1, P31, DOI 10.2174/1568007023339472; Chien CH, 2011, NUCLEIC ACIDS RES, V39, P9345, DOI 10.1093/nar/gkr604; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; Colciaghi F, 2002, MOL MED, V8, P67, DOI 10.1007/BF03402076; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; de la Monte SM, 2012, CURR ALZHEIMER RES, V9, P35; Doberstein K, 2011, CARCINOGENESIS, V32, P1713, DOI 10.1093/carcin/bgr195; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Fellgiebel A, 2009, J GERIATR PSYCH NEUR, V22, P3, DOI 10.1177/0891988708327810; Galardi S, 2011, NUCLEIC ACIDS RES, V39, P3892, DOI 10.1093/nar/gkr006; Gatta LB, 2002, NEUROREPORT, V13, P2031, DOI 10.1097/00001756-200211150-00008; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Hansson MD, 2008, ANAL BIOCHEM, V375, P373, DOI 10.1016/j.ab.2007.12.005; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Hebert SS, 2009, NEUROBIOL DIS, V33, P422, DOI 10.1016/j.nbd.2008.11.009; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Kawaji H, 2011, NUCLEIC ACIDS RES, V39, pD856, DOI 10.1093/nar/gkq1112; Kawaji H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r40; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lammich S, 2010, J BIOL CHEM, V285, P15753, DOI 10.1074/jbc.M110.110742; Laneve P, 2010, NUCLEIC ACIDS RES, V38, P6895, DOI 10.1093/nar/gkq604; Lee SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022312; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu W, 2012, NEUROBIOL AGING, V33, P522, DOI 10.1016/j.neurobiolaging.2010.04.034; Long JM, 2011, BIOCHEM BIOPH RES CO, V404, P889, DOI 10.1016/j.bbrc.2010.12.053; Marcus DL, 1998, NEUROBIOL AGING, V19, P393, DOI 10.1016/S0197-4580(98)00077-3; Mehler MF, 2006, J PHYSIOL-LONDON, V575, P333, DOI 10.1113/jphysiol.2006.113191; Misawa A, 2010, ONCOL RES, V19, P23, DOI 10.3727/096504010X12828372551759; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Patel N, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-10; Persengiev S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.014; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Postina R, 2008, CURR ALZHEIMER RES, V5, P179, DOI 10.2174/156720508783954668; Prinzen C, 2005, FASEB J, V19, P1522, DOI 10.1096/fj.04-3619fje; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sennvik K, 2000, NEUROSCI LETT, V278, P169, DOI 10.1016/S0304-3940(99)00929-5; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Thakur A, 2007, J NEUROSCI RES, V85, P1668, DOI 10.1002/jnr.21298; Vilardo E, 2010, J BIOL CHEM, V285, P18344, DOI 10.1074/jbc.M110.112664; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Vukic V, 2009, NEUROBIOL DIS, V34, P95, DOI 10.1016/j.nbd.2008.12.007; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Xu J, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-01-j0001.2001; Yankner BA, 2000, NATURE, V404, P125, DOI 10.1038/35004673; Yin KJ, 2002, J NEUROSCI, V22, P9764; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zhang XW, 2010, J MOL CELL CARDIOL, V49, P841, DOI 10.1016/j.yjmcc.2010.08.007; Zhu Q, 2012, ONCOL REP, V27, P1660, DOI 10.3892/or.2012.1682; Zhu XW, 2001, J NEUROCHEM, V76, P435, DOI 10.1046/j.1471-4159.2001.00046.x	70	72	77	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13748	13761		10.1074/jbc.M112.381392	http://dx.doi.org/10.1074/jbc.M112.381392			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23546882	Green Published, hybrid			2022-12-28	WOS:000318850300057
J	Kuo, JH; Chen, YP; Liu, JS; Dubrac, A; Quemener, C; Prats, H; Bikfalvi, A; Wu, WG; Sue, SC				Kuo, Je-Hung; Chen, Ya-Ping; Liu, Jai-Shin; Dubrac, Alexandre; Quemener, Cathy; Prats, Herve; Bikfalvi, Andreas; Wu, Wen-guey; Sue, Shih-Che			Alternative C-Terminal Helix Orientation Alters Chemokine Function STRUCTURE OF THE ANTI-ANGIOGENIC CHEMOKINE, CXCL4L1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-DERIVED CHEMOKINES; PLATELET-FACTOR-4 VARIANT; INHIBITS ANGIOGENESIS; CXC CHEMOKINES; SYSTEM; ATHEROSCLEROSIS; MELANOMA; TARGETS; HEPARIN; GROWTH	Chemokines, a subfamily of cytokines, are small, secreted proteins that mediate a variety of biological processes. Various chemokines adopt remarkable conserved tertiary structure comprising an anti-parallel beta-sheet core domain followed by a C-terminal helix that packs onto the beta-sheet. The conserved structural feature has been considered critical for chemokine function, including binding to cell surface receptor. The recently isolated variant, CXCL4L1, is a homologue of CXCL4 chemokine (or platelet factor 4) with potent anti-angiogenic activity and differed only in three amino acid residues of P58L, K66E, and L67H. In this study we show by x-ray structural determination that CXCL4L1 adopts a previously unrecognized structure at its C terminus. The orientation of the C-terminal helix protrudes into the aqueous space to expose the entire helix. The alternative helix orientation modifies the overall chemokine shape and surface properties. The L67H mutation is mainly responsible for the swing-out effect of the helix, whereas mutations of P58L and K66E only act secondarily. This is the first observation that reports an open conformation of the C-terminal helix in a chemokine. This change leads to a decrease of its glycosaminoglycan binding properties and to an enhancement of its anti-angiogenic and anti-tumor effects. This unique structure is recent in evolution and has allowed CXCL4L1 to gain novel functional properties.	[Wu, Wen-guey; Sue, Shih-Che] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Wu, Wen-guey; Sue, Shih-Che] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan; [Dubrac, Alexandre; Quemener, Cathy; Bikfalvi, Andreas] Univ Bordeaux, F-33405 Talence, France; [Dubrac, Alexandre; Bikfalvi, Andreas] INSERM, U1029, F-33405 Talence, France; [Prats, Herve] INSERM, U1037, F-31432 Toulouse, France	National Tsing Hua University; National Tsing Hua University; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)	Wu, WG (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan.	wgwu@life.nthu.edu.tw; scsue@life.nthu.edu.tw	Prats, Hervé/M-4495-2014; Dubrac, Alexandre/AAQ-9515-2021	Prats, Hervé/0000-0002-4861-2167; Dubrac, Alexandre/0000-0002-3829-2577; Kuo, Je-Hung/0000-0002-5499-8027	Taiwan National Science Council; National Tsing Hua University; Chang Gung Memorial Hospital; Agence National pour le Recherche; National Cancer Institute (INCA); Ligue National du Cancer grants	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Tsing Hua University; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Agence National pour le Recherche(French National Research Agency (ANR)); National Cancer Institute (INCA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)Institut National du Cancer (INCA) France); Ligue National du Cancer grants	This work was supported by Taiwan National Science Council grants (to W.-g. W. and S.-C. S.), a National Tsing Hua University and Chang Gung Memorial Hospital joint research grant (to S.-C. S.), an Agence National pour le Recherche grant, a National Cancer Institute (INCA) grant, and by Ligue National du Cancer grants (to A.B.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aidoudi S, 2010, THROMB HAEMOSTASIS, V104, P941, DOI 10.1160/TH10-03-0193; Aidoudi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002657; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Auerbach DJ, 2012, P NATL ACAD SCI USA, V109, P9569, DOI 10.1073/pnas.1207314109; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balestrieri ML, 2008, CARDIOVASC RES, V78, P250, DOI 10.1093/cvr/cvn029; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Bikfalvi A, 2012, HAND CLINIC, V104, P35, DOI 10.1016/B978-0-444-52138-5.00003-7; Bikfalvi A, 2011, BIOCHEM SOC T, V39, P1560, DOI 10.1042/BST20110710; Bikfalvi Andreas, 2009, Journal de la Societe de Biologie, V203, P167, DOI 10.1051/jbio/2009020; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; de Jong EK, 2008, J NEUROCHEM, V105, P1726, DOI 10.1111/j.1471-4159.2008.05267.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dubrac A, 2010, BLOOD, V116, P4703, DOI 10.1182/blood-2010-03-274852; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiore MM, 2009, BIOCHEM BIOPH RES CO, V379, P1072, DOI 10.1016/j.bbrc.2009.01.016; Flad HD, 2010, CELL MOL LIFE SCI, V67, P2363, DOI 10.1007/s00018-010-0306-x; Gleissner CA, 2008, ARTERIOSCL THROM VAS, V28, P1920, DOI 10.1161/ATVBAHA.108.169417; Gleissner CA, 2012, CURR VASC PHARMACOL, V10, P563; Goddard T. D., SPARKY 3; Gouwy M, 2008, MOL PHARMACOL, V74, P485, DOI 10.1124/mol.108.045146; Keeley EC, 2011, EXP CELL RES, V317, P685, DOI 10.1016/j.yexcr.2010.10.020; Kiefer F, 2011, CELL MOL LIFE SCI, V68, P2811, DOI 10.1007/s00018-011-0677-7; Koelink PJ, 2012, PHARMACOL THERAPEUT, V133, P1, DOI 10.1016/j.pharmthera.2011.06.008; Koenen RR, 2011, EMBO MOL MED, V3, P713, DOI 10.1002/emmm.201100183; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Kowalska MA, 2010, THROMB RES, V125, P292, DOI 10.1016/j.thromres.2009.11.023; Lasagni L, 2007, BLOOD, V109, P4127, DOI 10.1182/blood-2006-10-052035; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lortat-Jacob H, 2002, P NATL ACAD SCI USA, V99, P1229, DOI 10.1073/pnas.032497699; MAYO KH, 1995, BIOCHEMISTRY-US, V34, P11399, DOI 10.1021/bi00036a012; Mukaida N, 2012, EXP CELL RES, V318, P95, DOI 10.1016/j.yexcr.2011.10.012; Nesmelova IV, 2008, J BIOL CHEM, V283, P24155, DOI 10.1074/jbc.M803308200; Nesmelova IV, 2005, J BIOL CHEM, V280, P4948, DOI 10.1074/jbc.M405364200; Nomiyama H, 2010, CYTOKINE GROWTH F R, V21, P253, DOI 10.1016/j.cytogfr.2010.03.004; Pouplard C, 1999, CIRCULATION, V99, P2530, DOI 10.1161/01.CIR.99.19.2530; Raman D, 2011, EXP CELL RES, V317, P575, DOI 10.1016/j.yexcr.2011.01.005; Reilly MP, 2001, BLOOD, V98, P2442, DOI 10.1182/blood.V98.8.2442; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Sarabi A, 2011, J THROMB HAEMOST, V9, P209, DOI 10.1111/j.1538-7836.2010.04119.x; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Schwartzkopff F, 2009, INNATE IMMUN-LONDON, V15, P368, DOI 10.1177/1753425909106171; Struyf S, 2004, CIRC RES, V95, P855, DOI 10.1161/01.RES.0000146674.38319.07; Struyf S, 2007, CANCER RES, V67, P5940, DOI 10.1158/0008-5472.CAN-06-4682; Struyf S, 2011, BLOOD, V117, P480, DOI 10.1182/blood-2009-11-253591; Van Sweringen HL, 2011, HEPATOLOGY, V54, P1445, DOI 10.1002/hep.24457; Vandercappellen J, 2011, CYTOKINE GROWTH F R, V22, P1, DOI 10.1016/j.cytogfr.2010.10.011; Vandercappellen J, 2010, MOL CANCER RES, V8, P322, DOI 10.1158/1541-7786.MCR-09-0176; Wang YL, 2010, J BIOL CHEM, V285, P37872, DOI 10.1074/jbc.M110.146290; Yeaman MR, 2007, BBA-BIOMEMBRANES, V1768, P609, DOI 10.1016/j.bbamem.2006.11.010; ZHANG XH, 1994, BIOCHEMISTRY-US, V33, P8361, DOI 10.1021/bi00193a025; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	55	21	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13522	13533		10.1074/jbc.M113.455329	http://dx.doi.org/10.1074/jbc.M113.455329			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23536183	Green Published, hybrid			2022-12-28	WOS:000318850300036
J	Lum, MA; Pundt, KE; Paluch, BE; Black, AR; Black, JD				Lum, Michelle A.; Pundt, Krista E.; Paluch, Benjamin E.; Black, Adrian R.; Black, Jennifer D.			Agonist-induced Down-regulation of Endogenous Protein Kinase C alpha through an Endolysosomal Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAFT-DEPENDENT ENDOCYTOSIS; CLOSTRIDIUM-DIFFICILE TOXINS; INTESTINAL EPITHELIAL-CELLS; HAMSTER OVARY CELLS; PKC-ALPHA; PHORBOL ESTER; LIPID RAFTS; INDEPENDENT MECHANISM; DOPAMINE TRANSPORTER; RECYCLING ENDOSOMES	Protein kinase C (PKC) isozymes undergo down-regulation upon sustained stimulation. Previous studies have pointed to the existence of both proteasome-dependent and -independent pathways of PKC alpha processing. Here we demonstrate that these down-regulation pathways are engaged in different subcellular compartments; proteasomal degradation occurs mainly at the plasma membrane, whereas non-proteasomal processing occurs in the perinuclear region. Using cholesterol depletion, pharmacological inhibitors, RNA interference, and dominant-negative mutants, we define the mechanisms involved in perinuclear accumulation of PKC alpha and identify the non-proteasomal mechanism mediating its degradation. We show that intracellular accumulation of PKC alpha involves at least two clathrin-independent, cholesterol/lipid raft-mediated pathways that do not require ubiquitination of the protein; one is dynamin-dependent and likely involves caveolae, whereas the other is dynaminand small GTPase-independent. Internalized PKC alpha traffics through endosomes and is delivered to the lysosome for degradation. Supportive evidence includes (a) detection of the enzyme in EEA1-positive early endosomes, Rab7-positive late endosomes/multivesicular bodies, and LAMP1-positive lysosomes and (b) inhibition of its down-regulation by lysosome-disrupting agents and leupeptin. Only limited dephosphorylation of PKC alpha occurs during trafficking, with fully mature enzyme being the main target for lysosomal degradation. These studies define a novel and widespread mechanism of desensitization of PKC alpha signaling that involves endocytic trafficking and lysosome-mediated degradation of the mature, fully phosphorylated protein.	[Lum, Michelle A.; Black, Adrian R.; Black, Jennifer D.] Univ Nebraska Med Ctr, Eppley Inst, Omaha, NE 68198 USA; [Lum, Michelle A.; Pundt, Krista E.; Paluch, Benjamin E.; Black, Adrian R.; Black, Jennifer D.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	University of Nebraska System; University of Nebraska Medical Center; Roswell Park Cancer Institute	Black, JD (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	jennifer.black@unmc.edu			National Institutes of Health [DK60632, DK54909, CA16056, CA036727]; NATIONAL CANCER INSTITUTE [P30CA036727, P30CA016056, T32CA009072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK060632, R01DK054909, R01DK060632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK60632, DK54909, CA16056, and CA036727.	Abrahamsen H, 2012, J BIOL CHEM, V287, P13262, DOI 10.1074/jbc.M112.349753; Agostinelli E, 2007, INT J ONCOL, V31, P473; ALLEN LAH, 1995, EMBO J, V14, P1109, DOI 10.1002/j.1460-2075.1995.tb07094.x; Alvi F, 2007, CELL MOL LIFE SCI, V64, P263, DOI 10.1007/s00018-006-6363-5; Black JD, 2001, GASTROENTEROLOGY, V120, P1868, DOI 10.1053/gast.2001.25287; Black JD, 2000, FRONT BIOSCI-LANDMRK, V5, pD406, DOI 10.2741/Black; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Caino MC, 2011, J BIOL CHEM, V286, P11254, DOI 10.1074/jbc.M110.194332; Carmena D, 2007, BIOCHEM SOC T, V35, P1043, DOI 10.1042/BST0351043; Chua T, 1998, FEBS LETT, V436, P439, DOI 10.1016/S0014-5793(98)01161-2; CLEMENS MJ, 1992, J CELL SCI, V103, P881; COULDWELL WT, 1991, NEUROSURGERY, V29, P880, DOI 10.1227/00006123-199112000-00013; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; da Rocha AB, 2002, ONCOLOGIST, V7, P17, DOI 10.1634/theoncologist.7-1-17; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; de Diego I, 2002, J BIOL CHEM, V277, P32187, DOI 10.1074/jbc.M205499200; Decathelineau AM, 2009, INFECT IMMUN, V77, P348, DOI 10.1128/IAI.01005-08; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Faghiri Z, 2006, INVEST OPHTH VIS SCI, V47, P397, DOI 10.1167/iovs.05-0290; Favit A, 1998, P NATL ACAD SCI USA, V95, P5562, DOI 10.1073/pnas.95.10.5562; Feng X, 1998, J BIOL CHEM, V273, P26870, DOI 10.1074/jbc.273.41.26870; Feng X, 1998, J BIOL CHEM, V273, P10755, DOI 10.1074/jbc.273.17.10755; Fields AP, 2007, PHARMACOL RES, V55, P487, DOI 10.1016/j.phrs.2007.04.015; Finger EC, 2008, J BIOL CHEM, V283, P34808, DOI 10.1074/jbc.M804741200; FIORENTINI C, 1989, TOXICON, V27, P1209, DOI 10.1016/0041-0101(89)90029-9; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Genth H, 2008, INT J BIOCHEM CELL B, V40, P592, DOI 10.1016/j.biocel.2007.12.014; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Gould CM, 2008, CURR DRUG TARGETS, V9, P614, DOI 10.2174/138945008785132411; Gutcher I, 2003, CELL MOL LIFE SCI, V60, P1061, DOI 10.1007/s00018-003-2281-y; Hamer I, 1998, BIOCHEM J, V329, P183, DOI 10.1042/bj3290183; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; Hansra G, 1996, J BIOL CHEM, V271, P32785, DOI 10.1074/jbc.271.51.32785; Hansra G, 1999, BIOCHEM J, V342, P337, DOI 10.1042/0264-6021:3420337; HATCH GM, 1993, J LIPID RES, V34, P1873; Heikkila O, 2010, J VIROL, V84, P3666, DOI 10.1128/JVI.01340-09; Hing JDNY, 2004, BIOCHEM BIOPH RES CO, V319, P810, DOI 10.1016/j.bbrc.2004.05.054; Hippenstiel S, 2002, AM J PHYSIOL-LUNG C, V283, pL830, DOI 10.1152/ajplung.00467.2001; HONG DH, 1995, BBA-MOL CELL RES, V1267, P45, DOI 10.1016/0167-4889(95)00024-M; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Junoy B, 2002, ENDOCRINOLOGY, V143, P1386, DOI 10.1210/en.143.4.1386; JUST I, 1994, J BIOL CHEM, V269, P10706; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Kermorgant S, 2005, CELL CYCLE, V4, P352, DOI 10.4161/cc.4.3.1519; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; KISHIMOTO A, 1989, J BIOL CHEM, V264, P4088; Kojic LD, 2007, J BIOL CHEM, V282, P29305, DOI 10.1074/jbc.M704069200; Kojic LD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003597; Lahn M, 2004, ONCOLOGY-BASEL, V67, P1, DOI 10.1159/000080279; Lahn M, 2004, BJU INT, V93, P1076, DOI 10.1111/j.1464-410X.2003.04784.x; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Le PU, 2003, J CELL SCI, V116, P1059, DOI 10.1242/jcs.00327; Lee HW, 1996, AM J PHYSIOL-CELL PH, V271, pC304, DOI 10.1152/ajpcell.1996.271.1.C304; Lee HW, 1996, J BIOL CHEM, V271, P20973, DOI 10.1074/jbc.271.35.20973; Lee HW, 1997, MOL PHARMACOL, V51, P439; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Lu A, 2009, J CELL BIOL, V184, P863, DOI 10.1083/jcb.200807186; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Maccario H, 2004, NEUROENDOCRINOLOGY, V79, P204, DOI 10.1159/000078102; Manna PT, 2010, J BIOL CHEM, V285, P5963, DOI 10.1074/jbc.M109.066902; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Melnikov S, 2009, CELL SIGNAL, V21, P1607, DOI 10.1016/j.cellsig.2009.06.007; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Misinzo G, 2005, J GEN VIROL, V86, P2057, DOI 10.1099/vir.0.80652-0; Moskowitz HS, 2005, MOL BIOL CELL, V16, P1769, DOI 10.1091/mbc.E04-08-0739; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nankoe SR, 2006, TRENDS CELL BIOL, V16, P607, DOI 10.1016/j.tcb.2006.10.004; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Okamoto Y, 2000, J BIOL CHEM, V275, P6439, DOI 10.1074/jbc.275.9.6439; OLIVIER AR, 1994, J BIOL CHEM, V269, P2758; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; PARKER PJ, 1995, BIOCHEM SOC T, V23, P153, DOI 10.1042/bst0230153; Prevostel C, 2000, J CELL SCI, V113, P2575; Pysz MA, 2009, EXP CELL RES, V315, P1415, DOI 10.1016/j.yexcr.2009.02.002; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; SAVART M, 1992, INT J CANCER, V52, P399, DOI 10.1002/ijc.2910520312; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Srivastava J, 2002, BIOCHEM J, V368, P349, DOI 10.1042/BJ20020737; STYRT B, 1986, BLOOD, V67, P334; Szallasi Z, 1996, CANCER RES, V56, P2105; TAPPER H, 1995, J LEUKOCYTE BIOL, V58, P485, DOI 10.1002/jlb.58.4.485; Torgersen ML, 2001, J CELL SCI, V114, P3737; van der Aa MAEM, 2007, PHARM RES-DORDR, V24, P1590, DOI 10.1007/s11095-007-9287-3; Vassilieva EV, 2008, AM J PHYSIOL-GASTR L, V295, pG965, DOI 10.1152/ajpgi.00082.2008; Vercauteren D, 2010, MOL THER, V18, P561, DOI 10.1038/mt.2009.281; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Wang TL, 2011, CELL SIGNAL, V23, P516, DOI 10.1016/j.cellsig.2010.09.012; Ward NE, 2000, BIOCHEMISTRY-US, V39, P10319, DOI 10.1021/bi000781g; Yanagawa Y, 2003, BLOOD, V101, P4923, DOI 10.1182/blood-2002-11-3474; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zemskov EA, 2003, NEUROREPORT, V14, P1435, DOI 10.1097/00001756-200308060-00006	106	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13093	13109		10.1074/jbc.M112.437061	http://dx.doi.org/10.1074/jbc.M112.437061			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23508961	Green Published, hybrid			2022-12-28	WOS:000318555100060
J	Sulthana, S; Deutscher, MP				Sulthana, Shaheen; Deutscher, Murray P.			Multiple Exoribonucleases Catalyze Maturation of the 3 ' Terminus of 16S Ribosomal RNA (rRNA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; POLYNUCLEOTIDE PHOSPHORYLASE; BACILLUS-SUBTILIS; QUALITY-CONTROL; IN-VIVO; PRECURSORS; ENCODES; PROTEIN; PLAYS; YBEY	Processing of ribosomal RNA (rRNA) precursors is an important component of RNA metabolism in all cells. However, in no system have we yet identified all the RNases involved in this process. Here, we show that four 3'-> 5'-exoribonucleases, RNases II, R, and PH, and polynucleotide phosphorylase (PNPase), participate in maturation of the 3' end of 16S rRNA. In their absence, 16S precursor molecules with 33 extra 3'-nt accumulate; however, the presence of any one of the four RNases is sufficient to allow processing to occur, although with different efficiencies. Additionally, we find that in the absence of 3' maturation, 5' processing proceeds much less efficiently. Moreover, mutant 30S particles, containing immature 16S rRNA, form 70S ribosomes very poorly. These findings, together with the earlier discovery that RNases E and G are the 5'-processing enzymes, completes the catalogue of RNases involved in maturation of Escherichia coli 16S rRNA.	[Sulthana, Shaheen; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.	mdeutsch@med.miami.edu			National Institutes of Health [GM16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM016317, R01GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM16317 (to M. P. D.).	APIRION D, 1993, BIOESSAYS, V15, P113, DOI 10.1002/bies.950150207; Basturea GN, 2011, RNA, V17, P338, DOI 10.1261/rna.2448911; Bollenbach TJ, 2005, NUCLEIC ACIDS RES, V33, P2751, DOI 10.1093/nar/gki576; Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100; Cheng ZF, 1998, J BIOL CHEM, V273, P14077, DOI 10.1074/jbc.273.23.14077; Davies BW, 2010, MOL MICROBIOL, V78, P506, DOI 10.1111/j.1365-2958.2010.07351.x; Deutscher MP, 2009, PROG MOL BIOL TRANSL, V85, P369, DOI 10.1016/S0079-6603(08)00809-X; DONOVAN WP, 1986, P NATL ACAD SCI USA, V83, P120, DOI 10.1073/pnas.83.1.120; DUNN JJ, 1973, P NATL ACAD SCI USA, V70, P3296, DOI 10.1073/pnas.70.12.3296; Gutgsell NS, 2012, RNA, V18, P345, DOI 10.1261/rna.027854.111; HUANG S, 1992, J BIOL CHEM, V267, P25609; Jacob AI, 2013, MOL CELL, V49, P427, DOI 10.1016/j.molcel.2012.11.025; LI ZW, 1995, P NATL ACAD SCI USA, V92, P6883, DOI 10.1073/pnas.92.15.6883; Li ZW, 1999, RNA, V5, P139, DOI 10.1017/S1355838299981669; Li ZW, 1998, P NATL ACAD SCI USA, V95, P2856, DOI 10.1073/pnas.95.6.2856; Li ZW, 1999, EMBO J, V18, P2878, DOI 10.1093/emboj/18.10.2878; Li ZW, 1996, CELL, V86, P503, DOI 10.1016/S0092-8674(00)80123-3; Pellegrini O, 2003, EMBO J, V22, P4534, DOI 10.1093/emboj/cdg435; Purusharth RI, 2007, J BIOL CHEM, V282, P16267, DOI 10.1074/jbc.M605588200; Redko Y, 2008, MOL MICROBIOL, V68, P1096, DOI 10.1111/j.1365-2958.2008.06207.x; SOGIN ML, 1977, J BIOL CHEM, V252, P1350; SRIVASTAVA AK, 1991, BIOCHIMIE, V73, P631, DOI 10.1016/0300-9084(91)90042-Y; Wachi M, 1999, BIOCHEM BIOPH RES CO, V259, P483, DOI 10.1006/bbrc.1999.0806; Zhou ZH, 1997, J BACTERIOL, V179, P4391, DOI 10.1128/jb.179.13.4391-4395.1997	24	52	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12574	12579		10.1074/jbc.C113.459172	http://dx.doi.org/10.1074/jbc.C113.459172			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23532845	Green Published, hybrid			2022-12-28	WOS:000318555100016
J	Tahmasebi, S; Ghorbani, M; Savage, P; Yan, KZ; Gocevski, G; Xiao, L; You, LY; Yang, XJ				Tahmasebi, Soroush; Ghorbani, Mohammad; Savage, Paul; Yan, Kezhi; Gocevski, Goran; Xiao, Lin; You, Linya; Yang, Xiang-Jiao			Sumoylation of Kruppel-like Factor 4 Inhibits Pluripotency Induction but Promotes Adipocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; TRANSCRIPTIONAL ACTIVITY; SUMO-1 MODIFICATION; DIRECT CONVERSION; HUMAN FIBROBLASTS; DNA-BINDING; PHOSPHORYLATION; MOTIF; KLF4; UBIQUITIN	Ectopic expression of transcription factors has been shown to reprogram somatic cells into induced pluripotent stem (iPS) cells. It remains largely unexplored how this process is regulated by post-translational modifications. Several reprogramming factors possess conserved sumoylation sites, so we investigated whether and how this modification regulates reprogramming of fibroblasts into iPS cells. Substitution of the sole sumoylation site of the Kruppel-like factor (KLF4), a well known reprogramming factor, promoted iPS cell formation. In comparison, much smaller effects on reprogramming were observed for sumoylation-deficient mutants of SOX2 and OCT4, two other classical reprogramming factors. We also analyzed KLF2, a KLF4 homolog and a member of the KLF family of transcription factors with a known role in reprogramming. KLF2 was sumoylated at two conserved neighboring motifs, but substitution of the key lysine residues only stimulated reprogramming slightly. KLF5 is another KLF member with an established link to embryonic stem cell pluripotency. Interestingly, although it was much more efficiently sumoylated than either KLF2 or KLF4, KLF5 was inactive in reprogramming, and its sumoylation was not responsible for this deficiency. Furthermore, sumoylation of KLF4 but not KLF2 or KLF5 stimulated adipocyte differentiation. These results thus demonstrate the importance KLF4 sumoylation in regulating pluripotency and adipocyte differentiation.	[Tahmasebi, Soroush; Ghorbani, Mohammad; Savage, Paul; Yan, Kezhi; Gocevski, Goran; Xiao, Lin; You, Linya; Yang, Xiang-Jiao] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Tahmasebi, Soroush; Yang, Xiang-Jiao] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 1A3, Canada; [Savage, Paul; Yan, Kezhi; Yang, Xiang-Jiao] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Ghorbani, Mohammad; Gocevski, Goran; Xiao, Lin; You, Linya; Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3A 1A3, Canada	McGill University; McGill University; McGill University; McGill University	Yang, XJ (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.	xiang-jiao.yang@mcgill.ca		You, Linya/0000-0002-2569-0269	Natural Sciences and Engineering Research Council of Canada; Ministere du Developpement Economique, Innovation et Exportation du Quebec; Faculty of Medicine, McGill University; Goodman Cancer Research Center, McGill University, Montreal, Quebec, Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ministere du Developpement Economique, Innovation et Exportation du Quebec; Faculty of Medicine, McGill University; Goodman Cancer Research Center, McGill University, Montreal, Quebec, Canada	This work was supported in part by operating grants from Natural Sciences and Engineering Research Council of Canada and Ministere du Developpement Economique, Innovation et Exportation du Quebec (to X. J. Y.).; Supported in part by studentships from the Faculty of Medicine, McGill University.; Awarded a studentship by the Natural Sciences and Engineering Research Council of Canada.; Recipient of a Canderel studentship from Goodman Cancer Research Center, McGill University, Montreal, Quebec, Canada.	Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Blomster HA, 2009, MOL CELL PROTEOMICS, V8, P1382, DOI 10.1074/mcp.M800551-MCP200; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brey CW, 2009, INT J BIOL SCI, V5, P622; Cao ZX, 2010, BLOOD, V116, P4404, DOI 10.1182/blood-2010-05-285353; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Du JX, 2010, J BIOL CHEM, V285, P28298, DOI 10.1074/jbc.M110.101717; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Gagnon AM, 1998, OBES RES, V6, P157, DOI 10.1002/j.1550-8528.1998.tb00330.x; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gray JS, 2010, BIOLOGICALS, V38, P273, DOI 10.1016/j.biologicals.2009.09.006; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kawai-Kowase K, 2009, ARTERIOSCL THROM VAS, V29, P99, DOI 10.1161/ATVBAHA.108.172700; Komatsu T, 2004, MOL ENDOCRINOL, V18, P2451, DOI 10.1210/me.2004-0173; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mohideen F, 2009, NAT STRUCT MOL BIOL, V16, P945, DOI 10.1038/nsmb.1648; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Oishi Y, 2008, NAT MED, V14, P656, DOI 10.1038/nm1756; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Siatecka M, 2007, MOL CELL BIOL, V27, P8547, DOI 10.1128/MCB.00589-07; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tolkunova E, 2007, J MOL BIOL, V374, P1200, DOI 10.1016/j.jmb.2007.09.081; Tremblay AM, 2008, MOL ENDOCRINOL, V22, P570, DOI 10.1210/me.2007-0357; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Wei HJ, 2006, J BIOL CHEM, V281, P16664, DOI 10.1074/jbc.M513135200; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; Wu YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039606; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2006, MOL CELL, V23, P779, DOI 10.1016/j.molcel.2006.08.009; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	72	34	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12791	12804		10.1074/jbc.M113.465443	http://dx.doi.org/10.1074/jbc.M113.465443			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23515309	Green Published, hybrid			2022-12-28	WOS:000318555100035
J	Than, JYXL; Li, L; Hasan, R; Zhang, XM				Than, Jonathan Y. -X. L.; Li, Lin; Hasan, Raquibul; Zhang, Xuming			Excitation and Modulation of TRPA1, TRPV1, and TRPM8 Channel-expressing Sensory Neurons by the Pruritogen Chloroquine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CHANNEL; COLD; RECEPTOR; PAIN; HISTAMINE; G-ALPHA(Q/11); NOCICEPTORS; SENSATION	The sensations of pain, itch, and cold often interact with each other. Pain inhibits itch, whereas cold inhibits both pain and itch. TRPV1 and TRPA1 channels transduce pain and itch, whereas TRPM8 transduces cold. The pruritogen chloroquine (CQ) was reported to excite TRPA1, leading to the sensation of itch. It is unclear how CQ excites and modulates TRPA1(+), TRPV1(+), and TRPM8(+) neurons and thus affects the sensations of pain, itch, and cold. Here, we show that only 43% of CQ-excited dorsal root ganglion neurons expressed TRPA1; as expected, the responses of these neurons were completely prevented by the TRPA1 antagonist HC-030031. The remaining 57% of CQ-excited neurons did not express TRPA1, and excitation was not prevented by either a TRPA1 or TRPV1 antagonist but was prevented by the general transient receptor potential canonical (TRPC) channel blocker BTP2 and the selective TRPC3 inhibitor Pyr3. Furthermore, CQ caused potent sensitization of TRPV1 in 51.9% of TRPV1(+) neurons and concomitant inhibition of TRPM8 in 48.8% of TRPM8(+) dorsal root ganglion neurons. Sensitization of TRPV1 is caused mainly by activation of the phospholipase C-PKC pathway following activation of the CQ receptor MrgprA3. By contrast, inhibition of TRPM8 is caused by a direct action of activated G alpha(q) independent of the phospholipase C pathway. Our data suggest the involvement of the TRPC3 channel acting together with TRPA1 to mediate CQ-induced itch. CQ not only elicits itch by directly exciting itch-encoding neurons but also exerts previously unappreciated widespread actions on pain-, itch-, and cold-sensing neurons, leading to enhanced pain and itch.	[Than, Jonathan Y. -X. L.; Li, Lin; Hasan, Raquibul; Zhang, Xuming] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	Zhang, XM (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	xz213@cam.ac.uk		Zhang, Xuming/0000-0002-5331-8675; Than, Jonathan/0000-0002-0665-7359	Medical Research Council [G0801387]; Islamic Development Bank scholarship; MRC [G0801387] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Islamic Development Bank scholarship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council New Investigator Research Grant G0801387 (to X.Z.).; Supported by an Islamic Development Bank scholarship.	Biro T, 2007, BBA-MOL BASIS DIS, V1772, P1004, DOI 10.1016/j.bbadis.2007.03.002; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Davidson S, 2007, J NEUROSCI, V27, P10007, DOI 10.1523/JNEUROSCI.2862-07.2007; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Han JH, 2012, ACTA DERM-VENEREOL, V92, P561, DOI 10.2340/00015555-1244; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Han SK, 2006, NEURON, V52, P691, DOI 10.1016/j.neuron.2006.09.036; Han SK, 2002, P NATL ACAD SCI USA, V99, P14740, DOI 10.1073/pnas.192565799; Harrington AM, 2011, PAIN, V152, P1459, DOI 10.1016/j.pain.2011.01.027; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Jeffry J, 2011, PHYSIOLOGY, V26, P286, DOI 10.1152/physiol.00007.2011; Kammermeier PJ, 2000, J NEUROSCI, V20, P5623, DOI 10.1523/JNEUROSCI.20-15-05623.2000; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kress M, 2008, HISTOCHEM CELL BIOL, V130, P655, DOI 10.1007/s00418-008-0477-9; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lagerstrom MC, 2010, NEURON, V68, P529, DOI 10.1016/j.neuron.2010.09.016; Li L, 2013, CHANNELS, V7, P115, DOI 10.4161/chan.23466; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Papoiu ADP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017786; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Qu LT, 2012, J NEUROSCI, V32, P9554, DOI 10.1523/JNEUROSCI.6355-11.2012; Ross SE, 2011, CURR OPIN NEUROBIOL, V21, P880, DOI 10.1016/j.conb.2011.10.012; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Vetter I, 2012, EMBO J, V31, P3795, DOI 10.1038/emboj.2012.207; Wang S, 2008, BRAIN, V131, P1241, DOI 10.1093/brain/awn060; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015; Zhang XM, 2012, NAT CELL BIOL, V14, P850, DOI 10.1038/ncb2529	33	59	60	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12818	12827		10.1074/jbc.M113.450072	http://dx.doi.org/10.1074/jbc.M113.450072			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23508958	hybrid, Green Published			2022-12-28	WOS:000318555100037
J	Wang, JB; Sun, Z; Zhang, ZC; Saadi, I; Wang, J; Li, X; Gao, S; Engle, JJ; Kuburas, A; Fu, XY; Yu, WJ; Klein, WH; Russo, AF; Amendt, BA				Wang, Jianbo; Sun, Zhao; Zhang, Zichao; Saadi, Irfan; Wang, Jun; Li, Xiao; Gao, Shan; Engle, Jamison J.; Kuburas, Adisa; Fu, Xueyao; Yu, Wenjie; Klein, William H.; Russo, Andrew F.; Amendt, Brad A.			Protein Inhibitors of Activated STAT (Pias1 and Piasy) Differentially Regulate Pituitary Homeobox 2 (PITX2) Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; RIEGER-SYNDROME; HOMEODOMAIN PROTEIN; GENE-ACTIVATION; FLUORESCENCE COMPLEMENTATION; FUNCTIONAL INTERACTIONS; MEDIATED REPRESSION; ANDROGEN RECEPTOR; NUCLEAR-BODIES; BETA-CATENIN	Protein inhibitors of activated STAT (Pias) proteins can act independent of sumoylation to modulate the activity of transcription factors and Pias proteins interacting with transcription factors can either activate or repress their activity. Pias proteins are expressed in many tissues and cells during development and we asked if Pias proteins regulated the pituitary homeobox 2 (PITX2) homeodomain protein, which modulates developmental gene expression. Piasy and Pias1 proteins are expressed during craniofacial/tooth development and directly interact and differentially regulate PITX2 transcriptional activity. Piasy and Pias1 are co-expressed in craniofacial tissues with PITX2. Yeast two-hybrid, co-immunoprecipitation and pull-down experiments demonstrate Piasy and Pias1 interactions with the PITX2 protein. Piasy interacts with the PITX2 C-terminal tail to attenuate its transcriptional activity. In contrast, Pias1 interacts with the PITX2 C-terminal tail to increase PITX2 transcriptional activity. The E3 ligase activity associated with the RING domain in Piasy is not required for the attenuation of PITX2 activity, however, the RING domain of Pias1 is required for enhanced PITX2 transcriptional activity. Bimolecular fluorescence complementation assays reveal PITX2 interactions with Piasy and Pias1 in the nucleus. Piasy represses the synergistic activation of PITX2 with interacting co-factors and Piasy represses Pias1 activation of PITX2 transcriptional activity. In contrast, Pias1 did not affect the synergistic interaction of PITX2 with transcriptional co-factors. Last, we demonstrate that Pias proteins form a complex with PITX2 and Lef-1, and PITX2 and beta-catenin. Lef-1, beta-catenin, and Pias interactions with PITX2 provide new molecular mechanisms for the regulation of PITX2 transcriptional activity and the activity of Pias proteins.	[Wang, Jianbo; Sun, Zhao; Zhang, Zichao; Gao, Shan] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Ctr Environm & Genet Med, Houston, TX 77030 USA; [Saadi, Irfan; Engle, Jamison J.; Kuburas, Adisa; Russo, Andrew F.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Li, Xiao; Yu, Wenjie; Amendt, Brad A.] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Amendt, Brad A.] Univ Iowa, Craniofacial Anomalies Res Ctr, Iowa City, IA 52242 USA; [Wang, Jun] Texas Heart Inst, Ctr Stem Cell Engn, Houston, TX 77030 USA; [Fu, Xueyao; Klein, William H.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Iowa; University of Iowa; University of Iowa; Texas Heart Institute; University of Texas System; UTMD Anderson Cancer Center	Amendt, BA (corresponding author), Univ Iowa, Craniofacial Anomalies Res Ctr, Dept Anat & Cell Biol, 1-675 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	brad-amendt@uiowa.edu	Li, Xiao/X-3429-2019; sun, zhao/B-3291-2018; Saadi, Irfan/I-5989-2019	Li, Xiao/0000-0001-8527-4438; Saadi, Irfan/0000-0002-6250-6651; Russo, Andrew/0000-0002-8156-5649; Amendt, Brad A./0000-0001-6524-1006; Yu, Wenjie/0000-0002-3013-1218	National Institutes of Health from the NEI [EY011930, EY010608]; NIDCR [DE 016511, DE 13941]; Robert A. Welch Foundation [G-0010]; NATIONAL EYE INSTITUTE [P30EY010608, R01EY011930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016511] Funding Source: NIH RePORTER	National Institutes of Health from the NEI; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Robert A. Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants EY011930 and EY010608 from the NEI, Grants DE 016511 (to A. F. R.) and DE 13941 (to B. A. A.) from the NIDCR, and Robert A. Welch Foundation Grant G-0010 (to W. H. K.).	Amen M, 2008, NUCLEIC ACIDS RES, V36, P462, DOI 10.1093/nar/gkm1047; Amen M, 2007, MOL CELL BIOL, V27, P7560, DOI 10.1128/MCB.00315-07; Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Berry FB, 2006, HUM MOL GENET, V15, P905, DOI 10.1093/hmg/ddl008; CHEN LS, 1992, ARCH ORAL BIOL, V37, P771, DOI 10.1016/0003-9969(92)90110-T; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Cox CJ, 2002, J BIOL CHEM, V277, P25001, DOI 10.1074/jbc.M201737200; Diamond E, 2006, NUCLEIC ACIDS RES, V34, P5951, DOI 10.1093/nar/gkl689; Duval D, 2003, FEBS LETT, V554, P111, DOI 10.1016/S0014-5793(03)01116-5; Espinoza HM, 2005, BIOCHEMISTRY-US, V44, P3942, DOI 10.1021/bi048362x; Gage PJ, 1999, MAMM GENOME, V10, P197, DOI 10.1007/s003359900970; Galleguillos D, 2004, J BIOL CHEM, V279, P2005, DOI 10.1074/jbc.M308113200; Ganga M, 2003, J BIOL CHEM, V278, P22437, DOI 10.1074/jbc.M210163200; Green PD, 2001, GENE EXPRESSION, V9, P265, DOI 10.3727/000000001783992515; Gross M, 2004, ONCOGENE, V23, P3059, DOI 10.1038/sj.onc.1207443; Gross M, 2001, ONCOGENE, V20, P3880, DOI 10.1038/sj.onc.1204489; Hjalt TA, 2000, DEV DYNAM, V218, P195, DOI 10.1002/(SICI)1097-0177(200005)218:1<195::AID-DVDY17>3.0.CO;2-C; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Ilmarinen T, 2008, MOL IMMUNOL, V45, P1847, DOI 10.1016/j.molimm.2007.10.045; Imoto S, 2004, BIOCHEM BIOPH RES CO, V319, P275, DOI 10.1016/j.bbrc.2004.04.161; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Liang M, 2004, J BIOL CHEM, V279, P22857, DOI 10.1074/jbc.M401554200; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu B, 2005, MOL CELL BIOL, V25, P1113, DOI 10.1128/MCB.25.3.1113-1123.2005; Long JY, 2004, P NATL ACAD SCI USA, V101, P99, DOI 10.1073/pnas.0307598100; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Mucchielli ML, 1997, DEV BIOL, V189, P275, DOI 10.1006/dbio.1997.8672; Nishida T, 2006, BIOCHEM BIOPH RES CO, V345, P1536, DOI 10.1016/j.bbrc.2006.05.065; Oh HJ, 2007, MOL REPROD DEV, V74, P1446, DOI 10.1002/mrd.20737; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Toro R, 2004, J BIOL CHEM, V279, P52087, DOI 10.1074/jbc.M404802200; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; Venugopalan SR, 2008, HUM MOL GENET, V17, P3643, DOI 10.1093/hmg/ddn258; Wang J, 2004, J BIOL CHEM, V279, P49091, DOI 10.1074/jbc.M407494200; Wang J, 2008, J BIOL CHEM, V283, P23235, DOI 10.1074/jbc.M709748200; Wang J, 2007, MOL CELL BIOL, V27, P622, DOI 10.1128/MCB.01160-06; Wong KA, 2004, MOL CELL BIOL, V24, P5577, DOI 10.1128/MCB.24.12.5577-5586.2004; Zheng Z, 2006, J BIOL CHEM, V281, P4002, DOI 10.1074/jbc.M509260200; Zhou S, 2008, J BIOL CHEM, V283, P20137, DOI 10.1074/jbc.M801307200	48	6	7	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12580	12595		10.1074/jbc.M112.374561	http://dx.doi.org/10.1074/jbc.M112.374561			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23515314	Green Published, hybrid			2022-12-28	WOS:000318555100017
J	Malpede, BM; Lin, DH; Tolia, NH				Malpede, Brian M.; Lin, Daniel H.; Tolia, Niraj H.			Molecular Basis for Sialic Acid-dependent Receptor Recognition by the Plasmodium falciparum Invasion Protein Erythrocyte-binding Antigen-140/BAEBL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA PARASITES; GLYCOPHORIN-C; LIGAND; MEROZOITES; BAEBL; SPECIFICITY; ANTIGEN; SURFACE; VIVAX; HEMAGGLUTININ	Plasmodium falciparum erythrocyte invasion is dependent on high affinity recognition of sialic acid on cell surface receptors. The erythrocyte binding-like (EBL) family of invasion ligands mediates recognition of sialic acid on erythrocyte glycoproteins. Erythrocyte-binding antigen-140 (PfEBA-140/BAEBL) is a critical EBL ligand that binds sialic acid on its receptor glycophorin C. We present here the crystal structure of the two-domain receptor-binding region of PfEBA-140 in complex with a glycan containing sialic acid. The structure identifies two glycan-binding pockets unique to PfEBA-140 and not shared by other EBL ligands. Specific molecular interactions that enable receptor engagement are identified and reveal that the glycan binding mode is distinct from that of apicomplexan and viral cell surface recognition ligands as well as host immune factors that bind sialic acid. Erythrocyte binding experiments elucidated essential glycan contact residues and identified divergent functional roles for each receptor-binding site. One of four polymorphisms proposed to affect receptor binding was localized to a glycan-binding site, providing a structural basis for altered erythrocyte engagement. The studies described here provide the first full description of sialic acid-dependent molecular interactions at the P. falciparum erythrocyte invasion interface and define a framework for development of PfEBA-140-based therapeutics, vaccines, and diagnostics assessing vaccine efficacy and natural immunity to infection.	[Malpede, Brian M.; Lin, Daniel H.; Tolia, Niraj H.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Tolia, NH (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	tolia@wustl.edu	Tolia, Niraj H/D-2332-2014	Tolia, Niraj H/0000-0002-2689-1337	National Institutes of Health [AI080792]; Edward Mallinckrodt, Jr. Foundation; National Science Foundation [DGE-1143954]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI080792, R01AI080792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt, Jr. Foundation; National Science Foundation(National Science Foundation (NSF)); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI080792 from the National Institutes of Health and by a grant from the Edward Mallinckrodt, Jr. Foundation (to N. H. T.). This work was also supported by a National Science Foundation Graduate Research Fellowship (to B. M. M.) under Grant DGE-1143954.; We thank Nichole Salinas for assistance with experiments, Wandy Beatty for help with confocal imaging, David Sibley for constructive comments on the manuscript, the Structural Biology Center (SBC) at Argonne National Laboratory for use of beamline 19-ID at the Advanced Photon Source, and Stephen L. Ginell and SBC beamline scientists for assistance during data collection. Argonne is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Attrill H, 2006, BIOCHEM J, V397, P271, DOI 10.1042/BJ20060103; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; Baum J, 2003, GENETICS, V163, P1327; Blumenschein TMA, 2007, EMBO J, V26, P2808, DOI 10.1038/sj.emboj.7601704; Boyle MJ, 2010, BLOOD, V115, P4559, DOI 10.1182/blood-2009-09-243725; CAMUS D, 1985, SCIENCE, V230, P553, DOI 10.1126/science.3901257; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ford L, 2007, AM J TROP MED HYG, V77, P977, DOI 10.4269/ajtmh.2007.77.977; Gosi P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-112; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Jiang LB, 2009, MOL BIOCHEM PARASIT, V168, P49, DOI 10.1016/j.molbiopara.2009.06.006; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kobayashi K, 2010, J BIOL CHEM, V285, P1716, DOI 10.1074/jbc.M109.021576; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Lin DH, 2012, J BIOL CHEM, V287, P36830, DOI 10.1074/jbc.M112.409276; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Maier AG, 2009, INFECT IMMUN, V77, P1689, DOI 10.1128/IAI.01331-08; Mayer DCG, 2006, P NATL ACAD SCI USA, V103, P2358, DOI 10.1073/pnas.0510648103; Mayer DCG, 2002, J EXP MED, V196, P1523, DOI 10.1084/jem.20020750; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; Mayor A, 2005, BLOOD, V105, P2557, DOI 10.1182/blood-2004-05-1722; MILLER LH, 1977, AM J TROP MED HYG, V26, P204, DOI 10.4269/ajtmh.1977.26.204; Narum DL, 2002, MOL BIOCHEM PARASIT, V119, P159, DOI 10.1016/S0166-6851(01)00428-5; SIM BKL, 1990, J CELL BIOL, V111, P1877, DOI 10.1083/jcb.111.5.1877; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Thompson JK, 2001, MOL MICROBIOL, V41, P47, DOI 10.1046/j.1365-2958.2001.02484.x; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Vigan-Womas I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002781; WATOWICH SJ, 1994, STRUCTURE, V2, P719, DOI 10.1016/S0969-2126(00)00073-3	41	50	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12406	12415		10.1074/jbc.M113.450643	http://dx.doi.org/10.1074/jbc.M113.450643			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23508963	Green Published, hybrid			2022-12-28	WOS:000318157600071
J	Zhou, G; Marathe, GK; Hartiala, J; Hazen, SL; Allayee, H; Tang, WHW; McIntyre, TM				Zhou, Gang; Marathe, Gopal K.; Hartiala, Jaana; Hazen, Stanley L.; Allayee, Hooman; Tang, W. H. Wilson; McIntyre, Thomas M.			Aspirin Hydrolysis in Plasma Is a Variable Function of Butyrylcholinesterase and Platelet-activating Factor Acetylhydrolase 1b2 (PAFAH1b2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNITS; ESTERASE-ACTIVITY; RESISTANCE; CHOLINESTERASE; PHARMACOKINETICS; CYCLOOXYGENASE; PARAOXONASE-1; ACETYLATION; ASSOCIATION; ERYTHROCYTE	Aspirin is rapidly hydrolyzed within erythrocytes by a heterodimer of PAFAH1b2/PAFAH1b3 but also in plasma by an unidentified activity. Hydrolysis in both compartments was variable, with a 12-fold variation in plasma among 2226 Cleveland Clinic GeneBank patients. Platelet inhibition by aspirin was suppressed in plasma that rapidly hydrolyzed aspirin. Plasma aspirin hydrolysis was significantly higher in patients with coronary artery disease compared with control subjects (16.5 +/- 4.4 versus 15.1 +/- 3.7 nmol/ml/min; p = 3.4 x 10(-8)). A genome-wide association study of 2054 GeneBank subjects identified a single locus immediately adjacent to the BCHE (butyrylcholinesterase) gene associated with plasma aspirin hydrolytic activity (lead SNP, rs6445035; p = 9.1 x 10(-17)). However, its penetrance was low, and plasma from an individual with an inactivating mutation in BCHE still effectively hydrolyzed aspirin. A second aspirin hydrolase was identified in plasma, the purification of which showed it to be homomeric PAFAH1b2. This is distinct from the erythrocyte PAFAH1b2/PAFAH1b3 heterodimer. Inhibitors showed that both butyrylcholinesterase (BChE) and PAFAH1b2 contribute to aspirin hydrolysis in plasma, with variation primarily reflecting non-genetic variation of BChE activity. Therefore, aspirin is hydrolyzed in plasma by two enzymes, BChE and a new extracellular form of platelet-activating factor acetylhydrolase, PAFAH1b2. Hydrolytic effectiveness varies widely primarily from non-genetic variation of BChE activity that affects aspirin bioavailability in blood and the ability of aspirin to inhibit platelet aggregation.	[Zhou, Gang; Marathe, Gopal K.; Hazen, Stanley L.; Tang, W. H. Wilson; McIntyre, Thomas M.] Cleveland Clin, Dept Cellular & Mol Med, Lerner Res Inst, Lerner Coll Med, Cleveland, OH 44195 USA; [Hartiala, Jaana; Allayee, Hooman] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA; [Hartiala, Jaana; Allayee, Hooman] Univ So Calif, Inst Med Genet, Keck Sch Med, Los Angeles, CA 90089 USA	Case Western Reserve University; Cleveland Clinic Foundation; University of Southern California; University of Southern California	McIntyre, TM (corresponding author), Cleveland Clin, Dept Cellular & Mol Med, Lerner Res Inst, Lerner Coll Med, NE10,9500 Euclid Ave, Cleveland, OH 44195 USA.	mcintyt@ccf.org	Hartiala, Jaana A/GLR-1825-2022; Hazen, Stanley L/ABD-5845-2021; Tang, Wai Hong Wilson/I-1238-2013	Hartiala, Jaana A/0000-0003-4883-9318; Tang, W. H. Wilson/0000-0002-8335-735X; Marathe, Gopal/0000-0002-0025-6677	National Institutes of Health [P01 HL087018, AA017748, P50 HL081011]; NHLBI [P01 HL098055, P01 HL076491, R01 HL103866, P20 HL113452, R01 HL103931]; Cleveland Clinic Clinical Research Unit of the Case Western Reserve University through National Institutes of Health Clinical and Translational Science Award [1UL1RR024989]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL081011, P01HL076491, R01HL103866, P01HL098055, P20HL113452, R01HL103931, P01HL087018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cleveland Clinic Clinical Research Unit of the Case Western Reserve University through National Institutes of Health Clinical and Translational Science Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL087018, AA017748, and P50 HL081011. The Cleveland Clinic GeneBank study was supported by NHLBI Grants P01 HL098055, P01 HL076491, R01 HL103866, P20 HL113452, and R01 HL103931 and by the Cleveland Clinic Clinical Research Unit of the Case Western Reserve University through National Institutes of Health Clinical and Translational Science Award Grant 1UL1RR024989.	Adebayo GI, 2007, EUR J INTERN MED, V18, P299, DOI 10.1016/j.ejim.2006.12.004; Aharoni A, 2004, P NATL ACAD SCI USA, V101, P482, DOI 10.1073/pnas.2536901100; AKOPOV SS, 1992, J CLIN PHARMACOL, V32, P133, DOI 10.1002/j.1552-4604.1992.tb03817.x; Alberts MJ, 2004, STROKE, V35, P175, DOI 10.1161/01.STR.0000106763.46123.F6; Awtry EH, 2000, CIRCULATION, V101, P1206, DOI 10.1161/01.CIR.101.10.1206; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Bouman HJ, 2011, NAT MED, V17, P110, DOI 10.1038/nm.2281; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Coma-Canella I, 2005, INT J CARDIOL, V101, P71, DOI 10.1016/j.ijcard.2004.03.069; COSTELLO PB, 1984, ARTHRITIS RHEUM, V27, P422, DOI 10.1002/art.1780270409; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fitzgerald Desmond J, 2007, Hematology Am Soc Hematol Educ Program, P114; FITZGERALD GA, 1991, AM J CARDIOL, V68, pB11, DOI 10.1016/0002-9149(91)90379-Y; Goodall R, 2004, ANN CLIN BIOCHEM, V41, P98, DOI 10.1258/000456304322879971; Gresner P, 2006, BBA-GEN SUBJECTS, V1760, P207, DOI 10.1016/j.bbagen.2005.11.018; Grosser T, 2013, CIRCULATION, V127, P377, DOI 10.1161/CIRCULATIONAHA.112.117283; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Hartiala J, 2011, HUM GENET, V129, P617, DOI 10.1007/s00439-011-0963-3; HELGASON CM, 1994, STROKE, V25, P2331, DOI 10.1161/01.STR.25.12.2331; HELGASON CM, 1993, STROKE, V24, P345, DOI 10.1161/01.STR.24.3.345; HIGGS GA, 1987, P NATL ACAD SCI USA, V84, P1417, DOI 10.1073/pnas.84.5.1417; Ho YS, 1997, NATURE, V385, P89, DOI 10.1038/385089a0; Jack DB, 1997, LANCET, V350, P437, DOI 10.1016/S0140-6736(97)07087-6; Koizumi H, 2003, J BIOL CHEM, V278, P12489, DOI 10.1074/jbc.M211836200; Kotani K, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-50; KUO CL, 1995, DRUG METAB DISPOS, V23, P935; Lev EI, 2009, J AM COLL CARDIOL, V53, P678, DOI 10.1016/j.jacc.2008.11.018; LEVY G, 1965, ANESTH ANAL CURR RES, V44, P837; Manya H, 1998, J BIOL CHEM, V273, P18567, DOI 10.1074/jbc.273.29.18567; Manya H, 1999, J BIOL CHEM, V274, P31827, DOI 10.1074/jbc.274.45.31827; Masson P, 1998, BBA-PROTEIN STRUCT M, V1387, P41, DOI 10.1016/S0167-4838(98)00104-6; NEEDS CJ, 1985, CLIN PHARMACOKINET, V10, P164, DOI 10.2165/00003088-198510020-00004; NOGUEIRA CP, 1990, AM J HUM GENET, V46, P934; Patrono C, 2007, NAT CLIN PRACT CARD, V4, P42, DOI 10.1038/ncpcardio0728; PEDERSEN AK, 1984, NEW ENGL J MED, V311, P1206, DOI 10.1056/NEJM198411083111902; PUCHE E, 1993, ACTA ANAESTH SCAND, V37, P20, DOI 10.1111/j.1399-6576.1993.tb03590.x; ROTH GJ, 1975, P NATL ACAD SCI USA, V72, P3073, DOI 10.1073/pnas.72.8.3073; ROWLAND M, 1972, J PHARM SCI-US, V61, P379, DOI 10.1002/jps.2600610312; Santanam N, 2007, ATHEROSCLEROSIS, V191, P272, DOI 10.1016/j.atherosclerosis.2006.05.027; Santilli F, 2009, J AM COLL CARDIOL, V53, P667, DOI 10.1016/j.jacc.2008.10.047; Simeon-Rudolf V, 1999, CHEM-BIOL INTERACT, V119, P165, DOI 10.1016/S0009-2797(99)00025-3; SMITH WL, 1990, ADV PROSTAG THROMB L, V20, P14; Soliday Flanna K, 2010, AANA J, V78, P313; Tang WHW, 2012, ARTERIOSCL THROM VAS, V32, P516, DOI 10.1161/ATVBAHA.111.237040; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Warner TD, 2002, P NATL ACAD SCI USA, V99, P13371, DOI 10.1073/pnas.222543099; WILLIAMS FM, 1987, EUR J CLIN PHARMACOL, V33, P387, DOI 10.1007/BF00637635; Zhou G, 2011, J BIOL CHEM, V286, P34820, DOI 10.1074/jbc.M111.267161	48	28	29	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11940	11948		10.1074/jbc.M112.427674	http://dx.doi.org/10.1074/jbc.M112.427674			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23508960	Green Published, hybrid			2022-12-28	WOS:000318157600029
J	Khan, DH; He, SH; Yu, J; Winter, S; Cao, WG; Seiser, C; Davie, JR				Khan, Dilshad H.; He, Shihua; Yu, Jenny; Winter, Stefan; Cao, Wenguang; Seiser, Christian; Davie, James R.			Protein Kinase CK2 Regulates the Dimerization of Histone Deacetylase 1 (HDAC1) and HDAC2 during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-II-ALPHA; BREAST-CANCER CELLS; TRANSCRIPTION FACTORS; PHOSPHORYLATION; ACETYLATION; CHROMATIN; SP3; DNA	Histone deacetylase 1 (HDAC1) and HDAC2 are components of corepressor complexes that are involved in chromatin remodeling and regulation of gene expression by regulating dynamic protein acetylation. HDAC1 and -2 form homo- and heterodimers, and their activity is dependent upon dimer formation. Phosphorylation of HDAC1 and/or HDAC2 in interphase cells is required for the formation of HDAC corepressor complexes. In this study, we show that during mitosis, HDAC2 and, to a lesser extent, HDAC1 phosphorylation levels dramatically increase. When HDAC1 and -2 are displaced from the chromosome during metaphase, they dissociate from each other, but each enzyme remains in association with components of the HDAC corepressor complexes Sin3, NuRD, and CoREST as homodimers. Enzyme inhibition studies and mutational analyses demonstrated that protein kinase CK2-catalyzed phosphorylation of HDAC1 and -2 is crucial for the dissociation of these two enzymes. These results suggest that corepressor complexes, including HDAC1 or HDAC2 homodimers, might target different cellular proteins during mitosis.	[Khan, Dilshad H.; He, Shihua; Cao, Wenguang; Davie, James R.] Univ Manitoba, Manitoba Inst Child Hlth, Winnipeg, MB R3E 3P4, Canada; [Winter, Stefan; Seiser, Christian] Med Univ Vienna, Vienna Bioctr, Max F Perutz Labs, A-1030 Vienna, Austria; [Yu, Jenny] Univ Texas MD Anderson Canc Ctr, Houston, TX 77054 USA	University of Manitoba; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Texas System; UTMD Anderson Cancer Center	Davie, JR (corresponding author), Manitoba Inst Child Hlth, 715 McDermot Ave,Rm 600A, Winnipeg, MB R3E 3P4, Canada.	davie@cc.umanitoba.ca		Seiser, Christian/0000-0002-7046-9352; Davie, James/0000-0002-0420-6888	Canadian Institutes of Health Research Grant [MOP-9186]; Canada Research Chair; Manitoba Health Research Council/CancerCare Manitoba studentship; FWF; Austrian Science Fund (FWF) [P22340]; Genome Research in Austria (GEN-AU) project "Epigenetic Regulation of Cell Fate Decisions" (BM: WF); Austrian Science Fund (FWF) [P 22340] Funding Source: researchfish	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Manitoba Health Research Council/CancerCare Manitoba studentship; FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Genome Research in Austria (GEN-AU) project "Epigenetic Regulation of Cell Fate Decisions" (BM: WF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Canadian Institutes of Health Research Grant MOP-9186, a Canada Research Chair (to J. R. D.), and a Manitoba Health Research Council/CancerCare Manitoba studentship (to D. K.).; Fellow of the Vienna Biocenter International Ph.D. program supported by the FWF.; Work in the laboratory of C. S. was supported by the Austrian Science Fund (FWF) Grant P22340 and the Genome Research in Austria (GEN-AU) project "Epigenetic Regulation of Cell Fate Decisions" (BM: WF).	Brunmeir R, 2009, INT J DEV BIOL, V53, P275, DOI 10.1387/ijdb.082649rb; Chuang C, 2010, J PROTEOME RES, V9, P4554, DOI 10.1021/pr100281h; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Escargueil AE, 2000, J BIOL CHEM, V275, P34710, DOI 10.1074/jbc.M005179200; Escargueil AE, 2007, BIOCHEM J, V403, P235, DOI 10.1042/BJ20061460; Galasinski SC, 2002, J BIOL CHEM, V277, P19618, DOI 10.1074/jbc.M201174200; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; He SH, 2006, J CELL SCI, V119, P1063, DOI 10.1242/jcs.02829; He SH, 2005, MOL BIOL CELL, V16, P4073, DOI 10.1091/mbc.e05-05-0388; Hnilicova J, 2011, NUCLEUS-PHILA, V2, P182, DOI 10.4161/nucl.2.3.15876; Jurkin J, 2011, CELL CYCLE, V10, P406, DOI 10.4161/cc.10.3.14712; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; Luo Y, 2009, J BIOL CHEM, V284, P34901, DOI 10.1074/jbc.M109.038356; Marshall GM, 2010, ONCOGENE, V29, P5957, DOI 10.1038/onc.2010.332; Patzlaff JS, 2010, EXP CELL RES, V316, P2123, DOI 10.1016/j.yexcr.2010.05.003; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Samuel SK, 1998, CANCER RES, V58, P3004; Segre CV, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/690848; Sun JM, 2007, J BIOL CHEM, V282, P33227, DOI 10.1074/jbc.M703549200; Sun JM, 2002, J BIOL CHEM, V277, P35783, DOI 10.1074/jbc.C200378200; Taplick J, 2001, J MOL BIOL, V308, P27, DOI 10.1006/jmbi.2001.4569; Tsai SC, 2002, J BIOL CHEM, V277, P31826, DOI 10.1074/jbc.M204149200; Upadhyay AK, 2008, CURR CANCER DRUG TAR, V8, P741, DOI 10.2174/156800908786733405; Wang WP, 2008, GENETICS, V179, P1823, DOI 10.1534/genetics.108.091959; Winter S, 2008, EMBO J, V27, P88, DOI 10.1038/sj.emboj.7601954; Zhou HL, 2011, P NATL ACAD SCI USA, V108, pE627, DOI 10.1073/pnas.1103344108	27	41	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16518	16528		10.1074/jbc.M112.440446	http://dx.doi.org/10.1074/jbc.M112.440446			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612983	hybrid, Green Published			2022-12-28	WOS:000320378900028
J	Feng, L; Sharma, A; Slaughter, A; Jena, N; Koh, Y; Shkriabai, N; Larue, RC; Patel, PA; Mitsuya, H; Kessl, JJ; Engelman, A; Fuchs, JR; Kvaratskhelia, M				Feng, Lei; Sharma, Amit; Slaughter, Alison; Jena, Nivedita; Koh, Yasuhiro; Shkriabai, Nikolozi; Larue, Ross C.; Patel, Pratiq A.; Mitsuya, Hiroaki; Kessl, Jacques J.; Engelman, Alan; Fuchs, James R.; Kvaratskhelia, Mamuka			The A128T Resistance Mutation Reveals Aberrant Protein Multimerization as the Primary Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; DNA INTEGRATION; LEDGF/P75; DOMAIN; SITE	Allosteric HIV-1 integrase (IN) inhibitors (ALLINIs) are a very promising new class of anti-HIV-1 agents that exhibit a multimodal mechanism of action by allosterically modulating IN multimerization and interfering with IN-lens epithelium-derived growth factor (LEDGF)/p75 binding. Selection of viral strains under ALLINI pressure has revealed an A128T substitution in HIV-1 IN as a primary mechanism of resistance. Here, we elucidated the structural and mechanistic basis for this resistance. The A128T substitution did not affect the hydrogen bonding between ALLINI and IN that mimics the IN-LEDGF/p75 interaction but instead altered the positioning of the inhibitor at the IN dimer interface. Consequently, the A128T substitution had only a minor effect on the ALLINI IC50 values for IN-LEDGF/p75 binding. Instead, ALLINIs markedly altered the multimerization of IN by promoting aberrant higher order WT (but not A128T) IN oligomers. Accordingly, WT IN catalytic activities and HIV-1 replication were potently inhibited by ALLINIs, whereas the A128T substitution in IN resulted in significant resistance to the inhibitors both in vitro and in cell culture assays. The differential multimerization of WT and A128T INs induced by ALLINIs correlated with the differences in infectivity of HIV-1 progeny virions. We conclude that ALLINIs primarily target IN multimerization rather than IN-LEDGF/p75 binding. Our findings provide the structural foundations for developing improved ALLINIs with increased potency and decreased potential to select for drug resistance.	[Feng, Lei; Sharma, Amit; Slaughter, Alison; Shkriabai, Nikolozi; Larue, Ross C.; Kessl, Jacques J.; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Feng, Lei; Sharma, Amit; Slaughter, Alison; Shkriabai, Nikolozi; Larue, Ross C.; Kessl, Jacques J.; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Jena, Nivedita; Patel, Pratiq A.; Fuchs, James R.] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [Koh, Yasuhiro; Mitsuya, Hiroaki] Kumamoto Univ, Sch Med, Dept Hematol, Kumamoto 8608556, Japan; [Koh, Yasuhiro; Mitsuya, Hiroaki] Kumamoto Univ, Sch Med, Dept Infect Dis, Kumamoto 8608556, Japan; [Engelman, Alan] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA; [Engelman, Alan] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Kumamoto University; Kumamoto University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Kvaratskhelia, M (corresponding author), Ohio State Univ, Coll Pharm, Ctr Retrovirus Res, 500 West 12th Ave, Columbus, OH 43210 USA.	kvaratskhelia.1@osu.edu	Kessl, Jacques/AAV-2526-2021; Kessl, Jacques/J-6073-2015	Fuchs, James/0000-0002-8743-6389; Larue, Ross/0000-0002-0170-7345	National Institutes of Health [AI081581, AI062520, GM103368, AI097044]; NATIONAL CANCER INSTITUTE [ZIASC006738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062520, R21AI097044, R01AI081581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM103368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI081581 and AI062520 (to M. K.), GM103368 (to A. E. and M. K.), AI097044 (to J.J.K. and J.R.F.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brown P. O., 1997, P161; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Christ F, 2012, ANTIMICROB AGENTS CH, V56, P4365, DOI 10.1128/AAC.00717-12; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FENWICK C, 2011, INT WORKSH HIV HEP V; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; Johnson AA, 2004, CURR TOP MED CHEM, V4, P1059, DOI 10.2174/1568026043388394; Kessl JJ, 2012, J BIOL CHEM, V287, P16801, DOI 10.1074/jbc.M112.354373; Kessl JJ, 2011, NUCLEIC ACIDS RES, V39, P9009, DOI 10.1093/nar/gkr581; Kessl JJ, 2009, MOL PHARMACOL, V76, P824, DOI 10.1124/mol.109.058883; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pesant M, 2007, International Patent, Patent No. [PCT/CA2007/000845, 2007000845]; Raghavendra NK, 2007, VIROLOGY, V360, P1, DOI 10.1016/j.virol.2006.12.022; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Shen L, 2009, TRENDS PHARMACOL SCI, V30, P610, DOI 10.1016/j.tips.2009.09.003; Tsiang M, 2012, J BIOL CHEM, V287, P21189, DOI 10.1074/jbc.M112.347534	27	72	74	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15813	15820		10.1074/jbc.M112.443390	http://dx.doi.org/10.1074/jbc.M112.443390			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23615903	Green Published, hybrid			2022-12-28	WOS:000319822300035
J	Ishiyama, N; Tanaka, N; Abe, K; Yang, YJ; Abbas, YM; Umitsu, M; Nagar, B; Bueler, SA; Rubinstein, JL; Takeichi, M; Ikura, M				Ishiyama, Noboru; Tanaka, Nobutoshi; Abe, Kentaro; Yang, Yoo Jeong; Abbas, Yazan M.; Umitsu, Masataka; Nagar, Bhushan; Bueler, Stephanie A.; Rubinstein, John L.; Takeichi, Masatoshi; Ikura, Mitsuhiko			An Autoinhibited Structure of alpha-Catenin and Its Implications for Vinculin Recruitment to Adherens Junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN; CRYSTAL-STRUCTURE; BIOLOGICAL MACROMOLECULES; FLUORESCENT PROTEIN; SOLUTION SCATTERING; ACTIN-BINDING; CELL-ADHESION; BETA-CATENIN; N-CATENIN; IN-VITRO	a-Catenin is an actin- and vinculin-binding protein that regulates cell-cell adhesion by interacting with cadherin adhesion receptors through beta-catenin, but the mechanisms by which it anchors the cadherin-catenin complex to the actin cytoskeleton at adherens junctions remain unclear. Here we determined crystal structures of alpha E-catenin in the autoinhibited state and the actin-binding domain of alpha N-catenin. Together with the small-angle x-ray scattering analysis of full-length alpha N-catenin, we deduced an elongated multidomain assembly of monomeric alpha-catenin that structurally and functionally couples the vinculin- and actin-binding mechanisms. Cellular and biochemical studies of alpha E- and alpha N-catenins show that alpha E-catenin recruits vinculin to adherens junctions more effectively than alpha N-catenin, partly because of its higher affinity for actin filaments. We propose a molecular switch mechanism involving multistate conformational changes of alpha-catenin. This would be driven by actomyosin-generated tension to dynamically regulate the vinculin-assisted linkage between adherens junctions and the actin cytoskeleton.	[Ishiyama, Noboru; Yang, Yoo Jeong; Umitsu, Masataka; Ikura, Mitsuhiko] Univ Toronto, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M5G 1L7, Canada; [Rubinstein, John L.; Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Tanaka, Nobutoshi; Abe, Kentaro] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068501, Japan; [Tanaka, Nobutoshi; Takeichi, Masatoshi] RIKEN, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan; [Abbas, Yazan M.; Nagar, Bhushan] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Abbas, Yazan M.; Nagar, Bhushan] McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada; [Bueler, Stephanie A.; Rubinstein, John L.] Univ Toronto, Hosp Sick Children, Res Inst, Mol Struct & Funct Program, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Kyoto University; RIKEN; McGill University; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Ikura, M (corresponding author), Univ Toronto, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M5G 1L7, Canada.	mikura@uhnres.utoronto.ca	Abe, Kentaro/T-2247-2019; Takeichi, Masatoshi/G-5903-2012	Abe, Kentaro/0000-0002-3923-6323; Takeichi, Masatoshi/0000-0002-9931-3378; Ikura, Mitsuhiko/0000-0002-9524-1303; Rubinstein, John/0000-0003-0566-2209; Ishiyama, Noboru/0000-0002-1426-6083	Canadian Cancer Society; Canadian Institutes of Health Research postdoctoral fellowship	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research postdoctoral fellowship(Canadian Institutes of Health Research (CIHR))	This work was supported in part by grants from the Canadian Cancer Society (to M. I.).; Recipient of a Canadian Institutes of Health Research postdoctoral fellowship.	Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; ABERLE H, 1994, J CELL SCI, V107, P3655; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Borgon RA, 2004, STRUCTURE, V12, P1189, DOI 10.1016/j.str.2004.05.009; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2012, STRUCTURE, V20, P957, DOI 10.1016/j.str.2012.04.020; Choi HJ, 2012, P NATL ACAD SCI USA, V109, P8576, DOI 10.1073/pnas.1203906109; Desai R, 2013, NAT CELL BIOL, V15, P261, DOI 10.1038/ncb2685; Dickinson DJ, 2011, SCIENCE, V331, P1336, DOI 10.1126/science.1199633; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esnouf RM, 1998, ACTA CRYSTALLOGR D, V54, P938, DOI 10.1107/S0907444998004284; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Ichii T, 2007, GENES CELLS, V12, P827, DOI 10.1111/j.1365-2443.2007.01095.x; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kwiatkowski AV, 2010, P NATL ACAD SCI USA, V107, P14591, DOI 10.1073/pnas.1007349107; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Park C, 2002, NAT GENET, V31, P279, DOI 10.1038/ng908; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Pokutta S, 2002, J BIOL CHEM, V277, P18868, DOI 10.1074/jbc.M201463200; Rangarajan ES, 2013, NAT STRUCT MOL BIOL, V20, P188, DOI 10.1038/nsmb.2479; Rangarajan ES, 2012, J BIOL CHEM, V287, P18492, DOI 10.1074/jbc.M112.351023; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sarpal R, 2012, J CELL SCI, V125, P233, DOI 10.1242/jcs.096644; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Taguchi K, 2011, J CELL BIOL, V194, P643, DOI 10.1083/jcb.201104124; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tamada M, 2007, J CELL BIOL, V176, P27, DOI 10.1083/jcb.200609116; Uemura M, 2006, DEV DYNAM, V235, P2559, DOI 10.1002/dvdy.20841; van Hengel J, 2013, EUR HEART J, V34, P201, DOI 10.1093/eurheartj/ehs373; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WATABE M, 1994, J CELL BIOL, V127, P247, DOI 10.1083/jcb.127.1.247; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wriggers W, 2001, J STRUCT BIOL, V133, P193, DOI 10.1006/jsbi.2000.4350; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	65	81	81	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15913	15925		10.1074/jbc.M113.453928	http://dx.doi.org/10.1074/jbc.M113.453928			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23589308	Green Published, hybrid			2022-12-28	WOS:000319822300044
J	Whelan, KA; Schwab, LP; Karakashev, SV; Franchetti, L; Johannes, GJ; Seagroves, TN; Reginato, MJ				Whelan, Kelly A.; Schwab, Luciana P.; Karakashev, Sergey V.; Franchetti, Lisa; Johannes, Gregg J.; Seagroves, Tiffany N.; Reginato, Mauricio J.			The Oncogene HER2/neu (ERBB2) Requires the Hypoxia-inducible Factor HIF-1 for Mammary Tumor Growth and Anoikis Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BREAST; LUMEN FORMATION; UP-REGULATION; EXPRESSION; BIM; ACTIVATION; OVEREXPRESSION; DEHYDROGENASE; SUPPRESSION; INDUCTION	ERBB2, a receptor tyrosine kinase amplified in breast cancer, is a well established regulator of tumor growth in vivo and anoikis resistance leading to disruption of architecture in three-dimensional mammary epithelial acinar structures in vitro. ERBB2 promotes anoikis resistance by maintaining signaling pathways and by rescuing metabolic defects and thus inhibiting accumulation of deleterious reactive oxygen species. Recent evidence suggests that hypoxia, via hypoxia-inducible factors (HIFs), can inhibit anoikis; thus, we hypothesized that HIF-1 may play a role in ERBB2-mediated anoikis resistance and oncogenesis. Indeed, tumors isolated from MMTV-Neu mice contain elevated HIF-1 alpha levels and tumor cells created from MMTV-Neu mice harboring deletion of Hif1 alpha alleles reduced primary tumor growth in vivo. ERBB2 overexpressing cancer cells stabilize HIF under normoxic conditions and require HIF-1 for ERBB2-mediated anchorage-independence, three-dimensional culture growth and anoikis resistance. HIF-1 reduction in ERBB2 cells was associated with induction of the pro-anoikis protein BIM and decreased ERK and AKT signaling during cell detachment. ERBB2-mediated inhibition of metabolic defects, including decreased reactive oxygen species generation in suspension, required HIF-1 expression that was critical for ERBB2-mediated oncogenesis. Gene expression profiling of hypoxic three-dimensional acinar structures identified a number of genes elevated in response to hypoxia that are known ERBB2 targets, suggesting that hypoxic conditions and ERBB2 overexpression share both phenotypic and genetic components via HIF-1 regulation. Thus, our data demonstrate that ERBB2 requires HIF-1 for tumor growth and suggest that HIF is a major downstream regulator of ERBB2 that protects cells from anoikis and metabolic stress caused by decreased matrix adhesion.	[Whelan, Kelly A.; Karakashev, Sergey V.; Reginato, Mauricio J.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; [Franchetti, Lisa; Johannes, Gregg J.] Drexel Univ, Coll Med, Dept Pathol, Philadelphia, PA 19102 USA; [Schwab, Luciana P.; Seagroves, Tiffany N.] Univ Tennessee, Ctr Hlth Sci, Ctr Adult Canc Res, Memphis, TN 38163 USA; [Schwab, Luciana P.; Seagroves, Tiffany N.] Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA	Drexel University; Drexel University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Reginato, MJ (corresponding author), 245 N 15th St, Philadelphia, PA 19102 USA.	Mauricio.Reginato@drexelmed.edu	Reginato, Mauricio/I-6155-2013; Seagroves, Tiffany/AAE-3278-2019	Reginato, Mauricio/0000-0002-7541-4094; Seagroves, Tiffany/0000-0002-6937-943X	Department of Defense Breast Cancer Research Program Concept Award; Drexel University College of Medicine CURE; American Cancer Society [RGS-07-029-01-CNE, R01 CA138488]; NATIONAL CANCER INSTITUTE [R01CA155413, R01CA138488] Funding Source: NIH RePORTER	Department of Defense Breast Cancer Research Program Concept Award(United States Department of Defense); Drexel University College of Medicine CURE; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Department of Defense Breast Cancer Research Program Concept Award (to M. J. R.), Drexel University College of Medicine CURE grants (to G. J. J. and M. J. R.), and American Cancer Society Grants RGS-07-029-01-CNE and R01 CA138488 (to T. N. S. and L. P. S.).	Bartosova M, 2002, J PATHOL, V197, P314, DOI 10.1002/path.1120; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Chrestensen CA, 2007, J BIOL CHEM, V282, P4243, DOI 10.1074/jbc.M607368200; Cormier-Regard S, 1998, J BIOL CHEM, V273, P17787, DOI 10.1074/jbc.273.28.17787; Faber AC, 2011, CANCER DISCOV, V1, P352, DOI 10.1158/2159-8290.CD-11-0106; Franovic A, 2009, P NATL ACAD SCI USA, V106, P21306, DOI 10.1073/pnas.0906432106; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gatza ML, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2899; Generali D, 2006, CLIN CANCER RES, V12, P4562, DOI 10.1158/1078-0432.CCR-05-2690; Goonewardene TI, 2002, MICROSC RES TECHNIQ, V59, P41, DOI 10.1002/jemt.10175; Gullick WJ, 2002, BREAST CANCER RES, V4, P176, DOI 10.1186/bcr447; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Haenssen KK, 2010, J CELL SCI, V123, P1373, DOI 10.1242/jcs.050906; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Knuefermann C, 2003, ONCOGENE, V22, P3205, DOI 10.1038/sj.onc.1206394; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Li YM, 2005, CANCER RES, V65, P3257, DOI 10.1158/0008-5472.CAN-04-1284; Mackay A, 2003, ONCOGENE, V22, P2680, DOI 10.1038/sj.onc.1206349; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pedersen K, 2009, MOL CELL BIOL, V29, P3319, DOI 10.1128/MCB.01803-08; Pradeep CR, 2012, ONCOGENE, V31, P3569, DOI 10.1038/onc.2011.547; Reginato MJ, 2006, J MAMMARY GLAND BIOL, V11, P205, DOI 10.1007/s10911-006-9030-4; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Rohwer N, 2008, CANCER RES, V68, P10113, DOI 10.1158/0008-5472.CAN-08-1839; Ryan HE, 2000, CANCER RES, V60, P4010; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Schmelzle T, 2007, P NATL ACAD SCI USA, V104, P3787, DOI 10.1073/pnas.0700115104; Schwab LP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3087; Schwartz MA, 1997, J CELL BIOL, V139, P575, DOI 10.1083/jcb.139.3.575; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Sowter HM, 2001, CANCER RES, V61, P6669; Spangenberg C, 2006, CANCER RES, V66, P3715, DOI 10.1158/0008-5472.CAN-05-2823; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Tan M, 2002, MOL CELL, V9, P993, DOI 10.1016/S1097-2765(02)00510-5; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Whelan KA, 2011, CELL CYCLE, V10, P2287, DOI 10.4161/cc.10.14.16532; Whelan KA, 2010, MOL BIOL CELL, V21, P3829, DOI 10.1091/mbc.E10-04-0353; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018	49	49	49	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15865	15877		10.1074/jbc.M112.426999	http://dx.doi.org/10.1074/jbc.M112.426999			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23585570	Green Published, hybrid			2022-12-28	WOS:000319822300040
J	Carver, BJ; Plosa, EJ; Stinnett, AM; Blackwell, TS; Prince, LS				Carver, Billy J.; Plosa, Erin J.; Stinnett, Amanda M.; Blackwell, Timothy S.; Prince, Lawrence S.			Interactions between NF-kappa B and SP3 Connect Inflammatory Signaling with Reduced FGF-10 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID RECEPTOR; TRANSCRIPTION FACTORS; MICE LACKING; IKK-ALPHA; BRONCHOPULMONARY DYSPLASIA; BRANCHING MORPHOGENESIS; LUNG DEVELOPMENT; GENE-EXPRESSION; MOUSE LUNG; ACTIVATION	Inflammation inhibits normal lung morphogenesis in preterm infants. Soluble inflammatory mediators present in the lungs of patients developing bronchopulmonary dysplasia disrupt expression of multiple genes critical for development. However, the mechanisms linking innate immune signaling and developmental programs are not clear. NF-kappa B activation inhibits expression of the critical morphogen FGF-10. Here, we show that interactions between the RELA subunit of NF-kappa B and SP3 suppress SP1-mediated FGF-10 expression. SP3 co-expression reduced SP1-mediated Fgf-10 promoter activity, suggesting antagonistic interactions between SP1 and SP3. Chromatin immunoprecipitation of LPS-treated primary mouse fetal lung mesenchymal cells detected increased interactions between SP3, RELA, and the Fgf-10 promoter. Expression of a constitutively active I kappa B kinase beta mutant not only decreased Fgf-10 promoter activity but also increased RELA-SP3 nuclear interactions. Expression of a dominant-negative I kappa B, which blocks NF-kappa B nuclear translocation, prevented inhibition of FGF-10 by SP3. The inhibitory functions of SP3 required sequences located in the N-terminal region of the protein. These data suggested that inhibition of FGF-10 by inflammatory signaling involves the NF-kappa B-dependent interactions between RELA, SP3, and the Fgf-10 promoter. NF-kappa B activation may therefore lead to reduced gene expression by recruiting inhibitory factors to specific gene promoters following exposure to inflammatory stimuli.	[Carver, Billy J.; Blackwell, Timothy S.; Prince, Lawrence S.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Plosa, Erin J.; Stinnett, Amanda M.; Prince, Lawrence S.] Vanderbilt Univ, Sch Med, Div Neonatol, Dept Pediat, Nashville, TN 37232 USA; [Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Dept Med Pulm & Crit Care Med, Div Allergy, Nashville, TN 37232 USA; [Prince, Lawrence S.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92093 USA; [Prince, Lawrence S.] Univ Calif San Diego, Rady Childrens Hosp, San Diego, CA 92093 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego	Prince, LS (corresponding author), Univ Calif San Diego, Dept Pediat, Div Neonatol, 9500 Gilman Dr,Mail Code 0734, La Jolla, CA 92093 USA.	lprinceucsd@gmail.com			March of Dimes [5FY07-555]; National Institutes of Health [HL097195, HL086324, HD060554, HL086324-2S1, CA68485, DK20593, DK58404, HD15052, DK59637, EY08126]; Ikaria Advancing Newborn Medicine fellowship; Marshall Klaus Perinatal Research award from the American Academy of Pediatrics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007502, P30HD015052, T32HD060554] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086324, R01HL097195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, U24DK059637, P60DK020593, U2CDK059637, P30DK020593] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ikaria Advancing Newborn Medicine fellowship; Marshall Klaus Perinatal Research award from the American Academy of Pediatrics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the March of Dimes Grant 5FY07-555 (to L. S. P.); National Institutes of Health Grants HL097195 (to L. S. P.), HL086324 (to L. S. P.), HD060554 (to E. J. P.), and HL086324-2S1 (to A. M. S. and L. S. P.); an Ikaria Advancing Newborn Medicine fellowship grant (to E. J. P.), and the Marshall Klaus Perinatal Research award from the American Academy of Pediatrics (to E. J. P.). The Vanderbilt Cell Imaging Shared Resource Center is supported by the National Institutes of Health (CA68485, DK20593, DK58404, HD15052, DK59637, and EY08126).	Adams S, 2007, J INVEST DERMATOL, V127, P538, DOI 10.1038/sj.jid.5700588; Albensi BC, 2000, SYNAPSE, V35, P151; Arman E, 1999, P NATL ACAD SCI USA, V96, P11895, DOI 10.1073/pnas.96.21.11895; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Avital A, 2003, HIPPOCAMPUS, V13, P826, DOI 10.1002/hipo.10135; Balkhi MY, 2012, BLOOD, V119, P5467, DOI 10.1182/blood-2012-01-401547; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Baus-Loncar M, 2004, PEPTIDES, V25, P849, DOI 10.1016/j.peptides.2003.11.019; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Benjamin JT, 2007, AM J PHYSIOL-LUNG C, V292, pL550, DOI 10.1152/ajplung.00329.2006; Benjamin JT, 2010, J IMMUNOL, V185, P4896, DOI 10.4049/jimmunol.1001857; Benko S, 2003, J BIOL CHEM, V278, P43797, DOI 10.1074/jbc.M306199200; Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; Bhandari A, 2009, PEDIATRICS, V123, P1562, DOI 10.1542/peds.2008-1962; Bienz M, 1998, CURR OPIN CELL BIOL, V10, P366, DOI 10.1016/S0955-0674(98)80013-6; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Blackwell TS, 2011, J IMMUNOL, V187, P2740, DOI 10.4049/jimmunol.1101495; Cao YX, 2003, J MAMMARY GLAND BIOL, V8, P215, DOI 10.1023/A:1025905008934; Celli G, 1998, EMBO J, V17, P1642, DOI 10.1093/emboj/17.6.1642; CHEN L, 2011, PLOS ONE, V6; Christou Helen, 2005, J Intensive Care Med, V20, P76, DOI 10.1177/0885066604273494; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; DELESCLUSE C, 1991, MOL PHARMACOL, V40, P556; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; GUENARD V, 1991, J NEUROSCI RES, V29, P396, DOI 10.1002/jnr.490290315; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hokuto I, 2003, J BIOL CHEM, V278, P415, DOI 10.1074/jbc.M208328200; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Kennett SB, 2002, J BIOL CHEM, V277, P9780, DOI 10.1074/jbc.M108661200; Kennett SB, 1997, NUCLEIC ACIDS RES, V25, P3110, DOI 10.1093/nar/25.15.3110; Klar J, 2011, J MED GENET, V48, P705, DOI 10.1136/jmedgenet-2011-100166; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Li YK, 2003, J NEUROSCI, V23, P1605; Lynch MA, 1998, PROG NEUROBIOL, V56, P571, DOI 10.1016/S0301-0082(98)00054-9; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721; PETERS K, 1994, EMBO J, V13, P3296, DOI 10.1002/j.1460-2075.1994.tb06631.x; Rippe RA, 1999, DNA CELL BIOL, V18, P751, DOI 10.1089/104454999314890; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Sapetschnig A, 2004, J BIOL CHEM, V279, P42095, DOI 10.1074/jbc.M404989200; Shaw J, 2006, CIRC RES, V99, P1347, DOI 10.1161/01.RES.0000251744.06138.50; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Yamamoto Y, 2012, STEM CELLS DEV, V21, P1455, DOI 10.1089/scd.2011.0219; Zhang WZ, 2002, AM J PHYSIOL-RENAL, V283, pF904, DOI 10.1152/ajprenal.00156.2002	55	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15318	15325		10.1074/jbc.M112.447318	http://dx.doi.org/10.1074/jbc.M112.447318			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23558680	Green Published, hybrid			2022-12-28	WOS:000319452100057
J	Ma, ZY; Vocadlo, DJ; Vosseller, K				Ma, Zhiyuan; Vocadlo, David J.; Vosseller, Keith			Hyper-O-GlcNAcylation Is Anti-apoptotic and Maintains Constitutive NF-kappa B Activity in Pancreatic Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOCARCINOMA CELLS; TRANSCRIPTION FACTOR; GLUCOSE-METABOLISM; NUTRIENT SENSOR; PATHWAY; ACETYLGLUCOSAMINE; GROWTH; BETA; GENE; TRANSFORMATION	Cancer cell metabolic reprogramming includes a shift in energy production from oxidative phosphorylation to less efficient glycolysis even in the presence of oxygen (Warburg effect) and use of glutamine for increased biosynthetic needs. This necessitates greatly increased glucose and glutamine uptake, both of which enter the hexosamine biosynthetic pathway (HBP). The HBP end product UDP-N-acetylglucosamine (UDP-GlcNAc) is used in enzymatic post-translational modification of many cytosolic and nuclear proteins by O-linked beta-N-acetylglucosamine (O-GlcNAc). Here, we observed increased HBP flux and hyper-O-GlcNAcylation in human pancreatic ductal adenocarcinoma (PDAC). PDAC hyper-O-GlcNAcylation was associated with elevation of OGT and reduction of the enzyme that removes O-GlcNAc (OGA). Reducing hyper-O-GlcNAcylation had no effect on non-transformed pancreatic epithelial cell growth, but inhibited PDAC cell proliferation, anchorage-independent growth, orthotopic tumor growth, and triggered apoptosis. PDAC is supported by oncogenic NF-kappa B transcriptional activity. The NF-kappa B p65 subunit and upstream kinases IKK alpha/IKK beta were O-GlcNAcylated in PDAC. Reducing hyper-O-GlcNAcylation decreased PDAC cell p65 activating phosphorylation (S536), nuclear translocation, NF-kappa B transcriptional activity, and target gene expression. Conversely, mimicking PDAC hyper-O-GlcNAcylation through pharmacological inhibition of OGA suppressed suspension culture-induced apoptosis and increased IKK alpha and p65 O-GlcNAcylation, accompanied by activation of NF-kappa B signaling. Finally, reducing p65 O-GlcNAcylation specifically by mutating two p65 O-GlcNAc sites (T322A and T352A) attenuated the induction of PDAC cell anchorage-independent growth. Our data indicate that hyper-O-GlcNAcylation is anti-apoptotic and contributes to NF-kappa B oncogenic activation in PDAC.	[Ma, Zhiyuan; Vosseller, Keith] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; [Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Vocadlo, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Drexel University; Simon Fraser University; Simon Fraser University	Vosseller, K (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 N 15th St New Coll Bldg,Room 10112, Philadelphia, PA 19102 USA.	keith.vosseller@drexelmed.edu	Ma, Zhiyuan/I-6678-2015; Vocadlo, David J/E-5508-2014	Ma, Zhiyuan/0000-0002-0381-7804; Vocadlo, David J/0000-0001-6897-5558	Natural Sciences and Engineering Research Council of Canada; Natural Sciences and Engineering Research Council of Canada through an E.W.R Steacie Memorial Fellowship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Sciences and Engineering Research Council of Canada through an E.W.R Steacie Memorial Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by grants from the Natural Sciences and Engineering Research Council of Canada.; A Canada Research Chair in Chemical Glycobiology and supported by the Natural Sciences and Engineering Research Council of Canada through an E.W.R Steacie Memorial Fellowship.	Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; DeBerardinis RJ, 2008, GENET MED, V10, P267, DOI 10.1097/GIM.0b013e31818b0d9b; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; Fan YH, 2009, J BIOL CHEM, V284, P29290, DOI 10.1074/jbc.M109.018994; Furukawa T, 1996, AM J PATHOL, V148, P1763; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ito H, 2004, SURGERY, V136, P548, DOI 10.1016/j.surg.2004.05.032; James LR, 2002, DIABETES, V51, P1146, DOI 10.2337/diabetes.51.4.1146; Kaadige MR, 2009, P NATL ACAD SCI USA, V106, P14878, DOI 10.1073/pnas.0901221106; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kawauchi K, 2009, P NATL ACAD SCI USA, V106, P3431, DOI 10.1073/pnas.0813210106; Kong R, 2010, CANCER LETT, V291, P90, DOI 10.1016/j.canlet.2009.10.001; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Krzeslak A, 2012, CLIN EXP MED, V12, P61, DOI 10.1007/s10238-011-0138-5; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Liptay S, 2003, INT J CANCER, V105, P735, DOI 10.1002/ijc.11081; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Maher JC, 2005, PANCREAS, V30, pE34, DOI 10.1097/01.mpa.0000153327.46945.26; Maier HJ, 2010, CANCER LETT, V295, P214, DOI 10.1016/j.canlet.2010.03.003; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Park SY, 2010, EMBO J, V29, P3787, DOI 10.1038/emboj.2010.254; Ren Q, 2006, CANCER RES, V66, P5209, DOI 10.1158/0008-5472.CAN-05-4158; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; ROBINSON KA, 1995, DIABETES, V44, P1438, DOI 10.2337/diabetes.44.12.1438; Schneiderhan W, 2009, GUT, V58, P1391, DOI 10.1136/gut.2009.181412; Shi Y, 2010, LEUKEMIA, V24, P1588, DOI 10.1038/leu.2010.152; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Varadhachary GR, 2006, ANN SURG ONCOL, V13, P1035, DOI 10.1245/ASO.2006.08.011; Wang WX, 1999, CLIN CANCER RES, V5, P119; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; WICE BM, 1985, J BIOL CHEM, V260, P139; Wilson W, 2008, CANCER RES, V68, P8156, DOI 10.1158/0008-5472.CAN-08-1061; Wolff RA, 2007, CANCER J, V13, P175, DOI 10.1097/PPO.0b013e318074e6c3; WU MC, 1978, INT J CANCER, V22, P728, DOI 10.1002/ijc.2910220615; Yang WH, 2008, P NATL ACAD SCI USA, V105, P17345, DOI 10.1073/pnas.0806198105; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zhu QQ, 2012, MED ONCOL, V29, P985, DOI 10.1007/s12032-011-9912-1	47	177	184	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15121	15130		10.1074/jbc.M113.470047	http://dx.doi.org/10.1074/jbc.M113.470047			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23592772	Green Published, hybrid			2022-12-28	WOS:000319452100041
J	Asai, S; Ichikawa, T; Nomura, H; Kobayashi, M; Kamiyoshihara, Y; Mori, H; Kadota, Y; Zipfel, C; Jones, JDG; Yoshioka, H				Asai, Shuta; Ichikawa, Tatsushi; Nomura, Hironari; Kobayashi, Michie; Kamiyoshihara, Yusuke; Mori, Hitoshi; Kadota, Yasuhiro; Zipfel, Cyril; Jones, Jonathan D. G.; Yoshioka, Hirofumi			The Variable Domain of a Plant Calcium-dependent Protein Kinase (CDPK) Confers Subcellular Localization and Substrate Recognition for NADPH Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE LOCALIZATION; SIGNAL-TRANSDUCTION; NITRIC-OXIDE; IN-VIVO; ARABIDOPSIS; POTATO; CA2+; MYRISTOYLATION; SPECIFICITY; RESISTANCE	Calcium-dependent protein kinases (CDPKs) are Ca2+ sensors that regulate diverse biological processes in plants and api-complexans. However, how CDPKs discriminate specific substrates in vivo is still largely unknown. Previously, we found that a potato StCDPK5 is dominantly localized to the plasma membrane and activates the plasma membrane NADPH oxidase (RBOH; for respiratory burst oxidase homolog) StRBOHB by direct phosphorylation of the N-terminal region. Here, we report the contribution of the StCDPK5 N-terminal variable (V) domain to activation of StRBOHB in vivo using heterologous expression system in Nicotiana benthamiana. Mutations of N-terminal myristoylation and palmitoylation sites in the V domain eliminated the predominantly plasma membrane localization and the capacity of StCDPK5 to activate StRBOHB in vivo. A tomato SlCDPK2, which also contains myristoylation and palmitoylation sites in its N terminus, phosphorylated StRBOHB in vitro but not in vivo. Functional domains responsible for activation and phosphorylation of StRBOHB were identified by swapping regions for each domain between StCDPK5 and SlCDPK2. The substitution of the V domain of StCDPK5 with that of SlCDPK2 abolished the activation and phosphorylation abilities of StRBOHB in vivo and relocalized the chimeric CDPK to the trans-Golgi network, as observed for SlCDPK2. Conversely, SlCDPK2 substituted with the V domain of StCDPK5 localized to the plasma membrane and activated StRBOHB. These results suggest that the V domains confer substrate specificity in vivo by dictating proper subcellular localization of CDPKs.	[Asai, Shuta; Ichikawa, Tatsushi; Nomura, Hironari; Kobayashi, Michie; Kamiyoshihara, Yusuke; Mori, Hitoshi; Yoshioka, Hirofumi] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Asai, Shuta; Kadota, Yasuhiro; Zipfel, Cyril; Jones, Jonathan D. G.] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Kobayashi, Michie] Iwate Biotechnol Res Ctr, Kitakami, Iwate 0240003, Japan; [Kamiyoshihara, Yusuke] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA	Nagoya University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Iwate Biotechnology Research Center; State University System of Florida; University of Florida	Yoshioka, H (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	hyoshiok@agr.nagoya-u.ac.jp	Asai, Shuta/P-1647-2015; Kadota, Yasuhiro/A-9406-2011; ZIPFEL, CYRIL/ABD-5076-2021; Kadota, Yasuhiro/AAC-4545-2019; Kadota, Yasuhiro/AGJ-3017-2022; Jones, Jonathan DG/J-5129-2012; ZIPFEL, CYRIL B/D-7103-2011	Asai, Shuta/0000-0003-1898-1786; Kadota, Yasuhiro/0000-0002-4782-1418; ZIPFEL, CYRIL/0000-0003-4935-8583; Kadota, Yasuhiro/0000-0002-4782-1418; Kadota, Yasuhiro/0000-0002-4782-1418; Jones, Jonathan DG/0000-0002-4953-261X; ZIPFEL, CYRIL B/0000-0003-4935-8583; Kobayashi, Michie/0000-0003-0277-8978	Ministry of Education, Science, and Culture, Sports, Science, and Technology of Japan [23117707]; Japan Society for the Promotion of Science [23580068]; Excellent Young Researcher Overseas Visit Program; Uehara memorial foundation; Gatsby Charitable Foundation	Ministry of Education, Science, and Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Excellent Young Researcher Overseas Visit Program; Uehara memorial foundation(Uehara Memorial Foundation); Gatsby Charitable Foundation	This work was supported by a Grant-in-aid for Scientific Research on Innovative Areas 23117707 from the Ministry of Education, Science, and Culture, Sports, Science, and Technology of Japan (to H. Y.), a research fellowship from the Japan Society for the Promotion of Science (to S. A.), 23580068 (to Y. K.), the Excellent Young Researcher Overseas Visit Program (to Y. K.), the Uehara memorial foundation (to Y. K), and the Gatsby Charitable Foundation (to C. Z. and J. D. G. J.).	Asai S, 2008, PLANT CELL, V20, P1390, DOI 10.1105/tpc.107.055855; Asai S, 2009, MOL PLANT MICROBE IN, V22, P619, DOI 10.1094/MPMI-22-6-0619; Benetka W, 2008, CELL CYCLE, V7, P3709, DOI 10.4161/cc.7.23.7176; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Boudsocq M, 2013, TRENDS PLANT SCI, V18, P30, DOI 10.1016/j.tplants.2012.08.008; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Choi HI, 2005, PLANT PHYSIOL, V139, P1750, DOI 10.1104/pp.105.069757; Curran A, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00036; Dammann C, 2003, PLANT PHYSIOL, V132, P1840, DOI 10.1104/pp.103.020008; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; ECKHART W, 1979, CELL, V18, P925, DOI 10.1016/0092-8674(79)90205-8; Gao XQ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003127; Geiger D, 2010, P NATL ACAD SCI USA, V107, P8023, DOI 10.1073/pnas.0912030107; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Harper JE, 2004, ANNU REV PLANT BIOL, V55, P263, DOI 10.1146/annurev.arplant.55.031903.141627; HARPER JF, 1994, BIOCHEMISTRY-US, V33, P7267, DOI 10.1021/bi00189a031; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Ishida S, 2008, PLANT CELL, V20, P3273, DOI 10.1105/tpc.107.057489; Ishihama N, 2012, CURR OPIN PLANT BIOL, V15, P431, DOI 10.1016/j.pbi.2012.02.003; Ito T, 2010, PLANT CELL, V22, P1592, DOI 10.1105/tpc.109.073577; Kamiyoshihara Y, 2010, PLANT J, V64, P140, DOI 10.1111/j.1365-313X.2010.04316.x; Karimi M, 2007, PLANT PHYSIOL, V145, P1144, DOI 10.1104/pp.107.106989; Kobayashi M, 2006, J EXP BOT, V57, P1373, DOI 10.1093/jxb/erj113; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; Kobayashi M, 2012, NEW PHYTOL, V196, P223, DOI 10.1111/j.1469-8137.2012.04226.x; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; Lu SX, 2002, PLANT PHYSIOL, V128, P1008, DOI 10.1104/pp.010770; Ludwig AA, 2005, P NATL ACAD SCI USA, V102, P10736, DOI 10.1073/pnas.0502954102; Mair A, 2012, NEW PHYTOL, V196, P4, DOI 10.1111/j.1469-8137.2012.04293.x; Martin ML, 2000, PLANT J, V24, P429, DOI 10.1046/j.1365-313x.2000.00889.x; Matsubara M, 2003, J BIOL CHEM, V278, P48898, DOI 10.1074/jbc.M305488200; Mehlmer N, 2010, PLANT J, V63, P484, DOI 10.1111/j.1365-313X.2010.04257.x; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Ogasawara Y, 2008, J BIOL CHEM, V283, P8885, DOI 10.1074/jbc.M708106200; Perraki A, 2012, PLANT PHYSIOL, V160, P624, DOI 10.1104/pp.112.200519; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Rietz S, 2010, MOL PLANT, V3, P524, DOI 10.1093/mp/ssp109; Romeis T, 2001, EMBO J, V20, P5556, DOI 10.1093/emboj/20.20.5556; Rutschmann F, 2002, PLANT PHYSIOL, V129, P156, DOI 10.1104/pp.000869; Saint-Jore-Dupas C, 2006, PLANT CELL, V18, P3182, DOI 10.1105/tpc.105.036400; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; Suzuki N, 2011, CURR OPIN PLANT BIOL, V14, P691, DOI 10.1016/j.pbi.2011.07.014; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Viotti C, 2010, PLANT CELL, V22, P1344, DOI 10.1105/tpc.109.072637; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wernimont AK, 2010, NAT STRUCT MOL BIOL, V17, P596, DOI 10.1038/nsmb.1795; Witte CP, 2010, J BIOL CHEM, V285, P9740, DOI 10.1074/jbc.M109.052126; Yamamizo C, 2006, PLANT PHYSIOL, V140, P681, DOI 10.1104/pp.105.074906; YONEMOTO W, 1993, J BIOL CHEM, V268, P2348; Yoshioka H, 2003, PLANT CELL, V15, P706, DOI 10.1105/tpc.008680; Zhu SY, 2007, PLANT CELL, V19, P3019, DOI 10.1105/tpc.107.050666	59	77	83	2	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14332	14340		10.1074/jbc.M112.448910	http://dx.doi.org/10.1074/jbc.M112.448910			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23569203	Green Published, hybrid			2022-12-28	WOS:000319253500037
J	Jin, JL; Iakova, P; Jiang, YJ; Lewis, K; Sullivan, E; Jawanmardi, N; Donehower, L; Timchenko, L; Timchenko, NA				Jin, Jingling; Iakova, Polina; Jiang, Yanjun; Lewis, Kyle; Sullivan, Emily; Jawanmardi, Nicole; Donehower, Lawrence; Timchenko, Lubov; Timchenko, Nikolai A.			Transcriptional and Translational Regulation of C/EBP beta-HDAC1 Protein Complexes Controls Different Levels of p53, SIRT1, and PGC1 alpha Proteins at the Early and Late Stages of Liver Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; C/EBP-BETA; OLD MICE; PROLIFERATION; INHIBITION; REPRESSION; BINDING; ALPHA; E2F7	Cancer changes biological processes in the liver by altering gene expression at the levels of transcription, translation, and protein modification. The RNA binding protein CUGBP1 is a key regulator of translation of CCAAT enhancer binding protein beta and histone deacetylase 1 (HDAC1). These proteins form complexes that are involved in the regulation of liver biology. Here we show a critical role of the translational activation of CCAAT/enhancer binding protein beta-HDAC1 complexes in the development of liver cancer mediated by diethylnitrosamine. We found that diethylnitrosamine increases the levels of CUGBP1 and activates CUGBP1 by phosphorylation, leading to the formation of the CUGBP1-eIF2 complex, which is an activator of translation of CUGBP1-dependent mRNAs. The elevation of the CUGBP1-eIF2 complex increases translation of C/EBP beta and HDAC1, resulting in an increase of C/EBP beta-HDAC1 complexes at later stages of liver cancer. We found that C/EBP beta-HDAC1 complexes repress promoters of three key regulators of liver functions: p53, SIRT1, and PGC1 alpha. As the result of this suppression, the p53-, SIRT1-, and PGC1 alpha-dependent downstream pathways are reduced, leading to increased liver proliferation. We also found that the proper regulation of C/EBP beta-HDAC1 complexes is required for the maintenance of biological levels of p53, SIRT1, and PGC1 alpha in quiescent livers and at early stages of liver cancer. Taken together, these studies showed that the development of liver cancer includes a tight regulation of levels of C/EBP beta-HDAC1 complexes on the levels of transcription, translation, and posttranslational modifications.	[Timchenko, Nikolai A.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Jin, Jingling; Iakova, Polina; Jiang, Yanjun; Lewis, Kyle; Sullivan, Emily; Jawanmardi, Nicole; Donehower, Lawrence; Timchenko, Nikolai A.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Jin, Jingling; Iakova, Polina; Jiang, Yanjun; Lewis, Kyle; Sullivan, Emily; Jawanmardi, Nicole; Donehower, Lawrence; Timchenko, Nikolai A.] Baylor Coll Med, Dept Virol, Houston, TX 77030 USA; [Jin, Jingling; Iakova, Polina; Jiang, Yanjun; Lewis, Kyle; Sullivan, Emily; Jawanmardi, Nicole; Donehower, Lawrence; Timchenko, Nikolai A.] Baylor Coll Med, Dept Microbiol, Houston, TX 77030 USA; [Timchenko, Lubov] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Timchenko, NA (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, 1 Baylor Plaza, Houston, TX 77030 USA.	nikolait@bcm.tmc.edu		Jin, Jingling/0000-0002-4365-1837	National Institutes of Health [GM551888, CA100070, AG039885, AG028865, CA159942]; NATIONAL CANCER INSTITUTE [R01CA159942, R01CA100070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG039885, R01AG028865, T32AG000183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM551888, CA100070, AG039885, AG028865, and CA159942 (to N. A. T.).	Boggs K, 2007, J BIOL CHEM, V282, P7982, DOI 10.1074/jbc.M611675200; Buurman R, 2012, GASTROENTEROLOGY, V143, P811, DOI 10.1053/j.gastro.2012.05.033; Carvajal LA, 2012, GENE DEV, V26, P1533, DOI 10.1101/gad.184911.111; Di Stefano L, 2003, EMBO J, V22, P6289, DOI 10.1093/emboj/cdg613; Ewing SJ, 2008, CELL DEATH DIFFER, V15, P1734, DOI 10.1038/cdd.2008.105; Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0; Jiang YJ, 2013, HEPATOLOGY, V57, P1098, DOI 10.1002/hep.26146; Jin JL, 2013, CELL REP, V3, P831, DOI 10.1016/j.celrep.2013.02.009; Jin JL, 2011, HEPATOLOGY, V54, P989, DOI 10.1002/hep.24471; Jin JL, 2010, AGING CELL, V9, P895, DOI 10.1111/j.1474-9726.2010.00617.x; Jin JL, 2009, MOL CELL BIOL, V29, P3867, DOI 10.1128/MCB.00456-09; Jones K, 2012, AGEING RES REV, V11, P442, DOI 10.1016/j.arr.2012.02.007; Liu WR, 2012, CHINESE MED J-PEKING, V125, P2349, DOI 10.3760/cma.j.issn.0366-6999.2012.13.020; Mandrekar P, 2011, WORLD J GASTROENTERO, V17, P2456, DOI 10.3748/wjg.v17.i20.2456; Nishida N, 2011, CURR GENOMICS, V12, P130, DOI 10.2174/138920211795564359; Pal D, 2012, CARCINOGENESIS, V33, P2424, DOI 10.1093/carcin/bgs276; Slee EA, 2010, P NATL ACAD SCI USA, V107, P19479, DOI 10.1073/pnas.1005165107; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200; Wang GL, 2008, J BIOL CHEM, V283, P26169, DOI 10.1074/jbc.M803544200; Wang GL, 2008, J BIOL CHEM, V283, P26179, DOI 10.1074/jbc.M803545200; Wang GL, 2010, J CLIN INVEST, V120, P2549, DOI 10.1172/JCI41933; Wang Y, 2011, EPIGENOMICS-UK, V3, P235, DOI [10.2217/epi.11.5, 10.2217/EPI.11.5]; Xie HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034265	24	34	35	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14451	14462		10.1074/jbc.M113.460840	http://dx.doi.org/10.1074/jbc.M113.460840			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23564453	hybrid, Green Published			2022-12-28	WOS:000319253500048
J	Ferreira, JG; Diniz, PMM; de Paula, CAA; Lobo, YA; Paredes-Gamero, EJ; Paschoalin, T; Nogueira-Pedro, A; Maza, PK; Toledo, MS; Suzuki, E; Oliva, MLV				Ferreira, Joana Gasperazzo; Motta Diniz, Paula Malloy; Andrade de Paula, Claudia Alessandra; Lobo, Yara Aparecida; Paredes-Gamero, Edgar Julian; Paschoalin, Thaysa; Nogueira-Pedro, Amanda; Maza, Paloma Korehisa; Toledo, Marcos Sergio; Suzuki, Erika; Vilela Oliva, Maria Luiza			The Impaired Viability of Prostate Cancer Cell Lines by the Recombinant Plant Kallikrein Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE-ACTIVATED RECEPTOR-1; KUNITZ PROTEINASE-INHIBITORS; ENTEROLOBIUM-CONTORTISILIQUUM; PLASMA KALLIKREIN; REACTIVE-SITE; GENE FAMILY; IN-VITRO; ANGIOGENESIS; EXPRESSION; BAUHINIA	Prostate cancer is the most common type of cancer, and kallikreins play an important role in the establishment of this disease. rBbKIm is the recombinant Bauhinia bauhinioides kallikreins inhibitor that was modified to include the RGD/RGE motifs of the inhibitor BrTI from Bauhinia rufa. This work reports the effects of rBbKIm on DU145 and PC3 prostate cancer cell lines. rBbKIm inhibited the cell viability of DU145 and PC3 cells but did not affect the viability of fibroblasts. rBbKIm caused an arrest of the PC3 cell cycle at the G0/G1 and G2/M phases but did not affect the DU145 cell cycle, although rBbKIm triggers apoptosis and cytochrome c release into the cytosol of both cell types. The differences in caspase activation were observed because rBbKIm treatment promoted activation of caspase-3 in DU145 cells, whereas caspase-9 but not caspase-3 was activated in PC3 cells. Because angiogenesis is important to the development of a tumor, the effect of rBbKIm in this process was also analyzed, and an inhibition of 49% was observed in in vitro endothelial cell capillary-like tube network formation. In summary, we demonstrated that different properties of the protease inhibitor rBbKIm may be explored for investigating the androgen-independent prostate cancer cell lines PC3 and DU145.	[Ferreira, Joana Gasperazzo; Motta Diniz, Paula Malloy; Andrade de Paula, Claudia Alessandra; Lobo, Yara Aparecida; Paredes-Gamero, Edgar Julian; Nogueira-Pedro, Amanda; Toledo, Marcos Sergio; Vilela Oliva, Maria Luiza] Univ Fed Sao Paulo, Escola Paulista Med, Dept Bioquim, BR-04044020 Sao Paulo, Brazil; [Paredes-Gamero, Edgar Julian] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biophys, BR-04044020 Sao Paulo, Brazil; [Paschoalin, Thaysa; Maza, Paloma Korehisa; Suzuki, Erika] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Immunol & Parasitol, BR-04044020 Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Oliva, MLV (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Bioquim, Rua Tres Maio 100, BR-04044020 Sao Paulo, Brazil.	olivaml.bioq@epm.br	de Paula, Claudia/X-2904-2018; Suzuki, Erika/B-3456-2008; Vilela Oliva, Maria Luiza/AGI-6283-2022; Toledo, Marcos S/B-6243-2008; Oliva, Maria Luiza V/B-9537-2012; Paredes-Gamero, Edgar J/C-4791-2012; de Toledo, Marcos Sergio/M-7185-2019	Suzuki, Erika/0000-0002-4010-8716; Paredes-Gamero, Edgar J/0000-0003-3686-8402; de Toledo, Marcos Sergio/0000-0002-6605-0874; Oliva, Maria Luiza/0000-0002-5822-0060	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/53766-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant 2009/53766-5, and by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior.	Abdallah RT, 2010, J BIOL CHEM, V285, P35206, DOI 10.1074/jbc.M110.171769; AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Alvarez S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016100; de Paula CAA, 2012, J BIOL CHEM, V287, P170, DOI 10.1074/jbc.M111.263996; Andrade D, 2010, ARCH BIOCHEM BIOPHYS, V498, P74, DOI 10.1016/j.abb.2010.03.022; ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Araujo APU, 2005, BIOL CHEM, V386, P561, DOI 10.1515/BC.2005.066; Arya M, 2006, SURG ONCOL, V15, P117, DOI 10.1016/j.suronc.2006.10.002; Birk Y., 2003, PLANT PROTEINASE INH, P1; Black PC, 2007, PROSTATE, V67, P743, DOI 10.1002/pros.20503; Bok RA, 2003, PROSTATE CANCER P D, V6, P272, DOI 10.1038/sj.pcan.4500676; BOOKSTEIN R, 1990, SCIENCE, V247, P712, DOI 10.1126/science.2300823; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Chau CH, 2010, DRUG MANAGEMENT OF PROSTATE CANCER, P197, DOI 10.1007/978-1-60327-829-4_17; Chieng-Yane P, 2011, J PHARMACOL EXP THER, V336, P643, DOI 10.1124/jpet.110.175182; Clements JA, 2004, CRIT REV CL LAB SCI, V41, P265, DOI 10.1080/10408360490471931; Cohen I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011135; Cooper CR, 2002, NEOPLASIA, V4, P191, DOI 10.1038/sj.neo.7900224; Dardik R, 1997, INT J CANCER, V70, P201, DOI 10.1002/(SICI)1097-0215(19970117)70:2<201::AID-IJC11>3.0.CO;2-L; Darmoul D, 2003, AM J PATHOL, V162, P1503, DOI 10.1016/S0002-9440(10)64283-6; Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; DUFTON MJ, 1990, FEBS LETT, V271, P9, DOI 10.1016/0014-5793(90)80360-U; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Giannis A, 1997, ANGEW CHEM INT EDIT, V36, P588, DOI 10.1002/anie.199705881; Goettig P, 2010, BIOCHIMIE, V92, P1546, DOI 10.1016/j.biochi.2010.06.022; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Katayama H, 2010, BBA-GENE REGUL MECH, V1799, P829, DOI 10.1016/j.bbagrm.2010.09.004; Kaushal V, 2006, PROSTATE, V66, P273, DOI 10.1002/pros.20326; Kennedy AR, 1998, PHARMACOL THERAPEUT, V78, P167, DOI 10.1016/S0163-7258(98)00010-2; KENNEDY AR, 1994, CANCER RES, V54, pS1999; Krem MM, 1999, J BIOL CHEM, V274, P28063, DOI 10.1074/jbc.274.40.28063; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Liu J, 2003, UROL RES, V31, P163, DOI 10.1007/s00240-003-0309-2; Loberg RD, 2007, J CELL BIOCHEM, V101, P1292, DOI 10.1002/jcb.21252; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; MacGrogan D, 1997, SEMIN CANCER BIOL, V8, P11, DOI 10.1006/scbi.1997.0048; Meoli DF, 2009, AM J PHYSIOL-LUNG C, V297, pL706, DOI 10.1152/ajplung.90598.2008; Metcalf DG, 2010, P NATL ACAD SCI USA, V107, P22481, DOI 10.1073/pnas.1015545107; Nakahata AM, 2006, INT J BIOL MACROMOL, V40, P22, DOI 10.1016/j.ijbiomac.2006.05.008; Nakahata AM, 2011, BIOL CHEM, V392, P327, DOI [10.1515/bc.2011.031, 10.1515/BC.2011.031]; Noonan EJ, 2010, ONCOTARGET, V1, P349, DOI 10.18632/oncotarget.167; Obiezu CV, 2005, CANCER LETT, V224, P1, DOI 10.1016/j.canlet.2004.09.024; Oliva MLV, 2010, BIOCHIMIE, V92, P1667, DOI 10.1016/j.biochi.2010.03.021; Oliva MLV, 2001, BIOL CHEM, V382, P109; Oliva MLV, 1999, IMMUNOPHARMACOLOGY, V45, P145, DOI 10.1016/S0162-3109(99)00146-0; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Pampalakis G, 2007, BBA-REV CANCER, V1776, P22, DOI 10.1016/j.bbcan.2007.06.001; Paschoalin T, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-44; Podgorski I, 2005, NEOPLASIA, V7, P207, DOI 10.1593/neo.04349; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; PYTELA R, 1985, P NATL ACAD SCI USA, V82, P5766, DOI 10.1073/pnas.82.17.5766; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Rodriguez Luis G., 2004, V294, P23; Salvesen, 1986, PROTEINASE INHIBITOR, P23; Shi XL, 2004, MOL CANCER RES, V2, P395; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sumikawa JT, 2010, PHYTOCHEMISTRY, V71, P214, DOI 10.1016/j.phytochem.2009.10.009; Tantivejkul K, 2004, J CELL BIOCHEM, V91, P706, DOI 10.1002/jcb.10664; Thompson IM, 2007, J CLIN ONCOL, V25, P3076, DOI 10.1200/JCO.2006.07.6836; Trabocchi A, 2010, J MED CHEM, V53, P7119, DOI 10.1021/jm100754z; Veiseh O, 2011, ADV DRUG DELIVER REV, V63, P582, DOI 10.1016/j.addr.2011.01.010; Oliva MLV, 2008, BIOL CHEM, V389, P1007, DOI 10.1515/BC.2008.119; Oliva MLV, 2011, CURR PROTEIN PEPT SC, V12, P348; Whitbread AK, 2006, BIOL CHEM, V387, P707, DOI 10.1515/BC.2006.089; Wilkinson R, 2012, CANCER IMMUNOL IMMUN, V61, P169, DOI 10.1007/s00262-011-1095-2; YAMADA KM, 1984, J CELL BIOL, V99, P29, DOI 10.1083/jcb.99.1.29	72	15	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13641	13654		10.1074/jbc.M112.404053	http://dx.doi.org/10.1074/jbc.M112.404053			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23511635	hybrid, Green Published			2022-12-28	WOS:000318850300048
J	Zgheib, A; Lamy, S; Annabi, B				Zgheib, Alain; Lamy, Sylvie; Annabi, Borhane			Epigallocatechin Gallate Targeting of Membrane Type 1 Matrix Metalloproteinase-mediated Src and Janus Kinase/Signal Transducers and Activators of Transcription 3 Signaling Inhibits Transcription of Colony-stimulating Factors 2 and 3 in Mesenchymal Stromal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW; GREEN TEA; GLUCOSE-6-PHOSPHATE TRANSPORTER; ENDOTHELIAL-CELLS; MT1-MMP; EXPRESSION; INVASION; GROWTH; PHOSPHORYLATION; PROLIFERATION	Epigallocatechin gallate (EGCG), a major form of tea catechins, possesses immunomodulatory and antiangiogenic effects, both of which contribute to its chemopreventive properties. In this study, we evaluated the impact of EGCG treatment on the expression of colony-stimulating factors (CSF) secreted from human bone marrow-derived mesenchymal stromal cells (MSCs), all of which also contribute to the immunomodulatory and angiogenic properties of these cells. MSCs were activated with concanavalin A (ConA), a Toll-like receptor (TLR)-2 and TLR-6 agonist as well as a membrane type 1 matrix metalloproteinase (MT1-MMP) inducer, which increased granulocyte macrophage-CSF (GM-CSF, CSF-2), granulocyte CSF (G-CSF, CSF-3), and MT1-MMP gene expression. EGCG antagonized the ConA-induced CSF-2 and CSF-3 gene expression, and this process required an MT1-MMP-mediated sequential activation of the Src and JAK/STAT pathways. Gene silencing of MT1-MMP expression further demonstrated its requirement in the phosphorylation of Src and STAT3, whereas overexpression of a nonphosphorylatable MT1-MMP mutant (Y573F) abrogated CSF-2 and CSF-3 transcriptional increases. Given that MSCs are recruited within vascularizing tumors and are believed to contribute to tumor angiogenesis, possibly through secretion of CSF-2 and CSF-3, our study suggests that diet-derived polyphenols such as EGCG may exert chemopreventive action through pharmacological targeting of the MT1-MMP intracellular signaling.	[Zgheib, Alain; Lamy, Sylvie; Annabi, Borhane] Univ Quebec, Lab Oncol Mol, Ctr Rech BIOMED, Dept Chim, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Montreal	Annabi, B (corresponding author), Univ Quebec, Lab Oncol Mol, CP 8888,Succ Ctr Ville, Montreal, PQ H3C 3P8, Canada.	annabi.borhane@uqam.ca			Chaire de Recherche en Prevention et Traitement du Cancer; Natural Sciences and Engineering Research Council of Canada (NSERC)	Chaire de Recherche en Prevention et Traitement du Cancer; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the "Chaire de Recherche en Prevention et Traitement du Cancer" and by the Natural Sciences and Engineering Research Council of Canada (NSERC).	Abarrategi A, 2011, CLIN TRANSL ONCOL, V13, P611, DOI 10.1007/s12094-011-0706-x; Akla N, 2012, EXP CELL RES, V318, P2498, DOI 10.1016/j.yexcr.2012.08.003; Annabi B, 2004, J BIOL CHEM, V279, P21888, DOI 10.1074/jbc.M313694200; Annabi B, 2003, EXP HEMATOL, V31, P640, DOI 10.1016/S0301-472X(03)00090-0; Annabi B, 2002, BBA-MOL CELL RES, V1542, P209, DOI 10.1016/S0167-4889(01)00187-2; Annabi B, 2004, J CELL BIOCHEM, V91, P1146, DOI 10.1002/jcb.10763; Annabi B, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-8; Arroyo AG, 2007, CURR PHARM DESIGN, V13, P1787, DOI 10.2174/138161207780831284; Bautz F, 2001, BLOOD, V97, P3433, DOI 10.1182/blood.V97.11.3433; Bauvois B, 2004, ONCOGENE, V23, P317, DOI 10.1038/sj.onc.1207124; Bergfeld SA, 2010, CANCER METAST REV, V29, P249, DOI 10.1007/s10555-010-9222-7; Birnbaum T, 2007, J NEURO-ONCOL, V83, P241, DOI 10.1007/s11060-007-9332-4; BOCCHIETTO E, 1993, J CELL PHYSIOL, V155, P89, DOI 10.1002/jcp.1041550112; BUSSOLINO F, 1991, J CLIN INVEST, V87, P986, DOI 10.1172/JCI115107; BUSSOLINO F, 1989, NATURE, V337, P471, DOI 10.1038/337471a0; Byun EB, 2012, BIOCHEM BIOPH RES CO, V426, P480, DOI 10.1016/j.bbrc.2012.08.096; Byun EH, 2011, FEBS LETT, V585, P814, DOI 10.1016/j.febslet.2011.02.010; Currie JC, 2007, J BIOL CHEM, V282, P8142, DOI 10.1074/jbc.M610894200; Eisenach PA, 2012, J BIOL CHEM, V287, P11533, DOI 10.1074/jbc.M111.306340; Eisenach PA, 2010, J CELL SCI, V123, P4182, DOI 10.1242/jcs.062711; Ferriz-Martinez RA., 2010, NEW APPROACHES TREAT, P71; Gonzalo P, 2010, BIOFACTORS, V36, P248, DOI 10.1002/biof.99; Goutagny N, 2012, TARGET ONCOL, V7, P29, DOI 10.1007/s11523-012-0213-1; Grote K., 2011, SCI WORLD J, V11, P71; Huang WH, 2013, ONCOGENE, V32, P4343, DOI 10.1038/onc.2012.458; Ingvarsen S, 2013, J BIOL CHEM, V288, P10195, DOI 10.1074/jbc.M112.447169; KANELLOPOULOS JM, 1985, EUR J IMMUNOL, V15, P479, DOI 10.1002/eji.1830150512; Kong Y, 2011, INT IMMUNOPHARMACOL, V11, P1407, DOI 10.1016/j.intimp.2011.04.025; Lin RZ, 2012, ANGIOGENESIS, V15, P443, DOI 10.1007/s10456-012-9272-2; Lord-Dufour S, 2009, STEM CELLS, V27, P489, DOI 10.1634/stemcells.2008-0855; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Meriane M, 2006, STEM CELLS, V24, P2557, DOI 10.1634/stemcells.2006-0209; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Moss NM, 2009, J BIOL CHEM, V284, P19791, DOI 10.1074/jbc.M109.020362; Nyalendo C, 2008, CARCINOGENESIS, V29, P1655, DOI 10.1093/carcin/bgn159; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Pratt J, 2012, GLYCOBIOLOGY, V22, P1245, DOI 10.1093/glycob/cws093; Remacle AG, 2012, CANCER RES, V72, P2339, DOI 10.1158/0008-5472.CAN-11-4149; Ribatti D, 2012, LEUKEMIA RES, V36, P537, DOI 10.1016/j.leukres.2012.02.003; Sassoli Chiara, 2012, Cells, V1, P832, DOI 10.3390/cells1040832; Savinov AY, 2013, EXP THER MED, V5, P438, DOI 10.3892/etm.2012.821; Sina A., 2009, CANC LETT, V279, P171; Strongin AY, 2010, BBA-MOL CELL RES, V1803, P133, DOI 10.1016/j.bbamcr.2009.04.009; Sun XT, 2012, WORLD J GASTROENTERO, V18, P4925, DOI 10.3748/wjg.v18.i35.4925; Umegaki K, 2001, J NUTR SCI VITAMINOL, V47, P402, DOI 10.3177/jnsv.47.402; Yang CS, 1998, CANCER EPIDEM BIOMAR, V7, P351; Yoshioka T, 2006, CARDIOVASC RES, V70, P61, DOI 10.1016/j.cardiores.2005.12.013	47	36	37	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13378	13386		10.1074/jbc.M113.456533	http://dx.doi.org/10.1074/jbc.M113.456533			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23548906	Green Published, hybrid			2022-12-28	WOS:000318850300023
J	Alfassy, OS; Cohen, I; Reiss, Y; Tirosh, B; Ravid, T				Alfassy, Omri S.; Cohen, Itamar; Reiss, Yuval; Tirosh, Boaz; Ravid, Tommer			Placing a Disrupted Degradation Motif at the C Terminus of Proteasome Substrates Attenuates Degradation without Impairing Ubiquitylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; NUCLEAR-QUALITY CONTROL; SACCHAROMYCES-CEREVISIAE; ORNITHINE-DECARBOXYLASE; MAT-ALPHA-2 REPRESSOR; MESSENGER-RNA; UBIQUITIN; RETICULUM; SYSTEM; SIGNAL	Protein elimination by the ubiquitin-proteasome system requires the presence of a cis-acting degradation signal. Efforts to discern degradation signals of misfolded proteasome substrates thus far revealed a general mechanism whereby the exposure of cryptic hydrophobic motifs provides a degradation determinant. We have previously characterized such a determinant, employing the yeast kinetochore protein Ndc10 as a model substrate. Ndc10 is essentially a stable protein that is rapidly degraded upon exposure of a hydrophobic motif located at the C-terminal region. The degradation motif comprises two distinct and essential elements: DegA, encompassing two amphipathic helices, and DegB, a hydrophobic sequence within the loosely structured C-terminal tail of Ndc10. Here we show that the hydrophobic nature of DegB is irrelevant for the ubiquitylation of substrates containing the Ndc10 degradation motif, but is essential for proteasomal degradation. Mutant DegB, in which the hydrophobic sequence was disrupted, acted as a dominant degradation inhibitory element when expressed at the C-terminal regions of ubiquitin-dependent and -independent substrates of the 26S proteasome. This mutant stabilized substrates in both yeast and mammalian cells, indicative of a modular recognition moiety. The dominant function of the mutant DegB provides a powerful experimental tool for evaluating the physiological implications of stabilization of specific proteasome substrates in intact cells and for studying the associated pathological effects.	[Alfassy, Omri S.; Cohen, Itamar; Reiss, Yuval; Ravid, Tommer] Hebrew Univ Jerusalem, A Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Tirosh, Boaz] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Inst Drug Res, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Ravid, T (corresponding author), Hebrew Univ Jerusalem, A Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	travid@cc.huji.ac.il			Israel Science Foundation [786/08]; Marie Curie International Reintegration Grant [MIRG-CT-2007-205425]; Lejwa Fund for Biochemistry; Israeli Multiple Myeloma Foundation; Israeli Cancer Association	Israel Science Foundation(Israel Science Foundation); Marie Curie International Reintegration Grant(European Commission); Lejwa Fund for Biochemistry; Israeli Multiple Myeloma Foundation; Israeli Cancer Association	This work was supported by Israel Science Foundation Grant 786/08, Marie Curie International Reintegration Grant MIRG-CT-2007-205425, and the Lejwa Fund for Biochemistry (to T. R.), the Israeli Multiple Myeloma Foundation and the Israeli Cancer Association (to B.T.).	Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; Bercovich Z, 2004, J BIOL CHEM, V279, P54097, DOI 10.1074/jbc.M410234200; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Fredrickson EK, 2011, MOL BIOL CELL, V22, P2384, DOI 10.1091/mbc.E11-03-0256; Furth N, 2011, MOL BIOL CELL, V22, P4726, DOI 10.1091/mbc.E11-05-0463; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Gur E, 2008, GENE DEV, V22, P2267, DOI 10.1101/gad.1670908; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Isasa M, 2010, MOL CELL, V38, P733, DOI 10.1016/j.molcel.2010.05.001; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Kahana Chaim, 2005, V301, P83; Kim HT, 2012, METHODS MOL BIOL, V832, P653, DOI 10.1007/978-1-61779-474-2_46; Lambertson D, 1999, GENETICS, V153, P69; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lipinszki Z, 2012, BIOCHEMISTRY-US, V51, P2461, DOI 10.1021/bi3001006; Loayza D, 1998, MOL CELL BIOL, V18, P779, DOI 10.1128/MCB.18.2.779; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MAMROUDKIDRON E, 1994, FEBS LETT, V356, P162, DOI 10.1016/0014-5793(94)01260-1; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; MURAKAMI Y, 1992, BIOCHEM J, V283, P661, DOI 10.1042/bj2830661; Navon A, 2010, FEBS LETT, V584, P67, DOI 10.1016/j.febslet.2009.11.069; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Takeuchi J, 2008, BIOCHEM J, V410, P401, DOI 10.1042/BJ20071239; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Tirosh B, 2006, J BIOL CHEM, V281, P5852, DOI 10.1074/jbc.M509061200; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	35	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12645	12653		10.1074/jbc.M113.453027	http://dx.doi.org/10.1074/jbc.M113.453027			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23519465	Green Published, hybrid			2022-12-28	WOS:000318555100022
J	Barber, CJS; Pujara, PT; Reed, DW; Chiwocha, S; Zhang, HX; Covello, PS				Barber, Carla J. S.; Pujara, Pareshkumar T.; Reed, Darwin W.; Chiwocha, Shiela; Zhang, Haixia; Covello, Patrick S.			The Two-step Biosynthesis of Cyclic Peptides from Linear Precursors in a Member of the Plant Family Caryophyllaceae Involves Cyclization by a Serine Protease-like Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLYL OLIGOPEPTIDASE; SAPONARIA-VACCARIA; CIRCULAR PROTEINS; NATURAL-PRODUCTS; MACROCYCLIZATION; CYCLOPEPTIDES; CYCLOTIDES; ARCHITECTURE; PROTEOLYSIS; EXTRACTION	Caryophyllaceae-type cyclic peptides (CPs) of 5-12 proteinogenic amino acids occur in 10 plant families. In Saponaria vaccaria (Caryophyllaceae), they have been shown to be formed from linear peptide precursors derived from ribosomal translation. There is also evidence for such precursors in other members of the Caryophyllaceae, Rutaceae, and Linaceae families. The biosynthesis of CP in the developing seeds of S. vaccaria was investigated with respect to the enzymes involved in precursor processing. Through biochemical assays with seed extracts and synthetic peptides, an enzyme named oligopeptidase 1 (OLP1) was found that catalyzes the cleavage of intermediates at the N terminus of the incipient CP. A second enzyme, peptide cyclase 1 (PCY1), which was separated chromatographically from OLP1, was found to act on the product of OLP1, giving rise to a cyclic peptide and concomitant removal of a C-terminal flanking sequence. PCY1 was partially purified, and using the methods of proteomics, a full-length cDNA clone encoding an enzyme matching the properties of PCY1 was obtained. The substrate specificity of purified recombinant PCY1, believed to be the first cloned plant enzyme whose function is peptide cyclization, was tested with synthetic peptides. The results are discussed in the light of CP biosynthetic systems of other organisms.	[Barber, Carla J. S.; Pujara, Pareshkumar T.; Reed, Darwin W.; Chiwocha, Shiela; Zhang, Haixia; Covello, Patrick S.] Natl Res Council Canada, Saskatoon, SK S7N 0W9, Canada	National Research Council Canada	Covello, PS (corresponding author), Natl Res Council Canada, 110 Gymnasium Pl, Saskatoon, SK S7N 0W9, Canada.	patrick.covello@nrc-cnrc.gc.ca		Reed, Darwin/0000-0001-8038-8647	Genome Canada; McGill Innovation Centre; Saskatchewan Agriculture Development Fund	Genome Canada(Genome Canada); McGill Innovation Centre; Saskatchewan Agriculture Development Fund	This work was supported in part by Genome Canada and affiliates, McGill Innovation Centre, and the Saskatchewan Agriculture Development Fund.	Agarwal V, 2012, CHEM BIOL, V19, P1411, DOI 10.1016/j.chembiol.2012.09.012; Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Berkers CR, 2009, INT J BIOCHEM CELL B, V41, P66, DOI 10.1016/j.biocel.2008.08.036; Cascales L, 2010, ORG BIOMOL CHEM, V8, P5035, DOI 10.1039/c0ob00139b; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Condie JA, 2011, PLANT J, V67, P682, DOI 10.1111/j.1365-313X.2011.04626.x; Conlan BF, 2010, BIOPOLYMERS, V94, P573, DOI 10.1002/bip.21422; Craik DJ, 2004, CURR PROTEIN PEPT SC, V5, P297, DOI 10.2174/1389203043379512; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Gaasterland T, 1996, BIOCHIMIE, V78, P302, DOI 10.1016/0300-9084(96)84761-4; Gambino G, 2008, PHYTOCHEM ANALYSIS, V19, P520, DOI 10.1002/pca.1078; Garcia Angie E, 2010, Curr Mol Pharmacol, V3, P153; GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0; Gui B, 2012, J AGR FOOD CHEM, V60, P8571, DOI 10.1021/jf301847u; Hoogerhout P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019110; Hourani R, 2011, J AM CHEM SOC, V133, P15296, DOI 10.1021/ja2063082; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jia AQ, 2006, SCI CHINA SER B, V49, P63, DOI 10.1007/s11426-005-0204-5; JOHNSTON RB, 1950, J BIOL CHEM, V187, P205; Jones AC, 2009, CURR OPIN CHEM BIOL, V13, P216, DOI 10.1016/j.cbpa.2009.02.019; Katoh T, 2011, CHEM COMMUN, V47, P9946, DOI 10.1039/c1cc12647d; KAUFMANN HP, 1959, CHEM BER-RECL, V92, P2805, DOI 10.1002/cber.19590921122; Koehnke J, 2012, NAT STRUCT MOL BIOL, V19, P767, DOI 10.1038/nsmb.2340; Lee J, 2009, J AM CHEM SOC, V131, P2122, DOI 10.1021/ja8092168; Marx UC, 2003, J BIOL CHEM, V278, P21782, DOI 10.1074/jbc.M212996200; Meesapyodsuk D, 2007, J BIOL CHEM, V282, P20191, DOI 10.1074/jbc.M702196200; Meesapyodsuk D, 2007, PLANT PHYSIOL, V143, P959, DOI 10.1104/pp.106.088484; Meier JL, 2009, CHEM SOC REV, V38, P2012, DOI 10.1039/b805115c; MORITA H, 1994, TETRAHEDRON LETT, V35, P9593, DOI 10.1016/0040-4039(94)88519-2; Morita H, 2006, BIOORG MED CHEM LETT, V16, P4458, DOI 10.1016/j.bmcl.2006.06.083; Morita H, 2010, HETEROCYCLES, V80, P739, DOI 10.3987/REV-09-SR(S)7; Mylne JS, 2012, PLANT CELL, V24, P2765, DOI 10.1105/tpc.112.099085; Mylne JS, 2011, NAT CHEM BIOL, V7, P257, DOI 10.1038/nchembio.542; Namjoshi S, 2010, BIOPOLYMERS, V94, P673, DOI 10.1002/bip.21476; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Picur B, 2006, J PEPT SCI, V12, P569, DOI 10.1002/psc.779; Pomilio AB, 2006, CURR ORG CHEM, V10, P2075, DOI 10.2174/138527206778742669; Poth AG, 2012, J BIOL CHEM, V287, P27033, DOI 10.1074/jbc.M112.370841; Poth AG, 2011, P NATL ACAD SCI USA, V108, P10127, DOI 10.1073/pnas.1103660108; Poth AG, 2011, ACS CHEM BIOL, V6, P345, DOI 10.1021/cb100388j; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sancheti H, 2009, ADV DRUG DELIVER REV, V61, P908, DOI 10.1016/j.addr.2009.07.003; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Selsted ME, 2004, CURR PROTEIN PEPT SC, V5, P365, DOI 10.2174/1389203043379459; Sheoran IS, 2005, PROTEOMICS, V5, P3752, DOI 10.1002/pmic.200401209; Sivonen K, 2010, APPL MICROBIOL BIOT, V86, P1213, DOI 10.1007/s00253-010-2482-x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Szeltner Z, 2004, J MOL BIOL, V340, P627, DOI 10.1016/j.jmb.2004.05.011; Tan NH, 2006, CHEM REV, V106, P840, DOI 10.1021/cr040699h; Walsh CT, 2001, CURR OPIN CHEM BIOL, V5, P525, DOI 10.1016/S1367-5931(00)00235-0; Walton JD, 2010, BIOPOLYMERS, V94, P659, DOI 10.1002/bip.21416; White CJ, 2011, NAT CHEM, V3, P509, DOI 10.1038/nchem.1062; Wong CTT, 2012, ANGEW CHEM INT EDIT, V51, P5620, DOI 10.1002/anie.201200984	56	65	70	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12500	12510		10.1074/jbc.M112.437947	http://dx.doi.org/10.1074/jbc.M112.437947			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23486480	Green Published, hybrid			2022-12-28	WOS:000318555100009
J	Larner, J				Larner, Joseph			Inositol, Glycogen, Insulin, and Six Nobelists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							D-CHIRO-INOSITOL; ALPHA-GLUCAN TRANSGLUCOSYLASE; POLYCYSTIC-OVARY-SYNDROME; RABBIT SKELETAL-MUSCLE; STREPTOZOTOCIN-DIABETIC RATS; DEPENDENT PROTEIN-KINASE; 2 FORMS; PHOSPHORYLATION STATE; MEDIATOR; RESISTANCE		Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Virginia	Larner, J (corresponding author), Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA.	jl6d@virginia.edu						ASPLIN I, 1993, P NATL ACAD SCI USA, V90, P5924, DOI 10.1073/pnas.90.13.5924; Baillargeon JP, 2010, METAB SYNDR RELAT D, V8, P127, DOI 10.1089/met.2009.0052; Brautigan DL, 2005, BIOCHEMISTRY-US, V44, P11067, DOI 10.1021/bi0508845; CORI GT, 1951, J BIOL CHEM, V188, P17; CRAIG JW, 1964, NATURE, V202, P971, DOI 10.1038/202971a0; DAUGHADAY WH, 1954, J CLIN INVEST, V33, P1075, DOI 10.1172/JCI102979; DAUGHADAY WH, 1954, J CLIN INVEST, V33, P326, DOI 10.1172/JCI102901; DAUGHADAY WH, 1955, J BIOL CHEM, V212, P869; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Farias VX, 2011, DIABETES OBES METAB, V13, P243, DOI 10.1111/j.1463-1326.2010.01344.x; Fonteles MC, 2000, HORM METAB RES, V32, P129, DOI 10.1055/s-2007-978606; FRIEDMAN DL, 1963, BIOCHEMISTRY-US, V2, P669, DOI 10.1021/bi00904a009; GUINOVART JJ, 1978, BIOCHIM BIOPHYS ACTA, V539, P181, DOI 10.1016/0304-4165(78)90005-3; Hans SK, 2010, BIOORGAN MED CHEM, V18, P1103, DOI 10.1016/j.bmc.2009.12.056; HIRAGA A, 1981, EUR J BIOCHEM, V119, P503, DOI 10.1111/j.1432-1033.1981.tb05636.x; HIZUKURI S, 1964, BIOCHEMISTRY-US, V3, P1783, DOI 10.1021/bi00899a034; HUANG LC, 1993, ENDOCRINOLOGY, V132, P652, DOI 10.1210/en.132.2.652; JARETT L, 1979, SCIENCE, V206, P1407, DOI 10.1126/science.505013; KENNINGTON AS, 1990, NEW ENGL J MED, V323, P373, DOI 10.1056/NEJM199008093230603; Ku Bon-Jeong, 2007, [The Korean Journal of Medicine, 대한내과학회지], V72, P29; LARNER J, 1952, J BIOL CHEM, V199, P641; LARNER J, 1979, SCIENCE, V206, P1408, DOI 10.1126/science.228395; Larner J, 2003, J MED CHEM, V46, P3283, DOI 10.1021/jm030071j; LARNER J, 1949, J BIOL CHEM, V178, P373; LARNER J, 1956, ARCH BIOCHEM BIOPHYS, V60, P352, DOI 10.1016/0003-9861(56)90437-4; LARNER J, 1960, ARCH BIOCHEM BIOPHYS, V86, P56, DOI 10.1016/0003-9861(60)90367-2; LARNER J, 1988, COLD SPRING HARB SYM, V53, P965, DOI 10.1101/SQB.1988.053.01.111; LARNER J, 1953, J BIOL CHEM, V202, P491; LARNER J, 1982, FED PROC, V41, P2724; LARNER J, 1960, FED PROC, V19, P971; Larner J, 1996, DIABETES CARE, V19, P76, DOI 10.2337/diacare.19.1.76; LARNER J, 1955, ARCH BIOCHEM BIOPHYS, V58, P252, DOI 10.1016/0003-9861(55)90117-X; LARNER J, 1988, BIOCHEM BIOPH RES CO, V151, P1416, DOI 10.1016/S0006-291X(88)80520-5; LARNER J, 1969, BIOCHIM BIOPHYS ACTA, V178, P470, DOI 10.1016/0005-2744(69)90216-2; LARNER J, 1955, J BIOL CHEM, V215, P723; LARNER J, 1959, P NATL ACAD SCI USA, V45, P1234, DOI 10.1073/pnas.45.8.1234; Larner J., 1998, Journal of Basic and Clinical Physiology and Pharmacology, V9, P127; Lin XB, 2009, BRIT J NUTR, V102, P1426, DOI 10.1017/S0007114509990456; MOSCATELLI EA, 1959, ARCH BIOCHEM BIOPHYS, V80, P26, DOI 10.1016/0003-9861(59)90337-6; NARAYANAN CR, 1987, CURR SCI INDIA, V56, P139; Nascimento NRF, 2006, P NATL ACAD SCI USA, V103, P218, DOI 10.1073/pnas.0509779103; Nestler JE, 1998, J CLIN ENDOCR METAB, V83, P2001, DOI 10.1210/jc.83.6.2001; Nestler JE, 1999, NEW ENGL J MED, V340, P1314, DOI 10.1056/NEJM199904293401703; Pak Y, 1998, MOL CELLS, V8, P301; Pitt J, 2013, FASEB J, V27, P199, DOI 10.1096/fj.12-211896; ROACH PJ, 1976, J BIOL CHEM, V251, P1920; ROACH PJ, 1976, J BIOL CHEM, V251, P1913; ROMERO G, 1988, SCIENCE, V240, P509, DOI 10.1126/science.3282305; ROSELLPEREZ M, 1964, BIOCHEMISTRY-US, V3, P81, DOI 10.1021/bi00889a014; ROSELLPEREZ M, 1964, BIOCHEMISTRY-US, V3, P75, DOI 10.1021/bi00889a013; Rubenstein A. H., 1962, LANCET, V280, P1348; SALTIEL AR, 1986, P NATL ACAD SCI USA, V83, P5793, DOI 10.1073/pnas.83.16.5793; SCHLENDER KK, 1973, BIOCHIM BIOPHYS ACTA, V293, P73, DOI 10.1016/0005-2744(73)90377-X; Scioscia M, 2006, J CLIN ENDOCR METAB, V91, P709, DOI 10.1210/jc.2005-1965; Shashkin PN, 1997, DIABETOLOGIA, V40, P557, DOI 10.1007/s001250050715; Sun TH, 2002, BIOCHEM BIOPH RES CO, V293, P1092, DOI 10.1016/S0006-291X(02)00313-3; TAKEDA Y, 1975, J BIOL CHEM, V250, P8943; TAMURA S, 1989, P NATL ACAD SCI USA, V86, P1796, DOI 10.1073/pnas.86.6.1796; VILLARPALASI C, 1960, BIOCHIM BIOPHYS ACTA, V39, P171, DOI 10.1016/0006-3002(60)90142-6; VILLARPALASI C, 1960, ARCH BIOCHEM BIOPHYS, V86, P61, DOI 10.1016/0003-9861(60)90368-4; VILLARPALASI C, 1960, ARCH BIOCHEM BIOPHYS, V86, P270, DOI 10.1016/0003-9861(60)90417-3; WALKENBACH RJ, 1978, MOL CELL BIOCHEM, V19, P31; WALSH DA, 1971, J BIOL CHEM, V246, P1977; Woolley DW, 1940, SCIENCE, V92, P384, DOI 10.1126/science.92.2391.384-a; Yoshizaki T, 2004, J BIOL CHEM, V279, P22715, DOI 10.1074/jbc.M313745200	65	4	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12313	12324		10.1074/jbc.X113.471177	http://dx.doi.org/10.1074/jbc.X113.471177			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23515311	Green Published, hybrid			2022-12-28	WOS:000318157600062
J	Feng, L; Fong, KW; Wang, JD; Wang, WQ; Chen, JJ				Feng, Lin; Fong, Ka-Wing; Wang, Jiadong; Wang, Wenqi; Chen, Junjie			RIF1 Counteracts BRCA1-mediated End Resection during DNA Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; HOMOLOGOUS RECOMBINATION; IONIZING-RADIATION; CELL-CYCLE; BRCA1 DEFICIENCY; DAMAGE-RESPONSE; BLM HELICASE; BREAK REPAIR; IN-VIVO	BRCA1 promotes homologous recombination repair and antagonizes 53BP1-dependent nonhomologous end joining (NHEJ) pathway. However, the molecular basis of the competition between BRCA1 and 53BP1 pathways remains elusive. Here we report that RIF1 protein translocates to damage sites via ATM-dependent 53BP1 phosphorylation. Strikingly, loss of RIF1 rescues initial DNA end resection and checkpoint activation in BRCA1-depleted cells. Interestingly RIF1 accumulation at damage sites is antagonized by BRCA1 in S and G(2) phases. Conversely, the translocation of BRCA1 to damage sites is inhibited by RIF1 in G(1) phase. However, loss of RIF1 differs from that of 53BP1 deficiency, as it cannot fully rescue RAD51 foci formation, homologous recombination defect, and radio-hypersensitivity in BRCA1-deficient cells. This is likely because RIF1, but not 53BP1, also regulates the foci formation and chromatin loading of BLM (the Bloom syndrome helicase). Thus, RIF1 not only acts downstream of 53BP1 and counteracts BRCA1-mediated end resection but also has a secondary role in promoting BLM function in DNA repair.	[Feng, Lin; Fong, Ka-Wing; Wang, Jiadong; Wang, Wenqi; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jchen8@mdanderson.org		Wang, Wenqi/0000-0003-4053-5088; Fong, Ka-wing/0000-0001-6995-0264; Feng, Lin/0000-0001-6461-5838	National Institutes of Health [CA089239, CA092312, CA100109, CA016672]; Department of Defense [W81XWH-05-1-0470]; NATIONAL CANCER INSTITUTE [R01CA092312, R01CA089239, R01CA100109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA089239, CA092312, and CA100109 (to J. C.).; Recipient of an Era of Hope Scholar award from the Department of Defense (W81XWH-05-1-0470) and a member of MD Anderson Cancer Center (National Institutes of Health Grant CA016672). To whom correspondence should be addressed: Dept. of Experimental Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030. Tel.: 713-792-4863; Fax: 713-794-5369; E-mail: jchen8@mdanderson.org.	Bohgaki T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001381; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bothmer A, 2010, J EXP MED, V207, P855, DOI 10.1084/jem.20100244; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Buisson R, 2010, NAT STRUCT MOL BIOL, V17, P1247, DOI 10.1038/nsmb.1915; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Feng L, 2012, NAT STRUCT MOL BIOL, V19, P201, DOI 10.1038/nsmb.2211; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; Jowsey PA, 2004, J BIOL CHEM, V279, P55562, DOI 10.1074/jbc.M411021200; Kousholt AN, 2012, J CELL BIOL, V197, P869, DOI 10.1083/jcb.201111065; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Liu JS, 2006, DNA REPAIR, V5, P369, DOI 10.1016/j.dnarep.2005.11.007; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Marcand S, 1997, CIBA F SYMP, V211, P76; Martinez P, 2012, J CELL BIOL, V197, P283, DOI 10.1083/jcb.201110124; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Nakamura K, 2010, J SYN ORG CHEM JPN, V68, P1, DOI 10.5059/yukigoseikyokaishi.68.1; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Pandita TK, 2000, ONCOGENE, V19, P1386, DOI 10.1038/sj.onc.1203444; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Ribeyre C, 2012, NAT STRUCT MOL BIOL, V19, P307, DOI 10.1038/nsmb.2225; Schlegel BP, 2006, CANCER RES, V66, P5181, DOI 10.1158/0008-5472.CAN-05-3209; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Ward I, 2006, J BIOL CHEM, V281, P38472, DOI 10.1074/jbc.M607577200; Wu JX, 2012, J BIOL CHEM, V287, P22919, DOI 10.1074/jbc.M112.351007; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xu DY, 2010, EMBO J, V29, P3140, DOI 10.1038/emboj.2010.186; Xue Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002417; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	51	194	200	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11135	11143		10.1074/jbc.M113.457440	http://dx.doi.org/10.1074/jbc.M113.457440			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23486525	Green Published, hybrid			2022-12-28	WOS:000317915500018
J	Sergeeva, OA; Chen, B; Haase-Pettingell, C; Ludtke, SJ; Chiu, W; King, JA				Sergeeva, Oksana A.; Chen, Bo; Haase-Pettingell, Cameron; Ludtke, Steven J.; Chiu, Wah; King, Jonathan A.			Human CCT4 and CCT5 Chaperonin Subunits Expressed in Escherichia coli Form Biologically Active Homo-oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-II CHAPERONIN; GAMMA-D CRYSTALLIN; CRYO-EM STRUCTURE; BINDING-SITES; IN-VITRO; MOLECULAR CHAPERONES; FOLDING CYCLE; COMPLEX; PROTEIN; TRIC/CCT	Chaperonins are a family of chaperones that encapsulate their substrates and assist their folding in an ATP-dependent manner. The ubiquitous eukaryotic chaperonin, TCP-1 ring complex (TRiC), is a hetero-oligomeric complex composed of two rings, each formed from eight different CCT (chaperonin containing TCP-1) subunits. Each CCT subunit may have distinct substrate recognition and ATP hydrolysis properties. We have expressed each human CCT subunit individually in Escherichia coli to investigate whether they form chaperonin-like double ring complexes. CCT4 and CCT5, but not the other six CCT subunits, formed high molecular weight complexes within the E. coli cells that sedimented about 20S in sucrose gradients. When CCT4 and CCT5 were purified, they were both organized as two back-to-back rings of eight subunits each, as seen by negative stain and cryo-electron microscopy. This morphology is consistent with that of the hetero-oligomeric double-ring TRiC purified from bovine testes and HeLa cells. Both CCT4 and CCT5 homo-oligomers hydrolyzed ATP at a rate similar to human TRiC and were active as assayed by luciferase refolding and human gamma D-crystallin aggregation suppression and refolding. Thus, both CCT4 and CCT5 homo-oligomers have the property of forming 8-fold double rings absent the other subunits, and these complexes carry out chaperonin reactions without other partner subunits.	[Sergeeva, Oksana A.; Haase-Pettingell, Cameron; King, Jonathan A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Chen, Bo; Ludtke, Steven J.; Chiu, Wah] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Chen, Bo; Ludtke, Steven J.] Baylor Coll Med, Natl Ctr Macromol Imaging, Houston, TX 77030 USA	Massachusetts Institute of Technology (MIT); Baylor College of Medicine; Baylor College of Medicine	King, JA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave 68-330, Cambridge, MA 02139 USA.	jaking@mit.edu	; Ludtke, Steven/A-4478-2008	Sergeeva, Oksana/0000-0002-4830-0518; Ludtke, Steven/0000-0002-1903-1574	National Institutes of Health [PN2EY016525, R01EY015834, P41GM103832]; NATIONAL EYE INSTITUTE [R01EY015834, PN2EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Common Fund Grants PN2EY016525, R01EY015834, and P41GM103832.	Acosta-Sampson L, 2010, J MOL BIOL, V401, P134, DOI 10.1016/j.jmb.2010.05.067; Bigotti MG, 2008, ARCH BIOCHEM BIOPHYS, V474, P331, DOI 10.1016/j.abb.2008.03.015; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Chen DH, 2006, STRUCTURE, V14, P1711, DOI 10.1016/j.str.2006.09.010; CHENG MY, 1990, NATURE, V348, P455, DOI 10.1038/348455a0; Cong Y, 2012, EMBO J, V31, P720, DOI 10.1038/emboj.2011.366; Cong Y, 2010, P NATL ACAD SCI USA, V107, P4967, DOI 10.1073/pnas.0913774107; Dekker C, 2011, EMBO J, V30, P3078, DOI 10.1038/emboj.2011.208; Douglas NR, 2011, CELL, V144, P240, DOI 10.1016/j.cell.2010.12.017; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; Ferreyra RG, 2000, METH MOL B, V140, P153; Finnigan GC, 2012, NATURE, V481, P360, DOI 10.1038/nature10724; Flaugh SL, 2005, PROTEIN SCI, V14, P571, DOI 10.1110/ps.041111405; FRYDMAN J, 1992, EMBO J, V11, P4767, DOI 10.1002/j.1460-2075.1992.tb05582.x; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; HEYN MP, 1975, BIOPHYS CHEM, V3, P35, DOI 10.1016/0301-4622(75)80035-4; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Hynes GM, 2000, J BIOL CHEM, V275, P18985, DOI 10.1074/jbc.M910297199; Kalisman N, 2012, P NATL ACAD SCI USA, V109, P2884, DOI 10.1073/pnas.1119472109; KIKUCHI Y, 1975, J MOL BIOL, V99, P695, DOI 10.1016/S0022-2836(75)80180-X; KIM S, 1994, TRENDS BIOCHEM SCI, V19, P543, DOI 10.1016/0968-0004(94)90058-2; Knee KM, 2013, CELL STRESS CHAPERON, V18, P137, DOI 10.1007/s12192-012-0357-z; Knee KM, 2011, PROTEIN SCI, V20, P30, DOI 10.1002/pro.531; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Kubota H, 1999, EUR J BIOCHEM, V262, P492, DOI 10.1046/j.1432-1327.1999.00405.x; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; LEWIS VA, 1992, NATURE, V358, P249, DOI 10.1038/358249a0; Liou AKF, 1997, EMBO J, V16, P4311, DOI 10.1093/emboj/16.14.4311; Llorca O, 1999, NATURE, V402, P693, DOI 10.1038/45294; Llorca O, 2001, J STRUCT BIOL, V135, P205, DOI 10.1006/jsbi.2001.4359; Llorca O, 2000, EMBO J, V19, P5971, DOI 10.1093/emboj/19.22.5971; Machida K, 2012, PROTEIN EXPRES PURIF, V82, P61, DOI 10.1016/j.pep.2011.11.010; Martin-Benito J, 2004, P NATL ACAD SCI USA, V101, P17410, DOI 10.1073/pnas.0405070101; Martin-Benito J, 2007, EMBO REP, V8, P252, DOI 10.1038/sj.embor.7400894; Moreau KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037256; Munoz IG, 2011, NAT STRUCT MOL BIOL, V18, P14, DOI 10.1038/nsmb.1971; Neirynck K, 2006, J MOL BIOL, V355, P124, DOI 10.1016/j.jmb.2005.10.051; Pappenberger G, 2006, J MOL BIOL, V360, P484, DOI 10.1016/j.jmb.2006.05.003; Pereira JH, 2012, EMBO J, V31, P731, DOI 10.1038/emboj.2011.468; Pereira JH, 2010, J BIOL CHEM, V285, P27958, DOI 10.1074/jbc.M110.125344; Reissmann S, 2007, NAT STRUCT MOL BIOL, V14, P432, DOI 10.1038/nsmb1236; Reissmann S, 2012, CELL REP, V2, P866, DOI 10.1016/j.celrep.2012.08.036; Roobol A, 1999, EUR J CELL BIOL, V78, P21, DOI 10.1016/S0171-9335(99)80004-1; ROOBOL A, 1995, J CELL SCI, V108, P1477; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Satish L, 2011, CELL STRESS CHAPERON, V16, P675, DOI 10.1007/s12192-011-0274-6; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Sontag EM, 2013, P NATL ACAD SCI USA, V110, P3077, DOI 10.1073/pnas.1222663110; Spiess C, 2006, MOL CELL, V24, P25, DOI 10.1016/j.molcel.2006.09.003; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Thulasiraman V, 2000, METH MOL B, V140, P169; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Trent JD, 1997, P NATL ACAD SCI USA, V94, P5383, DOI 10.1073/pnas.94.10.5383; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Zhang JJ, 2010, NATURE, V463, P379, DOI 10.1038/nature08701; Zhang QH, 2012, J BIOL CHEM, V287, P20625, DOI 10.1074/jbc.M112.341487	60	39	41	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17734	17744		10.1074/jbc.M112.443929	http://dx.doi.org/10.1074/jbc.M112.443929			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23612981	Green Published, hybrid			2022-12-28	WOS:000320380600063
J	Chen, Y; Decker, KF; Zheng, DL; Matkovich, SJ; Jia, L; Dorn, GW				Chen, Yun; Decker, Keith F.; Zheng, Dali; Matkovich, Scot J.; Jia, Li; Dorn, Gerald W., II			A Nucleus-targeted Alternately Spliced Nix/Bnip3L Protein Isoform Modifies Nuclear Factor kappa B (NF kappa B)-mediated Cardiac Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; PROGRAMMED CELL-DEATH; ENDOPLASMIC-RETICULUM CA2+; BCL-2 FAMILY-MEMBERS; MITOCHONDRIAL APOPTOSIS; HEART-FAILURE; C-ELEGANS; NIX; MICE; CARDIOMYOPATHY	Several Bcl2 family proteins are expressed both as mitochondrial-targeted full-length and as cytosolic truncated alternately spliced isoforms. Recombinantly expressed shorter Bcl2 family isoforms can heterotypically bind to and prevent mitochondrial localization of their full-length analogs, thus suppressing their activity by sequestration. This "sponge" role requires 1:1 expression stoichiometry; absent this an alternate role is suggested. Here, RNA sequencing revealed coordinate regulation of BH3-only protein Nix/Bnip3L (Nix) and its alternately spliced soluble form (sNix) in hearts, but relative sNix/Nix expression of similar to 1:10. Accordingly, we examined other putative functions of sNix. Although Nix expressed in H9c2 rat myoblasts localized to mitochondria, sNix showed variable cytoplasmic and nuclear distribution. Tumor necrosis factor alpha (TNF alpha) induced rapid and complete sNix nucleoplasmic translocation concomitant with nuclear translocation of the p65/RelA subunit of NF kappa B. sNix co-localized and co-precipitated with p65/RelA after TNF alpha stimulation; TNF alpha-induced sNix nuclear translocation did not occur in p65/RelA null murine embryonic fibroblasts. ChIP sequencing of TNF alpha-stimulated H9c2 cells revealed sNix suppression of p65/RelA binding to a subset of weaker DNA binding sites, accounting for its ability to alter gene expression in cultured cells and in vivo mouse hearts. These findings reveal TNF alpha-stimulated cytoplasmic-nuclear shuttling of the alternately spliced non-mitochondrial Nix isoform and uncover a role for sNix as a modulator of TNF alpha/NF kappa B-stimulated cardiac gene expression. Transcriptional co-regulation of sNix and Nix, combined with sNix posttranslational regulation by TNF alpha, comprises a previously unknown mechanism for molecular cross-talk between extrinsic death receptor and intrinsic mitochondrial apoptosis pathways.	[Chen, Yun; Decker, Keith F.; Zheng, Dali; Matkovich, Scot J.; Jia, Li; Dorn, Gerald W., II] Washington Univ, Ctr Pharmacogenom, Dept Med, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Jia, L (corresponding author), Washington Univ, Ctr Pharmacogenom, Campus Box 8220,660 S Euclid Ave, St Louis, MO 63110 USA.	ljia@dom.wustl.edu; gdorn@dom.wustl.edu	li, jia/GVT-7587-2022; Matkovich, Scot J/B-9077-2009; Jia, li/GPW-8015-2022; Zheng, Dali/J-2973-2019; Matkovich, Scot J/AFP-0908-2022; Zheng, Dali/B-4577-2012	Matkovich, Scot J/0000-0002-7398-6857; Zheng, Dali/0000-0003-2345-4040; Matkovich, Scot J/0000-0002-7398-6857; Zheng, Dali/0000-0003-2345-4040	National Institutes of Health through the NHLBI [R01 HL059888]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059888] Funding Source: NIH RePORTER	National Institutes of Health through the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL059888 through the NHLBI (to G.W.D.).	Aronow BJ, 2001, PHYSIOL GENOMICS, V6, P19, DOI 10.1152/physiolgenomics.2001.6.1.19; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bergmann MW, 2001, J MOL CELL CARDIOL, V33, P1223, DOI 10.1006/jmcc.2001.1385; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Ceconi C, 1998, PROG CARDIOVASC DIS, V41, P25, DOI 10.1016/S0033-0620(98)80028-5; Chang NC, 2010, EMBO J, V29, P606, DOI 10.1038/emboj.2009.369; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Chen Y, 2010, P NATL ACAD SCI USA, V107, P9035, DOI 10.1073/pnas.0914013107; Cizeau J, 2000, ONCOGENE, V19, P5453, DOI 10.1038/sj.onc.1203929; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; Decker KF, 2012, NUCLEIC ACIDS RES, V40, P10765, DOI 10.1093/nar/gks888; Diwan A, 2008, CIRCULATION, V117, P396, DOI 10.1161/CIRCULATIONAHA.107.727073; Diwan A, 2007, P NATL ACAD SCI USA, V104, P6794, DOI 10.1073/pnas.0610666104; Diwan A, 2009, J CLIN INVEST, V119, P203, DOI 10.1172/JCI36445; Dorn GW, 2010, CELL CYCLE, V9, P3442, DOI 10.4161/cc.9.17.12944; Dorn GW, 2010, J CARDIOVASC TRANSL, V3, P374, DOI 10.1007/s12265-010-9174-x; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Fujimoto K, 2010, J CLIN INVEST, V120, P4031, DOI 10.1172/JCI44011; Galvez AS, 2006, J BIOL CHEM, V281, P1442, DOI 10.1074/jbc.M509056200; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Higuchi Y, 2004, CIRCULATION, V109, P1892, DOI 10.1161/01.CIR.0000124227.00670.AB; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kitsis RN, 2010, P NATL ACAD SCI USA, V107, P9031, DOI 10.1073/pnas.1003827107; Klee M, 2009, EMBO J, V28, P1757, DOI 10.1038/emboj.2009.90; Kubota T, 2001, J MOL CELL CARDIOL, V33, P1331, DOI 10.1006/jmcc.2001.1393; Matkovich SJ, 2010, CIRC RES, V106, P1459, DOI 10.1161/CIRCRESAHA.110.217513; Mercatante DR, 2001, J BIOL CHEM, V276, P16411, DOI 10.1074/jbc.M009256200; Minn AJ, 1996, J BIOL CHEM, V271, P6306, DOI 10.1074/jbc.271.11.6306; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Oakes SA, 2003, BIOCHEM PHARMACOL, V66, P1335, DOI 10.1016/S0006-2952(03)00482-9; Sakata Y, 1998, CIRCULATION, V97, P1488; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Syed F, 2004, CIRC RES, V95, P1200, DOI 10.1161/01.RES.0000150366.08972.7f; TANAKA S, 1993, J BIOL CHEM, V268, P10920; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Yussman MG, 2002, NAT MED, V8, P725, DOI 10.1038/nm719	46	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15455	15465		10.1074/jbc.M113.452342	http://dx.doi.org/10.1074/jbc.M113.452342			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23603904	hybrid, Green Published			2022-12-28	WOS:000319822300004
J	Garcia-Nafria, J; Baumgart, M; Turkenburg, JP; Wilkinson, AJ; Bott, M; Wilson, KS				Garcia-Nafria, Javier; Baumgart, Meike; Turkenburg, Johan P.; Wilkinson, Anthony J.; Bott, Michael; Wilson, Keith S.			Crystal and Solution Studies Reveal That the Transcriptional Regulator AcnR of Corynebacterium glutamicum Is Regulated by Citrate-Mg2+ Binding to a Non-canonical Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETR FAMILY; STRUCTURAL BASIS; ACONITASE GENE; REPRESSOR; PROTEIN; TETRACYCLINE; IDENTIFICATION; DNA; TRANSFORMATION; EXPRESSION	Corynebacterium glutamicum is an important industrial bacterium as well as a model organism for the order Corynebacteriales, whose citric acid cycle occupies a central position in energy and precursor supply. Expression of aconitase, which isomerizes citrate into isocitrate, is controlled by several transcriptional regulators, including the dimeric aconitase repressor AcnR, assigned by sequence identity to the TetR family. We report the structures of AcnR in two crystal forms together with ligand binding experiments and in vivo studies. First, there is a citrate-Mg2+ moiety bound in both forms, not in the canonical TetR ligand binding site but rather in a second pocket more distant from the DNA binding domain. Second, the citrate-Mg2+ binds with a K-D of 6 mM, within the range of physiological significance. Third, citrate-Mg2+ lowers the affinity of AcnR for its target DNA in vitro. Fourth, analyses of several AcnR point mutations provide evidence for the possible involvement of the corresponding residues in ligand binding, DNA binding, and signal transfer. AcnR derivatives defective in citrate-Mg2+ binding severely inhibit growth of C. glutamicum on citrate. Finally, the structures do have a pocket corresponding to the canonical tetracycline site, and although we have not identified a ligand that binds there, comparison of the two crystal forms suggests differences in the region of the canonical pocket that may indicate a biological significance.	[Garcia-Nafria, Javier; Turkenburg, Johan P.; Wilkinson, Anthony J.; Wilson, Keith S.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Baumgart, Meike; Bott, Michael] Forschungszentrum Julich, Inst Bio & Geosci, Biotechnol IBG 1, D-52425 Julich, Germany	University of York - UK; Helmholtz Association; Research Center Julich	Bott, M (corresponding author), Forschungszentrum Julich, Inst Bio & Geosci, Biotechnol IBG 1, Wilhelm Johnen Str, D-52425 Julich, Germany.	m.bott@fz-juelich.de; keith.wilson@york.ac.uk	Garcia, Javier/R-5524-2019; Bott, Michael/E-8004-2011; Baumgart, Meike/GWC-5464-2022; Baumgart, Meike/ABA-7414-2020	Garcia, Javier/0000-0002-4254-3148; Bott, Michael/0000-0002-4701-8254; Baumgart, Meike/0000-0002-9874-1151; Wilson, Keith/0000-0002-3581-2194; Turkenburg, Johan/0000-0001-6992-6838; Wilkinson, Anthony/0000-0003-4577-9479	Biotechnology and Biological Sciences Research Council	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported in part by a postgraduate studentship from the Biotechnology and Biological Sciences Research Council.	Aleksandrov A, 2008, J MOL BIOL, V378, P898, DOI 10.1016/j.jmb.2008.03.022; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Baumgart M, 2011, J BACTERIOL, V193, P6864, DOI 10.1128/JB.05465-11; Baumgart M, 2011, J BIOTECHNOL, V154, P163, DOI 10.1016/j.jbiotec.2010.07.002; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bott M, 2007, TRENDS MICROBIOL, V15, P417, DOI 10.1016/j.tim.2007.08.004; Brocker M, 2009, J BACTERIOL, V191, P3869, DOI 10.1128/JB.00113-09; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cramer A, 2006, J BACTERIOL, V188, P2554, DOI 10.1128/JB.188.7.2554-2567.2006; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Eggeling L., 2005, HDB CORYNEBACTERIUM, DOI 10.1201/9781420039696; EIKMANNS BJ, 1994, MICROBIOL-SGM, V140, P1817, DOI 10.1099/13500872-140-8-1817; Emer D, 2009, J BIOTECHNOL, V140, P92, DOI 10.1016/j.jbiotec.2008.11.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Frenois F, 2004, MOL CELL, V16, P301, DOI 10.1016/j.molcel.2004.09.020; Frunzke Julia, 2008, P241; Garcia-Nafria J, 2010, ACTA CRYSTALLOGR F, V66, P1074, DOI 10.1107/S1744309110029015; GRUER MJ, 1994, MICROBIOL-SGM, V140, P2531, DOI 10.1099/00221287-140-10-2531; Gu RY, 2007, J MOL BIOL, V372, P583, DOI 10.1016/j.jmb.2007.06.072; Han SO, 2008, MICROBIOL-SGM, V154, P3073, DOI 10.1099/mic.0.2008/019828-0; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hanssler Eva, 2008, P183; Itou H, 2005, J BIOL CHEM, V280, P38711, DOI 10.1074/jbc.M505999200; Itou H, 2010, J MOL BIOL, V403, P174, DOI 10.1016/j.jmb.2010.07.042; Jo S, 2008, NUCLEIC ACIDS RES, V36, pW270, DOI 10.1093/nar/gkn314; KEILHAUER C, 1993, J BACTERIOL, V175, P5595, DOI 10.1128/JB.175.17.5595-5603.1993; Kinoshita S., 1957, J GEN APPL MICROBIOL, V3, P193, DOI [10.2323/jgam.3.193, DOI 10.2323/JGAM.3.193]; Kohl TA, 2009, J BIOTECHNOL, V143, P239, DOI 10.1016/j.jbiotec.2009.08.005; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krug A, 2005, J BIOL CHEM, V280, P585, DOI 10.1074/jbc.M408271200; Le TBK, 2011, NUCLEIC ACIDS RES, V39, P9433, DOI 10.1093/nar/gkr640; Le TBK, 2011, J MOL BIOL, V408, P40, DOI 10.1016/j.jmb.2011.02.035; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Leuchtenberger W, 2005, APPL MICROBIOL BIOT, V69, P1, DOI 10.1007/s00253-005-0155-y; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Niebisch A, 2006, J BIOL CHEM, V281, P12300, DOI 10.1074/jbc.M512515200; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Orth P, 1999, BIOCHEMISTRY-US, V38, P191, DOI 10.1021/bi9816610; Orth P, 1998, J MOL BIOL, V279, P439, DOI 10.1006/jmbi.1998.1775; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Polen T, 2007, FEMS MICROBIOL LETT, V273, P109, DOI 10.1111/j.1574-6968.2007.00793.x; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Toyoda K, 2011, J BACTERIOL, V193, P4123, DOI 10.1128/JB.00384-11; van der Rest ME, 1999, APPL MICROBIOL BIOT, V52, P541, DOI 10.1007/s002530051557; Wendisch VF, 2000, J BACTERIOL, V182, P3088, DOI 10.1128/JB.182.11.3088-3096.2000; Wennerhold J, 2005, J BIOL CHEM, V280, P40500, DOI 10.1074/jbc.M508693200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu Z, 2010, J MOL BIOL, V400, P847, DOI 10.1016/j.jmb.2010.05.062; Yukawa H., 2013, CORYNEBACTERIUM GLUT, P281; Yukawa H., 2013, CORYNEBACTERIUM GLUT	62	9	11	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15800	15812		10.1074/jbc.M113.462440	http://dx.doi.org/10.1074/jbc.M113.462440			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23589369	hybrid, Green Published			2022-12-28	WOS:000319822300034
J	Lek, HS; Morrison, VL; Conneely, M; Campbell, PA; McGloin, D; Kliche, S; Watts, C; Prescott, A; Fagerholm, SC				Lek, Hwee San; Morrison, Vicky L.; Conneely, Michael; Campbell, Paul A.; McGloin, David; Kliche, Stefanie; Watts, Colin; Prescott, Alan; Fagerholm, Susanna C.			The Spontaneously Adhesive Leukocyte Function-associated Antigen-1 (LFA-1) Integrin in Effector T Cells Mediates Rapid Actin- and Calmodulin-dependent Adhesion Strengthening to Ligand under Shear Flow	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR ENDOTHELIUM; SIGNALING PATHWAY; IN-VIVO; ACTIVATION; ARREST; LYMPHOCYTES; MIGRATION; FORCE	Integrins in effector T cells are highly expressed and important for trafficking of these cells and for their effector functions. However, how integrins are regulated in effector T cells remains poorly characterized. Here, we have investigated effector T cell leukocyte function-associated antigen-1 (LFA-1) regulation in primary murine effector T cells. These cells have high LFA-1 integrin expression and display high spontaneous binding to intercellular adhesion molecule-1 (ICAM-1) ligand under static conditions. In addition, these cells are able to migrate spontaneously on ICAM-1. Atomic force microscopy measurements showed that the force required for unbinding of integrin-ligand interactions increases over time (0.5-20-s contact time). The maximum unbinding force for this interaction was similar to 140 piconewtons at 0.5-s contact time, increasing to 580 piconewtons at 20-s contact time. Also, the total work required to disrupt the interaction increased over the 20-s contact time, indicating LFA-1-mediated adhesion strengthening in primary effector T cells over a very quick time frame. Effector T cells adhered spontaneously to ICAM-1 under conditions of shear flow, in the absence of chemokine stimulation, and this binding was independent of protein kinase B/Akt and protein kinase C kinase activity, but dependent on calcium/calmodulin signaling and an intact actin cytoskeleton. These results indicate that effector T cell integrins are highly expressed and spontaneously adhesive in the absence of inside-out integrin signaling but that LFA-1-mediated firm adhesion under conditions of shear flow requires downstream integrin signaling, which is dependent on calcium/calmodulin and the actin cytoskeleton.	[Lek, Hwee San; Morrison, Vicky L.; Fagerholm, Susanna C.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland; [Conneely, Michael; McGloin, David] Univ Dundee, Elect Engn & Phys Div, Dundee DD1 9SY, Scotland; [Campbell, Paul A.; Watts, Colin; Prescott, Alan] Univ Dundee, Coll Life Sci, Dundee DD1 9SY, Scotland; [Campbell, Paul A.] Univ Dundee, Carnegie Phys Lab, Dundee DD1 9SY, Scotland; [Kliche, Stefanie] Otto Von Guericke Univ, Inst Mol & Clin Immunol, D-39106 Magdeburg, Germany	University of Dundee; University of Dundee; University of Dundee; University of Dundee; Otto von Guericke University	Fagerholm, SC (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Jacqui Wood Canc Ctr, Dundee DD1 9SY, Scotland.	s.c.fagerholm@dundee.ac.uk	campbell, paul a/C-3174-2009; Prescott, Alan/Y-5956-2018; McGloin, David/J-6167-2018	campbell, paul a/0000-0001-9417-4586; Prescott, Alan/0000-0002-0747-7317; McGloin, David/0000-0002-0075-4481; Morrison, Vicky/0000-0002-4351-8737; Watts, Colin/0000-0001-6183-2087; Fagerholm, Susanna Carola/0000-0002-0354-8763	Tenovus Scotland grant; Cancer Research UK; Biotechnology and Biological Sciences Research Council; Finnish Academy; Arthritis Research UK; Dundee Cancer Centre; Medical Research Council Milstein Award; Royal Society Industry Fellowship; Engineering and Physical Sciences Research Council [EP/H004238/1]; Royal Society; Medical Research Council [G0701272] Funding Source: researchfish; EPSRC [EP/H004238/1] Funding Source: UKRI; MRC [G0701272] Funding Source: UKRI	Tenovus Scotland grant; Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Finnish Academy(Academy of Finland); Arthritis Research UK(Versus Arthritis); Dundee Cancer Centre; Medical Research Council Milstein Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society Industry Fellowship(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Tenovus Scotland grant (to S. C. F). Work in the authors' laboratories was funded by Cancer Research UK, the Biotechnology and Biological Sciences Research Council, The Finnish Academy, Arthritis Research UK, The Dundee Cancer Centre, a Medical Research Council Milstein Award, a Royal Society Industry Fellowship (to P. A. C), Engineering and Physical Sciences Research Council Grant EP/H004238/1, and the Royal Society.	Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Alon R, 2012, CURR OPIN CELL BIOL, V24, P670, DOI 10.1016/j.ceb.2012.06.001; Anikeeva N, 2005, P NATL ACAD SCI USA, V102, P6437, DOI 10.1073/pnas.0502467102; Bertram A, 2012, J IMMUNOL, V188, P4043, DOI 10.4049/jimmunol.1101651; Chen YH, 2008, BLOOD, V111, P4627, DOI 10.1182/blood-2007-12-128140; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; de Bruyn KMT, 2002, J BIOL CHEM, V277, P29468, DOI 10.1074/jbc.M204990200; Evans R, 2011, BLOOD, V117, P3331, DOI 10.1182/blood-2010-06-289140; Fagerholm SC, 2001, FEBS LETT, V491, P131, DOI 10.1016/S0014-5793(01)02182-2; Galkina E, 2005, J CLIN INVEST, V115, P3473, DOI 10.1172/JCI24482; Giagulli C, 2004, IMMUNITY, V20, P25, DOI 10.1016/S1074-7613(03)00350-9; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Hyduk SJ, 2007, BLOOD, V109, P176, DOI 10.1182/blood-2006-01-029199; Kliche S, 2006, MOL CELL BIOL, V26, P7130, DOI 10.1128/MCB.00331-06; MacPherson M, 2011, J BIOL CHEM, V286, P17303, DOI 10.1074/jbc.M110.182998; Manevich-Mendelson E, 2010, BLOOD, V116, P5907, DOI 10.1182/blood-2010-06-293506; Manevich-Mendelson E, 2009, BLOOD, V114, P2344, DOI 10.1182/blood-2009-04-218636; Matthews SA, 2012, EUR J IMMUNOL, V42, P1316, DOI 10.1002/eji.201142004; Reif K, 2004, J IMMUNOL, V173, P2236, DOI 10.4049/jimmunol.173.4.2236; Salas A, 2006, J BIOL CHEM, V281, P10876, DOI 10.1074/jbc.M512472200; Sanchez-Martin L, 2004, J BIOL CHEM, V279, P16194, DOI 10.1074/jbc.M400905200; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Shulman Z, 2012, NAT IMMUNOL, V13, P67, DOI 10.1038/ni.2173; Sigal A, 2000, J IMMUNOL, V165, P442, DOI 10.4049/jimmunol.165.1.442; Smith DF, 2006, J LEUKOCYTE BIOL, V80, P1491, DOI 10.1189/jlb.0306227; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Waugh C, 2009, MOL CELL BIOL, V29, P5952, DOI 10.1128/MCB.00585-09; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; Yin H, 2008, BLOOD, V111, P658, DOI 10.1182/blood-2007-04-085514	29	20	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14698	14708		10.1074/jbc.M112.430918	http://dx.doi.org/10.1074/jbc.M112.430918			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23585567	hybrid, Green Published			2022-12-28	WOS:000319452100004
J	Assumpcao, TCF; Ma, DY; Schwarz, A; Reiter, K; Santana, JM; Andersen, JF; Ribeiro, JMC; Nardone, G; Yu, LL; Francischetti, IMB				Assumpcao, Teresa C. F.; Ma, Dongying; Schwarz, Alexandra; Reiter, Karine; Santana, Jaime M.; Andersen, John F.; Ribeiro, Jose M. C.; Nardone, Glenn; Yu, Lee L.; Francischetti, Ivo M. B.			Salivary Antigen-5/CAP Family Members Are Cu2+-dependent Antioxidant Enzymes That Scavenge O-2(radical anion) and Inhibit Collagen-induced Platelet Aggregation and Neutrophil Oxidative Burst	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-SUPEROXIDE DISMUTASE; SECONDARY STRUCTURE ANALYSES; HYDROGEN-PEROXIDE; PULSE-RADIOLYSIS; BINDING-SPECIFICITY; ARACHIDONIC-ACID; COPPER-BINDING; NADPH OXIDASE; ACTIVATION; OXYGEN	The function of the antigen-5/CAP family of proteins found in the salivary gland of bloodsucking animals has remained elusive for decades. Antigen-5 members from the hematophagous insects Dipetalogaster maxima (DMAV) and Triatoma infestans (TIAV) were expressed and discovered to attenuate platelet aggregation, ATP secretion, and thromboxane A(2) generation by low doses of collagen (< 1 mu g/ml) but no other agonists. DMAV did not interact with collagen, glycoprotein VI, or integrin alpha 2 beta 1. This inhibitory profile resembles the effects of antioxidants Cu,Zn-superoxide dismutase (Cu,Zn-SOD) in platelet function. Accordingly, DMAV was found to inhibit cytochrome c reduction by O-2(radical anion) generated by the xanthine/xanthine oxidase, implying that it exhibits antioxidant activity. Moreover, our results demonstrate that DMAV blunts the luminescence signal of O-2(radical anion) generated by phorbol 12-myristate 13-acetate-stimulated neutrophils. Mechanistically, inductively coupled plasma mass spectrometry and fluorescence spectroscopy revealed that DMAV, like Cu,Zn-SOD, interacts with Cu2+, which provides redox potential for catalytic removal of O-2(radical anion). Notably, surface plasmon resonance experiments (BIAcore) determined that DMAV binds sulfated glycosaminoglycans (e.g. heparin, K-D similar to 100 nmol/liter), as reported for extracellular SOD. Finally, fractions of the salivary gland of D. maxima with native DMAV contain Cu2+ and display metal-dependent antioxidant properties. Antigen-5/CAP emerges as novel family of Cu2+-dependent antioxidant enzymes that inhibit neutrophil oxidative burst and negatively modulate platelet aggregation by a unique salivary mechanism.	[Assumpcao, Teresa C. F.; Ma, Dongying; Andersen, John F.; Ribeiro, Jose M. C.; Francischetti, Ivo M. B.] NIAID, Vector Biol Sect, Lab Malaria & Vector Res, NIH, Bethesda, MD USA; [Schwarz, Alexandra] Acad Sci Czech Republic, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Reiter, Karine] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Bethesda, MD 20852 USA; [Santana, Jaime M.] Univ Brasilia, Dept Cell Biol, Pathogen Host Interface Lab, BR-70910900 Brasilia, DF, Brazil; [Nardone, Glenn] NIAID, Res Technol Branch, NIH, Bethesda, MD 20852 USA; [Yu, Lee L.] NIST, Div Chem Sci, Gaithersburg, MD 20899 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade de Brasilia; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institute of Standards & Technology (NIST) - USA	Francischetti, IMB (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 12735 Twinbrook Pkwy,Rm 2E-32C, Bethesda, MD 20852 USA.	ifrancischetti@niaid.nih.gov	Yu, Lee/N-7263-2015; Santana, Jaime/H-5319-2013; ma, dongying/D-8623-2012; Ribeiro, Jose/J-7011-2015	Yu, Lee/0000-0002-8043-6853; Ribeiro, Jose/0000-0002-9107-0818	National Institutes of Health Grant [ZIA Al000810-16]; Intramural Research Program of the Division of Intramural Research, NIAID, National Institutes of Health; Fundacao de Amparo a Pesquisa do Distrito Federal, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Financiadora de Estudos e Projetos; Grant Agency of the Czech Republic Grant [P302/11/P798]; Ministry of Education, Youth, and Sports of the Czech Republic KONTAKT II Grant [LH12002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001012, ZIAAI000810, ZICAI001051] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the Division of Intramural Research, NIAID, National Institutes of Health; Fundacao de Amparo a Pesquisa do Distrito Federal, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); Grant Agency of the Czech Republic Grant(Grant Agency of the Czech Republic); Ministry of Education, Youth, and Sports of the Czech Republic KONTAKT II Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant ZIA Al000810-16 and by the Intramural Research Program of the Division of Intramural Research, NIAID, National Institutes of Health. This work was also supported by and Brazilian grants from Fundacao de Amparo a Pesquisa do Distrito Federal, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and Financiadora de Estudos e Projetos.; Supported by Grant Agency of the Czech Republic Grant P302/11/P798 and Ministry of Education, Youth, and Sports of the Czech Republic KONTAKT II Grant LH12002.	Arthur JF, 2012, J THROMB HAEMOST, V10, P1133, DOI 10.1111/j.1538-7836.2012.04734.x; Arthur JF, 2008, PLATELETS, V19, P1, DOI 10.1080/09537100701817224; Asojo OA, 2011, ACTA CRYSTALLOGR D, V67, P455, DOI 10.1107/S0907444911008560; Assumpcao TCF, 2008, INSECT BIOCHEM MOLEC, V38, P213, DOI 10.1016/j.ibmb.2007.11.001; Assumpcao TCF, 2011, J PROTEOME RES, V10, P669, DOI 10.1021/pr100866h; Assumpcao TCF, 2010, J BIOL CHEM, V285, P39001, DOI 10.1074/jbc.M110.152835; Bakdash N, 2008, FREE RADICAL BIO MED, V45, P158, DOI 10.1016/j.freeradbiomed.2008.03.021; Barnese K, 2008, J AM CHEM SOC, V130, P4604, DOI 10.1021/ja710162n; Batinic-Haberle I, 2010, ANTIOXID REDOX SIGN, V13, P877, DOI 10.1089/ars.2009.2876; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Begonja AJ, 2006, BLOOD CELL MOL DIS, V36, P166, DOI 10.1016/j.bcmd.2005.12.028; Begonja AJ, 2005, BLOOD, V106, P2757, DOI 10.1182/blood-2005-03-1047; Bento I, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-28; Bowler RP, 2004, AM J RESP CELL MOL, V31, P432, DOI 10.1165/rcmb.2004-0057OC; BRIGELIUS R, 1974, FEBS LETT, V47, P72, DOI 10.1016/0014-5793(74)80428-X; BUTLER J, 1982, J BIOL CHEM, V257, P747; Caccese D, 2000, THROMB HAEMOSTASIS, V83, P485, DOI 10.1055/s-0037-1613841; Chlopicki S, 2004, ANTIOXID REDOX SIGN, V6, P691, DOI 10.1089/1523086041361640; Clemetson KJ, 2007, CURR PHARM DESIGN, V13, P2673, DOI 10.2174/138161207781662894; Clutton P, 2004, ARTERIOSCL THROM VAS, V24, P187, DOI 10.1161/01.ATV.0000105889.29687.CC; Collin N, 2012, ARTERIOSCL THROM VAS, V32, P2185, DOI 10.1161/ATVBAHA.112.253906; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Davies P, 2008, BIOCHEM J, V410, P237, DOI 10.1042/BJ20071477; Davies P, 2011, BIOCHEMISTRY-US, V50, P37, DOI 10.1021/bi101582p; FAILI A, 1994, BIOCHEM J, V298, P87, DOI 10.1042/bj2980087; Faraci FM, 2004, ARTERIOSCL THROM VAS, V24, P1367, DOI 10.1161/01.ATV.0000133604.20182.cf; FIELDEN EM, 1974, BIOCHEM J, V139, P49, DOI 10.1042/bj1390049; Francischetti IMB, 1997, TOXICON, V35, P1217, DOI 10.1016/S0041-0101(97)00021-4; Francischetti IMB, 1998, ARCH BIOCHEM BIOPHYS, V353, P239, DOI 10.1006/abbi.1998.0598; Francischetti IMB, 2013, J PROTEOMICS, V82, P288, DOI 10.1016/j.jprot.2013.01.009; Francischetti IMB, 2010, TOXICON, V56, P1130, DOI 10.1016/j.toxicon.2009.12.003; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; FRIEDEN E, 1965, J GEN PHYSIOL, V49, P213, DOI 10.1085/jgp.49.1.213; Gao F, 2008, J BIOL CHEM, V283, P6058, DOI 10.1074/jbc.M709273200; Gardner R, 2002, FREE RADICAL BIO MED, V32, P1351, DOI 10.1016/S0891-5849(02)00861-4; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; GOLDSTEIN IM, 1979, J BIOL CHEM, V254, P4040; Goldstein S, 2006, FREE RADICAL BIO MED, V41, P937, DOI 10.1016/j.freeradbiomed.2006.05.026; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Hassett P, 2011, INTENS CARE MED, V37, P1680, DOI 10.1007/s00134-011-2309-y; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Hubbard GP, 2004, J THROMB HAEMOST, V2, P2138, DOI 10.1111/j.1538-7836.2004.01067.x; Hung IH, 1998, J BIOL CHEM, V273, P1749, DOI 10.1074/jbc.273.3.1749; Iuliano L, 1997, FREE RADICAL BIO MED, V22, P999, DOI 10.1016/S0891-5849(96)00488-1; Jandrot-Perrus M, 2000, BLOOD, V96, P1798, DOI 10.1182/blood.V96.5.1798.h8001798_1798_1807; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; KLUG D, 1972, J BIOL CHEM, V247, P4839; Kosman DJ, 2010, J BIOL INORG CHEM, V15, P15, DOI 10.1007/s00775-009-0590-9; Krishna MC, 1996, J BIOL CHEM, V271, P26026, DOI 10.1074/jbc.271.42.26026; Krishna MC, 1996, J BIOL CHEM, V271, P26018, DOI 10.1074/jbc.271.42.26018; Krotz F, 2004, ARTERIOSCL THROM VAS, V24, P1988, DOI 10.1161/01.ATV.0000145574.90840.7d; Krotz F, 2002, BLOOD, V100, P917, DOI 10.1182/blood.V100.3.917; KUBOTA S, 1984, P NATL ACAD SCI-BIOL, V81, P3283, DOI 10.1073/pnas.81.11.3283; Lee YS, 2013, J INVEST DERMATOL, V133, P732, DOI 10.1038/jid.2012.406; Leo R, 1997, CIRCULATION, V95, P885; Leonarduzzi G, 2011, CURR PHARM DESIGN, V17, P3994, DOI 10.2174/138161211798764906; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; LI YB, 1995, CHEM-BIOL INTERACT, V94, P101, DOI 10.1016/0009-2797(94)03326-4; Ma DY, 2011, THROMB HAEMOSTASIS, V105, P1032, DOI 10.1160/TH11-01-0029; Mans BJ, 2010, TOXINS HEMOSTASIS BE; MARKLUND S L, 1986, Journal of Free Radicals in Biology and Medicine, V2, P255, DOI 10.1016/S0748-5514(86)80007-1; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Pignatelli P, 1998, BLOOD, V91, P484, DOI 10.1182/blood.V91.2.484.484_484_490; PRATICO D, 1992, J LAB CLIN MED, V119, P364; PRATICO D, 1993, AM J PHYSIOL, V264, pH1582, DOI 10.1152/ajpheart.1993.264.5.H1582; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Sakurai T, 2007, CELL MOL LIFE SCI, V64, P2642, DOI 10.1007/s00018-007-7183-y; SALVEMINI D, 1989, BRIT J PHARMACOL, V97, P1145, DOI 10.1111/j.1476-5381.1989.tb12572.x; SANDSTROM J, 1992, J BIOL CHEM, V267, P18205; Schultz MK, 1999, J ENVIRON MONITOR, V1, P183, DOI 10.1039/a900534j; Segel GB, 2011, J LEUKOCYTE BIOL, V89, P359, DOI 10.1189/jlb.0910538; Spasojevic I, 2001, INORG CHEM, V40, P726, DOI 10.1021/ic0004986; Tang WH, 2011, J CLIN INVEST, V121, P4462, DOI 10.1172/JCI59291; Thomas SR, 2008, ANTIOXID REDOX SIGN, V10, P1713, DOI 10.1089/ars.2008.2027; Ueda J, 2008, FREE RADICAL BIO MED, V45, P897, DOI 10.1016/j.freeradbiomed.2008.06.016; Vara D, 2013, BRIT J PHARMACOL, V168, P212, DOI 10.1111/j.1476-5381.2012.02130.x; VARGAFTIG BB, 1980, EUR J PHARMACOL, V68, P451, DOI 10.1016/0014-2999(80)90420-3; Wang YL, 2010, J BIOL CHEM, V285, P37872, DOI 10.1074/jbc.M110.146290; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; Watson SP, 2009, CURR PHARM DESIGN, V15, P1358, DOI 10.2174/138161209787846702; Weser U, 1981, Agents Actions Suppl, V8, P103; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Widlansky ME, 2011, ANTIOXID REDOX SIGN, V15, P1517, DOI 10.1089/ars.2010.3642; Xu XQ, 2012, J BIOL CHEM, V287, P10967, DOI 10.1074/jbc.M112.340471; YAO SK, 1993, CIRC RES, V73, P952, DOI 10.1161/01.RES.73.5.952; Yasui K, 2006, INFLAMM RES, V55, P359, DOI 10.1007/s00011-006-5195-y	90	53	53	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14341	14361		10.1074/jbc.M113.466995	http://dx.doi.org/10.1074/jbc.M113.466995			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23564450	Green Published, hybrid			2022-12-28	WOS:000319253500038
J	Nakamura, T; Aizawa, T; Kariya, R; Okada, S; Demura, M; Kawano, K; Makabe, K; Kuwajima, K				Nakamura, Takashi; Aizawa, Tomoyasu; Kariya, Ryusho; Okada, Seiji; Demura, Makoto; Kawano, Keiichi; Makabe, Koki; Kuwajima, Kunihiro			Molecular Mechanisms of the Cytotoxicity of Human alpha-Lactalbumin Made Lethal to Tumor Cells (HAMLET) and Other Protein-Oleic Acid Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANINE MILK LYSOZYME; MOLTEN GLOBULE STATE; STRUCTURAL-CHARACTERIZATION; HYDROGEN-EXCHANGE; ESCHERICHIA-COLI; FOLDING VARIANT; FATTY-ACIDS; APOPTOSIS; FORMS; DEATH	Although HAMLET human alpha-lactalbumin made lethal to tumor cells), a complex formed by human alpha-lactalbumin and oleic acid, has a unique apoptotic activity for the selective killing of tumor cells, the molecular mechanisms of expression of the HAMLET activity are not well understood. Therefore, we studied the molecular properties of HAMLET and its goat counterpart, GAMLET (goat alpha-lactalbumin made lethal to tumor cells), by pulse field gradient NMR and 920-MHz two-dimensional NMR techniques. We also examined the expression of HAMLET-like activities of complexes between oleic acid and other proteins that form a stable molten globule state. We observed that both HAMLET and GAMLET at pH 7.5 were heterogeneous, composed of the native protein, the monomeric molten globule-like state, and the oligomeric species. At pH 2.0 and 50 degrees C, HAMLET and GAMLET appeared in the monomeric state, and we identified the oleic acid-binding site in the complexes by two-dimensional NMR. Rather surprisingly, the binding site thus identified was markedly different between HAMLET and GAMLET. Furthermore, canine milk lysozyme, apo-myoglobin, and beta(2)-microglobulin all formed the HAMLET-like complex with the anti-tumor activity, when the protein was treated with oleic acid under conditions in which their molten globule states were stable. From these results, we conclude that the protein portion of HAMLET, GAMLET, and the other HAMLET-like protein-oleic acid complexes is not the origin of their cytotoxicity to tumor cells and that the protein portion of these complexes plays a role in the delivery of cytotoxic oleic acid molecules into tumor cells across the cell membrane.	[Nakamura, Takashi; Makabe, Koki; Kuwajima, Kunihiro] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Nakamura, Takashi; Makabe, Koki; Kuwajima, Kunihiro] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Aizawa, Tomoyasu; Demura, Makoto; Kawano, Keiichi] Hokkaido Univ, Fac Adv Life Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Kariya, Ryusho; Okada, Seiji] Kumamoto Univ, Ctr AIDS Res, Div Hematopoiesis, Chuo Ku, Kumamoto 8600811, Japan; [Makabe, Koki; Kuwajima, Kunihiro] Grad Univ Adv Studies Sokendai, Sch Phys Sci, Dept Funct Mol Sci, Okazaki, Aichi 4448787, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Hokkaido University; Kumamoto University; Graduate University for Advanced Studies - Japan	Kuwajima, K (corresponding author), Grad Univ Adv Studies Sokendai, Ctr Promot Integrated Sci, Hayama, Kanagawa 2400193, Japan.	kuwajima@ims.ac.jp	Demura, Makoto/F-5272-2011; Aizawa, Tomoyasu/F-5278-2011; Okada, Seiji/F-5785-2013	Demura, Makoto/0000-0003-0912-9284; Aizawa, Tomoyasu/0000-0001-9134-7576; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [20107009, 23107725]; Nanotechnology Network Project of the Ministry of Education, Culture, Sports, Science and Technology; Joint Studies Program of the Institute for Molecular Science (Japan)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nanotechnology Network Project of the Ministry of Education, Culture, Sports, Science and Technology; Joint Studies Program of the Institute for Molecular Science (Japan)	This work was supported by Grants-in-Aid for Scientific Research in Innovative Areas 20107009 and 23107725 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. A part of this work was supported by the Nanotechnology Network Project of the Ministry of Education, Culture, Sports, Science and Technology, and the Joint Studies Program of the Institute for Molecular Science (Japan).	Arai M, 2000, ADV PROTEIN CHEM, V53, P209; Barbana C, 2006, INT DAIRY J, V16, P18, DOI 10.1016/j.idairyj.2005.01.007; Baumann A, 2012, J MOL BIOL, V418, P90, DOI 10.1016/j.jmb.2012.02.006; Brinkmann CR, 2011, FEBS J, V278, P1955, DOI 10.1111/j.1742-4658.2011.08112.x; Casbarra A, 2004, PROTEIN SCI, V13, P1322, DOI 10.1110/ps.03474704; Chaudhuri TK, 2000, BIOCHEMISTRY-US, V39, P15643, DOI 10.1021/bi001735j; Cury-Boaventura MF, 2006, CLIN NUTR, V25, P1004, DOI 10.1016/j.clnu.2006.05.008; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Dymkowska D, 2006, BBA-MOL CELL RES, V1763, P152, DOI 10.1016/j.bbamcr.2005.12.009; Dymkowska D, 2004, TOXICOL MECH METHOD, V14, P73, DOI 10.1080/15376520490257518; Faudry E, 2007, FEBS J, V274, P3601, DOI 10.1111/j.1742-4658.2007.05893.x; Fischer W, 2004, CANCER RES, V64, P2105, DOI 10.1158/0008-5472.CAN-03-2661; Gast K, 1998, PROTEIN SCI, V7, P2004, DOI 10.1002/pro.5560070917; Gustafsson L, 2004, NEW ENGL J MED, V350, P2663, DOI 10.1056/NEJMoa032454; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hallgren O, 2008, ADV EXP MED BIOL, V606, P217, DOI 10.1007/978-0-387-74087-4_8; Halskau O, 2009, CURR PROTEIN PEPT SC, V10, P339, DOI 10.2174/138920309788922199; Hamada D, 2005, FEBS J, V272, P756, DOI 10.1111/j.1742-4658.2004.04513.x; HUGHSON FM, 1990, SCIENCE, V249, P1544, DOI 10.1126/science.2218495; Jensen RG, 1999, LIPIDS, V34, P1243, DOI 10.1007/s11745-999-0477-2; Kamijima T, 2008, BIOCHEM BIOPH RES CO, V376, P211, DOI 10.1016/j.bbrc.2008.08.127; Knyazeva EL, 2008, BIOCHEMISTRY-US, V47, P13127, DOI 10.1021/bi801423s; Kobashigawa Y, 2000, PROTEINS, V40, P579, DOI 10.1002/1097-0134(20000901)40:4&lt;579::AID-PROT40&gt;3.0.CO;2-1; Kohler C, 1999, EXP CELL RES, V249, P260, DOI 10.1006/excr.1999.4472; Kohler C, 2001, EUR J BIOCHEM, V268, P186, DOI 10.1046/j.1432-1327.2001.01870.x; Koshiba T, 1999, PROTEIN ENG, V12, P429, DOI 10.1093/protein/12.5.429; Krantz BA, 2004, J MOL BIOL, V344, P739, DOI 10.1016/j.jmb.2004.09.067; KRONMAN MJ, 1964, BIOCHEMISTRY-US, V3, P1152, DOI 10.1021/bi00896a025; Lindquist S, 2010, CURR OPIN CLIN NUTR, V13, P314, DOI 10.1097/MCO.0b013e328337bbf0; Liskova K, 2011, EUR J LIPID SCI TECH, V113, P1207, DOI 10.1002/ejlt.201100109; Man P, 2010, FEBS J, V277, P653, DOI 10.1111/j.1742-4658.2009.07511.x; Miller WL, 2007, BBA-MOL CELL BIOL L, V1771, P663, DOI 10.1016/j.bbalip.2007.02.012; Mizotani K, 2002, J SAITAMA MED SCH, V29, P117; Mok KH, 2007, BIOCHEM BIOPH RES CO, V354, P1, DOI 10.1016/j.bbrc.2006.12.167; Mossberg AK, 2010, FEBS J, V277, P4614, DOI 10.1111/j.1742-4658.2010.07890.x; Mossberg AK, 2010, J UROLOGY, V183, P1590, DOI 10.1016/j.juro.2009.12.008; Mossberg AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009384; Mukaiyama A, 2013, J MOL BIOL, V425, P273, DOI 10.1016/j.jmb.2012.11.002; Nakamura T, 2010, J MOL BIOL, V396, P1361, DOI 10.1016/j.jmb.2010.01.021; Nakatani H, 2007, BIOCHEMISTRY-US, V46, P5238, DOI 10.1021/bi602464v; Nielsen SB, 2010, J MOL BIOL, V398, P351, DOI 10.1016/j.jmb.2010.03.012; Nishimura C, 2002, J MOL BIOL, V322, P483, DOI 10.1016/S0022-2836(02)00810-0; Permyakovz SE, 2012, BIOL CHEM, V393, P85, DOI 10.1515/BC-2011-230; Pettersson-Kastberg J, 2009, J MOL BIOL, V394, P994, DOI 10.1016/j.jmb.2009.09.026; Ramboarina S, 2003, J MOL BIOL, V330, P1177, DOI 10.1016/S0022-2836(03)00639-9; Redfield C, 1999, NAT STRUCT BIOL, V6, P948, DOI 10.1038/13318; Roman C, 2007, PEDIATR RES, V61, P83, DOI 10.1203/01.pdr.0000250199.24107.fb; SCHULMAN BA, 1995, J MOL BIOL, V253, P651, DOI 10.1006/jmbi.1995.0579; Sirangelo I, 1998, BBA-PROTEIN STRUCT M, V1385, P69, DOI 10.1016/S0167-4838(98)00038-7; Spolaore B, 2010, BIOCHEMISTRY-US, V49, P8658, DOI 10.1021/bi1012832; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 2003, PROTEIN SCI, V12, P2805, DOI 10.1110/ps.0231103; Svensson M, 1999, J BIOL CHEM, V274, P6388, DOI 10.1074/jbc.274.10.6388; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; Tolin S, 2010, FEBS J, V277, P163, DOI 10.1111/j.1742-4658.2009.07466.x; Trinh CH, 2002, P NATL ACAD SCI USA, V99, P9771, DOI 10.1073/pnas.152337399; Wilhelm K, 2009, FEBS J, V276, P3975, DOI 10.1111/j.1742-4658.2009.07107.x; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176; Yu FR, 2008, J PHARM PHARMACOL, V60, P253, DOI 10.1211/jpp.60.2.0015; Zhang M, 2009, CHEM-BIOL INTERACT, V180, P131, DOI 10.1016/j.cbi.2009.03.019; Zherelova OM, 2009, J BIOENERG BIOMEMBR, V41, P229, DOI 10.1007/s10863-009-9222-x; Zhu Y, 2005, NEUROCHEM INT, V46, P127, DOI 10.1016/j.neuint.2004.08.003; [No title captured]	64	39	41	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14408	14416		10.1074/jbc.M112.437889	http://dx.doi.org/10.1074/jbc.M112.437889			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23580643	Green Published, hybrid			2022-12-28	WOS:000319253500044
J	Zhang, Y; An, XX; Stubbe, J; Huang, MX				Zhang, Yan; An, Xiuxiang; Stubbe, JoAnne; Huang, Mingxia			Investigation of in Vivo Roles of the C-terminal Tails of the Small Subunit (beta beta ') of Saccharomyces cerevisiae Ribonucleotide Reductase CONTRIBUTION TO COFACTOR FORMATION AND INTERSUBUNIT ASSOCIATION WITHIN THE ACTIVE HOLOENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ALLOSTERIC REGULATION; SUPEROXIDE-DISMUTASE; KINETIC-ANALYSIS; PROTEIN R2; YEAST; INHIBITION; IRON; OLIGOMERIZATION; MAINTENANCE	The small subunit (beta(2)) of class Ia ribonucleotide reductase (RNR) houses a diferric tyrosyl cofactor (Fe-2(III)-Y-center dot) that initiates nucleotide reduction in the large subunit (alpha(2)) via a long range radical transfer (RT) pathway in the holo-(alpha(2))(m)(beta(2))(n) complex. The C-terminal tails of beta(2) are predominantly responsible for interaction with alpha(2), with a conserved tyrosine residue in the tail (Tyr(356) in Escherichia coli NrdB) proposed to participate in cofactor assembly/maintenance and in RT. In the absence of structure of any holo-RNR, the role of the beta tail in cluster assembly/maintenance and its predisposition within the holo-complex have remained unknown. In this study, we have taken advantage of the unusual heterodimeric nature of the Saccharomyces cerevisiae RNR small subunit (beta beta'), of which only beta contains a cofactor, to address both of these issues. We demonstrate that neither beta-Tyr(376) nor beta'-Tyr(323) (Tyr(356) equivalent in NrdB) is required for cofactor assembly in vivo, in contrast to the previously proposed mechanism for E. coli cofactor maintenance and assembly in vitro. Furthermore, studies with reconstituted-beta beta' and an in vivo viability assay show that beta-Tyr(376) is essential for RT, whereas Tyr(323) in beta' is not. Although the C-terminal tail of beta' is dispensable for cofactor formation and RT, it is essential for interactions with beta and alpha to form the active holo-RNR. Together the results provide the first evidence of a directed orientation of the beta and beta' C-terminal tails relative to alpha within the holoenzyme consistent with a docking model of the two sub-units and argue against RT across the beta beta' interface.	[Zhang, Yan; Stubbe, JoAnne] MIT, Dept Chem, Cambridge, MA 02139 USA; [Stubbe, JoAnne] MIT, Dept Biol, Cambridge, MA 02139 USA; [An, Xiuxiang; Huang, Mingxia] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Colorado System; University of Colorado Anschutz Medical Campus	Huang, MX (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	mingxia.huang@ucdenver.edu	Zhang, Yan/K-1638-2015	Zhang, Yan/0000-0003-2031-0631	National Institutes of Health [GM29595, CA125574, GM81393]; NATIONAL CANCER INSTITUTE [R01CA125574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029595, R01GM029595, R01GM081393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM29595 (to J. S.), CA125574 (to M. H.), and GM81393 (to J. S. and M. H.).	An XX, 2006, GENETICS, V173, P63, DOI 10.1534/genetics.105.055236; Ando N, 2011, P NATL ACAD SCI USA, V108, P21046, DOI 10.1073/pnas.1112715108; ATKIN CL, 1973, J BIOL CHEM, V248, P7464; BOLLINGER JM, 1995, METHOD ENZYMOL, V258, P278; Chabes A, 2000, P NATL ACAD SCI USA, V97, P2474, DOI 10.1073/pnas.97.6.2474; CLIMENT I, 1991, BIOCHEMISTRY-US, V30, P5164, DOI 10.1021/bi00235a008; CLIMENT I, 1992, BIOCHEMISTRY-US, V31, P4801, DOI 10.1021/bi00135a009; COHEN EA, 1986, NATURE, V321, P441, DOI 10.1038/321441a0; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; COVES J, 1995, EUR J BIOCHEM, V233, P357, DOI 10.1111/j.1432-1033.1995.357_1.x; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DUTIA BM, 1986, NATURE, V321, P439, DOI 10.1038/321439a0; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Ge H, 2001, P NATL ACAD SCI USA, V98, P10067, DOI 10.1073/pnas.181336498; Ge J, 2003, BIOCHEMISTRY-US, V42, P10071, DOI 10.1021/bi034374r; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Hristova D, 2008, BIOCHEMISTRY-US, V47, P3989, DOI 10.1021/bi702408k; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Kashlan OB, 2003, BIOCHEMISTRY-US, V42, P1696, DOI 10.1021/bi020634d; KOSHLAND D, 1985, CELL, V40, P393, DOI 10.1016/0092-8674(85)90153-9; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Minnihan C. C., 2013, ACC CHEM RE IN PRESS; Minnihan EC, 2013, P NATL ACAD SCI USA, V110, P3835, DOI 10.1073/pnas.1220691110; Nguyen HHT, 1999, P NATL ACAD SCI USA, V96, P12339, DOI 10.1073/pnas.96.22.12339; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Ortigosa AD, 2006, BIOCHEMISTRY-US, V45, P12282, DOI 10.1021/bi0610404; Perlstein DL, 2005, BIOCHEMISTRY-US, V44, P15366, DOI 10.1021/bi051616+; Rofougaran R, 2006, J BIOL CHEM, V281, P27705, DOI 10.1074/jbc.M605573200; Rofougaran R, 2008, J BIOL CHEM, V283, P35310, DOI 10.1074/jbc.M806738200; Sommerhalter M, 2004, BIOCHEMISTRY-US, V43, P7736, DOI 10.1021/bi049510m; STEEPER JR, 1970, ANAL BIOCHEM, V34, P123, DOI 10.1016/0003-2697(70)90092-8; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; van der Donk WA, 1998, BIOCHEMISTRY-US, V37, P6419, DOI 10.1021/bi9729357; Wang J, 2009, BIOCHEMISTRY-US, V48, P11612, DOI 10.1021/bi901588z; Wang PJ, 1997, MOL CELL BIOL, V17, P6114, DOI 10.1128/MCB.17.10.6114; Wu CH, 2007, BIOCHEMISTRY-US, V46, P11577, DOI 10.1021/bi7012454; Yee CS, 2003, BIOCHEMISTRY-US, V42, P14541, DOI 10.1021/bi0352365; Yee CS, 2003, J AM CHEM SOC, V125, P10506, DOI 10.1021/ja036242r; Zhang Y, 2011, J BIOL CHEM, V286, P41499, DOI 10.1074/jbc.M111.294074	43	8	8	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					13951	13959		10.1074/jbc.M113.467001	http://dx.doi.org/10.1074/jbc.M113.467001			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23532842	hybrid, Green Published			2022-12-28	WOS:000319253500003
J	Li, H; Redinbo, MR; Venkatesh, M; Ekins, S; Chaudhry, A; Bloch, N; Negassa, A; Mukherjee, P; Kalpana, G; Mani, S				Li, Hao; Redinbo, Matthew R.; Venkatesh, Madhukumar; Ekins, Sean; Chaudhry, Anik; Bloch, Nicolin; Negassa, Abdissa; Mukherjee, Paromita; Kalpana, Ganjam; Mani, Sridhar			Novel Yeast-based Strategy Unveils Antagonist Binding Regions on the Nuclear Xenobiotic Receptor PXR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREGNANE-X-RECEPTOR; ANDROGEN RECEPTOR; SACCHAROMYCES-CEREVISIAE; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; PROSTATE-CANCER; CELL-GROWTH; CANDIDA-ALBICANS; GENOTOXIC AGENTS; 2-HYBRID SYSTEM	The pregnane X receptor (PXR) is a master regulator of xenobiotic metabolism, and its activity is critical toward understanding the pathophysiology of several diseases, including inflammation, cancer, and steatosis. Previous studies have demonstrated that ketoconazole binds to ligand-activated PXR and antagonizes receptor control of gene expression. Structure-function as well as computational docking analysis suggested a putative binding region containing critical charge clamp residues Gln-272, and Phe-264 on the AF-2 surface of PXR. To define the antagonist binding surface(s) of PXR, we developed a novel assay to identify key amino acid residues on PXR based on a yeast two-hybrid screen that examined mutant forms of PXR. This screen identified multiple "gain-of-function" mutants that were "resistant" to the PXR antagonist effects of ketoconazole. We then compared our screen results identifying key PXR residues to those predicted by computational methods. Of 15 potential or putative binding residues based on docking, we identified three residues in the yeast screen that were then systematically verified to functionally interact with ketoconazole using mammalian assays. Among the residues confirmed by our study was Ser-208, which is on the opposite side of the protein from the AF-2 region critical for receptor regulation. The identification of new locations for antagonist binding on the surface or buried in PXR indicates novel aspects to the mechanism of receptor antagonism. These results significantly expand our understanding of antagonist binding sites on the surface of PXR and suggest new avenues to regulate this receptor for clinical applications.	[Li, Hao; Venkatesh, Madhukumar; Chaudhry, Anik; Bloch, Nicolin; Mani, Sridhar] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Negassa, Abdissa] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Mukherjee, Paromita; Kalpana, Ganjam] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Redinbo, Matthew R.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Ekins, Sean] Collaborat Chem, Fuquay Varina, NC 27526 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Mani, S (corresponding author), Albert Einstein Coll Med, 1300 Morris Pk Ave,Chanin 302D-1, Bronx, NY 10461 USA.	sridhar.mani@einstein.yu.edu		Kalpana, Ganjam/0000-0003-4111-0604	National Institutes of Health [CA127231]; Damon Runyon Foundation [CI 1502]; NATIONAL CANCER INSTITUTE [R01CA127231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA127231. This work was also supported by a Damon Runyon Foundation Clinical Investigator Award (CI 1502) (to S. M.).	BARD M, 1993, LIPIDS, V28, P963, DOI 10.1007/BF02537115; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Biswas A, 2011, BIOCHEM BIOPH RES CO, V406, P371, DOI 10.1016/j.bbrc.2011.02.048; Biswas A, 2009, PHARM RES-DORDR, V26, P1807, DOI 10.1007/s11095-009-9901-7; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Buzon V, 2012, MOL CELL ENDOCRINOL, V348, P394, DOI 10.1016/j.mce.2011.08.012; Carnahan VE, 2005, CURR DRUG METAB, V6, P357, DOI 10.2174/1389200054633844; Chang CY, 2005, TRENDS PHARMACOL SCI, V26, P225, DOI 10.1016/j.tips.2005.03.002; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Clark FS, 1996, ANTIMICROB AGENTS CH, V40, P419, DOI 10.1128/AAC.40.2.419; Das BC, 2008, BIOORG MED CHEM LETT, V18, P3974, DOI 10.1016/j.bmcl.2008.06.018; Das Supratik, 2009, V485, P271, DOI 10.1007/978-1-59745-170-3_19; Dong HQ, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-23; Eglen R, 2011, PHARMACOL THERAPEUT, V130, P144, DOI 10.1016/j.pharmthera.2011.01.007; Egner R, 2000, MOL MICROBIOL, V35, P1255, DOI 10.1046/j.1365-2958.2000.01798.x; Egner R, 1998, MOL BIOL CELL, V9, P523, DOI 10.1091/mbc.9.2.523; Ekins S, 2008, MOL PHARMACOL, V74, P662, DOI 10.1124/mol.108.049437; Ekins S, 2007, MOL PHARMACOL, V72, P592, DOI 10.1124/mol.107.038398; Ekins S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000594; GEBER A, 1995, ANTIMICROB AGENTS CH, V39, P2708, DOI 10.1128/AAC.39.12.2708; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Gunther JR, 2009, ACS CHEM BIOL, V4, P435, DOI 10.1021/cb900043e; Healan-Greenberg C, 2008, DRUG METAB DISPOS, V36, P500, DOI 10.1124/dmd.107.019547; Huang H, 2007, ONCOGENE, V26, P258, DOI 10.1038/sj.onc.1209788; Joseph JD, 2009, P NATL ACAD SCI USA, V106, P12178, DOI 10.1073/pnas.0900185106; KALPANA GV, 1993, P NATL ACAD SCI USA, V90, P10593, DOI 10.1073/pnas.90.22.10593; Kaur R, 1999, MICROBIOL-UK, V145, P809, DOI 10.1099/13500872-145-4-809; Kim JY, 2007, MOL CELL PROTEOMICS, V6, P1727, DOI 10.1074/mcp.M700079-MCP200; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Lei F., 2009, THESIS U TENNESSEE H; Mani S, 2005, CLIN CANCER RES, V11, P6359, DOI 10.1158/1078-0432.CCR-05-0252; Mani S, 2013, DRUG METAB REV, V45, P60, DOI 10.3109/03602532.2012.746363; Masuyama H, 2005, MOL ENDOCRINOL, V19, P1170, DOI 10.1210/me.2004-0434; Mellado E, 2005, ANTIMICROB AGENTS CH, V49, P2536, DOI 10.1128/AAC.49.6.2536-2538.2005; Millard PJ, 1997, APPL ENVIRON MICROB, V63, P2897, DOI 10.1128/AEM.63.7.2897-2905.1997; Moore TW, 2010, MOL ENDOCRINOL, V24, P683, DOI 10.1210/me.2009-0362; Mukherjee PK, 2003, INFECT IMMUN, V71, P4333, DOI 10.1128/IAI.71.8.4333-4340.2003; Mukhopadhyay K, 2002, ANTIMICROB AGENTS CH, V46, P3695, DOI 10.1128/AAC.46.12.3695-3705.2002; Noble SM, 2006, BIOCHEMISTRY-US, V45, P8579, DOI 10.1021/bi0602821; Pondugula SR, 2013, CANCER LETT, V328, P1, DOI 10.1016/j.canlet.2012.08.030; Rao SN, 2007, J CHEM INF MODEL, V47, P2159, DOI 10.1021/ci6004299; Serebriiskii IG, 2002, GENOME RES, V12, P1785, DOI 10.1101/gr.450702; Sharifi N, 2010, EXPERT OPIN INV DRUG, V19, P837, DOI 10.1517/13543784.2010.494178; Staudinger JL, 2011, PHARMACOL RES, V64, P4, DOI 10.1016/j.phrs.2011.02.011; Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912; Takeshita A, 2002, J BIOL CHEM, V277, P32453, DOI 10.1074/jbc.M111245200; Teotico D. G., 2008, COMPUT BIOL, V4; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Toussaint M, 2006, NAT PROTOC, V1, P1922, DOI 10.1038/nprot.2006.304; Toussaint M, 2006, MUTAT RES-GEN TOX EN, V606, P92, DOI 10.1016/j.mrgentox.2006.03.006; Venkatesh M, 2011, MOL PHARMACOL, V80, P124, DOI 10.1124/mol.111.071787; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wang HW, 2008, MOL ENDOCRINOL, V22, P838, DOI 10.1210/me.2007-0218; Wang HW, 2007, CLIN CANCER RES, V13, P2488, DOI 10.1158/1078-0432.CCR-06-1592; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Xue Y, 2007, BIOORGAN MED CHEM, V15, P2156, DOI 10.1016/j.bmc.2006.12.026; Zhou CC, 2007, MOL PHARMACOL, V71, P220, DOI 10.1124/mol.106.029264	60	27	28	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13655	13668		10.1074/jbc.M113.455485	http://dx.doi.org/10.1074/jbc.M113.455485			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23525103	Green Published, hybrid			2022-12-28	WOS:000318850300049
J	Mendel, RR				Mendel, Ralf R.			The Molybdenum Cofactor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							AFFINITY MOLYBDATE TRANSPORTER; THALIANA PROVIDES INSIGHT; NIFS-LIKE DOMAIN; MOLYBDOPTERIN SYNTHASE; XANTHINE DEHYDROGENASE; NITRATE REDUCTASE; CRYSTAL-STRUCTURE; ALDEHYDE OXIDASE; CARRIER PROTEIN; BIOSYNTHESIS	The transition element molybdenum needs to be complexed by a special cofactor to gain catalytic activity. Molybdenum is bound to a unique pterin, thus forming the molybdenum cofactor (Moco), which, in different variants, is the active compound at the catalytic site of all molybdenum-containing enzymes in nature, except bacterial molybdenum nitrogenase. The biosynthesis of Moco involves the complex interaction of six proteins and is a process of four steps, which also require iron, ATP, and copper. After its synthesis, Moco is distributed, involving Moco-binding proteins. A deficiency in the biosynthesis of Moco has lethal consequences for the respective organisms.	Braunschweig Univ Technol, Dept Plant Biol, D-38106 Braunschweig, Germany	Braunschweig University of Technology	Mendel, RR (corresponding author), Braunschweig Univ Technol, Dept Plant Biol, D-38106 Braunschweig, Germany.	r.mendel@tu-bs.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft. This is the first article in the Thematic Minireview Series on Metals in Biology 2013.	Baxter I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000004; Belaidi AA, 2013, BIOCHEM J, V450, P149, DOI 10.1042/BJ20121078; Bittner F, 2001, J BIOL CHEM, V276, P40381, DOI 10.1074/jbc.C100472200; Dobbek H, 2011, COORDIN CHEM REV, V255, P1104, DOI 10.1016/j.ccr.2010.11.017; Fischer K, 2005, PLANT CELL, V17, P1167, DOI 10.1105/tpc.104.029694; Fischer K, 2006, J BIOL CHEM, V281, P30186, DOI 10.1074/jbc.M603919200; Fitzpatrick KL, 2008, FEBS LETT, V582, P1508, DOI 10.1016/j.febslet.2008.03.045; Gasber A, 2011, PLANT BIOLOGY, V13, P710, DOI 10.1111/j.1438-8677.2011.00448.x; Gehl C, 2009, MOL PLANT, V2, P1051, DOI 10.1093/mp/ssp040; Gutzke G, 2001, J BIOL CHEM, V276, P36268, DOI 10.1074/jbc.M105321200; Hagen WR, 2011, COORDIN CHEM REV, V255, P1117, DOI 10.1016/j.ccr.2011.02.009; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Hanzelmann P, 2004, J BIOL CHEM, V279, P34721, DOI 10.1074/jbc.M313398200; Heidenreich T, 2005, J BIOL CHEM, V280, P4213, DOI 10.1074/jbc.M411195200; Hille R, 2011, COORDIN CHEM REV, V255, P1179, DOI 10.1016/j.ccr.2010.11.034; HOFF T, 1995, J BIOL CHEM, V270, P6100, DOI 10.1074/jbc.270.11.6100; Hu YL, 2013, J BIOL CHEM, V288, P13173, DOI 10.1074/jbc.R113.454041; JOHNSON JL, 1980, J BIOL CHEM, V255, P1783; JOHNSON JL, 1982, P NATL ACAD SCI-BIOL, V79, P6856, DOI 10.1073/pnas.79.22.6856; Kaufholdt D., 2013, J EXP BOT IN PRESS; Kruse T, 2010, J BIOL CHEM, V285, P6623, DOI 10.1074/jbc.M109.060640; Kuper J, 2004, NATURE, V430, P803, DOI 10.1038/nature02681; Lehrke M, 2012, BIOCHEM J, V441, P823, DOI 10.1042/BJ20111170; Leimkuhler S, 2011, COORDIN CHEM REV, V255, P1129, DOI 10.1016/j.ccr.2010.12.003; Leimkuhler S, 2003, J BIOL CHEM, V278, P26127, DOI 10.1074/jbc.M303092200; LEWIS NJ, 1978, EUR J BIOCHEM, V91, P311, DOI 10.1111/j.1432-1033.1978.tb20967.x; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Llamas A, 2004, J BIOL CHEM, V279, P55241, DOI 10.1074/jbc.M409862200; Llamas A, 2006, J BIOL CHEM, V281, P18343, DOI 10.1074/jbc.M601415200; Magalon A, 2011, COORDIN CHEM REV, V255, P1159, DOI 10.1016/j.ccr.2010.12.031; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Matthies A, 2005, BIOCHEMISTRY-US, V44, P7912, DOI 10.1021/bi0503448; Matthies A, 2004, P NATL ACAD SCI USA, V101, P5946, DOI 10.1073/pnas.0308191101; Mehta AP, 2013, BIOCHEMISTRY-US, V52, P1134, DOI 10.1021/bi3016026; Mendel R. R., 1992, CURRENT TOPICS PLANT, P11; Mendel RR, 2011, COORDIN CHEM REV, V255, P1145, DOI 10.1016/j.ccr.2011.01.054; Mendel RR, 2002, J EXP BOT, V53, P1689, DOI 10.1093/jxb/erf038; Millar LJ, 2001, MOL GENET GENOMICS, V266, P445, DOI 10.1007/s004380100543; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; Reiss J, 2005, MOL GENET METAB, V85, P12, DOI 10.1016/j.ymgme.2005.01.008; Reiss J, 1998, NAT GENET, V20, P51, DOI 10.1038/1706; Rieder C, 1998, EUR J BIOCHEM, V255, P24, DOI 10.1046/j.1432-1327.1998.2550024.x; ROMAO MJ, 1995, SCIENCE, V270, P1170, DOI 10.1126/science.270.5239.1170; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Santamaria-Araujo JA, 2012, J BIOL INORG CHEM, V17, P113, DOI 10.1007/s00775-011-0835-2; Schwarz G, 2000, PLANT CELL, V12, P2455, DOI 10.1105/tpc.12.12.2455; Schwarz G, 2006, ANNU REV PLANT BIOL, V57, P623, DOI 10.1146/annurev.arplant.57.032905.105437; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Stallmeyer B, 1999, AM J HUM GENET, V64, P698, DOI 10.1086/302295; Stallmeyer B, 1999, P NATL ACAD SCI USA, V96, P1333, DOI 10.1073/pnas.96.4.1333; Stiefel EL, 2002, MET IONS BIOL SYST, V39, P1; Tejada-Jimenez M, 2007, P NATL ACAD SCI USA, V104, P20126, DOI 10.1073/pnas.0704646104; Tejada-Jimenez M, 2011, P NATL ACAD SCI USA, V108, P6420, DOI 10.1073/pnas.1100700108; Teschner J, 2010, PLANT CELL, V22, P468, DOI 10.1105/tpc.109.068478; Tomatsu H, 2007, P NATL ACAD SCI USA, V104, P18807, DOI 10.1073/pnas.0706373104; Veldman A, 2010, PEDIATRICS, V125, pE1249, DOI 10.1542/peds.2009-2192; WAHL RC, 1984, ARCH BIOCHEM BIOPHYS, V230, P264, DOI 10.1016/0003-9861(84)90107-3; WARNER CK, 1981, MOL GEN GENET, V184, P92, DOI 10.1007/BF00271201; Witte CP, 1998, FEBS LETT, V431, P205, DOI 10.1016/S0014-5793(98)00756-X; Wollers S, 2008, J BIOL CHEM, V283, P9642, DOI 10.1074/jbc.M708549200; WUEBBENS MM, 1993, J BIOL CHEM, V268, P13493; Wuebbens MM, 2003, J BIOL CHEM, V278, P14523, DOI 10.1074/jbc.M300453200; Zhang Y, 2011, COORDIN CHEM REV, V255, P1206, DOI 10.1016/j.ccr.2011.02.016	63	149	152	5	101	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13165	13172		10.1074/jbc.R113.455311	http://dx.doi.org/10.1074/jbc.R113.455311			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23539623	hybrid, Green Published			2022-12-28	WOS:000318850300002
J	Kim, YM; Gayen, S; Kang, CB; Joy, J; Huang, QW; Chen, AS; Wee, JLK; Ang, MJY; Lim, HA; Hung, AW; Li, R; Noble, CG; Lee, LT; Yip, A; Wang, QY; Chia, CSB; Hill, J; Shi, PY; Keller, TH				Kim, Young Mee; Gayen, Shovanlal; Kang, CongBao; Joy, Joma; Huang, Qiwei; Chen, Angela Shuyi; Wee, John Liang Kuan; Ang, Melgious Jin Yan; Lim, Huichang Annie; Hung, Alvin W.; Li, Rong; Noble, Christian G.; Lee, Le Tian; Yip, Andy; Wang, Qing-Yin; Chia, Cheng San Brian; Hill, Jeffrey; Shi, Pei-Yong; Keller, Thomas H.			NMR Analysis of a Novel Enzymatically Active Unlinked Dengue NS2B-NS3 Protease Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS NS3 PROTEASE; N-TERMINAL DOMAIN; WEST-NILE; INHIBITORS; PROTEINASE; EXPRESSION; COFACTOR; BINDING; FLAVIVIRUSES; PURIFICATION	The dengue virus (DENV) is a mosquito-borne pathogen responsible for an estimated 100 million human infections annually. The viral genome encodes a two-component trypsin-like protease that contains the cofactor region from the nonstructural protein NS2B and the protease domain from NS3 (NS3pro). The NS2B-NS3pro complex plays a crucial role in viral maturation and has been identified as a potential drug target. Using a DENV protease construct containing NS2B covalently linked to NS3pro via a Gly(4)-Ser-Gly(4) linker ("linked protease"), previous x-ray crystal structures show that the C-terminal fragment of NS2B is remote from NS3pro and exists in an open state in the absence of an inhibitor; however, in the presence of an inhibitor, NS2B complexes with NS3pro to form a closed state. This linked enzyme produced NMR spectra with severe signal overlap and line broadening. To obtain a protease construct with a resolved NMR spectrum, we expressed and purified an unlinked protease complex containing a 50-residue segment of the NS2B cofactor region and NS3pro without the glycine linker using a coexpression system. This unlinked protease complex was catalytically active at neutral pH in the absence of glycerol and produced dispersed cross-peaks in a H-1-N-15 heteronuclear single quantum correlation spectrum that enabled us to conduct backbone assignments using conventional techniques. In addition, titration with an active-site peptide aldehyde inhibitor and paramagnetic relaxation enhancement studies demonstrated that the unlinked DENV protease exists predominantly in a closed conformation in solution. This protease complex can serve as a useful tool for drug discovery against DENV.	[Kim, Young Mee; Gayen, Shovanlal; Kang, CongBao; Joy, Joma; Huang, Qiwei; Chen, Angela Shuyi; Wee, John Liang Kuan; Ang, Melgious Jin Yan; Lim, Huichang Annie; Hung, Alvin W.; Li, Rong; Chia, Cheng San Brian; Hill, Jeffrey; Keller, Thomas H.] ASTAR, Ctr Expt Therapeut, Singapore 138669, Singapore; [Noble, Christian G.; Lee, Le Tian; Yip, Andy; Wang, Qing-Yin; Shi, Pei-Yong] Novartis Inst Trop Dis, Singapore 138670, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; Novartis	Kang, CB (corresponding author), ASTAR, Ctr Expt Therapeut, Nanos 03-01,31 Biopolis Way, Singapore 138669, Singapore.	cbkang@etc.a-star.edu.sg; qing_yin.wang@novatis.com; thkeller@etc.a-star.edu.sg	gayen, shovanlal/B-7409-2013; Kang, Congbao/AAP-7572-2020	gayen, shovanlal/0000-0002-3367-578X; Kang, Congbao/0000-0002-9886-9374; Ang Jin Yan, Melgious/0000-0002-4817-9658; Kanikadu Joy, Joma/0000-0002-8008-3365; Keller, Thomas/0000-0002-7553-6235	A*STAR; A*STAR investigatorship	A*STAR(Agency for Science Technology & Research (A*STAR)); A*STAR investigatorship(Agency for Science Technology & Research (A*STAR))	This work was supported in part by A*STAR.; Supported by an A*STAR investigatorship.	Bi YC, 2013, BIOMOL NMR ASSIGN, V7, P137, DOI 10.1007/s12104-012-9395-9; Chen AS, 2011, BBA-BIOMEMBRANES, V1808, P2224, DOI 10.1016/j.bbamem.2011.05.014; CHENG H, 1995, ARCH BIOCHEM BIOPHYS, V316, P619, DOI 10.1006/abbi.1995.1082; Clore GM, 2007, CURR OPIN STRUC BIOL, V17, P603, DOI 10.1016/j.sbi.2007.08.013; Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715; de la Cruz L, 2011, J AM CHEM SOC, V133, P19205, DOI 10.1021/ja208435s; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ekonomiuk D, 2009, J MED CHEM, V52, P4860, DOI 10.1021/jm900448m; Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Ezgimen M, 2012, ANTIVIR RES, V94, P18, DOI [10.1016/j.antivira1.2012.02.003, 10.1016/j.antiviral.2012.02.003]; Ezgimen MD, 2009, BIOORGAN MED CHEM, V17, P3278, DOI 10.1016/j.bmc.2009.03.050; Gayen S, 2012, BIOCHEM BIOPH RES CO, V423, P799, DOI 10.1016/j.bbrc.2012.06.043; Gayen S, 2011, PROTEINS, V79, P2557, DOI 10.1002/prot.23089; Huang QW, 2011, PROTEIN EXPRES PURIF, V80, P169, DOI 10.1016/j.pep.2011.08.008; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Johnston PA, 2007, ASSAY DRUG DEV TECHN, V5, P737, DOI 10.1089/adt.2007.101; Kang CB, 2013, ANTIVIR RES, V97, P137, DOI 10.1016/j.antiviral.2012.11.008; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001; Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200; Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200; Li QX, 2010, BIOCHEM BIOPH RES CO, V403, P126, DOI 10.1016/j.bbrc.2010.10.132; Li QX, 2010, BIOMOL NMR ASSIGN, V4, P211, DOI 10.1007/s12104-010-9248-3; Lim HA, 2011, EUR J MED CHEM, V46, P3130, DOI 10.1016/j.ejmech.2011.04.055; Lindback H, 2003, EMERG INFECT DIS, V9, P438, DOI 10.3201/eid0904.020267; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007; Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11; Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004; Schuller A, 2011, ANTIVIR RES, V92, P96, DOI 10.1016/j.antiviral.2011.07.002; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shiryaev SA, 2007, PROTEIN EXPRES PURIF, V52, P334, DOI 10.1016/j.pep.2006.11.009; Steuer C, 2011, BIOORGAN MED CHEM, V19, P4067, DOI 10.1016/j.bmc.2011.05.015; Stevens AJ, 2009, J MED CHEM, V52, P7911, DOI 10.1021/jm900652e; Stoermer MJ, 2008, J MED CHEM, V51, P5714, DOI 10.1021/jm800503y; Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Xu T., 2006, NOVART FDN SYMP, V277, P251; Xu T., 2006, NOVART FDN SYMP, V277, P97; Xu Ting, 2006, Novartis Found Symp, V277, P87, DOI 10.1002/0470058005.ch7; Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062; Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963	44	83	82	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12891	12900		10.1074/jbc.M112.442723	http://dx.doi.org/10.1074/jbc.M112.442723			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23511634	Green Published, hybrid			2022-12-28	WOS:000318555100043
J	Wilkie-Grantham, RP; Matsuzawa, SI; Reed, JC				Wilkie-Grantham, Rachel P.; Matsuzawa, Shu-Ichi; Reed, John C.			Novel Phosphorylation and Ubiquitination Sites Regulate Reactive Oxygen Species-dependent Degradation of Anti-apoptotic c-FLIP Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRAIL-INDUCED APOPTOSIS; FAS-MEDIATED APOPTOSIS; DOWN-REGULATION; CELL-DEATH; TRITERPENOID CDDO; SIGNALING PATHWAY; OXIDATIVE STRESS; INDUCE APOPTOSIS; JNK ACTIVATION	The cytosolic protein c-FLIP (cellular Fas-associated death domain-like interleukin 1 beta-converting enzyme inhibitory protein) is an inhibitor of death receptor-mediated apoptosis that is up-regulated in a variety of cancers, contributing to apoptosis resistance. Several compounds found to restore sensitivity of cancer cells to TRAIL, a TNF family death ligand with promising therapeutic potential, act by targeting c-FLIP ubiquitination and degradation by the proteasome. The generation of reactive oxygen species (ROS) has been implicated in c-FLIP protein degradation. However, the mechanism by which ROS post-transcriptionally regulate c-FLIP protein levels is not well understood. We show here that treatment of prostate cancer PPC-1 cells with the superoxide generators menadione, paraquat, or buthionine sulfoximine down-regulates c-FLIP long (c-FLIPL) protein levels, which is prevented by the proteasome inhibitor MG132. Furthermore, pretreatment of PPC-1 cells with a ROS scavenger prevented ubiquitination and loss of c-FLIPL protein induced by menadione or paraquat. We identified lysine 167 as a novel ubiquitination site of c-FLIPL important for ROS-dependent degradation. We also identified threonine 166 as a novel phosphorylation site and demonstrate that Thr-166 phosphorylation is required for ROS-induced Lys-167 ubiquitination. The mutation of either Thr-166 or Lys-167 was sufficient to stabilize c-FLIP protein levels in PPC-1, HEK293T, and HeLa cancer cells treated with menadione or paraquat. Accordingly, expression of c-FLIP T166A or K167R mutants protected cells from ROS-mediated sensitization to TRAIL-induced cell death. Our findings reveal novel ROS-dependent post-translational modifications of the c-FLIP protein that regulate its stability, thus impacting sensitivity of cancer cells to TRAIL.	[Wilkie-Grantham, Rachel P.; Matsuzawa, Shu-Ichi; Reed, John C.] Sanford Burnham Med Res Inst, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	reedoffice@sanfordburnham.org			National Institutes of Health Grant [R01-CA-163743]; NATIONAL CANCER INSTITUTE [R01CA163743] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA-163743.	Abedini MR, 2008, CANCER RES, V68, P4511, DOI 10.1158/0008-5472.CAN-08-0673; Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Cazanave SC, 2011, J BIOL CHEM, V286, P39336, DOI 10.1074/jbc.M111.280420; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chanvorachote P, 2005, J BIOL CHEM, V280, P42044, DOI 10.1074/jbc.M510080200; Chen SZ, 2007, MOL PHARMACOL, V72, P1269, DOI 10.1124/mol.107.037465; Chen YW, 2012, ARCH TOXICOL, V86, P1547, DOI 10.1007/s00204-012-0873-8; Conde de la Rosa L, 2006, J HEPATOL, V44, P918, DOI 10.1016/j.jhep.2005.07.034; Deeb D, 2010, BIOCHEM PHARMACOL, V79, P350, DOI 10.1016/j.bcp.2009.09.006; Dejeans N, 2010, BIOCHEM PHARMACOL, V79, P1221, DOI 10.1016/j.bcp.2009.12.009; Frew AJ, 2008, P NATL ACAD SCI USA, V105, P11317, DOI 10.1073/pnas.0801868105; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Ge W, 2010, FREE RADICAL BIO MED, V49, P2068, DOI 10.1016/j.freeradbiomed.2010.10.686; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Higuchi H, 2003, J BIOL CHEM, V278, P454, DOI 10.1074/jbc.M209387200; Ikeda T, 2003, CANCER RES, V63, P5551; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Kaunisto A, 2009, CELL DEATH DIFFER, V16, P1215, DOI 10.1038/cdd.2009.35; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Lee SJ, 2011, INT J ONCOL, V38, P485, DOI 10.3892/ijo.2010.878; Lin YD, 2008, MOL CANCER THER, V7, P3556, DOI 10.1158/1535-7163.MCT-08-0648; Martin-Perez R, 2012, APOPTOSIS, V17, P349, DOI 10.1007/s10495-011-0673-2; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; McCourt C, 2012, CLIN CANCER RES, V18, P3822, DOI 10.1158/1078-0432.CCR-11-3277; Muruganandan S, 2006, TOXICOL SCI, V94, P118, DOI 10.1093/toxsci/kfl084; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Nakajima A, 2006, EMBO J, V25, P5549, DOI 10.1038/sj.emboj.7601423; Nitobe J, 2003, CARDIOVASC RES, V57, P119, DOI 10.1016/S0008-6363(02)00646-6; Noh HJ, 2012, J CELL BIOCHEM, V113, P3692, DOI 10.1002/jcb.24242; Oberst A, 2011, NAT REV MOL CELL BIO, V12, P757, DOI 10.1038/nrm3214; Palacios C, 2006, CANCER RES, V66, P8858, DOI 10.1158/0008-5472.CAN-06-0808; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Park SK, 2010, BREAST CANCER RES TR, V124, P361, DOI 10.1007/s10549-010-0786-2; Ravanan P, 2011, MOL CANCER THER, V10, P1635, DOI 10.1158/1535-7163.MCT-10-0887; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Roth W, 2004, VITAM HORM, V67, P189; Safa Ahmad R, 2011, Cancers (Basel), V3, P1639, DOI 10.3390/cancers3021639; Sanchez-Perez T, 2010, CELL DEATH DIFFER, V17, P883, DOI 10.1038/cdd.2009.176; Schattenberg JM, 2012, FREE RADICAL BIO MED, V52, P1911, DOI 10.1016/j.freeradbiomed.2012.02.049; Sharma M, 2012, MOL PHARMACOL, V82, P1001, DOI 10.1124/mol.112.079863; Shi B, 2009, J BIOL CHEM, V284, P14513, DOI 10.1074/jbc.M807918200; Stagni V, 2010, CARCINOGENESIS, V31, P1956, DOI 10.1093/carcin/bgq193; Suh WS, 2003, LEUKEMIA, V17, P2122, DOI 10.1038/sj.leu.2403112; Tiwary R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011865; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang LY, 2008, J IMMUNOL, V180, P3072, DOI 10.4049/jimmunol.180.5.3072; Xiao C, 2005, EXP CELL RES, V304, P244, DOI 10.1016/j.yexcr.2004.11.002; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yang BF, 2007, CLIN EXP PHARMACOL P, V34, P1245, DOI 10.1111/j.1440-1681.2007.04711.x; Yang BF, 2003, J BIOL CHEM, V278, P7043, DOI 10.1074/jbc.M211278200; Yang JF, 2012, CANCER CHEMOTH PHARM, V69, P195, DOI 10.1007/s00280-011-1686-9; Yang W, 2009, TOXICOL LETT, V191, P203, DOI 10.1016/j.toxlet.2009.08.024; Yerbes R, 2012, INVEST NEW DRUG, V30, P541, DOI 10.1007/s10637-010-9597-x; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299; Zhang SY, 2005, MOL CANCER THER, V4, P1972, DOI 10.1158/1535-7163.MCT-05-0249; Zhu DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018291	64	43	44	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12777	12790		10.1074/jbc.M112.431320	http://dx.doi.org/10.1074/jbc.M112.431320			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23519470	Green Published, hybrid			2022-12-28	WOS:000318555100034
J	Yang, YC; Yoshikai, Y; Hsu, SW; Saitoh, H; Chang, LK				Yang, Ya-Chun; Yoshikai, Yushi; Hsu, Shih-Wei; Saitoh, Hisato; Chang, Li-Kwan			Role of RNF4 in the Ubiquitination of Rta of Epstein-Barr Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; PROTEIN-KINASE-C; HISTONE DEACETYLASE INHIBITORS; IMMEDIATE-EARLY PROTEIN; DNA-BINDING-PROTEIN; E3 LIGASE ACTIVITY; LYTIC CYCLE; TRANSCRIPTION FACTOR; PROMOTES DEGRADATION; VIRAL REPLICATION	Epstein-Barr virus (EBV) encodes a transcription factor, Rta, which is required to activate the transcription of EBV lytic genes. This study demonstrates that treating P3HR1 cells with a proteasome inhibitor, MG132, causes the accumulation of SUMO-Rta and promotes the expression of EA-D. GST pulldown and coimmunoprecipitation studies reveal that RNF4, a RING-domain-containing ubiquitin E3 ligase, interacts with Rta. RNF4 also targets SUMO-2-conjugated Rta and promotes its ubiquitination in vitro. Additionally, SUMO interaction motifs in RNF4 are important to the ubiquitination of Rta because the RNF4 mutant with a mutation at the motifs eliminates ubiquitination. The mutation of four lysine residues on Rta that abrogated SUMO-3 conjugation to Rta also decreases the enhancement of the ubiquitination of Rta by RNF4. This finding demonstrates that RNF4 is a SUMO-targeted ubiquitin E3 ligase of Rta. Finally, knockdown of RNF4 enhances the expression of Rta and EA-D, subsequently promoting EBV lytic replication and virions production. Results of this study significantly contribute to efforts to elucidate a SUMO-targeted ubiquitin E3 ligase that regulates Rta ubiquitination to influence the lytic development of EBV.	[Yang, Ya-Chun; Hsu, Shih-Wei; Chang, Li-Kwan] Natl Taiwan Univ, Coll Life Sci, Dept Biochem Sci & Technol, Taipei 106, Taiwan; [Yoshikai, Yushi; Saitoh, Hisato] Kumamoto Univ, Grad Sch Sci & Technol, Dept Biol Sci, Kumamoto 8608555, Japan	National Taiwan University; Kumamoto University	Saitoh, H (corresponding author), Kumamoto Univ, Grad Sch Sci & Technol, Dept Biol Sci, 2-39-1 Kurokami, Kumamoto 8608555, Japan.	hisa@kumamoto-u.ac.jp; changlk@ntu.edu.tw	Hsiao, Wei-Hung/B-9931-2013		National Health Research Institute [NHRI-EX102-10030BI]; National Science Council [NSC-100-2311-B-002-011]; National Science Council	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by National Health Research Institute Grant NHRI-EX102-10030BI, National Science Council NSC-100-2311-B-002-011, and a National Science Council program, Funding for science and technology personnel engaging in short-term foreign research, for a visit to Kumamoto University, Japan.	Adamson AL, 2000, J VIROL, V74, P1224, DOI 10.1128/JVI.74.3.1224-1233.2000; Bekker-Jensen S, 2011, FEBS LETT, V585, P2914, DOI 10.1016/j.febslet.2011.05.056; Calderwood MA, 2008, J VIROL, V82, P8509, DOI 10.1128/JVI.00315-08; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Chang FR, 2010, ANTIVIR RES, V85, P490, DOI 10.1016/j.antiviral.2009.12.002; Chang LK, 2008, J MOL BIOL, V379, P231, DOI 10.1016/j.jmb.2008.04.011; Chang LK, 2010, NUCLEIC ACIDS RES, V38, P4687, DOI 10.1093/nar/gkq243; Chang LK, 2005, NUCLEIC ACIDS RES, V33, P6528, DOI 10.1093/nar/gki956; Chang LK, 2004, J BIOL CHEM, V279, P38803, DOI 10.1074/jbc.M405470200; Chang PJ, 1998, J VIROL, V72, P5128, DOI 10.1128/JVI.72.6.5128-5136.1998; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHEVALLIERGRECO A, 1986, EMBO J, V5, P3243, DOI 10.1002/j.1460-2075.1986.tb04635.x; Chiu YF, 2007, J GEN VIROL, V88, P2463, DOI 10.1099/vir.0.82881-0; Countryman J, 2009, J VIROL, V83, P10694, DOI 10.1128/JVI.01172-09; Countryman JK, 2008, J VIROL, V82, P4706, DOI 10.1128/JVI.00116-08; CRAWFORD DH, 1986, IMMUNOLOGY, V59, P405; DAVIES AH, 1991, J VIROL, V65, P6838, DOI 10.1128/JVI.65.12.6838-6844.1991; Dong XN, 2012, J VIROL, V86, P1930, DOI 10.1128/JVI.06127-11; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; Fryrear KA, 2012, BLOOD, V119, P1173, DOI 10.1182/blood-2011-06-358564; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Geoffroy MC, 2010, MOL BIOL CELL, V21, P4227, DOI 10.1091/mbc.E10-05-0449; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; GIOT JF, 1991, NUCLEIC ACIDS RES, V19, P1251, DOI 10.1093/nar/19.6.1251; Gonzalez-Santamaria J, 2011, J VIROL, V85, P12890, DOI 10.1128/JVI.05628-11; Gould F, 2009, J VIROL, V83, P6727, DOI 10.1128/JVI.00351-09; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Gradoville L, 2002, J VIROL, V76, P5612, DOI 10.1128/JVI.76.11.5612-5626.2002; GRUFFAT H, 1990, NUCLEIC ACIDS RES, V18, P6835, DOI 10.1093/nar/18.23.6835; Hakli M, 2004, FEBS LETT, V560, P56, DOI 10.1016/S0014-5793(04)00070-5; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Heideker J, 2009, DNA REPAIR, V8, P517, DOI 10.1016/j.dnarep.2009.01.010; Heilmann AMF, 2010, J VIROL, V84, P9920, DOI 10.1128/JVI.00573-10; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOLLEYGUTHRIE EA, 1990, J VIROL, V64, P3753, DOI 10.1128/JVI.64.8.3753-3759.1990; Hu XYV, 2010, P NATL ACAD SCI USA, V107, P15087, DOI 10.1073/pnas.1009025107; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; KENNEY S, 1989, J VIROL, V63, P3878, DOI 10.1128/JVI.63.9.3878-3883.1989; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Liu CN, 1996, J VIROL, V70, P2545, DOI 10.1128/JVI.70.4.2545-2555.1996; Liu ST, 2006, VIRUS RES, V119, P163, DOI 10.1016/j.virusres.2006.01.004; LUKA J, 1979, VIROLOGY, V94, P228, DOI 10.1016/0042-6822(79)90455-0; Luo KT, 2012, EMBO J, V31, P3008, DOI 10.1038/emboj.2012.158; Lyst MJ, 2007, BIOCHEM SOC T, V35, P1389, DOI 10.1042/BST0351389; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Mattsson K, 2001, P NATL ACAD SCI USA, V98, P1012, DOI 10.1073/pnas.031566998; Mukhopadhyay D, 2010, J CELL BIOL, V188, P681, DOI 10.1083/jcb.200909008; Mullen JR, 2008, J BIOL CHEM, V283, P19912, DOI 10.1074/jbc.M802690200; Murata T, 2012, J VIROL, V86, P4752, DOI 10.1128/JVI.06768-11; Oh Y, 2012, CELL DEATH DIFFER, V19, P1196, DOI 10.1038/cdd.2011.209; Parker JL, 2012, NUCLEIC ACIDS RES, V40, P11380, DOI 10.1093/nar/gks892; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Poukka H, 2000, J BIOL CHEM, V275, P571, DOI 10.1074/jbc.275.1.571; Praefcke GJK, 2012, TRENDS BIOCHEM SCI, V37, P23, DOI 10.1016/j.tibs.2011.09.002; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Sun WJ, 2010, CELL SIGNAL, V22, P386, DOI 10.1016/j.cellsig.2009.10.008; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tojo M, 2002, J BIOL CHEM, V277, P46576, DOI 10.1074/jbc.M205987200; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; van Hagen M, 2010, NUCLEIC ACIDS RES, V38, P1922, DOI 10.1093/nar/gkp1157; Wang YT, 2011, J MOL BIOL, V414, P1, DOI 10.1016/j.jmb.2011.09.027; Wang Z, 2009, MOL CELL BIOL, V29, P1694, DOI 10.1128/MCB.01470-08; Wiedmer A, 2008, J VIROL, V82, P4647, DOI 10.1128/JVI.02198-07; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Yang ZL, 2008, J VIROL, V82, P3590, DOI 10.1128/JVI.02229-07; Ye JJ, 2007, J VIROL, V81, P9279, DOI 10.1128/JVI.00982-07; Ye JJ, 2010, J VIROL, V84, P12405, DOI 10.1128/JVI.01415-10; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011; Zacny VL, 1998, J VIROL, V72, P8043, DOI 10.1128/JVI.72.10.8043-8051.1998	82	27	27	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12866	12879		10.1074/jbc.M112.413393	http://dx.doi.org/10.1074/jbc.M112.413393			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23504328	hybrid, Green Published			2022-12-28	WOS:000318555100041
J	Ren, AX; Zhang, WQ; Yarlagadda, S; Sinha, C; Arora, K; Moon, CS; Naren, AP				Ren, Aixia; Zhang, Weiqiang; Yarlagadda, Sunitha; Sinha, Chandrima; Arora, Kavisha; Moon, Chang-Suk; Naren, Anjaparavanda P.			MAST205 Competes with Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-associated Ligand for Binding to CFTR to Regulate CFTR-mediated Fluid Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PDZ-INTERACTING DOMAIN; PROTEIN; EXPRESSION; FAMILY; PHOSPHORYLATION; IDENTIFICATION; MICROTUBULES; TRAFFICKING; INHIBITION; GENE	The PDZ (postsynaptic density-95/discs large/zona occludens-1) domain-based interactions play important roles in regulating the expression and function of the cystic fibrosis transmembrane conductance regulator (CFTR). Several PDZ domain-containing proteins (PDZ proteins for short) have been identified as directly or indirectly interacting with the C terminus of CFTR. To better understand the regulation of CFTR processing, we conducted a genetic screen and identified MAST205 (a microtubule-associated serine/threonine kinase with a molecular mass of 205 kDa) as a new CFTR regulator. We found that overexpression of MAST205 increased the expression of CFTR and augmented CFTR-mediated fluid transport in a dose-dependent manner. Conversely, knockdown of MAST205 inhibited CFTR function. The PDZ motif of CFTR is required for the regulatory role of MAST205 in CFTR expression and function. We further demonstrated that MAST205 and the CFTR-associated ligand competed for binding to CFTR, which facilitated the processing of CFTR and consequently up-regulated the expression and function of CFTR at the plasma membrane. More importantly, we found that MAST205 could facilitate the processing of F508del-CFTR mutant and augment its quantity and channel function at the plasma membrane. Taken together, our data suggest that MAST205 plays an important role in regulating CFTR expression and function. Our findings have important clinical implications for treating CFTR-associated diseases such as cystic fibrosis and secretory diarrheas.	[Ren, Aixia; Zhang, Weiqiang; Yarlagadda, Sunitha; Sinha, Chandrima; Arora, Kavisha; Moon, Chang-Suk; Naren, Anjaparavanda P.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; [Zhang, Weiqiang] Univ Tennessee, Cyst Fibrosis Care & Res Ctr, Le Bonheur Childrens Hosp, Memphis, TN 38103 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Naren, AP (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave,426 Nash Res Bldg, Memphis, TN 38163 USA.	anaren@uthsc.edu			National Institutes of Health [DK080834, DK093045]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093045, R01DK080834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK080834 and DK093045 (to A. P. N.).	Chen J, 2005, J BIOL CHEM, V280, P29912, DOI 10.1074/jbc.M504516200; Cheng J, 2004, J BIOL CHEM, V279, P1892, DOI 10.1074/jbc.M308640200; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Cheng J, 2010, MOL BIOL CELL, V21, P1178, DOI 10.1091/mbc.E09-03-0229; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Cushing PR, 2010, ANGEW CHEM INT EDIT, V49, P9907, DOI 10.1002/anie.201005585; Cutting GR, 2005, ANNU REV GENOM HUM G, V6, P237, DOI 10.1146/annurev.genom.6.080604.162254; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; Guggino Sandra E., 1994, Trends in Microbiology, V2, P91, DOI 10.1016/0966-842X(94)90541-X; Guggino WB, 1999, CELL, V96, P607, DOI 10.1016/S0092-8674(00)80570-X; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Lamprecht G, 2006, AM J PHYSIOL-GASTR L, V291, pG766, DOI 10.1152/ajpgi.00135.2006; Li CY, 2011, METHODS MOL BIOL, V741, P255, DOI 10.1007/978-1-61779-117-8_17; Li CY, 2010, INTEGR BIOL-UK, V2, P161, DOI [10.1039/B924455G, 10.1039/b924455g]; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Li CY, 2004, J BIOL CHEM, V279, P24673, DOI 10.1074/jbc.M400688200; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; Liang XB, 2012, MOL BIOL CELL, V23, P996, DOI 10.1091/mbc.E11-08-0662; Lumeng C, 1999, NAT NEUROSCI, V2, P611, DOI 10.1038/10165; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Moyer BD, 2000, J BIOL CHEM, V275, P27069; Okazaki N, 2002, CARCINOGENESIS, V23, P1139, DOI 10.1093/carcin/23.7.1139; Penmatsa H, 2010, MOL BIOL CELL, V21, P1097, DOI 10.1091/mbc.E09-08-0655; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schultz BD, 1997, AM J PHYSIOL-CELL PH, V273, pC2080, DOI 10.1152/ajpcell.1997.273.6.C2080; SCHWIEBERT EM, 1994, AM J PHYSIOL, V267, pC272, DOI 10.1152/ajpcell.1994.267.1.C272; SFERRA TJ, 1993, ANNU REV MED, V44, P133, DOI 10.1146/annurev.med.44.1.133; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Tousson A, 1996, J CELL SCI, V109, P1325; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; WALDEN PD, 1993, MOL CELL BIOL, V13, P7625, DOI 10.1128/MCB.13.12.7625; Walden PD, 1996, BIOL REPROD, V55, P1039, DOI 10.1095/biolreprod55.5.1039; Walker NM, 2008, GASTROENTEROLOGY, V135, P1645, DOI 10.1053/j.gastro.2008.07.083; Wang DS, 2006, AM J PHYSIOL-RENAL, V290, pF428, DOI 10.1152/ajprenal.00161.2005; Wolde M, 2007, J BIOL CHEM, V282, P8099, DOI 10.1074/jbc.M611049200; Xiong HB, 2004, J BIOL CHEM, V279, P43675, DOI 10.1074/jbc.M404328200; Zeng WZ, 1997, AM J PHYSIOL-CELL PH, V273, pC442, DOI 10.1152/ajpcell.1997.273.2.C442	41	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12325	12334		10.1074/jbc.M112.432724	http://dx.doi.org/10.1074/jbc.M112.432724			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504457	Green Published, hybrid			2022-12-28	WOS:000318157600063
J	Hamilton, BS; Whittaker, GR				Hamilton, Brian S.; Whittaker, Gary R.			Cleavage Activation of Human-adapted Influenza Virus Subtypes by Kallikrein-related Peptidases 5 and 12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMAGGLUTININ CLEAVAGE; PROTEOLYTIC ACTIVATION; CANCER PROGRESSION; PROTEASES TMPRSS2; SERINE PROTEASES; MEMBRANE-FUSION; A VIRUSES; GLYCOPROTEIN; EXPRESSION; VIRULENCE	A critical step in the influenza virus replication cycle is the cleavage activation of the HA precursor. Cleavage activation of influenza HA enables fusion with the host endosome, allowing for release of the viral genome into the host cell. To date, studies have determined that HA activation is driven by trypsin-like host cell proteases, as well as yet to be identified bacterial proteases. Although the number of host proteases that can activate HA is growing, there is still uncertainty regarding which secreted proteases are able to support multicycle replication of influenza. In this study, we have determined that the kallikrein-related peptidases 5 and 12 are secreted from the human respiratory tract and have the ability to cleave and activate HA from the H1, H2, and H3 subtypes. Each peptidase appears to have a preference for particular influenza subtypes, with kallikrein 5 cleaving the H1 and H3 subtypes most efficiently and kallikrein 12 cleaving the H1 and H2 subtypes most efficiently. Cleavage analysis using HA cleavage site peptide mimics revealed that the amino acids neighboring the arginine cleavage site affect cleavage efficiency. Additionally, the thrombolytic zymogens plasminogen, urokinase, and plasma kallikrein have all been shown to cleave and activate influenza but are found circulating mainly as inactive precursors. Kallikrein 5 and kallikrein 12 were examined for their ability to activate the thrombolytic zymogens, and both resulted in activation of each zymogen, with kallikrein 12 being a more potent activator. Activation of the thrombolytic zymogens may therefore allow for both direct and indirect activation of the HA of human-adapted influenza viruses by kallikrein 5 and kallikrein 12.	[Whittaker, Gary R.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; Univ Rochester, Med Ctr, New York Ctr Excellence Influenza Res & Surveilla, Rochester, NY 14627 USA	Cornell University; University of Rochester	Whittaker, GR (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.	grw7@cornell.edu			National Institutes of Health [R01 AI48678]; United States Department of Health and Human Services from the NIAID Centers of Excellence for Influenza Research and Surveillance [HHSN266200700008C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048678] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Health and Human Services from the NIAID Centers of Excellence for Influenza Research and Surveillance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI48678 and United States Department of Health and Human Services Contract HHSN266200700008C from the NIAID Centers of Excellence for Influenza Research and Surveillance.	Ahmed R, 2007, NAT IMMUNOL, V8, P1188, DOI 10.1038/ni1530; BELIN D, 1985, EUR J BIOCHEM, V148, P225, DOI 10.1111/j.1432-1033.1985.tb08829.x; Bertram S, 2010, J VIROL, V84, P10016, DOI 10.1128/JVI.00239-10; Bottcher E, 2009, VACCINE, V27, P6324, DOI 10.1016/j.vaccine.2009.03.029; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; Chu VC, 2004, P NATL ACAD SCI USA, V101, P18153, DOI 10.1073/pnas.0405172102; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; Deryugina EI, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/564259; Emami N, 2007, MOL ONCOL, V1, P269, DOI 10.1016/j.molonc.2007.09.003; Hamilton BS, 2012, J VIROL, V86, P10579, DOI 10.1128/JVI.00306-12; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Kesic MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035108; KIDO H, 1992, J BIOL CHEM, V267, P13573; Korbakis D, 2009, CLIN CHEM, V55, P904, DOI 10.1373/clinchem.2008.103788; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Michael IP, 2006, J BIOL CHEM, V281, P12743, DOI 10.1074/jbc.M600326200; Michael IP, 2005, J BIOL CHEM, V280, P14628, DOI 10.1074/jbc.M408132200; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Oshansky CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021183; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; Planque C, 2008, CLIN CANCER RES, V14, P1355, DOI 10.1158/1078-0432.CCR-07-4117; Renne T, 1999, J BIOL CHEM, V274, P25777, DOI 10.1074/jbc.274.36.25777; SCHEIBLAUER H, 1992, J INFECT DIS, V166, P783, DOI 10.1093/infdis/166.4.783; Schnitzler SU, 2009, VIRUS GENES, V39, P279, DOI 10.1007/s11262-009-0404-8; Sharma JN, 2002, CURR MED RES OPIN, V18, P10, DOI 10.1185/03007990212500093; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; STEINHAUER DA, 1991, VIROLOGY, V184, P445, DOI 10.1016/0042-6822(91)90867-B; Sun XJ, 2010, J VIROL, V84, P8683, DOI 10.1128/JVI.00797-10; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; TASHIRO M, 1987, NATURE, V325, P536, DOI 10.1038/325536a0; Taubenberger JK, 1998, P NATL ACAD SCI USA, V95, P9713, DOI 10.1073/pnas.95.17.9713; Thoennes S, 2008, VIROLOGY, V370, P403, DOI 10.1016/j.virol.2007.08.035; Tumpey TM, 2009, ANNU REV MICROBIOL, V63, P79, DOI 10.1146/annurev.micro.091208.073359; Watanabe Y, 2012, TRENDS MICROBIOL, V20, P11, DOI 10.1016/j.tim.2011.10.003; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; Yousef GM, 2000, GENOMICS, V69, P331, DOI 10.1006/geno.2000.6346	41	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17399	17407		10.1074/jbc.M112.440362	http://dx.doi.org/10.1074/jbc.M112.440362			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23612974	Green Published, hybrid			2022-12-28	WOS:000320380600032
J	Matmati, N; Metelli, A; Tripathi, K; Yan, SQ; Mohanty, BK; Hannun, YA				Matmati, Nabil; Metelli, Alessandra; Tripathi, Kaushlendra; Yan, Shuqi; Mohanty, Bidyut K.; Hannun, Yusuf A.			Identification of C-18:1-Phytoceramide as the Candidate Lipid Mediator for Hydroxyurea Resistance in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOSPHINGOLIPID-PHOSPHOLIPASE-C; ACTIVATED PROTEIN PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; NEUTRAL SPHINGOMYELINASES; SWE1P DEGRADATION; GROWTH-INHIBITION; CERAMIDE; STRESS; ISC1	Recent studies showed that deletion of ISC1, the yeast homologue of the mammalian neutral sphingomyelinase, resulted in an increased sensitivity to hydroxyurea (HU). This raised an intriguing question as to whether sphingolipids are involved in pathways initiated by HU. In this study, we show that HU treatment led to a significant increase in Isc1 activity. Analysis of sphingolipid deletion mutants and pharmacological analysis pointed to a role for ceramide in mediating HU resistance. Lipid analysis revealed that HU induced increases in phytoceramides in WT cells but not in isc1 Delta cells. To probe functions of specific ceramides, we developed an approach to supplement the medium with fatty acids. Oleate (C-18:1) was the only fatty acid protecting isc1 Delta cells from HU toxicity in a ceramide-dependent manner. Because phytoceramide activates protein phosphatases in yeast, we evaluated the role of CDC55, the regulatory subunit of ceramide-activated protein phosphatase PP2A. Overexpression of CDC55 overcame the sensitivity to HU in isc1 Delta cells. However, addition of oleate did not protect the isc1 Delta,cdc55 Delta double mutant from HU toxicity. These results demonstrate that HU launches a lipid pathway mediated by a specific sphingolipid, C-18:1-phytoceramide, produced by Isc1, which provides protection from HU by modulating Swe1 levels through the PP2A subunit Cdc55.	[Matmati, Nabil; Yan, Shuqi; Hannun, Yusuf A.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Matmati, Nabil; Yan, Shuqi; Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Metelli, Alessandra; Tripathi, Kaushlendra; Mohanty, Bidyut K.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29403 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Medical University of South Carolina	Hannun, YA (corresponding author), SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA.	yusuf.hannun@stonybrookmedicine.edu	tripathi, kaushlendra/O-3022-2013	tripathi, kaushlendra/0000-0002-3578-2917; Yan, Shuqi/0000-0002-6537-4906	National Institutes of Health [R01GM063265, R01GM43825, P30 CA138313, P20 RR017677]; Lipidomics Core in the SC Lipidomics and Pathobiology COBRE, Department Biochemistry, Medical University of South Carolina; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043825, R01GM043825, R01GM063265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lipidomics Core in the SC Lipidomics and Pathobiology COBRE, Department Biochemistry, Medical University of South Carolina; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM063265 and R01GM43825 (to Y. A. H.).; We are grateful Dr. Cungui Mao for revising the manuscript and to Lina Obeid, Chiara Luberto, and the Hannun group members for helpful discussions. We thank the Lipidomics Center at the Medical University of South Carolina for all lipid analyses performed in this study. Research at the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina, was supported in part by National Institutes of Health Grant P30 CA138313 and at the Lipidomics Core in the SC Lipidomics and Pathobiology COBRE, Department Biochemistry, Medical University of South Carolina, by National Institutes of Health Grant P20 RR017677.	Al-Feel W, 2003, P NATL ACAD SCI USA, V100, P3095, DOI 10.1073/pnas.0538069100; Almeida T, 2008, MOL BIOL CELL, V19, P865, DOI 10.1091/mbc.E07-06-0604; Betz C, 2002, EUR J BIOCHEM, V269, P4033, DOI 10.1046/j.1432-1033.2002.03096.x; Bielawski J, 2010, ADV EXP MED BIOL, V688, P46; Clarke CJ, 2006, BIOCHEMISTRY-US, V45, P11247, DOI 10.1021/bi061307z; Cowart LA, 2007, J BIOL CHEM, V282, P12330, DOI 10.1074/jbc.M700685200; Cowart LA, 2005, BIOCHEM SOC T, V33, P1166, DOI 10.1042/BST0331166; de Avalos SV, 2004, J BIOL CHEM, V279, P11537, DOI 10.1074/jbc.M309586200; Dickson RC, 1998, ANNU REV BIOCHEM, V67, P27, DOI 10.1146/annurev.biochem.67.1.27; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; FISHBEIN JD, 1993, J BIOL CHEM, V268, P9255; Gottlieb D, 1999, Mol Cell Biol Res Commun, V1, P66, DOI 10.1006/mcbr.1999.0109; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Jenkins GM, 2001, J BIOL CHEM, V276, P8574, DOI 10.1074/jbc.M007425200; Kim S, 2000, GENETICS, V156, P1519; Kitagaki H, 2009, J BIOL CHEM, V284, P10818, DOI 10.1074/jbc.M805029200; Kroesen BJ, 2003, J BIOL CHEM, V278, P14723, DOI 10.1074/jbc.M210756200; Liu H, 2006, MOL BIOL CELL, V17, P2746, DOI 10.1091/mbc.E05-11-1093; Liu H, 2011, GENETICS, V187, P397, DOI 10.1534/genetics.110.125468; Mao CG, 2000, J BIOL CHEM, V275, P31369, DOI 10.1074/jbc.M003683200; Matmati N, 2008, J LIPID RES, V49, P922, DOI 10.1194/jlr.R800004-JLR200; Matmati N, 2009, J BIOL CHEM, V284, P8241, DOI 10.1074/jbc.M900004200; McCourt PC, 2009, J BIOL CHEM, V284, P11930, DOI 10.1074/jbc.M900857200; McMillan JN, 1999, MOL CELL BIOL, V19, P6929; Nickels JT, 1996, GENE DEV, V10, P382, DOI 10.1101/gad.10.4.382; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Okamoto Y, 2003, BIOCHEMISTRY-US, V42, P7855, DOI 10.1021/bi0341354; Reid RJD, 1997, J BIOL CHEM, V272, P12091, DOI 10.1074/jbc.272.18.12091; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Sawai H, 1999, CHEM PHYS LIPIDS, V102, P141, DOI 10.1016/S0009-3084(99)00082-1; Senkal CE, 2007, MOL CANCER THER, V6, P712, DOI 10.1158/1535-7163.MCT-06-0558; Tripathi K, 2011, GENETICS, V189, P533, DOI 10.1534/genetics.111.132092; Wooten-Blanks LG, 2007, FASEB J, V21, P3386, DOI 10.1096/fj.07-8621com; Yang HF, 2000, MOL CELL BIOL, V20, P8143, DOI 10.1128/MCB.20.21.8143-8156.2000	35	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17272	17284		10.1074/jbc.M112.444802	http://dx.doi.org/10.1074/jbc.M112.444802			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23620586	Green Published, hybrid			2022-12-28	WOS:000320380600023
J	Jiang, X; Huang, QF; Wang, WJ; Dong, HH; Ly, H; Liang, YY; Dong, CJ				Jiang, Xue; Huang, Qinfeng; Wang, Wenjian; Dong, Haohao; Ly, Hinh; Liang, Yuying; Dong, Changjiang			Structures of Arenaviral Nucleoproteins with Triphosphate dsRNA Reveal a Unique Mechanism of Immune Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; RIG-I; DNA; TREX1; RNA; BINDING; VIRUS; SITE; AUTOIMMUNITY; PATHOGENESIS	A hallmark of severe Lassa fever is the generalized immune suppression, the mechanism of which is poorly understood. Lassa virus (LASV) nucleoprotein (NP) is the only known 3'-5' exoribonuclease that can suppress type I interferon (IFN) production possibly by degrading immune-stimulatory RNAs. How this unique enzymatic activity of LASV NP recognizes and processes RNA substrates is unknown. We provide an atomic view of a catalytically active exoribonuclease domain of LASV NP (LASV NP-C) in the process of degrading a 5' triphosphate double-stranded (ds) RNA substrate, a typical pathogen-associated molecular pattern molecule, to induce type I IFN production. Additionally, we provide for the first time a high-resolution crystal structure of an active exoribonuclease domain of Tacaribe arenavirus (TCRV) NP. Coupled with the in vitro enzymatic and cell-based interferon suppression assays, these structural analyses strongly support a unified model of an exoribonuclease-dependent IFN suppression mechanism shared by all known arenaviruses. New knowledge learned from these studies should aid the development of therapeutics against pathogenic arenaviruses that can infect hundreds of thousands of individuals and kill thousands annually.	[Jiang, Xue; Dong, Haohao; Dong, Changjiang] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Huang, Qinfeng; Ly, Hinh; Liang, Yuying] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Wang, Wenjian] Sun Yat Sen Univ, Affiliated Hosp 1, Lab Dept Surg, Guangzhou 510080, Guangdong, Peoples R China; [Dong, Haohao] Univ St Andrews, St Andrews KY16 9ST, Fife, Scotland	University of East Anglia; University of Minnesota System; University of Minnesota Twin Cities; Sun Yat Sen University; University of St Andrews	Ly, H (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	hly@umn.edu; liangy@umn.edu; c.dong@uea.ac.uk	Huang, Qinfeng/AAJ-7454-2021		National Institutes of Health [R01AI083409, R01AI093580, R56AI091805]; Medical Research Council [G1100110/1]; Welcome Trust Career Development Fellowship [WT083501MA]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083409, R01AI093580, R56AI091805] Funding Source: NIH RePORTER; Medical Research Council [G1100110] Funding Source: researchfish; MRC [G1100110] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Welcome Trust Career Development Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI083409 (to Y. L.), and R01AI093580 and R56AI091805 (to H. L.). This work was also supported by Medical Research Council Grant G1100110/1 (to C. J. D.) and Welcome Trust Career Development Fellowship Grant WT083501MA (to C. J. D.).	Andrade JM, 2009, PROG MOL BIOL TRANSL, V85, P187, DOI 10.1016/S0079-6603(08)00805-2; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; Brucet M, 2007, J BIOL CHEM, V282, P14547, DOI 10.1074/jbc.M700236200; Buchmeier MJ., 2007, FIELDS VIROLOGY, P1791; Cisneros GA, 2009, J AM CHEM SOC, V131, P1550, DOI 10.1021/ja8082818; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; de Silva U, 2009, NUCLEIC ACIDS RES, V37, P2411, DOI 10.1093/nar/gkp025; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Geisbert TW, 2004, NAT MED, V10, pS110, DOI 10.1038/nm1142; Harmon B, 2013, J BIOL CHEM, V288, P8702, DOI 10.1074/jbc.M112.444760; Hastie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044211; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P2396, DOI 10.1073/pnas.1016404108; Khan SH, 2008, ANTIVIR RES, V78, P103, DOI 10.1016/j.antiviral.2007.11.003; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; Martinez-Sobrido L, 2007, J VIROL, V81, P12696, DOI 10.1128/JVI.00882-07; Martinez-Sobrido L, 2006, J VIROL, V80, P9192, DOI 10.1128/JVI.00555-06; Martinez-Sobrido L, 2009, J VIROL, V83, P11330, DOI 10.1128/JVI.00763-09; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moraz ML, 2011, EXPERT REV ANTI-INFE, V9, P49, DOI 10.1586/ERI.10.142; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Peters CJ, 2002, CURR TOP MICROBIOL, V262, P65; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Qi XX, 2010, NATURE, V468, P779, DOI 10.1038/nature09605; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zuo YH, 2007, STRUCTURE, V15, P417, DOI 10.1016/j.str.2007.02.004	31	61	64	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16949	16959		10.1074/jbc.M112.420521	http://dx.doi.org/10.1074/jbc.M112.420521			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23615902	hybrid, Green Published			2022-12-28	WOS:000320378900067
J	Yang, DR; Ding, XF; Luo, J; Shan, YX; Wang, RH; Lin, SJ; Li, GH; Huang, CK; Zhu, J; Chen, Y; Lee, SO; Chang, C				Yang, Dong-Rong; Ding, Xian-Fan; Luo, Jie; Shan, Yu-Xi; Wang, Ronghao; Lin, Shin-Jen; Li, Gonghui; Huang, Chiung-Kuei; Zhu, Jin; Chen, Yuhchyau; Lee, Soo Ok; Chang, Chawnshang			Increased Chemosensitivity via Targeting Testicular Nuclear Receptor 4 (TR4)-Oct4-Interleukin 1 Receptor Antagonist (IL1Ra) Axis in Prostate Cancer CD133(+) Stem/Progenitor Cells to Battle Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOXANTRONE PLUS PREDNISONE; TUMOR-INITIATING CELLS; STEM-CELLS; DOCETAXEL; RESISTANT; CHEMOTHERAPY; THERAPY; ABIRATERONE; APOPTOSIS; 1ST-LINE	Prostate cancer (PCa) stem/progenitor cells are known to have higher chemoresistance than non-stem/progenitor cells, but the underlying molecular mechanism remains unclear. We found the expression of testicular nuclear receptor 4 (TR4) is significantly higher in PCa CD133(+) stem/progenitor cells compared with CD133(+) non-stem/progenitor cells. Knockdown of TR4 levels in the established PCa stem/progenitor cells and the CD133(+) population of the C4-2 PCa cell line with lentiviral TR4 siRNA led to increased drug sensitivity to the two commonly used chemotherapeutic drugs, docetaxel and etoposide, judging from significantly reduced IC50 values and increased apoptosis in the TR4 knockdown cells. Mechanism dissection studies found that suppression of TR4 in these stem/progenitor cells led to down-regulation of Oct4 expression, which, in turn, down-regulated the IL-1 receptor antagonist (IL1Ra) expression. Neutralization experiments via adding these molecules into the TR4 knockdown PCa stem/progenitor cells reversed the chemoresistance, suggesting that the TR4-Oct4-IL1Ra axis may play a critical role in the development of chemoresistance in the PCa stem/progenitor cells. Together, these studies suggest that targeting TR4 may alter chemoresistance of PCa stem/progenitor cells, and this finding provides the possibility of targeting TR4 as a new and better approach to overcome the chemoresistance problem in PCa therapeutics.	[Yang, Dong-Rong; Ding, Xian-Fan; Luo, Jie; Wang, Ronghao; Lin, Shin-Jen; Huang, Chiung-Kuei; Zhu, Jin; Chen, Yuhchyau; Chang, Chawnshang] Univ Rochester Med Ctr, George Whipple Lab Canc Res, Dept Pathol, Rochester, NY 14642 USA; [Yang, Dong-Rong; Ding, Xian-Fan; Luo, Jie; Wang, Ronghao; Lin, Shin-Jen; Huang, Chiung-Kuei; Zhu, Jin; Chen, Yuhchyau; Chang, Chawnshang] Univ Rochester Med Ctr, George Whipple Lab Canc Res, Dept Urol, Rochester, NY 14642 USA; [Yang, Dong-Rong; Ding, Xian-Fan; Luo, Jie; Wang, Ronghao; Lin, Shin-Jen; Huang, Chiung-Kuei; Zhu, Jin; Chen, Yuhchyau; Chang, Chawnshang] Univ Rochester Med Ctr, George Whipple Lab Canc Res, Dept Radiat Oncol, Rochester, NY 14642 USA; [Yang, Dong-Rong; Ding, Xian-Fan; Luo, Jie; Wang, Ronghao; Lin, Shin-Jen; Huang, Chiung-Kuei; Zhu, Jin; Chen, Yuhchyau; Chang, Chawnshang] Univ Rochester Med Ctr, Wilmot Canc Ctr, Rochester, NY 14642 USA; [Yang, Dong-Rong; Shan, Yu-Xi; Zhu, Jin; Lee, Soo Ok] Soochow Univ, Affiliated Hosp 2, Dept Urol, Suzhou 215004, Peoples R China; [Ding, Xian-Fan; Li, Gonghui] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Urol, Hangzhou 310016, Zhejiang, Peoples R China; [Chang, Chawnshang] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung 404, Taiwan	University of Rochester; University of Rochester; University of Rochester; University of Rochester; Soochow University - China; Zhejiang University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lee, SO (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Urol, Suzhou 215004, Peoples R China.	soook_lee@urmc.rochester.edu; chang@urmc.rochester.edu	Luo, Jie/AAG-3091-2019	Chang, Chawnshang/0000-0001-8510-3516	National Institutes of Health [CA122840, CA156700]; George Whipple Professorship Endowment; Taiwan Department of Health Clinical Trial; Research Center of Excellence Grant [DOH99-TD-B-111-004]; National Basic Research Program of China [2012CB518304]; Pao Yu-Kong Chair Professorship [201006]; NATIONAL CANCER INSTITUTE [R01CA122840, R01CA156700] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George Whipple Professorship Endowment; Taiwan Department of Health Clinical Trial; Research Center of Excellence Grant; National Basic Research Program of China(National Basic Research Program of China); Pao Yu-Kong Chair Professorship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA122840 and CA156700. This work was also supported by the George Whipple Professorship Endowment, a Taiwan Department of Health Clinical Trial, Research Center of Excellence Grant DOH99-TD-B-111-004 (to China Medical University), National Basic Research Program of China Grant 2012CB518304, and Pao Yu-Kong Chair Professorship 201006.	Beer TM, 2008, CANCER, V112, P326, DOI 10.1002/cncr.23163; Berthold DR, 2008, J CLIN ONCOL, V26, P242, DOI 10.1200/JCO.2007.12.4008; Caffo O, 2010, UROL ONCOL-SEMIN ORI, V28, P152, DOI 10.1016/j.urolonc.2008.07.033; CHANG CS, 1994, P NATL ACAD SCI USA, V91, P6040, DOI 10.1073/pnas.91.13.6040; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Colloca G, 2012, MED ONCOL, V29, P776, DOI 10.1007/s12032-011-9855-6; Crea F, 2009, EPIGENOMICS-UK, V1, P63, DOI 10.2217/EPI.09.4; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dinarello CA, 2010, CANCER METAST REV, V29, P317, DOI 10.1007/s10555-010-9229-0; Duhagon MA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-324; Fan XL, 2012, UROL ONCOL-SEMIN ORI, V30, P314, DOI 10.1016/j.urolonc.2010.03.019; Frame FM, 2012, ADV EXP MED BIOL, V720, P105, DOI 10.1007/978-1-4614-0254-1_9; Gan L, 2011, PROSTATE, V71, P1158, DOI 10.1002/pros.21331; Greco SJ, 2007, STEM CELLS, V25, P3143, DOI 10.1634/stemcells.2007-0351; Harper LJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-166; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Heidenreich A, 2013, ANN ONCOL, V24, P329, DOI 10.1093/annonc/mds505; Heidenreich A, 2013, EUR UROL, V63, P977, DOI 10.1016/j.eururo.2012.08.058; Hwang C, 2012, THER ADV MED ONCOL, V4, P329, DOI 10.1177/1758834012449685; James ND, 2012, LANCET ONCOL, V13, P549, DOI 10.1016/S1470-2045(12)70088-8; Kawasaki BT, 2009, PROSTATE, V69, P827, DOI 10.1002/pros.20931; Kim E, 2007, BIOCHEM BIOPH RES CO, V361, P323, DOI 10.1016/j.bbrc.2007.06.168; Kim E, 2011, DIABETES, V60, P1493, DOI 10.2337/db10-0393; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Lee YF, 2011, AM J PHYSIOL-ENDOC M, V301, pE91, DOI 10.1152/ajpendo.00701.2010; Linn Douglas E, 2010, Genes Cancer, V1, P908, DOI 10.1177/1947601910388271; Liu S, 2011, J BIOL CHEM, V286, P38103, DOI 10.1074/jbc.M111.259523; Liu T, 2010, MOL CELL BIOCHEM, V340, P265, DOI 10.1007/s11010-010-0426-5; Loriot Y, 2010, EUR J CANCER, V46, P1770, DOI 10.1016/j.ejca.2010.04.010; Maitland NJ, 2005, BJU INT, V96, P1219, DOI 10.1111/j.1464-410X.2005.05744.x; Malik Babar, 2012, Front Biosci (Elite Ed), V4, P2142; Matsumoto A, 2009, INT J UROL, V16, P687, DOI 10.1111/j.1442-2042.2009.02341.x; Mezynski J, 2012, ANN ONCOL, V23, P2943, DOI 10.1093/annonc/mds119; Michels J, 2006, CANCER-AM CANCER SOC, V106, P1041, DOI 10.1002/cncr.21695; Mimeault M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031919; Morrison R, 2011, J ONCOL, V2011, DOI 10.1155/2011/941876; Nakabayashi M, 2008, BJU INT, V101, P308, DOI 10.1111/j.1464-410X.2007.07331.x; Reuter CWM, 2010, WORLD J UROL, V28, P391, DOI 10.1007/s00345-010-0527-5; Rosenberg JE, 2009, J CLIN ONCOL, V27, P2772, DOI 10.1200/JCO.2008.19.8002; Ross RW, 2008, CANCER-AM CANCER SOC, V112, P521, DOI 10.1002/cncr.23195; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Seruga B, 2011, J CLIN ONCOL, V29, P3686, DOI 10.1200/JCO.2010.34.3996; Shyr CR, 2009, ENDOCRINOLOGY, V150, P2454, DOI 10.1210/en.2008-1165; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smith DC, 2011, UROLOGY, V77, P1172, DOI 10.1016/j.urology.2010.12.043; Sternberg CN, 2013, ANN ONCOL, V24, P1017, DOI 10.1093/annonc/mds585; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Thomas S, 2005, CANCER BIOL THER, V4, P1226, DOI 10.4161/cbt.4.11.2093; Tsai LL, 2011, J ORAL PATHOL MED, V40, P621, DOI 10.1111/j.1600-0714.2011.01015.x; Wang XQ, 2010, HEPATOLOGY, V52, P528, DOI 10.1002/hep.23692; Wen KM, 2013, CANCER LETT, V333, P56, DOI 10.1016/j.canlet.2013.01.009; Yan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024397; Yan SJ, 2012, CELL MOL BIOL LETT, V17, P309, DOI 10.2478/s11658-012-0012-9; Yap TA, 2012, EXPERT REV ANTICANC, V12, P1129, DOI [10.1586/era.12.88, 10.1586/ERA.12.88]; Yin ST, 2012, APOPTOSIS, V17, P388, DOI 10.1007/s10495-011-0687-9; Zhang LL, 2012, J CANCER RES CLIN, V138, P675, DOI 10.1007/s00432-011-1146-2	56	49	51	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16476	16483		10.1074/jbc.M112.448142	http://dx.doi.org/10.1074/jbc.M112.448142			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23609451	Green Published, hybrid			2022-12-28	WOS:000320378900024
J	Ahn, SW; Gang, GT; Kim, YD; Ahn, RS; Harris, RA; Lee, CH; Choi, HS				Ahn, Seung Won; Gang, Gil-Tae; Kim, Yong Deuk; Ahn, Ryun-Sup; Harris, Robert A.; Lee, Chul-Ho; Choi, Hueng-Sik			Insulin Directly Regulates Steroidogenesis via Induction of the Orphan Nuclear Receptor DAX-1 in Testicular Leydig Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-BINDING GLOBULIN; BODY-FAT DISTRIBUTION; SEX-HORMONES; TESTOSTERONE SECRETION; RESISTANCE; GLUCOSE; LEPTIN; SENSITIVITY; ANDROGENS; OBESITY	Testosterone level is low in insulin-resistant type 2 diabetes. Whether this is due to negative effects of high level of insulin on the testes caused by insulin resistance has not been studied in detail. In this study, we found that insulin directly binds to insulin receptors in Leydig cell membranes and activates phospho-insulin receptor-beta (phospho-IR-beta), phospho-IRS1, and phospho-AKT, leading to up-regulation of DAX-1 (dosage-sensitive sex reversal, adrenal hypoplasia critical region, on chromosome X, gene 1) gene expression in the MA-10 mouse Leydig cell line. Insulin also inhibits cAMP-induced and liver receptor homolog-1 (LRH-1)-induced steroidogenic enzyme gene expression and steroidogenesis. In contrast, knockdown of DAX-1 reversed insulin-mediated inhibition of steroidogenesis. Whether insulin directly represses steroidogenesis through regulation of steroidogenic enzyme gene expression was assessed in insulin-injected mouse models and high fat diet-induced obesity. In insulin-injected mouse models, insulin receptor signal pathway was activated and subsequently inhibited steroidogenesis via induction of DAX-1 without significant change of luteinizing hormone or FSH levels. Likewise, the levels of steroidogenic enzyme gene expression and steroidogenesis were low, but interestingly, the level of DAX-1 was high in the testes of high fat diet-fed mice. These results represent a novel regulatory mechanism of steroidogenesis in Leydig cells. Insulin-mediated induction of DAX-1 in Leydig cells of testis may be a key regulatory step of serum sex hormone level in insulin-resistant states.	[Ahn, Seung Won; Kim, Yong Deuk; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Kwangju 500757, South Korea; [Ahn, Seung Won; Kim, Yong Deuk; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea; [Gang, Gil-Tae; Lee, Chul-Ho] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea; [Ahn, Ryun-Sup] CHA Univ, Sch Med, Grad Sch Integrated Med, Seoul 135913, South Korea; [Harris, Robert A.] Indiana Univ Sch Med, Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; [Harris, Robert A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Kwangju 500757, South Korea; [Choi, Hueng-Sik] Res Inst Med Sci, Kwangju 500757, South Korea	Chonnam National University; Chonnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Pochon Cha University; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University Bloomington; Chonnam National University	Lee, CH (corresponding author), Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea.	chullee@kribb.re.kr; hsc@chonnam.ac.kr	Ahn, Ryun S./D-1218-2011		National Creative Research Initiatives Center for Nuclear Receptor Signals from the Korean Ministry of Education, Science, and Technology [20110018305]; Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea (NRF), by the Ministry of Education, Science, and Technology [20100019512]; Korea Research Institute of Bioscience & Biotechnology (KRIBB) Research Initiative Program of Korea, Republic of Korea	National Creative Research Initiatives Center for Nuclear Receptor Signals from the Korean Ministry of Education, Science, and Technology; Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea (NRF), by the Ministry of Education, Science, and Technology; Korea Research Institute of Bioscience & Biotechnology (KRIBB) Research Initiative Program of Korea, Republic of Korea	This work was supported by the National Creative Research Initiatives Center for Nuclear Receptor Signals from the Korean Ministry of Education, Science, and Technology (Grant 20110018305) and the Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea (NRF), by the Ministry of Education, Science, and Technology (Grant 20100019512) (to H. S. C.), and by the Korea Research Institute of Bioscience & Biotechnology (KRIBB) Research Initiative Program of Korea, Republic of Korea (to C. H. L.).	AGARDH CD, 1986, METABOLISM, V35, P244, DOI 10.1016/0026-0495(86)90208-8; Ahn SW, 2012, J BIOL CHEM, V287, P41875, DOI 10.1074/jbc.M112.421552; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; Ballester J, 2005, J ANDROL, V26, P706, DOI 10.2164/jandrol.04156; Chanda D, 2010, NUCLEIC ACIDS RES, V38, P4607, DOI 10.1093/nar/gkq227; Christensen L, 1997, DAN MED BULL, V44, P547; Dhindsa S, 2004, J CLIN ENDOCR METAB, V89, P5462, DOI 10.1210/jc.2004-0804; EBELING P, 1995, CLIN ENDOCRINOL, V43, P601, DOI 10.1111/j.1365-2265.1995.tb02925.x; Fayard E, 2004, TRENDS CELL BIOL, V14, P250, DOI 10.1016/j.tcb.2004.03.008; GRIZARD G, 1991, J ENDOCRINOL, V128, P375, DOI 10.1677/joe.0.1280375; HAFFNER SM, 1993, INT J OBESITY, V17, P643; HAFFNER SM, 1994, DIABETES, V43, P212, DOI 10.2337/diabetes.43.2.212; HAVRANKOVA J, 1979, J CLIN INVEST, V64, P636, DOI 10.1172/JCI109504; Hong CY, 2004, MOL CELL BIOL, V24, P2593, DOI 10.1128/MCB.24.7.2593-2604.2004; Isidori AM, 1999, J CLIN ENDOCR METAB, V84, P3673, DOI 10.1210/jc.84.10.3673; Khaw K T, 1992, Ann Epidemiol, V2, P675, DOI 10.1016/1047-2797(92)90012-F; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Kokk K, 2007, ANN NY ACAD SCI, V1095, P262, DOI 10.1196/annals.1397.030; Kokk Kersti, 2005, Anatomical Science International, V80, P91, DOI 10.1111/j.1447-073x.2005.00091.x; Le TN, 2012, TRENDS ENDOCRIN MET, V23, P32, DOI 10.1016/j.tem.2011.09.005; LIN T, 1986, ENDOCRINOLOGY, V119, P1641, DOI 10.1210/endo-119-4-1641; Liu SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011302; Lubik AA, 2011, CANCER RES, V71, P5754, DOI 10.1158/0008-5472.CAN-10-2470; MILLER WL, 1988, ENDOCR REV, V9, P295, DOI 10.1210/edrv-9-3-295; Nedumaran B, 2009, J BIOL CHEM, V284, P27511, DOI 10.1074/jbc.M109.034660; PASQUALI R, 1995, J CLIN ENDOCR METAB, V80, P654, DOI 10.1210/jc.80.2.654; PHILLIPS GB, 1977, P NATL ACAD SCI USA, V74, P1729, DOI 10.1073/pnas.74.4.1729; Pitteloud N, 2005, DIABETES CARE, V28, P1636, DOI 10.2337/diacare.28.7.1636; Pitteloud N, 2005, J CLIN ENDOCR METAB, V90, P2636, DOI 10.1210/jc.2004-2190; ROSENZWEIG JL, 1980, P NATL ACAD SCI-BIOL, V77, P572, DOI 10.1073/pnas.77.1.572; Rosmond R, 1996, OBES RES, V4, P245, DOI 10.1002/j.1550-8528.1996.tb00542.x; Schoeller EL, 2012, DIABETES, V61, P1869, DOI 10.2337/db11-1527; Sechi LA, 1999, J HYPERTENS, V17, P1229, DOI 10.1097/00004872-199917090-00001; Shirneshan K, 2008, MOL CELL ENDOCRINOL, V295, P79, DOI 10.1016/j.mce.2008.07.007; Simon D, 2001, DIABETES CARE, V24, P2149, DOI 10.2337/diacare.24.12.2149; Song KH, 2004, MOL ENDOCRINOL, V18, P1929, DOI 10.1210/me.2004-0043; Suzuki T, 2003, MOL CELL BIOL, V23, P238, DOI 10.1128/MCB.23.1.238-249.2003; Tena-Sempere M, 1999, J ENDOCRINOL, V161, P211, DOI 10.1677/joe.0.1610211	39	56	57	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15937	15946		10.1074/jbc.M113.451773	http://dx.doi.org/10.1074/jbc.M113.451773			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23589295	Green Published, hybrid			2022-12-28	WOS:000319822300046
J	Perry, AJ; Wijeyewickrema, LC; Wilmann, PG; Gunzburg, MJ; D'Andrea, L; Irving, JA; Pang, SS; Duncan, RC; Wilce, JA; Whisstock, JC; Pike, RN				Perry, Andrew J.; Wijeyewickrema, Lakshmi C.; Wilmann, Pascal G.; Gunzburg, Menachem J.; D'Andrea, Laura; Irving, James A.; Pang, Siew Siew; Duncan, Renee C.; Wilce, Jacqueline A.; Whisstock, James C.; Pike, Robert N.			A Molecular Switch Governs the Interaction between the Human Complement Protease C1s and Its Substrate, Complement C4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; STRUCTURAL BASIS; DIFFRACTION DATA; COMPONENT C4; ACTIVATION; ZYMOGEN; SYSTEM; REFINEMENT	The complement system is an ancient innate immune defense pathway that plays a front line role in eliminating microbial pathogens. Recognition of foreign targets by antibodies drives sequential activation of two serine proteases, C1r and C1s, which reside within the complement Component 1 (C1) complex. Active C1s propagates the immune response through its ability to bind and cleave the effector molecule complement Component 4 (C4). Currently, the precise structural and biochemical basis for the control of the interaction between C1s and C4 is unclear. Here, using surface plasmon resonance, we show that the transition of the C1s zymogen to the active form is essential for C1s binding to C4. To understand this, we determined the crystal structure of a zymogen C1s construct (comprising two complement control protein (CCP) domains and the serine protease (SP) domain). These data reveal that two loops (492-499 and 573-580) in the zymogen serine protease domain adopt a conformation that would be predicted to sterically abrogate C4 binding. The transition from zymogen to active C1s repositions both loops such that they would be able to interact with sulfotyrosine residues on C4. The structure also shows the junction of the CCP1 and CCP2 domains of C1s for the first time, yielding valuable information about the exosite for C4 binding located at this position. Together, these data provide a structural explanation for the control of the interaction with C1s and C4 and, furthermore, point to alternative strategies for developing therapeutic approaches for controlling activation of the complement cascade.	[Perry, Andrew J.; Wijeyewickrema, Lakshmi C.; Wilmann, Pascal G.; Gunzburg, Menachem J.; D'Andrea, Laura; Irving, James A.; Pang, Siew Siew; Duncan, Renee C.; Wilce, Jacqueline A.; Whisstock, James C.; Pike, Robert N.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Whisstock, James C.] Monash Univ, Ctr Excellence Struct & Funct Microbial Genom, Australian Res Council, Clayton, Vic 3800, Australia	Monash University; Monash University	Whisstock, JC (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	James.Whisstock@monash.edu; Rob.Pike@monash.edu	Wijeyewickrema, Lakshmi/A-9676-2015; Irving, James/P-3860-2019; Perry, Andrew/E-5607-2010; Wilce, Jacqueline/N-5018-2017; Irving, James A/I-8467-2015	Wijeyewickrema, Lakshmi/0000-0001-6084-4887; Irving, James/0000-0003-3204-6356; Perry, Andrew/0000-0001-9256-6068; Wilce, Jacqueline/0000-0002-8344-2626; Whisstock, James/0000-0003-4200-5611; Wilmann, Pascal/0000-0002-8376-5150; Pike, Robert/0000-0002-2083-0269; , Laura/0000-0001-5765-8717	National Health and Medical Research Council of Australia; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by the National Health and Medical Research Council of Australia and the Australian Research Council.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Androulakis S, 2008, ACTA CRYSTALLOGR D, V64, P810, DOI 10.1107/S0907444908015540; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Budayova-Spano M, 2002, STRUCTURE, V10, P1509, DOI 10.1016/S0969-2126(02)00881-X; Budayova-Spano M, 2002, EMBO J, V21, P231, DOI 10.1093/emboj/21.3.231; BUSBY TF, 1990, BIOCHEMISTRY-US, V29, P4613, DOI 10.1021/bi00471a016; Duncan RC, 2008, BIOCHIMIE, V90, P387, DOI 10.1016/j.biochi.2007.07.023; Duncan RC, 2012, J IMMUNOL, V189, P2365, DOI 10.4049/jimmunol.1201085; Duncan RC, 2012, MOL IMMUNOL, V49, P593, DOI 10.1016/j.molimm.2011.10.006; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Forneris F, 2012, CURR OPIN STRUC BIOL, V22, P333, DOI 10.1016/j.sbi.2012.04.001; FREER ST, 1970, BIOCHEMISTRY-US, V9, P1997, DOI 10.1021/bi00811a022; Gaboriaud C, 2000, EMBO J, V19, P1755, DOI 10.1093/emboj/19.8.1755; Gal P, 2005, J BIOL CHEM, V280, P33435, DOI 10.1074/jbc.M506051200; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Harmat V, 2004, J MOL BIOL, V342, P1533, DOI 10.1016/j.jmb.2004.07.014; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kardos J, 2001, J IMMUNOL, V167, P5202, DOI 10.4049/jimmunol.167.9.5202; Kidmose RT, 2012, P NATL ACAD SCI USA, V109, P15425, DOI 10.1073/pnas.1208031109; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; MADISON EL, 1993, SCIENCE, V262, P419, DOI 10.1126/science.8211162; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCLACHLAN AD, 1982, ACTA CRYSTALLOGR A, V38, P871, DOI 10.1107/S0567739482001806; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; de Cordoba SR, 2012, IMMUNOBIOLOGY, V217, P1034, DOI 10.1016/j.imbio.2012.07.021; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Rossi V, 1998, J BIOL CHEM, V273, P1232, DOI 10.1074/jbc.273.2.1232; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VIJAYALAKSHMI J, 1994, PROTEIN SCI, V3, P2254, DOI 10.1002/pro.5560031211; VILLIERS CL, 1985, P NATL ACAD SCI USA, V82, P4477, DOI 10.1073/pnas.82.13.4477; WANG DC, 1985, J MOL BIOL, V185, P595, DOI 10.1016/0022-2836(85)90074-9; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	41	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15821	15829		10.1074/jbc.M113.464545	http://dx.doi.org/10.1074/jbc.M113.464545			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23592783	Green Published, hybrid			2022-12-28	WOS:000319822300036
J	Gao, R; Yu, Y; Inoue, A; Widodo, N; Kaul, SC; Wadhwa, R				Gao, Ran; Yu, Yue; Inoue, Atsushi; Widodo, Nashi; Kaul, Sunil C.; Wadhwa, Renu			Heterogeneous Nuclear Ribonucleoprotein K (hnRNP-K) Promotes Tumor Metastasis by Induction of Genes Involved in Extracellular Matrix, Cell Movement, and Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTION EVOLUTION DATA; PROTEIN INTERACTS; IE63 PROTEIN; EXPRESSION; CARCINOMA; CANCER; ACTIVATION; RECEPTOR; KINASE; P53	Cancer is a leading cause of death and still awaits effective therapies. Rapid industrialization has contributed to increase in incidence of cancer. One of the reasons why most of the cancers fail therapy is due to their metastatic property. Hence identification of factors leading to metastasis is highly important to design effective and novel anti-cancer therapeutics. In our earlier study (Inoue, A., Sawata, S. Y., Taira, K., and Wadhwa, R. (2007) Loss-of-function screening by randomized intracellular antibodies: identification of hnRNP-K as a potential target for metastasis. Proc. Natl. Acad. Sci. U.S.A. 104, 8983-8988), we had reported that the involvement of heterogeneous nuclear ribonucleoprotein K (hnRNP-K) in metastasis. Here, we established hnRNP-K-overexpressing and -underexpressing derivative cell lines and examined their proliferation and metastatic properties in vitro and in vivo. Whereas hnRNP-K compromised cells showed delayed tumor growth, its overexpression resulted in enhanced malignancy and metastasis. Molecular basis of the hnRNP-K induced malignant and metastatic phenotypes was dissected by cDNA microarray and pathway analyses. We found that the hnRNP-K regulates extracellular matrix, cell motility, and angiogenesis pathways. Involvement of the selected genes (Cck, Mmp-3, Ptgs2, and Ctgf) and pathways was validated by gene-specific expression analysis. Our results demonstrated that the hnRNP-K is a potential target for metastasis therapy.	[Gao, Ran; Yu, Yue; Inoue, Atsushi; Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan; [Widodo, Nashi] Brawijaya Univ, Fac Math & Nat Sci, Dept Biol, Malang 65145, Indonesia	National Institute of Advanced Industrial Science & Technology (AIST); Brawijaya University	Kaul, SC (corresponding author), Natl Inst Adv Ind Sci & Technol, Cent 4,1-1-1 Higashi, Tsukuba, Ibaraki 3058562, Japan.	s-kaul@aist.go.jp; renu-wadhwa@aist.go.jp	Kaul, Sunil C/L-8671-2018; Yu, Yue/AAM-9329-2020; widodo, nashi/X-4595-2019; Wadhwa, Renu/L-8898-2018	Kaul, Sunil C/0000-0002-0046-3916; Yu, Yue/0000-0002-7620-6078; widodo, nashi/0000-0002-1126-498X; Wadhwa, Renu/0000-0001-8248-5192; Gao, Ran/0000-0001-8712-429X				Backe PH, 2005, STRUCTURE, V13, P1055, DOI 10.1016/j.str.2005.04.008; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r23; Bryant HE, 2000, J VIROL, V74, P11322, DOI 10.1128/JVI.74.23.11322-11328.2000; Chan JYH, 2008, INT J BIOCHEM CELL B, V40, P2078, DOI 10.1016/j.biocel.2008.02.005; Chen LC, 2010, CELL DEATH DIFFER, V17, P1463, DOI 10.1038/cdd.2010.24; Chen Yan, 2008, Zhongguo Fei Ai Za Zhi, V11, P241, DOI 10.3779/j.issn.1009-3419.2008.02.017; Chen YB, 2008, FEBS LETT, V582, P1761, DOI 10.1016/j.febslet.2008.04.051; Denisenko O, 2002, MOL CELL BIOL, V22, P286, DOI 10.1128/MCB.22.1.286-297.2002; Du QF, 2010, MED ONCOL, V27, P673, DOI 10.1007/s12032-009-9267-z; Fang WF, 2010, INT J CANCER, V127, P32, DOI 10.1002/ijc.25029; Feliers D, 2007, AM J PHYSIOL-RENAL, V293, pF607, DOI 10.1152/ajprenal.00497.2006; Fukuda T, 2009, GENES CELLS, V14, P113, DOI 10.1111/j.1365-2443.2008.01256.x; Guo Y S, 2000, J Hepatobiliary Pancreat Surg, V7, P276, DOI 10.1007/s005340070049; Gyorffy B, 2008, INT J GYNECOL CANCER, V18, P1215, DOI 10.1111/j.1525-1438.2007.01169.x; Hatakeyama H, 2006, PROTEOMICS, V6, P6300, DOI 10.1002/pmic.200600488; Hsieh TY, 1998, J BIOL CHEM, V273, P17651, DOI 10.1074/jbc.273.28.17651; Inoue A, 2007, P NATL ACAD SCI USA, V104, P8983, DOI 10.1073/pnas.0607595104; Lai TY, 2010, MOL CELL BIOCHEM, V342, P63, DOI 10.1007/s11010-010-0469-7; Laury-Kleintop LD, 2005, J CELL BIOCHEM, V95, P1042, DOI 10.1002/jcb.20486; Lee MH, 1996, J BIOL CHEM, V271, P3420; Mandal M, 2001, J BIOL CHEM, V276, P9699, DOI 10.1074/jbc.M008514200; Matta A, 2009, INT J CANCER, V125, P1398, DOI 10.1002/ijc.24517; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Miau LH, 1998, J BIOL CHEM, V273, P10784, DOI 10.1074/jbc.273.17.10784; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; Mikula M, 2011, J BIOL CHEM, V286, P9763, DOI 10.1074/jbc.M110.213330; Mitchell K, 2010, CANCER RES, V70, P6359, DOI 10.1158/0008-5472.CAN-09-4283; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Mukhopadhyay NK, 2009, CANCER RES, V69, P2210, DOI 10.1158/0008-5472.CAN-08-2308; Niki T, 2002, AM J PATHOL, V160, P1129, DOI 10.1016/S0002-9440(10)64933-4; Olbryt M, 2006, GENE EXPRESSION, V13, P191, DOI 10.3727/000000006783991818; Ostrowski J, 2003, BRIT J CANCER, V89, P1493, DOI 10.1038/sj.bjc.6601250; Ostrowski J, 2002, J BIOL CHEM, V277, P6303, DOI 10.1074/jbc.M110267200; Roychoudhury P, 2007, BRIT J CANCER, V97, P574, DOI 10.1038/sj.bjc.6603911; Shanmugam N, 2008, J BIOL CHEM, V283, P36221, DOI 10.1074/jbc.M806322200; Shnyreva M, 2000, J BIOL CHEM, V275, P15498, DOI 10.1074/jbc.275.20.15498; Tang Feng-ming, 2008, Sichuan Da Xue Xue Bao Yi Xue Ban, V39, P823; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Wadd S, 1999, J BIOL CHEM, V274, P28991, DOI 10.1074/jbc.274.41.28991; Wang F, 2011, MED ONCOL; Wen FS, 2010, ANN SURG ONCOL, V17, P2619, DOI 10.1245/s10434-010-1121-1; Yoo YD, 2006, J BIOL CHEM, V281, P15352, DOI 10.1074/jbc.M511825200; Yu HG, 2006, INT J CANCER, V119, P2724, DOI 10.1002/ijc.22207; Zhou RY, 2010, INT J CANCER, V126, P395, DOI 10.1002/ijc.24744	46	76	76	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15046	15056		10.1074/jbc.M113.466136	http://dx.doi.org/10.1074/jbc.M113.466136			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23564449	Green Published, hybrid			2022-12-28	WOS:000319452100034
J	Ma, D; Lu, PL; Shi, YG				Ma, Dan; Lu, Peilong; Shi, Yigong			Substrate Selectivity of the Acid-activated Glutamate/gamma-Aminobutyric acid (GABA) Antiporter GadC from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGMATINE ANTIPORTER; RESISTANCE; DECARBOXYLASE; ARGININE; MECHANISM; SEQUENCE; GENE; PH	GadC, a central component of the Escherichia coli acid resistance system, is a Glu/GABA antiporter. A previous structural study and biochemical characterization showed that GadC exhibits a stringent pH dependence for substrate transport, with no detectable activity at pH values above 6.5. However, the substrate selectivity and the mechanism of pH-dependent transport activity of GadC remain enigmatic. In this study, we demonstrate that GadC selectively transports Glu with no net charge and GABA with a positive charge. AC-plug-truncated variant of GadC (residues 1-470) transported Gln (a mimic of Glu with no net charge), but not Glu, even at pH 8.0. The pH-dependent transport of Gln by this GadC variant was shifted similar to 1 unit toward a higher pH compared with Glu transport. Taken together, the results identify the substrate selectivity for GadC and show that the protonation states of substrates are crucial for transport.	Tsinghua Univ, Sch Life Sci, Prot Sci Lab, Minist Educ, Beijing 100084, Peoples R China; Tsinghua Univ, Sch Life Sci, Joint Ctr Life Sci, Struct Biol Ctr, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Sch Life Sci, Med Sci Bldg,Rm C331, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn		Lu, Peilong/0000-0001-5894-9268; Shi, Yigong/0000-0003-2030-168X	Ministry of Science and Technology 973 Program Grant [2009CB918801]; National Natural Science Foundation of China [30888001, 31021002, 31130002]	Ministry of Science and Technology 973 Program Grant(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology 973 Program Grant 2009CB918801 and National Natural Science Foundation of China Grants 30888001, 31021002, and 31130002.	Audia JP, 2001, INT J MED MICROBIOL, V291, P97, DOI 10.1078/1438-4221-00106; Casagrande F, 2008, J BIOL CHEM, V283, P33240, DOI 10.1074/jbc.M806917200; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Castanie-Cornet MP, 2001, MICROBIOL-UK, V147, P709, DOI 10.1099/00221287-147-3-709; DeBiase D, 1996, PROTEIN EXPRES PURIF, V8, P430; Donnenberg MS, 2000, NATURE, V406, P768, DOI 10.1038/35021212; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Gong S, 2003, J BACTERIOL, V185, P4402, DOI 10.1128/JB.185.15.4402-4409.2003; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; Lin JS, 1996, APPL ENVIRON MICROB, V62, P3094, DOI 10.1128/AEM.62.9.3094-3100.1996; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; Lu PL, 2013, CELL RES, V23, P635, DOI 10.1038/cr.2013.13; Ma D, 2012, NATURE, V483, P632, DOI 10.1038/nature10917; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; SMITH DK, 1992, J BACTERIOL, V174, P5820, DOI 10.1128/jb.174.18.5820-5826.1992; STIM KP, 1993, J BACTERIOL, V175, P1221, DOI 10.1128/JB.175.5.1221-1234.1993; Tsai MF, 2013, P NATL ACAD SCI USA, V110, P5898, DOI 10.1073/pnas.1301444110	21	32	33	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15148	15153		10.1074/jbc.M113.474502	http://dx.doi.org/10.1074/jbc.M113.474502			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23589309	Green Published, hybrid			2022-12-28	WOS:000319452100044
J	Qin, ZW; Baker, AT; Raab, A; Huang, S; Wang, TH; Yu, Y; Jaspars, M; Secombes, CJ; Deng, H				Qin, Zhiwei; Baker, Alexander Thomas; Raab, Andrea; Huang, Sheng; Wang, Tiehui; Yu, Yi; Jaspars, Marcel; Secombes, Christopher J.; Deng, Hai			The Fish Pathogen Yersinia ruckeri Produces Holomycin and Uses an RNA Methyltransferase for Self-resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-CLUSTER; STREPTOMYCES; IDENTIFICATION; BACTERIA; VECTORS; MUTANTS; ENCODES; PEPTIDE; MODE	Holomycin and its derivatives belong to a class of broad-spectrum antibacterial natural products containing a rare dithiolopyrrolone heterobicyclic scaffold. The antibacterial mechanism of dithiolopyrrolone compounds has been attributed to the inhibition of bacterial RNA polymerase activities, although the exact mode of action has not been established in vitro. Some dithiopyrrolone derivatives display potent anticancer activities. Recently the biosynthetic gene cluster of holomycin has been identified and characterized in Streptomyces clavuligerus. Here we report that the fish pathogen Yersinia ruckeri is a holomycin producer, as evidenced through genome mining, chemical isolation, and structural elucidation as well as genetic manipulation. We also identified a unique regulatory gene hom15 at one end of the gene cluster encoding a cold-shock-like protein that likely regulates the production of holomycin in low cultivation temperatures. Inactivation of hom15 resulted in a significant loss of holomycin production. Finally, gene disruption of an RNA methyltransferase gene hom12 resulted in the sensitivity of the mutant toward holomycin. A complementation experiment of hom12 restored the resistance against holomycin. Although the wild-type Escherichia coli BL21(DE3) Gold is susceptible to holomycin, the mutant harboring hom12 showed tolerance toward holomycin. High resolution liquid chromatography (LC)-ESI/MS analysis of digested RNA fragments demonstrated that the wild-type Y. ruckeri and E. coli harboring hom12 contain a methylated RNA fragment, whereas the mutated Y. ruckeri and the wild-type E. coli only contain normal non-methylated RNA fragments. Taken together, our results strongly suggest that this putative RNA methyltransferase Hom12 is the self-resistance protein that methylates the RNA of Y. ruckeri to reduce the cytotoxic effect of holomycin during holomycin production.	[Qin, Zhiwei; Baker, Alexander Thomas; Raab, Andrea; Jaspars, Marcel; Deng, Hai] Univ Aberdeen, Dept Chem, Marine Biodiscovery Ctr, Aberdeen AB24 3UE, Scotland; [Wang, Tiehui; Secombes, Christopher J.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen AB24 3FX, Scotland; [Huang, Sheng; Yu, Yi] Wuhan Univ, Sch Pharmaceut Sci, Key Lab Combinatory Biosynth & Drug Discovery, Minist Educ, Wuhan 430071, Peoples R China	University of Aberdeen; University of Aberdeen; Wuhan University	Secombes, CJ (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen AB24 3FX, Scotland.	c.secombes@abdn.ac.uk; h.deng@abdn.ac.uk	Baker, Alexander/AAC-5273-2019; Baker, Alexander Thomas/AAC-5345-2019; Deng, Hai/AAE-1758-2020	Baker, Alexander Thomas/0000-0001-8232-0531; Deng, Hai/0000-0002-0047-0622; QIN, ZHIWEI/0000-0002-1444-3684; Wang, Tiehui/0000-0002-1148-8959; Raab, Andrea/0000-0003-2058-0105; Jaspars, Marcel/0000-0002-2426-6028	College of Physical Sciences, University of Aberdeen; British Society of Antimicrobial Chemotherapy [GA2012_11V]; Marine Alliance for Science and Technology Scotland (MASTS); 973 Project from the Ministry of Science and Technology of China [2012CB721006]	College of Physical Sciences, University of Aberdeen; British Society of Antimicrobial Chemotherapy; Marine Alliance for Science and Technology Scotland (MASTS); 973 Project from the Ministry of Science and Technology of China(National Basic Research Program of China)	Supported in part by the College of Physical Sciences, University of Aberdeen for Funds.; Supported in part by a vacation studentship from the British Society of Antimicrobial Chemotherapy (GA2012_11V).; Supported by the Marine Alliance for Science and Technology Scotland (MASTS).; Supported in part by the 973 Project from the Ministry of Science and Technology of China (2012CB721006).	Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Bate N, 1999, CHEM BIOL, V6, P617, DOI 10.1016/S1074-5521(99)80113-6; Blaesse M, 2000, EMBO J, V19, P6299, DOI 10.1093/emboj/19.23.6299; Bouras N, 2006, J APPL MICROBIOL, V100, P390, DOI 10.1111/j.1365-2672.2005.02762.x; Charusanti P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033727; Chen PE, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r1; Fernandez L, 2004, APPL ENVIRON MICROB, V70, P5199, DOI 10.1128/AEM.70.9.5199-5207.2004; Fernandez L, 2007, MICROBIOL-SGM, V153, P483, DOI 10.1099/mic.0.29284-0; Fukuda D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018031; Giessing AMB, 2011, J AM SOC MASS SPECTR, V22, P1242, DOI 10.1007/s13361-011-0126-8; Golovina AY, 2012, RNA, V18, P1725, DOI 10.1261/rna.034207.112; Harun NO, 2011, VACCINE, V29, P4388, DOI 10.1016/j.vaccine.2011.04.003; Hopwood DA, 2007, MOL MICROBIOL, V63, P937, DOI 10.1111/j.1365-2958.2006.05584.x; Hou YH, 2008, MICROBIOL RES, V163, P96, DOI 10.1016/j.micres.2006.07.003; Huang S, 2011, PROCESS BIOCHEM, V46, P811, DOI 10.1016/j.procbio.2010.11.024; JIMENEZ A, 1973, ANTIMICROB AGENTS CH, V3, P729, DOI 10.1128/AAC.3.6.729; Katzen F, 1999, APPL ENVIRON MICROB, V65, P278; KENIG M, 1979, J ANTIBIOT, V32, P549, DOI 10.7164/antibiotics.32.549; Li B, 2007, BIOORGAN MED CHEM, V15, P4601, DOI 10.1016/j.bmc.2007.04.017; Li B, 2012, CHEMBIOCHEM, V13, P2521, DOI 10.1002/cbic.201200536; Li B, 2011, BIOCHEMISTRY-US, V50, P4615, DOI 10.1021/bi200321c; Li B, 2010, P NATL ACAD SCI USA, V107, P19731, DOI 10.1073/pnas.1014140107; Liu MF, 2000, MOL MICROBIOL, V37, P811, DOI 10.1046/j.1365-2958.2000.02046.x; Marlow VL, 2009, J BACTERIOL, V191, P1519, DOI 10.1128/JB.01661-08; Mendez J, 2011, J BACTERIOL, V193, P944, DOI 10.1128/JB.01058-10; Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; O'Neill A, 2000, ANTIMICROB AGENTS CH, V44, P3163, DOI 10.1128/AAC.44.11.3163-3166.2000; Oliva B, 2001, ANTIMICROB AGENTS CH, V45, P532, DOI 10.1128/AAC.45.2.532-539.2001; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; PRIDMORE RD, 1987, GENE, V56, P309, DOI 10.1016/0378-1119(87)90149-1; Robles-Reglero V, 2013, J BIOTECHNOL, V163, P69, DOI 10.1016/j.jbiotec.2012.09.017; SAMBROOK J, 1989, MOL CLONING LAB MANU, P7; Scott HN, 2003, PLASMID, V50, P74, DOI 10.1016/S0147-619X(03)00030-1; Tenson T, 2002, CELL, V108, P591, DOI 10.1016/S0092-8674(02)00669-4; Wietz M, 2010, MAR DRUGS, V8, P2946, DOI 10.3390/md8122946; ZALACAIN M, 1991, GENE, V97, P137, DOI 10.1016/0378-1119(91)90021-3	37	30	33	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14688	14697		10.1074/jbc.M112.448415	http://dx.doi.org/10.1074/jbc.M112.448415			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23572522	Green Published, hybrid			2022-12-28	WOS:000319452100003
J	Sanz-Garcia, C; Ferrer-Mayorga, G; Gonzalez-Rodriguez, A; Valverde, AM; Martin-Duce, A; Velasco-Martin, JP; Regadera, J; Fernandez, M; Alemany, S				Sanz-Garcia, Carlos; Ferrer-Mayorga, Gemma; Gonzalez-Rodriguez, Agueda; Valverde, Angela M.; Martin-Duce, Antonio; Velasco-Martin, Juan P.; Regadera, Javier; Fernandez, Margarita; Alemany, Susana			Sterile Inflammation in Acetaminophen-induced Liver Injury Is Mediated by Cot/tpl2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED KINASE; PAIN RELIEVERS; KAPPA-B; CELLS; MACROPHAGES; MECHANISMS; TPL2; IDENTIFICATION; ACTIVATION; IL-1-ALPHA	Cot/tpl2 (MAP3K8) activates MKK1/2-Erk1/2 following stimulation of the Toll-like/IL-1 receptor superfamily. Here, we investigated the role of Cot/tpl2 in sterile inflammation and drug-induced liver toxicity. Cot/tpl2 KO mice exhibited reduced hepatic injury after acetaminophen challenge, as evidenced by decreased serum levels of both alanine and aspartate aminotransferases, decreased hepatic necrosis, and increased survival relative to Wt mice. Serum levels of both alanine and aspartate aminotransferases were also lower after intraperitoneal injection of acetaminophen in mice expressing an inactive form of Cot/tpl2 compared with Wt mice, suggesting that Cot/tpl2 activity contributes to acetaminophen-induced liver injury. Furthermore, Cot/tpl2 deficiency reduced neutrophil and macrophage infiltration in the liver of mice treated with acetaminophen, as well as their hepatic and systemic levels of IL-1 alpha. Intraperitoneal injection of damage-associated molecular patterns from necrotic hepatocytes also impaired the recruitment of leukocytes and decreased the levels of several cytokines in the peritoneal cavity in Cot/tpl2 KO mice compared with Wt counterparts. Moreover, similar activation profiles of intracellular pathways were observed in Wt macrophages stimulated with Wt or Cot/tpl2 KO damage-associated molecular patterns. However, upon stimulation with damage-associated molecular patterns, the activation of Erk1/2 and JNK was deficient in Cot/tpl2 KO macrophages compared with their Wt counterparts; an effect accompanied by weaker release of several cytokines, including IL-1 alpha, an important component in the development of sterile inflammation. Taken together, these findings indicate that Cot/tpl2 contributes to acetaminophen-induced liver injury, providing some insight into the underlying molecular mechanisms.	[Sanz-Garcia, Carlos; Ferrer-Mayorga, Gemma; Gonzalez-Rodriguez, Agueda; Valverde, Angela M.; Martin-Duce, Antonio; Fernandez, Margarita; Alemany, Susana] CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain; [Gonzalez-Rodriguez, Agueda; Valverde, Angela M.] ISCIII, CIBERDEM, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Velasco-Martin, Juan P.; Regadera, Javier] UAM, Fac Med, Dpto Anat Histol & Neurociencia, Madrid 28029, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Autonomous University of Madrid	Alemany, S (corresponding author), CSIC UAM, Arturo Duperier 4, Madrid 28029, Spain.	salemany@iib.uam.es	Alemany, Susana/J-6307-2014; González-Rodróguez, Águeda/D-7651-2012; Sanz Garcia, Carlos/ABF-9146-2020	Alemany, Susana/0000-0002-4089-7620; González-Rodróguez, Águeda/0000-0001-6559-0847; Sanz Garcia, Carlos/0000-0002-4213-8871; Martinez Valverde, Angela/0000-0003-1192-9045; Gonzalez-Rodriguez, Agueda/0000-0003-2851-2318	MINECO (Spain) Comunidad de Madrid [SAF 2011-24481, SAF 2012-33283, S2010/BMD-2423]; EFSD/Amylin Programme; Mutua Madrilena; FPI fellowship; CIBERDEM (ISCIII)	MINECO (Spain) Comunidad de Madrid; EFSD/Amylin Programme; Mutua Madrilena; FPI fellowship(Spanish Government); CIBERDEM (ISCIII)(Instituto de Salud Carlos III)	This work was supported by Grants SAF 2011-24481 (to S. A.) and SAF 2012-33283 (to A. M. V.) from MINECO (Spain) Comunidad de Madrid S2010/BMD-2423, EFSD/Amylin Programme 2011 (to A. M. V.) and a grant from the Mutua Madrilena (to S. A.).; Recipient of an FPI fellowship.; Recipient of a CIBERDEM (ISCIII) postdoctoral contract.	Adams DH, 2010, TOXICOL SCI, V115, P307, DOI 10.1093/toxsci/kfq009; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Antoniades CG, 2012, HEPATOLOGY, V56, P735, DOI 10.1002/hep.25657; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P3274, DOI 10.1073/pnas.0511113103; Berda-Haddad Y, 2011, P NATL ACAD SCI USA, V108, P20684, DOI 10.1073/pnas.1116848108; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Blazer DG, 2009, J AM GERIATR SOC, V57, P1252, DOI 10.1111/j.1532-5415.2009.02306.x; Bourdi M, 2002, HEPATOLOGY, V35, P289, DOI 10.1053/jhep.2002.30956; Caivano M, 2003, J BIOL CHEM, V278, P52124, DOI 10.1074/jbc.M306583200; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Cohen P, 2009, CURR OPIN CELL BIOL, V21, P317, DOI 10.1016/j.ceb.2009.01.015; Das S, 2005, J BIOL CHEM, V280, P23748, DOI 10.1074/jbc.M412837200; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Eigenbrod T, 2008, J IMMUNOL, V181, P8194, DOI 10.4049/jimmunol.181.12.8194; Elkon KB, 2007, NAT MED, V13, P778, DOI 10.1038/nm0707-778; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Gandara ML, 2003, MOL CELL BIOL, V23, P7377, DOI 10.1128/MCB.23.20.7377-7390.2003; Gantke T, 2012, IMMUNOL REV, V246, P168, DOI 10.1111/j.1600-065X.2012.01104.x; Gonzalez-Rodriguez A, 2007, J CELL PHYSIOL, V212, P76, DOI 10.1002/jcp.21004; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Jaeschke H, 2013, HEPATOLOGY, V57, P419, DOI 10.1002/hep.25877; Jones DP, 2010, MOL INTERV, V10, P98, DOI 10.1124/mi.10.2.7; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; Kaufman DW, 2002, JAMA-J AM MED ASSOC, V287, P337, DOI 10.1001/jama.287.3.337; Koliaraki V, 2012, J CLIN INVEST, V122, P4231, DOI 10.1172/JCI63917; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kono H, 2010, J IMMUNOL, V184, P4470, DOI 10.4049/jimmunol.0902485; Kontoyiannis D, 2002, J EXP MED, V196, P1563, DOI 10.1084/jem.20020281; Liu ZX, 2006, HEPATOLOGY, V43, P1220, DOI 10.1002/hep.21175; Lopez-Pelaez M, 2012, MOL BIOL CELL, V23, P2982, DOI 10.1091/mbc.E12-02-0135; Lopez-Pelaez M, 2011, EUR J IMMUNOL, V41, P1733, DOI 10.1002/eji.201041101; Maher JJ, 2009, J CLIN INVEST, V119, P246, DOI 10.1172/JCI38178; Marques PE, 2012, HEPATOLOGY, V56, P1971, DOI 10.1002/hep.25801; McCall K, 2010, CURR OPIN CELL BIOL, V22, P882, DOI 10.1016/j.ceb.2010.09.002; Mielke LA, 2009, J IMMUNOL, V183, P7984, DOI 10.4049/jimmunol.0901336; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Perugorria MJ, 2013, HEPATOLOGY, V57, P1238, DOI 10.1002/hep.26108; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Rodriguez C, 2008, CELL SIGNAL, V20, P1625, DOI 10.1016/j.cellsig.2008.05.008; Rodriguez C, 2006, CELL SIGNAL, V18, P1376, DOI 10.1016/j.cellsig.2005.10.016; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Serebrennikova OB, 2012, P NATL ACAD SCI USA, V109, pE1082, DOI 10.1073/pnas.1115098109; Sirisinha S, 2011, ASIAN PAC J ALLERGY, V29, P1; Soria-Castro I, 2010, J BIOL CHEM, V285, P33805, DOI 10.1074/jbc.M110.169409; Stirnimann G, 2010, SWISS MED WKLY, V140, P18, DOI 10.4414/smw.2010.13080; Sugimoto K, 2004, J CLIN INVEST, V114, P857, DOI 10.1172/JCI200420014; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Van Acker GJD, 2007, J BIOL CHEM, V282, P22140, DOI 10.1074/jbc.M702225200; Vougioukalaki M, 2011, CANCER LETT, V304, P80, DOI 10.1016/j.canlet.2011.02.004; Wang XF, 2013, HEPATOLOGY, V57, P373, DOI 10.1002/hep.25982; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Watford WT, 2010, J IMMUNOL, V184, P105, DOI 10.4049/jimmunol.0803730; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Wilcox CM, 2005, J RHEUMATOL, V32, P2218	60	39	42	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15342	15351		10.1074/jbc.M112.439547	http://dx.doi.org/10.1074/jbc.M112.439547			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23572518	Green Published, hybrid			2022-12-28	WOS:000319452100059
J	Chikazawa, M; Otaki, N; Shibata, T; Miyashita, H; Kawai, Y; Maruyama, S; Toyokuni, S; Kitaura, Y; Matsuda, T; Uchida, K				Chikazawa, Miho; Otaki, Natsuki; Shibata, Takahiro; Miyashita, Hiroaki; Kawai, Yoshichika; Maruyama, Shoichi; Toyokuni, Shinya; Kitaura, Yasuyuki; Matsuda, Tsukasa; Uchida, Koji			Multispecificity of Immunoglobulin M Antibodies Raised against Advanced Glycation End Products INVOLVEMENT OF ELECTRONEGATIVE POTENTIAL OF ANTIGENS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PATTERN-RECOGNITION RECEPTORS; OXIDATION-SPECIFIC EPITOPES; LOW-DENSITY-LIPOPROTEIN; CELL-SURFACE PROTEIN; DIABETIC COMPLICATIONS; HUMAN LENS; NATURAL AUTOANTIBODIES; MONOCLONAL-ANTIBODIES; GENE-EXPRESSION	Advanced glycation end products (AGEs) are a heterogeneous and complex group of compounds that are formed when reducing sugars, such as dehydroascorbic acid, react in a nonenzymatic way with amino acids in proteins and other macromolecules. AGEs are prevalent in the diabetic vasculature and contribute to the development of atherosclerosis. The presence and accumulation of AGEs in many different cell types affect the extracellular and intracellular structure and function. In the present study, we studied the immune response to the dehydroascorbic acid-derived AGEs and provide multiple lines of evidence suggesting that the AGEs could be an endogenous source of innate epitopes recognized by natural IgM antibodies. Prominent IgM titers to the AGEs were detected in the sera of normal mice and were significantly accelerated by the immunization with the AGEs. Patients with systemic lupus erythematosus (SLE), a potentially fatal systemic autoimmune disease characterized by the increased production of autoantibodies, showed significantly higher serum levels of the IgM titer against the AGEs than healthy individuals. A progressive increase in the IgM response against the AGEs was also observed in the SLE-prone mice. Strikingly, a subset of monoclonal antibodies, showing a specificity toward the AGEs, prepared from normal mice immunized with the AGEs and from the SLE mice cross-reacted with the double-stranded DNA. Moreover, they also cross-reacted with several other modified proteins, including the acetylated proteins, suggesting that the multiple specificity of the antibodies might be ascribed, at least in part, to the increased electronegative potential of the proteins. These findings suggest that the protein modification by the endogenous carbonyl compounds, generating electronegative proteins, could be a source of multispecific natural antibodies.	[Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan; [Kitaura, Yasuyuki] Nagoya Univ, Grad Sch Bioagr Sci, Lab Nutr Biochem, Nagoya, Aichi 4648601, Japan; [Matsuda, Tsukasa] Nagoya Univ, Grad Sch Bioagr Sci, Lab Mol Bioregulat, Nagoya, Aichi 4648601, Japan; [Maruyama, Shoichi] Nagoya Univ, Grad Sch Med Sci, Dept Nephrol, Nagoya, Aichi 4648601, Japan; [Toyokuni, Shinya] Nagoya Univ, Grad Sch Med Sci, Dept Pathol & Biol Responses, Nagoya, Aichi 4668550, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University; Nagoya University	Uchida, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan.	uchidak@agr.nagoya-u.ac.jp	Toyokuni, Shinya/C-1358-2010; Toyokuni, Shinya/ABE-7714-2021; Shibata, Takahiro/I-6872-2014	Toyokuni, Shinya/0000-0002-5757-1109; Toyokuni, Shinya/0000-0002-5757-1109; Uchida, Koji/0000-0003-3894-5299; Shibata, Takahiro/0000-0003-3194-607X	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the project "Signaling Functions of Reactive Oxygen Species (ROS Signal)," Grants-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Research Area), Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antone SM, 1997, J IMMUNOL, V159, P5422; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Baynes JW., 1989, PROG CLIN BIOL RES, V304, P1; Boes M, 2000, P NATL ACAD SCI USA, V97, P1184, DOI 10.1073/pnas.97.3.1184; BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315; Chan TM, 2002, J AM SOC NEPHROL, V13, P1219, DOI 10.1097/01.ASN.0000014223.71109.13; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Diaw L, 1997, J IMMUNOL, V158, P968; DUNN JA, 1990, BIOCHEMISTRY-US, V29, P10964, DOI 10.1021/bi00501a014; Engelbertsen D, 2012, J INTERN MED, V271, P82, DOI 10.1111/j.1365-2796.2011.02411.x; Gronwall C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00066; Gronwall C, 2012, CLIN IMMUNOL, V142, P390, DOI 10.1016/j.clim.2012.01.002; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; Hartvigsen K, 2009, J LIPID RES, V50, pS388, DOI 10.1194/jlr.R800100-JLR200; Hayakawa K, 2000, CURR OPIN IMMUNOL, V12, P346, DOI 10.1016/S0952-7915(00)00098-4; HOLMBERG D, 1987, EUR J IMMUNOL, V17, P399, DOI 10.1002/eji.1830170315; JACOB L, 1987, P NATL ACAD SCI USA, V84, P2956, DOI 10.1073/pnas.84.9.2956; Kawasaki T, 2011, IMMUNOL REV, V243, P61, DOI 10.1111/j.1600-065X.2011.01048.x; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Kowal C, 1999, EUR J IMMUNOL, V29, P1901, DOI 10.1002/(SICI)1521-4141(199906)29:06<1901::AID-IMMU1901>3.0.CO;2-L; LIMPANASITHIKUL W, 1995, J IMMUNOL, V155, P967; Lindemose S, 2011, NUCLEIC ACIDS RES, V39, P6269, DOI 10.1093/nar/gkr204; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Monnier VM, 2005, ANN NY ACAD SCI, V1043, P567, DOI 10.1196/annals.1333.065; NAGARAJ RH, 1991, P NATL ACAD SCI USA, V88, P10257, DOI 10.1073/pnas.88.22.10257; Nemet I, 2011, J BIOL CHEM, V286, P37128, DOI 10.1074/jbc.M111.245100; PENNELL CA, 1988, J IMMUNOL, V141, P2788; RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415; Shibata T, 2011, J BIOL CHEM, V286, P19943, DOI 10.1074/jbc.M110.187047; Shibayama P, 1999, DIABETES, V48, P1842, DOI 10.2337/diabetes.48.9.1842; Shoenfeld Y, 2005, ARTHRITIS RHEUM, V52, P2599, DOI 10.1002/art.21252; Spatz L, 1997, METHODS, V11, P70, DOI 10.1006/meth.1996.0389; Tessier F, 1999, J BIOL CHEM, V274, P20796, DOI 10.1074/jbc.274.30.20796; THOMPSON KM, 1992, IMMUNOLOGY, V76, P146; Vlassara H, 2001, DIABETES-METAB RES, V17, P436, DOI 10.1002/dmrr.233; Wardemann H, 2002, J EXP MED, V195, P771, DOI 10.1084/jem.20011140; Weismann D, 2012, BBA-BIOMEMBRANES, V1818, P2465, DOI 10.1016/j.bbamem.2012.01.018; Witte T, 2008, CLIN REV ALLERG IMMU, V34, P345, DOI 10.1007/s12016-007-8046-x; WITZTUM JL, 1984, P NATL ACAD SCI-BIOL, V81, P3204, DOI 10.1073/pnas.81.10.3204; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551	42	26	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13204	13214		10.1074/jbc.M113.452177	http://dx.doi.org/10.1074/jbc.M113.452177			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23543734	Green Published, hybrid			2022-12-28	WOS:000318850300007
J	Jaiswal, R; Stepanik, V; Rankova, A; Molinar, O; Goode, BL; McCartney, BM				Jaiswal, Richa; Stepanik, Vince; Rankova, Aneliya; Molinar, Olivia; Goode, Bruce L.; McCartney, Brooke M.			Drosophila Homologues of Adenomatous Polyposis Coli (APC) and the Formin Diaphanous Collaborate by a Conserved Mechanism to Stimulate Actin Filament Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEATION-PROMOTING FACTOR; TUMOR-SUPPRESSOR; PROTEIN; SPIRE; MICROTUBULE; PROFILIN; DOMAIN; LOCALIZATION; CAPPUCCINO; ARMADILLO	Adenomatous polyposis coli (APC) is a large multidomain protein that regulates the cytoskeleton. Recently, it was shown that vertebrate APC through its Basic domain directly collaborates with the formin mDia1 to stimulate actin filament assembly in the presence of nucleation barriers. However, it has been unclear whether these activities extend to homologues of APC and Dia in other organisms. Drosophila APC and Dia are each required to promote actin furrow formation in the syncytial embryo, suggesting a potential collaboration in actin assembly, but low sequence homology between the Basic domains of Drosophila and vertebrate APC has left their functional and mechanistic parallels uncertain. To address this question, we purified Drosophila APC1 and Dia and determined their individual and combined effects on actin assembly using both bulk fluorescence assays and total internal reflection fluorescence microscopy. Our data show that APC1, similar to its vertebrate homologue, bound to actin monomers and nucleated and bundled filaments. Further, Drosophila Dia nucleated actin assembly and protected growing filament barbed ends from capping protein. Drosophila APC1 and Dia directly interacted and collaborated to promote actin assembly in the combined presence of profilin and capping protein. Thus, despite limited sequence homology, Drosophila and vertebrate APCs exhibit highly related activities and mechanisms and directly collaborate with formins. These results suggest that APC-Dia interactions in actin assembly are conserved and may underlie important in vivo functions in a broad range of animal phyla.	[Jaiswal, Richa; Rankova, Aneliya; Goode, Bruce L.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, Waltham, MA 02454 USA; [Stepanik, Vince; Molinar, Olivia; McCartney, Brooke M.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Brandeis University; Carnegie Mellon University	Goode, BL (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, Waltham, MA 02454 USA.	goode@brandeis.edu; bmccartney@cmu.edu		Molinar-Inglis, Olivia/0000-0002-4974-9608	National Institutes of Health [GM083137, GM098143, GM073891]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083137, R01GM098143, R01GM073891] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM083137 and GM098143 (to B. L. G.) and GM073891 (to B. M. M.).	Afshar K, 2000, DEVELOPMENT, V127, P1887; Ahmed Y, 1998, CELL, V93, P1171, DOI 10.1016/S0092-8674(00)81461-0; Ahmed Y, 2002, DEVELOPMENT, V129, P1751; Akong K, 2002, DEV BIOL, V250, P91, DOI 10.1006/dbio.2002.0776; Bosch M, 2007, MOL CELL, V28, P555, DOI 10.1016/j.molcel.2007.09.018; Breitsprecher D, 2012, SCIENCE, V336, P1164, DOI 10.1126/science.1218062; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; De Graeve FM, 2012, DEV BIOL, V368, P76, DOI 10.1016/j.ydbio.2012.05.017; Deka J, 1998, EUR J BIOCHEM, V253, P591, DOI 10.1046/j.1432-1327.1998.2530591.x; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Graziano BR, 2011, MOL BIOL CELL, V22, P4016, DOI 10.1091/mbc.E11-05-0404; Grosshans J, 2005, DEVELOPMENT, V132, P1009, DOI 10.1242/dev.01669; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hayashi S, 1997, P NATL ACAD SCI USA, V94, P242, DOI 10.1073/pnas.94.1.242; Heimsath EG, 2012, J BIOL CHEM, V287, P3087, DOI 10.1074/jbc.M111.312207; Higashi T, 2010, J BIOL CHEM, V285, P16231, DOI 10.1074/jbc.M109.079236; Homem CCF, 2008, DEVELOPMENT, V135, P1005, DOI 10.1242/dev.016337; Jarrett CR, 2001, CANCER RES, V61, P7978; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; Langford KJ, 2006, CELL MOTIL CYTOSKEL, V63, P483, DOI 10.1002/cm.20139; Langford KJ, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-3; MANSEAU LJ, 1989, GENE DEV, V3, P1437, DOI 10.1101/gad.3.9.1437; McCartney BM, 2008, CURR OPIN CELL BIOL, V20, P186, DOI 10.1016/j.ceb.2008.02.001; McCartney BM, 2006, DEVELOPMENT, V133, P2407, DOI 10.1242/dev.02398; MIYASHIRO I, 1995, ONCOGENE, V11, P89; Moseley JB, 2007, J BIOL CHEM, V282, P12661, DOI 10.1074/jbc.M610615200; Moseley JB, 2006, METHOD ENZYMOL, V406, P215, DOI 10.1016/S0076-6879(06)06016-2; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; MUNEMITSU S, 1994, CANCER RES, V54, P3676; Nathke I, 2006, NAT REV CANCER, V6, P967, DOI 10.1038/nrc2010; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Nathke IS, 2004, ANNU REV CELL DEV BI, V20, P337, DOI 10.1146/annurev.cellbio.20.012103.094541; Okada K, 2010, J CELL BIOL, V189, P1087, DOI 10.1083/jcb.201001016; Pai LM, 1996, J BIOL CHEM, V271, P32411, DOI 10.1074/jbc.271.50.32411; Pechlivanis M, 2009, J BIOL CHEM, V284, P25324, DOI 10.1074/jbc.M109.030320; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Rosales-Nieves AE, 2006, NAT CELL BIOL, V8, P367, DOI 10.1038/ncb1385; Rosin-Arbesfeld R, 2001, EMBO J, V20, P5929, DOI 10.1093/emboj/20.21.5929; Sitar T, 2011, P NATL ACAD SCI USA, V108, P19575, DOI 10.1073/pnas.1115465108; Soeno Y, 1998, J MUSCLE RES CELL M, V19, P639, DOI 10.1023/A:1005329114263; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Subramanian A, 2003, CURR BIOL, V13, P1086, DOI 10.1016/S0960-9822(03)00416-0; Tu DQ, 2012, P NATL ACAD SCI USA, V109, pE3424, DOI 10.1073/pnas.1203035109; Vizcarra CL, 2011, P NATL ACAD SCI USA, V108, P11884, DOI 10.1073/pnas.1105703108; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Webb RL, 2009, DEVELOPMENT, V136, P1283, DOI 10.1242/dev.026963; Wen YD, 2004, KENYON REV, V26, P1; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Zeth K, 2011, J BIOL CHEM, V286, P30732, DOI 10.1074/jbc.M111.257782	59	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13897	13905		10.1074/jbc.M113.462051	http://dx.doi.org/10.1074/jbc.M113.462051			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23558679	Green Published, hybrid			2022-12-28	WOS:000318850300070
J	Chimploy, K; Song, SW; Wheeler, LJ; Mathews, CK				Chimploy, Korakod; Song, Shiwei; Wheeler, Linda J.; Mathews, Christopher K.			Ribonucleotide Reductase Association with Mammalian Liver Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA PRECURSOR ASYMMETRIES; THYMIDINE TRIPHOSPHATE; REPLICATION FIDELITY; POOL ASYMMETRY; HUMAN-CELLS; DNTP POOLS; DISEASE; QUANTITATION; MUTAGENESIS; NUCLEOIDS	Deoxyribonucleoside triphosphate pools in mammalian mitochondria are highly asymmetric, and this asymmetry probably contributes to the elevated mutation rate for the mitochondrial genome as compared with the nuclear genome. To understand this asymmetry, we must identify pathways for synthesis and accumulation of dNTPs within mitochondria. We have identified ribonucleotide reductase activity specifically associated with mammalian tissue mitochondria. Examination of immunoprecipitated proteins by mass spectrometry revealed R1, the large ribonucleotide reductase subunit, in purified mitochondria. Significant enzymatic and immunological activity was seen in rat liver mitochondrial nucleoids, isolated as described by Wang and Bogenhagen (Wang, Y., and Bogenhagen, D. F. (2006) J. Biol. Chem. 281, 25791-25802). Moreover, incubation of respiring rat liver mitochondria with [C-14]cytidine diphosphate leads to accumulation of radiolabeled deoxycytidine and thymidine nucleotides within the mitochondria. Comparable results were seen with [C-14]guanosine diphosphate. Ribonucleotide reduction within the mitochondrion, as well as outside the organelle, needs to be considered as a possibly significant contributor to mitochondrial dNTP pools.	[Chimploy, Korakod; Song, Shiwei; Wheeler, Linda J.; Mathews, Christopher K.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University	Mathews, CK (corresponding author), Oregon State Univ, Dept Biochem & Biophys, 2011 Agr & Life Sci Bldg, Corvallis, OR 97331 USA.	mathewsc@onid.orst.edu			National Institutes of Health Grant [R01 GM073744]; Army Research Office Grant [55953-LS]; NIEHS Center Grant [ES000210]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073744] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office Grant; NIEHS Center Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM073744. This work was also supported by Army Research Office Grant 55953-LS and NIEHS Center Grant ES000210 (to the Oregon State University Environmental Health Sciences Center mass spectrometry facility).	Anderson DD, 2011, P NATL ACAD SCI USA, V108, P15163, DOI 10.1073/pnas.1103623108; ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763; DARLEYUSMAR VM, 1987, MITOCHONDRIA PRACTIC, P113; Dudek J, 2013, BBA-MOL CELL RES, V1833, P274, DOI 10.1016/j.bbamcr.2012.05.028; ELFORD HL, 1970, J BIOL CHEM, V245, P5228; Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; KANG D, 1995, J BIOL CHEM, V270, P14659, DOI 10.1074/jbc.270.24.14659; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; Martomo SA, 2002, MUTAT RES-FUND MOL M, V499, P197, DOI 10.1016/S0027-5107(01)00283-4; Mathews CK, 2009, METHODS MOL BIOL, V554, P371, DOI 10.1007/978-1-59745-521-3_22; MATHEWS CK, 1992, BIOESSAYS, V14, P295, DOI 10.1002/bies.950140502; Morris GW, 2009, BIOCHEM J, V422, P513, DOI 10.1042/BJ20082427; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109; Ragan C. I., 1987, MITOCHONDRIA PRACTIC, P113; Rampazzo C, 2000, P NATL ACAD SCI USA, V97, P8239, DOI 10.1073/pnas.97.15.8239; Rampazzo C, 2007, J BIOL CHEM, V282, P34758, DOI 10.1074/jbc.M705923200; Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002; Robinson JB., 1987, MITOCHONDRIA PRACTIC, P153, DOI DOI 10.1016/J.BBRC.2005.02.135; Rotskaya UN, 2010, MUTAT RES-FUND MOL M, V685, P97, DOI 10.1016/j.mrfmmm.2009.12.010; Schaaper RM, 2013, DNA REPAIR, V12, P73, DOI 10.1016/j.dnarep.2012.10.011; SCHNAITMAN C, 1968, J CELL BIOL, V38, P158, DOI 10.1083/jcb.38.1.158; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; SHEWACH DS, 1992, ANAL BIOCHEM, V206, P178, DOI 10.1016/S0003-2697(05)80030-2; SLABAUGH MB, 1984, J VIROL, V52, P507, DOI 10.1128/JVI.52.2.507-514.1984; Song S., 2005, THESIS OREGON STATE; Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102; Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200; TURNER MK, 1968, J BIOL CHEM, V243, P3725; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; Wheeler LJ, 2011, J BIOL CHEM, V286, P16992, DOI 10.1074/jbc.M111.236968; WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210; YOUNG P, 1994, BIOCHEM BIOPH RES CO, V203, P46, DOI 10.1006/bbrc.1994.2146	41	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13145	13155		10.1074/jbc.M113.461111	http://dx.doi.org/10.1074/jbc.M113.461111			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23504325	Green Published, hybrid			2022-12-28	WOS:000318555100064
J	Corti, F; Finetti, F; Ziche, M; Simons, M				Corti, Federico; Finetti, Federica; Ziche, Marina; Simons, Michael			The Syndecan-4/Protein Kinase C alpha Pathway Mediates Prostaglandin E-2-induced Extracellular Regulated Kinase (ERK) Activation in Endothelial Cells and Angiogenesis in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RANDOMIZED CONTROLLED-TRIALS; GROWTH-FACTOR; PKC-ALPHA; DAILY ASPIRIN; PROTEIN; CANCER; MIGRATION; E-2; RECEPTOR; EP4	Prostaglandin E-2 (PGE(2)) is regarded as the main mediator of inflammatory symptoms. In addition, it also plays an important role in tumor growth and angiogenesis. In this study, we examined the mechanism of PGE(2)-induced angiogenic response. We show that in the absence of proteoglycan syndecan-4 (Sdc4), PGE(2)-induced ERK activation is decreased significantly, as is endothelial cell migration and cord formation in a two-dimensional Matrigel assay. In vivo, PGE(2)-induced angiogenesis is reduced dramatically in Sdc4(-/-) mice. The mechanism was traced to Sdc4-dependent activation of protein kinase C alpha (PKC alpha). Transduction of an Sdc4 S183E mutant (a cytoplasmic domain mutation that blocks Sdc4-dependent PKC alpha activation) into Sdc4(-/-) endothelial cells was not able to rescue the loss of PGE(2)-induced ERK activation, whereas a transduction with full-length Sdc4 resulted in full rescue. Furthermore, PGE(2)-induced angiogenesis was also reduced in PKC alpha(-/-) mice. Taken together, these results demonstrate that PGE(2)-induced activation of angiogenesis is mediated via syndecan-4-dependent activation of PKC alpha.	[Corti, Federico; Simons, Michael] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med,Yale Cardiovasc Res Ctr, New Haven, CT 06520 USA; [Simons, Michael] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Finetti, Federica; Ziche, Marina] Univ Siena, Dept Biotechnol, I-53100 Siena, Italy	Yale University; Yale University; University of Siena	Simons, M (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med,Yale Cardiovasc Res Ctr, 333 Cedar St, New Haven, CT 06520 USA.	michael.simons@yale.edu	Simons, Michael/G-8553-2014; Corti, Federico/R-6262-2016; Finetti, Federica/J-9089-2016	Simons, Michael/0000-0003-0348-7734; Corti, Federico/0000-0003-2160-245X; Ziche, Marina/0000-0002-9564-214X	National Institutes of Health Grant [R01 HL062289]; Fondazione Istituto Toscano Tumori; Associazione Italiana per la Ricerca sul Cancro (AIRC); Societa Italiana di Farmacologia (SIF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062289] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondazione Istituto Toscano Tumori; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Societa Italiana di Farmacologia (SIF); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL062289 (to M. S.). This work was also supported by the Fondazione Istituto Toscano Tumori (to F. C.) and the Associazione Italiana per la Ricerca sul Cancro (AIRC) (to M. Z.).; We thank Sandra Donnini for guidance and helpful suggestions, the Societa Italiana di Farmacologia (SIF) for initial support for this project, Jiasheng Zhang for technical help in endothelial cell preparation, John Rhodes and Rong Ju for discussion and technical help, and Antony Lanahan for helpful suggestions during manuscript revision.	Allport JR, 2002, J LEUKOCYTE BIOL, V71, P821; Aoki T, 2012, TRENDS PHARMACOL SCI, V33, P304, DOI 10.1016/j.tips.2012.02.004; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Chua CC, 2004, CIRC RES, V94, P316, DOI 10.1161/01.RES.0000112965.70691.AC; Clark JA, 2004, J BIOL CHEM, V279, P9233, DOI 10.1074/jbc.M312268200; COLEMAN RA, 1994, PROSTAGLANDINS, V47, P151, DOI 10.1016/0090-6980(94)90084-1; Dada S, 2008, BIOCHEM BIOPH RES CO, V372, P875, DOI 10.1016/j.bbrc.2008.05.154; Dormond O, 2002, J BIOL CHEM, V277, P45838, DOI 10.1074/jbc.M209213200; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Elfenbein A, 2009, J CELL BIOL, V186, P75, DOI 10.1083/jcb.200810179; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Finetti F, 2008, J BIOL CHEM, V283, P2139, DOI 10.1074/jbc.M703090200; Finetti F, 2009, CIRC RES, V105, P657, DOI 10.1161/CIRCRESAHA.109.203760; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Harris R. E., 2009, Inflammopharmacology, V17, P55, DOI 10.1007/s10787-009-8049-8; Horowitz A, 1998, J BIOL CHEM, V273, P25548, DOI 10.1074/jbc.273.40.25548; Horowitz A, 1998, J BIOL CHEM, V273, P10914, DOI 10.1074/jbc.273.18.10914; Horowitz A, 2002, J CELL BIOL, V157, P715, DOI 10.1083/jcb.200112145; Ishiguro K, 2001, J BIOL CHEM, V276, P47483, DOI 10.1074/jbc.M106268200; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Liang XB, 2011, J CLIN INVEST, V121, P4362, DOI 10.1172/JCI46279; Marais R, 1998, SCIENCE, V280, P109, DOI 10.1126/science.280.5360.109; Mastyugin V, 2004, J BIOMOL SCREEN, V9, P712, DOI 10.1177/1087057104269495; Matsui Y, 2011, CIRC RES, V108, P1328, DOI 10.1161/CIRCRESAHA.110.235689; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Murakami M, 2002, J BIOL CHEM, V277, P20367, DOI 10.1074/jbc.M202501200; Nakanishi M, 2013, SEMIN IMMUNOPATHOL, V35, P123, DOI 10.1007/s00281-012-0342-8; Pai R, 2001, BIOCHEM BIOPH RES CO, V286, P923, DOI 10.1006/bbrc.2001.5494; Partovian C, 2008, MOL CELL, V32, P140, DOI 10.1016/j.molcel.2008.09.010; Pozzi A, 2004, J BIOL CHEM, V279, P29797, DOI 10.1074/jbc.M313989200; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Salcedo R, 2003, BLOOD, V102, P1966, DOI 10.1182/blood-2002-11-3400; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Tkachenko E, 2002, J BIOL CHEM, V277, P19946, DOI 10.1074/jbc.M200841200; Volk R, 1999, J BIOL CHEM, V274, P24417, DOI 10.1074/jbc.274.34.24417; Wang AH, 2002, CIRC RES, V90, P609, DOI 10.1161/01.RES.0000012503.30315.E8; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Xin XP, 2012, LAB INVEST, V92, P1115, DOI 10.1038/labinvest.2012.90; Xu H, 2008, CARDIOVASC RES, V78, P349, DOI 10.1093/cvr/cvm085; Zhang YS, 2011, BLOOD, V118, P5355, DOI 10.1182/blood-2011-04-350587	44	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12712	12721		10.1074/jbc.M113.452383	http://dx.doi.org/10.1074/jbc.M113.452383			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23525101	Green Published, hybrid			2022-12-28	WOS:000318555100028
J	Ramos, TN; Bullard, DC; Darley, MM; McDonald, K; Crawford, DF; Barnum, SR				Ramos, Theresa N.; Bullard, Daniel C.; Darley, Meghan M.; McDonald, Kristin; Crawford, David F.; Barnum, Scott R.			Experimental Cerebral Malaria Develops Independently of Endothelial Expression of Intercellular Adhesion Molecule-1 (ICAM-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM-FALCIPARUM; LEUKOCYTE RECRUITMENT; ICAM-1-DEFICIENT MICE; MOUSE MODEL; TNF-ALPHA; IN-VIVO; RECEPTORS; SEQUESTRATION; VISUALIZATION; ERYTHROCYTES	Cerebral malaria (CM) is a severe clinical complication of Plasmodium falciparum malaria infection and is characterized by a high fatality rate and neurological damage. Sequestration of parasite-infected red blood cells in brain microvasculature utilizes host-and parasite-derived adhesion molecules and is an important factor in the development of CM. ICAM-1, an alternatively spliced adhesion molecule, is believed to be critical on endothelial cells for infected red blood cell sequestration in CM. Using ICAM-1 mutant mice, we found that the full-length ICAM-1 isoform is not required for development of murine experimental CM (ECM) and that ECM phenotype varies with the combination of ICAM-1 isoforms expressed. Furthermore, we observed development of ECM in transgenic mice expressing ICAM-1 only on leukocytes, indicating that endothelial cell expression of this adhesion molecule is not required for disease pathogenesis. We propose that ICAM-1-dependent cellular aggregation, independent of ICAM-1 expression on the cerebral microvasculature, contributes to ECM.	[Ramos, Theresa N.; Darley, Meghan M.; Barnum, Scott R.] Univ Alabama Birmingham, Dept Microbiol & Neurol, Birmingham, AL 35294 USA; [Bullard, Daniel C.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [McDonald, Kristin] Duke Univ, Ctr Human Genet, Durham, NC 27710 USA; [Crawford, David F.] Univ Oklahoma, Dept Pediat, Oklahoma City, OK 73104 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Duke University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Barnum, SR (corresponding author), Univ Alabama Birmingham, Dept Microbiol, 845 19th St S, Birmingham, AL 35294 USA.	sbarnum@uab.edu		McDonald Gibson, Kristin/0000-0002-3297-2002	National Institutes of Health [T32 AI07051, F31NS077811, P30 CA13148, P30 AR048311]; National Multiple Sclerosis Society Grant [PP1058]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS077811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society Grant(National Multiple Sclerosis Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 AI07051 (to T.N.R.), F31NS077811 (to T.N.R.), and P30 CA13148 and P30 AR048311. This work was also supported by National Multiple Sclerosis Society Grant PP1058 (to S.R.B. and D.C.B.).	BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Chewning JH, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-44; Cox MA, 2013, P NATL ACAD SCI USA, V110, P1416, DOI 10.1073/pnas.1213480110; Craig A, 2000, HUM MOL GENET, V9, P525, DOI 10.1093/hmg/9.4.525; Dietrich JB, 2002, J NEUROIMMUNOL, V128, P58, DOI 10.1016/S0165-5728(02)00114-5; Dunne JL, 2003, J IMMUNOL, V171, P6105, DOI 10.4049/jimmunol.171.11.6105; DUSTIN ML, 1986, J IMMUNOL, V137, P245; FALANGA PB, 1991, EUR J IMMUNOL, V21, P2259, DOI 10.1002/eji.1830210938; Favre N, 1999, MICROBES INFECT, V1, P961, DOI 10.1016/S1286-4579(99)80513-9; FernandezReyes D, 1997, HUM MOL GENET, V6, P1357, DOI 10.1093/hmg/6.8.1357; Fry AE, 2008, GENES IMMUN, V9, P462, DOI 10.1038/gene.2008.38; Giorelli M, 2002, CELL COMMUN ADHES, V9, P259, DOI 10.1080/15419060216305; GRAU GE, 1991, EUR J IMMUNOL, V21, P2265, DOI 10.1002/eji.1830210939; Hafalla JC, 2011, IMMUNOL REV, V240, P297, DOI 10.1111/j.1600-065X.2010.00988.x; Ho M, 2000, J EXP MED, V192, P1205, DOI 10.1084/jem.192.8.1205; Hu XZ, 2010, MOL IMMUNOL, V47, P1692, DOI 10.1016/j.molimm.2010.03.005; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; KING PD, 1995, J IMMUNOL, V154, P6080; Limb GA, 1999, CLIN EXP IMMUNOL, V118, P213; Liu LX, 2003, THROMB HAEMOSTASIS, V89, P213; Nacer A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002982; Ochietti B, 2002, GENE THER, V9, P939, DOI 10.1038/sj.gt.3301716; OCKENHOUSE CF, 1992, CELL, V68, P63, DOI 10.1016/0092-8674(92)90206-R; Ramos TN, 2012, PARASITE IMMUNOL, V34, P547, DOI 10.1111/pim.12002; Ramos TN, 2012, J BIOL CHEM, V287, P24734, DOI 10.1074/jbc.C112.378364; Robledo O, 2003, EUR J IMMUNOL, V33, P1351, DOI 10.1002/eji.200323195; Sinden Robert E, 2002, Methods Mol Med, V72, P25, DOI 10.1385/1-59259-271-6:25; SLIGH JE, 1993, P NATL ACAD SCI USA, V90, P8529, DOI 10.1073/pnas.90.18.8529; Smith JD, 2000, P NATL ACAD SCI USA, V97, P1766, DOI 10.1073/pnas.040545897; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Steeber DA, 2005, TRENDS IMMUNOL, V26, P9, DOI 10.1016/j.it.2004.11.012; Tailor A, 2005, MICROCIRCULATION, V12, P275, DOI 10.1080/10739680590925691; Tse MT, 2004, MOL MICROBIOL, V51, P1039, DOI 10.1046/j.1365-2958.2003.03895.x; van den Engel NK, 2000, BLOOD, V95, P1350, DOI 10.1182/blood.V95.4.1350.004k07_1350_1355; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Werner A, 2001, CELL TISSUE RES, V305, P25, DOI 10.1007/s004410100393; WILLIMANN K, 1995, J EXP MED, V182, P643, DOI 10.1084/jem.182.3.643; Wohler JE, 2009, EUR J IMMUNOL, V39, P1516, DOI 10.1002/eji.200839176; XU H, 1994, J EXP MED, V180, P95, DOI 10.1084/jem.180.1.95; Yipp BG, 2007, MICROCIRCULATION, V14, P593, DOI 10.1080/10739680701404705; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	43	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					10962	10966		10.1074/jbc.C113.457028	http://dx.doi.org/10.1074/jbc.C113.457028			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23493396	hybrid, Green Published			2022-12-28	WOS:000317915500002
J	Ishino, T; Wang, MM; Mosyak, L; Tam, A; Duan, WL; Svenson, K; Joyce, A; O'Hara, DM; Lin, L; Somers, WS; Kriz, R				Ishino, Tetsuya; Wang, Mengmeng; Mosyak, Lidia; Tam, Amy; Duan, Weili; Svenson, Kristine; Joyce, Alison; O'Hara, Denise M.; Lin, Laura; Somers, William S.; Kriz, Ronald			Engineering a Monomeric Fc Domain Modality by N-Glycosylation for the Half-life Extension of Biotherapeutics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; IMMUNOGLOBULIN-G; AMINO-ACID; HUMAN IGG1; RECEPTOR; PHARMACOKINETICS; MICE; VARIANTS; PRIMATES; FRAGMENT	Human IgG is a bivalent molecule that has two identical Fab domains connected by a dimeric Fc domain. For therapeutic purposes, however, the bivalency of IgG and Fc fusion proteins could cause undesired properties. We therefore engineered the conversion of the natural dimeric Fc domain to a highly soluble monomer by introducing two Asn-linked glycans onto the hydrophobic C(H)3-C(H)3 dimer interface. The monomeric Fc (monoFc) maintained the binding affinity for neonatal Fc receptor (FcRn) in a pH-dependent manner. We solved the crystal structure of monoFc, which explains how the carbohydrates can stabilize the protein surface and provides the rationale for molecular recognition between monoFc and FcRn. The monoFc prolonged the in vivo half-life of an antibody Fab domain, and a tandem repeat of the monoFc further prolonged the half-life. This monoFc modality can be used to improve the pharmacokinetics of monomeric therapeutic proteins with an option to modulate the degree of half-life extension.	[Ishino, Tetsuya; Mosyak, Lidia; Tam, Amy; Duan, Weili; Svenson, Kristine; Lin, Laura; Somers, William S.; Kriz, Ronald] Pfizer Inc, Global Biotherapeut Technol, Cambridge, MA 02140 USA; [Wang, Mengmeng; Joyce, Alison; O'Hara, Denise M.] Pfizer Inc, Pharmacokinet Dynam & Metab, Andover, MA 01810 USA	Pfizer; Pfizer	Ishino, T (corresponding author), Pfizer Inc, Global Biotherapeut Technol, 87 Cambridge Pk Dr, Cambridge, MA 02140 USA.	tetsuya.ishino@pfizer.com						BAUSE E, 1981, BIOCHEM J, V195, P639, DOI 10.1042/bj1950639; BRAMBELL FW, 1964, NATURE, V203, P1352, DOI 10.1038/2031352a0; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Datta-Mannan A, 2007, DRUG METAB DISPOS, V35, P86, DOI 10.1124/dmd.106.011734; DEMIGNOT S, 1990, CANCER RES, V50, P2936; Deng R, 2010, DRUG METAB DISPOS, V38, P600, DOI 10.1124/dmd.109.031310; Dumont JA, 2006, BIODRUGS, V20, P151, DOI 10.2165/00063030-200620030-00002; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Elliott S, 2003, NAT BIOTECHNOL, V21, P414, DOI 10.1038/nbt799; GRIBBEN JG, 1990, LANCET, V335, P434, DOI 10.1016/0140-6736(90)90665-R; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; MARRACK J, 1955, ANNU REV MICROBIOL, V9, P369, DOI 10.1146/annurev.mi.09.100155.002101; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Oganesyan V, 2008, MOL IMMUNOL, V45, P1872, DOI 10.1016/j.molimm.2007.10.042; Prat M, 1998, J CELL SCI, V111, P237; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; Raghavan M, 1996, ANNU REV CELL DEV BI, V12, P181, DOI 10.1146/annurev.cellbio.12.1.181; ROITSCH T, 1989, EUR J BIOCHEM, V181, P525, DOI 10.1111/j.1432-1033.1989.tb14755.x; Rose RJ, 2013, MABS-AUSTIN, V5, P219, DOI 10.4161/mabs.23532; ShakinEshleman SH, 1996, J BIOL CHEM, V271, P6363, DOI 10.1074/jbc.271.11.6363; Sola RJ, 2009, J PHARM SCI-US, V98, P1223, DOI 10.1002/jps.21504; Suzuki T, 2010, J IMMUNOL, V184, P1968, DOI 10.4049/jimmunol.0903296; Tesar DB, 2006, TRAFFIC, V7, P1127, DOI 10.1111/j.1600-0854.2006.00457.x; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; Wang WR, 2011, DRUG METAB DISPOS, V39, P1469, DOI 10.1124/dmd.111.039453; Ye LL, 2011, NAT BIOTECHNOL, V29, P158, DOI 10.1038/nbt.1742; Yeung YA, 2009, J IMMUNOL, V182, P7663, DOI 10.4049/jimmunol.0804182; Ying TL, 2012, J BIOL CHEM, V287, P19399, DOI 10.1074/jbc.M112.368647; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601	31	35	40	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16529	16537		10.1074/jbc.M113.457689	http://dx.doi.org/10.1074/jbc.M113.457689			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23615911	hybrid, Green Published			2022-12-28	WOS:000320378900029
J	Salewski, J; Escobar, FV; Kaminski, S; von Stetten, D; Keidel, A; Rippers, Y; Michael, N; Scheerer, P; Piwowarski, P; Bartl, F; Frankenberg-Dinkel, N; Ringsdorf, S; Gartner, W; Lamparter, T; Mroginski, MA; Hildebrandt, P				Salewski, Johannes; Escobar, Francisco Velazquez; Kaminski, Steve; von Stetten, David; Keidel, Anke; Rippers, Yvonne; Michael, Norbert; Scheerer, Patrick; Piwowarski, Patrick; Bartl, Franz; Frankenberg-Dinkel, Nicole; Ringsdorf, Simone; Gaertner, Wolfgang; Lamparter, Tilman; Mroginski, Maria Andrea; Hildebrandt, Peter			Structure of the Biliverdin Cofactor in the Pfr State of Bathy and Prototypical Phytochromes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA BACTERIOPHYTOCHROME; RESONANCE RAMAN-SPECTROSCOPY; P-FR PHOTOTRANSFORMATION; MOLECULAR-DYNAMICS; GROUND-STATE; AGROBACTERIUM-TUMEFACIENS; TETRAPYRROLE CHROMOPHORE; BACTERIAL PHYTOCHROMES; ASPERGILLUS-NIDULANS; SPECTRAL PROPERTIES	Phytochromes act as photoswitches between the red-and farred absorbing parent states of phytochromes (Pr and Pfr). Plant phytochromes display an additional thermal conversion route from the physiologically active Pfr to Pr. The same reaction pattern is found in prototypical biliverdin-binding bacteriophytochromes in contrast to the reverse thermal transformation in bathy bacteriophytochromes. However, the molecular origin of the different thermal stabilities of the Pfr states in prototypical and bathy bacteriophytochromes is not known. Weanalyzed the structures of the chromophore binding pockets in the Pfr states of various bathy and prototypical biliverdin-binding phytochromes using a combined spectroscopic-theoretical approach. For the Pfr state of the bathy phytochrome from Pseudomonas aeruginosa, the very good agreement between calculated and experimental Raman spectra of the biliverdin cofactor is in line with important conclusions of previous crystallographic analyses, particularly the ZZEssa configuration of the chromophore and its mode of covalent attachment to the protein. The highly homogeneous chromophore conformation seems to be a unique property of the Pfr states of bathy phytochromes. This is in sharp contrast to the Pfr states of prototypical phytochromes that display conformational equilibria between two sub-states exhibiting small structural differences at the terminal methine bridges A-B and C-D. These differences may mainly root in the interactions of the cofactor with the highly conserved Asp-194 that occur via its carboxylate function in bathy phytochromes. The weaker interactions via the carbonyl function in prototypical phytochromes may lead to a higher structural flexibility of the chromophore pocket opening a reaction channel for the thermal (ZZE -> ZZZ) Pfr to Pr back-conversion.	[Salewski, Johannes; Escobar, Francisco Velazquez; Kaminski, Steve; von Stetten, David; Keidel, Anke; Rippers, Yvonne; Michael, Norbert; Mroginski, Maria Andrea; Hildebrandt, Peter] Tech Univ Berlin, Inst Chem, D-10623 Berlin, Germany; [von Stetten, David] European Synchrotron Radiat Facil, Struct Biol Grp, F-38043 Grenoble, France; [Scheerer, Patrick; Piwowarski, Patrick; Bartl, Franz] Charite, Inst Med Phys & Biophys CCO, D-10117 Berlin, Germany; [Scheerer, Patrick] Charite, AG Prot Xray Crystallog, D-10117 Berlin, Germany; [Piwowarski, Patrick; Bartl, Franz] Charite, AG Spect, D-10117 Berlin, Germany; [Frankenberg-Dinkel, Nicole] Ruhr Univ Bochum, AG Physiol Mikroorganismen, D-44780 Bochum, Germany; [Ringsdorf, Simone; Gaertner, Wolfgang] Max Planck Inst Chem Energiekonvers, D-45470 Mulheim, Germany; [Lamparter, Tilman] Karlsruher Inst Technol, Inst Allgemeine Bot, D-76131 Karlsruhe, Germany	Technical University of Berlin; European Synchrotron Radiation Facility (ESRF); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruhr University Bochum; Max Planck Society; Helmholtz Association; Karlsruhe Institute of Technology	Mroginski, MA (corresponding author), Tech Univ Berlin, Inst Chem, Sekr PC 14,Str 17 Juni 135, D-10623 Berlin, Germany.	andrea.mroginski@tu-berlin.de; Hildebrandt@tu-berlin.de	Hildebrandt, Peter/J-5658-2014; Frankenberg-Dinkel, Nicole/C-1058-2011; Lamparter, Tilman/E-4421-2013	Hildebrandt, Peter/0000-0003-1030-5900; Frankenberg-Dinkel, Nicole/0000-0002-7757-6839; Kaminski, Steve/0000-0002-0047-8819; Scheerer, Patrick/0000-0001-5028-2075; Lamparter, Tilman/0000-0003-4327-9737; Gartner, Wolfgang/0000-0002-6898-7011; von Stetten, David/0000-0001-7906-9788; Velazquez Escobar, Francisco/0000-0003-0365-8118	Deutsche Forschungsgemeinschaft [Sfb1078 (B5), Sfb1078 (B6), Sfb1078 (C3)]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Sfb1078 (B5, B6, and C3).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], 2007, MATH STAT METASTATIS; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Blumenstein A, 2005, CURR BIOL, V15, P1833, DOI 10.1016/j.cub.2005.08.061; Borucki B, 2005, J BIOL CHEM, V280, P34358, DOI 10.1074/jbc.M505493200; Borucki B, 2009, BIOCHEMISTRY-US, V48, P6305, DOI 10.1021/bi900436v; Brandt S, 2008, J BIOL CHEM, V283, P34605, DOI 10.1074/jbc.M805506200; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Buckler DR, 2002, STRUCTURE, V10, P153, DOI 10.1016/S0969-2126(01)00706-7; Chen Y, 2012, FEBS J, V279, P40, DOI 10.1111/j.1742-4658.2011.08397.x; Christie JM, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P277, DOI 10.1002/352760510X.ch13; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; FODOR SPA, 1990, BIOCHEMISTRY-US, V29, P11141, DOI 10.1021/bi00502a018; Freer LH, 2012, J PHYS CHEM B, V116, P10571, DOI 10.1021/jp302637u; HILDEBRANDT P, 1992, BIOCHEMISTRY-US, V31, P7957, DOI 10.1021/bi00149a029; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hughes J, 1997, NATURE, V386, P663, DOI 10.1038/386663a0; Hughes J, 2010, BIOCHEM SOC T, V38, P710, DOI 10.1042/BST0380710; Inomata K, 2006, J BIOL CHEM, V281, P28162, DOI 10.1074/jbc.M603983200; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karniol B, 2003, P NATL ACAD SCI USA, V100, P2807, DOI 10.1073/pnas.0437914100; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; Kim PW, 2012, BIOCHEMISTRY-US, V51, P619, DOI 10.1021/bi2017365; Kneip C, 1999, BIOCHEMISTRY-US, V38, P15185, DOI 10.1021/bi990688w; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; Lamparter T, 2001, EUR J BIOCHEM, V268, P4720, DOI 10.1046/j.1432-1327.2001.02395.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lindner I, 1998, ANGEW CHEM INT EDIT, V37, P1843, DOI 10.1002/(SICI)1521-3773(19980803)37:13/14<1843::AID-ANIE1843>3.0.CO;2-W; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MANITTO P, 1980, J CHEM SOC CHEM COMM, P178, DOI 10.1039/c39800000178; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Montgomery BL, 2002, TRENDS PLANT SCI, V7, P357, DOI 10.1016/S1360-1385(02)02304-X; Mroginski MA, 2011, J MOL STRUCT, V993, P15, DOI 10.1016/j.molstruc.2011.02.038; Mroginski MA, 2010, CHEMPHYSCHEM, V11, P1265, DOI 10.1002/cphc.200900895; Mroginski MA, 2007, BIOPHYS J, V93, P1885, DOI 10.1529/biophysj.107.108878; Mroginski MA, 2011, J PHYS CHEM B, V115, P1220, DOI 10.1021/jp108265h; Mroginski MA, 2009, BIOPHYS J, V96, P4153, DOI 10.1016/j.bpj.2009.02.029; Murgida DH, 2007, BIOPHYS J, V93, P2410, DOI 10.1529/biophysj.107.108092; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Quest B, 2007, FEBS J, V274, P2088, DOI 10.1111/j.1742-4658.2007.05751.x; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; Rockwell NC, 2009, P NATL ACAD SCI USA, V106, P6123, DOI 10.1073/pnas.0902370106; Rottwinkel G, 2010, J BACTERIOL, V192, P5124, DOI 10.1128/JB.00672-10; Scheerer P, 2010, CHEMPHYSCHEM, V11, P1090, DOI 10.1002/cphc.200900913; Schmidt P, 1998, PHOTOCHEM PHOTOBIOL, V68, P754, DOI 10.1111/j.1751-1097.1998.tb02541.x; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Schwinte P, 2008, BIOPHYS J, V95, P1256, DOI 10.1529/biophysj.108.131441; Senn HM, 2007, CURR OPIN CHEM BIOL, V11, P182, DOI 10.1016/j.cbpa.2007.01.684; Sharda S, 2007, EUR BIOPHYS J BIOPHY, V36, P815, DOI 10.1007/s00249-007-0171-1; Sherwood P, 2003, J MOL STRUC-THEOCHEM, V632, P1, DOI 10.1016/S0166-1280(03)00285-9; Song C, 2013, PHOTOCHEM PHOTOBIOL, V89, P259, DOI 10.1111/php.12029; Song C, 2012, MOL PLANT, V5, P698, DOI 10.1093/mp/sss017; Song C, 2011, P NATL ACAD SCI USA, V108, P3842, DOI 10.1073/pnas.1013377108; Tasler R, 2005, FEBS J, V272, P1927, DOI 10.1111/j.1742-4658.2005.04623.x; THUMMLER F, 1992, PLANT MOL BIOL, V20, P1003, DOI 10.1007/BF00028888; von Stetten D, 2008, ANGEW CHEM INT EDIT, V47, P4753, DOI 10.1002/anie.200705716; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wilde A, 1997, FEBS LETT, V406, P89, DOI 10.1016/S0014-5793(97)00248-2; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yang XJ, 2011, NATURE, V479, P428, DOI 10.1038/nature10506; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	71	51	51	0	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16800	16814		10.1074/jbc.M113.457531	http://dx.doi.org/10.1074/jbc.M113.457531			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23603902	hybrid, Green Published			2022-12-28	WOS:000320378900053
J	Yang, QH; Liang, Y; Si, LY; Ji, Q; Xu, Q; Zhang, Y; Li, XJ				Yang, Qihong; Liang, Yong; Si, Liangyi; Ji, Qing; Xu, Qiang; Zhang, Yi; Li, Xuejun			Antigen-specific Immunotherapy Regulates B Cell Activities in the Intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLERGIC INFLAMMATION; IGE; RECEPTOR; MEMORY; CD23; IL-10	Mature B cells (BCs) express CD23 and B cell receptors. Whether activation of CD23 and B cell receptors has different effects on BC activities is unclear. This study aims to investigate the mechanism by which the specific antigen immunotherapy regulates the activation of BCs in the skewed Th2 responses. Mice were sensitized to ovalbumin. The specific antigen vaccination (SAV) at graded doses was employed to modulate the activities of BCs in which the expression of IL-10, IgE, matrix metalloproteinase-9 (MMP9), CD23, and serum soluble CD23 by BCs was evaluated. The immune regulatory effect of BCs primed by lower or higher SAV doses was observed with an adoptive transfer mouse experiment. SAV activated CD23 to produce IL-10 in BCs at lower doses. The higher doses of SAV increased the expression of MMP9 in BCs that reduced the amounts of CD23 in BCs and increased the serum levels of soluble CD23, which was abrogated by the pretreatment with MMP9 inhibitor. Adoptively transfer with BCs primed by lower doses of SAV inhibited the ongoing antigen-specific Th2 responses whereas the BCs primed by higher doses of SAV exacerbated the ongoing Th2 responses. Exposure to specific antigens at optimal doses can activate BCs to produce IL-10 to suppress the skewed antigen-specific Th2 responses. The antigen doses of SAV higher than the optimal doses may promote the production of soluble CD23 to exacerbate the ongoing immune responses.	[Yang, Qihong; Si, Liangyi; Xu, Qiang; Zhang, Yi; Li, Xuejun] Third Mil Med Univ, Southwest Hosp, Dept Geriatr, Chongqing 400038, Peoples R China; [Liang, Yong] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthoped, Chongqing 40016, Peoples R China; [Ji, Qing] Third Mil Med Univ, Southwest Hosp, Dept Gastroenterol, Chongqing 40038, Peoples R China	Army Medical University; Chongqing Medical University; Army Medical University	Yang, QH (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Geriatr, Chongqing 400038, Peoples R China.	yangqh121@163.com						Agematsu K, 2000, IMMUNOL TODAY, V21, P204, DOI 10.1016/S0167-5699(00)01605-4; Amin K, 2012, RESP MED, V106, P9, DOI 10.1016/j.rmed.2011.09.007; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Barnes PJ, 2011, IMMUNOL REV, V242, P31, DOI 10.1111/j.1600-065X.2011.01020.x; Cooper AM, 2012, J IMMUNOL, V188, P3199, DOI 10.4049/jimmunol.1102689; Ebo DG, 2012, EXPERT REV CLIN IMMU, V8, P9, DOI [10.1586/eci.11.73, 10.1586/ECI.11.73]; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Galitovskiy V, 2011, J IMMUNOL, V187, P2677, DOI 10.4049/jimmunol.1002711; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Haczku A, 2000, AM J RESP CRIT CARE, V161, P952, DOI 10.1164/ajrccm.161.3.9905046; He SH, 2011, GASTROENTEROLOGY, V141, P249, DOI 10.1053/j.gastro.2011.04.006; Ishijima Y, 2012, GENES CELLS, V17, P285, DOI 10.1111/j.1365-2443.2012.01588.x; Jabara HH, 2008, J ALLERGY CLIN IMMUN, V121, P191, DOI 10.1016/j.jaci.2007.08.008; Jackson L, 2009, J IMMUNOL, V183, P2585, DOI 10.4049/jimmunol.0803660; Kasprowicz DJ, 2000, J IMMUNOL, V165, P680, DOI 10.4049/jimmunol.165.2.680; Mossalayi MD, 2009, INFECT IMMUN, V77, P5537, DOI 10.1128/IAI.01457-08; Mousallem T, 2012, CLIN EXP IMMUNOL, V167, P26, DOI 10.1111/j.1365-2249.2011.04499.x; Oliphant CJ, 2011, IMMUNOLOGY, V134, P378, DOI 10.1111/j.1365-2567.2011.03499.x; Passante E, 2009, INFLAMM RES, V58, P737, DOI 10.1007/s00011-009-0074-y; Shamji MH, 2011, CLIN EXP ALLERGY, V41, P1235, DOI 10.1111/j.1365-2222.2011.03804.x; Uchimura K, 2002, CLIN EXP IMMUNOL, V128, P308, DOI 10.1046/j.1365-2249.2002.01818.x; van der Vlugt LEPM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030883; Yang Y, 2012, P NATL ACAD SCI USA, V109, P5388, DOI 10.1073/pnas.1121627109	23	2	2	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16383	16390		10.1074/jbc.M113.456202	http://dx.doi.org/10.1074/jbc.M113.456202			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23589293	hybrid, Green Published			2022-12-28	WOS:000320378900016
J	Babcock, JT; Nguyen, HB; He, YJ; Hendricks, JW; Wek, RC; Quilliam, LA				Babcock, Justin T.; Nguyen, Hoa B.; He, Yujun; Hendricks, Jeremiah W.; Wek, Ronald C.; Quilliam, Lawrence A.			Mammalian Target of Rapamycin Complex 1 (mTORC1) Enhances Bortezomib-induced Death in Tuberous Sclerosis Complex (TSC)-null Cells by a c-MYC-dependent Induction of the Unfolded Protein Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-RESPONSE; GENE-PRODUCTS; TSC2; ACTIVATION; EXPRESSION; KINASE; PERK; RHEB; TRANSLATION; DOWNSTREAM	Many factors, including duration and intensity of the unfolded protein response (UPR), dictate whether cells will adapt to endoplasmic reticulum stress or undergo apoptosis. In tuberous sclerosis (TSC), elevation of mammalian target of rapamycin complex 1 (mTORC1) activity has been proposed to compound the induction of UPR transcription factors ATF4 and CHOP, suggesting that the UPR could be targeted to eradicate TSC1/2-null cells during patient therapy. Here we report that control of c-MYC translation by mTORC1 plays a key role in determining whether TSC2-null Elt3 rat leiomyoma cells apoptose in response to UPR induction by the proteasome inhibitor bortezomib. Although bortezomib induces eukaryotic initiating factor 2 alpha phosphorylation, mTORC1 activity was also required for downstream induction of the UPR transcription factors ATF4 and CHOP by a mechanism involving increased expression of c-MYC. Although bortezomib-induced c-MYC transcription was resistant to rapamycin treatment, mTORC1 activity was required for efficient c-MYC translation. c-MYC subsequently bound to the ATF4 promoter, suggesting direct involvement of an mTORC1/c-MYC-driven signaling pathway in the activation of the UPR. Consistent with this notion, exogenously expressed c-MYC reversed the ability of rapamycin to prevent bortezomib-induced CHOP and ATF4 expression as well as apoptosis. These findings indicate that the induction of ATF4/CHOP expression occurs via mTORC1 regulation of c-MYC and that this signaling pathway is a major determinant in the ability of bortezomib to induce apoptosis.	[Babcock, Justin T.; Nguyen, Hoa B.; He, Yujun; Hendricks, Jeremiah W.; Wek, Ronald C.; Quilliam, Lawrence A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Quilliam, LA (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr,MS4075, Indianapolis, IN 46202 USA.	lquillia@iupui.edu	Quilliam, Lawrence/B-6447-2015; Quilliam, Lawrence/Q-4987-2019		United States Department of Defense [W81XWH1110355]; LAM foundation; DeVault Gift Estate; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164] Funding Source: NIH RePORTER	United States Department of Defense(United States Department of Defense); LAM foundation; DeVault Gift Estate; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the United States Department of Defense Award W81XWH1110355 and The LAM foundation (to L. A. Q.).; Supported by a student fellowship awarded by the DeVault Gift Estate.	Armstrong JL, 2010, J BIOL CHEM, V285, P6091, DOI 10.1074/jbc.M109.014092; Benvenuto G, 2000, ONCOGENE, V19, P6306, DOI 10.1038/sj.onc.1204009; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Chen SQ, 2010, CANCER RES, V70, P4318, DOI 10.1158/0008-5472.CAN-09-4428; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Di Nardo A, 2009, J NEUROSCI, V29, P5926, DOI 10.1523/JNEUROSCI.0778-09.2009; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hosoi H, 1998, MOL PHARMACOL, V54, P815, DOI 10.1124/mol.54.5.815; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Kang YJ, 2011, CELL DEATH DIFFER, V18, P133, DOI 10.1038/cdd.2010.82; Kumar R, 2003, J CEREBR BLOOD F MET, V23, P462, DOI 10.1097/01.WCB.0000056064.25434.CA; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Nawrocki ST, 2008, BLOOD, V112, P2917, DOI 10.1182/blood-2007-12-130823; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Teske BF, 2011, MOL BIOL CELL, V22, P4390, DOI 10.1091/mbc.E11-06-0510; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; WALKER C, 1992, CARCINOGENESIS, V13, P25, DOI 10.1093/carcin/13.1.25; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Yecies JL, 2011, CANCER RES, V71, P2815, DOI 10.1158/0008-5472.CAN-10-4158; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	39	28	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15687	15698		10.1074/jbc.M112.431056	http://dx.doi.org/10.1074/jbc.M112.431056			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23612979	hybrid, Green Published			2022-12-28	WOS:000319822300025
J	Cai, F; Sutter, M; Cameron, JC; Stanley, DN; Kinney, JN; Kerfeld, CA				Cai, Fei; Sutter, Markus; Cameron, Jeffrey C.; Stanley, Desiree N.; Kinney, James N.; Kerfeld, Cheryl A.			The Structure of CcmP, a Tandem Bacterial Microcompartment Domain Protein from the beta-Carboxysome, Forms a Subcompartment Within a Microcompartment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHELL PROTEIN; IDENTIFICATION; GENOME; OPERON	The carboxysome is a bacterial organelle found in all cyanobacteria; it encapsulates CO2 fixation enzymes within a protein shell. The most abundant carboxysome shell protein contains a single bacterial microcompartment (BMC) domain. We present in vivo evidence that a hypothetical protein (dubbed CcmP) encoded in all beta-cyanobacterial genomes is part of the carboxysome. We show that CcmP is a tandem BMC domain protein, the first to be structurally characterized from a beta-carboxysome. CcmP forms a dimer of tightly stacked trimers, resulting in a nanocompartment-containing shell protein that may weakly bind 3-phosphoglycerate, the product of CO2 fixation. The trimers have a large central pore through which metabolites presumably pass into the carboxysome. Conserved residues surrounding the pore have alternate side-chain conformations suggesting that it can be open or closed. Furthermore, CcmP and its orthologs in alpha-cyanobacterial genomes form a distinct clade of shell proteins. Members of this subgroup are also found in numerous heterotrophic BMC-associated gene clusters encoding functionally diverse bacterial organelles, suggesting that the potential to form a nanocompartment within a microcompartment shell is widespread. Given that carboxysomes and architecturally related bacterial organelles are the subject of intense interest for applications in synthetic biology/metabolic engineering, our results describe a new type of building block with which to functionalize BMC shells.	[Cai, Fei; Sutter, Markus; Kinney, James N.; Kerfeld, Cheryl A.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Cai, Fei; Cameron, Jeffrey C.; Stanley, Desiree N.; Kerfeld, Cheryl A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Kerfeld, Cheryl A.] Univ Calif Berkeley, Synthet Biol Inst, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Kerfeld, CA (corresponding author), US DOE, Joint Genome Inst, 2800 Mitchell Dr, Walnut Creek, CA 94598 USA.	ckerfeld@lbl.gov		Sutter, Markus/0000-0001-6290-4820	National Science Foundation [MCB0851094, EF1105897]; Swiss National Science Foundation; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]	National Science Foundation(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE))	1 Supported by National Science Foundation Grant MCB0851094.; 2 Supported by a postdoctoral fellowship from the Swiss National Science Foundation.; 3 Supported by National Science Foundation Grant EF1105897.; We thank the staff at the Advanced Light Source, Lawrence Berkeley National Laboratory, which is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract No. DE-AC02-05CH11231. We thank Annette Salmeen for help in synchrotron data collection and Kent McDonald and Reena Zalpuri at the Electron Microscope Laboratory of the University of California, Berkeley, for help with electron microscopy. We thank Seth D. Axen and Kirsten Fagnan for help with Rosetta-Docking and running modeling jobs on the supercomputing cluster Genepool at The National Energy Research Scientific Computing Center. We also thank Seth D. Axen, Jonathan Lassila, and Beth Wurzburg for critical reading of the manuscript.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; ALLEN MM, 1968, J GEN MICROBIOL, V51, P203, DOI 10.1099/00221287-51-2-203; Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Bonacci W, 2012, P NATL ACAD SCI USA, V109, P478, DOI 10.1073/pnas.1108557109; Cai F, 2012, ADV PHOTOSYNTH RESP, V33, P345, DOI 10.1007/978-94-007-1533-2_14; Crowley CS, 2010, J BIOL CHEM, V285, P37838, DOI 10.1074/jbc.M110.160580; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Heinhorst S., 2006, COMPLEX INTRACELLULA, P141; Heldt D, 2009, BIOCHEM J, V423, P199, DOI 10.1042/BJ20090780; Iancu CV, 2007, J MOL BIOL, V372, P764, DOI 10.1016/j.jmb.2007.06.059; Iancu CV, 2010, J MOL BIOL, V396, P105, DOI 10.1016/j.jmb.2009.11.019; Ivleva NB, 2005, EMBO J, V24, P1202, DOI 10.1038/sj.emboj.7600606; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Kinney JN, 2012, J BIOL CHEM, V287, P17729, DOI 10.1074/jbc.M112.355305; Kinney JN, 2011, PHOTOSYNTH RES, V109, P21, DOI 10.1007/s11120-011-9624-6; Klein MG, 2009, J MOL BIOL, V392, P319, DOI 10.1016/j.jmb.2009.03.056; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Mackey Shannon R, 2007, Methods Mol Biol, V362, P115; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Pang A, 2012, ACTA CRYSTALLOGR D, V68, P1642, DOI 10.1107/S0907444912039315; Roberts EW, 2012, J BACTERIOL, V194, P787, DOI 10.1128/JB.06444-11; Sagermann M, 2009, P NATL ACAD SCI USA, V106, P8883, DOI 10.1073/pnas.0902324106; Samborska B, 2012, STRUCTURE, V20, P1353, DOI 10.1016/j.str.2012.05.013; Savage DF, 2010, SCIENCE, V327, P1258, DOI 10.1126/science.1186090; Schmid MF, 2006, J MOL BIOL, V364, P526, DOI 10.1016/j.jmb.2006.09.024; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seedorf H, 2008, P NATL ACAD SCI USA, V105, P2128, DOI 10.1073/pnas.0711093105; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2010, SCIENCE, V327, P81, DOI 10.1126/science.1179513; Tanaka S, 2009, PROTEIN SCI, V18, P108, DOI 10.1002/pro.14; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144; Tsai YS, 2009, ACTA CRYSTALLOGR D, V65, P980, DOI 10.1107/S0907444909025153; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050	41	73	75	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16055	16063		10.1074/jbc.M113.456897	http://dx.doi.org/10.1074/jbc.M113.456897			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23572529	Green Published, hybrid			2022-12-28	WOS:000319822300056
J	Eklof, JM; Shojania, S; Okon, M; McIntosh, LP; Brumer, H				Eklof, Jens M.; Shojania, Shaheen; Okon, Mark; McIntosh, Lawrence P.; Brumer, Harry			Structure-Function Analysis of a Broad Specificity Populus trichocarpa Endo-beta-glucanase Reveals an Evolutionary Link between Bacterial Licheninases and Plant XTH Gene Products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-ACTIVE ENZYMES; TRIPLE-RESONANCE EXPERIMENTS; CELL-WALLS; SENSITIVITY ENHANCEMENT; BIOLOGICAL IMPLICATIONS; XYLOGLUCANASE ACTIVITY; KAPPA-CARRAGEENASE; SIGNAL PEPTIDES; CHEMICAL-SHIFT; GREEN-ALGAE	The large xyloglucan endotransglycosylase/hydrolase (XTH) gene family continues to be the focus of much attention in studies of plant cell wall morphogenesis due to the unique catalytic functions of the enzymes it encodes. The XTH gene products compose a subfamily of glycoside hydrolase family 16 (GH16), which also comprises a broad range of microbial endoglucanases and endogalactanases, as well as yeast cell wall chitin/beta-glucan transglycosylases. Previous whole-family phylogenetic analyses have suggested that the closest relatives to the XTH gene products are the bacterial licheninases (EC 3.2.1.73), which specifically hydrolyze linear mixed linkage beta(1 -> 3)/beta(1 -> 4)-glucans. In addition to their specificity for the highly branched xyloglucan polysaccharide, XTH gene products are distinguished from the licheninases and other GH16 enzyme subfamilies by significant active site loop alterations and a large C-terminal extension. Given these differences, the molecular evolution of the XTH gene products in GH16 has remained enigmatic. Here, we present the biochemical and structural analysis of a unique, mixed function endoglucanase from black cottonwood (Populus trichocarpa), which reveals a small, newly recognized subfamily of GH16 members intermediate between the bacterial licheninases and plant XTH gene products. We postulate that this clade comprises an important link in the evolution of the large plant XTH gene families from a putative microbial ancestor. As such, this analysis provides new insights into the diversification of GH16 and further unites the apparently disparate members of this important family of proteins.	[Eklof, Jens M.; Brumer, Harry] Royal Inst Technol KTH, Sch Biotechnol, Div Glycosci, SE--10691 Stockholm, Sweden; [Eklof, Jens M.; Shojania, Shaheen; McIntosh, Lawrence P.; Brumer, Harry] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Okon, Mark; McIntosh, Lawrence P.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Okon, Mark; McIntosh, Lawrence P.; Brumer, Harry] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada	Royal Institute of Technology; University of British Columbia; University of British Columbia; University of British Columbia	Brumer, H (corresponding author), Royal Inst Technol KTH, Sch Biotechnol, Div Glycosci, SE--10691 Stockholm, Sweden.	brumer@msl.ubc.ca			Swedish Research Council; Swedish Research Council Formas; Michael Smith Laboratories, University of British Columbia	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Michael Smith Laboratories, University of British Columbia	This work was supported, in part, by grants from the Swedish Research Council and the Swedish Research Council Formas (to H. B.). Instrument and infrastructure support was provided by the Canadian Institutes of Health Research (CIHR), the Canada Foundation for Innovation (CFI), the British Columbia Knowledge Development Fund (BCKDF), the UBC Blusson Fund, and the Michael Smith Foundation for Health Research (MSFHR).; Supported by faculty funding from the Michael Smith Laboratories, University of British Columbia. To whom correspondence should be addressed. Tel.: 604-827-3738; Fax: 604-822-2114; E-mail: brumer@msl.ubc.ca.	Addington T, 2011, PROTEINS, V79, P365, DOI 10.1002/prot.22884; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Barbeyron T, 1998, MOL BIOL EVOL, V15, P528, DOI 10.1093/oxfordjournals.molbev.a025952; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baumann MJ, 2007, PLANT CELL, V19, P1947, DOI 10.1105/tpc.107.051391; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Burton RA, 2009, MOL PLANT, V2, P873, DOI 10.1093/mp/ssp063; Camilloni C, 2012, BIOCHEMISTRY-US, V51, P2224, DOI 10.1021/bi3001825; Campbell P, 1998, PLANT J, V15, P553, DOI 10.1046/j.1365-313X.1998.00239.x; Campbell P, 1999, PLANT J, V18, P371, DOI 10.1046/j.1365-313X.1999.00459.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carpita N., 2000, BIOCH MOL BIOL PLANT, P52; Chen JH, 2010, PROTEINS, V78, P2820, DOI 10.1002/prot.22798; Childs KL, 2007, NUCLEIC ACIDS RES, V35, pD846, DOI 10.1093/nar/gkl785; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Czisch M, 1998, J MAGN RESON, V134, P158, DOI 10.1006/jmre.1998.1483; Davies G.J., 2008, BIOCHEM J, DOI [10.1042/BJ20080382, DOI 10.1042/BJ20080382]; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Del Bem LEV, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-341; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Domozych DS, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00082; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eklof JM, 2012, METHOD ENZYMOL, V510, P97, DOI 10.1016/B978-0-12-415931-0.00006-9; Eklof JM, 2010, PLANT PHYSIOL, V153, P456, DOI 10.1104/pp.110.156844; Eletsky A, 2001, J BIOMOL NMR, V20, P177, DOI 10.1023/A:1011265430149; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Fangel JU, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00152; Fernandez-Fuentes N, 2007, NUCLEIC ACIDS RES, V35, pW363, DOI 10.1093/nar/gkm341; FRY SC, 1993, PHYSIOL PLANTARUM, V89, P1; Gaiser OJ, 2006, J MOL BIOL, V357, P1211, DOI 10.1016/j.jmb.2006.01.014; Geisler-Lee J, 2006, PLANT PHYSIOL, V140, P946, DOI 10.1104/pp.105.072652; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAHN M, 1995, EUR J BIOCHEM, V232, P849, DOI 10.1111/j.1432-1033.1995.tb20883.x; HAHN M, 1995, FEBS LETT, V374, P221, DOI 10.1016/0014-5793(95)01111-Q; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hamby SE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-500; Hehemann JH, 2012, J BIOL CHEM, V287, P30571, DOI 10.1074/jbc.M112.377184; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Henrissat B, 2001, PLANT MOL BIOL, V47, P55, DOI 10.1023/A:1010667012056; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hrmova M, 2007, J BIOL CHEM, V282, P12951, DOI 10.1074/jbc.M611487200; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johansson P, 2004, PLANT CELL, V16, P874, DOI 10.1105/tpc.020065; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kaewthai N, 2013, PLANT PHYSIOL, V161, P440, DOI 10.1104/pp.112.207308; Kallas AM, 2005, BIOCHEM J, V390, P105, DOI 10.1042/BJ20041749; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kneller D. G., 2008, SPARKY VERSION 3 115; Mark P, 2011, MOL SIMULAT, V37, P1001, DOI 10.1080/08927022.2011.566605; Mark P, 2009, PROTEINS, V75, P820, DOI 10.1002/prot.22291; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; MCFEETERS RF, 1980, ANAL BIOCHEM, V103, P302, DOI 10.1016/0003-2697(80)90614-4; Meissner A, 1998, MOL PHYS, V95, P1137, DOI 10.1080/002689798166152; Michel G, 2001, STRUCTURE, V9, P513, DOI 10.1016/S0969-2126(01)00612-8; Mohler KE, 2013, NEW PHYTOL, V197, P111, DOI 10.1111/j.1469-8137.2012.04371.x; Nelson N, 1944, J BIOL CHEM, V153, P375; Oganesyan Natalia, 2005, Journal of Structural and Functional Genomics, V6, P177, DOI 10.1007/s10969-005-2827-3; Planas N, 2000, BBA-PROTEIN STRUCT M, V1543, P361, DOI 10.1016/S0167-4838(00)00231-4; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Rance M, 1999, J MAGN RESON, V136, P92, DOI 10.1006/jmre.1998.1626; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Saura-Valls M, 2008, J BIOL CHEM, V283, P21853, DOI 10.1074/jbc.M803058200; Shen Y, 2012, J BIOMOL NMR, V52, P211, DOI 10.1007/s10858-012-9602-0; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sorensen I, 2011, PLANT J, V68, P201, DOI 10.1111/j.1365-313X.2011.04686.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Van Sandt VST, 2007, ANN BOT-LONDON, V99, P39, DOI 10.1093/aob/mcl232; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Weigelt J, 1998, J AM CHEM SOC, V120, P10778, DOI 10.1021/ja982649y; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pW496, DOI 10.1093/nar/gkn305; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Ye X, 2012, TREE GENET GENOMES, V8, P177, DOI 10.1007/s11295-011-0431-1; Yokoyama R, 2004, PLANT PHYSIOL, V134, P1088, DOI 10.1104/pp.103.035261; Yokoyama R, 2010, PLANT J, V64, P645, DOI 10.1111/j.1365-313X.2010.04351.x; YORK WS, 1993, CARBOHYD RES, V248, P285, DOI 10.1016/0008-6215(93)84135-S; YORK WS, 1995, CARBOHYD RES, V267, P79, DOI 10.1016/0008-6215(94)00287-P; Zhu G, 1999, J BIOMOL NMR, V13, P77, DOI 10.1023/A:1008398227519	83	32	32	1	42	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15786	15799		10.1074/jbc.M113.462887	http://dx.doi.org/10.1074/jbc.M113.462887			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23572521	hybrid, Green Published			2022-12-28	WOS:000319822300033
J	Ha, Y; Akiyama, Y; Xue, Y				Ha, Ya; Akiyama, Yoshinori; Xue, Yi			Structure and Mechanism of Rhomboid Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							INTRAMEMBRANE PROTEOLYSIS; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; SERINE PROTEASES; FAMILY; GLPG; SEQUENCE; CLEAVAGE; REVEALS; 3,4-DICHLOROISOCOUMARIN	Rhomboid protease was first discovered in Drosophila. Mutation of the fly gene interfered with growth factor signaling and produced a characteristic phenotype of a pointed head skeleton. The name rhomboid has since been widely used to describe a large family of related membrane proteins that have diverse biological functions but share a common catalytic core domain composed of six membrane-spanning segments. Most rhomboid proteases cleave membrane protein substrates near the N terminus of their transmembrane domains. How these proteases function within the confines of the membrane is not completely understood. Recent progress in crystallographic analysis of the Escherichia coli rhomboid protease GlpG in complex with inhibitors has provided new insights into the catalytic mechanism of the protease and its conformational change. Improved biochemical assays have also identified a substrate sequence motif that is specifically recognized by many rhomboid proteases.	[Ha, Ya; Xue, Yi] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Akiyama, Yoshinori] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan	Yale University; Kyoto University	Ha, Y (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	ya.ha@yale.edu; yakiyama@virus.kyoto-u.ac.jp			National Institutes of Health [GM082839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM082839 (to Y.H.).	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Adrain C, 2011, EMBO REP, V12, P421, DOI 10.1038/embor.2011.50; Akiyama Y, 2007, MOL MICROBIOL, V64, P1028, DOI 10.1111/j.1365-2958.2007.05715.x; Baker RP, 2007, P NATL ACAD SCI USA, V104, P8257, DOI 10.1073/pnas.0700814104; Baker RP, 2006, PLOS PATHOG, V2, P922, DOI 10.1371/journal.ppat.0020113; Baker RP, 2012, NAT CHEM BIOL, V8, P759, DOI [10.1038/NCHEMBIO.1021, 10.1038/nchembio.1021]; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Bondar AN, 2009, STRUCTURE, V17, P395, DOI 10.1016/j.str.2008.12.017; Brooks CL, 2011, J MOL BIOL, V407, P687, DOI 10.1016/j.jmb.2011.01.046; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Buguliskis JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000858; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Del Rio A, 2007, J MOL BIOL, V365, P109, DOI 10.1016/j.jmb.2006.09.047; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Erez E, 2009, BIOCHEMISTRY-US, V48, P12314, DOI 10.1021/bi901648g; Fersht A., 1999, STRUCTURE MECH PROTE, P29; Freeman M, 2008, ANNU REV GENET, V42, P191, DOI 10.1146/annurev.genet.42.110807.091628; Gallio M, 2002, P NATL ACAD SCI USA, V99, P12208, DOI 10.1073/pnas.192138799; Ha Y, 2009, SEMIN CELL DEV BIOL, V20, P240, DOI 10.1016/j.semcdb.2008.11.006; HARPER JW, 1985, BIOCHEMISTRY-US, V24, P1831, DOI 10.1021/bi00329a005; Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022; Hill RB, 2010, SEMIN CELL DEV BIOL, V21, P582, DOI 10.1016/j.semcdb.2009.12.011; Koonin EV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r19; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Lemberg MK, 2005, EMBO J, V24, P464, DOI 10.1038/sj.emboj.7600537; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Lohi O, 2004, CURR BIOL, V14, P236, DOI 10.1016/j.cub.2004.01.025; Maegawa S, 2005, BIOCHEMISTRY-US, V44, P13543, DOI 10.1021/bi051363k; Maegawa S, 2007, MOL MICROBIOL, V64, P435, DOI 10.1111/j.1365-2958.2007.05679.x; MAYER U, 1988, GENE DEV, V2, P1496, DOI 10.1101/gad.2.11.1496; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Pierrat OA, 2011, ACS CHEM BIOL, V6, P325, DOI 10.1021/cb100314y; Santos JM, 2011, SCIENCE, V331, P473, DOI 10.1126/science.1199284; Schafer A, 2010, J MOL BIOL, V401, P182, DOI 10.1016/j.jmb.2010.06.014; Sherratt AR, 2012, BIOCHEMISTRY-US, V51, P7794, DOI 10.1021/bi301087c; Sherratt AR, 2009, BBA-BIOMEMBRANES, V1788, P2444, DOI 10.1016/j.bbamem.2009.09.003; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; Tatsuta T, 2007, EMBO J, V26, P325, DOI 10.1038/sj.emboj.7601514; Tsruya R, 2007, EMBO J, V26, P1211, DOI 10.1038/sj.emboj.7601581; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Urban S, 2002, CURR BIOL, V12, P1507, DOI 10.1016/S0960-9822(02)01092-8; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Urban S, 2008, BIOL CHEM, V389, P1107, DOI 10.1515/BC.2008.122; Urban S, 2006, GENE DEV, V20, P3054, DOI 10.1101/gad.1488606; Vinothkumar KR, 2011, J MOL BIOL, V407, P232, DOI 10.1016/j.jmb.2011.01.029; Vinothkumar KR, 2010, EMBO J, V29, P3797, DOI 10.1038/emboj.2010.243; Wang L., 2012, PLOS ONE, V7; Wang YC, 2007, J MOL BIOL, V374, P1104, DOI 10.1016/j.jmb.2007.10.014; Wang YC, 2007, P NATL ACAD SCI USA, V104, P2098, DOI 10.1073/pnas.0611080104; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Xue Y, 2013, J BIOL CHEM, V288, P16645, DOI 10.1074/jbc.M112.438127; Xue Y, 2012, BIOCHEMISTRY-US, V51, P3723, DOI 10.1021/bi300368b; Xue Y, 2012, J BIOL CHEM, V287, P3099, DOI 10.1074/jbc.M111.310482; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047	62	28	29	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15430	15436		10.1074/jbc.R112.422378	http://dx.doi.org/10.1074/jbc.R112.422378			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23585569	Green Published, hybrid			2022-12-28	WOS:000319822300001
J	Lennartsson, J; Ma, HS; Wardega, P; Pelka, K; Engstrom, U; Hellberg, C; Heldin, CH				Lennartsson, Johan; Ma, Haisha; Wardega, Piotr; Pelka, Karin; Engstrom, Ulla; Hellberg, Carina; Heldin, Carl-Henrik			The Fer Tyrosine Kinase Is Important for Platelet-derived Growth Factor-BB-induced Signal Transducer and Activator of Transcription 3 (STAT3) Protein Phosphorylation, Colony Formation in Soft Agar, and Tumor Growth in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PDGF BETA-RECEPTOR; SRC FAMILY; AUTOPHOSPHORYLATION SITES; IDENTIFICATION; INVOLVEMENT; FPS/FES; EFFECTOR; INSULIN; CANCER	Fer is a cytoplasmic tyrosine kinase that is activated in response to platelet-derived growth factor (PDGF) stimulation. In the present report, we show that Fer associates with the activated PDGF beta-receptor (PDGFR beta) through multiple autophosphorylation sites, i.e. Tyr-579, Tyr-581, Tyr-740, and Tyr-1021. Using low molecular weight inhibitors, we found that PDGF-BB-induced Fer activation is dependent on PDGFR beta kinase activity, but not on the enzymatic activity of Src or Jak kinases. In cells in which Fer was down-regulated using siRNA, PDGF-BB was unable to induce phosphorylation of STAT3, whereas phosphorylations of STAT5, ERK1/2, and Akt were unaffected. PDGF-BB-induced activation of STAT3 occurred also in cells expressing kinase-dead Fer, suggesting a kinase-independent adaptor role of Fer. Expression of Fer was dispensable for PDGF-BB-induced proliferation and migration but essential for colony formation in soft agar. Tumor growth in vivo was delayed in cells depleted of Fer expression. Our data suggest a critical role of Fer in PDGF-BB-induced STAT3 activation and cell transformation.	[Lennartsson, Johan; Ma, Haisha; Wardega, Piotr; Pelka, Karin; Engstrom, Ulla; Hellberg, Carina; Heldin, Carl-Henrik] Uppsala Univ, Ludwig Inst Canc Res, Sci Life Lab, SE-75124 Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University	Lennartsson, J (corresponding author), Ludwig Inst Canc Res, Biomed Ctr, Box 595, SE-75124 Uppsala, Sweden.	johan.lennartsson@licr.uu.se			Swedish Cancer Society [090715]; Swedish Research Council [K2011-67X-21859-01-6]; Ludwig Institute for Cancer Research	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Ludwig Institute for Cancer Research	This work was supported by Swedish Cancer Society Grant 090715, Swedish Research Council Grant K2011-67X-21859-01-6, and the Ludwig Institute for Cancer Research.	Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Allard P, 2000, MOL CELL ENDOCRINOL, V159, P63, DOI 10.1016/S0303-7207(99)00205-1; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Craig AWB, 1999, J BIOL CHEM, V274, P19934, DOI 10.1074/jbc.274.28.19934; Craig AWB, 2002, MOL CELL BIOL, V22, P6363, DOI 10.1128/MCB.22.18.6363-6374.2002; Craig AWB, 2001, MOL CELL BIOL, V21, P603, DOI 10.1128/MCB.21.2.603-613.2001; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Greer P, 2002, NAT REV MOL CELL BIO, V3, P278, DOI 10.1038/nrm783; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Itoh T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000393; Iwanishi M, 2000, J BIOL CHEM, V275, P38995, DOI 10.1074/jbc.M006665200; Jucker M, 1997, J BIOL CHEM, V272, P2104; KIM L, 1995, MOL CELL BIOL, V15, P4553; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; Li HY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-366; MORI S, 1993, EMBO J, V12, P2257, DOI 10.1002/j.1460-2075.1993.tb05879.x; Paukku K, 2000, BIOCHEM J, V345, P759, DOI 10.1042/0264-6021:3450759; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Priel-Halachmi S, 2000, J BIOL CHEM, V275, P28902, DOI 10.1074/jbc.M003402200; Putzke AP, 2005, DEVELOPMENT, V132, P3185, DOI 10.1242/dev.01900; RONNSTRAND L, 1992, EMBO J, V11, P3911, DOI 10.1002/j.1460-2075.1992.tb05484.x; Rosato R, 1998, MOL CELL BIOL, V18, P5762, DOI 10.1128/MCB.18.10.5762; Salem Y, 2005, CELL SIGNAL, V17, P341, DOI 10.1016/j.cellsig.2004.08.001; Sangrar W, 2004, EXP HEMATOL, V32, P935, DOI 10.1016/j.exphem.2004.07.004; Sangrar W, 2003, EXP HEMATOL, V31, P1259, DOI 10.1016/j.exphem.2003.09.013; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; SNYDER SP, 1969, NATURE, V221, P1074, DOI 10.1038/2211074a0; Taler M, 2003, MOL ENDOCRINOL, V17, P1580, DOI 10.1210/me.2002-0328; Voisset E, 2007, BLOOD, V110, P2593, DOI 10.1182/blood-2007-02-076471; Zoubeidi A, 2009, MOL CANCER RES, V7, P142, DOI 10.1158/1541-7786.MCR-08-0117	33	25	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15736	15744		10.1074/jbc.M113.476424	http://dx.doi.org/10.1074/jbc.M113.476424			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23589302	Green Published, hybrid			2022-12-28	WOS:000319822300029
J	Li, YY; Tsun, A; Gao, ZM; Han, ZJ; Gao, YY; Li, ZY; Lin, F; Wang, Y; Wei, G; Yao, ZJ; Li, B				Li, Yangyang; Tsun, Andy; Gao, Zhimei; Han, Zhijun; Gao, Yayi; Li, Zhiyuan; Lin, Fang; Wang, Yan; Wei, Gang; Yao, Zhengju; Li, Bin			60-kDa Tat-interactive Protein (TIP60) Positively Regulates Th-inducing POK (ThPOK)-mediated Repression of Eomesodermin in Human CD4(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE; GENE-EXPRESSION; C-KROX; THPOK; LINEAGE; BET; ACETYLATION; DIFFERENTIATION; SUPPRESSION; COMMITMENT	The abundant expression of IFN gamma in Th-inducing POK (ThPOK)-deficient CD4(+) T cells requires the activation of Eomesodermin (Eomes); however, the underlying mechanism of this phenomenon remains unclear. Here we report that ThPOK binds directly to the promoter region of the Eomes gene to repress its expression in CD4(+) T cells. We identified the histone acetyltransferase TIP60 as a co-repressor of ThPOK-target genes, where ectopically expressed TIP60 increased ThPOK protein stability by promoting its acetylation at its Lys(360) residue to then augment the transcriptional repression of Eomes. Moreover, knockdown of endogenous TIP60 abolished the stabilization of ThPOK in CD4(+) T cells, which led to the transcriptional activation of Eomes and increased production of IFN gamma. Our results reveal a novel pathway by which TIP60 and ThPOK synergistically suppresses Eomes function and IFN gamma production, which could contribute to the regulation of inflammation.	[Li, Yangyang; Tsun, Andy; Gao, Zhimei; Gao, Yayi; Li, Zhiyuan; Lin, Fang; Yao, Zhengju; Li, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol,Unit Mol Immunol, Shanghai 200025, Peoples R China; [Han, Zhijun; Wang, Yan] Chinese Acad Sci, Shanghai Inst Biol Sci, Chinese Acad Sci Max Planck Soc MPG Partner Inst, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, B (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol,Unit Mol Immunol, 411 Hefei Rd, Shanghai 200025, Peoples R China.	binli@sibs.ac.cn	li, zhiyuan/HGD-9581-2022; lI, Bin/AAR-4966-2021	lI, Bin/0000-0002-7640-8884	National Institutes of Health-National Science Foundation of China [81161120417]; National Science Foundation of China [30972702, 31170825, 81270083, 31150110337, 31200646, 31200647, 81271835]; Shanghai Rising Star Program [10QA1407900]; Novo Nordisk-Chinese Academy of Sciences Foundation; Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2010KIP205, 2012KIP204]	National Institutes of Health-National Science Foundation of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising Star Program; Novo Nordisk-Chinese Academy of Sciences Foundation; Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences)	This work was supported, in whole or in part, by National Institutes of Health-National Science Foundation of China Collaborative Grant 81161120417. This work was also supported by National Science Foundation of China Grants 30972702, 31170825, 81270083, 31150110337, 31200646, 31200647, and 81271835; Shanghai Rising Star Program 10QA1407900; the Novo Nordisk-Chinese Academy of Sciences Foundation; the Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program, and the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Grants 2010KIP205 and 2012KIP204.	Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Carpenter AC, 2012, IMMUNITY, V37, P622, DOI 10.1016/j.immuni.2012.06.019; Chen JZ, 2009, CELL IMMUNOL, V254, P85, DOI 10.1016/j.cellimm.2008.09.001; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Endo Y, 2011, IMMUNITY, V35, P733, DOI 10.1016/j.immuni.2011.08.017; GALERA P, 1994, P NATL ACAD SCI USA, V91, P9372, DOI 10.1073/pnas.91.20.9372; Galera P, 1996, J BIOL CHEM, V271, P21331, DOI 10.1074/jbc.271.35.21331; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; Ichiyama K, 2011, IMMUNITY, V34, P741, DOI 10.1016/j.immuni.2011.02.021; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jenkinson SR, 2007, J EXP MED, V204, P267, DOI 10.1084/jem.20061982; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Lin SY, 2012, SCIENCE, V336, P477, DOI 10.1126/science.1217032; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; Narayanan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010636; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Rui JX, 2012, J IMMUNOL, V189, P1380, DOI 10.4049/jimmunol.1201077; Sliva D, 1999, BIOCHEM BIOPH RES CO, V263, P149, DOI 10.1006/bbrc.1999.1083; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; von Herrath MG, 2003, NAT REV IMMUNOL, V3, P223, DOI 10.1038/nri1029; Wang L, 2010, EUR J IMMUNOL, V40, P2385, DOI 10.1002/eji.201040534; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004; Yamagata K, 2009, BIOCHEM BIOPH RES CO, V390, P1355, DOI 10.1016/j.bbrc.2009.10.156; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; Yang Y, 2008, J IMMUNOL, V181, P8700, DOI 10.4049/jimmunol.181.12.8700; Zhang JW, 2007, J CLIN INVEST, V117, P871, DOI 10.1172/JCI31860; Zhang M, 2010, J IMMUNOL, V185, P3960, DOI 10.4049/jimmunol.1001462	40	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15537	15546		10.1074/jbc.M112.430207	http://dx.doi.org/10.1074/jbc.M112.430207			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23609452	hybrid, Green Published			2022-12-28	WOS:000319822300012
J	Lu, CX; Kumar, PA; Sun, JH; Aggarwal, A; Fan, Y; Sperling, MA; Lumeng, CN; Menon, RK				Lu, Chunxia; Kumar, P. Anil; Sun, Jinhong; Aggarwal, Anjali; Fan, Yong; Sperling, Mark A.; Lumeng, Carey N.; Menon, Ram K.			Targeted Deletion of Growth Hormone (GH) Receptor in Macrophage Reveals Novel Osteopontin-mediated Effects of GH on Glucose Homeostasis and Insulin Sensitivity in Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; BINDING-PROTEINS; INFLAMMATION; LIPOPOLYSACCHARIDE; INFILTRATION; STIMULATION; DEFICIENCY; METABOLISM; RESISTANCE; SECRETION	We investigated GH action on macrophage (M Phi) by creating a M Phi-specific GH receptor-null mouse model (MacGHR KO). On a normal diet (10% fat), MacGHR KO and littermate controls exhibited similar growth profiles and glucose excursions on intraperitoneal glucose (ipGTT) and insulin tolerance (ITT) tests. However, when challenged with high fat diet (HFD, 45% fat) for 18 weeks, MacGHR KO mice exhibited impaired ipGTT and ITT compared with controls. In MacGHR KO, adipose-tissue (AT) M Phi abundance was increased with skewing toward M1 polarization. Expression of pro-inflammatory cytokines (IL1 beta, TNF-alpha, IL6, and osteopontin (OPN)) were increased in MacGHR KO AT stromal vascular fraction (SVF). In MacGHR KO AT, crown-like-structures were increased with decreased insulin-dependent Akt phosphorylation. The abundance of phosphorylated NF-kappa B and of OPN was increased in SVF and bone-marrow-derived M Phi in MacGHR KO. GH, acting via an NF-kappa B site in the distal OPN promoter, inhibited the OPN promoter. Thus in diet-induced obesity (DIO), lack of GH action on the M Phi exerts an unexpected deleterious effect on glucose homeostasis by accentuating AT inflammation and NF-kappa B-dependent activation of OPN expression. These novel results in mice support the possibility that administration of GH could have salutary effects on DIO-associated chronic inflammation and insulin resistance in humans.	[Lu, Chunxia; Kumar, P. Anil; Sun, Jinhong; Aggarwal, Anjali; Lumeng, Carey N.; Menon, Ram K.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Lumeng, Carey N.; Menon, Ram K.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Fan, Yong; Sperling, Mark A.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15224 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lu, CX (corresponding author), Univ Michigan, Sch Med, D1205 MPB-SPC 5718,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	rammenon@umich.edu	Aggarwal, Anjali/AAD-2800-2020	Pasupulati, Anil Kumar/0000-0001-9467-7650; Lumeng, Carey/0000-0003-0303-6204	National Institutes of Health [DK49845, P60DK-20572 Center]; D.R.E.A.M. Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, P30DK020572, R29DK049845, R56DK049845, R01DK049845, R01DK090262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); D.R.E.A.M. Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by grants from the National Institutes of Health (DK49845 (to R. K. M.) and P60DK-20572 Center) and the D.R.E.A.M. Foundation.	BLOCH CA, 1987, J PEDIATR-US, V110, P481, DOI 10.1016/S0022-3476(87)80522-X; Chapman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013959; Clayton PE, 2000, GROWTH HORM IGF RES, V10, P306, DOI 10.1054/ghir.2000.0175; Clemmons DR, 2010, CURR OPIN ENDOCRINOL, V17, P377, DOI 10.1097/MED.0b013e32833b6bc7; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; DiPietro LA, 1998, J CLIN INVEST, V101, P1693, DOI 10.1172/JCI1020; Fan Y, 2009, J BIOL CHEM, V284, P19937, DOI 10.1074/jbc.M109.014308; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Haeffner A, 1997, J IMMUNOL, V158, P1310; HOCHBERG Z, 1992, ENDOCRINOLOGY, V131, P430, DOI 10.1210/en.131.1.430; Hull KL, 1996, CELL TISSUE RES, V286, P69, DOI 10.1007/s004410050676; Johansen T, 2005, GROWTH HORM IGF RES, V15, P55, DOI 10.1016/j.ghir.2004.11.006; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kaplan SA, 2007, J CLIN ENDOCR METAB, V92, P4529, DOI 10.1210/jc.2007-0526; Kiefer FW, 2010, DIABETES, V59, P935, DOI 10.2337/db09-0404; List EO, 2013, MOL ENDOCRINOL, V27, P524, DOI 10.1210/me.2012-1330; Liu ZH, 2002, ANN CLIN LAB SCI, V32, P164; Lu CX, 2010, ENDOCRINOLOGY, V151, P2189, DOI 10.1210/en.2009-1194; Makimura H, 2008, J CLIN ENDOCR METAB, V93, P4254, DOI 10.1210/jc.2008-1333; Mantovani A, 2006, BLOOD, V108, P408, DOI 10.1182/blood-2006-05-019430; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; Mavalli MD, 2010, J CLIN INVEST, V120, P4007, DOI 10.1172/JCI42447; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Newbern D, 2011, CURR OPIN ENDOCRINOL, V18, P409, DOI 10.1097/MED.0b013e32834c800d; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; RASMUSSEN MH, 1995, J CLIN ENDOCR METAB, V80, P796, DOI 10.1210/jc.80.3.796; RASMUSSEN MH, 1995, J CLIN ENDOCR METAB, V80, P1407, DOI 10.1210/jc.80.4.1407; Rasmussen MH, 2008, OBESITY, V16, P1516, DOI 10.1038/oby.2008.249; Rasmussen MH, 2006, EUR J ENDOCRINOL, V155, P575, DOI 10.1530/eje.1.02246; Rittling SR, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001839; SCHULTZ RM, 1976, CANCER RES, V36, P1641; Smith JR, 2000, BIOMED SCI INSTRUM, V395, P111; Standal T, 2004, EXP ONCOL, V26, P179; TATRO JB, 1987, ENDOCRINOLOGY, V120, P373, DOI 10.1210/endo-120-1-373; Thirone ACP, 1999, ENDOCRINOLOGY, V140, P55, DOI 10.1210/en.140.1.55; Tripathi A, 2007, MOL IMMUNOL, V44, P3185, DOI 10.1016/j.molimm.2007.01.024; VELDHUIS JD, 1991, J CLIN ENDOCR METAB, V72, P51, DOI 10.1210/jcem-72-1-51; Vijayakumar A, 2012, DIABETES, V61, P94, DOI 10.2337/db11-0814; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wilson E., 2012, OXIDATIVE M IN PRESS; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yakar Shoshana, 2005, Pediatr Endocrinol Rev, V3, P11; Zeyda M, 2007, IMMUNOL LETT, V112, P61, DOI 10.1016/j.imlet.2007.07.003; Zeyda M, 2011, ENDOCRINOLOGY, V152, P2219, DOI 10.1210/en.2010-1328; Zhao W, 2011, J IMMUNOL, V186, P3173, DOI 10.4049/jimmunol.1003626	48	45	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15725	15735		10.1074/jbc.M113.460212	http://dx.doi.org/10.1074/jbc.M113.460212			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23595986	hybrid, Green Published			2022-12-28	WOS:000319822300028
J	Sandbo, N; Ngam, C; Torr, E; Kregel, S; Kach, J; Dulin, N				Sandbo, Nathan; Ngam, Caitlyn; Torr, Elizabeth; Kregel, Steve; Kach, Jacob; Dulin, Nickolai			Control of Myofibroblast Differentiation by Microtubule Dynamics through a Regulated Localization of mDia2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS FIBER FORMATION; EXTRACELLULAR-MATRIX; ACTIN CYTOSKELETON; GENE-EXPRESSION; CELL STRUCTURE; GROWTH-FACTOR; RHO; MODEL; PHOSPHORYLATION; INHIBITION	Myofibroblast differentiation plays a critical role in wound healing and in the pathogenesis of fibrosis. We have previously shown that myofibroblast differentiation is mediated by the activity of serum response factor (SRF), which is tightly controlled by the actin polymerization state. In this study, we investigated the role of the microtubule cytoskeleton in modulating myofibroblast phenotype. Treatment of human lung fibroblasts with the microtubule-destabilizing agent, colchicine, resulted in a formation of numerous stress fibers and expression of myofibroblast differentiation marker proteins. These effects of colchicine were independent of Smad signaling but were mediated by Rho signaling and SRF, as they were attenuated by the Rho kinase inhibitor, Y27632, or by the SRF inhibitor, CCG-1423. TGF-beta-induced myofibroblast differentiation was not accompanied by gross changes in the microtubule polymerization state. However, microtubule stabilization by paclitaxel attenuated TGF-beta-induced myofibroblast differentiation. Paclitaxel had no effect on TGF-beta-induced Smad activation and Smad-dependent gene transcription but inhibited actin polymerization, nuclear accumulation of megakaryoblastic leukemia-1 protein, and SRF activation. The microtubule-associated formin, mDIA2, localized to actin stress fibers upon treatment with TGF-beta, and paclitaxel prevented this localization. Treatment with the formin inhibitor, SMI formin homology 2 domain, inhibited stress fiber formation and myofibroblast differentiation induced by TGF-beta, without affecting Smad-phosphorylation or microtubule polymerization. Together, these data suggest that (a) TGF-beta promotes association of mDia2 with actin stress fibers, which further drives stress fiber formation and myofibroblast differentiation, and (b) microtubule polymerization state controls myofibroblast differentiation through the regulation of mDia2 localization.	[Sandbo, Nathan; Ngam, Caitlyn; Torr, Elizabeth] Univ Wisconsin, Div Allergy Pulm & Crit Care Med, Madison, WI 53792 USA; [Kregel, Steve; Kach, Jacob; Dulin, Nickolai] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA	University of Wisconsin System; University of Wisconsin Madison; University of Chicago	Sandbo, N (corresponding author), Univ Wisconsin, Dept Med, Div Allergy Pulm & Crit Care Med, MFCB 5229,1685 Highland Ave, Madison, WI 53792 USA.	nsandbo@medicine.wisc.edu; ndulin@medicine.bsd.uchicago.edu			National Institutes of Health [K08 HL093367, R01 GM85058, T32HL007237]; American Lung Association Dalsemer Award [DA-161895-N]; American Heart Association Fellowship [10PRE4190120]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007237, K08HL093367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association Dalsemer Award; American Heart Association Fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants K08 HL093367 (to N. S.), R01 GM85058 (to N. O. D), and T32HL007237 (to J. K.). This work was also supported by American Lung Association Dalsemer Award DA-161895-N (to N. S.) and American Heart Association Fellowship 10PRE4190120 (to J. K.).	Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; BRAHN E, 1994, ARTHRITIS RHEUM, V37, P839, DOI 10.1002/art.1780370611; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Dai P, 2007, MOL BIOL CELL, V18, P2264, DOI 10.1091/mbc.E06-12-1064; DANOWSKI BA, 1989, J CELL SCI, V93, P255; Davis A, 2003, CELL SIGNAL, V15, P597, DOI 10.1016/S0898-6568(02)00148-1; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Gaillard J, 2011, MOL BIOL CELL, V22, P4575, DOI 10.1091/mbc.E11-07-0616; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Heck JN, 2012, MOL BIOL CELL, V23, P2583, DOI 10.1091/mbc.E11-10-0876; Hogarth DK, 2004, AM J PHYSIOL-CELL PH, V287, pC449, DOI 10.1152/ajpcell.00547.2003; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Katoh K, 2000, METHOD ENZYMOL, V325, P369; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Liu XL, 2005, PLOS MED, V2, P1334, DOI 10.1371/journal.pmed.0020354; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; MOONEY DJ, 1994, MOL BIOL CELL, V5, P1281, DOI 10.1091/mbc.5.12.1281; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Ott C, 2003, J BIOL CHEM, V278, P44305, DOI 10.1074/jbc.M309140200; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Platts SH, 1999, AM J PHYSIOL-HEART C, V277, pH100, DOI 10.1152/ajpheart.1999.277.1.H100; Putnam AJ, 2001, AM J PHYSIOL-CELL PH, V280, pC556, DOI 10.1152/ajpcell.2001.280.3.C556; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Samarakoon R, 2002, J CELL SCI, V115, P3093; Samarakoon R, 2010, CELL SIGNAL, V22, P1413, DOI 10.1016/j.cellsig.2010.03.020; Samarakoon R, 2009, CELL SIGNAL, V21, P986, DOI 10.1016/j.cellsig.2009.02.007; Sandbo N, 2011, AM J PHYSIOL-LUNG C, V301, pL656, DOI 10.1152/ajplung.00166.2011; Sandbo N, 2011, TRANSL RES, V158, P181, DOI 10.1016/j.trsl.2011.05.004; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; Staus DP, 2011, BIOCHEM J, V439, P57, DOI 10.1042/BJ20101700; Sun L, 2011, J PATHOL, V225, P364, DOI 10.1002/path.2961; Taurin S, 2009, J BIOL CHEM, V284, P33789, DOI 10.1074/jbc.M109.048983; Wen YD, 2004, KENYON REV, V26, P1; Yu JZ, 2009, J BIOL CHEM, V284, P10462, DOI 10.1074/jbc.M809166200; Zhang DS, 2010, LAB INVEST, V90, P436, DOI 10.1038/labinvest.2009.149; Zhang QH, 1997, MOL BIOL CELL, V8, P1415, DOI 10.1091/mbc.8.8.1415; Zhu SK, 2004, CIRC RES, V94, P617, DOI 10.1161/01.RES.0000118599.25944.D5	38	45	47	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15466	15473		10.1074/jbc.M113.464461	http://dx.doi.org/10.1074/jbc.M113.464461			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23580645	Green Published, hybrid			2022-12-28	WOS:000319822300005
J	Tang, Z; Bereczki, E; Zhang, HY; Wang, S; Li, CX; Ji, XY; Branca, RM; Lehtio, J; Guan, ZZ; Filipcik, P; Xu, SH; Winblad, B; Pei, JJ				Tang, Zhi; Bereczki, Erika; Zhang, Haiyan; Wang, Shan; Li, Chunxia; Ji, Xinying; Branca, Rui M.; Lehtio, Janne; Guan, Zhizhong; Filipcik, Peter; Xu, Shaohua; Winblad, Bengt; Pei, Jin-Jing			Mammalian Target of Rapamycin (mTor) Mediates Tau Protein Dyshomeostasis IMPLICATION FOR ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P70 S6 KINASE; ABNORMALLY PHOSPHORYLATED-TAU; GLYCOGEN-SYNTHASE KINASE-3-BETA; NEUROFIBRILLARY DEGENERATION; HYPERPHOSPHORYLATED-TAU; AMYLOID-BETA; MICROTUBULE-BINDING; TEMPORAL CORTEX; UP-REGULATION; NEUROBLASTOMA	Previous evidence from post-mortem Alzheimer disease (AD) brains and drug (especially rapamycin)-oriented in vitro and in vivo models implicated an aberrant accumulation of the mammalian target of rapamycin (mTor) in tangle-bearing neurons in AD brains and its role in the formation of abnormally hyperphosphorylated tau. Compelling evidence indicated that the sequential molecular events such as the synthesis and phosphorylation of tau can be regulated through p70 S6 kinase, the well characterized immediate downstream target of mTor. In the present study, we further identified that the active form of mTor per se accumulates in tangle-bearing neurons, particularly those at early stages in AD brains. By using mass spectrometry and Western blotting, we identified three phosphoepitopes of tau directly phosphorylated by mTor. We have developed a variety of stable cell lines with genetic modification of mTor activity using SH-SY5Y neuroblastoma cells as background. In these cellular systems, we not only confirmed the tau phosphorylation sites found in vitro but also found that mTor mediates the synthesis and aggregation of tau, resulting in compromised microtubule stability. Changes of mTor activity cause fluctuation of the level of a battery of tau kinases such as protein kinase A, v-Akt murine thymoma viral oncogene homolog-1, glycogen synthase kinase 3 beta, cyclin-dependent kinase 5, and tau protein phosphatase 2A. These results implicate mTor in promoting an imbalance of tau homeostasis, a condition required for neurons to maintain physiological function.	[Tang, Zhi; Bereczki, Erika; Zhang, Haiyan; Wang, Shan; Li, Chunxia; Guan, Zhizhong; Xu, Shaohua; Winblad, Bengt; Pei, Jin-Jing] Karolinska Inst, Kl Alzheimers Dis Res Ctr, SE-14186 Stockholm, Sweden; [Ji, Xinying] Henan Univ, Sch Med, Inst Immunol, Henan Prov Key Med Lab Cellular & Mol Immunol, Kaifeng 475004, Henan, Peoples R China; [Branca, Rui M.; Lehtio, Janne] Karolinska Univ Sjukhuset Solna, Karolinska Inst, Dept Oncol Pathol, S-17176 Stockholm, Sweden; [Guan, Zhizhong] Guiyang Med Coll, Dept Pathol, Guiyang 550004, Guizhou, Peoples R China; [Guan, Zhizhong] Guiyang Med Coll, Dept Mol Biol, Guiyang 550004, Guizhou, Peoples R China; [Filipcik, Peter] Slovak Acad Sci, Inst Neuroimmunol, Bratislava 84510, Slovakia	Karolinska Institutet; Henan University; Karolinska Institutet; Guizhou Medical University; Guizhou Medical University; Slovak Academy of Sciences	Pei, JJ (corresponding author), Karolinska Inst, Kl Alzheimers Dis Res Ctr, Floor 5, SE-14186 Stockholm, Sweden.	Jin-Jing.Pei@ki.se	Filipcik, Peter/AGE-9297-2022; Bereczki, Erika/GSD-4808-2022	Filipcik, Peter/0000-0001-8919-5964; Bereczki, Erika/0000-0002-0373-7417; Branca, Rui/0000-0003-3890-6476; Lehtio, Janne/0000-0002-8100-9562	Karolinska Institutet research funds; Dementia Foundation; Alzheimerfonden; Wallenberg Foundation; Gun and Bertil Stohne Foundation; Gamla Tjanarinnor Foundation	Karolinska Institutet research funds; Dementia Foundation; Alzheimerfonden; Wallenberg Foundation(European Commission); Gun and Bertil Stohne Foundation; Gamla Tjanarinnor Foundation	This work was supported by Karolinska Institutet research funds and the Dementia Foundation, Alzheimerfonden, Wallenberg Foundation, Gun and Bertil Stohne Foundation, and Gamla Tjanarinnor Foundation.	Allen B, 2002, J NEUROSCI, V22, P9340; Alonso AD, 1997, P NATL ACAD SCI USA, V94, P298, DOI 10.1073/pnas.94.1.298; Alonso AD, 2010, J BIOL CHEM, V285, P30851, DOI 10.1074/jbc.M110.110957; An WL, 2005, MOL BRAIN RES, V135, P40, DOI 10.1016/j.molbrainres.2004.11.010; An WL, 2005, J NEUROCHEM, V92, P1104, DOI 10.1111/j.1471-4159.2004.02948.x; An WL, 2003, AM J PATHOL, V163, P591, DOI 10.1016/S0002-9440(10)63687-5; Bereczki E, 2011, NANOMED-NANOTECHNOL, V7, P560, DOI 10.1016/j.nano.2011.05.009; Bjorkdahl C, 2005, NEUROREPORT, V16, P591; Bjorkdahl C, 2008, J NEUROSCI RES, V86, P1343, DOI 10.1002/jnr.21589; Boutajangout A, 2004, FEBS LETT, V576, P183, DOI 10.1016/j.febslet.2004.09.011; Bove J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068; BRAAK H, 1986, NEUROSCI LETT, V65, P351, DOI 10.1016/0304-3940(86)90288-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brandt R, 2005, BBA-MOL BASIS DIS, V1739, P331, DOI 10.1016/j.bbadis.2004.06.018; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; Ding HP, 2006, J BIOL CHEM, V281, P19107, DOI 10.1074/jbc.M511697200; Garelick MG, 2011, EXP GERONTOL, V46, P155, DOI 10.1016/j.exger.2010.08.030; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; GUSTKE N, 1992, FEBS LETT, V307, P199, DOI 10.1016/0014-5793(92)80767-B; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Iqbal K, 2010, ALZHEIMERS DEMENT, V6, P420, DOI 10.1016/j.jalz.2010.04.006; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Jicha GA, 1999, J NEUROSCI, V19, P7486, DOI 10.1523/JNEUROSCI.19-17-07486.1999; KHATOON S, 1992, J NEUROCHEM, V59, P750, DOI 10.1111/j.1471-4159.1992.tb09432.x; KHATOON S, 1994, FEBS LETT, V351, P80, DOI 10.1016/0014-5793(94)00829-9; Kickstein E, 2010, P NATL ACAD SCI USA, V107, P21830, DOI 10.1073/pnas.0912793107; Kimura T, 2007, EMBO J, V26, P5143, DOI 10.1038/sj.emboj.7601917; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Ksiezak-Reding H, 2003, BBA-MOL BASIS DIS, V1639, P159, DOI 10.1016/j.bbadis.2003.09.001; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laplante M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011593; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li X, 2005, FEBS J, V272, P4211, DOI 10.1111/j.1742-4658.2005.04833.x; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu R, 2008, J CELL MOL MED, V12, P241, DOI 10.1111/j.1582-4934.2008.00249.x; MAH VH, 1992, MOL BRAIN RES, V12, P85, DOI 10.1016/0169-328X(92)90071-I; Meske V, 2008, J BIOL CHEM, V283, P100, DOI 10.1074/jbc.M704292200; Morita T, 2009, J BIOL CHEM, V284, P27734, DOI 10.1074/jbc.M109.008177; Oddo Salvatore, 2012, Front Biosci (Schol Ed), V4, P941; Pei JJ, 2008, J ALZHEIMERS DIS, V14, P385; Pei JJ, 2008, J CELL MOL MED, V12, P2525, DOI 10.1111/j.1582-4934.2008.00509.x; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Pei JJ, 2006, FEBS LETT, V580, P107, DOI 10.1016/j.febslet.2005.11.059; Pei JJ, 1997, J NEUROPATH EXP NEUR, V56, P70, DOI 10.1097/00005072-199701000-00007; Pei JJ, 2003, AM J PATHOL, V163, P845, DOI 10.1016/S0002-9440(10)63445-1; Pei JJ, 2003, ACTA NEUROPATHOL, V105, P381, DOI 10.1007/s00401-002-0657-y; Pei JJ, 2002, MOL BRAIN RES, V109, P45, DOI 10.1016/S0169-328X(02)00488-6; Pei JJ, 1998, J NEURAL TRANSM, V105, P69, DOI 10.1007/s007020050039; Pei JJ, 1998, BRAIN RES, V797, P267, DOI 10.1016/S0006-8993(98)00296-0; PEI JJ, 1994, BRAIN RES, V655, P70, DOI 10.1016/0006-8993(94)91598-9; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarker KP, 2004, ONCOGENE, V23, P6064, DOI 10.1038/sj.onc.1207819; Shea TB, 1997, NEUROSCI RES COMMUN, V21, P195, DOI 10.1002/(SICI)1520-6769(199711/12)21:3<195::AID-NRC224>3.0.CO;2-8; Stahl S, 2011, J PROTEOME RES, V10, P2566, DOI 10.1021/pr200037u; TANAKA T, 1995, FEBS LETT, V360, P5, DOI 10.1016/0014-5793(95)00061-D; Uberti D, 1997, NEUROSCI LETT, V235, P149, DOI 10.1016/S0304-3940(97)00715-5; Vingtdeux V, 2011, ACTA NEUROPATHOL, V121, P337, DOI 10.1007/s00401-010-0759-x; Virdee K, 2007, FEBS LETT, V581, P2657, DOI 10.1016/j.febslet.2007.05.009; Wang S, 2011, J NEUROSCI RES, V89, P1267, DOI 10.1002/jnr.22660; Yoshida H, 2012, J NEUROCHEM, V120, P165, DOI 10.1111/j.1471-4159.2011.07523.x; Zhong J, 1999, FEBS LETT, V453, P224, DOI 10.1016/S0014-5793(99)00715-2; Zhou XW, 2006, NEUROBIOL DIS, V22, P657, DOI 10.1016/j.nbd.2006.01.006; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	70	89	94	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15556	15570		10.1074/jbc.M112.435123	http://dx.doi.org/10.1074/jbc.M112.435123			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23585566	Green Published, hybrid			2022-12-28	WOS:000319822300014
J	Hart, R; Stanley, P; Chakravarty, P; Hogg, N				Hart, Rosie; Stanley, Paula; Chakravarty, Probir; Hogg, Nancy			The Kindlin 3 Pleckstrin Homology Domain Has an Essential Role in Lymphocyte Function-associated Antigen 1 (LFA-1) Integrin-mediated B Cell Adhesion and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE DOMAIN; TALIN HEAD; LEUKOCYTE ADHESION; DEFICIENCY-III; IN-VIVO; ACTIVATION; BINDING; RECEPTOR; STABILIZATION; MUTATIONS	The protein kindlin 3 is mutated in the leukocyte adhesion deficiency III (LAD-III) disorder, leading to widespread infection due to the failure of leukocytes to migrate into infected tissue sites. To gain understanding of how kindlin 3 controls leukocyte function, we have focused on its pleckstrin homology (PH) domain and find that deletion of this domain eliminates the ability of kindlin 3 to participate in adhesion and migration of B cells mediated by the leukocyte integrin lymphocyte function-associated antigen 1 (LFA-1). PH domains are often involved in membrane localization of proteins through binding to phosphoinositides. We show that the kindlin 3 PH domain has binding affinity for phosphoinositide PI(3,4,5)P-3 over PI(4,5)P-2. It has a major role in membrane association of kindlin 3 that is enhanced by the binding of LFA-1 to intercellular adhesion molecule 1 (ICAM-1). A splice variant, kindlin 3-IPRR, has a four-residue insert in the PH domain at a critical site that influences phosphoinositide binding by enhancing binding to PI(4,5)P-2 as well as by binding to PI(3,4,5)P-3. However kindlin 3-IPRR is unable to restore the ability of LAD-III B cells to adhere to and migrate on LFA-1 ligand ICAM-1, potentially by altering the dynamics or PI specificity of binding to the membrane. Thus, the correct functioning of the kindlin 3 PH domain is central to the role that kindlin 3 performs in guiding lymphocyte adhesion and motility behavior, which in turn is required for a successful immune response.	[Hart, Rosie; Stanley, Paula; Hogg, Nancy] Canc Res United Kingdom London Res Inst, Leukocyte Adhes Lab, London WC2A 3LY, England; [Chakravarty, Probir] Canc Res United Kingdom London Res Inst, Bioinformat & Biostat Unit, London WC2A 3LY, England	Cancer Research UK; Cancer Research UK	Hogg, N (corresponding author), Canc Res United Kingdom London Res Inst, Leukocyte Adhes Lab, London WC2A 3LY, England.	nancy.hogg@cancer.org.uk		chakravarty, probir/0000-0003-1146-8824				Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Bledzka K, 2012, J BIOL CHEM, V287, P24585, DOI 10.1074/jbc.M111.336743; Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Bouaouina M, 2012, J BIOL CHEM, V287, P6979, DOI 10.1074/jbc.M111.330845; Cronin TC, 2004, EMBO J, V23, P3711, DOI 10.1038/sj.emboj.7600388; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; DRANSFIELD I, 1989, EMBO J, V8, P3759, DOI 10.1002/j.1460-2075.1989.tb08552.x; Elliott PR, 2010, STRUCTURE, V18, P1289, DOI 10.1016/j.str.2010.07.011; Etzioni A, 2004, CURR OPIN ALLERGY CL, V4, P485, DOI 10.1097/00130832-200412000-00003; Evans R, 2009, J CELL SCI, V122, P215, DOI 10.1242/jcs.019117; Feigelson SW, 2011, BLOOD, V117, P7042, DOI 10.1182/blood-2010-12-322859; Feng C, 2012, J BIOL CHEM, V287, P10714, DOI 10.1074/jbc.M111.299594; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Goult BT, 2009, J MOL BIOL, V394, P944, DOI 10.1016/j.jmb.2009.09.061; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Hyduk SJ, 2011, J IMMUNOL, V187, P4360, DOI 10.4049/jimmunol.1003725; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Kahner BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034056; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kinashi T, 2007, ADV IMMUNOL, V93, P185, DOI 10.1016/S0065-2776(06)93005-3; Klarlund JK, 2000, J BIOL CHEM, V275, P32816, DOI 10.1074/jbc.M002435200; Kuijpers TW, 2009, BLOOD, V113, P4740, DOI 10.1182/blood-2008-10-182154; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Lefort CT, 2012, BLOOD, V119, P4275, DOI 10.1182/blood-2011-08-373118; Legate KR, 2011, EMBO J, V30, P4539, DOI 10.1038/emboj.2011.332; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Liu JM, 2011, J BIOL CHEM, V286, P43334, DOI 10.1074/jbc.M111.295352; Liu Y, 2012, PROTEIN CELL, V3, P434, DOI 10.1007/s13238-012-2046-1; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; McDowall A, 2010, BLOOD, V115, P4834, DOI 10.1182/blood-2009-08-238709; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mory A, 2008, BLOOD, V112, P2591, DOI 10.1182/blood-2008-06-163162; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Mueller KL, 2004, J IMMUNOL, V173, P2222, DOI 10.4049/jimmunol.173.4.2222; Perera HD, 2011, STRUCTURE, V19, P1664, DOI 10.1016/j.str.2011.08.012; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; Raab M, 2011, J BIOL CHEM, V286, P29663, DOI 10.1074/jbc.M111.222661; Saltel F, 2009, J CELL BIOL, V187, P715, DOI 10.1083/jcb.200908134; Sanchez-Martin L, 2004, J BIOL CHEM, V279, P16194, DOI 10.1074/jbc.M400905200; Smith DF, 2006, J LEUKOCYTE BIOL, V80, P1491, DOI 10.1189/jlb.0306227; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; van de Vijver E., 2012, BLOOD CELL MOL DIS, V48, P53; Ward SG, 2009, BIOCHEM J, V418, P13, DOI 10.1042/BJ20081969; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zhang TT, 2009, IMMUNOL REV, V232, P255, DOI 10.1111/j.1600-065X.2009.00838.x	53	29	30	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14852	14862		10.1074/jbc.M112.434621	http://dx.doi.org/10.1074/jbc.M112.434621			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23595985	hybrid, Green Published			2022-12-28	WOS:000319452100017
J	Jeon, AHW; Boehm, C; Chen, FS; Huo, HR; Ruan, XY; Ren, CH; Ho, K; Qamar, S; Mathews, PM; Fraser, PE; Mount, HTJ; St George-Hyslop, P; Schmitt-Ulms, G				Jeon, Amy Hye Won; Boehm, Christopher; Chen, Fusheng; Huo, Hairu; Ruan, Xueying; Ren, Carl He; Ho, Keith; Qamar, Seema; Mathews, Paul M.; Fraser, Paul E.; Mount, Howard T. J.; St George-Hyslop, Peter; Schmitt-Ulms, Gerold			Interactome Analyses of Mature gamma-Secretase Complexes Reveal Distinct Molecular Environments of Presenilin (PS) Paralogs and Preferential Binding of Signal Peptide Peptidase to PS2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; CELL-CELL ADHESION; PRECURSOR PROTEIN; GLYCOSYLATED NICASTRIN; MISSENSE MUTATIONS; BETA; ASSOCIATION; CHROMOSOME-1; DEGRADATION; PROTEASOME	gamma-Secretase plays a pivotal role in the production of neurotoxic amyloid beta-peptides (A beta) in Alzheimer disease (AD) and consists of a heterotetrameric core complex that includes the aspartyl intramembrane protease presenilin (PS). The human genome codes for two presenilin paralogs. To understand the causes for distinct phenotypes of PS paralog-deficient mice and elucidate whether PS mutations associated with early-onset AD affect the molecular environment of mature gamma-secretase complexes, quantitative interactome comparisons were undertaken. Brains of mice engineered to express wild-type or mutant PS1, or HEK293 cells stably expressing PS paralogs with N-terminal tandem-affinity purification tags served as biological source materials. The analyses revealed novel interactions of the gamma-secretase core complex with a molecular machinery that targets and fuses synaptic vesicles to cellular membranes and with the H+-transporting lysosomal ATPase macrocomplex but uncovered no differences in the interactomes of wild-type and mutant PS1. The catenin/cadherin network was almost exclusively found associated with PS1. Another intramembrane protease, signal peptide peptidase, predominantly co-purified with PS2-containing gamma-secretase complexes and was observed to influence A beta production.	[Jeon, Amy Hye Won; Boehm, Christopher; Chen, Fusheng; Huo, Hairu; Ruan, Xueying; Ren, Carl He; Ho, Keith; Fraser, Paul E.; Mount, Howard T. J.; St George-Hyslop, Peter; Schmitt-Ulms, Gerold] Univ Toronto, Dept Lab Med & Pathobiol, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5S3H2, Canada; [Jeon, Amy Hye Won; Boehm, Christopher; Chen, Fusheng; Huo, Hairu; Ruan, Xueying; Ren, Carl He; Ho, Keith; Fraser, Paul E.; Mount, Howard T. J.; St George-Hyslop, Peter; Schmitt-Ulms, Gerold] Univ Toronto, Dept Neurol, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5S3H2, Canada; [Jeon, Amy Hye Won; Boehm, Christopher; Chen, Fusheng; Huo, Hairu; Ruan, Xueying; Ren, Carl He; Ho, Keith; Fraser, Paul E.; Mount, Howard T. J.; St George-Hyslop, Peter; Schmitt-Ulms, Gerold] Univ Toronto, Dept Physiol, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5S3H2, Canada; [Jeon, Amy Hye Won; Boehm, Christopher; Chen, Fusheng; Huo, Hairu; Ruan, Xueying; Ren, Carl He; Ho, Keith; Fraser, Paul E.; Mount, Howard T. J.; St George-Hyslop, Peter; Schmitt-Ulms, Gerold] Univ Toronto, Dept Med Biophys, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5S3H2, Canada; [Jeon, Amy Hye Won; Boehm, Christopher; Chen, Fusheng; Huo, Hairu; Ruan, Xueying; Ren, Carl He; Ho, Keith; Fraser, Paul E.; Mount, Howard T. J.; St George-Hyslop, Peter; Schmitt-Ulms, Gerold] Univ Toronto, Dept Med Neurol, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5S3H2, Canada; [Qamar, Seema; St George-Hyslop, Peter] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Mathews, Paul M.] NYU, Sch Med, Orangeburg, NY 10962 USA	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Cambridge; New York University	Schmitt-Ulms, G (corresponding author), 6 Queens Pk Crescent West, Toronto, ON M5S 3H2, Canada.	g.schmittulms@utoronto.ca		Mathews, Paul/0000-0003-1742-7687	Canadian Institutes of Health Research; Howard Hughes Medical Institute; Wellcome Trust; Alzheimer Society of Ontario; Scottish Rite Foundation of Canada; Peterborough KM Hunter Scholarship; Scace Alzheimer's Fellowship; University of Toronto Fellowship from the Faculty of Medicine, University of Toronto; W. Garfield Weston Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wellcome Trust(Wellcome TrustEuropean Commission); Alzheimer Society of Ontario; Scottish Rite Foundation of Canada; Peterborough KM Hunter Scholarship; Scace Alzheimer's Fellowship; University of Toronto Fellowship from the Faculty of Medicine, University of Toronto; W. Garfield Weston Foundation	This work was supported in part by the Canadian Institutes of Health Research, Howard Hughes Medical Institute, Wellcome Trust, and the Alzheimer Society of Ontario.; Supported by the Scottish Rite Foundation of Canada, a Peterborough KM Hunter Scholarship, a Scace Alzheimer's Fellowship, and a University of Toronto Fellowship from the Faculty of Medicine, University of Toronto.; Supported by the W. Garfield Weston Foundation. To whom correspondence should be addressed: 6 Queen's Park Crescent West, Toronto, Ontario M5S 3H2, Canada. Tel.: 416-946-0066; Fax: 416-978-1878; E-mail: g.schmittulms@utoronto.ca.	Arawaka S, 2002, J NEUROCHEM, V83, P1065, DOI 10.1046/j.1471-4159.2002.01207.x; Baki L, 2001, P NATL ACAD SCI USA, V98, P2381, DOI 10.1073/pnas.041603398; Bergman A, 2004, J BIOL CHEM, V279, P16744, DOI 10.1074/jbc.M313999200; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Franberg J, 2011, BIOCHEM BIOPH RES CO, V404, P564, DOI 10.1016/j.bbrc.2010.12.029; Georgakopoulos A, 1999, MOL CELL, V4, P893, DOI 10.1016/S1097-2765(00)80219-1; Ghidoni R, 2007, MECH AGEING DEV, V128, P350, DOI 10.1016/j.mad.2007.01.003; Golde TE, 2009, SEMIN CELL DEV BIOL, V20, P225, DOI 10.1016/j.semcdb.2009.02.003; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Hutton M, 1997, HUM MOL GENET, V6, P1639, DOI 10.1093/hmg/6.10.1639; Huynh DP, 1997, J NEUROPATH EXP NEUR, V56, P1009, DOI 10.1097/00005072-199709000-00006; Janus C, 2000, NEUROBIOL AGING, V21, P541, DOI 10.1016/S0197-4580(00)00107-X; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Kimberly WT, 2002, J BIOL CHEM, V277, P35113, DOI 10.1074/jbc.M204446200; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kouchi Z, 2009, J BIOL CHEM, V284, P1954, DOI 10.1074/jbc.M806250200; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lee MK, 1996, J NEUROSCI, V16, P7513, DOI 10.1523/jneurosci.16-23-07513.1996; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; Mastrangelo P, 2005, P NATL ACAD SCI USA, V102, P8972, DOI 10.1073/pnas.0500940102; Parisiadou L, 2004, NEURODEGENER DIS, V1, P184, DOI 10.1159/000080984; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Schenk D, 2000, NATURE, V407, P34, DOI 10.1038/35024194; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Serban G, 2005, J BIOL CHEM, V280, P36007, DOI 10.1074/jbc.M507503200; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shirotani K, 2007, NEUROBIOL DIS, V27, P102, DOI 10.1016/j.nbd.2007.04.011; Spasic D, 2008, J CELL SCI, V121, P413, DOI 10.1242/jcs.015255; Spasic D, 2006, J BIOL CHEM, V281, P26569, DOI 10.1074/jbc.M600592200; Stahl B, 1999, J BIOL CHEM, V274, P9141, DOI 10.1074/jbc.274.14.9141; Tomita T, 2002, FEBS LETT, V520, P117, DOI 10.1016/S0014-5793(02)02802-8; Trono D, 2000, GENE THER, V7, P20, DOI 10.1038/sj.gt.3301105; Vetrivel KS, 2008, J BIOL CHEM, V283, P19489, DOI 10.1074/jbc.M801037200; Wakabayashi T, 2009, NAT CELL BIOL, V11, P1340, DOI 10.1038/ncb1978; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Winkler E, 2009, BIOCHEMISTRY-US, V48, P1183, DOI 10.1021/bi801204g; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P11223, DOI 10.1021/bi991080q; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yang DS, 2002, J BIOL CHEM, V277, P28135, DOI 10.1074/jbc.M110871200; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102; Zieske LR, 2006, J EXP BOT, V57, P1501, DOI 10.1093/jxb/erj168	55	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15352	15366		10.1074/jbc.M112.441840	http://dx.doi.org/10.1074/jbc.M112.441840			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23589300	Green Published, hybrid			2022-12-28	WOS:000319452100060
J	Oka, M; Moriyama, T; Asally, M; Kawakami, K; Yoneda, Y				Oka, Masahiro; Moriyama, Tetsuji; Asally, Munehiro; Kawakami, Koichi; Yoneda, Yoshihiro			Differential Role for Transcription Factor Oct4 Nucleocytoplasmic Dynamics in Somatic Cell Reprogramming and Self-renewal of Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POU-DOMAIN; ES CELLS; MAMMALIAN EMBRYO; INTERACTION NETWORK; DNA-BINDING; PLURIPOTENCY; MOUSE; EXPRESSION; PROTEIN; GENERATION	Oct4 is a member of the POU family of transcription factors and plays a critical role in both maintenance of the undifferentiated state of embryonic stem (ES) cells and in the reprogramming of somatic cells to induced pluripotent stem cells. Oct4 is imported into the nucleus where it functions as a transcription factor; however, the spatiotemporal dynamic behavior of Oct4 remains largely unknown. In the present study we show that Oct4 is a nucleocytoplasmic shuttling protein. Furthermore, although Oct4 mutants with altered nuclear import/export activity were able to maintain the self-renewal of ES cells, they displayed limited potential for cellular reprogramming. These results indicate that the intracellular localization of Oct4, which is dependent on nucleocytoplasmic shuttling, must be more strictly regulated for cellular reprogramming, suggesting that Oct4 plays differential roles in the self-renewal of ES cells and in somatic cell reprogramming.	[Oka, Masahiro; Moriyama, Tetsuji; Asally, Munehiro; Yoneda, Yoshihiro] Osaka Univ, Biomol Dynam Grp, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Oka, Masahiro; Yoneda, Yoshihiro] Osaka Univ, Dept Biochem, Grad Sch Med, Suita, Osaka 5650871, Japan; [Oka, Masahiro; Yoneda, Yoshihiro] Japan Sci & Technol Agcy, CREST, Suita, Osaka 5650871, Japan; [Kawakami, Koichi] Grad Univ Adv Studies SOKENDAI, Div Mol & Dev Biol, Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Kawakami, Koichi] Grad Univ Adv Studies SOKENDAI, Dept Genet, Mishima, Shizuoka 4118540, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST); Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan	Oka, M (corresponding author), Osaka Univ, Dept Biochem, Grad Sch Med, 1-3 Yamada Oka, Suita, Osaka 5650871, Japan.	moka@anat3.med.osaka-u.ac.jp; yyoneda@anat3.med.osaka-u.ac.jp	moriyama, tetsuji/ABE-4678-2020; Asally, Munehiro/AAZ-3693-2020; Kawakami, Koichi/AAF-1380-2019	Asally, Munehiro/0000-0002-8273-7617; zhe si, sheng shan/0000-0001-8099-3716	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Core Research for Evolutional Science and Technology (CREST) program of Japan Science and Technology Agency (JST)	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) program of Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Core Research for Evolutional Science and Technology (CREST) program of Japan Science and Technology Agency (JST).	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Baranek C, 2005, NUCLEIC ACIDS RES, V33, P6277, DOI 10.1093/nar/gki947; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brehm A, 1997, MOL CELL BIOL, V17, P154, DOI 10.1128/MCB.17.1.154; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kawakami K, 2004, GENETICS, V166, P895, DOI 10.1534/genetics.166.2.895; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Li XQ, 2008, J GENET GENOMICS, V35, P723, DOI 10.1016/S1673-8527(08)60227-1; Liang GY, 2010, J BIOL CHEM, V285, P25516, DOI 10.1074/jbc.M110.142059; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2001, CELL STRUCT FUNCT, V26, P137, DOI 10.1247/csf.26.137; Okada M, 2010, BBA-GEN SUBJECTS, V1800, P956, DOI 10.1016/j.bbagen.2010.04.004; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Ovitt CE, 1998, MOL HUM REPROD, V4, P1021, DOI 10.1093/molehr/4.11.1021; Pan GJ, 2004, J BIOL CHEM, V279, P37013, DOI 10.1074/jbc.M405117200; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Plachta N, 2011, NAT CELL BIOL, V13, P117, DOI 10.1038/ncb2154; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Shimozaki K, 2003, DEVELOPMENT, V130, P2505, DOI 10.1242/dev.00476; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sun CH, 2009, MOL CELL BIOL, V29, P4574, DOI 10.1128/MCB.01863-08; Swaney DL, 2009, P NATL ACAD SCI USA, V106, P995, DOI 10.1073/pnas.0811964106; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; van den Boom V, 2007, J CELL BIOL, V178, P913, DOI 10.1083/jcb.200702058; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Young JC, 2011, FASEB J, V25, P3958, DOI 10.1096/fj.10-176941	48	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15085	15097		10.1074/jbc.M112.448837	http://dx.doi.org/10.1074/jbc.M112.448837			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23580657	Green Published, hybrid			2022-12-28	WOS:000319452100038
J	Tanik, SA; Schultheiss, CE; Volpicelli-Daley, LA; Brunden, KR; Lee, VMY				Tanik, Selcuk A.; Schultheiss, Christine E.; Volpicelli-Daley, Laura A.; Brunden, Kurt R.; Lee, Virginia M. Y.			Lewy Body-like alpha-Synuclein Aggregates Resist Degradation and Impair Macroautophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; NUTRIENT DEPRIVATION; PROTEIN AGGREGATION; INCLUSION-BODIES; IN-VIVO; CELLS; MICE	Cytoplasmic alpha-synuclein (alpha-syn) aggregates, referred to as Lewy bodies, are pathological hallmarks of a number of neurodegenerative diseases, most notably Parkinson disease. Activation of macroautophagy is suggested to facilitate degradation of certain proteinaceous inclusions, but it is unclear if this pathway is capable of degrading alpha-syn aggregates. Here, we examined this issue by utilizing cellular models in which intracellular Lewy body-like alpha-syn inclusions accumulate after internalization of pre-formed alpha-syn fibrils into alpha-syn-expressing HEK293 cells or cultured primary neurons. We demonstrate that alpha-syn inclusions cannot be effectively degraded, even though they co-localize with essential components of both the autophagic and proteasomal protein degradation pathways. The alpha-syn aggregates persist even after soluble alpha-syn levels have been substantially reduced, suggesting that once formed, the alpha-syn inclusions are refractory to clearance. Importantly, we also find that alpha-syn aggregates impair overall macroautophagy by reducing autophagosome clearance, which may contribute to the increased cell death that is observed in aggregate-bearing cells.	[Tanik, Selcuk A.; Schultheiss, Christine E.; Volpicelli-Daley, Laura A.; Brunden, Kurt R.; Lee, Virginia M. Y.] Univ Penn, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Tanik, Selcuk A.; Lee, Virginia M. Y.] Univ Penn, Biol Grad Grp, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Lee, VMY (corresponding author), Ctr Neurodegenerat Dis Res, 3rd Fl Maloney Bldg,3600 Spruce St, Philadelphia, PA 19104 USA.	vmylee@upenn.edu			National Institutes of Health Grant [NS053488]; J. P. B. Foundation; Jeff and Anne Keefer Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS053488] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J. P. B. Foundation; Jeff and Anne Keefer Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS053488. This work was also supported by the J. P. B. Foundation and the Jeff and Anne Keefer Fund.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Angot E, 2010, LANCET NEUROL, V9, P1128, DOI 10.1016/S1474-4422(10)70213-1; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bove J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Gomez-Suaga P, 2012, HUM MOL GENET, V21, P511, DOI 10.1093/hmg/ddr481; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Higashi S, 2011, J NEUROPATH EXP NEUR, V70, P264, DOI 10.1097/NEN.0b013e318211c86a; Ii K, 1997, J NEUROPATH EXP NEUR, V56, P125, DOI 10.1097/00005072-199702000-00002; Jenner P, 1996, NEUROLOGY, V47, pS161, DOI 10.1212/WNL.47.6_Suppl_3.161S; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kawai A, 2007, AUTOPHAGY, V3, P154, DOI 10.4161/auto.3634; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; Lee HJ, 2002, J BIOL CHEM, V277, P5411, DOI 10.1074/jbc.M105326200; Lee JA, 2009, J NEUROSCI, V29, P8506, DOI 10.1523/JNEUROSCI.0924-09.2009; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Li LY, 2011, NEUROSCI LETT, V489, P62, DOI 10.1016/j.neulet.2010.11.068; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Markossian KA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P971, DOI 10.1023/B:BIRY.0000043539.07961.4c; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; Michiorri S, 2010, CELL DEATH DIFFER, V17, P962, DOI 10.1038/cdd.2009.200; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mortimore G E, 1996, Subcell Biochem, V27, P93; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Pollitt SK, 2003, NEURON, V40, P685, DOI 10.1016/S0896-6273(03)00697-4; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Seglen PO, 1996, ADV EXP MED BIOL, V389, P103; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Soper JH, 2011, J MOL NEUROSCI, V43, P391, DOI 10.1007/s12031-010-9455-5; Soto C, 2012, NEURON, V73, P621, DOI 10.1016/j.neuron.2012.02.006; Spillantini MG, 1999, PARKINSONISM RELAT D, V5, P157, DOI 10.1016/S1353-8020(99)00031-0; Usenovic M, 2012, J NEUROSCI, V32, P4240, DOI 10.1523/JNEUROSCI.5575-11.2012; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x; Watanabe Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052868; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Wong ESP, 2008, HUM MOL GENET, V17, P2570, DOI 10.1093/hmg/ddn157; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Young JE, 2009, J BIOL CHEM, V284, P2363, DOI 10.1074/jbc.M806088200; Zagranichnaya TK, 2005, PHYSIOL GENOMICS, V21, P14, DOI 10.1152/physiolgenomics.00099.2004; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068; Zhang XJ, 2011, AUTOPHAGY, V7, P412, DOI 10.4161/auto.7.4.14541; Zhang Y, 2000, NEUROBIOL DIS, V7, P240, DOI 10.1006/nbdi.2000.0319	83	213	215	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15194	15210		10.1074/jbc.M113.457408	http://dx.doi.org/10.1074/jbc.M113.457408			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23532841	Green Published, hybrid			2022-12-28	WOS:000319452100048
J	Tomita, T; Iwatsubo, T				Tomita, Taisuke; Iwatsubo, Takeshi			Structural Biology of Presenilins and Signal Peptide Peptidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GAMMA-SECRETASE COMPLEX; AMYLOID PRECURSOR PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; CARBOXYL-TERMINAL FRAGMENT; TRANSMEMBRANE DOMAIN 1; VIRUS CORE PROTEIN; CATALYTIC PORE; INTRAMEMBRANE PROTEOLYSIS; ASPARTIC PROTEASE; BETA-PROTEIN	Presenilin and signal peptide peptidase are multispanning intramembrane-cleaving proteases with a conserved catalytic GxGD motif. Presenilin comprises the catalytic subunit of gamma-secretase, a protease responsible for the generation of amyloid-beta peptides causative of Alzheimer disease. Signal peptide peptidase proteins are implicated in the regulation of the immune system. Both protease family proteins have been recognized as druggable targets for several human diseases, but their detailed structure still remains unknown. Recently, the x-ray structures of some archaeal GxGD proteases have been determined. We review the recent progress in biochemical and biophysical probing of the structure of these atypical proteases.	[Tomita, Taisuke; Iwatsubo, Takeshi] Univ Tokyo, Dept Neuropathol & Neurosci, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Iwatsubo, Takeshi] Univ Tokyo, Dept Neuropathol, Grad Sch Med, Tokyo 1130033, Japan; [Tomita, Taisuke; Iwatsubo, Takeshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Tomita, T (corresponding author), Univ Tokyo, Dept Neuropathol & Neurosci, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan.	taisuke@mol.f.u-tokyo.ac.jp	Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943	Japan Society for the Promotion of Science; Cell Science Research Foundation; Takeda Science Foundation; Targeted Proteins Research Program; Core Research for Evolutional Science and Technology of Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Grants-in-Aid for Scientific Research [24659028] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Young Scientists (S) from the Japan Society for the Promotion of Science; grants from the Cell Science Research Foundation, the Takeda Science Foundation, the Targeted Proteins Research Program, and Core Research for Evolutional Science and Technology of Japan Science and Technology Agency; Grants-in-aid for Scientific Research on Innovative Areas "Brain Environment" and "Foundation of Synapses and Neurocircuit Pathology" from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and Grants-in-aid for Scientific Research (Comprehensive Research on Aging and Health) from the Ministry of Health, Labor and Welfare of Japan.	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Beisner DR, 2013, J EXP MED, V210, P23, DOI 10.1084/jem.20121072; Bergman A, 2004, J BIOL CHEM, V279, P45564, DOI 10.1074/jbc.M407717200; Bergmann H, 2013, J EXP MED, V210, P31, DOI 10.1084/jem.20121076; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Das C, 2003, J AM CHEM SOC, V125, P11794, DOI 10.1021/ja037131v; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Filipovic A, 2011, BREAST CANCER RES TR, V125, P43, DOI 10.1007/s10549-010-0823-1; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Fuwa H, 2007, ACS CHEM BIOL, V2, P408, DOI 10.1021/cb700073y; Golde TE, 2009, SEMIN CELL DEV BIOL, V20, P225, DOI 10.1016/j.semcdb.2009.02.003; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Hayashi I, 2004, J BIOL CHEM, V279, P38040, DOI 10.1074/jbc.M405597200; Hayashi I, 2012, ONCOGENE, V31, P787, DOI 10.1038/onc.2011.265; Hu J, 2011, NATURE, V475, P528, DOI 10.1038/nature10218; Imamura Y, 2013, J MED CHEM, V56, P1443, DOI 10.1021/jm301306c; Imamura Y, 2009, J AM CHEM SOC, V131, P7353, DOI 10.1021/ja9001458; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; Isoo N, 2007, J BIOL CHEM, V282, P12388, DOI 10.1074/jbc.M611549200; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; LaPointe CF, 2000, J BIOL CHEM, V275, P1502, DOI 10.1074/jbc.275.2.1502; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Liu XS, 2013, CELL RES, V23, P351, DOI 10.1038/cr.2012.167; Loo TW, 1999, BBA-BIOMEMBRANES, V1461, P315, DOI 10.1016/S0005-2736(99)00165-0; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Miyashita H, 2011, J BIOL CHEM, V286, P26188, DOI 10.1074/jbc.M111.260273; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Ogura T, 2006, BIOCHEM BIOPH RES CO, V343, P525, DOI 10.1016/j.bbrc.2006.02.158; Ohki Y, 2011, EMBO J, V30, P4815, DOI 10.1038/emboj.2011.372; Okamoto K, 2004, J VIROL, V78, P6370, DOI 10.1128/JVI.78.12.6370-6380.2004; Okochi M, 2013, CELL REP, V3, P42, DOI 10.1016/j.celrep.2012.11.028; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Pester O, 2013, J AM CHEM SOC, V135, P1317, DOI 10.1021/ja3112093; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Renzi F, 2011, J BIOL CHEM, V286, P21440, DOI 10.1074/jbc.M110.193326; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato C, 2012, CURR ALZHEIMER RES, V9, P227, DOI 10.2174/156720512799361600; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Sato T, 2009, P NATL ACAD SCI USA, V106, P1421, DOI 10.1073/pnas.0812261106; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Schneppenheim J, 2013, J EXP MED, V210, P41, DOI 10.1084/jem.20121069; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Sobhanifar S, 2010, P NATL ACAD SCI USA, V107, P9644, DOI 10.1073/pnas.1000778107; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Takagi S, 2010, J NEUROSCI, V30, P15943, DOI 10.1523/JNEUROSCI.3318-10.2010; Takagi-Niidome S, 2013, BIOCHEMISTRY-US, V52, P61, DOI 10.1021/bi301252r; Takami Mako, 2012, Int J Alzheimers Dis, V2012, P591392, DOI 10.1155/2012/591392; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Takeo K, 2012, J BIOL CHEM, V287, P25834, DOI 10.1074/jbc.M111.336347; Tarassishin L, 2004, P NATL ACAD SCI USA, V101, P17050, DOI 10.1073/pnas.0408007101; Targett-Adams P, 2006, J BIOL CHEM, V281, P29221, DOI 10.1074/jbc.M605373200; Thathiah A, 2013, NAT MED, V19, P43, DOI 10.1038/nm.3023; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Tomita T, 1998, J BIOL CHEM, V273, P21153, DOI 10.1074/jbc.273.33.21153; Tomita T, 2001, J BIOL CHEM, V276, P33273, DOI 10.1074/jbc.M011152200; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Torres-Arancivia C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013072; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Watanabe N, 2010, J BIOL CHEM, V285, P19738, DOI 10.1074/jbc.M110.101287; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P8534, DOI 10.1073/pnas.1202691109	100	33	34	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14673	14680		10.1074/jbc.R113.463281	http://dx.doi.org/10.1074/jbc.R113.463281			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23585568	Green Published, hybrid			2022-12-28	WOS:000319452100001
J	Wu, YT; Janetopoulos, C				Wu, Yuantai; Janetopoulos, Chris			Systematic Analysis of gamma-Aminobutyric Acid (GABA) Metabolism and Function in the Social Amoeba Dictyostelium discoideum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE-BRAIN; 2 ISOFORMS; EXPRESSION; GENE; TRANSPORTER; DIFFERENTIATION; RECEPTOR; PROTEIN; GENOME; IDENTIFICATION	While GABA has been suggested to regulate spore encapsulation in the social amoeba Dictyostelium discoideum, the metabolic profile and other potential functions of GABA during development remain unclear. In this study, we investigated the homeostasis of GABA metabolism by disrupting genes related to GABA metabolism and signaling. Extracellular levels of GABA are tightly regulated during early development, and GABA is generated by the glutamate decarboxylase, GadB, during growth and in early development. However, overexpression of the prespore-specific homologue, GadA, in the presence of GadB reduces production of extracellular GABA. Perturbation of extracellular GABA levels delays the process of aggregation. Cytosolic GABA is degraded by the GABA transaminase, GabT, in the mitochondria. Disruption of a putative vesicular GABA transporter (vGAT) homologue DdvGAT reduces secreted GABA. We identified the GABAB receptor-like family member GrlB as the major GABA receptor during early development, and either disruption or overexpression of GrlB delays aggregation. This delay is likely the result of an abolished pre-starvation response and late expression of several "early" developmental genes. Distinct genes are employed for GABA generation during sporulation. During sporulation, GadA alone is required for generating GABA and DdvGAT is likely responsible for GABA secretion. GrlE but not GrlB is the GABA receptor during late development.	[Wu, Yuantai; Janetopoulos, Chris] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Janetopoulos, Chris] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Janetopoulos, C (corresponding author), Vanderbilt Univ, Dept Biol Sci, 465 21st Ave South, Nashville, TN 37235 USA.	c.janetopoulos@vanderbilt.edu			National Institutes of Health [GM080370]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080370 (to C. J.).	Aarskog NK, 2000, HUM GENET, V107, P494, DOI 10.1007/s004390000399; Anjard C, 2006, DEVELOPMENT, V133, P2253, DOI 10.1242/dev.02399; Anjard C, 2009, DEVELOPMENT, V136, P803, DOI 10.1242/dev.032607; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Charette SJ, 2004, BIOTECHNIQUES, V36, P574, DOI 10.2144/04364BM01; CLARKE M, 1987, DIFFERENTIATION, V34, P79, DOI 10.1111/j.1432-0436.1987.tb00053.x; DeBiase D, 1996, PROTEIN EXPRES PURIF, V8, P430; Ehrenman K, 2004, J BIOL CHEM, V279, P837, DOI 10.1074/jbc.M310539200; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; Gasnier B, 2004, PFLUG ARCH EUR J PHY, V447, P756, DOI 10.1007/s00424-003-1091-2; Gomer RH, 2011, DEV GROWTH DIFFER, V53, P482, DOI 10.1111/j.1440-169X.2010.01248.x; HADWIGER JA, 1991, P NATL ACAD SCI USA, V88, P8213, DOI 10.1073/pnas.88.18.8213; Heidel AJ, 2011, GENOME RES, V21, P1882, DOI 10.1101/gr.121137.111; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iranfar N, 2003, EUKARYOT CELL, V2, P664, DOI 10.1128/EC.2.4.664-670.2003; Iranfar N, 2001, MOL BIOL CELL, V12, P2590, DOI 10.1091/mbc.12.9.2590; JAKOBY WB, 1959, J BIOL CHEM, V234, P2145; Journet A, 2012, PROTEOMICS, V12, P241, DOI 10.1002/pmic.201100313; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Kleppner S. R., 2002, ENCY HUMAN BRAIN, P353; Kriebel PW, 2003, CELL, V112, P549, DOI 10.1016/S0092-8674(03)00081-3; LIU QR, 1993, J BIOL CHEM, V268, P2106; LIU QR, 1992, P NATL ACAD SCI USA, V89, P12145, DOI 10.1073/pnas.89.24.12145; LOPEZCORCUERA B, 1992, J BIOL CHEM, V267, P17491; Maeda Y, 2011, DEV GROWTH DIFFER, V53, P463, DOI 10.1111/j.1440-169X.2011.01264.x; Maruo T, 2004, EUKARYOT CELL, V3, P1241, DOI 10.1128/EC.3.5.1241-1248.2004; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MELDRUM BS, 1989, BRIT J CLIN PHARMACO, V27, pS3, DOI 10.1111/j.1365-2125.1989.tb03454.x; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Palanivelu R, 2003, CELL, V114, P47, DOI 10.1016/S0092-8674(03)00479-3; Prabhu Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-44; Prabhu Y, 2007, DEV BIOL, V312, P29, DOI 10.1016/j.ydbio.2007.08.055; Prabhu Y, 2006, EUR J CELL BIOL, V85, P937, DOI 10.1016/j.ejcb.2006.04.003; Reddy PH, 1999, TRENDS NEUROSCI, V22, P248, DOI 10.1016/S0166-2236(99)01415-0; ROBERTS E, 1950, J BIOL CHEM, V187, P55; ROBERTS E, 1953, J BIOL CHEM, V203, P195; Shelp BJ, 2012, TRENDS PLANT SCI, V17, P57, DOI 10.1016/j.tplants.2011.12.006; Sillo A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-291; Siu CH, 2011, DEV GROWTH DIFFER, V53, P518, DOI 10.1111/j.1440-169X.2011.01267.x; SNAARJAGALSKA BE, 1991, EUR J BIOCHEM, V195, P715, DOI 10.1111/j.1432-1033.1991.tb15758.x; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; STEWARD FC, 1949, SCIENCE, V110, P439; Sucgang R, 1997, DEV BIOL, V192, P181, DOI 10.1006/dbio.1997.8720; Taniura H, 2006, J BIOL CHEM, V281, P12336, DOI 10.1074/jbc.M512723200	46	9	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15280	15290		10.1074/jbc.M112.427047	http://dx.doi.org/10.1074/jbc.M112.427047			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23548898	Green Published, hybrid			2022-12-28	WOS:000319452100054
J	Nambi, S; Gupta, K; Bhattacharyya, M; Ramakrishnan, P; Ravikumar, V; Siddiqui, N; Thomas, AT; Visweswariah, SS				Nambi, Subhalaxmi; Gupta, Kallol; Bhattacharyya, Moitrayee; Ramakrishnan, Parvathy; Ravikumar, Vaishnavi; Siddiqui, Nida; Thomas, Ann Terene; Visweswariah, Sandhya S.			Cyclic AMP-dependent Protein Lysine Acylation in Mycobacteria Regulates Fatty Acid and Propionate Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA SYNTHETASE; SUBSTRATE-SPECIFICITY; NUCLEOTIDE CYCLASES; STRUCTURAL INSIGHTS; METHYLCITRATE CYCLE; IN-VIVO; TUBERCULOSIS; ENZYME; BIOSYNTHESIS; REQUIRES	Acetylation of lysine residues is a posttranslational modification that is used by both eukaryotes and prokaryotes to regulate a variety of biological processes. Here we identify multiple substrates for the cAMP-dependent protein lysine acetyltransferase from Mycobacterium tuberculosis (KATmt). We demonstrate that a catalytically important lysine residue in a number of FadD (fatty acyl CoA synthetase) enzymes is acetylated by KATmt in a cAMP-dependent manner and that acetylation inhibits the activity of FadD enzymes. A sirtuin-like enzyme can deacetylate multiple FadDs, thus completing the regulatory cycle. Using a strain deleted for the KATmt ortholog in Mycobacterium bovis Bacillus Calmette-Guerin (BCG), we show for the first time that acetylation is dependent on intracellular cAMP levels. KATmt can utilize propionyl CoA as a substrate and, therefore, plays a critical role in alleviating propionyl CoA toxicity in mycobacteria by inactivating acyl CoA synthetase (ACS). The precision by which mycobacteria can regulate the metabolism of fatty acids in a cAMP-dependent manner appears to be unparalleled in other biological organisms and is ideally suited to adapt to the complex environment that pathogenic mycobacteria experience in the host.	[Nambi, Subhalaxmi; Ramakrishnan, Parvathy; Ravikumar, Vaishnavi; Siddiqui, Nida; Thomas, Ann Terene; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Gupta, Kallol; Bhattacharyya, Moitrayee] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Visweswariah, SS (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	sandhya@mrdg.iisc.ernet	Visweswariah, Sandhya/Q-7500-2019	Visweswariah, Sandhya/0000-0003-2786-7344; Nambi, Subhalaxmi/0000-0001-7104-659X; Siddiqui, Nida/0000-0002-5416-8533; Gupta, Kallol/0000-0002-3557-3242	Department of Biotechnology, Council for Scientific and Industrial Research; Department of Science and Technology, Government of India; Research Associate Fellowship from the Indian Institute of Science	Department of Biotechnology, Council for Scientific and Industrial Research; Department of Science and Technology, Government of India(Department of Science & Technology (India)); Research Associate Fellowship from the Indian Institute of Science	This work was supported by the Department of Biotechnology, Council for Scientific and Industrial Research, by the Department of Science and Technology, Government of India, and by a Research Associate Fellowship from the Indian Institute of Science (to S. N.).	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Andersson CS, 2012, STRUCTURE, V20, P1062, DOI 10.1016/j.str.2012.03.012; Bai G, 2011, CELL MICROBIOL, V13, P349, DOI 10.1111/j.1462-5822.2010.01562.x; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Casabon I, 2013, MOL MICROBIOL, V87, P269, DOI 10.1111/mmi.12095; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Crosby HA, 2012, J BIOL CHEM, V287, P41392, DOI 10.1074/jbc.M112.417360; Dam T, 2006, J INFECT DIS, V193, P1135, DOI 10.1086/501469; Dass BKM, 2008, J BACTERIOL, V190, P3824, DOI 10.1128/JB.00138-08; Dormeyer W, 2005, METHODS, V36, P376, DOI 10.1016/j.ymeth.2005.03.006; Duckworth BP, 2012, CURR TOP MED CHEM, V12, P766; Dunphy KY, 2010, J INFECT DIS, V201, P1232, DOI 10.1086/651452; Ferreras JA, 2008, CHEM BIOL, V15, P51, DOI 10.1016/j.chembiol.2007.11.010; Ficner R, 2009, CURR TOP MED CHEM, V9, P235, DOI 10.2174/156802609788085304; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Harman JG, 2001, BBA-PROTEIN STRUCT M, V1547, P1, DOI 10.1016/S0167-4838(01)00187-X; He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hotter GS, 2005, J BACTERIOL, V187, P2267, DOI 10.1128/JB.187.7.2267-2277.2005; Jatana N, 2011, J MOL MODEL, V17, P301, DOI 10.1007/s00894-010-0727-3; Khare G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008387; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HJ, 2012, NAT STRUCT MOL BIOL, V19, P811, DOI 10.1038/nsmb.2318; Li R, 2011, ACTA BIOCH BIOPH SIN, V43, P891, DOI 10.1093/abbs/gmr076; Liu KY, 2003, MICROBIOL-SGM, V149, P1829, DOI 10.1099/mic.0.26234-0; Liu L, 1999, MOL CELL BIOL, V19, P1202; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; McCue LA, 2000, GENOME RES, V10, P204, DOI 10.1101/gr.10.2.204; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Nambi S, 2012, J BIOL CHEM, V287, P18115, DOI 10.1074/jbc.M111.328112; Nambi S, 2010, J BIOL CHEM, V285, P24313, DOI 10.1074/jbc.M110.118398; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Russell DG, 2010, CELL HOST MICROBE, V8, P68, DOI 10.1016/j.chom.2010.06.002; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Sadoul K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/970382; Savvi S, 2008, J BACTERIOL, V190, P3886, DOI 10.1128/JB.01767-07; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shenoy AR, 2004, COMP FUNCT GENOM, V5, P17, DOI 10.1002/cfg.349; Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005; Simeone R, 2010, FEBS J, V277, P2715, DOI [10.1111/j.1742-4658.2010.07688.x, 10.1111/j.1742-464X.2010.07688.x]; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; TAKEMURA R, 1992, J CELL SCI, V103, P953; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Thao S, 2011, MBIO, V2, DOI 10.1128/mBio.00216-11; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Upton AM, 2007, MICROBIOL-SGM, V153, P3973, DOI 10.1099/mic.0.2007/011726-0; Xu H, 2011, BIOCHEMISTRY-US, V50, P5883, DOI 10.1021/bi200156t	59	77	78	0	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14114	14124		10.1074/jbc.M113.463992	http://dx.doi.org/10.1074/jbc.M113.463992			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23553634	Green Published, hybrid			2022-12-28	WOS:000319253500016
J	Ringel, P; Krausze, J; van den Heuvel, J; Curth, U; Pierik, AJ; Herzog, S; Mendel, RR; Kruse, T				Ringel, Phillip; Krausze, Joern; van den Heuvel, Joop; Curth, Ute; Pierik, Antonio J.; Herzog, Stephanie; Mendel, Ralf R.; Kruse, Tobias			Biochemical Characterization of Molybdenum Cofactor-free Nitrate Reductase from Neurospora crassa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; IN-VITRO FORMATION; ASPERGILLUS-NIDULANS; ESCHERICHIA-COLI; PICHIA-PASTORIS; GENOME SEQUENCE; PROTEIN; PURIFICATION; INVOLVEMENT; MUTANT	Nitrate reductase (NR) is a complex molybdenum cofactor (Moco)-dependent homodimeric metalloenzyme that is vitally important for autotrophic organism as it catalyzes the first and rate-limiting step of nitrate assimilation. Beside Moco, eukaryotic NR also binds FAD and heme as additional redox active cofactors, and these are involved in electron transfer from NAD(P)H to the enzyme molybdenum center where reduction of nitrate to nitrite takes place. We report the first biochemical characterization of a Moco-free eukaryotic NR from the fungus Neurospora crassa, documenting that Moco is necessary and sufficient to induce dimer formation. The molybdenum center of NR reconstituted in vitro from apo-NR and Moco showed an EPR spectrum identical to holo-NR. Analysis of mutants unable to bind heme or FAD revealed that insertion of Moco into NR occurs independent from the insertion of any other NR redox cofactor. Furthermore, we showed that at least in vitro the active site formation of NR is an autonomous process.	[Ringel, Phillip; Herzog, Stephanie; Mendel, Ralf R.; Kruse, Tobias] Braunschweig Univ Technol, Dept Plant Biol, D-38106 Braunschweig, Germany; [Krausze, Joern; van den Heuvel, Joop] Helmholtz Ctr Infect Res, Dept Mol Struct Biol, D-38124 Braunschweig, Germany; [Curth, Ute] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany; [Pierik, Antonio J.] Univ Marburg, Inst Cytobiol & Cytopathol, Core Facil Prot Spect, D-35032 Marburg, Germany	Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Philipps University Marburg	Mendel, RR (corresponding author), Braunschweig Univ Technol, Dept Plant Biol, Humboldt St 1, D-38106 Braunschweig, Germany.	r.mendel@tu-bs.de	Pierik, Antonio J/G-1108-2010	Pierik, Antonio J/0000-0002-1509-6370	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft.	[Anonymous], PYMOL MOL GRAPH SYST; Barbier GG, 2004, PROTEIN EXPRES PURIF, V37, P61, DOI 10.1016/j.pep.2004.05.021; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campbell WH, 1999, ANNU REV PLANT PHYS, V50, P277, DOI 10.1146/annurev.arplant.50.1.277; CAMPBELL WH, 1990, TRENDS BIOCHEM SCI, V15, P315, DOI 10.1016/0968-0004(90)90021-3; Campbell WH, 2001, CELL MOL LIFE SCI, V58, P194, DOI 10.1007/PL00000847; DEVRIES SE, 1986, PLANT SCI, V44, P105, DOI 10.1016/0168-9452(86)90078-6; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; EVANS HJ, 1952, ARCH BIOCHEM BIOPHYS, V39, P234, DOI 10.1016/0003-9861(52)90281-6; Fischer K, 2005, PLANT CELL, V17, P1167, DOI 10.1105/tpc.104.029694; Fischer K, 2006, J BIOL CHEM, V281, P30186, DOI 10.1074/jbc.M603919200; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; GARRETT RH, 1969, J BIOL CHEM, V244, P2870; GARRETT RH, 1967, P NATL ACAD SCI USA, V58, P1603, DOI 10.1073/pnas.58.4.1603; Gonzalez C, 1995, MOL GEN GENET, V249, P456; GUTTERIDGE S, 1983, BIOCHEM J, V213, P137, DOI 10.1042/bj2130137; HORNER RD, 1983, BIOCHIM BIOPHYS ACTA, V744, P7, DOI 10.1016/0167-4838(83)90333-3; Ilbert M, 2003, J BIOL CHEM, V278, P28787, DOI 10.1074/jbc.M302730200; KAY CJ, 1990, BIOCHEM J, V272, P545, DOI 10.1042/bj2720545; KAY CJ, 1989, BIOCHEMISTRY-US, V28, P5750, DOI 10.1021/bi00440a008; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KETCHUM PA, 1970, P NATL ACAD SCI USA, V66, P1016, DOI 10.1073/pnas.66.3.1016; KETCHUM PA, 1973, J BACTERIOL, V116, P600, DOI 10.1128/JB.116.2.600-609.1973; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lanciano P, 2007, J BIOL CHEM, V282, P17468, DOI 10.1074/jbc.M700994200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laue M. T., 1991, ANAL ULTRACENTRIFUGA, P90; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lillo C, 2004, J EXP BOT, V55, P1275, DOI 10.1093/jxb/erh132; Macheroux P, 1999, METH MOL B, V131, P1; Magalon A, 2011, COORDIN CHEM REV, V255, P1159, DOI 10.1016/j.ccr.2010.12.031; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; MCDONALD DW, 1974, EUR J BIOCHEM, V46, P169, DOI 10.1111/j.1432-1033.1974.tb03609.x; Mendel RR, 2012, BBA-MOL CELL RES, V1823, P1568, DOI 10.1016/j.bbamcr.2012.02.007; Mertens JA, 2000, PLANT PHYSIOL, V123, P743, DOI 10.1104/pp.123.2.743; MINAGAWA N, 1982, J BIOCHEM, V91, P761, DOI 10.1093/oxfordjournals.jbchem.a133763; NASON A, 1971, P NATL ACAD SCI USA, V68, P3242, DOI 10.1073/pnas.68.12.3242; NASON A, 1970, P NATL ACAD SCI USA, V65, P137, DOI 10.1073/pnas.65.1.137; NUSSAUME L, 1995, PLANT CELL, V7, P611, DOI 10.1105/tpc.7.5.611; OKAMOTO PM, 1991, MOL GEN GENET, V227, P213, DOI 10.1007/BF00259673; Orme-Johnson W. H., 1980, MOLYBDENUM MOLYBDENU, P327; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; PAN SS, 1978, BIOCHIM BIOPHYS ACTA, V523, P297, DOI 10.1016/0005-2744(78)90033-5; Poll A.M., 1991, PLANT SCI LIMERICK, V76, P201; REDINBAUGH MG, 1985, J BIOL CHEM, V260, P3380; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwarz G, 1997, J BIOL CHEM, V272, P26811, DOI 10.1074/jbc.272.43.26811; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; STEWART V, 1982, J BACTERIOL, V151, P788, DOI 10.1128/JB.151.2.788-799.1982; Zhao H., 2013, ANAL BIOCH IN PRESS	54	17	17	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14657	14671		10.1074/jbc.M113.457960	http://dx.doi.org/10.1074/jbc.M113.457960			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23539622	hybrid, Green Published			2022-12-28	WOS:000319253500065
J	Yang, L; Sha, HB; Davisson, RL; Qi, L				Yang, Liu; Sha, Haibo; Davisson, Robin L.; Qi, Ling			Phenformin Activates the Unfolded Protein Response in an AMP-activated Protein Kinase (AMPK)-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER STRESS; GENE-EXPRESSION; CELL FATE; INHIBITION; APOPTOSIS; PHOSPHORYLATION; PATHWAY; IRE1; PERK	Activation of the unfolded protein response (UPR) is associated with the disruption of endoplasmic reticulum (ER) homeostasis and has been implicated in the pathogenesis of many human metabolic diseases, including obesity and type 2 diabetes. However, the nature of the signals activating UPR under these conditions remains largely unknown. Using a method that we recently optimized to directly measure UPR sensor activation, we screened the effect of various metabolic drugs on UPR activation and show that the anti-diabetic drug phenformin activates UPR sensors IRE1 alpha and pancreatic endoplasmic reticulum kinase (PERK) in both an ER-dependent and ER-independent manner. Mechanistically, AMP-activated protein kinase (AMPK) activation is required but not sufficient to initiate phenformin-mediated IRE1 alpha and PERK activation, suggesting the involvement of additional factor(s). Interestingly, activation of the IRE1 alpha (but not PERK) pathway is partially responsible for the cytotoxic effect of phenformin. Together, our data show the existence of a non-canonical UPR whose activation requires the cytosolic kinase AMPK, adding another layer of complexity to UPR activation upon metabolic stress.	[Yang, Liu; Qi, Ling] Cornell Univ, Coll Vet Med, Grad Program Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Sha, Haibo; Qi, Ling] Cornell Univ, Coll Vet Med, Div Nutr Sci, Ithaca, NY 14853 USA; [Davisson, Robin L.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Qi, L (corresponding author), Cornell Univ, Coll Vet Med, Grad Program Biochem Mol & Cell Biol, Ithaca, NY 14853 USA.	lq35@cornell.edu		Qi, Ling/0000-0001-8229-0184	National Institutes of Health [R01 DK082582, R21 AA020351]; American Diabetes Association [7-08-JF-46, 1-12-CD-04]; American Heart Association [12PRE9400033]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL084207, R01HL063887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA020351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK082582 and R21 AA020351 (to L. Q.). This work was also supported by American Diabetes Association Grants 7-08-JF-46 and 1-12-CD-04 (to L. Q.).; Supported in part by American Heart Association Founders Affiliate Predoctoral Fellowship 12PRE9400033.	Allagnat F, 2010, DIABETOLOGIA, V53, P1120, DOI 10.1007/s00125-010-1699-7; Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; Appleyard MVCL, 2012, BRIT J CANCER, V106, P1117, DOI 10.1038/bjc.2012.56; ASSAN R, 1975, DIABETES, V24, P791, DOI 10.2337/diabetes.24.9.791; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Caraci F, 2003, LIFE SCI, V74, P643, DOI 10.1016/j.lfs.2003.07.015; CHANCE B, 1963, J BIOL CHEM, V238, P418; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; DAVIDOFF F, 1968, J CLIN INVEST, V47, P2331, DOI 10.1172/JCI105918; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; Dong YZ, 2010, DIABETES, V59, P1386, DOI 10.2337/db09-1637; Gomez E, 2008, BIOCHEM J, V410, P485, DOI 10.1042/BJ20071367; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; He Y, 2010, GENE EXPRESSION, V15, P13, DOI 10.3727/105221610X12819686555051; He Y, 2012, J SYST ENG ELECTRON, V23, P1, DOI 10.1109/JSEE.2012.00001; Heishi M, 2008, J TOXICOL SCI, V33, P339, DOI 10.2131/jts.33.339; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee EK, 2012, NEPHRON EXP NEPHROL, V121, pE38, DOI 10.1159/000342802; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lu J, 2012, ENDOCRINOLOGY, V153, P5275, DOI 10.1210/en.2012-1418; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Mao T, 2011, P NATL ACAD SCI USA, V108, P15852, DOI 10.1073/pnas.1107394108; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; Meares GP, 2011, MOL CELL BIOL, V31, P4286, DOI 10.1128/MCB.05668-11; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Qi L, 2011, METHOD ENZYMOL, V490, P137, DOI 10.1016/B978-0-12-385114-7.00008-8; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Quentin T, 2012, DIS MODEL MECH, V5, P259, DOI 10.1242/dmm.008110; Sha HB, 2011, TRENDS ENDOCRIN MET, V22, P374, DOI 10.1016/j.tem.2011.05.002; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; SOLS A, 1954, J BIOL CHEM, V210, P581; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; TATU U, 1993, EMBO J, V12, P2151, DOI 10.1002/j.1460-2075.1993.tb05863.x; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Xue Z, 2011, J BIOL CHEM, V286, P30859, DOI 10.1074/jbc.M111.273714; Yang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011621; Young CN, 2012, J CLIN INVEST, V122, P3960, DOI 10.1172/JCI64583; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	54	19	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13631	13638		10.1074/jbc.M113.462762	http://dx.doi.org/10.1074/jbc.M113.462762			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23548904	Green Published, hybrid			2022-12-28	WOS:000318850300045
J	Cho, HY; Lee, YH; Bae, YS; Kim, E; Kang, BS				Cho, Ha Yeon; Lee, Young-Hoon; Bae, Young-Seuk; Kim, Eungbin; Kang, Beom Sik			Activation of ATP Binding for the Autophosphorylation of DosS, a Mycobacterium tuberculosis Histidine Kinase Lacking an ATP Lid Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAF DOMAIN; SENSOR; MECHANISM; INSIGHTS	The sensor histidine kinases of Mycobacterium tuberculosis, DosS and DosT, are responsible for sensing hypoxic conditions and consist of sensor and kinase cores responsible for accepting signals and phosphorylation activity, respectively. The kinase core contains a dimerization and histidine phosphate-accepting (DHp) domain and an ATP binding domain (ABD). The 13 histidine kinase genes of M. tuberculosis can be grouped based on the presence or absence of the ATP lid motif and F box (elements known to play roles in ATP binding) in their ABDs; DosS and DosT have ABDs lacking both these elements, and the crystal structures of their ABDs indicated that they were unsuitable for ATP binding, as a short loop covers the putative ATP binding site. Although the ABD alone cannot bind ATP, the kinase core is functional in autophosphorylation. Appropriate spatial arrangement of the ABD and DHp domain within the kinase core is required for both autophosphorylation and ATP binding. An ionic interaction between Arg(440) in the DHp domain and Glu(537) in the short loop of the ABD is available and may open the ATP binding site, by repositioning the short loop away from the site. Mutations at Arg(440) and Glu(537) reduce autophosphorylation activity. Unlike other histidine kinases containing an ATP lid, which protects bound ATP, DosS is unable to accept ATP until the ABD is properly positioned relative to the histidine; this may prevent unexpected ATP reactions. ATP binding can, therefore, function as a control mechanism for histidine kinase activity.	[Cho, Ha Yeon; Lee, Young-Hoon; Bae, Young-Seuk; Kang, Beom Sik] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 702701, South Korea; [Kim, Eungbin] Yonsei Univ, Dept Biol, Seoul 120749, South Korea	Kyungpook National University; Yonsei University	Kang, BS (corresponding author), 1370 Sangyeok Dong, Taegu 702701, South Korea.	bskang2@knu.ac.kr		, Eungbin/0000-0002-4851-4743; Bae, Young-Seuk/0000-0002-5520-4444	National Research Foundation of Korea by the Korean government (Ministry of Education, Science, and Technology) [2009-0077493, 2011-0015987]	National Research Foundation of Korea by the Korean government (Ministry of Education, Science, and Technology)	This work was supported by National Research Foundation of Korea Grants 2009-0077493 and 2011-0015987 by the Korean government (Ministry of Education, Science, and Technology).	Albanesi D, 2009, P NATL ACAD SCI USA, V106, P16185, DOI 10.1073/pnas.0906699106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Cho HY, 2011, FEBS LETT, V585, P1873, DOI 10.1016/j.febslet.2011.04.050; Cho HY, 2009, J BIOL CHEM, V284, P13057, DOI 10.1074/jbc.M808905200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Lee JM, 2008, J BACTERIOL, V190, P6795, DOI 10.1128/JB.00401-08; Marina A, 2005, EMBO J, V24, P4247, DOI 10.1038/sj.emboj.7600886; Marina A, 2001, J BIOL CHEM, V276, P41182, DOI 10.1074/jbc.M106080200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nowak E, 2006, STRUCTURE, V14, P275, DOI 10.1016/j.str.2005.10.006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Saini DK, 2004, FEBS LETT, V565, P75, DOI 10.1016/j.febslet.2004.02.092; Sardiwal S, 2005, J MOL BIOL, V353, P929, DOI 10.1016/j.jmb.2005.09.011; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; Stewart RC, 2010, CURR OPIN MICROBIOL, V13, P133, DOI 10.1016/j.mib.2009.12.013; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Trajtenberg F, 2010, J BIOL CHEM, V285, P24892, DOI 10.1074/jbc.M110.147843; Tucker PA, 2007, METHOD ENZYMOL, V423, P479, DOI 10.1016/S0076-6879(07)23023-X; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139	30	11	13	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12437	12447		10.1074/jbc.M112.442467	http://dx.doi.org/10.1074/jbc.M112.442467			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23486471	Green Published, hybrid			2022-12-28	WOS:000318555100003
J	Nahomi, RB; Wang, B; Raghavan, CT; Voss, O; Doseff, AI; Santhoshkumar, P; Nagaraj, RH				Nahomi, Rooban B.; Wang, Benlian; Raghavan, Cibin T.; Voss, Oliver; Doseff, Andrea I.; Santhoshkumar, Puttur; Nagaraj, Ram H.			Chaperone Peptides of alpha-Crystallin Inhibit Epithelial Cell Apoptosis, Protein Insolubilization, and Opacification in Experimental Cataracts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CRYSTALLIN; A-CRYSTALLIN; POSTTRANSLATIONAL MODIFICATIONS; FUNCTIONAL ELEMENT; HUMAN LENSES; EXPRESSION; ACTIVATION; PATHOLOGY; CATARACTOGENESIS; RAF/MEK/ERK	alpha-Crystallin is a member of the small heat-shock protein (sHSP) family and consists of two subunits, alpha A and alpha B. Both alpha A-and alpha B-crystallin act as chaperones and anti-apoptotic proteins. Previous studies have identified the peptide (KFVIFLD)-K-70-VKHFSPEDLTVK88 in alpha A-crystallin and the peptide (DRFS)-D-73-VNLDVKHFSPEELKVK92 in alpha B-crystallin as mini-chaperones. In the human lens, lysine 70 (Lys(70)) of alpha A and Lys92 of alpha B (in the mini-chaperone sequences) are acetylated. In this study, we investigated the cellular effects of the unmodified and acetyl mini-chaperones. The alpha A-and alpha B-crystallin peptides inhibited stress-induced aggregation of four client proteins, and the alpha A-acetyl peptide was more effective than the native peptide against three of the client proteins. Both the acetyl and native crystallin peptides inhibited stress-induced apoptosis in two mammalian cell types, and this property was directly related to the inhibition of cytochrome c release from mitochondria and the activity of caspase-3 and -9. In organ-cultured rat lenses, the peptides inhibited calcimycin-induced epithelial cell apoptosis. Intraperitoneal injection of the peptides inhibited cataract development in selenite-treated rats, which was accompanied by inhibition of oxidative stress, protein insolubilization, and caspase activity in the lens. These inhibitory effects were more pronounced for acetyl peptides than native peptides. A scrambled alpha A-crystallin peptide produced no such effects. The results suggest that the alpha-crystallin chaperone peptides could be used as therapeutic agents to treat cataracts and diseases in which protein aggregation and apoptosis are contributing factors.	[Nahomi, Rooban B.; Raghavan, Cibin T.; Nagaraj, Ram H.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Wang, Benlian] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Voss, Oliver; Doseff, Andrea I.] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Santhoshkumar, Puttur] Univ Missouri, Dept Ophthalmol, Columbia, MO 65212 USA	Case Western Reserve University; Case Western Reserve University; University System of Ohio; Ohio State University; University of Missouri System; University of Missouri Columbia	Nagaraj, RH (corresponding author), Rm 311,2085 Adelbert Rd, Cleveland, OH 44106 USA.	ram.nagaraj@case.edu	Santhoshkumar, Puttur/G-1798-2010; Doseff, Andrea/E-2991-2011	Santhoshkumar, Puttur/0000-0002-6897-7278; 	National Institutes of Health [R01EY-022061, R01EY-09912, P30EY-11373]; Research to Prevent Blindness, NY; Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [R01EY009912, R01EY022061, P30EY011373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, NY(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY-022061 and R01EY-09912 (to R.H.N.), and P30EY-11373 to the Visual Sciences Research Center of Case Western Reserve University, and grants from the Research to Prevent Blindness, NY (to Case Western Reserve University and the University of Missouri-Columbia) and The Ohio Lions Eye Research Foundation.	Andley UP, 2000, J BIOL CHEM, V275, P36823, DOI 10.1074/jbc.M004233200; Andley UP, 2008, INT J BIOCHEM CELL B, V40, P317, DOI 10.1016/j.biocel.2007.10.034; Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Andley UP, 2009, CURR MOL MED, V9, P887, DOI 10.2174/156652409789105598; AOYAMA A, 1993, MOL CELL BIOL, V13, P1824, DOI 10.1128/MCB.13.3.1824; Arac A, 2011, P NATL ACAD SCI USA, V108, P13287, DOI 10.1073/pnas.1107368108; Bhattacharyya J, 2006, BIOCHEMISTRY-US, V45, P3069, DOI 10.1021/bi0518141; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; DASGUPTA S, 1992, EXP EYE RES, V54, P461, DOI 10.1016/0014-4835(92)90058-Z; DAVID LL, 1984, TOXICOL APPL PHARM, V74, P109, DOI 10.1016/0041-008X(84)90276-X; DAVID LL, 1984, INVEST OPHTH VIS SCI, V25, P1275; DUBIN RA, 1989, MOL CELL BIOL, V9, P1083, DOI 10.1128/MCB.9.3.1083; Ghosh JG, 2007, BIOCHEMISTRY-US, V46, P6308, DOI 10.1021/bi700149h; Hains PG, 2007, J PROTEOME RES, V6, P3935, DOI 10.1021/pr070138h; Harrington V, 2007, MOL VIS, V13, P1680; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kannan R, 2012, PROG RETIN EYE RES, V31, P576, DOI 10.1016/j.preteyeres.2012.06.001; Kim YH, 2012, DIABETOLOGIA, V55, P2835, DOI 10.1007/s00125-012-2625-y; Kurnellas MP, 2012, J BIOL CHEM, V287, P36423, DOI 10.1074/jbc.M112.371229; Launay N, 2010, J BIOL CHEM, V285, P37324, DOI 10.1074/jbc.M110.124388; Li DWC, 2005, MOL BIOL CELL, V16, P4437, DOI 10.1091/mbc.E05-01-0010; LI WC, 1995, EXP EYE RES, V61, P91, DOI 10.1016/S0014-4835(95)80062-X; Liu JP, 2004, EXP EYE RES, V79, P393, DOI 10.1016/j.exer.2004.06.015; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; Masilamoni JG, 2005, BBA-MOL BASIS DIS, V1740, P411, DOI 10.1016/j.bbadis.2004.11.002; MEHLEN P, 1995, J IMMUNOL, V154, P363; Nagaraj RH, 2012, BBA-MOL BASIS DIS, V1822, P120, DOI 10.1016/j.bbadis.2011.11.011; NAGARAJ RH, 1991, P NATL ACAD SCI USA, V88, P10257, DOI 10.1073/pnas.88.22.10257; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Padival S, 2006, OPHTHALMIC RES, V38, P294, DOI 10.1159/000095773; Pangratz-Fuehrer S, 2011, EYE, V25, P809, DOI 10.1038/eye.2011.42; Pasupuleti N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.3; Rao NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033582; Reddy GB, 2006, IUBMB LIFE, V58, P632, DOI 10.1080/15216540601010096; Santhoshkumar P, 2006, PROTEIN SCI, V15, P2488, DOI 10.1110/ps.062338206; Sharma KK, 2000, J BIOL CHEM, V275, P3767, DOI 10.1074/jbc.275.6.3767; Shearer T R, 1997, Mol Vis, V3, P8; SRINIVASAN AN, 1992, J BIOL CHEM, V267, P23337; Staniszewska MM, 2006, MOL CELL BIOCHEM, V288, P29, DOI 10.1007/s11010-005-9115-1; Velotta JB, 2011, ANN THORAC SURG, V91, P1907, DOI 10.1016/j.athoracsur.2011.02.072; Voss OH, 2007, J BIOL CHEM, V282, P25088, DOI 10.1074/jbc.M701740200; Wilmarth PA, 2006, J PROTEOME RES, V5, P2554, DOI 10.1021/pr050473a; Yan Q, 2006, DIFFERENTIATION, V74, P195, DOI 10.1111/j.1432-0436.2006.00068.x; Zhang ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026102	47	61	65	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13022	13035		10.1074/jbc.M112.440214	http://dx.doi.org/10.1074/jbc.M112.440214			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23508955	Green Published, hybrid			2022-12-28	WOS:000318555100054
J	Fu, XM; Shi, XD; Yin, LX; Liu, JF; Joo, K; Lee, J; Chang, ZY				Fu, Xinmiao; Shi, Xiaodong; Yin, Linxiang; Liu, Jiafeng; Joo, Keehyoung; Lee, Jooyoung; Chang, Zengyi			Small Heat Shock Protein IbpB Acts as a Robust Chaperone in Living Cells by Hierarchically Activating Its Multi-type Substrate-binding Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ALPHA-CRYSTALLIN; MOLECULAR CHAPERONES; 1,1'-BI(4-ANILINO)NAPHTHALENE-5,5'-DISULFONIC ACID; DENATURED PROTEINS; STRESS; HSP26; OLIGOMERIZATION; DISORDER; OVEREXPRESSION	As ubiquitous molecular chaperones, small heat shock proteins (sHSPs) are crucial for protein homeostasis. It is not clear why sHSPs are able to bind a wide spectrum of non-native substrate proteins and how such binding is enhanced by heat shock. Here, by utilizing a genetically incorporated photo-cross-linker (p-benzoyl-L-phenylalanine), we systematically characterized the substrate-binding residues in IbpB (a sHSP from Escherichia coli) in living cells over a wide spectrum of temperatures (from 20 to 50 degrees C). A total of 20 and 48 residues were identified at normal and heat shock temperatures, respectively. They are not necessarily hydrophobic and can be classified into three types: types I and II were activated at low and normal temperatures, respectively, and type III mediated oligomerization at low temperature but switched to substrate binding at heat shock temperature. In addition, substrate binding of IbpB in living cells began at temperatures as low as 25 degrees C and was further enhanced upon temperature elevation. Together, these in vivo data provide novel structural insights into the wide substrate spectrum of sHSPs and suggest that sHSP is able to hierarchically activate its multi-type substrate-binding residues and thus act as a robust chaperone in cells under fluctuating growth conditions.	[Fu, Xinmiao; Shi, Xiaodong; Yin, Linxiang; Liu, Jiafeng; Chang, Zengyi] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Fu, Xinmiao; Shi, Xiaodong; Yin, Linxiang; Liu, Jiafeng; Chang, Zengyi] Peking Univ, Ctr Prot Sci, Beijing 100871, Peoples R China; [Shi, Xiaodong] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou 221002, Peoples R China; [Joo, Keehyoung; Lee, Jooyoung] Korea Inst Adv Study, Ctr Silico Prot Sci, Seoul 130722, South Korea; [Joo, Keehyoung] Korea Inst Adv Study, Ctr Adv Computat, Seoul 130722, South Korea; [Lee, Jooyoung] Korea Inst Adv Study, Sch Computat Sci, Seoul 130722, South Korea	Peking University; Peking University; Xuzhou Medical University; Korea Institute for Advanced Study (KIAS); Korea Institute for Advanced Study (KIAS); Korea Institute for Advanced Study (KIAS)	Fu, XM (corresponding author), Peking Univ, Sch Life Sci, 5 Yiheyuan Rd, Beijing 100871, Peoples R China.	fuxinmiao@pku.edu.cn; changzy@pku.edu.cn	Fu, Xinmiao/ABE-9050-2020	Fu, Xinmiao/0000-0003-3361-6904; Yin, Linxiang/0000-0002-9884-8194	National Basic Research Program of China (973 Program) [2012CB917300]; National Natural Science Foundation of China [31170738, 31100559, 31270804]; Creative Research Initiatives (Center for In Silico Protein Science) Grant from the National Research Foundation of Korea (MEST/KOSEF) [20110000040]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Creative Research Initiatives (Center for In Silico Protein Science) Grant from the National Research Foundation of Korea (MEST/KOSEF)	This work was supported by National Basic Research Program of China (973 Program) Research Grant 2012CB917300 (to Z. C. and X. F.), National Natural Science Foundation of China Research Grants 31170738 (to Z. C.) and 31100559 and 31270804 (to X. F.), and Creative Research Initiatives (Center for In Silico Protein Science) Grant 20110000040 from the National Research Foundation of Korea (MEST/KOSEF; to K. J. and J. Lee).	ALLEN SP, 1992, J BACTERIOL, V174, P6938, DOI 10.1128/JB.174.21.6938-6947.1992; ARATA S, 1995, J CELL PHYSIOL, V163, P458, DOI 10.1002/jcp.1041630305; Balogi Z, 2008, J BIOL CHEM, V283, P22983, DOI 10.1074/jbc.M710400200; Bardwell JCA, 2012, TRENDS BIOCHEM SCI, V37, P517, DOI 10.1016/j.tibs.2012.08.006; Basha E, 2004, J BIOL CHEM, V279, P7566, DOI 10.1074/jbc.M310684200; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; Benesch JLP, 2008, J BIOL CHEM, V283, P28513, DOI 10.1074/jbc.M804729200; Bova MP, 2002, J BIOL CHEM, V277, P38468, DOI 10.1074/jbc.M205594200; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; Franzmann TM, 2008, MOL CELL, V29, P207, DOI 10.1016/j.molcel.2007.11.025; Franzmann TM, 2005, J MOL BIOL, V350, P1083, DOI 10.1016/j.jmb.2005.05.034; Fu XM, 2005, J BIOL CHEM, V280, P6337, DOI 10.1074/jbc.M406319200; Fuchs M, 2010, BIOCHEM J, V425, P245, DOI 10.1042/BJ20090907; Gu LX, 2002, J MOL BIOL, V319, P517, DOI 10.1016/S0022-2836(02)00311-X; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M, 2004, J MOL BIOL, V343, P445, DOI 10.1016/j.jmb.2004.08.048; Haslbeck M, 2008, J MOL BIOL, V378, P362, DOI 10.1016/j.jmb.2008.01.095; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Jiao WW, 2008, BIOCHEM J, V410, P63, DOI 10.1042/BJ20071120; Jiao WW, 2005, BIOCHEM BIOPH RES CO, V335, P227, DOI 10.1016/j.bbrc.2005.07.065; Jiao WW, 2005, J MOL BIOL, V347, P871, DOI 10.1016/j.jmb.2005.01.029; Joo K, 2008, BIOPHYS J, V95, P4813, DOI 10.1529/biophysj.108.129684; Joo K, 2007, PROTEINS, V69, P83, DOI 10.1002/prot.21628; Joo K, 2009, PROTEINS, V75, P1010, DOI 10.1002/prot.22312; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Laskowska E, 2010, CURR PHARM BIOTECHNO, V11, P146, DOI 10.2174/138920110790909669; Leroux MR, 1997, J BIOL CHEM, V272, P24646, DOI 10.1074/jbc.272.39.24646; LeThanh H, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-6; Matuszewska M, 2005, J BIOL CHEM, V280, P12292, DOI 10.1074/jbc.M412706200; Mogk A, 2003, MOL MICROBIOL, V50, P585, DOI 10.1046/j.1365-2958.2003.03710.x; Morrow G, 2004, J BIOL CHEM, V279, P43382, DOI 10.1074/jbc.C400357200; Nakamoto H, 2007, CELL MOL LIFE SCI, V64, P294, DOI 10.1007/s00018-006-6321-2; Plater ML, 1996, J BIOL CHEM, V271, P28558, DOI 10.1074/jbc.271.45.28558; Raman B, 1997, J BIOL CHEM, V272, P23559, DOI 10.1074/jbc.272.38.23559; Reichmann D, 2012, CELL, V148, P947, DOI 10.1016/j.cell.2012.01.045; Richards EH, 1996, CANCER RES, V56, P2446; Sharma KK, 1998, J BIOL CHEM, V273, P15474, DOI 10.1074/jbc.273.25.15474; Sharma KK, 1998, J BIOL CHEM, V273, P8965, DOI 10.1074/jbc.273.15.8965; Shearstone JR, 1999, J BIOL CHEM, V274, P9937, DOI 10.1074/jbc.274.15.9937; Shi J, 2013, J BIOL CHEM, V288, P4819, DOI 10.1074/jbc.M112.388132; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Strozecka J, 2012, J BIOL CHEM, V287, P2843, DOI 10.1074/jbc.M111.273847; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Torok Z, 2001, P NATL ACAD SCI USA, V98, P3098, DOI 10.1073/pnas.051619498; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; Welker S, 2010, MOL CELL, V39, P507, DOI 10.1016/j.molcel.2010.08.001; Zhang M, 2011, NAT CHEM BIOL, V7, P671, DOI [10.1038/NCHEMBIO.644, 10.1038/nchembio.644]	52	30	31	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11897	11906		10.1074/jbc.M113.450437	http://dx.doi.org/10.1074/jbc.M113.450437			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486475	Green Published, hybrid			2022-12-28	WOS:000318157600025
J	Medina, F; Carter, AM; Dada, O; Gutowski, S; Hadas, J; Chen, Z; Sternweis, PC				Medina, Frank; Carter, Angela M.; Dada, Olugbenga; Gutowski, Stephen; Hadas, Jana; Chen, Zhe; Sternweis, Paul C.			Activated RhoA Is a Positive Feedback Regulator of the Lbc Family of Rho Guanine Nucleotide Exchange Factor Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; P115 RHOGEF; G-ALPHA(13); IDENTIFICATION; MECHANISMS; GTPASES	The monomeric Rho GTPases are essential for cellular regulation including cell architecture and movement. A direct mechanism for hormonal regulation of the RhoA-type GTPases is their modulation by the G(12) and G(13) proteins via RH (RGS homology) containing RhoGEFs. In addition to the interaction of the Gprotein alpha subunits with the RH domain, activated RhoA also binds to the pleckstrin homology (PH) domain of PDZRhoGEF. The latter interaction is now extended to all seven members of the homologous Lbc family of RhoGEFs which includes the RH-RhoGEFs. This is evinced by direct measurements of binding or through effects on selected signaling pathways in cells. Overexpression of these PH domains alone can block RhoA-dependent signaling in cells to various extents. Whereas activated RhoA does not modulate the intrinsic activity of the RhoGEFs, activated RhoA associated with phospholipid vesicles can facilitate increased activity of soluble RhoGEFs on vesicle-delimited substrate (RhoA-GDP). This demonstrates feasibility of the hypothesis that binding of activated RhoA to the PH domains acts as a positive feedback mechanism. This is supported by cellular studies in which mutation of this binding site on PH strongly attenuates the stimulation of RhoA observed by overexpression of five of the RhoGEF DH-PH domains. This mutation is even more dramatic in the context of full-length p115RhoGEF. The utilization of this mechanism by multiple RhoGEFs suggests that this regulatory paradigm may be a common feature in the broader family of RhoGEFs.	[Medina, Frank; Carter, Angela M.; Dada, Olugbenga; Gutowski, Stephen; Hadas, Jana; Sternweis, Paul C.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Chen, Zhe] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sternweis, PC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	paul.sternweis@UTsouthwestern.edu		Carter, Angela/0000-0001-5766-3743; Chen, Zhe/0000-0002-1668-4051	National Institutes of Health [GM31954]; Robert A. Welch Foundation [I-1262]; Alfred and Mabel Gilman Chair in Molecular Pharmacology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Alfred and Mabel Gilman Chair in Molecular Pharmacology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM31954 (to P. C. S.). This work was also supported by Robert A. Welch Foundation Grant I-1262 (to P. C. S.) and the Alfred and Mabel Gilman Chair in Molecular Pharmacology (to P. C. S.).	Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Aittaleb M, 2009, CELL SIGNAL, V21, P1569, DOI 10.1016/j.cellsig.2009.06.003; Blomquist A, 2000, BIOCHEM J, V352, P319, DOI 10.1042/0264-6021:3520319; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Chen Z, 2008, STRUCTURE, V16, P1532, DOI 10.1016/j.str.2008.07.009; Chen Z, 2012, J BIOL CHEM, V287, P25490, DOI 10.1074/jbc.M111.333716; Chen Z, 2011, PROTEIN SCI, V20, P107, DOI 10.1002/pro.542; Chen Z, 2010, J BIOL CHEM, V285, P21070, DOI 10.1074/jbc.M110.122549; Cheng L, 2004, J BIOL CHEM, V279, P12786, DOI 10.1074/jbc.M313099200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sternweis PC, 2007, ADV PROTEIN CHEM, V74, P189, DOI 10.1016/S0065-3233(07)74006-8; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; Wells CD, 2002, J BIOL CHEM, V277, P1174, DOI 10.1074/jbc.M105274200; Wells CD, 2001, J BIOL CHEM, V276, P28897, DOI 10.1074/jbc.M102913200	20	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11325	11333		10.1074/jbc.M113.450056	http://dx.doi.org/10.1074/jbc.M113.450056			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23493395	Green Published, hybrid			2022-12-28	WOS:000317915500035
J	Davey, L; Ng, CKW; Halperin, SA; Lee, SF				Davey, Lauren; Ng, Crystal K. W.; Halperin, Scott A.; Lee, Song F.			Functional Analysis of Paralogous Thiol-disulfide Oxidoreductases in Streptococcus gordonii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMOLECULAR ISOPEPTIDE BONDS; CYTOCHROME-C MATURATION; GRAM-POSITIVE BACTERIA; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; BIOFILM FORMATION; IN-VIVO; MYCOBACTERIUM-TUBERCULOSIS; FORMATION PATHWAY; CRYSTAL-STRUCTURE	Disulfide bonds are important for the stability of many extracellular proteins, including bacterial virulence factors. Formation of these bonds is catalyzed by thiol-disulfide oxidoreductases (TDORs). Little is known about their formation in Gram-positive bacteria, particularly among facultative anaerobic Firmicutes, such as streptococci. To investigate disulfide bond formation in Streptococcus gordonii, we identified five putative TDORs from the sequenced genome. Each of the putative TDOR genes was insertionally inactivated with an erythromycin resistance cassette, and the mutants were analyzed for autolysis, extracellular DNA release, biofilm formation, bacteriocin production, and genetic competence. This analysis revealed a single TDOR, SdbA, which exhibited a pleiotropic mutant phenotype. Using an in silico analysis approach, we identified the major autolysin AtlS as a natural substrate of SdbA and showed that SdbA is critical to the formation of a disulfide bond that is required for autolytic activity. Analysis by BLAST search revealed homologs to SdbA in other Gram-positive species. This study provides the first in vivo evidence of an oxidoreductase, SdbA, that affects multiple phenotypes in a Gram-positive bacterium. SdbA shows low sequence homology to previously identified oxidoreductases, suggesting that it may belong to a different class of enzymes. Our results demonstrate that SdbA is required for disulfide bond formation in S. gordonii and indicate that this enzyme may represent a novel type of oxidoreductase in Gram-positive bacteria.	[Davey, Lauren; Ng, Crystal K. W.; Halperin, Scott A.; Lee, Song F.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada; [Davey, Lauren; Ng, Crystal K. W.; Halperin, Scott A.; Lee, Song F.] Dalhousie Univ, Canadian Ctr Vaccinol, Halifax, NS B3K 6R8, Canada; [Davey, Lauren; Ng, Crystal K. W.; Halperin, Scott A.; Lee, Song F.] Izaak Walton Killam Hlth Ctr, Halifax, NS B3K 6R8, Canada; [Halperin, Scott A.; Lee, Song F.] Dalhousie Univ, Fac Med, Dept Pediat, Halifax, NS B3K 6R8, Canada; [Lee, Song F.] Dalhousie Univ, Fac Dent, Dept Appl Oral Sci, Halifax, NS B3H 4R2, Canada	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University	Lee, SF (corresponding author), Dalhousie Univ, Fac Dent, Dept Appl Oral Sci, 5981 Univ Ave, Halifax, NS B3H 4R2, Canada.	song.lee@dal.ca		Davey, Lauren/0000-0002-9541-485X; Halperin, Scott/0000-0003-0525-589X	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC).	Ahn SJ, 2007, J BACTERIOL, V189, P6293, DOI 10.1128/JB.00546-07; Ahn SJ, 2006, J BACTERIOL, V188, P6877, DOI 10.1128/JB.00536-06; Akif M, 2008, J BACTERIOL, V190, P7087, DOI 10.1128/JB.00159-08; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andisi VF, 2012, INFECT IMMUN, V80, P1037, DOI 10.1128/IAI.05563-11; Baker MD, 2004, PROTEIN SCI, V13, P2285, DOI 10.1110/ps.04826804; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bernsel A, 2008, P NATL ACAD SCI USA, V105, P7177, DOI 10.1073/pnas.0711151105; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; Burne RA, 1999, J BACTERIOL, V181, P2863, DOI 10.1128/JB.181.9.2863-2871.1999; Chim N, 2010, J MOL BIOL, V396, P1211, DOI 10.1016/j.jmb.2009.12.060; CLAVERYS JP, 1995, GENE, V164, P123, DOI 10.1016/0378-1119(95)00485-O; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daniels R, 2010, J BIOL CHEM, V285, P3300, DOI 10.1074/jbc.M109.081398; Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09; Davis E, 2011, APPL ENVIRON MICROB, V77, P1660, DOI 10.1128/AEM.02178-10; Dorenbos R, 2002, J BIOL CHEM, V277, P16682, DOI 10.1074/jbc.M201158200; Draskovic I, 2005, MOL MICROBIOL, V55, P881, DOI 10.1111/j.1365-2958.2004.04430.x; DUNNY GM, 1991, APPL ENVIRON MICROB, V57, P1194, DOI 10.1128/AEM.57.4.1194-1201.1991; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Fontaine L, 2008, APPL ENVIRON MICROB, V74, P1102, DOI 10.1128/AEM.02030-07; Forsgren N, 2010, J MOL BIOL, V397, P740, DOI 10.1016/j.jmb.2010.01.065; GLOCKSHUBER R, 1992, BIOCHEMISTRY-US, V31, P1270, DOI 10.1021/bi00120a002; Goulding CW, 2004, J BIOL CHEM, V279, P3516, DOI 10.1074/jbc.M311833200; Heng NCK, 2007, J BACTERIOL, V189, P1468, DOI 10.1128/JB.01174-06; Hennecke J, 1999, J MOL BIOL, V286, P1197, DOI 10.1006/jmbi.1998.2531; Heras B, 2007, ACTA CRYSTALLOGR F, V63, P953, DOI 10.1107/S174430910704821X; Heras B, 2008, J BIOL CHEM, V283, P4261, DOI 10.1074/jbc.M707838200; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; ISHIHARA T, 1995, J BACTERIOL, V177, P745, DOI 10.1128/jb.177.3.745-749.1995; Itzek A, 2011, J BACTERIOL, V193, P6912, DOI 10.1128/JB.05791-11; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; Kim YK, 2009, MOL MICROBIOL, V72, P699, DOI 10.1111/j.1365-2958.2009.06680.x; Knight JB, 2008, CLIN VACCINE IMMUNOL, V15, P925, DOI 10.1128/CVI.00500-07; Kobayashi T, 1999, EMBO J, V18, P1192, DOI 10.1093/emboj/18.5.1192; Kreth J, 2009, J BACTERIOL, V191, P6281, DOI 10.1128/JB.00906-09; Layec S, 2008, J MOL MICROB BIOTECH, V14, P31, DOI 10.1159/000106080; Lee SF, 2002, FEMS MICROBIOL LETT, V208, P175, DOI 10.1016/S0378-1097(02)00457-3; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; Liu G, 2009, MICROBIOL-SGM, V155, P584, DOI 10.1099/mic.0.022707-0; Liu YL, 2011, J BACTERIOL, V193, P2826, DOI 10.1128/JB.00056-11; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; Lunsford RD, 1996, J BACTERIOL, V178, P5831, DOI 10.1128/jb.178.19.5831-5835.1996; Mavridou DAI, 2012, FEBS LETT, V586, P1702, DOI 10.1016/j.febslet.2012.04.055; Meima R, 2002, J BIOL CHEM, V277, P6994, DOI 10.1074/jbc.M111380200; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; Pirazzini M, 2011, CELL MICROBIOL, V13, P1731, DOI 10.1111/j.1462-5822.2011.01654.x; Rietsch A, 1996, P NATL ACAD SCI USA, V93, P13048, DOI 10.1073/pnas.93.23.13048; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stenson TH, 2002, INFECT IMMUN, V70, P2297, DOI 10.1128/IAI.70.5.2297-2303.2002; Stirnimann CU, 2005, STRUCTURE, V13, P985, DOI 10.1016/j.str.2005.04.014; Su D, 2007, BIOCHEMISTRY-US, V46, P6903, DOI 10.1021/bi700152b; Tremblay YDN, 2009, MICROBIOL-SGM, V155, P2856, DOI 10.1099/mic.0.028456-0; van der Kooi-Pol MM, 2012, APPL ENVIRON MICROB, V78, P7124, DOI 10.1128/AEM.01565-12; Wey JJ, 2006, ACTA PHARMACOL SIN, V27, P1238, DOI 10.1111/j.1745-7254.2006.00372.x; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265; YAMANAKA H, 1994, J BACTERIOL, V176, P2906, DOI 10.1128/JB.176.10.2906-2913.1994; Zhang Y, 2005, INFECT IMMUN, V73, P3351, DOI 10.1128/IAI.73.6.3351-3357.2005; Zhang YS, 2009, MICROBIOL-SGM, V155, P165, DOI 10.1099/mic.0.023168-0	63	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16416	16429		10.1074/jbc.M113.464578	http://dx.doi.org/10.1074/jbc.M113.464578			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23615907	hybrid, Green Published			2022-12-28	WOS:000320378900019
J	Neukamm, SS; Ott, J; Dammeier, S; Lehmann, R; Haring, HU; Schleicher, E; Weigert, C				Neukamm, Sabine S.; Ott, Jennifer; Dammeier, Sascha; Lehmann, Rainer; Haering, Hans-Ulrich; Schleicher, Erwin; Weigert, Cora			Phosphorylation of Serine 1137/1138 of Mouse Insulin Receptor Substrate (IRS) 2 Regulates cAMP-dependent Binding to 14-3-3 Proteins and IRS2 Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; MEDIATED PHOSPHORYLATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; FATTY-ACIDS; DUAL ROLE; 14-3-3-PROTEINS; EXPRESSION; SPECIFICITY; INDUCTION	Insulin receptor substrate (IRS) 2 as intermediate docking platform transduces the insulin/IGF-1 (insulin like growth factor 1) signal to intracellular effector molecules that regulate glucose homeostasis, beta-cell growth, and survival. Previously, IRS2 has been identified as a 14-3-3 interaction protein. 14-3-3 proteins can bind their target proteins via phosphorylated serine/threonine residues located within distinct motifs. In this study the binding of 14-3-3 to IRS2 upon stimulation with forskolin or the cAMP analog 8-(4-chlorophenylthio)-cAMP was demonstrated in HEK293 cells. Binding was reduced with PKA inhibitors H89 or R-p-8-Br-cAMPS. Phosphorylation of IRS2 on PKA consensus motifs was induced by forskolin and the PKA activator N-6-Phe-cAMP and prevented by both PKA inhibitors. The amino acid region after position 952 on IRS2 was identified as the 14-3-3 binding region by GST-14-3-3 pulldown assays. Mass spectrometric analysis revealed serine 1137 and serine 1138 as cAMP-dependent, potential PKA phosphorylation sites. Mutation of serine 1137/1138 to alanine strongly reduced the cAMP-dependent 14-3-3 binding. Application of cycloheximide revealed that forskolin enhanced IRS2 protein stability in HEK293 cells stably expressing IRS2 as well as in primary hepatocytes. Stimulation with forskolin did not increase protein stability either in the presence of a 14-3-3 antagonist or in the double 1137/1138 alanine mutant. Thus the reduced IRS2 protein degradation was dependent on the interaction with 14-3-3 proteins and the presence of serine 1137/1138. We present serine 1137/1138 as novel cAMP-dependent phosphorylation sites on IRS2 and show their importance in 14-3-3 binding and IRS2 protein stability.	[Neukamm, Sabine S.; Lehmann, Rainer; Schleicher, Erwin; Weigert, Cora] Univ Tubingen Hosp, Div Clin Chem & Pathobiochem, D-72076 Tubingen, Germany; [Haering, Hans-Ulrich] Univ Tubingen Hosp, Div Endocrinol Diabetol Vasc Med Nephrol & Clin C, Dept Internal Med 4, D-72076 Tubingen, Germany; [Lehmann, Rainer; Haering, Hans-Ulrich; Schleicher, Erwin; Weigert, Cora] Univ Tubingen Hosp, German Ctr Diabet Res DZD, D-72076 Tubingen, Germany; [Ott, Jennifer; Dammeier, Sascha] Univ Tubingen Hosp, Inst Ophtalm Res, Med Proteome Ctr, D-72076 Tubingen, Germany; [Neukamm, Sabine S.; Lehmann, Rainer; Haering, Hans-Ulrich; Schleicher, Erwin; Weigert, Cora] Univ Tubingen, Inst Diabet Res & Metab Dis, Helmholtz Ctr Munich, Paul Langerhans Inst Tuebingen, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Weigert, C (corresponding author), Univ Tubingen, Dept Internal Med 4, Div Pathobiochem & Clin Chem, Otfried Mueller Str 10, D-72076 Tubingen, Germany.	Cora.Weigert@med.uni-tuebingen.de	Lehmann, Rainer/AAF-4281-2019	Lehmann, Rainer/0000-0003-1218-6810	Deutsche Forschungsgemeinschaft, German Federal Ministry of Education and Research (BMBF) [GRK 1302/2]; European Community's Seventh Framework Programme [241955]	Deutsche Forschungsgemeinschaft, German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Community's Seventh Framework Programme	This work was supported by Grant GRK 1302/2 from the Deutsche Forschungsgemeinschaft (to H. U. H., E. S., and C. W.) in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.), and by European Community's Seventh Framework Programme FP7/2009 Grant 241955.	Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200; Canettieri G, 2005, CELL METAB, V2, P331, DOI 10.1016/j.cmet.2005.09.008; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Danielsson A, 2005, J BIOL CHEM, V280, P34389, DOI 10.1074/jbc.C500230200; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dubois F, 2009, MOL CELL PROTEOMICS, V8, P2487, DOI 10.1074/mcp.M800544-MCP200; Ferl RJ, 2004, PHYSIOL PLANTARUM, V120, P173, DOI 10.1111/j.0031-9317.2004.0239.x; Fritsche L, 2011, AM J PHYSIOL-ENDOC M, V300, pE824, DOI 10.1152/ajpendo.00409.2010; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Greene MW, 2002, BIOCHEMISTRY-US, V41, P7082, DOI 10.1021/bi015992f; Gurevitch D, 2010, DIABETES, V59, P2188, DOI 10.2337/db09-0890; Hausser A, 2006, J CELL SCI, V119, P3613, DOI 10.1242/jcs.03104; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirashima Y, 2003, J ENDOCRINOL, V179, P253, DOI 10.1677/joe.0.1790253; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kleppe R, 2011, SEMIN CELL DEV BIOL, V22, P713, DOI 10.1016/j.semcdb.2011.08.008; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Li XF, 2004, J BIOL CHEM, V279, P34201, DOI 10.1074/jbc.M405179200; Lingohr MK, 2006, J BIOL CHEM, V281, P15884, DOI 10.1074/jbc.M600356200; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Masters SC, 1999, BIOCHEMISTRY-US, V38, P5216, DOI 10.1021/bi982492m; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Neukamm SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043296; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Ogihara T, 1997, J BIOL CHEM, V272, P25267, DOI 10.1074/jbc.272.40.25267; Oriente F, 2001, J BIOL CHEM, V276, P37109, DOI 10.1074/jbc.M104405200; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Roscioni SS, 2008, N-S ARCH PHARMACOL, V377, P345, DOI 10.1007/s00210-007-0246-7; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Rui LY, 2001, J BIOL CHEM, V276, P40362, DOI 10.1074/jbc.M105332200; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Schuppin GT, 1998, DIABETES, V47, P1074, DOI 10.2337/diabetes.47.7.1074; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Sharfi H, 2008, AM J PHYSIOL-ENDOC M, V294, pE307, DOI 10.1152/ajpendo.00534.2007; Short JD, 2010, MOL CARCINOGEN, V49, P429, DOI 10.1002/mc.20613; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Sumioka A, 2005, J BIOL CHEM, V280, P42364, DOI 10.1074/jbc.M504278200; Van de Velde S, 2011, P NATL ACAD SCI USA, V108, P16876, DOI 10.1073/pnas.1114228108; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Weigert C, 2008, MOL ENDOCRINOL, V22, P2729, DOI 10.1210/me.2008-0102; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wu H, 2010, ANGEW CHEM INT EDIT, V49, P6528, DOI 10.1002/anie.201003257; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang HY, 2003, MOL CELL BIOL, V23, P7096, DOI 10.1128/MCB.23.20.7096-7107.2003; Yi ZP, 2005, ANAL CHEM, V77, P5693, DOI 10.1021/ac050760y; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450	60	24	25	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16403	16415		10.1074/jbc.M113.474593	http://dx.doi.org/10.1074/jbc.M113.474593			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23615913	Green Published, hybrid			2022-12-28	WOS:000320378900018
J	Yang, JB; Singh, V; Cha, BY; Chen, TE; Sarker, R; Murtazina, R; Jin, S; Zachos, NC; Patterson, GH; Tse, CM; Kovbasnjuk, O; Li, XH; Donowitz, M				Yang, Jianbo; Singh, Varsha; Cha, Boyoung; Chen, Tian-E; Sarker, Rafiquel; Murtazina, Rakhilya; Jin, Shi; Zachos, Nicholas C.; Patterson, George H.; Tse, C. Ming; Kovbasnjuk, Olga; Li, Xuhang; Donowitz, Mark			NHERF2 Protein Mobility Rate Is Determined by a Unique C-terminal Domain That Is Also Necessary for Its Regulation of NHE3 Protein in OK Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/H+ EXCHANGER ISOFORM; ILEAL BRUSH-BORDER; PLASMA-MEMBRANE; CA2+-DEPENDENT INHIBITION; SCAFFOLDING PROTEINS; DEPENDENT MECHANISM; BINDING PARTNERS; 2-PHOTON FRAP; H+ EXCHANGER; LIPID RAFTS	Na+/H+ exchanger regulatory factor (NHERF) proteins are a family of PSD-95/Discs-large/ZO-1 (PDZ)-scaffolding proteins, three of which (NHERFs 1-3) are localized to the brush border in kidney and intestinal epithelial cells. All NHERF proteins are involved in anchoring membrane proteins that contain PDZ recognition motifs to form multiprotein signaling complexes. In contrast to their predicted immobility, NHERF1, NHERF2, and NHERF3 were all shown by fluorescence recovery after photobleaching/confocal microscopy to be surprisingly mobile in the microvilli of the renal proximal tubule OK cell line. Their diffusion coefficients, although different among the three, were all of the same magnitude as that of the transmembrane proteins, suggesting they are all anchored in the microvilli but to different extents. NHERF3 moves faster than NHERF1, and NHERF2 moves the slowest. Several chimeras and mutants of NHERF1 and NHERF2 were made to determine which part of NHERF2 confers the slower mobility rate. Surprisingly, the slower mobility rate of NHERF2 was determined by a unique C-terminal domain, which includes a nonconserved region along with the ezrin, radixin, moesin (ERM) binding domain. Also, this C-terminal domain of NHERF2 determined its greater detergent insolubility and was necessary for the formation of larger multiprotein NHERF2 complexes. In addition, this NHERF2 domain was functionally significant in NHE3 regulation, being necessary for stimulation by lysophosphatidic acid of activity and increased mobility of NHE3, as well as necessary for inhibition of NHE3 activity by calcium ionophore 4-Br-A23187. Thus, multiple functions of NHERF2 require involvement of an additional domain in this protein.	[Yang, Jianbo; Singh, Varsha; Cha, Boyoung; Chen, Tian-E; Sarker, Rafiquel; Murtazina, Rakhilya; Jin, Shi; Zachos, Nicholas C.; Tse, C. Ming; Kovbasnjuk, Olga; Li, Xuhang; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA; [Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Patterson, George H.] Natl Inst Biomed Imaging & Bioengn, Biophoton Sect, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Donowitz, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, 925 Ross Res Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.	mdonowit@jhmi.edu	Patterson, George/ABI-4751-2020; Zachos, Nicholas/GWC-7914-2022; Yang, Jianbo/G-1254-2013	Jin, Shi/0000-0003-0177-5716	National Institutes of Health from NIDDK [R01DK26523, R01DK61765, P01DK072084, K08DK088950]; National Institutes of Health [P30DK089502]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502, P01DK072084, R01DK026523, K08DK088950, R01DK061765] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01DK26523, R01DK61765, P01DK072084, and K08DK088950 from NIDDK.; We thank John Gibas and Molee Chakraborty (Johns Hopkins University) for technical assistance. We thank Dr. Chris Yun (Emory University) for providing rabbit polyclonal antibody against NHERF2 and plasmid pcDNA3.1-LPA5R. We thank Dr. Jerrold Turner (University of Chicago) for providing the Caco-2/bbe cell line. We acknowledge use of the Kudsi Imaging Core Facility of the Conte Hopkins Digestive Disease Basic and Translational Research Core Center (supported by National Institutes of Health Grant P30DK089502).	Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Ardura JA, 2011, J BIOL CHEM, V286, P35020, DOI 10.1074/jbc.M111.264978; BERRYMAN M, 1995, J CELL BIOL, V131, P1231, DOI 10.1083/jcb.131.5.1231; BRANT SR, 1995, AM J PHYSIOL-CELL PH, V269, pC198, DOI 10.1152/ajpcell.1995.269.1.C198; Brown JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009406; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; Cha BY, 2010, J CELL SCI, V123, P2434, DOI 10.1242/jcs.056713; Cha BY, 2004, J CELL SCI, V117, P3353, DOI 10.1242/jcs.01180; Chen MM, 2010, J PHYSIOL-LONDON, V588, P5049, DOI 10.1113/jphysiol.2010.198721; Cinar A, 2007, J PHYSIOL-LONDON, V581, P1235, DOI 10.1113/jphysiol.2007.131722; COLE JA, 1989, AM J PHYSIOL, V256, pF672, DOI 10.1152/ajprenal.1989.256.4.F672; Coscoy S, 2002, P NATL ACAD SCI USA, V99, P12813, DOI 10.1073/pnas.192084599; Cotton LM, 2010, MOL REPROD DEV, V77, P114, DOI 10.1002/mrd.21122; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Finnerty CM, 2004, J CELL SCI, V117, P1547, DOI 10.1242/jcs.01038; Garbett D, 2012, J CELL BIOL, V198, P195, DOI 10.1083/jcb.201204008; Haggie PM, 2004, J BIOL CHEM, V279, P5494, DOI 10.1074/jbc.M312445200; Han W, 2006, J BIOL CHEM, V281, P1461, DOI 10.1074/jbc.M509786200; Itoh K, 2002, J IMMUNOL, V168, P541, DOI 10.4049/jimmunol.168.2.541; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Kim JH, 2002, J BIOL CHEM, V277, P23714, DOI 10.1074/jbc.M200835200; LaLonde DP, 2010, MOL BIOL CELL, V21, P1519, DOI 10.1091/mbc.E10-01-0008; Lange K, 2011, J CELL PHYSIOL, V226, P896, DOI 10.1002/jcp.22302; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Lee-Kwon W, 2003, AM J PHYSIOL-CELL PH, V285, pC1527, DOI 10.1152/ajpcell.00017.2003; Lee-Kwon W, 2003, J BIOL CHEM, V278, P16494, DOI 10.1074/jbc.M300580200; Li XH, 2004, J PHYSIOL-LONDON, V556, P791, DOI 10.1113/jphysiol.2004.060921; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; Lin R, 2011, GASTROENTEROLOGY, V140, P560, DOI 10.1053/j.gastro.2010.10.042; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; Lissner S, 2010, AM J PHYSIOL-GASTR L, V299, pG907, DOI 10.1152/ajpgi.00191.2010; Mavrakis M., 2008, CURR PROTOC CELL BIO; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Morales FC, 2007, MOL CELL BIOL, V27, P2527, DOI 10.1128/MCB.01372-06; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Murtazina R, 2011, AM J PHYSIOL-CELL PH, V301, pC126, DOI 10.1152/ajpcell.00311.2010; Padanyi R, 2010, J BIOL CHEM, V285, P31704, DOI 10.1074/jbc.M110.164137; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; Sarker R, 2011, AM J PHYSIOL-CELL PH, V300, pC771, DOI 10.1152/ajpcell.00119.2010; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Seidler U, 2009, ANN NY ACAD SCI, V1165, P249, DOI 10.1111/j.1749-6632.2009.04046.x; Terawaki S, 2006, STRUCTURE, V14, P777, DOI 10.1016/j.str.2006.01.015; Tyska MJ, 2002, BIOPHYS J, V82, P1869, DOI 10.1016/S0006-3495(02)75537-9; Wade JB, 2003, AM J PHYSIOL-CELL PH, V285, pC1494, DOI 10.1152/ajpcell.00092.2003; Waharte F, 2005, BIOPHYS J, V88, P1467, DOI 10.1529/biophysj.104.049619; Weinman EJ, 2009, AM J PHYSIOL-RENAL, V297, pF1560, DOI 10.1152/ajprenal.90657.2008; Weinman EJ, 2003, BIOCHEMISTRY-US, V42, P12662, DOI 10.1021/bi035244l; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; Weinman EJ, 2001, AM J PHYSIOL-RENAL, V281, pF374, DOI 10.1152/ajprenal.2001.281.2.F374; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zachos NC, 2008, CELL PHYSIOL BIOCHEM, V22, P693, DOI 10.1159/000185553; Zhu XJ, 2011, J BIOL CHEM, V286, P34486, DOI 10.1074/jbc.M111.230219	55	11	11	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16960	16974		10.1074/jbc.M113.470799	http://dx.doi.org/10.1074/jbc.M113.470799			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612977	hybrid, Green Published			2022-12-28	WOS:000320378900068
J	Bi, D; Toyama, K; Lemaitre, V; Takai, J; Fan, F; Jenkins, DP; Wulff, H; Gutterman, DD; Park, F; Miura, H				Bi, Dan; Toyama, Kazuyoshi; Lemaitre, Vincent; Takai, Jun; Fan, Fan; Jenkins, David P.; Wulff, Heike; Gutterman, David D.; Park, Frank; Miura, Hiroto			The Intermediate Conductance Calcium-activated Potassium Channel KCa3.1 Regulates Vascular Smooth Muscle Cell Proliferation via Controlling Calcium-dependent Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; UP-REGULATION; PHENOTYPIC MODULATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; GROWTH-FACTOR; CA2+; BLOCKADE; IKCA1; DIFFERENTIATION	The intermediate conductance calcium-activated potassium channel KCa3.1 contributes to a variety of cell activation processes in pathologies such as inflammation, carcinogenesis, and vascular remodeling. We examined the electrophysiological and transcriptional mechanisms by which KCa3.1 regulates vascular smooth muscle cell (VSMC) proliferation. Platelet-derived growth factor-BB (PDGF)-induced proliferation of human coronary artery VSMCs was attenuated by lowering intracellular Ca2+ concentration ([Ca2+](i)) and was enhanced by elevating [Ca2+](i). KCa3.1 blockade or knockdown inhibited proliferation by suppressing the rise in [Ca2+](i) and attenuating the expression of phosphorylated cAMP-response element-binding protein (CREB), c-Fos, and neuron-derived orphan receptor-1 (NOR-1). This antiproliferative effect was abolished by elevating [Ca2+](i). KCa3.1 overexpression induced VSMC proliferation, and potentiated PDGF-induced proliferation, by inducing CREB phosphorylation, c-Fos, and NOR-1. Pharmacological stimulation of KCa3.1 unexpectedly suppressed proliferation by abolishing the expression and activity of KCa3.1 and PDGF beta-receptors and inhibiting the rise in [Ca2+](i). The stimulation also attenuated the levels of phosphorylated CREB, c-Fos, and cyclin expression. After KCa3.1 blockade, the characteristic round shape of VSMCs expressing high l-caldesmon and low calponin-1 (dedifferentiation state) was maintained, whereas KCa3.1 stimulation induced a spindle-shaped cellular appearance, with low l-caldesmon and high calponin-1. In conclusion, KCa3.1 plays an important role in VSMC proliferation via controlling Ca2+-dependent signaling pathways, and its modulation may therefore constitute a new therapeutic target for cell proliferative diseases such as atherosclerosis.	[Bi, Dan; Lemaitre, Vincent; Takai, Jun; Miura, Hiroto] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA; [Toyama, Kazuyoshi; Fan, Fan; Gutterman, David D.; Park, Frank; Miura, Hiroto] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Toyama, Kazuyoshi; Fan, Fan; Gutterman, David D.; Park, Frank; Miura, Hiroto] Med Coll Wisconsin, Ctr Cardiovasc, Milwaukee, WI 53226 USA; [Jenkins, David P.; Wulff, Heike] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Medical College of Wisconsin; Medical College of Wisconsin; University of California System; University of California Davis	Miura, H (corresponding author), Univ Nevada, Sch Med, Dept Physiol & Cell Biol, 1664 N Virginia St,MS0575, Reno, NV 89557 USA.	hmiura@medicine.nevada.edu	wulff, Heike/Z-2056-2019; Park, Frank/I-4590-2019	Park, Frank/0000-0003-2324-2937	National Institutes of Health [RO1HL080173, HL080173-02S1, P20 RR018751, P20 GM103513, RO1 GM076063, P01 HL68769, RO1 DK090123]; Advancing a Healthier Wisconsin grant from the Medical College of Wisconsin; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018751] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068769, R01HL113612, R01HL080173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103513, R01GM076063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Advancing a Healthier Wisconsin grant from the Medical College of Wisconsin; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1HL080173, HL080173-02S1, P20 RR018751, and P20 GM103513 (to H. M.); RO1 GM076063 (to H. W.); P01 HL68769 (to D. D. G.); and RO1 DK090123 (to F. P.). This work was also supported by an Advancing a Healthier Wisconsin grant from the Medical College of Wisconsin.	Barlow CA, 2006, J PHYSIOL-LONDON, V570, P59, DOI 10.1113/jphysiol.2005.098426; Berkefeld H, 2010, PHYSIOL REV, V90, P1437, DOI 10.1152/physrev.00049.2009; BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; BOONSTRA J, 1981, J CELL PHYSIOL, V107, P75, DOI 10.1002/jcp.1041070110; Brugnara C, 1996, J CLIN INVEST, V97, P1227, DOI 10.1172/JCI118537; Cheong A, 2005, MOL CELL, V20, P45, DOI 10.1016/j.molcel.2005.08.030; Choi J, 2006, CIRC RES, V98, P1273, DOI 10.1161/01.RES.0000223059.19250.91; Chou CC, 2008, EXPERT REV MOL DIAGN, V8, P179, DOI 10.1586/14737159.8.2.179; DESDOUETS C, 1995, MOL CELL BIOL, V15, P3301; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Grgic I, 2005, ARTERIOSCL THROM VAS, V25, P704, DOI 10.1161/01.ATV.0000156399.12787.5c; Hollenbeck ST, 2004, J VASC SURG, V40, P351, DOI 10.1016/j.jvs.2004.03.047; Kaplan-Albuquerque N, 2005, CIRC RES, V97, P427, DOI 10.1161/01.RES.0000179776.40216.a9; Koegel H, 2003, J BIOL CHEM, V278, P3323, DOI 10.1074/jbc.M208914200; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Koledova VV, 2006, CIRC RES, V98, P1240, DOI 10.1161/01.RES.0000225860.41648.63; Martinez-Gonzalez J, 2003, CIRC RES, V92, P96, DOI 10.1161/01.ES.0000050921.53008.47; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McAllister J, 2008, BIOCHEM PHARMACOL, V75, P956, DOI 10.1016/j.bcp.2007.10.019; MIANO JM, 1993, AM J PATHOL, V142, P715; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Neylon CB, 2002, VASC PHARMACOL, V38, P35, DOI 10.1016/S1537-1891(02)00124-6; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Park F, 2000, NAT GENET, V24, P49, DOI 10.1038/71673; Pena TL, 1999, J MEMBRANE BIOL, V172, P249, DOI 10.1007/s002329900601; Pulver RA, 2004, CIRC RES, V94, P1351, DOI 10.1161/01.RES.0000127618.34500.FD; Raicu M, 2000, FUNDAM CLIN PHARM, V14, P477, DOI 10.1111/j.1472-8206.2000.tb00430.x; ROTHMAN A, 1994, J BIOL CHEM, V269, P6399; Rouzaire-Dubois B, 2000, PFLUG ARCH EUR J PHY, V440, P881, DOI 10.1007/s004240000371; Saito T, 2002, CLIN EXP PHARMACOL P, V29, P324, DOI 10.1046/j.1440-1681.2002.03652.x; Sankaranarayanan A, 2009, MOL PHARMACOL, V75, P281, DOI 10.1124/mol.108.051425; Shepherd MC, 2007, AM J RESP CELL MOL, V37, P525, DOI 10.1165/rcmb.2006-0358OC; Si H, 2006, BRIT J PHARMACOL, V148, P909, DOI 10.1038/sj.bjp.0706793; Sirois MG, 1997, CIRCULATION, V95, P669, DOI 10.1161/01.CIR.95.3.669; Strobaek D, 2004, BBA-BIOMEMBRANES, V1665, P1, DOI 10.1016/j.bbamem.2004.07.006; Sun D, 2003, AM J PHYSIOL-GASTR L, V285, pG12, DOI 10.1152/ajpgi.00513.2002; Sylvester AM, 1998, J CLIN INVEST, V101, P940, DOI 10.1172/JCI1630; Tao R, 2008, AM J PHYSIOL-CELL PH, V295, pC1409, DOI 10.1152/ajpcell.00268.2008; Terata Y, 2003, PHARMACOLOGY, V68, P169, DOI 10.1159/000070455; Tharp DL, 2008, ARTERIOSCL THROM VAS, V28, P1084, DOI 10.1161/ATVBAHA.107.155796; Tharp DL, 2006, AM J PHYSIOL-HEART C, V291, pH2493, DOI 10.1152/ajpheart.01254.2005; Tolic-Norrelykke IM, 2005, J BIOMECH, V38, P1405, DOI 10.1016/j.jbiomech.2004.06.027; Toyama K, 2008, J CLIN INVEST, V118, P3025, DOI 10.1172/JCI30836; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2004, J IMMUNOL, V173, P776, DOI 10.4049/jimmunol.173.2.776; Wulff H, 2007, CURR MED CHEM, V14, P1437, DOI 10.2174/092986707780831186; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11; Yamashita M, 2006, FEBS J, V273, P3585, DOI 10.1111/j.1742-4658.2006.05365.x	51	60	63	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15843	15853		10.1074/jbc.M112.427187	http://dx.doi.org/10.1074/jbc.M112.427187			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23609438	Green Published, hybrid			2022-12-28	WOS:000319822300038
J	Girgenrath, T; Mahalingam, M; Svensson, B; Nitu, FR; Cornea, RL; Fessenden, JD				Girgenrath, Tanya; Mahalingam, Mohana; Svensson, Bengt; Nitu, Florentin R.; Cornea, Razvan L.; Fessenden, James D.			N-terminal and Central Segments of the Type 1 Ryanodine Receptor Mediate Its Interaction with FK506-binding Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE CHANNEL; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; BINDING-PROTEIN; IMMUNOSUPPRESSANT FK506; SARCOPLASMIC-RETICULUM; SELECTIVE BINDING; FKBP12.6 BINDING; CORE; LOCALIZATION; DISEASE	We used site-directed labeling of the type 1 ryanodine receptor (RyR1) and fluorescence resonance energy transfer (FRET) measurements to map RyR1 sequence elements forming the binding site of the 12-kDa binding protein for the immunosuppressant drug, FK506. This protein, FKBP12, promotes the RyR1 closed state, thereby inhibiting Ca2+ leakage in resting muscle. Although FKBP12 function is well established, its binding determinants within the RyR1 protein sequence remain unresolved. To identify these sequence determinants using FRET, we created five single-Cys FKBP variants labeled with Alexa Fluor 488 (denoted D-FKBP) and then targeted these D-FKBPs to full-length RyR1 constructs containing decahistidine (His(10)) "tags" placed within N-terminal (amino acid residues 76-619) or central (residues 2157-2777) regions of RyR1. The FRET acceptor Cy3NTA bound specifically and saturably to these His tags, allowing distance analysis of FRET measured from each D-FKBP variant to Cy3NTA bound to each His tag. Results indicate that D-FKBP binds proximal to both N-terminal and central domains of RyR1, thus suggesting that the FKBP binding site is composed of determinants from both regions. These findings further imply that the RyR1 N-terminal and central domains are proximal to one another, a core premise of the domain-switch hypothesis of RyR function. We observed FRET from GFP fused at position 620 within the N-terminal domain to central domain His-tagged sites, thus further supporting this hypothesis. Taken together, these results support the conclusion that N-terminal and central domain elements are closely apposed near the FKBP binding site within the RyR1 three-dimensional structure.	[Girgenrath, Tanya; Mahalingam, Mohana; Fessenden, James D.] Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, Boston, MA 02115 USA; [Svensson, Bengt; Nitu, Florentin R.; Cornea, Razvan L.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	Harvard University; Brigham & Women's Hospital; University of Minnesota System; University of Minnesota Twin Cities	Fessenden, JD (corresponding author), Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.	jfessenden@partners.org		Cornea, Razvan/0000-0001-5739-0992; Nitu, Florentin/0000-0001-9768-6333	National Institutes of Health [R01AR059124, R01HL092097]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612, R01AR059124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AR059124 ( to J.D.F.) and R01HL092097 ( to R. L. C.).	AIREY JA, 1990, J BIOL CHEM, V265, P14187; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Burkhard P, 2000, J MOL BIOL, V295, P953, DOI 10.1006/jmbi.1999.3411; Cameron AM, 1997, J BIOL CHEM, V272, P27582, DOI 10.1074/jbc.272.44.27582; CHEN SRW, 1993, J BIOL CHEM, V268, P22642; Cornea RL, 2010, J BIOL CHEM, V285, P19219, DOI 10.1074/jbc.M109.066944; Cornea RL, 2009, P NATL ACAD SCI USA, V106, P6128, DOI 10.1073/pnas.0813010106; DENBOROUGH MA, 1973, BMJ-BRIT MED J, V1, P272, DOI 10.1136/bmj.1.5848.272; Fessenden JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007338; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Gaburjakova M, 2001, J BIOL CHEM, V276, P16931, DOI 10.1074/jbc.M100856200; Guo T, 2011, BIOPHYS J, V101, P2170, DOI 10.1016/j.bpj.2011.09.030; Guo T, 2010, CIRC RES, V106, P1743, DOI 10.1161/CIRCRESAHA.110.219816; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; Ikemoto N, 2002, FRONT BIOSCI-LANDMRK, V7, pD671, DOI 10.2741/ikemoto; JAYARAMAN T, 1992, J BIOL CHEM, V267, P9474; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Liu Z, 2010, J CELL SCI, V123, P1775, DOI 10.1242/jcs.064071; Marks AR, 1996, PHYSIOL REV, V76, P631, DOI 10.1152/physrev.1996.76.3.631; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Masumiya H, 2003, J BIOL CHEM, V278, P3786, DOI 10.1074/jbc.M210962200; MAYRLEITNER M, 1994, CELL CALCIUM, V15, P99, DOI 10.1016/0143-4160(94)90048-5; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raina SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038594; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Samso M, 2006, J MOL BIOL, V356, P917, DOI 10.1016/j.jmb.2005.12.023; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; TIMERMAN AP, 1994, BIOCHEM BIOPH RES CO, V198, P701, DOI 10.1006/bbrc.1994.1101; Timerman AP, 1996, J BIOL CHEM, V271, P20385, DOI 10.1074/jbc.271.34.20385; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Wagenknecht T, 1996, BIOPHYS J, V70, P1709, DOI 10.1016/S0006-3495(96)79733-3; Wang RW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194316; Xin HB, 1999, J BIOL CHEM, V274, P15315, DOI 10.1074/jbc.274.22.15315; Yamamoto T, 2000, J BIOL CHEM, V275, P11618, DOI 10.1074/jbc.275.16.11618; Zissimopoulos S, 2005, CELL BIOCHEM BIOPHYS, V43, P203, DOI 10.1385/CBB:43:2:203; Zissimopoulos S, 2005, J BIOL CHEM, V280, P5475, DOI 10.1074/jbc.M412954200	40	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16073	16084		10.1074/jbc.M113.463299	http://dx.doi.org/10.1074/jbc.M113.463299			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23585572	Green Published, hybrid			2022-12-28	WOS:000319822300058
J	Burke, KA; Kauffman, KJ; Umbaugh, CS; Frey, SL; Legleiter, J				Burke, Kathleen A.; Kauffman, Karlina J.; Umbaugh, C. Samuel; Frey, Shelli L.; Legleiter, Justin			The Interaction of Polyglutamine Peptides with Lipid Membranes Is Regulated by Flanking Sequences Associated with Huntingtin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; N-TERMINAL FRAGMENTS; MUTANT HUNTINGTIN; MECHANICAL-PROPERTIES; AMINO-TERMINUS; HD MUTATION; IN-VITRO; DISEASE; AGGREGATION; PHOSPHOLIPIDS	Huntington disease (HD) is caused by an expanded polyglutamine (poly(Q)) repeat near the N terminus of the huntingtin (htt) protein. Expanded poly(Q) facilitates formation of htt aggregates, eventually leading to deposition of cytoplasmic and intranuclear inclusion bodies containing htt. Flanking sequences directly adjacent to the poly(Q) domain, such as the first 17 amino acids on the N terminus (Nt17) and the polyproline (poly(P)) domain on the C-terminal side of the poly(Q) domain, heavily influence aggregation. Additionally, htt interacts with a variety of membraneous structures within the cell, and Nt17 is implicated in lipid binding. To investigate the interaction between htt exon1 and lipid membranes, a combination of in situ atomic force microscopy, Langmuir trough techniques, and vesicle permeability assays were used to directly monitor the interaction of a variety of synthetic poly(Q) peptides with different combinations of flanking sequences (KK-Q(35)-KK, KK-Q(35)-P-10-KK, Nt17-Q(35)-KK, and Nt17-Q(35)-P-10-KK) on model membranes and surfaces. Each peptide aggregated on mica, predominately forming extended, fibrillar aggregates. In contrast, poly(Q) peptides that lacked the Nt17 domain did not appreciably aggregate on or insert into lipid membranes. Nt17 facilitated the interaction of peptides with lipid surfaces, whereas the poly(P) region enhanced this interaction. The aggregation of Nt17-Q(35)-P-10-KK on the lipid bilayer closely resembled that of a htt exon1 construct containing 35 repeat glutamines. Collectively, this data suggests that the Nt17 domain plays a critical role in htt binding and aggregation on lipid membranes, and this lipid/htt interaction can be further modulated by the presence of the poly(P) domain.	[Burke, Kathleen A.; Umbaugh, C. Samuel; Legleiter, Justin] W Virginia Univ, C Eugene Bennett Dept Chem, Morgantown, WV 26505 USA; [Legleiter, Justin] W Virginia Univ, WVnano Initiat, Morgantown, WV 26505 USA; [Legleiter, Justin] W Virginia Univ, Ctr Neurosci, Morgantown, WV 26505 USA; [Kauffman, Karlina J.; Frey, Shelli L.] Gettysburg Coll, Dept Chem, Gettysburg, PA 17325 USA	West Virginia University; West Virginia University; West Virginia University; Gettysburg College	Legleiter, J (corresponding author), 217 Clark Hall, Morgantown, WV 26506 USA.	justin.legleiter@mail.wvu.edu		Legleiter, Justin/0000-0002-5262-1867	Brodie Discovery and Innovation fund, National Science Foundation Grant [1054211]; Gettysburg College; West Virginia University Summer Undergraduate Research Experience program; Directorate For Engineering [1054211] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	Brodie Discovery and Innovation fund, National Science Foundation Grant; Gettysburg College; West Virginia University Summer Undergraduate Research Experience program; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Brodie Discovery and Innovation fund, National Science Foundation Grant 1054211, and Gettysburg College (to K. J. K. and S. L. F.).; Supported by the West Virginia University Summer Undergraduate Research Experience program.	ANDERSON RL, 1982, CLIN CHIM ACTA, V121, P111, DOI 10.1016/0009-8981(82)90216-9; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Bugg CW, 2012, J BIOL CHEM, V287, P31739, DOI 10.1074/jbc.M112.353839; Bulone D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000111; Burke KA, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00017; Burke KA, 2011, METHODS, V53, P275, DOI 10.1016/j.ymeth.2010.12.028; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chen SM, 2001, PROTEIN SCI, V10, P887, DOI 10.1110/ps.42301; Chou HT, 2010, PEPTIDES, V31, P1811, DOI 10.1016/j.peptides.2010.06.021; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Colby DW, 2004, J MOL BIOL, V342, P901, DOI 10.1016/j.jmb.2004.07.054; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; Darnell GD, 2009, BIOPHYS J, V97, P2295, DOI 10.1016/j.bpj.2009.07.062; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; GEKKO K, 1979, J PHYS CHEM-US, V83, P2706, DOI 10.1021/j100484a006; Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Hirakura Y, 2000, J NEUROSCI RES, V60, P490, DOI 10.1002/(SICI)1097-4547(20000515)60:4<490::AID-JNR7>3.0.CO;2-9; Ignatova Z, 2006, J BIOL CHEM, V281, P12959, DOI 10.1074/jbc.M511523200; Janmey PA, 2004, TRENDS BIOCHEM SCI, V29, P364, DOI 10.1016/j.tibs.2004.05.003; Jayaraman M, 2012, J MOL BIOL, V415, P881, DOI 10.1016/j.jmb.2011.12.010; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kegel KB, 2005, J BIOL CHEM, V280, P36464, DOI 10.1074/jbc.M503672200; Kegel KB, 2009, J NEUROCHEM, V110, P1585, DOI 10.1111/j.1471-4159.2009.06255.x; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Lamaziere A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000201; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Legleiter J, 2006, P NATL ACAD SCI USA, V103, P4813, DOI 10.1073/pnas.0505628103; Legleiter J, 2004, J COLLOID INTERF SCI, V278, P96, DOI 10.1016/j.jcis.2004.05.009; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; LLOYD KG, 1979, SCIENCE, V205, P1147, DOI 10.1126/science.224459; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Michalek M, 2013, BIOCHEMISTRY-US, V52, P847, DOI 10.1021/bi301325q; Mishra R, 2012, J MOL BIOL, V415, P900, DOI 10.1016/j.jmb.2011.12.011; Monoi H, 2000, BIOPHYS J, V78, P2892, DOI 10.1016/S0006-3495(00)76830-5; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Ravina B, 2008, MOVEMENT DISORD, V23, P1223, DOI 10.1002/mds.21988; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Seelig A, 2000, J BIOL CHEM, V275, P17954, DOI 10.1074/jbc.M002264200; SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7; Shamitko-Klingensmith N, 2012, LANGMUIR, V28, P13411, DOI 10.1021/la302705f; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; SQUIRE PG, 1979, ARCH BIOCHEM BIOPHYS, V196, P165, DOI 10.1016/0003-9861(79)90563-0; Suopanki J, 2006, J NEUROCHEM, V96, P870, DOI 10.1111/j.1471-4159.2005.03620.x; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Valencia A, 2010, J NEUROSCI RES, V88, P179, DOI 10.1002/jnr.22184; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Williamson TE, 2010, J MOL BIOL, V396, P1295, DOI 10.1016/j.jmb.2009.12.017	57	60	62	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14993	15005		10.1074/jbc.M112.446237	http://dx.doi.org/10.1074/jbc.M112.446237			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23572526	Green Published, hybrid			2022-12-28	WOS:000319452100029
J	Chan, NLS; Guo, JZ; Zhang, TY; Mao, GG; Hou, CX; Yuan, FH; Huang, J; Zhang, YB; Wu, JX; Gu, LY; Li, GM				Chan, Nelson L. S.; Guo, Jinzhen; Zhang, Tianyi; Mao, Guogen; Hou, Caixia; Yuan, Fenghua; Huang, Jian; Zhang, Yanbin; Wu, Jianxin; Gu, Liya; Li, Guo-Min			Coordinated Processing of 3 ' Slipped (CAG)(n)/(CTG)(n) Hairpins by DNA Polymerases beta and delta Preferentially Induces Repeat Expansions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLET REPEATS; HUMAN-DISEASE; TRINUCLEOTIDE REPEATS; EXONUCLEASE ACTIVITY; DYNAMIC MUTATIONS; IN-VITRO; REPAIR; INSTABILITY; CELLS; MECHANISMS	Expansion of CAG/CTG trinucleotide repeats causes certain familial neurological disorders. Hairpin formation in the nascent strand during DNA synthesis is considered a major path for CAG/CTG repeat expansion. However, the underlying mechanism is unclear. We show here that removal or retention of a nascent strand hairpin during DNA synthesis depends on hairpin structures and types of DNA polymerases. Polymerase (pol) delta alone removes the 3'-slipped hairpin using its 3'-5' proofreading activity when the hairpin contains no immediate 3' complementary sequences. However, in the presence of pol beta, pol delta preferentially facilitates hairpin retention regardless of hairpin structures. In this reaction, pol beta incorporates several nucleotides to the hairpin 3'-end, which serves as an effective primer for the continuous DNA synthesis by pol delta, thereby leading to hairpin retention and repeat expansion. These findings strongly suggest that coordinated processing of 3'-slipped (CAG)(n)/(CTG)(n) hairpins by polymerases delta and beta on during DNA synthesis induces CAG/CTG repeat expansions.	[Chan, Nelson L. S.; Guo, Jinzhen; Zhang, Tianyi; Mao, Guogen; Hou, Caixia; Li, Guo-Min] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Chan, Nelson L. S.; Guo, Jinzhen; Zhang, Tianyi; Mao, Guogen; Hou, Caixia; Li, Guo-Min] Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY 40536 USA; [Guo, Jinzhen; Wu, Jianxin] Peking Univ, Capital Inst Pediat, Teaching Hosp, Dept Biochem, Beijing 100020, Peoples R China; [Zhang, Tianyi; Huang, Jian] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Yuan, Fenghua; Zhang, Yanbin] Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA	University of Kentucky; University of Kentucky; Capital Institute of Pediatrics (CIP); Peking University; Wuhan University; University of Miami	Wu, JX (corresponding author), Peking Univ, Capital Inst Pediat, Teaching Hosp, Dept Biochem, Beijing 100020, Peoples R China.	wjianxin@gmail.com	Zhang, Yanbin/F-2998-2011; Li, Guo-Min/I-5016-2014	Zhang, Yanbin/0000-0002-7263-5510; Li, Guo-Min/0000-0002-9842-4578	National Institutes of Health Grant [GM089684]; China Scholarship Council Grant [2010601083]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089684] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council Grant(China Scholarship Council); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported, in whole or in part, by National Institutes of Health Grant GM089684 (to G.-M.L.) and a China Scholarship Council Grant (Contract 2010601083) (to J.G.).	BYRNES JJ, 1976, BIOCHEMISTRY-US, V15, P2817, DOI 10.1021/bi00658a018; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Chan NLS, 2012, J BIOL CHEM, V287, P30151, DOI 10.1074/jbc.M112.389791; Daee DL, 2007, MOL CELL BIOL, V27, P102, DOI 10.1128/MCB.01167-06; de Noronha C M, 1992, PCR Methods Appl, V2, P131; Fazlieva R, 2009, NUCLEIC ACIDS RES, V37, P2854, DOI 10.1093/nar/gkp155; GACY AM, 1995, CELL, V81, P533; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Hou CX, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-11; Hou CX, 2009, NAT STRUCT MOL BIOL, V16, P869, DOI 10.1038/nsmb.1638; Kedar PS, 2002, J BIOL CHEM, V277, P31115, DOI 10.1074/jbc.M201497200; Kerrest A, 2009, NAT STRUCT MOL BIOL, V16, P159, DOI 10.1038/nsmb.1544; Kornberg A., 1992, DNA REPLICATION; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Krasilnikova MM, 2004, MOL CELL BIOL, V24, P2286, DOI 10.1128/MCB.24.6.2286-2295.2004; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Li XJ, 2011, NEUROBIOL DIS, V43, P4, DOI 10.1016/j.nbd.2010.11.018; Liu GQ, 2010, NAT CHEM BIOL, V6, P652, DOI [10.1038/nchembio.416, 10.1038/NCHEMBIO.416]; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Moore H, 1999, P NATL ACAD SCI USA, V96, P1504, DOI 10.1073/pnas.96.4.1504; Panigrahi GB, 2005, NAT STRUCT MOL BIOL, V12, P654, DOI 10.1038/nsmb959; Pearson CE, 2002, NUCLEIC ACIDS RES, V30, P4534, DOI 10.1093/nar/gkf572; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pelletier R, 2005, NUCLEIC ACIDS RES, V33, P5667, DOI 10.1093/nar/gki880; Petruska J, 1998, J BIOL CHEM, V273, P5204, DOI 10.1074/jbc.273.9.5204; Petruska J, 1996, NUCLEIC ACIDS RES, V24, P1992, DOI 10.1093/nar/24.11.1992; SMITH GK, 1995, NUCLEIC ACIDS RES, V23, P4303; TANABE K, 1979, BIOCHEMISTRY-US, V18, P3401, DOI 10.1021/bi00582a029; Usdin K, 2000, CELL MOL LIFE SCI, V57, P914, DOI 10.1007/PL00000734; WANG TSF, 1980, BIOCHEMISTRY-US, V19, P1782, DOI 10.1021/bi00550a009; Yamtich J, 2010, BBA-PROTEINS PROTEOM, V1804, P1136, DOI 10.1016/j.bbapap.2009.07.008; Zhang TY, 2012, DNA REPAIR, V11, P201, DOI 10.1016/j.dnarep.2011.10.020; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	35	18	18	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15015	15022		10.1074/jbc.M113.464370	http://dx.doi.org/10.1074/jbc.M113.464370			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23585564	Green Published, hybrid			2022-12-28	WOS:000319452100031
J	Fowler, T; Suh, H; Buratowski, S; Roy, AL				Fowler, Trent; Suh, Hyunsuk; Buratowski, Stephen; Roy, Ananda L.			Regulation of Primary Response Genes in B Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; C-FOS; TRANSCRIPTION; EXPRESSION; RECRUITMENT; ELONGATION; ACTIVATION; INDUCTION; LYMPHOCYTES; METHYLATION	Deregulated gene expression in B cells often results in various lymphoid malignancies and immune deficiencies. Therefore, understanding signal-induced gene regulatory pathways involved during B cell activation is important to tackle pathologies associated with altered B cell function. Primary response genes (PRGs) are rapidly induced upon signaling in B cells and other cell types and often encode oncogenic transcription factors, which are associated with various malignancies. However, an important issue that remains unclear is whether the fundamental mechanism of activation of these genes is essentially the same under such diverse conditions. c-fos is a PRG that is induced rapidly upon activation of B cells in response to a wide variety of stimuli. Using the c-fos gene as a candidate PRG, we addressed here how it is regulated in response to tumor-promoting and antigen-mimicking signals. Our results show that although the mRNA was induced and extinguished within minutes in response to both signals, surprisingly, apparently full-length unspliced pre-mRNA persisted for several hours in both cases. However, although the mitogenic signal resulted in a more sustained mRNA response that persisted for 4 h, antigenic signaling resulted in a more robust but very transient response that lasted for < 1 h. Moreover, the pre-mRNA profile exhibited significant differences between the two signals. Additionally, the splicing regulation was also observed with egr-2, but not with c-myc. Together, these results suggest a previously underappreciated regulatory step in PRG expression in B cells.	Tufts Univ, Sch Med, Sackler Sch Biomed Sci, Dept Pathol, Boston, MA 02111 USA; [Roy, Ananda L.] Tufts Univ, Sch Med, Sackler Sch Biomed Sci, Genet Program, Boston, MA 02111 USA; [Roy, Ananda L.] Tufts Univ, Sch Med, Sackler Sch Biomed Sci, Program Immunol, Boston, MA 02111 USA; [Suh, Hyunsuk; Buratowski, Stephen] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Tufts University; Tufts University; Tufts University; Harvard University; Harvard Medical School	Roy, AL (corresponding author), Tufts Univ, Dept Pathol, Genet Program, Sackler Sch Biomed Sci,Sch Med, 150 Harrison Ave, Boston, MA 02111 USA.	ananda.roy@tufts.edu			National Institutes of Health [AI079206]; American Heart Association [12GRNT12180023]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI079206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI079206 (to A. L. R.). This work was also supported by American Heart Association Grant 12GRNT12180023 (to A. L. R.).	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Albert BJ, 2009, MOL CANCER THER, V8, P2308, DOI 10.1158/1535-7163.MCT-09-0051; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; CHEN TA, 1987, P NATL ACAD SCI USA, V84, P5252, DOI 10.1073/pnas.84.15.5252; Chiba K, 2010, EXP CELL RES, V316, P2723, DOI 10.1016/j.yexcr.2010.05.036; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; COLLART MA, 1991, MOL CELL BIOL, V11, P2826, DOI 10.1128/MCB.11.5.2826; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Damdinsuren B, 2010, IMMUNITY, V32, P355, DOI 10.1016/j.immuni.2010.02.013; David CJ, 2011, GENE DEV, V25, P972, DOI 10.1101/gad.2038011; de Almeida SF, 2011, NAT STRUCT MOL BIOL, V18, P977, DOI 10.1038/nsmb.2123; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Fivaz J, 2000, GENE, V255, P185, DOI 10.1016/S0378-1119(00)00340-1; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Galbraith MD, 2011, CURR OPIN GENET DEV, V21, P160, DOI 10.1016/j.gde.2011.01.011; Glauser DA, 2006, NUCLEIC ACIDS RES, V34, P5175, DOI 10.1093/nar/gkl654; Gururajan M, 2008, J IMMUNOL, V181, P4590, DOI 10.4049/jimmunol.181.7.4590; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hartzog GA, 1996, MOL CELL BIOL, V16, P2848; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; HUO L, 1995, J IMMUNOL, V154, P3300; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kim S, 2011, N KOREAN REV, V7, P3; KLEMSZ MJ, 1989, J IMMUNOL, V143, P1032; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Lim KH, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011247; Listerman I, 2006, NAT STRUCT MOL BIOL, V13, P815, DOI 10.1038/nsmb1135; Maciejewski JP, 2012, BRIT J HAEMATOL, V158, P165, DOI 10.1111/j.1365-2141.2012.09158.x; MITTELSTADT PR, 1993, J IMMUNOL, V150, P4822; MONROE JG, 1985, J IMMUNOL, V135, P1674; Pinaud S, 1998, J MOL BIOL, V280, P785, DOI 10.1006/jmbi.1998.1905; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Rando OJ, 2012, CURR OPIN GENET DEV, V22, P148, DOI 10.1016/j.gde.2012.02.013; Richards S, 2008, IMMUNOL REV, V224, P183, DOI 10.1111/j.1600-065X.2008.00652.x; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Sims RJ, 2009, NAT GENET, V41, P270, DOI 10.1038/ng0309-270; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; THOMPSON CB, 1987, CELL, V51, P371, DOI 10.1016/0092-8674(87)90633-7; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343	46	7	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14906	14916		10.1074/jbc.M113.454355	http://dx.doi.org/10.1074/jbc.M113.454355			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23536186	hybrid, Green Published			2022-12-28	WOS:000319452100021
J	Temel, DB; Dutta, K; Alphonse, S; Nourikyan, J; Grangeasse, C; Ghose, R				Temel, Deniz B.; Dutta, Kaushik; Alphonse, Sebastien; Nourikyan, Julien; Grangeasse, Christophe; Ghose, Ranajeet			Regulatory Interactions between a Bacterial Tyrosine Kinase and Its Cognate Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOTYROSINE-PROTEIN PHOSPHATASE; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; CAPSULAR POLYSACCHARIDES; STREPTOCOCCUS-PNEUMONIAE; SUBSTRATE RECOGNITION; PHOSPHORYLATION; WZC; AUTOPHOSPHORYLATION; EXOPOLYSACCHARIDE	The cyclic process of autophosphorylation of the C-terminal tyrosine cluster (YC) of a bacterial tyrosine kinase and its subsequent dephosphorylation following interactions with a counter-acting tyrosine phosphatase regulates diverse physiological processes, including the biosynthesis and export of polysaccharides responsible for the formation of biofilms or virulence-determining capsules. We provide here the first detailed insight into this hitherto uncharacterized regulatory interaction at residue-specific resolution using Escherichia coli Wzc, a canonical bacterial tyrosine kinase, and its opposing tyrosine phosphatase, Wzb. The phosphatase Wzb utilizes a surface distal to the catalytic elements of the kinase, Wzc, to dock onto its catalytic domain (Wzc(CD)). Wzc(CD) binds in a largely YC-independent fashion near the Wzb catalytic site, inducing allosteric changes therein. YC dephosphorylation is proximity-mediated and reliant on the elevated concentration of phosphorylated YC near the Wzb active site resulting from Wzc(CD) docking. Wzb principally recognizes the phosphate of its phosphotyrosine substrate and further stabilizes the tyrosine moiety through ring stacking interactions with a conserved active site tyrosine.	[Temel, Deniz B.; Alphonse, Sebastien; Ghose, Ranajeet] CUNY City Coll, Dept Chem, New York, NY 10031 USA; [Temel, Deniz B.; Ghose, Ranajeet] CUNY, Grad Ctr, New York, NY 10016 USA; [Dutta, Kaushik] New York Struct Biol Ctr, New York, NY 10027 USA; [Nourikyan, Julien; Grangeasse, Christophe] Univ Lyon 1, BMSSI UMR 5086, CNRS, Inst Biol & Chim Prot, F-69367 Lyon, France	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Dutta, K (corresponding author), New York Struct Biol Ctr, 89 Convent Ave, New York, NY 10027 USA.	dutta@nysbc.org; rghose@sci.ccny.cuny.edu		Alphonse, Sebastien/0000-0002-2054-2005; Nourikyan, Julien/0000-0001-9943-1326; Grangeasse, Christophe/0000-0002-5484-4589	National Institutes of Health [GM084278, AI101792, 2G12RR03060, 8G12MD007603, CO6RR015495, P41GM066354]; CNRS, Universite de Lyon; Agence National de la Recherche [ANR-08-BLAN-0143, ANR-10-BLAN-1303-01]; New York State Office for Science, Technology, and Academic Research (NYSTAR); Keck Foundation; New York City Economic Development Corporation; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015495, G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084278, P41GM066354] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRS, Universite de Lyon(Centre National de la Recherche Scientifique (CNRS)); Agence National de la Recherche(French National Research Agency (ANR)); New York State Office for Science, Technology, and Academic Research (NYSTAR); Keck Foundation(W.M. Keck Foundation); New York City Economic Development Corporation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants GM084278 and AI101792. This work was also supported by CNRS, Universite de Lyon, and the Agence National de la Recherche (ANR-08-BLAN-0143 and ANR-10-BLAN-1303-01). The NMR facilities at City College of New York are partially supported by National Institutes of Health Grants 2G12RR03060 and 8G12MD007603. Facilities at the New York Structural Biology Center are supported by National Institutes of Health Grants CO6RR015495 and P41GM066354; the New York State Office for Science, Technology, and Academic Research (NYSTAR); the Keck Foundation; and the New York City Economic Development Corporation.	Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Bechet E, 2010, MOL MICROBIOL, V77, P1315, DOI 10.1111/j.1365-2958.2010.07291.x; Bechet E, 2009, AMINO ACIDS, V37, P499, DOI 10.1007/s00726-009-0237-8; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; BOGGS PT, 1989, ACM T MATH SOFTWARE, V15, P348, DOI 10.1145/76909.76913; Byrne JP, 2011, J BACTERIOL, V193, P2341, DOI 10.1128/JB.00074-11; Chen HB, 2008, P NATL ACAD SCI USA, V105, P19660, DOI 10.1073/pnas.0807752105; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; Cowan-Jacob SW, 2006, CELL MOL LIFE SCI, V63, P2608, DOI 10.1007/s00018-006-6202-8; Cozzone AJ, 2004, ARCH MICROBIOL, V181, P171, DOI 10.1007/s00203-003-0640-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doublet P, 2002, J BIOL CHEM, V277, P37339, DOI 10.1074/jbc.M204465200; Duclos B, 1996, J MOL BIOL, V259, P891, DOI 10.1006/jmbi.1996.0366; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Grangeasse C, 2003, J BIOL CHEM, V278, P39323, DOI 10.1074/jbc.M305134200; Grangeasse C, 1997, GENE, V204, P259, DOI 10.1016/S0378-1119(97)00554-4; Grangeasse C, 1998, J MOL BIOL, V278, P339, DOI 10.1006/jmbi.1998.1650; Grangeasse C, 2007, TRENDS BIOCHEM SCI, V32, P86, DOI 10.1016/j.tibs.2006.12.004; Grangeasse C, 2012, PHILOS T R SOC B, V367, P2640, DOI 10.1098/rstb.2011.0424; Grangeasse C, 2010, BBA-PROTEINS PROTEOM, V1804, P628, DOI 10.1016/j.bbapap.2009.08.018; Hagelueken G, 2009, J MOL BIOL, V392, P678, DOI 10.1016/j.jmb.2009.07.026; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Jadeau F, 2008, BIOINFORMATICS, V24, P2427, DOI 10.1093/bioinformatics/btn462; Jadeau F, 2012, NUCLEIC ACIDS RES, V40, pD321, DOI 10.1093/nar/gkr915; Jers C, 2008, EXPERT REV PROTEOMIC, V5, P619, DOI 10.1586/14789450.5.4.619; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kolot M, 2008, VIROLOGY, V375, P383, DOI 10.1016/j.virol.2008.02.011; Lacour S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003053; Latham MP, 2009, J AM CHEM SOC, V131, P5052, DOI 10.1021/ja900695m; Lee DC, 2008, EMBO J, V27, P1758, DOI 10.1038/emboj.2008.97; Lemak A, 2011, J BIOMOL NMR, V49, P27, DOI 10.1007/s10858-010-9458-0; Lescop E, 2006, J BIOL CHEM, V281, P19570, DOI 10.1074/jbc.M601263200; Madhurantakam C, 2005, J BACTERIOL, V187, P2175, DOI 10.1128/JB.187.6.2175-2181.2005; MANAI M, 1982, BIOCHEM BIOPH RES CO, V107, P981, DOI 10.1016/0006-291X(82)90619-2; Mao Y, 2006, LETT APPL MICROBIOL, V42, P642, DOI 10.1111/j.1472-765X.2006.01875.x; Mijakovic I, 2003, EMBO J, V22, P4709, DOI 10.1093/emboj/cdg458; Morona JK, 2006, P NATL ACAD SCI USA, V103, P8505, DOI 10.1073/pnas.0602148103; Muratore KE, 2007, ACS CHEM BIOL, V2, P454, DOI 10.1021/cb7001285; Nadler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037984; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Obadia B, 2007, J MOL BIOL, V367, P42, DOI 10.1016/j.jmb.2006.12.048; Olivares-Illana V, 2008, PLOS BIOL, V6, P1321, DOI 10.1371/journal.pbio.0060143; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Paiment A, 2002, J BACTERIOL, V184, P6437, DOI 10.1128/JB.184.23.6437-6447.2002; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Petranovic D, 2007, MOL MICROBIOL, V63, P1797, DOI 10.1111/j.1365-2958.2007.05625.x; Pettiford SM, 2003, LEUKEMIA, V17, P366, DOI 10.1038/sj.leu.2402767; Preneta R, 2002, COMP BIOCHEM PHYS B, V131, P103, DOI 10.1016/S1096-4959(01)00490-0; Rainey MA, 2005, J AM CHEM SOC, V127, P10494, DOI 10.1021/ja052915p; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Stehle T, 2012, J BIOL CHEM, V287, P34569, DOI 10.1074/jbc.M112.399261; Tabernero L, 2008, FEBS J, V275, P867, DOI 10.1111/j.1742-4658.2008.06251.x; Temel DB, 2014, BIOMOL NMR ASSIGN, V8, P37, DOI 10.1007/s12104-012-9448-0; Tsygankov AY, 2003, FRONT BIOSCI-LANDMRK, V8, pS595, DOI 10.2741/1106; Vega C, 2011, J MOL BIOL, V413, P24, DOI 10.1016/j.jmb.2011.08.015; Vincent C, 1999, J BACTERIOL, V181, P3472, DOI 10.1128/JB.181.11.3472-3477.1999; Vincent C, 2000, J MOL BIOL, V304, P311, DOI 10.1006/jmbi.2000.4217; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	67	22	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15212	15228		10.1074/jbc.M113.457804	http://dx.doi.org/10.1074/jbc.M113.457804			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23543749	hybrid, Green Published			2022-12-28	WOS:000319452100049
J	Tobe, R; Naranjo-Suarez, S; Everley, RA; Carlson, BA; Turanov, AA; Tsuji, PA; Yoo, MH; Gygi, SP; Gladyshev, VN; Hatfield, DL				Tobe, Ryuta; Naranjo-Suarez, Salvador; Everley, Robert A.; Carlson, Bradley A.; Turanov, Anton A.; Tsuji, Petra A.; Yoo, Min-Hyuk; Gygi, Steven P.; Gladyshev, Vadim N.; Hatfield, Dolph L.			High Error Rates in Selenocysteine Insertion in Mammalian Cells Treated with the Antibiotic Doxycycline, Chloramphenicol, or Geneticin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOREDOXIN REDUCTASE; GLUTATHIONE-PEROXIDASE; TRANSFER-RNA; PROTEIN-SYNTHESIS; CANCER-CELLS; SELENOPROTEINS; SELENIUM; AMINOGLYCOSIDES; TRANSLATION; SENSITIVITY	Antibiotics target bacteria by interfering with essential processes such as translation, but their effects on translation in mammalian cells are less well characterized. We found that doxycycline, chloramphenicol, and Geneticin (G418) interfered with insertion of selenocysteine (Sec), which is encoded by the stop codon, UGA, into selenoproteins in murine EMT6 cells. Treatment of EMT6 cells with these antibiotics reduced enzymatic activities and Sec insertion into thioredoxin reductase 1 (TR1) and glutathione peroxidase 1 (GPx1). However, these proteins were differentially affected due to varying errors in Sec insertion at UGA. In the presence of doxycycline, chloramphenicol, or G418, the Sec-containing form of TR1 decreased, whereas the arginine-containing and truncated forms of this protein increased. We also detected antibiotic-specific misinsertion of cysteine and tryptophan. Furthermore, misinsertion of arginine in place of Sec was commonly observed in GPx1 and glutathione peroxidase 4. TR1 was the most affected and GPx1 was the least affected by these translation errors. These observations were consistent with the differential use of two Sec tRNA isoforms and their distinct roles in supporting accuracy of Sec insertion into selenoproteins. The data reveal widespread errors in inserting Sec into proteins and in dysregulation of selenoprotein expression and function upon antibiotic treatment.	[Tobe, Ryuta; Naranjo-Suarez, Salvador; Carlson, Bradley A.; Yoo, Min-Hyuk; Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Everley, Robert A.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Turanov, Anton A.; Gladyshev, Vadim N.] Harvard Univ, Brigham & Womens Hosp, Div Genet, Sch Med,Dept Med, Boston, MA 02115 USA; [Tsuji, Petra A.] Towson Univ, Dept Biol Sci, Towson, MD 21252 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University System of Maryland; Towson University	Hatfield, DL (corresponding author), NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	hatfield@mail.nih.gov	Gladyshev, Vadim N/J-6187-2013; Suarez, Salvador Naranjo/K-8450-2017	Suarez, Salvador Naranjo/0000-0002-7038-0753; Gladyshev, Vadim/0000-0002-0372-7016	Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research; National Institutes of Health [GM065204, CA080946]; NATIONAL CANCER INSTITUTE [ZIABC010767, R01CA080946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM065204, R01GM065204, R01GM061603] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research (to D. L. H.) and by National Institutes of Health Grants GM065204 and CA080946 (to V. N. G.).	Arner ESJ, 1999, METHOD ENZYMOL, V300, P226; Birringer M, 2002, NAT PROD REP, V19, P693, DOI 10.1039/b205802m; Carlson BA, 2005, TOP CURR GENET, V12, P431, DOI 10.1007/b106652; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; Carlson BA, 2007, J BIOL CHEM, V282, P32591, DOI 10.1074/jbc.M707036200; Carvalho CML, 2011, FASEB J, V25, P370, DOI 10.1096/fj.10-157594; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Fife RS, 1997, J LAB CLIN MED, V130, P530, DOI 10.1016/S0022-2143(97)90130-X; Floquet C, 2011, NUCLEIC ACIDS RES, V39, P3350, DOI 10.1093/nar/gkq1277; GILBERTSONBEADLING S, 1995, CANCER CHEMOTH PHARM, V36, P418, DOI 10.1007/BF00686191; Gladyshev VN, 1998, BIOCHEM BIOPH RES CO, V251, P488, DOI 10.1006/bbrc.1998.9495; Handy DE, 2006, J BIOL CHEM, V281, P3382, DOI 10.1074/jbc.M511295200; HATFIELD D, 1979, BIOCHIM BIOPHYS ACTA, V564, P414, DOI 10.1016/0005-2787(79)90032-7; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hatfield DL, 2012, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, THIRD EDITION, P1, DOI 10.1007/978-1-4614-1025-6; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; Hermann T, 2007, CELL MOL LIFE SCI, V64, P1841, DOI 10.1007/s00018-007-7034-x; Ho YS, 1997, J BIOL CHEM, V272, P16644, DOI 10.1074/jbc.272.26.16644; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; JUNG JE, 1994, J BIOL CHEM, V269, P29739; Kim JY, 2011, BIOCHEM BIOPH RES CO, V409, P814, DOI 10.1016/j.bbrc.2011.05.096; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; McCoy LS, 2011, WIRES RNA, V2, P209, DOI 10.1002/wrna.60; Naranjo-Suarez S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030470; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Smith AD, 2002, METHOD ENZYMOL, V347, P113; Son K, 2009, ANTICANCER RES, V29, P3995; Squires JE, 2007, MOL CELL BIOL, V27, P7848, DOI 10.1128/MCB.00793-07; Stadtman TC, 2002, ANNU REV BIOCHEM, V71, P1, DOI 10.1146/annurev.biochem.71.083101.134224; Tan L K, 1999, Singapore Med J, V40, P445; Thompson J, 2002, J MOL BIOL, V322, P273, DOI 10.1016/S0022-2836(02)00784-2; Turanov AA, 2006, J BIOL CHEM, V281, P22953, DOI 10.1074/jbc.M604326200; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Xu XM, 2010, P NATL ACAD SCI USA, V107, P21430, DOI 10.1073/pnas.1009947107	34	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14709	14715		10.1074/jbc.M112.446666	http://dx.doi.org/10.1074/jbc.M112.446666			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23589299	Green Published, hybrid			2022-12-28	WOS:000319452100005
J	Bertsova, YV; Fadeeva, MS; Kostyrko, VA; Serebryakova, MV; Baykov, AA; Bogachev, AV				Bertsova, Yulia V.; Fadeeva, Maria S.; Kostyrko, Vitaly A.; Serebryakova, Marina V.; Baykov, Alexander A.; Bogachev, Alexander V.			Alternative Pyrimidine Biosynthesis Protein ApbE Is a Flavin Transferase Catalyzing Covalent Attachment of FMN to a Threonine Residue in Bacterial Flavoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-TRANSLOCATING NADH; QUINONE OXIDOREDUCTASE; VIBRIO-CHOLERAE; UBIQUINONE OXIDOREDUCTASE; NADHQUINONE OXIDOREDUCTASE; SUCCINATE-DEHYDROGENASE; THIAMINE SYNTHESIS; PROSTHETIC GROUPS; REDOX PROPERTIES; NQRC SUBUNITS	Na+-translocating NADH:quinone oxidoreductase (Na+-NQR) contains two flavin residues as redox-active prosthetic groups attached by a phosphoester bond to threonine residues in subunits NqrB and NqrC. We demonstrate here that flavinylation of truncated Vibrio harveyi NqrC at Thr-229 in Escherichia coli cells requires the presence of a co-expressed Vibrio apbE gene. The apbE genes cluster with genes for Na+-NQR and other FMN-binding flavoproteins in bacterial genomes and encode proteins with previously unknown function. Experiments with isolated NqrC and ApbE proteins confirmed that ApbE is the only protein factor required for NqrC flavinylation and also indicated that the reaction is Mg2+-dependent and proceeds with FAD but not FMN. Inactivation of the apbE gene in Klebsiella pneumoniae, wherein the nqr operon and apbE are well separated in the chromosome, resulted in a complete loss of the quinone reductase activity of Na+-NQR, consistent with its dependence on covalently bound flavin. Our data thus identify ApbE as a novel modifying enzyme, flavin transferase.	[Bertsova, Yulia V.; Fadeeva, Maria S.; Kostyrko, Vitaly A.; Serebryakova, Marina V.; Baykov, Alexander A.; Bogachev, Alexander V.] Moscow MV Lomonosov State Univ, Belozersky Inst Phys Chem Biol, Moscow 119992, Russia	Lomonosov Moscow State University	Bogachev, AV (corresponding author), Moscow MV Lomonosov State Univ, Belozersky Inst Phys Chem Biol, Dept Mol Energet Microorganisms, Moscow 119992, Russia.	bogachev@genebee.msu.ru	Bertsova, Yulia V./B-5505-2014; Bogachev, Alexander V/E-5844-2012; Baykov, Alexander A/C-7981-2012; Serebryakova, Marina/E-2986-2012; Baykov, Alexander/AAH-5301-2021	Bogachev, Alexander V/0000-0003-3035-4494; Serebryakova, Marina/0000-0002-5402-8215; Baykov, Alexander/0000-0002-2495-8200	Russian Foundation for Basic Research Project [13-04-00332, 12-04-01002]	Russian Foundation for Basic Research Project(Russian Foundation for Basic Research (RFBR))	This work was supported by Russian Foundation for Basic Research Project Numbers 13-04-00332 and 12-04-01002.	Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Backiel J, 2008, BIOCHEMISTRY-US, V47, P11273, DOI 10.1021/bi800920j; Barquera B, 2001, FEBS LETT, V492, P45, DOI 10.1016/S0014-5793(01)02224-4; Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2006, J BIOL CHEM, V281, P36482, DOI 10.1074/jbc.M605765200; Beck BJ, 1999, J BACTERIOL, V181, P7285, DOI 10.1128/JB.181.23.7285-7290.1999; Beck BJ, 1998, J BACTERIOL, V180, P885, DOI 10.1128/JB.180.4.885-891.1998; Bertsova YV, 2004, FEBS LETT, V563, P207, DOI 10.1016/S0014-5793(04)00312-6; Besteiro S, 2002, J BIOL CHEM, V277, P38001, DOI 10.1074/jbc.M201759200; Bogachev AV, 2012, MOL MICROBIOL, V86, P1452, DOI 10.1111/mmi.12067; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6291, DOI 10.1021/bi900524m; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6299, DOI 10.1021/bi900525v; Bogachev AV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P143, DOI 10.1007/s10541-005-0093-4; BOURNE RM, 1992, BIOCHEM SOC T, V20, P577, DOI 10.1042/bst0200577; Boyd JM, 2011, J BACTERIOL, V193, P887, DOI 10.1128/JB.00730-10; Casutt MS, 2012, BBA-BIOENERGETICS, V1817, P1817, DOI 10.1016/j.bbabio.2012.02.012; Casutt MS, 2010, J BIOL CHEM, V285, P27088, DOI 10.1074/jbc.M109.071126; Curatti L, 2005, P NATL ACAD SCI USA, V102, P6291, DOI 10.1073/pnas.0501216102; Deka RK, 2013, J BIOL CHEM, V288, P11106, DOI 10.1074/jbc.M113.449975; Fadeeva MS, 2008, FEMS MICROBIOL LETT, V279, P116, DOI 10.1111/j.1574-6968.2007.01015.x; Fadeeva MS, 2007, ARCH MICROBIOL, V188, P341, DOI 10.1007/s00203-007-0254-5; Han GW, 2006, PROTEINS, V64, P1083, DOI 10.1002/prot.20950; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; HAYASHI M, 1995, FEBS LETT, V363, P75, DOI 10.1016/0014-5793(95)00283-F; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Juarez O, 2012, BBA-BIOENERGETICS, V1817, P1823, DOI 10.1016/j.bbabio.2012.03.017; Kim J, 1995, J BIOL CHEM, V270, P31202, DOI 10.1074/jbc.270.52.31202; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawrence J, 1999, CURR OPIN GENET DEV, V9, P642, DOI 10.1016/S0959-437X(99)00025-8; Li QB, 2005, J PROTEOME RES, V4, P112, DOI 10.1021/pr049832c; Martinez-Gomez NC, 2008, BIOCHEMISTRY-US, V47, P9054, DOI 10.1021/bi8010253; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; Mcneil MB, 2012, J BIOL CHEM, V287, P18418, DOI 10.1074/jbc.M111.293803; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Muller V, 2008, ANN NY ACAD SCI, V1125, P137, DOI 10.1196/annals.1419.011; Munro AW, 1999, METH MOL B, V131, P25; Nakayama Y, 1998, FEBS LETT, V422, P240, DOI 10.1016/S0014-5793(98)00016-7; Rentzsch R, 2009, TRENDS BIOTECHNOL, V27, P210, DOI 10.1016/j.tibtech.2009.01.002; RICH PR, 1995, FEBS LETT, V375, P5, DOI 10.1016/0014-5793(95)01164-A; Saunders NFW, 2000, J BACTERIOL, V182, P5211, DOI 10.1128/JB.182.18.5211-5217.2000; SCHMEHL M, 1993, MOL GEN GENET, V241, P602, DOI 10.1007/BF00279903; Skovran E, 2003, J BACTERIOL, V185, P98, DOI 10.1128/JB.185.1.98-106.2003; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Turk K, 2004, J BIOL CHEM, V279, P21349, DOI 10.1074/jbc.M311692200; Verkhovsky MI, 2010, BBA-BIOENERGETICS, V1797, P738, DOI 10.1016/j.bbabio.2009.12.020; Wunsch P, 2005, J BACTERIOL, V187, P1992, DOI 10.1128/JB.187.6.1992-2001.2005; Yeats C, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-3; Zhou WD, 1999, BIOCHEMISTRY-US, V38, P16246, DOI 10.1021/bi991664s	52	52	55	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14276	14286		10.1074/jbc.M113.455402	http://dx.doi.org/10.1074/jbc.M113.455402			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23558683	hybrid, Green Published			2022-12-28	WOS:000319253500032
J	Bettaieb, A; Nagata, N; AbouBechara, D; Chahed, S; Morisseau, C; Hammock, BD; Haj, FG				Bettaieb, Ahmed; Nagata, Naoto; AbouBechara, Daniel; Chahed, Samah; Morisseau, Christophe; Hammock, Bruce D.; Haj, Fawaz G.			Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates Diet-induced Endoplasmic Reticulum Stress in Liver and Adipose Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ER STRESS; EPOXYEICOSATRIENOIC ACIDS; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; METABOLIC SYNDROME; BLOOD-PRESSURE; MESSENGER-RNA; CELL-DEATH; OBESITY	Soluble epoxide hydrolase (sEH) is a cytosolic enzyme whose inhibition has beneficial effects in cardiovascular, inflammatory, and metabolic diseases in murine models. Mice with targeted deletion or pharmacological inhibition of sEH exhibit improved insulin signaling in liver and adipose tissue. Herein, we assessed the role of sEH in regulating endoplasmic reticulum (ER) stress in liver and adipose tissue. We report that sEH expression was increased in the livers and adipose tissue of mice fed a high fat diet, the adipose tissue of overweight humans, and palmitate-treated cells. Importantly, sEH deficiency or inhibition in mice attenuated chronic high fat diet-induced ER stress in liver and adipose tissue. Similarly, pharmacological inhibition of sEH in HepG2 cells and 3T3-L1 adipocytes mitigated chemical-induced ER stress and activation of JNK, p38, and cell death. In addition, insulin signaling was enhanced in HepG2 cells treated with sEH substrates and attenuated in cells treated with sEH products. In summary, these findings demonstrate that sEH is a physiological modulator of ER stress and a potential target for mitigating complications associated with obesity.	[Bettaieb, Ahmed; Nagata, Naoto; AbouBechara, Daniel; Chahed, Samah; Haj, Fawaz G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Morisseau, Christophe; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Haj, Fawaz G.] Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA; [Morisseau, Christophe; Hammock, Bruce D.; Haj, Fawaz G.] Univ Calif Davis, Ctr Comprehens Canc, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Haj, FG (corresponding author), Univ Calif Davis, Dept Nutr, 3135 Meyer Hall, Davis, CA 95616 USA.	fghaj@ucdavis.edu	NAGATA, Naoto/D-9261-2012	NAGATA, Naoto/0000-0002-2389-2334	National Institutes of Health [R56 DK084317, R01 DK090492, ES02710]; Superfund Basic Research Program from NIEHS [P42 ES04699]; NHLBI [HL059699]; Juvenile Diabetes Research Foundation [1-2009-337]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059699, R29HL059699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK084317, R01DK090492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002710, R37ES002710, P42ES004699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Superfund Basic Research Program from NIEHS; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R56 DK084317 and R01 DK090492 (to F. G. H.) and by National Institutes of Health Grant ES02710 and Superfund Basic Research Program Grant P42 ES04699 from NIEHS and Grant HL059699 from NHLBI (to B. D. H.). This work was also supported by Juvenile Diabetes Research Foundation Research Grant 1-2009-337 (to F. G. H.).	Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Burgess A, 2012, PROSTAG OTH LIPID M, V97, P1, DOI 10.1016/j.prostaglandins.2011.10.002; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; De Taeye BM, 2010, OBESITY, V18, P489, DOI 10.1038/oby.2009.227; Enayetallah AE, 2004, J HISTOCHEM CYTOCHEM, V52, P447, DOI 10.1177/002215540405200403; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; GILL SS, 1980, BIOCHEM PHARMACOL, V29, P389, DOI 10.1016/0006-2952(80)90518-3; HAMMOCK BD, 1983, TOXICOL APPL PHARM, V71, P254, DOI 10.1016/0041-008X(83)90342-3; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; Imig JD, 2002, HYPERTENSION, V39, P690, DOI 10.1161/hy0202.103788; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Inceoglu B, 2007, PROSTAG OTH LIPID M, V82, P42, DOI 10.1016/j.prostaglandins.2006.05.004; Jeffrey KD, 2008, P NATL ACAD SCI USA, V105, P8452, DOI 10.1073/pnas.0711232105; Jones PD, 2006, BIOORG MED CHEM LETT, V16, P5212, DOI 10.1016/j.bmcl.2006.07.009; Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Kim DH, 2010, STEM CELLS DEV, V19, P1863, DOI 10.1089/scd.2010.0098; Koh IU, 2010, FEBS J, V277, P2304, DOI 10.1111/j.1742-4658.2010.07646.x; Kundu S, 2013, J LIPID RES, V54, P436, DOI 10.1194/jlr.M031914; Latreille M, 2011, AM J PHYSIOL-ENDOC M, V300, pE423, DOI 10.1152/ajpendo.00088.2010; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039165; Lowe CE, 2012, INT J OBESITY, V36, P1248, DOI 10.1038/ijo.2011.233; Luo PC, 2010, J PHARMACOL EXP THER, V334, P430, DOI 10.1124/jpet.110.167544; Luria A, 2011, P NATL ACAD SCI USA, V108, P9038, DOI 10.1073/pnas.1103482108; McElroy NR, 2003, J MED CHEM, V46, P1066, DOI 10.1021/jm020269o; Mensah GA, 2004, CARDIOL CLIN, V22, P485, DOI 10.1016/j.ccl.2004.06.005; Morisseau C, 1999, P NATL ACAD SCI USA, V96, P8849, DOI 10.1073/pnas.96.16.8849; Nagata N, 2012, ENDOCRINOLOGY, V153, P3158, DOI 10.1210/en.2012-1406; Nair S, 2007, TOXICOL LETT, V168, P21, DOI 10.1016/j.toxlet.2006.10.012; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Newman JW, 2005, PROG LIPID RES, V44, P1, DOI 10.1016/j.plipres.2004.10.001; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; PINOT F, 1995, BIOCHEM PHARMACOL, V50, P501, DOI 10.1016/0006-2952(95)00167-X; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sabio G, 2010, TRENDS BIOCHEM SCI, V35, P490, DOI 10.1016/j.tibs.2010.04.004; Schmidt-Ott KM, 2005, J AM SOC NEPHROL, V16, P1993, DOI 10.1681/ASN.2004121127; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Sharma NK, 2008, J CLIN ENDOCR METAB, V93, P4532, DOI 10.1210/jc.2008-1001; Shen HC, 2012, J MED CHEM, V55, P1789, DOI 10.1021/jm201468j; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Wagner K, 2011, J AGR FOOD CHEM, V59, P2816, DOI 10.1021/jf102559q; Xiao CT, 2011, DIABETES, V60, P918, DOI 10.2337/db10-1433; Xu C, 2004, J BIOL CHEM, V279, P17973, DOI 10.1074/jbc.M313263200; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Ye RS, 2010, DIABETES, V59, P6, DOI 10.2337/db09-0755; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zha BS, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/312943; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52; Zhang Y, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-81; Zhou LJ, 2009, MOL PHARMACOL, V76, P596, DOI 10.1124/mol.109.057067; Zhou YJ, 2011, NAT MED, V17, P356, DOI 10.1038/nm.2293; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	66	86	91	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14189	14199		10.1074/jbc.M113.458414	http://dx.doi.org/10.1074/jbc.M113.458414			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23576437	Green Published, hybrid			2022-12-28	WOS:000319253500023
J	Cestari, I; Stuart, K				Cestari, Igor; Stuart, Kenneth			Inhibition of Isoleucyl-tRNA Synthetase as a Potential Treatment for Human African Trypanosomiasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-RESISTANCE; CELL-CYCLE; BRUCEI; TARGETS; SITE; SELECTION; DISEASES; MODEL	Trypanosoma brucei sp. causes human African trypanosomiasis (HAT; African sleeping sickness). The parasites initially proliferate in the hemolymphatic system and then invade the central nervous system, which is lethal if not treated. New drugs are needed for HAT because the approved drugs are few, toxic, and difficult to administer, and drug resistance is spreading. We showed by RNAi knockdown that T. brucei isoleucyl-tRNA synthetase is essential for the parasites in vitro and in vivo in a mouse model of infection. By structure prediction and experimental analysis, we also identified small molecules that inhibit recombinant isoleucyl-tRNA synthetase and that are lethal to the parasites in vitro and highly selective compared with mammalian cells. One of these molecules acts as a competitive inhibitor of the enzyme and cures mice of the infection. Because members of this class of molecules are known to cross the blood-brain barrier in humans and to be tolerated, they may be attractive as leading candidates for drug development for HAT.	[Cestari, Igor; Stuart, Kenneth] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Stuart, Kenneth] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle	Stuart, K (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	ken.stuart@seattlebiomed.org			National Institutes of Health [R01 AI078962, 5T32AI007509-12]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078962, T32AI007509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI078962 (to K. S) and National Institutes of Health Fellowship 5T32AI007509-12 administered by the University of Washington (to I. C.).	Aguero F, 2008, NAT REV DRUG DISCOV, V7, P900, DOI 10.1038/nrd2684; Alsford S, 2012, NUCLEIC ACIDS RES, V40, P10150, DOI 10.1093/nar/gks813; Alsford S, 2012, NATURE, V482, P232, DOI 10.1038/nature10771; Badjatia N, 2013, MOL CELL BIOL, V33, P1965, DOI 10.1128/MCB.00156-13; Barrett MP, 2011, FUTURE MICROBIOL, V6, P1037, DOI [10.2217/FMB.11.88, 10.2217/fmb.11.88]; Barrett MP, 2010, CURR OPIN INFECT DIS, V23, P603, DOI 10.1097/QCO.0b013e32833f9fd0; Bishop AC, 2002, P NATL ACAD SCI USA, V99, P585, DOI 10.1073/pnas.012611299; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Cestari I, 2013, J BIOMOL SCREEN, V18, P490, DOI 10.1177/1087057112465980; Chitanga S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001454; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; Fevre EM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000333; Frearson JA, 2010, NATURE, V464, P728, DOI 10.1038/nature08893; Frevert U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043913; Hoepfner D, 2012, CELL HOST MICROBE, V11, P654, DOI 10.1016/j.chom.2012.04.015; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Inoue M, 2005, J BIOL CHEM, V280, P14085, DOI 10.1074/jbc.M412336200; Jacobs RT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001151; Koh CY, 2012, STRUCTURE, V20, P1681, DOI 10.1016/j.str.2012.07.011; LANDRY ML, 1982, JAMA-J AM MED ASSOC, V247, P332, DOI 10.1001/jama.247.3.332; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; MORSE GD, 1993, CLIN PHARMACOKINET, V24, P101, DOI 10.2165/00003088-199324020-00002; Nakama T, 2001, J BIOL CHEM, V276, P47387, DOI 10.1074/jbc.M109089200; Nishihara K, 2000, APPL ENVIRON MICROB, V66, P884, DOI 10.1128/AEM.66.3.884-889.2000; Nomanbhoy TK, 2001, BIOORG MED CHEM LETT, V11, P1485, DOI 10.1016/S0960-894X(01)00127-5; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Renslo AR, 2006, NAT CHEM BIOL, V2, P701, DOI 10.1038/nchembio837; Rettig J, 2012, NUCLEIC ACIDS RES, V40, P1299, DOI 10.1093/nar/gkr794; Rottenberg ME, 2005, J INFECT DIS, V192, P1658, DOI 10.1086/496896; Schimmel P, 1998, FASEB J, V12, P1599, DOI 10.1096/fasebj.12.15.1599; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	37	14	14	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14256	14263		10.1074/jbc.M112.447441	http://dx.doi.org/10.1074/jbc.M112.447441			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23548908	Green Published, hybrid			2022-12-28	WOS:000319253500030
J	Mount, MP; Zhang, Y; Amini, M; Callaghan, S; Kulczycki, J; Mao, ZX; Slack, RS; Anisman, H; Park, DS				Mount, Matthew P.; Zhang, Yi; Amini, Mandana; Callaghan, Steve; Kulczycki, Jerzy; Mao, Zixu; Slack, Ruth S.; Anisman, Hymie; Park, David S.			Perturbation of Transcription Factor Nur77 Expression Mediated by Myocyte Enhancer Factor 2D (MEF2D) Regulates Dopaminergic Neuron Loss in Response to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; ORPHAN NUCLEAR RECEPTORS; INDUCED CELL-DEATH; PARKINSONS-DISEASE; INDUCED APOPTOSIS; INDUCED DYSKINESIAS; MOUSE MODEL; DNA-DAMAGE; T-CELLS; SURVIVAL	We have earlier reported the critical nature of calpain-CDK5-MEF2 signaling in governing dopaminergic neuronal loss in vivo. CDK5 mediates phosphorylation of the neuronal survival factor myocyte enhancer factor 2 (MEF2) leading to its inactivation and loss. However, the downstream factors that mediate MEF2-regulated survival are unknown. Presently, we define Nur77 as one such critical downstream survival effector. Following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment in vivo, Nur77 expression in the nigrostriatal region is dramatically reduced. This loss is attenuated by expression of MEF2. Importantly, MEF2 constitutively binds to the Nur77 promoter in neurons under basal conditions. This binding is lost following 1-methyl-4-phenylpyridinium treatment. Nur77 deficiency results in significant sensitization to dopaminergic loss following 1-methyl-4-phenylpyridinium/MPTP treatment, in vitro and in vivo. Furthermore, Nur77-deficient MPTP-treated mice displayed significantly reduced levels of dopamine and 3,4-Dihydroxyphenylacetic acid in the striatum as well as elevated post synaptic FosB activity, indicative of increased nigrostriatal damage when compared with WT MPTP-treated controls. Importantly, this sensitization in Nur77-deficient mice was rescued with ectopic Nur77 expression in the nigrostriatal system. These results indicate that the inactivation of Nur77, induced by loss of MEF2 activity, plays a critical role in nigrostriatal degeneration in vivo.	[Mount, Matthew P.; Zhang, Yi; Amini, Mandana; Callaghan, Steve; Slack, Ruth S.; Park, David S.] Univ Ottawa, Dept Neurosci & Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Kulczycki, Jerzy; Anisman, Hymie] Carleton Univ, Inst Neurosci, Ottawa, ON K1S 5B6, Canada; [Mao, Zixu] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Dept Pharmacol, Atlanta, GA 30322 USA; [Mao, Zixu] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Dept Neurol, Atlanta, GA 30322 USA; [Park, David S.] Pusan Natl Univ, Dept Cogno Mechatron Engn, Miryang 627706, South Korea	University of Ottawa; Carleton University; Emory University; Emory University; Pusan National University	Park, DS (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	dpark@uottawa.ca		Slack, Ruth/0000-0002-1552-2835; Park, David/0000-0002-4490-3784	Parkinson Society Canada; Canadian Institutes of Health Research, Network of Centres of Excellence in Neurodegeneration; Heart and Stroke Foundation of Ontario; Neuroscience Canada/Krembil Foundation; Parkinson Research Consortium; Canadian Stroke Network; Heart and Stroke Foundation Centre for Stroke Recovery; World Class University program through the National Research Foundation of Korea; Ministry of Education, Science, and Technology (South Korea) [R31-2008-000-20004-0]; Canadian Institutes of Health Research; HSFO Career Investigator Award	Parkinson Society Canada; Canadian Institutes of Health Research, Network of Centres of Excellence in Neurodegeneration(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Neuroscience Canada/Krembil Foundation; Parkinson Research Consortium; Canadian Stroke Network; Heart and Stroke Foundation Centre for Stroke Recovery(Heart & Stroke Foundation of Canada); World Class University program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology (South Korea)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); HSFO Career Investigator Award	This work was supported by grants from Parkinson Society Canada, the Canadian Institutes of Health Research, Network of Centres of Excellence in Neurodegeneration, the Heart and Stroke Foundation of Ontario, Neuroscience Canada/Krembil Foundation, the Parkinson's Disease Foundation, The Michael J. Fox Foundation for Parkinson's research, the Parkinson Research Consortium, the Canadian Stroke Network, the Heart and Stroke Foundation Centre for Stroke Recovery, and the World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (South Korea) (R31-2008-000-20004-0 to D. S. P.).; Recipient of the Canadian Institutes of Health Research doctoral research award.; Recipient of the HSFO Career Investigator Award. To whom correspondence should be addressed: Dept. of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Rd., Ottawa, Ontario K1H 8M5, Canada. Tel.: 613-5625800 (ext. 8816); Fax: 613-562-5403; E-mail: dpark@uottawa.ca.	Ananieva O, 2008, EUR J IMMUNOL, V38, P2534, DOI 10.1002/eji.200737867; Bras A, 2000, CELL DEATH DIFFER, V7, P262, DOI 10.1038/sj.cdd.4400653; Chao LC, 2007, MOL ENDOCRINOL, V21, P2152, DOI 10.1210/me.2007-0169; Chao LC, 2008, MOL ENDOCRINOL, V22, P2596, DOI 10.1210/me.2008-0161; Cheng ZK, 2011, EUR HEART J, V32, P2179, DOI 10.1093/eurheartj/ehq496; Cheung NS, 1997, NEUROSCI LETT, V233, P13, DOI 10.1016/S0304-3940(97)00613-7; Cho SD, 2007, CANCER RES, V67, P674, DOI 10.1158/0008-5472.CAN-06-2907; Crocker SJ, 2003, NEUROBIOL DIS, V12, P150, DOI 10.1016/S0969-9961(02)00020-7; de Leseleuc L, 2006, CELL DEATH DIFFER, V13, P293, DOI 10.1038/sj.cdd.4401737; Dequiedt F, 2003, IMMUNITY, V18, P687, DOI 10.1016/S1074-7613(03)00109-2; DRAGUNOW M, 1995, MOL BRAIN RES, V30, P393, DOI 10.1016/0169-328X(95)00037-S; Fujii Y, 2008, GENES CELLS, V13, P411, DOI 10.1111/j.1365-2443.2008.01177.x; Gilbert F, 2006, BIOL PSYCHIAT, V60, P538, DOI 10.1016/j.biopsych.2006.04.023; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Harbison RA, 2011, NEUROTOX RES, V19, P374, DOI 10.1007/s12640-010-9172-4; Hayley S, 2004, J NEUROSCI, V24, P2045, DOI 10.1523/JNEUROSCI.4564-03.2004; He YW, 2002, J LEUKOCYTE BIOL, V72, P440; Heidenreich KA, 2004, MOL NEUROBIOL, V29, P155, DOI 10.1385/MN:29:2:155; Huang E, 2010, NAT CELL BIOL, V12, P563, DOI 10.1038/ncb2058; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Kim MK, 2011, NEUROCHEM RES, V36, P223, DOI 10.1007/s11064-010-0309-x; Ko J, 2001, J NEUROSCI, V21, P6758; KOSTIC V, 1991, NEUROLOGY, V41, P202, DOI 10.1212/WNL.41.2_Part_1.202; Lam BYH, 2010, J NEUROCHEM, V112, P1065, DOI 10.1111/j.1471-4159.2009.06521.x; LEE SL, 1995, J BIOL CHEM, V270, P9971, DOI 10.1074/jbc.270.17.9971; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; Levesque D, 2007, TRENDS NEUROSCI, V30, P22, DOI 10.1016/j.tins.2006.11.006; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Liu WF, 2001, EUR J IMMUNOL, V31, P1757, DOI 10.1002/1521-4141(200106)31:6<1757::AID-IMMU1757>3.0.CO;2-J; Mahmoudi S, 2009, NEUROBIOL DIS, V36, P213, DOI 10.1016/j.nbd.2009.07.017; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Meissner W, 2003, MOL NEUROBIOL, V28, P209, DOI 10.1385/MN:28:3:209; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Mount MP, 2007, J NEUROSCI, V27, P3328, DOI 10.1523/JNEUROSCI.5321-06.2007; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PINES J, 1993, TRENDS BIOCHEM SCI, V18, P195, DOI 10.1016/0968-0004(93)90185-P; Przedborski S, 2001, ADV NEUROL, V86, P177; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; Rymar VV, 2004, J COMP NEUROL, V469, P325, DOI 10.1002/cne.11008; Sedarous M, 2003, J BIOL CHEM, V278, P26031, DOI 10.1074/jbc.M302833200; She H, 2011, J CLIN INVEST, V121, P930, DOI 10.1172/JCI43871; Sheline CT, 2013, NEURODEGENER DIS, V11, P49, DOI 10.1159/000336558; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; St-Hilaire M, 2006, EUR J NEUROSCI, V24, P795, DOI 10.1111/j.1460-9568.2006.04954.x; Suzuki S, 2003, P NATL ACAD SCI USA, V100, P8276, DOI 10.1073/pnas.0932598100; Thompson J, 2008, J EXP MED, V205, P1029, DOI 10.1084/jem.20080101; Tian XY, 2010, MOL CELL NEUROSCI, V44, P94, DOI 10.1016/j.mcn.2010.01.012; TSAI LH, 1993, DEVELOPMENT, V119, P1029; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Tsukahara T, 2011, BIOCHEM BIOPH RES CO, V406, P558, DOI 10.1016/j.bbrc.2011.02.090; Verdaguer E, 2005, BRIT J PHARMACOL, V145, P1103, DOI 10.1038/sj.bjp.0706280; Verdin Eric, 2004, Novartis Found Symp, V259, P115; Wang XM, 2005, J BIOL CHEM, V280, P16705, DOI 10.1074/jbc.M501819200; Wang XM, 2009, J BIOL CHEM, V284, P32619, DOI 10.1074/jbc.M109.067785; WORONICZ JD, 1995, MOL CELL BIOL, V15, P6364; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8; Zhang Y, 2006, J NEUROSCI, V26, P8819, DOI 10.1523/JNEUROSCI.2593-06.2006; Zhang Y, 2010, J NEUROCHEM, V112, P497, DOI 10.1111/j.1471-4159.2009.06476.x; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163	65	23	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14362	14371		10.1074/jbc.M112.439216	http://dx.doi.org/10.1074/jbc.M112.439216			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23536182	Green Published, hybrid			2022-12-28	WOS:000319253500039
J	Guengerich, FP				Guengerich, F. Peter			Thematic Minireview Series: Metals in Biology 2013	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								One-half of the available protein structures contain metals, explaining their roles as essential trace elements. Metals are also critical in many aspects of nucleic acid biochemistry. This prologue briefly introduces the fifth of the Thematic Series on Metals in Biology, which began in the Journal of Biological Chemistry in 2009. The five minireviews in this 2013 series deal with the molybdenum prosthetic group (a pterin known as Moco); the biosynthesis of the "M-cluster" molybdenum prosthetic group of nitrogenase; the biosynthesis of the nickel-based metallocenter of the enzyme urease; several of the processing, transport, and medical aspects of cobalamins; and the growing roles of heme sensor proteins.	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			NIEHS NIH HHS [P30 ES000267] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Guengerich FP, 2012, J BIOL CHEM, V287, P13508, DOI 10.1074/jbc.R112.355933; Guengerich FP, 2010, J BIOL CHEM, V285, P26727, DOI 10.1074/jbc.R110.150870; Guengerich FP, 2009, J BIOL CHEM, V284, P18557, DOI 10.1074/jbc.M109.003863; Guengerich FP, 2009, J BIOL CHEM, V284, P709, DOI 10.1074/jbc.R800060200; Rosen BP, 2011, BIOESSAYS, V33, P350, DOI 10.1002/bies.201100012; Wolfe-Simon F, 2011, SCIENCE, V332, P1163, DOI 10.1126/science.1197258	7	8	8	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13164	13164		10.1074/jbc.R113.467712	http://dx.doi.org/10.1074/jbc.R113.467712			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23539620	Green Published, hybrid			2022-12-28	WOS:000318850300001
J	Kera, Y; Katoh, Y; Ohta, M; Matsumoto, M; Takano-Yamamoto, T; Igarashi, K				Kera, Yohei; Katoh, Yasutake; Ohta, Mineto; Matsumoto, Mitsuyo; Takano-Yamamoto, Teruko; Igarashi, Kazuhiko			Methionine Adenosyltransferase II-dependent Histone H3K9 Methylation at the COX-2 Gene Locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CANCER CELLS; MAT2A GENE; MAMMALIAN-CELLS; CARCINOMA CELLS; DNA; TRANSCRIPTION; EXPRESSION; CHROMATIN; PROTEINS; GROWTH	Methionine adenosyltransferase (MAT) synthesizes S-adenosylmethionine (AdoMet), which is utilized as a methyl donor in transmethylation reactions involving histones. MATII alpha, a MAT isozyme, serves as a transcriptional corepressor in the oxidative stress response and forms the AdoMet-integrating transcription regulation module, affecting histone methyltransferase activities. However, the identities of genes regulated by MATII alpha or its associated methyltransferases are unclear. We show that MATII alpha represses the expression of cyclooxygenase 2 (COX-2), encoded by Ptgs2, by specifically interacting with histone H3K9 methyltransferase SETDB1, thereby promoting the trimethylation of H3K9 at the COX-2 locus. We discuss both gene-specific and epigenome-wide functions of MATII alpha.	[Kera, Yohei; Katoh, Yasutake; Ohta, Mineto; Matsumoto, Mitsuyo; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 9808575, Japan; [Kera, Yohei; Katoh, Yasutake; Ohta, Mineto; Matsumoto, Mitsuyo; Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Ctr Regulatory Epigenome & Dis, Sendai, Miyagi 9808575, Japan; [Kera, Yohei; Takano-Yamamoto, Teruko] Tohoku Univ, Grad Sch Dent, Dept Orthoped & Dentofacial Orthoped, Sendai, Miyagi 9808575, Japan; [Igarashi, Kazuhiko] Japan Sci & Technol Agcy, CREST, Sendai, Miyagi 9808575, Japan	Tohoku University; Tohoku University; Tohoku University; Japan Science & Technology Agency (JST)	Igarashi, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Biochem, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan.	igarashi@med.tohoku.ac.jp	Matsumoto, Mitsuyo/AAC-3065-2019	Igarashi, Kazuhiko/0000-0002-2470-2475	Ministry of Education, Science, Sports, and Culture of Japan; global COE (Center of Excellence) program for Network Medicine, Tohoku University; Biomedical Research Core of Tohoku University School of Medicine; Grants-in-Aid for Scientific Research [23249085] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); global COE (Center of Excellence) program for Network Medicine, Tohoku University; Biomedical Research Core of Tohoku University School of Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Science, Sports, and Culture of Japan, and the global COE (Center of Excellence) program for Network Medicine, Tohoku University. This work was also supported in part by the Biomedical Research Core of Tohoku University School of Medicine.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Cai JX, 1998, CANCER RES, V58, P1444; CANTONI GL, 1975, ANNU REV BIOCHEM, V44, P435, DOI 10.1146/annurev.bi.44.070175.002251; Dohi Y, 2008, NAT STRUCT MOL BIOL, V15, P1246, DOI 10.1038/nsmb.1516; Fowler Brian, 2005, Semin Vasc Med, V5, P77; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Halim AB, 1999, J BIOL CHEM, V274, P29720, DOI 10.1074/jbc.274.42.29720; Halim AB, 2001, J BIOL CHEM, V276, P9784, DOI 10.1074/jbc.M002347200; Harper KA, 2008, BIOCHEM SOC T, V36, P543, DOI 10.1042/BST0360543; Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107; Jani TS, 2009, CELL RES, V19, P358, DOI 10.1038/cr.2008.314; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Katoh Y, 2011, MOL CELL, V41, P554, DOI 10.1016/j.molcel.2011.02.018; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Kotb M, 1997, TRENDS GENET, V13, P51, DOI 10.1016/S0168-9525(97)01013-5; LeGros HL, 2000, J BIOL CHEM, V275, P2359, DOI 10.1074/jbc.275.4.2359; Li B., 2007, CELL, V4, P653; Loyola A, 2009, EMBO REP, V10, P769, DOI 10.1038/embor.2009.90; Markham GD, 2009, CELL MOL LIFE SCI, V66, P636, DOI 10.1007/s00018-008-8516-1; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Popovich DG, 2002, ARCH BIOCHEM BIOPHYS, V406, P1, DOI 10.1016/S0003-9861(02)00398-3; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Rodriguez JL, 2007, INT J BIOCHEM CELL B, V39, P842, DOI 10.1016/j.biocel.2007.01.009; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Sherratt PJ, 2003, BIOCHEM PHARMACOL, V66, P51, DOI 10.1016/S0006-2952(03)00206-5; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Verdone Loredana, 2006, Briefings in Functional Genomics & Proteomics, V5, P209, DOI 10.1093/bfgp/ell028; Yang HP, 2011, BIOCHEM J, V436, P507, DOI 10.1042/BJ20101754; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zhang T, 2013, ACTA HISTOCHEM, V115, P48, DOI 10.1016/j.acthis.2012.03.006; Zhu YN, 2012, MOL CELL, V46, P408, DOI 10.1016/j.molcel.2012.05.011	38	50	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13592	13601		10.1074/jbc.M112.429738	http://dx.doi.org/10.1074/jbc.M112.429738			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23539621	Green Published, hybrid			2022-12-28	WOS:000318850300041
J	Liu, YJ; Fan, HB; Jin, Y; Ren, CG; Jia, XE; Wang, L; Chen, Y; Dong, M; Zhu, KY; Dong, ZW; Ye, BX; Zhong, Z; Deng, M; Liu, TX; Ren, RB				Liu, Yi-Jie; Fan, Hong-Bo; Jin, Yi; Ren, Chun-Guang; Jia, Xiao-E; Wang, Lei; Chen, Yi; Dong, Mei; Zhu, Kang-Yong; Dong, Zhi-Wei; Ye, Bai-Xin; Zhong, Zhong; Deng, Min; Liu, Ting Xi; Ren, Ruibao			Cannabinoid Receptor 2 Suppresses Leukocyte Inflammatory Migration by Modulating the JNK/c-Jun/Alox5 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL GENETICS; CB2 RECEPTOR; C-JUN; ANTITUMOR-ACTIVITY; SMALL MOLECULES; IN-VITRO; ZEBRAFISH; EXPRESSION; MODEL; CANNABIDIOL	Inflammatory migration of immune cells is involved in many human diseases. Identification of molecular pathways and modulators controlling inflammatory migration could lead to therapeutic strategies for treating human inflammation-associated diseases. The role of cannabinoid receptor type 2 (Cnr2) in regulating immune function had been widely investigated, but the mechanism is not fully understood. Through a chemical genetic screen using a zebrafish model for leukocyte migration, we found that both anagonist of the Cnr2 and inhibitor of the 5-lipoxygenase (Alox5, encoded by alox5) inhibit leukocyte migration in response to acute injury. These agents have a similar effect on migration of human myeloid cells. Consistent with these results, we found that inactivation of Cnr2 by zinc finger nuclease-mediated mutagenesis enhances leukocyte migration, while inactivation of Alox5 blocks leukocyte migration. Further investigation indicates that there is a signaling link between Cnr2 and Alox5 and that alox5 is a target of c-Jun. Cnr2 activation down-regulates alox5 expression by suppressing the JNK/c-Jun activation. These studies demonstrate that Cnr2, JNK, and Alox5 constitute a pathway regulating leukocyte migration. The cooperative effect between the Cnr2 agonist and Alox5 inhibitor also provides a potential therapeutic strategy for treating human inflammation-associated diseases.	[Liu, Yi-Jie; Jin, Yi; Chen, Yi; Ye, Bai-Xin; Liu, Ting Xi; Ren, Ruibao] Shanghai Jiao Tong Univ, Sch Med, RuiJin Hosp, Shanghai Inst Hematol,State Key Lab Med Genom, Shanghai 200025, Peoples R China; [Fan, Hong-Bo; Ren, Chun-Guang; Jia, Xiao-E; Wang, Lei; Dong, Mei; Zhu, Kang-Yong; Dong, Zhi-Wei; Deng, Min; Liu, Ting Xi] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200025, Peoples R China; [Fan, Hong-Bo; Ren, Chun-Guang; Jia, Xiao-E; Wang, Lei; Dong, Mei; Zhu, Kang-Yong; Dong, Zhi-Wei; Deng, Min; Liu, Ting Xi] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China; [Zhong, Zhong] GlaxoSmithKline Res & Dev China, Shanghai 201203, Peoples R China; [Ren, Ruibao] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Ren, Ruibao] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; GlaxoSmithKline; Brandeis University; Brandeis University	Zhong, Z (corresponding author), GlaxoSmithKline Res & Dev China, Shanghai 201203, Peoples R China.	zhong.z.zhong@gsk.com; mdeng@sibs.ac.cn; ren@brandeis.edu	ren, Chunguang/L-9609-2019		National Basic Research Program of China [2007CB947003, 2011CB964803]; National Natural Science Foundation of China [30830047, 31000636]; Chinese Academy of Science [XDA 01010106]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences)	This work was supported by the National Basic Research Program of China (2007CB947003 and 2011CB964803), the National Natural Science Foundation of China (30830047, 31000636), and the Strategic Priority Research Program of the Chinese Academy of Science (XDA 01010106).	Adhikary S, 2012, BLOOD, V120, P3741, DOI 10.1182/blood-2012-06-435362; Basu S, 2011, IMMUNOL RES, V51, P26, DOI 10.1007/s12026-011-8210-5; Borner C, 2009, J BIOL CHEM, V284, P35450, DOI 10.1074/jbc.M109.006338; Castillo A, 2010, NEUROBIOL DIS, V37, P434, DOI 10.1016/j.nbd.2009.10.023; Clifton JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012386; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Correa F, 2010, GLIA, V58, P135, DOI 10.1002/glia.20907; Correa F, 2009, BIOCHEM PHARMACOL, V77, P86, DOI 10.1016/j.bcp.2008.09.014; Csoka B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006409; Fraczek LA, 2011, MOL IMMUNOL, V49, P201, DOI 10.1016/j.molimm.2011.08.013; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Gerits N, 2008, CELL SIGNAL, V20, P1592, DOI 10.1016/j.cellsig.2008.02.022; Ghosh S, 2006, MOL IMMUNOL, V43, P2169, DOI 10.1016/j.molimm.2006.01.005; Griffin G, 1997, EUR J PHARMACOL, V339, P53, DOI 10.1016/S0014-2999(97)01336-8; Grose R, 2003, CURR BIOL, V13, pR678, DOI 10.1016/S0960-9822(03)00607-9; Gustafsson K, 2006, MOL PHARMACOL, V70, P1612, DOI 10.1124/mol.106.025981; Hosoda H, 2011, LIFE SCI, V89, P115, DOI 10.1016/j.lfs.2011.05.007; Klegeris A, 2003, J LEUKOCYTE BIOL, V73, P369, DOI 10.1189/jlb.1002482; Klegeris A, 2003, BRIT J PHARMACOL, V139, P775, DOI 10.1038/sj.bjp.0705304; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Krens SFG, 2006, GENE EXPR PATTERNS, V6, P1019, DOI 10.1016/j.modgep.2006.04.008; Kucharova K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-158; Lam CS, 2006, NEUROSCIENCE, V138, P83, DOI 10.1016/j.neuroscience.2005.10.069; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Ligresti A, 2006, J PHARMACOL EXP THER, V318, P1375, DOI 10.1124/jpet.106.105247; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Loynes CA, 2010, J LEUKOCYTE BIOL, V87, P203, DOI 10.1189/jlb.0409255; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; Massi P, 2008, J NEUROCHEM, V104, P1091, DOI 10.1111/j.1471-4159.2007.05073.x; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Molina G, 2009, NAT CHEM BIOL, V5, P680, DOI 10.1038/nchembio.190; Monteiro APT, 2011, J IMMUNOL, V186, P6562, DOI 10.4049/jimmunol.1002400; Mukhopadhyay P, 2010, FREE RADICAL BIO MED, V48, P457, DOI 10.1016/j.freeradbiomed.2009.11.022; NEWTON CA, 1994, INFECT IMMUN, V62, P4015, DOI 10.1128/IAI.62.9.4015-4020.1994; Ni X, 2004, MULT SCLER J, V10, P158, DOI 10.1191/1352458504ms1009oa; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Olea-Herrero N, 2009, BRIT J CANCER, V101, P940, DOI 10.1038/sj.bjc.6605248; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Raborn ES, 2008, J NEUROIMMUNE PHARM, V3, P117, DOI 10.1007/s11481-007-9077-z; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Ridges S, 2012, BLOOD, V119, P5621, DOI 10.1182/blood-2011-12-398818; Romero-Sandoval EA, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-25; Sacerdote P, 2005, J NEUROIMMUNOL, V159, P97, DOI 10.1016/j.jneuroim.2004.10.003; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Seo J, 2010, J CELL BIOCHEM, V110, P1022, DOI 10.1002/jcb.22616; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Stern HM, 2005, NAT CHEM BIOL, V1, P366, DOI 10.1038/nchembio749; Stockwell BR, 2000, NAT REV GENET, V1, P116, DOI 10.1038/35038557; Szekanecz Z, 2006, CURR DRUG TARGETS, V7, P91, DOI 10.2174/138945006775270231; Tager AM, 2000, J EXP MED, V192, P439, DOI 10.1084/jem.192.3.439; Tak PP, 2000, ARTHRITIS RHEUM-US, V43, P2619, DOI 10.1002/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tschop J, 2009, J IMMUNOL, V183, P499, DOI 10.4049/jimmunol.0900203; Venkatesh N, 2004, P NATL ACAD SCI USA, V101, P8969, DOI 10.1073/pnas.0402803101; Wardle FC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r71; Wu XR, 2006, ARTERIOSCL THROM VAS, V26, P2414, DOI 10.1161/01.ATV.0000238361.07225.fc; Yeh JRJ, 2009, NAT CHEM BIOL, V5, P236, DOI 10.1038/nchembio.147; YOSHIMOTO T, 1982, BIOCHIM BIOPHYS ACTA, V713, P470; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang M, 2007, J CEREBR BLOOD F MET, V27, P1387, DOI 10.1038/sj.jcbfm.9600447; Zhang Y, 2008, J IMMUNOL, V181, P2155, DOI 10.4049/jimmunol.181.3.2155	62	45	45	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13551	13562		10.1074/jbc.M113.453811	http://dx.doi.org/10.1074/jbc.M113.453811			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23539630	hybrid, Green Published			2022-12-28	WOS:000318850300038
J	Takahashi, M; Yoshioka, K; Imai, T; Miyoshi, Y; Nakano, Y; Yoshida, K; Yamashita, T; Furuta, Y; Watanabe, T; Sugiyama, J; Takeda, T				Takahashi, Machiko; Yoshioka, Koichi; Imai, Tomoya; Miyoshi, Yuka; Nakano, Yuki; Yoshida, Kentaro; Yamashita, Tetsuro; Furuta, Yuzo; Watanabe, Takashi; Sugiyama, Junji; Takeda, Takumi			Degradation and Synthesis of beta-Glucans by a Magnaporthe oryzae Endotransglucosylase, a Member of the Glycoside Hydrolase 7 Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI; CELL-WALL; XYLOGLUCAN ENDOTRANSGLYCOSYLASE; COLEOPTILE SEGMENTS; ENZYMATIC-SYNTHESIS; ENDOGLUCANASE-I; MIXED-LINKAGE; CELLULOSE; TRANSGLYCOSYLATION; CELLULASES	A Magnaporthe oryzae enzyme, which was encoded by the Mocel7B gene, was predicted to act on 1,3-1,4-beta-glucan degradation and transglycosylation reaction of cellotriose after partial purification from a culture filtrate of M. oryzae cells, followed by liquid chromatography-tandem mass spectrometry. A recombinant MoCel7B prepared by overexpression in M. oryzae exhibited endo-typical depolymerization of polysaccharides containing beta-1,4-linkages, in which 1,3-1,4-beta-glucan was the best substrate. When cellooligosaccharides were used as the substrate, the recombinant enzyme generated reaction products with both shorter and longer chain lengths than the substrate. In addition, incorporation of glucose and various oligosaccharides including sulforhodamine-conjugated cellobiose, laminarioligosaccharides, gentiobiose, xylobiose, mannobiose, and xyloglucan nonasaccharide into beta-1,4-linked glucans were observed after incubation with the enzyme. These results indicate that the recombinant enzyme acts as an endotransglucosylase (ETG) that cleaves the glycosidic bond of beta-1,4-glucan as a donor substrate and transfers the cleaved glucan chain to another molecule functioning as an acceptor substrate. Furthermore, ETG treatment caused greater extension of heat-treated wheat coleoptiles. The result suggests that ETG functions to induce wall loosening by cleaving the 1,3-1,4-beta-glucan tethers of plant cell walls. On the other hand, use of cellohexaose as a substrate for ETG resulted in the production of cellulose II with a maximum length (degree of polymerization) of 26 glucose units. Thus, ETG functions to depolymerize and polymerize beta-glucans, depending on the size of the acceptor substrate.	[Takahashi, Machiko; Nakano, Yuki; Takeda, Takumi] Iwate Biotechnol Res Ctr, Kitakami, Iwate 0240003, Japan; [Takahashi, Machiko; Yamashita, Tetsuro] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan; [Yoshioka, Koichi; Imai, Tomoya; Watanabe, Takashi; Sugiyama, Junji] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto 6110011, Japan; [Miyoshi, Yuka; Furuta, Yuzo] Kyoto Prefectural Univ, Fac Life & Environm Sci, Sakyo Ku, Shimogamo, Kyoto 6068522, Japan; [Yoshida, Kentaro] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	Iwate Biotechnology Research Center; Iwate University; Kyoto University; Kyoto Prefectural University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Takeda, T (corresponding author), Iwate Biotechnol Res Ctr, 22-174-4 Narita, Kitakami, Iwate 0240003, Japan.	ttakeda@ibrc.or.jp	今井, 友也/M-1834-2019; Sugiyama, Junji/G-2879-2019; Sugiyama, Junji/ABD-5589-2020	今井, 友也/0000-0001-7026-0287; Sugiyama, Junji/0000-0002-5388-4925; Sugiyama, Junji/0000-0002-5388-4925; Yoshida, Kentaro/0000-0002-3614-1759	Iwate prefecture; Japanese Society for the Promotion of Science [21612009]	Iwate prefecture; Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Iwate prefecture and Grant 21612009 from the Japanese Society for the Promotion of Science.	Vu BA, 2012, MOL PLANT MICROBE IN, V25, P1135, DOI 10.1094/MPMI-02-12-0043-R; Bauer MW, 1999, J BACTERIOL, V181, P284, DOI 10.1128/JB.181.1.284-290.1999; Burton RA, 2009, MOL PLANT, V2, P873, DOI 10.1093/mp/ssp063; CLAEYSSENS M, 1990, BIOCHEM J, V270, P251, DOI 10.1042/bj2700251; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Dische Z, 1958, METHODS CARBOHYDRATE, V1, P475; Federici L, 2006, TRENDS PLANT SCI, V11, P65, DOI 10.1016/j.tplants.2005.12.005; Fort S, 2000, J AM CHEM SOC, V122, P5429, DOI 10.1021/ja9936520; FRY SC, 1992, BIOCHEM J, V282, P821, DOI 10.1042/bj2820821; Fry SC, 1997, PLANT J, V11, P1141, DOI 10.1046/j.1365-313X.1997.11051141.x; Fry SC, 2008, PLANT J, V55, P240, DOI 10.1111/j.1365-313X.2008.03504.x; GIBEAUT DM, 1993, P NATL ACAD SCI USA, V90, P3850, DOI 10.1073/pnas.90.9.3850; Gibeaut DM, 2005, PLANTA, V221, P729, DOI 10.1007/s00425-005-1481-0; GILKES NR, 1991, MICROBIOL REV, V55, P303, DOI 10.1128/MMBR.55.2.303-315.1991; Hashimoto A, 2011, CARBOHYD RES, V346, P2760, DOI 10.1016/j.carres.2011.09.031; Hattori T, 2012, CARBOHYD RES, V353, P22, DOI 10.1016/j.carres.2012.03.018; HENRISSAT B, 1985, BIO-TECHNOL, V3, P722, DOI 10.1038/nbt0885-722; Hiraishi M, 2009, CARBOHYD RES, V344, P2468, DOI 10.1016/j.carres.2009.10.002; HOSON T, 1989, PLANT PHYSIOL, V90, P1353, DOI 10.1104/pp.90.4.1353; Hreggvidsson GO, 1996, APPL ENVIRON MICROB, V62, P3047, DOI 10.1128/.62.8.3047-3049.1996; Hrmova M, 2007, J BIOL CHEM, V282, P12951, DOI 10.1074/jbc.M611487200; Kars I, 2005, PLANT J, V43, P213, DOI 10.1111/j.1365-313X.2005.02436.x; Kim H, 2001, MOL PLANT MICROBE IN, V14, P1436, DOI 10.1094/MPMI.2001.14.12.1436; Kimpara T, 2008, ANN BOT-LONDON, V102, P221, DOI 10.1093/aob/mcn077; KOBAYASHI S, 1991, J AM CHEM SOC, V113, P3079, DOI 10.1021/ja00008a042; Kwon I, 2002, BIOSCI BIOTECH BIOCH, V66, P110, DOI 10.1271/bbb.66.110; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Matsumura H, 1999, PLANT J, V20, P719, DOI 10.1046/j.1365-313X.1999.00640.x; NIDETZKY B, 1994, BIOCHEM J, V298, P705, DOI 10.1042/bj2980705; NISHITANI K, 1992, J BIOL CHEM, V267, P21058; Pal S, 2010, BIORESOURCE TECHNOL, V101, P2412, DOI 10.1016/j.biortech.2009.11.064; Park YW, 2004, FEBS LETT, V564, P183, DOI 10.1016/S0014-5793(04)00346-1; Qin Q, 2003, PLANT J, V34, P327, DOI 10.1046/j.1365-313X.2003.01726.x; SAKURAI N, 1977, PLANT CELL PHYSIOL, V18, P371, DOI 10.1093/oxfordjournals.pcp.a075443; SCHOU C, 1993, EUR J BIOCHEM, V217, P947, DOI 10.1111/j.1432-1033.1993.tb18325.x; SHODA S, 1993, CARBOHYD RES, V249, P127, DOI 10.1016/0008-6215(93)84066-F; Takeda T, 2002, P NATL ACAD SCI USA, V99, P9055, DOI 10.1073/pnas.132080299; Takeda T, 2010, APPL MICROBIOL BIOT, V88, P1113, DOI 10.1007/s00253-010-2781-2; Tominaga R, 1999, PLANT PHYSIOL, V119, P249, DOI 10.1104/pp.119.1.249; WOOD TM, 1992, BIOCHEM SOC T, V20, P46, DOI 10.1042/bst0200046; Yang SQ, 2008, J AGR FOOD CHEM, V56, P602, DOI 10.1021/jf072279+; Zhou J, 2008, CURR GENET, V53, P217, DOI 10.1007/s00294-008-0179-9	42	9	9	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13821	13830		10.1074/jbc.M112.448902	http://dx.doi.org/10.1074/jbc.M112.448902			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23530038	Green Published, hybrid			2022-12-28	WOS:000318850300063
J	Toepfer, C; Caorsi, V; Kampourakis, T; Sikkel, MB; West, TG; Leung, MC; Al-Saud, SA; MacLeod, KT; Lyon, AR; Marston, SB; Sellers, JR; Ferenczi, MA				Toepfer, Christopher; Caorsi, Valentina; Kampourakis, Thomas; Sikkel, Markus B.; West, Timothy G.; Leung, Man-Ching; Al-Saud, Sara A.; MacLeod, Kenneth T.; Lyon, Alexander R.; Marston, Steven B.; Sellers, James R.; Ferenczi, Michael A.			Myosin Regulatory Light Chain (RLC) Phosphorylation Change as a Modulator of Cardiac Muscle Contraction in Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEBRATE STRIATED-MUSCLE; HUMAN HEART-FAILURE; SKELETAL-MUSCLE; SARCOMERE-LENGTH; FAILING HUMAN; MOLECULAR MOTORS; ISOMETRIC FORCE; SMOOTH-MUSCLE; RAT-HEART; FIBERS	Understanding how cardiac myosin regulatory light chain (RLC) phosphorylation alters cardiac muscle mechanics is important because it is often altered in cardiac disease. The effect this protein phosphorylation has on muscle mechanics during a physiological range of shortening velocities, during which the heart generates power and performs work, has not been addressed. We have expressed and phosphorylated recombinant Rattus norvegicus left ventricular RLC. In vitro we have phosphorylated these recombinant species with cardiac myosin light chain kinase and zipper-interacting protein kinase. We compare rat permeabilized cardiac trabeculae, which have undergone exchange with differently phosphorylated RLC species. We were able to enrich trabecular RLC phosphorylation by 40% compared with controls and, in a separate series, lower RLC phosphorylation to 60% of control values. Compared with the trabeculae with a low level of RLC phosphorylation, RLC phosphorylation enrichment increased isometric force by more than 3-fold and peak power output by more than 7-fold and approximately doubled both maximum shortening speed and the shortening velocity that generated peak power. We augmented these measurements by observing increased RLC phosphorylation of human and rat HF samples from endocardial left ventricular homogenate. These results demonstrate the importance of increased RLC phosphorylation in the up-regulation of myocardial performance and suggest that reduced RLC phosphorylation is a key aspect of impaired contractile function in the diseased myocardium.	[Toepfer, Christopher; Caorsi, Valentina; Al-Saud, Sara A.; Ferenczi, Michael A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Mol Med Sect, London SW7 2AZ, England; [Kampourakis, Thomas] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Sikkel, Markus B.; Leung, Man-Ching; MacLeod, Kenneth T.; Lyon, Alexander R.; Marston, Steven B.] Natl Heart & Lung Inst, Imperial Ctr Translat & Expt Med, London W12 0NN, England; [West, Timothy G.] Royal Vet Coll London, Struct & Motion Lab, N Mymms AL9 7TA, England; [Lyon, Alexander R.] Royal Brompton Hosp, Cardiovasc Biomed Res Unit, London SW3 6MP, England; [Toepfer, Christopher; Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Ferenczi, Michael A.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 637553, Singapore	Imperial College London; University of London; King's College London; Imperial College London; University of London; University of London Royal Veterinary College; Royal Brompton Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Ferenczi, MA (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, RTP Level 4,50 Nanyang Dr, Singapore 637553, Singapore.	m.ferenczi@ntu.edu.sg	Ferenczi, Michael/F-9510-2015; Sikkel, Markus/ABC-1043-2020; MacLeod, Kenneth/GWU-8940-2022	Ferenczi, Michael/0000-0002-0349-331X; Sikkel, Markus/0000-0001-9801-8978; Kampourakis, Thomas/0000-0002-8269-1567; Toepfer, Christopher/0000-0003-4671-2030	National Institutes of Health; NHLBI [HL004232]; Wellcome Trust [091460/Z/10/Z, 092852/Z/10/Z]; Biotechnology and Biological Sciences Research Council [BB/I019448/1]; British Heart Foundation; BBSRC [BB/I019448/1] Funding Source: UKRI; British Heart Foundation [PG/08/077/25587, PG/09/032/27241, FS/11/67/28954, RG/11/20/29266] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL004232, ZIAHL006174, K08HL004232, ZIAHL001786] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI Grant HL004232 12. This work presented herein was also supported by Wellcome Trust Grants 091460/Z/10/Z, 092852/Z/10/Z, 092852/Z/10/Z, Biotechnology and Biological Sciences Research Council Grant BB/I019448/1, and The British Heart Foundation (to M.-C. L., S. B. M., and M.A.F.).	Abraham TP, 2009, CARDIOVASC RES, V82, P84, DOI 10.1093/cvr/cvp016; Bershitsky S, 1996, BIOPHYS J, V71, P1462, DOI 10.1016/S0006-3495(96)79347-5; Borejdo J, 2001, BIOCHEMISTRY-US, V40, P3796, DOI 10.1021/bi002527u; Borejdo Julian, 2012, Methods Mol Biol, V875, P311, DOI 10.1007/978-1-61779-806-1_17; Caorsi V, 2011, EUR BIOPHYS J BIOPHY, V40, P13, DOI 10.1007/s00249-010-0624-9; Chang AN, 2010, J BIOL CHEM, V285, P5122, DOI 10.1074/jbc.C109.076489; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; Curtin NA, 1998, J EXP BIOL, V201, P103; DANIELS M, 1984, J PHYSIOL-LONDON, V355, P367, DOI 10.1113/jphysiol.1984.sp015424; Davis JS, 2001, CELL, V107, P631, DOI 10.1016/S0092-8674(01)00586-4; DETOMBE PP, 1990, CIRC RES, V66, P1239, DOI 10.1161/01.RES.66.5.1239; Ding PG, 2010, J BIOL CHEM, V285, P40819, DOI 10.1074/jbc.M110.160499; EDMAN KAP, 1979, J PHYSIOL-LONDON, V291, P143, DOI 10.1113/jphysiol.1979.sp012804; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Greenberg MJ, 2009, AM J PHYSIOL-REG I, V297, pR265, DOI 10.1152/ajpregu.00171.2009; HERLAND JS, 1990, AM J PHYSIOL, V259, pH1118, DOI 10.1152/ajpheart.1990.259.4.H1118; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Hinken AC, 2007, PHYSIOLOGY, V22, P73, DOI 10.1152/physiol.00043.2006; Huang J, 2008, J BIOL CHEM, V283, P19748, DOI 10.1074/jbc.M802605200; Jacques AM, 2008, CARDIOVASC RES, V79, P481, DOI 10.1093/cvr/cvn094; Josephson MP, 2011, BIOCHEM BIOPH RES CO, V416, P367, DOI 10.1016/j.bbrc.2011.11.044; Kerrick WGL, 2009, FASEB J, V23, P855, DOI 10.1096/fj.08-118182; Khromov AS, 1998, J PHYSIOL-LONDON, V512, P345, DOI 10.1111/j.1469-7793.1998.345be.x; KUMAR CC, 1986, J BIOL CHEM, V261, P2866; Levine RJC, 1996, BIOPHYS J, V71, P898, DOI 10.1016/S0006-3495(96)79293-7; Linari M, 1998, BIOPHYS J, V74, P2459, DOI 10.1016/S0006-3495(98)77954-8; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; METZGER JM, 1989, J GEN PHYSIOL, V93, P855, DOI 10.1085/jgp.93.5.855; Mizutani H, 2010, CIRC J, V74, P120, DOI 10.1253/circj.CJ-09-0462; Morano I, 1999, J MOL MED-JMM, V77, P544, DOI 10.1007/s001099900031; MORANO I, 1992, BASIC RES CARDIOL, V87, P129; Morita H, 2005, J CLIN INVEST, V115, P518, DOI 10.1172/JCI200524351; Moss RL, 2010, J GEN PHYSIOL, V136, P21, DOI 10.1085/jgp.201010471; Muthu P, 2012, J CELL MOL MED, V16, P911, DOI 10.1111/j.1582-4934.2011.01371.x; Nishio H, 1997, BIOCHEM BIOPH RES CO, V236, P570, DOI 10.1006/bbrc.1997.7005; Okamoto R, 2006, CELL SIGNAL, V18, P1408, DOI 10.1016/j.cellsig.2005.11.001; PAGE SG, 1963, J CELL BIOL, V19, P369, DOI 10.1083/jcb.19.2.369; Poetter K, 1996, NAT GENET, V13, P63, DOI 10.1038/ng0596-63; RICCIARDI L, 1986, CARDIOVASC RES, V20, P117, DOI 10.1093/cvr/20.2.117; Sanbe A, 1999, J BIOL CHEM, V274, P21085, DOI 10.1074/jbc.274.30.21085; Scruggs SB, 2010, MOL CELL PROTEOMICS, V9, P1804, DOI 10.1074/mcp.M110.000075; Scruggs SB, 2009, J BIOL CHEM, V284, P5097, DOI 10.1074/jbc.M807414200; Sheikh F, 2012, J CLIN INVEST, V122, P1209, DOI 10.1172/JCI61134; SOSA H, 1994, BIOPHYS J, V67, P283, DOI 10.1016/S0006-3495(94)80479-5; Spudich JA, 2001, NAT REV MOL CELL BIO, V2, P387, DOI 10.1038/35073086; STRACHER A, 1969, BIOCHEM BIOPH RES CO, V35, P519, DOI 10.1016/0006-291X(69)90377-5; SWEENEY HL, 1995, BIOPHYS J, V68, pS112; SWEENEY HL, 1994, P NATL ACAD SCI USA, V91, P1490, DOI 10.1073/pnas.91.4.1490; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; Szczesna D, 2001, J BIOL CHEM, V276, P7086, DOI 10.1074/jbc.M009823200; Szczesna-Cordary D, 2007, FASEB J, V21, P3974, DOI 10.1096/fj.07-8630com; van der Velden J, 2003, ADV EXP MED BIOL, V538, P3; van der Velden J, 2003, CARDIOVASC RES, V57, P37, DOI 10.1016/S0008-6363(02)00606-5; van der Velden J, 2001, CIRCULATION, V104, P1140, DOI 10.1161/hc3501.095485; WEEDS AG, 1969, NATURE, V223, P1362, DOI 10.1038/2231362a0	55	47	48	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13446	13454		10.1074/jbc.M113.455444	http://dx.doi.org/10.1074/jbc.M113.455444			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23530050	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000318850300029
J	Lee, JH; Mand, MR; Deshpande, RA; Kinoshita, E; Yang, SH; Wyman, C; Paull, TT				Lee, Ji-Hoon; Mand, Michael R.; Deshpande, Rajashree A.; Kinoshita, Eri; Yang, Soo-Hyun; Wyman, Claire; Paull, Tanya T.			Ataxia Telangiectasia-Mutated (ATM) Kinase Activity Is Regulated by ATP-driven Conformational Changes in the Mre11/Rad50/Nbs1 (MRN) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND-BREAK; RAD50 ZINC-HOOK; MRE11 COMPLEX; DNA-DAMAGE; MRE11-RAD50-NBS1 COMPLEX; NUCLEASE ACTIVITY; HUMAN RAD50/MRE11; REPAIR; ACTIVATION; BINDING	The Ataxia Telangiectasia-Mutated (ATM) protein kinase is recruited to sites of double-strand DNA breaks by the Mre11/Rad50/Nbs1 (MRN) complex, which also facilitates ATM monomerization and activation. MRN exists in at least two distinct conformational states, dependent on ATP binding and hydrolysis by the Rad50 protein. Here we use an ATP analog-sensitive form of ATM to determine that ATP binding, but not hydrolysis, by Rad50 is essential for MRN stimulation of ATM. Mre11 nuclease activity is dispensable, although some mutations in the Mre11 catalytic domain block ATM activation independent of nuclease function, as does the mirin compound. The coiled-coil domains of Rad50 are important for the DNA binding ability of MRN and are essential for ATM activation, but loss of the zinc hook connection can be substituted by higher levels of the complex. Nbs1 binds to the "closed" form of the MR complex, promoted by the zinc hook and by ATP binding. Thus the primary role of the hook is to tether Rad50 monomers together, promoting the association of the Rad50 catalytic domains into a form that binds ATP and also binds Nbs1. Collectively, these results show that the ATP-bound form of MRN is the critical conformation for ATM activation.	[Lee, Ji-Hoon; Mand, Michael R.; Deshpande, Rajashree A.; Yang, Soo-Hyun; Paull, Tanya T.] Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA; [Lee, Ji-Hoon; Mand, Michael R.; Deshpande, Rajashree A.; Yang, Soo-Hyun; Paull, Tanya T.] Univ Texas Austin, Dept Mol Genet & Microbiol, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Kinoshita, Eri] Erasmus Univ, Med Ctr, Dept Genet, NL-3000 CA Rotterdam, Netherlands; [Wyman, Claire] Erasmus Univ, Med Ctr, Dept Radiat Oncol, NL-3000 CA Rotterdam, Netherlands	Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Paull, TT (corresponding author), Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA.	tpaull@utexas.edu	Lee, Jihoon/AAK-3497-2021	Lee, Jihoon/0000-0001-7387-935X; Paull, Tanya/0000-0002-2991-651X; Mand, Michael/0000-0002-3457-3822; Deshpande, Rajashree/0000-0001-5728-716X	National Institutes of Health [CA094008, CA132813]; Netherlands Organization for Scientific Research (NWO) [VICI 700.56.441, STW NWONano-11425]; NATIONAL CANCER INSTITUTE [R01CA132813, R01CA094008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in whole or in part, by National Institutes of Health Grants CA094008 and CA132813 (to T.P.). This work was also supported by grants from the Netherlands Organization for Scientific Research (NWO) VICI 700.56.441, and STW NWONano-11425 (to C.W.).	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Bressan DA, 1998, GENETICS, V150, P591; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Costanzo V, 2004, PLOS BIOL, V2, P600, DOI 10.1371/journal.pbio.0020110; Darling RJ, 2004, ASSAY DRUG DEV TECHN, V2, P647, DOI 10.1089/adt.2004.2.647; de Jager M, 2004, J MOL BIOL, V339, P937, DOI 10.1016/j.jmb.2004.04.014; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; de Jager M, 2002, NUCLEIC ACIDS RES, V30, P4425, DOI 10.1093/nar/gkf574; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; He J, 2012, J BIOL CHEM, V287, P31747, DOI 10.1074/jbc.M112.384750; Hohl M, 2011, NAT STRUCT MOL BIOL, V18, P1124, DOI 10.1038/nsmb.2116; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Jazayeri A, 2008, EMBO J, V27, P1953, DOI 10.1038/emboj.2008.128; Kinoshita E, 2009, CHROMOSOME RES, V17, P277, DOI 10.1007/s10577-008-9018-6; Kodama M, 2010, MOL CELL BIOL, V30, P1620, DOI 10.1128/MCB.00810-09; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; Lee JH, 2003, J BIOL CHEM, V278, P45171, DOI 10.1074/jbc.M308705200; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lee JH, 2006, METHOD ENZYMOL, V408, P529, DOI 10.1016/S0076-6879(06)08033-5; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lim HS, 2011, GENE DEV, V25, P1091, DOI 10.1101/gad.2037811; Mockel C, 2012, NUCLEIC ACIDS RES, V40, P914, DOI 10.1093/nar/gkr749; Moreau S, 1999, MOL CELL BIOL, V19, P556; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Wiltzius JJW, 2005, NAT STRUCT MOL BIOL, V12, P403, DOI 10.1038/nsmb928	41	70	71	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12840	12851		10.1074/jbc.M113.460378	http://dx.doi.org/10.1074/jbc.M113.460378			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23525106	hybrid, Green Published			2022-12-28	WOS:000318555100039
J	Fu, HL; Sohail, A; Valiathan, RR; Wasinski, BD; Kumarasiri, M; Mahasenan, KV; Bernardo, MM; Tokmina-Roszyk, D; Fields, GB; Mobashery, S; Fridman, R				Fu, Hsueh-Liang; Sohail, Anjum; Valiathan, Rajeshwari R.; Wasinski, Benjamin D.; Kumarasiri, Malika; Mahasenan, Kiran V.; Bernardo, M. Margarida; Tokmina-Roszyk, Dorota; Fields, Gregg B.; Mobashery, Shahriar; Fridman, Rafael			Shedding of Discoidin Domain Receptor 1 by Membrane-type Matrix Metalloproteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASES; COLLAGEN-BINDING; TISSUE INHIBITOR; ECTODOMAIN; IDENTIFICATION; MT1-MMP; DDR1; SITE; CLEAVAGE; CELLS	The discoidin domain receptors (DDRs) are receptor tyrosine kinases that upon binding to collagens undergo receptor phosphorylation, which in turn activates signal transduction pathways that regulate cell-collagen interactions. We report here that collagen-dependent DDR1 activation is partly regulated by the proteolytic activity of the membrane-anchored collagenases, MT1-, MT2-, and MT3-matrix metalloproteinase (MMP). These collagenases cleave DDR1 and attenuate collagen I-and IV-induced receptor phosphorylation. This effect is not due to ligand degradation, as it proceeds even when the receptor is stimulated with collagenase-resistant collagen I (r/r) or with a triple-helical peptide harboring the DDR recognition motif in collagens. Moreover, the secreted collagenases MMP-1 and MMP-13 and the glycosylphosphatidylinositol-anchored membrane-type MMPs (MT4- and MT6-MMP) have no effect on DDR1 cleavage or activation. N-terminal sequencing of the MT1-MMP-mediated cleaved products and mutational analyses show that cleavage of DDR1 takes place within the extracellular juxtamembrane region, generating a membrane-anchored C-terminal fragment. Metalloproteinase inhibitor studies show that constitutive shedding of endogenous DDR1 in breast cancer HCC1806 cells is partly mediated by MT1-MMP, which also regulates collagen-induced receptor activation. Taken together, these data suggest a role for the collagenase of membrane-type MMPs in regulation of DDR1 cleavage and activation at the cell-matrix interface.	[Fu, Hsueh-Liang; Sohail, Anjum; Valiathan, Rajeshwari R.; Wasinski, Benjamin D.; Bernardo, M. Margarida; Fridman, Rafael] Wayne State Univ, Dept Pathol, Sch Med, Detroit, MI 48201 USA; [Kumarasiri, Malika; Mahasenan, Kiran V.; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Kumarasiri, Malika; Mahasenan, Kiran V.; Mobashery, Shahriar] Univ Notre Dame, Walther Canc Res Ctr, Notre Dame, IN 46556 USA; [Tokmina-Roszyk, Dorota; Fields, Gregg B.] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA	Wayne State University; University of Notre Dame; University of Notre Dame; Walther Cancer Institute; Torrey Pines Institute for Molecular Studies, Florida	Fridman, R (corresponding author), Wayne State Univ, Dept Pathol, Sch Med, 540 E Canfield Ave, Detroit, MI 48201 USA.	rfridman@med.wayne.edu		Sohail, Anjum/0000-0001-5567-9645	National Institutes of Health [CA-61986, CA-98799]; NATIONAL CANCER INSTITUTE [R01CA061986, R01CA098799] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-61986 (to R. F.) and CA-98799 (to G. B. F.).	Abdulhussein R, 2004, J BIOL CHEM, V279, P31462, DOI 10.1074/jbc.M400651200; Abdulhussein R, 2008, J BIOL CHEM, V283, P12026, DOI 10.1074/jbc.M704592200; Agarwal G, 2007, J MOL BIOL, V367, P443, DOI 10.1016/j.jmb.2006.12.073; ALVES F, 1995, ONCOGENE, V10, P609; Ancot F, 2009, ONCOGENE, V28, P2185, DOI 10.1038/onc.2009.88; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Babine RE, 1997, CHEM REV, V97, P1359, DOI 10.1021/cr960370z; Butler GS, 2008, MOL CELL BIOL, V28, P4896, DOI 10.1128/MCB.01775-07; Carafoli F, 2012, STRUCTURE, V20, P688, DOI 10.1016/j.str.2012.02.011; Cho JA, 2008, J BIOL CHEM, V283, P17391, DOI 10.1074/jbc.M708943200; Flynn LA, 2010, J MOL BIOL, V395, P533, DOI 10.1016/j.jmb.2009.10.073; GRAMS F, 1995, BIOCHEMISTRY-US, V34, P14012, DOI 10.1021/bi00043a007; Hachehouche LN, 2010, MOL IMMUNOL, V47, P1866, DOI 10.1016/j.molimm.2010.02.023; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Hayashida K, 2010, ANAT REC, V293, P925, DOI 10.1002/ar.20757; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Higashiyama S, 2011, J BIOCHEM, V150, P15, DOI 10.1093/jb/mvr068; Holmbeck K, 2004, J CELL PHYSIOL, V200, P11, DOI 10.1002/jcp.20065; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Hou GP, 2001, J CLIN INVEST, V107, P727, DOI 10.1172/JCI10720; Ikejiri M, 2005, J BIOL CHEM, V280, P33992, DOI 10.1074/jbc.M504303200; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Kridel SJ, 2002, J BIOL CHEM, V277, P23788, DOI 10.1074/jbc.M111574200; L'hote CGML, 2001, FASEB J, V15, P234, DOI 10.1096/fj.01-0414fje; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; Leitinger B, 2004, J MOL BIOL, V344, P993, DOI 10.1016/j.jmb.2004.09.089; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Leitinger B, 2006, MATRIX BIOL, V25, P355, DOI 10.1016/j.matbio.2006.05.006; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Lemeer S, 2012, J PROTEOMICS, V75, P3465, DOI 10.1016/j.jprot.2011.10.007; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; Ohkubo S, 1999, BIOCHEM BIOPH RES CO, V266, P308, DOI 10.1006/bbrc.1999.1816; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Robichaud TK, 2011, J BIOL CHEM, V286, P37535, DOI 10.1074/jbc.M111.273391; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Schenk S, 2003, TRENDS CELL BIOL, V13, P366, DOI 10.1016/S0962-8924(03)00129-6; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; Slack BE, 2006, J CELL BIOCHEM, V98, P672, DOI 10.1002/jcb.20812; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; Tomari T, 2009, CANCER SCI, V100, P1284, DOI 10.1111/j.1349-7006.2009.01173.x; Toth M, 2005, BIOCHEM J, V387, P497, DOI 10.1042/BJ20041324; Toth M, 2002, J BIOL CHEM, V277, P26340, DOI 10.1074/jbc.M200655200; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; van Kilsdonk JWJ, 2010, EUR J CELL BIOL, V89, P415, DOI 10.1016/j.ejcb.2009.11.026; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Vogel WF, 2002, FEBS LETT, V514, P175, DOI 10.1016/S0014-5793(02)02360-8; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; WU H, 1990, P NATL ACAD SCI USA, V87, P5888, DOI 10.1073/pnas.87.15.5888; Xu HF, 2011, MATRIX BIOL, V30, P16, DOI 10.1016/j.matbio.2010.10.004	54	62	62	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12114	12129		10.1074/jbc.M112.409599	http://dx.doi.org/10.1074/jbc.M112.409599			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23519472	hybrid, Green Published			2022-12-28	WOS:000318157600044
J	Varkey, J; Mizuno, N; Hegde, BG; Cheng, NQ; Steven, AC; Langen, R				Varkey, Jobin; Mizuno, Naoko; Hegde, Balachandra G.; Cheng, Naiqian; Steven, Alasdair C.; Langen, Ralf			alpha-Synuclein Oligomers with Broken Helical Conformation Form Lipoprotein Nanoparticles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEINS; APOLIPOPROTEIN-A-I; FAMILIAL PARKINSONS-DISEASE; PULSED ESR MEASUREMENTS; FATTY-ACIDS; TRANSGENIC MICE; MEMBRANE INTERACTIONS; UNILAMELLAR VESICLES; HIPPOCAMPAL-NEURONS; SECONDARY STRUCTURE	alpha-Synuclein (alpha S) is a membrane-binding protein with sequence similarity to apolipoproteins and other lipid-carrying proteins, which are capable of forming lipid-containing nanoparticles, sometimes referred to as "discs." Previously, it has been unclear whether alpha S also possesses this property. Using cryo-electron microscopy and light scattering, we found that alpha S can remodel phosphatidylglycerol vesicles into nanoparticles whose shape (ellipsoidal) and dimensions (in the 7-10-nm range) resemble those formed by apolipoproteins. The molar ratio of alpha S to lipid in nanoparticles is similar to 1:20, and alpha S is oligomeric (including trimers and tetramers). Similar nanoparticles form when alpha S is added to vesicles of mitochondrial lipids. This observation suggests a mechanism for the previously reported disruption of mitochondrial membranes by alpha S. Circular dichroism and four-pulse double electron electron resonance experiments revealed that in nanoparticles alpha S assumes a broken helical conformation distinct from the extended helical conformation adopted when alpha S is bound to intact vesicles or membrane tubules. We also observed alpha S-dependent tubule and nanoparticle formation in the presence of oleic acid, implying that alpha S can interact with fatty acids and lipids in a similar manner. alpha S-related nanoparticles might play a role in lipid and fatty acid transport functions previously attributed to this protein.	[Varkey, Jobin; Langen, Ralf] Univ So Calif, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Mizuno, Naoko] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany; [Hegde, Balachandra G.] PES Inst Technol, Bangalore, Karnataka, India; [Mizuno, Naoko; Cheng, Naiqian; Steven, Alasdair C.] NIAMS, Struct Biol Lab, NIH, Bethesda, MD 20892 USA	University of Southern California; Max Planck Society; PES University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Steven, AC (corresponding author), NIAMS, Struct Biol Lab, NIH, Bethesda, MD 20892 USA.	stevena@mail.nih; langen@usc.edu	Varkey, Jobin/I-5845-2019; Hegde, Balachandra/GPS-6028-2022; Mizuno, Naoko/AAY-1926-2021	Mizuno, Naoko/0000-0002-1594-2821	National Institutes of Health [2 R01 M063915]; Intramural Research Program of the NIAMS; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041157, ZIAAR027015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIAMS; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2 R01 M063915 (to R. L.) and by the Intramural Research Program of the NIAMS.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Ben Gedalya T, 2009, TRAFFIC, V10, P218, DOI 10.1111/j.1600-0854.2008.00853.x; Beyer K, 2007, CELL BIOCHEM BIOPHYS, V47, P285, DOI 10.1007/s12013-007-0014-9; Bisaglia M, 2009, FASEB J, V23, P329, DOI 10.1096/fj.08-119784; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Borbat P, 2006, J AM CHEM SOC, V128, P10004, DOI 10.1021/ja063122l; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Bulankina AV, 2009, J CELL BIOL, V185, P641, DOI 10.1083/jcb.200812042; Cabin DE, 2002, J NEUROSCI, V22, P8797; Castagnet PI, 2005, J NEUROCHEM, V94, P839, DOI 10.1111/j.1471-4159.2005.03247.x; Catte A, 2006, BIOPHYS J, V90, P4345, DOI 10.1529/biophysj.105.071456; Chiang YW, 2005, J MAGN RESON, V172, P279, DOI 10.1016/j.jmr.2004.10.012; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Davidson WS, 2007, J BIOL CHEM, V282, P22249, DOI 10.1074/jbc.R700014200; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; De Franceschi G, 2011, J BIOL CHEM, V286, P22262, DOI 10.1074/jbc.M110.202937; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; DeWitt DC, 2013, BIOCHEMISTRY-US, V52, P2385, DOI 10.1021/bi4002369; Drescher M, 2008, CHEMBIOCHEM, V9, P2411, DOI 10.1002/cbic.200800238; Drescher M, 2008, J AM CHEM SOC, V130, P7796, DOI 10.1021/ja801594s; Drescher M, 2010, J AM CHEM SOC, V132, P4080, DOI 10.1021/ja909247j; Fauvet B, 2012, J BIOL CHEM, V287, P28243, DOI 10.1074/jbc.M112.383711; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Fujita Y, 2006, ACTA NEUROPATHOL, V112, P261, DOI 10.1007/s00401-006-0114-4; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; Golovko MY, 2009, MOL CELL BIOCHEM, V326, P55, DOI 10.1007/s11010-008-0008-y; Golovko MY, 2005, BIOCHEMISTRY-US, V44, P8251, DOI 10.1021/bi0502137; Gosavi N, 2002, J BIOL CHEM, V277, P48984, DOI 10.1074/jbc.M208194200; Gu FF, 2010, J BIOL CHEM, V285, P4652, DOI 10.1074/jbc.M109.069914; Halliday GM, 2005, BRAIN, V128, P2654, DOI 10.1093/brain/awh584; HUANG C, 1978, P NATL ACAD SCI USA, V75, P308, DOI 10.1073/pnas.75.1.308; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jones MK, 2011, BIOCHEMISTRY-US, V50, P2249, DOI 10.1021/bi101301g; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lee SJ, 2008, ACTA NEUROBIOL EXP, V68, P509; Li L, 2004, J MOL BIOL, V343, P1293, DOI 10.1016/j.jmb.2004.09.017; Lokappa SB, 2011, J BIOL CHEM, V286, P21450, DOI 10.1074/jbc.M111.224055; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Lucke C, 2006, J LIPID RES, V47, P1714, DOI 10.1194/jlr.M600003-JLR200; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Meredith GE, 2002, BRAIN RES, V956, P156, DOI 10.1016/S0006-8993(02)03514-X; Mishra VK, 1998, BIOCHEMISTRY-US, V37, P10313, DOI 10.1021/bi980042o; MISHRA VK, 1995, J BIOL CHEM, V270, P1602, DOI 10.1074/jbc.270.4.1602; Mizuno N, 2012, J BIOL CHEM, V287, P29301, DOI 10.1074/jbc.M112.365817; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nakamura K., 2013, NEUROTHERAP IN PRESS; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Newhouse Y, 2005, ACTA CRYSTALLOGR F, V61, P981, DOI 10.1107/S1744309105032410; Norris EH, 2004, CURR TOP DEV BIOL, V60, P17; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Pandey AP, 2011, J PHYS CHEM B, V115, P5886, DOI 10.1021/jp1121917; Perrin RJ, 2001, J BIOL CHEM, V276, P41958, DOI 10.1074/jbc.M105022200; Peters-Libeu CA, 2007, J LIPID RES, V48, P1035, DOI 10.1194/jlr.M600545-JLR200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rao JN, 2010, J AM CHEM SOC, V132, P8657, DOI 10.1021/ja100646t; SEGREST JP, 1992, J LIPID RES, V33, P141; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Sharon R, 2003, J BIOL CHEM, V278, P49874, DOI 10.1074/jbc.M309127200; Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X; Stichel CC, 2007, HUM MOL GENET, V16, P2377, DOI 10.1093/hmg/ddm083; TERTOV VV, 1985, BIOCHEM BIOPH RES CO, V128, P1196, DOI 10.1016/0006-291X(85)91067-8; Tofaris GK, 2007, CELL MOL LIFE SCI, V64, P2194, DOI 10.1007/s00018-007-7217-5; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Uversky VN, 2002, NEUROTOXICOLOGY, V23, P527, DOI 10.1016/S0161-813X(02)00067-0; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; Wang GF, 2010, PROTEIN SCI, V19, P1686, DOI 10.1002/pro.449; Wang WJ, 2011, APPL CATAL B-ENVIRON, V108, P108, DOI 10.1016/j.apcatb.2011.08.015; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Westphal CH, 2013, J BIOL CHEM, V288, P1829, DOI 10.1074/jbc.M112.418871; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Withers GS, 1997, DEV BRAIN RES, V99, P87, DOI 10.1016/S0165-3806(96)00210-6; Xie WL, 2012, J NEUROCHEM, V122, P404, DOI 10.1111/j.1471-4159.2012.07769.x	90	56	56	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17620	17630		10.1074/jbc.M113.476697	http://dx.doi.org/10.1074/jbc.M113.476697			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23609437	hybrid, Green Published			2022-12-28	WOS:000320380600053
J	Furuya, F; Shimura, H; Asami, K; Ichijo, S; Takahashi, K; Kaneshige, M; Oikawa, Y; Aida, K; Endo, T; Kobayashi, T				Furuya, Fumihiko; Shimura, Hiroki; Asami, Keiichi; Ichijo, Sayaka; Takahashi, Kazuya; Kaneshige, Masahiro; Oikawa, Yoichi; Aida, Kaoru; Endo, Toyoshi; Kobayashi, Tetsuro			Ligand-bound Thyroid Hormone Receptor Contributes to Reprogramming of Pancreatic Acinar Cells into Insulin-producing Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; BETA-CELLS; FACTOR-ALPHA; GUINEA-PIG; IN-VITRO; METAMORPHOSIS; ACTIVATION; EXPRESSION; GENE; PROLIFERATION	One goal of diabetic regenerative medicine is to instructively convert mature pancreatic exocrine cells into insulin-producing cells. We recently reported that ligand-bound thyroid hormone receptor alpha (TR alpha) plays a critical role in expansion of the beta-cell mass during postnatal development. Here, we used an adenovirus vector that expresses TR alpha driven by the amylase 2 promoter (AdAmy2TR alpha) to induce the reprogramming of pancreatic acinar cells into insulin-producing cells. Treatment with L-3,5,3-triiodothyronine increases the association of TR alpha with the p85 alpha subunit of phosphatidylinositol 3-kinase (PI3K), leading to the phosphorylation and activation of Akt and the expression of Pdx1, Ngn3, and MafA in purified acinar cells. Analyses performed with the lectin-associated cell lineage tracing system and the Cre/loxP-based direct cell lineage tracing system indicate that newly synthesized insulin-producing cells originate from elastase-expressing pancreatic acinar cells. Insulin-containing secretory granules were identified in these cells by electron microscopy. The inhibition of p85 alpha expression by siRNA or the inhibition of PI3K by LY294002 prevents the expression of Pdx1, Ngn3, and MafA and the reprogramming to insulin-producing cells. In immunodeficient mice with streptozotocin-induced hyperglycemia, treatment with AdAmy2TR alpha leads to the reprogramming of pancreatic acinar cells to insulin-producing cells in vivo. Our findings suggest that ligand-bound TR alpha plays a critical role in beta-cell regeneration during postnatal development via activation of PI3K signaling.	[Furuya, Fumihiko; Asami, Keiichi; Ichijo, Sayaka; Takahashi, Kazuya; Kaneshige, Masahiro; Aida, Kaoru; Endo, Toyoshi; Kobayashi, Tetsuro] Univ Yamanashi, Dept Internal Med 3, Yamanashi 4093898, Japan; [Shimura, Hiroki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Environm Med, Yamanashi 4093898, Japan; [Oikawa, Yoichi] Saiseikai Cent Hosp, Dept Internal Med, Tokyo 1080073, Japan	University of Yamanashi; University of Yamanashi; Tokyo Saiseikai Central Hospital	Kobayashi, T (corresponding author), 1110 Shimokato,Chou Shi, Yamanashi 4093898, Japan.	tetsurou@yamanashi.ac.jp			The Japan Society for the Promotion of Science (JSPS) KAKENHI [24591359]	The Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by The Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 24591359.	Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Baeyens L, 2009, GASTROENTEROLOGY, V136, P1750, DOI 10.1053/j.gastro.2009.01.047; BOLLIN E, 1973, DEV BIOL, V31, P185, DOI 10.1016/0012-1606(73)90329-1; Brown DD, 2005, P NATL ACAD SCI USA, V102, P12455, DOI 10.1073/pnas.0505989102; CHIN WW, 1994, THYROID, V4, P389, DOI 10.1089/thy.1994.4.389; Cras-Meneur C, 2001, DIABETES, V50, P1571, DOI 10.2337/diabetes.50.7.1571; Das B, 2002, P NATL ACAD SCI USA, V99, P12230, DOI 10.1073/pnas.182430599; DeMatteo RP, 1997, J SURG RES, V72, P155, DOI 10.1006/jsre.1997.5096; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Edlund H, 1998, DIABETES, V47, P1817, DOI 10.2337/diabetes.47.12.1817; Furuya F, 2006, P NATL ACAD SCI USA, V103, P1780, DOI 10.1073/pnas.0510849103; Furuya F, 2010, J BIOL CHEM, V285, P24477, DOI 10.1074/jbc.M109.100222; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; GUMUCIO DL, 1985, J BIOL CHEM, V260, P3483; Hafezi-Moghadam A, 2002, NAT MED, V8, P473, DOI 10.1038/nm0502-473; HANAICHI T, 1986, J ELECTRON MICROSC, V35, P304; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Heremans Y, 2002, J CELL BIOL, V159, P303, DOI 10.1083/jcb.200203074; Hiroi Y, 2006, P NATL ACAD SCI USA, V103, P14104, DOI 10.1073/pnas.0601600103; Jensen J, 2004, DEV DYNAM, V229, P176, DOI 10.1002/dvdy.10460; LAZAR MA, 1993, ENDOCR REV, V14, P184, DOI 10.1210/er.14.2.184; Li L, 2003, AM J PHYSIOL-ENDOC M, V285, pE577, DOI 10.1152/ajpendo.00120.2003; Marsh-Armstrong N, 2004, P NATL ACAD SCI USA, V101, P165, DOI 10.1073/pnas.2136755100; MAYLIEPFENNINGER MF, 1979, J CELL BIOL, V80, P77, DOI 10.1083/jcb.80.1.77; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; Minami K, 2008, J BIOL CHEM, V283, P13753, DOI 10.1074/jbc.M710034200; Miyatsuka T, 2006, GENE DEV, V20, P1435, DOI 10.1101/gad.1412806; Mukhi S, 2008, P NATL ACAD SCI USA, V105, P8962, DOI 10.1073/pnas.0803569105; Murtaugh LC, 2003, ANNU REV CELL DEV BI, V19, P71, DOI 10.1146/annurev.cellbio.19.111301.144752; Sakaguchi Y, 1996, ENDOCRINOLOGY, V137, P4744, DOI 10.1210/en.137.11.4744; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Sen LY, 2002, AM J PHYSIOL-HEART C, V283, pH2119, DOI 10.1152/ajpheart.00326.2002; Shifrin AL, 2001, GENE THER, V8, P1480, DOI 10.1038/sj.gt.3301544; Shih A, 2004, ENDOCRINOLOGY, V145, P1708, DOI 10.1210/en.2003-0742; STERN PH, 1985, J CLIN INVEST, V76, P2016, DOI 10.1172/JCI112202; Sun ZQ, 2000, AM J PHYSIOL-ENDOC M, V278, pE302, DOI 10.1152/ajpendo.2000.278.2.E302; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	40	26	32	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16155	16166		10.1074/jbc.M112.438192	http://dx.doi.org/10.1074/jbc.M112.438192			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23595988	Green Published, hybrid			2022-12-28	WOS:000319822300066
J	Agarwal, NK; Qu, CJ; Kunkulla, K; Liu, YD; Vega, F				Agarwal, Nitin K.; Qu, Changju; Kunkulla, Kranthi; Liu, Yadong; Vega, Francisco			Transcriptional Regulation of Serine/Threonine Protein Kinase (AKT) Genes by Glioma-associated Oncogene Homolog 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL LYMPHOMA; HEDGEHOG SIGNALING PATHWAY; SONIC-HEDGEHOG; MOLECULAR-CLONING; DIFFUSE; SURVIVAL; MEDULLOBLASTOMA; ACTIVATION; INHIBITOR; CARCINOMA	Aberrant activation of Hedgehog signaling has been described in a growing number of cancers, including malignant lymphomas. Here, we report that canonical Hedgehog signaling modulates the transcriptional expression of AKT genes and that AKT1 is a direct transcriptional target of GLI1. We identified two putative binding sites for GLI1 in the AKT1 promoter region and confirmed their functionality using chromatin immunoprecipitation, luciferase reporter, and site-directed mutagenesis assays. Moreover, we provide evidence that GLI1 contributes to the survival of diffuse large B-cell lymphoma (DLBCL) cells and that this effect occurs in part through promotion of the transcription of AKT genes. This finding is of interest as constitutive activation of AKT has been described in DLBCL, but causative factors that explain AKT expression in this lymphoma type are not completely known. In summary, we demonstrated the existence of a novel cross-talk at the transcriptional level between Hedgehog signaling and AKT with biological significance in DLBCL.	[Agarwal, Nitin K.; Qu, Changju; Kunkulla, Kranthi; Liu, Yadong; Vega, Francisco] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Vega, F (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Unit 72, 1515 Holcombe Blvd, Houston, TX 77030 USA.	fvegava@mdanderson.org	Vega, Francisco/AGY-4571-2022	Vega, Francisco/0000-0001-5956-452X	NCI, National Institutes of Health [CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672, K08CA143151] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Jin Q. Cheng (Departments of Pathology and Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL) for providing the AKT1 promoter-luciferase constructs. We also thank Dr. Peter Zaphiropoulos (Department of Bioscience and Nutrition, Karolinska Institutet, Sweden) for providing full-length FLAG-tagged GLI1 plasmid and Dr. Richard Ford (Department of Hematopathology, M. D. Anderson Cancer Center) for providing LP cells. The primary tumor samples were provided by the Hematopathology Tissue Bank of The University of Texas M. D. Anderson Cancer Center (supported by the NCI, National Institutes of Health Grant CA16672).	Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Armitage JO, 1998, J CLIN ONCOL, V16, P2780, DOI 10.1200/JCO.1998.16.8.2780; Bacus SS, 2002, ONCOGENE, V21, P3532, DOI 10.1038/sj.onc.1205438; Baohua Yu, 2008, Diagn Mol Pathol, V17, P159, DOI 10.1097/PDM.0b013e31815d0588; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Boulbes D, 2010, MOL CANCER RES, V8, P896, DOI 10.1158/1541-7786.MCR-09-0409; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Dihlmann S, 2005, CARCINOGENESIS, V26, P1503, DOI 10.1093/carcin/bgi120; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Guillaud L, 2003, J NEUROSCI, V23, P131; Hasselblom S, 2010, BRIT J HAEMATOL, V149, P560, DOI 10.1111/j.1365-2141.2010.08123.x; He SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027684; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Johnson RL, 1998, CURR OPIN GENET DEV, V8, P450, DOI 10.1016/S0959-437X(98)80117-2; Kalderon D, 2000, CELL, V103, P371, DOI 10.1016/S0092-8674(00)00129-X; Kim JE, 2009, MODERN PATHOL, V22, P1312, DOI 10.1038/modpathol.2009.98; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Kuphal S, 2011, ONCOGENE, V30, P4523, DOI 10.1038/onc.2011.163; Laner-Plamberger S, 2009, ONCOGENE, V28, P1639, DOI 10.1038/onc.2009.10; Larouche JF, 2010, J CLIN ONCOL, V28, P2094, DOI 10.1200/JCO.2009.24.5860; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Park S, 2005, J BIOL CHEM, V280, P38932, DOI 10.1074/jbc.M504011200; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pham LV, 2011, BLOOD, V117, P200, DOI 10.1182/blood-2010-06-290437; Pharm L. V., 2005, BLOOD, V106, P3940; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Ramirez E, 2012, LEUKEMIA RES, V36, P1267, DOI 10.1016/j.leukres.2012.06.014; Rao G, 2004, ONCOGENE, V23, P6156, DOI 10.1038/sj.onc.1207818; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Sakai A, 1998, BLOOD, V92, P3410, DOI 10.1182/blood.V92.9.3410.421a06_3410_3415; Schmittgen TD, 2001, METHODS, V25, P383, DOI 10.1006/meth.2001.1260; Singh RR, 2011, ONCOGENE, V30, P4874, DOI 10.1038/onc.2011.195; Singh RR, 2010, LEUKEMIA, V24, P1025, DOI 10.1038/leu.2010.35; Singh RR, 2009, CANCER RES, V69, P2550, DOI 10.1158/0008-5472.CAN-08-1808; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tang T, 2011, CLIN CANCER RES, V17, P3378, DOI 10.1158/1078-0432.CCR-10-3370; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Uddin S, 2006, BLOOD, V108, P4178, DOI 10.1182/blood-2006-04-016907; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Voorzanger N, 1996, CANCER RES, V56, P5499; Wang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018434; Wang Y, 2012, CANCER CELL, V21, P374, DOI 10.1016/j.ccr.2011.12.028; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386	53	33	33	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15390	15401		10.1074/jbc.M112.425249	http://dx.doi.org/10.1074/jbc.M112.425249			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23580656	Green Published, hybrid			2022-12-28	WOS:000319452100063
J	Bartholomeeusen, K; Fujinaga, K; Xiang, YH; Peterlin, BM				Bartholomeeusen, Koen; Fujinaga, Koh; Xiang, Yanhui; Peterlin, B. Matija			Histone Deacetylase Inhibitors (HDACis) That Release the Positive Transcription Elongation Factor b (P-TEFb) from Its Inhibitory Complex Also Activate HIV Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BET BROMODOMAIN INHIBITION; REACTIVATES LATENT HIV-1; CYCLIN T1; 7SK SNRNA; EXPRESSION; TYPE-1; TAT; REPLICATION; ESTABLISHMENT; EQUILIBRIUM	Numerous studies have looked at the effects of histone deacetylase inhibitors (HDACis) on HIV reactivation in established transformed cell lines and primary CD4(+) T cells. However, their findings remain confusing, and differences between effects of class I- and class II-specific HDACis persist. Because no clear picture emerged, we decided to determine how HDACis reactivate HIV in transformed cell lines and primary cells. We found that neither histone H3 nor tubulin acetylation correlated with HIV reactivation in Jurkat and HeLa cells. Rather, HDACis that could reactivate HIV in chromatin or on episomal plasmids also released free positive transcription elongation factor b (P-TEFb) from its inhibitory 7SK snRNP. In resting primary CD4(+) T cells, where levels of P-TEFb are vanishingly low, the most potent HDACi, suberoylanilide hydroxyamic acid (SAHA), had minimal effects. In contrast, when these cells were treated with a PKC agonist, bryostatin 1, which increased levels of P-TEFb, then SAHA once again reactivated HIV. We conclude that HDACis, which can reactivate HIV, work via the release of free P-TEFb from the 7SK snRNP.	[Bartholomeeusen, Koen; Fujinaga, Koh; Xiang, Yanhui; Peterlin, B. Matija] Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Med, San Francisco, CA 94143 USA; [Bartholomeeusen, Koen; Fujinaga, Koh; Xiang, Yanhui; Peterlin, B. Matija] Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Microbiol, San Francisco, CA 94143 USA; [Bartholomeeusen, Koen; Fujinaga, Koh; Xiang, Yanhui; Peterlin, B. Matija] Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Immunol, San Francisco, CA 94143 USA; [Xiang, Yanhui] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Peterlin, BM (corresponding author), Rm U432,CSF,533 Parnassus Ave, San Francisco, CA 94143 USA.	matija.peterlin@ucsf.edu	bartholomeeusen, koen/J-1843-2015	bartholomeeusen, koen/0000-0001-9576-2400	Collaboratory of AIDS Researchers for Eradication (CARE) Center Grant [U19 AI96113]; University of California San Francisco Center for AIDS Research grant; American Foundation for AIDS Research Grant [108241-51-RGRL]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, R01AI049104, U19AI096113] Funding Source: NIH RePORTER	Collaboratory of AIDS Researchers for Eradication (CARE) Center Grant; University of California San Francisco Center for AIDS Research grant; American Foundation for AIDS Research Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by Collaboratory of AIDS Researchers for Eradication (CARE) Center Grant U19 AI96113.; Supported by a University of California San Francisco Center for AIDS Research grant.; Supported by American Foundation for AIDS Research Grant 108241-51-RGRL.	Ai NP, 2011, NUCLEIC ACIDS RES, V39, P9592, DOI 10.1093/nar/gkr698; Archin NM, 2009, AIDS, V23, P1799, DOI 10.1097/QAD.0b013e32832ec1dc; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Banerjee C, 2012, J LEUKOCYTE BIOL, V92, P1147, DOI 10.1189/jlb.0312165; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Barboric M, 2010, NAT STRUCT MOL BIOL, V17, P928, DOI 10.1038/nsmb0810-928; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Biglione S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-47; Blazek D, 2011, GENE DEV, V25, P2158, DOI 10.1101/gad.16962311; Boehm D, 2013, CELL CYCLE, V12, P452, DOI 10.4161/cc.23309; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Budhiraja S, 2013, J VIROL, V87, P1211, DOI 10.1128/JVI.02413-12; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Chiang KR, 2012, VIRUSES-BASEL, V4, P1390, DOI 10.3390/v4091390; Chiang K, 2012, J VIROL, V86, P3244, DOI 10.1128/JVI.05065-11; Cho SY, 2009, EMBO J, V28, P1407, DOI 10.1038/emboj.2009.99; Choudhary SK, 2008, J INFECT DIS, V197, P1162, DOI 10.1086/529525; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Contreras X, 2006, FUTURE VIROL, V1, P733, DOI 10.2217/17460794.1.6.733; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; FELBER BK, 1988, SCIENCE, V239, P184, DOI 10.1126/science.3422113; Friedman J, 2011, J VIROL, V85, P9078, DOI 10.1128/JVI.00836-11; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; Gallastegui E, 2012, J VIROL, V86, P3795, DOI 10.1128/JVI.05972-11; Gryder BE, 2012, FUTURE MED CHEM, V4, P505, DOI [10.4155/FMC.12.3, 10.4155/fmc.12.3]; He NH, 2006, MOL CELL BIOL, V26, P7068, DOI 10.1128/MCB.00778-06; He NH, 2011, J NEUROIMMUNE PHARM, V6, P260, DOI 10.1007/s11481-011-9267-6; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Heltweg B, 2004, J MED CHEM, V47, P5235, DOI 10.1021/jm0497592; Hoque M, 2011, J MOL BIOL, V410, P917, DOI 10.1016/j.jmb.2011.03.060; Huber K, 2011, J BIOL CHEM, V286, P22211, DOI 10.1074/jbc.M110.180224; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Lassen KG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030176; LEONARD J, 1989, J VIROL, V63, P4919, DOI 10.1128/JVI.63.11.4919-4924.1989; Li ZC, 2013, NUCLEIC ACIDS RES, V41, P277, DOI 10.1093/nar/gks976; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Marshall RM, 2006, FRONT BIOSCI-LANDMRK, V11, P2598, DOI 10.2741/1994; Mbonye U, 2011, CURR HIV RES, V9, P554, DOI 10.2174/157016211798998736; Mehla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011160; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Peterlin BM, 2012, WIRES RNA, V3, P92, DOI 10.1002/wrna.106; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Sahu GK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-400; Schroder S, 2012, J BIOL CHEM, V287, P1090, DOI 10.1074/jbc.M111.282855; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Shishido T, 2012, J VIROL, V86, P9055, DOI 10.1128/JVI.00793-12; Siliciano RF, 2012, DRUG DISCOV TODAY; Sung TL, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-66; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Tyagi M, 2010, J VIROL, V84, P6425, DOI 10.1128/JVI.01519-09; Wender PA, 2011, P NATL ACAD SCI USA, V108, P6721, DOI 10.1073/pnas.1015270108; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Xing SF, 2011, J VIROL, V85, P6060, DOI 10.1128/JVI.02033-10; Ying H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048832; Ying H, 2010, INT J MOL MED, V26, P265, DOI 10.3892/ijmm_00000461; Zhao R, 2011, NAT CELL BIOL, V13, P1295, DOI 10.1038/ncb2341; Zhu J, 2012, CELL REP, V2, P807, DOI 10.1016/j.celrep.2012.09.008; Zumer K, 2012, MOL CELL BIOL, V32, P1354, DOI 10.1128/MCB.06359-11	61	60	62	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14400	14407		10.1074/jbc.M113.464834	http://dx.doi.org/10.1074/jbc.M113.464834			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23539624	Green Published, hybrid			2022-12-28	WOS:000319253500043
J	van der Post, S; Subramani, DB; Backstram, M; Johansson, MEV; Vester-Christensen, MB; Mandel, U; Bennett, EP; Clausen, H; Dahlen, G; Sroka, A; Potempa, J; Hansson, GC				van der Post, Sjoerd; Subramani, Durai B.; Backstrom, Malin; Johansson, Malin E. V.; Vester-Christensen, Malene B.; Mandel, Ulla; Bennett, Eric P.; Clausen, Henrik; Dahlen, Gunnar; Sroka, Aneta; Potempa, Jan; Hansson, Gunnar C.			Site-specific O-Glycosylation on the MUC2 Mucin Protein Inhibits Cleavage by the Porphyromonas gingivalis Secreted Cysteine Protease (RgpB)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL TUMORAL CALCINOSIS; VIRULENCE FACTORS; C-TERMINUS; 3 MEMBERS; COLON; GINGIPAINS; INTESTINE; LAYERS; GEL; MUTATIONS	The colonic epithelial surface is protected by an inner mucus layer that the commensal microflora cannot penetrate. We previously demonstrated that Entamoeba histolytica secretes a protease capable of dissolving this layer that is required for parasite penetration. Here, we asked whether there are bacteria that can secrete similar proteases. We screened bacterial culture supernatants for such activity using recombinant fragments of the MUC2 mucin, the major structural component, and the only gel-forming mucin in the colonic mucus. MUC2 has two central heavily O-glycosylated mucin domains that are protease-resistant and has cysteine-rich N and C termini responsible for polymerization. Culture supernatants of Porphyromonas gingivalis, a bacterium that secretes proteases responsible for periodontitis, cleaved the MUC2 C-terminal region, whereas the N-terminal region was unaffected. The active enzyme was isolated and identified as Arg-gingipain B (RgpB). Two cleavage sites were localized to IR down arrow TT and NR down arrow QA. IR down arrow TT cleavage will disrupt the MUC2 polymers. Because this site has two potential O-glycosylation sites, we tested whether recombinant GalNAc-transferases (GalNAc-Ts) could glycosylate a synthetic peptide covering the IRTT sequence. Only GalNAc-T3 was able to glycosylate the second Thr in IRTT, rendering the sequence resistant to cleavage by RgpB. Furthermore, when GalNAc-T3 was expressed in CHO cells expressing the MUC2 C terminus, the second threonine was glycosylated, and the protein became resistant to RgpB cleavage. These findings suggest that bacteria can produce proteases capable of dissolving the inner protective mucus layer by specific cleavages in the MUC2 mucin and that this cleavage can be modulated by site-specific O-glycosylation.	[van der Post, Sjoerd; Subramani, Durai B.; Backstrom, Malin; Johansson, Malin E. V.; Hansson, Gunnar C.] Univ Gothenburg, Dept Med Biochem, S-40530 Gothenburg, Sweden; [Dahlen, Gunnar] Univ Gothenburg, Dept Oral Microbiol, S-40530 Gothenburg, Sweden; [Vester-Christensen, Malene B.; Mandel, Ulla; Bennett, Eric P.; Clausen, Henrik] Univ Copenhagen, Copenhagen Ctr Glyc, Dept Cellular & Mol Med & Odontol, DK-2200 Copenhagen, Denmark; [Sroka, Aneta] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Potempa, Jan] Univ Louisville, Sch Dent, Oral Hlth & Syst Dis Grp, Louisville, KY 40202 USA	University of Gothenburg; University of Gothenburg; University of Copenhagen; Jagiellonian University; University of Louisville	Hansson, GC (corresponding author), Univ Gothenburg, Dept Med Biochem, S-40530 Gothenburg, Sweden.	gunnar.hansson@medkem.gu.se	Johansson, Malin E. V./HCH-7451-2022; Hansson, Gunnar C/A-1236-2009; Potempa, Jan/AAA-6850-2021; Subramani, Durai/N-1448-2013; Hansson, Gunnar C./AAF-7324-2019; clausen, henrik/AAD-8016-2021; Bennett, Eric/AAG-6120-2020	Hansson, Gunnar C/0000-0002-1900-1869; Subramani, Durai/0000-0002-2256-3096; Hansson, Gunnar C./0000-0002-1900-1869; Bennett, Eric/0000-0002-4976-0647; Sroka, Aneta/0000-0002-3386-5364; Johansson, Malin E. V./0000-0002-4237-6677; Potempa, Jan/0000-0002-3600-7461; Clausen, Henrik/0000-0002-0915-5055; Mandel, Ulla/0000-0001-7012-9836; van der Post, Sjoerd/0000-0002-7965-5311	National Institutes of Health [DE 09761]; Swedish Research Council [746121027]; Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation [2011.0025]; IngaBritt and Arne Lundberg Foundation; Sahlgren's University Hospital (LUAALF); Wilhelm and Martina Lundgren's Foundation; Torsten och Ragnar Soderbergs Stiftelser; Sahlgrenska Academy; Mucosal Immunology Studies Team (MIST) consortium [U01AI095473]; Swedish Foundation for Strategic Research; Mucus-Bacteria-Colitis Center of the Innate Immunity Program; Foundation for Polish Science TEAM Project [DPS/424-329/10]; National Science Center [2012/04/A/NZ1/00051]; European Union [POIG.02.01.00-12-064/08]; centre of excellence grant from the University of Copenhagen; Danish National Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE009761] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); IngaBritt and Arne Lundberg Foundation; Sahlgren's University Hospital (LUAALF); Wilhelm and Martina Lundgren's Foundation; Torsten och Ragnar Soderbergs Stiftelser; Sahlgrenska Academy; Mucosal Immunology Studies Team (MIST) consortium; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Mucus-Bacteria-Colitis Center of the Innate Immunity Program; Foundation for Polish Science TEAM Project; National Science Center(National Science Centre, Poland); European Union(European Commission); centre of excellence grant from the University of Copenhagen; Danish National Research Foundation(Danmarks Grundforskningsfond); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE 09761. This work was also supported by Swedish Research Council Grant 746121027; a grant from the Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation Grant 2011.0025; grants from the IngaBritt and Arne Lundberg Foundation, Sahlgren's University Hospital (LUAALF), Wilhelm and Martina Lundgren's Foundation, Torsten och Ragnar Soderbergs Stiftelser, the Sahlgrenska Academy; Mucosal Immunology Studies Team (MIST) consortium Grant U01AI095473; the Swedish Foundation for Strategic Research, the Mucus-Bacteria-Colitis Center of the Innate Immunity Program; Foundation for Polish Science TEAM Project DPS/424-329/10; National Science Center Grant 2012/04/A/NZ1/00051; European Union Grant POIG.02.01.00-12-064/08; and a centre of excellence grant from the University of Copenhagen and the Danish National Research Foundation.	Abe N, 1998, J BIOCHEM, V123, P305; Ambort D, 2012, P NATL ACAD SCI USA, V109, P5645, DOI 10.1073/pnas.1120269109; Ambort D, 2011, BIOCHEM J, V436, P61, DOI 10.1042/BJ20102066; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Asker N, 1998, J BIOL CHEM, V273, P18857, DOI 10.1074/jbc.273.30.18857; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baudet M, 2010, MOL CELL PROTEOMICS, V9, P415, DOI 10.1074/mcp.M900359-MCP200; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; CARLSTEDT I, 1993, J BIOL CHEM, V268, P18771; Curtis MA, 1999, J PERIODONTAL RES, V34, P464, DOI 10.1111/j.1600-0765.1999.tb02282.x; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Godl K, 2002, J BIOL CHEM, V277, P47248, DOI 10.1074/jbc.M208483200; Guda K, 2009, P NATL ACAD SCI USA, V106, P12921, DOI 10.1073/pnas.0901454106; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Huang ZH, 1999, ANAL BIOCHEM, V268, P305, DOI 10.1006/abio.1998.3085; Ichikawa S, 2010, AM J MED GENET A, V152A, P896, DOI 10.1002/ajmg.a.33337; Johansson MEV, 2011, CELL MOL LIFE SCI, V68, P3635, DOI 10.1007/s00018-011-0822-3; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kato K, 2001, GLYCOBIOLOGY, V11, P821, DOI 10.1093/glycob/11.10.821; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Lidell ME, 2006, P NATL ACAD SCI USA, V103, P9298, DOI 10.1073/pnas.0600623103; Lidell ME, 2003, BIOCHEM J, V372, P335, DOI 10.1042/BJ20030003; Lidell ME, 2003, J BIOL CHEM, V278, P13944, DOI 10.1074/jbc.M210069200; Lu AP, 2009, J PROTEOME RES, V8, P2418, DOI 10.1021/pr8010364; Mandel U, 1999, GLYCOBIOLOGY, V9, P43, DOI 10.1093/glycob/9.1.43; PIKE R, 1994, J BIOL CHEM, V269, P406; Potempa J, 1998, J BIOL CHEM, V273, P21648, DOI 10.1074/jbc.273.34.21648; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schjoldager KTBG, 2011, J BIOL CHEM, V286, P40122, DOI 10.1074/jbc.M111.287912; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Subramani DB, 2010, BENEF MICROBES, V1, P343, DOI 10.3920/BM2010.0039; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; WHITEHEAD RH, 1987, IN VITRO CELL DEV B, V23, P436; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yoshino T, 2007, FEMS MICROBIOL LETT, V270, P75, DOI 10.1111/j.1574-6968.2007.00651.x	41	61	62	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14636	14646		10.1074/jbc.M113.459479	http://dx.doi.org/10.1074/jbc.M113.459479			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23546879	hybrid, Green Published			2022-12-28	WOS:000319253500063
J	Zhang, Y; Leung, DYM; Goleva, E				Zhang, Yong; Leung, Donald Y. M.; Goleva, Elena			Vitamin D Enhances Glucocorticoid Action in Human Monocytes INVOLVEMENT OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND MEDIATOR COMPLEX SUBUNIT 14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR SUPERFAMILY; NF-KAPPA-B; MAP KINASE; 1,25-DIHYDROXYVITAMIN D-3; DIFFERENTIAL REGULATION; MOLECULAR-MECHANISMS; DNA-BINDING; FACTOR GENE; GM-CSF; ACTIVATION	Vitamin D (VitD) is now recognized for its pleiotrophic roles in regulating immune function. VitD interaction with other steroid receptor superfamily receptors in peripheral blood mononuclear cells is poorly understood. In the current study, we demonstrate that VitD enhanced glucocorticoid (GC) responses in human peripheral blood mononuclear cells because it stimulated GC induction of mitogen-activated protein kinase phosphatase-1 (MKP-1) and enhanced GC inhibition of LPS-induced IL-6. These VitD effects were abolished in purified CD14(+) and CD14(-) cells but were recovered in CD14(+) cells co-cultured with CD14(-) cells separated by tissue culture inserts. GM-CSF, found in culture supernatants from CD14(-) cells, was shown to mediate VitD enhancement of GC-induced MKP-1 production in monocytes via increased production of mediator complex subunit 14 (MED14). Recruitment of VitD receptor and MED14, 4.7 kbp upstream of the human MKP-1 gene transcription start site, enhanced binding of glucocorticoid receptor and histone H4 acetylation at the 4.6-kbp glucocorticoid response element of the MKP-1 promoter in the presence of GM-CSF in U937 cells. Knockdown of MED14 abolished VitD-mediated enhancement of GC-induced MKP-1 production. These data demonstrate VitD-mediated stimulation of GC anti-inflammatory effects in human monocytes and identify a role for GM-CSF and MED14 as mediators of this process.	[Zhang, Yong; Leung, Donald Y. M.; Goleva, Elena] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Leung, Donald Y. M.] Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA	National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Goleva, E (corresponding author), Natl Jewish Hlth, 1400 Jackson St K1016A, Denver, CO 80206 USA.	golevae@njhealth.org			National Institutes of Health; NIAID; NHLBI [AI070140, 2R56AI070140, HL37260]; Edelstein Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL037260, R01HL037260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070140, R56AI070140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Edelstein Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID and NHLBI, Grants AI070140, 2R56AI070140, and HL37260. This work was also supported by the Edelstein Family Foundation.	Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Adcock IM, 2001, IMMUNOL CELL BIOL, V79, P376, DOI 10.1046/j.1440-1711.2001.01025.x; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Bikle DD, 2010, TRENDS ENDOCRIN MET, V21, P375, DOI 10.1016/j.tem.2010.01.003; Brehm JM, 2010, J ALLERGY CLIN IMMUN, V126, P52, DOI 10.1016/j.jaci.2010.03.043; Carlberg C, 1996, ENDOCRINE, V4, P91, DOI 10.1007/BF02782754; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Chen WW, 2006, MOL ENDOCRINOL, V20, P560, DOI 10.1210/me.2005-0318; Clark AR, 2003, CURR OPIN PHARMACOL, V3, P404, DOI 10.1016/S1471-4892(03)00073-0; Clark AR, 2003, FEBS LETT, V546, P37, DOI 10.1016/S0014-5793(03)00439-3; Clark AR, 2003, J ENDOCRINOL, V178, P5, DOI 10.1677/joe.0.1780005; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kim S, 2005, J BONE MINER RES, V20, P305, DOI 10.1359/JBMR.041112; KIM YR, 1991, LEUKEMIA RES, V15, P409, DOI 10.1016/0145-2126(91)90050-4; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; Krishnan AV, 2010, ENDOCR-RELAT CANCER, V17, pR19, DOI 10.1677/ERC-09-0139; Lee J, 2008, ANN CLIN LAB SCI, V38, P331; Leung DYM, 2003, J ALLERGY CLIN IMMUN, V111, P3, DOI 10.1067/mai.2003.97; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Martinez-Moczygemba M, 2003, J ALLERGY CLIN IMMUN, V112, P653, DOI 10.1067/mai.2003.1796; Newton R, 2000, THORAX, V55, P603, DOI 10.1136/thorax.55.7.603; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Plum LA, 2010, NAT REV DRUG DISCOV, V9, P941, DOI 10.1038/nrd3318; Quack M, 2000, J MOL BIOL, V296, P743, DOI 10.1006/jmbi.2000.3499; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rosen J, 2005, ENDOCR REV, V26, P452, DOI 10.1210/er.2005-0002; Searing DA, 2010, J ALLERGY CLIN IMMUN, V125, P995, DOI 10.1016/j.jaci.2010.03.008; Skversky AL, 2011, J CLIN ENDOCR METAB, V96, P3838, DOI 10.1210/jc.2011-1600; Stio M, 2007, J STEROID BIOCHEM, V103, P51, DOI 10.1016/j.jsbmb.2006.07.008; Sutherland ER, 2010, AM J RESP CRIT CARE, V181, P699, DOI 10.1164/rccm.200911-1710OC; Tchen CR, 2010, J BIOL CHEM, V285, P2642, DOI 10.1074/jbc.M109.037309; TOBLER A, 1987, J CLIN INVEST, V79, P1700, DOI 10.1172/JCI113009; Towers TL, 1998, J BIOL CHEM, V273, P10338, DOI 10.1074/jbc.273.17.10338; Towers TL, 1999, MOL CELL BIOL, V19, P4191; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Weber G, 2005, J INVEST DERMATOL, V124, P1080, DOI 10.1111/j.0022-202X.2005.23687.x; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412; Zhang Y, 2009, J BIOL CHEM, V284, P24542, DOI 10.1074/jbc.M109.021469	49	56	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14544	14553		10.1074/jbc.M112.427054	http://dx.doi.org/10.1074/jbc.M112.427054			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23572530	Green Published, hybrid			2022-12-28	WOS:000319253500056
J	Salzmann, S; Seher, A; Trebing, J; Weisenberger, D; Rosenthal, A; Siegmund, D; Wajant, H				Salzmann, Steffen; Seher, Axel; Trebing, Johannes; Weisenberger, Daniela; Rosenthal, Alevtina; Siegmund, Daniela; Wajant, Harald			Fibroblast Growth Factor Inducible (Fn14)-specific Antibodies Concomitantly Display Signaling Pathway-specific Agonistic and Antagonistic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; WEAK INDUCER; STRUCTURAL BASIS; CELL-DEATH; TWEAK; RECEPTOR; APOPTOSIS; TNF; FN14; PROLIFERATION	The Fn14-specific monoclonal antibodies PDL192 and P4A8, which are under consideration in clinical trials, showed no agonistic activity with respect to IL8 production and cell death induction. However, oligomerization with protein G or binding to Fc gamma receptors converted both anti-Fn14 antibodies into potent agonists. TNF-like weak inducer of apoptosis (TWEAK), the ligand of Fn14, occurs naturally in two forms with partly different signaling capabilities, as a membrane-bound ligand and as a soluble trimeric molecule. Although membrane TWEAK strongly triggers all Fn14-associated pathways, soluble TWEAK predominately triggers the alternative nuclear factor kappa B (NF kappa B) pathway and enhances TNF-induced cell death but has only a poor effect on the classical NF kappa B pathway and chemokine production. Thus, the oligomerized and Fc gamma R-bound anti-Fn14 mAbs mimicked the activity of membrane TWEAK. Notably, both anti-Fn14 antibodies significantly triggered p100 processing, the hallmark of the alternative NF kappa B pathway, and therefore resembled soluble TWEAK. In contrast to the latter, however, the anti-Fn14s showed no effect on TNF receptor 1-induced cell death and P4A8 even blocked the corresponding TWEAK response. Thus, we showed that Fn14 antibodies display an alternative NF kappa B pathway-specific agonistic activity but fail to phenocopy other activities of soluble TWEAK, whereas oligomerized or Fc gamma R-bound Fn14 antibodies fully mimic the activity of membrane TWEAK. In view of the trivalent nature of the TWEAK-Fn14 interaction, this suggests that the alternative NF kappa B pathway is uniquely responsive already to Fn14 dimerization enabling antibodies to elicit an unnatural response pattern distinct from that of the naturally occurring Fn14 ligands.	[Salzmann, Steffen; Seher, Axel; Trebing, Johannes; Weisenberger, Daniela; Rosenthal, Alevtina; Siegmund, Daniela; Wajant, Harald] Univ Hosp Wurzburg, Dept Internal Med 2, Div Mol Internal Med, D-97070 Wurzburg, Germany	University of Wurzburg	Wajant, H (corresponding author), Univ Hosp Wurzburg, Dept Internal Med 2, Div Mol Internal Med, Rontgenring 11, D-97070 Wurzburg, Germany.	harald.wajant@mail.uni-wuerzburg.de	Wajant, Harald/A-3020-2017	Wajant, Harald/0000-0002-2005-3949	Deutsche Forschungsgemeinschaft [DFG Wa 1025/19-2, SFB 487, TP B7]; Deutsche Krebshilfe [109922]; Argen-X BVBA	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Argen-X BVBA	This work was supported by the Deutsche Forschungsgemeinschaft (DFG Wa 1025/19-2, SFB 487, TP B7), Deutsche Krebshilfe (Project 109922), and Argen-X BVBA. H. W. is a consultant of Argen-X BVBA. Because of a Research Services Agreement between the University Hospital Wurzburg and Argen-X BVBA, antibodies not described in this publication have been analyzed for Argen-X BVBA.	Adams C, 2008, CELL DEATH DIFFER, V15, P751, DOI 10.1038/sj.cdd.4402306; Culp P., 2009, Therapeutic use of anti-TWEAK antibodies, Patent No. [WO2009020933A2, 2009020933]; Culp PA, 2010, CLIN CANCER RES, V16, P497, DOI 10.1158/1078-0432.CCR-09-1929; Desplat-Jego S, 2005, CLIN IMMUNOL, V117, P15, DOI 10.1016/j.clim.2005.06.005; Desplat-Jego S, 2002, J NEUROIMMUNOL, V133, P116, DOI 10.1016/S0165-5728(02)00368-5; DHEIN J, 1992, J IMMUNOL, V149, P3166; Dohi T, 2009, GASTROENTEROLOGY, V136, P912, DOI 10.1053/j.gastro.2008.11.017; Fick A, 2012, J BIOL CHEM, V287, P484, DOI 10.1074/jbc.M111.287656; Garber E., 2009, Anti-Fn14 antibodies and uses thereof, Patent No. [WO2009140177A2, 2009140177]; Hotta K, 2011, KIDNEY INT, V79, P179, DOI 10.1038/ki.2010.379; Ikner A, 2011, J BIOL CHEM, V286, P21546, DOI 10.1074/jbc.M110.203745; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Kamata K, 2006, J IMMUNOL, V177, P6433, DOI 10.4049/jimmunol.177.9.6433; Kanarek N, 2012, IMMUNOL REV, V246, P77, DOI 10.1111/j.1600-065X.2012.01098.x; Kawakita T, 2004, BIOCHEM BIOPH RES CO, V318, P726, DOI 10.1016/j.bbrc.2004.04.084; Kawashima R, 2011, GASTROENTEROLOGY, V141, P2119, DOI 10.1053/j.gastro.2011.08.040; Meighan-Mantha RL, 1999, J BIOL CHEM, V274, P33166, DOI 10.1074/jbc.274.46.33166; Michaelson JS, 2011, MABS-AUSTIN, V3, P362, DOI 10.4161/mabs.3.4.16090; Michaelson JS, 2009, RESULTS PROBL CELL D, V49, P145, DOI 10.1007/400_2008_18; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mueller AM, 2005, J NEUROIMMUNOL, V159, P55, DOI 10.1016/j.jneuroim.2004.10.001; Munoz-Garcia B, 2009, ARTERIOSCL THROM VAS, V29, P2061, DOI 10.1161/ATVBAHA.109.194852; Natoni A, 2007, BRIT J HAEMATOL, V139, P568, DOI 10.1111/j.1365-2141.2007.06852.x; O'Donnell MA, 2011, FEBS J, V278, P877, DOI 10.1111/j.1742-4658.2011.08016.x; Ortiz A, 2009, CYTOKINE GROWTH F R, V20, P251, DOI 10.1016/j.cytogfr.2009.05.002; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Perper SJ, 2006, J IMMUNOL, V177, P2610, DOI 10.4049/jimmunol.177.4.2610; Potrovita I, 2004, J NEUROSCI, V24, P8237, DOI 10.1523/JNEUROSCI.1089-04.2004; Razani B, 2011, IMMUNOL REV, V244, P44, DOI 10.1111/j.1600-065X.2011.01059.x; Roos C, 2010, J IMMUNOL, V185, P1593, DOI 10.4049/jimmunol.0903555; Schapira K, 2009, ARTERIOSCL THROM VAS, V29, P2021, DOI 10.1161/ATVBAHA.109.195040; Schneider P, 1999, EUR J IMMUNOL, V29, P1785, DOI 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U; Tran NL, 2006, CANCER RES, V66, P9535, DOI 10.1158/0008-5472.CAN-06-0418; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wicovsky A, 2009, CELL DEATH DIFFER, V16, P1445, DOI 10.1038/cdd.2009.80; Willis AL, 2008, MOL CANCER RES, V6, P725, DOI 10.1158/1541-7786.MCR-08-0005; Wilson NS, 2011, CANCER CELL, V19, P101, DOI 10.1016/j.ccr.2010.11.012; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Yepes M, 2005, AM J PATHOL, V166, P511, DOI 10.1016/S0002-9440(10)62273-0; Zhao Z, 2007, J IMMUNOL, V179, P7949, DOI 10.4049/jimmunol.179.11.7949; Zheng C, 2010, MOL CELL, V38, P101, DOI 10.1016/j.molcel.2010.03.009	43	33	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13455	13466		10.1074/jbc.M112.435917	http://dx.doi.org/10.1074/jbc.M112.435917			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23532848	Green Published, hybrid			2022-12-28	WOS:000318850300030
J	Jerke, U; Rolle, S; Purfurst, B; Luft, FC; Nauseef, WM; Kettritz, R				Jerke, Uwe; Rolle, Susanne; Purfuerst, Bettina; Luft, Friedrich C.; Nauseef, William M.; Kettritz, Ralph			beta 2 Integrin-mediated Cell-Cell Contact Transfers Active Myeloperoxidase from Neutrophils to Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGNOSTIC VALUE; INHIBITOR; SURFACE; CERULOPLASMIN; CYTOTOXICITY; INACTIVATION; PROTEOLYSIS; CD11B/CD18; ACTIVATION; EXPRESSION	Atherosclerosis and vasculitis both feature inflammation mediated by neutrophil-endothelial cell (EC) contact. Neutrophil myeloperoxidase (MPO) can disrupt normal EC function, although the mechanism(s) by which MPO is transferred to ECs are unknown. We tested the hypothesis that close, beta 2 integrin-dependent neutrophil-EC contact mediates MPO transfer from neutrophils to ECs. We used sensitive MPO assays and flow cytometry to detect MPO in ECs and demonstrate that ECs acquired MPO when contacted by neutrophils directly but not when ECs and neutrophils were separated in Transwells. The transfer was dependent on neutrophil number, exposure time, and incubation temperature. Transfer occurred in several EC types, increased with endotoxin, was not accompanied by MPO release into the medium, and was not abrogated by inhibiting degranulation to secretagogues. Confocal microscopy showed MPO internalization by ECs with cytoplasmic and nuclear staining. Neutrophils and ECs formed intimate contact sites demonstrated by electron microscopy. Blocking CD11b or CD18 beta 2 integrin chains, or using neutrophils from CD11b gene-deleted mice, reduced MPO transfer. EC-acquired MPO was enzymatically active, as demonstrated by its ability to oxidize the fluorescent probe aminophenyl fluorescein in the presence of a hydrogen peroxide source. The data suggest an alternative to EC uptake of soluble MPO, namely the cell contact-dependent, beta 2 integrin-mediated transfer from neutrophils. The findings could be of therapeutic relevance in atherosclerosis and vasculitis.	[Jerke, Uwe; Rolle, Susanne; Luft, Friedrich C.; Kettritz, Ralph] Charite, Expt & Clin Res Ctr, D-13125 Berlin, Germany; [Purfuerst, Bettina] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Nauseef, William M.] Univ Iowa, Roy & Lucille A Carver Coll Med, Iowa Inflammat Program, Coralville, IA 52241 USA; [Nauseef, William M.] Univ Iowa, Roy & Lucille A Carver Coll Med, Dept Med, Coralville, IA 52241 USA; [Nauseef, William M.] Vet Affairs Med Ctr, Iowa City, IA 52246 USA; [Kettritz, Ralph] Charite, Fac Med, Clin Nephrol & Intens Care Med, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kettritz, R (corresponding author), Charite, Expt & Clin Res Ctr, Lindenberger Weg 80, D-13125 Berlin, Germany.	kettritz@charite.de		Jerke, Uwe/0000-0001-6887-8010; Luft, Friedrich/0000-0002-8635-1199; Nauseef, William/0000-0003-4032-757X; Kettritz, Ralph/0000-0001-5821-6718	National Institutes of Health [AI 70958, AI 044642]; Deutsche Forschungsgemeinschaft [KE 576/7-1]; Experimental and Clinical Research Center; Veterans Affairs Medical Center, Iowa City; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044642, R56AI070958, R01AI070958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Experimental and Clinical Research Center; Veterans Affairs Medical Center, Iowa City; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants AI 70958 and AI 044642 (to W.M.N.). This work was also supported by Deutsche Forschungsgemeinschaft Grant KE 576/7-1 (to R.K. and F.C.L.), the Experimental and Clinical Research Center (to R.K. and F.C.L.), and the Veterans Affairs Medical Center, Iowa City (to W.M.N.).	Agner K., 1941, ACTA PHYSIOL SCAND, V2, P1; Astern JM, 2007, AM J PATHOL, V171, P349, DOI 10.2353/ajpath.2007.060831; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Boudjeltia KZ, 2004, BIOCHEM BIOPH RES CO, V325, P434, DOI 10.1016/j.bbrc.2004.10.049; Bouma MG, 1997, J IMMUNOL, V158, P5400; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Buffon A, 2002, NEW ENGL J MED, V347, P5, DOI 10.1056/NEJMoa012295; CAMPBELL EJ, 1982, J CLIN INVEST, V70, P845, DOI 10.1172/JCI110681; Chapman ALP, 2013, J BIOL CHEM, V288, P6465, DOI 10.1074/jbc.M112.418970; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Essin K, 2009, BLOOD, V113, P1326, DOI 10.1182/blood-2008-07-166660; Flemmig J, 2012, J BIOL CHEM, V287, P27913, DOI 10.1074/jbc.M112.364299; Horner H, 2007, J IMMUNOL, V179, P337, DOI 10.4049/jimmunol.179.1.337; Kalantar-Zadeh K, 2006, AM J KIDNEY DIS, V48, P59, DOI 10.1053/j.ajkd.2006.03.047; Karakas M, 2012, J INTERN MED, V271, P43, DOI 10.1111/j.1365-2796.2011.02397.x; Klebanoff SJ, 2013, J LEUKOCYTE BIOL, V93, P185, DOI 10.1189/jlb.0712349; Klinke A, 2011, BLOOD, V117, P1350, DOI 10.1182/blood-2010-05-284513; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; LOIKE JD, 1992, ANN NY ACAD SCI, V667, P163, DOI 10.1111/j.1749-6632.1992.tb51608.x; McMillen TS, 2005, CIRCULATION, V111, P2798, DOI 10.1161/CIRCULATIONAHA.104.516278; Meotti FC, 2011, J BIOL CHEM, V286, P12901, DOI 10.1074/jbc.M110.172460; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; RICE WG, 1990, SCIENCE, V249, P178, DOI 10.1126/science.2371565; Rudolph V, 2010, NAT MED, V16, P470, DOI 10.1038/nm.2124; Segelmark M, 1997, CLIN EXP IMMUNOL, V108, P167, DOI 10.1046/j.1365-2249.1997.d01-992.x; SENGELOV H, 1995, J IMMUNOL, V154, P4157; SENGELOV H, 1993, J IMMUNOL, V150, P1535; SHOCK A, 1988, CELL BIOCHEM FUNCT, V6, P13, DOI 10.1002/cbf.290060104; Uriarte Silvia M, 2011, J Immunol, V187, P391, DOI 10.4049/jimmunol.1003112; van Spriel AB, 2001, BLOOD, V97, P2478, DOI 10.1182/blood.V97.8.2478; von Vietinghoff S, 2007, BLOOD, V109, P4487, DOI 10.1182/blood-2006-10-055327; Wang AYM, 2010, AM J KIDNEY DIS, V56, P937, DOI 10.1053/j.ajkd.2010.05.008; Xiao H, 2002, J CLIN INVEST, V110, P955, DOI 10.1172/JCI200215918	33	40	42	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12910	12919		10.1074/jbc.M112.434613	http://dx.doi.org/10.1074/jbc.M112.434613			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23532856	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000318555100045
J	Tonkin, ML; Arredondo, SA; Loveless, BC; Serpa, JJ; Makepeace, KAT; Sundar, N; Petrotchenko, EV; Miller, LH; Grigg, ME; Boulanger, MJ				Tonkin, Michelle L.; Arredondo, Silvia A.; Loveless, Bianca C.; Serpa, Jason J.; Makepeace, Karl A. T.; Sundar, Natarajan; Petrotchenko, Evgeniy V.; Miller, Louis H.; Grigg, Michael E.; Boulanger, Martin J.			Structural and Biochemical Characterization of Plasmodium falciparum 12 (Pf12) Reveals a Unique Interdomain Organization and the Potential for an Antiparallel Arrangement with Pf41	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMETE-SURFACE PROTEIN; TRANSMISSION-BLOCKING IMMUNITY; MULTIPLE SEQUENCE ALIGNMENT; TOXOPLASMA-GONDII; TARGET ANTIGEN; MALARIA; POLYMORPHISM; PFS230; GENES; IDENTIFICATION	Plasmodium falciparum is the most devastating agent of human malaria. A major contributor to its virulence is a complex lifecycle with multiple parasite forms, each presenting a different repertoire of surface antigens. Importantly, members of the 6-Cys s48/45 family of proteins are found on the surface of P. falciparum in every stage, and several of these antigens have been investigated as vaccine targets. Pf12 is the archetypal member of the 6-Cys protein family, containing just two s48/45 domains, whereas other members have up to 14 of these domains. Pf12 is strongly recognized by immune sera from naturally infected patients. Here we show that Pf12 is highly conserved and under purifying selection. Immunofluorescence data reveals a punctate staining pattern with an apical organization in late schizonts. Together, these data are consistent with an important functional role for Pf12 in parasite-host cell attachment or invasion. To infer the structural and functional diversity between Pf12 and the other 11 6-Cys domain proteins, we solved the 1.90A resolution crystal structure of the Pf12 ectodomain. Structural analysis reveals a unique organization between the membrane proximal and membrane distal domains and clear homology with the SRS-domain containing proteins of Toxoplasma gondii. Cross-linking and mass spectrometry confirm the previously identified Pf12-Pf41 heterodimeric complex, and analysis of individual cross-links supports an unexpected antiparallel organization. Collectively, the localization and structure of Pf12 and details of its interaction with Pf41 reveal important insight into the structural and functional properties of this archetypal member of the 6-Cys protein family.	[Tonkin, Michelle L.; Loveless, Bianca C.; Boulanger, Martin J.] Univ Victoria, Victoria, BC V8W 3P6, Canada; [Arredondo, Silvia A.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Miller, Louis H.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Serpa, Jason J.; Makepeace, Karl A. T.; Petrotchenko, Evgeniy V.] Univ Victoria, Genome British Columbia Prote Ctr, Victoria, BC V8Z 7X8, Canada; [Sundar, Natarajan; Grigg, Michael E.] NIAID, Mol Parasitol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	University of Victoria; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Victoria; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Boulanger, MJ (corresponding author), Univ Victoria, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	mboulang@uvic.ca		Makepeace, Karl/0000-0001-9584-2750	Canadian Institutes of Health Research [MOP82915]; NIAID, National Institutes of Health; Natural Sciences and Engineering Research Council of Canada [CGS-D3]; Genome Canada/Genome British Columbia Technology Development Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000241, ZIAAI001017] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Genome Canada/Genome British Columbia Technology Development Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by Canadian Institutes of Health Research Grant MOP82915 (to M.J.B.). This work was also supported by the intramural funds of the NIAID, National Institutes of Health (to L.H.M.); Supported by a Natural Sciences and Engineering Research Council of Canada Alexander Graham Bell Canada Graduate Scholarship (CGS-D3).; Supported by a Genome Canada/Genome British Columbia Technology Development Grant.	Alexander DL, 2006, EUKARYOT CELL, V5, P1169, DOI 10.1128/EC.00040-06; Anthony TG, 2007, MOL BIOCHEM PARASIT, V156, P117, DOI 10.1016/j.molbiopara.2007.07.008; Arredondo SA, 2012, P NATL ACAD SCI USA, V109, P6692, DOI 10.1073/pnas.1204363109; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Beeson JG, 2007, J BIOL CHEM, V282, P22426, DOI 10.1074/jbc.M700231200; Boothroyd JC, 1998, INT J PARASITOL, V28, P3, DOI 10.1016/S0020-7519(97)00182-3; Boulanger MJ, 2010, CURR OPIN STRUC BIOL, V20, P551, DOI 10.1016/j.sbi.2010.08.003; CARTER R, 1995, MOL BIOCHEM PARASIT, V71, P203, DOI 10.1016/0166-6851(94)00054-Q; CESBRONDELAUW MF, 1994, J BIOL CHEM, V269, P16217; Chowdhury DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006352; Crawford J, 2010, J BIOL CHEM, V285, P12063, DOI 10.1074/jbc.M109.054866; Crawford J, 2009, J BIOL CHEM, V284, P9192, DOI 10.1074/jbc.M808714200; Davidson EA, 2001, BIOCHIMIE, V83, P601, DOI 10.1016/S0300-9084(01)01316-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eksi S, 2006, MOL MICROBIOL, V61, P991, DOI 10.1111/j.1365-2958.2006.05284.x; ELLIOTT JF, 1990, P NATL ACAD SCI USA, V87, P6363, DOI 10.1073/pnas.87.16.6363; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escalante AA, 1998, GENETICS, V149, P189; Escalante AA, 2002, MOL BIOCHEM PARASIT, V119, P17, DOI 10.1016/S0166-6851(01)00386-3; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gerloff DL, 2005, P NATL ACAD SCI USA, V102, P13598, DOI 10.1073/pnas.0502378102; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; He XL, 2002, NAT STRUCT BIOL, V9, P606, DOI 10.1038/nsb819; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Jung C, 2004, INT J PARASITOL, V34, P285, DOI 10.1016/j.ijpara.2003.12.004; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUMAR N, 1992, MOL BIOCHEM PARASIT, V53, P113, DOI 10.1016/0166-6851(92)90013-A; KUMAR N, 1987, PARASITE IMMUNOL, V9, P321, DOI 10.1111/j.1365-3024.1987.tb00511.x; Lekutis C, 2000, EXP PARASITOL, V96, P89, DOI 10.1006/expr.2000.4556; Lekutis C, 2001, INT J PARASITOL, V31, P1285, DOI 10.1016/S0020-7519(01)00261-2; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Li J, 2012, PARASITOL INT, V61, P443, DOI 10.1016/j.parint.2012.02.008; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moreno-Perez DA, 2013, PROTIST, V164, P37, DOI 10.1016/j.protis.2012.03.001; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Outchkourov NS, 2008, P NATL ACAD SCI USA, V105, P4301, DOI 10.1073/pnas.0800459105; Petrotchenko EV, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013524; Petrotchenko EV, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-64; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polley SD, 2001, GENETICS, V158, P1505; QUAKYI IA, 1987, J IMMUNOL, V139, P4213; Reeder JC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-126; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Schwarzenbacher R, 2004, ACTA CRYSTALLOGR D, V60, P1229, DOI 10.1107/S0907444904010145; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Taechalertpaisarn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041937; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanabe K, 2007, MOL BIOCHEM PARASIT, V156, P74, DOI 10.1016/j.molbiopara.2007.07.002; Tetteh KKA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005568; van Dijk MR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000853; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; van Schaijk BCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015121; van Schaijk BCL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003549; VanBuskirk KM, 2009, P NATL ACAD SCI USA, V106, P13004, DOI 10.1073/pnas.0906387106; Wasmuth JD, 2012, MBIO, V3, DOI 10.1128/mBio.00321-12; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Waters A, 2006, CELL, V124, P689, DOI 10.1016/j.cell.2006.02.011; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wickramarachchi T, 2009, INT J PARASITOL, V39, P763, DOI 10.1016/j.ijpara.2008.12.004; WILLIAMSON KC, 1993, MOL BIOCHEM PARASIT, V58, P355, DOI 10.1016/0166-6851(93)90058-6; Williamson KC, 2003, PARASITE IMMUNOL, V25, P351, DOI 10.1046/j.1365-3024.2003.00643.x; Williamson KC, 1995, MOL BIOCHEM PARASIT, V75, P33, DOI 10.1016/0166-6851(95)02507-3; WILLIAMSON KC, 1993, MOL BIOCHEM PARASIT, V62, P125, DOI 10.1016/0166-6851(93)90186-2; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; World Health Organization, 2010, WORLD MALARIA REPORT	68	48	51	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12805	12817		10.1074/jbc.M113.455667	http://dx.doi.org/10.1074/jbc.M113.455667			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23511632	Green Published, hybrid			2022-12-28	WOS:000318555100036
J	Das, S; Samant, RS; Shevde, LA				Das, Shamik; Samant, Rajeev S.; Shevde, Lalita A.			Nonclassical Activation of Hedgehog Signaling Enhances Multidrug Resistance and Makes Cancer Cells Refractory to Smoothened-targeting Hedgehog Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; MULTIFACETED ROLES; GENE-EXPRESSION; OSTEOPONTIN; PATHWAY; WNT; IDENTIFICATION; TRANSCRIPTION; CHEMOTHERAPY	The Hedgehog (Hh) pathway is critical in normal development. However, it has been reported to be up-regulated in numerous cancers and implicated in tumorigenicity and metastasis. Classical activation of Hh signaling initiated by Hh ligands results in activation of Smoothened (SMOH) and culminates in the activation of the GLI transcription factors. Classical Hh signaling is autocrine or paracrine (involving interaction between tumor cells and their stroma/microenvironment). The tumor milieu is rich in inflammatory cytokines that can modulate tumor cell behavior. Here, we show for the first time that the Hh pathway can be nonclassically up-regulated by the inflammatory cytokine, osteopontin (OPN). OPN-initiated Akt-GSK3 beta signaling mediates the subcellular distribution and activation of GLI1 resulting in the modulation of epithelial mesenchymal plasticity and drug resistance. Interestingly, the SMOH inhibitor cyclopamine was unable to uncouple the effects of OPN on Hh signaling, indicating that OPN nonclassically activates GLI-mediated transcription. Given the fact that OPN is itself transcriptionally activated upon Hh signaling, our current findings highlight the possibility of a feedforward vicious cycle such that the Hh pathway might be turned on nonclassically by stimuli from the tumor milieu. Thus, drugs that target the classical Hh ligand-mediated activation of Hh signaling may be compromised in their ability to interfere with the functioning of the pathway.	[Das, Shamik; Samant, Rajeev S.; Shevde, Lalita A.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35233 USA; [Samant, Rajeev S.; Shevde, Lalita A.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Shevde, LA (corresponding author), Univ Alabama Birmingham, Dept Pathol, WTI320D,1720 2nd Ave South, Birmingham, AL 35294 USA.	lsamant@uab.edu		Samant, Rajeev/0000-0001-5681-4976	National Institutes of Health from NCI [R01CA138850, R01CA140472]; Mayer Mitchell award; University of Alabama at Birmingham Center for Metabolic Bone Disease pilot grant; NATIONAL CANCER INSTITUTE [R01CA140472, R01CA138850] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mayer Mitchell award; University of Alabama at Birmingham Center for Metabolic Bone Disease pilot grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA138850 (to L. A. S.) and R01CA140472 (to R. S. S.) from NCI. This work was also supported by a Mayer Mitchell award (to L. A. S.) and a University of Alabama at Birmingham Center for Metabolic Bone Disease pilot grant (to L. A. S.).	Benelli R, 2006, CURR PHARM DESIGN, V12, P3101, DOI 10.2174/138161206777947461; Chakraborty G, 2006, CURR MOL MED, V6, P819, DOI 10.2174/156652406779010803; Chikazawa N, 2010, ANTICANCER RES, V30, P2041; Cook AC, 2005, MOL CARCINOGEN, V43, P225, DOI 10.1002/mc.20105; CRAIG AM, 1988, BIOCHEM BIOPH RES CO, V157, P166, DOI 10.1016/S0006-291X(88)80028-7; Das R, 2003, J BIOL CHEM, V278, P28593, DOI 10.1074/jbc.M303445200; Das S, 2009, J BIOL CHEM, V284, P22888, DOI 10.1074/jbc.M109.021949; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Evangelista M, 2006, CLIN CANCER RES, V12, P5924, DOI 10.1158/1078-0432.CCR-06-1736; Gibalova L, 2012, TOXICOL IN VITRO, V26, P435, DOI 10.1016/j.tiv.2012.01.014; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Harris LG, 2012, ONCOGENE, V31, P3370, DOI 10.1038/onc.2011.496; Harris LG, 2011, MOL CANCER RES, V9, P1165, DOI 10.1158/1541-7786.MCR-11-0175; Huo HR, 2010, CANCER RES, V70, P8726, DOI 10.1158/0008-5472.CAN-10-0755; Jiang J, 2008, OSTEOARTHR CARTILAGE, V16, P70, DOI 10.1016/j.joca.2007.05.014; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lauth M, 2010, MOL PHARMACOL, V78, P486, DOI 10.1124/mol.110.066431; Li X, 2007, ONCOGENE, V26, P4489, DOI 10.1038/sj.onc.1210241; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Manoukian AS, 2002, ADV CANCER RES, V84, P203, DOI 10.1016/S0065-230X(02)84007-6; Mazumdar T, 2011, CANCER RES, V71, P5904, DOI 10.1158/0008-5472.CAN-10-4173; Mukherjee S, 2006, CANCER BIOL THER, V5, P674, DOI 10.4161/cbt.5.6.2906; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Ougolkov Andrei V, 2006, Future Oncol, V2, P91, DOI 10.2217/14796694.2.1.91; Philip S, 2004, GLYCOCONJUGATE J, V21, P429, DOI 10.1007/s10719-004-5533-7; Rangaswami H, 2006, GLYCOCONJUGATE J, V23, P221, DOI 10.1007/s10719-006-7927-1; Robertson BW, 2010, EXP CELL RES, V316, P1, DOI 10.1016/j.yexcr.2009.10.012; Robinson SC, 2005, ADV CANCER RES, V93, P159, DOI 10.1016/S0065-230X(05)93005-4; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Shevde LA, 2010, CURR MOL MED, V10, P71, DOI 10.2174/156652410791065381; Shevde LA, 2006, CLIN EXP METASTAS, V23, P123, DOI 10.1007/s10585-006-9013-2; Sims-Mourtada J, 2007, ONCOGENE, V26, P5674, DOI 10.1038/sj.onc.1210356; Weinberg RA, 2008, NAT CELL BIOL, V10, P1021, DOI 10.1038/ncb0908-1021; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200; Zavadil J, 2008, CANCER RES, V68, P9574, DOI 10.1158/0008-5472.CAN-08-2316; Zhou BHP, 2005, CELL CYCLE, V4, P772, DOI 10.4161/cc.4.6.1744	40	80	82	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11824	11833		10.1074/jbc.M112.432302	http://dx.doi.org/10.1074/jbc.M112.432302			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23508962	hybrid, Green Published			2022-12-28	WOS:000318157600018
J	Kang, H; Viollet, B; Wu, DQ				Kang, Heeseog; Viollet, Benoit; Wu, Dianqing			Genetic Deletion of Catalytic Subunits of AMP-activated Protein Kinase Increases Osteoclasts and Reduces Bone Mass in Young Adult Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEPTIN REGULATION; DIFFERENTIATION; INFLAMMATION; OVARIECTOMY; PROGENITOR; METFORMIN; FUSION	AMP-activated protein kinase (AMPK) is a key regulator of cellular and systemic energy homeostasis and a potential therapeutic target for the intervention of cancer and metabolic disorders. However, the role of AMPK in bone homeostasis remains incompletely understood. Here we assessed the skeletal phenotype of mice lacking catalytic subunits of AMPK and found that mice lacking AMPK alpha 1 (Prkaa1(-/-)) or AMPK alpha 2 (Prkaa2(-/-)) had reduced bone mass compared with the WT mice, although the reduction was less in Prkaa2(-/-) mice than in Prkaa1(-/-) mice. Static and dynamic bone histomorphometric analyses revealed that Prkaa1(-/-) mice had an elevated rate of bone remodeling because of increases in bone formation and resorption, whereas AMPK alpha 2 KO-induced bone mass reduction was largely attributable to elevated bone resorption. In agreement with our in vivo results, AMPK alpha deficiency was associated with increased osteoclastogenesis in vitro. Moreover, we found that AMPK alpha 1 inhibited the receptor activator of nuclear factor kappa B (RANK) signaling, providing an explanation for AMPK-mediated inhibition of osteoclastogenesis. Therefore, our findings further underscore the importance of AMPKin bone homeostasis, in particular osteoclastogenesis, in young adult mammals.	[Kang, Heeseog; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol & Vasc Biol, New Haven, CT 06520 USA; [Kang, Heeseog; Wu, Dianqing] Yale Univ, Sch Med, Therapeut Program, New Haven, CT 06520 USA; [Viollet, Benoit] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Viollet, Benoit] CNRS, UMR8104, F-75014 Paris, France; [Viollet, Benoit] Univ Paris 05, F-75014 Paris, France	Yale University; Yale University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Kang, H (corresponding author), Yale Univ, Sch Med, Dept Orthopaed & Rehabil, 330 Cedar St, New Haven, CT 06520 USA.	heeseog.kang@yale.edu; dan.wu@yale.edu	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224	National Institutes of Health [AR046032]; NATIONAL CANCER INSTITUTE [R01CA132317, R01CA139395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by a National Institutes of Health Grant AR046032 (to D. W.).	Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bess E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020848; Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; BURGESS AW, 1985, J BIOL CHEM, V260, P6004; Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; HA J, 1994, J BIOL CHEM, V269, P22162; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; INGEBRITSEN TS, 1978, BIOCHEM BIOPH RES CO, V81, P1268, DOI 10.1016/0006-291X(78)91273-1; Jeyabalan J, 2012, J ENDOCRINOL, V214, P349, DOI 10.1530/JOE-12-0184; Jeyabalan J, 2012, J ENDOCRINOL, V212, P277, DOI 10.1530/JOE-11-0306; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Kasai T, 2009, J CELL PHYSIOL, V221, P740, DOI 10.1002/jcp.21917; Katerelos M, 2010, IMMUNOL CELL BIOL, V88, P754, DOI 10.1038/icb.2010.44; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Khaliulin I, 2007, J PHYSIOL-LONDON, V581, P1147, DOI 10.1113/jphysiol.2007.130369; Kim JE, 2008, BONE, V43, P394, DOI 10.1016/j.bone.2008.03.021; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Lee SH, 2012, CALCIFIED TISSUE INT, V90, P404, DOI 10.1007/s00223-012-9584-7; Lee YS, 2010, BONE, V47, P926, DOI 10.1016/j.bone.2010.08.001; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Liu F, 2007, BONE, V40, P1135, DOI 10.1016/j.bone.2006.12.003; Mahlapuu M, 2004, AM J PHYSIOL-ENDOC M, V286, pE194, DOI 10.1152/ajpendo.00147.2003; Mao JQ, 2009, P NATL ACAD SCI USA, V106, P17576, DOI 10.1073/pnas.0909055106; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Merrell GA, 2005, BIOTECH HISTOCHEM, V80, P139, DOI 10.1080/10520290500303414; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Quinn JMW, 2010, FASEB J, V24, P275, DOI 10.1096/fj.09-137158; Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Shah M, 2010, BONE, V47, P309, DOI 10.1016/j.bone.2010.04.596; Molinuevo MS, 2010, J BONE MINER RES, V25, P211, DOI 10.1359/jbmr.090732; Suda T, 1997, METHOD ENZYMOL, V282, P223; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tanaka Yoshiya, 2005, Nihon Rinsho, V63, P1535; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yamaguchi N, 2008, FEBS LETT, V582, P451, DOI 10.1016/j.febslet.2007.12.037; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Yokota T, 2006, STEM CELLS, V24, P13, DOI 10.1634/stemcells.2004-0346; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	48	45	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12187	12196		10.1074/jbc.M112.430389	http://dx.doi.org/10.1074/jbc.M112.430389			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486478	Green Published, hybrid			2022-12-28	WOS:000318157600050
J	Li, H; Zhang, XY; Wu, TJ; Cheng, W; Liu, X; Jiang, TT; Wen, J; Li, J; Ma, QL; Hua, ZC				Li, Huang; Zhang, Xiang-Yu; Wu, Tuo-Jiang; Cheng, Wei; Liu, Xin; Jiang, Ting-Ting; Wen, Juan; Li, Jie; Ma, Qiao-Ling; Hua, Zi-Chun			Endoplasmic Reticulum Stress Regulates Rat Mandibular Cartilage Thinning under Compressive Mechanical Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOMIC ANALYSIS; CONDYLAR CARTILAGE; SUBCHONDRAL BONE; OSTEOARTHRITIS; CHONDROCYTES; PROTECTS; FORCES; INJURY; CELLS; XBP1	Compressive mechanical stress-induced cartilage thinning has been characterized as a key step in the progression of temporomandibular joint diseases, such as osteoarthritis. However, the regulatory mechanisms underlying this loss have not been thoroughly studied. Here, we used an established animal model for loading compressive mechanical stress to induce cartilage thinning in vivo. The mechanically stressed mandibular chondrocytes were then isolated to screen potential candidates using a proteomics approach. A total of 28 proteins were identified that were directly or indirectly associated with endoplasmic reticulum stress, including protein disulfide-isomerase, calreticulin, translationally controlled tumor protein, and peptidylprolyl cis/trans-isomerase protein. The altered expression of these candidates was validated at both the mRNA and protein levels. The induction of endoplasmic reticulum stress by mechanical stress loading was confirmed by the activation of endoplasmic reticulum stress markers, the elevation of the cytoplasmic Ca2+ level, and the expansion of endoplasmic reticulum membranes. More importantly, the use of a selective inhibitor to block endoplasmic reticulum stress in vivo reduced the apoptosis observed at the early stages of mechanical stress loading and inhibited the proliferation observed at the later stages of mechanical stress loading. Accordingly, the use of the inhibitor significantly restored cartilage thinning. Taken together, these results demonstrated that endoplasmic reticulum stress is significantly activated in mechanical stress-induced mandibular cartilage thinning and, more importantly, that endoplasmic reticulum stress inhibition alleviates this loss, suggesting a novel pharmaceutical strategy for the treatment of mechanical stress-induced temporomandibular joint diseases.	[Li, Huang; Zhang, Xiang-Yu; Cheng, Wei; Liu, Xin; Jiang, Ting-Ting; Wen, Juan; Li, Jie; Ma, Qiao-Ling; Hua, Zi-Chun] Nanjing Univ, Sch Stomatol, Nanjing 210009, Jiangsu, Peoples R China; [Li, Huang; Zhang, Xiang-Yu; Cheng, Wei; Liu, Xin; Jiang, Ting-Ting; Wen, Juan; Li, Jie; Ma, Qiao-Ling; Hua, Zi-Chun] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210009, Jiangsu, Peoples R China; [Wu, Tuo-Jiang] Nanjing Med Univ, Stomatol Coll, Nanjing 210029, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing Medical University	Li, H (corresponding author), Nanjing Univ, Sch Stomatol, 30 Zhongyang Rd, Nanjing 210009, Jiangsu, Peoples R China.	Lihuang76@nju.edu.cn; zchua@nju.edu.cn		Wen, Juan/0000-0001-9832-2056	National Natural Science Foundation of China; Nanjing Medical Science and Technique Development Foundation [81070807, 81200764, 81121062, 50973046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Medical Science and Technique Development Foundation	This work was supported by the National Natural Science Foundation of China and Nanjing Medical Science and Technique Development Foundation Contract Grants 81070807, 81200764, 81121062, and 50973046.	Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; COPRAY JCVM, 1985, ARCH ORAL BIOL, V30, P305, DOI 10.1016/0003-9969(85)90002-0; Embree M, 2011, J DENT RES, V90, P1331, DOI 10.1177/0022034511421930; Gobom J, 2001, ANAL CHEM, V73, P434, DOI 10.1021/ac001241s; Habib H, 2005, J DENT RES, V84, P474, DOI 10.1177/154405910508400514; Hermansson M, 2004, J BIOL CHEM, V279, P43514, DOI 10.1074/jbc.M407041200; Jiao K, 2011, BONE, V48, P362, DOI 10.1016/j.bone.2010.09.010; Kiliaridis S, 1999, AM J ORTHOD DENTOFAC, V116, P121, DOI 10.1016/S0889-5406(99)70207-6; Kronfeld K, 2005, MOL CELL PROTEOMICS, V4, P1876, DOI 10.1074/mcp.M500194-MCP200; Kuroda S, 2009, OSTEOARTHR CARTILAGE, V17, P1408, DOI 10.1016/j.joca.2009.04.025; Lee JH, 2005, ARTHRITIS RHEUM-US, V52, P2386, DOI 10.1002/art.21215; Li H, 2010, J CELL PHYSIOL, V223, P610, DOI 10.1002/jcp.22052; MIKI T, 1987, CLIN ORTHOP RELAT R, P276; Millward-Sadler SJ, 1999, J CELL BIOL, V145, P183, DOI 10.1083/jcb.145.1.183; Mizoguchi I, 1996, ARCH ORAL BIOL, V41, P863, DOI 10.1016/S0003-9969(96)00021-0; Murray RC, 1999, J ORTHOPAED RES, V17, P725, DOI 10.1002/jor.1100170516; Roberts SR, 2001, J APPL PHYSIOL, V90, P1385, DOI 10.1152/jappl.2001.90.4.1385; Ruiz-Romero C, 2005, PROTEOMICS, V5, P3048, DOI 10.1002/pmic.200402106; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; SICHER H, 1947, Am J Orthod, V43, P123; Sohen Satoshi, 2001, Pathophysiology, V8, P93, DOI 10.1016/S0928-4680(01)00066-9; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sriram D, 2009, J DENT RES, V88, P466, DOI 10.1177/0022034509336616; Suzuki S, 2004, J Orthod, V31, P138, DOI 10.1179/146531204225020436; Takebe K, 2011, INT J MOL MED, V27, P329, DOI 10.3892/ijmm.2010.588; Tasci A, 2011, J TISSUE ENG REGEN M, V5, P210, DOI 10.1002/term.307; Teramoto M, 2003, J BONE MINER METAB, V21, P276, DOI 10.1007/s00774-003-0421-y; Wadhwa S, 2008, J DENT EDUC, V72, P930; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Yang W, 2006, PROTEOMICS, V6, P2982, DOI 10.1002/pmic.200500036; Yu LR, 2000, ELECTROPHORESIS, V21, P3058, DOI 10.1002/1522-2683(20000801)21:14<3058::AID-ELPS3058>3.0.CO;2-U	33	51	54	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18172	18183		10.1074/jbc.M112.407296	http://dx.doi.org/10.1074/jbc.M112.407296			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23603905	hybrid, Green Published			2022-12-28	WOS:000320721900022
J	Paulsel, AL; Merz, AJ; Nickerson, DP				Paulsel, Andrew L.; Merz, Alexey J.; Nickerson, Daniel P.			Vps9 Family Protein Muk1 Is the Second Rab5 Guanosine Nucleotide Exchange Factor in Budding Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY ENDOCYTIC PATHWAY; MULTIVESICULAR BODY; SACCHAROMYCES-CEREVISIAE; BINDING-PROTEIN; MEMBRANE RECRUITMENT; VACUOLAR PROTEINS; FACTOR RECEPTOR; GAMMA-ADAPTIN; DOMAIN; GTPASES	VPS9 domains can act as guanosine nucleotide exchange factors (GEFs) against small G proteins of the Rab5 family. Saccharomyces cerevisiae vps9 Delta mutants have trafficking defects considerably less severe than multiple deletions of the three cognate Rab5 paralogs (Vps21, Ypt52, and Ypt53). Here, we show that Muk1, which also contains a VPS9 domain, acts as a second GEF against Vps21, Ypt52, and Ypt53. Muk1 is partially redundant with Vps9 in vivo, with vps9 Delta muk1 Delta double mutant cells displaying hypersensitivity to temperature and ionic stress, as well as profound impairments in endocytic and Golgi endosome trafficking, including defects in sorting through the multivesicular body. Cells lacking both Vps9 and Muk1 closely phenocopy double and triple knock-out strains lacking Rab5 paralogs. Microscopy and overexpression experiments demonstrate that Vps9 and Muk1 have distinct localization determinants. These experiments establish Muk1 as the second Rab5 GEF in budding yeast.	[Paulsel, Andrew L.; Merz, Alexey J.; Nickerson, Daniel P.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Merz, Alexey J.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Merz, AJ (corresponding author), Amer Canc Soc, Atlanta, GA 30329 USA.	merza@uw.edu; dpn2@uw.edu			National Institutes of Health [GM077349]; NIGMS, National Institutes of Health [T32 GM09270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077349] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM077349.; Supported in part by NIGMS, National Institutes of Health Grant T32 GM09270.	Abdul-Ghani M, 2001, J BIOL CHEM, V276, P6225, DOI 10.1074/jbc.M009073200; Albert S, 2000, BIOL CHEM, V381, P453, DOI 10.1515/BC.2000.059; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; Barbieri MA, 2003, J BIOL CHEM, V278, P32027, DOI 10.1074/jbc.M304324200; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Barrowman J, 2003, NAT CELL BIOL, V5, P955, DOI 10.1038/ncb1103-955; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; Brett CL, 2008, J CELL BIOL, V182, P1141, DOI 10.1083/jcb.200801001; Bridges D, 2012, J BIOL CHEM, V287, P20913, DOI 10.1074/jbc.M111.334060; Burd CG, 1996, MOL CELL BIOL, V16, P2369; Cabrera M, 2013, J BIOL CHEM, V288, P5166, DOI 10.1074/jbc.M112.431536; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; Chen LY, 2000, J CELL BIOL, V151, P731, DOI 10.1083/jcb.151.3.731; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Collins RN, 2003, MOL CELL, V12, P1064, DOI 10.1016/S1097-2765(03)00445-3; Darsow T, 2000, METHOD ENZYMOL, V327, P95, DOI 10.1016/S0076-6879(00)27270-4; Davies BA, 2003, J BIOL CHEM, V278, P19826, DOI 10.1074/jbc.M301059200; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hama H, 1999, J BIOL CHEM, V274, P15284, DOI 10.1074/jbc.274.21.15284; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; HORAZDOVSKY BF, 1994, EMBO J, V13, P1297, DOI 10.1002/j.1460-2075.1994.tb06382.x; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kajiho H, 2003, J CELL SCI, V116, P4159, DOI 10.1242/jcs.00718; Lachmann J, 2012, MOL BIOL CELL, V23, P2516, DOI 10.1091/mbc.E11-12-1030; Liu Y, 2011, MOL BIOL CELL, V22, P1575, DOI 10.1091/mbc.E10-08-0716; Lo SY, 2012, NAT STRUCT MOL BIOL, V19, P40, DOI 10.1038/nsmb.2162; MacDonald C, 2012, TRAFFIC, V13, P586, DOI 10.1111/j.1600-0854.2011.01326.x; Mattera R, 2003, EMBO J, V22, P78, DOI 10.1093/emboj/cdg015; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; McNatt MW, 2007, MOL BIOL CELL, V18, P697, DOI 10.1091/mbc.E06-08-0663; Menant A, 2006, EMBO J, V25, P4436, DOI 10.1038/sj.emboj.7601330; Mizuno-Yamasaki E, 2010, DEV CELL, V18, P828, DOI 10.1016/j.devcel.2010.03.016; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Nickerson DP, 2012, TRAFFIC, V13, P1411, DOI 10.1111/j.1600-0854.2012.01390.x; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Oestreich AJ, 2007, MOL BIOL CELL, V18, P707, DOI 10.1091/mbc.E06-08-0680; Olsen B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-141; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Plemel RL, 2011, MOL BIOL CELL, V22, P1353, DOI 10.1091/mbc.E10-03-0260; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Russell MRG, 2012, J CELL SCI, V125, P5208, DOI 10.1242/jcs.111310; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Samanta MP, 2003, P NATL ACAD SCI USA, V100, P12579, DOI 10.1073/pnas.2132527100; Shiba Y, 2002, J BIOCHEM, V131, P327, DOI 10.1093/oxfordjournals.jbchem.a003107; SIKORSKI RS, 1989, GENETICS, V122, P19; SINGERKRUGER B, 1995, J CELL SCI, V108, P3509; SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; Stawiecka-Mirota M, 2007, TRAFFIC, V8, P1280, DOI 10.1111/j.1600-0854.2007.00610.x; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Weisman LS, 2006, NAT REV MOL CELL BIO, V7, P243, DOI 10.1038/nrm1892; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	61	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18162	18171		10.1074/jbc.M113.457069	http://dx.doi.org/10.1074/jbc.M113.457069			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23612966	Green Published, hybrid			2022-12-28	WOS:000320721900021
J	Chew, YC; Adhikary, G; Xu, W; Wilson, GM; Eckert, RL				Chew, Yap Ching; Adhikary, Gautam; Xu, Wen; Wilson, Gerald M.; Eckert, Richard L.			Protein Kinase C delta Increases Kruppel-like Factor 4 Protein, which Drives Involucrin Gene Transcription in Differentiating Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; DISTAL REGULATORY REGION; GREEN TEA POLYPHENOL; PROMOTER ACTIVITY; PKC-DELTA; IN-VIVO; EXPRESSION CLONING; CORNIFIED ENVELOPE; CORNEAL EPITHELIUM; P38-DELTA MAPK	KLF4 is a member of the Kruppel-like factor family of transcriptional regulators. KLF4 has been shown to be required for normal terminal differentiation of keratinocytes, but the molecular mechanism whereby KLF4 regulates genes associated with the differentiation process has not been studied. In the present study, we explore the impact of KLF4 on expression of involucrin, a gene that is specifically expressed in differentiated keratinocytes. KLF4 overexpression and knockdown studies show that involucrin mRNA and protein level correlates directly with KLF4 level. Moreover, studies of mutant KLF4 proteins indicate that transcriptionally inactive forms do not increase involucrin expression. PKC delta is a regulator of keratinocyte differentiation that increases expression of differentiation-associated target genes, including involucrin. Overexpression of KLF4 augments the PKC delta-dependent increase in involucrin expression, whereas KLF4 knockdown attenuates this response. The KLF4 induction of human involucrin (hINV) promoter activity is mediated via KLF4 binding to a GC-rich element located in the hINV promoter distal regulatory region, a region of the promoter required for in vivo involucrin expression. Mutation of the GC-rich element, an adjacent AP1 factor binding site, or both sites severely attenuates the response. Moreover, loss of KLF4 in an epidermal equivalent model of differentiation results in loss of hINV expression. These studies suggest that KLF4 is part of a multiprotein complex that interacts that the hINV promoter distal regulatory region to drive differentiation-dependent hINV gene expression in epidermis.	[Chew, Yap Ching; Adhikary, Gautam; Xu, Wen; Wilson, Gerald M.; Eckert, Richard L.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Obstet & Gynecol & Reprod Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Eckert, RL (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	reckert@umaryland.edu	Wilson, Gerald/AAF-3874-2019	Wilson, Gerald/0000-0002-1273-7507; Chew, Yap Ching/0000-0002-1686-6541	National Institutes of Health [R01 AR046494, R01 AR053851]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053851, R01AR046494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR046494 and R01 AR053851 (to R. L. E.).	Adhikary G, 2005, INVEST OPHTH VIS SCI, V46, P3109, DOI 10.1167/iovs.05-0053; Adhikary G, 2005, INVEST OPHTH VIS SCI, V46, P1219, DOI 10.1167/iovs.04-1285; Adhikary G, 2004, INVEST OPHTH VIS SCI, V45, P1080, DOI 10.1167/iovs.03-1180; Adhikary G, 2010, J INVEST DERMATOL, V130, P2017, DOI 10.1038/jid.2010.108; Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; APFEL C, 1992, P NATL ACAD SCI USA, V89, P7129, DOI 10.1073/pnas.89.15.7129; Balasubramanian S, 2004, J BIOL CHEM, V279, P24007, DOI 10.1074/jbc.M314331200; Balasubramanian S, 2002, J BIOL CHEM, V277, P1828, DOI 10.1074/jbc.M110376200; Balasubramanian S, 2007, TOXICOL APPL PHARM, V224, P214, DOI 10.1016/j.taap.2007.03.020; Balasubramanian S, 2006, J BIOL CHEM, V281, P36162, DOI 10.1074/jbc.M605368200; Banks EB, 1999, BIOCHEM J, V337, P507, DOI 10.1042/0264-6021:3370507; Banks EB, 1998, BIOCHEM J, V331, P61, DOI 10.1042/bj3310061; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BYRNE C, 1994, DEVELOPMENT, V120, P2369; Chen XM, 2003, J MOL BIOL, V326, P665, DOI 10.1016/S0022-2836(02)01449-3; Chew YC, 2011, J BIOL CHEM, V286, P28772, DOI 10.1074/jbc.M110.205245; Cordani N, 2011, ONCOGENE, V30, P922, DOI 10.1038/onc.2010.474; Crish JF, 2008, J INVEST DERMATOL, V128, P530, DOI 10.1038/sj.jid.5701049; Crish JF, 2006, J INVEST DERMATOL, V126, P305, DOI 10.1038/sj.jid.5700019; Crish JF, 2000, CARCINOGENESIS, V21, P1031, DOI 10.1093/carcin/21.5.1031; Crish JF, 1998, J BIOL CHEM, V273, P30460, DOI 10.1074/jbc.273.46.30460; CRISH JF, 1993, DIFFERENTIATION, V53, P191, DOI 10.1111/j.1432-0436.1993.tb00708.x; Crish JF, 2002, ONCOGENE, V21, P738, DOI 10.1038/sj.onc.1205038; Dai X, 2004, CURR OPIN GENET DEV, V14, P485, DOI 10.1016/j.gde.2004.07.002; Denning MF, 2000, EXP DERMATOL, V9, P192, DOI 10.1034/j.1600-0625.2000.009003192.x; DENNING MF, 1995, CELL GROWTH DIFFER, V6, P149; Deucher A, 2002, J BIOL CHEM, V277, P17032, DOI 10.1074/jbc.M109076200; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; ECKERT RL, 1993, J INVEST DERMATOL, V100, P613, DOI 10.1111/1523-1747.ep12472288; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Efimova T, 2000, J BIOL CHEM, V275, P1601, DOI 10.1074/jbc.275.3.1601; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Jaubert J, 2004, J INVEST DERMATOL, V123, P313, DOI 10.1111/j.0022-202X.2004.23203.x; Jaubert J, 2003, DEVELOPMENT, V130, P2767, DOI 10.1242/dev.00477; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; KIKKAWA U, 1984, ADV CYCLIC NUCL PROT, V17, P437; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kraft CA, 2007, ARCH DERMATOL RES, V299, P71, DOI 10.1007/s00403-006-0727-4; Ohba M, 1998, MOL CELL BIOL, V18, P5199, DOI 10.1128/MCB.18.9.5199; Patel S, 2006, P NATL ACAD SCI USA, V103, P18668, DOI 10.1073/pnas.0608658103; Pincelli C, 2010, J CELL PHYSIOL, V225, P310, DOI 10.1002/jcp.22275; Poumay Y, 2004, ARCH DERMATOL RES, V296, P203, DOI 10.1007/s00403-004-0507-y; RICE RH, 1977, CELL, V11, P417, DOI 10.1016/0092-8674(77)90059-9; RICE RH, 1979, CELL, V18, P681, DOI 10.1016/0092-8674(79)90123-5; Robinson NA, 1996, J INVEST DERMATOL, V107, P101, DOI 10.1111/1523-1747.ep12298323; Robinson NA, 1997, J BIOL CHEM, V272, P12035, DOI 10.1074/jbc.272.18.12035; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Segre J, 2003, CURR OPIN CELL BIOL, V15, P778, DOI 10.1016/j.ceb.2003.10.001; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Steinert PM, 1997, J BIOL CHEM, V272, P2021, DOI 10.1074/jbc.272.3.2021; Sturniolo MT, 2005, ONCOGENE, V24, P2963, DOI 10.1038/sj.onc.1208392; Swamynathan SK, 2008, INVEST OPHTH VIS SCI, V49, P3360, DOI 10.1167/iovs.08-1811; Swamynathan SK, 2007, MOL CELL BIOL, V27, P182, DOI 10.1128/MCB.00846-06; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Welter JF, 1996, J BIOL CHEM, V271, P14727, DOI 10.1074/jbc.271.25.14727; WELTER JF, 1995, J BIOL CHEM, V270, P12614, DOI 10.1074/jbc.270.21.12614; Whitney EM, 2006, GENE EXPRESSION, V13, P85, DOI 10.3727/000000006783991908; Yoon HS, 2004, J BIOL CHEM, V279, P5035, DOI 10.1074/jbc.M307631200; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhu L, 2008, J INVEST DERMATOL, V128, P833, DOI 10.1038/sj.jid.5701103	64	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17759	17768		10.1074/jbc.M113.477133	http://dx.doi.org/10.1074/jbc.M113.477133			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23599428	Green Published, hybrid			2022-12-28	WOS:000320380600065
J	Leiba, J; Syson, K; Baronian, G; Zanella-Cleon, I; Kalscheuer, R; Kremer, L; Bornemann, S; Molle, V				Leiba, Jade; Syson, Karl; Baronian, Gregory; Zanella-Cleon, Isabelle; Kalscheuer, Rainer; Kremer, Laurent; Bornemann, Stephen; Molle, Virginie			Mycobacterium tuberculosis Maltosyltransferase GlgE, a Genetically Validated Antituberculosis Target, Is Negatively Regulated by Ser/Thr Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; PROTEIN SECONDARY STRUCTURE; ALPHA-GLUCAN; BACTERIAL GLYCOGEN; KINASES; BIOSYNTHESIS; EXPRESSION; GROWTH; SMEGMATIS; SURVIVAL	GlgE is a maltosyltransferase involved in the biosynthesis of alpha-glucans that has been genetically validated as a potential therapeutic target against Mycobacterium tuberculosis. Despite also making alpha-glucan, the GlgC/GlgA glycogen pathway is distinct and allosterically regulated. We have used a combination of genetics and biochemistry to establish how the GlgE pathway is regulated. M. tuberculosis GlgE was phosphorylated specifically by the Ser/Thr protein kinase PknB in vitro on one serine and six threonine residues. Furthermore, GlgE was phosphorylated in vivo when expressed in Mycobacterium bovis bacillus Calmette-Guerin (BCG) but not when all seven phosphorylation sites were replaced by Ala residues. The GlgE orthologues from Mycobacterium smegmatis and Streptomyces coelicolor were phosphorylated by the corresponding PknB orthologues in vitro, implying that the phosphorylation of GlgE is widespread among actinomycetes. PknB-dependent phosphorylation of GlgE led to a 2 orders of magnitude reduction in catalytic efficiency in vitro. The activities of phosphoablative and phosphomimetic GlgE derivatives, where each phosphorylation site was substituted with either Ala or Asp residues, respectively, correlated with negative phosphoregulation. Complementation studies of a M. smegmatis glgE mutant strain with these GlgE derivatives, together with both classical and chemical forward genetics, were consistent with flux through the GlgE pathway being correlated with GlgE activity. We conclude that the GlgE pathway appears to be negatively regulated in actinomycetes through the phosphorylation of GlgE by PknB, a mechanism distinct from that known in the classical glycogen pathway. Thus, these findings open new opportunities to target the GlgE pathway therapeutically.	[Leiba, Jade; Baronian, Gregory; Kremer, Laurent; Molle, Virginie] Univ Montpellier 2, CNRS, UMR 5235, Lab Dynam Interact Membranaires Normales & Pathol, F-34095 Montpellier 05, France; [Leiba, Jade; Baronian, Gregory; Kremer, Laurent; Molle, Virginie] Univ Montpellier I, CNRS, UMR 5235, Lab Dynam Interact Membranaires Normales & Pathol, F-34095 Montpellier 05, France; [Syson, Karl; Bornemann, Stephen] John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Zanella-Cleon, Isabelle] Univ Lyon 1, CNRS, BioSci IFR128, IBCP,UMR 5086,Lyon Gerland, F-69367 Lyon 07, France; [Kalscheuer, Rainer] Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, D-40225 Dusseldorf, Germany; [Kremer, Laurent] INSERM, F-34095 Montpellier 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Heinrich Heine University Dusseldorf; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Bornemann, S (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	stephen.bornemann@jic.ac.uk; virginie.molle@univ-montp2.fr	Bornemann, Stephen/K-2938-2012; Kremer, Laurent/M-4935-2017; Kalscheuer, Rainer/AAF-1381-2020; MOLLE, Virginie/D-4050-2019; Kalscheuer, Rainer/A-2852-2015	Bornemann, Stephen/0000-0001-5930-9473; Kremer, Laurent/0000-0002-6604-4458; Kalscheuer, Rainer/0000-0002-3378-2067; MOLLE, Virginie/0000-0002-6573-3411; Leiba, Jade/0000-0003-0584-9524	French National Research Agency [ANR-09-MIEN-004]; United Kingdom Biotechnology and Biological Sciences Research Council [BB/I012850/1, BB/J004561/1]; John Innes Foundation; Jurgen Manchot Foundation; Region Languedoc-Roussillon; University of Montpellier 1; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0647, BB/I012850/1] Funding Source: researchfish; BBSRC [BBS/E/J/000C0647, BB/I012850/1] Funding Source: UKRI	French National Research Agency(French National Research Agency (ANR)); United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; Jurgen Manchot Foundation; Region Languedoc-Roussillon(Region OccitanieRegion Ile-de-France); University of Montpellier 1; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by in part grants from the French National Research Agency (Grant ANR-09-MIEN-004) (to V. M. and L. K.), the United Kingdom Biotechnology and Biological Sciences Research Council (Grant BB/I012850/1 and BB/J004561/1) and the John Innes Foundation (to S. B.), and the Jurgen Manchot Foundation (to R. K.).; Supported by the Region Languedoc-Roussillon and the University of Montpellier 1.	Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Ballicora MA, 2003, MICROBIOL MOL BIOL R, V67, P213, DOI 10.1128/MMBR.67.2.213-225.2003; Barthe P, 2010, STRUCTURE, V18, P606, DOI 10.1016/j.str.2010.02.013; Barthe P, 2009, STRUCTURE, V17, P568, DOI 10.1016/j.str.2009.02.012; Belanger AE, 1999, J BACTERIOL, V181, P6670, DOI 10.1128/JB.181.21.6670-6678.1999; Canova MJ, 2008, PLASMID, V60, P149, DOI 10.1016/j.plasmid.2008.05.002; Canova MJ, 2009, J BACTERIOL, V191, P2876, DOI 10.1128/JB.01569-08; Chandra G, 2011, MICROBIOL-SGM, V157, P1565, DOI 10.1099/mic.0.044263-0; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Corrales RM, 2012, J BIOL CHEM, V287, P26187, DOI 10.1074/jbc.M112.373209; Dinadayala P, 2008, GLYCOBIOLOGY, V18, P502, DOI 10.1093/glycob/cwn031; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; England P, 2009, FEBS LETT, V583, P301, DOI 10.1016/j.febslet.2008.12.036; Gagliardi MC, 2007, CELL MICROBIOL, V9, P2081, DOI 10.1111/j.1462-5822.2007.00940.x; Geurtsen J, 2009, J IMMUNOL, V183, P5221, DOI 10.4049/jimmunol.0900768; Hale KJ, 2002, NAT PROD REP, V19, P413, DOI 10.1039/b009211h; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; Kalscheuer R, 2010, DRUG NEWS PERSPECT, V23, P619, DOI 10.1358/dnp.2010.23.10.1534855; Kalscheuer R, 2010, NAT CHEM BIOL, V6, P376, DOI 10.1038/nchembio.340; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Mendes V, 2012, NAT PROD REP, V29, P834, DOI 10.1039/c2np20014g; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Molle V, 2010, MOL MICROBIOL, V78, P1591, DOI 10.1111/j.1365-2958.2010.07446.x; Molle V, 2010, PROTEOMICS, V10, P3910, DOI 10.1002/pmic.201000316; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Noens EE, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-27; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Slama N, 2011, BIOCHEM BIOPH RES CO, V412, P401, DOI 10.1016/j.bbrc.2011.07.051; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Syson K, 2011, J BIOL CHEM, V286, P38298, DOI 10.1074/jbc.M111.279315; Veyron-Churlet R, 2004, MOL MICROBIOL, V54, P1161, DOI 10.1111/j.1365-2958.2004.04334.x; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371	41	24	25	5	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16546	16556		10.1074/jbc.M112.398503	http://dx.doi.org/10.1074/jbc.M112.398503			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23609448	Green Published, hybrid			2022-12-28	WOS:000320378900031
J	Cerny, AC; Oberacker, T; Pfannstiel, J; Weigold, S; Will, C; Huber, A				Cerny, Alexander C.; Oberacker, Tina; Pfannstiel, Jens; Weigold, Sebastian; Will, Carina; Huber, Armin			Mutation of Light-dependent Phosphorylation Sites of the Drosophila Transient Receptor Potential-like (TRPL) Ion Channel Affects Its Subcellular Localization and Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; SYNAPTIC PLASTICITY; POTASSIUM CHANNEL; IN-VIVO; TRANSLOCATION; TRAFFICKING; ACTIVATION; DYNAMICS; REQUIRES; KINASES	The Drosophila phototransduction cascade terminates in the opening of the ion channel transient receptor potential (TRP) and TRP-like (TRPL). Contrary to TRP, TRPL undergoes light-dependent subcellular trafficking between rhabdomeric photoreceptor membranes and an intracellular storage compartment, resulting in long term light adaptation. Here, we identified in vivo phosphorylation sites of TRPL that affect TRPL stability and localization. Quantitative mass spectrometry revealed a light-dependent change in the TRPL phosphorylation pattern. Mutation of eight C-terminal phosphorylation sites neither affected multimerization of the channels nor the electrophysiological response of flies expressing the mutated channels. However, these mutations resulted in mislocalization and enhanced degradation of TRPL after prolonged dark-adaptation. Mutation of subsets of the eight C-terminal phosphorylation sites also led to a reduction of TRPL content and partial mislocalization in the dark. This suggests that a light-dependent switch in the phosphorylation pattern of the TRPL channel mediates stable expression of TRPL in the rhabdomeres upon prolonged dark-adaptation.	[Cerny, Alexander C.; Oberacker, Tina; Weigold, Sebastian; Will, Carina; Huber, Armin] Univ Hohenheim, Dept Biosensor, Inst Physiol, D-70599 Stuttgart, Germany; [Pfannstiel, Jens; Huber, Armin] Univ Hohenheim, Life Sci Ctr, Prote Core Facil, D-70599 Stuttgart, Germany	University Hohenheim; University Hohenheim	Huber, A (corresponding author), Univ Hohenheim, Dept Biosensor, August von Hartmann Str 3, D-70599 Stuttgart, Germany.	armin.huber@uni-hohenheim.de	Huber, Armin/GYU-6322-2022	Huber, Armin/0000-0003-3977-089X	Deutsche Forschungsgemeinschaft [Hu839/2-6]; German-Israeli-Foundation for Scientific Research and Development [I-1001-96.13]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German-Israeli-Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development)	This work was supported by Deutsche Forschungsgemeinschaft (Hu839/2-6) and German-Israeli-Foundation for Scientific Research and Development Grant I-1001-96.13.	Bahner M, 2002, NEURON, V34, P83, DOI 10.1016/S0896-6273(02)00630-X; Bodenmiller B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100182; Butcher Adrian J, 2012, Handb Exp Pharmacol, P79, DOI 10.1007/978-3-642-23274-9_5; Chorna-Ornan I, 2005, J CELL BIOL, V171, P143, DOI 10.1083/jcb.200503014; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Cronin MA, 2006, J CELL SCI, V119, P2935, DOI 10.1242/jcs.03049; Greenspan R. J., 1997, THEORY PRACTICE DROS, P3; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hart JR, 2011, ONCOTARGET, V2, P467, DOI 10.18632/oncotarget.293; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Leung HT, 2000, J NEUROSCI, V20, P6797, DOI 10.1523/JNEUROSCI.20-18-06797.2000; Lieu MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031622; Meyer NE, 2006, J CELL SCI, V119, P2592, DOI 10.1242/jcs.02986; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Oberegelsbacher C, 2011, EUR J CELL BIOL, V90, P620, DOI 10.1016/j.ejcb.2011.02.003; Odell AF, 2005, J BIOL CHEM, V280, P37974, DOI 10.1074/jbc.M503646200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; OTOUSA JE, 1992, VISUAL NEUROSCI, V8, P385, DOI 10.1017/S0952523800004910; Pak W.L., 1979, P67; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Pichaud F, 2001, DEVELOPMENT, V128, P815; Popescu DC, 2006, J NEUROSCI, V26, P8570, DOI 10.1523/JNEUROSCI.1478-06.2006; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Reuss H, 1997, NEURON, V19, P1249, DOI 10.1016/S0896-6273(00)80416-X; Richter D, 2011, J BIOL CHEM, V286, P34234, DOI 10.1074/jbc.M111.278564; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Voolstra O, 2010, J BIOL CHEM, V285, P14275, DOI 10.1074/jbc.M110.102053; Wang N, 2008, J NEUROSCI, V28, P1444, DOI 10.1523/JNEUROSCI.5134-07.2008; Yang JW, 2007, P NATL ACAD SCI USA, V104, P20055, DOI 10.1073/pnas.0708574104; Yang ZH, 1998, NEURON, V21, P215, DOI 10.1016/S0896-6273(00)80528-0; Yao XQ, 2005, NEUROSIGNALS, V14, P273, DOI 10.1159/000093042; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893	36	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15600	15613		10.1074/jbc.M112.426981	http://dx.doi.org/10.1074/jbc.M112.426981			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23592784	hybrid, Green Published			2022-12-28	WOS:000319822300018
J	Xi, G; Shen, XC; Wai, C; Clemmons, DR				Xi, Gang; Shen, Xin-Chun; Wai, Christine; Clemmons, David R.			Recruitment of Nox4 to a Plasma Membrane Scaffold Is Required for Localized Reactive Oxygen Species Generation and Sustained Src Activation in Response to Insulin-like Growth Factor-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; PROTEIN; KINASE; H2O2; PHOSPHORYLATION; IDENTIFICATION; ASSOCIATION; BINDING; SHPS-1; SHC	Nox4-derived ROS is increased in response to hyperglycemia and is required for IGF-I-stimulated Src activation. This study was undertaken to determine the mechanism by which Nox4 mediates sustained Src activation. IGF-I stimulated sustained Src activation, which occurred primarily on the SHPS-1 scaffold protein. In vitro oxidation experiments indicated that Nox4-derived ROS was able to oxidize Src when they are in close proximity, and Src oxidation leads to its activation. Therefore we hypothesized that Nox4 recruitment to the plasma membrane scaffold SHPS-1 allowed localized ROS generation to mediate sustained Src oxidation and activation. To determine the mechanism of Nox4 recruitment, we analyzed the role of Grb2, a component of the SHPS-1 signaling complex. We determined that Nox4 Tyr-491 was phosphorylated after IGF-I stimulation and was responsible for Nox4 binding to the SH2 domain of Grb2. Overexpression of a Nox4 mutant, Y491F, prevented Nox4/Grb2 association. Importantly, it also prevented Nox4 recruitment to SHPS-1. The role of Grb2 was confirmed using a Pyk2 Y881F mutant, which blocked Grb2 recruitment to SHPS-1. Cells expressing this mutant had impaired Nox4 recruitment to SHPS-1. IGF-I-stimulated downstream signaling and biological actions were also significantly impaired in Nox4 Y491F-overexpressing cells. Disruption of Nox4 recruitment to SHPS-1 in aorta from diabetic mice inhibited IGF-I-stimulated Src oxidation and activation as well as cell proliferation. These findings provide insight into the mechanism by which localized Nox4-derived ROS regulates the sustained activity of a tyrosine kinase that is critical for mediating signal transduction and biological actions.	[Xi, Gang; Shen, Xin-Chun; Wai, Christine; Clemmons, David R.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Clemmons, DR (corresponding author), Univ N Carolina, Div Endocrinol, CB 7170,8024 Burnett Womack, Chapel Hill, NC 27599 USA.	david_clemmons@med.unc.edu			National Institutes of Health [AG02331]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG002331, R01AG002331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG02331.	Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; Block K, 2008, J BIOL CHEM, V283, P24061, DOI 10.1074/jbc.M803964200; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; COURTNEIDGE SA, 1980, P NATL ACAD SCI-BIOL, V77, P3783, DOI 10.1073/pnas.77.7.3783; Czernichow S, 2009, AM J CLIN NUTR, V90, P329, DOI 10.3945/ajcn.2009.27635; Ellmark SHM, 2005, CARDIOVASC RES, V65, P495, DOI 10.1016/j.cardiores.2004.10.026; GOCKERMAN A, 1995, CIRC RES, V76, P514, DOI 10.1161/01.RES.76.4.514; Guo J, 2006, NEUROSCIENCE, V143, P827, DOI 10.1016/j.neuroscience.2006.08.031; Guo J, 2003, NEUROSCI LETT, V345, P101, DOI 10.1016/S0304-3940(03)00483-X; Helmcke I, 2009, ANTIOXID REDOX SIGN, V11, P1279, DOI [10.1089/ars.2008.2383, 10.1089/ARS.2008.2383]; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Ikeda S, 2005, ARTERIOSCL THROM VAS, V25, P2295, DOI 10.1161/01.ATV.0000187472.55437.af; Kreuzer J, 2002, FASEB J, V16, P38, DOI 10.1096/fj.01-1036fje; Kris-Etherton PM, 2004, CIRCULATION, V110, P637, DOI 10.1161/01.CIR.0000137822.39831.F1; Krymskaya VP, 2004, FASEB J, V18, P428, DOI 10.1096/fj.04-2869fje; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Lieskovska J, 2006, J BIOL CHEM, V281, P25041, DOI 10.1074/jbc.M602866200; Ling Y, 2005, MOL BIOL CELL, V16, P3353, DOI 10.1091/mbc.E04-10-0918; Maile LA, 2008, DIABETES, V57, P2637, DOI 10.2337/db08-0326; Nam TJ, 2000, ENDOCRINOLOGY, V141, P1100, DOI 10.1210/en.141.3.1100; Radhakrishnan Y, 2008, J BIOL CHEM, V283, P16320, DOI 10.1074/jbc.M801687200; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Sakellariou GK, 2013, ANTIOXID REDOX SIGN, V18, P603, DOI 10.1089/ars.2012.4623; Shen XC, 2010, CELL MOL LIFE SCI, V67, P3893, DOI 10.1007/s00018-010-0411-x; Shen XC, 2009, MOL CELL PROTEOMICS, V8, P1539, DOI 10.1074/mcp.M800543-MCP200; Sorenson CM, 2002, AM J PHYSIOL-RENAL, V283, pF1085, DOI 10.1152/ajprenal.00380.2001; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Toledano MB, 2010, CELL, V140, P454, DOI 10.1016/j.cell.2010.02.003; von Lohneysen K, 2010, MOL CELL BIOL, V30, P961, DOI 10.1128/MCB.01393-09; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Xi G, 2008, MOL ENDOCRINOL, V22, P2162, DOI 10.1210/me.2008-0079; Xi G, 2012, DIABETES, V61, P104, DOI 10.2337/db11-0990	33	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15641	15653		10.1074/jbc.M113.456046	http://dx.doi.org/10.1074/jbc.M113.456046			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23612968	hybrid, Green Published			2022-12-28	WOS:000319822300021
J	Yoshinaga, S; Sato, T; Hirakane, M; Esaki, K; Hamaguchi, T; Haga-Yamanaka, S; Tsunoda, M; Kimoto, H; Shimada, I; Touhara, K; Terasawa, H				Yoshinaga, Sosuke; Sato, Toru; Hirakane, Makoto; Esaki, Kaori; Hamaguchi, Takashi; Haga-Yamanaka, Sachiko; Tsunoda, Mai; Kimoto, Hiroko; Shimada, Ichio; Touhara, Kazushige; Terasawa, Hiroaki			Structure of the Mouse Sex Peptide Pheromone ESP1 Reveals a Molecular Basis for Specific Binding to the Class C G-protein-coupled Vomeronasal Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; NMR SOLUTION STRUCTURE; SWEET PROTEINS; CRYSTAL-STRUCTURE; COMMUNICATION; RECOGNITION; EVOLUTION; BRAZZEIN; MONELLIN; PROGRAM	Exocrine gland-secreting peptide 1 (ESP1) is a sex pheromone that is released in male mouse tear fluids and enhances female sexual receptive behavior. ESP1 is selectively recognized by a specific class C G-protein-coupled receptor (GPCR), V2Rp5, among the hundreds of receptors expressed in vomeronasal sensory neurons (VSNs). The specific sensing mechanism of the mammalian peptide pheromone by the classC GPCR remains to be elucidated. Here we identified the minimal functional region needed to retain VSN-stimulating activity in ESP1 and determined its three-dimensional structure, which adopts a helical fold stabilized by an intramolecular disulfide bridge with extensive charged patches. We then identified the amino acids involved in the activation of VSNs by a structure-based mutational analysis, revealing that the highly charged surface is crucial for the ESP1 activity. We also demonstrated that ESP1 specifically bound to an extracellular region of V2Rp5 by an in vitro pulldown assay. Based on homology modeling of V2Rp5 using the structure of the metabotropic glutamate receptor, we constructed a docking model of the ESP1-V2Rp5 complex in which the binding interface exhibited good electrostatic complementarity. These experimental results, supported by the molecular docking simulations, reveal that charge-charge interactions determine the specificity of ESP1 binding to V2Rp5 in the large extracellular region characteristic of class C GPCRs. The present study provides insights into the structural basis for the narrowly tuned sensing of mammalian peptide pheromones by class C GPCRs.	[Yoshinaga, Sosuke; Hirakane, Makoto; Esaki, Kaori; Hamaguchi, Takashi; Terasawa, Hiroaki] Kumamoto Univ, Fac Life Sci, Chuo Ku, Kumamoto 8620973, Japan; [Sato, Toru; Haga-Yamanaka, Sachiko; Tsunoda, Mai; Kimoto, Hiroko; Touhara, Kazushige] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Sato, Toru; Haga-Yamanaka, Sachiko; Tsunoda, Mai; Kimoto, Hiroko; Touhara, Kazushige] Univ Tokyo, Grad Sch Agr & Life Sci, JST ERATO Touhara Chemosensory Signal Project, Bunkyo Ku, Tokyo 1138657, Japan; [Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Div Phys Chem, Bunkyo Ku, Tokyo 1130033, Japan	Kumamoto University; University of Tokyo; University of Tokyo; University of Tokyo	Terasawa, H (corresponding author), Kumamoto Univ, Fac Life Sci, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	terasawa@gpo.kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [19036022]; JST; Japan Society for the Promotion of Science [24780104]; KUMAYAKU Alumni Research Fund; Medical Institute of Bioregulation, Kyushu University	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); KUMAYAKU Alumni Research Fund; Medical Institute of Bioregulation, Kyushu University	This work was supported by the Targeted Proteins Research Program (to S.Y., K. T., and H. T.) and Grant-in-aid for Scientific Research on Priority Areas 19036022 (to S.Y., K. T., and H. T.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, by ERATO Touhara Chemosensory Signal Project from JST (to K. T.), by Grant-in-aid for Young Scientists (B) 24780104 (to S.Y.) from the Japan Society for the Promotion of Science, by the KUMAYAKU Alumni Research Fund (to S.Y.), and by the Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University (to H. T.).	BOCSKEI Z, 1992, NATURE, V360, P186, DOI 10.1038/360186a0; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Garimella R, 2003, BIOCHEMISTRY-US, V42, P9970, DOI 10.1021/bi0274322; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Haga S, 2007, PURE APPL CHEM, V79, P775, DOI 10.1351/pac200779040775; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hurst JL, 2009, BEHAV BRAIN RES, V200, P295, DOI 10.1016/j.bbr.2008.12.020; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Kimoto H, 2007, CURR BIOL, V17, P1879, DOI 10.1016/j.cub.2007.09.042; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Masuda K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035380; Morini G, 2005, J MED CHEM, V48, P5520, DOI 10.1021/jm0503345; MRONGA S, 1994, PROTEIN SCI, V3, P1527, DOI 10.1002/pro.5560030918; Novotny MV, 2003, BIOCHEM SOC T, V31, P117, DOI 10.1042/BST0310117; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Stowers L, 2010, CURR OPIN NEUROBIOL, V20, P770, DOI 10.1016/j.conb.2010.08.015; Swaney WT, 2009, BEHAV BRAIN RES, V200, P239, DOI 10.1016/j.bbr.2008.09.039; Takai K, 2010, NAT PROTOC, V5, P227, DOI 10.1038/nprot.2009.207; Tancredi T, 2004, EUR J BIOCHEM, V271, P2231, DOI 10.1111/j.1432-1033.2004.04154.x; Temussi PA, 2002, FEBS LETT, V526, P1, DOI 10.1016/S0014-5793(02)03155-1; TEMUSSI PA, 1991, ACS SYM SER, V450, P143; Touhara K, 2007, ADV GENET, V59, P147, DOI 10.1016/S0065-2660(07)59006-1; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Touhara K, 2008, CURR OPIN PHARMACOL, V8, P759, DOI 10.1016/j.coph.2008.09.001; VESTWEBER D, 1988, J CELL BIOL, V107, P2045, DOI 10.1083/jcb.107.6.2045; Vincent F, 2001, J MOL BIOL, V305, P459, DOI 10.1006/jmbi.2000.4241; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; WEISS MS, 1995, P NATL ACAD SCI USA, V92, P10172, DOI 10.1073/pnas.92.22.10172	38	14	16	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16064	16072		10.1074/jbc.M112.436782	http://dx.doi.org/10.1074/jbc.M112.436782			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23576433	Green Published, hybrid			2022-12-28	WOS:000319822300057
J	Dunn, HA; Walther, C; Godin, CM; Hall, RA; Ferguson, SSG				Dunn, Henry A.; Walther, Cornelia; Godin, Christina M.; Hall, Randy A.; Ferguson, Stephen S. G.			Role of SAP97 Protein in the Regulation of Corticotropin-releasing Factor Receptor 1 Endocytosis and Extracellular Signal-regulated Kinase 1/2 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL REGULATION; TYPE-1 RECEPTOR; PEPTIDE FAMILY; PHOSPHORYLATION; DESENSITIZATION; SCAFFOLD; INTERNALIZATION; LOCALIZATION; ASSOCIATION; ANTAGONIST	The corticotropin-releasing factor (CRF) receptor 1 (CRFR1) is a target for the treatment of psychiatric diseases such as depression, schizophrenia, anxiety disorder, and bipolar disorder. The carboxyl-terminal tail of the CRFR1 terminates in a PDZ-binding motif that provides a potential site for the interaction of PSD-95/Discs Large/Zona Occludens 1 (PDZ) domain-containing proteins. In this study, we found that CRFR1 interacts with synapse-associated protein 97 (SAP97; also known as DLG1) by co-immunoprecipitation in human embryonic 293 (HEK 293) cells and cortical brain lysates and that this interaction is dependent upon an intact PDZ-binding motif at the end of the CRFR1 carboxyl-terminal tail. Similarly, we demonstrated that SAP97 is recruited to the plasma membrane in HEK 293 cells expressing CRFR1 and that mutation of the CRFR1 PDZ-binding motif results in the redistribution of SAP97 into the cytoplasm. Overexpression of SAP97 antagonized agonist-stimulated CRFR1 internalization, whereas single hairpin (shRNA) knockdown of endogenous SAP97 in HEK 293 cells resulted in increased agonist-stimulated CRFR1 endocytosis. CRFR1 was internalized as a complex with SAP97 resulting in the redistribution of SAP97 to endocytic vesicles. Overexpression or shRNA knockdown of SAP97 did not significantly affect CRFR1-mediated cAMP formation, but SAP97 knockdown did significantly attenuate CRFR1-stimulated ERK1/2 phosphorylation in a PDZ interaction-independent manner. Taken together, our studies show that SAP97 interactions with CRFR1 attenuate CRFR1 endocytosis and that SAP97 is involved in coupling G protein-coupled receptors to the activation of the ERK1/2 signaling pathway.	[Dunn, Henry A.; Walther, Cornelia; Godin, Christina M.; Ferguson, Stephen S. G.] Univ Western Ontario, Robarts Res Inst, J Allyn Taylor Ctr Cell Biol, London, ON N6A 5K8, Canada; [Dunn, Henry A.; Walther, Cornelia; Godin, Christina M.; Ferguson, Stephen S. G.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5K8, Canada; [Hall, Randy A.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Emory University	Ferguson, SSG (corresponding author), Robarts Res Inst, J Allyn Taylor Ctr Cell Biol, Mol Brain Res Grp, 100 Perth Dr, London, ON N6A 5K8, Canada.	ferguson@robarts.ca		Dunn, Henry A./0000-0002-2543-4740; Hall, Randy/0000-0002-8318-8728	Canadian Institutes of Health Research Grant [MOP-62738]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-62738 (to S.S.G.F.).	Arzt E, 2006, TRENDS PHARMACOL SCI, V27, P531, DOI 10.1016/j.tips.2006.08.007; Balasubramanian S, 2007, J BIOL CHEM, V282, P4162, DOI 10.1074/jbc.M607695200; Barak LS, 2008, MOL PHARMACOL, V74, P585, DOI 10.1124/mol.108.048884; Becamel C, 2004, J BIOL CHEM, V279, P20257, DOI 10.1074/jbc.M312106200; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Brady AE, 2002, CELL SIGNAL, V14, P297, DOI 10.1016/S0898-6568(01)00239-X; Cai C, 2008, NEUROSCIENCE, V157, P833, DOI 10.1016/j.neuroscience.2008.09.048; Chaki S, 2004, EUR J PHARMACOL, V485, P145, DOI 10.1016/j.ejphar.2003.11.032; Chalmers DT, 1996, TRENDS PHARMACOL SCI, V17, P166, DOI 10.1016/0165-6147(96)81594-X; CHALMERS DT, 1995, J NEUROSCI, V15, P6340; CHEN FM, 1986, BRAIN RES, V381, P49; Dautzenberg FM, 2000, EUR J PHARMACOL, V390, P51, DOI 10.1016/S0014-2999(99)00915-2; Dautzenberg FM, 2002, TRENDS PHARMACOL SCI, V23, P71, DOI 10.1016/S0165-6147(02)01946-6; Fam SR, 2005, P NATL ACAD SCI USA, V102, P8042, DOI 10.1073/pnas.0408818102; Ferguson SSG, 1998, LIFE SCI, V62, P1561, DOI 10.1016/S0024-3205(98)00107-6; Ferguson Stephen S. G., 2003, V237, P121; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Gardner LA, 2004, J BIOL CHEM, V279, P21135, DOI 10.1074/jbc.M313652200; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; Gavarini S, 2006, MOL BIOL CELL, V17, P4619, DOI 10.1091/mbc.E06-03-0218; Gee HY, 2009, GASTROENTEROLOGY, V137, P607, DOI 10.1053/j.gastro.2009.01.065; Grammatopoulos DK, 2001, J NEUROCHEM, V76, P509, DOI 10.1046/j.1471-4159.2001.00067.x; Grammatopoulos DK, 2002, TRENDS ENDOCRIN MET, V13, P436, DOI 10.1016/S1043-2760(02)00670-7; Guillaume JL, 2008, J BIOL CHEM, V283, P16762, DOI 10.1074/jbc.M802069200; Gutknecht E, 2009, MOL PHARMACOL, V75, P648, DOI 10.1124/mol.108.050427; Hauger Richard L., 2006, CNS & Neurological Disorders-Drug Targets, V5, P453, DOI 10.2174/187152706777950684; He JQ, 2006, J BIOL CHEM, V281, P2820, DOI 10.1074/jbc.M509503200; Holmes KD, 2006, J NEUROCHEM, V96, P934, DOI 10.1111/j.1471-4159.2005.03603.x; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Kageyama K, 2007, MOL CELL ENDOCRINOL, V263, P90, DOI 10.1016/j.mce.2006.08.011; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Leonard BE, 2005, EUR PSYCHIAT, V20, pS302, DOI 10.1016/S0924-9338(05)80180-4; Lorenzen A, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-11; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Magalhaes AC, 2010, NAT NEUROSCI, V13, P622, DOI 10.1038/nn.2529; Marshall F H, 2001, Curr Opin Pharmacol, V1, P40, DOI 10.1016/S1471-4892(01)00001-7; Oakley RH, 2007, AM J PHYSIOL-REG I, V293, pR209, DOI 10.1152/ajpregu.00099.2006; Overstreet DH, 2004, EUR J PHARMACOL, V497, P49, DOI 10.1016/j.ejphar.2004.06.035; Palchaudhuri MR, 1998, EUR J BIOCHEM, V258, P78, DOI 10.1046/j.1432-1327.1998.2580078.x; Perry SJ, 2005, J BIOL CHEM, V280, P11560, DOI 10.1074/jbc.M412914200; Rasmussen TN, 2004, EUR J BIOCHEM, V271, P4366, DOI 10.1111/j.1432-1033.2004.04371.x; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Sabio G, 2004, BIOCHEM J, V380, P19, DOI 10.1042/BJ20031628; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; von Zastrow M, 2001, BIOCHEM SOC T, V29, P500, DOI 10.1042/BST0290500; Wang B, 2009, MOL PHARMACOL, V75, P1189, DOI 10.1124/mol.108.054486; WESTENDORF JM, 1985, ENDOCRINOLOGY, V116, P2528, DOI 10.1210/endo-116-6-2528; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200; Xu JG, 2001, J BIOL CHEM, V276, P41310, DOI 10.1074/jbc.M107480200	52	23	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15023	15034		10.1074/jbc.M113.473660	http://dx.doi.org/10.1074/jbc.M113.473660			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23576434	Green Published, hybrid			2022-12-28	WOS:000319452100032
J	Dirndorfer, D; Seidel, RP; Nimrod, G; Miesbauer, M; Ben-Tal, N; Engelhard, M; Zimmermann, R; Winklhofer, KF; Tatzelt, J				Dirndorfer, Daniela; Seidel, Ralf P.; Nimrod, Guy; Miesbauer, Margit; Ben-Tal, Nir; Engelhard, Martin; Zimmermann, Richard; Winklhofer, Konstanze F.; Tatzelt, Joerg			The alpha-Helical Structure of Prodomains Promotes Translocation of Intrinsically Disordered Neuropeptide Hormones into the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; PROTHYROTROPIN-RELEASING HORMONE; PROTEIN TRANSLOCATION; PRION PROTEIN; NASCENT POLYPEPTIDE; SECRETORY PROTEINS; QUALITY-CONTROL; PREDICTION; SEQUENCES; MEMBRANE	Different neuropeptide hormones, which are either too small to adopt a stable conformation or are predicted to be intrinsically disordered, are synthesized as larger precursors containing a prodomain in addition to an N-terminal signal peptide. We analyzed the biogenesis of three unstructured neuropeptide hormones and observed that translocation of these precursors into the lumen of the endoplasmic reticulum (ER) is critically dependent on the presence of the prodomain. The hormone domains could be deleted from the precursors without interfering with ER import and secretion, whereas constructs lacking the prodomain remained in the cytosol. Domain-swapping experiments revealed that the activity of the prodomains to promote productive ER import resides in their ability to adopt an alpha-helical structure. Removal of the prodomain from the precursor did not interfere with co-translational targeting of the nascent chain to the Sec61 translocon but with its subsequent productive translocation into the ER lumen. Our study reveals a novel function of prodomains to enable import of small or intrinsically disordered secretory proteins into the ER based on their ability to adopt an alpha-helical conformation.	[Dirndorfer, Daniela; Miesbauer, Margit; Winklhofer, Konstanze F.; Tatzelt, Joerg] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Seidel, Ralf P.; Engelhard, Martin] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; [Nimrod, Guy; Ben-Tal, Nir] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel; [Zimmermann, Richard] Saarland Univ Homburg, D-66421 Homburg, Germany; [Winklhofer, Konstanze F.; Tatzelt, Joerg] German Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Winklhofer, Konstanze F.] Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany	University of Munich; Max Planck Society; Tel Aviv University; Universitatsklinikum des Saarlandes; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich	Tatzelt, J (corresponding author), Univ Munich, Schillerstr 44, D-80336 Munich, Germany.	Joerg.Tatzelt@med.uni-muenchen.de		Winklhofer, Konstanze/0000-0002-7256-8231; Ben-Tal, Nir/0000-0001-6901-832X; Tatzelt, Jorg/0000-0001-5017-5528	Deutsche Forschungsgemeinschaft Grant [SFB 596]; Max Planck Society	Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	The work was supported by Deutsche Forschungsgemeinschaft Grant SFB 596 and by the Max Planck Society.	Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Bundgaard JR, 2008, J BIOL CHEM, V283, P4014, DOI 10.1074/jbc.M707908200; Chavali GB, 1997, J MOL BIOL, V272, P731, DOI 10.1006/jmbi.1997.1274; CHEN YG, 1995, J BIOL CHEM, V270, P18598, DOI 10.1074/jbc.270.31.18598; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Conticello SG, 2003, J BIOL CHEM, V278, P26311, DOI 10.1074/jbc.C300141200; Daniel CJ, 2008, J BIOL CHEM, V283, P20864, DOI 10.1074/jbc.M803517200; Daude N, 2010, J NEUROCHEM, V113, P92, DOI 10.1111/j.1471-4159.2010.06575.x; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fuxreiter M, 2008, NAT CHEM BIOL, V4, P728, DOI 10.1038/nchembio.127; Fuxreiter M, 2012, ADV EXP MED BIOL, V725, P1, DOI 10.1007/978-1-4614-0659-4_1; GILMORE R, 1982, J CELL BIOL, V95, P463, DOI 10.1083/jcb.95.2.463; GILMORE R, 1982, J CELL BIOL, V95, P470, DOI 10.1083/jcb.95.2.470; Hegde RS, 2008, J CELL BIOL, V182, P225, DOI 10.1083/jcb.200804157; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Heske J, 2004, J BIOL CHEM, V279, P5435, DOI 10.1074/jbc.M309570200; Ibanez CF, 2002, TRENDS NEUROSCI, V25, P284, DOI 10.1016/S0166-2236(02)02169-0; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Khan AR, 1998, PROTEIN SCI, V7, P815; Kjeldsen T, 1998, BIOTECHNOL APPL BIOC, V27, P109, DOI 10.1111/j.1470-8744.1998.tb01382.x; Longhi S, 2012, ADV EXP MED BIOL, V725, P126, DOI 10.1007/978-1-4614-0659-4_8; Lu JL, 2005, BIOCHEMISTRY-US, V44, P8230, DOI 10.1021/bi050372q; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; MEYER DI, 1980, J CELL BIOL, V87, P503, DOI 10.1083/jcb.87.2.503; Miesbauer M, 2009, J BIOL CHEM, V284, P24384, DOI 10.1074/jbc.M109.023135; Mingarro I, 2000, BMC Cell Biol, V1, P3, DOI 10.1186/1471-2121-1-3; Mulcahy LR, 2005, J BIOL CHEM, V280, P39818, DOI 10.1074/jbc.M507193200; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; PATEL YC, 1995, CIBA F SYMP, V190, P26; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Pfeiffer NV, 2013, EMBO J, V32, P1036, DOI 10.1038/emboj.2013.46; PLUTNER H, 1992, J CELL BIOL, V119, P1097, DOI 10.1083/jcb.119.5.1097; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Romero A, 2008, J BIOL CHEM, V283, P31438, DOI 10.1074/jbc.M803413200; Rutkowski DT, 2007, MOL BIOL CELL, V18, P3681, DOI 10.1091/mbc.e07-03-0272; Rutkowski DT, 2003, J BIOL CHEM, V278, P30365, DOI 10.1074/jbc.M302117200; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Samson WK, 2008, J BIOL CHEM, V283, P31949, DOI 10.1074/jbc.M804784200; Shaffer KL, 2005, DEV CELL, V9, P545, DOI 10.1016/j.devcel.2005.09.001; Shimizu K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-78; STOLLER TJ, 1989, J CELL BIOL, V108, P1647, DOI 10.1083/jcb.108.5.1647; SUTER U, 1991, EMBO J, V10, P2395, DOI 10.1002/j.1460-2075.1991.tb07778.x; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; TSAI FCS, 1993, BIOCHEM BIOPH RES CO, V196, P435, DOI 10.1006/bbrc.1993.2268; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WALTER P, 1980, P NATL ACAD SCI-BIOL, V77, P7112, DOI 10.1073/pnas.77.12.7112; WALTER P, 1984, CELL, V38, P5, DOI 10.1016/0092-8674(84)90520-8; WALTER P, 1982, NATURE, V299, P691, DOI 10.1038/299691a0; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Watts JC, 2007, EMBO J, V26, P4038, DOI 10.1038/sj.emboj.7601830; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Woolhead CA, 2006, MOL CELL, V22, P587, DOI 10.1016/j.molcel.2006.05.021; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yogev O, 2011, FEBS J, V278, P4230, DOI 10.1111/j.1742-4658.2011.08359.x; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	75	12	12	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					13961	13973		10.1074/jbc.M112.430264	http://dx.doi.org/10.1074/jbc.M112.430264			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23532840	hybrid, Green Published			2022-12-28	WOS:000319253500004
J	Sircar, R; Greenswag, AR; Bilwes, AM; Gonzalez-Bonet, G; Crane, BR				Sircar, Ria; Greenswag, Anna R.; Bilwes, Alexandrine M.; Gonzalez-Bonet, Gabriela; Crane, Brian R.			Structure and Activity of the Flagellar Rotor Protein FliY A MEMBER OF THE CheC PHOSPHATASE FAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BACTERIAL CHEMOTAXIS; COMPLEX; MOTOR; MECHANISM; COMPONENT; ROTATION; MOBILITY; SYSTEM; MUTANT	Rotating flagella propel bacteria toward favorable environments. Sense of rotation is determined by the intracellular response regulator CheY, which when phosphorylated (CheY-P) interacts directly with the flagellar motor. In many different types of bacteria, the CheC/CheX/FliY (CXY) family of phosphatases terminates the CheY-P signal. Unlike CheC and CheX, FliY is localized in the flagellar switch complex, which also contains the stator-coupling protein FliG and the target of CheY-P, FliM. The 2.5 angstrom resolution crystal structure of the FliY catalytic domain from Thermotoga maritima bears strong resemblance to the middle domain of FliM. Regions of FliM that mediate contacts within the rotor compose the phosphatase active sites in FliY. Despite the similarity between FliY and FliM, FliY does not bind FliG and thus is unlikely to be a substitute for FliM in the center of the switch complex. Solution studies indicate that FliY dimerizes through its C-terminal domains, which resemble the Escherichia coli switch complex component FliN. FliY differs topologically from the E. coli chemotaxis phosphatase CheZ but appears to utilize similar structural motifs for CheY dephosphorylation in close analogy to CheX. Recognition properties and phosphatase activities of site-directed mutants identify two pseudosymmetric active sites in FliY (Glu(35)/Asn(38) and Glu(132)/Asn(135)), with the second site (Glu(132)/Asn(135)) being more active. A putative N-terminal CheY binding domain conserved with FliM is not required for binding CheY-P or phosphatase activity.	[Sircar, Ria; Greenswag, Anna R.; Bilwes, Alexandrine M.; Gonzalez-Bonet, Gabriela; Crane, Brian R.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14850 USA	Cornell University	Crane, BR (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14850 USA.	bc69@cornell.edu		Bilwes Crane, Alexandrine/0000-0001-9922-0692	National Institutes of Health, NIGMS [GM064664]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064664] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health, NIGMS Grant GM064664.	BILWES AM, 2003, HISTIDINE KINASES SI, P48; BISCHOFF DS, 1992, MOL MICROBIOL, V6, P2715, DOI 10.1111/j.1365-2958.1992.tb01448.x; BISCHOFF DS, 1992, MOL MICROBIOL, V6, P23, DOI 10.1111/j.1365-2958.1992.tb00833.x; Brown PN, 2007, J BACTERIOL, V189, P305, DOI 10.1128/JB.01281-06; Brown PN, 2005, J BACTERIOL, V187, P2890, DOI 10.1128/JB.187.8.2890-2902.2005; Brown PN, 2002, EMBO J, V21, P3225, DOI 10.1093/emboj/cdf332; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Chao XJ, 2006, CELL, V124, P561, DOI 10.1016/j.cell.2005.11.046; Clausznitzer D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000784; Dyer CM, 2004, J MOL BIOL, V342, P1325, DOI 10.1016/j.jmb.2004.07.084; Dyer CM, 2009, J MOL BIOL, V388, P71, DOI 10.1016/j.jmb.2009.02.004; Glekas GD, 2012, MOL MICROBIOL, V86, P743, DOI 10.1111/mmi.12015; Guhaniyogi J, 2006, J MOL BIOL, V359, P624, DOI 10.1016/j.jmb.2006.03.050; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Khan S, 2000, CURR BIOL, V10, P927, DOI 10.1016/S0960-9822(00)00629-1; Kirby JR, 2001, MOL MICROBIOL, V42, P573, DOI 10.1046/j.1365-2958.2001.02581.x; KUO SC, 1987, J BACTERIOL, V169, P1307, DOI 10.1128/jb.169.3.1307-1314.1987; Lee LK, 2010, NATURE, V466, P996, DOI 10.1038/nature09300; Lee SY, 2001, J BIOL CHEM, V276, P16425, DOI 10.1074/jbc.M101002200; Lee SY, 2001, NAT STRUCT BIOL, V8, P52; Liao SM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-253; Lloyd SA, 1999, NATURE, V400, P472, DOI 10.1038/22794; Lowenthal AC, 2009, J BACTERIOL, V191, P7147, DOI 10.1128/JB.00749-09; Mathews MAA, 1998, J BACTERIOL, V180, P5580, DOI 10.1128/JB.180.21.5580-5590.1998; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Minamino T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000616; Muff TJ, 2007, J BIOL CHEM, V282, P34120, DOI 10.1074/jbc.M706432200; Muff TJ, 2007, J BACTERIOL, V189, P7007, DOI 10.1128/JB.00896-07; Muff TJ, 2007, METHOD ENZYMOL, V423, P336, DOI 10.1016/S0076-6879(07)23015-0; Muff TJ, 2008, MOL MICROBIOL, V70, P1054, DOI 10.1111/j.1365-2958.2008.06482.x; Murphy GE, 2006, NATURE, V442, P1062, DOI 10.1038/nature05015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SY, 2006, P NATL ACAD SCI USA, V103, P11886, DOI 10.1073/pnas.0602811103; Park SY, 2004, MOL CELL, V16, P563, DOI 10.1016/j.molcel.2004.10.018; Paul K, 2011, EMBO J, V30, P2962, DOI 10.1038/emboj.2011.188; Pazy Y, 2010, P NATL ACAD SCI USA, V107, P1924, DOI 10.1073/pnas.0911185107; Raddi G, 2012, J BACTERIOL, V194, P1299, DOI 10.1128/JB.06474-11; Sarkar MK, 2010, P NATL ACAD SCI USA, V107, P9370, DOI 10.1073/pnas.1000935107; Silversmith RE, 2005, BIOCHEMISTRY-US, V44, P7768, DOI 10.1021/bi0501636; Silversmith RE, 2003, J BACTERIOL, V185, P1495, DOI 10.1128/JB.185.5.1495-1502.2003; Silversmith RE, 2010, CURR OPIN MICROBIOL, V13, P177, DOI 10.1016/j.mib.2010.01.004; SOCKETT H, 1992, J BACTERIOL, V174, P793, DOI 10.1128/jb.174.3.793-806.1992; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sowa Y, 2008, Q REV BIOPHYS, V41, P103, DOI 10.1017/S0033583508004691; Swanson RV, 1996, J BACTERIOL, V178, P484, DOI 10.1128/jb.178.2.484-489.1996; Szurmant H, 2004, J BIOL CHEM, V279, P21787, DOI 10.1074/jbc.M311497200; Szurmant H, 2003, J BIOL CHEM, V278, P48611, DOI 10.1074/jbc.M306180200; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Toker AS, 1997, J MOL BIOL, V273, P623, DOI 10.1006/jmbi.1997.1335; Vartanian AS, 2012, J BIOL CHEM, V287, P35779, DOI 10.1074/jbc.C112.378380; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724; Zhao R, 2002, NAT STRUCT BIOL, V9, P570	56	28	31	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13493	13502		10.1074/jbc.M112.445171	http://dx.doi.org/10.1074/jbc.M112.445171			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23532838	Green Published, hybrid			2022-12-28	WOS:000318850300033
J	Sumitomo, T; Nakata, M; Higashino, M; Terao, Y; Kawabata, S				Sumitomo, Tomoko; Nakata, Masanobu; Higashino, Miharu; Terao, Yutaka; Kawabata, Shigetada			Group A Streptococcal Cysteine Protease Cleaves Epithelial Junctions and Contributes to Bacterial Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT JUNCTION; PYOGENES; GENE; PROTEINASE; SPEB; PATHOGENESIS; FIBRONECTIN; SITE; SPECIFICITY; ACTIVATION	Group A Streptococcus (GAS) is an important human pathogen that possesses an ability to translocate across the epithelial barrier. In this study, culture supernatants of tested GAS strains showed proteolytic activity against human occludin and E-cadherin. Utilizing various types of protease inhibitors and amino acid sequence analysis, we identified SpeB (streptococcal pyrogenic exotoxin B) as the proteolytic factor that cleaves E-cadherin in the region neighboring the calcium-binding sites within the extracellular domain. The cleaving activities of culture supernatants from several GAS isolates were correlated with the amount of active SpeB, whereas culture supernatants from an speB mutant showed no such activities. Of note, the wild type strain efficiently translocated across the epithelial monolayer along with cleavage of occludin and E-cadherin, whereas deletion of the speB gene compromised those activities. Moreover, destabilization of the junctional proteins was apparently relieved in cells infected with the speB mutant, as compared with those infected with the wild type. Taken together, our findings indicate that the proteolytic efficacy of SpeB in junctional degradation allows GAS to invade deeper into tissues.	[Sumitomo, Tomoko; Nakata, Masanobu; Higashino, Miharu; Terao, Yutaka; Kawabata, Shigetada] Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Suita, Osaka 5650871, Japan	Osaka University	Kawabata, S (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	kawabata@dent.osaka-u.ac.jp		Nakata, Masanobu/0000-0003-1686-5415; Terao, Yutaka/0000-0002-4450-5583	Japan Society for the Promotion of Science [20390465]; Ministry of Education, Culture, Sports, Science and Technology [18073011, 2189048, 20791336, 21791786]; Grants-in-Aid for Scientific Research [24659812, 23592700] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-aid for Scientific Research (B) 20390465 from the Japan Society for the Promotion of Science and a Grant-in-aid for Scientific Research on Priority Areas 18073011; a Grant-in-aid for Scientific Research for Young Scientists (A) 2189048; and Grants-in-aid for Scientific Research for Young Scientists (B) 20791336 and 21791786 from the Ministry of Education, Culture, Sports, Science and Technology.	Amagai M, 2003, J AM ACAD DERMATOL, V48, P244, DOI 10.1067/mjd.2003.7; Balkovetz DF, 2003, MICROBES INFECT, V5, P613, DOI 10.1016/S1286-4579(03)00089-3; Bentley CC, 2005, CELL MICROBIOL, V7, P945, DOI 10.1111/j.1462-5822.2005.00525.x; BERGE A, 1995, J BIOL CHEM, V270, P9862, DOI 10.1074/jbc.270.17.9862; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carroll RK, 2011, MOL MICROBIOL, V81, P588, DOI 10.1111/j.1365-2958.2011.07709.x; Carroll RK, 2011, J CLIN INVEST, V121, P1956, DOI 10.1172/JCI45169; Chaussee MS, 2000, INFECT IMMUN, V68, P3226, DOI 10.1128/IAI.68.6.3226-3232.2000; Chiang-Ni C, 2008, J FORMOS MED ASSOC, V107, P677, DOI 10.1016/S0929-6646(08)60112-6; Cole JN, 2008, PROTEOM CLIN APPL, V2, P387, DOI 10.1002/prca.200780048; Collin M, 2001, INFECT IMMUN, V69, P7187, DOI 10.1128/IAI.69.11.7187-7189.2001; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Cywes C, 2001, NATURE, V414, P648, DOI 10.1038/414648a; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Eriksson A, 2003, INFECT IMMUN, V71, P211, DOI 10.1128/IAI.71.1.211-217.2003; FERRIERI P, 1972, J CLIN INVEST, V51, P2851, DOI 10.1172/JCI107108; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; HAUSER AR, 1990, J BACTERIOL, V172, P4536, DOI 10.1128/jb.172.8.4536-4542.1990; KAPUR V, 1993, MICROB PATHOGENESIS, V15, P327, DOI 10.1006/mpat.1993.1083; Nakagawa I, 2001, CELL MICROBIOL, V3, P395, DOI 10.1046/j.1462-5822.2001.00122.x; Nakata M, 2011, J BIOL CHEM, V286, P37566, DOI 10.1074/jbc.M111.239780; Nelson DC, 2011, BIOL CHEM, V392, P1077, DOI [10.1515/BC-2011-208, 10.1515/BC.2011.208]; Nomizu M, 2001, J BIOL CHEM, V276, P44551, DOI 10.1074/jbc.M106306200; Olsen RJ, 2009, CELL MICROBIOL, V11, P1, DOI 10.1111/j.1462-5822.2008.01225.x; OZAWA M, 1990, CELL, V63, P1033, DOI 10.1016/0092-8674(90)90506-A; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Sousa S, 2005, CURR OPIN CELL BIOL, V17, P489, DOI 10.1016/j.ceb.2005.08.013; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Sumitomo T, 2011, J BIOL CHEM, V286, P2750, DOI 10.1074/jbc.M110.171504; Sun H, 2008, EXPERT OPIN DRUG MET, V4, P395, DOI 10.1517/17425255.4.4.395 ; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Tart AH, 2007, TRENDS MICROBIOL, V15, P318, DOI 10.1016/j.tim.2007.05.001; Terao Y, 2001, MOL MICROBIOL, V42, P75, DOI 10.1046/j.1365-2958.2001.02579.x; Terao Y, 2008, J BIOL CHEM, V283, P6253, DOI 10.1074/jbc.M704821200; TRIEUCUOT P, 1991, GENE, V102, P99, DOI 10.1016/0378-1119(91)90546-N; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612	40	35	35	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13317	13324		10.1074/jbc.M113.459875	http://dx.doi.org/10.1074/jbc.M113.459875			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23532847	hybrid, Green Published			2022-12-28	WOS:000318850300017
J	Steen, A; Thiele, S; Guo, D; Hansen, LS; Frimurer, TM; Rosenkilde, MM				Steen, Anne; Thiele, Stefanie; Guo, Dong; Hansen, Laerke S.; Frimurer, Thomas M.; Rosenkilde, Mette M.			Biased and Constitutive Signaling in the CC-chemokine Receptor CCR5 by Manipulating the Interface between Transmembrane Helices 6 and 7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC-ACID RECEPTOR; SMALL-MOLECULE; CRYSTAL-STRUCTURE; HIV-1 INFECTION; BETA-ARRESTIN; PROTEIN; POTENT; IDENTIFICATION; ANTAGONISTS; MECHANISM	The equilibrium state of CCR5 is manipulated here toward either activation or inactivation by introduction of single amino acid substitutions in the transmembrane domains (TMs) 6 and 7. Insertion of a steric hindrance mutation in the center of TM7 (G286F in position VII:09/7.42) resulted in biased signaling. Thus, beta-arrestin recruitment was eliminated, whereas constitutive activity was observed in G alpha(i)-mediated signaling. Furthermore, the CCR5 antagonist aplaviroc was converted to a full agonist (a so-called efficacy switch). Computational modeling revealed that the position of the 7TM receptor-conserved Trp in TM6 (Trp-248 in position VI:13/6.48, part of the CWXP motif) was influenced by the G286F mutation, causing Trp-248 to change orientation away from TM7. The essential role of Trp-248 in CCR5 activation was supported by complete inactivity of W248A-CCR5 despite maintaining chemokine binding. Furthermore, replacing Trp-248 with a smaller aromatic amino acid (Tyr/Phe) impaired the beta-arrestin recruitment, yet with maintained G protein activity (biased signaling); also, here aplaviroc switched to a full agonist. Thus, the altered positioning of Trp-248, induced by G286F, led to a constraint of G protein active, but beta-arrestin inactive and thus biased, CCR5 conformation. These results provide important information on the molecular interplay and impact of TM6 and TM7 for CCR5 activity, which may be extrapolated to other chemokine receptors and possibly to other 7TM receptors.	[Steen, Anne; Thiele, Stefanie; Hansen, Laerke S.; Rosenkilde, Mette M.] Univ Copenhagen, Panum Inst, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Guo, Dong] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Med Chem, NL-2333 CC Leiden, Netherlands; [Frimurer, Thomas M.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark	University of Copenhagen; Leiden University; Leiden University - Excl LUMC; Novo Nordisk Foundation; University of Copenhagen	Rosenkilde, MM (corresponding author), Univ Copenhagen, Panum Inst, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.	rosenkilde@sund.ku.dk	Guo, Dong/T-6126-2019; Gasbjerg, Lærke Smidt/AAR-9363-2020	Guo, Dong/0000-0001-6142-4825; Gasbjerg, Lærke Smidt/0000-0002-7880-8515; Rosenkilde, Mette Marie/0000-0001-9600-3254; Frimruer, Thomas/0000-0002-9682-8245; Karlshoj, Stefanie/0000-0001-6505-0883	Danish Council for Independent Research Medical Sciences; Aase and Einar Danielsen Foundation; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF12OC0001900] Funding Source: researchfish	Danish Council for Independent Research Medical Sciences(Det Frie Forskningsrad (DFF)); Aase and Einar Danielsen Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by The Danish Council for Independent Research Medical Sciences, the Aase and Einar Danielsen Foundation, and the Novo Nordisk Foundation.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Blanpain C, 2003, J BIOL CHEM, V278, P5179, DOI 10.1074/jbc.M205684200; Bottegoni G, 2009, J MED CHEM, V52, P397, DOI 10.1021/jm8009958; Castonguay LA, 2003, BIOCHEMISTRY-US, V42, P1544, DOI 10.1021/bi026639s; Chen WW, 2012, CURR PHARM DESIGN, V18, P100, DOI 10.2174/138161212798919084; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cho W, 1996, MOL PHARMACOL, V50, P1338; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Ditzel HJ, 1998, P NATL ACAD SCI USA, V95, P5241, DOI 10.1073/pnas.95.9.5241; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; Ferain T, 2011, J PHARMACOL EXP THER, V337, P655, DOI 10.1124/jpet.111.179622; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Gbahou F, 2010, J PHARMACOL EXP THER, V333, P51, DOI 10.1124/jpet.109.162131; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Heydorn A, 2004, MOL PHARMACOL, V66, P250, DOI 10.1124/mol.66.2.250; Holst B, 2004, J BIOL CHEM, V279, P53806, DOI 10.1074/jbc.M407676200; Holst B, 2007, J BIOL CHEM, V282, P15799, DOI 10.1074/jbc.M609796200; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jardon-Valadez E, 2008, J PHYS CHEM B, V112, P10704, DOI 10.1021/jp800544x; Kissow H, 2012, REGUL PEPTIDES, V179, P91, DOI 10.1016/j.regpep.2012.08.016; Kostenis E, 1998, J BIOL CHEM, V273, P17886, DOI 10.1074/jbc.273.28.17886; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; Maeda K, 2004, J VIROL, V78, P8654, DOI 10.1128/JVI.78.16.8654-8662.2004; Marie J, 1999, MOL PHARMACOL, V55, P92, DOI 10.1124/mol.55.1.92; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; O'Hayre M, 2010, EXPERT OPIN DRUG DIS, V5, P1109, DOI 10.1517/17460441.2010.525633; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park SH, 2012, NATURE, V491, P779, DOI 10.1038/nature11580; Pellissier LP, 2009, MOL PHARMACOL, V75, P982, DOI 10.1124/mol.108.053686; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Richman JG, 2007, J BIOL CHEM, V282, P18028, DOI 10.1074/jbc.M701866200; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rosenkilde MM, 2004, J BIOL CHEM, V279, P32524, DOI 10.1074/jbc.M313392200; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Semple G, 2008, J MED CHEM, V51, P5101, DOI 10.1021/jm800258p; Sharman JL, 2011, NUCLEIC ACIDS RES, V39, pD534, DOI 10.1093/nar/gkq1062; Shiraishi M, 2000, J MED CHEM, V43, P2049, DOI 10.1021/jm9906264; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Singh IP, 2011, EXPERT OPIN THER PAT, V21, P227, DOI 10.1517/13543776.2011.542412; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Steen A, 2009, MINI-REV MED CHEM, V9, P1605, DOI 10.2174/138955709791012265; Strizki JM, 2001, P NATL ACAD SCI USA, V98, P12718, DOI 10.1073/pnas.221375398; Thiele S, 2011, J BIOL CHEM, V286, P37543, DOI 10.1074/jbc.M111.243808; Tilton JC, 2010, J VIROL, V84, P10863, DOI 10.1128/JVI.01109-10; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; Tsamis F, 2003, J VIROL, V77, P5201, DOI 10.1128/JVI.77.9.5201-5208.2003; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Walters RW, 2009, J CLIN INVEST, V119, P1312, DOI 10.1172/JCI36806; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2012, STRUCTURE, V20, P841, DOI 10.1016/j.str.2012.03.014; Westby M, 2007, J VIROL, V81, P2359, DOI 10.1128/JVI.02006-06; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	72	50	50	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12511	12521		10.1074/jbc.M112.449587	http://dx.doi.org/10.1074/jbc.M112.449587			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23493400	Green Published, hybrid			2022-12-28	WOS:000318555100010
J	Hakim, A; Nguyen, JB; Basu, K; Zhu, DF; Thakral, D; Davies, PL; Isaacs, FJ; Modis, Y; Meng, WY				Hakim, Aaron; Nguyen, Jennifer B.; Basu, Koli; Zhu, Darren F.; Thakral, Durga; Davies, Peter L.; Isaacs, Farren J.; Modis, Yorgo; Meng, Wuyi			Crystal Structure of an Insect Antifreeze Protein and Its Implications for Ice Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; BETA-HELIX; MODEL; MECHANISM; INSIGHTS; IDENTIFICATION; INTERFACES; BEETLES; ISOFORM; SURFACE	Antifreeze proteins (AFPs) help some organisms resist freezing by binding to ice crystals and inhibiting their growth. The molecular basis for how these proteins recognize and bind ice is not well understood. The longhorn beetle Rhagium inquisitor can supercool to below -25 degrees C, in part by synthesizing the most potent antifreeze protein studied thus far (RiAFP). We report the crystal structure of the 13-kDa RiAFP, determined at 1.21 angstrom resolution using direct methods. The structure, which contains 1,914 nonhydrogen protein atoms in the asymmetric unit, is the largest determined ab initio without heavy atoms. It reveals a compressed beta-solenoid fold in which the top and bottom sheets are held together by a silk-like interdigitation of short side chains. RiAFP is perhaps the most regular structure yet observed. It is a second independently evolved AFP type in beetles. The two beetle AFPs have in common an extremely flat ice-binding surface comprising regular outward-projecting parallel arrays of threonine residues. The more active, wider RiAFP has four (rather than two) of these arrays between which the crystal structure shows the presence of ice-like waters. Molecular dynamics simulations independently reproduce the locations of these ordered crystallographic waters and predict additional waters that together provide an extensive view of the AFP interaction with ice. By matching several planes of hexagonal ice, these waters may help freeze the AFP to the ice surface, thus providing the molecular basis of ice binding.	[Hakim, Aaron; Nguyen, Jennifer B.; Zhu, Darren F.; Thakral, Durga; Modis, Yorgo; Meng, Wuyi] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Hakim, Aaron; Isaacs, Farren J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Basu, Koli; Davies, Peter L.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Isaacs, Farren J.] Yale Univ, Syst Biol Inst, West Haven, CT 06516 USA	Yale University; Yale University; Queens University - Canada; Yale University	Meng, WY (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	wuyi.meng@yale.edu	Nguyen, Jennifer/GVS-4347-2022	Modis, Yorgo/0000-0002-6084-0429; Hakim, Aaron/0000-0002-9752-8826	National Institutes of Health [P01 GM022778, T32 GM08383]; Burroughs Wellcome Investigator in the Pathogenesis of Infectious Disease award; Yale College Dean's fellowships; Arnold and Mabel Beckman Foundation; Barry M. Goldwater scholarships; Canadian Institutes for Health Research; Canada Research Chair Program; Raymond and Beverly Sackler Institute for Biological, Physical, and Engineering Sciences; Yale Science and Engineering Association; Yale University West Campus; Yale Department of Molecular Biophysics and Biochemistry, Molecular, Cellular; Yale Department of Molecular, Cellular, and Developmental Biology; Yale Department of Biomedical Engineering; Yale Department of Physics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Investigator in the Pathogenesis of Infectious Disease award(Burroughs Wellcome Fund); Yale College Dean's fellowships; Arnold and Mabel Beckman Foundation; Barry M. Goldwater scholarships; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair Program(Canada Research Chairs); Raymond and Beverly Sackler Institute for Biological, Physical, and Engineering Sciences; Yale Science and Engineering Association; Yale University West Campus; Yale Department of Molecular Biophysics and Biochemistry, Molecular, Cellular; Yale Department of Molecular, Cellular, and Developmental Biology; Yale Department of Biomedical Engineering; Yale Department of Physics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 GM022778 (to Y. M.) and Training Grant T32 GM08383. This work was also supported by a Burroughs Wellcome Investigator in the Pathogenesis of Infectious Disease award (to Y. M.), Yale College Dean's fellowships (to A. H. and D. F. Z.), the Arnold and Mabel Beckman Foundation and Barry M. Goldwater scholarships (to D. T.), funds from the Canadian Institutes for Health Research and the Canada Research Chair Program (to P. L. D.) and by the Raymond and Beverly Sackler Institute for Biological, Physical, and Engineering Sciences, the Yale Science and Engineering Association, Yale University West Campus, and the Yale Departments of Molecular Biophysics and Biochemistry, Molecular, Cellular, and Developmental Biology, Biomedical Engineering, and Physics.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Antson AA, 2001, J MOL BIOL, V305, P875, DOI 10.1006/jmbi.2000.4336; Asakura T, 2002, PROTEIN SCI, V11, P2706, DOI 10.1110/ps.0221702; Baardsnes J, 2003, J BIOL CHEM, V278, P38942, DOI 10.1074/jbc.M306776200; Bar-Dolev M, 2012, J R SOC INTERFACE, V9, P3249, DOI 10.1098/rsif.2012.0388; Chao H, 1996, PROTEIN SCI, V5, P1150; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garnham CP, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-36; Garnham CP, 2011, P NATL ACAD SCI USA, V108, P7363, DOI 10.1073/pnas.1100429108; Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610; Hakim A, 2012, ACTA CRYSTALLOGR F, V68, P547, DOI 10.1107/S1744309112010421; Hayward JA, 2001, J CHEM PHYS, V114, P3713, DOI 10.1063/1.1333680; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hobbes P. V., 1974, ICE PHYS, P525; Jia ZC, 2002, TRENDS BIOCHEM SCI, V27, P101, DOI 10.1016/S0968-0004(01)02028-X; Jia-xing Yao, 2005, Acta Crystallogr D Biol Crystallogr, V61, P1465, DOI 10.1107/S090744490502576X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Knight CA, 2000, NATURE, V406, P249, DOI 10.1038/35018671; Kristiansen E, 2011, INSECT BIOCHEM MOLEC, V41, P109, DOI 10.1016/j.ibmb.2010.11.002; Kristiansen E, 2012, J INSECT PHYSIOL, V58, P1502, DOI 10.1016/j.jinsphys.2012.09.004; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leinala EK, 2002, J BIOL CHEM, V277, P33349, DOI 10.1074/jbc.M205575200; Leinala EK, 2002, STRUCTURE, V10, P619, DOI 10.1016/S0969-2126(02)00745-1; Lin FH, 2011, BIOCHEMISTRY-US, V50, P4467, DOI 10.1021/bi2003108; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Liu Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000548; Marshall CB, 2004, BIOCHEMISTRY-US, V43, P11637, DOI 10.1021/bi0488909; Marshall CB, 2002, FEBS LETT, V529, P261, DOI 10.1016/S0014-5793(02)03355-0; Matthews BHM, 2006, ACTA CRYSTALLOGR D, V62, P165, DOI 10.1107/S0907444905037212; Middleton AJ, 2012, J MOL BIOL, V416, P713, DOI 10.1016/j.jmb.2012.01.032; Modig K, 2010, PHYS CHEM CHEM PHYS, V12, P10189, DOI 10.1039/c002970j; Mok YF, 2010, BIOCHEMISTRY-US, V49, P2593, DOI 10.1021/bi901929n; Nada H, 2011, PHYS CHEM CHEM PHYS, V13, P19936, DOI 10.1039/c1cp21929d; Nishimiya Y, 2008, J MOL BIOL, V382, P734, DOI 10.1016/j.jmb.2008.07.042; Nutt DR, 2008, J AM CHEM SOC, V130, P13066, DOI 10.1021/ja8034027; Oszlanyi G, 2004, ACTA CRYSTALLOGR A, V60, P134, DOI 10.1107/S0108767303027569; Palatinus L, 2004, ACTA CRYSTALLOGR A, V60, P604, DOI 10.1107/S0108767304022433; Pentelute BL, 2008, J AM CHEM SOC, V130, P9695, DOI 10.1021/ja8013538; RAYMOND JA, 1977, P NATL ACAD SCI USA, V74, P2589, DOI 10.1073/pnas.74.6.2589; Scotter AJ, 2006, CRYOBIOLOGY, V53, P229, DOI 10.1016/j.cryobiol.2006.06.006; SICHERI F, 1995, NATURE, V375, P427, DOI 10.1038/375427a0; Takamichi M, 2007, FEBS J, V274, P6469, DOI 10.1111/j.1742-4658.2007.06164.x; Venketesh S, 2008, CRIT REV BIOTECHNOL, V28, P57, DOI [10.1080/07388550801891152, 10.1080/07388550801891152 ]; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yang DSC, 1998, BIOPHYS J, V74, P2142, DOI 10.1016/S0006-3495(98)77923-8; Zachariassen KE, 2008, J COMP PHYSIOL B, V178, P977, DOI 10.1007/s00360-008-0284-6	49	78	78	3	121	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12295	12304		10.1074/jbc.M113.450973	http://dx.doi.org/10.1074/jbc.M113.450973			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486477	Green Published, hybrid			2022-12-28	WOS:000318157600060
J	Biedenkopf, N; Hartlieb, B; Hoenen, T; Becker, S				Biedenkopf, Nadine; Hartlieb, Bettina; Hoenen, Thomas; Becker, Stephan			Phosphorylation of Ebola Virus VP30 Influences the Composition of the Viral Nucleocapsid Complex IMPACT ON VIRAL TRANSCRIPTION AND REPLICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNCYTIAL VIRUS; MARBURG-VIRUS; GENOME RNA; SECONDARY STRUCTURE; VACCINE DEVELOPMENT; BINDING PROTEIN; MESSENGER-RNA; P-PROTEIN; IDENTIFICATION; M2-1	Ebola virus is a non-segmented negative-sense RNA virus causing severe hemorrhagic fever with high fatality rates in humans and nonhuman primates. For transcription of the viral genome four viral proteins are essential: the nucleoprotein NP, the polymerase L, the polymerase cofactor VP35, and VP30. VP30 represents an essential Ebola virus-specific transcription factor whose activity is regulated via its phosphorylation state. In contrast to viral transcription, VP30 is not required for viral replication. Using a minigenome assay, we show that phosphorylation of VP30 inhibits viral transcription while viral replication is increased. Concurrently, phosphorylation of VP30 reciprocally regulates a newly described interaction of VP30 with VP35, and strengthens the interaction with NP. Our results indicate a critical role of VP30 phosphorylation for viral transcription and replication, suggesting a mechanism by which VP30 phosphorylation modulates the composition of the viral polymerase complex presumably forming a transcriptase in the presence of non-phosphorylated VP30 or a replicase in the presence of phosphorylated VP30.	[Biedenkopf, Nadine; Hartlieb, Bettina; Hoenen, Thomas; Becker, Stephan] Univ Marburg, Inst Virol, D-35043 Marburg, Germany	Philipps University Marburg	Becker, S (corresponding author), Univ Marburg, Inst Virol, Hans Meerwein Str 2, D-35043 Marburg, Germany.	becker@staff.uni-marburg.de	Hoenen, Thomas/H-8990-2019	Hoenen, Thomas/0000-0002-5829-6305	Schering Foundation; Deutsche Forschungsgemeinschaft [SFB 593, TP B12]	Schering Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Schering Foundation (to N. B. and T. H.) and the Deutsche Forschungsgemeinschaft through the SFB 593, TP B12 (to N. B.).	Asenjo A, 2006, J GEN VIROL, V87, P3637, DOI 10.1099/vir.0.82165-0; Bharat TAM, 2012, P NATL ACAD SCI USA, V109, P4275, DOI 10.1073/pnas.1120453109; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Chen MZ, 2007, J VIROL, V81, P13478, DOI 10.1128/JVI.01244-07; Falzarano D, 2011, EXPERT REV VACCINES, V10, P63, DOI [10.1586/erv.10.152, 10.1586/ERV.10.152]; Fearns R, 1999, J VIROL, V73, P5852, DOI 10.1128/JVI.73.7.5852-5864.1999; Gupta AK, 2003, J VIROL, V77, P732, DOI 10.1128/JVI.77.1.732-738.2003; Hartlieb B, 2003, J BIOL CHEM, V278, P41830, DOI 10.1074/jbc.M307036200; Hartlieb B, 2007, P NATL ACAD SCI USA, V104, P624, DOI 10.1073/pnas.0606730104; Hoenen T, 2010, J VIROL, V84, P7053, DOI 10.1128/JVI.00737-10; Hoenen T, 2010, VIROLOGY, V403, P56, DOI 10.1016/j.virol.2010.04.002; Hoenen T, 2006, TRENDS MOL MED, V12, P206, DOI 10.1016/j.molmed.2006.03.006; Hoenen T, 2006, J VIROL, V80, P7260, DOI 10.1128/JVI.00051-06; Hoenen T, 2011, ANTIVIR RES, V91, P195, DOI 10.1016/j.antiviral.2011.06.003; John SP, 2007, J VIROL, V81, P8967, DOI 10.1128/JVI.02523-06; Kolesnikova L, 2004, J VIROL, V78, P12277, DOI 10.1128/JVI.78.22.12277-12287.2004; Mahanty S, 2004, LANCET INFECT DIS, V4, P487, DOI 10.1016/S1473-3099(04)01103-X; Martinez MJ, 2011, J INFECT DIS, V204, pS934, DOI 10.1093/infdis/jir320; Martinez MJ, 2008, J VIROL, V82, P12569, DOI 10.1128/JVI.01395-08; Mason SW, 2003, J VIROL, V77, P10670, DOI 10.1128/JVI.77.19.10670-10676.2003; Modrof J, 2003, J VIROL, V77, P3334, DOI 10.1128/JVI.77.5.3334-3338.2003; Modrof J, 2002, J BIOL CHEM, V277, P33099, DOI 10.1074/jbc.M203775200; Muhlberger E, 1999, J VIROL, V73, P2333; Muhlberger E, 1996, VIROLOGY, V223, P376, DOI 10.1006/viro.1996.0490; Noda T, 2011, J INFECT DIS, V204, pS878, DOI 10.1093/infdis/jir310; Qanungo KR, 2004, P NATL ACAD SCI USA, V101, P5952, DOI 10.1073/pnas.0401449101; Saikia P, 2008, ARCH VIROL, V153, P615, DOI 10.1007/s00705-008-0034-9; SANCHEZ A, 1993, VIRUS RES, V29, P215, DOI 10.1016/0168-1702(93)90063-S; SANCHEZ A, 1987, VIROLOGY, V157, P414, DOI 10.1016/0042-6822(87)90283-2; Sanchez A., 2007, VIROLOGY, P1409; Sarwar UN, 2011, TRAVEL MED INFECT DI, V9, P126, DOI 10.1016/j.tmaid.2010.05.003; Watanabe S, 2006, J VIROL, V80, P3743, DOI 10.1128/JVI.80.8.3743-3751.2006; Weik M, 2002, J VIROL, V76, P8532, DOI 10.1128/JVI.76.17.8532-8539.2002; Wenigenrath J, 2010, J GEN VIROL, V91, P1325, DOI 10.1099/vir.0.018226-0	34	68	71	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11165	11174		10.1074/jbc.M113.461285	http://dx.doi.org/10.1074/jbc.M113.461285			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23493393	hybrid, Green Published			2022-12-28	WOS:000317915500021
J	Fecher-Trost, C; Wissenbach, U; Beck, A; Schalkowsky, P; Stoerger, C; Doerr, J; Dembek, A; Simon-Thomas, M; Weber, A; Wollenberg, P; Ruppert, T; Middendorff, R; Maurer, HH; Flockerzi, V				Fecher-Trost, Claudia; Wissenbach, Ulrich; Beck, Andreas; Schalkowsky, Pascal; Stoerger, Christof; Doerr, Janka; Dembek, Anna; Simon-Thomas, Martin; Weber, Armin; Wollenberg, Peter; Ruppert, Thomas; Middendorff, Ralf; Maurer, Hans H.; Flockerzi, Veit			The in Vivo TRPV6 Protein Starts at a Non-AUG Triplet, Decoded as Methionine, Upstream of Canonical Initiation at AUG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVE TRANSLATION INITIATION; ACTIVATED CALCIUM-CHANNEL; MESSENGER-RNA SEQUENCES; MAMMALIAN-CELLS; PORE PROPERTIES; ANKYRIN REPEAT; CAT-LIKE; CODON; CUG; ABSORPTION	TRPV6 channels function as epithelial Ca2+ entry pathways in the epididymis, prostate, and placenta. However, the identity of the endogenous TRPV6 protein relies on predicted gene coding regions and is only known to a certain level of approximation. We show that in vivo the TRPV6 protein has an extended N terminus. Translation initiates at a non-AUG codon, at ACG, which is decoded by methionine and which is upstream of the annotated AUG, which is not used for initiation. The in vitro properties of channels formed by the extended full-length TRPV6 proteins and the so-far annotated and smaller TRPV6 are similar, but the extended N terminus increases trafficking to the plasma membrane and represents an additional scaffold for channel assembly. The increased translation of the smaller TRPV6 cDNA version may overestimate the in vivo situation where translation efficiency may represent an additional mechanism to tightly control the TRPV6-mediated Ca2+ entry to prevent deleterious Ca2+ overload.	[Fecher-Trost, Claudia; Wissenbach, Ulrich; Beck, Andreas; Schalkowsky, Pascal; Stoerger, Christof; Doerr, Janka; Dembek, Anna; Simon-Thomas, Martin; Weber, Armin; Wollenberg, Peter; Maurer, Hans H.; Flockerzi, Veit] Univ Saarland, Inst Expt & Klin Pharmakol & Toxikol, D-66421 Homburg, Germany; [Ruppert, Thomas] Heidelberg Univ, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Middendorff, Ralf] Univ Giessen, Inst Anat & Zellbiol, D-35385 Giessen, Germany	Saarland University; Ruprecht Karls University Heidelberg; Justus Liebig University Giessen	Fecher-Trost, C (corresponding author), Univ Saarland, Inst Expt & Klin Pharmakol & Toxikol, Geb 46, D-66421 Homburg, Germany.	claudia.fecher-trost@uks.eu; ulrich.wissenbach@uks.eu; veit.flockerzi@uks.eu	Ruppert, Thomas/AAC-2467-2021	Ruppert, Thomas/0000-0001-9152-2266; Maurer, Hans/0000-0003-4579-4660	Deutsche Forschungsgemeinschaft; Forschungsausschuss der Medizinischen Fakultat "HOMFOR"; Forschungsausschuss der Universitat des Saarlandes	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungsausschuss der Medizinischen Fakultat "HOMFOR"; Forschungsausschuss der Universitat des Saarlandes	This work was supported by the Deutsche Forschungsgemeinschaft (to C. F.-T., A. B., P. S., and V. F.), Forschungsausschuss der Medizinischen Fakultat "HOMFOR," and Forschungsausschuss der Universitat des Saarlandes (to U. W., H. H. M., and V. F.).	Arnaud E, 1999, MOL CELL BIOL, V19, P505; Bolanz KA, 2008, MOL CANCER THER, V7, P271, DOI 10.1158/1535-7163.MCT-07-0478; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; den Dekker E, 2005, PFLUG ARCH EUR J PHY, V450, P236, DOI 10.1007/s00424-005-1409-3; Erler I, 2004, J BIOL CHEM, V279, P34456, DOI 10.1074/jbc.M404778200; GRANA X, 1994, ONCOGENE, V9, P2097; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Hirnet D, 2003, CELL CALCIUM, V33, P509, DOI 10.1016/S0143-4160(03)00066-6; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; KOZAK M, 1978, CELL, V15, P1109, DOI 10.1016/0092-8674(78)90039-9; KOZAK M, 1994, BIOCHIMIE, V76, P815, DOI 10.1016/0300-9084(94)90182-1; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Niemeyer BA, 2001, P NATL ACAD SCI USA, V98, P3600, DOI 10.1073/pnas.051511398; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; PEABODY DS, 1987, J BIOL CHEM, V262, P11847; Peng JB, 2000, BIOCHEM BIOPH RES CO, V278, P326, DOI 10.1006/bbrc.2000.3716; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Schwab SR, 2004, PLOS BIOL, V2, P1774, DOI 10.1371/journal.pbio.0020366; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Simkin D, 2008, J PHYSIOL-LONDON, V586, P5651, DOI 10.1113/jphysiol.2008.161927; Starck SR, 2012, SCIENCE, V336, P1719, DOI 10.1126/science.1220270; Stumpf T, 2008, J BIOL CHEM, V283, P18086, DOI 10.1074/jbc.M801821200; Suzuki Y, 2008, J BONE MINER RES, V23, P1249, DOI [10.1359/jbmr.080314, 10.1359/JBMR.080314]; TAIRA M, 1990, J BIOL CHEM, V265, P16491; Tee MK, 2001, BIOCHEM J, V359, P219, DOI 10.1042/0264-6021:3590219; Thomas D, 2008, NEURON, V58, P859, DOI 10.1016/j.neuron.2008.04.016; Tikole S, 2006, J BIOMOL STRUCT DYN, V24, P33, DOI 10.1080/07391102.2006.10507096; van de Graaf SFJ, 2006, AM J PHYSIOL-RENAL, V290, pF1295, DOI 10.1152/ajprenal.00443.2005; Voets T, 2001, J BIOL CHEM, V276, P47767, DOI 10.1074/jbc.C100607200; Wegrzyn JL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-232; Weissgerber P, 2012, J BIOL CHEM, V287, P17930, DOI 10.1074/jbc.M111.328286; Weissgerber P, 2011, SCI SIGNAL, V4, P6, DOI 10.1126/scisignal.2001791; Winnard PT, 2007, CANCER BIOL THER, V6, P1889, DOI 10.4161/cbt.6.12.4963; Wissenbach U, 2001, J BIOL CHEM, V276, P19461, DOI 10.1074/jbc.M009895200; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596	42	48	50	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16629	16644		10.1074/jbc.M113.469726	http://dx.doi.org/10.1074/jbc.M113.469726			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612980	hybrid, Green Published			2022-12-28	WOS:000320378900039
J	Schwappacher, R; Kilic, A; Kojonazarov, B; Lang, M; Diep, T; Zhuang, SH; Gawlowski, T; Schermuly, RT; Pfeifer, A; Boss, GR; Pilz, RB				Schwappacher, Raphaela; Kilic, Ana; Kojonazarov, Baktybek; Lang, Michaela; Diep, Thuan; Zhuang, Shunhui; Gawlowski, Thomas; Schermuly, Ralph T.; Pfeifer, Alexander; Boss, Gerry R.; Pilz, Renate B.			A Molecular Mechanism for Therapeutic Effects of cGMP-elevating Agents in Pulmonary Arterial Hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; SOLUBLE GUANYLATE-CYCLASE; GENE-EXPRESSION; CYCLIC-GMP; INCREASED SUSCEPTIBILITY; NITRIC-OXIDE; MICE; ACTIVATION; PROLIFERATION; PENETRANCE	Pulmonary arterial hypertension (PAH) is a progressive, usually fatal disease with abnormal vascular remodeling. Pulmonary artery smooth muscle cells (PASMCs) from PAH patients are hyperproliferative and apoptosis-resistant and demonstrate decreased signaling in response to bone morphogenetic proteins (BMPs). Cyclic GMP-elevating agents are beneficial in PAH, but their mechanism(s) of action are incompletely understood. Here we show that BMP signaling via Smad1/5/8 requires cGMP-dependent protein kinase isotype I (PKGI) to maintain PASMCs in a differentiated, low proliferative state. BMP cooperation with cGMP/PKGI was crucial for transcription of contractile genes and suppression of pro-proliferative and anti-apoptotic genes. Lungs from mice with low or absent PKGI (Prkg1(+/-) and Prkg1(-/-) mice) exhibited impaired BMP signaling, decreased contractile gene expression, and abnormal vascular remodeling. Conversely, cGMP stimulation of PKGI restored defective BMP signaling in rats with hypoxia-induced PAH, consistent with cGMP-elevating agents reversing vascular remodeling in this PAH model. Our results provide a mechanism for the therapeutic effects of cGMP-elevating agents in PAH and suggest that combining them with BMP mimetics may provide a novel, disease-modifying approach to PAH therapy.	[Schwappacher, Raphaela; Diep, Thuan; Zhuang, Shunhui; Gawlowski, Thomas; Boss, Gerry R.; Pilz, Renate B.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Kilic, Ana; Pfeifer, Alexander] Univ Bonn, Inst Pharmacol & Toxicol, D-53113 Bonn, Germany; [Kojonazarov, Baktybek; Lang, Michaela; Schermuly, Ralph T.] Univ Giessen, D-35392 Giessen, Germany; [Kojonazarov, Baktybek; Lang, Michaela; Schermuly, Ralph T.] Marburg Lung Ctr, D-35392 Giessen, Germany	University of California System; University of California San Diego; University of Bonn; Justus Liebig University Giessen	Schwappacher, R (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr,Basic Sci Bldg,Rm 5076, La Jolla, CA 92093 USA.	rschwappacher@ucsd.edu		Schermuly, Ralph/0000-0002-5167-6970; Boss, Gerry/0000-0002-9758-8714	National Institutes of Health [R01-AR051300, NS047101]; Deutsche Forschungsgemeinschaft fellowship grant; BONFOR grant from the University of Bonn; Bayer-Schering; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft fellowship grant(German Research Foundation (DFG)); BONFOR grant from the University of Bonn; Bayer-Schering(Bayer AG); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AR051300 (to R. B. P.) and NS047101 (to the University of California San Diego Neuroscience Microscopy Facility). This work was also supported by a Deutsche Forschungsgemeinschaft fellowship grant (to R. S.) and a BONFOR grant from the University of Bonn (to A. K.). R. S. is an inventor on the patent "A method for restoring BMP-receptor signalling in a cell" (PCT/EP2009/001408, Germany). R. T. S. has received honoraria from Actelion, Pfizer, Bayer-Schering, Novartis and Solvay and research grant support from Bayer-Schering.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Baliga RS, 2008, AM J RESP CRIT CARE, V178, P861, DOI 10.1164/rccm.200801-121OC; Bao SL, 2004, ONCOGENE, V23, P5586, DOI 10.1038/sj.onc.1207753; Barford D, 2011, Q REV BIOPHYS, V44, P153, DOI 10.1017/S0033583510000259; Bauer NR, 2007, AM J PHYSIOL-LUNG C, V293, pL580, DOI 10.1152/ajplung.00281.2007; Beppu H, 2004, AM J PHYSIOL-LUNG C, V287, pL1241, DOI 10.1152/ajplung.00239.2004; Boerth NJ, 1997, J VASC RES, V34, P245, DOI 10.1159/000159231; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Chen CN, 2013, VASC PHARMACOL, V58, P211, DOI 10.1016/j.vph.2012.09.001; Chiche JD, 1998, J BIOL CHEM, V273, P34263, DOI 10.1074/jbc.273.51.34263; Dey NB, 1998, CIRC RES, V82, P139; Dumitrascu R, 2006, CIRCULATION, V113, P286, DOI 10.1161/CIRCULATIONAHA.105.581405; Fantozzi I, 2005, EXP LUNG RES, V31, P783, DOI 10.1080/01902140500461026; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Frank DB, 2008, AM J PHYSIOL-LUNG C, V294, pL98, DOI 10.1152/ajplung.00034.2007; Geraci MW, 2001, CIRC RES, V88, P555, DOI 10.1161/01.RES.88.6.555; Hamid R, 2009, HUM MUTAT, V30, P649, DOI 10.1002/humu.20922; Hansmann G, 2008, J CLIN INVEST, V118, P1846, DOI 10.1172/JCI32503; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; Lagna G, 2006, AM J PHYSIOL-LUNG C, V291, pL1059, DOI 10.1152/ajplung.00180.2006; Lang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043433; Leoni AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009298; Lincoln TM, 2006, FRONT BIOSCI-LANDMRK, V11, P356, DOI 10.2741/1803; Morrell NW, 2001, CIRCULATION, V104, P790, DOI 10.1161/hc3201.094152; Morty RE, 2007, ARTERIOSCL THROM VAS, V27, P1072, DOI 10.1161/ATVBAHA.107.141200; Neuman NA, 2009, J BIOL CHEM, V284, P13202, DOI 10.1074/jbc.M900282200; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Schermuly RT, 2011, NAT REV CARDIOL, V8, P443, DOI 10.1038/nrcardio.2011.87; Schwappacher R, 2009, EMBO J, V28, P1537, DOI 10.1038/emboj.2009.103; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Song YL, 2005, CIRCULATION, V112, P553, DOI 10.1161/CIRCULATIONAHA.104.492488; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Tada Y, 2007, AM J PHYSIOL-LUNG C, V292, pL1556, DOI 10.1152/ajplung.00305.2006; Weissmann N, 2009, AM J PHYSIOL-LUNG C, V297, pL658, DOI 10.1152/ajplung.00189.2009; West J, 2004, CIRC RES, V94, P1109, DOI 10.1161/01.RES.0000126047.82846.20; Whitelaw NC, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r111; Yang J, 2008, CIRC RES, V102, P1212, DOI 10.1161/CIRCRESAHA.108.173567; Yang J, 2010, CIRC RES, V107, P252, DOI 10.1161/CIRCRESAHA.109.209940; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang S, 2003, AM J PHYSIOL-LUNG C, V285, pL740, DOI 10.1152/ajplung.00284.2002; Zhang T, 2007, J BIOL CHEM, V282, P33367, DOI 10.1074/jbc.M707186200; Zhao YDD, 2012, AM J PATHOL, V180, P2268, DOI 10.1016/j.ajpath.2012.02.016; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338; Zuckerbraun BS, 2010, CIRCULATION, V121, P98, DOI 10.1161/CIRCULATIONAHA.109.891077	48	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16557	16566		10.1074/jbc.M113.458729	http://dx.doi.org/10.1074/jbc.M113.458729			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612967	Green Published, hybrid			2022-12-28	WOS:000320378900032
J	Vu, TT; Stafford, AR; Leslie, BA; Kim, PY; Fredenburgh, JC; Weitz, JI				Vu, Trang T.; Stafford, Alan R.; Leslie, Beverly A.; Kim, Paul Y.; Fredenburgh, James C.; Weitz, Jeffrey I.			Batroxobin Binds Fibrin with Higher Affinity and Promotes Clot Expansion to a Greater Extent than Thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VENOM PLASMINOGEN-ACTIVATOR; CRYSTAL-STRUCTURE; GAMMA-CHAIN; SERINE PROTEINASES; MOLECULAR-BASIS; BOUND THROMBIN; ANTITHROMBIN; INHIBITION; EXOSITES; SEQUENCE	Batroxobin is a thrombin-like serine protease from the venom of Bothrops atrox moojeni that clots fibrinogen. In contrast to thrombin, which releases fibrinopeptide A and B from the NH2 terminal domains of the A alpha -and B beta -chains of fibrinogen, respectively, batroxobin only releases fibrinopeptide A. Because the mechanism responsible for these differences is unknown, we compared the interactions of batroxobin and thrombin with the predominant gamma(A)/gamma(A) isoform of fibrin(ogen) and the gamma(A)/gamma' variant with an extended gamma-chain. Thrombin binds to the gamma'-chain and forms a higher affinity interaction with gamma(A)/gamma(A) -fibrin(ogen) than gamma(A)/gamma(A) -fibrin(ogen). In contrast, batroxobin binds both fibrin(ogen) isoforms with similar high affinity (K-d values of about 0.5 mu M) even though it does not interact with the gamma'-chain. The batroxobin-binding sites on fibrin(ogen) only partially overlap with those of thrombin because thrombin attenuates, but does not abrogate, the interaction of gamma(A)/gamma(A)-fibrinogen with batroxobin. Furthermore, although both thrombin and batroxobin bind to the central E-region of fibrinogen with a Kd value of 2-5 mu M, the alpha(17-51) and B beta(1-42) regions bind thrombin but not batroxobin. Once bound to fibrin, the capacity of batroxobin to promote fibrin accretion is 18-fold greater than that of thrombin, a finding that may explain the microvascular thrombosis that complicates envenomation by B. atrox moojeni. Therefore, batroxobin binds fibrin(ogen) in a manner distinct from thrombin, which may contribute to its higher affinity interaction, selective fibrinopeptide A release, and prothrombotic properties.	[Vu, Trang T.; Stafford, Alan R.; Leslie, Beverly A.; Kim, Paul Y.; Fredenburgh, James C.; Weitz, Jeffrey I.] McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON L8L 2X2, Canada; [Vu, Trang T.; Weitz, Jeffrey I.] McMaster Univ, Dept Med Sci, Hamilton, ON L8L 2X2, Canada; [Stafford, Alan R.; Leslie, Beverly A.; Kim, Paul Y.; Fredenburgh, James C.; Weitz, Jeffrey I.] McMaster Univ, Dept Med, Hamilton, ON L8L 2X2, Canada; [Weitz, Jeffrey I.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8L 2X2, Canada	McMaster University; McMaster University; McMaster University; McMaster University	Weitz, JI (corresponding author), Thrombosis & Atherosclerosis Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	weitzj@taari.ca	Weitz, Jeffrey/AAD-1929-2019; Kim, Paul/GYV-3258-2022	Weitz, Jeffrey/0000-0002-1092-7550; Kim, Paul/0000-0003-0943-4924	Canadian Institutes of Health Research [MOP 3992, MOP 102735, CTP 79846]; Heart and Stroke Foundation of Ontario [T4792, T4730]; Ontario Research and Development Challenge Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ontario Research and Development Challenge Fund(General Electric)	This work was supported in part by Canadian Institutes of Health Research Grants MOP 3992, MOP 102735, and CTP 79846, Heart and Stroke Foundation of Ontario Grants T4792 and T4730, and the Ontario Research and Development Challenge Fund.	Adams TE, 2006, ARTERIOSCL THROM VAS, V26, P1738, DOI 10.1161/01.ATV.0000228844.65168.d1; ARONSON DL, 1976, THROMB HAEMOSTASIS, V36, P9, DOI 10.1055/s-0038-1648004; Becker DL, 1999, J BIOL CHEM, V274, P6226, DOI 10.1074/jbc.274.10.6226; BLOMBACK B, 1978, NATURE, V275, P501, DOI 10.1038/275501a0; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; Braud S, 2000, BIOCHIMIE, V82, P851, DOI 10.1016/S0300-9084(00)01178-0; Butantan-British Bothrops Systematics Project, 1996, Symposia of the Zoological Society of London, V70, P89; Castro HC, 2004, CELL MOL LIFE SCI, V61, P843, DOI 10.1007/s00018-003-3325-z; CHUNG DW, 1984, BIOCHEMISTRY-US, V23, P4232, DOI 10.1021/bi00313a033; Cooper AV, 2003, BLOOD, V102, P535, DOI 10.1182/blood-2002-10-3150; Di Cera E, 2001, ANN NY ACAD SCI, V936, P133; FORNACE AJ, 1984, J BIOL CHEM, V259, P2826; Fredenburgh JC, 2008, J BIOL CHEM, V283, P2470, DOI 10.1074/jbc.M707710200; Fredenburgh JC, 2004, BIOPHYS CHEM, V112, P277, DOI 10.1016/j.bpc.2004.07.031; Henschen-Edman AH, 1999, THROMB HAEMOSTASIS, V81, P81; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; Isbister GK, 2010, SEMIN THROMB HEMOST, V36, P444, DOI 10.1055/s-0030-1254053; KOOPMAN J, 1992, J CLIN INVEST, V90, P238, DOI 10.1172/JCI115841; Kretz CA, 2010, THROMB HAEMOSTASIS, V103, P83, DOI 10.1160/TH09-04-0237; LATALLO ZS, 1983, THROMB HAEMOSTASIS, V50, P604; Liu S, 2011, STROKE, V42, P3277, DOI 10.1161/STROKEAHA.111.622753; LORD ST, 1995, J BIOL CHEM, V270, P24790, DOI 10.1074/jbc.270.42.24790; Lovely LP, 2003, SOUTH MED J, V96, P548, DOI 10.1097/01.SMJ.0000054567.79881.E9; Lovely RS, 2010, CLIN CHEM, V56, P781, DOI 10.1373/clinchem.2009.138347; Maroun RC, 2004, J MOL RECOGNIT, V17, P51, DOI 10.1002/jmr.644; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; Moen JL, 2003, BLOOD, V102, P2466, DOI 10.1182/blood-2003-01-0204; Mosesson MW, 2007, THROMB HAEMOSTASIS, V98, P105, DOI 10.1160/Th07-04-0274; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Mullin JL, 2000, J BIOL CHEM, V275, P25239, DOI 10.1074/jbc.M004142200; OLEXA SA, 1979, J BIOL CHEM, V254, P4925; Parry MAA, 1998, STRUCT FOLD DES, V6, P1195, DOI 10.1016/S0969-2126(98)00119-1; Pechik I, 2004, P NATL ACAD SCI USA, V101, P2718, DOI 10.1073/pnas.0303440101; Petrera NS, 2009, J BIOL CHEM, V284, P25620, DOI 10.1074/jbc.M109.000042; Pospisil CH, 2003, J BIOL CHEM, V278, P21584, DOI 10.1074/jbc.M300545200; Riedel T, 2011, BLOOD, V117, P1700, DOI 10.1182/blood-2010-08-300301; Rose T, 2003, J BIOL CHEM, V278, P11320, DOI 10.1074/jbc.M211820200; Schaefer AVL, 2006, BIOCHEMISTRY-US, V45, P4257, DOI 10.1021/bi0525730; Serrano SMT, 2005, TOXICON, V45, P1115, DOI 10.1016/j.toxicon.2005.02.020; Stocker K. F., 1998, HEMOSTASIS ANIMAL VE, P525; STONE SR, 1986, BIOCHEMISTRY-US, V25, P4622, DOI 10.1021/bi00364a025; van den Herik EG, 2011, THROMB HAEMOSTASIS, V105, P430, DOI 10.1160/TH10-09-0569; Vu TT, 2011, J BIOL CHEM, V286, P30314, DOI 10.1074/jbc.M111.253831; Wang J, 2010, ANN VASC SURG, V24, P876, DOI 10.1016/j.avsg.2010.03.030; WEISEL JW, 1993, J MOL BIOL, V232, P285, DOI 10.1006/jmbi.1993.1382; WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723; White J, 2005, TOXICON, V45, P951, DOI 10.1016/j.toxicon.2005.02.030; Wolberg AS, 2012, CURR OPIN HEMATOL, V19, P349, DOI 10.1097/MOH.0b013e32835673c2; WOLFENSTEINTODEL C, 1980, P NATL ACAD SCI-BIOL, V77, P5069, DOI 10.1073/pnas.77.9.5069; Xu GL, 2007, BLOOD COAGUL FIBRIN, V18, P193, DOI 10.1097/MBC.0b013e328040c0f2; Zhang Y, 1997, J BIOL CHEM, V272, P20531, DOI 10.1074/jbc.272.33.20531	51	26	29	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16862	16871		10.1074/jbc.M113.464750	http://dx.doi.org/10.1074/jbc.M113.464750			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612970	hybrid, Green Published			2022-12-28	WOS:000320378900059
J	Cheng, JJ; Goldstein, R; Gershenson, A; Stec, B; Roberts, MF				Cheng, Jiongjia; Goldstein, Rebecca; Gershenson, Anne; Stec, Boguslaw; Roberts, Mary F.			The Cation-pi Box Is a Specific Phosphatidylcholine Membrane Targeting Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C; CRYSTAL-STRUCTURE; STAPHYLOCOCCUS-AUREUS; INTERFACIAL BINDING; PROTEIN; SUBSTRATE; COMPLEX; RECOGNITION; MODULATION; RESOLUTION	Peripheral membrane proteins can be targeted to specific organelles or the plasma membrane by differential recognition of phospholipid headgroups. Although molecular determinants of specificity for several headgroups, including phosphatidylserine and phosphoinositides are well defined, specific recognition of the headgroup of the zwitterionic phosphatidylcholine (PC) is less well understood. In cytosolic proteins the cation-pi box provides a suitable receptor for choline recognition and binding through the trimethylammonium moiety. In PC, this moiety might provide a sufficient handle to bind to peripheral proteins via a cation-pi cage, where the pi systems of two or more aromatic residues are within 4-5 angstrom of the quaternary amine. We prove this hypothesis by engineering the cation-pi box into secreted phosphatidylinositol-specific phospholipase C from Staphylococcus aureus, which lacks specific PC recognition. The N254Y/H258Y variant selectively binds PC-enriched vesicles, and x-ray crystallography reveals N254Y/H258Y binds choline and dibutyroylphosphatidylcholine within the cation-pi motif. Such simple PC recognition motifs could be engineered into a wide variety of secondary structures providing a generally applicable method for specific recognition of PC.	[Cheng, Jiongjia; Roberts, Mary F.] Boston Coll, Dept Chem, Chestnut Hill, MA 02467 USA; [Goldstein, Rebecca; Gershenson, Anne] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Stec, Boguslaw] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Boston College; University of Massachusetts System; University of Massachusetts Amherst; Sanford Burnham Prebys Medical Discovery Institute	Roberts, MF (corresponding author), Boston Coll, Merkert Chem Dept, Chestnut Hill, MA 02167 USA.	mary.roberts@bc.edu	Cheng, Jiongjia/AAM-9464-2020	Cheng, Jiongjia/0000-0002-0908-3880; Stec, Boguslaw/0000-0002-8696-0349; Gershenson, Anne/0000-0003-3124-9610	National Institutes of Health [R01 GM60418]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM60418 (to M. F. R.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BIAN JR, 1992, J COLLOID INTERF SCI, V153, P420, DOI 10.1016/0021-9797(92)90333-H; Cheng JJ, 2013, BIOPHYS J, V104, P185, DOI 10.1016/j.bpj.2012.11.015; Cheng JJ, 2012, J BIOL CHEM, V287, P40317, DOI 10.1074/jbc.M112.395277; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; CONCHA NO, 1993, SCIENCE, V261, P1321, DOI 10.1126/science.8362244; DAUGHERTY S, 1993, INFECT IMMUN, V61, P5078, DOI 10.1128/IAI.61.12.5078-5089.1993; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng JW, 2002, J BIOL CHEM, V277, P19867, DOI 10.1074/jbc.M200938200; Goldstein R, 2012, BIOCHEMISTRY-US, V51, P2579, DOI 10.1021/bi300057q; Grauffel C, 2013, J AM CHEM SOC, V135, P5740, DOI 10.1021/ja312656v; HEINZ DW, 1995, EMBO J, V14, P3855, DOI 10.1002/j.1460-2075.1995.tb00057.x; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Knight JD, 2010, BIOPHYS J, V99, P2879, DOI 10.1016/j.bpj.2010.08.046; Krick R, 2012, P NATL ACAD SCI USA, V109, pE2042, DOI 10.1073/pnas.1205128109; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lovgren A, 1998, CURR MICROBIOL, V37, P245, DOI 10.1007/s002849900373; Macedo-Ribeiro S, 1999, NATURE, V402, P434, DOI 10.1038/46594; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moser J, 1997, J MOL BIOL, V273, P269, DOI 10.1006/jmbi.1997.1290; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Oswald C, 2008, J BIOL CHEM, V283, P32848, DOI 10.1074/jbc.M806021200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pittelkow M, 2011, J MOL BIOL, V411, P53, DOI 10.1016/j.jmb.2011.05.037; Pu MM, 2010, J BIOL CHEM, V285, P26916, DOI 10.1074/jbc.M110.123083; Pu MM, 2009, BIOCHEMISTRY-US, V48, P6835, DOI 10.1021/bi900633p; Redfield AG, 2012, J BIOMOL NMR, V52, P159, DOI 10.1007/s10858-011-9594-1; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Schiefner A, 2004, J BIOL CHEM, V279, P5588, DOI 10.1074/jbc.M309771200; Shao C, 2008, J BIOL CHEM, V283, P7230, DOI 10.1074/jbc.M705195200; Shi XM, 2009, J BIOL CHEM, V284, P15607, DOI 10.1074/jbc.M901601200; Tripsianes K, 2011, NAT STRUCT MOL BIOL, V18, P1414, DOI 10.1038/nsmb.2185; Tschapek B, 2011, J MOL BIOL, V411, P36, DOI 10.1016/j.jmb.2011.05.039; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wehbi H, 2003, BIOCHEMISTRY-US, V42, P9374, DOI 10.1021/bi034195+; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Zhou C, 1997, BIOCHEMISTRY-US, V36, P10089, DOI 10.1021/bi970846o	41	36	36	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14863	14873		10.1074/jbc.M113.466532	http://dx.doi.org/10.1074/jbc.M113.466532			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23576432	hybrid, Green Published			2022-12-28	WOS:000319452100018
J	Hu, Q; Wu, D; Chen, W; Yan, Z; Shi, YG				Hu, Qi; Wu, Di; Chen, Wen; Yan, Zhen; Shi, Yigong			Proteolytic Processing of the Caspase-9 Zymogen Is Required for Apoptosome-mediated Activation of Caspase-9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; CYTOCHROME-C; INHIBITION; XIAP; PROCASPASE-9; SMAC/DIABLO; MECHANISMS; INSIGHTS; APAF-1	Maturation of the single-chain caspase-9 zymogen through autoproteolytic processing is mediated by the Apaf-1 apoptosome at the onset of apoptosis. Processed caspase-9 and the apoptosome form a holoenzyme with robust proteolytic activity that is 2-3 orders of magnitude higher than that of free processed caspase-9. An unresolved important question is the role of caspase-9 processing, with some experimental data suggesting its dispensability. In this study, we demonstrate that, in contrast to wild-type caspase-9, the unprocessed single-chain caspase-9 triple mutant E306A/D315A/D330A (Casp9-TM) could no longer be adequately activated by the apoptosome. Compared with the protease activity of wild-type caspase-9, that of Casp9-TM in the presence of the apoptosome was drastically reduced. The crippled protease activity of Casp9-TM in the presence of the apoptosome is likely attributable to a markedly reduced ability of Casp9-TM to form homodimers. These data identify an essential role for the autoproteolytic processing of caspase-9 in its activation.	[Hu, Qi; Wu, Di; Yan, Zhen; Shi, Yigong] Tsinghua Univ, Struct Biol Ctr, Key Lab Prot Sci,Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci,Minist Educ, Beijing 100084, Peoples R China; [Hu, Qi; Wu, Di; Yan, Zhen; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Chen, Wen] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China	Tsinghua University; Tsinghua University; Peking University	Shi, YG (corresponding author), Tsinghua Univ, Sch Med, Med Sci Bldg,Rm C331, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn		Shi, Yigong/0000-0003-2030-168X; Yan, Zhen/0000-0002-1999-8451	Ministry of Science and Technology Grant [2009CB918801]; National Natural Science Foundation of China [30888001]; Beijing Municipal Commissions of Education, Science and Technology	Ministry of Science and Technology Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commissions of Education, Science and Technology	This work was supported by Ministry of Science and Technology Grant 2009CB918801, National Natural Science Foundation of China Project 30888001, and the Beijing Municipal Commissions of Education, Science and Technology.	Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Burke SP, 2010, J BIOL CHEM, V285, P30061, DOI 10.1074/jbc.M110.125955; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Gao Z, 2007, J BIOL CHEM, V282, P30718, DOI 10.1074/jbc.M705258200; Huang YH, 2003, J BIOL CHEM, V278, P49517, DOI 10.1074/jbc.M310061200; Keller N, 2009, STRUCTURE, V17, P438, DOI 10.1016/j.str.2008.12.019; Lavrik I, 2005, J CELL SCI, V118, P265, DOI 10.1242/jcs.01610; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Mace PD, 2010, CURR OPIN CELL BIOL, V22, P828, DOI 10.1016/j.ceb.2010.08.004; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 2003, J BIOL CHEM, V278, P8091, DOI 10.1074/jbc.M204783200	23	39	40	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15142	15147		10.1074/jbc.M112.441568	http://dx.doi.org/10.1074/jbc.M112.441568			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23572523	hybrid, Green Published			2022-12-28	WOS:000319452100043
J	Lee, GS; He, YZ; Dougherty, EJ; Jimenez-Movilla, M; Avella, M; Grullon, S; Sharlin, DS; Guo, CH; Blackford, JA; Awasthi, S; Zhang, ZH; Armstrong, SP; London, EC; Chen, WP; Dean, J; Simons, SS				Lee, Geun-Shik; He, Yuanzheng; Dougherty, Edward J.; Jimenez-Movilla, Maria; Avella, Matteo; Grullon, Sean; Sharlin, David S.; Guo, Chunhua; Blackford, John A., Jr.; Awasthi, Smita; Zhang, Zhenhuan; Armstrong, Stephen P.; London, Edra C.; Chen, Weiping; Dean, Jurrien; Simons, S. Stoney, Jr.			Disruption of Ttll5/Stamp Gene (Tubulin Tyrosine Ligase-like Protein 5/SRC-1 and TIF2-associated Modulatory Protein Gene) in Male Mice Causes Sperm Malformation and Infertility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARDET-BIEDL-SYNDROME; GLUCOCORTICOID-RECEPTOR; CAENORHABDITIS-ELEGANS; ABNORMAL-DEVELOPMENT; CANCER CELLS; POLYGLUTAMYLATION; FLAGELLA; GROWTH; STAMP; TRANSCRIPTION	TTLL5/STAMP (tubulin tyrosine ligase-like family member 5) has multiple activities in cells. TTLL5 is one of 13 TTLLs, has polyglutamylation activity, augments the activity of p160 coactivators (SRC-1 and TIF2) in glucocorticoid receptor-regulated gene induction and repression, and displays steroid-independent growth activity with several cell types. To examine TTLL5/STAMP functions in whole animals, mice were prepared with an internal deletion that eliminated several activities of the Stamp gene. This mutation causes both reduced levels of STAMP mRNA and C-terminal truncation of STAMP protein. Homozygous targeted mutant (Stamp(tm/tm)) mice appear normal except for marked decreases in male fertility associated with defects in progressive sperm motility. Abnormal axonemal structures with loss of tubulin doublets occur in most Stamp(tm/tm) sperm tails in conjunction with substantial reduction in alpha-tubulin polyglutamylation, which closely correlates with the reduction in mutant STAMP mRNA. The axonemes in other structures appear unaffected. There is no obvious change in the organs for sperm development of WT versus Stamp(tm/tm) males despite the levels of WT STAMP mRNA in testes being 20-fold higher than in any other organ examined. This defect in male fertility is unrelated to other Ttll genes or 24 genes previously identified as important for sperm function. Thus, STAMP appears to participate in a unique, tissue-selective TTLL-mediated pathway for alpha-tubulin polyglutamylation that is required for sperm maturation and motility and may be relevant for male fertility.	[Lee, Geun-Shik; He, Yuanzheng; Dougherty, Edward J.; Guo, Chunhua; Blackford, John A., Jr.; Awasthi, Smita; Zhang, Zhenhuan; Armstrong, Stephen P.; London, Edra C.; Simons, S. Stoney, Jr.] NIDDK, Steroid Hormones Sect, Lab Endocrinol & Receptor Biol, Bethesda, MD 20892 USA; [Jimenez-Movilla, Maria; Avella, Matteo; Dean, Jurrien] NIDDK, Lab Cellular & Dev Biol, Bethesda, MD 20892 USA; [Grullon, Sean] NIDDK, Adipocyte Biol & Gene Regulat Sect, Lab Endocrinol & Receptor Biol, Bethesda, MD 20892 USA; [Sharlin, David S.] NIDDK, Nucl Receptor Biol Sect, Lab Endocrinol & Receptor Biol, Bethesda, MD 20892 USA; [Chen, Weiping] NIDDK, Genom Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Simons, SS (corresponding author), NIDDK, LERB, NIH, Bldg 10,Rm 8N-307B, Bethesda, MD 20892 USA.	stoneys@helix.nih.gov	Movilla, Maria Jiménez/I-1004-2015; Chen, Wei/GZK-7348-2022; Avella, Matteo/M-6857-2019; Guo, Chunhua/N-2586-2014	Movilla, Maria Jiménez/0000-0002-1572-8219; London, Edra/0000-0003-2766-749X; He, Yuanzheng/0000-0001-9131-140X; Awasthi, Smita/0000-0002-2065-5800	NIDDK, National Institutes of Health Intramural Research Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015603, ZIADK047039] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the NIDDK, National Institutes of Health Intramural Research Program.	Awasthi S, 2012, MOL CELL ENDOCRINOL, V355, P121, DOI 10.1016/j.mce.2012.02.001; Campbell PK, 2002, GENETICS, V162, P307; Dawe HR, 2005, J CELL SCI, V118, P5421, DOI 10.1242/jcs.02659; Escalier D, 2006, HUM REPROD UPDATE, V12, P449, DOI 10.1093/humupd/dml013; FACKENTHAL JD, 1995, GENETICS, V139, P267; Fath MA, 2005, HUM MOL GENET, V14, P1109, DOI 10.1093/hmg/ddi123; Fouquet JP, 1996, MOL REPROD DEV, V43, P358, DOI 10.1002/(SICI)1098-2795(199603)43:3&lt;358::AID-MRD10&gt;3.0.CO;2-Y; Gaertig J, 2008, CURR TOP DEV BIOL, V85, P83, DOI 10.1016/S0070-2153(08)00804-1; Gagnon C, 1996, J CELL SCI, V109, P1545; He YZ, 2007, MOL CELL BIOL, V27, P1467, DOI 10.1128/MCB.01360-06; He YZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-128; Horowitz E, 2005, MOL HUM REPROD, V11, P307, DOI 10.1093/molehr/gah163; HUNTER DG, 1986, ARCH OPHTHALMOL-CHIC, V104, P385; Ichijo T, 2005, J BIOL CHEM, V280, P42067, DOI 10.1074/jbc.M509338200; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Ikegami K, 2010, P NATL ACAD SCI USA, V107, P10490, DOI 10.1073/pnas.1002128107; Inaba K, 2011, MOL HUM REPROD, V17, P524, DOI 10.1093/molehr/gar034; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Janke C, 2008, EMBO REP, V9, P636, DOI 10.1038/embor.2008.114; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kashiwaya K, 2010, CANCER RES, V70, P4024, DOI 10.1158/0008-5472.CAN-09-4444; Lei N, 2002, BIOL REPROD, V66, P675, DOI 10.1095/biolreprod66.3.675; Liang H, 2012, GENOME RES, V22, P2120, DOI 10.1101/gr.137596.112; Lorenzetti D, 2004, P NATL ACAD SCI USA, V101, P8402, DOI 10.1073/pnas.0401832101; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Montagutelli X, 2000, J AM SOC NEPHROL, V11, pS101; Mykytyn K, 2004, P NATL ACAD SCI USA, V101, P8664, DOI 10.1073/pnas.0402354101; Nayernia K, 2003, J BIOL CHEM, V278, P48377, DOI 10.1074/jbc.M309583200; Needham M, 2000, J STEROID BIOCHEM, V72, P35, DOI 10.1016/S0960-0760(00)00027-3; Neesen J, 2001, HUM MOL GENET, V10, P1117, DOI 10.1093/hmg/10.11.1117; Newman GR, 1999, HISTOCHEM J, V31, P79, DOI 10.1023/A:1003402514042; Osman BAH, 2011, J REPROD DEVELOP, V57, P457, DOI 10.1262/jrd.10-179N; Pathak N, 2011, J BIOL CHEM, V286, P11685, DOI 10.1074/jbc.M110.209817; Pinto FM, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-71; Reeb CA, 2011, ENDOCRINOLOGY, V152, P2174, DOI 10.1210/en.2011-0149; Rogowski K, 2009, CELL, V137, P1076, DOI 10.1016/j.cell.2009.05.020; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; Sun YG, 2008, MOL CELL ENDOCRINOL, V295, P59, DOI 10.1016/j.mce.2008.05.008; Szapary D, 2008, MOL CELL ENDOCRINOL, V283, P114, DOI 10.1016/j.mce.2007.11.031; Tokuhiro K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000712; Trichet V, 2000, GENE, V257, P109, DOI 10.1016/S0378-1119(00)00383-8; Uhrin P, 2000, J CLIN INVEST, V106, P1531, DOI 10.1172/JCI10768; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Vogel P, 2010, VET PATHOL, V47, P703, DOI 10.1177/0300985810363485; Vollrath B, 2001, MOL CELL BIOL, V21, P7481, DOI 10.1128/MCB.21.21.7481-7494.2001; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003; Yang KF, 2012, MOL CELL BIOL, V32, P216, DOI 10.1128/MCB.06158-11; Zhang ZB, 2005, MOL CELL PROTEOMICS, V4, P914, DOI 10.1074/mcp.M400177-MCP200	51	34	36	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15167	15180		10.1074/jbc.M113.453936	http://dx.doi.org/10.1074/jbc.M113.453936			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23558686	Green Published, hybrid			2022-12-28	WOS:000319452100046
J	Casadesus, J; Low, DA				Casadesus, Josep; Low, David A.			Programmed Heterogeneity: Epigenetic Mechanisms in Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PAP PHASE VARIATION; ENTERICA SEROVAR TYPHIMURIUM; OUTER-MEMBRANE PROTEIN; ESCHERICHIA-COLI K-12; BACILLUS-SUBTILIS; DNA METHYLATION; REGULATORY PROTEIN; H-NS; FIMBRIAL TRANSCRIPTION; COMPETENCE DEVELOPMENT	Contrary to the traditional view that bacterial populations are clonal, single-cell analysis reveals that phenotypic heterogeneity is common in bacteria. Formation of distinct bacterial lineages appears to be frequent during adaptation to harsh environments, including the colonization of animals by bacterial pathogens. Formation of bacterial subpopulations is often controlled by epigenetic mechanisms that generate inheritable phenotypic diversity without altering the DNA sequence. Such mechanisms are diverse, ranging from relatively simple feedback loops to complex self-perpetuating DNA methylation patterns.	[Casadesus, Josep] Univ Seville, Fac Biol, Dept Genet, E-41080 Seville, Spain; [Low, David A.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of Sevilla; University of California System; University of California Santa Barbara	Casadesus, J (corresponding author), Univ Seville, Fac Biol, Dept Genet, E-41080 Seville, Spain.	casadesus@us.es; david.low@lifesci.ucsb.edu	Casadesús, Josep/C-6222-2016	Casadesús, Josep/0000-0002-2308-293X				ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; Bailly-Bechet M, 2011, J MATH BIOL, V63, P637, DOI 10.1007/s00285-010-0385-1; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; BLYN LB, 1990, EMBO J, V9, P4045, DOI 10.1002/j.1460-2075.1990.tb07626.x; BOYE E, 1992, J BACTERIOL, V174, P1682, DOI 10.1128/jb.174.5.1682-1685.1992; BRAATEN BA, 1994, CELL, V76, P577, DOI 10.1016/0092-8674(94)90120-1; Broadbent SE, 2010, MOL MICROBIOL, V77, P337, DOI 10.1111/j.1365-2958.2010.07203.x; Brunet YR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002205; Casadesus J, 2002, BIOESSAYS, V24, P512, DOI 10.1002/bies.10102; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Chai YR, 2008, MOL MICROBIOL, V67, P254, DOI 10.1111/j.1365-2958.2007.06040.x; Chessa D, 2009, MOL MICROBIOL, V71, P864, DOI 10.1111/j.1365-2958.2008.06566.x; Correnti J, 2002, MOL MICROBIOL, V44, P521, DOI 10.1046/j.1365-2958.2002.02918.x; Cota I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036863; Cummings LA, 2006, MOL MICROBIOL, V61, P795, DOI 10.1111/j.1365-2958.2006.05271.x; Dandach SH, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000985; Danese PN, 2000, MOL MICROBIOL, V37, P424, DOI 10.1046/j.1365-2958.2000.02008.x; Davidson CJ, 2008, ANNU REV GENET, V42, P253, DOI 10.1146/annurev.genet.42.110807.091601; de los Rios S, 2007, J MOL BIOL, V366, P1589, DOI 10.1016/j.jmb.2006.12.032; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; EISENSTEIN BI, 1987, P NATL ACAD SCI USA, V84, P6506, DOI 10.1073/pnas.84.18.6506; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; FORSMAN K, 1989, EMBO J, V8, P1271, DOI 10.1002/j.1460-2075.1989.tb03501.x; Fox KL, 2007, NUCLEIC ACIDS RES, V35, P5242, DOI 10.1093/nar/gkm571; Fox KL, 2007, MOL MICROBIOL, V65, P1375, DOI 10.1111/j.1365-2958.2007.05873.x; Portillo FG, 2008, MICROBES INFECT, V10, P1063, DOI 10.1016/j.micinf.2008.07.004; Gibson KE, 2008, ANNU REV GENET, V42, P413, DOI 10.1146/annurev.genet.42.110807.091427; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gordon AJE, 2009, PLOS BIOL, V7, P364, DOI 10.1371/journal.pbio.1000044; Graveline R, 2011, MOL MICROBIOL, V81, P1286, DOI 10.1111/j.1365-2958.2011.07761.x; Hamoen LW, 2003, FEMS MICROBIOL LETT, V218, P299, DOI 10.1111/j.1574-6968.2003.tb11532.x; Harel J, 2000, CAN J MICROBIOL, V46, P1101, DOI 10.1139/cjm-46-12-1101; Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107; Henderson IR, 1999, J BACTERIOL, V181, P2132, DOI 10.1128/JB.181.7.2132-2141.1999; Hernday A, 2004, ADV EXP MED BIOL, V547, P83; Hernday A, 2002, P NATL ACAD SCI USA, V99, P16470, DOI 10.1073/pnas.182427199; Hernday AD, 2004, MOL CELL, V16, P537, DOI 10.1016/S1097-2765(04)00646-X; Hernday AD, 2003, MOL CELL, V12, P947, DOI 10.1016/S1097-2765(03)00383-6; Hoa TT, 2002, MOL MICROBIOL, V43, P15, DOI 10.1046/j.1365-2958.2002.02727.x; Hung DL, 2001, EMBO J, V20, P1508, DOI 10.1093/emboj/20.7.1508; Jakomin M, 2008, J BACTERIOL, V190, P7406, DOI 10.1128/JB.01136-08; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; Kaiser D, 2008, ANNU REV GENET, V42, P109, DOI 10.1146/annurev.genet.42.110807.091615; KALTENBACH LS, 1995, J BACTERIOL, V177, P6449, DOI 10.1128/jb.177.22.6449-6455.1995; Kaminska R, 2010, J BACTERIOL, V192, P1937, DOI 10.1128/JB.01629-09; Kawamura T, 2011, J MOL BIOL, V409, P311, DOI 10.1016/j.jmb.2011.01.058; Kirkpatrick CL, 2012, FEMS MICROBIOL REV, V36, P193, DOI 10.1111/j.1574-6976.2011.00309.x; Laurent M, 2005, CELL MOL BIOL, V51, P583, DOI 10.1170/T667; Leonard PM, 2001, EMBO J, V20, P990, DOI 10.1093/emboj/20.5.990; LEVINSON G, 1987, NUCLEIC ACIDS RES, V15, P5323, DOI 10.1093/nar/15.13.5323; Lopez-Garrido J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030499; Luthje P, 2010, J CLIN MICROBIOL, V48, P2316, DOI 10.1128/JCM.00611-10; MAGNUSON R, 1994, CELL, V77, P207, DOI 10.1016/0092-8674(94)90313-1; Martin C, 1996, MOL MICROBIOL, V21, P281, DOI 10.1046/j.1365-2958.1996.00651.x; Munsky B, 2010, IET SYST BIOL, V4, P356, DOI 10.1049/iet-syb.2010.0013; Nicholson B, 2000, MOL MICROBIOL, V35, P728, DOI 10.1046/j.1365-2958.2000.01743.x; NOU XW, 1995, EMBO J, V14, P5785, DOI 10.1002/j.1460-2075.1995.tb00267.x; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Owen P, 1996, FEMS IMMUNOL MED MIC, V16, P63; PEARCE UB, 1967, J GEN MICROBIOL, V49, P335, DOI 10.1099/00221287-49-2-335; Peterson SN, 2006, J MOL BIOL, V355, P459, DOI 10.1016/j.jmb.2005.11.003; Peterson SN, 2008, J MOL BIOL, V383, P92, DOI 10.1016/j.jmb.2008.07.086; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; RINGQUIST S, 1992, P NATL ACAD SCI USA, V89, P4539, DOI 10.1073/pnas.89.10.4539; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Satory D, 2011, CURR OPIN MICROBIOL, V14, P212, DOI 10.1016/j.mib.2010.12.004; Silva-Rocha R, 2010, ANNU REV MICROBIOL, V64, P257, DOI 10.1146/annurev.micro.091208.073229; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Smits WK, 2005, MOL MICROBIOL, V56, P604, DOI 10.1111/j.1365-2958.2005.04488.x; Sohanpal BK, 2001, MOL MICROBIOL, V42, P483, DOI 10.1046/j.1365-2958.2001.02655.x; Srikhanta YN, 2010, NAT REV MICROBIOL, V8, P196, DOI 10.1038/nrmicro2283; Srikhanta YN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000400; STERN A, 1986, CELL, V47, P61, DOI 10.1016/0092-8674(86)90366-1; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; STREISINGER G, 1966, S QUANT BIOL, V31, P77; Turgay K, 1998, EMBO J, V17, P6730; van der Woude M, 1998, J BACTERIOL, V180, P5913, DOI 10.1128/JB.180.22.5913-5920.1998; van der Woude MW, 2008, ANNU REV MICROBIOL, V62, P153, DOI 10.1146/annurev.micro.62.081307.162938; van der Woude MW, 2011, CURR OPIN MICROBIOL, V14, P205, DOI 10.1016/j.mib.2011.01.002; VANDERWOUDE MW, 1992, MOL MICROBIOL, V6, P2429; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P455; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105; WADDINGTON I, 1957, STRATEGY GENES; Waldron DE, 2002, MOL MICROBIOL, V44, P509, DOI 10.1046/j.1365-2958.2002.02905.x; Wallecha A, 2002, J BACTERIOL, V184, P3338, DOI 10.1128/JB.184.12.3338-3347.2002; WANG MX, 1992, NATURE, V360, P606, DOI 10.1038/360606a0; Weyand NJ, 2000, J BIOL CHEM, V275, P3192, DOI 10.1074/jbc.275.5.3192; Weyand NJ, 2001, MOL MICROBIOL, V39, P1504, DOI 10.1046/j.1365-2958.2001.02338.x; White-Ziegler CA, 2000, J BACTERIOL, V182, P6391, DOI 10.1128/JB.182.22.6391-6400.2000; White-Ziegler CA, 1998, MOL MICROBIOL, V28, P1121, DOI 10.1046/j.1365-2958.1998.00872.x; White-Ziegler CA, 2002, J BACTERIOL, V184, P4334, DOI 10.1128/JB.184.16.4334-4342.2002; White-Ziegler CA, 2009, J BACTERIOL, V191, P1106, DOI 10.1128/JB.00599-08; ZIEG J, 1978, CELL, V15, P237, DOI 10.1016/0092-8674(78)90098-3	98	144	150	2	73	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					13929	13935		10.1074/jbc.R113.472274	http://dx.doi.org/10.1074/jbc.R113.472274			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23592777	Green Published, hybrid			2022-12-28	WOS:000319253500001
J	Josekutty, J; Iqbal, J; Iwawaki, T; Kohno, K; Hussain, MM				Josekutty, Joby; Iqbal, Jahangir; Iwawaki, Takao; Kohno, Kenji; Hussain, M. Mahmood			Microsomal Triglyceride Transfer Protein Inhibition Induces Endoplasmic Reticulum Stress and Increases Gene Transcription via Ire1 alpha/cJun to Enhance Plasma ALT/AST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONALCOHOLIC STEATOHEPATITIS; LIVER-DISEASE; RAPID METHOD; CHOLESTEROL; EXPRESSION; GLUTAMINE; SERUM; MICE; HYPERCHOLESTEROLEMIA; AMINOTRANSFERASE	Microsomal triglyceride transfer protein (MTP) is a target to reduce plasma lipids because of its indispensable role in triglyceride-rich lipoprotein biosynthesis. MTP inhibition in Western diet fed mice decreased plasma triglycerides/cholesterol, whereas increasing plasma alanine/aspartate aminotransferases (ALT/AST) and hepatic triglycerides/free cholesterol. Free cholesterol accumulated in the endoplasmic reticulum (ER) and mitochondria resulting in ER and oxidative stresses. Mechanistic studies revealed that MTP inhibition increased transcription of the GPT/GOT1 genes through up-regulation of the IRE1 alpha/cJun pathway leading to increased synthesis and release of ALT1/AST1. Thus, transcriptional up-regulation of GPT/GOT1 genes is a major mechanism, in response to ER stress, elevating plasma transaminases. Increases in plasma and tissue transaminases might represent a normal response to stress for survival.	[Josekutty, Joby] Suny Downstate Med Ctr, Sch Grad Studies, Mol & Cell Biol Program, Brooklyn, NY 11203 USA; [Josekutty, Joby; Iqbal, Jahangir; Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Josekutty, Joby; Iqbal, Jahangir; Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA; [Iwawaki, Takao] Gunma Univ, Adv Sci Res Leaders Dev Unit, Gunma, Japan; [Kohno, Kenji] Nara Inst Sci & Technol, Nara, Japan	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Gunma University; Nara Institute of Science & Technology	Hussain, MM (corresponding author), 450 Clarkson Ave,Box 5, Brooklyn, NY 11203 USA.	Mahmood.Hussain@downstate.edu	Iqbal, Jahangir/B-3903-2014; Kohno, Kenji/AAZ-6573-2020	Iqbal, Jahangir/0000-0002-9021-2271; Kohno, Kenji/0000-0002-3503-6551; Thoppil, Joby/0000-0002-3722-3369	National Institutes of Health Grant [HL095924]; Grants-in-Aid for Scientific Research [24390049] Funding Source: KAKEN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081879] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant HL095924 (to M. M. H.).	Arduino DM, 2009, BMB REP, V42, P719, DOI 10.5483/BMBRep.2009.42.11.719; Athar H, 2004, J LIPID RES, V45, P764, DOI 10.1194/jlr.D300026-JLR200; Bjorkegren J, 2002, J BIOL CHEM, V277, P5476, DOI 10.1074/jbc.M108514200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BURSTEIN M, 1970, J LIPID RES, V11, P583; Chandler CE, 2003, J LIPID RES, V44, P1887, DOI 10.1194/jlr.M300094-JLR200; Chang G, 2002, CURR OPIN DRUG DISC, V5, P562; Cheng SS, 2012, CIRCULATION, V125, P2222, DOI 10.1161/CIRCULATIONAHA.111.067827; Crooke R., 2008, ANTISENSE DRUG TECHN, P614; Cuchel M, 2007, NEW ENGL J MED, V356, P148, DOI 10.1056/NEJMoa061189; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; HONG RW, 1992, ANN SURG, V215, P114, DOI 10.1097/00000658-199202000-00004; Hussain MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-14; Iqbal J, 2008, J BIOL CHEM, V283, P19967, DOI 10.1074/jbc.M800398200; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lee AH, 2009, CELL MOL LIFE SCI, V66, P2835, DOI 10.1007/s00018-009-0049-8; Leibowitz A, 2012, INT J MOL SCI, V13, P10041, DOI 10.3390/ijms130810041; Liao W, 2003, J LIPID RES, V44, P978, DOI 10.1194/jlr.M300020-JLR200; Liu R, 2009, LIVER INT, V29, P337, DOI 10.1111/j.1478-3231.2008.01862.x; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; MCKENNEY JM, 1988, CLIN PHARMACY, V7, P21; Miyazaki Toshiko, 2007, Journal of Toxicological Sciences, V32, P161; Nair S, 2007, TOXICOL LETT, V168, P21, DOI 10.1016/j.toxlet.2006.10.012; Pajor AM, 1999, ANNU REV PHYSIOL, V61, P663, DOI 10.1146/annurev.physiol.61.1.663; Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707; REICHLING JJ, 1988, DIGEST DIS SCI, V33, P1601, DOI 10.1007/BF01535953; Robl JA, 2001, J MED CHEM, V44, P851, DOI 10.1021/jm000494a; Samaha FF, 2008, NAT CLIN PRACT CARD, V5, P497, DOI 10.1038/ncpcardio1250; Sookoian S, 2012, WORLD J GASTROENTERO, V18, P3775, DOI 10.3748/wjg.v18.i29.3775; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SY, 2012, CELL METAB, V16, P473, DOI 10.1016/j.cmet.2012.09.003; Whillier S, 2011, FEBS J, V278, P3152, DOI 10.1111/j.1742-4658.2011.08241.x; Yu XX, 2008, AM J PHYSIOL-ENDOC M, V295, pE436, DOI 10.1152/ajpendo.00629.2007	37	40	42	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14372	14383		10.1074/jbc.M113.459602	http://dx.doi.org/10.1074/jbc.M113.459602			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23532846	Green Published, hybrid			2022-12-28	WOS:000319253500040
J	Burnett, BJ; Altman, RB; Ferrao, R; Alejo, JL; Kaur, N; Kanji, J; Blanchard, SC				Burnett, Benjamin J.; Altman, Roger B.; Ferrao, Ryan; Alejo, Jose L.; Kaur, Navdep; Kanji, Joshua; Blanchard, Scott C.			Elongation Factor Ts Directly Facilitates the Formation and Disassembly of the Escherichia coli Elongation Factor Tu center dot GTP center dot Aminoacyl-tRNA Ternary Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EF-TU; GUANINE-NUCLEOTIDES; CONFORMATIONAL-CHANGE; PROTEIN-BIOSYNTHESIS; BACTERIAL RIBOSOME; KINETIC MECHANISM; CRYSTAL-STRUCTURE; P-LOOP; BINDING; TRANSLATION	Aminoacyl-tRNA enters the translating ribosome in a ternary complex with elongation factor Tu (EF-Tu) and GTP. Here, we describe bulk steady state and pre-steady state fluorescence methods that enabled us to quantitatively explore the kinetic features of Escherichia coli ternary complex formation and decay. The data obtained suggest that both processes are controlled by a nucleotide-dependent, rate-determining conformational change in EF-Tu. Unexpectedly, we found that this conformational change is accelerated by elongation factor Ts (EF-Ts), the guanosine nucleotide exchange factor for EF-Tu. Notably, EF-Ts attenuates the affinity of EF-Tu for GTP and destabilizes ternary complex in the presence of non-hydrolyzable GTP analogs. These results suggest that EF-Ts serves an unanticipated role in the cell of actively regulating the abundance and stability of ternary complex in a manner that contributes to rapid and faithful protein synthesis.	[Burnett, Benjamin J.; Altman, Roger B.; Alejo, Jose L.; Kaur, Navdep; Kanji, Joshua; Blanchard, Scott C.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Ferrao, Ryan; Blanchard, Scott C.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA	Cornell University; Cornell University	Blanchard, SC (corresponding author), Weill Cornell Med Coll, Dept Physiol & Biophys, 1300 York Ave, New York, NY 10065 USA.	scb2005@med.cornell.edu	Blanchard, Scott C./A-5804-2009	Blanchard, Scott C./0000-0003-2717-9365; Alejo, Jose/0000-0002-1952-4109	National Institutes of Health [GM079238, MH099491]; National Science Foundation Faculty Early Career Development Award [MCB-0747230]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH099491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Faculty Early Career Development Award(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants GM079238 and MH099491. This work was also supported by National Science Foundation Faculty Early Career Development Award MCB-0747230.	Abel K, 1996, STRUCTURE, V4, P1153, DOI 10.1016/S0969-2126(96)00123-2; ABRAHAMSON JK, 1985, BIOCHEMISTRY-US, V24, P692, DOI 10.1021/bi00324a023; Altman RB, 2012, NAT METHODS, V9, P68, DOI [10.1038/nmeth.1774, 10.1038/NMETH.1774]; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Bremer H., 1987, ESCHERICHIA COLI SAL, V2, P1527, DOI [10.1046/j.1365-2486.2000.06017.x, DOI 10.1046/J.1365-2486.2000.06017.X]; BUBUNENKO MG, 1992, BIOCHIMIE, V74, P419, DOI 10.1016/0300-9084(92)90081-O; Cai YC, 2000, J BIOL CHEM, V275, P20308, DOI 10.1074/jbc.M001899200; Chapman SJ, 2012, J BIOL CHEM, V287, P1229, DOI 10.1074/jbc.M111.294850; Dahl LD, 2006, J BIOL CHEM, V281, P21139, DOI 10.1074/jbc.M602068200; Dale T., BIOCHEMISTRY, V43, P6159; DELARIA K, 1991, ARCH BIOCHEM BIOPHYS, V286, P207, DOI 10.1016/0003-9861(91)90029-I; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Endo M, 2003, J BIOL CHEM, V278, P843, DOI 10.1074/jbc.M209714200; Fersht A., 1985, ENZYME STRUCTURE MEC; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Geggier P, 2010, J MOL BIOL, V399, P576, DOI 10.1016/j.jmb.2010.04.038; Gonzalez RL, 2007, RNA, V13, P2091, DOI 10.1261/rna.499407; Goodrich J., 2007, BINDING KINETICS MOL; Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w; Gromadski KB, 2007, J BIOL CHEM, V282, P35629, DOI 10.1074/jbc.M707245200; HAZLETT TL, 1989, BIOCHEMISTRY-US, V28, P4109, DOI 10.1021/bi00435a073; HOPFIELD JJ, 1976, P NATL ACAD SCI USA, V73, P1164, DOI 10.1073/pnas.73.4.1164; JANIAK F, 1990, BIOCHEMISTRY-US, V29, P4268, DOI 10.1021/bi00470a002; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; Kothe U, 2006, BIOCHEMISTRY-US, V45, P12767, DOI 10.1021/bi061192z; Kristensen O, 1996, FEBS LETT, V399, P59, DOI 10.1016/S0014-5793(96)01281-1; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Levitus M, 2011, Q REV BIOPHYS, V44, P123, DOI 10.1017/S0033583510000247; LOUIE A, 1985, BIOCHEMISTRY-US, V24, P6433, DOI 10.1021/bi00344a019; MILLER DL, 1970, BIOCHEM BIOPH RES CO, V38, P1016, DOI 10.1016/0006-291X(70)90341-4; MIYAJIMA A, 1978, J BIOCHEM, V83, P453, DOI 10.1093/oxfordjournals.jbchem.a131932; Munro JB, 2010, NAT STRUCT MOL BIOL, V17, P1470, DOI 10.1038/nsmb.1925; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Nissen P, 1996, BIOCHIMIE, V78, P921, DOI 10.1016/S0300-9084(97)86714-4; OTT G, 1989, EUR J BIOCHEM, V184, P345, DOI 10.1111/j.1432-1033.1989.tb15025.x; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Parmeggiani A, 2006, FEBS LETT, V580, P4576, DOI 10.1016/j.febslet.2006.07.039; Parmeggiani A, 2006, BIOCHEMISTRY-US, V45, P6846, DOI 10.1021/bi0525122; PEDERSEN S, 1978, CELL, V14, P179, DOI 10.1016/0092-8674(78)90312-4; PINGOUD A, 1977, EUR J BIOCHEM, V78, P403, DOI 10.1111/j.1432-1033.1977.tb11752.x; PLUMBRIDGE JA, 1980, NUCLEIC ACIDS RES, V8, P827; PODKOWINSKI J, 1989, ACTA BIOCHIM POL, V36, P235; Polekhina G, 1996, STRUCTURE, V4, P1141, DOI 10.1016/S0969-2126(96)00122-0; Rodnina MV, 1999, FEMS MICROBIOL REV, V23, P317, DOI 10.1016/S0168-6445(99)00010-8; Rodnina MV, 2005, FEBS LETT, V579, P938, DOI 10.1016/j.febslet.2004.11.048; RODNINA MV, 1995, EMBO J, V14, P2613, DOI 10.1002/j.1460-2075.1995.tb07259.x; Rodnina MV, 1995, BIOCHEM CELL BIOL, V73, P1221, DOI 10.1139/o95-132; ROMERO G, 1985, J BIOL CHEM, V260, P6167; Sanderson LE, 2007, J MOL BIOL, V368, P119, DOI 10.1016/j.jmb.2007.01.075; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schmitt E, 2012, NAT STRUCT MOL BIOL, V19, P450, DOI 10.1038/nsmb.2259; SCHWARTZBACH CJ, 1991, J BIOL CHEM, V266, P16324; Spahn CMT, 1996, J MOL MED, V74, P423, DOI 10.1007/s001090050044; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Stumber M, 2002, J MOL BIOL, V323, P899, DOI 10.1016/S0022-2836(02)01010-0; Takeshita D, 2012, NAT STRUCT MOL BIOL, V19, P229, DOI 10.1038/nsmb.2204; THOMPSON RC, 1982, J BIOL CHEM, V257, P6677; Urano T, 1996, EMBO J, V15, P810, DOI 10.1002/j.1460-2075.1996.tb00416.x; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vogeley L, 2001, J BIOL CHEM, V276, P17149, DOI 10.1074/jbc.M100017200; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; WATSON BS, 1995, BIOCHEMISTRY-US, V34, P7904, DOI 10.1021/bi00024a015; Weaver R. F., 2007, MOL BIOL; WEISSBACH H, 1972, ARCH BIOCHEM BIOPHYS, V149, P110, DOI 10.1016/0003-9861(72)90304-9; WEISSBACH H, 1970, ARCH BIOCHEM BIOPHYS, V137, P262, DOI 10.1016/0003-9861(70)90433-9; Wieden HJ, 2010, BIOPHYS J, V99, P3735, DOI 10.1016/j.bpj.2010.10.013; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Young TS, 2011, P NATL ACAD SCI USA, V108, P13053, DOI 10.1073/pnas.1110435108	73	26	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13917	13928		10.1074/jbc.M113.460014	http://dx.doi.org/10.1074/jbc.M113.460014			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23539628	Green Published, hybrid			2022-12-28	WOS:000318850300072
J	Jin, TC; Perry, A; Smith, P; Jiang, JS; Xiao, TS				Jin, Tengchuan; Perry, Andrew; Smith, Patrick; Jiang, Jiansheng; Xiao, T. Sam			Structure of the Absent in Melanoma 2 (AIM2) Pyrin Domain Provides Insights into the Mechanisms of AIM2 Autoinhibition and Inflammasome Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; CASPASE ACTIVATION; PROTEIN DOCKING; NMR STRUCTURE; DEATH; FOLD; APOPTOSIS; FAMILY	Absent in melanoma 2 (AIM2) is a cytosolic double-stranded (dsDNA) sensor essential for innate immune responses against DNA viruses and bacteria such as Francisella and Listeria. Upon dsDNA engagement, the AIM2 amino-terminal pyrin domain (PYD) is responsible for downstream signaling to the adapter protein apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) through homotypic PYD-PYD interactions and the assembly of an inflammasome. Toward a better understanding of the AIM2 signaling mechanism, we determined the crystal structure of the human AIM2 PYD. The structure reveals a death domain fold with a short alpha 3 helix that is buttressed by a highly conserved lysine residue at the alpha 2 helix, which may stabilize the alpha 3 helix for potential interaction with partner domains. The surface of the AIM2 PYD exhibits distinct charge distribution with highly acidic alpha 1-alpha 2 helices and highly basic alpha 5-alpha 6 helices. A prominent solvent-exposed hydrophobic patch formed by residues Phe-27 and Phe-28 at the alpha 2 helix resembles a similar surface involved in the death effector domain homotypic interactions. Docking studies suggest that the AIM2 PYD may bind the AIM2 hematopoietic interferon-inducible nuclear (HIN) domain or ASC PYD using overlapping surface near the alpha 2 helix. This may ensure that AIM2 interacts with the downstream adapter ASC only upon release of the autoinhibition by the dsDNA ligand. Our work thus unveils novel structural features of the AIM2 PYD and provides insights into the potential mechanisms of the PYD-HIN and PYD-PYD interactions important for AIM2 autoinhibition and inflammasome assembly.	[Jin, Tengchuan; Perry, Andrew; Smith, Patrick; Jiang, Jiansheng; Xiao, T. Sam] NIAID, NIH, Immunol Lab, Struct Immunobiol Unit, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Xiao, TS (corresponding author), NIAID, NIH, Immunol Lab, Struct Immunobiol Unit, 9000 Rockville Pike, Bethesda, MD 20892 USA.	xiaot@niaid.nih.gov	Jin, Tengchuan/B-5883-2014; Xiao, Tsan/I-7616-2013; Xiao, Tsan Sam/A-8590-2010	Jin, Tengchuan/0000-0002-1395-188X; Xiao, Tsan/0000-0001-9688-475X; Xiao, Tsan Sam/0000-0001-9688-475X; Jiang, Jiansheng/0000-0003-0964-5481	National Institutes of Health grant from the Division of Intramural Research, NIAID; NCI [Y1-CO-1020]; NIGMS, National Institutes of Health [Y1-GM-1104]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000960] Funding Source: NIH RePORTER	National Institutes of Health grant from the Division of Intramural Research, NIAID; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by a National Institutes of Health grant from the Division of Intramural Research, NIAID (to T. S. X.).; We thank Dr. Lars C. Pedersen at the NIEHS, National Institutes of Health for the MBP fusion plasmids, Dr. David S. Waugh at the NCI, National Institutes of Health for the tobacco etch virus protease expression construct, and Dr. Gerhard Wagner at Harvard Medical School for the GB1 encoding plasmid. We thank Dr. Tinghe Wu for help with the ASC PYD expression construct and Dr. D. Eric Anderson at the Mass Spectrometry facility of the NIDDK, National Institutes of Health for technical support. We are grateful to the beam line scientists at the GM/CA-CAT, Advanced Photon Source for support, which is funded in whole or in part with federal funds from the NCI (Grant Y1-CO-1020) and NIGMS (Grant Y1-GM-1104), National Institutes of Health.	Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; Bertin J, 2000, CELL DEATH DIFFER, V7, P1273, DOI 10.1038/sj.cdd.4400774; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cridland JA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-140; de Alba E, 2009, J BIOL CHEM, V284, P32932, DOI 10.1074/jbc.M109.024273; Dombrowski Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002001; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; Eibl C, 2012, BIOCHEMISTRY-US, V51, P7330, DOI 10.1021/bi3007059; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fairbrother WJ, 2001, PROTEIN SCI, V10, P1911, DOI 10.1110/ps.13801; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Ge JN, 2012, P NATL ACAD SCI USA, V109, P6193, DOI 10.1073/pnas.1117490109; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kwon D, 2012, NUCLEIC ACIDS RES, V40, pD331, DOI 10.1093/nar/gkr1149; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Ludlow LEA, 2005, EXP CELL RES, V308, P1, DOI 10.1016/j.yexcr.2005.03.032; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2001, CURR BIOL, V11, pR118, DOI 10.1016/S0960-9822(01)00056-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; Natarajan A, 2006, J BIOL CHEM, V281, P31863, DOI 10.1074/jbc.M605458200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Pawlowski K, 2001, TRENDS BIOCHEM SCI, V26, P85, DOI 10.1016/S0968-0004(00)01729-1; Pinheiro AS, 2011, J MOL BIOL, V413, P790, DOI 10.1016/j.jmb.2011.09.024; Pinheiro AS, 2010, J BIOL CHEM, V285, P27402, DOI 10.1074/jbc.M110.113191; Potter JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-11; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Qi SQ, 2010, CELL, V141, P446, DOI 10.1016/j.cell.2010.03.017; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Staub E, 2001, TRENDS BIOCHEM SCI, V26, P83, DOI 10.1016/S0968-0004(00)01717-5; Sung MW, 2012, ACTA CRYSTALLOGR F, V68, P1081, DOI 10.1107/S174430911203103X; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ullah H, 2008, PROTEIN SCI, V17, P1771, DOI 10.1110/ps.035121.108; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Weber CH, 2001, FEBS LETT, V492, P171, DOI 10.1016/S0014-5793(01)02162-7; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023	60	112	116	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13225	13235		10.1074/jbc.M113.468033	http://dx.doi.org/10.1074/jbc.M113.468033			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23530044	Green Published, hybrid			2022-12-28	WOS:000318850300009
J	Aria, V; De Felice, M; Di Perna, R; Uno, S; Masai, H; Syvaoja, JE; van Loon, B; Hubscher, U; Pisani, FM				Aria, Valentina; De Felice, Mariarita; Di Perna, Roberta; Uno, Shuji; Masai, Hisao; Syvaoja, Juhani E.; van Loon, Barbara; Huebscher, Ulrich; Pisani, Francesca M.			The Human Tim-Tipin Complex Interacts Directly with DNA Polymerase epsilon and Stimulates Its Synthetic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION FORK PROTECTION; SISTER-CHROMATID COHESION; S-PHASE CHECKPOINT; SACCHAROMYCES-CEREVISIAE; EUKARYOTIC DNA; FISSION YEAST; HUMAN CLASPIN; TIMELESS; MRC1; PROTEIN	The Tim-Tipin complex plays an important role in the S phase checkpoint and replication fork stability in metazoans, but the molecular mechanism underlying its biological function is poorly understood. Here, we present evidence that the recombinant human Tim-Tipin complex (and Tim alone) markedly enhances the synthetic activity of DNA polymerase epsilon. In contrast, no significant effect on the synthetic ability of human DNA polymerase alpha and delta by Tim-Tipin was observed. Surface plasmon resonance measurements and co-immunoprecipitation experiments revealed that recombinant DNA polymerase epsilon directly interacts with either Tim or Tipin. In addition, the results of DNA band shift assays suggest that the Tim-Tipin complex (or Tim alone) is able to associate with DNA polymerase epsilon bound to a 40-/80-mer DNA ligand. Our results are discussed in view of the molecular dynamics at the human DNA replication fork.	[Aria, Valentina; De Felice, Mariarita; Di Perna, Roberta; Pisani, Francesca M.] CNR, Ist Biochim Proteine, I-80131 Naples, Italy; [Uno, Shuji; Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Genome Dynam Project, Setagaya Ku, Tokyo 1568506, Japan; [Syvaoja, Juhani E.] Univ Eastern Finland, Inst Biomed, FI-70211 Kuopio, Finland; [van Loon, Barbara; Huebscher, Ulrich] Univ Zurich Irchel, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Tokyo Metropolitan Institute of Medical Science; University of Eastern Finland; University of Zurich	Pisani, FM (corresponding author), CNR, Ist Biochim Proteine, Via P Castellino 111, I-80131 Naples, Italy.	fm.pisani@ibp.cnr.it	Pisani, Francesca M./AAX-4025-2020; van Loon, Barbara/E-6771-2014	van Loon, Barbara/0000-0002-7597-207X	Associazione Italiana per la Ricerca sul Cancro Grant [IG 9087]; European Molecular Biology Organization Short Term Fellowship [ASTF 239.00-2009]; Academy of Finland [123082, 251576]; Swiss National Science Foundation; University of Zurich; Ministry of Education, Culture, Sports, Science, and Technology of Japan [14208079, 17080014]; Grants-in-Aid for Scientific Research [23657081] Funding Source: KAKEN	Associazione Italiana per la Ricerca sul Cancro Grant(Fondazione AIRC per la ricerca sul cancro); European Molecular Biology Organization Short Term Fellowship; Academy of Finland(Academy of Finland); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Associazione Italiana per la Ricerca sul Cancro Grant IG 9087 (to F. M. P.), European Molecular Biology Organization Short Term Fellowship ASTF 239.00-2009 (to V. A.), Academy of Finland Grants 123082 and 251576 (to J. E. S.), Swiss National Science Foundation and University of Zurich grants (to B. v. L. and U. H.), and Ministry of Education, Culture, Sports, Science, and Technology of Japan Grant-in-aid for Scientific Research A 14208079 and Grant-in-aid for Scientific Research on Priority Area Chromosome Cycle 17080014 (to S. U. and H. M.).	Asturias FJ, 2006, NAT STRUCT MOL BIOL, V13, P35, DOI 10.1038/nsmb1040; Bando M, 2009, J BIOL CHEM, V284, P34355, DOI 10.1074/jbc.M109.065730; Branzei D, 2005, CURR OPIN CELL BIOL, V17, P568, DOI 10.1016/j.ceb.2005.09.003; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Chan RC, 2003, NATURE, V423, P1002, DOI 10.1038/nature01697; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Errico A, 2007, P NATL ACAD SCI USA, V104, P14929, DOI 10.1073/pnas.0706347104; Errico A, 2012, CRIT REV BIOCHEM MOL, V47, P222, DOI 10.3109/10409238.2012.655374; Errico A, 2009, EMBO J, V28, P3681, DOI 10.1038/emboj.2009.304; Foss EJ, 2001, GENETICS, V157, P567; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gotter AL, 2000, NAT NEUROSCI, V3, P755, DOI 10.1038/77653; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Hodgson B, 2007, MOL BIOL CELL, V18, P3894, DOI 10.1091/mbc.E07-05-0500; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Lee J, 2005, MOL BIOL CELL, V16, P5269, DOI 10.1091/mbc.E05-07-0671; Lee J, 2003, MOL CELL, V11, P329, DOI 10.1016/S1097-2765(03)00045-5; Li ZX, 2000, P NATL ACAD SCI USA, V97, P10038, DOI 10.1073/pnas.97.18.10038; Lin SY, 2004, P NATL ACAD SCI USA, V101, P6484, DOI 10.1073/pnas.0401847101; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Nedelcheva MN, 2005, J MOL BIOL, V347, P509, DOI 10.1016/j.jmb.2005.01.041; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Petermann E, 2008, MOL BIOL CELL, V19, P2373, DOI 10.1091/mbc.E07-10-1035; Podust VN, 2002, J BIOL CHEM, V277, P3894, DOI 10.1074/jbc.M109684200; Sercin O, 2011, CELL CYCLE, V10, P1599, DOI 10.4161/cc.10.10.15562; Smith-Roe SL, 2011, CELL CYCLE, V10, P1618, DOI 10.4161/cc.10.10.15613; SYVAOJA J, 1990, P NATL ACAD SCI USA, V87, P6664, DOI 10.1073/pnas.87.17.6664; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tanaka T, 2010, J BIOL CHEM, V285, P39609, DOI 10.1074/jbc.M110.173344; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Uno S, 2012, METHODS, V57, P214, DOI 10.1016/j.ymeth.2012.06.016; Uno S, 2011, GENES CELLS, V16, P842, DOI 10.1111/j.1365-2443.2011.01535.x; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; WEISER T, 1991, J BIOL CHEM, V266, P10420; Xiao J, 2003, DEV DYNAM, V228, P82, DOI 10.1002/dvdy.10346; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	40	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12742	12752		10.1074/jbc.M112.398073	http://dx.doi.org/10.1074/jbc.M112.398073			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23511638	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000318555100031
J	Hoffmann-Thoms, S; Weininger, U; Eckert, B; Jakob, RP; Koch, JR; Balbach, J; Schmid, FX				Hoffmann-Thoms, Stephanie; Weininger, Ulrich; Eckert, Barbara; Jakob, Roman P.; Koch, Johanna R.; Balbach, Jochen; Schmid, Franz X.			Initiation of Phage Infection by Partial Unfolding and Prolyl Isomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-TRANS ISOMERIZATION; N-TERMINAL DOMAINS; CRYSTAL-STRUCTURE; PROTEIN; FD; STATE; G3P; GENE-3-PROTEIN; STABILIZATION; CORECEPTOR	Infection of Escherichia coli by the filamentous phage fd starts with the binding of the N2 domain of the phage gene-3-protein to an F pilus. This interaction triggers partial unfolding of the gene-3-protein, cis -> trans isomerization at Pro-213, and domain disassembly, thereby exposing its binding site for the ultimate receptor TolA. The trans-proline sets a molecular timer to maintain the binding-active state long enough for the phage to interact with TolA. We elucidated the changes in structure and local stability that lead to partial unfolding and thus to the activation of the gene-3-protein for phage infection. Protein folding and TolA binding experiments were combined with real-time NMR spectroscopy, amide hydrogen exchange measurements, and phage infectivity assays. In combination, the results provide a molecular picture of how a local unfolding reaction couples with prolyl isomerization not only to generate the activated state of a protein but also to maintain it for an extended time.	[Hoffmann-Thoms, Stephanie; Eckert, Barbara; Jakob, Roman P.; Koch, Johanna R.; Schmid, Franz X.] Univ Bayreuth, Biochem Lab, D-95440 Bayreuth, Germany; [Weininger, Ulrich; Balbach, Jochen] Univ Halle Wittenberg, Biophys & Mitteldeutsches Zentrum Struktur & Dyna, Inst Phys, D-06120 Halle, Germany	University of Bayreuth; Martin Luther University Halle Wittenberg	Balbach, J (corresponding author), Univ Halle Wittenberg, Biophys & Mitteldeutsches Zentrum Struktur & Dyna, Inst Phys, Betty Heinemann Str 7, D-06120 Halle, Germany.	jochen.balbach@physik.uni-halle.de; fx.schmid@uni-bayreuth.de		Jakob, Roman/0000-0002-6451-8656; Weininger, Ulrich/0000-0003-0841-8332	Deutsche Forschungsgemeinschaft [SCHM 444/17-3, BA 1821/5-2]; German Bundesministerium fuer Forschung und Entwicklung [ProNet-T3]; European Union	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Bundesministerium fuer Forschung und Entwicklung; European Union(European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft (SCHM 444/17-3 and BA 1821/5-2) and the German Bundesministerium fuer Forschung und Entwicklung (ProNet-T3).; We thank the members of our groups for many fruitful discussions and Hartmut Oschkinat, Forschungsinstitut fur Molekulare Pharmakologie Berlin, for NMR time at the 900-MHz instrument. Significant investments into the NMR infrastructure from the European Regional Development Fund by the European Union are also gratefully acknowledged.	Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710; Click EM, 1997, J BACTERIOL, V179, P6464, DOI 10.1128/jb.179.20.6464-6471.1997; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Eckert B, 2005, NAT STRUCT MOL BIOL, V12, P619, DOI 10.1038/nsmb946; Eckert B, 2007, J MOL BIOL, V373, P452, DOI 10.1016/j.jmb.2007.07.060; Fischer G, 2004, REV PHYSIOL BIOCH P, V148, P105, DOI 10.1007/s10254-003-0011-3; Holliger P, 1997, STRUCTURE, V5, P265, DOI 10.1016/S0969-2126(97)00184-6; Holliger P, 1999, J MOL BIOL, V288, P649, DOI 10.1006/jmbi.1999.2720; Jakob RP, 2008, J MOL BIOL, V377, P1560, DOI 10.1016/j.jmb.2008.02.010; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Krebber C, 1997, J MOL BIOL, V268, P607, DOI 10.1006/jmbi.1997.0981; Lorenz SH, 2011, J MOL BIOL, V405, P989, DOI 10.1016/j.jmb.2010.11.030; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lubkowski J, 1999, STRUCTURE, V7, P711, DOI 10.1016/S0969-2126(99)80092-6; Lubkowski J, 1998, NAT STRUCT BIOL, V5, P140, DOI 10.1038/nsb0298-140; Martin A, 2003, J MOL BIOL, V328, P863, DOI 10.1016/S0022-2836(03)00359-0; Martin A, 2003, J MOL BIOL, V331, P1131, DOI 10.1016/S0022-2836(03)00864-7; Martin A, 2003, J MOL BIOL, V329, P599, DOI 10.1016/S0022-2836(03)00433-9; MAYR LM, 1993, BIOCHEMISTRY-US, V32, P7994, DOI 10.1021/bi00082a021; Pletneva EV, 2006, J MOL BIOL, V357, P550, DOI 10.1016/j.jmb.2005.12.073; Rakonjac J, 2011, CURR ISSUES MOL BIOL, V13, P51, DOI 10.21775/cimb.013.051; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Riechmann L, 1997, CELL, V90, P351, DOI 10.1016/S0092-8674(00)80342-6; RUSSEL M, 1988, J BACTERIOL, V170, P5312, DOI 10.1128/jb.170.11.5312-5316.1988; Sarkar P, 2007, MOL CELL, V25, P413, DOI 10.1016/j.molcel.2007.01.004; Schwartz TU, 2006, P NATL ACAD SCI USA, V103, P6823, DOI 10.1073/pnas.0602083103; Sieber V, 1998, NAT BIOTECHNOL, V16, P955, DOI 10.1038/nbt1098-955; Thiele A, 2011, J MOL BIOL, V411, P896, DOI 10.1016/j.jmb.2011.06.040; Weininger U, 2009, P NATL ACAD SCI USA, V106, P12335, DOI 10.1073/pnas.0902102106; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	31	11	14	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12979	12991		10.1074/jbc.M112.442525	http://dx.doi.org/10.1074/jbc.M112.442525			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23486474	Green Published, hybrid			2022-12-28	WOS:000318555100051
J	Sharma, M; Celver, J; Octeau, JC; Kovoor, A				Sharma, Meenakshi; Celver, Jeremy; Octeau, J. Christopher; Kovoor, Abraham			Plasma Membrane Compartmentalization of D2 Dopamine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERGENT-RESISTANT MEMBRANES; LIPID RAFTS; G-PROTEIN; SIGNAL-TRANSDUCTION; CELL-MEMBRANES; LIVE CELLS; MICRODOMAINS; DOMAIN; DISSOCIATION; TRAFFICKING	Plasma membrane microcompartments could allow different signaling pathways to operate more efficiently and prevent cross-talk. We utilized a novel in-cell biotin transfer assay to demonstrate that the majority of plasma membrane-expressed D2 dopamine receptor (D2R) is microcompartmentalized within detergent-resistant structures. Conversely, a minority of D2R existed in a detergent-soluble form and interacted in a relatively unrestricted manner with other cellular proteins. The microcompartmentalization of D2R had functional consequences because dopamine-induced internalization of D2R was largely restricted to the compartmentalized receptor. The D2R-containing microcompartments did not correspond to putative detergent-resistant lipid raft structures. First, the detergent-insoluble D2R structures were significantly denser than detergent-resistant membrane fragments containing flotillin, a widely utilized lipid raft marker protein. Second, the detergent solubility of D2R was unaffected by treatment of cells with the cholesterol chelating agent, methyl-beta-cyclodextrin, that is thought to disrupt lipid rafts. Finally, the in-cell biotinylation assay did not provide any evidence for the membrane compartmentalization of peptide motifs thought to target to lipid rafts. Thus, our observations form one of the first demonstrations, in living cells, of plasma membrane microcompartments defined by the ability of the compartment structure to broadly restrict the interaction of resident molecules with other cellular proteins.	[Sharma, Meenakshi; Celver, Jeremy; Octeau, J. Christopher; Kovoor, Abraham] Univ Rhode Isl, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA	University of Rhode Island	Celver, J (corresponding author), Univ Rhode Isl, 7 Green House Rd, Kingston, RI 02881 USA.	jeremy.celver@hotmail.com; abekovoor@uri.edu			National Institutes of Health, NIMH [R15MH091639]; Rhode Island Institutional Development Award (IDeA) Network of Biomedical Research Excellence (INBRE) Award from the National Center for Research Resources (NCRR), National Institutes of Health [P20RR016457-10]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R15MH091639] Funding Source: NIH RePORTER	National Institutes of Health, NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Rhode Island Institutional Development Award (IDeA) Network of Biomedical Research Excellence (INBRE) Award from the National Center for Research Resources (NCRR), National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health, NIMH, Grant R15MH091639 (to A. K. and M. S.) and a Rhode Island Institutional Development Award (IDeA) Network of Biomedical Research Excellence (INBRE) Award, P20RR016457-10, from the National Center for Research Resources (NCRR), National Institutes of Health.	Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Celver J, 2012, J NEUROCHEM, V120, P56, DOI 10.1111/j.1471-4159.2011.07559.x; Celver JP, 2001, J BIOL CHEM, V276, P4894, DOI 10.1074/jbc.M007437200; Chen CA, 2001, ONCOGENE, V20, P1643, DOI 10.1038/sj.onc.1204185; Cho D, 2010, MOL ENDOCRINOL, V24, P574, DOI 10.1210/me.2009-0369; Fernandez-Suarez M, 2008, J AM CHEM SOC, V130, P9251, DOI 10.1021/ja801445p; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Heerklotz H, 2003, J MOL BIOL, V329, P793, DOI 10.1016/S0022-2836(03)00504-7; Ji YY, 2009, P NATL ACAD SCI USA, V106, P19593, DOI 10.1073/pnas.0904289106; Kovoor A, 2005, J NEUROSCI, V25, P2157, DOI 10.1523/JNEUROSCI.2840-04.2005; Krager KJ, 2012, J LIPID RES, V53, P2214, DOI 10.1194/jlr.D026468; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lindner R, 2009, EXP CELL RES, V315, P2871, DOI 10.1016/j.yexcr.2009.07.020; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Parton RG, 2004, TRENDS CELL BIOL, V14, P141, DOI 10.1016/j.tcb.2004.02.001; Patel H. H., 2008, V186, P167, DOI 10.1007/978-3-540-72843-6_7; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Prou D, 2001, J CELL SCI, V114, P3517; Remington G, 2003, J PSYCHIATR NEUROSCI, V28, P275; Ritchie K, 2003, MOL MEMBR BIOL, V20, P13, DOI 10.1080/0968768021000055698; Shaw AS, 2006, NAT IMMUNOL, V7, P1139, DOI 10.1038/ni1405; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Takeuchi Y, 2003, J NEUROCHEM, V85, P1064, DOI 10.1046/j.1471-4159.2003.01763.x; Tanner W, 2011, PLANT CELL, V23, P1191, DOI 10.1105/tpc.111.086249; Tong J, 2008, BIOPHYS J, V94, P125, DOI 10.1529/biophysj.107.110536; Yu JZ, 2002, MOL PHARMACOL, V61, P352, DOI 10.1124/mol.61.2.352; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	40	21	21	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12554	12568		10.1074/jbc.M112.443945	http://dx.doi.org/10.1074/jbc.M112.443945			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23493394	Green Published, hybrid			2022-12-28	WOS:000318555100014
J	Riaz, A; Ilan, N; Vlodavsky, I; Li, JP; Johansson, S				Riaz, Anjum; Ilan, Neta; Vlodavsky, Israel; Li, Jin-Ping; Johansson, Staffan			Characterization of Heparanase-induced Phosphatidylinositol 3-Kinase-AKT Activation and Its Integrin Dependence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; EPIDERMAL-GROWTH-FACTOR; SRC FAMILY KINASES; CELL-MIGRATION; SULFATE PROTEOGLYCANS; CLINICAL-SIGNIFICANCE; AKT PHOSPHORYLATION; SIGNALING PATHWAY; TYROSINE KINASE; TERMINAL DOMAIN	Heparanase functions as a heparan sulfate-degrading enzyme and as a ligand for an unidentified signaling receptor(s). Here, several reactions involved in the activation of the PI3K-AKT pathway by latent heparanase were characterized. Protein suppression using specific siRNAs revealed that heparanase-induced phosphorylation of AKT at Ser-473 was RICTOR-mTOR-dependent, whereas ILK and PAK1/2 were dispensable. p110 alpha was the PI3K catalytic isoform preferred by heparanase for AKT activation and cell proliferation because the p110 alpha inhibitor YM024 blocked these processes. Heparanase-induced AKT phosphorylation was low in mouse embryonic fibroblast cells expressing a RAS interaction-defective p110 alpha compared with wild type cells, indicating that RAS has an important role in the PI3K-AKT activation. The response to heparanase was also inefficient in suspension cultures of several cell lines, suggesting a requirement of integrins in this pathway. Adhesion via either alpha V beta 3 or alpha 5 beta 1 promoted heparanase-induced AKT phosphorylation, and a stronger effect was seen when both integrins were engaged. Simultaneous inhibition of FAK and PYK2 using a chemical inhibitor, or suppression of their expression, inhibited heparanase-induced AKT activation and cell proliferation. Stimulation of cells with heparanase enhanced their resistance against oxidative stress-or growth factor starvation-induced apoptosis. These results demonstrate that there is an intimate crosstalk between the heparanase receptor(s) and integrins during induction of the prosurvival PI3K-AKT pathway by heparanase.	[Riaz, Anjum; Li, Jin-Ping; Johansson, Staffan] Uppsala Univ, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden; [Ilan, Neta; Vlodavsky, Israel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel	Uppsala University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Johansson, S (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr Box 582, S-75123 Uppsala, Sweden.	staffan.johanason@imbim.uu.se			National Institutes of Health from the NCI [CA106456]; Swedish Cancer Foundation; Swedish Childhood Cancer Foundation; Swedish Research Council; NATIONAL CANCER INSTITUTE [R01CA106456] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Cancer Foundation; Swedish Childhood Cancer Foundation(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA106456 from the NCI (to I. V). This work was also supported by grants from the Swedish Cancer Foundation and Swedish Childhood Cancer Foundation (to S. J.) and the Swedish Research Council and Swedish Cancer Foundation (to J.-P. L.)	Astier A, 1997, J BIOL CHEM, V272, P228; Ben-Zaken O, 2007, BIOCHEM BIOPH RES CO, V361, P829, DOI 10.1016/j.bbrc.2007.06.188; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Caporali S, 2008, MOL PHARMACOL, V74, P173, DOI 10.1124/mol.107.044743; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; Cohen-Kaplan V, 2012, J BIOL CHEM, V287, P6668, DOI 10.1074/jbc.M111.271346; Cohen-Kaplan V, 2008, CANCER RES, V68, P10077, DOI 10.1158/0008-5472.CAN-08-2910; Dong LQ, 2005, AM J PHYSIOL-ENDOC M, V289, pE187, DOI 10.1152/ajpendo.00011.2005; Edin ML, 2005, MOL CELL BIOL, V25, P4466, DOI 10.1128/MCB.25.11.4466-4475.2005; Edmondson JM., 1988, J TISSUE CULT METHOD, V11, P15, DOI DOI 10.1007/BF01404408; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Fux L, 2009, CANCER RES, V69, P1758, DOI 10.1158/0008-5472.CAN-08-1837; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P44084, DOI 10.1074/jbc.M402131200; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Gohji K, 2001, J UROLOGY, V166, P1286, DOI 10.1016/S0022-5347(05)65754-0; Goldschmidt O, 2003, FASEB J, V17, P1015, DOI 10.1096/fj.02-0773com; Gopal S, 2010, J BIOL CHEM, V285, P14247, DOI 10.1074/jbc.M109.056945; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Ivaska J, 2011, ANNU REV CELL DEV BI, V27, P291, DOI 10.1146/annurev-cellbio-092910-154017; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Maeda T, 2006, ONCOGENE, V25, P1408, DOI 10.1038/sj.onc.1209168; McDonald PC, 2008, CANCER RES, V68, P1618, DOI 10.1158/0008-5472.CAN-07-5869; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Pellinen T, 2008, DEV CELL, V15, P371, DOI 10.1016/j.devcel.2008.08.001; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Riaz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032081; Rohloff J, 2002, BRIT J CANCER, V86, P1270, DOI 10.1038/sj.bjc.6600232; Salazar EP, 2001, J BIOL CHEM, V276, P17788, DOI 10.1074/jbc.M100984200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shinyo Y, 2003, ANN ONCOL, V14, P1505, DOI 10.1093/annonc/mdg407; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Svineng G, 1998, BIOCHEM J, V330, P1255, DOI 10.1042/bj3301255; Takaoka M, 2003, LAB INVEST, V83, P613, DOI 10.1097/01.LAB.0000067482.84946.BD; Velling T, 2008, EXP CELL RES, V314, P309, DOI 10.1016/j.yexcr.2007.08.018; Vlodavsky I, 2012, CANCER MICROENVIRON, V5, P115, DOI 10.1007/s12307-011-0082-7; Vreys V, 2005, J BIOL CHEM, V280, P33141, DOI 10.1074/jbc.M503007200; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Xian XJ, 2010, CELL TISSUE RES, V339, P31, DOI 10.1007/s00441-009-0829-3; Zeller KS, 2010, CELL SIGNAL, V22, P1838, DOI 10.1016/j.cellsig.2010.07.011; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zetser A, 2003, CANCER RES, V63, P7733; Zheng CH, 1998, J BIOL CHEM, V273, P2384, DOI 10.1074/jbc.273.4.2384	54	46	51	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12366	12375		10.1074/jbc.M112.435172	http://dx.doi.org/10.1074/jbc.M112.435172			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504323	hybrid, Green Published			2022-12-28	WOS:000318157600067
J	Fonvielle, M; Le Du, MH; Lequin, O; Lecoq, A; Jacquet, M; Thai, R; Dubois, S; Grach, G; Gondry, M; Belin, P				Fonvielle, Matthieu; Le Du, Marie-Helene; Lequin, Olivier; Lecoq, Alain; Jacquet, Mickael; Thai, Robert; Dubois, Steven; Grach, Guillaume; Gondry, Muriel; Belin, Pascal			Substrate and Reaction Specificity of Mycobacterium tuberculosis Cytochrome P450 CYP121 INSIGHTS FROM BIOCHEMICAL STUDIES AND CRYSTAL STRUCTURES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDE-CHAIN; HYDROXYLATION; TRYPTOPHAN; BENZENE; PHENOL; IDENTIFICATION; METABOLISM; MECHANISM; P450; DIKETOPIPERAZINES	Cytochrome P450 CYP121 is essential for the viability of Mycobacterium tuberculosis. Studies in vitro show that it can use the cyclodipeptide cyclo(L-Tyr-L-Tyr) (cYY) as a substrate. We report an investigation of the substrate and reaction specificities of CYP121 involving analysis of the interaction between CYP121 and 14cYY analogues with various modifications of the side chains or the diketopiperazine (DKP) ring. Spectral titration experiments show that CYP121 significantly bound only cyclodipeptides with a conserved DKP ring carrying two aryl side chains in L-configuration. CYP121 did not efficiently or selectively transform any of the cYY analogues tested, indicating a high specificity for cYY. The molecular determinants of this specificity were inferred from both crystal structures of CYP121-analog complexes solved at high resolution and solution NMR spectroscopy of the analogues. Bound cYY or its analogues all displayed a similar set of contacts with CYP121 residues Asn(85), Phe(168), and Trp(182). The propensity of the cYY tyrosyl to point toward Arg(386) was dependent on the presence of the DKP ring that limits the conformational freedom of the ligand. The correct positioning of the hydroxyl of this tyrosyl was essential for conversion of cYY. Thus, the specificity of CYP121 results from both a restricted binding specificity and a fine-tuned P450 substrate relationship. These results document the catalytic mechanism of CYP121 and improve our understanding of its function in vivo. This work contributes to progress toward the design of inhibitors of this essential protein of M. tuberculosis that could be used for antituberculosis therapy.	[Dubois, Steven; Grach, Guillaume; Gondry, Muriel; Belin, Pascal] Commissariat Energie Atom & Energies Alternat CEA, iBiTec S, Serv Ingn Mol Prot, F-91191 Gif Sur Yvette, France; [Le Du, Marie-Helene] CEA, iBiTec S, Serv Bioenerget Biol Struct & Mecanismes, Lab Biol Struct & Radiobiol, F-91191 Gif Sur Yvette, France; [Lequin, Olivier] Univ Paris 06, UMR CNRS UPMC ENS 7203, Lab Biomol, F-75252 Paris 05, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Belin, P (corresponding author), Commissariat Energie Atom & Energies Alternat CEA, iBiTec S, Serv Ingn Mol Prot, F-91191 Gif Sur Yvette, France.	pascal.belin@cea.fr	Belin, Pascal/C-6247-2009; Fonvielle, Matthieu/G-5644-2015	Belin, Pascal/0000-0002-7578-6365; Fonvielle, Matthieu/0000-0002-8013-8311; LEQUIN, Olivier/0000-0001-5307-3068; Thai, Robert/0000-0001-9438-4225; Gondry, Muriel/0000-0003-0398-3404	Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA); CNRS; Region Ile-de-France; CEA postdoctoral fellowship; Region Ile-de-France postdoctoral fellowship	Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA)(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Ile-de-France(Region Ile-de-France); CEA postdoctoral fellowship; Region Ile-de-France postdoctoral fellowship(Region Ile-de-France)	This work was supported by the Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA), CNRS, and grants from the Region Ile-de-France. The Service d'Ingenierie Moleculaire des Proteines is a member of the Laboratory of Excellence LERMIT.; Recipient of a CEA postdoctoral fellowship. Present address: Centre de Recherche des Cordeliers, LRMA, Equipe 12, Universite Pierre et Marie Curie-Paris 6, UMR S 872, Paris, F-75006 France.; Recipient of a Region Ile-de-France postdoctoral fellowship.	Ahmad Z, 2005, FEMS MICROBIOL LETT, V251, P19, DOI 10.1016/j.femsle.2005.07.022; Ahmad Z, 2006, INT J ANTIMICROB AG, V28, P543, DOI 10.1016/j.ijantimicag.2006.07.028; Belin P, 2012, NAT PROD REP, V29, P961, DOI 10.1039/c2np20010d; Belin P, 2009, P NATL ACAD SCI USA, V106, P7426, DOI 10.1073/pnas.0812191106; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Bogatcheva E, 2006, J MED CHEM, V49, P3045, DOI 10.1021/jm050948+; BORCH RF, 1971, J AM CHEM SOC, V93, P2897, DOI 10.1021/ja00741a013; Bricogne G, 2009, BUSTER VERSION 2 8 0; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coon MJ, 2005, ANNU REV PHARMACOL, V45, P1, DOI 10.1146/annurev.pharmtox.45.120403.100030; de Visser SP, 2003, J AM CHEM SOC, V125, P7413, DOI 10.1021/ja034142f; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gondry M, 2009, NAT CHEM BIOL, V5, P414, DOI 10.1038/nchembio.175; GROSSWEINER LI, 1984, CURR EYE RES, V3, P137, DOI 10.3109/02713688408997195; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; Horton DA, 2000, MOL DIVERS, V5, P289, DOI 10.1023/A:1021365402751; Hudson SA, 2012, ANGEW CHEM INT EDIT, V51, P9311, DOI 10.1002/anie.201202544; Huynh MHV, 2007, CHEM REV, V107, P5004, DOI 10.1021/cr0500030; JAYSON GG, 1954, BIOCHEM J, V57, P386, DOI 10.1042/bj0570386; Jeedigunta S, 2000, TETRAHEDRON, V56, P3303, DOI 10.1016/S0040-4020(00)00249-0; Jung C., 2007, UBIQUITOUS ROLES CYT, V3, P187, DOI 10.1002/9780470028155.ch7/summary; KELL G, 1990, J FOOD SCI, V55, P1120, DOI 10.1111/j.1365-2621.1990.tb01613.x; KOOP DR, 1989, TOXICOL APPL PHARM, V98, P278, DOI 10.1016/0041-008X(89)90233-0; KOPPLE KD, 1967, J AM CHEM SOC, V89, P6193, DOI 10.1021/ja01000a035; KORZEKWA KR, 1989, BIOCHEMISTRY-US, V28, P9019, DOI 10.1021/bi00449a010; Leys D, 2003, J BIOL CHEM, V278, P5141, DOI 10.1074/jbc.M209928200; MARTINEZ J, 1985, J MED CHEM, V28, P1874, DOI 10.1021/jm00150a020; MASKOS Z, 1992, ARCH BIOCHEM BIOPHYS, V296, P514, DOI 10.1016/0003-9861(92)90605-V; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; McLean KJ, 2002, MICROBIOL-SGM, V148, P2937, DOI 10.1099/00221287-148-10-2937; McLean KJ, 2002, J INORG BIOCHEM, V91, P527, DOI 10.1016/S0162-0134(02)00479-8; Mizutani H, 2005, SYNLETT, P328, DOI 10.1055/s-2004-836065; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson David R., 2009, Human Genomics, V4, P59; Ortiz de Montellano P.R., 2005, CYTOCHROME P450 STRU, P183, DOI [10.1007/b139087, DOI 10.1007/B139087]; Pochapsky TC, 2010, ANTIOXID REDOX SIGN, V13, P1273, DOI 10.1089/ars.2010.3109; Powley MW, 2001, TOXICOL LETT, V125, P117, DOI 10.1016/S0378-4274(01)00441-6; RAAG R, 1989, BIOCHEMISTRY-US, V28, P917, DOI 10.1021/bi00428a077; RAAG R, 1991, BIOCHEMISTRY-US, V30, P2674, DOI 10.1021/bi00224a016; Roback P, 2007, NUCLEIC ACIDS RES, V35, P5085, DOI 10.1093/nar/gkm518; SCHLOSSER PM, 1993, CARCINOGENESIS, V14, P2477, DOI 10.1093/carcin/14.12.2477; Schmidt JM, 2007, J BIOMOL NMR, V37, P287, DOI 10.1007/s10858-006-9140-8; Simat TJ, 1998, J AGR FOOD CHEM, V46, P490, DOI 10.1021/jf970818c; Stiborova M, 2003, GEN PHYSIOL BIOPHYS, V22, P167; UCHIDA K, 1990, ARCH BIOCHEM BIOPHYS, V279, P14, DOI 10.1016/0003-9861(90)90456-9; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van den Boogaard J, 2009, ANTIMICROB AGENTS CH, V53, P849, DOI 10.1128/AAC.00749-08; Vetting MW, 2010, NAT CHEM BIOL, V6, P797, DOI 10.1038/NCHEMBIO.440; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	51	36	40	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17347	17359		10.1074/jbc.M112.443853	http://dx.doi.org/10.1074/jbc.M112.443853			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23620594	Green Published, hybrid			2022-12-28	WOS:000320380600028
J	Rehault-Godbert, S; Labas, V; Helloin, E; Herve-Grepinet, V; Slugocki, C; Berges, M; Bourin, MC; Brionne, A; Poirier, JC; Gautron, J; Coste, F; Nys, Y				Rehault-Godbert, Sophie; Labas, Valerie; Helloin, Emmanuelle; Herve-Grepinet, Virginie; Slugocki, Cindy; Berges, Magali; Bourin, Marie-Christine; Brionne, Aurelien; Poirier, Jean-Claude; Gautron, Joel; Coste, Franck; Nys, Yves			Ovalbumin-related Protein X Is a Heparin-binding Ov-Serpin Exhibiting Antimicrobial Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGG-WHITE PROTEOME; HEN EGG; CHICK OVIDUCT; GENE FAMILY; COFACTOR-II; IDENTIFICATION; INHIBITION; EVOLUTION; SEQUENCE; PEPTIDE	Ovalbumin family contains three proteins with high sequence similarity: ovalbumin, ovalbumin-related protein Y (OVAY), and ovalbumin-related protein X (OVAX). Ovalbumin is the major egg white protein with still undefined function, whereas the biological activity of OVAX and OVAY has not yet been explored. Similar to ovalbumin and OVAY, OVAX belongs to the ovalbumin serine protease inhibitor family (ov-serpin). We show that OVAX is specifically expressed by the magnum tissue, which is responsible for egg white formation. OVAX is also the main heparin-binding protein of egg white. This glycoprotein with a predicted reactive site at Lys(367)-His(368) is not able to inhibit trypsin, plasmin, or cathepsin G with or without heparin as a cofactor. Secondary structure of OVAX is similar to that of ovalbumin, but the three-dimensional model of OVAX reveals the presence of a cluster of exposed positive charges, which potentially explains the affinity of this ov-serpin for heparin, as opposed to ovalbumin. Interestingly, OVAX, unlike ovalbumin, displays antibacterial activities against both Listeria monocytogenes and Salmonella enterica sv. Enteritidis. These properties partly involve heparin-binding site(s) of the molecule as the presence of heparin reverses its anti-Salmonella but not its anti-Listeria potential. Altogether, these results suggest that OVAX and ovalbumin, although highly similar in sequence, have peculiar sequential and/or structural features that are likely to impact their respective biological functions.	[Rehault-Godbert, Sophie; Berges, Magali; Brionne, Aurelien; Poirier, Jean-Claude; Gautron, Joel; Nys, Yves] INRA, Rech Avicoles Fonct & Regulat Prot CEuF UR83, F-37380 Nouzilly, France; [Labas, Valerie] INRA, Physiol Reprod & Comportements UMR85, Lab Spectrometrie Masse & Sequencage, F-37380 Nouzilly, France; [Helloin, Emmanuelle; Slugocki, Cindy] INRA, ISP311, UMR1282, Ctr Int Ressources Microbiennes Bacteries Pathoge, F-37380 Nouzilly, France; [Herve-Grepinet, Virginie] Ctr Etud Pathol Resp, EA 6305, UMR 1100, INSERM, F-37032 Tours, France; [Bourin, Marie-Christine] Inst Tech Aviculture, Rech Avicoles UR83, F-37380 Nouzilly, France; [Coste, Franck] Ctr Biophys Mol, UPR4301, CNRS, F-45071 Orleans, France	INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Rehault-Godbert, S (corresponding author), INRA, Rech Avicoles Fonct & Regulat Prot CEuF UR83, F-37380 Nouzilly, France.	srehault@tours.inra.fr	GAUTRON, Joël/A-1753-2017; coste, franck/ABC-1407-2020; REHAULT-GODBERT, Sophie/Y-3890-2019; coste, franck/F-6832-2015; BOURIN, Marie/AAV-5212-2021	GAUTRON, Joël/0000-0001-7800-0578; coste, franck/0000-0002-7409-0470; coste, franck/0000-0002-7409-0470; BOURIN, Marie/0000-0002-1222-5325; Rehault-Godbert, Sophie/0000-0003-2800-3417	National French Agency (OVO-mining) [ANR-09-BLAN-0136-01]; European Commission ("Reducing Egg Susceptibility to Contamination in Avian Production in Europe,") [FOOD-CT-2006-036018]	National French Agency (OVO-mining); European Commission ("Reducing Egg Susceptibility to Contamination in Avian Production in Europe,")	This work was supported by the National French Agency (OVO-mining, ANR-09-BLAN-0136-01) and the European Commission ("Reducing Egg Susceptibility to Contamination in Avian Production in Europe," FOOD-CT-2006-036018).	Albrecht MT, 2002, RESPIR RES, V3, DOI 10.1186/rr167; Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Baranger K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020976; Belleannee C, 2011, PROTEOMICS, V11, P1952, DOI 10.1002/pmic.201000662; Benarafa C, 2005, P NATL ACAD SCI USA, V102, P11367, DOI 10.1073/pnas.0502934102; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bourin M, 2012, POULTRY SCI, V91, P2288, DOI 10.3382/ps.2011-01910; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; COLBERT DA, 1980, BIOCHEMISTRY-US, V19, P5586, DOI 10.1021/bi00565a020; D'Ambrosio C, 2008, J PROTEOME RES, V7, P3461, DOI 10.1021/pr800193y; Fortenberry YM, 2004, J BIOL CHEM, V279, P43237, DOI 10.1074/jbc.M406716200; GREENGARD JS, 1991, THROMB HAEMOSTASIS, V65, P834; HEILIG R, 1982, NUCLEIC ACIDS RES, V10, P4363, DOI 10.1093/nar/10.14.4363; HEILIG R, 1980, CELL, V20, P625, DOI 10.1016/0092-8674(80)90309-8; Herve-Grepinet V, 2010, ANTIMICROB AGENTS CH, V54, P4401, DOI 10.1128/AAC.00204-10; Hirose J, 2006, BIOSCI BIOTECH BIOCH, V70, P144, DOI 10.1271/bbb.70.144; Ito K, 2007, J BIOCHEM, V141, P193, DOI 10.1093/jb/mvm021; Kett WC, 2003, BBA-GEN SUBJECTS, V1620, P225, DOI 10.1016/S0304-4165(02)00539-1; KNOLL BJ, 1981, J BIOL CHEM, V256, P7949; LEE YC, 1962, ARCH BIOCHEM BIOPHYS, V97, P9, DOI 10.1016/0003-9861(62)90037-1; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Malmstrom E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000698; Mann K, 2008, PROTEOMICS, V8, P2322, DOI 10.1002/pmic.200800032; Mann K, 2008, PROTEOMICS, V8, P178, DOI 10.1002/pmic.200700790; Mann K, 2007, PROTEOMICS, V7, P3558, DOI 10.1002/pmic.200700397; MARGALIT H, 1993, J BIOL CHEM, V268, P19228; Meyer-Hoffert U, 2008, FASEB J, V22, P2427, DOI 10.1096/fj.07-103440; Munoz EM, 2004, ARTERIOSCL THROM VAS, V24, P1549, DOI 10.1161/01.ATV.0000137189.22999.3f; Nau F, 2005, J AGR FOOD CHEM, V53, P2158, DOI 10.1021/jf048369l; Nys Y, 2011, WOODHEAD PUBL FOOD S, P83; PALMITER RD, 1978, P NATL ACAD SCI USA, V75, P94, DOI 10.1073/pnas.75.1.94; PALMITER RD, 1972, J BIOL CHEM, V247, P6450; PROCTOR VA, 1988, CRC CR REV FOOD SCI, V26, P359, DOI 10.1080/10408398809527473; Rehault SM, 2005, BBA-PROTEINS PROTEOM, V1748, P57, DOI 10.1016/j.bbapap.2004.12.003; Rehault-Godbert S., 2011, Pat., Patent No. [WO/ 2011/ 151407, 2011151407]; Rehault-Godbert S, 2008, J AGR FOOD CHEM, V56, P6294, DOI 10.1021/jf8003948; REMOLDODONNELL E, 1993, FEBS LETT, V315, P105, DOI 10.1016/0014-5793(93)81143-N; ROGERS SJ, 1992, J BIOL CHEM, V267, P3613; Sava G, 1996, EXS, V75, P433; Schick C, 1998, BIOCHEMISTRY-US, V37, P5258, DOI 10.1021/bi972521d; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shinohara H, 2007, BBA-GEN SUBJECTS, V1770, P5, DOI 10.1016/j.bbagen.2006.06.019; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Tian X, 2010, BIOL REPROD, V83, P893, DOI 10.1095/biolreprod.110.085019	44	53	54	8	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17285	17295		10.1074/jbc.M113.469759	http://dx.doi.org/10.1074/jbc.M113.469759			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23615912	Green Published, hybrid			2022-12-28	WOS:000320380600024
J	Abbonante, V; Gruppi, C; Rubel, D; Gross, O; Moratti, R; Balduini, A				Abbonante, Vittorio; Gruppi, Cristian; Rubel, Diana; Gross, Oliver; Moratti, Remigio; Balduini, Alessandra			Discoidin Domain Receptor 1 Protein Is a Novel Modulator of Megakaryocyte-Collagen Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; TYROSINE KINASE; PROPLATELET FORMATION; EXTRACELLULAR-MATRIX; BONE-MARROW; GLYCOPROTEIN VI; MYOSIN IIA; IN-VITRO; MIGRATION; ACTIVATION	Growing evidence demonstrates that extracellular matrices regulate many aspects of megakaryocyte (MK) development; however, among the different extracellular matrix receptors, integrin alpha 2 beta 1 and glycoprotein VI are the only collagen receptors studied in platelets and MKs. In this study, we demonstrate the expression of the novel collagen receptor discoidin domain receptor 1 (DDR1) by human MKs at both mRNA and protein levels and provide evidence of DDR1 involvement in the regulation of MK motility on type I collagen through a mechanism based on the activity of SHP1 phosphatase and spleen tyrosine kinase (Syk). Specifically, we demonstrated that inhibition of DDR1 binding to type I collagen, preserving the engagement of the other collagen receptors, glycoprotein VI, alpha 2 beta 1, and LAIR-1, determines a decrease in MK migration due to the reduction in SHP1 phosphatase activity and consequent increase in the phosphorylation level of its main substrate Syk. Consistently, inhibition of Syk activity restored MK migration on type I collagen. In conclusion, we report the expression and function of a novel collagen receptor on human MKs, and we point out that an increasing level of complexity is necessary to better understand MK-collagen interactions in the bone marrow environment.	[Abbonante, Vittorio; Gruppi, Cristian; Moratti, Remigio; Balduini, Alessandra] Univ Pavia, IRCCS San Matteo Fdn, Dept Mol Med, Biotechnol Res Labs, I-27100 Pavia, Italy; [Rubel, Diana; Gross, Oliver] Univ Med Ctr Goettingen, Dept Nephrol & Rheumatol, D-37075 Gottingen, Germany; [Balduini, Alessandra] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	IRCCS Fondazione San Matteo; University of Pavia; University of Gottingen; Tufts University	Balduini, A (corresponding author), Univ Pavia, IRCCS San Matteo Fdn, Dept Mol Med, Biotechnol Res Labs, Viale Forlanini 6, I-27100 Pavia, Italy.	alessandra.balduini@unipv.it	BALDUINI, ALESSANDRA/AAC-3363-2022; Balduini, Alessandra/K-6802-2016; Abbonante, Vittorio/AAA-9303-2020; Gross, Oliver/AAR-3936-2021; Abbonante, Vittorio/K-4028-2016	BALDUINI, ALESSANDRA/0000-0003-3145-1245; Balduini, Alessandra/0000-0003-3145-1245; Abbonante, Vittorio/0000-0001-8066-9895; Gross, Oliver/0000-0002-8390-8852; Abbonante, Vittorio/0000-0001-8066-9895	Cariplo Foundation [2010-0807]; Regione Lombardia - Project SAL-45; Almamater Foundation (Pavia); Regione Lombardia Progetto di cooperazione scientifica e tecnologica internazionale; National Institutes of Health Grant [1R01 EB016041-01]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB016041] Funding Source: NIH RePORTER	Cariplo Foundation(Fondazione Cariplo); Regione Lombardia - Project SAL-45(Regione Lombardia); Almamater Foundation (Pavia); Regione Lombardia Progetto di cooperazione scientifica e tecnologica internazionale; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Cariplo Foundation (Grant 2010-0807), Regione Lombardia - Project SAL-45, Almamater Foundation (Pavia), and Regione Lombardia Progetto di cooperazione scientifica e tecnologica internazionale and by National Institutes of Health Grant 1R01 EB016041-01 (to A. B.).	Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Balduini A, 2008, J THROMB HAEMOST, V6, P1900, DOI 10.1111/j.1538-7836.2008.03132.x; Balduini A, 2004, EXP CELL RES, V300, P84, DOI 10.1016/j.yexcr.2004.07.011; Bhatt RS, 2000, GENE DEV, V14, P2216, DOI 10.1101/gad.821600; Chang Y, 2007, BLOOD, V109, P4229, DOI 10.1182/blood-2006-04-020024; Chen Z, 2007, BLOOD, V110, P171, DOI 10.1182/blood-2007-02-071589; Chetoui N, 2011, J CELL BIOCHEM, V112, P3666, DOI 10.1002/jcb.23300; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; Du J, 2011, P NATL ACAD SCI USA, V108, P9466, DOI 10.1073/pnas.1106467108; Dustin LB, 1999, J IMMUNOL, V162, P2717; Finney BA, 2012, BLOOD, V119, P1747, DOI 10.1182/blood-2011-09-380709; Hachehouche LN, 2010, MOL IMMUNOL, V47, P1866, DOI 10.1016/j.molimm.2010.02.023; He L, 2003, BLOOD, V102, P3652, DOI 10.1182/blood-2003-04-1323; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Honorat JF, 2006, BLOOD, V107, P4130, DOI 10.1182/blood-2005-06-2421; Huang Y, 2009, J CELL SCI, V122, P1637, DOI 10.1242/jcs.046219; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kaushansky Kenneth, 2009, Hematology Am Soc Hematol Educ Program, P147, DOI 10.1182/asheducation-2009.1.147; Kim SH, 2007, FREE RADICAL BIO MED, V42, P343, DOI 10.1016/j.freeradbiomed.2006.10.052; Lagrue-Lak-Hal AH, 2001, J BIOL CHEM, V276, P15316, DOI 10.1074/jbc.M009117200; Larson MK, 2006, BLOOD, V108, P1509, DOI 10.1182/blood-2005-11-011957; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Lemeer S, 2012, J PROTEOMICS, V75, P3465, DOI 10.1016/j.jprot.2011.10.007; Li J, 2005, INT J CANCER, V117, P14, DOI 10.1002/ijc.21074; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Loyau S, 2012, ARTERIOSCL THROM VAS, V32, P778, DOI 10.1161/ATVBAHA.111.241067; Lu KK, 2011, CARDIOVASC PATHOL, V20, P71, DOI 10.1016/j.carpath.2009.12.006; Malara A, 2011, BLOOD, V118, P4449, DOI 10.1182/blood-2011-04-345876; Malara A, 2011, BLOOD, V117, P2476, DOI 10.1182/blood-2010-06-288795; Mazharian A, 2010, BLOOD, V116, P793, DOI 10.1182/blood-2010-03-275990; Mazharian A, 2009, EXP HEMATOL, V37, P1238, DOI 10.1016/j.exphem.2009.07.006; Mossuz P, 1997, BRIT J HAEMATOL, V98, P819, DOI 10.1046/j.1365-2141.1997.3013118.x; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Neuhaus B, 2011, CELL MOL LIFE SCI, V68, P3757, DOI 10.1007/s00018-011-0676-8; Nilsson SK, 1998, J HISTOCHEM CYTOCHEM, V46, P371, DOI 10.1177/002215549804600311; Oberoi TK, 2012, EMBO J, V31, P14, DOI 10.1038/emboj.2011.423; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Pasquet JM, 2000, J BIOL CHEM, V275, P28526, DOI 10.1074/jbc.M001531200; Patel SR, 2005, J CLIN INVEST, V115, P3348, DOI 10.1172/JCI26891; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Poole AW, 2005, CELL SIGNAL, V17, P1323, DOI 10.1016/j.cellsig.2005.05.016; Sabri S, 2004, BLOOD, V104, P3117, DOI 10.1182/blood-2003-12-4398; Takaku T, 2010, BLOOD, V116, pE41, DOI 10.1182/blood-2010-02-268466; Tenni R, 2006, MICRON, V37, P640, DOI 10.1016/j.micron.2006.01.011; Vogel W, 1999, FASEB J, V13, pS77, DOI 10.1096/fasebj.13.9001.s77; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; Wang CZ, 2006, MOL BIOL CELL, V17, P2839, DOI 10.1091/mbc.E05-11-1068; Wang L, 2005, CANCER RES, V65, P10289, DOI 10.1158/0008-5472.CAN-05-2231; Xue JN, 2011, BIOCHEM BIOPH RES CO, V405, P128, DOI 10.1016/j.bbrc.2010.12.140; Zou ZY, 2009, BLOOD, V113, P6428, DOI 10.1182/blood-2008-08-175356	50	32	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16738	16746		10.1074/jbc.M112.431528	http://dx.doi.org/10.1074/jbc.M112.431528			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23530036	Green Published, hybrid			2022-12-28	WOS:000320378900048
J	Chen, WZ; Zhou, ZR; Li, LS; Zhong, CQ; Zheng, XR; Wu, XR; Zhang, YY; Ma, H; Huang, DL; Li, WJ; Xia, ZP; Han, JH				Chen, Wanze; Zhou, Zhenru; Li, Lisheng; Zhong, Chuan-Qi; Zheng, Xinru; Wu, Xiurong; Zhang, Yingying; Ma, Huan; Huang, Deli; Li, Wenjuan; Xia, Zongping; Han, Jiahuai			Diverse Sequence Determinants Control Human and Mouse Receptor Interacting Protein 3 (RIP3) and Mixed Lineage Kinase domain-Like (MLKL) Interaction in Necroptotic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED NECROSIS; CELL-DEATH; TNF-ALPHA; INFLAMMATION; APOPTOSIS; PHOSPHORYLATION; MACROPHAGES; DOWNSTREAM; INHIBITION; COMPLEXES	Receptor interacting protein 3 (RIP3) is a protein kinase essential for TNF-induced necroptosis. Phosphorylation on Ser227 in human RIP3 (hRIP3) is required for its interaction with human mixed lineage kinase domain-like (MLKL) in the necrosome, a signaling complex induced by TNF stimulation. RIP1 and RIP3 mediate necrosome aggregation leading to the formation of amyloid-like signaling complexes. We found that TNF induces Thr-231 and Ser-232 phosphorylation in mouse RIP3 (mRIP3) and this phosphorylation is required for mRIP3 to interact with mMLKL. Ser-232 in mRIP3 corresponds to Ser-227 in hRIP3, whereas Thr-231 is not conserved in hRIP3. Although the RIP3-MLKL interaction is required for necroptosis in both human and mouse cells, hRIP3 does not interact with mMLKL and mRIP3 cannot bind to hMLKL. The species specificity of the RIP3-MLKL interaction is primarily determined by the sequence differences in the phosphorylation sites and the flanking sequence around the phosphorylation sites in hRIP3 and mRIP3. It appears that the RIP3-MLKL interaction has been selected as an evolutionarily conserved mechanism in mediating necroptosis signaling despite that differing structural and mechanistic bases for this interaction emerged simultaneously in different organisms. In addition, we further revealed that the interaction of RIP3 with MLKL prevented massive abnormal RIP3 aggregation, and therefore should be crucial for formation of the amyloid signaling complex of necrosomes. We also found that the interaction between RIP3 and MLKL is required for the translocation of necrosomes to mitochondria-associated membranes. Our data demonstrate the importance of the RIP3-MLKL interaction in the formation of functional necrosomes and suggest that translocation of necrosomes to mitochondria-associated membranes is essential for necroptosis signaling.	[Chen, Wanze; Zhou, Zhenru; Li, Lisheng; Zhong, Chuan-Qi; Zheng, Xinru; Wu, Xiurong; Zhang, Yingying; Ma, Huan; Huang, Deli; Li, Wenjuan; Han, Jiahuai] Xiamen Univ, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China; [Chen, Wanze; Zhou, Zhenru; Li, Lisheng; Zhong, Chuan-Qi; Zheng, Xinru; Wu, Xiurong; Zhang, Yingying; Ma, Huan; Huang, Deli; Li, Wenjuan; Han, Jiahuai] Xiamen Univ, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China; [Xia, Zongping] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	Xiamen University; Xiamen University; Zhejiang University	Han, JH (corresponding author), Xiamen Univ, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China.	jhan@xmu.edu.cn	黄, 德力/GWU-7847-2022; Han, J/G-4671-2010; Zhang, Yingying/G-5244-2017	黄, 德力/0000-0002-6989-639X; Chen, Wanze/0000-0002-7946-3336; Li, Lisheng/0000-0002-0793-272X	973 program Grant [2009CB522201]; National Science Foundation of China [91029304, 31221065, 81061160512, 91229201]; 863 program Grant [2012AA02A201]; 111 Project [B12001]; Chinese National Scientific and Technological Major Project Grant [2013ZX10002002]; Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University [SKLCSB2012KF003]	973 program Grant(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 program Grant; 111 Project(Ministry of Education, China - 111 Project); Chinese National Scientific and Technological Major Project Grant; Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University	This work was supported by 973 program Grant 2009CB522201, National Science Foundation of China Grants 91029304, 31221065, 81061160512, 91229201, 863 program Grant 2012AA02A201, 111 Project B12001, Chinese National Scientific and Technological Major Project Grant 2013ZX10002002, and Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University Grant SKLCSB2012KF003.	Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Ciarlo L, 2010, CELL DEATH DIFFER, V17, P1047, DOI 10.1038/cdd.2009.208; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Fortes GB, 2012, BLOOD, V119, P2368, DOI 10.1182/blood-2011-08-375303; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Han JH, 2011, NAT IMMUNOL, V12, P1143, DOI 10.1038/ni.2159; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Liedtke C, 2011, GASTROENTEROLOGY, V141, P2176, DOI 10.1053/j.gastro.2011.08.037; Lin J, 2013, CELL REP, V3, P200, DOI 10.1016/j.celrep.2012.12.012; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Murakami Y, 2012, P NATL ACAD SCI USA, V109, P14598, DOI 10.1073/pnas.1206937109; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wu XR, 2012, MOL CELL PROTEOMICS, V11, P1640, DOI 10.1074/mcp.M112.019091; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	34	179	187	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16247	16261		10.1074/jbc.M112.435545	http://dx.doi.org/10.1074/jbc.M112.435545			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612963	Green Published, hybrid			2022-12-28	WOS:000320378900005
J	Frisz, JF; Klitzing, HA; Lou, KY; Hutcheon, ID; Weber, PK; Zimmerberg, J; Kraft, ML				Frisz, Jessica F.; Klitzing, Haley A.; Lou, Kaiyan; Hutcheon, Ian D.; Weber, Peter K.; Zimmerberg, Joshua; Kraft, Mary L.			Sphingolipid Domains in the Plasma Membranes of Fibroblasts Are Not Enriched with Cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION MASS-SPECTROMETRY; LIPID-MEMBRANES; INFLUENZA-VIRUS; PROTEINS; CELLS; RAFTS; ACTIN; HEMAGGLUTININ; ORGANIZATION; ADHESION	The plasma membranes of mammalian cells are widely expected to contain domains that are enriched with cholesterol and sphingolipids. In this work, we have used high-resolution secondary ion mass spectrometry to directly map the distributions of isotope-labeled cholesterol and sphingolipids in the plasma membranes of intact fibroblast cells. Although acute cholesterol depletion reduced sphingolipid domain abundance, cholesterol was evenly distributed throughout the plasma membrane and was not enriched within the sphingolipid domains. Thus, we rule out favorable cholesterol-sphingolipid interactions as dictating plasma membrane organization in fibroblast cells. Because the sphingolipid domains are disrupted by drugs that depolymerize the cells actin cytoskeleton, cholesterol must instead affect the sphingolipid organization via an indirect mechanism that involves the cytoskeleton.	[Frisz, Jessica F.; Klitzing, Haley A.; Kraft, Mary L.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Lou, Kaiyan; Kraft, Mary L.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Hutcheon, Ian D.; Weber, Peter K.] Lawrence Livermore Natl Lab, Glenn T Seaborg Inst, Livermore, CA 94551 USA; [Zimmerberg, Joshua] Eunice Kennedy Shriver NICHD, Program Phys Biol, NIH, Bethesda, MD 20892 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kraft, ML (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, 600 S Mathews Ave, Urbana, IL 61801 USA.	mlkraft@illinois.edu	Weber, Peter Kilian/AAP-9517-2020	Weber, Peter Kilian/0000-0001-6022-6050	Career Award at the Scientific Interface from the Burroughs Wellcome Fund; NICHD; National Institutes of Health; National Institutes of Health Training Program in the Chemistry-Biology Interface [T32 GM070421]; National Science Foundation [CHE-1058809]; Laboratory Directed Research and Development funding at the Lawrence Livermore National Laboratory; U.S. Department of Energy [DE-AC52-07NA27344]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1058809] Funding Source: National Science Foundation	Career Award at the Scientific Interface from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Program in the Chemistry-Biology Interface(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Laboratory Directed Research and Development funding at the Lawrence Livermore National Laboratory; U.S. Department of Energy(United States Department of Energy (DOE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by a Career Award at the Scientific Interface from the Burroughs Wellcome Fund (to M. L. K.), the Intramural Program of the NICHD, National Institutes of Health, National Institutes of Health Training Program in the Chemistry-Biology Interface T32 GM070421 (to J. F. F.), National Science Foundation Grant CHE-1058809, and Laboratory Directed Research and Development funding at the Lawrence Livermore National Laboratory. Work at the Lawrence Livermore National Laboratory was performed under the auspices of U.S. Department of Energy Contract DE-AC52-07NA27344.	Altelaar AFM, 2006, ANAL CHEM, V78, P734, DOI 10.1021/ac0513111; Anderton CR, 2011, BBA-BIOMEMBRANES, V1808, P307, DOI 10.1016/j.bbamem.2010.09.016; Bezrukov L, 2009, ANAL BIOCHEM, V394, P171, DOI 10.1016/j.ab.2009.07.027; Dondoni A., 2000, ORG SYNTH, V77, P64; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Fan J, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.011908; Fan J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.178102; Frisz JF, 2013, P NATL ACAD SCI USA, V110, pE613, DOI 10.1073/pnas.1216585110; GARNER P, 1988, J ORG CHEM, V53, P4395, DOI 10.1021/jo00253a039; Gheber LA, 1999, BIOPHYS J, V77, P3163, DOI 10.1016/S0006-3495(99)77147-X; Ghosal S, 2008, ANAL CHEM, V80, P5986, DOI 10.1021/ac8006279; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; Hess ST, 2005, J CELL BIOL, V169, P965, DOI 10.1083/jcb.200412058; Klitzing Haley A, 2013, Methods Mol Biol, V950, P483, DOI 10.1007/978-1-62703-137-0_26; Kraft ML, 2006, SCIENCE, V313, P1948, DOI 10.1126/science.1130279; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lavi Y, 2007, BIOPHYS J, V93, pL35, DOI 10.1529/biophysj.107.111567; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; Leslie M, 2011, SCIENCE, V334, P1046, DOI 10.1126/science.334.6059.1046-b; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lozano MM, 2013, J AM CHEM SOC, V135, P5620, DOI 10.1021/ja310831m; Maxfield FR, 2006, CURR OPIN CELL BIOL, V18, P379, DOI 10.1016/j.ceb.2006.06.012; MCKENNIS H, 1948, J BIOL CHEM, V172, P313; McMahon G, 2006, APPL SURF SCI, V252, P6895, DOI 10.1016/j.apsusc.2006.02.170; Norman LL, 2010, CELL MOL BIOENG, V3, P151, DOI 10.1007/s12195-010-0119-x; Polozov IV, 2008, NAT CHEM BIOL, V4, P248, DOI 10.1038/nchembio.77; Ramprasad OG, 2007, CELL MOTIL CYTOSKEL, V64, P199, DOI 10.1002/cm.20176; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Sheng R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2221; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Steinhauser ML, 2012, NATURE, V481, P516, DOI 10.1038/nature10734; Turner MS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.168301; Veatch SL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.148101; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Wilson RL, 2012, BIOCONJUGATE CHEM, V23, P450, DOI 10.1021/bc200482z; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	38	115	117	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16855	16861		10.1074/jbc.M113.473207	http://dx.doi.org/10.1074/jbc.M113.473207			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23609440	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000320378900058
J	Gari, RRS; Frey, NC; Mao, CF; Randall, LL; King, GM				Gari, Raghavendar Reddy Sanganna; Frey, Nathan C.; Mao, Chunfeng; Randall, Linda L.; King, Gavin M.			Dynamic Structure of the Translocon SecYEG in Membrane DIRECT SINGLE MOLECULE OBSERVATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TRANSLOCATION; ESCHERICHIA-COLI; LATERAL GATE; CHANNEL; SECA; COMPLEX; RESOLUTION; ATPASE	Purified SecYEG was reconstituted into liposomes and studied in near-native conditions using atomic force microscopy. These SecYEG proteoliposomes were active in translocation assays. Changes in the structure of SecYEG as a function of time were directly visualized. The dynamics observed were significant in magnitude (similar to 1-10 angstrom) and were attributed to the two large loops of SecY linking transmembrane helices 6-7 and 8-9. In addition, we identified a distribution between monomers and dimers of SecYEG as well as a smaller population of higher order oligomers. This work provides a new vista of the flexible and dynamic structure of SecYEG, an intricate and vital membrane protein.	[Gari, Raghavendar Reddy Sanganna; Frey, Nathan C.; King, Gavin M.] Univ Missouri, Dept Phys & Astron, Columbia, MO 65211 USA; [Mao, Chunfeng; Randall, Linda L.; King, Gavin M.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	King, GM (corresponding author), Univ Missouri, Dept Phys & Astron, 223 Phys Bldg, Columbia, MO 65211 USA.	kinggm@missouri.edu	Frey, Nathan C./M-7197-2019	Frey, Nathan C./0000-0001-5291-6131; King, Gavin/0000-0002-5811-7012	National Science Foundation CAREER Award [1054832]; Burroughs Wellcome Fund Career Award at the Scientific Interface; National Institutes of Health [GM29798]; Hugo Wurdack Trust at the University of Missouri; Div Of Molecular and Cellular Bioscience [1054832] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029798, R37GM029798] Funding Source: NIH RePORTER	National Science Foundation CAREER Award(National Science Foundation (NSF)); Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hugo Wurdack Trust at the University of Missouri; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation CAREER Award 1054832 (to G. M .K.), the Burroughs Wellcome Fund Career Award at the Scientific Interface (to G. M .K.), National Institutes of Health Grant GM29798 (to L. L .R.), and an endowment from the Hugo Wurdack Trust at the University of Missouri.	Bessonneau P, 2002, EMBO J, V21, P995, DOI 10.1093/emboj/21.5.995; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Bippes CA, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/8/086601; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Dalal K, 2012, P NATL ACAD SCI USA, V109, P4104, DOI 10.1073/pnas.1117783109; Deville K, 2011, J BIOL CHEM, V286, P4659, DOI 10.1074/jbc.M110.175638; du Plessis DJF, 2009, J BIOL CHEM, V284, P15805, DOI 10.1074/jbc.M901855200; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Gumbart J, 2007, BIOCHEMISTRY-US, V46, P11147, DOI 10.1021/bi700835d; Howard J., 2001, MECH MOTOR PROTEINS; Kedrov A, 2011, EMBO J, V30, P4387, DOI 10.1038/emboj.2011.314; Luckey M., 2008, MEMBRANE STRUCTURAL; Manting EH, 2000, EMBO J, V19, P852, DOI 10.1093/emboj/19.5.852; Mao CF, 2009, J BACTERIOL, V191, P978, DOI 10.1128/JB.01321-08; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Miyagi A, 2008, CHEMPHYSCHEM, V9, P1859, DOI 10.1002/cphc.200800210; Mori H, 2001, P NATL ACAD SCI USA, V98, P5128, DOI 10.1073/pnas.081617398; Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9; Muller DJ, 1997, BIOPHYS J, V73, P1633, DOI 10.1016/S0006-3495(97)78195-5; Muller DJ, 1998, FEBS LETT, V430, P105, DOI 10.1016/S0014-5793(98)00623-1; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; Richter RP, 2006, LANGMUIR, V22, P3497, DOI 10.1021/la052687c; Rico F, 2011, NANO LETT, V11, P3983, DOI 10.1021/nl202351t; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; Schaap IAT, 2006, BIOPHYS J, V91, P1521, DOI 10.1529/biophysj.105.077826; Scheuring J, 2005, J MOL BIOL, V354, P258, DOI 10.1016/j.jmb.2005.09.058; Scheuring S, 2005, SCIENCE, V309, P484, DOI 10.1126/science.1110879; Scheuring S, 1999, EMBO J, V18, P4981, DOI 10.1093/emboj/18.18.4981; SHIBA K, 1984, EMBO J, V3, P631, DOI 10.1002/j.1460-2075.1984.tb01859.x; Shibata M, 2010, NAT NANOTECHNOL, V5, P208, DOI [10.1038/NNANO.2010.7, 10.1038/nnano.2010.7]; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Todd BA, 2001, SURF SCI, V491, P473, DOI 10.1016/S0039-6028(01)01313-9; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Villarrubia JS, 1997, J RES NATL INST STAN, V102, P425, DOI 10.6028/jres.102.030; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	42	25	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16848	16854		10.1074/jbc.M113.471870	http://dx.doi.org/10.1074/jbc.M113.471870			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23609442	Green Published, hybrid			2022-12-28	WOS:000320378900057
J	Olson, LJ; Orsi, R; Alculumbre, SG; Peterson, FC; Stigliano, ID; Parodi, AJ; D'Alessio, C; Dahms, NM				Olson, Linda J.; Orsi, Ramiro; Alculumbre, Solana G.; Peterson, Francis C.; Stigliano, Ivan D.; Parodi, Armando J.; D'Alessio, Cecilia; Dahms, Nancy M.			Structure of the Lectin Mannose 6-Phosphate Receptor Homology (MRH) Domain of Glucosidase II, an Enzyme That Regulates Glycoprotein Folding Quality Control in the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SUBUNIT; OLIGOSACCHARIDE RECOGNITION; SCHIZOSACCHAROMYCES-POMBE; HUMAN OS-9; PROTEIN; CALNEXIN; GLUCOSYLATION; LOCALIZATION; DEGRADATION; ASSIGNMENT	Here we report for the first time the three-dimensional structure of a mannose 6-phosphate receptor homology (MRH) domain present in a protein with enzymatic activity, glucosidase II (GII). GII is involved in glycoprotein folding in the endoplasmic reticulum. GII removes the two innermost glucose residues from the Glc(3)Man(9)GlcNAc(2) transferred to nascent proteins and the glucose added by UDP-Glc:glycoprotein glucosyltransferase. GII is composed of a catalytic GII alpha subunit and a regulatory GII alpha subunit. GII beta participates in the endoplasmic reticulum localization of GII alpha and mediates in vivo enhancement of N-glycan trimming by GII through its C-terminal MRH domain. We determined the structure of a functional GII alpha MRH domain by NMR spectroscopy. It adopts a beta-barrel fold similar to that of other MRH domains, but its binding pocket is the most shallow known to date as it accommodates a single mannose residue. In addition, we identified a conserved residue outside the binding pocket (Trp-409) present in GII beta but not in other MRHs that influences GII glucose trimming activity.	[Olson, Linda J.; Peterson, Francis C.; Dahms, Nancy M.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Orsi, Ramiro; Alculumbre, Solana G.; Stigliano, Ivan D.; Parodi, Armando J.; D'Alessio, Cecilia] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, RA-1405 Buenos Aires, DF, Argentina; [Orsi, Ramiro; Alculumbre, Solana G.; Stigliano, Ivan D.; Parodi, Armando J.; D'Alessio, Cecilia] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, RA-1405 Buenos Aires, DF, Argentina; [D'Alessio, Cecilia] Univ Buenos Aires, Sch Sci, Buenos Aires, DF, Argentina	Medical College of Wisconsin; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	D'Alessio, C (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, Fdn Inst Leloir, Lab Glycobiol, Av Patricias Argentinas 435,C1405BWE, Buenos Aires, DF, Argentina.	cdalessio@leloir.org.ar; ndahms@mcw.edu		D'Alessio, Cecilia/0000-0001-7371-5080	National Institutes of Health [R01DK042667, GM44500]; Mizutani Foundation for Glycoscience Grant [10-0056]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2010-0734]; Howard Hughes Medical Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP-N824]; University of Buenos Aires [UBACYT-X290]; Advancing a Healthier Wisconsin program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mizutani Foundation for Glycoscience Grant; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires(University of Buenos Aires); Advancing a Healthier Wisconsin program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK042667 (to N. M. D.) and GM44500 (to A. J. P.). This work was also supported by Mizutani Foundation for Glycoscience Grant 10-0056 (to N. M. D.), Agencia Nacional de Promocion Cientifica y Tecnologica Grant PICT 2010-0734 and the Howard Hughes Medical Institute (to A. P.), and Consejo Nacional de Investigaciones Cientificas y Tecnicas Grant PIP-N824 and University of Buenos Aires Grant UBACYT-X290 (to C. D.).; The BIAcore 3000 instrument was purchased through a grant from the Advancing a Healthier Wisconsin program. Acid alpha-glucosidase was generously provided by Dr. William Canfield. We thank Drs. J. J. Caramelo, L. Alonso, and G. Paris from the Fundacion Instituto Leloir for helpful discussions and advice with GII beta purification. UDP-[<SUP>14</SUP>C] Glc was efficiently synthesized by Susana Raffo. We also thank Dr. Jung-Ja Kim for critical reading of the manuscript.	Alfa C., 1993, EXPT FISSION YEAST L, P133; ALLEN HJ, 1976, CARBOHYD RES, V50, P121; Bartels C, 1996, J BIOMOL NMR, V7, P207, DOI 10.1007/BF00202037; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bohnsack RN, 2009, J BIOL CHEM, V284, P35215, DOI 10.1074/jbc.M109.056184; Brown J, 2008, EMBO J, V27, P265, DOI 10.1038/sj.emboj.7601938; Castonguay AC, 2011, BBA-GEN SUBJECTS, V1810, P815, DOI 10.1016/j.bbagen.2011.06.016; Chavez CA, 2007, BIOCHEMISTRY-US, V46, P12604, DOI 10.1021/bi7011806; D'Alessio C, 1999, J BIOL CHEM, V274, P25899, DOI 10.1074/jbc.274.36.25899; D'Alessio C, 2010, SEMIN CELL DEV BIOL, V21, P491, DOI 10.1016/j.semcdb.2009.12.014; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Fernandez F, 1998, EMBO J, V17, P5877, DOI 10.1093/emboj/17.20.5877; FERNANDEZ FS, 1994, J BIOL CHEM, V269, P30701; Fujimori T, 2013, FEBS J, V280, P1563, DOI 10.1111/febs.12157; GRINNA LS, 1980, J BIOL CHEM, V255, P2255; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hancock MK, 2002, J BIOL CHEM, V277, P47205, DOI 10.1074/jbc.M208534200; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Hu D, 2009, GLYCOBIOLOGY, V19, P1127, DOI 10.1093/glycob/cwp104; JANNATIPOUR M, 1995, J BIOL CHEM, V270, P4845, DOI 10.1074/jbc.270.9.4845; Kamiya Y, 2012, BBA-GEN SUBJECTS, V1820, P1327, DOI 10.1016/j.bbagen.2011.12.017; Kim JJP, 2009, CURR OPIN STRUC BIOL, V19, P534, DOI 10.1016/j.sbi.2009.09.002; Kumari M, 2011, PHYS CHEM CHEM PHYS, V13, P6517, DOI 10.1039/c0cp02559c; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Mikami K, 2010, GLYCOBIOLOGY, V20, P310, DOI 10.1093/glycob/cwp175; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Munro S, 2001, CURR BIOL, V11, pR499, DOI 10.1016/S0960-9822(01)00302-5; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Olson LJ, 2010, P NATL ACAD SCI USA, V107, P12493, DOI 10.1073/pnas.1004232107; Olson LJ, 2004, J BIOL CHEM, V279, P34000, DOI 10.1074/jbc.M404588200; Olson LJ, 2004, EMBO J, V23, P2019, DOI 10.1038/sj.emboj.7600215; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Quinn RP, 2009, GLYCOBIOLOGY, V19, P1408, DOI 10.1093/glycob/cwp087; Roberts DL, 1998, CELL, V93, P639, DOI 10.1016/S0092-8674(00)81192-7; Satoh T, 2010, MOL CELL, V40, P905, DOI 10.1016/j.molcel.2010.11.017; Schallus T, 2008, MOL BIOL CELL, V19, P3404, DOI 10.1091/mbc.E08-04-0354; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Stigliano ID, 2011, MOL BIOL CELL, V22, P1810, DOI 10.1091/mbc.E11-01-0019; Stigliano ID, 2009, MOL BIOL CELL, V20, P3974, DOI 10.1091/mbc.E09-04-0316; Totani K, 2008, J AM CHEM SOC, V130, P2101, DOI 10.1021/ja077570k; Totani K, 2006, J BIOL CHEM, V281, P31502, DOI 10.1074/jbc.M605457200; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; TROMBETTA SE, 1989, BIOCHEMISTRY-US, V28, P8108, DOI 10.1021/bi00446a022; Uson I, 2003, ACTA CRYSTALLOGR D, V59, P57, DOI 10.1107/S090744490201884X; Walker JM, 2002, PROTEIN PROTOCOLS HD, P803; Watanabe T, 2009, GLYCOBIOLOGY, V19, P834, DOI 10.1093/glycob/cwp061; Woods RJ, 1998, EUR J BIOCHEM, V258, P372, DOI 10.1046/j.1432-1327.1998.2580372.x; WRIGHT A, 1965, P NATL ACAD SCI USA, V54, P235, DOI 10.1073/pnas.54.1.235	53	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16460	16475		10.1074/jbc.M113.450239	http://dx.doi.org/10.1074/jbc.M113.450239			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23609449	Green Published, hybrid			2022-12-28	WOS:000320378900023
J	Wang, H; Tian, Y; Wang, JR; Phillips, KLE; Binch, ALA; Dunn, S; Cross, A; Chiverton, N; Zheng, ZM; Shapiro, IM; Le Maitre, CL; Risbud, MV				Wang, Hua; Tian, Ye; Wang, Jianru; Phillips, Kate L. E.; Binch, Abbie L. A.; Dunn, Sara; Cross, Alison; Chiverton, Neil; Zheng, Zhaomin; Shapiro, Irving M.; Le Maitre, Christine L.; Risbud, Makarand V.			Inflammatory Cytokines Induce NOTCH Signaling in Nucleus Pulposus Cells IMPLICATIONS IN INTERVERTEBRAL DISC DEGENERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; KAPPA-B ACTIVATION; MATRIX METALLOPROTEINASES; BASIC SCIENCE; FACTOR-ALPHA; BACK-PAIN; TNF-ALPHA; EXPRESSION; PATHWAY; DEGRADATION	The objective of the study was to investigate how inflammatory cytokines, IL-1 beta, and TNF-alpha control NOTCH signaling activity in nucleus pulposus (NP) cells. An increase in expression of selective NOTCH receptors (NOTCH1 and -2), ligand (JAGGED2), and target genes (HES1, HEY1, and HEY2) was observed in NP cells following cytokine treatment. A concomitant increase in NOTCH signaling as evidenced by induction in activity of target gene HES1 and HEY1 promoters and reporter 12xCSL was seen. Moreover, treatment increased activity of a 2-kb NOTCH2 promoter. Treatment of cells with NF-kappa B and MAPK inhibitors abolished the inductive effect of cytokines on NOTCH2 promoter and its expression. Gain and loss-of-function studies confirmed the inductive effect of p65 on NOTCH2 promoter activity. In contrast, p50 blocked the cytokine induction of promoter activity. Supporting promoter studies, lentiviral delivery of sh-p65, and sh-IKK beta significantly decreased cytokine dependent change in NOTCH2 expression. Interestingly, MAPK signaling showed an isoform-specific control of NOTCH2 promoter; p38 alpha/beta 2/delta, ERK1, and ERK2 contributed to cytokine dependent induction, whereas p38 gamma played no role. Analysis of human NP tissues showed that NOTCH1 and -2 and HEY2 expression correlated with each other. Moreover, expression of NOTCH2 and IL-1 beta as well as the number of cells immunopositive for NOTCH2 significantly increased in histologically degenerate discs compared with non-degenerate discs. Taken together, these results explain the observed dysregulated expression of NOTCH genes in degenerative disc disease. Thus, controlling IL-1 beta and TNF-alpha activities during disc disease may restore NOTCH signaling and nucleus pulposus cell function.	[Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Grad Program Cell & Dev Biol, Philadelphia, PA 19107 USA; [Wang, Hua; Zheng, Zhaomin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Orthopaed, Guangzhou 510275, Guangdong, Peoples R China; [Tian, Ye] Second Mil Med Univ, Changzheng Hosp, Dept Orthopaed Surg, Shanghai, Peoples R China; [Phillips, Kate L. E.; Binch, Abbie L. A.; Dunn, Sara; Cross, Alison; Le Maitre, Christine L.] Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England; [Chiverton, Neil] Sheffield Teaching Hosp Natl Hlth Serv Fdn Trust, Sheffield S5 7AU, S Yorkshire, England	Jefferson University; Jefferson University; Sun Yat Sen University; Naval Medical University; Sheffield Hallam University	Risbud, MV (corresponding author), Thomas Jefferson Univ, Dept Orthopaed Surg, 1015 Walnut St,Ste 501 Curtis Bldg, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu		Le Maitre, Christine/0000-0003-4489-7107; Phillips, Kate/0000-0002-6594-2635	National Institutes of Health [AR050087, AR055655]; DISCs grant; Sheffield Hallam University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050087, R01AR055655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DISCs grant; Sheffield Hallam University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants AR050087 and AR055655, a DISCs grant, and a biomedical research PhD studentship from Sheffield Hallam University.	Ahn SH, 2002, SPINE, V27, P911, DOI 10.1097/00007632-200205010-00005; Ando K, 2003, ONCOGENE, V22, P7796, DOI 10.1038/sj.onc.1206965; Blaise R, 2009, ARTHRITIS RHEUM-US, V60, P428, DOI 10.1002/art.24250; Boonyatecha N, 2012, MOL IMMUNOL, V51, P255, DOI 10.1016/j.molimm.2012.03.017; Curry CL, 2007, MOL CANCER THER, V6, P1983, DOI 10.1158/1535-7163.MCT-07-0093; Dong YF, 2010, DEVELOPMENT, V137, P1461, DOI 10.1242/dev.042911; Elsharkawy AM, 2010, J HEPATOL, V53, P519, DOI 10.1016/j.jhep.2010.03.025; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Glossop JR, 2009, GENE EXPR PATTERNS, V9, P381, DOI 10.1016/j.gep.2009.01.001; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hiyama A, 2011, ARTHRITIS RHEUM-US, V63, P1355, DOI 10.1002/art.30246; Hoyland JA, 2008, RHEUMATOLOGY, V47, P809, DOI 10.1093/rheumatology/ken056; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Igarashi T, 2000, SPINE, V25, P2975, DOI 10.1097/00007632-200012010-00003; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Johnston DA, 2009, GENE, V435, P36, DOI 10.1016/j.gene.2009.01.003; Kang JD, 1996, SPINE, V21, P271, DOI 10.1097/00007632-199602010-00003; Karlsson C, 2008, CELLS TISSUES ORGANS, V188, P287, DOI 10.1159/000121610; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Le Maitre CL, 2004, J PATHOL, V204, P47, DOI 10.1002/path.1608; Li HX, 2008, CYTOKINE, V41, P1, DOI 10.1016/j.cyto.2007.09.016; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; Maniadakis N, 2000, PAIN, V84, P95, DOI 10.1016/S0304-3959(99)00187-6; Mead TJ, 2009, P NATL ACAD SCI USA, V106, P14420, DOI 10.1073/pnas.0902306106; Oakley F, 2005, AM J PATHOL, V166, P695, DOI 10.1016/S0002-9440(10)62291-2; Ottaviani S, 2010, ANN RHEUM DIS, V69, P1488, DOI 10.1136/ard.2009.120816; Panzer U, 2009, AM J PHYSIOL-RENAL, V297, pF429, DOI 10.1152/ajprenal.90435.2008; Peng BG, 2009, SPINE, V34, pE178, DOI 10.1097/BRS.0b013e3181908ab3; Pockert AJ, 2009, ARTHRITIS RHEUM-US, V60, P482, DOI 10.1002/art.24291; Richards GS, 2009, COLD SH Q B, V74, P81, DOI 10.1101/sqb.2009.74.028; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; TIAN Y, 2013, AM J PATHOL IN PRESS; Ungerback J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017957; Wang JR, 2013, ARTHRITIS RHEUM-US, V65, P832, DOI 10.1002/art.37819; Wang JR, 2011, J BIOL CHEM, V286, P39738, DOI 10.1074/jbc.M111.264549; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wei ZL, 2011, STROKE, V42, P2589, DOI 10.1161/STROKEAHA.111.614834; Weiler C, 2005, SPINE, V30, P44, DOI 10.1097/01.brs.0000149186.63457.20; Weiler C, 2002, EUR SPINE J, V11, P308, DOI 10.1007/s00586-002-0472-0; Wongchana W, 2012, CELL MOL IMMUNOL, V9, P155, DOI 10.1038/cmi.2011.36; Zhang QH, 2012, J BIOL CHEM, V287, P6208, DOI 10.1074/jbc.M111.310375	42	74	82	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16761	16774		10.1074/jbc.M112.446633	http://dx.doi.org/10.1074/jbc.M112.446633			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23589286	Green Published, hybrid			2022-12-28	WOS:000320378900050
J	Lyukmanova, EN; Shulepko, MA; Buldakova, SL; Kasheverov, IE; Shenkarev, ZO; Reshetnikov, RV; Filkin, SY; Kudryavtsev, DS; Ojomoko, LO; Kryukova, EV; Dolgikh, DA; Kirpichnikov, MP; Bregestovski, PD; Tsetlin, VI				Lyukmanova, Ekaterina N.; Shulepko, Mikhail A.; Buldakova, Svetlana L.; Kasheverov, Igor E.; Shenkarev, Zakhar O.; Reshetnikov, Roman V.; Filkin, Sergey Y.; Kudryavtsev, Denis S.; Ojomoko, Lucy O.; Kryukova, Elena V.; Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.; Bregestovski, Piotr D.; Tsetlin, Victor I.			Water-soluble LYNX1 Residues Important for Interaction with Muscle-type and/or Neuronal Nicotinic Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-BINDING PROTEIN; BACTERIAL EXPRESSION; ALPHA-BUNGAROTOXIN; CRYSTAL-STRUCTURE; NEUROTOXIN II; NAJA-KAOUTHIA; WEAK TOXIN; SNAKE; CHANNEL; COMPLEX	Human LYNX1, belonging to the Ly6/neurotoxin family of three-finger proteins, is membrane-tethered with a glycosylphosphatidylinositol anchor and modulates the activity of nicotinic acetylcholine receptors (nAChR). Recent preparation of LYNX1 as an individual protein in the form of water-soluble domain lacking glycosylphosphatidylinositol anchor (ws-LYNX1; Lyukmanova, E. N., Shenkarev, Z. O., Shulepko, M. A., Mineev, K. S., D'Hoedt, D., Kasheverov, I. E., Filkin, S. Y., Krivolapova, A. P., Janickova, H., Dolezal, V., Dolgikh, D. A., Arseniev, A. S., Bertrand, D., Tsetlin, V. I., and Kirpichnikov, M. P. (2011) NMR structure and action on nicotinic acetylcholine receptors of water-soluble domain of human LYNX1. J. Biol. Chem. 286, 10618-10627) revealed the attachment at the agonist-binding site in the acetylcholine-binding protein (AChBP) and muscle nAChR but outside it, in the neuronal nAChRs. Here, we obtained a series of ws-LYNX1 mutants (T35A, P36A, T37A, R38A, K40A, Y54A, Y57A, K59A) and examined by radioligand analysis or patch clamp technique their interaction with the AChBP, Torpedo californica nAChR and chimeric receptor composed of the alpha 7 nAChR extracellular ligand-binding domain and the transmembrane domain of alpha 1 glycine receptor (alpha 7-GlyR). Against AChBP, there was either no change in activity (T35A, T37A), slight decrease (K40A, K59A), and even enhancement for the rest mutants (most pronounced for P36A and R38A). With both receptors, many mutants lost inhibitory activity, but the increased inhibition was observed for P36A at alpha 7-GlyR. Thus, there are subtype-specific and common ws-LYNX1 residues recognizing distinct targets. Because ws-LYNX1 was inactive against glycine receptor, its "non-classical" binding sites on alpha 7 nAChR should be within the extracellular domain. Micromolar affinities and fast washout rates measured for ws-LYNX1 and its mutants are in contrast to nanomolar affinities and irreversibility of binding for alpha-bungarotoxin and similar snake alpha-neurotoxins also targeting alpha 7 nAChR. This distinction may underlie their different actions, i.e. nAChRs modulation versus irreversible inhibition, for these two types of three-finger proteins.	[Lyukmanova, Ekaterina N.; Shulepko, Mikhail A.; Kasheverov, Igor E.; Shenkarev, Zakhar O.; Filkin, Sergey Y.; Kudryavtsev, Denis S.; Ojomoko, Lucy O.; Kryukova, Elena V.; Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.; Tsetlin, Victor I.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Buldakova, Svetlana L.; Bregestovski, Piotr D.] Aix Marseille Univ, INSERM, U1106, Brain Dynam Inst, F-13005 Marseille, France; [Shulepko, Mikhail A.; Reshetnikov, Roman V.; Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.] Moscow MV Lomonosov State Univ, Moscow 119991, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Lomonosov Moscow State University	Tsetlin, VI (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, 16-10 Miklukho Maklaya Str, Moscow 117997, Russia.	vits@mx.ibch.ru	Ojomoko, Lucy/ABD-9910-2020; Tsetlin, Victor/X-2491-2018; Dolgikh, Dmitry A/F-2369-2014; Shenkarev, Zakhar O./P-1808-2015; Bregestovski, Piotr/F-5820-2016; Shulepko, Mikhail/N-9124-2016; Reshetnikov, Roman/AAJ-3094-2020; Kudryavtsev, Denis S/O-4811-2015; Lyukmanova, Ekaterina/F-2340-2014; Kasheverov, Igor E/F-6024-2014; Filkin, Sergey/B-9991-2016	Shenkarev, Zakhar O./0000-0003-1383-3522; Reshetnikov, Roman/0000-0002-9661-0254; Kudryavtsev, Denis S/0000-0002-0313-9193; Lyukmanova, Ekaterina/0000-0002-9728-9407; Dolgikh, Dmitry/0000-0002-9880-7202; Shulepko, Mikhail/0000-0002-0436-2127; Filkin, Sergey/0000-0002-4710-6051; Kirpichnikov, Mikhail/0000-0001-8170-1607	Program "Molecular and Cellular Biology" of the Presidium of Russian Academy of Sciences; Russian Foundation for Basic Research [09-04-01567, 11-04-0111, 11-04-12133, 12-04-01639, 12-04-01746]; Ministry of Education and Science of Russia [8268]; Russian Federation [NSh5597.2012.4]; NeuroCypres EU 7th Framework Programme [HEALTH-F4-2008-202088]	Program "Molecular and Cellular Biology" of the Presidium of Russian Academy of Sciences; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of Russia(Ministry of Education and Science, Russian Federation); Russian Federation(Russian Federation); NeuroCypres EU 7th Framework Programme	This work was supported by the Program "Molecular and Cellular Biology" of the Presidium of Russian Academy of Sciences, Russian Foundation for Basic Research Grants 09-04-01567, 11-04-0111, 11-04-12133, 12-04-01639, and 12-04-01746, Ministry of Education and Science of Russia Project 8268, President of the Russian Federation Grant NSh5597.2012.4, and NeuroCypres EU 7th Framework Programme Grant HEALTH-F4-2008-202088.	Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Choo YM, 2008, MOL CELL NEUROSCI, V38, P224, DOI 10.1016/j.mcn.2008.02.011; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; Friis S, 2009, J NEUROSCI METH, V177, P142, DOI 10.1016/j.jneumeth.2008.10.007; Fruchart-Gaillard C, 2002, P NATL ACAD SCI USA, V99, P3216, DOI 10.1073/pnas.042699899; Fu XW, 2012, AM J PHYSIOL-LUNG C, V303, pL661, DOI 10.1152/ajplung.00075.2012; Grutter T, 2005, CR BIOL, V328, P223, DOI 10.1016/j.crvi.2004.11.004; Hruska M, 2009, J NEUROSCI, V29, P14847, DOI 10.1523/JNEUROSCI.2271-09.2009; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kasheverov IE, 2009, J NEUROCHEM, V111, P934, DOI 10.1111/j.1471-4159.2009.06359.x; Kini RM, 2010, TOXICON, V56, P855, DOI 10.1016/j.toxicon.2010.07.010; Krabben L, 2009, J MOL BIOL, V390, P662, DOI 10.1016/j.jmb.2009.05.016; Lesovoy DM, 2009, BIOPHYS J, V97, P2089, DOI 10.1016/j.bpj.2009.07.037; Lyukmanova EN, 2011, J BIOL CHEM, V286, P10618, DOI 10.1074/jbc.M110.189100; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Miwa JM, 2006, NEURON, V51, P587, DOI 10.1016/j.neuron.2006.07.025; Miwa JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043302; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Mordvintsev DY, 2009, FEBS J, V276, P5065, DOI 10.1111/j.1742-4658.2009.07203.x; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; Mukherjee S, 2011, STRUCTURE, V19, P955, DOI 10.1016/j.str.2011.04.006; Nemecz A, 2011, J BIOL CHEM, V286, P42555, DOI 10.1074/jbc.M111.286583; Nirthanan S, 2002, J BIOL CHEM, V277, P17811, DOI 10.1074/jbc.M111152200; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Rayes D, 2005, MOL PHARMACOL, V68, P1475, DOI 10.1124/mol.105.015438; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shulepko MA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P204, DOI 10.1134/S0006297913020090; Shulepko MA, 2011, RUSS J BIOORG CHEM+, V37, P543, DOI 10.1134/S1068162011050165; Tekinay AB, 2009, P NATL ACAD SCI USA, V106, P4477, DOI 10.1073/pnas.0813109106; TREMEAU O, 1995, J BIOL CHEM, V270, P9362, DOI 10.1074/jbc.270.16.9362; Tsetlin VI, 2004, FEBS LETT, V557, P9, DOI 10.1016/S0014-5793(03)01454-6; Tsetlin V, 2009, BIOCHEM PHARMACOL, V78, P720, DOI 10.1016/j.bcp.2009.05.032; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Utkin YN, 2001, J BIOL CHEM, V276, P15810, DOI 10.1074/jbc.M100788200; Waseem T, 2010, J NEUROSCI METH, V193, P14, DOI 10.1016/j.jneumeth.2010.08.002; Wiehe K, 2007, PROTEINS, V69, P719, DOI 10.1002/prot.21747; Young HS, 2003, BIOPHYS J, V85, P943, DOI 10.1016/S0006-3495(03)74533-0	41	40	41	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15888	15899		10.1074/jbc.M112.436576	http://dx.doi.org/10.1074/jbc.M112.436576			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23585571	hybrid, Green Published			2022-12-28	WOS:000319822300042
J	Cuellar, J; Perales-Calvo, J; Muga, A; Valpuesta, JM; Moro, F				Cuellar, Jorge; Perales-Calvo, Judit; Muga, Arturo; Maria Valpuesta, Jose; Moro, Fernando			Structural Insights into the Chaperone Activity of the 40-kDa Heat Shock Protein DnaJ BINDING AND REMODELING OF A NATIVE SUBSTRATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION INITIATOR PROTEIN; ESCHERICHIA-COLI DNAJ; FINGER-LIKE DOMAIN; MINI-F PLASMID; CRYSTAL-STRUCTURE; YEAST HSP40; MOLECULAR CHAPERONE; ELECTRON-MICROSCOPY; PEPTIDE SUBSTRATE; IN-VITRO	Hsp40 chaperones bind and transfer substrate proteins to Hsp70s and regulate their ATPase activity. The interaction of Hsp40s with native proteins modifies their structure and function. A good model for this function is DnaJ, the bacterial Hsp40 that interacts with RepE, the repressor/activator of plasmid F replication, and together with DnaK regulates its function. We characterize here the structure of the DnaJ-RepE complex by electron microscopy, the first described structure of a complex between an Hsp40 and a client protein. The comparison of the complexes of DnaJ with two RepE mutants reveals an intrinsic plasticity of the DnaJ dimer that allows the chaperone to adapt to different substrates. We also show that DnaJ induces conformational changes in dimeric RepE, which increase the intermonomeric distance and remodel both RepE domains enhancing its affinity for DNA.	[Cuellar, Jorge; Maria Valpuesta, Jose] Ctr Nacl Biotecnol CNB CSIC, Dept Estruct Macromol, Madrid 28049, Spain; [Perales-Calvo, Judit; Muga, Arturo; Moro, Fernando] Univ Basque Country, Unidad Biofis, CSIC, UPV EHU, E-48080 Bilbao, Spain; [Perales-Calvo, Judit; Muga, Arturo; Moro, Fernando] Univ Basque Country, Fac Ciencias & Tecnol, Dept Bioquim & Biol Mol, E-48080 Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country	Valpuesta, JM (corresponding author), Ctr Nacl Biotecnol CNB CSIC, Dept Estruct Macromol, Darwin 3, Madrid 28049, Spain.	jmv@cnb.csic.es; fernando.moro@ehu.es	Cuéllar, Jorge/GOH-3100-2022; Cuéllar, Jorge/S-4269-2017; Valpuesta, José M/T-1977-2017; Valpuesta, Jose M/AAA-6002-2019; Muga, Arturo/N-1174-2014; Moro Pérez, Fernando/P-3891-2015	Cuéllar, Jorge/0000-0002-7789-807X; Cuéllar, Jorge/0000-0002-7789-807X; Valpuesta, José M/0000-0001-7468-8053; Muga, Arturo/0000-0003-0345-6882; Moro Pérez, Fernando/0000-0002-3568-3388	Ministerio de Educacion e Innovacion [BFU2010-15443, BFU2010-15703]; University of Basque Country and Gobierno Vasco Grant [IT-358-07]; Comunidad Autonoma de Madrid Grant [S2009MAT-1507]; University of Basque Country (UPV/EHU)	Ministerio de Educacion e Innovacion; University of Basque Country and Gobierno Vasco Grant; Comunidad Autonoma de Madrid Grant; University of Basque Country (UPV/EHU)	This work was supported in part by Ministerio de Educacion e Innovacion Grants BFU2010-15443 (to A. M.) and BFU2010-15703 (to J. M. V.), University of Basque Country and Gobierno Vasco Grant IT-358-07 (to A. M.), and Comunidad Autonoma de Madrid Grant S2009MAT-1507 (to J. M. V.).; Recipient of a postdoctoral fellowship from University of Basque Country (UPV/EHU). Present address: Dept. of Physics and Randall Division of Cell and Molecular Biophysics, King's College London, London WC2R 2LS, United Kingdom.	Ahmad A, 2011, P NATL ACAD SCI USA, V108, P18966, DOI 10.1073/pnas.1111220108; Banecki B, 1996, J BIOL CHEM, V271, P14840, DOI 10.1074/jbc.271.25.14840; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; ISHIAI M, 1994, P NATL ACAD SCI USA, V91, P3839, DOI 10.1073/pnas.91.9.3839; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; KAWASAKI Y, 1990, MOL GEN GENET, V220, P277; KAWASAKI Y, 1992, J BIOL CHEM, V267, P11520; Kim SY, 2002, J BIOL CHEM, V277, P44778, DOI 10.1074/jbc.M206176200; Komori H, 1999, EMBO J, V18, P4597, DOI 10.1093/emboj/18.17.4597; Kota P, 2009, P NATL ACAD SCI USA, V106, P11073, DOI 10.1073/pnas.0900746106; Lee S, 2002, J BIOL CHEM, V277, P21675, DOI 10.1074/jbc.M111075200; Li JZ, 2005, BIOCHEM J, V386, P453, DOI 10.1042/BJ20041050; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Moro F, 2003, FEBS LETT, V533, P119, DOI 10.1016/S0014-5793(02)03752-3; Nakamura A, 2004, BIOCHEM BIOPH RES CO, V315, P10, DOI 10.1016/j.bbrc.2004.01.018; Nakamura A, 2007, P NATL ACAD SCI USA, V104, P18484, DOI 10.1073/pnas.0705623104; Perales-Calvo J, 2010, J BIOL CHEM, V285, P34231, DOI 10.1074/jbc.M110.144642; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Puvirajesinghe TM, 2012, J BIOL CHEM, V287, P14169, DOI 10.1074/jbc.M111.331462; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; Shi YY, 2005, J BIOL CHEM, V280, P22761, DOI 10.1074/jbc.M503643200; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; WICKNER SH, 1990, P NATL ACAD SCI USA, V87, P2690, DOI 10.1073/pnas.87.7.2690; Wu YK, 2005, J MOL BIOL, V346, P1005, DOI 10.1016/j.jmb.2004.12.040; ZYLICZ M, 1985, J BIOL CHEM, V260, P7591; Zzaman S, 2005, MOL CELL, V20, P833, DOI 10.1016/j.molcel.2005.10.037; Zzaman S, 2004, J BIOL CHEM, V279, P17404, DOI 10.1074/jbc.M400021200	35	19	20	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15065	15074		10.1074/jbc.M112.430595	http://dx.doi.org/10.1074/jbc.M112.430595			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23580641	Green Published, hybrid			2022-12-28	WOS:000319452100036
J	He, M; Tseng, WC; Bennett, V				He, Meng; Tseng, Wei-Chou; Bennett, Vann			A Single Divergent Exon Inhibits Ankyrin-B Association with the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRONCHIAL EPITHELIAL-CELLS; AXON INITIAL SEGMENT; C-TERMINAL DOMAIN; NEONATAL CARDIOMYOCYTES; IN-VIVO; INOSITOL 1,4,5-TRISPHOSPHATE; ISOFORM SPECIFICITY; CARDIAC-ARRHYTHMIA; REGULATORY DOMAIN; LATERAL MEMBRANE	Vertebrate ankyrin-B and ankyrin-G exhibit divergent subcellular localization and function despite their high sequence and structural similarity and common origin from a single ancestral gene at the onset of chordate evolution. Previous studies of ankyrin family diversity have focused on the C-terminal regulatory domain. Here, we identify an ankyrin-B-specific linker peptide connecting the ankyrin repeat domain to the ZU5(2)-UPA module that inhibits binding of ankyrin-B to membrane protein partners E-cadherin and neurofascin 186 and prevents association of ankyrin-B with epithelial lateral membranes as well as neuronal plasma membranes. The residues of the ankyrin-B linker required for autoinhibition are encoded by a small exon that is highly divergent between ankyrin family members but conserved in the ankyrin-B lineage. We show that the ankyrin-B linker suppresses activity of the ANK repeat domain through an intramolecular interaction, likely with a groove on the surface of the ANK repeat solenoid, thereby regulating the affinities between ankyrin-B and its binding partners. These results provide a simple evolutionary explanation for how ankyrin-B and ankyrin-G have acquired striking differences in their plasma membrane association while maintaining overall high levels of sequence similarity.	[He, Meng; Tseng, Wei-Chou] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Bennett, Vann] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Bennett, Vann] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Bennett, Vann] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Bennett, Vann] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University	Bennett, V (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	vann.bennett@duke.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Abdi KM, 2006, J BIOL CHEM, V281, P5741, DOI 10.1074/jbc.M506697200; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Ayalon G, 2008, CELL, V135, P1189, DOI 10.1016/j.cell.2008.10.018; Banik SSR, 2002, MOL CELL BIOL, V22, P6234, DOI 10.1128/MCB.22.17.6234-6246.2002; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; BECK KA, 1994, J CELL BIOL, V127, P707, DOI 10.1083/jcb.127.3.707; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1982, NATURE, V299, P126, DOI 10.1038/299126a0; Bennett V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003012; Cai XJ, 2006, MOL BIOL EVOL, V23, P550, DOI 10.1093/molbev/msj056; Cunha SR, 2008, J MOL CELL CARDIOL, V45, P724, DOI 10.1016/j.yjmcc.2008.08.005; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; DAVIS LH, 1992, J BIOL CHEM, V267, P18966; Davis L, 2009, J BIOL CHEM, V284, P6982, DOI 10.1074/jbc.M809245200; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; HALL TG, 1987, J BIOL CHEM, V262, P10537; He M, 2012, J BIOL CHEM, V287, P43995, DOI 10.1074/jbc.M112.417501; Healy JA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000771; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Jenkins SM, 2002, P NATL ACAD SCI USA, V99, P2303, DOI 10.1073/pnas.042601799; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Kizhatil K, 2009, SCIENCE, V323, P1614, DOI 10.1126/science.1169789; Kizhatil K, 2009, EXP EYE RES, V88, P55, DOI 10.1016/j.exer.2008.09.022; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; LEVINE J, 1981, J CELL BIOL, V90, P631, DOI 10.1083/jcb.90.3.631; LIN HF, 1994, DEVELOPMENT, V120, P947; Lonergan KM, 1998, MOL CELL BIOL, V18, P732, DOI 10.1128/MCB.18.2.732; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; MARSILIO E, 1991, J VIROL, V65, P5647, DOI 10.1128/JVI.65.10.5647-5652.1991; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Mohler PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001051; Mohler PJ, 2007, CIRCULATION, V115, P432, DOI 10.1161/CIRCULATIONAHA.106.656512; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mohler PJ, 2004, J BIOL CHEM, V279, P40185, DOI 10.1074/jbc.M406018200; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P9137, DOI 10.1073/pnas.0402546101; Mohler PJ, 2004, J BIOL CHEM, V279, P25798, DOI 10.1074/jbc.M401296200; Mohler PJ, 2004, J BIOL CHEM, V279, P12980, DOI 10.1074/jbc.M313979200; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Mohler PJ, 2002, J BIOL CHEM, V277, P10599, DOI 10.1074/jbc.M110958200; Mosher RA, 2006, PLANT CELL, V18, P1750, DOI 10.1105/tpc.105.039677; PETERS LL, 1995, J CELL BIOL, V130, P313, DOI 10.1083/jcb.130.2.313; Scotland P, 1998, J CELL BIOL, V143, P1305, DOI 10.1083/jcb.143.5.1305; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; Sobotzik JM, 2009, P NATL ACAD SCI USA, V106, P17564, DOI 10.1073/pnas.0909267106; Wang C, 2012, P NATL ACAD SCI USA, V109, P4822, DOI 10.1073/pnas.1200613109; WILSON IA, 1985, P NATL ACAD SCI USA, V82, P5255, DOI 10.1073/pnas.82.16.5255; Zhang X, 1998, J BIOL CHEM, V273, P30785, DOI 10.1074/jbc.273.46.30785	51	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14769	14779		10.1074/jbc.M113.465328	http://dx.doi.org/10.1074/jbc.M113.465328			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23569209	hybrid, Green Published			2022-12-28	WOS:000319452100010
J	Chen, ZM; Sun, XX; Shen, SS; Zhang, HH; Ma, XQ; Liu, JL; Kuang, S; Yu, Q				Chen, Zhimin; Sun, Xiaoxiao; Shen, Shensi; Zhang, Haohao; Ma, Xiuquan; Liu, Jingli; Kuang, Shan; Yu, Qiang			Wedelolactone, a Naturally Occurring Coumestan, Enhances Interferon-gamma Signaling through Inhibiting STAT1 Protein Dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE TCPTP; CELL-GROWTH; INSULIN SENSITIVITY; NEGATIVE REGULATION; PROSTATE-CANCER; IN-VITRO; ACTIVATION; MICE; APOPTOSIS; IDENTIFICATION	Signal transducers and activators of transcription 1 (STAT1) transduces signals from cytokines and growth factors, particularly IFN-gamma, and regulates expression of genes involved in cell survival/death, proliferation, and migration. STAT1 is activated through phosphorylation on its tyrosine 701 by JAKs and is inactivated through dephosphorylation by tyrosine phosphatases. We discovered a natural compound, wedelolactone, that increased IFN-gamma signaling by inhibiting STAT1 dephosphorylation and prolonging STAT1 activation through specific inhibition of T-cell protein tyrosine phosphatase (TCPTP), an important tyrosine phosphatase for STAT1 dephosphorylation. More interestingly, wedelolactone inhibited TCPTP through interaction with the C-terminal autoinhibition domain of TCPTP. We also found that wedelolactone synergized with IFN-gamma to induce apoptosis of tumor cells. Our data suggest a new target for anticancer or antiproliferation drugs, a new mechanism to regulate PTPs specifically, and a new drug candidate for treating cancer or other proliferation disorders.	[Chen, Zhimin; Sun, Xiaoxiao; Shen, Shensi; Zhang, Haohao; Liu, Jingli; Kuang, Shan; Yu, Qiang] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Ma, Xiuquan] Chinese Acad Sci, Shanghai Inst Organ Chem, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS	Yu, Q (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China.	qyu@sibs.ac.cn	Ma, Hugh/S-4266-2019; SHEN, Shensi/AAW-2735-2020	Ma, Hugh/0000-0001-7227-1289; SHEN, Shensi/0000-0002-5087-8220; Sun, Xiaoxiao/0000-0002-9689-9385; Kuang, Shan/0000-0001-7316-0273	China Ministry of Science and Technology Key New Drug Creation and Manufacturing Program Grant [2013ZX09102015]; China Ministry of Science and Technology Research Grant [2013ZX10002010-009]; China National Natural Science Foundation [31129004, 91129701, 91213304]; National Science and Technology 973 [2012CB910704, 2013CB910900]	China Ministry of Science and Technology Key New Drug Creation and Manufacturing Program Grant; China Ministry of Science and Technology Research Grant; China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Science and Technology 973	This work was supported by China Ministry of Science and Technology Key New Drug Creation and Manufacturing Program Grant 2013ZX09102015; by China Ministry of Science and Technology Research Grant 2013ZX10002010-009; by China National Natural Science Foundation Grants 31129004, 91129701, and 91213304; and by National Science and Technology 973 Grants 2012CB910704 and 2013CB910900.	Battle T. E., 2002, Current Molecular Medicine (Hilversum), V2, P381, DOI 10.2174/1566524023362456; Benes P, 2011, CANCER LETT, V303, P29, DOI 10.1016/j.canlet.2011.01.002; Blaskovich MAT, 2009, CURR MED CHEM, V16, P2095, DOI 10.2174/092986709788612693; Bromberg JF, 1996, P NATL ACAD SCI USA, V93, P7673, DOI 10.1073/pnas.93.15.7673; Buard A, 1998, CANCER RES, V58, P840; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CANNON GW, 1989, ARTHRITIS RHEUM, V32, P964, DOI 10.1002/anr.1780320805; Chen ZM, 2011, CELL SIGNAL, V23, P1404, DOI 10.1016/j.cellsig.2011.04.003; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Condos R, 2003, INFECT IMMUN, V71, P2058, DOI 10.1128/IAI.71.4.2058-2064.2003; COOL DE, 1989, P NATL ACAD SCI USA, V86, P5257, DOI 10.1073/pnas.86.14.5257; Detjen KM, 2001, GUT, V49, P251, DOI 10.1136/gut.49.2.251; Diogo LC, 2009, BASIC CLIN PHARMACOL, V104, P293, DOI 10.1111/j.1742-7843.2008.00350.x; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Gooch JL, 2000, CELL GROWTH DIFFER, V11, P335; Hao LN, 1997, J BIOL CHEM, V272, P29322, DOI 10.1074/jbc.272.46.29322; Haspel RL, 1996, EMBO J, V15, P6262, DOI 10.1002/j.1460-2075.1996.tb01016.x; Horras CJ, 2011, CYTOKINE GROWTH F R, V22, P35, DOI 10.1016/j.cytogfr.2011.01.001; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; Huang YQ, 2000, J BIOL CHEM, V275, P6462, DOI 10.1074/jbc.275.9.6462; Ibarra-Sanchez MD, 2001, ONCOGENE, V20, P4728, DOI 10.1038/sj.onc.1204648; Idris AI, 2009, MOL CANCER THER, V8, P2339, DOI 10.1158/1535-7163.MCT-09-0133; Iversen LF, 2002, J BIOL CHEM, V277, P19982, DOI 10.1074/jbc.M200567200; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kaushik-Basu N, 2008, NUCLEIC ACIDS RES, V36, P1482, DOI 10.1093/nar/gkm1178; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kobori M, 2004, CELL DEATH DIFFER, V11, P123, DOI 10.1038/sj.cdd.4401325; Leonard WJ, 2001, INT J HEMATOL, V73, P271, DOI 10.1007/BF02981951; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Lin FM, 2007, CARCINOGENESIS, V28, P2521, DOI 10.1093/carcin/bgm137; Liu DX, 2002, BIOCHEM BIOPH RES CO, V299, P574, DOI 10.1016/S0006-291X(02)02694-3; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Mattila E, 2008, J CELL SCI, V121, P3570, DOI 10.1242/jcs.031898; Mertens C, 2006, GENE DEV, V20, P3372, DOI 10.1101/gad.1485406; Miller CHT, 2009, ANN NY ACAD SCI, V1182, P69, DOI 10.1111/j.1749-6632.2009.05069.x; Mo W, 2008, MOL CELL, V31, P695, DOI 10.1016/j.molcel.2008.06.017; Ning YX, 2010, MOL CANCER THER, V9, P1274, DOI 10.1158/1535-7163.MCT-09-1169; Pardanani A, 2011, LEUKEMIA, V25, P218, DOI 10.1038/leu.2010.269; Poras E. S., 2006, BIOORGAN MED CHEM, V14, P7962; Romsicki Y, 2003, ARCH BIOCHEM BIOPHYS, V414, P40, DOI 10.1016/S0003-9861(03)00178-4; Ruiz-Ruiz C, 2000, CANCER RES, V60, P5673; SAKAGUCHI AY, 1992, GENOMICS, V12, P151, DOI 10.1016/0888-7543(92)90418-R; Scarzello AJ, 2007, MOL BIOL CELL, V18, P2455, DOI 10.1091/mbc.E06-09-0843; Stephanou A, 2003, INT J EXP PATHOL, V84, P239, DOI 10.1111/j.0959-9673.2003.00363.x; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tsai CH, 2009, CLIN CANCER RES, V15, P5435, DOI 10.1158/1078-0432.CCR-09-0298; Upadhyay K, 2012, DRUG DEV IND PHARM, V38, P1152, DOI 10.3109/03639045.2011.643892; Vender JR, 2008, NEUROSURGERY, V62, P1122, DOI 10.1227/01.neu.0000325874.82999.75; Vijayakrishnan L, 2011, TRENDS PHARMACOL SCI, V32, P25, DOI 10.1016/j.tips.2010.10.004; Wang Y, 2009, CANCER RES, V69, P7302, DOI 10.1158/0008-5472.CAN-09-0462; Wu TR, 2002, J BIOL CHEM, V277, P47572, DOI 10.1074/jbc.M207536200; Youlyouz-Marfak I, 2008, CELL DEATH DIFFER, V15, P376, DOI 10.1038/sj.cdd.4402270; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683; Zhang S, 2009, J AM CHEM SOC, V131, P13072, DOI 10.1021/ja903733z; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102	57	29	33	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14417	14427		10.1074/jbc.M112.442970	http://dx.doi.org/10.1074/jbc.M112.442970			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23580655	Green Published, hybrid			2022-12-28	WOS:000319253500045
J	Liu, HJ; Chen, JW; Huang, RYC; Weisz, D; Gross, ML; Pakrasi, HB				Liu, Haijun; Chen, Jiawei; Huang, Richard Y. -C.; Weisz, Daniel; Gross, Michael L.; Pakrasi, Himadri B.			Mass Spectrometry-based Footprinting Reveals Structural Dynamics of Loop E of the Chlorophyll-binding Protein CP43 during Photosystem II Assembly in the Cyanobacterium Synechocystis 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE-STABILIZING PROTEIN; CRYSTAL-STRUCTURE; 12-KDA PROTEIN; PSB27; COMPLEX; CLUSTER; IDENTIFICATION; COMPONENTS; VULCANUS; RESIDUES	The PSII repair cycle is required for sustainable photosynthesis in oxygenic photosynthetic organisms. In cyanobacteria and higher plants, proteolysis of the precursor D1 protein (pD1) to expose a C-terminal carboxylate group is an essential step leading to coordination of the Mn4CaO5 cluster, the site of water oxidation. Psb27 appears to associate with both pD1- and D1-containing PSII assembly intermediates by closely interacting with CP43. Here, we report that reduced binding affinity between CP43 and Psb27 is triggered by the removal of the C-terminal extension of the pD1 protein. A mass spectrometry-based footprinting strategy was adopted to probe solvent-exposed aspartic and glutamic acid residues on the CP43 protein. By comparing the extent of footprinting between HT3 Delta ctpA Delta 27PSII and HT3 Delta ctpAPSII, two genetically modified PSII assembly complexes, we found that Psb27 binds to CP43 on the side of Loop E distal to the pseudo-symmetrical D1-D2 axis. By comparing a second pair of PSII assembly complexes, we discovered that Loop E of CP43 undergoes a significant conformational rearrangement due to the removal of the pD1 C-terminal extension, altering the Psb27-CP43 binding interface. The significance of this conformational rearrangement is discussed in the context of recruitment of the PSII lumenal extrinsic proteins and Mn4CaO5 cluster assembly. In addition to CP43's previously known function as one of the core PSII antenna proteins, this work demonstrates that Loop E of CP43 plays an important role in the functional assembly of the Water Oxidizing Center (WOC) during PSII biogenesis.	[Liu, Haijun; Weisz, Daniel; Pakrasi, Himadri B.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Chen, Jiawei; Huang, Richard Y. -C.; Weisz, Daniel; Gross, Michael L.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Pakrasi, HB (corresponding author), Washington Univ, Dept Biol, Campus Box 1137,1 Brookings Dr, St Louis, MO 63130 USA.	Pakrasi@wustl.edu		Liu, Haijun/0000-0003-0537-0302; Huang, Richard/0000-0002-7172-110X	National Institutes of Health [P41 GM103422];  [NSF-MCB0745611]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0745611] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grant P41 GM103422 (to M. L. G.) and by NSF-MCB0745611 (to H. B. P.).	Bentley FK, 2008, BIOCHEMISTRY-US, V47, P11637, DOI 10.1021/bi800804h; Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006; Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; Cormann KU, 2009, BIOCHEMISTRY-US, V48, P8768, DOI 10.1021/bi9012726; DeLano W.L, PYMOL MOL GRAPHICS S; Eaton-Rye J. J., 2005, PHOTOSYSTEM, P95; Fagerlund RD, 2011, J PHOTOCH PHOTOBIO B, V104, P191, DOI 10.1016/j.jphotobiol.2011.01.022; Frankel LK, 2012, BIOCHEMISTRY-US, V51, P6371, DOI 10.1021/bi300650n; HOARE DG, 1967, J BIOL CHEM, V242, P2447; Hutchison RS, 1998, BIOCHEMISTRY-US, V37, P5643, DOI 10.1021/bi9724467; Hwang HJ, 2008, BIOCHEMISTRY-US, V47, P9747, DOI 10.1021/bi800568p; Kashino Y, 2002, PLANT CELL PHYSIOL, V43, P1366, DOI 10.1093/pcp/pcf168; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Kashino Y, 2001, ELECTROPHORESIS, V22, P1004, DOI 10.1002/1522-2683()22:6<1004::AID-ELPS1004>3.0.CO;2-Y; Komenda J, 2012, PLANT PHYSIOL, V158, P476, DOI 10.1104/pp.111.184184; Liu HJ, 2011, P NATL ACAD SCI USA, V108, P18536, DOI 10.1073/pnas.1111597108; Liu HJ, 2011, J BIOL CHEM, V286, P24865, DOI 10.1074/jbc.M111.246231; Lydakis-Simantiris N, 1999, BIOCHEMISTRY-US, V38, P15528, DOI 10.1021/bi991599m; Mabbitt PD, 2009, BIOCHEMISTRY-US, V48, P8771, DOI 10.1021/bi901309c; Mendoza VL, 2009, MASS SPECTROM REV, V28, P785, DOI 10.1002/mas.20203; Michoux F, 2012, PHOTOSYNTH RES, V110, P169, DOI 10.1007/s11120-011-9712-7; Nakamura T, 2004, PROTEOMICS, V4, P2558, DOI 10.1002/pmic.200300812; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Nowaczyk MM, 2012, BBA-BIOENERGETICS, V1817, P1339, DOI 10.1016/j.bbabio.2012.02.017; Popelkova H, 2003, BIOCHEMISTRY-US, V42, P6193, DOI 10.1021/bi0207115; Popelkova L, 2011, J PHOTOCH PHOTOBIO B, V104, P179, DOI 10.1016/j.jphotobiol.2011.01.015; Roose JL, 2004, J BIOL CHEM, V279, P45417, DOI 10.1074/jbc.M408458200; Roose JL, 2008, J BIOL CHEM, V283, P4044, DOI 10.1074/jbc.M708960200; SHEN JR, 1992, FEBS LETT, V301, P145, DOI 10.1016/0014-5793(92)81235-E; SHEN JR, 1993, BIOCHEMISTRY-US, V32, P1825, DOI 10.1021/bi00058a017; SWAISGOOD H, 1973, J BIOCHEM, V74, P77, DOI 10.1093/oxfordjournals.jbchem.a130233; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Wei LL, 2010, J BIOL CHEM, V285, P21391, DOI 10.1074/jbc.M110.105064; Wen JZ, 2009, P NATL ACAD SCI USA, V106, P6134, DOI 10.1073/pnas.0901691106; Zhang H, 2012, INT J MASS SPECTROM, V312, P78, DOI 10.1016/j.ijms.2011.07.015; Zhang H, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M110.005678, 10.1074/mcp.M111.009936, 10.1186/1476-4598-10-108]	36	33	33	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14212	14220		10.1074/jbc.M113.467613	http://dx.doi.org/10.1074/jbc.M113.467613			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23546881	hybrid, Green Published			2022-12-28	WOS:000319253500025
J	Yue, J; Pan, YD; Sun, LF; Zhang, K; Liu, J; Lu, L; Chen, JF				Yue, Jiao; Pan, YouDong; Sun, LiFang; Zhang, Kun; Liu, Jie; Lu, Ling; Chen, JianFeng			The Unique Disulfide Bond-stabilized W1 beta 4-beta 1 Loop in the alpha(4)beta-Propeller Domain Regulates Integrin alpha(4)beta(7) Affinity and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DIVALENT-CATIONS; BINDING-SITES; FIRM ADHESION; OUTSIDE-IN; ACTIVATION; DISTINCT; SUBUNIT; LIGAND; LFA-1	Integrin alpha(4)beta(7) mediates rolling and firm adhesion of lymphocytes pre- and post-activation, which is distinct from most integrins only mediating firm cell adhesion upon activation. This two-phase cell adhesion suggests a unique molecular basis for the dynamic interaction of alpha(4)beta(7) with its ligand, mucosal addressin cell adhesion molecule 1 (MAdCAM-1). Here we report that a disulfide bond-stabilized W1 beta 4-beta 1 loop in alpha(4) beta-propeller domain plays critical roles in regulating integrin alpha(4)beta(7) affinity and signaling. Either breaking the disulfide bond or deleting the disulfide bond-occluded segment in the W1 beta 4-beta 1 loop inhibited rolling cell adhesion supported by the low-affinity interaction between MAdCAM-1 and inactive alpha(4)beta(7) but negligibly affected firm cell adhesion supported by the high-affinity interaction between MAdCAM-1 and Mn2+-activated alpha(4)beta(7). Additionally, disrupting the disulfide bond or deleting the disulfide bond-occluded segment not only blocked the conformational change and activation of alpha(4)beta(7) triggered by talin or phorbol-12-myristate-13-acetate via inside-out signaling but also disrupted integrin-mediated outside-in signaling and impaired phosphorylation of focal adhesion kinase and paxillin. Thus, these findings reveal a particular molecular basis for alpha(4)beta(7)-mediated rolling cell adhesion and a novel regulatory element of integrin affinity and signaling.	[Yue, Jiao; Pan, YouDong; Sun, LiFang; Zhang, Kun; Liu, Jie; Lu, Ling; Chen, JianFeng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, JF (corresponding author), Inst Biochem & Cell Biol, 320 YueYang Rd, Shanghai 200031, Peoples R China.	jfchen@sibcb.ac.cn			National Basic Research Program of China [2010CB529703]; National Natural Science Foundation of China [31190061, 31271487, 30970604]; Science and Technology Commission of Shanghai Municipality [11JC1414200]; Shanghai Pujiang Program [08PJ14106]; China Postdoctoral Science Foundation [2011M500079, 2012T50445]; Postdoctoral Research Program from Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2012KIP503]; Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) scholarship program	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Pujiang Program(Shanghai Pujiang Program); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postdoctoral Research Program from Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences; Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) scholarship program	This work was supported by National Basic Research Program of China Grant 2010CB529703; by National Natural Science Foundation of China Grants 31190061, 31271487, and 30970604; by Science and Technology Commission of Shanghai Municipality Grant 11JC1414200; by Shanghai Pujiang Program Grant 08PJ14106; by China Postdoctoral Science Foundation Grants 2011M500079 and 2012T50445; and by Postdoctoral Research Program from Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences Grant 2012KIP503. We acknowledge the support of the Sanofi-Aventis Shanghai Institutes for Biological Sciences (SA-SIBS) scholarship program.	ANDREW DP, 1994, J IMMUNOL, V153, P3847; Banno A, 2008, BIOCHEM SOC T, V36, P229, DOI 10.1042/BST0360229; BARGATZE RF, 1995, IMMUNITY, V3, P99, DOI 10.1016/1074-7613(95)90162-0; Barton SJ, 2004, BIOCHEM J, V380, P401, DOI 10.1042/BJ20031973; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; Chen JF, 2004, J BIOL CHEM, V279, P55556, DOI 10.1074/jbc.M407773200; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chen JS, 2006, AM J RESP CRIT CARE, V174, P103; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; de Chateau M, 2001, BIOCHEMISTRY-US, V40, P13972, DOI 10.1021/bi011582f; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; Gorfu G, 2009, CURR MOL MED, V9, P836, DOI 10.2174/156652409789105525; HAMANN A, 1994, J IMMUNOL, V152, P3282; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Lanzarotto F, 2006, DRUGS, V66, P1179, DOI 10.2165/00003495-200666090-00002; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; LAZAROVITS AI, 1984, J IMMUNOL, V133, P1857; Leitinger B, 2000, BBA-MOL CELL RES, V1498, P91, DOI 10.1016/S0167-4889(00)00086-0; Luo BH, 2009, J BIOL CHEM, V284, P3917, DOI 10.1074/jbc.M806312200; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Narayan M, 2012, FEBS J, V279, P2272, DOI 10.1111/j.1742-4658.2012.08636.x; Ni HY, 1998, J BIOL CHEM, V273, P7981, DOI 10.1074/jbc.273.14.7981; Pan YP, 2010, P NATL ACAD SCI USA, V107, P21388, DOI 10.1073/pnas.1015487107; SCHWEIGHOFFER T, 1993, J IMMUNOL, V151, P717; Sigal A, 2000, J IMMUNOL, V165, P442, DOI 10.4049/jimmunol.165.1.442; Sun H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208900; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Tidswell M, 1997, J IMMUNOL, V159, P1497; TOZEREN A, 1994, J CELL SCI, V107, P3153; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang W, 2004, P NATL ACAD SCI USA, V101, P2333, DOI 10.1073/pnas.0307291101; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Yu YM, 2012, J CELL BIOL, V196, P131, DOI 10.1083/jcb.201110023; Zhang K, 2012, CELL ADHES MIGR, V6, P20, DOI 10.4161/cam.18702; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, BLOOD, V110, P2475, DOI 10.1182/blood-2007-03-080077	47	5	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14228	14237		10.1074/jbc.M113.462630	http://dx.doi.org/10.1074/jbc.M113.462630			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23553626	hybrid, Green Published			2022-12-28	WOS:000319253500027
J	Lin, Y; Meng, Y; Wang, YX; Luo, J; Katsuma, S; Yang, CW; Banno, Y; Kusakabe, T; Shimada, T; Xia, QY				Lin, Ying; Meng, Yan; Wang, Yan-Xia; Luo, Juan; Katsuma, Susumu; Yang, Cong-Wen; Banno, Yutaka; Kusakabe, Takahiro; Shimada, Toru; Xia, Qing-You			Vitellogenin Receptor Mutation Leads to the Oogenesis Mutant Phenotype "scanty vitellin" of the Silkworm, Bombyx mori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; MOLECULAR CHARACTERIZATION; FIRE ANT; PROTEIN; LDL; YOLK; EXPRESSION; COCKROACH; CLONING; BINDING	In insects, the vitellogenin receptor (VgR) mediates the uptake of vitellogenin (Vg) from the hemolymph by developing oocytes. The oogenesis mutant scanty vitellin (vit) of Bombyx mori (Bm) lacks vitellin and 30-kDa proteins, but B. mori egg-specific protein and BmVg are normal. The vit eggs are white and smaller compared with the pale yellow eggs of the wild type and are embryonic lethal. This study found that a mutation in the B. mori VgR gene (BmVgR) is responsible for the vit phenotype. We cloned the cDNA sequences encoding WT and vit BmVgR. The functional domains of BmVgR are similar to those of other low-density lipoprotein receptors. When compared with the wild type, a 235-bp genomic sequence in vit BmVgR is substituted for a 7-bp sequence. This mutation has resulted in a 50-amino acid deletion in the third Class B region of the first epidermal growth factor (EGF1) domain. BmVgR is expressed specifically in oocytes, and the transcriptional level is changed dramatically and consistently with maturation of oocytes during the previtellogenic periods. Linkage analysis confirmed that BmVgR is mutated in the vit mutant. The coimmunoprecipitation assay confirmed that mutated BmVgR is able to bind BmVg but that BmVg cannot be dissociated under acidic conditions. The WT phenotype determined by RNA interference was similar to that of the vit phenotype for nutritional deficiency, such as BmVg and 30-kDa proteins. These results showed that BmVgR has an important role in transporting proteins for egg formation and embryonic development in B. mori.	[Lin, Ying; Wang, Yan-Xia; Luo, Juan; Yang, Cong-Wen; Xia, Qing-You] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400716, Peoples R China; [Meng, Yan] Anhui Agr Univ, Sch Life Sci, Hefei 230036, Anhui, Peoples R China; [Meng, Yan; Katsuma, Susumu; Shimada, Toru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo 1138657, Japan; [Banno, Yutaka; Kusakabe, Takahiro] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Lab Silkworm Sci, Fukuoka 8128581, Japan	Southwest University - China; Anhui Agricultural University; University of Tokyo; Kyushu University	Shimada, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	shimada@ss.ab.a.u-tokyo.ac.jp; xiaqy@swu.edu.cn	Meng, Yan/HGC-0394-2022; Shimada, Toru/A-2033-2011; meng, yan/GSE-2653-2022; Shimada, Toru/AAZ-2703-2021	Shimada, Toru/0000-0002-5791-0000; Shimada, Toru/0000-0002-5791-0000; Yang, Congwen/0000-0001-7865-7158	National Basic Research Program of China [2012CB114600]; Hi-Tech Research and Development Program of China [2011AA100306]; National Natural Science Foundation of China [31101768, 31172270]; Fundamental Research Funds for the Central Universities of China [XDJK2010C100]; Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science Japan [21658017, 22128004]; Professional Program for Agricultural Bioinformatics from MEXT; Science and Technological Fund of Anhui Province for Outstanding Youth of China [10040606Y16]; Anhui Agricultural University Fund for Excellent Talents of China [yj2009-17]	National Basic Research Program of China(National Basic Research Program of China); Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Professional Program for Agricultural Bioinformatics from MEXT; Science and Technological Fund of Anhui Province for Outstanding Youth of China; Anhui Agricultural University Fund for Excellent Talents of China	This work was supported by National Basic Research Program of China Grant 2012CB114600 (to Q. Y. X.), by Hi-Tech Research and Development Program of China Grant 2011AA100306 (to Q. Y. X.), by National Natural Science Foundation of China Grant 31101768 (to Y. L.), by Fundamental Research Funds for the Central Universities of China Grant XDJK2010C100 (to Y. L.), by Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science Japan Grants-in-Aid for Scientific Research 21658017 and 22128004 (to T. S.), by the Professional Program for Agricultural Bioinformatics from MEXT (to T. S.), by National Natural Science Foundation of China Grant 31172270 (to Y. M.), by Science and Technological Fund of Anhui Province for Outstanding Youth of China Grant 10040606Y16 (to Y. M.), and by Anhui Agricultural University Fund for Excellent Talents of China Grant yj2009-17 (to Y. M.).	Boldbaatar D, 2008, BIOCHEM CELL BIOL, V86, P331, DOI [10.1139/O08-071, 10.1139/o08-071]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUJO H, 1995, P NATL ACAD SCI USA, V92, P9905, DOI 10.1073/pnas.92.21.9905; Chen ME, 2004, INSECT MOL BIOL, V13, P195, DOI 10.1111/j.0962-1075.2004.00477.x; Ciudad L, 2006, FEBS J, V273, P325, DOI 10.1111/j.1742-4658.2005.05066.x; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; DHADIALLA TS, 1992, INSECT BIOCHEM MOLEC, V22, P803, DOI 10.1016/0965-1748(92)90107-P; Duan J, 2010, NUCLEIC ACIDS RES, V38, pD453, DOI 10.1093/nar/gkp801; Eystathioy T, 2001, MECH DEVELOP, V103, P107, DOI 10.1016/S0925-4773(01)00335-5; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; FERENZ HJ, 1993, INT J INSECT MORPHOL, V22, P295, DOI 10.1016/0020-7322(93)90016-T; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Fujikawa K, 1995, COMP BIOCHEM PHYS A, V112, P585, DOI 10.1016/0300-9629(95)02031-4; Fujikawa Kazuhiro, 2003, Journal of Insect Biotechnology and Sericology, V72, P111; Fujikawa Kazuhiro, 1993, Journal of Sericultural Science of Japan, V62, P286; Fujikawa Kazuhiro, 1996, Journal of Sericultural Science of Japan, V65, P145; Fujikawa Kazuhiro, 1993, Journal of Sericultural Science of Japan, V62, P88; Guidugli-Lazzarini KR, 2008, J INSECT PHYSIOL, V54, P1138, DOI 10.1016/j.jinsphys.2008.04.021; HIESBERGER T, 1995, J BIOL CHEM, V270, P18219, DOI 10.1074/jbc.270.31.18219; Innerarity TL, 2002, SCIENCE, V298, P2337, DOI 10.1126/science.1080669; Jeon H, 2003, STRUCTURE, V11, P133, DOI 10.1016/S0969-2126(03)00010-8; Kawaguchi Yutaka, 2008, Journal of Insect Biotechnology and Sericology, V77, P121; Kounnas MZ, 1996, J BIOL CHEM, V271, P6523, DOI 10.1074/jbc.271.11.6523; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li AK, 2003, J BIOL CHEM, V278, P2799, DOI 10.1074/jbc.M205067200; Lin Ying, 2005, Acta Zoologica Sinica, V51, P117; Liu QN, 2011, B INSECTOL, V64, P167; Lu HL, 2009, FEBS J, V276, P3110, DOI 10.1111/j.1742-4658.2009.07029.x; MACLACHLAN I, 1994, J BIOL CHEM, V269, P24127; Meng Y, 2008, ARCH INSECT BIOCHEM, V67, P9, DOI 10.1002/arch.20214; Meng Y, 2009, J BIOL CHEM, V284, P11698, DOI 10.1074/jbc.M900485200; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OGISO M, 1986, GEN COMP ENDOCR, V61, P82, DOI 10.1016/0016-6480(86)90252-2; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; Reading BJ, 2011, BIOL REPROD, V84, P392, DOI 10.1095/biolreprod.110.087981; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Sappington TW, 2005, REPRO BIOL, V12, P229; Sappington TW, 1996, P NATL ACAD SCI USA, V93, P8934, DOI 10.1073/pnas.93.17.8934; Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0; SAPPINGTON TW, 1995, INSECT BIOCHEM MOLEC, V25, P807, DOI 10.1016/0965-1748(95)00016-O; SCHONBAUM CP, 1995, P NATL ACAD SCI USA, V92, P1485, DOI 10.1073/pnas.92.5.1485; Schonbaum CP, 2000, MOL BIOL CELL, V11, P511, DOI 10.1091/mbc.11.2.511; Shu YH, 2011, INSECT MOL BIOL, V20, P61, DOI 10.1111/j.1365-2583.2010.01054.x; Snigirevskaya ES, 2005, REPRO BIOL, V12, P199; STIFANI S, 1990, P NATL ACAD SCI USA, V87, P1955, DOI 10.1073/pnas.87.5.1955; STRICKLAND DK, 1995, FASEB J, V9, P890, DOI 10.1096/fasebj.9.10.7615159; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tufail M, 2005, INSECT MOL BIOL, V14, P389, DOI 10.1111/j.1365-2583.2005.00570.x; Tufail M, 2009, J INSECT PHYSIOL, V55, P87, DOI 10.1016/j.jinsphys.2008.11.007; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Tufail M, 2007, INSECT BIOCHEM MOLEC, V37, P235, DOI 10.1016/j.ibmb.2006.11.007; Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314; Xu YingYing, 2012, African Journal of Agricultural Research, V7, P3166, DOI 10.5897/AJAR12.009; YAMASHITA O, 1980, NATURE, V283, P385, DOI 10.1038/283385a0; [No title captured]	55	59	65	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13345	13355		10.1074/jbc.M113.462556	http://dx.doi.org/10.1074/jbc.M113.462556			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23515308	hybrid, Green Published			2022-12-28	WOS:000318850300020
J	Rajamaki, K; Nordstrom, T; Nurmi, K; Akerman, KEO; Kovanen, PT; Oorni, K; Eklund, KK				Rajamaki, Kristiina; Nordstrom, Tommy; Nurmi, Katariina; Akerman, Karl E. O.; Kovanen, Petri T.; Oorni, Katariina; Eklund, Kari K.			Extracellular Acidosis Is a Novel Danger Signal Alerting Innate Immunity via the NLRP3 Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT ATHEROSCLEROTIC PLAQUES; SYNOVIAL FLUID PH; INTRACELLULAR PH; RHEUMATOID-ARTHRITIS; P2X(7) RECEPTOR; CYTOPLASMIC PH; ALVEOLAR MACROPHAGES; NALP3 INFLAMMASOME; BAFILOMYCIN A(1); NA+/H+ EXCHANGE	Local extracellular acidification has been demonstrated at sites of ischemia and inflammation. IL-1 beta is one of the key proinflammatory cytokines, and thus, its synthesis and secretion are tightly regulated. The NLRP3 (nucleotide-binding domain leucine-rich repeat containing family, pyrin domain containing 3) inflammasome complex, assembled in response to microbial components or endogenous danger signals, triggers caspase-1-mediated maturation and secretion of IL-1 beta. In this study, we explored whether acidic environment is sensed by immune cells as an inflammasome-activating danger signal. Human macrophages were exposed to custom cell culture media at pH 7.5-6.0. Acidic medium triggered pH-dependent secretion of IL-1 beta and activation of caspase-1 via a mechanism involving potassium efflux from the cells. Acidic extracellular pH caused rapid intracellular acidification, and the IL-1 beta-inducing effect of acidic medium could be mimicked by acidifying the cytosol with bafilomycin A1, a proton pump inhibitor. Knocking down the mRNA expression of NLRP3 receptor abolished IL-1 beta secretion at acidic pH. Remarkably, alkaline extracellular pH strongly inhibited the IL-1 beta response to several known NLRP3 activators, demonstrating bipartite regulatory potential of pH on the activity of this inflammasome. The data suggest that acidic environment represents a novel endogenous danger signal alerting the innate immunity. Low pH may thus contribute to inflammation in acidosis-associated pathologies such as atherosclerosis and post-ischemic inflammatory responses.	[Rajamaki, Kristiina; Nurmi, Katariina; Kovanen, Petri T.; Oorni, Katariina; Eklund, Kari K.] Biomedicum Helsinki, Wihuri Res Inst, FI-00290 Helsinki, Finland; [Nordstrom, Tommy; Akerman, Karl E. O.] Univ Helsinki, Inst Biomed Physiol, FI-00014 Helsinki, Finland	University of Helsinki; Wihuri Research Institute; University of Helsinki	Rajamaki, K (corresponding author), Biomedicum Helsinki, Wihuri Res Inst, Haartmaninkatu 8, FI-00290 Helsinki, Finland.	kristiina.rajamaki@helsinki.fi	Oorni, Katariina/G-2484-2011; Nordström, Tommy/H-9111-2016	Oorni, Katariina/0000-0002-9525-0250; Nordström, Tommy/0000-0002-2153-5819; Nurmi, Katariina/0000-0001-5406-5334; Rajamaki, Kristiina/0000-0001-5151-1220				Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Arslan F, 2011, NAT REV CARDIOL, V8, P292, DOI 10.1038/nrcardio.2011.38; Baldini PM, 2003, J LEUKOCYTE BIOL, V73, P502, DOI 10.1189/jlb.0702377; Baraldi PG, 2003, J MED CHEM, V46, P1318, DOI 10.1021/jm021049d; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; BIDANI A, 1995, J LEUKOCYTE BIOL, V57, P275, DOI 10.1002/jlb.57.2.275; Bidani A, 2000, LUNG, V178, P91, DOI 10.1007/s004080000012; BORREGAARD N, 1982, J CLIN INVEST, V70, P550, DOI 10.1172/JCI110647; Bresnihan B, 2003, RHEUMATOLOGY, V42, P22, DOI 10.1093/rheumatology/keg329; CUMMINGS NA, 1966, ARTHRITIS RHEUM, V9, P47, DOI 10.1002/art.1780090106; DeCoursey TE, 1996, J MEMBRANE BIOL, V152, P141, DOI 10.1007/s002329900093; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; EAGLE H, 1971, SCIENCE, V174, P500, DOI 10.1126/science.174.4008.500; Emsley HCA, 2005, J NEUROL NEUROSUR PS, V76, P1366, DOI 10.1136/jnnp.2004.054882; FARR M, 1985, CLIN EXP RHEUMATOL, V3, P99; FENTON MJ, 1988, J IMMUNOL, V140, P2267; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; GARLICK PB, 1979, BIOCHEM J, V184, P547, DOI 10.1042/bj1840547; GEBERT G, 1971, PFLUG ARCH EUR J PHY, V329, P72, DOI 10.1007/BF00586901; GEBOREK P, 1989, J RHEUMATOL, V16, P468; Gierut A, 2010, RHEUM DIS CLIN N AM, V36, P271, DOI 10.1016/j.rdc.2010.03.004; Gonzalez EB, 2012, CLIN RHEUMATOL, V31, P13, DOI 10.1007/s10067-011-1877-0; Gottlieb RA, 1996, P NATL ACAD SCI USA, V93, P654, DOI 10.1073/pnas.93.2.654; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; HAZUDA DJ, 1990, J BIOL CHEM, V265, P6318; Heming TA, 2003, IMMUNOBIOLOGY, V207, P141, DOI 10.1078/0171-2985-00224; HEUSER J, 1989, J CELL BIOL, V108, P855, DOI 10.1083/jcb.108.3.855; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; HOWE JR, 1991, J PHYSIOL-LONDON, V433, P183, DOI 10.1113/jphysiol.1991.sp018421; Hunt JF, 2000, AM J RESP CRIT CARE, V161, P694, DOI 10.1164/ajrccm.161.3.9911005; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; JEBENS EH, 1959, J BONE JOINT SURG BR, V41, P388, DOI 10.1302/0301-620X.41B2.388; Kim SY, 1996, J MEMBRANE BIOL, V152, P117, DOI 10.1007/s002329900091; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Leppanen O, 2006, ATHEROSCLEROSIS, V188, P323, DOI 10.1016/j.atherosclerosis.2005.11.017; Liu X, 2009, BRIT J PHARMACOL, V156, P135, DOI 10.1111/j.1476-5381.2008.00002.x; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; MENKIN V, 1956, SCIENCE, V123, P527, DOI 10.1126/science.123.3196.527; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Mitroulis I, 2010, EUR J INTERN MED, V21, P157, DOI 10.1016/j.ejim.2010.03.005; MURGIA M, 1993, J BIOL CHEM, V268, P8199; Naghavi M, 2002, ATHEROSCLEROSIS, V164, P27, DOI 10.1016/S0021-9150(02)00018-7; Nakanishi S, 2009, J LIPID RES, V50, P183, DOI 10.1194/jlr.M800196-JLR200; NEDERGAARD M, 1991, AM J PHYSIOL, V260, pR581, DOI 10.1152/ajpregu.1991.260.3.R581; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; Nordstrom T, 2012, BRAIN RES, V1461, P10, DOI 10.1016/j.brainres.2012.04.043; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; PERREGAUX D, 1992, J IMMUNOL, V149, P1294; Perregaux DG, 1998, AM J PHYSIOL-CELL PH, V275, pC1538, DOI 10.1152/ajpcell.1998.275.6.C1538; Perregaux DG, 1996, J BIOL CHEM, V271, P29830, DOI 10.1074/jbc.271.47.29830; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Ricciardolo FLM, 2004, J ALLERGY CLIN IMMUN, V113, P610, DOI 10.1016/j.jaci.2003.12.034; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189; Roiniotis J, 2009, J IMMUNOL, V182, P7974, DOI 10.4049/jimmunol.0804216; Sakai H, 2006, J PHYSIOL-LONDON, V576, P417, DOI 10.1113/jphysiol.2006.117176; Salvi A, 2002, AAPS PHARMSCI, V4, DOI 10.1208/ps040421; Scanu A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2930; Shalhoub J, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-9; SIEMKOWICZ E, 1981, STROKE, V12, P236, DOI 10.1161/01.STR.12.2.236; SWALLOW CJ, 1993, J CELL PHYSIOL, V157, P453, DOI 10.1002/jcp.1041570304; Talanian RV, 1996, J BIOL CHEM, V271, P21853, DOI 10.1074/jbc.271.36.21853; Tannahill GM, 2011, FEBS LETT, V585, P1568, DOI 10.1016/j.febslet.2011.05.008; TAPPER H, 1995, J CELL PHYSIOL, V163, P137, DOI 10.1002/jcp.1041630116; TREUHAFT PS, 1971, ARTHRITIS RHEUM, V14, P475, DOI 10.1002/art.1780140407; Vasconcelos MTSD, 1998, ANAL BIOCHEM, V265, P193, DOI 10.1006/abio.1998.2884; Vittone L, 1998, J BIOL CHEM, V273, P9804, DOI 10.1074/jbc.273.16.9804	72	206	209	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13410	13419		10.1074/jbc.M112.426254	http://dx.doi.org/10.1074/jbc.M112.426254			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23530046	Green Published, hybrid			2022-12-28	WOS:000318850300026
J	Feng, J; Hu, YT; Yi, H; Yin, SJ; Han, S; Hu, J; Chen, ZY; Yang, WS; Cao, ZJ; De Waard, M; Sabatier, JM; Li, WX; Wu, YL				Feng, Jing; Hu, Youtian; Yi, Hong; Yin, Shijin; Han, Song; Hu, Jun; Chen, Zongyun; Yang, Weishan; Cao, Zhijian; De Waard, Michel; Sabatier, Jean-Marc; Li, Wenxin; Wu, Yingliang			Two Conserved Arginine Residues from the SK3 Potassium Channel Outer Vestibule Control Selectivity of Recognition by Scorpion Toxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CHANNELS; NUCLEAR-MAGNETIC-RESONANCE; PEPTIDE INHIBITOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; INACTIVATION; SIMULATIONS; PLASTICITY; CONDUCTION; LIGAND	Potassium channel functions are often deciphered by using selective and potent scorpion toxins. Among these toxins, only a limited subset is capable of selectively blocking small conductance Ca2+-activated K+ (SK) channels. The structural bases of this selective SK channel recognition remain unclear. In this work, we demonstrate the key role of the electric charges of two conserved arginine residues (Arg-485 and Arg-489) from the SK3 channel outer vestibule in the selective recognition by the SK3-blocking BmP05 toxin. Indeed, individually substituting these residues with histidyl or lysyl (maintaining the positive electric charge partially or fully), although decreasing BmP05 affinity, still preserved the toxin sensitivity profile of the SK3 channel (as evidenced by the lack of recognition by many other types of potassium channel-sensitive charybdotoxin). In contrast, when Arg-485 or Arg-489 of the SK3 channel was mutated to an acidic (Glu) or alcoholic (Ser) amino acid residue, the channel lost its sensitivity to BmP05 and became susceptible to the "new" blocking activity by charybdotoxin. In addition to these SK3 channel basic residues important for sensitivity, two acidic residues, Asp-492 and Asp-518, also located in the SK3 channel outer vestibule, were identified as being critical for toxin affinity. Furthermore, molecular modeling data indicate the existence of a compact SK3 channel turret conformation (like a peptide screener), where the basic rings of Arg-485 and Arg-489 are stabilized by strong ionic interactions with Asp-492 and Asp-518. In conclusion, the unique properties of Arg-485 and Arg-489 (spatial orientations and molecular interactions) in the SK3 channel account for its toxin sensitivity profile.	[Feng, Jing; Hu, Youtian; Yi, Hong; Yin, Shijin; Han, Song; Hu, Jun; Chen, Zongyun; Yang, Weishan; Cao, Zhijian; Li, Wenxin; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [De Waard, Michel] Univ Grenoble 1, INSERM U836, Grenoble Neurosci Inst, Lab Excellence Ion Channels Sci & Therapeut, F-38042 Grenoble 09, France; [De Waard, Michel] Smartox Biotechnol, F-38700 La Tronche, France; [Sabatier, Jean-Marc] Aix Marseille Univ, INSERM UMR1097, F-13288 Marseille, France	Wuhan University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Aix-Marseille Universite	Wu, YL (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	ylwu@whu.edu.cn	Hu, Youtian/G-5408-2014; De Waard, Michel/G-7406-2014; Feng, Jing/C-1729-2018	De Waard, Michel/0000-0002-2782-9615; Feng, Jing/0000-0001-6726-7912; SABATIER, Jean-Marc/0000-0002-9040-5647	National Basic Research Program of China [2010CB529800]; National High Technology Research and Development Program of China [2012AA020304]; National Natural Sciences Foundation of China [30530140, 30973636, 31170789]; New Century Excellent Talents in Wuhan University from the Ministry of Education of China [NCET-10-0651]; Hubei Province Natural Sciences Foundation of China [2009CDA076]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA020304] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in Wuhan University from the Ministry of Education of China; Hubei Province Natural Sciences Foundation of China; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Basic Research Program of China Grant 2010CB529800; National High Technology Research and Development Program of China Grant 2012AA020304; National Natural Sciences Foundation of China Grants 30530140, 30973636, and 31170789; New Century Excellent Talents in Wuhan University Grant NCET-10-0651 from the Ministry of Education of China; and Hubei Province Natural Sciences Foundation of China Grant 2009CDA076.	Ader C, 2008, NAT STRUCT MOL BIOL, V15, P605, DOI 10.1038/nsmb.1430; Ader C, 2009, EMBO J, V28, P2825, DOI 10.1038/emboj.2009.218; Andreotti N, 2005, PEPTIDES, V26, P1095, DOI 10.1016/j.peptides.2005.01.022; Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Berkefeld H, 2010, PHYSIOL REV, V90, P1437, DOI 10.1152/physrev.00049.2009; Castle NA, 2003, MOL PHARMACOL, V63, P409, DOI 10.1124/mol.63.2.409; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Cui M, 2002, J MOL BIOL, V318, P417, DOI 10.1016/S0022-2836(02)00095-5; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; de la Vega RCR, 2003, TRENDS PHARMACOL SCI, V24, P222, DOI 10.1016/S0165-6147(02)00080-4; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; Gan GL, 2008, J BIOL CHEM, V283, P24177, DOI 10.1074/jbc.M800179200; Gross A, 1996, NEURON, V16, P399, DOI 10.1016/S0896-6273(00)80057-4; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; Han S, 2010, J PROTEOME RES, V9, P3118, DOI 10.1021/pr100027k; Lange A, 2006, NATURE, V440, P959, DOI 10.1038/nature04649; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; PEASE JHB, 1988, BIOCHEMISTRY-US, V27, P8491, DOI 10.1021/bi00422a029; Regaya I, 2004, J BIOL CHEM, V279, P55690, DOI 10.1074/jbc.M410055200; SABATIER JM, 1993, BIOCHEMISTRY-US, V32, P2763, DOI 10.1021/bi00062a005; Shakkottai VG, 2001, J BIOL CHEM, V276, P43145, DOI 10.1074/jbc.M106981200; Stackman RW, 2002, J NEUROSCI, V22, P10163; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Subbotina J, 2010, PROTEINS, V78, P2922, DOI 10.1002/prot.22815; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Tseng GN, 2007, BIOPHYS J, V92, P3524, DOI 10.1529/biophysj.106.097360; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wittekindt OH, 2004, MOL PHARMACOL, V65, P788, DOI 10.1124/mol.65.3.788; Wu JJ, 2002, BIOCHEMISTRY-US, V41, P2844, DOI 10.1021/bi011367z; Wulff H, 2008, CHEM REV, V108, P1744, DOI 10.1021/cr078234p; Yi H, 2007, J PROTEOME RES, V6, P611, DOI 10.1021/pr060368g; Yin SJ, 2008, J PROTEOME RES, V7, P4890, DOI 10.1021/pr800494a; Yu LP, 2005, BIOCHEMISTRY-US, V44, P15834, DOI 10.1021/bi051656d	38	26	27	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12544	12553		10.1074/jbc.M112.433888	http://dx.doi.org/10.1074/jbc.M112.433888			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23511633	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000318555100013
J	Hunt, LC; Gorman, C; Kintakas, C; McCulloch, DR; Mackie, EJ; White, JD				Hunt, Liam C.; Gorman, Chris; Kintakas, Christopher; McCulloch, Daniel R.; Mackie, Eleanor J.; White, Jason D.			Hyaluronan Synthesis and Myogenesis A REQUIREMENT FOR HYALURONAN SYNTHESIS DURING MYOGENIC DIFFERENTIATION INDEPENDENT OF PERICELLULAR MATRIX FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; HUMAN ARTICULAR CHONDROCYTES; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; INTRACELLULAR HYALURONAN; MYOBLAST DIFFERENTIATION; OVER-EXPRESSION; BINDING PROTEIN; ACID; SYNTHASE	Exogenous hyaluronan is known to alter muscle precursor cell proliferation, migration, and differentiation, ultimately inhibiting myogenesis in vitro. The aim of the current study was to investigate the role of endogenous hyaluronan synthesis during myogenesis. In quantitative PCR studies, the genes responsible for synthesizing hyaluronan were found to be differentially regulated during muscle growth, repair, and pathology. Although all Has genes (Has1, Has2, and Has3) were differentially regulated in these models, only Has2 gene expression consistently associated with myogenic differentiation. During myogenic differentiation in vitro, Has2 was the most highly expressed of the synthases and increased after induction of differentiation. To test whether this association between Has2 expression and myogenesis relates to a role for Has2 in myoblast differentiation and fusion, C2C12 myoblasts were depleted of Has2 by siRNA and induced to differentiate. Depletion of Has2 inhibited differentiation and caused a loss of cell-associated hyaluronan and the hyaluronan-dependent pericellular matrix. The inhibition of differentiation caused by loss of hyaluronan was confirmed with the hyaluronan synthesis inhibitor 4-methylumbelliferone. In hyaluronan synthesis-blocked cultures, restoration of the pericellular matrix could be achieved through the addition of exogenous hyaluronan and the proteoglycan versican, but this was not sufficient to restore differentiation to control levels. These data indicate that intrinsic hyaluronan synthesis is necessary for myoblasts to differentiate and form syncytial muscle cells, but the hyaluronan-dependent pericellular matrix is not sufficient to support differentiation alone; additional hyaluronan-dependent cell functions that are yet unknown may be required for myogenic differentiation.	[Hunt, Liam C.; Gorman, Chris; Kintakas, Christopher; White, Jason D.] Murdoch Childrens Res Inst, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Kintakas, Christopher; McCulloch, Daniel R.] Deakin Univ, Sch Med, Waurn Ponds, Vic 3216, Australia; [Gorman, Chris; Mackie, Eleanor J.; White, Jason D.] Univ Melbourne, Sch Vet Sci, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Deakin University; University of Melbourne	White, JD (corresponding author), Murdoch Childrens Res Inst, Muscular Dystrophy Res Grp, Flemington Rd, Parkville, Vic 3052, Australia.	jasondw@unimelb.edu.au	White, Jason/AAF-8712-2020; Mackie, Eleanor J/B-2045-2008; Hunt, Liam/C-7344-2017; McCulloch, Daniel/N-9142-2013	White, Jason/0000-0002-0557-392X; Mackie, Eleanor J/0000-0002-8057-5407; Hunt, Liam/0000-0001-5192-1473; McCulloch, Daniel/0000-0003-0269-5857	Muscular Dystrophy Association of Australia (MDA); Victorian Government	Muscular Dystrophy Association of Australia (MDA)(Muscular Dystrophy Association); Victorian Government	This work was supported by the Muscular Dystrophy Association of Australia (MDA) and the Victorian Government's Operational Infrastructure Support Program.	Allingham PG, 2006, ARCH BIOCHEM BIOPHYS, V452, P83, DOI 10.1016/j.abb.2006.05.010; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Calve S, 2012, AM J PHYSIOL-CELL PH, V303, pC577, DOI 10.1152/ajpcell.00057.2012; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Caskey RC, 2013, CELL TISSUE RES, V351, P117, DOI 10.1007/s00441-012-1504-7; Cohen M, 2007, SOFT MATTER, V3, P327, DOI 10.1039/b613770a; ELSON HF, 1980, J SUPRAMOL STR CELL, V14, P313, DOI 10.1002/jss.400140306; FOSANG AJ, 1990, MATRIX, V10, P306, DOI 10.1016/S0934-8832(11)80186-1; GRAMMATIKAKIS N, 1995, J BIOL CHEM, V270, P16198, DOI 10.1074/jbc.270.27.16198; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Hattori N, 2011, J BIOL CHEM, V286, P34298, DOI 10.1074/jbc.M111.254938; Huang L, 2000, J BIOL CHEM, V275, P29829, DOI 10.1074/jbc.M002737200; Huang L, 2003, J BIOMED MATER RES A, V66A, P880, DOI 10.1002/jbm.a.10535; Hunt L. C., 2011, PLOS CURR, V3; Hunt LC, 2013, HISTOCHEM CELL BIOL, V139, P13, DOI 10.1007/s00418-012-1018-0; Hunt LC, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-17; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; KELLY AM, 1983, HDB PHYSL 10, P507; KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825; KUJAWA MJ, 1986, DEV BIOL, V113, P10, DOI 10.1016/0012-1606(86)90103-X; KUJAWA MJ, 1983, DEV BIOL, V99, P277, DOI 10.1016/0012-1606(83)90277-4; KUJAWA MJ, 1986, DEV BIOL, V114, P519, DOI 10.1016/0012-1606(86)90215-0; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; LAURENT C, 1991, CELL TISSUE RES, V263, P201, DOI 10.1007/BF00318761; Laurent T.C, 1970, CHEM MOL BIOL INTERC, P703; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Melo F, 1996, J CELL BIOCHEM, V62, P227, DOI 10.1002/(SICI)1097-4644(199608)62:2<227::AID-JCB11>3.0.CO;2-I; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; Mikami T, 2012, J BIOL CHEM, V287, P38531, DOI 10.1074/jbc.M111.336925; Mylona E, 2006, J CELL PHYSIOL, V209, P314, DOI 10.1002/jcp.20724; NAKAMURA T, 1995, BIOCHEM BIOPH RES CO, V208, P470, DOI 10.1006/bbrc.1995.1362; NANDAN D, 1990, J CELL BIOL, V110, P1673, DOI 10.1083/jcb.110.5.1673; Nishida Y, 2000, ARTHRITIS RHEUM-US, V43, P206, DOI 10.1002/1529-0131(200001)43:1<206::AID-ANR25>3.0.CO;2-1; Nishida Y, 1999, J BIOL CHEM, V274, P21893, DOI 10.1074/jbc.274.31.21893; Nishida Y, 2000, ARTHRITIS RHEUM, V43, P1315, DOI 10.1002/1529-0131(200006)43:6<1315::AID-ANR14>3.0.CO;2-#; ORKIN RW, 1985, DEV BIOL, V107, P527, DOI 10.1016/0012-1606(85)90333-1; Osses N, 2002, AM J PHYSIOL-CELL PH, V282, pC383, DOI 10.1152/ajpcell.00322.2001; Osses N, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-73; Pedrosa-Domellof F, 1998, HISTOCHEM CELL BIOL, V110, P179, DOI 10.1007/s004180050279; Petillo O, 1999, J MATER SCI-MATER M, V10, P595, DOI 10.1023/A:1008998604276; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PIEHLAULIN K, 1991, J APPL PHYSIOL, V71, P2493, DOI 10.1152/jappl.1991.71.6.2493; Plant DR, 2006, MUSCLE NERVE, V34, P577, DOI 10.1002/mus.20616; REED RK, 1988, ACTA PHYSIOL SCAND, V134, P405, DOI 10.1111/j.1748-1716.1988.tb08508.x; SAITOH O, 1992, EXP CELL RES, V200, P70, DOI 10.1016/S0014-4827(05)80072-2; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; Spicer AP, 1997, J BIOL CHEM, V272, P8957; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; Stupka N, 2013, J BIOL CHEM, V288, P1907, DOI 10.1074/jbc.M112.429647; Tammi R, 2005, J INVEST DERMATOL, V124, P898, DOI 10.1111/j.0022-202X.2005.23697.x; Toole BP, 2005, CELLS TISSUES ORGANS, V179, P66, DOI 10.1159/000084510; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; Vuocolo T, 2007, PHYSIOL GENOMICS, V28, P253, DOI 10.1152/physiolgenomics.00121.2006; Wang H, 2001, STROKE, V32, P1020, DOI 10.1161/01.STR.32.4.1020; Watanabe K, 1996, J BIOL CHEM, V271, P22945, DOI 10.1074/jbc.271.38.22945; YOSHIMURA M, 1985, CELL DIFFER DEV, V16, P175, DOI 10.1016/0045-6039(85)90515-9; Yun BG, 2005, EXP CELL RES, V307, P212, DOI 10.1016/j.yexcr.2005.03.003	61	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13006	13021		10.1074/jbc.M113.453209	http://dx.doi.org/10.1074/jbc.M113.453209			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23493399	Green Published, hybrid			2022-12-28	WOS:000318555100053
J	Oz, S; Benmocha, A; Sasson, Y; Sachyani, D; Almagor, L; Lee, A; Hirsch, JA; Dascal, N				Oz, Shimrit; Benmocha, Adva; Sasson, Yehezkel; Sachyani, Dana; Almagor, Lior; Lee, Amy; Hirsch, Joel A.; Dascal, Nathan			Competitive and Non-competitive Regulation of Calcium-dependent Inactivation in Ca(V)1.2 L-type Ca2+ Channels by Calmodulin and Ca2+-binding Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-BETA-GAMMA; CA2+-DEPENDENT INACTIVATION; CA(V)2.1 CHANNELS; MOLECULAR DETERMINANTS; BINDING PROTEIN-1; CRYSTAL-STRUCTURE; VOLTAGE; MODULATION; COMPLEX; SUBUNIT	Ca(V)1.2 interacts with the Ca2+ sensor proteins, calmodulin (CaM) and calcium-binding protein 1 (CaBP1), via multiple, partially overlapping sites in the main subunit of Ca(V)1.2, alpha(1C). Ca2+/CaM mediates a negative feedback regulation of Ca(v)1.2 by incoming Ca2+ ions (Ca2+-dependent inactivation (CDI)). CaBP1 eliminates this action of CaM through a poorly understood mechanism. We examined the hypothesis that CaBP1 acts by competing with CaM for common interaction sites in the alpha(1C)-subunit using Forster resonance energy transfer (FRET) and recording of Ca(v)1.2 currents in Xenopus oocytes. FRET detected interactions between fluorescently labeled CaM or CaBP1 with the membrane-attached proximal C terminus (pCT) and the N terminus (NT) of alpha(1C). However, mutual overexpression of CaM and CaBP1 proved inadequate to quantitatively assess competition between these proteins for alpha(1C). Therefore, we utilized titrated injection of purified CaM and CaBP1 to analyze their mutual effects. CaM reduced FRET between CaBP1 and pCT, but not NT, suggesting competition between CaBP1 and CaM for pCT only. Titrated injection of CaBP1 and CaM altered the kinetics of CDI, allowing analysis of their opposite regulation of Ca(V)1.2. The CaBP1-induced slowing of CDI was largely eliminated by CaM, corroborating a competition mechanism, but 15-20% of the effect of CaBP1 was CaM-resistant. Both components of CaBP1 action were present in a truncated alpha(1C) where N-terminal CaM- and CaBP1-binding sites have been deleted, suggesting that the NT is not essential for the functional effects of CaBP1. We propose that CaBP1 acts via interaction(s) with the pCT and possibly additional sites in alpha(1C).	[Oz, Shimrit; Benmocha, Adva; Dascal, Nathan] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Sasson, Yehezkel; Sachyani, Dana; Almagor, Lior; Hirsch, Joel A.] Tel Aviv Univ, George S Wise Fac Life Sci, Inst Biol Struct, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel; [Lee, Amy] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Lee, Amy] Univ Iowa, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA; [Lee, Amy] Univ Iowa, Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; University of Iowa; University of Iowa; University of Iowa	Dascal, N (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	dascaln@post.tau.ac.il	Hirsch, Joel/AAC-8000-2021; Dascal, Nathan/O-3915-2015	Hirsch, Joel/0000-0001-7544-8668; Dascal, Nathan/0000-0002-5397-4146; Oz, Shimrit/0000-0001-5110-3833; Sachyani, Dana/0000-0002-4631-7084; Lee, Amy/0000-0001-8021-0443	Fields Center for Cardiovascular Research; United States-Israel Binational Science Foundation [2005340]; Israel Science Foundation [1201/04]; Deutsch-Israelische Projektkooperation	Fields Center for Cardiovascular Research; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); Deutsch-Israelische Projektkooperation	This work was supported by the Fields Center for Cardiovascular Research (to N. D.), United States-Israel Binational Science Foundation Grant 2005340 (to N. D. and A. L.), the Israel Science Foundation (1201/04), and the Deutsch-Israelische Projektkooperation (to J. H.).	Almagor L, 2012, J NEUROSCI, V32, P7602, DOI 10.1523/JNEUROSCI.5727-11.2012; Benmocha A, 2009, CHANNELS, V3, P337, DOI 10.4161/chan.3.5.9686; Berlin S, 2011, J BIOL CHEM, V286, P33223, DOI 10.1074/jbc.M111.271056; Berlin S, 2010, J BIOL CHEM, V285, P6179, DOI 10.1074/jbc.M109.085944; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cens T, 1999, J BIOL CHEM, V274, P5483, DOI 10.1074/jbc.274.9.5483; Christel C, 2012, BBA-GEN SUBJECTS, V1820, P1243, DOI 10.1016/j.bbagen.2011.12.012; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Fallon JL, 2009, P NATL ACAD SCI USA, V106, P5135, DOI 10.1073/pnas.0807487106; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Few AP, 2005, J NEUROSCI, V25, P7071, DOI 10.1523/JNEUROSCI.0452-05.2005; Findeisen F, 2010, CHANNELS, V4, P459, DOI 10.4161/chan.4.6.12867; Findeisen F, 2010, STRUCTURE, V18, P1617, DOI 10.1016/j.str.2010.09.012; Fowler MR, 2009, PFLUG ARCH EUR J PHY, V457, P1049, DOI 10.1007/s00424-008-0575-5; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Halling D Brent, 2006, Sci STKE, V2006, per1; Halling DB, 2009, J BIOL CHEM, V284, P20041, DOI 10.1074/jbc.M109.013326; Hayashi N, 1998, PROTEIN EXPRES PURIF, V12, P25, DOI 10.1006/prep.1997.0807; Haynes LP, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00009; Hering S, 1998, TRENDS PHARMACOL SCI, V19, P439, DOI 10.1016/S0165-6147(98)01258-9; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Kim EY, 2010, EMBO J, V29, P3924, DOI 10.1038/emboj.2010.260; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE; Lautermilch NJ, 2005, J NEUROSCI, V25, P7062, DOI 10.1523/JNEUROSCI.0447-05.2005; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Mori MX, 2008, STRUCTURE, V16, P607, DOI 10.1016/j.str.2008.01.011; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Mouton J, 2001, J BIOL CHEM, V276, P22359, DOI 10.1074/jbc.M100755200; Oz S, 2011, J BIOL CHEM, V286, P13945, DOI 10.1074/jbc.M110.198424; Park S, 2011, PROTEIN SCI, V20, P1356, DOI 10.1002/pro.662; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; PATTON DE, 1993, NEURON, V11, P967; PELLMAN D, 1985, NATURE, V314, P374, DOI 10.1038/314374a0; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Philips MR, 2005, BIOCHEM SOC T, V33, P657, DOI 10.1042/BST0330657; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; RICHTER JD, 1981, CELL, V27, P183, DOI 10.1016/0092-8674(81)90372-X; Rieke F, 2008, INVEST OPHTH VIS SCI, V49, P5126, DOI 10.1167/iovs.08-2236; Romanin C, 2000, FEBS LETT, V487, P301, DOI 10.1016/S0014-5793(00)02361-9; Sanabria H, 2008, BIOPHYS J, V95, P6002, DOI 10.1529/biophysj.108.138974; Schrauwen I, 2012, AM J HUM GENET, V91, P636, DOI 10.1016/j.ajhg.2012.08.018; Shaltiel L, 2012, J BIOL CHEM, V287, P36312, DOI 10.1074/jbc.M112.392811; Soldatov MM, 2003, TRENDS PHARMACOL SCI, V24, P167, DOI 10.1016/S0165-6147(03)00065-8; Soldatov NM, 1997, J BIOL CHEM, V272, P3560, DOI 10.1074/jbc.272.6.3560; Tadross MR, 2008, CELL, V133, P1228, DOI 10.1016/j.cell.2008.05.025; Tadross MR, 2010, J GEN PHYSIOL, V135, P197, DOI 10.1085/jgp.200910308; Takanishi CL, 2006, BRAIN RES, V1091, P132, DOI 10.1016/j.brainres.2006.01.119; Tang W, 2003, BIOPHYS J, V85, P1538, DOI 10.1016/S0006-3495(03)74586-X; Thomsen MB, 2009, CIRC RES, V104, P1382, DOI 10.1161/CIRCRESAHA.109.196972; Tippens AL, 2007, J BIOL CHEM, V282, P8464, DOI 10.1074/jbc.M611384200; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Wingard JN, 2005, J BIOL CHEM, V280, P37461, DOI 10.1074/jbc.M508541200; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zheng Jie, 2006, V337, P65; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200; Zhou H, 2004, J NEUROSCI, V24, P4698, DOI 10.1523/JNEUROSCI.5523-03.2004; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	71	28	29	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12680	12691		10.1074/jbc.M113.460949	http://dx.doi.org/10.1074/jbc.M113.460949			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23530039	Green Published, hybrid			2022-12-28	WOS:000318555100025
J	Yamakawa, D; Kidoya, H; Sakimoto, S; Jia, W; Naito, H; Takakura, N				Yamakawa, Daishi; Kidoya, Hiroyasu; Sakimoto, Susumu; Jia, Weizhen; Naito, Hisamichi; Takakura, Nobuyuki			Ligand-independent Tie2 Dimers Mediate Kinase Activity Stimulated by High Dose Angiopoietin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-TYROSINE KINASE; VASCULAR MORPHOGENESIS; VENOUS MALFORMATIONS; ENDOTHELIAL-CELLS; LIVING CELLS; ACTIVATION; GROWTH; ANGIOGENESIS; SURVIVAL; DOMAIN	Tie2 is a receptor tyrosine kinase expressed on vascular endothelial cells (ECs). It has dual roles in promoting angiogenesis and stabilizing blood vessels, and it has been suggested that Tie2 forms dimers and/or oligomers in the absence of angiopoietin-1 (Ang1); however, the mechanism of ligand-independent dimerization of Tie2 and its biological significance have not been clarified. Using a bimolecular fluorescence complementation assay and a kinase-inactive Tie2 mutant, we show here that ligand-independent Tie2 dimerization is induced without Tie2 phosphorylation. Moreover, based on the fact that Tie1 never forms heterodimers with Tie2 in the absence of Ang1 despite having high amino acid sequence homology with Tie2, we searched for ligand-independent dimerization domains of Tie2 by reference to the difference with Tie1. We found that the YIA sequence of the intracellular domain of Tie2 corresponding to the LAS sequence in Tie1 is essential for this dimerization. When the YIA sequence was replaced by LAS in Tie2 (Tie2YIA/LAS), ligand-independent dimer was not formed in the absence of Ang1. When activation of Tie2YIA/LAS was induced by a high dose of Ang1, phosphorylation of Tie2 was limited compared with wild-type Tie2, resulting in retardation of activation of Erk downstream of Tie2. Therefore, these data suggest that ligand-independent dimerization of Tie2 is essential for a strong response upon stimulation with high dose Ang1.	[Yamakawa, Daishi; Kidoya, Hiroyasu; Sakimoto, Susumu; Jia, Weizhen; Naito, Hisamichi; Takakura, Nobuyuki] Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, Suita, Osaka 5650871, Japan; [Takakura, Nobuyuki] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1020075, Japan	Osaka University; Japan Science & Technology Agency (JST)	Takakura, N (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Signal Transduct, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	ntakaku@biken.osaka-u.ac.jp		Naito, Hisamichi/0000-0002-0750-1743	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from the Ministry of Education, Science, Sports, and Culture of Japan.	Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bogdanovic E, 2006, J CELL SCI, V119, P3551, DOI 10.1242/jcs.03077; Bogdanovic E, 2009, HISTOCHEM CELL BIOL, V132, P225, DOI 10.1007/s00418-009-0603-3; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Eklund L, 2006, EXP CELL RES, V312, P630, DOI 10.1016/j.yexcr.2005.09.002; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kim I, 2000, ONCOGENE, V19, P4549, DOI 10.1038/sj.onc.1203800; Limaye N, 2009, NAT GENET, V41, P118, DOI 10.1038/ng.272; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Marron MB, 2007, J BIOL CHEM, V282, P30509, DOI 10.1074/jbc.M702535200; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Morris PN, 2005, J MOL MED, V83, P58, DOI 10.1007/s00109-004-0601-9; Niu XL, 2002, J BIOL CHEM, V277, P31768, DOI 10.1074/jbc.M203995200; Patan S, 1998, MICROVASC RES, V56, P1, DOI 10.1006/mvre.1998.2081; Puri MC, 1999, DEVELOPMENT, V126, P4569; PURI MC, 1995, EMBO J, V14, P5884, DOI 10.1002/j.1460-2075.1995.tb00276.x; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Saharinen P, 2005, J CELL BIOL, V169, P239, DOI 10.1083/jcb.200411105; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Saitoh T, 2002, FEBS LETT, V532, P45, DOI 10.1016/S0014-5793(02)03622-0; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Seegar TCM, 2010, MOL CELL, V37, P643, DOI 10.1016/j.molcel.2010.02.007; Shewchuk LM, 2000, STRUCTURE, V8, P1105, DOI 10.1016/S0969-2126(00)00516-5; Singh H, 2009, CELL SIGNAL, V21, P1346, DOI 10.1016/j.cellsig.2009.04.002; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Thomas M, 2009, ANGIOGENESIS, V12, P125, DOI 10.1007/s10456-009-9147-3; Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0; Yabkowitz R, 1999, BLOOD, V93, P1969, DOI 10.1182/blood.V93.6.1969.406k14_1969_1979; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Yuan HT, 2007, FASEB J, V21, P3171, DOI 10.1096/fj.07-8487com	37	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12469	12477		10.1074/jbc.M112.433979	http://dx.doi.org/10.1074/jbc.M112.433979			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23504320	Green Published, hybrid			2022-12-28	WOS:000318555100006
J	Liao, JM; Zhang, Y; Liao, WJ; Zeng, SX; Su, XH; Flores, ER; Lu, H				Liao, Jun-Ming; Zhang, Yu; Liao, Wenjuan; Zeng, Sheyla X.; Su, Xiaohua; Flores, Elsa R.; Lu, Hua			I kappa B Kinase beta (IKK beta) Inhibits p63 Isoform gamma (TAp63 gamma) Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-INDUCED APOPTOSIS; CELL-CYCLE ARREST; P53 HOMOLOG; TNF-ALPHA; EPIDERMAL MORPHOGENESIS; FOOT MALFORMATION; MICE LACKING; EEC-SYNDROME; ACTIVATION; MUTATIONS	Previously, we reported that I kappa B kinase-beta(IKK beta) phosphorylates and stabilizes TAp63 gamma. However, the effect of this phosphorylation on TAp63 gamma transcriptional activity remains unclear. In this study, we showed that overexpression of IKK beta, but not its kinase dead mutant and IKK beta, can surprisingly inhibit TAp63 gamma transcriptional activity as measured by luciferase assays and real-time PCR analyses of p63 target genes. This inhibition was impaired by ACHP, an IKK beta inhibitor, and enhanced by TNF alpha that activates IKK beta. Consistently, IKK beta inhibited the binding between TAp63 gamma and p300, a co-activator of TAp63 gamma, and consequently counteracted the positive effect of p300 on TAp63 gamma transcriptional activity. Through phosphorylation site prediction and mass spectrometry, we identified that Ser-4 and Ser-12 of p63 are IKK beta-targeting residues. As expected, IKK beta fails to suppress the transcriptional activity of the S4A/S12A double mutant p63. These results indicate that IKK beta can suppress TAp63 gamma activity by interfering with the interaction between TAp63 gamma and p300.	[Liao, Jun-Ming; Zhang, Yu; Liao, Wenjuan; Zeng, Sheyla X.; Lu, Hua] Tulane Univ, Sch Med, Dept Biochem Mol Biol, New Orleans, LA 70112 USA; [Liao, Jun-Ming; Zhang, Yu; Liao, Wenjuan; Zeng, Sheyla X.; Lu, Hua] Tulane Univ, Sch Med, Tulane Canc Ctr, New Orleans, LA 70112 USA; [Su, Xiaohua; Flores, Elsa R.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Tulane University; Tulane University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Lu, H (corresponding author), Tulane Univ, Sch Med, Dept Biochem Mol Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	hlu2@tulane.edu			NCI, National Institutes of Health (NIH) [095441, CA079721, CA129828, CA172468]; NIH [CA134796]; CPRIT [RP120124]; NSFC [81101966]; NATIONAL CANCER INSTITUTE [R01CA160394, R01CA134796, R01CA079721, R01CA172468, R01CA129828] Funding Source: NIH RePORTER	NCI, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NCI, National Institutes of Health (NIH) Grants 095441, CA079721, CA129828, and CA172468 (to H. L.); NIH Grant CA134796 and CPRIT (RP120124) (to E. R. F.); and NSFC Grant 81101966 (to Y. Z.).	Ak P, 2010, FASEB J, V24, P3643, DOI 10.1096/fj.10-160549; Antonini D, 2010, J INVEST DERMATOL, V130, P1249, DOI 10.1038/jid.2009.438; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dotsch V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004887; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Han ZY, 2002, J BIOL CHEM, V277, P17154, DOI 10.1074/jbc.M112401200; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Hwang I, 1999, P NATL ACAD SCI USA, V96, P4880, DOI 10.1073/pnas.96.9.4880; Ianakiev P, 2000, AM J HUM GENET, V67, P59, DOI 10.1086/302972; ISRAEL A, 1989, EMBO J, V8, P3793, DOI 10.1002/j.1460-2075.1989.tb08556.x; Jin Y, 2008, MOL CELL BIOL, V28, P1218, DOI 10.1128/MCB.01198-07; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Koster MI, 2006, DEV BIOL, V289, P253, DOI 10.1016/j.ydbio.2005.10.041; Liao JM, 2011, J BIOL CHEM, V286, P33901, DOI 10.1074/jbc.M111.262030; Lin YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000680; MacPartlin M, 2005, J BIOL CHEM, V280, P30604, DOI 10.1074/jbc.M503352200; MacPartlin M, 2008, J BIOL CHEM, V283, P15754, DOI 10.1074/jbc.M801394200; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; McGrath JA, 2001, HUM MOL GENET, V10, P221, DOI 10.1093/hmg/10.3.221; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Murata T, 2003, BIOORG MED CHEM LETT, V13, P913, DOI 10.1016/S0960-894X(02)01046-6; O'Dea EL, 2008, MOL CELL, V30, P632, DOI 10.1016/j.molcel.2008.03.017; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Romanov VS, 2010, CELL CYCLE, V9, P3945, DOI 10.4161/cc.9.19.13160; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; Serber Z, 2002, MOL CELL BIOL, V22, P8601, DOI 10.1128/MCB.22.24.8601-8611.2002; Su XH, 2012, CELL METAB, V16, P511, DOI 10.1016/j.cmet.2012.09.006; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Tang GL, 2001, MOL CELL, V8, P1005, DOI 10.1016/S1097-2765(01)00380-X; van Bokhoven H, 2001, AM J HUM GENET, V69, P481, DOI 10.1086/323123; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zeng SX, 2002, EMBO J, V21, P5487, DOI 10.1093/emboj/cdf540; Zhang Q, 2011, J BIOL CHEM, V286, P38264, DOI 10.1074/jbc.M111.277012; Zhang Y, 2011, EMBO REP, V12, P811, DOI 10.1038/embor.2011.98	43	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18184	18193		10.1074/jbc.M113.466540	http://dx.doi.org/10.1074/jbc.M113.466540			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23589370	hybrid, Green Published			2022-12-28	WOS:000320721900023
J	Okeyo, G; Wang, W; Wei, SP; Kirk, KL				Okeyo, George; Wang, Wei; Wei, Shipeng; Kirk, Kevin L.			Converting Nonhydrolyzable Nucleotides to Strong Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Agonists by Gain of Function (GOF) Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-BINDING; CATALYTIC CYCLE; CONFORMATIONAL-CHANGE; P-GLYCOPROTEIN; GAMMA-S; CHANNEL; DOMAIN; HYDROLYSIS; MECHANISM; 2ND	Cystic fibrosis transmembrane conductance regulator (CFTR) is the only ligand-gated ion channel that hydrolyzes its agonist, ATP. CFTR gating has been argued to be tightly coupled to its enzymatic activity, but channels do open occasionally in the absence of ATP and are reversibly activated (albeit weakly) by nonhydrolyzable nucleotides. Why the latter only weakly activates CFTR is not understood. Here we show that CFTR activation by adenosine 5'-O-(thiotriphosphate) (ATP gamma S), adenosine 5'-(beta,gamma-imino)triphosphate (AMP-PNP), and guanosine 5'-3-O-(thio)triphosphate (GTP gamma S) is enhanced substantially by gain of function (GOF) mutations in the cytosolic loops that increase unliganded activity. This enhancement correlated with the base-line nucleotide-independent activity for several GOF mutations. AMP-PNP or ATP gamma S activation required both nucleotide binding domains (NBDs) and was disrupted by a cystic fibrosis mutation in NBD1 (G551D). GOF mutant channels deactivated very slowly upon AMP-PNP or ATP gamma S removal (tau(deac) similar to 100 s) implying tight binding between the two NBDs. Despite this apparently tight binding, neither AMP-PNP nor ATP gamma S activated even the strongest GOF mutant as strongly as ATP. ATP gamma S-activated wild type channels deactivated more rapidly, indicating that GOF mutations in the cytosolic loops reciprocally/allosterically affect nucleotide occupancy of the NBDs. A GOF mutation substantially rescued defective ATP-dependent gating of G1349D-CFTR, a cystic fibrosis NBD2 signature sequence mutant. Interestingly, the G1349D mutation strongly disrupted activation by AMP-PNP but not by ATP gamma S, indicating that these analogs interact differently with the NBDs. We conclude that poorly hydrolyzable nucleotides are less effective than ATP at opening CFTR channels even when they bind tightly to the NBDs but are converted to stronger agonists by GOF mutations.	[Okeyo, George; Wang, Wei; Wei, Shipeng; Kirk, Kevin L.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Kirk, Kevin L.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Dept Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kirk, KL (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 982B MCLM,1720 2nd Ave South, Birmingham, AL 35294 USA.	klkirk@uab.edu			National Institutes of Health [R01 DK056796]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK056796.	Aleksandrov AA, 1998, FEBS LETT, V431, P97, DOI 10.1016/S0014-5793(98)00713-3; Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; Auerbach A, 2012, J PHYSIOL-LONDON, V590, P93, DOI 10.1113/jphysiol.2011.214684; Bai YH, 2010, J GEN PHYSIOL, V136, P293, DOI 10.1085/jgp.201010480; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Chang YC, 1999, BIOPHYS J, V77, P2542, DOI 10.1016/S0006-3495(99)77089-X; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Csanady L, 2006, J GEN PHYSIOL, V128, P523, DOI 10.1085/jgp.200609558; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Eckford PDW, 2012, J BIOL CHEM, V287, P36639, DOI 10.1074/jbc.M112.393637; Galzi JL, 1996, P NATL ACAD SCI USA, V93, P1853, DOI 10.1073/pnas.93.5.1853; Grosman C, 2000, J GEN PHYSIOL, V115, P621, DOI 10.1085/jgp.115.5.621; Gulick AM, 1997, BIOCHEMISTRY-US, V36, P11619, DOI 10.1021/bi9712596; GUNDERSON KL, 1995, CELL, V82, P231, DOI 10.1016/0092-8674(95)90310-0; GUNDERSON KL, 1994, J BIOL CHEM, V269, P19349; Hennager DJ, 2001, P NATL ACAD SCI USA, V98, P3594, DOI 10.1073/pnas.051633298; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Mathews CJ, 1998, J PHYSIOL-LONDON, V508, P365, DOI 10.1111/j.1469-7793.1998.365bq.x; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Payen L, 2005, MOL PHARMACOL, V67, P1944, DOI 10.1124/mol.104.007708; Purohit P, 2009, P NATL ACAD SCI USA, V106, P115, DOI 10.1073/pnas.0809272106; Ramjeesingh M, 1999, BIOCHEMISTRY-US, V38, P1463, DOI 10.1021/bi982243y; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; Szentpetery Z, 2004, J BIOL CHEM, V279, P41670, DOI 10.1074/jbc.M406484200; Szollosi A, 2010, J GEN PHYSIOL, V136, P407, DOI 10.1085/jgp.201010434; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang W, 2005, J BIOL CHEM, V280, P23622, DOI 10.1074/jbc.M503118200; Wang W, 2005, J GEN PHYSIOL, V125, P127, DOI 10.1085/jgp.200409115; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zhou M, 1999, P NATL ACAD SCI USA, V96, P10466, DOI 10.1073/pnas.96.18.10466	44	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17122	17133		10.1074/jbc.M112.442582	http://dx.doi.org/10.1074/jbc.M112.442582			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23620589	Green Published, hybrid			2022-12-28	WOS:000320380600010
J	Mendez, TL; De Chatterjee, A; Duarte, TT; Gazos-Lopes, F; Robles-Martinez, L; Roy, D; Sun, JJ; Maldonado, RA; Roychowdhury, S; Almeida, IC; Das, S				Mendez, Tavis L.; De Chatterjee, Atasi; Duarte, Trevor T.; Gazos-Lopes, Felipe; Robles-Martinez, Leobarda; Roy, Debarshi; Sun, Jianjun; Maldonado, Rosa A.; Roychowdhury, Sukla; Almeida, Igor C.; Das, Siddhartha			Glucosylceramide Transferase Activity Is Critical for Encystation and Viable Cyst Production by an Intestinal Protozoan, Giardia lamblia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-METABOLISM; SPHINGOLIPID SYNTHESIS; LIPID-METABOLISM; SYNTHASE; PROTEIN; CYCLE; WALL; DIFFERENTIATION; INHIBITOR; IDENTIFICATION	The production of viable cysts by Giardia is essential for its survival in the environment and for spreading the infection via contaminated food and water. The hallmark of cyst production (also known as encystation) is the biogenesis of encystation-specific vesicles (ESVs) that transport cyst wall proteins to the plasma membrane of the trophozoite before laying down the protective cyst wall. However, the molecules that regulate ESV biogenesis and maintain cyst viability have never before been identified. Here, we report that giardial glucosylceramide transferase-1 (gGlcT1), an enzyme of sphingolipid biosynthesis, plays a key role in ESV biogenesis and maintaining cyst viability. We find that overexpression of this enzyme induced the formation of aggregated/enlarged ESVs and generated clustered cysts with reduced viability. The silencing of gGlcT1 synthesis by antisense morpholino oligonucleotide abolished ESV production and generated mostly nonviable cysts. Interestingly, when gGlcT1-overexpressed Giardia was transfected with anti-gGlcT1 morpholino, the enzyme activity, vesicle biogenesis, and cyst viability returned to normal, suggesting that the regulated expression of gGlcT1 is important for encystation and viable cyst production. Furthermore, the overexpression of gGlcT1 increased the influx of membrane lipids and fatty acids without altering the fluidity of plasma membranes, indicating that the expression of gGlcT1 activity is linked to lipid internalization and maintaining the overall lipid balance in this parasite. Taken together, our results suggest that gGlcT1 is a key player of ESV biogenesis and cyst viability and therefore could be targeted for developing new anti-giardial therapies.	[Mendez, Tavis L.; De Chatterjee, Atasi; Duarte, Trevor T.; Gazos-Lopes, Felipe; Robles-Martinez, Leobarda; Roy, Debarshi; Sun, Jianjun; Maldonado, Rosa A.; Almeida, Igor C.; Das, Siddhartha] Univ Texas El Paso, El Paso, TX 79968 USA; [Robles-Martinez, Leobarda; Roychowdhury, Sukla] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA; [Mendez, Tavis L.; De Chatterjee, Atasi; Duarte, Trevor T.; Gazos-Lopes, Felipe; Roy, Debarshi; Sun, Jianjun; Maldonado, Rosa A.; Roychowdhury, Sukla; Almeida, Igor C.; Das, Siddhartha] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso	Das, S (corresponding author), Univ Texas El Paso, Dept Biol Sci, 500 W Univ Ave, El Paso, TX 79968 USA.	sdas@utep.edu	Roy, Debarshi/AAF-7179-2019; Almeida, Igor C./AAF-9409-2019; Maldonado, Rosa A/A-8363-2009	Almeida, Igor C./0000-0002-2443-8213; 	National Institutes of Health Grant [R01AI 095667]; National Institutes of Health RISE Grant from NIGMS [5R25GM069621-10]; National Institutes of Health Grant from the National Institutes of Minority Health and Disparity [G12MD007592]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008012, R25GM069621] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health RISE Grant from NIGMS; National Institutes of Health Grant from the National Institutes of Minority Health and Disparity; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI 095667 (S.D.).; Supported by National Institutes of Health RISE Grant 5R25GM069621-10 from NIGMS.; GC-MS, ESI-MS/MS, confocal microscopy, sequencing, and statistical analyses were carried out in the Biomolecule Analysis, Genomic Analysis, Cytometry, Screening and Imaging, and Statistical Consulting Core Facilities at the Border Biomedical Research Center, University of Texas at El Paso, supported by National Institutes of Health Grant G12MD007592 from the National Institutes of Minority Health and Disparity. We thank Dr. Julia Bader for helping us with statistical analysis and Dr. Armando Varela for help with confocal microscopy. We also thank Dr. Chin-Hung Sun (Taiwan) for providing us with pNT5 expression plasmid.	Acharya U, 2003, SCIENCE, V299, P1740, DOI 10.1126/science.1080549; Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Atilla-Gokcumen GE, 2011, J AM CHEM SOC, V133, P10010, DOI 10.1021/ja202804b; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Bittencourt-Silvestre J, 2010, ARCH MICROBIOL, V192, P259, DOI 10.1007/s00203-010-0554-z; BOUCHER SEM, 1990, INFECT IMMUN, V58, P3516, DOI 10.1128/IAI.58.11.3516-3522.1990; Carpenter ML, 2009, EUKARYOT CELL, V8, P916, DOI 10.1128/EC.00041-09; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Couto AS, 2004, EUR J BIOCHEM, V271, P2204, DOI 10.1111/j.1432-1033.2004.04150.x; Das S, 1996, EXP PARASITOL, V83, P19, DOI 10.1006/expr.1996.0045; Das S, 2002, INT J PARASITOL, V32, P655, DOI 10.1016/S0020-7519(02)00006-1; Das S, 2001, TRENDS PARASITOL, V17, P316, DOI 10.1016/S1471-4922(01)01901-8; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Dijkhuis AJ, 2006, MOL CANCER THER, V5, P593, DOI 10.1158/1535-7163.MCT-05-0457; DuBois KN, 2008, J BIOL CHEM, V283, P18024, DOI 10.1074/jbc.M802133200; Ellis JE, 1996, MOL BIOCHEM PARASIT, V81, P13, DOI 10.1016/0166-6851(96)02677-1; Fridberg A, 2008, J CELL SCI, V121, P522, DOI 10.1242/jcs.016741; Gable K, 2010, J BIOL CHEM, V285, P22844, DOI 10.1074/jbc.M110.122259; Gerwig GJ, 2002, GLYCOBIOLOGY, V12, P499, DOI 10.1093/glycob/cwf059; Gibson GR, 1999, EXP PARASITOL, V92, P1, DOI 10.1006/expr.1999.4389; GILLIN FD, 1989, EXP PARASITOL, V69, P164, DOI 10.1016/0014-4894(89)90185-9; Gottig N, 2006, J BIOL CHEM, V281, P18156, DOI 10.1074/jbc.M602081200; Gu YP, 2011, J CELL BIOL, V193, P667, DOI 10.1083/jcb.201010075; Gupta V, 2010, J LIPID RES, V51, P866, DOI 10.1194/jlr.D002949; Hehl AB, 2004, MOL MICROBIOL, V53, P19, DOI 10.1111/j.1365-2958.2004.04115.x; Hernandez Y, 2008, INFECT IMMUN, V76, P2939, DOI 10.1128/IAI.00116-08; Hernandez Y, 2007, INT J PARASITOL, V37, P21, DOI 10.1016/j.ijpara.2006.09.008; Hillig I, 2003, FEBS LETT, V553, P365, DOI 10.1016/S0014-5793(03)01058-5; House SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002167; ICHIKAWA S, 1994, P NATL ACAD SCI USA, V91, P2703, DOI 10.1073/pnas.91.7.2703; JARROLL EL, 1981, MOL BIOCHEM PARASIT, V2, P187, DOI 10.1016/0166-6851(81)90099-2; Jarroll EL, 2001, J EUKARYOT MICROBIOL, V48, P22, DOI 10.1111/j.1550-7408.2001.tb00412.x; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Kohyama-Koganeya A, 2011, J LIPID RES, V52, P1392, DOI 10.1194/jlr.M014266; Kovacs P, 2000, CELL BIOCHEM FUNCT, V18, P269; Lauwaet T, 2007, CURR OPIN MICROBIOL, V10, P554, DOI 10.1016/j.mib.2007.09.011; Li YS, 2008, GLYCOBIOLOGY, V18, P166, DOI 10.1093/glycob/cwm127; Lujan HD, 1996, J EUKARYOT MICROBIOL, V43, P237, DOI 10.1111/j.1550-7408.1996.tb01398.x; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; Lujan HD, 1996, P NATL ACAD SCI USA, V93, P7628, DOI 10.1073/pnas.93.15.7628; Maldonado RA, 2006, J PARASITOL, V92, P1064, DOI 10.1645/GE-845R.1; MCCAFFERY JM, 1994, EXP PARASITOL, V79, P220, DOI 10.1006/expr.1994.1086; MOWATT MR, 1995, MOL MICROBIOL, V15, P955, DOI 10.1111/j.1365-2958.1995.tb02364.x; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Norris-Cervetto E, 2004, J BIOL CHEM, V279, P40412, DOI 10.1074/jbc.M404466200; Pan YJ, 2009, J BIOL CHEM, V284, P17975, DOI 10.1074/jbc.M109.012047; Pata MO, 2010, NEW PHYTOL, V185, P611, DOI 10.1111/j.1469-8137.2009.03123.x; Pernet F, 2006, J CHROMATOGR A, V1137, P127, DOI 10.1016/j.chroma.2006.10.059; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; RANI CSS, 1995, J BIOL CHEM, V270, P2859, DOI 10.1074/jbc.270.6.2859; Reiner DS, 2008, INT J PARASITOL, V38, P935, DOI 10.1016/j.ijpara.2007.12.005; Rittershaus PC, 2006, J CLIN INVEST, V116, P1651, DOI 10.1172/JCI27890; SCHUPP DG, 1987, APPL ENVIRON MICROB, V53, P704, DOI 10.1128/AEM.53.4.704-707.1987; SCHUPP DG, 1987, J PARASITOL, V73, P723, DOI 10.2307/3282401; Sener K, 2004, MICROBIOL-SGM, V150, P1225, DOI 10.1099/mic.0.26898-0; Separovic D, 2012, ANTICANCER RES, V32, P753; SHUKLA A, 1991, J LIPID RES, V32, P713; Sonda S, 2008, ANTIMICROB AGENTS CH, V52, P563, DOI 10.1128/AAC.01105-07; Stefanic S, 2010, J LIPID RES, V51, P2527, DOI 10.1194/jlr.M003392; Stefanic S, 2009, J CELL SCI, V122, P2846, DOI 10.1242/jcs.049411; Stevens TL, 1997, EXP PARASITOL, V86, P133, DOI 10.1006/expr.1997.4162; Uchida Y, 2002, J LIPID RES, V43, P1293, DOI 10.1194/jlr.M100442-JLR200; Yichoy M, 2011, PARASITOLOGY, V138, P267, DOI 10.1017/S0031182010001277; Yichoy M, 2009, MOL BIOCHEM PARASIT, V165, P67, DOI 10.1016/j.molbiopara.2009.01.004; Zhang K, 2010, ADV EXP MED BIOL, V688, P238	66	7	7	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16747	16760		10.1074/jbc.M112.438416	http://dx.doi.org/10.1074/jbc.M112.438416			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23589290	Green Published, hybrid			2022-12-28	WOS:000320378900049
J	Erion, DM; Kotas, ME; McGlashon, J; Yonemitsu, S; Hsiao, JJ; Nagai, Y; Iwasaki, T; Murray, SF; Bhanot, S; Cline, GW; Samuel, VT; Shulman, GI; Gillum, MP				Erion, Derek M.; Kotas, Maya E.; McGlashon, Jacob; Yonemitsu, Shin; Hsiao, Jennifer J.; Nagai, Yoshio; Iwasaki, Takanori; Murray, Susan F.; Bhanot, Sanjay; Cline, Gary W.; Samuel, Varman T.; Shulman, Gerald I.; Gillum, Matthew P.			cAMP-responsive Element-binding Protein (CREB)-regulated Transcription Coactivator 2 (CRTC2) Promotes Glucagon Clearance and Hepatic Amino Acid Catabolism to Regulate Glucose Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULATES GLUCONEOGENESIS; ENDOGENOUS GLUCAGON; INSULIN-RESISTANCE; TORC2; LIVER; HYPERGLYCEMIA; IMMUNONEUTRALIZATION; STREPTOZOTOCIN; SOMATOSTATIN; MAINTENANCE	cAMP-responsive element-binding protein (CREB)-regulated transcription coactivator 2 (CRTC2) regulates transcription of gluconeogenic genes by specifying targets for the transcription factor CREB in response to glucagon. We used an antisense oligonucleotide directed against CRTC2 in both normal rodents and in rodent models of increased gluconeogenesis to better understand the role of CRTC2 in metabolic disease. In the context of severe hyperglycemia and elevated hepatic glucose production, CTRC2 knockdown (KD) improved glucose homeostasis by reducing endogenous glucose production. Interestingly, despite the known role of CRTC2 in coordinating gluconeogenic gene expression, CRTC2KD in a rodent model of type 2 diabetes resulted in surprisingly little alteration of glucose production. However, CRTC2KD animals had elevated circulating concentrations of glucagon and a similar to 80% reduction in glucagon clearance. When this phenomenon was prevented with somatostatin or a glucagon-neutralizing antibody, endogenous glucose production was reduced by CRTC2 KD. Additionally, CRTC2 inhibition resulted in reduced expression of several glucagon-induced pyridoxal 5'-phosphate-dependent enzymes that convert amino acids to gluconeogenic intermediates, suggesting that it may control substrate availability as well as gluconeogenic gene expression. CRTC2 is an important regulator of gluconeogenesis with tremendous impact in models of elevated hepatic glucose production. Surprisingly, it is also part of a previously unidentified negative feedback loop that degrades glucagon and regulates amino acid metabolism to coordinately control glucose homeostasis in vivo.	[Erion, Derek M.; Yonemitsu, Shin; Hsiao, Jennifer J.; Nagai, Yoshio; Iwasaki, Takanori; Cline, Gary W.; Samuel, Varman T.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06536 USA; [Erion, Derek M.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06536 USA; [Kotas, Maya E.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06536 USA; [Erion, Derek M.; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06536 USA; [Samuel, Varman T.] Vet Affairs Med Ctr, West Haven, CT 06516 USA; [Murray, Susan F.; Bhanot, Sanjay] ISIS Pharmaceut, Carlsbad, CA 92008 USA; [McGlashon, Jacob; Gillum, Matthew P.] Univ Iowa, Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Isis Pharmaceuticals Inc; University of Iowa	Gillum, MP (corresponding author), Univ Iowa, Carver Coll Med, Dept Neurol, 1000 ML,25 S Grand Ave, Iowa City, IA 52242 USA.	matthew-gillum@uiowa.edu	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Gillum, Matthew/0000-0003-4893-012X	United States Public Health Service [R01 DK-40936, P30 DK-45735]; University of Iowa; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, R01DK040936, U24DK059635] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); University of Iowa; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by United States Public Health Service Grants R01 DK-40936 and P30 DK-45735 (to G. I. S.) and the University of Iowa. S. F. M. and S. B. own stock and/or hold stock options in Isis Pharmaceuticals.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRAND CL, 1995, AM J PHYSIOL-ENDOC M, V269, pE469, DOI 10.1152/ajpendo.1995.269.3.E469; BRAND CL, 1994, DIABETOLOGIA, V37, P985, DOI 10.1007/BF00400461; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Erion DM, 2009, CELL METAB, V10, P499, DOI 10.1016/j.cmet.2009.10.007; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; KOERKER DJ, 1974, SCIENCE, V184, P482, DOI 10.1126/science.184.4135.482; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Le Lay J, 2009, CELL METAB, V10, P55, DOI 10.1016/j.cmet.2009.06.006; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Masiello P, 1998, DIABETES, V47, P224, DOI 10.2337/diabetes.47.2.224; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049572; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; ROCHA DM, 1972, J CLIN INVEST, V51, P2346, DOI 10.1172/JCI107046; Saberi M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1137, DOI 10.1152/ajpendo.00158.2009; Samuel VT, 2006, DIABETES, V55, P2042, DOI 10.2337/db05-0705; Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Sloop KW, 2004, J CLIN INVEST, V113, P1571, DOI 10.1172/JCI200420911; Sorensen H, 2006, DIABETES, V55, P2843, DOI 10.2337/db06-0222; WAHREN J, 1976, LANCET, V2, P1213; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Watanabe C, 2012, DIABETES, V61, P74, DOI 10.2337/db11-0739; Yang JX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-281	30	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16167	16176		10.1074/jbc.M113.460246	http://dx.doi.org/10.1074/jbc.M113.460246			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23595987	Green Published, hybrid			2022-12-28	WOS:000319822300067
J	Lee, M; Choy, JC				Lee, Martin; Choy, Jonathan C.			Positive Feedback Regulation of Human Inducible Nitric-oxide Synthase Expression by Ras Protein S-Nitrosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; CD8 T-CELLS; NEGATIVE-FEEDBACK; MOLECULAR-CLONING; MESSENGER-RNA; NO SYNTHASE; ALLOGENEIC RESPONSES; ACTIVATION; INDUCTION; PROMOTER	The production of nitric oxide (NO) by inducible NO synthase (iNOS) regulates many aspects of physiology and pathology. The expression of iNOS needs to be tightly regulated to balance the broad ranging properties of NO. We have investigated the feedback regulation of cytokine-induced iNOS expression by NO in human cells. The pharmacological inhibition of iNOS activity reduced iNOS protein levels in response to cytokine stimulation in a human epithelial cell line (A549 cells) as well as in primary human astrocytes and bronchial epithelial cells. The addition of exogenous NO using a NO donor prevented the reduction in iNOS levels caused by blockade of iNOS activity. Examination of signaling pathways affected by iNOS indicated that NO S-nitrosylated Ras. Transfection of cells with a S-nitrosylation-resistant Ras mutant reduced iNOS protein levels, indicating a role for this Ras modification in the amplification of iNOS levels. Further, the induction of iNOS protein levels correlated with the late activation of the phosphatidylinositol 3-kinase/Akt and mammalian target of rapamycin (mTOR) pathways, and inhibition of these signaling molecules reduced iNOS levels. Altogether, our findings reveal a previously unknown regulatory pathway that amplifies iNOS expression in human cells.	[Lee, Martin; Choy, Jonathan C.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Choy, JC (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	jonathan.choy@sfu.ca		Choy, Jonathan/0000-0003-1837-8514	Natural Sciences and Engineering Research Council; Canadian Institutes for Health Research (CIHR) Training Grant in Transplantation; CIHR New Investigator award; Michael Smith Foundation for Health Research Scholar award	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research (CIHR) Training Grant in Transplantation(Canadian Institutes of Health Research (CIHR)); CIHR New Investigator award(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research Scholar award(Michael Smith Foundation for Health Research)	This work was funded by a Natural Sciences and Engineering Research Council Discovery Grant (to J.C.C.).; Supported by a Canadian Institutes for Health Research (CIHR) Training Grant in Transplantation.; Recipient of CIHR New Investigator and Michael Smith Foundation for Health Research Scholar awards. To whom correspondence should be addressed: Dept. of Molecular Biology and Biochemistry, Simon Fraser University, 8888 University Dr., Burnaby, British Columbia V5A 1S6, Canada. Tel.: 778-782-8701; Fax: 778-782-5583; E-mail: jonathan.choy@sfu.ca.	Albakri QA, 1996, J BIOL CHEM, V271, P5414, DOI 10.1074/jbc.271.10.5414; Boese M, 1996, BRIT J PHARMACOL, V119, P707, DOI 10.1111/j.1476-5381.1996.tb15730.x; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Chang K, 2004, EXP MOL MED, V36, P311, DOI 10.1038/emm.2004.42; Chen SC, 2008, BIOCHEM BIOPH RES CO, V377, P1274, DOI 10.1016/j.bbrc.2008.10.144; Choy JC, 2009, AM J TRANSPLANT, V9, P2281, DOI 10.1111/j.1600-6143.2009.02771.x; Choy JC, 2007, P NATL ACAD SCI USA, V104, P1313, DOI 10.1073/pnas.0607731104; De Alba J, 1999, J NEUROCHEM, V72, P248, DOI 10.1046/j.1471-4159.1999.0720248.x; Deora AA, 2000, BIOCHEMISTRY-US, V39, P9901, DOI 10.1021/bi992954b; Deora AA, 1998, J BIOL CHEM, V273, P29923, DOI 10.1074/jbc.273.45.29923; Escalante NK, 2011, ARTERIOSCL THROM VAS, V31, P1177, DOI 10.1161/ATVBAHA.111.224162; Galijasevic S, 2003, P NATL ACAD SCI USA, V100, P14766, DOI 10.1073/pnas.2435008100; Ganster RW, 2001, P NATL ACAD SCI USA, V98, P8638, DOI 10.1073/pnas.151239498; GRISCAVAGE JM, 1993, J IMMUNOL, V151, P6329; Grumbach IM, 2005, J MOL CELL CARDIOL, V39, P595, DOI 10.1016/j.yjmcc.2005.06.012; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hinz B, 2000, BIOCHEM BIOPH RES CO, V271, P353, DOI 10.1006/bbrc.2000.2632; Ibiza S, 2008, P NATL ACAD SCI USA, V105, P10507, DOI 10.1073/pnas.0711062105; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jin HK, 2009, BIOL PHARM BULL, V32, P988, DOI 10.1248/bpb.32.988; Kristof AS, 2006, J BIOL CHEM, V281, P23958, DOI 10.1074/jbc.M513918200; Kristof AS, 2001, J BIOL CHEM, V276, P8445, DOI 10.1074/jbc.M009563200; LANDER HM, 1995, J BIOL CHEM, V270, P7017, DOI 10.1074/jbc.270.13.7017; Lander HM, 1997, J BIOL CHEM, V272, P4323, DOI 10.1074/jbc.272.7.4323; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee Sunhee C., 1996, Methods (Orlando), V10, P31, DOI 10.1006/meth.1996.0075; Liu AC, 2012, J IMMUNOL, V188, P1544, DOI 10.4049/jimmunol.1102527; LOWENSTEIN CJ, 1992, P NATL ACAD SCI USA, V89, P6711, DOI 10.1073/pnas.89.15.6711; MARSDEN PA, 1992, FEBS LETT, V307, P287, DOI 10.1016/0014-5793(92)80697-F; Moncada S, 2006, BRIT J PHARMACOL, V147, pS193, DOI 10.1038/sj.bjp.0706458; Mott HR, 1997, BIOCHEMISTRY-US, V36, P3640, DOI 10.1021/bi962790o; MUHL H, 1995, J CLIN INVEST, V95, P1941, DOI 10.1172/JCI117876; Nathan C, 2011, CELL, V147, P257, DOI 10.1016/j.cell.2011.09.031; Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293; NISHIDA K, 1992, J CLIN INVEST, V90, P2092, DOI 10.1172/JCI116092; NUSSLER AK, 1992, J EXP MED, V176, P261, DOI 10.1084/jem.176.1.261; Oliveira CJR, 2008, NITRIC OXIDE-BIOL CH, V18, P241, DOI 10.1016/j.niox.2008.02.001; PADGETT EL, 1992, BIOCHEM BIOPH RES CO, V186, P775, DOI 10.1016/0006-291X(92)90813-Z; Pahan K, 2000, J NEUROCHEM, V74, P2288, DOI 10.1046/j.1471-4159.2000.0742288.x; Perez-Sala D, 2001, AM J PHYSIOL-RENAL, V280, pF466, DOI 10.1152/ajprenal.2001.280.3.F466; Poljakovic M, 2003, EUR J PHARMACOL, V469, P21, DOI 10.1016/S0014-2999(03)01716-3; Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002; Rahman MA, 2010, J BIOL CHEM, V285, P3806, DOI 10.1074/jbc.M109.059782; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; SCHNEEMANN M, 1993, J INFECT DIS, V167, P1358, DOI 10.1093/infdis/167.6.1358; Schneemann M, 2002, NAT IMMUNOL, V3, P102, DOI 10.1038/ni0202-102a; SESSA WC, 1992, J BIOL CHEM, V267, P15274; Shanshiashvili L, 2011, CELL BIOCHEM BIOPHYS, V59, P191, DOI 10.1007/s12013-010-9132-x; SHEFFLER LA, 1995, J IMMUNOL, V155, P886; STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773; Switzer CH, 2012, MOL CANCER RES, V10, P1203, DOI 10.1158/1541-7786.MCR-12-0124; Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148; Teng KK, 1999, J BIOL CHEM, V274, P37315, DOI 10.1074/jbc.274.52.37315; Tennyson AG, 2011, CHEM BIOL, V18, P1211, DOI 10.1016/j.chembiol.2011.09.009; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Vaziri ND, 1999, HYPERTENSION, V34, P1237, DOI 10.1161/01.HYP.34.6.1237; von Rossum A, 2011, J BIOL CHEM, V286, P21137, DOI 10.1074/jbc.M110.197657; WEINBERG JB, 1995, BLOOD, V86, P1184; Williams JG, 2003, P NATL ACAD SCI USA, V100, P6376, DOI 10.1073/pnas.1037299100; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; XIE QW, 1993, J EXP MED, V177, P1779, DOI 10.1084/jem.177.6.1779; Yu ZY, 2006, J BIOL CHEM, V281, P9101, DOI 10.1074/jbc.M511049200; Yu ZY, 2005, AM J PHYSIOL-RENAL, V288, pF214, DOI 10.1152/ajprenal.00258.2004; Yuhanna IS, 1999, AM J RESP CELL MOL, V21, P629, DOI 10.1165/ajrcmb.21.5.3749	68	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15677	15686		10.1074/jbc.M113.475319	http://dx.doi.org/10.1074/jbc.M113.475319			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23599434	Green Published, hybrid			2022-12-28	WOS:000319822300024
J	Sun, Q; Gao, WT; Loughran, P; Shapiro, R; Fan, J; Billiar, TR; Scott, MJ				Sun, Qian; Gao, Wentao; Loughran, Patricia; Shapiro, Rick; Fan, Jie; Billiar, Timothy R.; Scott, Melanie J.			Caspase 1 Activation Is Protective against Hepatocyte Cell Death by Up-regulating Beclin 1 Protein and Mitochondrial Autophagy in the Setting of Redox Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER; HYPOXIA; DYSFUNCTION; INJURY; SENSITIVITY; INHIBITION; APOPTOSIS; RELEASE; TRAUMA; IL-18	Caspase 1 activation can be induced by oxidative stress, which leads to the release of the proinflammatory cytokines IL1 beta and IL18 in myeloid cells and a potentially damaging inflammatory response. However, little is known about the role of caspase 1 in non-immune cells, such as hepatocytes, that express and activate the inflammasome but do not produce a significant amount of IL1 beta/IL18. Here we demonstrate that caspase 1 activation protects against cell death after redox stress induced by hypoxia/reoxygenation in hepatocytes. Mechanistically, we show that caspase 1 reduces mitochondrial respiration and reactive oxygen species by increasing mitochondrial autophagy and subsequent clearance of mitochondria in hepatocytes after hypoxia/reoxygenation. Caspase 1 increases autophagic flux through up-regulating autophagy initiator beclin 1 during redox stress and is an important cell survival factor in hepatocytes. We find that during hemorrhagic shock with resuscitation, an in vivo mouse model associated with severe hepatic redox stress, caspase 1 activation is also protective against liver injury and excessive oxidative stress through the up-regulation of beclin 1. Our findings suggest an alternative role for caspase 1 activation in promoting adaptive responses to oxidative stress and, more specifically, in limiting reactive oxygen species production and damage in cells and tissues where IL1 beta/IL18 are not highly expressed.	[Sun, Qian; Gao, Wentao; Loughran, Patricia; Shapiro, Rick; Fan, Jie; Billiar, Timothy R.; Scott, Melanie J.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA; [Sun, Qian] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Loughran, Patricia] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA 15213 USA; [Fan, Jie] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Scott, MJ (corresponding author), Univ Pittsburgh, Dept Surg, NW607 MUH,3459 5th Ave, Pittsburgh, PA 15213 USA.	scottm@upmc.edu	Loughran, Patricia/AAB-1184-2021; Sun, Qian/E-8130-2015	Sun, Qian/0000-0002-1121-5344	National Institutes of Health [R01-HL-079669, P50-GM053789]; Surgical Infection Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM053789, R01GM102146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Surgical Infection Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-HL-079669 (to J. F.) and P50-GM053789 (to T. R. B.). This work was also supported by the Surgical Infection Society (to M. S.).	Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Burwell LS, 2009, J MOL CELL CARDIOL, V46, P804, DOI 10.1016/j.yjmcc.2009.02.026; Choi SW, 2011, J NEUROSCI, V31, P4524, DOI 10.1523/JNEUROSCI.5817-10.2011; Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341; Diaz F, 2008, CELL CALCIUM, V44, P24, DOI 10.1016/j.ceca.2007.12.004; FAULKNER KM, 1994, J BIOL CHEM, V269, P23471; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Gusdon AM, 2009, METHOD ENZYMOL, V456, P439, DOI 10.1016/S0076-6879(08)04424-8; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hoppeler H, 2003, EXP PHYSIOL, V88, P109, DOI 10.1113/eph8802513; Jarrar D, 2000, J TRAUMA, V49, P879, DOI 10.1097/00005373-200011000-00015; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kim JS, 2008, HEPATOLOGY, V47, P1725, DOI 10.1002/hep.22187; Kim JS, 2004, HEPATOLOGY, V39, P1533, DOI 10.1002/hep.20197; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lagoa CE, 2005, HEPATOLOGY, V42, P390, DOI 10.1002/hep.20797; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Li H, 2011, CANCER RES, V71, P3625, DOI 10.1158/0008-5472.CAN-10-4475; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; McCloskey CA, 2004, SHOCK, V22, P380, DOI 10.1097/01.shk.0000140660.78744.bf; Melnikov VY, 2001, J CLIN INVEST, V107, P1145, DOI 10.1172/JCI12089; Menzel CL, 2011, MOL MED, V17, P1031, DOI 10.2119/molmed.2011.00015; Mezzaroma E, 2011, P NATL ACAD SCI USA, V108, P19725, DOI 10.1073/pnas.1108586108; Miwa S, 2008, AGING CELL, V7, P920, DOI 10.1111/j.1474-9726.2008.00426.x; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Pagliaro P, 2011, ANTIOXID REDOX SIGN, V14, P833, DOI 10.1089/ars.2010.3245; Pessayre D, 2002, AM J PHYSIOL-GASTR L, V282, pG193, DOI 10.1152/ajpgi.00426.2001; Pomerantz BJ, 2001, P NATL ACAD SCI USA, V98, P2871, DOI 10.1073/pnas.041611398; Prince JM, 2007, SHOCK, V27, P157, DOI 10.1097/01.shk.0000245025.01365.8e; Pua HH, 2009, J IMMUNOL, V182, P4046, DOI 10.4049/jimmunol.0801143; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Venkatraman A, 2003, HEPATOLOGY, V38, P141, DOI 10.1053/jhep.2003.50293; Yoshioka J, 2012, J CLIN INVEST, V122, P267, DOI 10.1172/JCI44927; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zhang WH, 2003, P NATL ACAD SCI USA, V100, P16012, DOI 10.1073/pnas.2534856100; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	42	58	59	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15947	15958		10.1074/jbc.M112.426791	http://dx.doi.org/10.1074/jbc.M112.426791			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23589298	Green Published, hybrid			2022-12-28	WOS:000319822300047
J	Bonnet, M; Kurz, M; Mesa, S; Briand, C; Hennecke, H; Grutter, MG				Bonnet, Mariette; Kurz, Mareike; Mesa, Socorro; Briand, Christophe; Hennecke, Hauke; Gruetter, Markus G.			The Structure of Bradyrhizobium japonicum Transcription Factor FixK(2) Unveils Sites of DNA Binding and Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATABOLITE ACTIVATOR PROTEIN; LISTERIA-MONOCYTOGENES; ALLOSTERIC CONTROL; KEY REGULATOR; COMPLEX; OXYGEN; FNR; CASCADE; LEGUME; MODEL	FixK(2) is a regulatory protein that activates a large number of genes for the anoxic and microoxic, endosymbiotic, and nitrogen-fixing life styles of the alpha-proteobacterium Bradyrhizobium japonicum. FixK(2) belongs to the cAMP receptor protein (CRP) superfamily. Although most CRP family members are coregulated by effector molecules, the activity of FixK(2) is negatively controlled by oxidation of its single cysteine (Cys-183) located next to the DNA-binding domain and possibly also by proteolysis. Here, we report the three-dimensional x-ray structure of FixK(2), a representative of the FixK subgroup of the CRP superfamily. Crystallization succeeded only when (i) an oxidation- and protease-insensitive protein variant (FixK(2)(C183S)-His(6)) was used in which Cys-183 was replaced with serine and the C terminus was fused with a hexahistidine tag and (ii) this protein was allowed to form a complex with a 30-mer double-stranded target DNA. The structure of the FixK(2)-DNA complex was solved at a resolution of 1.77 angstrom, at which the protein formed a homodimer. The precise protein-DNA contacts were identified, which led to an affirmation of the canonical target sequence, the so-called FixK(2) box. The C terminus is surface-exposed, which might explain its sensitivity to specific cleavage and degradation. The oxidation-sensitive Cys-183 is also surface-exposed and in close proximity to DNA. Therefore, we propose a mechanism whereby the oxo acids generated after oxidation of the cysteine thiol cause an electrostatic repulsion, thus preventing specific DNA binding.	[Bonnet, Mariette; Mesa, Socorro; Hennecke, Hauke] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Kurz, Mareike; Briand, Christophe; Gruetter, Markus G.] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Grutter, MG (corresponding author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	gruetter@bioc.uzh.ch	Mesa, Socorro/G-7775-2015	Mesa, Socorro/0000-0001-7285-3940; , Mariette/0000-0001-5825-1708	Swiss National Science Foundation; ETH Zurich; University of Zurich; National Center of Competence in Research (NCCR) for Structural Biology; Ministerio de Economia y Competitividad of Spain	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich); University of Zurich; National Center of Competence in Research (NCCR) for Structural Biology(Swiss National Science Foundation (SNSF)); Ministerio de Economia y Competitividad of Spain(Spanish Government)	This work was supported in part by grants from the Swiss National Science Foundation (to H. H., S. M., and M. G. G.) and by funds from ETH Zurich and University of Zurich. Work in the laboratory of M. G. G. was supported through the framework of the National Center of Competence in Research (NCCR) for Structural Biology.; Supported by the Ministerio de Economia y Competitividad of Spain. Present address: Dept. of Soil Microbiology and Symbiotic Systems, Estacion Experimental del Zaidin, CSIC, E-18008 Granada, Spain.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agari Y, 2008, MOL MICROBIOL, V70, P60, DOI 10.1111/j.1365-2958.2008.06388.x; Bonnet M, 2013, FEBS LETT, V587, P88, DOI 10.1016/j.febslet.2012.11.014; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Chang C, 2009, MOL PLANT, V2, P370, DOI 10.1093/mp/ssn090; Chin KH, 2010, J MOL BIOL, V396, P646, DOI 10.1016/j.jmb.2009.11.076; Dufour YS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001027; Eiting M, 2005, MOL MICROBIOL, V56, P433, DOI 10.1111/j.1365-2958.2005.04561.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fic E, 2009, J MOL MICROB BIOTECH, V17, P1, DOI 10.1159/000178014; Giardina G, 2011, BIOCHEM SOC T, V39, P294, DOI 10.1042/BST0390294; Herler M, 2001, J BACTERIOL, V183, P5562, DOI 10.1128/JB.183.19.5562-5570.2001; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiley PJ, 1998, FEMS MICROBIOL REV, V22, P341, DOI 10.1111/j.1574-6976.1998.tb00375.x; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Levy C, 2008, MOL MICROBIOL, V70, P151, DOI 10.1111/j.1365-2958.2008.06399.x; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Masloboeva N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043421; Mesa S, 2005, J BACTERIOL, V187, P3329, DOI 10.1128/JB.187.10.3329-3338.2005; Mesa S, 2008, J BACTERIOL, V190, P6568, DOI 10.1128/JB.00748-08; Mesa S, 2009, P NATL ACAD SCI USA, V106, P21860, DOI 10.1073/pnas.0908097106; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nellen-Anthamatten D, 1998, J BACTERIOL, V180, P5251, DOI 10.1128/JB.180.19.5251-5255.1998; Parkinson G, 1996, J MOL BIOL, V260, P395, DOI 10.1006/jmbi.1996.0409; Passner JM, 1997, P NATL ACAD SCI USA, V94, P2843, DOI 10.1073/pnas.94.7.2843; Pauly N, 2006, J EXP BOT, V57, P1769, DOI 10.1093/jxb/erj184; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Santos R, 2001, MOL PLANT MICROBE IN, V14, P86, DOI 10.1094/MPMI.2001.14.1.86; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Sharma H, 2009, P NATL ACAD SCI USA, V106, P16604, DOI 10.1073/pnas.0908380106; Zhao MX, 2010, P NATL ACAD SCI USA, V107, P12487, DOI 10.1073/pnas.1001556107	34	17	17	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14238	14246		10.1074/jbc.M113.465484	http://dx.doi.org/10.1074/jbc.M113.465484			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23546876	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000319253500028
J	Couturier, M; Roussel, A; Rosengren, A; Leone, P; Stalbrand, H; Berrin, JG				Couturier, Marie; Roussel, Alain; Rosengren, Anna; Leone, Philippe; Stalbrand, Henrik; Berrin, Jean-Guy			Structural and Biochemical Analyses of Glycoside Hydrolase Families 5 and 26 beta-(1,4)-Mannanases from Podospora anserina Reveal Differences upon Manno-oligosaccharide Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULE; REESEI BETA-MANNANASE; TRICHODERMA-REESEI; SACCHAROMYCES-CEREVISIAE; 3-DIMENSIONAL STRUCTURE; SUBSTRATE-SPECIFICITY; CELLULOMONAS-FIMI; CRYSTAL-STRUCTURE; MYTILUS-EDULIS; ACTIVE-SITE	The microbial deconstruction of the plant cell wall is a key biological process that is of increasing importance with the development of a sustainable biofuel industry. The glycoside hydrolase families GH5 (PaMan5A) and GH26 (PaMan26A) endo-beta-1,4-mannanases from the coprophilic ascomycete Podospora anserina contribute to the enzymatic degradation of lignocellulosic biomass. In this study, P. anserina mannanases were further subjected to detailed comparative analysis of their substrate specificities, active site organization, and transglycosylation capacity. Although PaMan5A displays a classical mode of action, PaMan26A revealed an atypical hydrolysis pattern with the release of mannotetraose and mannose from mannopentaose resulting from a predominant binding mode involving the -4 subsite. The crystal structures of PaMan5A and PaMan26A were solved at 1.4 and 2.85 angstrom resolution, respectively. Analysis of the PaMan26A structure supported strong interaction with substrate at the -4 subsite mediated by two aromatic residues Trp-244 and Trp-245. The PaMan26A structure appended to its family 35 carbohydrate binding module revealed a short and proline-rich rigid linker that anchored together the catalytic and the binding modules.	[Couturier, Marie; Berrin, Jean-Guy] Aix Marseille Univ, INRA, BCF UMR1163, Polytech Marseille, F-13288 Marseille, France; [Roussel, Alain; Leone, Philippe] Aix Marseille Univ, CNRS UMR7257, F-13288 Marseille, France; [Rosengren, Anna; Stalbrand, Henrik] Lund Univ, Dept Biochem & Struct Biol, S-22100 Lund, Sweden	INRAE; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Lund University	Berrin, JG (corresponding author), INRA, Lab Biotechnol Champignons Filamenteux, Marseille, France.	jean-guy.berrin@univ-amu.fr	BERRIN, Jean-Guy/AAF-3107-2021; BERRIN, Jean-Guy/E-1460-2014; Couturier, Marie/ABB-1893-2021	BERRIN, Jean-Guy/0000-0001-7570-3745; Couturier, Marie/0000-0002-0032-1280	FUTUROL project; OSEO Innovation; FORMAS; VINNOVA	FUTUROL project; OSEO Innovation; FORMAS(Swedish Research Council Formas); VINNOVA(Vinnova)	This work was funded by the FUTUROL project and OSEO Innovation. This work was also supported by FORMAS and VINNOVA (to H. S.).	Anderson L, 2008, BIOCATAL BIOTRANSFOR, V26, P86, DOI 10.1080/10242420701788835; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Berrin JG, 2007, APPL MICROBIOL BIOT, V74, P1001, DOI 10.1007/s00253-006-0764-0; Bey M, 2013, APPL ENVIRON MICROB, V79, P488, DOI 10.1128/AEM.02942-12; Blanc E., 2011, BUSTER VERSION 2 11; Bolam DN, 1996, BIOCHEMISTRY-US, V35, P16195, DOI 10.1021/bi961866d; Bourgault R, 2005, PROTEIN SCI, V14, P1233, DOI 10.1110/ps.041260905; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; Correia MAS, 2010, BIOCHEMISTRY-US, V49, P6193, DOI 10.1021/bi1006139; Couturier M, 2011, APPL ENVIRON MICROB, V77, P237, DOI 10.1128/AEM.01761-10; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dilokpimol A, 2011, BBA-PROTEINS PROTEOM, V1814, P1720, DOI 10.1016/j.bbapap.2011.08.003; Ducros VMA, 2002, ANGEW CHEM INT EDIT, V41, P2824, DOI 10.1002/1521-3773(20020802)41:15<2824::AID-ANIE2824>3.0.CO;2-G; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FANUTTI C, 1995, J BIOL CHEM, V270, P29314, DOI 10.1074/jbc.270.49.29314; Fujimoto Z, 2002, J MOL BIOL, V316, P65, DOI 10.1006/jmbi.2001.5338; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Hagglund P, 2003, J BIOTECHNOL, V101, P37, DOI 10.1016/S0168-1656(02)00290-0; Harjunpaa V, 1999, FEBS LETT, V443, P149, DOI 10.1016/S0014-5793(98)01692-5; Hekmat O, 2010, BIOCHEMISTRY-US, V49, P4884, DOI 10.1021/bi100097f; Henrissat B, 1996, P NATL ACAD SCI USA, V93, P5674; Hilge M, 1996, ACTA CRYSTALLOGR D, V52, P1224, DOI 10.1107/S0907444996009006; Hogg D, 2003, BIOCHEM J, V371, P1027, DOI 10.1042/BJ20021860; Hogg D, 2001, J BIOL CHEM, V276, P31186, DOI 10.1074/jbc.M010290200; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ichinose H, 2005, J BIOL CHEM, V280, P25820, DOI 10.1074/jbc.M501024200; JENKINS J, 1995, FEBS LETT, V362, P281, DOI 10.1016/0014-5793(95)00252-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kauppinen M. S., 2003, U. S. Patent, Patent No. [6,566,114, 6566114]; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lafond M, 2012, APPL ENVIRON MICROB, V78, P8540, DOI 10.1128/AEM.02572-12; Larsson AM, 2006, J MOL BIOL, V357, P1500, DOI 10.1016/j.jmb.2006.01.044; Le Nours K, 2005, BIOCHEMISTRY-US, V44, P12700, DOI 10.1021/bi050779v; MATSUI I, 1991, J BIOCHEM-TOKYO, V109, P566, DOI 10.1093/oxfordjournals.jbchem.a123420; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Pell G, 2004, J BIOL CHEM, V279, P11777, DOI 10.1074/jbc.M311947200; Rosengren A, 2012, BIOCATAL BIOTRANSFOR, V30, P338, DOI 10.3109/10242422.2012.674726; Roussel A, 1991, SILICON GRAPHICS GEO, P86; Sabini E, 2000, ACTA CRYSTALLOGR D, V56, P3, DOI 10.1107/S0907444999013943; Setati ME, 2001, PROTEIN EXPRES PURIF, V21, P105, DOI 10.1006/prep.2000.1371; STALBRAND H, 1993, J BIOTECHNOL, V29, P229, DOI 10.1016/0168-1656(93)90055-R; Stoll D, 2000, FEMS MICROBIOL LETT, V183, P265, DOI 10.1111/j.1574-6968.2000.tb08969.x; Tailford LE, 2009, BIOCHEMISTRY-US, V48, P7009, DOI 10.1021/bi900515d; Timell T. E., 1967, Wood Science and Technology, V1, P45, DOI 10.1007/BF00592255; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Xu BZ, 2002, J BIOTECHNOL, V92, P267, DOI 10.1016/S0168-1656(01)00367-4; Yan XX, 2008, J MOL BIOL, V379, P535, DOI 10.1016/j.jmb.2008.03.068; Zhang YL, 2008, J BIOL CHEM, V283, P31551, DOI 10.1074/jbc.M803409200	53	72	79	3	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14624	14635		10.1074/jbc.M113.459438	http://dx.doi.org/10.1074/jbc.M113.459438			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23558681	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000319253500062
J	He, RS; Wu, QX; Zhou, HN; Huang, N; Chen, JG; Teng, JL				He, Runsheng; Wu, Qixi; Zhou, Haining; Huang, Ning; Chen, Jianguo; Teng, Junlin			Cep57 Protein Is Required for Cytokinesis by Facilitating Central Spindle Microtubule Organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUNDLING PROTEIN; CROSS-LINKING; AURORA-B; COMPLETION; INTEGRITY; BINDING; PRC1; TRAFFICKING; ABSCISSION; COMPONENT	Cytokinesis is the final stage of cell division in which the cytoplasm of a cell is divided into two daughter cells after the segregation of genetic material, and the central spindle and midbody are considered to be the essential structures required for the initiation and completion of cytokinesis. Here, we determined that the centrosome protein Cep57, which is localized to the central spindle and midbody, acts as a spindle organizer and is required for cytokinesis. Depletion of Cep57 disrupted microtubule assembly of the central spindle and further led to abnormal midbody localization of MKLP1, Plk1, and Aurora B, which resulted in cytokinesis failure and the formation of binuclear cells. Furthermore, we found that Cep57 directly recruited Tektin 1 to the midbody matrix to regulate microtubule organization. Thus, our data reveal that Cep57 is essential for cytokinesis via regulation of central spindle assembly and formation of the midbody.	[He, Runsheng; Wu, Qixi; Zhou, Haining; Huang, Ning; Chen, Jianguo; Teng, Junlin] Peking Univ, Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China; [He, Runsheng; Wu, Qixi; Zhou, Haining; Huang, Ning; Chen, Jianguo; Teng, Junlin] Peking Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Bioengn, Beijing 100871, Peoples R China; [Chen, Jianguo] Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Chen, JG (corresponding author), Peking Univ, Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing 100871, Peoples R China.	chenjg@pku.edu.cn; junlinteng@pku.edu.cn	Zhou, Haining/S-1863-2019; Zhang, Xiaoming/L-2904-2013; Huang, Ning/AAP-4851-2021	Huang, Ning/0000-0002-8233-2572; Wu, Qixi/0000-0002-9959-2629	National Natural Science Foundation of China [30971433, 31171283]; Major State Basic Research Development Program of China 973 Program Grant [2010CB833705]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China 973 Program Grant(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 30971433 and 31171283 and Major State Basic Research Development Program of China 973 Program Grant 2010CB833705.	Amos LA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-229; AMOS WB, 1986, J CELL SCI, P55; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Bossard C, 2003, NAT CELL BIOL, V5, P433, DOI 10.1038/ncb979; Cuevas R, 2013, CANCER RES, V73, P1400, DOI 10.1158/0008-5472.CAN-12-1857; Durcan TM, 2008, J CELL BIOL, V181, P595, DOI 10.1083/jcb.200711160; Emanuele MJ, 2007, CELL, V130, P893, DOI 10.1016/j.cell.2007.07.023; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Guse A, 2005, CURR BIOL, V15, P778, DOI 10.1016/j.cub.2005.03.041; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Li HH, 2006, J CELL SCI, V119, P4452, DOI 10.1242/jcs.03219; Lukinaviclus G, 2013, CURR BIOL, V23, P265, DOI 10.1016/j.cub.2012.12.030; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Meunier S, 2009, TRAFFIC, V10, P1765, DOI 10.1111/j.1600-0854.2009.00985.x; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Momotani K, 2008, BIOCHEM J, V412, P265, DOI 10.1042/BJ20071501; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Otegui MS, 2005, TRENDS CELL BIOL, V15, P404, DOI 10.1016/j.tcb.2005.06.003; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Snape K, 2011, NAT GENET, V43, P527, DOI 10.1038/ng.822; Steigemann P, 2009, TRENDS CELL BIOL, V19, P606, DOI 10.1016/j.tcb.2009.07.008; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Subramanian R, 2010, CELL, V142, P433, DOI 10.1016/j.cell.2010.07.012; Wu QX, 2012, CELL RES, V22, P1390, DOI 10.1038/cr.2012.61; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015; Zhu CJ, 2006, P NATL ACAD SCI USA, V103, P6196, DOI 10.1073/pnas.0506926103	32	11	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14384	14390		10.1074/jbc.M112.441501	http://dx.doi.org/10.1074/jbc.M112.441501			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23569207	Green Published, hybrid			2022-12-28	WOS:000319253500041
J	Jenkins, PM; Vasavda, C; Hostettler, J; Davis, JQ; Abdi, K; Bennett, V				Jenkins, Paul M.; Vasavda, Chirag; Hostettler, Janell; Davis, Jonathan Q.; Abdi, Khadar; Bennett, Vann			E-cadherin Polarity Is Determined by a Multifunction Motif Mediating Lateral Membrane Retention through Ankyrin-G and Apical-lateral Transcytosis through Clathrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DARBY CANINE KIDNEY; POLYMERIC IMMUNOGLOBULIN RECEPTOR; BRONCHIAL EPITHELIAL-CELLS; CYTOPLASMIC DOMAIN; BETA-CATENIN; BASOLATERAL POLARITY; ERYTHROCYTE ANKYRIN; ADHERENS JUNCTIONS; ADHESION MOLECULE; DILEUCINE MOTIF	We report a highly conserved motif in the E-cadherin juxtamembrane domain that determines apical-lateral polarity by conferring both restricted mobility at the lateral membrane and transcytosis of apically mis-sorted protein to the lateral membrane. Mutations causing either increased lateral membrane mobility or loss of apical-lateral transcytosis result in partial mis-sorting of E-cadherin in Madin-Darby canine kidney cells. However, loss of both activities results in complete loss of polarity. We present evidence that residues required for restricted mobility mediate retention at the lateral membrane through interaction with ankyrin-G, whereas dileucine residues conferring apical-lateral transcytosis act through a clathrin-dependent process and function in an editing pathway. Ankyrin-G interaction with E-cadherin is abolished by the same mutations resulting in increased E-cadherin mobility. Clathrin heavy chain knockdown and dileucine mutation of E-cadherin both cause the same partial loss of polarity of E-cadherin. Moreover, clathrin knockdown causes no further change in polarity of E-cadherin with dileucine mutation but does completely randomize E-cadherin mutants lacking ankyrin-binding. Dileucine mutation, but not loss of ankyrin binding, prevented transcytosis of apically mis-sorted E-cadherin to the lateral membrane. Finally, neurofascin, which binds ankyrin but lacks dileucine residues, exhibited partial apical-lateral polarity that was abolished by mutation of its ankyrin-binding site but was not affected by clathrin knockdown. The polarity motif thus integrates complementary activities of lateral membrane retention through ankyrin-G and apical-lateral transcytosis of mis-localized protein through clathrin. Together, the combination of retention and editing function to ensure a high fidelity steady state localization of E-cadherin at the lateral membrane.	[Jenkins, Paul M.; Hostettler, Janell; Davis, Jonathan Q.; Bennett, Vann] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Jenkins, Paul M.; Vasavda, Chirag; Bennett, Vann] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Abdi, Khadar; Bennett, Vann] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Bennett, Vann] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University	Bennett, V (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	vann.bennett@duke.edu	Vasavda, Chirag/AAX-3751-2020; Jenkins, Paul/C-9098-2015	Vasavda, Chirag/0000-0003-4558-4698; Jenkins, Paul/0000-0002-4207-5823	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; BENNETT V, 1981, P NATL ACAD SCI-BIOL, V78, P7550, DOI 10.1073/pnas.78.12.7550; Bennett V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003012; Boiko T, 2007, J NEUROSCI, V27, P590, DOI 10.1523/JNEUROSCI.4302-06.2007; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716; Cai XJ, 2006, MOL BIOL EVOL, V23, P550, DOI 10.1093/molbev/msj056; CASANOVA JE, 1991, CELL, V66, P65, DOI 10.1016/0092-8674(91)90139-P; DAVIS JQ, 1993, J CELL BIOL, V121, P121, DOI 10.1083/jcb.121.1.121; de Beco S, 2009, P NATL ACAD SCI USA, V106, P7010, DOI 10.1073/pnas.0811253106; Deborde S, 2008, NATURE, V452, P719, DOI 10.1038/nature06828; Devarajan P, 1996, J CELL BIOL, V133, P819, DOI 10.1083/jcb.133.4.819; DRENCKHAHN D, 1987, EUR J CELL BIOL, V43, P479; Duffield A, 2004, TRAFFIC, V5, P449, DOI 10.1111/j.1398-9219.2004.00192.x; Farr GA, 2009, J CELL BIOL, V186, P269, DOI 10.1083/jcb.200901021; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Folsch H, 2003, J CELL BIOL, V163, P351, DOI 10.1083/jcb.200309020; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gravotta D, 2012, DEV CELL, V22, P811, DOI 10.1016/j.devcel.2012.02.004; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; He M, 2012, J BIOL CHEM, V287, P43995, DOI 10.1074/jbc.M112.417501; Hsu WL, 2013, PROTEIN SCI, V22, P258, DOI 10.1002/pro.2207; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Kizhatil K, 2004, J BIOL CHEM, V279, P16706, DOI 10.1074/jbc.M314296200; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Miranda KC, 2001, J BIOL CHEM, V276, P22565, DOI 10.1074/jbc.M101907200; Miyashita Y, 2007, J CELL SCI, V120, P4395, DOI 10.1242/jcs.03489; MOSTOV KE, 1986, CELL, V47, P359, DOI 10.1016/0092-8674(86)90592-1; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; NELSON WJ, 1990, J CELL BIOL, V110, P349, DOI 10.1083/jcb.110.2.349; NELSON WJ, 1986, J CELL BIOL, V103, P1751, DOI 10.1083/jcb.103.5.1751; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9; Reider A, 2011, J CELL SCI, V124, P1613, DOI 10.1242/jcs.073395; RODRIGUEZBOULAN E, 1978, P NATL ACAD SCI USA, V75, P5071, DOI 10.1073/pnas.75.10.5071; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Takahashi D, 2011, GASTROENTEROLOGY, V141, P621, DOI 10.1053/j.gastro.2011.04.056; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Zhang X, 1998, J BIOL CHEM, V273, P30785, DOI 10.1074/jbc.273.46.30785	49	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14018	14031		10.1074/jbc.M113.454439	http://dx.doi.org/10.1074/jbc.M113.454439			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23530049	hybrid, Green Published			2022-12-28	WOS:000319253500008
J	Hu, YL; Ribbe, MW				Hu, Yilin; Ribbe, Markus W.			Biosynthesis of the Iron-Molybdenum Cofactor of Nitrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEIN ALPHA-SUBUNIT; MOFE-PROTEIN; MOLECULAR INSIGHTS; FEMOCO INSERTION; STRUCTURAL BASIS; NIFEN; PRECURSOR; CARBON; MATURATION; MECHANISM	The iron-molybdenum cofactor (the M-cluster) serves as the active site of molybdenum nitrogenase. Arguably one of the most complex metal cofactors in biological systems, the M-cluster is assembled through the formation of an 8Fe core prior to the insertion of molybdenum and homocitrate into this core. Here, we review the recent progress in the research area of M-cluster assembly, with an emphasis on our work that provides useful insights into the mechanistic details of this process.	[Hu, Yilin; Ribbe, Markus W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Hu, YL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	yilinh@uci.edu; mribbe@uci.edu			National Institutes of Health [GM67626]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM67626 (to M. W. R.). This is the second article in the Thematic Minireview Series on Metals in Biology 2013.	Boal AK, 2011, SCIENCE, V332, P1089, DOI 10.1126/science.1205358; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Corbett MC, 2006, P NATL ACAD SCI USA, V103, P1238, DOI 10.1073/pnas.0507853103; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; Fay AW, 2007, J INORG BIOCHEM, V101, P1630, DOI 10.1016/j.jinorgbio.2007.03.013; Fay AW, 2011, ANGEW CHEM INT EDIT, V50, P7787, DOI 10.1002/anie.201102724; Fay AW, 2010, DALTON T, V39, P3124, DOI 10.1039/c000264j; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Howard JB, 2006, P NATL ACAD SCI USA, V103, P17088, DOI 10.1073/pnas.0603978103; Howard JB, 1996, CHEM REV, V96, P2965, DOI 10.1021/cr9500545; Hu Y, 2007, J BIOL INORG CHEM, V12, P449, DOI 10.1007/s00775-006-0199-1; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17119, DOI 10.1073/pnas.0602647103; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17125, DOI 10.1073/pnas.0602651103; Hu YL, 2006, J BIOL CHEM, V281, P30534, DOI 10.1074/jbc.M605527200; Hu YL, 2005, P NATL ACAD SCI USA, V102, P3236, DOI 10.1073/pnas.0409201102; Jeoung JH, 2009, BIOCHEMISTRY-US, V48, P11505, DOI 10.1021/bi901443z; Kaiser JT, 2011, SCIENCE, V331, P91, DOI 10.1126/science.1196954; KIM JS, 1992, NATURE, V360, P553, DOI 10.1038/360553a0; Lancaster KM, 2013, J AM CHEM SOC, V135, P610, DOI 10.1021/ja309254g; Lancaster KM, 2011, SCIENCE, V334, P974, DOI 10.1126/science.1206445; Rubio LM, 2008, ANNU REV MICROBIOL, V62, P93, DOI 10.1146/annurev.micro.62.081307.162737; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Schmid B, 2002, SCIENCE, V296, P352, DOI 10.1126/science.1070010; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; Spatzal T, 2011, SCIENCE, V334, P940, DOI 10.1126/science.1214025; Wiig JA, 2012, SCIENCE, V337, P1672, DOI 10.1126/science.1224603; Wiig JA, 2011, P NATL ACAD SCI USA, V108, P8623, DOI 10.1073/pnas.1102773108; Yoshizawa JM, 2009, J AM CHEM SOC, V131, P9321, DOI 10.1021/ja9035225	30	40	46	4	77	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13173	13177		10.1074/jbc.R113.454041	http://dx.doi.org/10.1074/jbc.R113.454041			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23539617	Green Published, hybrid			2022-12-28	WOS:000318850300003
J	Wypijewski, KJ; Howie, J; Reilly, L; Tulloch, LB; Aughton, KL; McLatchie, LM; Shattock, MJ; Calaghan, SC; Fuller, W				Wypijewski, Krzysztof J.; Howie, Jacqueline; Reilly, Louise; Tulloch, Lindsay B.; Aughton, Karen L.; McLatchie, Linda M.; Shattock, Michael J.; Calaghan, Sarah C.; Fuller, William			A Separate Pool of Cardiac Phospholemman That Does Not Regulate or Associate with the Sodium Pump MULTIMERS OF PHOSPHOLEMMAN IN VENTRICULAR MUSCLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SARCOPLASMIC-RETICULUM; CA2+ PUMP; FXYD PROTEINS; CROSS-LINKING; PHOSPHORYLATION; PHOSPHOLAMBAN; OLIGOMERIZATION; NA,K-ATPASE; ACTIVATION	Phospholemman (PLM), the principal quantitative sarcolemmal substrate for protein kinases A and C in the heart, regulates the cardiac sodium pump. Much like phospholamban, which regulates the related ATPase SERCA, PLM is reported to oligomerize. We investigated subpopulations of PLM in adult rat ventricular myocytes based on phosphorylation status. Co-immunoprecipitation identified two pools of PLM: one not associated with the sodium pump phosphorylated at Ser(63) and one associated with the pump, both phosphorylated at Ser(68) and unphosphorylated. Phosphorylation of PLM at Ser(63) following activation of PKC did not abrogate association of PLM with the pump, so its failure to associate with the pump was not due to phosphorylation at this site. All pools ofPLMco-localized to cell surface caveolin-enriched microdomains with sodium pump alpha subunits, despite the lack of caveolin-binding motif in PLM. Mass spectrometry analysis of phosphospecific immunoprecipitation reactions revealed no unique protein interactions for Ser(63)-phosphorylated PLM, and cross-linking reagents also failed to identify any partner proteins for this pool. In lysates from hearts of heterozygous transgenic animals expressing wild type and unphosphorylatable PLM, Ser(63)-phosphorylated PLM co-immunoprecipitated unphosphorylatable PLM, confirming the existence of PLM multimers. Dephosphorylation of the PLM multimer does not change sodium pump activity. Hence like phospholamban, PLM exists as a pump-inhibiting monomer and an unassociated oligomer. The distribution of different PLM phosphorylation states to different pools may be explained by their differential proximity to protein phosphatases rather than a direct effect of phosphorylation on PLM association with the pump.	[Fuller, William] Univ Dundee, Div Cardiovasc & Diabet Med, Coll Med Dent & Nursing, Dundee DD1 9SY, Scotland; [Aughton, Karen L.; McLatchie, Linda M.; Shattock, Michael J.] Kings Coll London, Cardiovasc Div, London SE1 7EH, England; [Calaghan, Sarah C.] Univ Leeds, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England	University of Dundee; University of London; King's College London; University of Leeds	Fuller, W (corresponding author), Ninewells Hosp, Div Cardiovasc & Diabet Med, Mailbox 12,Level 5, Dundee DD1 9SY, Scotland.	w.fuller@dundee.ac.uk		Calaghan, Sarah/0000-0002-9145-2576; Tulloch, Lindsay/0000-0001-7223-5106; Fuller, William/0000-0002-5883-4433; Shattock, Michael/0000-0001-6242-7585	British Heart Foundation [RG/07/001, PG/10/93/28650]; Medical Research Council [G0700903]; British Heart Foundation [RG/12/4/29426, PG/12/6/29366] Funding Source: researchfish; Medical Research Council [1218481, G0001230] Funding Source: researchfish; MRC [G0700903, G0001230] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was support by grants from the British Heart Foundation (RG/07/001 to W. F., and M. J. S., and PG/10/93/28650 to W. F. and S. C. C.) and the Medical Research Council (G0700903 to W. F.).	Autry JM, 1997, J BIOL CHEM, V272, P15872, DOI 10.1074/jbc.272.25.15872; Beevers AJ, 2006, PROTEIN SCI, V15, P1127, DOI 10.1110/ps.051899406; Bell JR, 2009, EXP PHYSIOL, V94, P330, DOI 10.1113/expphysiol.2008.045823; Bibert S, 2011, J BIOL CHEM, V286, P18562, DOI 10.1074/jbc.M110.184101; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; Bossuyt J, 2005, CIRC RES, V97, P558, DOI 10.1161/01.RES.0000181172.27931.c3; Bossuyt J, 2006, J BIOL CHEM, V281, P32765, DOI 10.1074/jbc.M606254200; Bossuyt J, 2009, J BIOL CHEM, V284, P26749, DOI 10.1074/jbc.M109.047357; Byrne DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044879; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; Chen ZH, 2010, J BIOL CHEM, V285, P3253, DOI 10.1074/jbc.M109.080820; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Despa S, 2008, CIRCULATION, V117, P1849, DOI 10.1161/CIRCULATIONAHA.107.754051; Despa S, 2007, AM J PHYSIOL-CELL PH, V293, pC321, DOI 10.1152/ajpcell.00597.2006; Despa S, 2012, CARDIOVASC RES, V95, P480, DOI 10.1093/cvr/cvs213; Dhar-Chowdhury P, 2007, CELL MOL LIFE SCI, V64, P3069, DOI 10.1007/s00018-007-7332-3; El-Armouche A, 2011, FASEB J, V25, P4467, DOI 10.1096/fj.11-184903; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Fuller W, 2004, FASEB J, V18, P197, DOI 10.1096/fj.03-0213fje; Fuller W, 2013, CELL MOL LIFE SCI, V70, P1357, DOI 10.1007/s00018-012-1134-y; Fuller W, 2009, AM J PHYSIOL-CELL PH, V296, pC1346, DOI 10.1152/ajpcell.00523.2008; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Han F, 2006, CIRC RES, V99, P1376, DOI 10.1161/01.RES.0000251667.73461.fb; Hong MY, 2011, FASEB J, V25, P2456, DOI 10.1096/fj.10-176669; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Howie J, 2013, BIOCHEM SOC T, V41, P95, DOI 10.1042/BST20120269; Khafaga M, 2012, P NATL ACAD SCI USA, V109, P20756, DOI 10.1073/pnas.1207866109; Kimura T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029269; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Lecuona E, 2006, FASEB J, V20, P2618, DOI 10.1096/fj.06-6503fje; Li Y, 2011, J BIOL CHEM, V286, P32289, DOI 10.1074/jbc.M111.247825; Liu LJ, 2006, AM J PHYSIOL-CELL PH, V291, pC569, DOI 10.1152/ajpcell.00002.2006; MOORMAN JR, 1995, NATURE, V377, P737, DOI 10.1038/377737a0; Moshitzky S, 2012, J BIOL CHEM, V287, P21130, DOI 10.1074/jbc.M112.347807; Mueller B, 2004, BIOCHEMISTRY-US, V43, P8754, DOI 10.1021/bi049732k; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Pavlovic D, 2007, FASEB J, V21, P1539, DOI 10.1096/fj.06-7269com; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; Silverman BD, 2005, CARDIOVASC RES, V65, P93, DOI 10.1016/j.cardiores.2004.09.005; Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Song QJ, 2011, J BIOL CHEM, V286, P9120, DOI 10.1074/jbc.M110.198036; Sutherland BW, 2008, J MASS SPECTROM, V43, P699, DOI 10.1002/jms.1415; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Swift F, 2007, CARDIOVASC RES, V75, P109, DOI 10.1016/j.cardiores.2007.03.017; Tulloch LB, 2011, J BIOL CHEM, V286, P36020, DOI 10.1074/jbc.M111.282145; WALAAS SI, 1994, BIOCHEM J, V304, P635, DOI 10.1042/bj3040635; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200	52	23	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13808	13820		10.1074/jbc.M113.460956	http://dx.doi.org/10.1074/jbc.M113.460956			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23532852	hybrid, Green Published			2022-12-28	WOS:000318850300062
J	Kanaoka, Y; Maekawa, A; Austen, KF				Kanaoka, Yoshihide; Maekawa, Akiko; Austen, K. Frank			Identification of GPR99 Protein as a Potential Third Cysteinyl Leukotriene Receptor with a Preference for Leukotriene E-4 Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUINEA-PIG TRACHEAL; ASTHMATIC SUBJECTS; SMOOTH-MUSCLE; HISTAMINE HYPERRESPONSIVENESS; CYSLT(2) RECEPTOR; CONTROLLED-TRIAL; IN-VITRO; MONTELUKAST; ANTAGONIST; BIOSYNTHESIS	The cysteinyl leukotrienes (cys-LTs), leukotriene C-4 (LTC4), a conjugation product of glutathione and eicosatetraenoic acid, and its metabolites, LTD4 and LTE4, are lipid mediators of smooth muscle constriction and inflammation in asthma. LTD4 is the most potent ligand for the type 1 cys-LT receptor (CysLT(1)R), and LTC4 and LTD4 have similar lesser potency for CysLT(2)R, whereas LTE4 has little potency for either receptor. Cysltr1/Cysltr2(-/-) mice, lacking the two defined receptors, exhibited a comparable dose-dependent vascular leak to intradermal injection of LTC4 or LTD4 and an augmented response to LTE4 as compared with WT mice. As LTE4 retains a cysteine residue and might provide recognition via a dicarboxylic acid structure, we screened cDNAs within the P2Y nucleotide receptor family containing CysLTRs and dicarboxylic acid receptors with trans-activator reporter gene assays. GPR99, previously described as an oxoglutarate receptor (Oxgr1), showed both a functional and a binding response to LTE4 in these transfectants. We generated Gpr99(-/-) and Gpr99/Cysltr1/Cysltr2(-/-) mice for comparison with WT and Cysltr1/Cysltr2(-/-) mice. Strikingly, GPR99 deficiency in the Cysltr1/Cysltr2(-/-) mice virtually eliminated the vascular leak in response to the cys-LT ligands, indicating GPR99 as a potential CysLT(3)R active in the Cysltr1/Cysltr2(-/-) mice. Importantly, the Gpr99(-/-) mice showed a dose-dependent loss of LTE4-mediated vascular permeability, but not to LTC4 or LTD4, revealing a preference of GPR99 for LTE4 even when CysLT(1)R is present. As LTE4 is the predominant cys-LT species in inflamed tissues, GPR99 may provide a new therapeutic target.	Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Kanaoka, Y (corresponding author), Brigham & Womens Hosp, Smith Bldg,Rm 626C,1 Jimmy Fund Way, Boston, MA 02115 USA.	ykanaoka@rics.bwh.harvard.edu			National Institutes of Health [U19AI095219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095219] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant U19AI095219 (to Y.K.).	ARM JP, 1990, AM REV RESPIR DIS, V142, P1112, DOI 10.1164/ajrccm/142.5.1112; Austen KF, 2009, J ALLERGY CLIN IMMUN, V124, P406, DOI 10.1016/j.jaci.2009.05.046; Back M, 2011, PHARMACOL REV, V63, P539, DOI 10.1124/pr.110.004184; CHRISTIE PE, 1992, AM REV RESPIR DIS, V146, P1531, DOI 10.1164/ajrccm/146.6.1531; CHRISTIE PE, 1992, AM REV RESPIR DIS, V146, P1506, DOI 10.1164/ajrccm/146.6.1506; Dahlen SE, 2002, AM J RESP CRIT CARE, V165, P9, DOI 10.1164/ajrccm.165.1.2010080; DAVIDSON AB, 1987, AM REV RESPIR DIS, V135, P333; DRAZEN JM, 1992, AM REV RESPIR DIS, V146, P104, DOI 10.1164/ajrccm/146.1.104; Gauvreau GM, 2001, AM J RESP CRIT CARE, V164, P1495, DOI 10.1164/ajrccm.164.8.2102033; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Hui YQ, 2001, J BIOL CHEM, V276, P47489, DOI 10.1074/jbc.M107556200; Inbe H, 2004, J BIOL CHEM, V279, P19790, DOI 10.1074/jbc.M400360200; JACQUES CAJ, 1991, BRIT J PHARMACOL, V104, P859, DOI 10.1111/j.1476-5381.1991.tb12518.x; Kamohara M, 2001, BIOCHEM BIOPH RES CO, V287, P1088, DOI 10.1006/bbrc.2001.5695; LAITINEN LA, 1993, LANCET, V341, P989, DOI 10.1016/0140-6736(93)91073-U; LAM BK, 1989, J BIOL CHEM, V264, P12885; LAM S, 1988, J ALLERGY CLIN IMMUN, V81, P711, DOI 10.1016/0091-6749(88)91043-3; LEE TH, 1984, P NATL ACAD SCI-BIOL, V81, P4922, DOI 10.1073/pnas.81.15.4922; Leff JA, 1998, NEW ENGL J MED, V339, P147, DOI 10.1056/NEJM199807163390302; LEWIS RA, 1980, BIOCHEM BIOPH RES CO, V96, P271, DOI 10.1016/0006-291X(80)91210-3; Lynch KR, 1999, NATURE, V399, P789; Maekawa A, 2001, P NATL ACAD SCI USA, V98, P2256, DOI 10.1073/pnas.041624398; Maekawa A, 2008, P NATL ACAD SCI USA, V105, P16695, DOI 10.1073/pnas.0808993105; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; Ogasawara H, 2002, J BIOL CHEM, V277, P18763, DOI 10.1074/jbc.M109447200; Park JS, 2010, ALLERGY ASTHMA IMMUN, V2, P48, DOI 10.4168/aair.2010.2.1.48; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; SALA A, 1990, J BIOL CHEM, V265, P21771; Schoneberg T, 2007, PURINERG SIGNAL, V3, P255, DOI 10.1007/s11302-007-9064-0; Shirasaki H, 2002, CLIN EXP ALLERGY, V32, P1007, DOI 10.1046/j.1365-2222.2002.01425.x; SOTER NA, 1983, J INVEST DERMATOL, V80, P115, DOI 10.1111/1523-1747.ep12531738; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014; Wittenberger T, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-17; Zarini S, 2009, P NATL ACAD SCI USA, V106, P8296, DOI 10.1073/pnas.0903851106	35	137	141	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					10967	10972		10.1074/jbc.C113.453704	http://dx.doi.org/10.1074/jbc.C113.453704			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23504326	hybrid, Green Published			2022-12-28	WOS:000317915500003
J	Hudson, BD; Due-Hansen, ME; Christiansen, E; Hansen, AM; Mackenzie, AE; Murdoch, H; Pandey, SK; Ward, RJ; Marquez, R; Tikhonova, IG; Ulven, T; Milligan, G				Hudson, Brian D.; Due-Hansen, Maria E.; Christiansen, Elisabeth; Hansen, Anna Mette; Mackenzie, Amanda E.; Murdoch, Hannah; Pandey, Sunil K.; Ward, Richard J.; Marquez, Rudi; Tikhonova, Irina G.; Ulven, Trond; Milligan, Graeme			Defining the Molecular Basis for the First Potent and Selective Orthosteric Agonists of the FFA2 Free Fatty Acid Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BIOAVAILABLE GPR40 AGONIST; FUNCTIONAL-CHARACTERIZATION; EXTRACELLULAR LOOPS; PEPTIDE-1 SECRETION; SPECIES ORTHOLOGS; INSULIN-SECRETION; ADME PROPERTIES; IONIC LOCKS; ACTIVATION	FFA2 is a G protein-coupled receptor that responds to short chain fatty acids and has generated interest as a therapeutic target for metabolic and inflammatory conditions. However, definition of its functions has been slowed by a dearth of selective ligands that can distinguish it from the closely related FFA3. At present, the only selective ligands described for FFA2 suffer from poor potency, altered signaling due to allosteric modes of action, or a lack of function at non-human orthologs of the receptor. To address the need for novel selective ligands, we synthesized two compounds potentially having FFA2 activity and examined the molecular basis of their function. These compounds were confirmed to be potent and selective orthosteric FFA2 agonists. A combination of ligand structure-activity relationship, pharmacological analysis, homology modeling, species ortholog comparisons, and mutagenesis studies were then employed to define the molecular basis of selectivity and function of these ligands. From this, we identified key residues within both extracellular loop 2 and the transmembrane domain regions of FFA2 critical for ligand function. One of these ligands was active with reasonable potency at rodent orthologs of FFA2 and demonstrated the role of FFA2 in inhibition of lipolysis and glucagon-like peptide-1 secretion in murine-derived 3T3-L1 and STC-1 cell lines, respectively. Together, these findings describe the first potent and selective FFA2 orthosteric agonists and demonstrate key aspects of ligand interaction within the binding site of FFA2 that will be invaluable in future ligand development at this receptor.	[Hudson, Brian D.; Mackenzie, Amanda E.; Murdoch, Hannah; Ward, Richard J.; Milligan, Graeme] Univ Glasgow, Mol Pharmacol Grp, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Due-Hansen, Maria E.; Christiansen, Elisabeth; Pandey, Sunil K.; Ulven, Trond] Univ Southern Denmark, Dept Phys Chem & Pharm, DK-5230 Odense M, Denmark; [Hansen, Anna Mette; Marquez, Rudi] Univ Glasgow, Sch Chem, Glasgow G12 8QQ, Lanark, Scotland; [Tikhonova, Irina G.] Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland	University of Glasgow; University of Southern Denmark; University of Glasgow; Queens University Belfast	Milligan, G (corresponding author), Univ Glasgow, Mol Pharmacol Grp, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Wolfson Link Bldg 253, Glasgow G12 8QQ, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk	Due-Hansen, Maria E./K-1823-2019; Milligan, Graeme/F-9426-2011; Ulven, Trond/H-5500-2015; Hudson, B. D./H-4845-2013; Pandey, Sunil Kumar/AAP-2234-2021; Marquez, Rudi/F-4045-2014; Rexen Ulven, Elisabeth/S-2026-2017	Milligan, Graeme/0000-0002-6946-3519; Ulven, Trond/0000-0002-8135-1755; Hudson, B. D./0000-0001-7059-0091; Rexen Ulven, Elisabeth/0000-0003-1243-7587; Due-Hansen, Maria Elisabeth/0000-0001-8032-2189; Marquez, Rudi/0000-0001-9777-2012; Hansen, Anna Mette/0000-0003-1162-8592	Wellcome Trust [089600/Z/09/Z]; Danish Council for Strategic Research [11-116196]; Canadian Institutes of Health Research	Wellcome Trust(Wellcome TrustEuropean Commission); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	These studies were supported by Wellcome Trust Grant 089600/Z/09/Z (to G. M.), Danish Council for Strategic Research Grant 11-116196 (to T. U. and G. M.), and a fellowship from the Canadian Institutes of Health Research (to B. D. H.).	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Brantis C. E., 2011, Int. Appl, Patent No. [WO2011092284, 2011092284]; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Burt AR, 1996, BIOCHEM J, V320, P227, DOI 10.1042/bj3200227; Christiansen E, 2008, J MED CHEM, V51, P7061, DOI 10.1021/jm8010178; Christiansen E, 2012, J MED CHEM, V55, P6624, DOI 10.1021/jm3002026; Christiansen E, 2011, J MED CHEM, V54, P6691, DOI 10.1021/jm2005699; Christiansen E, 2010, ACS MED CHEM LETT, V1, P345, DOI 10.1021/ml100106c; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Hamid H., 2010, PCT Int. Appl., Patent No. 2010066682; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Houze JB, 2012, BIOORG MED CHEM LETT, V22, P1267, DOI 10.1016/j.bmcl.2011.10.118; Hudson BD, 2011, ADV PHARMACOL, V62, P175, DOI 10.1016/B978-0-12-385952-5.00006-3; Hudson BD, 2012, J BIOL CHEM, V287, P41195, DOI 10.1074/jbc.M112.396259; Hudson BD, 2012, FASEB J, V26, P4951, DOI 10.1096/fj.12-213314; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee T, 2008, MOL PHARMACOL, V74, P1599, DOI 10.1124/mol.108.049536; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Negoro N, 2010, ACS MED CHEM LETT, V1, P290, DOI 10.1021/ml1000855; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Schmidt J, 2011, J BIOL CHEM, V286, P10628, DOI 10.1074/jbc.M110.210872; Shimpukade B, 2012, J MED CHEM, V55, P4511, DOI 10.1021/jm300215x; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Smith NJ, 2011, MOL PHARMACOL, V80, P163, DOI 10.1124/mol.110.070789; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Sum CS, 2009, J BIOL CHEM, V284, P3529, DOI 10.1074/jbc.M806987200; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Ulven Trond, 2012, Front Endocrinol (Lausanne), V3, P111, DOI 10.3389/fendo.2012.00111; Vinolo MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021205; Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Zaibi MS, 2010, FEBS LETT, V584, P2381, DOI 10.1016/j.febslet.2010.04.027	37	77	82	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17296	17312		10.1074/jbc.M113.455337	http://dx.doi.org/10.1074/jbc.M113.455337			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23589301	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000320380600025
J	Villacampa, P; Ribera, A; Motas, S; Ramirez, L; Garcia, M; de la Villa, P; Haurigot, V; Bosch, F				Villacampa, Pilar; Ribera, Albert; Motas, Sandra; Ramirez, Laura; Garcia, Miquel; de la Villa, Pedro; Haurigot, Virginia; Bosch, Fatima			Insulin-like Growth Factor I (IGF-I)-induced Chronic Gliosis and Retinal Stress Lead to Neurodegeneration in a Mouse Model of Retinopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULLER CELLS; IGF-I; GENE-EXPRESSION; ACTIVATION; PROTEINS; MECHANISMS; RESPONSES; RECEPTOR; FAMILY; S100B	Insulin-like growth factor I (IGF-I) exerts multiple effects on different retinal cell types in both physiological and pathological conditions. Despite the growth factor's extensively described neuroprotective actions, transgenic mice with increased intraocular levels of IGF-I showed progressive impairment of electroretinographic amplitudes up to complete loss of response, with loss of photoreceptors and bipolar, ganglion, and amacrine neurons. Neurodegeneration was preceded by the overexpression of genes related to retinal stress, acute-phase response, and gliosis, suggesting that IGF-I altered normal retinal homeostasis. Indeed, gliosis and microgliosis were present from an early age in transgenic mice, before other alterations occurred, and were accompanied by signs of oxidative stress and impaired glutamate recycling. Older mice also showed overproduction of pro-inflammatory cytokines. Our results suggest that, when chronically increased, intraocular IGF-I is responsible for the induction of deleterious cellular processes that can lead to neurodegeneration, and they highlight the importance that this growth factor may have in the pathogenesis of conditions such as ischemic or diabetic retinopathy.	[Villacampa, Pilar; Ribera, Albert; Motas, Sandra; Garcia, Miquel; Haurigot, Virginia; Bosch, Fatima] Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy, E-08193 Bellaterra, Spain; [Villacampa, Pilar; Ribera, Albert; Motas, Sandra; Garcia, Miquel; Haurigot, Virginia; Bosch, Fatima] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, E-08193 Bellaterra, Spain; [Villacampa, Pilar; Ribera, Albert; Garcia, Miquel; Haurigot, Virginia; Bosch, Fatima] CIBER Diabet & Associated Metab Disorders, Barcelona 08017, Spain; [Ramirez, Laura; de la Villa, Pedro] Univ Alcala, Sch Med, Dept Physiol, Alcala De Henares 28871, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universidad de Alcala	Bosch, F (corresponding author), Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy, Edifici H, E-08193 Bellaterra, Spain.	fatima.bosch@uab.es	Ribera, Albert/K-9744-2014; Motas, Sandra/L-2502-2017; Villacampa, Pilar/B-1801-2019; de la Villa, Pedro/G-2322-2016	Ribera, Albert/0000-0002-7120-4276; Motas, Sandra/0000-0003-2748-5952; Villacampa, Pilar/0000-0002-2860-7475; de la Villa, Pedro/0000-0001-9856-6616; Garcia, Miguel/0000-0002-1602-4993; BOSCH, FATIMA/0000-0002-7705-5515; Haurigot, Virginia A./0000-0002-9772-2565	Instituto de Salud Carlos III [PI 061417]; Plan Nacional I + D + I Grant [SAF2011-24698]; Generalitat de Catalunya, Spain [2009 SGR224]; European Community [CLINIGENE LSHB-CT-2006-018933]; Fundacion Ramon Areces; Ministerio de Educacion y Ciencia	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Plan Nacional I + D + I Grant; Generalitat de Catalunya, Spain(Generalitat de Catalunya); European Community(European Commission); Fundacion Ramon Areces; Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported in part by Instituto de Salud Carlos III Grant PI 061417, Plan Nacional I + D + I Grant SAF2011-24698, Generalitat de Catalunya Grant 2009 SGR224, Spain, and European Community Grant CLINIGENE LSHB-CT-2006-018933.; Recipient of predoctoral fellowship from Fundacion Ramon Areces.; Recipient of predoctoral fellowship from Ministerio de Educacion y Ciencia.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Amin RH, 1997, INVEST OPHTH VIS SCI, V38, P36; Barakat DJ, 2012, J NEUROCHEM, V120, P586, DOI 10.1111/j.1471-4159.2011.07595.x; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bianchi R, 2010, NEUROBIOL AGING, V31, P665, DOI 10.1016/j.neurobiolaging.2008.05.017; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bonapace G, 2003, J MED GENET, V40, P913, DOI 10.1136/jmg.40.12.913; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2009, NEUROCHEM INT, V54, P143, DOI 10.1016/j.neuint.2008.10.014; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; DErcole AJ, 1996, MOL NEUROBIOL, V13, P227, DOI 10.1007/BF02740625; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gerhardinger C, 2005, INVEST OPHTH VIS SCI, V46, P349, DOI 10.1167/iovs.04-0860; Haurigot V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041511; Haurigot V, 2009, J BIOL CHEM, V284, P22961, DOI 10.1074/jbc.M109.014787; Hellstrom A, 2002, J CLIN ENDOCR METAB, V87, P3413, DOI 10.1210/jc.87.7.3413; Inokuchi N, 2001, CURR EYE RES, V23, P368, DOI 10.1076/ceyr.23.5.368.5441; Karlstetter M, 2010, IMMUNOBIOLOGY, V215, P685, DOI 10.1016/j.imbio.2010.05.010; Kermer P, 2000, J NEUROSCI, V20, P722, DOI 10.1523/JNEUROSCI.20-02-00722.2000; Kondo T, 2003, J CLIN INVEST, V111, P1835, DOI 10.1172/JCI200317455; Krady JK, 2005, DIABETES, V54, P1559, DOI 10.2337/diabetes.54.5.1559; Laviola L, 2007, CURR PHARM DESIGN, V13, P663, DOI 10.2174/138161207780249146; Lebrun-Julien F, 2009, J NEUROSCI, V29, P5536, DOI 10.1523/JNEUROSCI.0831-09.2009; Lieth E, 2000, EXP EYE RES, V70, P723, DOI 10.1006/exer.2000.0840; Moshage H, 1997, J PATHOL, V181, P257, DOI 10.1002/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U; Mrak RE, 2001, NEUROBIOL AGING, V22, P915, DOI 10.1016/S0197-4580(01)00293-7; Nair S, 2008, BRIT J CANCER, V99, P2070, DOI 10.1038/sj.bjc.6604703; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; O'Donnell SL, 2002, GLIA, V39, P85, DOI 10.1002/glia.10081; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Rodriguez-de la Rosa L, 2012, NEUROBIOL DIS, V46, P476, DOI 10.1016/j.nbd.2012.02.013; Ruberte J, 2004, J CLIN INVEST, V113, P1149, DOI 10.1172/JCI200419478; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Salminen A, 2010, CELL SIGNAL, V22, P573, DOI 10.1016/j.cellsig.2009.10.006; Samardzija M, 2012, EXP EYE RES, V99, P17, DOI 10.1016/j.exer.2012.04.004; Schutte M, 1998, NEUROSCI LETT, V246, P53, DOI 10.1016/S0304-3940(98)00229-8; Shaw LC, 2004, REV ENDOCR METAB DIS, V5, P199, DOI 10.1023/B:REMD.0000032408.18015.b1; Smith LEH, 1999, NAT MED, V5, P1390, DOI 10.1038/70963; Steele MR, 2006, INVEST OPHTH VIS SCI, V47, P977, DOI 10.1167/iovs.05-0865; Takeda M, 2002, INVEST OPHTH VIS SCI, V43, P907; Treins C, 2005, MOL ENDOCRINOL, V19, P1304, DOI 10.1210/me.2004-0239; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; Vardatsikos G, 2009, ANTIOXID REDOX SIGN, V11, P1165, DOI 10.1089/ARS.2008.2161; Venteclef N, 2011, TRENDS ENDOCRIN MET, V22, P333, DOI 10.1016/j.tem.2011.04.004; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805; Zelinka CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044477; Zong H, 2010, DIABETOLOGIA, V53, P2656, DOI 10.1007/s00125-010-1900-z; Zong HL, 2011, CURR DIABETES REP, V11, P244, DOI 10.1007/s11892-011-0198-7	50	14	16	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17631	17642		10.1074/jbc.M113.468819	http://dx.doi.org/10.1074/jbc.M113.468819			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23620587	hybrid, Green Published			2022-12-28	WOS:000320380600054
J	Biarc, J; Chalkley, RJ; Burlingame, AL; Bradshaw, RA				Biarc, Jordane; Chalkley, Robert J.; Burlingame, A. L.; Bradshaw, Ralph A.			Dissecting the Roles of Tyrosines 490 and 785 of TrkA Protein in the Induction of Downstream Protein Phosphorylation Using Chimeric Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; KINASE C-EPSILON; PC12 CELLS; NEURITE OUTGROWTH; MEDIATOR COMPLEX; ADAPTER PROTEIN; ACTIVATION; SITES; DIFFERENTIATION; IDENTIFICATION	Receptor tyrosine kinases generally act by forming phosphotyrosine-docking sites on their own endodomains that propagate signals through cascades of post-translational modifications driven by the binding of adaptor/effector proteins. The pathways that are stimulated in any given receptor tyrosine kinase are a function of the initial docking sites that are activated and the availability of downstream participants. In the case of the Trk receptors, which are activated by nerve growth factor, there are only two established phosphotyrosine-docking sites (Tyr-490 and Tyr-785 on TrkA) that are known to be directly involved in signal transduction. Taking advantage of this limited repertoire of docking sites and the availability of PC12 cell lines stably transfected with chimeric receptors composed of the extracellular domain of the PDGF receptor and the transmembrane and intracellular domains of TrkA, the downstream TrkA-induced phosphoproteome was assessed for the "native" receptor and mutants lacking Tyr-490 or both Tyr-490 and Tyr-785. Basal phosphorylation levels were compared with those formed after 20 min of stimulation with PDGF. Several thousand phosphopeptides were identified after TiO2 enrichment, and many were up- or down-regulated by receptor activation. The modified proteins in the native sample contained many of the well established participants in TrkA signaling. The results from the mutant receptors allowed grouping of these downstream targets by their dependence on the two characterized docking site(s). A clear subset that was not dependent on either Tyr-490 or Tyr-785 emerged, providing direct evidence that there are other sites on TrkA that are involved in downstream signaling.	[Biarc, Jordane; Chalkley, Robert J.; Burlingame, A. L.; Bradshaw, Ralph A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Bradshaw, Ralph A.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	University of California System; University of California San Francisco; University of California System; University of California Irvine	Chalkley, RJ (corresponding author), Univ Calif San Francisco, 600 16th St,Genentech Hall,Rm N474A, San Francisco, CA 94158 USA.	chalkley@cgl.ucsf.edu	Bradshaw, Ralph A/K-1515-2013; Biarc, Jordane/AAP-4958-2020	Chalkley, Robert/0000-0002-9757-7302	National Institutes of Health from NIGMS Biomedical Technology Research Center program [8P41GM103481]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS Biomedical Technology Research Center program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 8P41GM103481 from NIGMS Biomedical Technology Research Center program.	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Baker PR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008078; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; Biarc J, 2012, MOL CELL PROTEOMICS, V11, P15, DOI 10.1074/mcp.M111.013375; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bracken CP, 2008, CANCER RES, V68, P7621, DOI 10.1158/0008-5472.CAN-08-1217; Brodie C, 1999, CELL GROWTH DIFFER, V10, P183; Chalkley RJ, 2005, METHOD ENZYMOL, V402, P289, DOI 10.1016/S0076-6879(05)02009-4; Chalkley RJ, 2008, MOL CELL PROTEOMICS, V7, P2386, DOI 10.1074/mcp.M800021-MCP200; Chaudhri VK, 2010, J BIOL CHEM, V285, P1296, DOI 10.1074/jbc.M109.055863; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Foehr ED, 2001, J BIOL CHEM, V276, P37529, DOI 10.1074/jbc.M103234200; Gartsbein M, 2006, J CELL SCI, V119, P470, DOI 10.1242/jcs.02744; GOTOH N, 1992, BIOCHEM BIOPH RES CO, V186, P768, DOI 10.1016/0006-291X(92)90812-Y; Hara Y, 2009, NUCLEIC ACIDS RES, V37, P1115, DOI 10.1093/nar/gkn1013; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Kasof GM, 1999, MOL CELL BIOL, V19, P4390; Kebache S, 2002, P NATL ACAD SCI USA, V99, P5406, DOI 10.1073/pnas.082483399; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Lalli G, 2005, J CELL BIOL, V171, P857, DOI 10.1083/jcb.200507061; Llorens F, 2003, BIOCHEM J, V375, P623, DOI 10.1042/BJ20030915; MacDonald JIS, 2000, J BIOL CHEM, V275, P18225, DOI 10.1074/jbc.M001862200; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mulherkar N, 2006, ONCOGENE, V25, P6252, DOI 10.1038/sj.onc.1209650; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; OHMICHI M, 1993, BIOCHEM J, V295, P767, DOI 10.1042/bj2950767; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pawson T, 2002, EUR J CANCER, V38, pS3, DOI 10.1016/S0959-8049(02)80597-4; Peters JM, 1996, SCIENCE, V274, P1199, DOI 10.1126/science.274.5290.1199; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; Rajendran RR, 2003, J BIOL CHEM, V278, P4628, DOI 10.1074/jbc.M210066200; Robinson KN, 2005, J BIOL CHEM, V280, P225, DOI 10.1074/jbc.M410454200; Rockow S, 1996, ONCOGENE, V12, P2351; Salvi M, 2009, BIOCHEM BIOPH RES CO, V387, P606, DOI 10.1016/j.bbrc.2009.07.067; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi XQ, 2006, BIOCHEMISTRY-US, V45, P5857, DOI 10.1021/bi052490j; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suzuki S, 2002, BIOCHEM BIOPH RES CO, V294, P1087, DOI 10.1016/S0006-291X(02)00606-X; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tyson DR, 2003, INT J DEV NEUROSCI, V21, P63, DOI 10.1016/S0736-5748(02)00139-9; WELSH GI, 1994, BIOCHEM BIOPH RES CO, V201, P1279, DOI 10.1006/bbrc.1994.1843; Wisniewski JR, 2008, PROTEINS, V73, P710, DOI 10.1002/prot.22104; Wooten MW, 1999, CELL DEATH DIFFER, V6, P753, DOI 10.1038/sj.cdd.4400548; Wooten MW, 1998, CELL SIGNAL, V10, P265, DOI 10.1016/S0898-6568(97)00127-7; Zeng K, 2010, J CELL BIOL, V191, P1315, DOI 10.1083/jcb.201008106; Zwick E, 2002, TRENDS MOL MED, V8, P17, DOI 10.1016/S1471-4914(01)02217-1	54	12	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16606	16618		10.1074/jbc.M113.475285	http://dx.doi.org/10.1074/jbc.M113.475285			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23589303	Green Published, hybrid			2022-12-28	WOS:000320378900037
J	Liu, J; Wang, Y; Li, L; Zhou, L; Wei, HB; Zhou, QX; Liu, J; Wang, WC; Ji, L; Shan, PP; Wang, Y; Yang, YY; Jung, SY; Zhang, P; Wang, CG; Long, WW; Zhang, BH; Li, XT				Liu, Jiang; Wang, Ying; Li, Lei; Zhou, Li; Wei, Haibin; Zhou, Qingxia; Liu, Jian; Wang, Weicang; Ji, Lei; Shan, Peipei; Wang, Yan; Yang, Yuanyuan; Jung, Sung Yun; Zhang, Pei; Wang, Chuangui; Long, Weiwen; Zhang, Bianhong; Li, Xiaotao			Site-specific Acetylation of the Proteasome Activator REG gamma Directs Its Heptameric Structure and Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREB-BINDING PROTEIN; LYSINE ACETYLATION; POSTTRANSLATIONAL MODIFICATIONS; TRANSCRIPTIONAL REGULATION; CELL-CYCLE; DEGRADATION; P300; PA28-GAMMA; INHIBITORS; MICE	The proteasome activator REG gamma has been reported to promote degradation of steroid receptor coactivator-3 and cyclin-dependent kinase inhibitors p21, p16, and p19 in a ubiquitin- and ATP-independent manner. A recent comparative analysis of REG gamma expression in mouse and human tissues reveals a unique pattern of REG gamma in specific cell types, suggesting undisclosed functions and biological importance of this molecule. Despite the emerging progress made in REG gamma-related studies, how REG gamma function is regulated remains to be explored. In this study, we report for the first time that REG gamma can be acetylated mostly on its lysine 195 (Lys-195) residue by CREB binding protein (CBP), which can be reversed by sirtuin 1 (SIRT1) in mammalian cells. Site-directed mutagenesis abrogated acetylation at Lys-195 and significantly attenuated the capability of REG gamma to degrade its target substrates, p21 and hepatitis C virus core protein. Mechanistically, acetylation at Lys-195 is important for the interactions between REG gamma monomers and ultimately influences REG gamma heptamerization. Biological analysis of cells containing REG gamma-WT or REG gamma-K195R mutant indicates an impact of acetylation on REG gamma-mediated regulation of cell proliferation and cell cycle progression. These findings reveal a previously unknown mechanism in the regulation of REG gamma assembly and activity, suggesting a potential venue for the intervention of the ubiquitin-independent REG gamma proteasome activity.	[Liu, Jiang; Wang, Ying; Li, Lei; Zhou, Li; Wei, Haibin; Zhou, Qingxia; Wang, Weicang; Ji, Lei; Shan, Peipei; Wang, Yan; Yang, Yuanyuan; Wang, Chuangui; Zhang, Bianhong; Li, Xiaotao] E China Normal Univ, Inst Biomed Sci, Sch Life Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Liu, Jiang; Wang, Ying] Hangzhou Normal Univ, Sch Med, Inst Aging Res, Hangzhou 310036, Zhejiang, Peoples R China; [Liu, Jiang; Wang, Ying; Liu, Jian; Jung, Sung Yun; Long, Weiwen; Li, Xiaotao] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Zhang, Pei] Second Chengdu Municipal Hosp, Dept Pathol, Chengdu 610017, Sichuan, Peoples R China	East China Normal University; Hangzhou Normal University; Baylor College of Medicine	Zhang, BH (corresponding author), E China Normal Univ, Inst Biomed Sci, Sch Life Sci, 500 Dongchuan Rd, Shanghai 200241, Peoples R China.	bhzhang@bio.ecnu.edu.cn; xiaotaol@bcm.edu	Wang, Weicang/K-7618-2017	Wang, Weicang/0000-0002-2722-507X; Liu, Jian/0000-0002-1447-0973; Jung, Sung Yun/0000-0003-1521-7977	Excellent East China Normal University Ph.D. student award; National Institutes of Health Grant [1R01CA131914]; Norman Hackerman Advanced Research Program [1082318401, PN004949-0012-2009]; Pilot/Feasibility Program of the Diabetes & Endocrinology Research Center at Baylor College of Medicine [P30-DK079638]; National Natural Science Foundation of China [81261120555, 30870503, 81071657, 31100946, 31200878]; Science and Technology Commission of Shanghai Municipality [11DZ2260300, 10JC1404200, 11ZR1410000, 12ZR1409300]; National Basic Research Program [2009CB918402, 2011CB504200]; NATIONAL CANCER INSTITUTE [R01CA131914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER	Excellent East China Normal University Ph.D. student award; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norman Hackerman Advanced Research Program; Pilot/Feasibility Program of the Diabetes & Endocrinology Research Center at Baylor College of Medicine; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Basic Research Program(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by an Excellent East China Normal University Ph.D. student award (to J. L.). This work was also supported by National Institutes of Health Grant 1R01CA131914, Norman Hackerman Advanced Research Program Grants 1082318401 and PN004949-0012-2009), and the Pilot/Feasibility Program of the Diabetes & Endocrinology Research Center (P30-DK079638) at Baylor College of Medicine. This work was supported in part by National Natural Science Foundation of China Grants 81261120555, 30870503, 81071657, 31100946, and 31200878; Science and Technology Commission of Shanghai Municipality Grants 11DZ2260300, 10JC1404200, 11ZR1410000, and 12ZR1409300; and National Basic Research Program Grants 2009CB918402 and 2011CB504200.	Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Barton LF, 2004, J IMMUNOL, V172, P3948, DOI 10.4049/jimmunol.172.6.3948; Blackwell JS, 2007, J BIOL CHEM, V282, P20142, DOI 10.1074/jbc.M701989200; Chan HM, 2001, J CELL SCI, V114, P2363; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Deng QD, 2005, CANCER RES, V65, P8298, DOI 10.1158/0008-5472.CAN-05-0054; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Furumai R, 2001, P NATL ACAD SCI USA, V98, P87, DOI 10.1073/pnas.011405598; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Guo P, 2009, J BIOL CHEM, V284, P18184, DOI 10.1074/jbc.M109.007096; He J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-75; Jones JD, 2011, PROTEOMICS, V11, P3012, DOI 10.1002/pmic.201000812; Kanai K, 2011, J MOL ENDOCRINOL, V47, P119, DOI 10.1530/JME-11-0044; Kang SA, 2010, BIOCHEM PHARMACOL, V80, P867, DOI 10.1016/j.bcp.2010.04.026; Kasper LH, 2006, MOL CELL BIOL, V26, P789, DOI 10.1128/MCB.26.3.789-809.2006; Kawai Y, 2011, J BIOL CHEM, V286, P7629, DOI 10.1074/jbc.M110.208173; Kingsley-Kallesen ML, 1999, J BIOL CHEM, V274, P34020, DOI 10.1074/jbc.274.48.34020; Knowlton JR, 1997, NATURE, V390, P639, DOI 10.1038/37670; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kramer OH, 2006, GENE DEV, V20, P473, DOI 10.1101/gad.364306; Li J, 2001, EMBO J, V20, P3359, DOI 10.1093/emboj/20.13.3359; Li J, 2001, BIOCHIMIE, V83, P373, DOI 10.1016/S0300-9084(01)01236-6; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Liu JA, 2010, J CELL SCI, V123, P4076, DOI 10.1242/jcs.067405; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; MA CP, 1992, J BIOL CHEM, V267, P10515; Manohar M, 2009, J BIOL CHEM, V284, P23312, DOI 10.1074/jbc.M109.003202; Mao I, 2008, Cell Mol Life Sci, V65, P3971, DOI 10.1007/s00018-008-8291-z; Mariadason JM, 2008, EPIGENETICS-US, V3, P28, DOI 10.4161/epi.3.1.5736; Molloy D, 2006, VIROLOGY, V355, P115, DOI 10.1016/j.virol.2006.05.004; Moriishi K, 2003, J VIROL, V77, P10237, DOI 10.1128/JVI.77.19.10237-10249.2003; Murata S, 1999, J BIOL CHEM, V274, P38211, DOI 10.1074/jbc.274.53.38211; Nakagawa T, 2011, J CELL SCI, V124, P833, DOI 10.1242/jcs.081067; Nie J, 2010, FEBS LETT, V584, P3021, DOI 10.1016/j.febslet.2010.05.034; Roessler M, 2006, MOL CELL PROTEOMICS, V5, P2092, DOI 10.1074/mcp.M600118-MCP200; Shikama N, 2003, EMBO J, V22, P5175, DOI 10.1093/emboj/cdg502; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wang F, 2012, ONCOGENE, V31, P1546, DOI 10.1038/onc.2011.347; Weinberg WC, 2002, CRIT REV ORAL BIOL M, V13, P453, DOI 10.1177/154411130201300603; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Wu Y, 2011, CELL RES, V21, P807, DOI 10.1038/cr.2011.57; Xin FX, 2012, BIOINFORMATICS, V28, P2905, DOI 10.1093/bioinformatics/bts541; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yu GW, 2010, J MOL CELL BIOL, V2, P192, DOI 10.1093/jmcb/mjq009; Zhang Z, 2008, EMBO J, V27, P852, DOI 10.1038/emboj.2008.25; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	51	15	18	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16567	16578		10.1074/jbc.M112.437129	http://dx.doi.org/10.1074/jbc.M112.437129			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612972	Green Published, hybrid			2022-12-28	WOS:000320378900033
J	Zhao, WT; Zhou, CF; Li, XB; Zhang, YF; Fan, L; Pelletier, J; Fang, J				Zhao, Wen-Ting; Zhou, Cheng-Fu; Li, Xue-Bing; Zhang, Yun-Fang; Fan, Li; Pelletier, Jerry; Fang, Jing			The von Hippel-Lindau Protein pVHL Inhibits Ribosome Biogenesis and Protein Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; HUMAN BREAST-CANCER; TRANSLATION INITIATION; NUCLEAR EXPORT; PRE-RIBOSOMES; RNA SYNTHESIS; SUBUNITS; NETWORK; GROWTH; CELLS	pVHL, the product of von Hippel-Lindau (VHL) tumor suppressor gene, functions as the substrate recognition component of an E3-ubiquitin ligase complex that targets hypoxia inducible factor alpha (HIF-alpha) for ubiquitination and degradation. Besides HIF-alpha, pVHL also interacts with other proteins and has multiple functions. Here, we report that pVHL inhibits ribosome biogenesis and protein synthesis. We find that pVHL associates with the 40S ribosomal protein S3 (RPS3) but does not target it for destruction. Rather, the pVHL-RPS3 association interferes with the interaction between RPS3 and RPS2. Expression of pVHL also leads to nuclear retention of pre-40S ribosomal subunits, diminishing polysomes and 18S rRNA levels. We also demonstrate that pVHL suppresses both cap-dependent and cap-independent protein synthesis. Our findings unravel a novel function of pVHL and provide insight into the regulation of ribosome biogenesis by the tumor suppressor pVHL.	[Zhao, Wen-Ting; Li, Xue-Bing; Zhang, Yun-Fang; Fan, Li; Fang, Jing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China; [Zhou, Cheng-Fu] Fudan Univ, Sch Med, Zhongshan Hosp, Dept Surg, Shanghai 200030, Peoples R China; [Pelletier, Jerry] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; McGill University	Fang, J (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China.	jfang@sibs.ac.cn			Natural Science Foundation of China [30970586, 31270829]; Innovation Program of Chinese Academy of Sciences Grant [KSCX2-EW-R-09]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Chinese Academy of Sciences Grant	This work was supported by Natural Science Foundation of China Grants 30970586 and 31270829 and the Innovation Program of Chinese Academy of Sciences Grant KSCX2-EW-R-09.	Albanese V, 2010, J CELL BIOL, V189, P69, DOI 10.1083/jcb.201001054; Belin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007147; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Brandenburger Y, 2001, FASEB J, V15, P2051, DOI 10.1096/fj.00-0853fje; Bulygin K, 2005, BIOCHEMISTRY-US, V44, P2153, DOI 10.1021/bi0487802; Campbell MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016194; Carron C, 2011, NUCLEIC ACIDS RES, V39, P280, DOI 10.1093/nar/gkq734; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Davidowitz EJ, 2001, MOL CELL BIOL, V21, P865, DOI 10.1128/MCB.21.3.865-874.2001; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Frew IJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe30; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2010, EMBO J, V29, P2026, DOI 10.1038/emboj.2010.86; Grosfeld A, 2007, J BIOL CHEM, V282, P13264, DOI 10.1074/jbc.M611648200; HADJIOLOVA KV, 1993, EUR J BIOCHEM, V212, P211, DOI 10.1111/j.1432-1033.1993.tb17652.x; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Lafontaine DLJ, 2001, NAT REV MOL CELL BIO, V2, P514, DOI 10.1038/35080045; Lee S, 1999, MOL CELL BIOL, V19, P1486; Lewis MD, 2003, ONCOGENE, V22, P3992, DOI 10.1038/sj.onc.1206683; Mekhail K, 2006, CELL CYCLE, V5, P2401, DOI 10.4161/cc.5.20.3387; Milkereit P, 2003, NUCLEIC ACIDS RES, V31, P799, DOI 10.1093/nar/gkg165; Montanaro L, 2012, BBA-REV CANCER, V1825, P101, DOI 10.1016/j.bbcan.2011.10.006; Nemoto N, 2010, J BIOL CHEM, V285, P32200, DOI 10.1074/jbc.M110.146662; O'Donohue MF, 2010, J CELL BIOL, V190, P853, DOI 10.1083/jcb.201005117; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Okuda H, 2001, J BIOL CHEM, V276, P43611, DOI 10.1074/jbc.M107880200; Perreault A, 2008, NUCLEIC ACIDS RES, V36, P6132, DOI 10.1093/nar/gkn625; Rouquette J, 2005, EMBO J, V24, P2862, DOI 10.1038/sj.emboj.7600752; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Soudet J, 2010, EMBO J, V29, P80, DOI 10.1038/emboj.2009.307; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Thoma CR, 2007, NAT CELL BIOL, V9, P588, DOI 10.1038/ncb1579; Trere D, 2004, J HISTOCHEM CYTOCHEM, V52, P1601, DOI 10.1369/jhc.4A6454.2004; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Yan B, 2011, BIOCHEM BIOPH RES CO, V409, P315, DOI 10.1016/j.bbrc.2011.05.012; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010; Zemp I, 2009, J CELL BIOL, V185, P1167, DOI 10.1083/jcb.200904048	48	14	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16588	16597		10.1074/jbc.M113.455121	http://dx.doi.org/10.1074/jbc.M113.455121			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612971	hybrid, Green Published			2022-12-28	WOS:000320378900035
J	Baran, P; Nitz, R; Grotzinger, J; Scheller, J; Garbers, C				Baran, Paul; Nitz, Rebecca; Groetzinger, Joachim; Scheller, Juergen; Garbers, Christoph			Minimal Interleukin 6 (IL-6) Receptor Stalk Composition for IL-6 Receptor Shedding and IL-6 Classic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; CYTOKINE-RECEPTOR; MOLECULAR SWITCH; ADAM17; PROTEINS; GP130; DISINTEGRIN; MEMBRANE; CLEAVAGE; COMPLEX	Signaling of the pleiotropic cytokine Interleukin-6 (IL-6) is coordinated by membrane-bound and soluble forms of the IL-6 receptor (IL-6R) in processes called classic and trans-signaling, respectively. The soluble IL-6R is mainly generated by ADAM10- and ADAM17-mediated ectodomain shedding. Little is known about the role of the 52-amino acid-residue-long IL-6R stalk region in shedding and signal transduction. Therefore, we generated and analyzed IL-6R stalk region deletion variants for cleavability and biological activity. Deletion of 10 amino acids of the stalk region surrounding the ADAM17 cleavage site substantially blocked IL-6R proteolysis by ADAM17 but only slightly affected proteolysis by ADAM10. Interestingly, additional deletion of the remaining five juxtamembrane-located amino acids also abrogated ADAM10-mediated IL-6R shedding. Larger deletions within the stalk region, that do not necessarily include the ADAM17 cleavage site, also reduced ADAM10 and ADAM17-mediated IL-6R shedding, questioning the importance of cleavage site recognition. Furthermore, we show that a 22-amino acid-long stalk region is minimally required for IL-6 classic signaling. The gp130 cytokine binding sites are separated from the plasma membrane by similar to 96 angstrom. 22 amino acid residues, however, span maximally 83.6 angstrom (3.8 angstrom/amino acid), indicating that the three juxtamembrane fibronectin domains of gp130 are not necessarily elongated but somehow flexed to allow IL-6 classic signaling. Our findings underline a dual role of the IL-6R stalk region in IL-6 signaling. In IL-6 trans-signaling, it regulates proper proteolysis by ADAM10 and ADAM17. In IL-6 classic-signaling, it acts as a spacer to ensure IL-6.IL-6R.gp130 signal complex formation.	[Baran, Paul; Nitz, Rebecca; Scheller, Juergen; Garbers, Christoph] Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, D-40225 Dusseldorf, Germany; [Groetzinger, Joachim] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany	Heinrich Heine University Dusseldorf; University of Kiel	Scheller, J (corresponding author), Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, Univ Str 1, D-40225 Dusseldorf, Germany.	jscheller@uni-duesseldorf.de	Garbers, Christoph/D-9932-2015; Scheller, Jürgen/K-5290-2015	Garbers, Christoph/0000-0003-4939-6950; 				Althoff K, 2000, EUR J BIOCHEM, V267, P2624, DOI 10.1046/j.1432-1327.2000.01278.x; Althoff K, 2001, BIOCHEM J, V353, P663, DOI 10.1042/0264-6021:3530663; Arndt PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019938; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Chalaris A, 2011, EUR J CELL BIOL, V90, P484, DOI 10.1016/j.ejcb.2010.10.007; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Galkina E, 2003, J EXP MED, V198, P1323, DOI 10.1084/jem.20030485; Garbers C, 2013, J BIOL CHEM, V288, P4346, DOI 10.1074/jbc.M112.432955; Garbers C, 2012, CYTOKINE GROWTH F R, V23, P85, DOI 10.1016/j.cytogfr.2012.04.001; Garbers C, 2011, J BIOL CHEM, V286, P42959, DOI 10.1074/jbc.M111.295758; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Grotzinger J, 1997, PROTEINS, V27, P96; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Kenny PA, 2007, DIFFERENTIATION, V75, P800, DOI 10.1111/j.1432-0436.2007.00198.x; Ketteler R, 2002, GENE THER, V9, P477, DOI 10.1038/sj.gt.3301653; Lorenzen I, 2012, FEBS LETT, V586, P1093, DOI 10.1016/j.febslet.2012.03.012; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; LUST JA, 1992, CYTOKINE, V4, P96, DOI 10.1016/1043-4666(92)90043-Q; MACKIEWICZ A, 1992, J IMMUNOL, V149, P2021; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Moss ML, 2008, NAT CLIN PRACT RHEUM, V4, P300, DOI 10.1038/ncprheum0797; MULLBERG J, 1994, J IMMUNOL, V152, P4958; MULLBERG J, 1993, EUR J IMMUNOL, V23, P473, DOI 10.1002/eji.1830230226; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; Venturi GM, 2003, IMMUNITY, V19, P713, DOI 10.1016/S1074-7613(03)00295-4; Vollmer P, 1999, EUR J BIOCHEM, V263, P438, DOI 10.1046/j.1432-1327.1999.00511.x; Xu YB, 2010, J BIOL CHEM, V285, P21214, DOI 10.1074/jbc.C110.129502	38	59	60	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14756	14768		10.1074/jbc.M113.466169	http://dx.doi.org/10.1074/jbc.M113.466169			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23564454	Green Published, hybrid			2022-12-28	WOS:000319452100009
J	Pfaffen, S; Abdulqadir, R; Le Brun, NE; Murphy, MEP				Pfaffen, Stephanie; Abdulqadir, Raz; Le Brun, Nick E.; Murphy, Michael E. P.			Mechanism of Ferrous Iron Binding and Oxidation by Ferritin from a Pennate Diatom	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI BACTERIOFERRITIN; PYROCOCCUS-FURIOSUS; CRYSTAL-STRUCTURE; HIGH-RESOLUTION; HUMAN H; HYDROLYSIS; STORAGE; ECFTNA; CHEMISTRY; SITES	A novel ferritin was recently found in Pseudo-nitzschia multiseries (PmFTN), a marine pennate diatom that plays a major role in global primary production and carbon sequestration into the deep ocean. Crystals of recombinant PmFTN were soaked in iron and zinc solutions, and the structures were solved to 1.65-2.2-angstrom resolution. Three distinct iron binding sites were identified as determined from anomalous dispersion data from aerobically grown ferrous soaked crystals. Sites A and B comprise the conserved ferroxidase active site, and site C forms a pathway leading toward the central cavity where iron storage occurs. In contrast, crystal structures derived from anaerobically grown and ferrous soaked crystals revealed only one ferrous iron in the active site occupying site A. In the presence of dioxygen, zinc is observed bound to all three sites. Iron oxidation experiments using stopped-flow absorbance spectroscopy revealed an extremely rapid phase corresponding to Fe(II) oxidation at the ferroxidase site, which is saturated after adding 48 ferrous iron to apo-PmFTN (two ferrous iron per subunit), and a much slower phase due to iron core formation. These results suggest an ordered stepwise binding of ferrous iron and dioxygen to the ferroxidase site in preparation for catalysis and a partial mobilization of iron from the site following oxidation.	[Pfaffen, Stephanie; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Abdulqadir, Raz; Le Brun, Nick E.] Univ E Anglia, Ctr Mol & Struct Biochem, Sch Chem, Norwich NR4 7TJ, Norfolk, England	University of British Columbia; University of East Anglia	Murphy, MEP (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	Michael.Murphy@ubc.ca	Murphy, Michael/R-6805-2017	Murphy, Michael/0000-0003-2589-0014; Abdulqadir, Raz/0000-0003-4014-8213; Le Brun, Nick/0000-0001-9780-4061	Natural Sciences and Engineering Research Council of Canada discovery grant; Canadian Foundation for Innovation; Biotechnology and Biological Sciences Research Council [BB/I021884/1]; United States Department of Energy Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; National Center for Research Resources [P41RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER; BBSRC [BB/I021884/1] Funding Source: UKRI	Natural Sciences and Engineering Research Council of Canada discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United States Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Natural Sciences and Engineering Research Council of Canada discovery grant and the Canadian Foundation for Innovation (to M. E. P. M.) and Biotechnology and Biological Sciences Research Council Grant BB/I021884/1 (to N. E. L. B.).; Portions of this work were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the United States Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health, National Institute of General Medical Sciences (including Grant P41GM103393), and the National Center for Research Resources (Grant P41RR001209).	BAUMINGER ER, 1991, BIOCHIM BIOPHYS ACTA, V1118, P48, DOI 10.1016/0167-4838(91)90440-B; Bertini I, 2012, J AM CHEM SOC, V134, P6169, DOI 10.1021/ja210084n; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Crow A, 2009, J AM CHEM SOC, V131, P6808, DOI 10.1021/ja8093444; d'Estaintot BL, 2004, J MOL BIOL, V340, P277, DOI 10.1016/j.jmb.2004.04.036; Ebrahimi KH, 2012, NAT CHEM BIOL, V8, P941, DOI [10.1038/NCHEMBIO.1071, 10.1038/nchembio.1071]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Hwang J, 2000, SCIENCE, V287, P122, DOI 10.1126/science.287.5450.122; Johnson E, 2005, STRUCTURE, V13, P637, DOI 10.1016/j.str.2005.01.019; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; Lu Y, 1996, INORG CHEM, V35, P1692, DOI 10.1021/ic9513189; Marchetti A, 2009, NATURE, V457, P467, DOI 10.1038/nature07539; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; SCHWARTZ JH, 2010, PRESERVATION, V62, P2; Stillman TJ, 2001, J MOL BIOL, V307, P587, DOI 10.1006/jmbi.2001.4475; Tatur J, 2005, FEBS LETT, V579, P4729, DOI 10.1016/j.febslet.2005.07.045; Tatur J, 2007, J BIOL INORG CHEM, V12, P615, DOI 10.1007/s00775-007-0212-3; Theil E. C., 2001, HDB METALLOPROTEINS, V2, P771; Treffry A, 1998, J BIOL INORG CHEM, V3, P682, DOI 10.1007/s007750050282; TREFFRY A, 1992, FEBS LETT, V302, P108, DOI 10.1016/0014-5793(92)80417-F; Treffry A, 1998, FEBS LETT, V432, P213, DOI 10.1016/S0014-5793(98)00867-9; Treffry A, 1997, BIOCHEMISTRY-US, V36, P432, DOI 10.1021/bi961830l; Turano P, 2010, P NATL ACAD SCI USA, V107, P545, DOI 10.1073/pnas.0908082106; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Willies SC, 2009, J BIOL INORG CHEM, V14, P201, DOI 10.1007/s00775-008-0438-8; Wong SG, 2009, J BIOL CHEM, V284, P18873, DOI 10.1074/jbc.M901747200; Yang XK, 1998, BIOCHEMISTRY-US, V37, P9743, DOI 10.1021/bi973128a; Yang XK, 2000, BIOCHEM J, V349, P783, DOI 10.1042/bj3490783; Yang XO, 2000, BIOCHEMISTRY-US, V39, P4915, DOI 10.1021/bi992631f; Yasmin S, 2011, J BIOL CHEM, V286, P3473, DOI 10.1074/jbc.M110.175034	33	45	46	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14917	14925		10.1074/jbc.M113.454496	http://dx.doi.org/10.1074/jbc.M113.454496			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23548912	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000319452100022
J	Waldeck-Weiermair, M; Deak, AT; Groschner, LN; Alam, MR; Jean-Quartier, C; Malli, R; Graier, WF				Waldeck-Weiermair, Markus; Deak, Andras T.; Groschner, Lukas N.; Alam, Muhammad Rizwan; Jean-Quartier, Claire; Malli, Roland; Graier, Wolfgang F.			Molecularly Distinct Routes of Mitochondrial Ca2+ Uptake Are Activated Depending on the Activity of the Sarco/Endoplasmic Reticulum Ca2+ ATPase (SERCA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; ESSENTIAL COMPONENT; CALCIUM UNIPORTER; ER; HOMEOSTASIS; PROTEIN; MICU1; MCU; METABOLISM; MECHANISMS	The transfer of Ca2+ across the inner mitochondrial membrane is an important physiological process linked to the regulation of metabolism, signal transduction, and cell death. While the definite molecular composition of mitochondrial Ca2+ uptake sites remains unknown, several proteins of the inner mitochondrial membrane, that are likely to accomplish mitochondrial Ca2+ fluxes, have been described: the novel uncoupling proteins 2 and 3, the leucine zipper-EF-hand containing transmembrane protein 1 and the mitochondrial calcium uniporter. It is unclear whether these proteins contribute to one unique mitochondrial Ca2+ uptake pathway or establish distinct routes for mitochondrial Ca2+ sequestration. In this study, we show that a modulation of Ca2+ release from the endoplasmic reticulum by inhibition of the sarco/endoplasmatic reticulum ATPase modifies cytosolic Ca2+ signals and consequently switches mitochondrial Ca2+ uptake from an uncoupling protein 3- and mitochondrial calcium uniporter-dependent, but leucine zipper-EF-hand containing transmembrane protein 1-independent to a leucine zipper-EF-hand containing transmembrane protein 1- and mitochondrial calcium uniporter-mediated, but uncoupling protein 3-independent pathway. Thus, the activity of sarco/endoplasmatic reticulum ATPase is significant for the mode of mitochondrial Ca2+ sequestration and determines which mitochondrial proteins might actually accomplish the transfer of Ca2+ across the inner mitochondrial membrane. Moreover, our findings herein support the existence of distinct mitochondrial Ca2+ uptake routes that might be essential to ensure an efficient ion transfer into mitochondria despite heterogeneous cytosolic Ca2+ rises.	[Waldeck-Weiermair, Markus; Deak, Andras T.; Groschner, Lukas N.; Alam, Muhammad Rizwan; Jean-Quartier, Claire; Malli, Roland; Graier, Wolfgang F.] Med Univ Graz, Inst Mol Biol & Biochem, Ctr Mol Med, A-8010 Graz, Austria	Medical University of Graz	Graier, WF (corresponding author), Med Univ Graz, Inst Mol Biol & Biochem, Ctr Mol Med, Harrachgasse 21-3, A-8010 Graz, Austria.	wolfgang.graier@medunigraz.at	Groschner, Lukas/AHD-6319-2022; Graier, Wolfgang F./B-7052-2008; Alam, Muhammad Rizwan/AAE-2266-2019; Waldeck-Weiermair, Markus/AAV-5193-2020; Groschner, Lukas/J-9398-2012	Groschner, Lukas/0000-0002-4325-0232; Graier, Wolfgang F./0000-0003-1871-3298; Alam, Muhammad Rizwan/0000-0002-1578-5723; Waldeck-Weiermair, Markus/0000-0002-5792-6766; Groschner, Lukas/0000-0002-4325-0232; Jean-Quartier, Claire/0000-0002-0840-2173; Malli, Roland/0000-0001-6327-8729	Austrian Science Funds (FWF) [P20181-B05, P21857-B18, P22553-B18]; FWF within the PhD program Neuroscience at the Medical University of Graz; FWF within the PhD program MolMed of the Medical University of Graz; Austrian Science Fund (FWF) [P 22553, P 21857] Funding Source: researchfish	Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); FWF within the PhD program Neuroscience at the Medical University of Graz; FWF within the PhD program MolMed of the Medical University of Graz; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Funds (FWF, P20181-B05, P21857-B18, and P22553-B18).; Funded by the FWF within the PhD program Neuroscience at the Medical University of Graz.; Funded by the FWF within the PhD program MolMed of the Medical University of Graz.	Alam MR, 2012, J BIOL CHEM, V287, P34445, DOI 10.1074/jbc.M112.392084; Andras S, 2006, CELL CALCIUM, V40, P403, DOI 10.1016/j.ceca.2006.09.001; Azzolin L, 2010, BBA-BIOENERGETICS, V1797, P1775, DOI 10.1016/j.bbabio.2010.07.002; Bakowski D, 2001, BIOCHEM J, V353, P561, DOI 10.1042/0264-6021:3530561; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bondarenko AI, 2013, PFLUG ARCH EUR J PHY, V465, P997, DOI 10.1007/s00424-013-1224-1; Brini M, 2000, EMBO J, V19, P4926, DOI 10.1093/emboj/19.18.4926; Camello C, 2002, CELL CALCIUM, V32, P355, DOI 10.1016/S0143416002001926; Carafoli E, 2000, CURR OPIN CHEM BIOL, V4, P152, DOI 10.1016/S1367-5931(99)00069-1; Chami M, 2008, MOL CELL, V32, P641, DOI 10.1016/j.molcel.2008.11.014; Csordas G, 2001, CELL CALCIUM, V29, P249, DOI 10.1054/ceca.2000.0191; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; De Marchi U, 2011, J BIOL CHEM, V286, P32533, DOI 10.1074/jbc.M110.216044; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; Gergo S, 2006, CELL CALCIUM, V40, P527, DOI 10.1016/j.ceca.2006.08.019; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Graier WF, 2007, PFLUG ARCH EUR J PHY, V455, P375, DOI 10.1007/s00424-007-0296-1; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Jean-Quartier C, 2012, MOL CELL ENDOCRINOL, V353, P114, DOI 10.1016/j.mce.2011.10.033; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kornmann B, 2010, J CELL SCI, V123, P1389, DOI 10.1242/jcs.058636; Malli R, 2010, FEBS LETT, V584, P1942, DOI 10.1016/j.febslet.2010.01.010; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Marchi S, 2013, CURR BIOL, V23, P58, DOI 10.1016/j.cub.2012.11.026; Merkwirth C, 2008, CELL, V135, P1165, DOI 10.1016/j.cell.2008.12.005; Nedergaard J, 2003, EXP PHYSIOL, V88, P65, DOI 10.1113/eph8802502; Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200; Pan S, 2011, SCI CHINA LIFE SCI, V54, P763, DOI 10.1007/s11427-011-4203-9; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Pizzo P, 2012, PFLUG ARCH EUR J PHY, V464, P3, DOI 10.1007/s00424-012-1122-y; Poburko D, 2006, CELL CALCIUM, V40, P359, DOI 10.1016/j.ceca.2006.04.031; Raffaello A, 2012, CELL CALCIUM, V52, P16, DOI 10.1016/j.ceca.2012.04.006; Rimessi A, 2008, BBA-BIOENERGETICS, V1777, P808, DOI 10.1016/j.bbabio.2008.05.449; RIZZUTO R, 1994, J CELL BIOL, V126, P1183, DOI 10.1083/jcb.126.5.1183; Ryan T, 2011, J BIOL CHEM, V286, P17060, DOI 10.1074/jbc.M110.197186; Ryu SY, 2010, FEBS LETT, V584, P1948, DOI 10.1016/j.febslet.2010.01.032; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Spat A, 2009, ACTA PHYSIOL, V195, P139, DOI 10.1111/j.1748-1716.2008.01928.x; Spat A, 2008, CELL CALCIUM, V44, P51, DOI 10.1016/j.ceca.2007.11.015; Szabadkai G, 2006, BBA-MOL CELL RES, V1763, P442, DOI 10.1016/j.bbamcr.2006.04.002; Trenker M, 2008, NAT CELL BIOL, V10, P1237, DOI 10.1038/ncb1108-1237; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Waldeck-Weiermair M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045917; Waldeck-Weiermair M, 2011, J BIOL CHEM, V286, P28444, DOI 10.1074/jbc.M111.244517; Waldeck-Weiermair M, 2010, CELL CALCIUM, V48, P288, DOI 10.1016/j.ceca.2010.10.004; Waldeck-Weiermair M, 2010, CELL CALCIUM, V47, P433, DOI 10.1016/j.ceca.2010.03.004	54	29	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15367	15379		10.1074/jbc.M113.462259	http://dx.doi.org/10.1074/jbc.M113.462259			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23592775	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000319452100061
J	Gupta, M; Kamynina, E; Morley, S; Chung, S; Muakkassa, N; Wang, H; Brathwaite, S; Sharma, G; Manor, D				Gupta, Meghana; Kamynina, Elena; Morley, Samantha; Chung, Stacey; Muakkassa, Nora; Wang, Hong; Brathwaite, Shayna; Sharma, Gaurav; Manor, Danny			Plekhg4 Is a Novel Dbl Family Guanine Nucleotide Exchange Factor Protein for Rho Family GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT CEREBELLAR-ATAXIA; HOMOLOGY DOMAIN; CELLULAR-TRANSFORMATION; SPINOCEREBELLAR ATAXIA; NEURITE OUTGROWTH; ONCOGENE PRODUCT; CDC42; RAC; CHAPERONE; ACTIVATION	Mutations in the PLEKHG4 (puratrophin-1) gene are associated with the heritable neurological disorder autosomal dominant spinocerebellar ataxia. However, the biochemical functions of this gene product have not been described. We report here that expression of Plekhg4 in the murine brain is developmentally regulated, with pronounced expression in the newborn midbrain and brainstem that wanes with age and maximal expression in the cerebellar Purkinje neurons in adulthood. We show that Plekhg4 is subject to ubiquitination and proteasomal degradation, and its steady-state expression levels are regulated by the chaperones Hsc70 and Hsp90 and by the ubiquitin ligase CHIP. On the functional level, we demonstrate that Plekhg4 functions as a bona fide guanine nucleotide exchange factor (GEF) that facilitates activation of the small GTPases Rac1, Cdc42, and RhoA. Overexpression of Plekhg4 in NIH3T3 cells induces rearrangements of the actin cytoskeleton, specifically enhanced formation of lamellopodia and fillopodia. These findings indicate that Plekhg4 is an aggregation-prone member of the Dbl family GEFs and that regulation of GTPase signaling is critical for proper cerebellar function.	[Gupta, Meghana; Manor, Danny] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Morley, Samantha; Chung, Stacey; Wang, Hong; Brathwaite, Shayna; Manor, Danny] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Kamynina, Elena; Muakkassa, Nora; Sharma, Gaurav] Cornell Univ, Ithaca, NY 14853 USA	Case Western Reserve University; Case Western Reserve University; Cornell University	Manor, D (corresponding author), Case Western Reserve Univ, Sch Med, Dept Nutr, WG-48, Cleveland, OH 44106 USA.	dxm178@case.edu			National Institutes of Health Grant [CA82391]; American Cancer Society Award [RPG-99-269-01]; Case Comprehensive Cancer Center Pilot Grant [5P30-CA043703]; NATIONAL CANCER INSTITUTE [R01CA082391, P30CA043703, T32CA009338, R55CA082391] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Award(American Cancer Society); Case Comprehensive Cancer Center Pilot Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA82391. This work was also supported by American Cancer Society Award RPG-99-269-01 and Case Comprehensive Cancer Center Pilot Grant 5P30-CA043703 (to D. M.).	Aghazadeh B, 1998, NAT STRUCT BIOL, V5, P1098, DOI 10.1038/4209; Amino T, 2007, J HUM GENET, V52, P643, DOI 10.1007/s10038-007-0154-1; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Bastian AJ, 2011, CURR OPIN NEUROBIOL, V21, P596, DOI 10.1016/j.conb.2011.06.007; Bi F, 2001, MOL CELL BIOL, V21, P1463, DOI 10.1128/MCB.21.5.1463-1474.2001; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; EVA A, 1988, P NATL ACAD SCI USA, V85, P2061, DOI 10.1073/pnas.85.7.2061; Fard SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009647; Glickstein M, 2006, BRAIN, V129, P288, DOI 10.1093/brain/awh728; Govek EE, 2011, DEV NEUROBIOL, V71, P528, DOI 10.1002/dneu.20850; HALL A, 1992, MOL BIOL CELL, V3, P475, DOI 10.1091/mbc.3.5.475; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; HART MJ, 1994, J BIOL CHEM, V269, P62; Hatakeyama S, 2004, J NEUROCHEM, V91, P299, DOI 10.1111/j.1471-4159.2004.02713.x; Hynes NE, 2011, MOL CELL, V41, P5, DOI 10.1016/j.molcel.2010.12.024; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Ishikawa K, 2005, AM J HUM GENET, V77, P280, DOI 10.1086/432518; Ishikawa K, 2006, NEUROPATHOLOGY, V26, P352, DOI 10.1111/j.1440-1789.2006.00719.x; Kamynina E, 2007, MOL CELL BIOL, V27, P1809, DOI 10.1128/MCB.01051-06; Kauppinen KP, 2005, J BIOL CHEM, V280, P21638, DOI 10.1074/jbc.M413984200; Koeppen AH, 2005, CEREBELLUM, V4, P62, DOI 10.1080/14734220510007950; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kopito RR, 2000, EMBO REP, V1, P225, DOI 10.1093/embo-reports/kvd052; Lazer G, 2011, CELL SIGNAL, V23, P969, DOI 10.1016/j.cellsig.2010.10.022; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Liu XH, 1998, CELL, V95, P269, DOI 10.1016/S0092-8674(00)81757-2; Manto M, 2009, CURR OPIN NEUROL, V22, P419, DOI 10.1097/WCO.0b013e32832b9897; Marmolino D, 2010, CURR NEUROPHARMACOL, V8, P41, DOI 10.2174/157015910790909476; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Murata T, 2006, J NEUROSCI, V26, P12397, DOI 10.1523/JNEUROSCI.3981-06.2006; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Nozaki H, 2007, MOVEMENT DISORD, V22, P857, DOI 10.1002/mds.21443; Ohata T, 2006, J HUM GENET, V51, P461, DOI 10.1007/s10038-006-0385-6; Onodera Y, 2006, NEUROLOGY, V67, P1300, DOI 10.1212/01.wnl.0000238507.85436.20; Orrico A, 2000, FEBS LETT, V478, P216, DOI 10.1016/S0014-5793(00)01857-3; Ouyang Y, 2006, J NEUROL SCI, V247, P180, DOI 10.1016/j.jns.2006.04.009; Ren XD, 2000, METHOD ENZYMOL, V325, P264; RIDLEY AJ, 1992, COLD SPRING HARB SYM, V57, P661, DOI 10.1101/SQB.1992.057.01.072; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Roy S, 2005, ACTA NEUROPATHOL, V109, P5, DOI 10.1007/s00401-004-0952-x; Sakai H, 2010, NEUROGENETICS, V11, P409, DOI 10.1007/s10048-010-0245-6; Salminen A, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-41; Shi P, 2010, BBA-MOL BASIS DIS, V1802, P45, DOI 10.1016/j.bbadis.2009.08.012; Skinner PJ, 2001, AM J PATHOL, V159, P905, DOI 10.1016/S0002-9440(10)61766-X; SRIVASTAVA SK, 1986, P NATL ACAD SCI USA, V83, P8868, DOI 10.1073/pnas.83.23.8868; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Wu WJ, 1997, J BIOL CHEM, V272, P26153, DOI 10.1074/jbc.272.42.26153; Yoshizawa M, 2005, J NEUROSCI, V25, P4406, DOI 10.1523/JNEUROSCI.4955-04.2005; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhang H, 2004, J MOL MED, V82, P488, DOI 10.1007/s00109-004-0549-9; Zheng Y, 1996, J BIOL CHEM, V271, P19017, DOI 10.1074/jbc.271.32.19017	59	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14522	14530		10.1074/jbc.M112.430371	http://dx.doi.org/10.1074/jbc.M112.430371			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23572525	Green Published, hybrid			2022-12-28	WOS:000319253500054
J	Narayanan, M; Gabrieli, DJ; Leung, SA; Elguindy, MM; Glaser, CA; Saju, N; Sinha, SC; Nakamaru-Ogiso, E				Narayanan, Madhavan; Gabrieli, David J.; Leung, Steven A.; Elguindy, Mahmoud M.; Glaser, Carl A.; Saju, Nitha; Sinha, Subhash C.; Nakamaru-Ogiso, Eiko			Semiquinone and Cluster N6 Signals in His-tagged Proton-translocating NADH:Ubiquinone Oxidoreductase (Complex I) from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-QUINONE OXIDOREDUCTASE; IRON-SULFUR CLUSTERS; MITOCHONDRIAL RESPIRATORY-CHAIN; CONSERVED CHARGED RESIDUES; UBIQUINONE OXIDOREDUCTASE; ELECTRON-TRANSFER; PHOTOAFFINITY ANALOG; EPR CHARACTERIZATION; CRYSTAL-STRUCTURE; SUBUNIT	NADH:ubiquinone oxidoreductase (complex I) pumps protons across the membrane using downhill redox energy. The Escherichia coli complex I consists of 13 different subunits named NuoA-N coded by the nuo operon. Due to the low abundance of the protein and some difficulty with the genetic manipulation of its large similar to 15-kb operon, purification of E. coli complex I has been technically challenging. Here, we generated a new strain in which a polyhistidine sequence was inserted upstream of nuoE in the operon. This allowed us to prepare large amounts of highly pure and active complex I by efficient affinity purification. The purified complex I contained 0.94 +/- 0.1 mol of FMN, 29.0 +/- 0.37 mol of iron, and 1.99 +/- 0.07 mol of ubiquinone/1 mol of complex I. The extinction coefficient of isolated complex I was 495 mM(-1)cm(-1) at 274 nm and 50.3 mM(-1)cm(-1) at 410 nm. NADH: ferricyanide activity was 219 +/- 9.7 mu mol/min/mg by using HEPES-Bis-Tris propane, pH 7.5. Detailed EPR analyses revealed two additional iron-sulfur cluster signals, N6a and N6b, in addition to previously assigned signals. Furthermore, we found small but significant semiquinone signal(s), which have been reported only for bovine complex I. The line width was similar to 12 G, indicating its neutral semiquinone form. More than 90% of the semiquinone signal originated from the single entity with P-1/2 (half-saturation power level) = 1.85 milliwatts. The semiquinone signal(s) decreased by 60% when with asimicin, a potent complex I inhibitor. The functional role of semiquinone and the EPR assignment of clusters N6a/N6b are discussed.	[Narayanan, Madhavan; Gabrieli, David J.; Leung, Steven A.; Elguindy, Mahmoud M.; Glaser, Carl A.; Saju, Nitha; Nakamaru-Ogiso, Eiko] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Johnson Res Fdn, Philadelphia, PA 19104 USA; [Sinha, Subhash C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of Pennsylvania; Scripps Research Institute	Nakamaru-Ogiso, E (corresponding author), Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, 422 Curie Blvd, Philadelphia, PA 19104 USA.	eikoo@mail.med.upenn.edu		Elguindy, Mahmoud/0000-0001-9151-1751	National Institutes of Health Grant [RO1GM097409]; American Heart Association Grant [11SDG5560001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097409] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Grant(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM097409 (to E. N.-O.). This work was also supported by American Heart Association Grant 11SDG5560001 (to E. N.-O.).	Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Bowyer J. R., 1985, COENZYME Q, P409; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Braun M, 1998, BIOCHEMISTRY-US, V37, P1861, DOI 10.1021/bi971176p; Bridges HR, 2012, BIOCHEMISTRY-US, V51, P149, DOI 10.1021/bi201644x; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; CARTER P, 1971, ANAL BIOCHEM, V40, P450, DOI 10.1016/0003-2697(71)90405-2; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0; CRANE F. L., 1971, Methods in Enzymology, V18C, P137, DOI 10.1016/S0076-6879(71)18022-6; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Esterhazy D, 2008, BIOCHEMISTRY-US, V47, P3964, DOI 10.1021/bi702243b; Han HN, 2004, CHEM-EUR J, V10, P2149, DOI 10.1002/chem.200305557; HINKLE PC, 1991, BIOCHEMISTRY-US, V30, P3576, DOI 10.1021/bi00228a031; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kao MC, 2004, J BIOL CHEM, V279, P32360, DOI 10.1074/jbc.M403885200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magnitsky S, 2002, J BIOENERG BIOMEMBR, V34, P193, DOI 10.1023/A:1016083419979; Mamedova AA, 2004, J BIOL CHEM, V279, P23830, DOI 10.1074/jbc.M401539200; Murai M, 2007, BIOCHEMISTRY-US, V46, P6409, DOI 10.1021/bi7003697; Mustafa G, 2008, J BIOL CHEM, V283, P28169, DOI 10.1074/jbc.M804938200; Nakamaru-Ogiso E, 2005, J BIOL CHEM, V280, P301, DOI 10.1074/jbc.M410377200; Nakamaru-Ogiso E, 2003, BIOCHEMISTRY-US, V42, P746, DOI 10.1021/bi0269660; Nakamaru-Ogiso E, 2002, J BIOL CHEM, V277, P1680, DOI 10.1074/jbc.M108796200; Nakamaru-Ogiso E., 2012, STRUCTURAL PERSPECTI, P61; Nakamaru-Ogiso E, 2008, J BIOL CHEM, V283, P25979, DOI 10.1074/jbc.M804015200; Nakamaru-Ogiso E, 2010, J BIOL CHEM, V285, P39070, DOI 10.1074/jbc.M110.157826; Nakamaru-Ogiso E, 2010, FEBS LETT, V584, P883, DOI 10.1016/j.febslet.2010.01.004; Ohnishi ST, 2010, BBA-BIOENERGETICS, V1797, P1901, DOI 10.1016/j.bbabio.2010.05.012; Ohnishi ST, 2010, BBA-BIOENERGETICS, V1797, P1891, DOI 10.1016/j.bbabio.2010.06.010; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Ohnishi T, 2005, FEBS LETT, V579, P500, DOI 10.1016/j.febslet.2004.11.107; OHNISHI T, 1975, BIOCHIM BIOPHYS ACTA, V387, P475, DOI 10.1016/0005-2728(75)90087-0; Ohnishi T, 1998, BBA-BIOENERGETICS, V1365, P301, DOI 10.1016/S0005-2728(98)00082-6; Ohnishi T, 2008, BBA-BIOENERGETICS, V1777, P703, DOI 10.1016/j.bbabio.2008.04.032; Pohl T, 2007, BIOCHEMISTRY-US, V46, P10694, DOI 10.1021/bi701057t; Pohl T, 2007, BIOCHEMISTRY-US, V46, P6588, DOI 10.1021/bi700371c; Rapisarda VA, 2002, ARCH BIOCHEM BIOPHYS, V405, P87, DOI 10.1016/S0003-9861(02)00277-1; RUPP H, 1978, BIOCHIM BIOPHYS ACTA, V537, P255, DOI 10.1016/0005-2795(78)90509-3; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shinzawa-Itoh K, 2010, BIOCHEMISTRY-US, V49, P487, DOI 10.1021/bi9016318; Shiraishi Y, 2012, BIOCHEMISTRY-US, V51, P1953, DOI 10.1021/bi300047h; Sinha PK, 2012, J BIOL CHEM, V287, P17363, DOI 10.1074/jbc.M111.329649; SLED VD, 1994, BIOCHEMISTRY-US, V33, P10069, DOI 10.1021/bi00199a034; Tocilescu MA, 2010, BBA-BIOENERGETICS, V1797, P1883, DOI 10.1016/j.bbabio.2010.05.009; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Treberg JR, 2011, J BIOL CHEM, V286, P17579, DOI 10.1074/jbc.M111.227751; Uhlmann M, 2005, BIOCHEMISTRY-US, V44, P1653, DOI 10.1021/bi048136n; Velazquez I, 2005, FEBS LETT, V579, P3164, DOI 10.1016/j.febslet.2005.05.005; Verkhovsky M, 2012, BBA-BIOENERGETICS, V1817, P1550, DOI 10.1016/j.bbabio.2012.04.013; VINOGRADOV AD, 1995, FEBS LETT, V370, P83, DOI 10.1016/0014-5793(95)00803-H; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; YAGI T, 1988, J BIOL CHEM, V263, P16150; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; Yakovlev G, 2007, P NATL ACAD SCI USA, V104, P12720, DOI 10.1073/pnas.0705593104; Yano T, 1999, J BIOL CHEM, V274, P28598, DOI 10.1074/jbc.274.40.28598; Yano T, 2005, BIOCHEMISTRY-US, V44, P1744, DOI 10.1021/bi048132i; Yip CY, 2011, J BIOL CHEM, V286, P5023, DOI 10.1074/jbc.M110.194993; Zickermann V, 2000, BBA-BIOENERGETICS, V1459, P61, DOI 10.1016/S0005-2728(00)00113-4	67	11	11	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14310	14319		10.1074/jbc.M113.467803	http://dx.doi.org/10.1074/jbc.M113.467803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23543743	hybrid, Green Published			2022-12-28	WOS:000319253500035
J	Patananan, AN; Palmer, JM; Garvey, GS; Keller, NP; Clarke, SG				Patananan, Alexander N.; Palmer, Jonathan M.; Garvey, Graeme S.; Keller, Nancy P.; Clarke, Steven G.			A Novel Automethylation Reaction in the Aspergillus nidulans LaeA Protein Generates S-Methylmethionine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOASPARTYL CARBOXYL METHYLTRANSFERASE; SECONDARY METABOLISM; ARGININE METHYLTRANSFERASE; SUBSTRATE-SPECIFICITY; FILAMENTOUS FUNGI; ESCHERICHIA-COLI; GENE CLUSTERS; VIRULENCE; DOMAIN; BIOSYNTHESIS	The filamentous fungi in the genus Aspergillus are opportunistic plant and animal pathogens that can adapt to their environment by producing various secondary metabolites, including lovastatin, penicillin, and aflatoxin. The synthesis of these small molecules is dependent on gene clusters that are globally regulated by the LaeA protein. Null mutants of LaeA in all pathogenic fungi examined to date show decreased virulence coupled with reduced secondary metabolism. Although the amino acid sequence of LaeA contains the motifs characteristic of seven-beta-strand methyltransferases, a methyl-accepting substrate of LaeA has not been identified. In this work we did not find a methyl-accepting substrate in Aspergillus nidulans with various assays, including in vivo S-adenosyl-[methyl-H-3] methionine labeling, targeted in vitro methylation experiments using putative protein substrates, or in vitro methylation assays using whole cell extracts grown under different conditions. However, in each experiment LaeA was shown to self-methylate. Amino acid hydrolysis of radioactively labeled LaeA followed by cation exchange and reverse phase chromatography identified methionine as the modified residue. Point mutations show that the major site of modification of LaeA is on methionine 207. However, in vivo complementation showed that methionine 207 is not required for the biological function of LaeA. LaeA is the first protein to exhibit automethylation at a methionine residue. These findings not only indicate LaeA may perform novel chemistry with S-adenosylmethionine but also provide new insights into the physiological function of LaeA.	[Patananan, Alexander N.; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Patananan, Alexander N.; Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Palmer, Jonathan M.; Garvey, Graeme S.; Keller, Nancy P.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Keller, Nancy P.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr East, Los Angeles, CA 90095 USA.	clarke@chem.ucla.edu	Palmer, Jonathan/A-3890-2009; Keller, Nancy P./ABC-5911-2021	Palmer, Jonathan/0000-0003-0929-3658	National Institutes of Health from NRSA [GM026020, 1 R01 Al065728-01, AI55397, GM007185, F32AI082890-01A1]; National Institutes of Health Grant from NIEHS (through the Molecular and Environmental Toxicology Center) [T32ES007015]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI082890, T32AI055397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, R01GM026020, R37GM026020] Funding Source: NIH RePORTER	National Institutes of Health from NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Grant from NIEHS (through the Molecular and Environmental Toxicology Center); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM026020 (to S. G. C.), 1 R01 Al065728-01 (to N. P. K.), AI55397 from NRSA (to J. M. P.), and GM007185 from NRSA (Ruth L. Kirschstein award) (to A. N. P.).; Supported by National Institutes of Health Grant F32AI082890-01A1 from NRSA (Ruth L. Kirschstein Award) and Training Grant T32ES007015 from NIEHS (through the Molecular and Environmental Toxicology Center). Present address: Monsanto Vegetable Seeds, 37437 State Hwy., 16, Woodland, CA 95695.	ALBERTS AW, 1980, P NATL ACAD SCI-BIOL, V77, P3957, DOI 10.1073/pnas.77.7.3957; Amaike S, 2011, ANNU REV PHYTOPATHOL, V49, P107, DOI 10.1146/annurev-phyto-072910-095221; Amaike S, 2009, EUKARYOT CELL, V8, P1051, DOI 10.1128/EC.00088-09; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Bok JW, 2006, MOL MICROBIOL, V61, P1636, DOI 10.1111/j.1365-2958.2006.05330.x; Bok Jin Woo, 2012, Methods Mol Biol, V944, P163, DOI 10.1007/978-1-62703-122-6_11; Bok JW, 2005, EUKARYOT CELL, V4, P1574, DOI 10.1128/EC.4.9.1574-1582.2005; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Brakhage AA, 1998, MICROBIOL MOL BIOL R, V62, P547, DOI 10.1128/MMBR.62.3.547-585.1998; Brakhage AA, 2013, NAT REV MICROBIOL, V11, P21, DOI 10.1038/nrmicro2916; CHAMPE SP, 1989, J BACTERIOL, V171, P3982, DOI 10.1128/jb.171.7.3982-3988.1989; Chin HG, 2007, NUCLEIC ACIDS RES, V35, P7313, DOI 10.1093/nar/gkm726; Dhar S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01311; FAROOQUI JZ, 1985, J BIOL CHEM, V260, P537; Fernandes M, 1998, MOL MICROBIOL, V28, P1355, DOI 10.1046/j.1365-2958.1998.00907.x; Fisk JC, 2010, EUKARYOT CELL, V9, P866, DOI 10.1128/EC.00018-10; Forseth RR, 2013, ANGEW CHEM INT EDIT, V52, P1590, DOI 10.1002/anie.201207456; Fox EM, 2008, CURR OPIN MICROBIOL, V11, P481, DOI 10.1016/j.mib.2008.10.007; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Frankel A, 2000, J BIOL CHEM, V275, P32974, DOI 10.1074/jbc.M006445200; Garvey GS, 2010, CURR FUNGAL INFECT R, V4, P256, DOI 10.1007/s12281-010-0032-8; GOTTSCHLING H, 1962, NATURE, V196, P829, DOI 10.1038/196829a0; Gui SY, 2011, J BIOL CHEM, V286, P29118, DOI 10.1074/jbc.M111.224097; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Karimi-Aghcheh R, 2013, G3-GENES GENOM GENET, V3, P369, DOI 10.1534/g3.112.005140; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kinoshita E, 2011, PROTEOMICS, V11, P319, DOI 10.1002/pmic.201000472; Kuhn P, 2011, NUCLEIC ACIDS RES, V39, P2717, DOI 10.1093/nar/gkq1246; Lakowski TM, 2010, ACS CHEM BIOL, V5, P1053, DOI 10.1021/cb100161u; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; LINDQUIST JA, 1994, J PROTEIN CHEM, V13, P23, DOI 10.1007/BF01891989; Lindquist JA, 1996, J PROTEIN CHEM, V15, P115, DOI 10.1007/BF01886817; Lopez-Berges MS, 2013, MOL MICROBIOL, V87, P49, DOI 10.1111/mmi.12082; Marsden RL, 2002, PROTEIN SCI, V11, P2814, DOI 10.1110/ps.0209902; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Niu LF, 2012, PROTEIN CELL, V3, P450, DOI 10.1007/s13238-012-2935-3; Ogawa S, 2012, PHYSIOL PLANTARUM, V144, P13, DOI 10.1111/j.1399-3054.2011.01516.x; Palmer JM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003193; Palmer JM, 2010, MICROBIOL-SGM, V156, P3522, DOI 10.1099/mic.0.039255-0; Palmer JM, 2010, CURR OPIN MICROBIOL, V13, P431, DOI 10.1016/j.mib.2010.04.008; Palmer JM, 2008, EUKARYOT CELL, V7, P2052, DOI 10.1128/EC.00224-08; Pennini ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000995; Perrin RM, 2007, PLOS PATHOG, V3, P508, DOI 10.1371/journal.ppat.0030050; Petrossian TC, 2009, MOL CELL PROTEOMICS, V8, P1516, DOI 10.1074/mcp.M900025-MCP200; Reyes-Dominguez Y, 2010, MOL MICROBIOL, V76, P1376, DOI 10.1111/j.1365-2958.2010.07051.x; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Sambrook J., 2001, MOL CLONING LAB MANU; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Shaaban M, 2010, FUNGAL GENET BIOL, V47, P423, DOI 10.1016/j.fgb.2010.02.006; Shimizu K, 2001, GENETICS, V157, P591; Siddique A, 2011, FEBS J, V278, P2055, DOI 10.1111/j.1742-4658.2011.08121.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Strauss J, 2011, FUNGAL GENET BIOL, V48, P62, DOI 10.1016/j.fgb.2010.07.009; Sugui JA, 2007, EUKARYOT CELL, V6, P1552, DOI 10.1128/EC.00140-07; Szegedi SS, 2008, J BIOL CHEM, V283, P8939, DOI 10.1074/jbc.M710449200; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Thanbichler M, 1999, J BACTERIOL, V181, P662, DOI 10.1128/JB.181.2.662-665.1999; Tsitsigiannis D, 2004, EUKARYOT CELL, V3, P1398, DOI 10.1128/EC.3.6.1398-1411.2004; Tsitsigiannis DI, 2004, J BIOL CHEM, V279, P11344, DOI 10.1074/jbc.M310840200; Vinci CR, 2007, J BIOL CHEM, V282, P8604, DOI 10.1074/jbc.M610029200; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Webb KJ, 2011, J BIOL CHEM, V286, P18405, DOI 10.1074/jbc.M110.200410; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; Williamson EA, 2008, NUCLEIC ACIDS RES, V36, P5822, DOI 10.1093/nar/gkn560; Wu DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002542; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	74	46	51	1	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14032	14045		10.1074/jbc.M113.465765	http://dx.doi.org/10.1074/jbc.M113.465765			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23532849	hybrid, Green Published			2022-12-28	WOS:000319253500009
J	Sanchez, MA				Sanchez, Marco A.			Molecular Identification and Characterization of an Essential Pyruvate Transporter from Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-STREAM-FORM; LIFE-CYCLE STAGES; MONOCARBOXYLATE TRANSPORTER; PLASMA-MEMBRANE; NUCLEOSIDE TRANSPORTER; FUNCTIONAL EXPRESSION; AFRICAN TRYPANOSOMES; DRUG; DIFFERENTIATION; METABOLISM	Pyruvate export is an essential physiological process for the bloodstream form of Trypanosoma brucei as the parasite would otherwise accumulate this end product of glucose metabolism to toxic levels. In the studies reported here, genetic complementation in Saccharomyces cerevisiae has been employed to identify a gene (TbPT0) that encodes this vital pyruvate transporter from T. brucei. Expression of TbPT0 in S. cerevisiae reveals that TbPT0 is a high affinity pyruvate transporter. TbPT0 belongs to a clustered multigene family consisting of five members, whose expression is up-regulated in the bloodstream form. Interestingly, TbPT family permeases are related to polytopic proteins from plants but not to characterized monocarboxylate transporters from mammals. Remarkably, inhibition of the TbPT gene family expression in bloodstream parasites by RNAi is lethal, confirming the physiological relevance of these transporters. The discovery of TbPT0 reveals for the first time the identity of the essential pyruvate transporter and provides a potential drug target against the mammalian life cycle stage of T. brucei.	[Sanchez, Marco A.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA	Oregon Health & Science University	Sanchez, MA (corresponding author), 3181 SW Sam Jackson Pk Rd,L220, Portland, OR 97239 USA.	sanchezm@ohsu.edu			American Heart Association [0560056Z]	American Heart Association(American Heart Association)	This work was supported by Beginning Grant-in-aid 0560056Z (to M. A. S.) from the American Heart Association.	Akita O, 2000, BIOSCI BIOTECH BIOCH, V64, P980, DOI 10.1271/bbb.64.980; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Aronov AM, 1999, P NATL ACAD SCI USA, V96, P4273, DOI 10.1073/pnas.96.8.4273; Bakker BM, 2000, MOL BIOCHEM PARASIT, V106, P1, DOI 10.1016/S0166-6851(99)00197-8; BARNARD JP, 1993, J BIOL CHEM, V268, P3654; BARNARD JP, 1994, ARCH BIOCHEM BIOPHYS, V313, P77, DOI 10.1006/abbi.1994.1361; Barrett MP, 2006, ADV PARASIT, V63, P125, DOI 10.1016/S0065-308X(06)63002-9; Brems S, 2005, MOL BIOCHEM PARASIT, V139, P163, DOI 10.1016/j.molbiopara.2004.11.004; Butter F, 2013, MOL CELL PROTEOMICS, V12, P172, DOI 10.1074/mcp.M112.019224; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Choi WG, 2007, J BIOL CHEM, V282, P24209, DOI 10.1074/jbc.M700982200; Dean S, 2009, NATURE, V459, P213, DOI 10.1038/nature07997; Haanstra JR, 2011, MOL MICROBIOL, V79, P94, DOI 10.1111/j.1365-2958.2010.07435.x; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Halestrap AP, 2012, IUBMB LIFE, V64, P1, DOI 10.1002/iub.573; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hannaert V, 2003, P NATL ACAD SCI USA, V100, P1067, DOI 10.1073/pnas.0335769100; Hannaert Veronique, 2003, Kinetoplastid Biology and Disease, V2, pUnpaginated; Jensen BC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-482; Makuc J, 2004, FEMS YEAST RES, V4, P795, DOI 10.1016/j.femsyr.2004.06.003; Maser P, 1999, SCIENCE, V285, P242, DOI 10.1126/science.285.5425.242; MazhariTabrizi R, 1996, BIOCHEM J, V316, P853, DOI 10.1042/bj3160853; Merezhinskaya N, 2009, HISTOL HISTOPATHOL, V24, P243, DOI 10.14670/HH-24.243; Morris ME, 2008, AAPS J, V10, P311, DOI 10.1208/s12248-008-9035-6; Nolan DP, 2000, EUR J BIOCHEM, V267, P4615, DOI 10.1046/j.1432-1327.2000.01477.x; Opperdoes FR, 2001, INT J PARASITOL, V31, P482, DOI 10.1016/S0020-7519(01)00155-2; Ortiz D, 2009, MOL BIOCHEM PARASIT, V163, P67, DOI 10.1016/j.molbiopara.2008.09.011; Paulnock DM, 2010, PARASITOLOGY, V137, P2051, DOI 10.1017/S0031182010001460; Poole RC, 1996, BIOCHEM J, V320, P817, DOI 10.1042/bj3200817; Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495; SAMBROOK J, 1989, MOL CLONING LAB MANU, P7; Sanchez MA, 2004, MOL BIOCHEM PARASIT, V136, P265, DOI 10.1016/j.molbiopara.2004.04.009; Sanchez MA, 2002, J BIOL CHEM, V277, P21499, DOI 10.1074/jbc.M202319200; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Sunter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035167; Tielens AGM, 2009, TRENDS PARASITOL, V25, P482, DOI 10.1016/j.pt.2009.07.007; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; van Deursen FJ, 2001, MOL BIOCHEM PARASIT, V112, P163, DOI 10.1016/S0166-6851(00)00359-5; Van Hellemond JJ, 2000, J BIOL CHEM, V275, P8315, DOI 10.1074/jbc.275.12.8315; Vanderheyden N, 2000, BIOCHEM J, V346, P53, DOI 10.1042/0264-6021:3460053; Veitch NJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-124; WIEMER EAC, 1995, BIOCHEM J, V312, P479, DOI 10.1042/bj3120479; WIEMER EAC, 1992, BIOCHEM BIOPH RES CO, V184, P1028, DOI 10.1016/0006-291X(92)90694-G	43	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14428	14437		10.1074/jbc.M113.473157	http://dx.doi.org/10.1074/jbc.M113.473157			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23569205	hybrid, Green Published			2022-12-28	WOS:000319253500046
J	Seol, Y; Gentry, AC; Osheroff, N; Neuman, KC				Seol, Yeonee; Gentry, Amanda C.; Osheroff, Neil; Neuman, Keir C.			Chiral Discrimination and Writhe-dependent Relaxation Mechanism of Human Topoisomerase II alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; SINGLE-MOLECULE MEASUREMENTS; POSITIVELY SUPERCOILED DNA; MAGNETIC TWEEZERS; IN-VITRO; ATP; TOPOLOGY; ENZYME; IV; DECATENATION	Type IIA topoisomerases (Topo IIA) are essential enzymes that relax DNA supercoils and remove links joining replicated chromosomes. Human topoisomerase II alpha (htopo II alpha), one of two human isoforms, preferentially relaxes positive supercoils, a feature shared with Escherichia coli topoisomerase IV (Topo IV). The mechanistic basis of this chiral discrimination remains unresolved. To address this important issue, we measured the relaxation of individual supercoiled and "braided" DNA molecules by htopo II alpha using a magnetic tweezers-based single-molecule assay. Our study confirmed the chiral discrimination activity of htopo II alpha and revealed that the strand passage rate depends on DNA twist, tension on the DNA, and the C-terminal domain (CTD). Similar to Topo IV, chiral discrimination by htopo II alpha results from chiral interactions of the CTDs with DNA writhe. In contrast to Topo IV, however, these interactions lead to chiral differences in relaxation rate rather than processivity. Increasing tension or twist disrupts the CTD-DNA interactions with a subsequent loss of chiral discrimination. Together, these results suggest that transfer segment (T-segment) capture is the rate-limiting step in the strand passage cycle. We propose a model for T-segment capture that provides a mechanistic basis for chiral discrimination and provides a coherent explanation for the effects of DNA twist and tension on eukaryotic type IIA topoisomerases.	[Seol, Yeonee; Neuman, Keir C.] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Gentry, Amanda C.; Osheroff, Neil] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Gentry, Amanda C.; Osheroff, Neil] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Vanderbilt University; Vanderbilt University	Neuman, KC (corresponding author), NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA.	neumankc@mail.nih.gov	Neuman, Keir C./F-7400-2011	Neuman, Keir C./0000-0002-0863-5671	National Heart, Lung, and Blood Institute, National Institutes of Health; National Institutes of Health [GM033944, 5 T32 CA09582]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033944] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported, in whole or in part, by the Intramural Research Program of the National Heart, Lung, and Blood Institute, National Institutes of Health (to K. C. N.) and by extramural National Institutes of Health Grant GM033944 (to N. O.); Recipient of National Institutes of Health Trainee Grant 5 T32 CA09582.	Adachi N, 1997, NUCLEIC ACIDS RES, V25, P3135, DOI 10.1093/nar/25.15.3135; Baird CL, 1999, P NATL ACAD SCI USA, V96, P13685, DOI 10.1073/pnas.96.24.13685; Baird CL, 2001, J BIOL CHEM, V276, P27893, DOI 10.1074/jbc.M102544200; Bates A. D., 2005, DNA TOPOLOGY; CARDENAS ME, 1992, EMBO J, V11, P1785, DOI 10.1002/j.1460-2075.1992.tb05230.x; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Charvin G, 2005, BIOPHYS J, V88, P4124, DOI 10.1529/biophysj.104.056945; Charvin G, 2005, ANNU REV BIOPH BIOM, V34, P201, DOI 10.1146/annurev.biophys.34.040204.144433; Charvin G, 2003, P NATL ACAD SCI USA, V100, P9820, DOI 10.1073/pnas.1631550100; Corbett KD, 2005, J MOL BIOL, V351, P545, DOI 10.1016/j.jmb.2005.06.029; Corbett KD, 2004, P NATL ACAD SCI USA, V101, P7293, DOI 10.1073/pnas.0401595101; CRENSHAW DG, 1993, J BIOL CHEM, V268, P21328; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Dickey JS, 2005, BIOCHEMISTRY-US, V44, P11546, DOI 10.1021/bi050811l; Forterre P, 2007, BIOCHIMIE, V89, P427, DOI 10.1016/j.biochi.2006.12.009; Harkins TT, 1998, BIOCHEMISTRY-US, V37, P7299, DOI 10.1021/bi9729108; Hsieh TJ, 2010, NUCLEIC ACIDS RES, V38, P4173, DOI 10.1093/nar/gkq153; Jensen S, 1996, MOL CELL BIOL, V16, P3866; Kingma PS, 1997, BIOCHEMISTRY-US, V36, P5934, DOI 10.1021/bi970507v; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Marko JF, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021926; McClendon AK, 2008, BIOCHEMISTRY-US, V47, P13169, DOI 10.1021/bi800453h; McClendon AK, 2005, J BIOL CHEM, V280, P39337, DOI 10.1074/jbc.M503320200; Mirski SEL, 1997, EXP CELL RES, V237, P452, DOI 10.1006/excr.1997.3805; Mueller-Planitz F, 2006, J BIOL CHEM, V281, P23395, DOI 10.1074/jbc.M604119200; Neuman KC, 2009, P NATL ACAD SCI USA, V106, P6986, DOI 10.1073/pnas.0900574106; Neuman KC, 2005, J PHYS-CONDENS MAT, V17, pS3811, DOI 10.1088/0953-8984/17/47/012; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Neuman KC, 2010, J BIOL CHEM, V285, P18967, DOI 10.1074/jbc.R109.092437; Ramamoorthy M, 2012, NUCLEIC ACIDS RES, V40, P1621, DOI 10.1093/nar/gkr844; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; Roca J, 1996, GENES CELLS, V1, P17, DOI 10.1046/j.1365-2443.1996.01001.x; Roca J, 2011, CHROMOSOMA, V120, P323, DOI 10.1007/s00412-011-0324-y; Roca J, 2009, NUCLEIC ACIDS RES, V37, P721, DOI 10.1093/nar/gkn994; Ruthenburg AJ, 2005, J BIOL CHEM, V280, P26177, DOI 10.1074/jbc.M502838200; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Seol Y, 2011, METHODS MOL BIOL, V783, P265, DOI 10.1007/978-1-61779-282-3_15; Seol Y, 2011, METHODS MOL BIOL, V778, P229, DOI 10.1007/978-1-61779-261-8_15; Stone MD, 2003, P NATL ACAD SCI USA, V100, P8654, DOI 10.1073/pnas.1133178100; Strick TR, 2000, NATURE, V404, P901, DOI 10.1038/35009144; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Timsit Y, 2011, NUCLEIC ACIDS RES, V39, P8665, DOI 10.1093/nar/gkr556; Tinoco I, 2002, BIOPHYS CHEM, V101, P513, DOI 10.1016/S0301-4622(02)00177-1; Tretter EM, 2010, P NATL ACAD SCI USA, V107, P22055, DOI 10.1073/pnas.1012938107; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang JC, 2009, UNTANGLING DOUBLE HE; WELLS NJ, 1994, J BIOL CHEM, V269, P29746; Yogo K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034920	50	20	21	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13695	13703		10.1074/jbc.M112.444745	http://dx.doi.org/10.1074/jbc.M112.444745			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23508957	Green Published, hybrid			2022-12-28	WOS:000318850300052
J	Puljung, MC; Zagotta, WN				Puljung, Michael C.; Zagotta, William N.			A Secondary Structural Transition in the C-helix Promotes Gating of Cyclic Nucleotide-regulated Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING DOMAIN; LIGAND-BINDING; HCN CHANNELS; ACTIVATED CHANNELS; TERMINAL REGION; GATED CHANNELS; CAMP-BINDING; PROTEIN; MODULATION; MOVEMENT	Cyclic nucleotide-regulated ion channels bind second messengers like cAMP to a C-terminal domain, consisting of a beta-roll, followed by two alpha-helices (B- and C-helices). We monitored the cAMP-dependent changes in the structure of the C-helix of a C-terminal fragment of HCN2 channels using transition metal ion FRET between fluorophores on the C-helix and metal ions bound between histidine pairs on the same helix. cAMP induced a change in the dimensions of the C-helix and an increase in the metal binding affinity of the histidine pair. cAMP also caused an increase in the distance between a fluorophore on the C-helix and metal ions bound to the B-helix. Stabilizing the C-helix of intact CNGA1 channels by metal binding to a pair of histidines promoted channel opening. These data suggest that ordering of the C-helix is part of the gating conformational change in cyclic nucleotide-regulated channels.	[Puljung, Michael C.; Zagotta, William N.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.	zagotta@u.washington.edu		Puljung, Michael/0000-0002-9335-0936	National Institutes of Health [R01 EY010329, F32EY018981]; NATIONAL EYE INSTITUTE [F32EY018981, R01EY010329] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 EY010329 (to W.N.Z.) and F32EY018981 (to M.C.P.).	Altieri SL, 2008, J MOL BIOL, V381, P655, DOI 10.1016/j.jmb.2008.06.011; ARNOLD FH, 1991, SCIENCE, V252, P1796, DOI 10.1126/science.1648261; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Chow SS, 2012, J BIOL CHEM, V287, P600, DOI 10.1074/jbc.M111.269563; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Craven KB, 2008, J BIOL CHEM, V283, P14728, DOI 10.1074/jbc.M710463200; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Glaaser IW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1717; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; GORDON SE, 1995, NEURON, V14, P177; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; KARPEN JW, 1993, J GEN PHYSIOL, V101, P1, DOI 10.1085/jgp.101.1.1; KELLIS JT, 1991, BIO-TECHNOL, V9, P994, DOI 10.1038/nbt1091-994; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim Jeong Joo, 2011, PLoS One, V6, pe18413, DOI 10.1371/journal.pone.0018413; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P353; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Marques-Carvalho MJ, 2012, J MOL BIOL, V423, P34, DOI 10.1016/j.jmb.2012.06.025; Matulef K, 1999, NEURON, V24, P443, DOI 10.1016/S0896-6273(00)80857-0; Matulef K, 2002, NEURON, V36, P93, DOI 10.1016/S0896-6273(02)00878-4; Mazzolini M, 2002, BIOPHYS J, V83, P3283, DOI 10.1016/S0006-3495(02)75329-0; Molokanova E, 1997, J NEUROSCI, V17, P9068; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Puljung MC, 2011, BIOPHYS J, V100, P2513, DOI 10.1016/j.bpj.2011.03.063; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Schunke S, 2011, P NATL ACAD SCI USA, V108, P6121, DOI 10.1073/pnas.1015890108; Schunke S, 2009, EMBO REP, V10, P729, DOI 10.1038/embor.2009.68; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; SUH SS, 1991, PROTEIN ENG, V4, P301, DOI 10.1093/protein/4.3.301; Sunderman ER, 1999, J GEN PHYSIOL, V113, P601, DOI 10.1085/jgp.113.5.601; Taraska JW, 2009, P NATL ACAD SCI USA, V106, P16227, DOI 10.1073/pnas.0905207106; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Tibbs GR, 1998, J BIOL CHEM, V273, P4497, DOI 10.1074/jbc.273.8.4497; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; Wu SJ, 2011, BIOPHYS J, V100, P1226, DOI 10.1016/j.bpj.2011.01.034; Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033; Yu XZ, 2013, STRUCTURE, V21, P9, DOI 10.1016/j.str.2012.11.013; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; ZAGOTTA WN, 1989, P NATL ACAD SCI USA, V86, P7243, DOI 10.1073/pnas.86.18.7243; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012	46	28	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12944	12956		10.1074/jbc.M113.464123	http://dx.doi.org/10.1074/jbc.M113.464123			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23525108	hybrid, Green Published			2022-12-28	WOS:000318555100048
J	Yang, LK; Rezaie, AR				Yang, Likui; Rezaie, Alireza R.			Residues of the 39-Loop Restrict the Plasma Inhibitor Specificity of Factor IXa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEASE INHIBITOR; COAGULATION-FACTOR IXA; FACTOR PATHWAY INHIBITOR; FACTOR-XA; BLOOD-COAGULATION; MOLECULAR-BASIS; ACTIVE-SITE; SUBSTRATE; THROMBIN; COMPLEX	The two plasma inhibitors, protein Z-dependent protease inhibitor (ZPI) and tissue factor pathway inhibitor (TFPI), effectively inhibit the activity of activated factor X (FXa); however, neither inhibitor exhibits any reactivity with the homologous protease activated factor IX (FIXa). In this study, we investigated the molecular basis for the lack of reactivity of FIXa with these plasma inhibitors and discovered that unique structural features within residues of the 39-loop are responsible for restricting the inhibitor specificity of FIXa. This loop in FXa is highly acidic and contains three Glu residues at positions 36, 37, and 39. On the other hand, the loop is shorter by one residue in FIXa (residue 37 is missing), and it contains a Lys and an Asp at positions 36 and 39, respectively. We discovered that replacing residues of the 39-loop (residues 31-41) of FIXa with corresponding residues of FXa renders the FIXa chimera susceptible to inactivation by both ZPI and TFPI. Thus, the inactivation rate of the FIXa chimera by ZPI in the presence of protein Z (PZ), negatively charged membrane vesicles, and calcium ions approached the same diffusion-limited rate (>10(7) M-1 s(-1)) that has been observed for the PZ-dependent inhibition of FXa by ZPI. Interestingly, sequence alignments indicated that, similar to FXa, residue 36 is a Glu in both mouse and bovine FIXa and that both proteases are also susceptible to inhibition by the PZ-ZPI complex. These results suggest that structural features within residues of the 39-loop contribute to the resistance of FIXa to inhibition by plasma inhibitors ZPI and TFPI.	[Yang, Likui; Rezaie, Alireza R.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Rezaie, AR (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, 1100 S Grand Blvd, St Louis, MO 63104 USA.	rezaiear@slu.edu			National Institutes of Health from the National Heart, Lung, and Blood Institute [HL 101917, HL 62565]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101917, R01HL062565] Funding Source: NIH RePORTER	National Institutes of Health from the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 101917 and HL 62565 (to A. R. R.) from the National Heart, Lung, and Blood Institute.	BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; BRANDSTETTER H, 1995, P NATL ACAD SCI USA, V92, P9796, DOI 10.1073/pnas.92.21.9796; Broze GJ, 2001, THROMB HAEMOSTASIS, V86, P8; BROZE GJ, 1995, THROMB HAEMOSTASIS, V74, P90; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; FURIE B, 1982, J BIOL CHEM, V257, P3875; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Hopfner KP, 1997, EMBO J, V16, P6626, DOI 10.1093/emboj/16.22.6626; Huang X, 2008, J BIOL CHEM, V283, P29770, DOI 10.1074/jbc.M805214200; HUANG ZF, 1993, J BIOL CHEM, V268, P26950; Johnson DJD, 2010, P NATL ACAD SCI USA, V107, P645, DOI 10.1073/pnas.0910144107; Mann KG, 2003, ARTERIOSCL THROM VAS, V23, P17, DOI 10.1161/01.ATV.0000046238.23903.FC; OLSON ST, 1992, THROMBIN STRUCTURE F, P159; PADMANABHAN K, 1993, J MOL BIOL, V232, P947, DOI 10.1006/jmbi.1993.1441; Qureshi SH, 2007, BIOCHEM J, V407, P427, DOI 10.1042/BJ20070735; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; Rezaie AR, 2008, J BIOL CHEM, V283, P19922, DOI 10.1074/jbc.M802639200; Rezaie AR, 2004, J BIOL CHEM, V279, P48262, DOI 10.1074/jbc.M409964200; REZAIE AR, 1993, J BIOL CHEM, V268, P19943; Rezaie AR, 1996, J BIOL CHEM, V271, P23807, DOI 10.1074/jbc.271.39.23807; Sturzebecher J, 1997, FEBS LETT, V412, P295, DOI 10.1016/S0014-5793(97)00811-9; Wei ZQ, 2009, BLOOD, V114, P3662, DOI 10.1182/blood-2009-04-210021; Yang LK, 2006, PROTEIN EXPRES PURIF, V50, P196, DOI 10.1016/j.pep.2006.05.012; Yang LK, 2012, BIOCHEMISTRY-US, V51, P4078, DOI 10.1021/bi300353c; Yang LK, 2010, J BIOL CHEM, V285, P28488, DOI 10.1074/jbc.M110.143321; Zogg T, 2009, STRUCTURE, V17, P1669, DOI 10.1016/j.str.2009.10.011	27	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12692	12698		10.1074/jbc.M113.459347	http://dx.doi.org/10.1074/jbc.M113.459347			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23530052	hybrid, Green Published			2022-12-28	WOS:000318555100026
J	Zhu, XJ; Zhao, P; Liu, YD; Zhang, XY; Fu, J; Yu, HMI; Qiu, MS; Chen, YP; Hsu, W; Zhang, ZY				Zhu, XiaoJing; Zhao, Pan; Liu, YuDong; Zhang, XiaoYun; Fu, Jiang; Yu, H. -M. Ivy; Qiu, Mengsheng; Chen, YiPing; Hsu, Wei; Zhang, Zunyi			Intra-epithelial Requirement of Canonical Wnt Signaling for Tooth Morphogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL INTERACTIONS; HAIR FOLLICLE DEVELOPMENT; EMBRYONIC AXIS FORMATION; MAMMALIAN TOOTH; TRANSMEMBRANE PROTEIN; DENTAL MESENCHYME; REGULATES GROWTH; MOUSE TOOTH; ENAMEL KNOT; PATHWAY	Multiple Wnt ligands are expressed in the developing tooth and play important and redundant functions during odontogenesis. However, the source of Wnt ligands and their targeting cells and action mechanism in tooth organogenesis remain largely elusive. Here we show that epithelial inactivation of Gpr177, the mouse Wntless (Wls) whose product regulates Wnt sorting and secretion, leads to arrest of tooth development at the early cap stage and abrogates tooth-forming capability of the dental epithelium. Gpr177 in the epithelium is necessary for the activation of canonical Wnt signaling in the dental epithelium and formation of a functional enamel knot. Epithelial deletion of Gpr177 results in defective gene expression and cellular behavior in the dental epithelium but does not alter odontogenic program in the mesenchyme. Furthermore, deletion of Axin2, a negative intracellular regulator of canonical Wnt signaling, rescues the tooth defects in mice carrying Gpr177 mutation in the dental epithelium. Together with the fact that active Wnt canonical signaling is present predominantly in the dental epithelium during tooth development, our results demonstrate that Gpr177-mediated Wnt ligands in the dental epithelium act primarily in an intra-epithelial context to regulate enamel knot formation and subsequent tooth development.	[Zhu, XiaoJing; Zhao, Pan; Liu, YuDong; Zhang, XiaoYun; Qiu, Mengsheng; Zhang, Zunyi] Hangzhou Normal Univ, Coll Life & Environm Sci, Inst Dev & Regenerat Biol, Hangzhou 310036, Zhejiang, Peoples R China; [Fu, Jiang; Yu, H. -M. Ivy; Hsu, Wei] Univ Rochester, Med Ctr, Dept Biomed Genet, Ctr Oral Biol,James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [Chen, YiPing] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA	Hangzhou Normal University; University of Rochester; Tulane University	Zhang, ZY (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Inst Dev & Regenerat Biol, 16 Xuelin St, Hangzhou 310036, Zhejiang, Peoples R China.	zunyi_zhang@idrbio.org	Hsu, Wei/ABG-6856-2021	Hsu, Wei/0000-0001-6738-6030	National Science Foundation of Zhejiang Province [Z12C120004, LY12C12002]; National Key Basic Research Program of China [2012CB910402]; National Nature Science Foundation of China [31100845, 31201090]; Hangzhou Normal University; National Institutes of Health [DE015654, CA 10638, DE 14044, DE 17792]; NATIONAL CANCER INSTITUTE [R01CA106308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015654, R01DE017792, R01DE014044] Funding Source: NIH RePORTER	National Science Foundation of Zhejiang Province; National Key Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hangzhou Normal University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the National Science Foundation of Zhejiang Province (Z12C120004 and LY12C12002), the National Key Basic Research Program of China (2012CB910402), and the National Nature Science Foundation of China (31100845 and 31201090). This work was also supported in part by start funding from Hangzhou Normal University (to Z. Y. Z), National Institutes of Health Grants DE015654 and CA 10638 (to W. H.) and DE 14044 and DE 17792 (to Y. P. C).	Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Celli G, 1998, EMBO J, V17, P1642, DOI 10.1093/emboj/17.6.1642; Chen JQ, 2009, DEV BIOL, V334, P174, DOI 10.1016/j.ydbio.2009.07.015; Ching W, 2008, J BIOL CHEM, V283, P17092, DOI 10.1074/jbc.M802059200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; Fu JA, 2011, DEV DYNAM, V240, P365, DOI 10.1002/dvdy.22541; Fu J, 2009, P NATL ACAD SCI USA, V106, P18598, DOI 10.1073/pnas.0904894106; Fujimori S, 2010, DEV BIOL, V348, P97, DOI 10.1016/j.ydbio.2010.09.009; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Ishida K, 2011, BIOCHEM BIOPH RES CO, V405, P455, DOI 10.1016/j.bbrc.2011.01.052; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; JERNVALL J, 1994, INT J DEV BIOL, V38, P463; Jernvall J, 1998, DEVELOPMENT, V125, P161; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kettunen P, 2005, DEVELOPMENT, V132, P323, DOI 10.1242/dev.01541; Kratochwil K, 2002, GENE DEV, V16, P3173, DOI 10.1101/gad.1035602; Kratochwil K, 1996, GENE DEV, V10, P1; Lan Y, 2004, DEVELOPMENT, V131, P3207, DOI 10.1242/dev.01175; Lin MK, 2011, DEV DYNAM, V240, P432, DOI 10.1002/dvdy.22550; Liu F, 2010, J DENT RES, V89, P318, DOI 10.1177/0022034510363373; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lohi M, 2010, DEV DYNAM, V239, P160, DOI 10.1002/dvdy.22047; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; O'Connell DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002414; Qian LH, 2011, P NATL ACAD SCI USA, V108, P8692, DOI 10.1073/pnas.1100328108; Sarkar L, 1999, MECH DEVELOP, V85, P197, DOI 10.1016/S0925-4773(99)00095-7; Song YQ, 2006, DEV DYNAM, V235, P1334, DOI 10.1002/dvdy.20706; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085; Thesleff I, 2001, Adv Dent Res, V15, P14; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Vaahtokari A, 1996, DEVELOPMENT, V122, P121; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang YD, 2003, DEV DYNAM, V226, P713, DOI 10.1002/dvdy.10274; Zhang ZY, 2009, SCIENCE, V323, P1232, DOI 10.1126/science.1167418; Zhang ZY, 2002, DEVELOPMENT, V129, P4135; Zhu XJ, 2010, J BIOL CHEM, V285, P29903, DOI 10.1074/jbc.M110.105494	51	39	39	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12080	12089		10.1074/jbc.M113.462473	http://dx.doi.org/10.1074/jbc.M113.462473			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23525146	Green Published, hybrid			2022-12-28	WOS:000318157600041
J	Liu, J; Mei, ZQ; Li, NN; Qi, YT; Xu, YJ; Shi, YG; Wang, F; Lei, JL; Gao, N				Liu, Jing; Mei, Ziqing; Li, Ningning; Qi, Yutao; Xu, Yanji; Shi, Yigong; Wang, Feng; Lei, Jianlin; Gao, Ning			Structural Dynamics of the MecA-ClpC Complex A TYPE II AAA(+) PROTEIN UNFOLDING MACHINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-FUELED MACHINES; ELECTRON-MICROSCOPY; NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURE; ADAPTER PROTEIN; PLUS PROTEIN; CRYOELECTRON MICROGRAPHS; DISAGGREGATING MACHINE; CONFORMATIONAL-CHANGES; REGULATED PROTEOLYSIS	The MecA-ClpC complex is a bacterial type II AAA(+) molecular machine responsible for regulated unfolding of substrates, such as transcription factors ComK and ComS, and targeting them to ClpP for degradation. The six subunits of the MecA-ClpC complex form a closed barrel-like structure, featured with three stacked rings and a hollow passage, where substrates are threaded and translocated through successive pores. Although the general concepts of how polypeptides are unfolded and translocated by internal pore loops of AAA(+) proteins have long been conceived, the detailed mechanistic model remains elusive. With cryoelectron microscopy, we captured four different structures of the MecA-ClpC complexes. These complexes differ in the nucleotide binding states of the two AAA(+) rings and therefore might presumably reflect distinctive, representative snapshots from a dynamic unfolding cycle of this hexameric complex. Structural analysis reveals that nucleotide binding and hydrolysis modulate the hexameric complex in a number of ways, including the opening of the N-terminal ring, the axial and radial positions of pore loops, the compactness of the C-terminal ring, as well as the relative rotation between the two nucleotide-binding domain rings. More importantly, our structural and biochemical data indicate there is an active allosteric communication between the two AAA(+) rings and suggest that concerted actions of the two AAA(+) rings are required for the efficiency of the substrate unfolding and translocation. These findings provide important mechanistic insights into the dynamic cycle of the MecA-ClpC unfoldase and especially lay a foundation toward the complete understanding of the structural dynamics of the general type II AAA(+) hexamers.	[Liu, Jing; Li, Ningning; Xu, Yanji; Shi, Yigong; Lei, Jianlin; Gao, Ning] Tsinghua Univ, Sch Life Sci, Minist Educ, Struct Biol Ctr,Key Lab Prot Sci, Beijing 100084, Peoples R China; [Mei, Ziqing; Qi, Yutao; Shi, Yigong; Wang, Feng] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Wang, F (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	wfeng@tsinghua.edu.cn; jllei@tsinghuae.du.cn; ninggao@tsinghua.edu.cn	Wang, Feng/AAC-6221-2022; Gao, Ning/J-9623-2012; Gao, Ning/AAK-2214-2020; Mei, Ziqing/AHD-6788-2022	Wang, Feng/0000-0002-9403-4337; Gao, Ning/0000-0003-3067-9993; Gao, Ning/0000-0003-3067-9993; Mei, Ziqing/0000-0001-8554-6309; Li, Ningning/0000-0001-8601-5171; Shi, Yigong/0000-0003-2030-168X	Ministry of Science and Technology of China [2010CB912402, 2013CB910404, 2010CB912401, 2009CB918801]; National Natural Science Foundation of China [31100524, 31270764, 30888001]; Tsinghua-Peking Center for Life Sciences; China Postdoctoral Science Foundation [023201058]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua-Peking Center for Life Sciences; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by Ministry of Science and Technology of China Grants 2010CB912402 and 2013CB910404 (to N. G.), 2010CB912401 (to J. L.), and 2009CB918801 (to Y. S.), National Natural Science Foundation of China Grants 31100524 (to Z. M.), 31270764 (to F. W.), and 30888001 (to Y. S.), postdoctoral fellowships from Tsinghua-Peking Center for Life Sciences (to Z. M.), and China Postdoctoral Science Foundation Grant 023201058 (to Z. M.).	Andersson FI, 2006, J BIOL CHEM, V281, P5468, DOI 10.1074/jbc.M509661200; Fernandez-Higuero JA, 2011, J BIOL CHEM, V286, P25547, DOI 10.1074/jbc.M111.231365; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Biter AB, 2012, P NATL ACAD SCI USA, V109, P12515, DOI 10.1073/pnas.1207040109; Bohon J, 2008, STRUCTURE, V16, P1157, DOI 10.1016/j.str.2008.04.016; Bolon DN, 2004, MOL CELL, V16, P343, DOI 10.1016/j.molcel.2004.10.001; Burton RE, 2001, EMBO J, V20, P3092, DOI 10.1093/emboj/20.12.3092; Chan KY, 2011, STRUCTURE, V19, P1211, DOI 10.1016/j.str.2011.07.017; Chang LF, 2012, NAT STRUCT MOL BIOL, V19, P268, DOI 10.1038/nsmb.2237; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Effantin G, 2010, STRUCTURE, V18, P553, DOI 10.1016/j.str.2010.02.016; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Furst J, 2003, EMBO J, V22, P4365, DOI 10.1093/emboj/cdg420; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Gur E, 2011, NAT REV MICROBIOL, V9, P839, DOI 10.1038/nrmicro2669; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hattendorf DA, 2002, P NATL ACAD SCI USA, V99, P2732, DOI 10.1073/pnas.261693199; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hoskins JR, 2009, P NATL ACAD SCI USA, V106, P22233, DOI 10.1073/pnas.0911937106; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Kirstein J, 2009, NAT REV MICROBIOL, V7, P589, DOI 10.1038/nrmicro2185; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Lee S, 2010, P NATL ACAD SCI USA, V107, P8135, DOI 10.1073/pnas.1003572107; Lei JL, 2005, J STRUCT BIOL, V150, P69, DOI 10.1016/j.jsb.2005.01.002; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; LEVCHENKO I, 1995, GENE DEV, V9, P2399, DOI 10.1101/gad.9.19.2399; Li GT, 2012, P NATL ACAD SCI USA, V109, P3737, DOI 10.1073/pnas.1200255109; Li JZ, 2002, J MOL BIOL, V318, P1127, DOI 10.1016/S0022-2836(02)00188-2; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Mei ZQ, 2009, J BIOL CHEM, V284, P34366, DOI 10.1074/jbc.M109.053017; Mogk A, 2008, BIOCHEM SOC T, V36, P120, DOI 10.1042/BST0360120; Persuh M, 1999, MOL MICROBIOL, V33, P886, DOI 10.1046/j.1365-2958.1999.01544.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prepiak P, 2007, MOL CELL, V26, P639, DOI 10.1016/j.molcel.2007.05.011; Pruteanu M, 2009, RES MICROBIOL, V160, P677, DOI 10.1016/j.resmic.2009.08.012; Rath BK, 2004, J STRUCT BIOL, V145, P84, DOI 10.1016/j.jsb.2003.11.015; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Schlee S, 2001, J MOL BIOL, V306, P889, DOI 10.1006/jmbi.2001.4455; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Schlothauer T, 2003, P NATL ACAD SCI USA, V100, P2306, DOI 10.1073/pnas.0535717100; Schmidt R, 2009, RES MICROBIOL, V160, P629, DOI 10.1016/j.resmic.2009.08.018; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Turgay K, 1998, EMBO J, V17, P6730; Wang F, 2011, NATURE, V471, P331, DOI 10.1038/nature09780; Wang F, 2009, J BIOL CHEM, V284, P34376, DOI 10.1074/jbc.M109.053033; Watanabe Y, 2005, J BIOL CHEM, V280, P24562, DOI 10.1074/jbc.M414623200; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Wendler P, 2009, MOL CELL, V34, P81, DOI 10.1016/j.molcel.2009.02.026; WICKNER S, 1994, P NATL ACAD SCI USA, V91, P12218, DOI 10.1073/pnas.91.25.12218; Xia D, 2004, J STRUCT BIOL, V146, P166, DOI 10.1016/j.jsb.2003.11.025; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	76	17	18	0	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17597	17608		10.1074/jbc.M113.458752	http://dx.doi.org/10.1074/jbc.M113.458752			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23595989	Green Published, hybrid			2022-12-28	WOS:000320380600051
J	Chen, KQ; Liu, MY; Liu, Y; Wang, CY; Yoshimura, T; Gong, WH; Le, YY; Tessarollo, L; Wang, JM				Chen, Keqiang; Liu, Mingyong; Liu, Ying; Wang, Chunyan; Yoshimura, Teizo; Gong, Wanghua; Le, Yingying; Tessarollo, Lino; Wang, Ji Ming			Signal Relay by CC Chemokine Receptor 2 (CCR2) and Formylpeptide Receptor 2 (Fpr2) in the Recruitment of Monocyte-derived Dendritic Cells in Allergic Airway Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; INDUCED PULMONARY INFLAMMATION; ANTIMICROBIAL-PEPTIDE; EPITHELIAL-CELLS; BLOOD MONOCYTES; BONE-MARROW; DISEASE; LUNG; RESPONSES; MIGRATION	Chemoattractant receptors regulate leukocyte accumulation at sites of inflammation. In allergic airway inflammation, although a chemokine receptor CCR2 was implicated in mediating monocyte- derived dendritic cell (DC) recruitment into the lung, we previously also discovered reduced accumulation of DCs in the inflamed lung in mice deficient in formylpeptide receptor Fpr2 (Fpr2(-/-)). We therefore investigated the role of Fpr2 in the trafficking of monocyte- derived DCs in allergic airway inflammation in cooperation with CCR2. We report that in allergic airway inflammation, CCR2 mediated the recruitment of monocyte- derived DCs to the perivascular region, and Fpr2 was required for further migration of the cells into the bronchiolar area. We additionally found that the bronchoalveolar lavage liquid from mice with airway inflammation contained both the CCR2 ligand CCL2 and an Fpr2 agonist CRAMP. Furthermore, similar to Fpr2(-/-) mice, in the inflamed airway of CRAMP(-/-) mice, DC trafficking into the peribronchiolar areas was diminished. Our study demonstrates that the interaction of CCR2 and Fpr2 with their endogenous ligands sequentially mediates the trafficking of DCs within the inflamed lung.	[Chen, Keqiang; Liu, Mingyong; Liu, Ying; Wang, Chunyan; Yoshimura, Teizo; Wang, Ji Ming] NCI, Mol Immunoregulat Lab, Canc & Inflammat Program, Ctr Canc Res,NIH, Frederick, MD 21702 USA; [Tessarollo, Lino] NCI, Mouse Canc Genet Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Gong, Wanghua] SAIC Frederick, Frederick, MD 21702 USA; [Le, Yingying] Chinese Acad Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Chinese Academy of Sciences	Wang, JM (corresponding author), Frederick Natl Lab Canc Res, Ctr Canc Res, Canc & Inflammat Program, Mol Immunoregulat Lab, Bldg 560,Rm 31-76, Frederick, MD 21702 USA.	wangji@mail.nih.gov	Le, Yingying/L-9785-2017	Le, Yingying/0000-0002-7990-3899; Yoshimura, Teizo/0000-0002-3853-2075	Frederick National Laboratory for Cancer Research, National Institutes of Health [HHSN261200800001E]; NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010725, ZIABC010015, ZICBC011265] Funding Source: NIH RePORTER	Frederick National Laboratory for Cancer Research, National Institutes of Health; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by Frederick National Laboratory for Cancer Research, National Institutes of Health Contract HHSN261200800001E. This work was also supported by the Intramural Research Program of the NCI, National Institutes of Health.	Alves JC, 2009, P NATL ACAD SCI USA, V106, P4018, DOI 10.1073/pnas.0900196106; Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Bracke KR, 2007, CLIN EXP ALLERGY, V37, P1467, DOI 10.1111/j.1365-2222.2007.02808.x; Bracke KR, 2006, J IMMUNOL, V177, P4350, DOI 10.4049/jimmunol.177.7.4350; Buyukozturk S, 2004, TOHOKU J EXP MED, V204, P209, DOI 10.1620/tjem.204.209; Chaudhuri N, 2005, CLIN SCI, V109, P125, DOI 10.1042/CS20050044; Chen KQ, 2007, INT IMMUNOPHARMACOL, V7, P1271, DOI 10.1016/j.intimp.2007.05.016; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Chen KQ, 2006, J BIOL CHEM, V281, P3651, DOI 10.1074/jbc.M508125200; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Dominguez PM, 2010, IMMUNOL REV, V234, P90, DOI 10.1111/j.0105-2896.2009.00876.x; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Fox JM, 2011, BLOOD, V117, P1851, DOI 10.1182/blood-2010-05-287474; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Hajishengallis G, 2008, P NATL ACAD SCI USA, V105, P13532, DOI 10.1073/pnas.0803852105; Holt PG, 2004, CURR OPIN ALLERGY CL, V4, P39, DOI 10.1097/01.all.0000113677.18759.dc; Hu JY, 2001, J LEUKOCYTE BIOL, V70, P155; Kaisho T, 2003, CURR MOL MED, V3, P373, DOI 10.2174/1566524033479726; Kessel CHG, 2008, MUCOSAL IMMUNOL, V1, P442, DOI 10.1038/mi.2008.39; Kovach MA, 2012, J IMMUNOL, V189, P304, DOI 10.4049/jimmunol.1103196; Kurosaka K, 2005, J IMMUNOL, V174, P6257, DOI 10.4049/jimmunol.174.10.6257; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lambrecht BN, 2003, NAT REV IMMUNOL, V3, P994, DOI 10.1038/nri1249; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Maharshak N, 2010, WORLD J GASTROENTERO, V16, P3258, DOI 10.3748/wjg.v16.i26.3258; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; McKimmie CS, 2009, BLOOD, V113, P4224, DOI 10.1182/blood-2008-08-174698; Myou S, 2003, J EXP MED, V198, P1573, DOI 10.1084/jem.20030298; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Ozseker F, 2006, INT IMMUNOPHARMACOL, V6, P1569, DOI 10.1016/j.intimp.2006.05.006; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Pease JE, 2011, BIOCHEM J, V434, P11, DOI 10.1042/BJ20101132; Pelchen-Matthews A, 1999, IMMUNOL REV, V168, P33, DOI 10.1111/j.1600-065X.1999.tb01281.x; Provoost S, 2012, J ALLERGY CLIN IMMUN, V129, P483, DOI 10.1016/j.jaci.2011.07.051; Randolph GJ, 2005, SPRINGER SEMIN IMMUN, V26, P273, DOI 10.1007/s00281-004-0168-0; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Ritter U, 2004, J LEUKOCYTE BIOL, V76, P472, DOI 10.1189/jlb.0104037; Robays LJ, 2007, J IMMUNOL, V178, P5305, DOI 10.4049/jimmunol.178.8.5305; Sadik CD, 2012, J LEUKOCYTE BIOL, V91, P207, DOI 10.1189/jlb.0811402; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shao GH, 2011, AM J RESP CELL MOL, V44, P264, DOI 10.1165/rcmb.2010-0246RC; Sica A, 1997, J EXP MED, V185, P969, DOI 10.1084/jem.185.5.969; Sozzani S, 2005, CYTOKINE GROWTH F R, V16, P581, DOI 10.1016/j.cytogfr.2005.04.008; Takahashi M, 2009, J IMMUNOL, V183, P3463, DOI 10.4049/jimmunol.0802812; Ungaro R, 2009, AM J PHYSIOL-GASTR L, V296, pG1167, DOI 10.1152/ajpgi.90496.2008; Wu TL, 2007, J CLIN LAB ANAL, V21, P367, DOI 10.1002/jcla.20197; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	50	39	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16262	16273		10.1074/jbc.M113.450635	http://dx.doi.org/10.1074/jbc.M113.450635			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23603910	hybrid, Green Published			2022-12-28	WOS:000320378900006
J	Scott, AM; Antal, CE; Newton, AC				Scott, Angela M.; Antal, Corina E.; Newton, Alexandra C.			Electrostatic and Hydrophobic Interactions Differentially Tune Membrane Binding Kinetics of the C2 Domain of Protein Kinase C alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; PKC-ALPHA; PKC-ALPHA-C2 DOMAIN; GENOMIC ANALYSES; CALCIUM-IONS; C-2 DOMAIN; BETA-II; DOCKING; PHOSPHATIDYLSERINE; TRANSLOCATION	The cellular activation of conventional protein kinase C (PKC) isozymes is initiated by the binding of their C2 domains to membranes in response to elevations in intracellular Ca2+. Following this C2 domain-mediated membrane recruitment, the C1 domain binds its membrane-embedded ligand diacylglycerol, resulting in activation of PKC. Here we explore the molecular mechanisms by which the C2 domain controls the initial step in the activation of PKC. Using stopped-flow fluorescence spectroscopy to measure association and dissociation rate constants, we show that hydrophobic interactions are the major driving force in the binding of the C2 domain to anionic membranes, whereas electrostatic interactions dominate in membrane retention. Specifically, mutation of select hydrophobic or select basic residues in the Ca2+-binding loops reduces membrane affinity by distinct mechanisms; mutation of hydrophobic residues primarily alters association rate constants, whereas mutation of charged residues affects dissociation rate constants. Live cell imaging reveals that introduction of these mutations into full-length PKC alpha not only reduces the Ca2+-dependent translocation to plasma membrane but, by impairing the plasma membrane-sensing role of the C2 domain, causes phorbol ester-triggered redistribution of PKC alpha to other membranes, such as the Golgi. These data underscore the key role of the C2 domain in driving conventional PKC isozymes to the plasma membrane and reveal that not only the amplitude but also the subcellular location of conventional PKC signaling can be tuned by altering the affinity of this module for membranes.	[Scott, Angela M.; Antal, Corina E.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Scott, Angela M.; Antal, Corina E.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	anewton@ucsd.edu			National Institutes of Health [GM43154]; University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology; NIGMS, National Institutes of Health [T32 GM007752]; National Science Foundation [DGE1144086]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF))	This work was supported, in whole or in part, by National Institutes of Health Grant GM43154 (to A. C. N.).; Supported in part by the University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology through an institutional training grant from NIGMS, National Institutes of Health, Grant T32 GM007752.; Supported in part by the National Science Foundation Graduate Research Fellowship under Grant DGE1144086.	ASTUMIAN RD, 1985, J PHYS CHEM-US, V89, P3477, DOI 10.1021/j100262a012; Ausili A, 2011, BBA-BIOMEMBRANES, V1808, P684, DOI 10.1016/j.bbamem.2010.11.035; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bolsover SR, 2003, J BIOL CHEM, V278, P10282, DOI 10.1074/jbc.M212145200; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Conesa-Zamora P, 2001, BIOCHEMISTRY-US, V40, P13898, DOI 10.1021/bi011303o; Corbalan-Garcia S, 1999, BIOCHEM J, V337, P513, DOI 10.1042/0264-6021:3370513; Corbalan-Garcia S, 2007, BIOCHEM SOC T, V35, P1046, DOI 10.1042/BST0351046; Corbalan-Garcia S, 2003, J BIOL CHEM, V278, P4972, DOI 10.1074/jbc.M209385200; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Edwards AS, 1997, BIOCHEMISTRY-US, V36, P15615, DOI 10.1021/bi9718752; Evans JH, 2006, MOL BIOL CELL, V17, P56, DOI 10.1091/mbc.e05-06-0499; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Gallegos LL, 2008, IUBMB LIFE, V60, P782, DOI 10.1002/iub.122; Garcia-Garcia J, 1999, BIOCHEMISTRY-US, V38, P9667, DOI 10.1021/bi9905765; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Guerrero-Valero M, 2009, P NATL ACAD SCI USA, V106, P6603, DOI 10.1073/pnas.0813099106; Hurley JH, 2006, BBA-MOL CELL BIOL L, V1761, P805, DOI 10.1016/j.bbalip.2006.02.020; Johnson JA, 2000, J HEALTHC MANAG, V45, P1; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kohout SC, 2003, BIOCHEMISTRY-US, V42, P1254, DOI 10.1021/bi026596f; Kohout SC, 2002, BIOCHEMISTRY-US, V41, P11411, DOI 10.1021/bi026041k; Lai CL, 2010, J MOL BIOL, V402, P301, DOI 10.1016/j.jmb.2010.07.037; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P8301, DOI 10.1021/bi800711t; Malmberg NJ, 2005, ANNU REV BIOPH BIOM, V34, P71, DOI 10.1146/annurev.biophys.34.040204.144534; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; Marin-Vicente C, 2005, MOL BIOL CELL, V16, P2848, DOI 10.1091/mbc.E05-01-0067; Medkova M, 1998, J BIOL CHEM, V273, P17544, DOI 10.1074/jbc.273.28.17544; Mosior M, 1996, BIOCHEMISTRY-US, V35, P1612, DOI 10.1021/bi952031q; Murray D, 2002, MOL CELL, V9, P145, DOI 10.1016/S1097-2765(01)00426-9; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Nalefski EA, 2001, BIOCHEMISTRY-US, V40, P13216, DOI 10.1021/bi010761u; Nalefski EA, 1997, BIOCHEMISTRY-US, V36, P12011, DOI 10.1021/bi9717340; NEWTON AC, 1995, CURR BIOL, V5, P973, DOI 10.1016/S0960-9822(95)00191-6; Newton AC, 1998, BBA-REV BIOMEMBRANES, V1376, P155, DOI 10.1016/S0304-4157(98)00003-3; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Ochoa WF, 2002, J MOL BIOL, V320, P277, DOI 10.1016/S0022-2836(02)00464-3; ORR JW, 1992, J BIOL CHEM, V267, P15263; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Rodriguez-Alfaro JA, 2004, J MOL BIOL, V335, P1117, DOI 10.1016/j.jmb.2003.10.080; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; Stahelin RV, 2001, BIOCHEM J, V359, P679, DOI 10.1042/0264-6021:3590679; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125	49	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16905	16915		10.1074/jbc.M113.467456	http://dx.doi.org/10.1074/jbc.M113.467456			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23589289	Green Published, hybrid			2022-12-28	WOS:000320378900063
J	Chung, S; Miller, JT; Lapkouski, M; Tian, L; Yang, W; Le Grice, SFJ				Chung, Suhman; Miller, Jennifer T.; Lapkouski, Mikalai; Tian, Lan; Yang, Wei; Le Grice, Stuart F. J.			Examining the Role of the HIV-1 Reverse Transcriptase p51 Subunit in Positioning and Hydrolysis of RNA/DNA Hybrids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONNECTION DOMAIN; CRYSTAL-STRUCTURE; COMPLEX; N348I; MUTAGENESIS; MUTATIONS; 3'-AZIDO-3'-DEOXYTHYMIDINE; RESISTANCE; INHIBITORS; SUBDOMAIN	Recent crystallographic analysis of p66/p51 human immuno-deficiency virus (HIV) type 1 reverse transcriptase (RT) complexed with a non-polypurine tract RNA/DNA hybrid has illuminated novel and important contacts between structural elements at the C terminus of the noncatalytic p51 subunit and the nucleic acid duplex in the vicinity of the ribonuclease H (RNase H) active site. In particular, a short peptide spanning residues Phe-416-Pro-421 was shown to interact with theDNA strand, cross the minor groove of the helix, and then form Van der Waals contacts with the RNA strand adjacent to the scissile phosphate. At the base of the adjoining alpha-helix M', Tyr-427 forms a hydrogen bond with Asn-348, the latter of which, when mutated to Ile, is implicated in resistance to both nucleoside and non-nucleoside RT inhibitors. Based on our structural data, we analyzed the role of the p51 C terminus by evaluating selectively mutated p66/p51 heterodimers carrying (i) p51 truncations that encroach on alpha-M', (ii) alterations that interrupt the Asn-348-Tyr- 427 interaction, and (iii) alanine substitutions throughout the region Phe-416-Pro-421. Collectively, our data support the notion that the p51 C terminus makes an important contribution toward hybrid binding and orienting the RNA strand for catalysis at the RNase H active site.	[Chung, Suhman; Miller, Jennifer T.; Le Grice, Stuart F. J.] NCI, Natl Inst Hlth, Ctr Canc Res, RT Biochem Sect,HIV Drug Resistance Program, Frederick, MD 21702 USA; [Lapkouski, Mikalai; Tian, Lan; Yang, Wei] NIDDK, Natl Inst Hlth, Mol Biol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Le Grice, SFJ (corresponding author), NCI, Natl Inst Hlth, Ctr Canc Res, RT Biochem Sect,HIV Drug Resistance Program, Frederick, MD 21702 USA.	legrices@mail.nih.gov	Yang, Wei/D-4926-2011; Yang, Wei/ABB-4785-2020	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195	NIDDK, National Institutes of Health; NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010494, ZIABC011443] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the Intramural Research Programs of the NIDDK and NCI, respectively, of the National Institutes of Health (to W.Y. and S.F.J.L.G.)	Arts EJ, 1996, J BIOL CHEM, V271, P9054, DOI 10.1074/jbc.271.15.9054; Bauman JD, 2008, NUCLEIC ACIDS RES, V36, P5083, DOI 10.1093/nar/gkn464; Cameron CE, 1997, P NATL ACAD SCI USA, V94, P6700, DOI 10.1073/pnas.94.13.6700; Chung SM, 2012, J BIOL CHEM, V287, P4066, DOI 10.1074/jbc.M111.314781; Das K, 2011, J MED CHEM, V54, P2727, DOI 10.1021/jm101536x; DING J, 1995, STRUCTURE, V3, P365, DOI 10.1016/S0969-2126(01)00168-X; Ehteshami M, 2008, J BIOL CHEM, V283, P22222, DOI 10.1074/jbc.M803521200; Hachiya A, 2008, J VIROL, V82, P3261, DOI 10.1128/JVI.01154-07; Harris D, 1998, BIOCHEMISTRY-US, V37, P5903, DOI 10.1021/bi9728452; Himmel DM, 2006, ACS CHEM BIOL, V1, P702, DOI 10.1021/cb600303y; Hsiou Y, 1996, STRUCTURE, V4, P853, DOI 10.1016/S0969-2126(96)00091-3; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JACQUES PS, 1994, J BIOL CHEM, V269, P1388; Julias JG, 2003, J VIROL, V77, P8548, DOI 10.1128/JVI.77.15.8548-8554.2003; Kim S, 2010, J MOL BIOL, V395, P995, DOI 10.1016/j.jmb.2009.11.072; Kirschberg TA, 2008, BIOORG MED CHEM LETT, V18, P1131, DOI 10.1016/j.bmcl.2007.11.127; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Lapkouski M, 2013, NAT STRUCT MOL BIOL, V20, P230, DOI 10.1038/nsmb.2485; LEGRICE SFJ, 1988, EMBO J, V7, P2547, DOI 10.1002/j.1460-2075.1988.tb03103.x; LEGRICE SFJ, 1991, EMBO J, V10, P3905, DOI 10.1002/j.1460-2075.1991.tb04960.x; Nikolenko GN, 2007, P NATL ACAD SCI USA, V104, P317, DOI 10.1073/pnas.0609642104; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Phillips Kevin, 2011, Curr Protoc Mol Biol, VChapter 10, DOI 10.1002/0471142727.mb1028s94; Rausch JW, 2002, BIOCHEMISTRY-US, V41, P4856, DOI 10.1021/bi015970t; REN JS, 1995, STRUCTURE, V3, P915, DOI 10.1016/S0969-2126(01)00226-X; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Schuckmann MM, 2010, J BIOL CHEM, V285, P38700, DOI 10.1074/jbc.M110.153783; VERONESE FD, 1986, SCIENCE, V231, P1289, DOI 10.1126/science.2418504; WANG J, 1994, P NATL ACAD SCI USA, V91, P7242, DOI 10.1073/pnas.91.15.7242; Wendeler M, 2008, ACS CHEM BIOL, V3, P635, DOI 10.1021/cb8001039; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335	32	16	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16177	16184		10.1074/jbc.M113.465641	http://dx.doi.org/10.1074/jbc.M113.465641			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23595992	Green Published, hybrid			2022-12-28	WOS:000319822300068
J	Huang, X; Gong, R; Li, XY; Virtue, A; Yang, F; Yang, IH; Tran, AH; Yang, XF; Wang, H				Huang, Xiao; Gong, Ren; Li, Xinyuan; Virtue, Anthony; Yang, Fan; Yang, Irene H.; Tran, Anh H.; Yang, Xiao-Feng; Wang, Hong			Identification of Novel Pretranslational Regulatory Mechanisms for NF-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICRORNAS; PATHWAY	NF-kappa B-controlled transcriptional regulation plays a central role in inflammatory and immune responses. Currently, understanding about NF-kappa B activation mechanism emphasizes I kappa B-tethered complex inactivation in the cytoplasm. In the case of NF-kappa B activation, I kappa B phosphorylation leads to its degradation, followed by NF-kappa B relocation to the nucleus and trans-activation of NF-kappa B-targeted genes. Pretranslational mechanism mediated NF-kappa B activation remains poorly understood. In this study, we investigated NF-kappa B pretranslational regulation by performing a series of database mining analyses and using six large national experimental databases (National Center of Biotechnology Information UniGene expressed sequence tag profile database, Gene Expression Omnibus database, Transcription Element Search System database, AceView database, and Epigenomics database) and TargetScan software. We reported the following findings: 1) NF-kappa B-signaling genes are differentially expressed in human and mouse tissues; 2) heart and vessels are the inflammation-privileged tissues and less easy to be inflamed because lacking in key NF-kappa B-signaling molecular expression; 3) NF-kappa B-signaling genes are induced by cardiovascular disease risk factors oxidized phospholipids and proinflammatory cytokines in endothelial cells; 4) transcription factors CCAAT/enhancer-binding proteins and NF-kappa B have higher binding site frequencies in the promoters of proinflammatory cyto-kine-induced NF-kappa B genes; 5) most NF-kappa B-signaling genes have multiple alternative promoters and alternatively spliced isoforms; 6) NF-kappa B family genes can be regulated by DNA methylation; and 7) 27 of 38 NF-kappa B-signaling genes can be regulated by microRNAs. Our findings provide important insight into the mechanism of NF-kappa B activation, which may contribute to cardiovascular disease, inflammatory diseases, and immunological disorders.	[Huang, Xiao; Gong, Ren; Li, Xinyuan; Virtue, Anthony; Tran, Anh H.; Yang, Xiao-Feng; Wang, Hong] Temple Univ, Sch Med, Cardiovasc Res Ctr, Thrombosis Res Ctr,Dept Pharmacol, Philadelphia, PA 19140 USA; [Huang, Xiao] Nanchang Univ, Affiliated Hosp 2, Dept Cardiol, Nanchang 330006, Jiangxi, Peoples R China; [Gong, Ren] Jiangxi Prov Peoples Hosp, Dept Cardiol, Nanchang 330006, Jiangxi, Peoples R China; [Yang, Fan] Griffin Hosp, Dept Med, Derby, CT 06418 USA; [Yang, Irene H.] Yale Univ, New Haven Hosp, Dept Neurol, New Haven, CT 06510 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Nanchang University; Yale University	Yang, XF (corresponding author), Temple Univ, Sch Med, Cardiovasc Res Ctr, 3500 N Broad St,MERB 1059, Philadelphia, PA 19140 USA.	xfyang@temple.edu; hongw@temple.edu	Li, Xinyuan/Z-6299-2019; Li, Xinyuan/B-1139-2015	Li, Xinyuan/0000-0002-6746-8367; Li, Xinyuan/0000-0002-6746-8367	National Institutes of Health [HL67033, HL77288, HL82774, HL110764, HL117654, HL094451, HL108910]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067033, R01HL082774, R01HL108910, R01HL110764, R01HL077288, R01HL117654, R01HL094451] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL67033, HL77288 HL82774, HL110764, and HL117654 (to H. W.) and HL094451 and HL108910 (to X. F. Y.).	Baltimore D, 2011, NAT IMMUNOL, V12, P683, DOI 10.1038/ni.2072; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Gareus R, 2008, CELL METAB, V8, P372, DOI 10.1016/j.cmet.2008.08.016; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Holloway Dustin T, 2005, Genome Inform, V16, P83; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; Leeman JR, 2008, GENE, V423, P97, DOI 10.1016/j.gene.2008.07.015; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033628; Lopez-Pedrera C, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/974648; Maunakea AK, 2010, CIRC RES, V107, P327, DOI 10.1161/CIRCRESAHA.110.222463; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Naeem Haroon, 2010, BMC Bioinformatics, V11, P135, DOI 10.1186/1471-2105-11-135; Ng B, 2004, J ALLERGY CLIN IMMUN, V114, P1463, DOI 10.1016/j.jaci.2004.09.006; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Qi JN, 2012, FEBS LETT, V586, P1201, DOI 10.1016/j.febslet.2012.03.011; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Su ZX, 2006, GENOME RES, V16, P182, DOI 10.1101/gr.4197006; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Takata Y, 2002, CIRC RES, V91, P427, DOI 10.1161/01.RES.0000031271.20771.4F; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Virtue A, 2011, FRONT BIOSCI-LANDMRK, V16, P3133, DOI 10.2741/3901; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015; Yang F, 2006, CLIN IMMUNOL, V121, P121, DOI 10.1016/j.clim.2006.06.007; Yang Xiao-Feng, 2008, Drug Discov Today Ther Strateg, V5, P125, DOI 10.1016/j.ddstr.2008.11.003; Yin Y, 2009, INT J IMMUNOPATH PH, V22, P311, DOI 10.1177/039463200902200208; Zhang CX, 2008, CLIN SCI, V114, P699, DOI 10.1042/CS20070211	29	14	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15628	15640		10.1074/jbc.M113.460626	http://dx.doi.org/10.1074/jbc.M113.460626			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23515310	Green Published, hybrid			2022-12-28	WOS:000319822300020
J	Manecka, DL; Mahmood, SF; Grumolato, L; Lihrmann, I; Anouar, Y				Manecka, Destiny-Love; Mahmood, Sardar Faisal; Grumolato, Luca; Lihrmann, Isabelle; Anouar, Youssef			Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) Promotes Both Survival and Neuritogenesis in PC12 Cells through Activation of Nuclear Factor kappa B (NF-kappa B) Pathway INVOLVEMENT OF EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK), CALCIUM, AND c-REL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE NEURONS; NEURITE OUTGROWTH; TRANSCRIPTION FACTORS; DEPENDENT PATHWAY; BCL-2 EXPRESSION; GENE-EXPRESSION; NERVOUS-SYSTEM; IKK-ALPHA; APOPTOSIS; GROWTH	The pituitary adenylate cyclase-activating polypeptide (PACAP) is a trophic factor that promotes neuronal survival and neurite outgrowth. However, the signaling pathways and the transcriptional mechanisms involved are not completely elucidated. Our previous studies aimed at characterizing the transcriptome of PACAP-differentiated PC12 cells revealed an increase in the expression of nuclear factor kappa B2 (NF-kappa B2) gene coding for p100/p52 subunit of NF-kappa B transcription factor. Here, we examined the role of the NF-kappa B pathway in neuronal differentiation promoted by PACAP. We first showed that PACAP-driven survival and neuritic extension in PC12 cells are inhibited following NF-kappa B pathway blockade. PACAP stimulated both c-Rel and p52 NF-kappa B subunit gene expression and nuclear translocation, whereas c-Rel down-regulation inhibited cell survival and neuritogenesis elicited by the neuropeptide. PACAP-induced c-Rel nuclear translocation was inhibited by ERK1/2 and Ca2+ blockers. Furthermore, the neuropeptide stimulated NF-kappa B p100 subunit processing into p52, indicative of activation of the NF-kappa B alternative pathway. Taken together, our data show that PACAP promotes both survival and neuritogenesis in PC12 cells by activating NF-kappa B pathway, most likely via classical and alternative signaling cascades involving ERK1/2 kinases, Ca2+ , and c-Rel/p52 dimers.	[Manecka, Destiny-Love; Mahmood, Sardar Faisal; Grumolato, Luca; Lihrmann, Isabelle; Anouar, Youssef] Univ Rouen, INSERM, Lab Neuronal & Neuroendocrine Differentiat & Comm, U982,Inst Res & Innovat Biomed, F-76821 Mont St Aignan, France; [Manecka, Destiny-Love; Mahmood, Sardar Faisal; Grumolato, Luca; Lihrmann, Isabelle; Anouar, Youssef] Normandy Univ, Normandy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie	Anouar, Y (corresponding author), Univ Rouen, INSERM, Lab Neuronal & Neuroendocrine Differentiat & Comm, U982, F-76821 Mont St Aignan, France.	youssef.anouar@univ-rouen.fr	Lihrmann, Isabelle/S-6464-2019; Grumolato, Luca/A-1697-2015; Anouar, Youssef/F-9683-2017	Lihrmann, Isabelle/0000-0002-4486-7074; Grumolato, Luca/0000-0001-8231-3032; 	INSERM [U982]; Conseil Regional de Haute-Normandie; Institute for Research and Innovation in Biomedicine	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Conseil Regional de Haute-Normandie(Region Normandie); Institute for Research and Innovation in Biomedicine	This work was supported by INSERM (U982), the Conseil Regional de Haute-Normandie, and The Institute for Research and Innovation in Biomedicine.	Alsina FC, 2012, J NEUROCHEM, V123, P652, DOI 10.1111/jnc.12021; Aubert N, 2006, J NEUROCHEM, V99, P1237, DOI 10.1111/j.1471-4159.2006.04148.x; Azoitei N, 2005, J NEUROCHEM, V93, P1487, DOI 10.1111/j.1471-4159.2005.03148.x; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Botia B, 2007, PEPTIDES, V28, P1746, DOI 10.1016/j.peptides.2007.04.013; Bui NT, 2001, J CELL BIOL, V152, P753, DOI 10.1083/jcb.152.4.753; BULL P, 1990, MOL CELL BIOL, V10, P5473, DOI 10.1128/MCB.10.10.5473; Canadillas S, 2010, AM J PHYSIOL-RENAL, V298, pF1197, DOI 10.1152/ajprenal.00529.2009; Carey RG, 2002, J NEUROSCI, V22, P1583, DOI 10.1523/JNEUROSCI.22-05-01583.2002; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; DEUTSCH PJ, 1992, J BIOL CHEM, V267, P5108; DiCicco-Bloom E, 2000, DEV BIOL, V219, P197, DOI 10.1006/dbio.2000.9604; Emery AC, 2012, FASEB J, V26, P3199, DOI 10.1096/fj.11-203042; Falluel-Morel A, 2005, P NATL ACAD SCI USA, V102, P2637, DOI 10.1073/pnas.0409681102; Foehr ED, 2000, J BIOL CHEM, V275, P34021, DOI 10.1074/jbc.C000507200; Foehr ED, 2000, J NEUROSCI, V20, P7556; Gerlo S, 2011, CELL MOL LIFE SCI, V68, P3823, DOI 10.1007/s00018-011-0757-8; Ghosh G, 2012, IMMUNOL REV, V246, P36, DOI 10.1111/j.1600-065X.2012.01097.x; Ghzili H, 2008, FRONT NEUROENDOCRIN, V29, P128, DOI 10.1016/j.yfrne.2007.10.001; Grossmann M, 2000, EMBO J, V19, P6351, DOI 10.1093/emboj/19.23.6351; Grumolato L, 2003, ENDOCRINOLOGY, V144, P2368, DOI 10.1210/en.2002-0106; Grumolato L, 2003, EUR J NEUROSCI, V17, P71, DOI 10.1046/j.1460-9568.2003.02426.x; Gutierrez H, 2005, DEVELOPMENT, V132, P1713, DOI 10.1242/dev.01702; Hamelink C, 2002, P NATL ACAD SCI USA, V99, P461, DOI 10.1073/pnas.012608999; Haviv R, 1998, J NEUROSCI RES, V52, P380, DOI 10.1002/(SICI)1097-4547(19980515)52:4<380::AID-JNR2>3.3.CO;2-A; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Koulich E, 2001, J NEUROCHEM, V76, P1188, DOI 10.1046/j.1471-4159.2001.00134.x; Lazarovici P, 1998, MOL PHARMACOL, V54, P547, DOI 10.1124/mol.54.3.547; May V, 2010, J BIOL CHEM, V285, P9749, DOI 10.1074/jbc.M109.043117; Morio H, 1996, BRAIN RES, V741, P82, DOI 10.1016/S0006-8993(96)00920-1; NAUMANN M, 1993, ONCOGENE, V8, P2275; Noursadeghi M, 2008, J IMMUNOL METHODS, V329, P194, DOI 10.1016/j.jim.2007.10.015; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Pizzi M, 2005, CELL DEATH DIFFER, V12, P761, DOI 10.1038/sj.cdd.4401598; Racz B, 2008, REGUL PEPTIDES, V145, P105, DOI 10.1016/j.regpep.2007.09.015; Ravni A, 2006, J NEUROCHEM, V98, P321, DOI 10.1111/J.1471-4159.2006.03884.X; Schecterson LC, 2010, DEV NEUROBIOL, V70, P332, DOI 10.1002/dneu.20767; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; Shioda S, 2006, ANN NY ACAD SCI, V1070, P550, DOI 10.1196/annals.1317.080; Smale ST, 2012, IMMUNOL REV, V246, P193, DOI 10.1111/j.1600-065X.2011.01091.x; Taglialatela G, 1997, J NEUROSCI RES, V47, P155; Takei N, 1998, J NEUROSCI RES, V54, P698, DOI 10.1002/(SICI)1097-4547(19981201)54:5<698::AID-JNR15>3.0.CO;2-5; Vaudry D, 2002, ANN NY ACAD SCI, V971, P491, DOI 10.1111/j.1749-6632.2002.tb04513.x; Vaudry D, 2002, EUR J NEUROSCI, V15, P1451, DOI 10.1046/j.1460-9568.2002.01981.x; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Zhou CJ, 2001, PEPTIDES, V22, P1111, DOI 10.1016/S0196-9781(01)00437-5; Zocco D, 2010, MOL IMMUNOL, V47, P1426, DOI 10.1016/j.molimm.2010.02.012	55	16	17	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14936	14948		10.1074/jbc.M112.434597	http://dx.doi.org/10.1074/jbc.M112.434597			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23564451	hybrid, Green Published			2022-12-28	WOS:000319452100024
J	Bortoluzzi, A; Muskett, FW; Waters, LC; Addis, PW; Rieck, B; Munder, T; Schleier, S; Forti, F; Ghisotti, D; Carr, MD; O'Hare, HM				Bortoluzzi, Alessio; Muskett, Frederick W.; Waters, Lorna C.; Addis, Philip W.; Rieck, Barbara; Munder, Thomas; Schleier, Susanne; Forti, Francesca; Ghisotti, Daniela; Carr, Mark D.; O'Hare, Helen M.			Mycobacterium tuberculosis RNA Polymerase-binding Protein A (RbpA) and Its Interactions with Sigma Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; TISSUE INHIBITOR; MATRIX-METALLOPROTEINASE; PHENOTYPIC TOLERANCE; STRUCTURE PREDICTION; ESCHERICHIA-COLI; LARGER PROTEINS; NMR; SEQUENCE; ASSIGNMENT	RNA polymerase-binding protein A (RbpA), encoded by Rv2050, is specific to the actinomycetes, where it is highly conserved. In the pathogen Mycobacterium tuberculosis, RbpA is essential for growth and survival. RbpA binds to the beta subunit of the RNA polymerase where it activates transcription by unknown mechanisms, and it may also influence the response of M. tuberculosis to the current frontline anti-tuberculosis drug rifampicin. Here we report the solution structure of RbpA and identify the principle sigma factor sigma(A) and the stress-induced sigma(B) as interaction partners. The protein has a central ordered domain with a conserved hydrophobic surface that may be a potential protein interaction site. The N and C termini are highly dynamic and are involved in the interaction with the sigma factors. RbpA forms a tight complex with the N-terminal domain of sigma(B) via its N- and C-terminal regions. The interaction with sigma factors may explain how RbpA stabilizes sigma subunit binding to the core RNA polymerase and thereby promotes initiation complex formation. RbpA could therefore influence the competition between principal and alternative sigma factors and hence the transcription profile of the cell.	[Bortoluzzi, Alessio; Muskett, Frederick W.; Waters, Lorna C.; Addis, Philip W.; Carr, Mark D.; O'Hare, Helen M.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Rieck, Barbara; O'Hare, Helen M.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 9HN, Leics, England; [Munder, Thomas; Schleier, Susanne] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol eV, Dept Cell & Mol Biol, D-07745 Jena, Germany; [Forti, Francesca; Ghisotti, Daniela] Univ Milan, Dipartimento Biosci, I-20133 Milan, Italy	University of Leicester; University of Leicester; Hans Knoll Institute (HKI); University of Milan	Carr, MD (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England.	mdc12@le.ac.uk; hmo7@le.ac.uk	O'Hare, Helen/G-1528-2012; GHISOTTI, DANIELA ERICA/B-7732-2017	O'Hare, Helen/0000-0002-8666-7433; GHISOTTI, DANIELA ERICA/0000-0003-2924-5303; Addis, Philip/0000-0003-1185-651X; Carr, Mark/0000-0002-3939-0996	College of Medicine, Biological Sciences and Psychology, University of Leicester college studentship; Research Council UK fellowship; Biotechnology and Biological Sciences Research Council Grant [BB/H007865/1]; UCB; NM4TB EC_VI Framework [LSHP-CT-2005-018923]; BBSRC [BB/H007865/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H007865/1] Funding Source: researchfish	College of Medicine, Biological Sciences and Psychology, University of Leicester college studentship; Research Council UK fellowship; Biotechnology and Biological Sciences Research Council Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UCB(UCB Pharma SA); NM4TB EC_VI Framework; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a College of Medicine, Biological Sciences and Psychology, University of Leicester college studentship (to A. B.), a Research Council UK fellowship (to H. M. O.), Biotechnology and Biological Sciences Research Council Grant BB/H007865/1 (to H. M. O.), UCB support (to L. C. W. and P. W. A.), and NM4TB EC_VI Framework Contract LSHP-CT-2005-018923 (to D. G., F. F., and H. M. O.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bougdour A, 2004, J BIOL CHEM, V279, P19540, DOI 10.1074/jbc.M314145200; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Crubezy E, 1998, CR ACAD SCI III-VIE, V321, P941, DOI 10.1016/S0764-4469(99)80009-2; Dey A, 2011, MICROBIOL-SGM, V157, P2056, DOI 10.1099/mic.0.047480-0; Dey A, 2010, MICROBIOL-SGM, V156, P873, DOI 10.1099/mic.0.033670-0; Doreleijers JF, 2012, J BIOMOL NMR, V54, P267, DOI 10.1007/s10858-012-9669-7; England P, 2008, J BIOL CHEM, V283, P33455, DOI 10.1074/jbc.M807380200; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Fontan PA, 2009, J BACTERIOL, V191, P5628, DOI 10.1128/JB.00510-09; Forti F, 2011, TUBERCULOSIS, V91, P569, DOI 10.1016/j.tube.2011.07.004; Gao G, 2000, J MOL BIOL, V301, P537, DOI 10.1006/jmbi.2000.3976; Gilmore JM, 2010, BIOCHEMISTRY-US, V49, P6143, DOI 10.1021/bi1002635; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; GUNTERT P, 1991, Journal of Biomolecular NMR, V1, P447, DOI 10.1007/BF02192866; Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu YB, 2012, NUCLEIC ACIDS RES, V40, P6547, DOI 10.1093/nar/gks346; KARUNAIRATNAM MC, 1958, BIOCHIM BIOPHYS ACTA, V29, P649, DOI 10.1016/0006-3002(58)90028-3; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KLEBE RJ, 1983, GENE, V25, P333, DOI 10.1016/0378-1119(83)90238-X; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; MACURA S, 1980, MOL PHYS, V41, P95, DOI 10.1080/00268978000102601; Manganelli R, 2004, J BACTERIOL, V186, P895, DOI 10.1128/JB.186.4.895-902.2004; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Mihatsch K, 2009, CARDIOVASC RES, V81, P108, DOI 10.1093/cvr/cvn276; MUHANDIRAM DR, 1993, J MAGN RESON SER B, V102, P317, DOI 10.1006/jmrb.1993.1102; Murphy DJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-84; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Muskett FW, 1998, J BIOL CHEM, V273, P21736, DOI 10.1074/jbc.273.34.21736; Newell KV, 2006, MOL MICROBIOL, V60, P687, DOI 10.1111/j.1365-2958.2006.05116.x; O'Hare H, 2008, J MICROBIOL METH, V73, P79, DOI 10.1016/j.mimet.2008.02.008; Paget MSB, 2001, MOL MICROBIOL, V42, P1007, DOI 10.1046/j.1365-2958.2001.02675.x; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Rodrigue S, 2006, FEMS MICROBIOL REV, V30, P926, DOI 10.1111/j.1574-6976.2006.00040.x; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shepherd N, 2001, J BACTERIOL, V183, P2527, DOI 10.1128/JB.183.8.2527-2534.2001; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Tafelmeyer P, 2004, CHEM BIOL, V11, P681, DOI 10.1016/j.chembiol.2004.02.026; Teutschbein J, 2009, MICROBIOL RES, V164, P253, DOI 10.1016/j.micres.2006.11.016; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Typas A, 2007, EMBO J, V26, P1569, DOI 10.1038/sj.emboj.7601629; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Waters LC, 2007, ONCOGENE, V26, P4941, DOI 10.1038/sj.onc.1210305; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; Williamson RA, 1999, J BIOL CHEM, V274, P37226, DOI 10.1074/jbc.274.52.37226	69	32	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14438	14450		10.1074/jbc.M113.459883	http://dx.doi.org/10.1074/jbc.M113.459883			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23548911	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000319253500047
J	Pan, TC; Zhang, RZ; Markova, D; Arita, M; Zhang, YJ; Bogdanovich, S; Khurana, TS; Bonnemann, CG; Birk, DE; Chu, ML				Pan, Te-Cheng; Zhang, Rui-Zhu; Markova, Dessislava; Arita, Machiko; Zhang, Yejia; Bogdanovich, Sasha; Khurana, Tejvir S.; Boennemann, Carsten G.; Birk, David E.; Chu, Mon-Li			COL6A3 Protein Deficiency in Mice Leads to Muscle and Tendon Defects Similar to Human Collagen VI Congenital Muscular Dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETHLEM MYOPATHY; TENASCIN-X; ALPHA-3 CHAIN; C5 DOMAIN; RECOMBINANT EXPRESSION; MICROFIBRIL FORMATION; VONWILLEBRAND-FACTOR; MYOSTATIN BLOCKADE; SEQUENCE-ANALYSIS; GLOBULAR DOMAINS	Collagen VI is a ubiquitously expressed extracellular microfibrillar protein. Its most common molecular form is composed of the alpha 1(VI), alpha 2(VI), and alpha 3(VI) collagen alpha chains encoded by the COL6A1, COL6A2, and COL6A3 genes, respectively. Mutations in any of the three collagen VI genes cause congenital muscular dystrophy types Bethlem and Ullrich as well as intermediate phenotypes characterized by muscle weakness and connective tissue abnormalities. The alpha 3(VI) collagen alpha chain has much larger N- and C-globular domains than the other two chains. Its most C-terminal domain can be cleaved off after assembly into microfibrils, and the cleavage product has been implicated in tumor angiogenesis and progression. Here we characterize a Col6a3 mutant mouse that expresses a very low level of a nonfunctional alpha 3(VI) collagen chain. The mutant mice are deficient in extracellular collagen VI microfibrils and exhibit myopathic features, including decreased muscle mass and contractile force. Ultrastructurally abnormal collagen fibrils were observed in tendon, but not cornea, of the mutant mice, indicating a distinct tissue-specific effect of collagen VI on collagen I fibrillogenesis. Overall, the mice lacking normal alpha 3(VI) collagen chains displayed mild musculoskeletal phenotypes similar to mice deficient in the alpha 1(VI) collagen alpha chain, suggesting that the cleavage product of the alpha 3(VI) collagen does not elicit essential functions in normal growth and development. The Col6a3 mouse mutant lacking functional alpha 3(VI) collagen chains thus serves as an animal model for COL6A3-related muscular dystrophy.	[Pan, Te-Cheng; Zhang, Rui-Zhu; Markova, Dessislava; Arita, Machiko; Chu, Mon-Li] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Zhang, Yejia] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA; [Zhang, Yejia] Rush Univ, Med Ctr, Dept Phys Med & Rehabil, Chicago, IL 60612 USA; [Bogdanovich, Sasha; Khurana, Tejvir S.] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Bogdanovich, Sasha; Khurana, Tejvir S.] Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Boennemann, Carsten G.] NINDS, Neurogenet Branch, NIH, Bethesda, MD 20824 USA; [Birk, David E.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33612 USA	Jefferson University; Rush University; Rush University; University of Pennsylvania; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); State University System of Florida; University of South Florida	Chu, ML (corresponding author), Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	mon-li.chu@jefferson.edu	Birk, David/I-4072-2012	Birk, David/0000-0002-4865-9088	National Institutes of Health [AR053251, AR44745]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053251, R01AR044745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR053251 (to M. L. C.) and AR44745 (to D. E. B.).	Aigner T, 2002, BIOCHEM BIOPH RES CO, V290, P743, DOI 10.1006/bbrc.2001.6227; Allamand V, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-30; Allamand Valerie, 2010, Neuromuscul Disord, V20, P346, DOI 10.1016/j.nmd.2010.02.012; Birk DE, 2011, BIOL EXTRACELL MATR, P77, DOI 10.1007/978-3-642-16555-9_3; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Bogdanovich S, 2008, MUSCLE NERVE, V37, P308, DOI 10.1002/mus.20920; Bonaldo P, 1998, HUM MOL GENET, V7, P2135, DOI 10.1093/hmg/7.13.2135; Bonnemann CG, 2011, NAT REV NEUROL, V7, P379, DOI 10.1038/nrneurol.2011.81; BROOKS SV, 1990, AM J PHYSIOL, V258, pC436, DOI 10.1152/ajpcell.1990.258.3.C436; Chen SJ, 2010, DEV DYNAM, V239, P844, DOI 10.1002/dvdy.22216; CHU ML, 1990, EMBO J, V9, P385, DOI 10.1002/j.1460-2075.1990.tb08122.x; CHU ML, 1988, J BIOL CHEM, V263, P18601; CHU ML, 1989, EMBO J, V8, P1939, DOI 10.1002/j.1460-2075.1989.tb03598.x; Deldicque L, 2012, EXERC SPORT SCI REV, V40, P43, DOI 10.1097/JES.0b013e3182355e8c; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; FURTHMAYR H, 1983, BIOCHEM J, V211, P303, DOI 10.1042/bj2110303; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Gara SK, 2011, MATRIX BIOL, V30, P248, DOI 10.1016/j.matbio.2011.03.006; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Izu Y, 2011, MATRIX BIOL, V30, P53, DOI 10.1016/j.matbio.2010.10.001; Jobsis GJ, 1999, BRAIN, V122, P649, DOI 10.1093/brain/122.4.649; Kirschner J, 2005, AM J MED GENET A, V132A, P296, DOI 10.1002/ajmg.a.30443; Lamande SR, 2006, J BIOL CHEM, V281, P16607, DOI 10.1074/jbc.M510192200; Lamande SR, 2002, J BIOL CHEM, V277, P1949, DOI 10.1074/jbc.M109932200; MAYER U, 1994, EUR J BIOCHEM, V225, P573, DOI 10.1111/j.1432-1033.1994.00573.x; Merlini L, 1999, NEUROMUSCULAR DISORD, V9, P326, DOI 10.1016/S0960-8966(99)00022-X; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Minamitani T, 2004, EXP CELL RES, V298, P305, DOI 10.1016/j.yexcr.2004.04.030; Minamitani T, 2004, EXP CELL RES, V297, P49, DOI 10.1016/j.yexcr.2004.03.002; MOENS P, 1993, J MUSCLE RES CELL M, V14, P446, DOI 10.1007/BF00121296; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; Nanda A, 2004, CANCER RES, V64, P817, DOI 10.1158/0008-5472.CAN-03-2408; Pan TC, 2003, AM J HUM GENET, V73, P355, DOI 10.1086/377107; Park J, 2012, J CLIN INVEST, V122, P4243, DOI 10.1172/JCI63930; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Ritty TM, 2003, STRUCTURE, V11, P1179, DOI 10.1016/S0969-2126(03)00181-3; Schalkwijk J, 2001, NEW ENGL J MED, V345, P1167, DOI 10.1056/NEJMoa002939; Schessl J, 2008, MUSCLE NERVE, V38, P1184, DOI 10.1002/mus.21088; SPECKS U, 1992, EMBO J, V11, P4281, DOI 10.1002/j.1460-2075.1992.tb05527.x; TILLET E, 1994, EUR J BIOCHEM, V221, P177, DOI 10.1111/j.1432-1033.1994.tb18727.x; Voermans NC, 2007, AM J MED GENET A, V143A, P2215, DOI 10.1002/ajmg.a.31899; Voermans NC, 2011, CONNECT TISSUE RES, V52, P422, DOI 10.3109/03008207.2010.551616; ZANUSSI S, 1992, J BIOL CHEM, V267, P24082; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200; Zhang RZ, 2002, J BIOL CHEM, V277, P43557, DOI 10.1074/jbc.M207696200; ZHANG RZ, 1993, BIOCHEM J, V291, P787, DOI 10.1042/bj2910787; ZIMMERMANN DR, 1986, FEBS LETT, V197, P55, DOI 10.1016/0014-5793(86)80297-6	48	47	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14320	14331		10.1074/jbc.M112.433078	http://dx.doi.org/10.1074/jbc.M112.433078			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23564457	Green Published, hybrid			2022-12-28	WOS:000319253500036
J	Kasaai, B; Gaumond, MH; Moffatt, P				Kasaai, Bahar; Gaumond, Marie-Helene; Moffatt, Pierre			Regulation of the Bone-restricted IFITM-like (Bril) Gene Transcription by Sp and Gli Family Members and CpG Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPERFECTA TYPE-V; ZINC-FINGER GENE; WEST NILE VIRUS; OSTEOBLAST DIFFERENTIATION; OSTEOGENESIS IMPERFECTA; ENDOCHONDRAL OSSIFICATION; ALKALINE-PHOSPHATASE; ANTIVIRAL ACTIVITY; BINDING-PROTEINS; FACTOR OSTERIX	Bril encodes a small membrane protein present in osteoblasts. In humans, a single recurrent mutation in the 5'-UTR of BRIL causes osteogenesis imperfecta type V. The exact function of BRIL and the mechanism by which it contributes to disease are still unknown. The goal of the current study was to characterize the mechanisms governing Bril transcription in humans, rats, and mice. In the three species, as detected by luciferase reporter assays in UMR106 cells, we found that most of the base-line regulatory activity was localized within similar to 250 bp upstream of the coding ATG. Co-transfection experiments indicated that Sp1 and Sp3 were potent inducers of the promoter activity, through the binding of several GC-rich boxes. Osterix was a weak activator but acted cooperatively with Sp1 and GLI2 to synergistically induce the BRIL promoter. GLI2, a mediator of hedgehog signaling pathway, was also a potent activator of BRIL through a single GLI binding site. Correspondingly, agonists of the hedgehog pathway (purmorphamine and Indian hedgehog) in MC3T3 osteoblasts led to increased BRIL levels. The BRIL promoter activity was also found to be negatively modulated through two different mechanisms. First, the ZFP354C zinc finger protein repressed basal and Sp1-induced activity. Second, CpG methylation of the promoter region correlated with an inactive state and prevented Sp1 activation. The data provide the very first analyses of the cis- and trans-acting factors regulating Bril transcription. They revealed key roles for the Sp members and GLI2 that possibly cooperate to activate Bril when the promoter becomes demethylated.	[Kasaai, Bahar; Gaumond, Marie-Helene; Moffatt, Pierre] Shriners Hosp Children, Montreal, PQ H3G 1A6, Canada; [Moffatt, Pierre] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada	McGill University; McGill University	Moffatt, P (corresponding author), Shriners Hosp Children, 1529 Cedar Ave, Montreal, PQ H3G 1A6, Canada.	pmoffatt@shriners.mcgill.ca		Moffatt, Pierre/0000-0002-5793-1944	Shriners of North America; Recruitment Aid program from the Network of Oral and Bone Health Research of the Fonds de Recherche du Quebec en Sante	Shriners of North America; Recruitment Aid program from the Network of Oral and Bone Health Research of the Fonds de Recherche du Quebec en Sante	This work was supported in part by a grant from the Shriners of North America and by a Recruitment Aid program from the Network of Oral and Bone Health Research of the Fonds de Recherche du Quebec en Sante.	Almen MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031961; Aoyama T, 2004, J BIOL CHEM, V279, P28789, DOI 10.1074/jbc.M401273200; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Cho TJ, 2012, AM J HUM GENET, V91, P343, DOI 10.1016/j.ajhg.2012.06.005; Chung UI, 2001, J CLIN INVEST, V107, P295, DOI 10.1172/JCI11706; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Delgado-Calle J, 2012, J BONE MINER RES, V27, P926, DOI 10.1002/jbmr.1491; Delgado-Calle J, 2011, BONE, V49, P830, DOI 10.1016/j.bone.2011.06.006; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Faraonio R, 2000, EUR J BIOCHEM, V267, P1743, DOI 10.1046/j.1432-1327.2000.01167.x; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Gao L, 2004, BIOCHEM BIOPH RES CO, V325, P1145, DOI 10.1016/j.bbrc.2004.10.158; Glorieux FH, 2000, J BONE MINER RES, V15, P1650, DOI 10.1359/jbmr.2000.15.9.1650; Gollner H, 2001, MECH DEVELOP, V106, P77, DOI 10.1016/S0925-4773(01)00420-8; Goto T, 2006, J BONE MINER RES, V21, P661, DOI 10.1359/JBMR.020605; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Hanagata N, 2007, J BIOMED MATER RES A, V83A, P362, DOI 10.1002/jbm.a.31240; Hanagata N, 2011, BIOCHEM BIOPH RES CO, V409, P378, DOI 10.1016/j.bbrc.2011.04.136; Hanagata N, 2011, J BONE MINER METAB, V29, P279, DOI 10.1007/s00774-010-0221-0; Hickford D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-155; Hojo H, 2012, J BIOL CHEM, V287, P17860, DOI 10.1074/jbc.M112.347716; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Hupkes M, 2011, BBA-MOL CELL RES, V1813, P839, DOI 10.1016/j.bbamcr.2011.01.022; Jheon AH, 2001, J BIOL CHEM, V276, P18282, DOI 10.1074/jbc.M010885200; Jheon A, 2009, ARCH ORAL BIOL, V54, P705, DOI 10.1016/j.archoralbio.2009.04.007; Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Kennett SB, 1997, NUCLEIC ACIDS RES, V25, P3110, DOI 10.1093/nar/25.15.3110; Kesper DA, 2010, DEV DYNAM, V239, P1818, DOI 10.1002/dvdy.22301; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Koziel L, 2005, DEVELOPMENT, V132, P5249, DOI 10.1242/dev.02097; Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08; LaRochelle O, 2001, BIOCHEM J, V353, P591, DOI 10.1042/0264-6021:3530591; Le Mee S, 2005, EXP CELL RES, V302, P129, DOI 10.1016/j.yexcr.2004.08.028; Lee JY, 2006, MOL CELLS, V22, P182; LETOVSKY J, 1989, NUCLEIC ACIDS RES, V17, P2639, DOI 10.1093/nar/17.7.2639; LEWIN AR, 1991, EUR J BIOCHEM, V199, P417, DOI 10.1111/j.1432-1033.1991.tb16139.x; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu JZ, 2005, J CELL BIOCHEM, V96, P716, DOI 10.1002/jcb.20569; Long F, 2013, COLD SPRING HARB PER, V5; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Maeda Y, 2007, P NATL ACAD SCI USA, V104, P6382, DOI 10.1073/pnas.0608449104; Miao DS, 2004, EXP CELL RES, V294, P210, DOI 10.1016/j.yexcr.2003.10.021; Mo R, 1997, DEVELOPMENT, V124, P113; Moffatt P, 2004, GENE, V334, P123, DOI 10.1016/j.gene.2004.03.010; Moffatt P, 2002, NUCLEIC ACIDS RES, V30, P4285, DOI 10.1093/nar/gkf542; Moffatt P, 2008, J BONE MINER RES, V23, P1497, DOI 10.1359/JBMR.080412; MULLER MM, 1989, NUCLEIC ACIDS RES, V17, P6420, DOI 10.1093/nar/17.15.6420; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Niger C, 2011, BONE, V49, P683, DOI 10.1016/j.bone.2011.07.027; Nishimura R, 2012, J BIOL CHEM, V287, P33179, DOI 10.1074/jbc.M111.337063; Ohba S, 2008, DEV CELL, V14, P689, DOI 10.1016/j.devcel.2008.03.007; Park HL, 2000, DEVELOPMENT, V127, P1593; Rauch F, 2013, J MED GENET, V50, P21, DOI 10.1136/jmedgenet-2012-101307; Raychoudhuri A, 2011, J VIROL, V85, P12881, DOI 10.1128/JVI.05633-11; Rigden DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021507; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Sapetschnig A, 2004, J BIOL CHEM, V279, P42095, DOI 10.1074/jbc.M404989200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Semler O, 2012, AM J HUM GENET, V91, P349, DOI 10.1016/j.ajhg.2012.06.011; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; Siegrist F, 2011, J INTERF CYTOK RES, V31, P183, DOI 10.1089/jir.2010.0112; Sinha KM, 2013, J CELL BIOCHEM, V114, P975, DOI 10.1002/jcb.24439; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stains JP, 2003, J BIOL CHEM, V278, P24377, DOI 10.1074/jbc.M212554200; Stephens AS, 2011, J BIOL CHEM, V286, P30071, DOI 10.1074/jbc.M111.253518; Thaler R, 2012, EPIGENETICS-US, V7, P635, DOI 10.4161/epi.20163; Tian Y, 2012, CELL BIOCHEM BIOPHYS, V64, P169, DOI 10.1007/s12013-012-9369-7; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Winklmayr M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-2; WITZGALL R, 1994, P NATL ACAD SCI USA, V91, P4514, DOI 10.1073/pnas.91.10.4514; Wu X, 2004, CHEM BIOL, V11, P1229, DOI 10.1016/j.chembiol.2004.06.010; Wu X, 2002, J AM CHEM SOC, V124, P14520, DOI 10.1021/ja0283908; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Yusa N, 2000, J LEUKOCYTE BIOL, V68, P772; Zelko IN, 2010, FREE RADICAL BIO MED, V48, P895, DOI 10.1016/j.freeradbiomed.2010.01.007; Zhang Y, 2009, J BIOL CHEM, V284, P3125, DOI 10.1074/jbc.M807466200; Zhao M, 2006, MOL CELL BIOL, V26, P6197, DOI 10.1128/MCB.02214-05; Zhu WG, 2003, MOL CELL BIOL, V23, P4056, DOI 10.1128/MCB.23.12.4056-4065.2003	91	22	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13278	13294		10.1074/jbc.M113.457010	http://dx.doi.org/10.1074/jbc.M113.457010			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23530031	hybrid, Green Published			2022-12-28	WOS:000318850300014
J	Parakati, R; DiMario, JX				Parakati, Rajini; DiMario, Joseph X.			Repression of Myoblast Proliferation and Fibroblast Growth Factor Receptor 1 Promoter Activity by KLF10 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; FGF RECEPTOR; TERMINAL DIFFERENTIATION; TRANSCRIPTION FACTORS; MUSCLE CELLS; IN-VITRO; SKELETAL; MYOGENESIS; OSTEOBLASTS; TIEG1	Skeletal muscle development is controlled by regulation of myoblast proliferation and differentiation into muscle fibers. Growth factors such as fibroblast growth factors (FGFs) and their receptors (FGFRs) regulate cell proliferation and differentiation in numerous tissues, including skeletal muscle. Transcriptional regulation of FGFR1 gene expression is developmentally regulated by the Sp1 transcription factor, a member of the Kruppel-like factor (KLF) family of transcriptional regulators. Here, we show that another KLF transcription factor, KLF10, also regulates myoblast proliferation and FGFR1 promoter activity. Expression of KLF10 reduced myoblast proliferation by 86%. KLF10 expression also significantly reduced FGFR1 promoter activity in myoblasts and Sp1-mediated FGFR1 promoter activity in Drosophila SL2 cells. Southwestern blot, electromobility shift, and chromatin immunoprecipitation assays demonstrated that KLF10 bound to the proximal Sp factor binding site of the FGFR1 promoter and reduced Sp1 complex formation with the FGFR1 promoter at that site. These results indicate that KLF10 is an effective repressor of myoblast proliferation and represses FGFR1 promoter activity in these cells via an Sp1 binding site.	[DiMario, Joseph X.] Rosalind Franklin Univ Med & Sci, Dept Cell Biol & Anat, Sch Grad & Postdoctoral Studies, N Chicago, IL 60064 USA; [DiMario, Joseph X.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, N Chicago, IL 60064 USA	Rosalind Franklin University Medical & Science; Chicago Medical School; Rosalind Franklin University Medical & Science	DiMario, JX (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Cell Biol & Anat, Sch Grad & Postdoctoral Studies, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	joseph.dimario@rosalindfranklin.edu						Cook T, 2000, AM J PHYSIOL-GASTR L, V278, pG513, DOI 10.1152/ajpgi.2000.278.4.G513; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DIMARIO JX, 1995, EXP CELL RES, V216, P431, DOI 10.1006/excr.1995.1054; DiMario JX, 2002, INT J MOL MED, V10, P65; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Flanagan-Steet H, 2000, DEV BIOL, V218, P21, DOI 10.1006/dbio.1999.9535; GOSPODAROWICZ D, 1975, NATURE, V256, P216, DOI 10.1038/256216a0; Grothe C, 1996, DEV DYNAM, V206, P310, DOI 10.1002/(SICI)1097-0177(199607)206:3<310::AID-AJA8>3.0.CO;2-L; Itoh N, 1996, DEVELOPMENT, V122, P291; Ji CH, 1999, J BIOL CHEM, V274, P30487, DOI 10.1074/jbc.274.43.30487; KARDAMI E, 1985, DEV BIOL, V112, P353, DOI 10.1016/0012-1606(85)90406-3; Kim J, 2010, BIOCHEM BIOPH RES CO, V401, P412, DOI 10.1016/j.bbrc.2010.09.068; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; MOORE JW, 1991, DEVELOPMENT, V111, P741; OLWIN BB, 1988, J CELL BIOL, V107, P761, DOI 10.1083/jcb.107.2.761; OLWIN BB, 1990, J CELL BIOL, V110, P503, DOI 10.1083/jcb.110.2.503; ONEILL MC, 1972, J CELL BIOL, V52, P52, DOI 10.1083/jcb.52.1.52; Parakati R, 2005, J BIOL CHEM, V280, P21284, DOI 10.1074/jbc.M410744200; Parakati R, 2002, J BIOL CHEM, V277, P9278, DOI 10.1074/jbc.M108411200; Patel SG, 2001, GENE, V270, P171, DOI 10.1016/S0378-1119(01)00478-4; Patel SG, 1999, GENE, V237, P265, DOI 10.1016/S0378-1119(99)00278-4; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; PerezCastro AV, 1997, GENOMICS, V41, P10, DOI 10.1006/geno.1997.4616; Rajamannan NM, 2007, J CELL BIOCHEM, V100, P315, DOI 10.1002/jcb.21049; Reinholz MM, 2004, BREAST CANCER RES TR, V86, P75, DOI 10.1023/B:BREA.0000032926.74216.7d; Scata KA, 1999, EXP CELL RES, V250, P10, DOI 10.1006/excr.1999.4506; STOCKDALE F, 1961, EXP CELL RES, V24, P508, DOI 10.1016/0014-4827(61)90450-5; Subramaniam M, 1995, NUCLEIC ACIDS RES, V23, P4907, DOI 10.1093/nar/23.23.4907; Subramaniam M, 2005, MOL CELL BIOL, V25, P1191, DOI 10.1128/MCB.25.3.1191-1199.2005; Subramaniam M, 2007, J CELL BIOCHEM, V102, P539, DOI 10.1002/jcb.21492; Tachibana I, 1997, J CLIN INVEST, V99, P2365, DOI 10.1172/JCI119418; WANAKA A, 1991, DEVELOPMENT, V111, P455; Xiong YN, 2012, J BIOL CHEM, V287, P34372, DOI 10.1074/jbc.M111.325332	33	23	26	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13876	13884		10.1074/jbc.M113.457648	http://dx.doi.org/10.1074/jbc.M113.457648			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23569208	hybrid, Green Published			2022-12-28	WOS:000318850300068
J	Quimbar, P; Malik, U; Sommerhoff, CP; Kaas, Q; Chan, LY; Huang, YH; Grundhuber, M; Dunse, K; Craik, DJ; Anderson, MA; Daly, NL				Quimbar, Pedro; Malik, Uru; Sommerhoff, Christian P.; Kaas, Quentin; Chan, Lai Y.; Huang, Yen-Hua; Grundhuber, Maresa; Dunse, Kerry; Craik, David J.; Anderson, Marilyn A.; Daly, Norelle L.			High-affinity Cyclic Peptide Matriptase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE SERINE-PROTEASE; TRYPSIN-INHIBITOR; DISULFIDE BRIDGE; POTENT; DESIGN; SFTI-1; CYCLOTIDES; DYNAMICS; PROSTATE; COMPLEX	The type II transmembrane serine protease matriptase is a key activator of multiple signaling pathways associated with cell proliferation and modification of the extracellular matrix. Deregulated matriptase activity correlates with a number of diseases, including cancer and hence highly selective matriptase inhibitors may have therapeutic potential. The plant-derived cyclic peptide, sunflower trypsin inhibitor-1 (SFTI-1), is a promising drug scaffold with potent matriptase inhibitory activity. In the current study we have analyzed the structure-activity relationships of SFTI-1 and Momordica cochinchinensis trypsin inhibitor-II (MCoTI-II), a structurally divergent trypsin inhibitor from Momordica cochinchinensis that also contains a cyclic backbone. We show that MCoTI-II is a significantly more potent matriptase inhibitor than SFTI-1 and that all alanine mutants of both peptides, generated using positional scanning mutagenesis, have decreased trypsin affinity, whereas several mutations either maintain or result in enhanced matriptase inhibitory activity. These intriguing results were used to design one of the most potent matriptase inhibitors known to date with a 290 pM equilibrium dissociation constant, and provide the first indication on how to modulate affinity for matriptase over trypsin in cyclic peptides. This information might be useful for the design of more selective and therapeutically relevant inhibitors of matriptase.	[Dunse, Kerry; Anderson, Marilyn A.] La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic 3086, Australia; [Malik, Uru; Kaas, Quentin; Chan, Lai Y.; Huang, Yen-Hua; Craik, David J.; Daly, Norelle L.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Sommerhoff, Christian P.; Grundhuber, Maresa] Univ Munich, Univ Hosp, Inst Lab Med, D-80336 Munich, Germany; [Daly, Norelle L.] James Cook Univ, Sch Pharm & Mol Sci, Ctr Biodiscovery & Mol Dev Therapeut, Cairns, Qld 4878, Australia	La Trobe University; University of Queensland; University of Munich; James Cook University	Daly, NL (corresponding author), James Cook Univ, Smithfield, Qld 4870, Australia.	norelle.daly@jcu.edu.au	Dunse, Kerry/A-8624-2012; Huang, Yen-Hua/J-9056-2014; Craik, David/B-1695-2010; Kaas, Quentin/J-8727-2014; Daly, Norelle/D-4302-2013; Anderson, Marilyn/A-4259-2012; CHAN, LAI YUE/C-6489-2014	Huang, Yen-Hua/0000-0001-6937-2660; Craik, David/0000-0003-0007-6796; Dunse, Kerry/0000-0003-1490-3465; Kaas, Quentin/0000-0001-9988-6152; Daly, Norelle/0000-0002-4697-6602; Anderson, Marilyn/0000-0002-8257-5128; CHAN, LAI YUE/0000-0002-9346-2487	Queensland Government Smart State Fellowship; Hexima Limited; Deutsche Forschungsgemeinschaft [SO 249/1-1]; Australian Postgraduate Award	Queensland Government Smart State Fellowship; Hexima Limited; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Australian Postgraduate Award(Australian Government)	This work was supported in part by a Queensland Government Smart State Fellowship (to N. L. D.), which was co-funded by Hexima Limited, and Project SO 249/1-1, priority program 1394 "Mast cells-promoters of health and modulator of diseases," of the Deutsche Forschungsgemeinschaft (to C. P. S.).; Supported by an Australian Postgraduate Award.	Avrutina O, 2005, BIOL CHEM, V386, P1301, DOI 10.1515/BC.2005.148; Avrutina O, 2012, ORG BIOMOL CHEM, V10, P7753, DOI 10.1039/c2ob26162f; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barbeta BL, 2008, P NATL ACAD SCI USA, V105, P1221, DOI 10.1073/pnas.0710338104; Bergum C, 2010, PROSTATE, V70, P1422, DOI 10.1002/pros.21177; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cerutti DS, 2009, J PHYS CHEM B, V113, P6971, DOI 10.1021/jp9010372; Chan LY, 2011, BLOOD, V118, P6709, DOI 10.1182/blood-2011-06-359141; Clark RJ, 2010, ANGEW CHEM INT EDIT, V49, P6545, DOI 10.1002/anie.201000620; Conlan BF, 2011, CURR PHARM DESIGN, V17, P4318; Craik DJ, 2012, EXPERT OPIN DRUG DIS, V7, P179, DOI 10.1517/17460441.2012.661554; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; Daly NL, 2006, J BIOL CHEM, V281, P23668, DOI 10.1074/jbc.M601426200; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fittler H, 2013, ORG BIOMOL CHEM, V11, P1848, DOI 10.1039/c3ob27469a; Forbs D, 2005, INT J ONCOL, V27, P1061; Goddard T. D., SPARKY 3; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Guo X, 2006, CHEM BIOL DRUG DES, V68, P341, DOI 10.1111/j.1747-0285.2006.00457.x; Gustafson KR, 2004, CURR PROTEIN PEPT SC, V5, P331, DOI 10.2174/1389203043379468; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Heutinck KM, 2010, MOL IMMUNOL, V47, P1943, DOI 10.1016/j.molimm.2010.04.020; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Legowska A, 2010, BIOORGAN MED CHEM, V18, P8188, DOI 10.1016/j.bmc.2010.10.014; Legowska A, 2010, PROTEIN PEPTIDE LETT, V17, P1223, DOI 10.2174/092986610792231483; Li P, 2007, J MED CHEM, V50, P5976, DOI 10.1021/jm0704898; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; Long YQ, 2001, BIOORG MED CHEM LETT, V11, P2515, DOI 10.1016/S0960-894X(01)00493-0; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Mylne JS, 2011, NAT CHEM BIOL, V7, P257, DOI 10.1038/nchembio.542; Napp J, 2010, INT J CANCER, V127, P1958, DOI 10.1002/ijc.25405; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Rafal Lukajtis, 2011, J Pept Sci, V17, P281, DOI 10.1002/psc.1330; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanders Andrew J, 2006, J Exp Ther Oncol, V6, P39; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Steinmetzer T, 2006, J MED CHEM, V49, P4116, DOI 10.1021/jm051272l; Swedberg JE, 2012, CHEMBIOCHEM, V13, P336, DOI 10.1002/cbic.201100673; Swedberg JE, 2009, CHEM BIOL, V16, P633, DOI 10.1016/j.chembiol.2009.05.008; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tam JP, 1998, PROTEIN SCI, V7, P1583, DOI 10.1002/pro.5560070712; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wong CTT, 2012, ANGEW CHEM INT EDIT, V51, P5620, DOI 10.1002/anie.201200984; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yuan C, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-30	49	106	112	0	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13885	13896		10.1074/jbc.M113.460030	http://dx.doi.org/10.1074/jbc.M113.460030			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23548907	Green Published, hybrid			2022-12-28	WOS:000318850300069
J	Wheatley, RW; Lo, S; Jancewicz, LJ; Dugdale, ML; Huber, RE				Wheatley, Robert W.; Lo, Summie; Jancewicz, Larisa J.; Dugdale, Megan L.; Huber, Reuben E.			Structural Explanation for Allolactose (lac Operon Inducer) Synthesis by lacZ beta-Galactosidase and the Evolutionary Relationship between Allolactose Synthesis and the lac Repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ACTIVE-SITE; KLUYVEROMYCES-LACTIS; LACTOSE HYDROLYSIS; METAL-BINDING; CONFORMATIONS; OPTIMIZATION; REACTIVITY; CATALYSIS; VARIANTS	beta-Galactosidase (lacZ) has bifunctional activity. It hydrolyzes lactose to galactose and glucose and catalyzes the intramolecular isomerization of lactose to allolactose, the lac operon inducer. beta-Galactosidase promotes the isomerization by means of an acceptor site that binds glucose after its cleavage from lactose and thus delays its exit from the site. However, because of its relatively low affinity for glucose, details of this site have remained elusive. We present structural data mapping the glucose site based on a substituted enzyme (G794A-beta-galactosidase) that traps allolactose. Various lines of evidence indicate that the glucose of the trapped allolactose is in the acceptor position. The evidence includes structures with Bis-Tris (2,2-bis(hydroxymethyl)-2,2',2 ''-nitrilotriethanol) and L-ribose in the site and kinetic binding studies with substituted beta-galactosidases. The site is composed of Asn-102, His-418, Lys-517, Ser796, Glu-797, and Trp-999. Ser-796 and Glu-797 are part of a loop (residues 795-803) that closes over the active site. This loop appears essential for the bifunctional nature of the enzyme because it helps form the glucose binding site. In addition, because the loop is mobile, glucose binding is transient, allowing the release of some glucose. Bioinformatics studies showed that the residues important for interacting with glucose are only conserved in a subset of related enzymes. Thus, intramolecular isomerization is not a universal feature of beta-galactosidases. Genomic analyses indicated that lac repressors were co-selected only within the conserved subset. This shows that the glucose binding site of beta-galactosidase played an important role in lac operon evolution.	[Wheatley, Robert W.; Lo, Summie; Jancewicz, Larisa J.; Dugdale, Megan L.; Huber, Reuben E.] Univ Calgary, Fac Sci, Div Biochem, Calgary, AB T2N 1N4, Canada	University of Calgary	Huber, RE (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	huber@ucalgary.ca						Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; BOOS W, 1982, METHOD ENZYMOL, V89, P59; BURCHHARDT G, 1991, GENE, V106, P13, DOI 10.1016/0378-1119(91)90560-X; BURSTEIN C, 1965, BIOCHIM BIOPHYS ACTA, V95, P634, DOI 10.1016/0005-2787(65)90517-4; Daber R, 2007, J MOL BIOL, V370, P609, DOI 10.1016/j.jmb.2007.04.028; DESCHAVANNE PJ, 1978, J BIOL CHEM, V253, P833; Dugdale ML, 2010, BIOCHEM CELL BIOL, V88, P969, DOI 10.1139/O10-144; Dugdale ML, 2010, BIOCHEM CELL BIOL, V88, P861, DOI 10.1139/O10-009; EDWARDS RA, 1992, BIOCHEM CELL BIOL, V70, P63, DOI 10.1139/o92-009; EGEL R, 1979, J THEOR BIOL, V79, P117, DOI 10.1016/0022-5193(79)90260-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; FOWLER AV, 1978, J BIOL CHEM, V253, P5521; GEBLER JC, 1992, J BIOL CHEM, V267, P11126; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HALL BG, 1974, GENETICS, V76, P391; Huber RE, 2003, BIOCHEMISTRY-US, V42, P1796, DOI 10.1021/bi0270642; HUBER RE, 1984, ARCH BIOCHEM BIOPHYS, V234, P151, DOI 10.1016/0003-9861(84)90336-9; Huber RE, 1996, J PROTEIN CHEM, V15, P621, DOI 10.1007/BF01886744; HUBER RE, 1976, BIOCHEMISTRY-US, V15, P1994, DOI 10.1021/bi00654a029; HUBER RE, 1975, CAN J BIOCHEM CELL B, V53, P1035, DOI 10.1139/o75-142; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Jancewicz L., 2008, THESIS U CALGARY CAL; Jancewicz LJ, 2012, ARCH BIOCHEM BIOPHYS, V517, P111, DOI 10.1016/j.abb.2011.11.017; JOBE A, 1972, J MOL BIOL, V69, P397, DOI 10.1016/0022-2836(72)90253-7; Juers DH, 2003, BIOCHEMISTRY-US, V42, P13505, DOI 10.1021/bi035506j; Juers DH, 2001, BIOCHEMISTRY-US, V40, P14781, DOI 10.1021/bi011727i; Juers DH, 2000, PROTEIN SCI, V9, P1685, DOI 10.1110/ps.9.9.1685; Juers DH, 2012, PROTEIN SCI, V21, P1792, DOI 10.1002/pro.2165; Juers DH, 2009, PROTEIN SCI, V18, P1281, DOI 10.1002/pro.140; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kim CS, 2004, BIOCHEM BIOPH RES CO, V316, P738, DOI 10.1016/j.bbrc.2004.02.118; Kumari M, 2011, PHYS CHEM CHEM PHYS, V13, P6517, DOI 10.1039/c0cp02559c; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, P50; Lo S, 2010, PROTEIN J, V29, P26, DOI 10.1007/s10930-009-9216-x; Mahoney RR, 1998, FOOD CHEM, V63, P147, DOI 10.1016/S0308-8146(98)00020-X; MARKIEWICZ P, 1994, J MOL BIOL, V240, P421, DOI 10.1006/jmbi.1994.1458; Martinez-Villaluenga C, 2008, FOOD CHEM, V107, P258, DOI 10.1016/j.foodchem.2007.08.011; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pereira-Rodriguez A, 2012, J STRUCT BIOL, V177, P392, DOI 10.1016/j.jsb.2011.11.031; Richard JP, 1996, BIOCHEMISTRY-US, V35, P12377, DOI 10.1021/bi961028j; Skalova T, 2005, J MOL BIOL, V353, P282, DOI 10.1016/j.jmb.2005.08.028; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stoebel DM, 2005, MOL BIOL EVOL, V22, P683, DOI 10.1093/molbev/msi056; Toh H, 2006, GENOME RES, V16, P149, DOI 10.1101/gr.4106106; TURNER CL, 1977, J MOL BIOL, V115, P195, DOI 10.1016/0022-2836(77)90096-1; Wheatley RW, 2012, ARCH BIOCHEM BIOPHYS, V521, P51, DOI 10.1016/j.abb.2012.03.014	51	30	31	3	216	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12993	13005		10.1074/jbc.M113.455436	http://dx.doi.org/10.1074/jbc.M113.455436			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23486479	Green Published, hybrid			2022-12-28	WOS:000318555100052
J	Suh, YH; Park, JY; Park, S; Jou, I; Roche, PA; Roche, KW				Suh, Young Ho; Park, Ji-Young; Park, Sangwook; Jou, Ilo; Roche, Paul A.; Roche, Katherine W.			Regulation of Metabotropic Glutamate Receptor 7 (mGluR7) Internalization and Surface Expression by Ser/Thr Protein Phosphatase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE/THREONINE PHOSPHATASES; INTERACTING PROTEINS; SYNAPTIC PLASTICITY; PKC PHOSPHORYLATION; CATALYTIC SUBUNIT; NERVOUS-SYSTEM; OKADAIC ACID; CALYCULIN-A; S6 KINASE; 2A	The metabotropic glutamate receptor type 7 (mGluR7) is the predominant group III mGluR in the presynaptic active zone, where it serves as an autoreceptor to inhibit neurotransmitter release. Our previous studies show that PKC phosphorylation of mGluR7 on Ser-862 is a key mechanism controlling constitutive and activity-dependent surface expression of mGluR7 by regulating a competitive interaction of calmodulin and protein interacting with C kinase (PICK1). As receptor phosphorylation and dephosphorylation are tightly coordinated through the precise action of protein kinases and phosphatases, dephosphorylation by phosphatases is likely to play an active role in governing the activity-dependent or agonist-induced changes in mGluR7 receptor surface expression. In the present study, we find that the serine/threonine protein phosphatase 1 (PP1) has a crucial role in the constitutive and agonist-induced dephosphorylation of Ser-862 on mGluR7. Treatment of neurons with PP1 inhibitors leads to a robust increase in Ser-862 phosphorylation and increased surface expression of mGluR7. In addition, Ser-862 phosphorylation of both mGluR7a and mGluR7b is a target of PP1. Interestingly, agonist-induced dephosphorylation of mGluR7 is regulated by PP1, whereas NMDA-mediated activity-induced dephosphorylation is not, illustrating there are multiple signaling pathways that affect receptor phosphorylation and trafficking. Importantly, PP1 gamma 1 regulates agonist-dependent Ser-862 dephosphorylation and surface expression of mGluR7.	[Suh, Young Ho; Park, Ji-Young; Park, Sangwook; Jou, Ilo] Ajou Univ, Sch Med, Dept Pharmacol, Suwon 443721, South Korea; [Suh, Young Ho; Park, Ji-Young; Park, Sangwook; Jou, Ilo] Ajou Univ, Sch Med, Chron Inflammatory Dis Res Ctr, Suwon 443721, South Korea; [Suh, Young Ho; Roche, Paul A.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Suh, Young Ho; Roche, Katherine W.] NINDS, Receptor Biol Sect, NIH, Bethesda, MD 20892 USA	Ajou University; Ajou University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Roche, KW (corresponding author), NINDS, Receptor Biol Sect, NIH, Porter Neurosci Res Ctr, Bldg 35,Rm 2C903, Bethesda, MD 20892 USA.	rochek@ninds.nih.gov	Roche, Katherine/W-9893-2019; Suh, Young Ho/AAJ-6405-2021	Suh, Young Ho/0000-0003-3979-1615; Roche, Paul/0000-0002-8949-9172; Roche, Katherine/0000-0001-7282-6539	NINDS, National Institutes of Health, Intramural Research Program; NCI, National Institutes of Health, Intramural Research Program; Ajou University School of Medicine; Basic Science Research Program through the National Research Foundation of Korea [2011-0011694]; Medical Research Center Program through the National Research Foundation of Korea [NRF-2012R1A5A048183]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003036, ZIANS002994] Funding Source: NIH RePORTER	NINDS, National Institutes of Health, Intramural Research Program; NCI, National Institutes of Health, Intramural Research Program; Ajou University School of Medicine; Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Medical Research Center Program through the National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the NINDS, National Institutes of Health, Intramural Research Program (to K. W. R.), the NCI, National Institutes of Health, Intramural Research Program (to P. A. R.), the new faculty research fund of the Ajou University School of Medicine, and the Basic Science Research Program (2011-0011694) and Medical Research Center Program (NRF-2012R1A5A048183) through the National Research Foundation of Korea.	Bockaert J, 2010, ANNU REV PHARMACOL, V50, P89, DOI 10.1146/annurev.pharmtox.010909.105705; Boger DL, 2001, J AM CHEM SOC, V123, P4161, DOI 10.1021/ja010195q; Cohen PTW, 2002, J CELL SCI, V115, P241; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Corti C, 1998, EUR J NEUROSCI, V10, P3629, DOI 10.1046/j.1460-9568.1998.00371.x; Croci C, 2003, J BIOL CHEM, V278, P50682, DOI 10.1074/jbc.M305764200; Dev KK, 2000, J NEUROSCI, V20, P7252; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; El Far O, 2002, BIOCHEM J, V365, P329, DOI 10.1042/BJ20020481; Enz R, 2003, BIOCHEM J, V372, P183, DOI 10.1042/BJ20021750; Enz R, 2002, J NEUROCHEM, V81, P1130, DOI 10.1046/j.1471-4159.2002.00922.x; Fagni L, 2004, SEMIN CELL DEV BIOL, V15, P289, DOI 10.1016/j.semcdb.2003.12.018; Flor PJ, 1997, NEUROPHARMACOLOGY, V36, P153, DOI 10.1016/S0028-3908(96)00176-1; Herzig S, 2000, PHYSIOL REV, V80, P173, DOI 10.1152/physrev.2000.80.1.173; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Kinoshita A, 1998, J COMP NEUROL, V393, P332; Koss DJ, 2007, J NEUROCHEM, V102, P1009, DOI 10.1111/j.1471-4159.2007.04579.x; KREIENBUHL P, 1992, BLOOD, V80, P2911; Lavezzari G, 2007, NEUROPHARMACOLOGY, V52, P100, DOI 10.1016/j.neuropharm.2006.07.011; Lee HK, 2006, PHARMACOL THERAPEUT, V112, P810, DOI 10.1016/j.pharmthera.2006.06.003; Lee JH, 2008, P NATL ACAD SCI USA, V105, P12575, DOI 10.1073/pnas.0712033105; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Munton RP, 2004, FEBS LETT, V567, P121, DOI 10.1016/j.febslet.2004.03.121; Pelkey KA, 2005, NEURON, V46, P89, DOI 10.1016/j.neuron.2005.02.011; Pelkey KA, 2007, NEUROPHARMACOLOGY, V52, P108, DOI 10.1016/j.neuropharm.2006.07.020; Pelkey KA, 2008, NEURON, V60, P980, DOI 10.1016/j.neuron.2008.11.018; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Petritsch C, 2000, GENE DEV, V14, P3093, DOI 10.1101/gad.854200; Schwartz N, 2009, NEURON, V62, P655, DOI 10.1016/j.neuron.2009.05.007; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shi Y, 2010, P NATL ACAD SCI USA, V107, P16315, DOI 10.1073/pnas.1011706107; Shibasaki F, 2002, J BIOCHEM, V131, P1, DOI 10.1093/oxfordjournals.jbchem.a003063; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; Strack S, 1999, J COMP NEUROL, V413, P373; Suh YH, 2008, NEURON, V58, P736, DOI 10.1016/j.neuron.2008.03.028; Suh YH, 2010, NAT NEUROSCI, V13, P338, DOI 10.1038/nn.2488; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Zhang J, 1996, BIOCHEMISTRY-US, V35, P6276, DOI 10.1021/bi952954l	42	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17544	17551		10.1074/jbc.M112.439513	http://dx.doi.org/10.1074/jbc.M112.439513			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23612982	Green Published, hybrid			2022-12-28	WOS:000320380600045
J	Kalantari-Dehaghi, M; Chen, YM; Deng, W; Chernyavsky, A; Marchenko, S; Wang, PH; Grando, SA				Kalantari-Dehaghi, Mina; Chen, Yumay; Deng, Wu; Chernyavsky, Alex; Marchenko, Steve; Wang, Ping H.; Grando, Sergei A.			Mechanisms of Mitochondrial Damage in Keratinocytes by Pemphigus Vulgaris Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOSPORINE THERAPY; APOPTOTIC PATHWAYS; MOUSE MODEL; NICOTINAMIDE; TARGET; TETRACYCLINE; MINOCYCLINE; REMISSION; DEATH; AUTOIMMUNITY	The development of nonhormonal treatment of pemphigus vulgaris (PV) has been hampered by a lack of clear understanding of the mechanisms leading to keratinocyte (KC) detachment and death in pemphigus. In this study, we sought to identify changes in the vital mitochondrial functions in KCs treated with the sera from PV patients and healthy donors. PV sera significantly increased proton leakage from KCs, suggesting that PV IgGs increase production of reactive oxygen species. Indeed, measurement of intracellular reactive oxygen species production showed a drastic increase of cell staining in response to treatment by PV sera, which was confirmed by FACS analysis. Exposure of KCs to PV sera also caused dramatic changes in the mitochondrial membrane potential detected with the JC-1 dye. These changes can trigger the mitochondria-mediated intrinsic apoptosis. Although sera from different PV patients elicited unique patterns of mitochondrial damage, the mitochondria-protecting drugs nicotinamide (also called niacinamide), minocycline, and cyclosporine A exhibited a uniform protective effect. Their therapeutic activity was validated in the passive transfer model of PV in neonatal BALB/c mice. The highest efficacy of mitochondrial protection of the combination of these drugs found in mitochondrial assay was consistent with the ability of the same drug combination to abolish acantholysis in mouse skin. These findings provide a theoretical background for clinical reports of the efficacy of mitochondria-protecting drugs in PV patients. Pharmacological protection of mitochondria and/or compensation of an altered mitochondrial function may therefore become a novel approach to development of personalized nonhormonal therapies of patients with this potentially lethal autoimmune blistering disease.	[Kalantari-Dehaghi, Mina; Chernyavsky, Alex; Marchenko, Steve; Grando, Sergei A.] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92697 USA; [Chen, Yumay; Deng, Wu; Wang, Ping H.] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA; [Wang, Ping H.; Grando, Sergei A.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Grando, Sergei A.] Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Wang, PH (corresponding author), Univ Calif Irvine, C240 Med Sci 1, Irvine, CA 92697 USA.	phwang@uci.edu; sgrando@uci.edu			National Institutes of Health [R01 HL096987]; School of Medicine of the University of California Irvine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); School of Medicine of the University of California Irvine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL096987 (to P. H. W.) and the School of Medicine of the University of California Irvine (to S. A. G.).	AHMED AR, 1982, J AM ACAD DERMATOL, V7, P221; Alexandroff AB, 2009, BRIT J DERMATOL, V160, P502, DOI 10.1111/j.1365-2133.2008.08857.x; ALIJOTAS J, 1990, J AM ACAD DERMATOL, V23, P701, DOI 10.1016/0190-9622(90)70277-O; ALPSOY E, 1995, ARCH DERMATOL, V131, P1339, DOI 10.1001/archderm.131.11.1339; Amagai M, 2012, J INVEST DERMATOL, V132, P776, DOI 10.1038/jid.2011.390; Arredondo J, 2005, AM J PATHOL, V167, P1531, DOI 10.1016/S0002-9440(10)61239-4; Arredondo J, 2006, CANCER BIOL THER, V5, P511, DOI 10.4161/cbt.5.5.2601; Awazawa R, 2007, J DERMATOL, V34, P549, DOI 10.1111/j.1346-8138.2007.00329.x; BARTHELEMY H, 1988, J AM ACAD DERMATOL, V18, P1262, DOI 10.1016/S0190-9622(88)70132-2; BENJAMIN AM, 1981, SCIENCE, V213, P1495, DOI 10.1126/science.7280667; BERGMANN F, 1950, J BIOL CHEM, V186, P693; BONDESSON L, 1990, DERMATOLOGICA, V181, P308, DOI 10.1159/000247834; Bystryn JC, 2005, LANCET, V366, P61, DOI 10.1016/S0140-6736(05)66829-8; CANAFAX DM, 1983, CLIN PHARMACY, V2, P515; CHAFFINS ML, 1993, J AM ACAD DERMATOL, V28, P998, DOI 10.1016/S0190-9622(08)80651-2; Chams-Davatchi C, 2005, INT J DERMATOL, V44, P470, DOI 10.1111/j.1365-4632.2004.02501.x; Cirillo N, 2012, ORAL DIS, V18, P442, DOI 10.1111/j.1601-0825.2011.01899.x; Daoud YJ, 2006, INT IMMUNOPHARMACOL, V6, P600, DOI 10.1016/j.intimp.2005.11.002; Espana A, 2013, EXP DERMATOL, V22, P125, DOI 10.1111/exd.12088; Fimiani M, 1997, J AM GERIATR SOC, V45, P256, DOI 10.1111/j.1532-5415.1997.tb04529.x; Gaspar Z S, 1996, Australas J Dermatol, V37, P93, DOI 10.1111/j.1440-0960.1996.tb01013.x; GEOGHEGAN W, 1992, J INVEST DERMATOL, V98, P589; Gheorghe Emma, 2005, Rom J Morphol Embryol, V46, P73; Gil MP, 2012, EXP DERMATOL, V21, P254, DOI 10.1111/j.1600-0625.2012.01441.x; Gomez L, 2009, CARDIOVASC RES, V83, P226, DOI 10.1093/cvr/cvp063; Gooptu C, 1998, J AM ACAD DERMATOL, V38, P860, DOI 10.1016/S0190-9622(98)70476-1; Grando SA, 2000, DERMATOLOGY, V201, P290, DOI 10.1159/000051540; Grando SA, 2012, AUTOIMMUNITY, V45, P7, DOI 10.3109/08916934.2011.606444; Grando SA, 2009, EXP DERMATOL, V18, P764, DOI 10.1111/j.1600-0625.2009.00934.x; Gupta S, 2009, J CELL MOL MED, V13, P1004, DOI 10.1111/j.1582-4934.2009.00697.x; Hand SC, 2008, J EXP BIOL, V211, P1829, DOI 10.1242/jeb.000299; Hausermann P, 2002, HAUTARZT, V53, P813, DOI 10.1007/s00105-002-0376-2; Iraji F, 2010, DERMATOL THER, V23, P308, DOI 10.1111/j.1529-8019.2010.01329.x; Jenden D J, 1990, Adv Neurol, V51, P131; Kalantari-Dehaghi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057587; Kalantari-Dehaghi M, 2011, EXP DERMATOL, V20, P154, DOI 10.1111/j.1600-0625.2010.01193.x; Knip M, 2000, DIABETOLOGIA, V43, P1337, DOI 10.1007/s001250051536; Koppen A, 1997, J PHARMACOL EXP THER, V282, P1139; Lotti R, 2012, CURR PHARM BIOTECHNO, V13, P1877, DOI 10.2174/138920112802273236; Maiese K, 2003, TRENDS PHARMACOL SCI, V24, P228, DOI 10.1016/S0165-6147(03)00078-6; Marchenko S, 2010, J BIOL CHEM, V285, P3695, DOI 10.1074/jbc.M109.081570; Martin LK, 2011, J AM ACAD DERMATOL, V64, P903, DOI 10.1016/j.jaad.2010.04.039; McGill A, 2005, FASEB J, V19, P1012, DOI 10.1096/fj.04-2664fje; Mobini N, 1997, J AM ACAD DERMATOL, V36, P264, DOI 10.1016/S0190-9622(97)70296-2; Naziroglu Mustafa, 2003, Journal of Basic and Clinical Physiology and Pharmacology, V14, P31; Osman MM, 2011, NEUROPEPTIDES, V45, P359, DOI 10.1016/j.npep.2011.04.002; Ozog DM, 2000, ARCH DERMATOL, V136, P1133, DOI 10.1001/archderm.136.9.1133; PISANTI S, 1974, ORAL SURG ORAL MED O, V38, P382, DOI 10.1016/0030-4220(74)90365-X; Rallis E, 2011, AM J CLIN DERMATOL, V12, P283, DOI 10.2165/11586680-000000000-00000; ROMANENKO AV, 1987, FIZIOL ZH SSSR, V33, P51; ROSENBERG FR, 1976, ARCH DERMATOL, V112, P962, DOI 10.1001/archderm.112.7.962; SAWAI T, 1995, BRIT J DERMATOL, V132, P668; Stoytcheva M, 1996, ELECTROANAL, V8, P676, DOI 10.1002/elan.1140080714; Takae Y, 2009, EXP DERMATOL, V18, P252, DOI 10.1111/j.1600-0625.2008.00776.x; TSERAIDIS G S, 1972, Arkhiv Patologii, V34, P72; TSERAIDIS G S, 1971, Vestnik Dermatologii i Venerologii, V45, P8; Vardy DA, 2001, ARCH DERMATOL, V137, P505; Wan XL, 2001, ANTICANCER RES, V21, P2657; Yazdanpanah MJ, 2011, INT J DERMATOL, V50, P1343, DOI 10.1111/j.1365-4632.2011.04968.x; Yesilova Y, 2013, J EUR ACAD DERMATOL, V27, P465, DOI 10.1111/j.1468-3083.2012.04463.x	60	34	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16916	16925		10.1074/jbc.M113.472100	http://dx.doi.org/10.1074/jbc.M113.472100			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23599429	Green Published, hybrid			2022-12-28	WOS:000320378900064
J	Sachelaru, I; Petriman, NA; Kudva, R; Kuhn, P; Welte, T; Knapp, B; Drepper, F; Warscheid, B; Koch, HG				Sachelaru, Ilie; Petriman, Narcis Adrian; Kudva, Renuka; Kuhn, Patrick; Welte, Thomas; Knapp, Bettina; Drepper, Friedel; Warscheid, Bettina; Koch, Hans-Georg			YidC Occupies the Lateral Gate of the SecYEG Translocon and Is Sequentially Displaced by a Nascent Membrane Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-RECOGNITION PARTICLE; ESCHERICHIA-COLI REQUIRES; BACTERIAL SRP RECEPTOR; CONDUCTING CHANNEL; TRANSLATING RIBOSOME; PERIPLASMIC DOMAIN; CYTOPLASMIC MEMBRANE; BINDING-SITES; CROSS-LINKING; IN-VIVO	Most membrane proteins are co-translationally inserted into the lipid bilayer via the universally conserved SecY complex and they access the lipid phase presumably via a lateral gate in SecY. In bacteria, the lipid transfer of membrane proteins from the SecY channel is assisted by the SecY-associated protein YidC, but details on the SecY-YidC interaction are unknown. By employing an in vivo and in vitro site-directed cross-linking approach, we have mapped the SecY-YidC interface and found YidC in contact with all four transmembrane domains of the lateral gate. This interaction did not require the SecDFYajC complex and was not influenced by SecA binding to SecY. In contrast, ribosomes dissociated the YidC contacts to lateral gate helices 2b and 8. The major contact between YidC and the lateral gate was lost in the presence of ribosome nascent chains and new SecY-YidC contacts appeared. These data demonstrate that the SecY-YidC interaction is influenced by nascent-membrane-induced lateral gate movements.	[Sachelaru, Ilie; Petriman, Narcis Adrian; Kudva, Renuka; Kuhn, Patrick; Welte, Thomas; Koch, Hans-Georg] Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany; [Sachelaru, Ilie; Petriman, Narcis Adrian; Kudva, Renuka; Kuhn, Patrick; Knapp, Bettina; Drepper, Friedel; Warscheid, Bettina] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Kudva, Renuka; Koch, Hans-Georg] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79104 Freiburg, Germany; [Drepper, Friedel; Warscheid, Bettina] Univ Freiburg, Zentrum Biol Signalstudien, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Koch, HG (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany.	Hans-Georg.Koch@biochemie.uni-freiburg.de		Petriman, Narcis Adrian/0000-0002-3189-7530; Kudva, Renuka/0000-0003-0426-3716; Warscheid, Bettina/0000-0001-5096-1975; Drepper, Friedel/0000-0002-2043-5795; Welte, Thomas/0000-0003-4583-9216	Deutsche Forschungsgemeinschaft [FOR929, FOR 967, GRK1478]; Excellence Initiative of the German Federal and State Governments EXC [294]; FF-Nord Foundation Fellowship; European Union	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments EXC; FF-Nord Foundation Fellowship; European Union(European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft Grants FOR929, FOR 967, and GRK1478 (to H.G.K.), grants from the Excellence Initiative of the German Federal and State Governments EXC 294 BIOSS Centre for Biological Signaling Studies (to B.W.) and GSC-4 Spemann Graduate School for Biology and Medicine (to H.G.K.), a FF-Nord Foundation Fellowship (to T.W.), and an Erasmus Fellowship of the European Union (to N.P.).	Angelini S, 2005, EMBO REP, V6, P476, DOI 10.1038/sj.embor.7400385; Angelini S, 2006, J CELL BIOL, V174, P715, DOI 10.1083/jcb.200606093; BABA T, 1990, J BACTERIOL, V172, P7005, DOI 10.1128/jb.172.12.7005-7010.1990; Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Boy D, 2009, MOL BIOL CELL, V20, P1804, DOI 10.1091/mbc.E08-08-0886; Braig D, 2009, J MOL BIOL, V390, P401, DOI 10.1016/j.jmb.2009.04.061; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; Chen MY, 2005, BIOCHEMISTRY-US, V44, P10741, DOI 10.1021/bi047418k; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dalal K, 2012, P NATL ACAD SCI USA, V109, P4104, DOI 10.1073/pnas.1117783109; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; DARKEN MA, 1964, PHARMACOL REV, V16, P223; Das S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182931; du Plessis DJF, 2009, J BIOL CHEM, V284, P15805, DOI 10.1074/jbc.M901855200; Duong F, 1997, EMBO J, V16, P4871, DOI 10.1093/emboj/16.16.4871; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Funes S, 2009, P NATL ACAD SCI USA, V106, P6656, DOI 10.1073/pnas.0809951106; Gumbart J, 2009, STRUCTURE, V17, P1453, DOI 10.1016/j.str.2009.09.010; Haider S, 2006, BIOCHEMISTRY-US, V45, P13018, DOI 10.1021/bi061013d; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hizlan D, 2012, CELL REPORTS, V1, P21, DOI 10.1016/j.celrep.2011.11.003; Hou B, 2012, MOL CELL, V48, P398, DOI 10.1016/j.molcel.2012.08.023; Houben ENG, 2004, EMBO REP, V5, P970, DOI 10.1038/sj.embor.7400261; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; Koch HG, 2002, J BIOL CHEM, V277, P5715, DOI 10.1074/jbc.C100683200; Kohler R, 2009, MOL CELL, V34, P344, DOI 10.1016/j.molcel.2009.04.019; Kuhn P, 2011, TRAFFIC, V12, P563, DOI 10.1111/j.1600-0854.2011.01167.x; Lotz M, 2008, J MOL BIOL, V375, P901, DOI 10.1016/j.jmb.2007.10.089; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; MATSUYAMA S, 1993, EMBO J, V12, P265, DOI 10.1002/j.1460-2075.1993.tb05652.x; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Niemann M, 2013, MOL CELL PROTEOMICS, V12, P515, DOI 10.1074/mcp.M112.023093; Nijeholt JALA, 2011, J BIOL CHEM, V286, P43881, DOI 10.1074/jbc.M111.297507; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; Nouwen N, 2002, MOL MICROBIOL, V44, P1397, DOI 10.1046/j.1365-2958.2002.02972.x; Oliver DC, 2008, J BIOL CHEM, V283, P5208, DOI 10.1074/jbc.M708936200; Park E, 2012, J CELL BIOL, V198, P881, DOI 10.1083/jcb.201205140; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; POGLIANO JA, 1994, EMBO J, V13, P554, DOI 10.1002/j.1460-2075.1994.tb06293.x; Ravaud S, 2008, ACTA CRYSTALLOGR F, V64, P144, DOI 10.1107/S1744309108002364; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; Stiegler N, 2011, J MOL BIOL, V406, P362, DOI 10.1016/j.jmb.2010.12.036; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Urbanus ML, 2001, EMBO REP, V2, P524, DOI 10.1093/embo-reports/kve108; van Bloois E, 2008, FEBS LETT, V582, P1419, DOI 10.1016/j.febslet.2008.02.082; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; Wagner S, 2008, J BIOL CHEM, V283, P17881, DOI 10.1074/jbc.M801481200; Welte T, 2012, MOL BIOL CELL, V23, P464, DOI 10.1091/mbc.E11-07-0590; Xie K, 2006, BIOCHEMISTRY-US, V45, P13401, DOI 10.1021/bi060826z; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	61	74	75	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16295	16307		10.1074/jbc.M112.446583	http://dx.doi.org/10.1074/jbc.M112.446583			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23609445	hybrid, Green Published			2022-12-28	WOS:000320378900009
J	Tao, Y; Wu, MH; Zhou, X; Yin, W; Hu, B; de Crombrugghe, B; Sinha, KM; Zang, JY				Tao, Yue; Wu, Minhao; Zhou, Xing; Yin, Wu; Hu, Bin; de Crombrugghe, Benoit; Sinha, Krishna M.; Zang, Jianye			Structural Insights into Histone Demethylase NO66 in Interaction with Osteoblast-specific Transcription Factor Osterix and Gene Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING PROTEIN; BONE-FORMATION; DIFFERENTIATION; EXPRESSION; CHROMATIN; SOFTWARE	Osterix (Osx) is an osteoblast-specific transcriptional factor and is required for osteoblast differentiation and bone formation. A JmjC domain-containing protein NO66 was previously found to participate in regulation of Osx transcriptional activity and plays an important role in osteoblast differentiation through interaction with Osx. Here, we report the crystal structure of NO66 forming in a functional tetramer. A hinge domain links the N-terminal JmjC domain and C-terminal winged helix-turn-helix domain of NO66, and both domains are essential for tetrameric assembly. The oligomerization interface of NO66 interacts with a conserved fragment of Osx. We show that the hinge domain-dependent oligomerization of NO66 is essential for inhibition of Osx-dependent gene activation. Our findings suggest that homo-oligomerization of JmjC domain containing proteins might play a physiological role through interactions with other regulatory factors during gene expression.	[Tao, Yue; Wu, Minhao; Zhou, Xing; Yin, Wu; Hu, Bin; Zang, Jianye] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Tao, Yue; Wu, Minhao; Zhou, Xing; Yin, Wu; Hu, Bin; Zang, Jianye] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Tao, Yue; Wu, Minhao; Zhou, Xing; Yin, Wu; Hu, Bin; Zang, Jianye] Chinese Acad Sci, Key Lab Struct Biol, Hefei 230027, Anhui, Peoples R China; [de Crombrugghe, Benoit] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Sinha, Krishna M.] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Sinha, KM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, 1515 Holcomb Blvd,Unit 1006, Houston, TX 77030 USA.	ksinha@mdanderson.org; zangjy@ustc.edu.cn	Zang, Jianye/E-5228-2013; hu, bing/B-1030-2010	hu, bing/0000-0001-8627-5272	Chinese Ministry of Science and Technology [2009CB825502, 2012CB917202]; National Natural Science Foundation of China [31171241, 30970576]; Ph.D. Program Foundation of the Ministry of Education of China [20113402110033]; "100 Talents Program" of the Chinese Academy of Sciences; NIAMS, National Institutes of Health [AR061590]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR061590] Funding Source: NIH RePORTER	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Program Foundation of the Ministry of Education of China(Ministry of Education, China); "100 Talents Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Chinese Ministry of Science and Technology Grants 2009CB825502 and 2012CB917202, National Natural Science Foundation of China Grants 31171241 and 30970576, the Ph.D. Program Foundation of the Ministry of Education of China Grant 20113402110033, and the "100 Talents Program" of the Chinese Academy of Sciences (to J. Z.). This work was also supported by NIAMS, National Institutes of Health Grant AR061590 (to K. M. S.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Brien GL, 2012, NAT STRUCT MOL BIOL, V19, P1273, DOI 10.1038/nsmb.2449; Chang YY, 2011, BIOCHEM J, V433, P295, DOI 10.1042/BJ20101418; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Cheng SL, 2008, J BIOL CHEM, V283, P20505, DOI 10.1074/jbc.M800851200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Eilbracht J, 2004, MOL BIOL CELL, V15, P1816, DOI 10.1091/mbc.e03-08-0623; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang JM, 1997, ANAT EMBRYOL, V196, P349, DOI 10.1007/s004290050104; Ge W, 2012, NAT CHEM BIOL, V8, P960, DOI [10.1038/NCHEMBIO.1093, 10.1038/nchembio.1093]; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Kato M, 2011, NUCLEIC ACIDS RES, V39, P1576, DOI 10.1093/nar/gkq919; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Lee C, 2003, J BIOL CHEM, V278, P7558, DOI 10.1074/jbc.M210385200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Thirunavukkarasu K, 2000, J BIOL CHEM, V275, P25163, DOI 10.1074/jbc.M000322200; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Yang Y, 2010, CELL RES, V20, P886, DOI 10.1038/cr.2010.86; Youn MY, 2012, J BIOL CHEM, V287, P12994, DOI 10.1074/jbc.M111.323105; Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37; Zhou X, 2012, ACTA CRYSTALLOGR F, V68, P764, DOI 10.1107/S174430911201740X	29	15	16	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16430	16437		10.1074/jbc.M112.446849	http://dx.doi.org/10.1074/jbc.M112.446849			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23620590	Green Published, hybrid			2022-12-28	WOS:000320378900020
J	Harmel, J; Ruzzenente, B; Terzioglu, M; Spahr, H; Falkenberg, M; Larsson, NG				Harmel, Julia; Ruzzenente, Benedetta; Terzioglu, Mugen; Spahr, Henrik; Falkenberg, Maria; Larsson, Nils-Goran			The Leucine-rich Pentatricopeptide Repeat-containing Protein (LRPPRC) Does Not Activate Transcription in Mammalian Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; IN-VIVO; DOMAIN; GENE; TRANSLATION; BINDING; MTDNA; POLYADENYLATION; IDENTIFICATION; CONTRIBUTES	Regulation of mtDNA expression is critical for controlling oxidative phosphorylation capacity and has been reported to occur at several different levels in mammalian mitochondria. LRPPRC (leucine-rich pentatricopeptide repeat-containing protein) has a key role in this regulation and acts at the post-transcriptional level to stabilize mitochondrial mRNAs, to promote mitochondrial mRNA polyadenylation, and to coordinate mitochondrial translation. However, recent studies have suggested that LRPPRC may have an additional intramitochondrial role by directly interacting with the mitochondrial RNA polymerase POLRMT to stimulate mtDNA transcription. In this study, we have further examined the intramitochondrial roles for LRPPRC by creating bacterial artificial chromosome transgenic mice with moderately increased LRPPRC expression and heterozygous Lrpprc knock-out mice with moderately decreased LRPPRC expression. Variation of LRPPRC levels in mice in vivo, occurring within a predicted normal physiological range, strongly affected the levels of an unprocessed mitochondrial precursor transcript (ND5-cytochrome b) but had no effect on steady-state levels of mitochondrial transcripts or de novo transcription of mtDNA. We further assessed the role of LRPPRC in mitochondrial transcription by performing size exclusion chromatography and immunoprecipitation experiments in human cell lines and mice, but we found no interaction between LRPPRC and POLRMT. Furthermore, addition of purified LRPPRC to a recombinant human in vitro transcription system did not activate mtDNA transcription. On the basis of these data, we conclude that LRPPRC does not directly regulate mtDNA transcription but rather acts as a post-transcriptional regulator of mammalian mtDNA expression.	[Harmel, Julia; Ruzzenente, Benedetta; Terzioglu, Mugen; Spahr, Henrik; Larsson, Nils-Goran] Max Planck Inst Biol Ageing, Dept Mitochondrial Biol, D-50931 Cologne, Germany; [Falkenberg, Maria] Univ Gothenburg, Inst Biomed, SE-40530 Gothenburg, Sweden; [Larsson, Nils-Goran] Karolinska Inst, Dept Lab Med, SE-17177 Stockholm, Sweden	Max Planck Society; University of Gothenburg; Karolinska Institutet	Larsson, NG (corresponding author), Max Planck Inst Biol Ageing, Dept Mitochondrial Biol, Joseph Stelzmann Str 9B, D-50931 Cologne, Germany.	larsson@age.mpg.de	Ruzzenente, Benedetta/H-4793-2017; Larsson, Nils-Göran/GVS-5578-2022	Ruzzenente, Benedetta/0000-0001-7366-114X; Larsson, Nils-Göran/0000-0001-5100-996X; Terzioglu, Mugen/0000-0003-0872-3046	European Research Council advanced investigator grant; Swedish Research Council; Swedish Cancer Foundation; European Research Council starting independent investigator grant	European Research Council advanced investigator grant(European Research Council (ERC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; European Research Council starting independent investigator grant	The work was supported by a European Research Council advanced investigator grant (to N.-G.L.) and by Swedish Research Council grants, the Swedish Cancer Foundation, and a European Research Council starting independent investigator grant (to M.F.).	Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bratic A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002324; Camara Y, 2011, CELL METAB, V13, P527, DOI 10.1016/j.cmet.2011.04.002; Chujo T, 2012, NUCLEIC ACIDS RES, V40, P8033, DOI 10.1093/nar/gks506; Cooper MP, 2008, J BIOL CHEM, V283, P31960, DOI 10.1074/jbc.M805431200; Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906; Davies SMK, 2012, FEBS LETT, V586, P3555, DOI 10.1016/j.febslet.2012.07.043; Davies SMK, 2009, FEBS LETT, V583, P1853, DOI 10.1016/j.febslet.2009.04.048; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; Hallberg BM, 2011, NAT STRUCT MOL BIOL, V18, P1179, DOI 10.1038/nsmb.2167; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Liu LJ, 2011, J BIOL CHEM, V286, P41253, DOI 10.1074/jbc.M111.276121; Liu LY, 2002, GENOMICS, V79, P124, DOI 10.1006/geno.2001.6679; Mancebo R, 2001, MOL CELL BIOL, V21, P3462, DOI 10.1128/MCB.21.10.3462-3471.2001; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Mili S, 2001, MOL CELL BIOL, V21, P7307, DOI 10.1128/MCB.21.21.7307-7319.2001; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Rackham O, 2009, NUCLEIC ACIDS RES, V37, P5859, DOI 10.1093/nar/gkp627; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Shi YH, 2012, P NATL ACAD SCI USA, V109, P16510, DOI 10.1073/pnas.1119738109; Sondheimer N, 2010, BIOCHEMISTRY-US, V49, P7467, DOI 10.1021/bi1008479; Spahr H, 2012, P NATL ACAD SCI USA, V109, P15253, DOI 10.1073/pnas.1210688109; Sterky FH, 2010, BIOCHEM BIOPH RES CO, V398, P759, DOI 10.1016/j.bbrc.2010.07.019; Tiranti V, 1997, HUM MOL GENET, V6, P615, DOI 10.1093/hmg/6.4.615; Topisirovic I, 2009, MOL CELL BIOL, V29, P1152, DOI 10.1128/MCB.01532-08; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P6765, DOI 10.1093/nar/gkp750; Xu F, 2008, BIOCHEM J, V416, P15, DOI 10.1042/BJ20080847; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469; Zehrmann A, 2011, RNA BIOL, V8, P67, DOI 10.4161/rna.8.1.14298	38	21	21	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15510	15519		10.1074/jbc.M113.471649	http://dx.doi.org/10.1074/jbc.M113.471649			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23599432	hybrid, Green Published			2022-12-28	WOS:000319822300009
J	Hickok, JR; Vasudevan, D; Antholine, WE; Thomas, DD				Hickok, Jason R.; Vasudevan, Divya; Antholine, William E.; Thomas, Douglas D.			Nitric Oxide Modifies Global Histone Methylation by Inhibiting Jumonji C Domain-containing Demethylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; MOLECULAR-MECHANISMS; CELLULAR SENESCENCE; H3 LYSINE-9; IRON; G9A; METHYLTRANSFERASE; EXPRESSION; JMJD1A; REPRESSION	Methylation of lysine residues on histone tails is an important epigenetic modification that is dynamically regulated through the combined effects of methyltransferases and demethylases. The Jumonji C domain Fe(II) alpha-ketoglutarate family of proteins performs the majority of histone demethylation. We demonstrate that nitric oxide ((NO)-N-center dot) directly inhibits the activity of the demethylase KDM3A by forming a nitrosyliron complex in the catalytic pocket. Exposing cells to either chemical or cellular sources of (NO)-N-center dot resulted in a significant increase in dimethyl Lys-9 on histone 3 (H3K9me2), the preferred substrate for KDM3A. G9a, the primary methyltransferase acting on H3K9me2, was down-regulated in response to (NO)-N-center dot, and changes in methylation state could not be accounted for by methylation in general. Furthermore, cellular iron sequestration via dinitrosyliron complex formation correlated with increased methylation. The mRNA of several histone demethylases and methyltransferases was also differentially regulated in response to (NO)-N-center dot. Taken together, these data reveal three novel and distinct mechanisms whereby (NO)-N-center dot can affect histone methylation as follows: direct inhibition of Jumonji C demethylase activity, reduction in iron cofactor availability, and regulation of expression of methyl-modifying enzymes. This model of (NO)-N-center dot as an epigenetic modulator provides a novel explanation for nonclassical gene regulation by (NO)-N-center dot.	[Hickok, Jason R.; Vasudevan, Divya; Thomas, Douglas D.] Univ Illinois, Dept Med Chem, Chicago, IL 60612 USA; [Hickok, Jason R.; Vasudevan, Divya; Thomas, Douglas D.] Univ Illinois, Dept Pharmacognosy, Chicago, IL 60612 USA; [Antholine, William E.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Medical College of Wisconsin	Thomas, DD (corresponding author), Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, 833 S Wood St MC 781, Chicago, IL 60612 USA.	ddthomas@uic.edu		Thomas, Douglas/0000-0003-1252-0786	National Institutes of Health from NIGMS [R01GM085232, 1S10RR027848-01A1]; University of Illinois at Chicago Cancer Center; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094175, R01GM085232] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Illinois at Chicago Cancer Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM085232 and 1S10RR027848-01A1 from NIGMS. This work was also supported by the University of Illinois at Chicago Cancer Center.	Beshiri ML, 2012, P NATL ACAD SCI USA, V109, P18499, DOI 10.1073/pnas.1216724109; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Burgold T, 2012, CELL REP, V2, P1244, DOI 10.1016/j.celrep.2012.09.013; Cascella B, 2012, BIOCHEMISTRY-US, V51, P8699, DOI 10.1021/bi3012466; Chen HB, 2006, CANCER RES, V66, P9009, DOI 10.1158/0008-5472.CAN-06-0101; Chen HB, 2006, MOL CELL BIOL, V26, P3728, DOI 10.1128/MCB.26.10.3728-3737.2006; Chen HB, 2010, CARCINOGENESIS, V31, P2136, DOI 10.1093/carcin/bgq197; Chen HB, 2010, J BIOL CHEM, V285, P7374, DOI 10.1074/jbc.M109.058503; Chen H, 2009, BIOMETALS, V22, P191, DOI 10.1007/s10534-008-9190-3; Chervona Y, 2012, FREE RADICAL BIO MED, V53, P1041, DOI 10.1016/j.freeradbiomed.2012.07.020; Cho HS, 2012, INT J CANCER, V131, pE179, DOI 10.1002/ijc.26501; Chowdhury R, 2011, J MOL BIOL, V410, P268, DOI 10.1016/j.jmb.2011.04.075; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Cyr AR, 2011, ANTIOXID REDOX SIGN, V15, P551, DOI 10.1089/ars.2010.3492; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Ene CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051407; Falandry C, 2010, J BIOL CHEM, V285, P20234, DOI 10.1074/jbc.M109.052399; Fandrey J, 2006, CARDIOVASC RES, V71, P642, DOI 10.1016/j.cardiores.2006.05.005; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Guo X, 2011, NEOPLASMA, V58, P153, DOI 10.4149/neo_2011_02_153; Hickok JR, 2012, ANTIOXID REDOX SIGN, V17, P962, DOI 10.1089/ars.2012.4543; Hickok JR, 2011, J BIOL CHEM, V286, P41413, DOI 10.1074/jbc.M111.287052; Hickok JR, 2011, FREE RADICAL BIO MED, V51, P1558, DOI 10.1016/j.freeradbiomed.2011.06.030; Hickok JR, 2010, CURR PHARM DESIGN, V16, P381, DOI 10.2174/138161210790232149; Huang CY, 2010, CELL RES, V20, P154, DOI 10.1038/cr.2010.5; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Karytinos A, 2009, J BIOL CHEM, V284, P17775, DOI 10.1074/jbc.M109.003087; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; Khan SN, 2010, CLIN CHIM ACTA, V411, P1401, DOI 10.1016/j.cca.2010.06.020; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Knowles HJ, 2006, CANCER RES, V66, P2600, DOI 10.1158/0008-5472.CAN-05-2351; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; LEE MH, 1994, BIOCHEMISTRY-US, V33, P3679, DOI 10.1021/bi00178a026; Li Q, 2009, CARCINOGENESIS, V30, P1243, DOI 10.1093/carcin/bgp088; Lim S, 2010, INT J CANCER, V127, P1991, DOI 10.1002/ijc.25538; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Lohse B, 2011, BIOORGAN MED CHEM, V19, P3625, DOI 10.1016/j.bmc.2011.01.046; MacArthur PH, 2007, J CHROMATOGR B, V851, P93, DOI 10.1016/j.jchromb.2006.12.012; Mallette FA, 2012, CELL REP, V2, P1233, DOI 10.1016/j.celrep.2012.09.033; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mateo J, 2003, BIOCHEM J, V376, P537, DOI 10.1042/BJ20031155; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; Metzen E, 2003, MOL BIOL CELL, V14, P3470, DOI 10.1091/mbc.e02-12-0791; Minami T., 2013, CANC RES IN PRESS; Ohta K, 2013, INT J ONCOL, V42, P1212, DOI 10.3892/ijo.2013.1799; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Pierce BS, 2007, BIOCHEMISTRY-US, V46, P8569, DOI 10.1021/bi700662d; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Ramadoss S, 2012, J BIOL CHEM, V287, P44508, DOI 10.1074/jbc.M112.424903; Richardson DR, 2005, CURR MED CHEM, V12, P2711, DOI 10.2174/092986705774462996; Roberts NJ, 2012, SCI TRANSL MED, V4; Sanchez-Fernandez EM, 2013, BIOCHEM J, V449, P491, DOI 10.1042/BJ20121155; Sen N, 2011, P NATL ACAD SCI USA, V108, P20178, DOI 10.1073/pnas.1117820108; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tausendschon M, 2011, CYTOKINE, V53, P256, DOI 10.1016/j.cyto.2010.11.002; Thieme S, 2013, BLOOD, V121, P2462, DOI 10.1182/blood-2012-08-452003; Thomas DD, 2004, P NATL ACAD SCI USA, V101, P8894, DOI 10.1073/pnas.0400453101; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Toledo JC, 2008, J BIOL CHEM, V283, P28926, DOI 10.1074/jbc.M707862200; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tzatsos A, 2013, J CLIN INVEST, V123, P727, DOI 10.1172/JCI64535; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Wellmann S, 2008, BIOCHEM BIOPH RES CO, V372, P892, DOI 10.1016/j.bbrc.2008.05.150; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Ye L, 2012, CELL STEM CELL, V11, P50, DOI 10.1016/j.stem.2012.04.009; Yoshimi A, 2011, J CELL BIOCHEM, V112, P415, DOI 10.1002/jcb.22972; Zhou X, 2010, CANCER RES, V70, P4214, DOI 10.1158/0008-5472.CAN-09-2942; Zhu ZQ, 2010, CELL RES, V20, P794, DOI 10.1038/cr.2010.75	79	71	71	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16004	16015		10.1074/jbc.M112.432294	http://dx.doi.org/10.1074/jbc.M112.432294			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23546878	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000319822300052
J	Wang, X; Singh, S; Jung, HY; Yang, GJ; Jun, S; Sastry, KJ; Park, JI				Wang, Xin; Singh, Shailbala; Jung, Hae-Yun; Yang, Guojun; Jun, Sohee; Sastry, K. Jagannadha; Park, Jae-Il			HIV-1 Vpr Protein Inhibits Telomerase Activity via the EDD-DDB1-VPRBP E3 Ligase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; REVERSE-TRANSCRIPTASE; ENZYME APOBEC3G; CELL-CYCLE; INFECTION; EXPRESSION; GENE; VIF; DEGRADATION; INDUCTION	Viral pathogens utilize host cell machinery for their benefits. Herein, we identify that HIV-1 Vpr (viral protein R) negatively modulates telomerase activity. Telomerase enables stem and cancer cells to evade cell senescence by adding telomeric sequences to the ends of chromosomes. We found that Vpr inhibited telomerase activity by down-regulating TERT protein, a catalytic subunit of telomerase. As a molecular adaptor, Vpr enhanced the interaction between TERT and the VPRBP substrate receptor of the DYRK2-associated EDD-DDB1-VPRBP E3 ligase complex, resulting in increased ubiquitination of TERT. In contrast, the Vpr mutant identified in HIV-1-infected long-term nonprogressors failed to promote TERT destabilization. Our results suggest that Vpr inhibits telomerase activity by hijacking the host E3 ligase complex, and we propose the novel molecular mechanism of telomerase deregulation in possibly HIV-1 pathogenesis.	[Wang, Xin; Jung, Hae-Yun; Jun, Sohee; Park, Jae-Il] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Singh, Shailbala; Yang, Guojun; Sastry, K. Jagannadha] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Park, Jae-Il] Univ Texas MD Anderson Canc Ctr, Program Canc Biol, Houston, TX 77030 USA; [Park, Jae-Il] Univ Texas Houston, Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Park, Jae-Il] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Park, JI (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jaeil@mdanderson.org	park, jaeil/AAS-5894-2021	PARK, JAE-IL/0000-0002-0737-2654; Jung, Hae-Yun/0000-0001-9467-2219; Sastry, Jagannadha/0000-0002-6987-4422	Duncan Family Institute research program grant; University Cancer Foundation Grant [IRG-08-061-01]; American Association for Cancer Research-Pancreatic Cancer Action Network [11-20-25-PARK]; Center for Stem Cell and Developmental Biology transformative pilot grant; Metastasis Research Center grant; University of Texas MD Anderson Cancer Center; National Institutes of Health through The University of Texas MD Anderson Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Duncan Family Institute research program grant; University Cancer Foundation Grant; American Association for Cancer Research-Pancreatic Cancer Action Network; Center for Stem Cell and Developmental Biology transformative pilot grant; Metastasis Research Center grant; University of Texas MD Anderson Cancer Center; National Institutes of Health through The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Duncan Family Institute research program grant; University Cancer Foundation Grant IRG-08-061-01; American Association for Cancer Research-Pancreatic Cancer Action Network Grant 11-20-25-PARK; and a Center for Stem Cell and Developmental Biology transformative pilot grant, an institutional research grant, a new faculty support grant, a Metastasis Research Center grant, the Specialized Program of Research Excellence (SPORE) in Ovarian Cancer, research grant from The University of Texas MD Anderson Cancer Center. DNA sequencing and other core facilities were supported by National Institutes of Health Grant CA016672 through The University of Texas MD Anderson Cancer Center.	Armstrong L, 2005, STEM CELLS, V23, P516, DOI 10.1634/stemcells.2004-0269; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Ballon G, 2001, J INFECT DIS, V183, P417, DOI 10.1086/318072; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bostik P, 2002, J INFECT DIS, V185, P999, DOI 10.1086/339412; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Fauce SR, 2008, J IMMUNOL, V181, P7400, DOI 10.4049/jimmunol.181.10.7400; Franzese O, 2007, J MED VIROL, V79, P639, DOI 10.1002/jmv.20855; Gonzalez-Suarez E, 2002, MOL CELL BIOL, V22, P7291, DOI 10.1128/MCB.22.20.7291-7301.2002; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Huang J, 2008, ONCOGENE, V27, P4056, DOI 10.1038/onc.2008.44; Imamura S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003364; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Jung HY, 2013, J BIOL CHEM, V288, P7252, DOI 10.1074/jbc.M112.416792; Kogan M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-25; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Le Rouzic E, 2008, J BIOL CHEM, V283, P21686, DOI 10.1074/jbc.M710298200; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Reynoso R, 2006, AIDS RES HUM RETROV, V22, P425, DOI 10.1089/aid.2006.22.425; Roshal M, 2003, J BIOL CHEM, V278, P25879, DOI 10.1074/jbc.M303948200; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; SHIPPENLENTZ D, 1990, SCIENCE, V247, P546, DOI 10.1126/science.1689074; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Wang B, 1996, VIROLOGY, V223, P224, DOI 10.1006/viro.1996.0471; Yang CB, 2008, STEM CELLS, V26, P850, DOI 10.1634/stemcells.2007-0677; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang LQ, 1997, VIROLOGY, V228, P340, DOI 10.1006/viro.1996.8378; ZHAO LJ, 1994, J BIOL CHEM, V269, P15577	41	28	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15474	15480		10.1074/jbc.M112.416735	http://dx.doi.org/10.1074/jbc.M112.416735			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23612978	Green Published, hybrid			2022-12-28	WOS:000319822300006
J	Behrends, V; Bell, TJ; Liebeke, M; Cordes-Blauert, A; Ashraf, SN; Nair, C; Zlosnik, JEA; Williams, HD; Bundy, JG				Behrends, Volker; Bell, Thomas J.; Liebeke, Manuel; Cordes-Blauert, Anne; Ashraf, Syedah N.; Nair, Chandrika; Zlosnik, James E. A.; Williams, Huw D.; Bundy, Jacob G.			Metabolite Profiling to Characterize Disease-related Bacteria GLUCONATE EXCRETION BY PSEUDOMONAS AERUGINOSA MUTANTS AND CLINICAL ISOLATES FROM CYSTIC FIBROSIS PATIENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL DRUG-RESISTANCE; CARBON CATABOLITE REPRESSION; CYSTIC-FIBROSIS ISOLATE; CRC GLOBAL REGULATOR; VIRULENCE DETERMINANTS; ESCHERICHIA-COLI; RPON GENE; PHENOTYPE; EXPRESSION; SPECTRA	Metabolic footprinting of supernatants has been proposed as a tool for assigning gene function. We used NMR spectroscopy to measure the exometabolome of 86 single-gene transposon insertion mutant strains (mutants from central carbon metabolism and regulatory mutants) of the opportunistic pathogen Pseudomonas aeruginosa, grown on a medium designed to represent the nutritional content of cystic fibrosis sputum. Functionally related genes had similar metabolic profiles. E.g. for two-component system mutants, the cognate response regulator and sensor kinase genes clustered tightly together. Some strains had metabolic phenotypes (metabotypes) that could be related to the known gene function. E.g. pyruvate dehydrogenase mutants accumulated large amounts of pyruvate in the medium. In other cases, the metabolic phenotypes were not easily interpretable. The rpoN mutant, which lacks the alternative sigma factor RpoN (sigma(54)), accumulated high levels of gluconate in the medium. In addition, endometabolome profiling of intracellular metabolites identified a number of systemic metabolic changes. We linked this to indirect regulation of the catabolite repression protein Crc via the non-coding RNA crcZ and found that a crcZ (but not crc) mutant also shared the high-gluconate phenotype. We profiled an additional set of relevant metabolic enzymes and transporters, including Crc targets, and showed that the Crc-regulated edd mutant (gluconate-6-phosphate dehydratase) had similar gluconate levels as the rpoN mutant. Finally, a set of clinical isolates showed patient- and random amplification of polymorphic DNA (RAPD) type-specific differences in gluconate production, which were associated significantly with resistance across four antibiotics (tobramycin, ciprofloxacin, aztreonam, and imipenem), indicating that this has potential clinical relevance.	[Behrends, Volker; Bell, Thomas J.; Liebeke, Manuel; Cordes-Blauert, Anne; Ashraf, Syedah N.; Bundy, Jacob G.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London SW7 2AZ, England; [Nair, Chandrika; Williams, Huw D.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Zlosnik, James E. A.] Univ British Columbia, Dept Pediat, Fac Med, Ctr Understanding & Preventing Infect Children, Vancouver, BC V5Z 4H4, Canada	Imperial College London; Imperial College London; University of British Columbia	Bundy, JG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London SW7 2AZ, England.	j.bundy@imperial.ac.uk	Bundy, Jacob G/C-2131-2008; Liebeke, Manuel/F-3559-2012	Bundy, Jacob G/0000-0002-1164-8465; Liebeke, Manuel/0000-0002-2339-1409; nair, chandrika/0000-0001-7237-1933; Williams, Huw/0000-0003-2225-6413; Zlosnik, James/0000-0002-9708-9034; Behrends, Volker/0000-0003-4855-5497	Wellcome Trust [093612/Z/41/Z]; Medical Research Council [G0801056B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (reference 093612/Z/41/Z).	Allen J, 2003, NAT BIOTECHNOL, V21, P692, DOI 10.1038/nbt823; Astle W, 2012, J AM STAT ASSOC, V107, P1259, DOI 10.1080/01621459.2012.695661; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Behrends V, 2013, ENVIRON MICROBIOL, V15, P398, DOI 10.1111/j.1462-2920.2012.02840.x; Behrends V, 2011, ANAL BIOCHEM, V415, P206, DOI 10.1016/j.ab.2011.04.009; Behrends V, 2010, MOL BIOSYST, V6, P562, DOI 10.1039/b918710c; Behrends V, 2009, APPL ENVIRON MICROB, V75, P2453, DOI 10.1128/AEM.01742-08; Beier D, 2006, CURR OPIN MICROBIOL, V9, P143, DOI 10.1016/j.mib.2006.01.005; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; Browne P, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-300; Bundy JG, 2007, GENOME RES, V17, P510, DOI 10.1101/gr.5662207; Burrowes E, 2006, MICROBIOL-SGM, V152, P405, DOI 10.1099/mic.0.28324-0; Cases I, 2003, ENVIRON MICROBIOL, V5, P1281, DOI 10.1111/j.1462-2920.2003.00528.x; Ciofu O, 2008, MICROBIOL-SGM, V154, P103, DOI 10.1099/mic.0.2007/010421-0; Davies JC, 2007, BMJ-BRIT MED J, V335, P1255, DOI 10.1136/bmj.39391.713229.AD; Derewacz DK, 2013, P NATL ACAD SCI USA, V110, P2336, DOI 10.1073/pnas.1218524110; Dotsch A, 2009, ANTIMICROB AGENTS CH, V53, P2522, DOI 10.1128/AAC.00035-09; Hagins JM, 2011, CAN J MICROBIOL, V57, P186, DOI 10.1139/W10-118; Hagins JM, 2010, MICROBIOL-SGM, V156, P1201, DOI 10.1099/mic.0.033381-0; Hagins JM, 2009, J BACTERIOL, V191, P6335, DOI 10.1128/JB.00692-09; Hao J, 2012, BIOINFORMATICS, V28, P2088, DOI 10.1093/bioinformatics/bts308; Hendrickson EL, 2001, J BACTERIOL, V183, P7126, DOI 10.1128/JB.183.24.7126-7134.2001; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hoiby N, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-32; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jude F, 2003, J BACTERIOL, V185, P3558, DOI 10.1128/JB.185.12.3558-3566.2003; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; KOHLER T, 1989, J BACTERIOL, V171, P4326; Lee HH, 2012, NAT CHEM BIOL, V8, P6, DOI 10.1038/nchembio.740; Li W, 2007, J BACTERIOL, V189, P5413, DOI 10.1128/JB.00432-07; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Liebeke M, 2013, ANAL CHEM, V85, P4605, DOI 10.1021/ac400237w; Lindsey TL, 2008, MICROBIOL-SGM, V154, P1616, DOI 10.1099/mic.0.2007/014506-0; LUEDTKE J, 2006, J PHYS CHEM LAB, V10, P23; Mahenthiralingam E, 1996, J CLIN MICROBIOL, V34, P1129, DOI 10.1128/JCM.34.5.1129-1135.1996; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Moreno R, 2007, MOL MICROBIOL, V64, P665, DOI 10.1111/j.1365-2958.2007.05685.x; Moreno R, 2009, PROTEOMICS, V9, P2910, DOI 10.1002/pmic.200800918; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Nishijyo T, 2001, MOL MICROBIOL, V40, P917, DOI 10.1046/j.1365-2958.2001.02435.x; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Pessi G, 2001, J BACTERIOL, V183, P6676, DOI 10.1128/JB.183.22.6676-6683.2001; Pommerenke C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001074; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; Rojo F, 2010, FEMS MICROBIOL REV, V34, P658, DOI 10.1111/j.1574-6976.2010.00218.x; Schafer KC, 2009, ANGEW CHEM INT EDIT, V48, P8240, DOI 10.1002/anie.200902546; Silo-Suh L, 2005, J BACTERIOL, V187, P7561, DOI 10.1128/JB.187.22.7561-7568.2005; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sonnleitner E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044637; Sonnleitner E, 2009, P NATL ACAD SCI USA, V106, P21866, DOI 10.1073/pnas.pnas.0910308106; Speert DP, 2002, AM J RESP CRIT CARE, V166, P988, DOI 10.1164/rccm.2203011; TOTTEN PA, 1990, J BACTERIOL, V172, P389, DOI 10.1128/JB.172.1.389-396.1990; Tredwell GD, 2011, ANAL CHEM, V83, P8683, DOI 10.1021/ac202123k; Ueda A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000483; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Veselkov KA, 2009, ANAL CHEM, V81, P56, DOI 10.1021/ac8011544; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Williams HD, 2007, ADV MICROB PHYSIOL, V52, P1, DOI 10.1016/S0065-2911(06)52001-6; Williams HD, 2012, THORAX, V67, P465, DOI 10.1136/thoraxjnl-2011-201498; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Zhang XX, 2008, GENETICS, V178, P185, DOI 10.1534/genetics.107.081984; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003	66	29	29	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15098	15109		10.1074/jbc.M112.442814	http://dx.doi.org/10.1074/jbc.M112.442814			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23572517	hybrid, Green Published			2022-12-28	WOS:000319452100039
J	Gal, J; Chen, J; Barnett, KR; Yang, LQ; Brumley, E; Zhu, HN				Gal, Jozsef; Chen, Jing; Barnett, Kelly R.; Yang, Liuqing; Brumley, Erin; Zhu, Haining			HDAC6 Regulates Mutant SOD1 Aggregation through Two SMIR Motifs and Tubulin Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ZINC SUPEROXIDE-DISMUTASE; HISTONE-DEACETYLASE; MOUSE MODEL; CATALYTIC DOMAINS; MICROTUBULES; BINDING; TDP-43; DEGENERATION; INHIBITOR	Histone deacetylase 6 (HDAC6) is a tubulin deacetylase that regulates protein aggregation and turnover. Mutations in Cu/Zn superoxide dismutase (SOD1) linked to familial amyotrophic lateral sclerosis (ALS) make the mutant protein prone to aggregation. However, the role of HDAC6 in mutant SOD1 aggregation and the ALS etiology is unclear. Here we report that HDAC6 knockdown increased mutant SOD1 aggregation in cultured cells. Different from its known role in mediating the degradation of poly-ubiquitinated proteins, HDAC6 selectively interacted with mutant SOD1 via two motifs similar to the SOD1 mutant interaction region (SMIR) that we identified previously in p62/sequestosome 1. Expression of the aggregation-prone mutant SOD1 increased alpha-tubulin acetylation, and the acetylation-mimicking K40Q alpha-tubulin mutant promoted mutant SOD1 aggregation. Our results suggest that ALS-linked mutant SOD1 can modulate HDAC6 activity and increase tubulin acetylation, which, in turn, facilitates the microtubule- and retrograde transport-dependent mutant SOD1 aggregation. HDAC6 impairment might be a common feature in various subtypes of ALS.	[Gal, Jozsef; Chen, Jing; Barnett, Kelly R.; Yang, Liuqing; Brumley, Erin; Zhu, Haining] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky	Zhu, HN (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	haining@uky.edu	Yang, Liuqing/AAU-6593-2021; Zhu, Haining/A-6076-2008	Yang, Liuqing/0000-0003-0231-6837; Zhu, Haining/0000-0001-5498-6694; Barnett, Kelly/0000-0001-9790-0352; Gal, Jozsef/0000-0002-5865-6534	National Institutes of Health [R01NS049126, R01NS077284, R21AG032567]; NCRR Grant [P20RR020171-09]; NIGMS Grant [P20GM103486-09]; High-End Instrumentation Grant [S10RR029127]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171, S10RR029127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049126, R01NS077284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR Grant; NIGMS Grant; High-End Instrumentation Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS049126, R01NS077284, and R21AG032567 (to H. Z.); NCRR Grant P20RR020171-09; and NIGMS Grant P20GM103486-09. This work was also supported by High-End Instrumentation Grant S10RR029127 (to H. Z.) and by the federally funded work-study (summer research) program in the College of Medicine (to E. B.).	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; d'Ydewalle C, 2011, NAT MED, V17, P968, DOI 10.1038/nm.2396; Ding HP, 2008, J NEUROCHEM, V106, P2119, DOI 10.1111/j.1471-4159.2008.05564.x; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Du GP, 2010, MOL BIOL CELL, V21, P2128, DOI 10.1091/mbc.E10-03-0200; Fiesel FC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-64; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Gal J, 2007, J BIOL CHEM, V282, P11068, DOI 10.1074/jbc.M608787200; Gal J, 2009, J NEUROCHEM, V111, P1062, DOI 10.1111/j.1471-4159.2009.06388.x; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Guthrie CR, 2011, J MOL NEUROSCI, V45, P32, DOI 10.1007/s12031-011-9502-x; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hart PJ, 2006, CURR OPIN CHEM BIOL, V10, P131, DOI 10.1016/j.cbpa.2006.02.034; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Into T, 2010, J BIOL CHEM, V285, P35759, DOI 10.1074/jbc.M110.126904; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kuo KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039641; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Perez M, 2009, J NEUROCHEM, V109, P1756, DOI 10.1111/j.1471-4159.2009.06102.x; Piao YS, 2003, BRAIN PATHOL, V13, P10; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Schuetz A, 2008, J BIOL CHEM, V283, P11355, DOI 10.1074/jbc.M707362200; Shibata N, 1996, DEV NEUROSCI-BASEL, V18, P492, DOI 10.1159/000111445; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; Strom AL, 2008, J BIOL CHEM, V283, P22795, DOI 10.1074/jbc.M800276200; Taes I, 2013, HUM MOL GENET, V22, P1783, DOI 10.1093/hmg/ddt028; Tapia M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012908; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Van Langenhove T, 2012, ANN MED, V44, P817, DOI 10.3109/07853890.2012.665471; Verdel A, 2000, CURR BIOL, V10, P747, DOI 10.1016/S0960-9822(00)00542-X; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; Zhai JJ, 2009, FEBS J, V276, P3308, DOI 10.1111/j.1742-4658.2009.07057.x; Zhang FJ, 2007, J BIOL CHEM, V282, P16691, DOI 10.1074/jbc.M609743200; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200; Zou H, 2006, BIOCHEM BIOPH RES CO, V341, P45, DOI 10.1016/j.bbrc.2005.12.144	48	52	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15035	15045		10.1074/jbc.M112.431957	http://dx.doi.org/10.1074/jbc.M112.431957			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23580651	Green Published, hybrid			2022-12-28	WOS:000319452100033
J	Tang, YQ; Liang, P; Zhou, JH; Lu, YX; Lei, L; Bian, XL; Wang, KW				Tang, Yi-Quan; Liang, Ping; Zhou, Jingheng; Lu, Yanxin; Lei, Lei; Bian, Xiling; Wang, KeWei			Auxiliary KChIP4a Suppresses A-type K+ Current through Endoplasmic Reticulum (ER) Retention and Promoting Closed-state Inactivation of Kv4 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPORAL-LOBE EPILEPSY; POTASSIUM CHANNELS; ALPHA-SUBUNITS; SURFACE EXPRESSION; PYRAMIDAL NEURONS; CARDIAC REPOLARIZATION; TERMINAL DOMAINS; STRUCTURAL BASIS; TRAFFICKING; PROTEIN	In the brain and heart, auxiliary Kv channel-interacting proteins (KChIPs) co-assemble with pore-forming Kv4 alpha-subunits to form a native K+ channel complex and regulate the expression and gating properties of Kv4 currents. Among the KChIP1-4 members, KChIP4a exhibits a unique N terminus that is known to suppress Kv4 function, but the underlying mechanism of Kv4 inhibition remains unknown. Using a combination of confocal imaging, surface biotinylation, and electrophysiological recordings, we identified a novel endoplasmic reticulum (ER) retention motif, consisting of six hydrophobic and aliphatic residues, 12-17 (LIVIVL), within the KChIP4a N-terminal KID, that functions to reduce surface expression of Kv4-KChIP complexes. This ER retention capacity is transferable and depends on its flanking location. In addition, adjacent to the ER retention motif, the residues 19-21 (VKL motif) directly promote closed-state inactivation of Kv4.3, thus leading to an inhibition of channel current. Taken together, our findings demonstrate that KChIP4a suppresses A-type Kv4 current via ER retention and enhancement of Kv4 closed-state inactivation.	[Tang, Yi-Quan; Liang, Ping; Zhou, Jingheng; Lu, Yanxin; Lei, Lei; Bian, Xiling; Wang, KeWei] Peking Univ, Dept Neurobiol, Neurosci Res Inst, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Wang, KeWei] Peking Univ, Dept Mol & Cellular Pharmacol, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, Beijing 100191, Peoples R China; [Wang, KeWei] Peking Univ, Peking Univ Int Data Grp McGovern Inst Brain Res, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Wang, KW (corresponding author), Peking Univ, Dept Neurobiol, Neurosci Res Inst, Hlth Sci Ctr, Beijing 100191, Peoples R China.	wangkw@bjmu.edu.cn	Zhou, Jingheng/AAM-7318-2020; Zhou, Jingheng/ABH-9830-2020	Zhou, Jingheng/0000-0003-0280-6166; Tang, Yiquan/0000-0002-6639-8897	Ministry of Science and Technology of China [2013CB531300]; National Science Foundation of China [81221002, 30970919]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grant 2013CB531300 and National Science Foundation of China Grants 81221002 and 30970919 (to K. W. W.).	Aktas O, 2007, ARCH NEUROL-CHICAGO, V64, P185, DOI 10.1001/archneur.64.2.185; Amarillo Y, 2008, J PHYSIOL-LONDON, V586, P2093, DOI 10.1113/jphysiol.2007.150540; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Angelotti T, 2010, TRAFFIC, V11, P560, DOI 10.1111/j.1600-0854.2010.01033.x; Bahring R, 2011, J PHYSIOL-LONDON, V589, P461, DOI 10.1113/jphysiol.2010.191965; Bahring R, 2001, J PHYSIOL-LONDON, V535, P65, DOI 10.1111/j.1469-7793.2001.00065.x; Baranauskas G, 2004, EUR J NEUROSCI, V20, P385, DOI 10.1111/j.1460-9568.2004.03494.x; Barry DM, 1998, CIRC RES, V83, P560, DOI 10.1161/01.RES.83.5.560; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; Choi JS, 2012, BRAIN RES, V1466, P15, DOI 10.1016/j.brainres.2012.05.028; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; Ciczora Y, 2010, J GEN VIROL, V91, P404, DOI 10.1099/vir.0.015339-0; Covarrubias M, 2008, NEUROCHEM RES, V33, P1558, DOI 10.1007/s11064-008-9650-8; Cui YY, 2008, NEUROCHEM RES, V33, P2078, DOI 10.1007/s11064-008-9688-7; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; Decher N, 2004, J PHYSIOL-LONDON, V557, P761, DOI 10.1113/jphysiol.2004.066720; Duarri A, 2012, ANN NEUROL, V72, P870, DOI 10.1002/ana.23700; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Foeger NC, 2012, J BIOL CHEM, V287, P9640, DOI 10.1074/jbc.M111.324574; Foeger NC, 2010, J BIOL CHEM, V285, P33413, DOI 10.1074/jbc.M110.145185; Frigerio L, 2001, PLANT CELL, V13, P1109, DOI 10.1105/tpc.13.5.1109; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; Giudicessi JR, 2012, HUM MUTAT, V33, P989, DOI 10.1002/humu.22058; Giudicessi JR, 2011, HEART RHYTHM, V8, P1024, DOI 10.1016/j.hrthm.2011.02.021; GRIFFITHS G, 1994, J CELL BIOL, V127, P1557, DOI 10.1083/jcb.127.6.1557; Guo WN, 2002, CIRC RES, V90, P586, DOI 10.1161/01.RES.0000012664.05949.E0; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Holmqvist MH, 2002, P NATL ACAD SCI USA, V99, P1035, DOI 10.1073/pnas.022509299; Hoppe UC, 2000, J CLIN INVEST, V105, P1077, DOI 10.1172/JCI8757; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jeong I, 2011, BRIT J PHARMACOL, V163, P510, DOI 10.1111/j.1476-5381.2011.01210.x; Jeong I, 2012, NEUROPHARMACOLOGY, V62, P2261, DOI 10.1016/j.neuropharm.2011.12.006; Jerng HH, 2008, J BIOL CHEM, V283, P36046, DOI 10.1074/jbc.M806852200; Jerng HH, 2005, J PHYSIOL-LONDON, V568, P767, DOI 10.1113/jphysiol.2005.087858; Jerng HH, 2004, BIOPHYS J, V87, P2380, DOI 10.1529/biophysj.104.042358; Jerng HH, 1997, BIOPHYS J, V72, P163, DOI 10.1016/S0006-3495(97)78655-7; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kerschensteiner D, 1999, BIOPHYS J, V77, P248, DOI 10.1016/S0006-3495(99)76886-4; Kim HJ, 2011, J PHARMACOL EXP THER, V339, P952, DOI 10.1124/jpet.111.184176; Kim HJ, 2011, AM J PHYSIOL-CELL PH, V300, pC567, DOI 10.1152/ajpcell.00031.2010; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Klemic KG, 1998, BIOPHYS J, V74, P1779, DOI 10.1016/S0006-3495(98)77888-9; Kramer JW, 1998, AM J PHYSIOL-CELL PH, V274, pC1501, DOI 10.1152/ajpcell.1998.274.6.C1501; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; Lee YC, 2012, ANN NEUROL, V72, P859, DOI 10.1002/ana.23701; Liang P, 2010, BIOPHYS J, V98, P2867, DOI 10.1016/j.bpj.2010.03.044; Liang P, 2009, J BIOL CHEM, V284, P4960, DOI 10.1074/jbc.M807704200; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Massone S, 2011, J CELL BIOL, V193, P851, DOI 10.1083/jcb.201011053; Matsukawa S, 2012, INT J DEV BIOL, V56, P351, DOI 10.1387/ijdb.123514sm; Meur G, 2007, J BIOL CHEM, V282, P23096, DOI 10.1074/jbc.M702457200; Nadal MS, 2003, NEURON, V37, P449, DOI 10.1016/S0896-6273(02)01185-6; Norris AJ, 2010, J NEUROSCI, V30, P13644, DOI 10.1523/JNEUROSCI.2487-10.2010; O'Callaghan DW, 2003, J CELL SCI, V116, P4833, DOI 10.1242/jcs.00803; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Olesen MS, 2013, CARDIOVASC RES, V98, P488, DOI 10.1093/cvr/cvt028; Panama BK, 2011, CIRC RES, V108, P537, DOI 10.1161/CIRCRESAHA.110.229112; Parker AKT, 2004, J BIOL CHEM, V279, P23797, DOI 10.1074/jbc.M402098200; Pioletti M, 2006, NAT STRUCT MOL BIOL, V13, P987, DOI 10.1038/nsmb1164; Pruunsild P, 2005, GENOMICS, V86, P581, DOI 10.1016/j.ygeno.2005.07.001; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Renigunta V, 2006, TRAFFIC, V7, P168, DOI 10.1111/j.1600-0854.2005.00375.x; Rhodes KJ, 2004, J NEUROSCI, V24, P7903, DOI 10.1523/JNEUROSCI.0776-04.2004; Salinas M, 1997, J BIOL CHEM, V272, P24371, DOI 10.1074/jbc.272.39.24371; Salinas M, 1997, J BIOL CHEM, V272, P8774, DOI 10.1074/jbc.272.13.8774; Scannevin RH, 2004, NEURON, V41, P587, DOI 10.1016/S0896-6273(04)00049-2; Schwenk J, 2008, J BIOL CHEM, V283, P18937, DOI 10.1074/jbc.M800976200; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Shruti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033429; Singh B, 2006, NEUROBIOL DIS, V24, P245, DOI 10.1016/j.nbd.2006.07.001; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Szczesna-Skorupa E, 2000, J BIOL CHEM, V275, P19409, DOI 10.1074/jbc.M002394200; Takimoto K, 2002, J BIOL CHEM, V277, P26904, DOI 10.1074/jbc.M203651200; Van Hoorick D, 2007, J PHYSIOL-LONDON, V583, P959, DOI 10.1113/jphysiol.2007.139550; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Wang JM, 2002, NAT NEUROSCI, V5, P963, DOI 10.1038/nn918; Wang KW, 2008, NEUROCHEM RES, V33, P1964, DOI 10.1007/s11064-008-9705-x; Zarei MM, 2004, P NATL ACAD SCI USA, V101, P10072, DOI 10.1073/pnas.0302919101; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang ZN, 2008, J CELL SCI, V121, P3243, DOI 10.1242/jcs.026856	91	14	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14727	14741		10.1074/jbc.M113.466052	http://dx.doi.org/10.1074/jbc.M113.466052			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23576435	Green Published, hybrid			2022-12-28	WOS:000319452100007
J	Taylor, NMI; Glatt, S; Hennrich, ML; von Scheven, G; Grotsch, H; Fernandez-Tornero, C; Rybin, V; Gavin, AC; Kolb, P; Mulller, CW				Taylor, Nicholas M. I.; Glatt, Sebastian; Hennrich, Marco L.; von Scheven, Gudrun; Groetsch, Helga; Fernandez-Tornero, Carlos; Rybin, Vladimir; Gavin, Anne-Claude; Kolb, Peter; Muelller, Christoph W.			Structural and Functional Characterization of a Phosphatase Domain within Yeast General Transcription Factor IIIC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-III; SACCHAROMYCES-CEREVISIAE; POL II; PROMOTER; BINDING; IDENTIFICATION; RECRUITMENT; COMPLEXES; CHROMATIN; SUBUNIT	Saccharomyces cerevisiae tau 55, a subunit of the RNA polymerase III-specific general transcription factor TFIIIC, comprises an N-terminal histidine phosphatase domain (tau 55-HPD) whose catalytic activity and cellular function is poorly understood. We solved the crystal structures of tau 55-HPD and its closely related paralogue Huf and used in silico docking methods to identify phosphoserine- and phosphotyrosine-containing peptides as possible substrates that were subsequently validated using in vitro phosphatase assays. A comparative phosphoproteomic study identified additional phosphopeptides as possible targets that show the involvement of these two phosphatases in the regulation of a variety of cellular functions. Our results identify tau 55-HPD and Huf as bona fide protein phosphatases, characterize their substrate specificities, and provide a small set of regulated phosphosite targets in vivo.	[Taylor, Nicholas M. I.; Glatt, Sebastian; Hennrich, Marco L.; von Scheven, Gudrun; Groetsch, Helga; Rybin, Vladimir; Gavin, Anne-Claude; Muelller, Christoph W.] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Fernandez-Tornero, Carlos] Ctr Invest Biol, Madrid 28040, Spain; [Kolb, Peter] Univ Marburg, Dept Pharmaceut Chem, D-35032 Marburg, Germany	European Molecular Biology Laboratory (EMBL); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Philipps University Marburg	Mulller, CW (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	cmueller@embl.de	Fernandez-Tornero, Carlos/I-6888-2015; Taylor, Nicholas/O-6477-2016; Kolb, Peter/A-3782-2008; Glatt, Sebastian/AAS-1230-2020; Fernandez-Tornero, Carlos/AAV-8028-2021; Müller, Christoph W/I-7420-2012	Fernandez-Tornero, Carlos/0000-0001-5097-731X; Taylor, Nicholas/0000-0003-0761-4921; Kolb, Peter/0000-0003-4089-614X; Glatt, Sebastian/0000-0003-2815-7133; Fernandez-Tornero, Carlos/0000-0001-5097-731X; Müller, Christoph W/0000-0003-2176-8337; Gavin, Anne-Claude/0000-0003-4917-2340; Hennrich, Marco/0000-0003-2853-9748; Grotsch, Helga/0000-0003-1948-3922	EMBL Proteomics Core Facility; EMBL Heidelberg Crystallization Platform; EMBL/ESRF Joint Structural Biology Group	EMBL Proteomics Core Facility; EMBL Heidelberg Crystallization Platform; EMBL/ESRF Joint Structural Biology Group	We acknowledge support from the EMBL Proteomics Core Facility, the EMBL Heidelberg Crystallization Platform, and the EMBL/ESRF Joint Structural Biology Group for access and support at the ESRF beamlines. We also thank Melina Haupt and Ulrich Steuerwald for contributions during the initial phase of the project, Victoria McParland and Maja Kohn for help with the phosphatase assay, Galih Augustinus for help with the mass spectrometry analysis, Joel Acker for the gift of tau 55 virus, Nicolas Nassar for recombinant mouse Sts-1 protein, Christine Conesa and Olivier Lefebvre for the YNM2 strain and tau 55 plasmids, and Florence Baudin for comments on the manuscript.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Barski A, 2010, NAT STRUCT MOL BIOL, V17, P629, DOI 10.1038/nsmb.1806; BAZAN JF, 1989, P NATL ACAD SCI USA, V86, P9642, DOI 10.1073/pnas.86.24.9642; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Capozzo C, 2000, YEAST, V16, P1089, DOI 10.1002/1097-0061(20000915)16:12<1089::AID-YEA600>3.3.CO;2-7; Chen YT, 2009, BIOCHEMISTRY-US, V48, P1681, DOI 10.1021/bi802219n; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Conesa C, 2005, MOL CELL BIOL, V25, P8631, DOI 10.1128/MCB.25.19.8631-8642.2005; Donze D, 2012, GENE, V493, P169, DOI 10.1016/j.gene.2011.09.018; Ducrot C, 2006, J BIOL CHEM, V281, P11685, DOI 10.1074/jbc.M600101200; Dumay-Odelot H, 2007, J BIOL CHEM, V282, P17179, DOI 10.1074/jbc.M611542200; Flores A, 1999, P NATL ACAD SCI USA, V96, P7815, DOI 10.1073/pnas.96.14.7815; FOTHERGILL LA, 1982, PROC R SOC SER B-BIO, V215, P19, DOI 10.1098/rspb.1982.0026; Fothergill-Gilmore L. A., 1989, ADV ENZYMOLOGY RELAT, V62, P227; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Hennrich ML, 2011, ANAL CHEM, V83, P7137, DOI 10.1021/ac2015068; Herve M, 2000, EUR J BIOCHEM, V267, P3337, DOI 10.1046/j.1432-1327.2000.01365.x; Hou L, 2011, ACTA BIOCH BIOPH SIN, V43, P977, DOI 10.1093/abbs/gmr095; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; Kleinschmidt RA, 2011, P NATL ACAD SCI USA, V108, P8385, DOI 10.1073/pnas.1019175108; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Mak Lok Hang, 2010, J Chem Biol, V3, P157, DOI 10.1007/s12154-010-0041-7; Manaud N, 1998, MOL CELL BIOL, V18, P3191, DOI 10.1128/MCB.18.6.3191; Mayer A, 2012, SCIENCE, V336, P1723, DOI 10.1126/science.1219651; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Mikhailik A, 2007, MOL CELL, V27, P486, DOI 10.1016/j.molcel.2007.06.015; Moqtaderi Z, 2010, NAT STRUCT MOL BIOL, V17, P635, DOI 10.1038/nsmb.1794; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; San Luis B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.177634; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; SHOICHET BK, 1993, PROTEIN ENG, V6, P723, DOI 10.1093/protein/6.7.723; Shoichet BK, 1999, PROTEINS, V34, P4, DOI 10.1002/(SICI)1097-0134(19990101)34:1<4::AID-PROT2>3.0.CO;2-6; Smith TL, 2007, MOL CELL, V26, P491, DOI 10.1016/j.molcel.2007.03.025; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; STILLMAN DJ, 1984, EMBO J, V3, P847, DOI 10.1002/j.1460-2075.1984.tb01895.x; Zhou H., 2011, MOL CELL PROTEOMICS	42	7	7	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15110	15120		10.1074/jbc.M112.427856	http://dx.doi.org/10.1074/jbc.M112.427856			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23569204	Green Published, hybrid			2022-12-28	WOS:000319452100040
J	Chen, KY; Williams, KJ				Chen, Keyang; Williams, Kevin Jon			Molecular Mediators for Raft-dependent Endocytosis of Syndecan-1, a Highly Conserved, Multifunctional Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; CLATHRIN-INDEPENDENT ENDOCYTOSIS; IMMUNODEFICIENCY-VIRUS TYPE-1; SELECTIVE INSULIN-RESISTANCE; KINASE SIGNALING PATHWAY; REMNANT LIPOPROTEINS; CYTOPLASMIC DOMAINS; MEMBRANE; PROTEIN; CAVEOLAE	Endocytosis via rafts has attracted considerable recent interest, but the molecular mediators remain incompletely characterized. Here, we focused on the syndecan-1 heparan sulfate proteoglycan, a highly conserved, multifunctional receptor that we previously showed to undergo raft-dependent endocytosis upon clustering. Alanine scanning mutagenesis of three to five consecutive cytoplasmic residues at a time revealed that a conserved juxtamembrane motif, MKKK, was the only region required for efficient endocytosis after clustering. Endocytosis of clustered syndecan-1 occurs in two phases, each requiring a kinase and a corresponding cytoskeletal partner. In the initial phase, ligands trigger rapid MKKK-dependent activation of ERK and the localization of syndecan-1 into rafts. Activation of ERK drives the dissociation of syndecan-1 from alpha-tubulin, a molecule that may act as an anchor for syndecan-1 at the plasma membrane in the basal state. In the second phase, Src family kinases phosphorylate tyrosyl residues within the transmembrane and cytoplasmic regions of syndecan-1, a process that also requires MKKK. Tyrosine phosphorylation of syndecan-1 triggers the robust recruitment of cortactin, which we found to be an essential mediator of efficient actin-dependent endocytosis. These findings represent the first detailed characterization of the molecular events that drive endocytosis of a raft-dependent receptor and identify a novel endocytic motif, MKKK. Moreover, the results provide new tools to study syndecan function and regulation during uptake of its biologically and medically important ligands, such as HIV-1, atherogenic postprandial remnant lipoproteins, and molecules implicated in Alzheimer disease.	[Chen, Keyang; Williams, Kevin Jon] Temple Univ, Sch Med, Dept Med, Div Endocrinol, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Williams, KJ (corresponding author), Temple Univ, Sch Med, Sect Endocrinol Diabet & Metab, 3322 North Broad St,Med Off Bldg,Rm 205, Philadelphia, PA 19140 USA.	kjwilliams@temple.edu		Williams, Kevin Jon/0000-0002-0000-2159	National Institutes of Health [HL73898, HL94277]; Temple University School of Medicine; Ruth and Yonatan Ben-Avraham Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073898, R01HL094277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Temple University School of Medicine; Ruth and Yonatan Ben-Avraham Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL73898 and HL94277. This work was also supported by generous recruitment funds from the Temple University School of Medicine and the Ruth and Yonatan Ben-Avraham Fund.	Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Benmerah A, 2007, TRAFFIC, V8, P970, DOI 10.1111/j.1600-0854.2007.00585.x; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Boyanovsky BB, 2009, J LIPID RES, V50, P641, DOI 10.1194/jlr.M800450-JLR200; Chakravarti R, 2005, MOL BIOL CELL, V16, P3678, DOI 10.1091/mbc.E04-10-0907; Chen K, 2011, CIRCULATION, V124; Chen KY, 2010, HEPATOLOGY, V52, P1957, DOI 10.1002/hep.23916; Chen K, 2008, CIRCULATION, V118, pS453; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; de Parseval A, 2005, J BIOL CHEM, V280, P39493, DOI 10.1074/jbc.M504233200; Fuki IV, 2000, BIOCHEM J, V351, P607, DOI 10.1042/0264-6021:3510607; Fuki IV, 1997, J CLIN INVEST, V100, P1611, DOI 10.1172/JCI119685; Furler RL, 2010, IMMUNOL RES, V48, P99, DOI 10.1007/s12026-010-8170-1; Giannoni E, 2010, FREE RADICAL BIO MED, V49, P516, DOI 10.1016/j.freeradbiomed.2010.04.025; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P44084, DOI 10.1074/jbc.M402131200; Granes F, 2003, FEBS LETT, V547, P212, DOI 10.1016/S0014-5793(03)00712-9; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Hassing HC, 2012, HEPATOLOGY, V55, P1746, DOI 10.1002/hep.25580; HAYASHI K, 1987, J HISTOCHEM CYTOCHEM, V35, P1079, DOI 10.1177/35.10.2957423; Holowka D, 2005, BBA-MOL CELL RES, V1746, P252, DOI 10.1016/j.bbamcr.2005.06.007; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Kinnunen T, 1998, J BIOL CHEM, V273, P10702, DOI 10.1074/jbc.273.17.10702; Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002; Li XB, 2006, J CELL BIOCHEM, V99, P936, DOI 10.1002/jcb.20881; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Liberali P, 2008, ANNU REV CELL DEV BI, V24, P501, DOI 10.1146/annurev.cellbio.041008.145637; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; Michaely P, 2007, EMBO J, V26, P3273, DOI 10.1038/sj.emboj.7601769; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Rauch BH, 2005, J BIOL CHEM, V280, P17507, DOI 10.1074/jbc.M410848200; Rawat SS, 2006, GLYCOCONJUGATE J, V23, P189, DOI 10.1007/s10719-006-7924-4; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; ROSKAMS T, 1995, HEPATOLOGY, V21, P950, DOI 10.1016/0270-9139(95)90239-2; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Saphire ACS, 2001, J VIROL, V75, P9187, DOI 10.1128/JVI.75.19.9187-9200.2001; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; SPRING J, 1994, P NATL ACAD SCI USA, V91, P3334, DOI 10.1073/pnas.91.8.3334; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Stang E, 1997, MOL BIOL CELL, V8, P47, DOI 10.1091/mbc.8.1.47; Williams K J, 2001, Methods Mol Biol, V171, P457; Williams KJ, 2008, J CLIN INVEST, V118, P3247, DOI 10.1172/JCI35206; Williams KJ, 2010, CURR OPIN LIPIDOL, V21, P218, DOI 10.1097/MOL.0b013e328338cabc; Williams KJ, 2005, DIABETES, V54, P1116, DOI 10.2337/diabetes.54.4.1116; Williams KJ, 1997, CURR OPIN LIPIDOL, V8, P253; Wittrup A, 2010, P NATL ACAD SCI USA, V107, P13342, DOI 10.1073/pnas.1002622107; Wittrup A, 2009, J BIOL CHEM, V284, P32959, DOI 10.1074/jbc.M109.036129; Wu XD, 2012, CURR OPIN LIPIDOL, V23, P334, DOI 10.1097/MOL.0b013e3283544424; Wu XD, 2012, ARTERIOSCL THROM VAS, V32, P1236, DOI 10.1161/ATVBAHA.111.244525; Yang XY, 1999, J VIROL, V73, P3460, DOI 10.1128/JVI.73.4.3460-3466.1999; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011; Zimmermann P, 1999, FASEB J, V13, pS91	58	60	61	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					13988	13999		10.1074/jbc.M112.444737	http://dx.doi.org/10.1074/jbc.M112.444737			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23525115	Green Published, hybrid			2022-12-28	WOS:000319253500006
J	Johnson, ES; Lindblom, KR; Robeson, A; Stevens, RD; Ilkayeva, OR; Newgard, CB; Kornbluth, S; Andersen, JL				Johnson, Erika Segear; Lindblom, Kelly R.; Robeson, Alexander; Stevens, Robert D.; Ilkayeva, Olga R.; Newgard, Christopher B.; Kornbluth, Sally; Andersen, Joshua L.			Metabolomic Profiling Reveals a Role for Caspase-2 in Lipoapoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; SKELETAL-MUSCLE CELLS; SATURATED FATTY-ACIDS; NONALCOHOLIC STEATOHEPATITIS; INDUCED APOPTOSIS; AMINO-ACIDS; HEPATOCYTE LIPOAPOPTOSIS; CLINICAL-IMPLICATIONS; XENOPUS-LAEVIS; CYTOCHROME-C	The accumulation of long-chain fatty acids (LCFAs) in non-adipose tissues results in lipid-induced cytotoxicity (or lipoapoptosis). Lipoapoptosis has been proposed to play an important role in the pathogenesis of several metabolic diseases, including non-alcoholic fatty liver disease, diabetes mellitus, and cardiovascular disease. In this report, we demonstrate a novel role for caspase-2 as an initiator of lipoapoptosis. Using a metabolomics approach, we discovered that the activation of caspase-2, the initiator of apoptosis in Xenopus egg extracts, is associated with an accumulation of LCFA metabolites. Metabolic treatments that blocked the buildup of LCFAs potently inhibited caspase-2 activation, whereas adding back an LCFA in this scenario restored caspase activation. Extending these findings to mammalian cells, we show that caspase-2 was engaged and activated in response to treatment with the saturated LCFA palmitate. Down-regulation of caspase-2 significantly impaired cell death induced by saturated LCFAs, suggesting that caspase-2 plays a pivotal role in lipid-induced cytotoxicity. Together, these findings reveal a previously unknown role for caspase-2 as an initiator caspase in lipoapoptosis and suggest that caspase-2 may be an attractive therapeutic target for inhibiting pathological lipid-induced apoptosis.	[Johnson, Erika Segear; Lindblom, Kelly R.; Robeson, Alexander; Newgard, Christopher B.; Kornbluth, Sally] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Stevens, Robert D.; Andersen, Joshua L.] Duke Univ, Dept Med, Durham, NC 27710 USA; [Ilkayeva, Olga R.; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA	Duke University; Duke University; Duke University	Kornbluth, S (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, POB 3813,C370 LSRC Res Dr, Durham, NC 27710 USA.	kornb001@mc.duke.edu; jandersen@chem.byu.edu			National Institutes of Health [GM080333, 5F31CA165545-02]; Ruth L. Kirschstein National Research Service Award; NATIONAL CANCER INSTITUTE [F31CA165545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184, R01GM080333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM080333 (to S. K.) and 5F31CA165545-02, a Ruth L. Kirschstein National Research Service Award (to E. S. J).	An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Andersen JL, 2011, MOL CELL, V43, P834, DOI 10.1016/j.molcel.2011.07.028; Arici M, 2003, J AM SOC NEPHROL, V14, P17, DOI 10.1097/01.ASN.0000042167.66685.EA; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Canbay A, 2002, GASTROENTEROLOGY, V123, P1323, DOI 10.1053/gast.2002.35953; Cazanave SC, 2010, CLIN LIPIDOL, V5, P71, DOI 10.2217/CLP.09.85; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; deVries JE, 1997, J LIPID RES, V38, P1384; DWORKIN MB, 1991, TRENDS BIOCHEM SCI, V16, P229, DOI 10.1016/0968-0004(91)90091-9; DWORKIN MB, 1990, DEV BIOL, V138, P177, DOI 10.1016/0012-1606(90)90187-N; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; FOLBERGR.J, 1974, BRAIN RES, V80, P265, DOI 10.1016/0006-8993(74)90690-8; Frayn KN, 2002, DIABETOLOGIA, V45, P1201, DOI 10.1007/s00125-002-0873-y; Furstova V, 2008, LIFE SCI, V82, P684, DOI 10.1016/j.lfs.2007.12.023; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; GOLDBERG ND, 1966, J BIOL CHEM, V241, P3997; Hardy S, 2003, J BIOL CHEM, V278, P31861, DOI 10.1074/jbc.M300190200; Ho LH, 2008, ONCOGENE, V27, P3393, DOI 10.1038/sj.onc.1211005; HOCHACHKA PW, 1975, COMP BIOCHEM PHYSIOL, V50, P17, DOI 10.1016/0305-0491(75)90292-8; Hu W, 2011, J BIOL CHEM, V286, P16596, DOI 10.1074/jbc.M110.186916; Ibrahim SH, 2011, J PEDIATR GASTR NUTR, V53, P109, DOI 10.1097/MPG.0b013e31820e82a1; Imre G, 2012, EMBO J, V31, P2615, DOI 10.1038/emboj.2012.93; Kim JE, 2008, BONE, V43, P394, DOI 10.1016/j.bone.2008.03.021; Kluck RM, 1997, EMBO J, V16, P4639, DOI 10.1093/emboj/16.15.4639; Kotarsky H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041156; Kusminski CM, 2009, APOPTOSIS, V14, P1484, DOI 10.1007/s10495-009-0352-8; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Listenberger LL, 2002, TRENDS CARDIOVAS MED, V12, P134, DOI 10.1016/S1050-1738(02)00152-4; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Mei S, 2011, J PHARMACOL EXP THER, V339, P487, DOI 10.1124/jpet.111.184341; Miller TA, 2005, BIOCHEM BIOPH RES CO, V336, P309, DOI 10.1016/j.bbrc.2005.08.088; Mutomba MC, 2000, FEBS LETT, V478, P19, DOI 10.1016/S0014-5793(00)01817-2; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Ratziu V, 2012, HEPATOLOGY, V55, P419, DOI 10.1002/hep.24747; Sadagopan N, 2007, AM J HYPERTENS, V20, P1209, DOI 10.1016/j.amjhyper.2007.05.010; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; SHIOKAWA K, 1986, ZOOL SCI, V3, P793; SMYTHE C, 1991, METHOD CELL BIOL, V35, P449; Staiger K, 2006, DIABETES, V55, P3121, DOI 10.2337/db06-0188; TAEGTMEYER H, 1978, CIRC RES, V43, P808, DOI 10.1161/01.RES.43.5.808; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Vastag Livia, 2011, PLoS One, V6, pe16881, DOI 10.1371/journal.pone.0016881; Wieckowska A, 2005, CURR OPIN PEDIATR, V17, P636, DOI 10.1097/01.mop.0000172816.79637.c5; WIESNER RJ, 1989, J MOL CELL CARDIOL, V21, P49, DOI 10.1016/0022-2828(89)91492-2; Witek RP, 2009, HEPATOLOGY, V50, P1421, DOI 10.1002/hep.23167; Yuzefovych L, 2010, AM J PHYSIOL-ENDOC M, V299, pE1096, DOI 10.1152/ajpendo.00238.2010	57	30	30	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14463	14475		10.1074/jbc.M112.437210	http://dx.doi.org/10.1074/jbc.M112.437210			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23553630	Green Published, hybrid			2022-12-28	WOS:000319253500049
J	Kasiviswanathan, R; Minko, IG; Lloyd, RS; Copeland, WC				Kasiviswanathan, Rajesh; Minko, Irina G.; Lloyd, R. Stephen; Copeland, William C.			Translesion Synthesis Past Acrolein-derived DNA Adducts by Human Mitochondrial DNA Polymerase gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE CROSS-LINKS; NUCLEOTIDE INCORPORATION; 1,N(2)-PROPANODEOXYGUANOSINE ADDUCTS; 1,N-2-PROPANODEOXYGUANOSINE ADDUCTS; 1,N-2-DEOXYGUANOSINE ADDUCTS; DEOXYGUANOSINE ADDUCT; REPLICATION BYPASS; SEQUENTIAL ACTION; ESCHERICHIA-COLI; OXIDATIVE STRESS	Acrolein, a mutagenic aldehyde, is produced endogenously by lipid peroxidation and exogenously by combustion of organic materials, including tobacco products. Acrolein reacts with DNA bases forming exocyclic DNA adducts, such as gamma-hydroxy-1,N-2-propano-2'-deoxyguanosine (gamma-HOPdG) and gamma-hydroxy-1,N-6-propano-2'-deoxyadenosine (gamma-HOPdA). The bulky gamma-HOPdG adduct blocks DNA synthesis by replicative polymerases but can be bypassed by translesion synthesis polymerases in the nucleus. Although acrolein-induced adducts are likely to be formed and persist in mitochondrial DNA, animal cell mitochondria lack specialized translesion DNA synthesis polymerases to tolerate these lesions. Thus, it is important to understand how pol gamma, the sole mitochondrial DNA polymerase in human cells, acts on acrolein-adducted DNA. To address this question, we investigated the ability of pol gamma to bypass the minor groove gamma-HOPdG and major groove gamma-HOPdA adducts using single nucleotide incorporation and primer extension analyses. The efficiency of pol gamma-catalyzed bypass of gamma-HOPdG was low, and surprisingly, pol gamma preferred to incorporate purine nucleotides opposite the adduct. Pol gamma also exhibited similar to 2-fold lower rates of excision of the misincorporated purine nucleotides opposite gamma-HOPdG compared with the corresponding nucleotides opposite dG. Extension of primers from the termini opposite gamma-HOPdG was accomplished only following error-prone purine nucleotide incorporation. However, pol gamma preferentially incorporated dT opposite the gamma-HOPdA adduct and efficiently extended primers from the correctly paired terminus, indicating that gamma-HOPdA is probably non-mutagenic. In summary, our data suggest that acrolein-induced exocyclic DNA lesions can be bypassed by mitochondrial DNA polymerase but, in the case of the minor groove gamma-HOPdG adduct, at the cost of unprecedented high mutation rates.	[Kasiviswanathan, Rajesh; Copeland, William C.] NIEHS, Mitochondrial DNA Replicat Grp, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; [Minko, Irina G.; Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97239 USA; [Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Oregon Health & Science University; Oregon Health & Science University	Copeland, WC (corresponding author), NIEHS, Mol Genet Lab, NIH, 111 TW Alexander Dr,Bldg 101,Rm E316, Res Triangle Pk, NC 27709 USA.	copelan1@niehs.nih.gov	Copeland, William/C-4242-2019	Copeland, William/0000-0002-0359-0953; Lloyd, R. Stephen/0000-0001-7273-372X	National Institutes of Health Intramural Research Program; NIEHS [ES065078, ES065080, ES05355]; NCI [CA106858]; National Institute of Mental Health [R03 MH 094179]; NATIONAL CANCER INSTITUTE [R01CA106858, P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065080, ZIAES065078, P01ES005355, Z01ES065078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH094179] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program, Grants ES065078 and ES065080 from NIEHS (to W. C. C.), Grant ES05355 from NIEHS (to R. S. L.), NCI Grant CA106858 (to R. S. L.), and National Institute of Mental Health Grant R03 MH 094179 (to R. S. L.).	Arumugam N, 1999, ARCH ENVIRON CON TOX, V36, P373, DOI 10.1007/PL00006608; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; CHI NW, 1994, J BIOL CHEM, V269, P29984; CHIT NW, 1994, J BIOL CHEM, V269, P29993; Chung FL, 1999, MUTAT RES-FUND MOL M, V424, P71, DOI 10.1016/S0027-5107(99)00009-3; Chung FL, 1999, IARC SCI PUBL, P45; CHUNG FL, 1984, CANCER RES, V44, P990; Cline SD, 2012, BBA-GENE REGUL MECH, V1819, P979, DOI 10.1016/j.bbagrm.2012.06.002; de los Santos C, 2001, J BIOL CHEM, V276, P9077, DOI 10.1074/jbc.M009028200; GALLIANI G, 1983, TETRAHEDRON LETT, V24, P4491, DOI 10.1016/S0040-4039(00)85935-3; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; Graziewicz MA, 2004, NUCLEIC ACIDS RES, V32, P397, DOI 10.1093/nar/gkh213; Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227; Hanes JW, 2006, J BIOL CHEM, V281, P36241, DOI 10.1074/jbc.M607965200; Johnson AA, 2001, J BIOL CHEM, V276, P38090; Kalifa L, 2007, DNA REPAIR, V6, P1732, DOI 10.1016/j.dnarep.2007.06.005; Kanuri M, 2002, J BIOL CHEM, V277, P18257, DOI 10.1074/jbc.M112419200; Kasiviswanathan R, 2012, J BIOL CHEM, V287, P9222, DOI 10.1074/jbc.M111.306852; Kasiviswanathan R, 2010, METHODS, V51, P379, DOI 10.1016/j.ymeth.2010.02.015; Kim HYH, 2002, J AM CHEM SOC, V124, P9324, DOI 10.1021/ja020333r; Kozekov ID, 2003, J AM CHEM SOC, V125, P50, DOI 10.1021/ja020778f; Kurtz AJ, 2003, J BIOL CHEM, V278, P5970, DOI 10.1074/jbc.M212012200; Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4; Lim SE, 1999, J BIOL CHEM, V274, P38197, DOI 10.1074/jbc.274.53.38197; Longley MJ, 1998, BIOCHEMISTRY-US, V37, P10529, DOI 10.1021/bi980772w; Luo J, 2005, NEUROCHEM INT, V46, P243, DOI 10.1016/j.neuint.2004.09.001; McCulloch SD, 2009, NUCLEIC ACIDS RES, V37, P2830, DOI 10.1093/nar/gkp103; McCulloch SD, 2004, NATURE, V428, P97, DOI 10.1038/nature02352; Minko IG, 2003, J BIOL CHEM, V278, P784, DOI 10.1074/jbc.M207774200; Minko IG, 2008, CHEM RES TOXICOL, V21, P1983, DOI 10.1021/tx800174a; Minko IG, 2008, MUTAT RES-FUND MOL M, V637, P161, DOI 10.1016/j.mrfmmm.2007.08.001; Minko IG, 2009, CHEM RES TOXICOL, V22, P759, DOI 10.1021/tx9000489; NATH RG, 1994, P NATL ACAD SCI USA, V91, P7491, DOI 10.1073/pnas.91.16.7491; Nath RG, 1996, CANCER RES, V56, P452; Nechev LV, 2000, CHEM RES TOXICOL, V13, P421, DOI 10.1021/tx990167+; Pan J, 2002, CHEM RES TOXICOL, V15, P367, DOI 10.1021/tx010136q; Penn A, 2001, ENVIRON HEALTH PERSP, V109, P219, DOI 10.2307/3434688; PINZ KG, 1995, J BIOL CHEM, V270, P9202, DOI 10.1074/jbc.270.16.9202; SODUM RS, 1988, BIOORG CHEM, V16, P272, DOI 10.1016/0045-2068(88)90015-6; Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102; Stevens JF, 2008, MOL NUTR FOOD RES, V52, P7, DOI 10.1002/mnfr.200700412; Stone JE, 2011, DNA REPAIR, V10, P826, DOI 10.1016/j.dnarep.2011.04.032; Sun LJ, 2006, MITOCHONDRION, V6, P136, DOI 10.1016/j.mito.2006.04.003; Takata K, 2010, NUCLEIC ACIDS RES, V38, P3233, DOI 10.1093/nar/gkq048; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Vaisman A, 2000, J BIOL CHEM, V275, P13017, DOI 10.1074/jbc.275.17.13017; VanderVeen LA, 2001, J BIOL CHEM, V276, P9066, DOI 10.1074/jbc.M008900200; Washington MT, 2004, MOL CELL BIOL, V24, P6900, DOI 10.1128/MCB.24.16.6900-6906.2004; Washington MT, 2004, MOL CELL BIOL, V24, P5687, DOI 10.1128/MCB.24.13.5687-5693.2004; Wolfle WT, 2005, MOL CELL BIOL, V25, P8748, DOI 10.1128/MCB.25.19.8748-8754.2005; Wu JY, 2011, MOL NUTR FOOD RES, V55, P1401, DOI 10.1002/mnfr.201100255; Yamanaka K, 2011, J BACTERIOL, V193, P3815, DOI 10.1128/JB.01550-10; Yamanaka K, 2010, CHEM RES TOXICOL, V23, P689, DOI 10.1021/tx900449u; Yang IY, 2001, J BIOL CHEM, V276, P9071, DOI 10.1074/jbc.M008918200; Zang H, 2005, J BIOL CHEM, V280, P1165, DOI 10.1074/jbc.M405996200; Zhang HS, 2006, GENETICS, V172, P2683, DOI 10.1534/genetics.105.051029	59	18	19	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14247	14255		10.1074/jbc.M113.458802	http://dx.doi.org/10.1074/jbc.M113.458802			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23543747	Green Published, hybrid			2022-12-28	WOS:000319253500029
J	Vargas-Rodriguez, O; Musier-Forsyth, K				Vargas-Rodriguez, Oscar; Musier-Forsyth, Karin			Exclusive Use of trans-Editing Domains Prevents Proline Mistranslation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; TRANSLATIONAL QUALITY-CONTROL; MISCHARGED TRANSFER-RNA; AMINO-ACID; YBAK PROTEIN; ANGSTROM RESOLUTION; PHYLOGENETIC TREES; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ACTIVE-SITE	Aminoacyl-tRNA synthetases (ARSs) catalyze the attachment of specific amino acids to cognate tRNAs. Although the accuracy of this process is critical for overall translational fidelity, similar sizes of many amino acids provide a challenge to ARSs. For example, prolyl-tRNA synthetases (ProRSs) mischarge alanine and cysteine onto tRNA(Pro). Many bacterial ProRSs possess an alanine-specific proofreading domain (INS) but lack the capability to edit Cys-tRNA(Pro). Instead, Cys-tRNA(Pro) is cleared by a single-domain homolog of INS, the trans-editing YbaK protein. A global bioinformatics analysis revealed that there are six types of "INS-like" proteins. In addition to INS and YbaK, four additional single-domain homologs are widely distributed throughout bacteria: ProXp-ala (formerly named PrdX), ProXp-x (annotated as ProX), ProXp-y (annotated as YeaK), and ProXp-z (annotated as PA2301). The last three are domains of unknown function. Whereas many bacteria encode a ProRS containing an INS domain in addition to YbaK, many other combinations of INS-like proteins exist throughout the bacterial kingdom. Here, we focus on Caulobacter crescentus, which encodes a ProRS with a truncated INS domain that lacks catalytic activity, as well as YbaK and ProXp-ala. We show that C. crescentus ProRS can readily form Cys- and Ala-tRNA(Pro), and deacylation studies confirmed that these species are cleared by C. crescentus YbaK and ProXp-ala, respectively. Substrate specificity of C. crescentus ProXp-ala is determined, in part, by elements in the acceptor stem of tRNA(Pro) and further ensured through collaboration with elongation factor Tu. These results highlight the diversity of approaches used to prevent proline mistranslation and reveal a novel triple-sieve mechanism of editing that relies exclusively on trans-editing factors.	[Musier-Forsyth, Karin] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Musier-Forsyth, K (corresponding author), Ohio State Univ, Dept Chem & Biochem, 100 West 18th Ave, Columbus, OH 43210 USA.	musier@chemistry.ohio-state.edu		Vargas-Rodriguez, Oscar/0000-0002-2301-2800	National Institutes of Health Grant [GM049928]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049928, R55GM049928, R29GM049928] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM049928 (to K.M.-F.).	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; Ahel I, 2002, J BIOL CHEM, V277, P34743, DOI 10.1074/jbc.M206928200; An SG, 2004, J BIOL CHEM, V279, P42359, DOI 10.1074/jbc.C400304200; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beebe K, 2008, NATURE, V451, P90, DOI 10.1038/nature06454; Beuning PJ, 2000, P NATL ACAD SCI USA, V97, P8916, DOI 10.1073/pnas.97.16.8916; Beuning PJ, 1997, P NATL ACAD SCI USA, V94, P10150, DOI 10.1073/pnas.94.19.10150; Beuning PJ, 2001, J BIOL CHEM, V276, P30779, DOI 10.1074/jbc.M104761200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bullard JN, 1999, J MOL BIOL, V288, P567, DOI 10.1006/jmbi.1999.2708; Crepin T, 2006, STRUCTURE, V14, P1511, DOI 10.1016/j.str.2006.08.007; Cusack S, 1998, STRUCTURE, V6, P101, DOI 10.1016/S0969-2126(98)00011-2; Dale T, 2005, TRENDS BIOCHEM SCI, V30, P659, DOI 10.1016/j.tibs.2005.10.006; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hati S, 2006, J BIOL CHEM, V281, P27862, DOI 10.1074/jbc.M605856200; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kumar S, 2012, J PHYS CHEM B, V116, P6991, DOI 10.1021/jp300845h; Kumar S, 2012, J BIOL CHEM, V287, P3175, DOI 10.1074/jbc.M111.313619; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Ling J, 2007, RNA, V13, P1881, DOI 10.1261/rna.684107; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Ling JQ, 2009, MOL CELL, V33, P654, DOI 10.1016/j.molcel.2009.01.031; LIU HJ, 1995, NUCLEIC ACIDS RES, V23, P165, DOI 10.1093/nar/23.1.165; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; Lue SW, 2005, BIOCHEMISTRY-US, V44, P3010, DOI 10.1021/bi047901v; Novoa EM, 2010, FEBS LETT, V584, P460, DOI 10.1016/j.febslet.2009.11.016; Mascarenhas A. P., 2009, V22, P155; MCCLAIN WH, 1988, SCIENCE, V240, P793, DOI 10.1126/science.2452483; Murayama K, 2005, ACTA CRYSTALLOGR F, V61, P26, DOI 10.1107/S1744309104032555; Musier-Forsyth K, 1997, Nucleic Acids Symp Ser, P5; Nordin BE, 2002, J BIOL CHEM, V277, P20510, DOI 10.1074/jbc.M202023200; RAUNIO R, 1970, ACTA CHEM SCAND, V24, P2737, DOI 10.3891/acta.chem.scand.24-2737; Reynolds NM, 2010, NAT REV MICROBIOL, V8, P849, DOI 10.1038/nrmicro2472; Reynolds NM, 2010, P NATL ACAD SCI USA, V107, P4063, DOI 10.1073/pnas.0909640107; Roy H, 2005, J BIOL CHEM, V280, P38186, DOI 10.1074/jbc.M508281200; Ruan BF, 2005, J BIOL CHEM, V280, P25887, DOI 10.1074/jbc.M502174200; Ruan LL, 2013, BIOCHEM J, V450, P243, DOI 10.1042/BJ20121493; Schimmel P, 2011, PHILOS T R SOC B, V366, P2965, DOI 10.1098/rstb.2011.0158; Shiba K, 1997, TRENDS BIOCHEM SCI, V22, P453, DOI 10.1016/S0968-0004(97)01135-3; So BR, 2011, J BIOL CHEM, V286, P31810, DOI 10.1074/jbc.M111.232611; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; Wolf YI, 1999, GENOME RES, V9, P689; Yadavalli SS, 2012, ADV PROTEIN CHEM STR, V86, P1, DOI 10.1016/B978-0-12-386497-0.00001-3; Yadavalli SS, 2009, FEBS LETT, V583, P3204, DOI 10.1016/j.febslet.2009.09.008; Yaremchuk A, 2000, EMBO J, V19, P4745, DOI 10.1093/emboj/19.17.4745; Zhang H, 2000, PROTEINS, V40, P86, DOI 10.1002/(SICI)1097-0134(20000701)40:1<86::AID-PROT100>3.0.CO;2-Y	54	26	26	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14391	14399		10.1074/jbc.M113.467795	http://dx.doi.org/10.1074/jbc.M113.467795			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23564458	Green Published, hybrid			2022-12-28	WOS:000319253500042
J	Jaru-Ampornpan, P; Liang, FC; Nisthal, A; Nguyen, TX; Wang, PC; Shen, K; Mayo, SL; Shan, SO				Jaru-Ampornpan, Peera; Liang, Fu-Cheng; Nisthal, Alex; Nguyen, Thang X.; Wang, Pengcheng; Shen, Kuang; Mayo, Steven L.; Shan, Shu-ou			Mechanism of an ATP-independent Protein Disaggregase II. DISTINCT MOLECULAR INTERACTIONS DRIVE MULTIPLE STEPS DURING AGGREGATE DISASSEMBLY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; SUBSTRATE RECOGNITION; CHAPERONE; HSP104; DEGRADATION; BINDING; CYTOSOL; DOMAIN; HSP70	The ability of molecular chaperones to overcome the misfolding and aggregation of proteins is essential for the maintenance of proper protein homeostasis in all cells. Thus far, the best studied disaggregase systems are the Clp/Hsp100 family of "ATPases associated with various cellular activities" (AAA(+)) ATPases, which use mechanical forces powered by ATP hydrolysis to remodel protein aggregates. An alternative system to disassemble large protein aggregates is provided by the 38-kDa subunit of the chloroplast signal recognition particle (cpSRP43), which uses binding energy with its substrate proteins to drive disaggregation. The mechanism of this novel chaperone remains unclear. Here, molecular genetics and structure-activity analyses show that the action of cpSRP43 can be dissected into two steps with distinct molecular requirements: (i) initial recognition, during which cpSRP43 binds specifically to a recognition motif displayed on the surface of the aggregate; and (ii) aggregate remodeling, during which highly adaptable binding interactions of cpSRP43 with hydrophobic transmembrane domains of the substrate protein compete with the packing interactions within the aggregate. This establishes a useful framework to understand the molecular mechanism by which binding interactions from a molecular chaperone can be used to overcome protein aggregates in the absence of external energy input from ATP.	[Jaru-Ampornpan, Peera; Liang, Fu-Cheng; Nguyen, Thang X.; Wang, Pengcheng; Shen, Kuang; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Nisthal, Alex; Mayo, Steven L.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	sshan@caltech.edu	Shen, Kuang/H-9441-2016		Department of Defense, National Security Science and Engineering Faculty Fellowship; David and Lucile Packard Fellowship in science and engineering; Henry Dreyfus Teacher-Scholar Award; American Federation for Aging Research	Department of Defense, National Security Science and Engineering Faculty Fellowship; David and Lucile Packard Fellowship in science and engineering(The David & Lucile Packard Foundation); Henry Dreyfus Teacher-Scholar Award; American Federation for Aging Research	Supported by the Department of Defense, National Security Science and Engineering Faculty Fellowship.; Supported by the David and Lucile Packard Fellowship in science and engineering, the Henry Dreyfus Teacher-Scholar Award, and the Break-throughs in Gerontology award from the American Federation for Aging Research. To whom correspondence should be addressed: Division of Chemistry and Chemical Engineering, California Institute of Technology, 1200 E. California Blvd., Pasadena, CA 91125. Tel.: 626-395-3879; Fax: 626-568-9430; E-mail: sshan@caltech.edu.	Abramoff M. D., 2004, J BIOPHOTONICS INT, V11, P36; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bieschke J, 2009, PROTEIN SCI, V18, P2231, DOI 10.1002/pro.234; Cain P, 2011, BIOCHEM J, V437, P149, DOI 10.1042/BJ20110270; Chakraborty A, 2002, J BIOL CHEM, V277, P47451, DOI 10.1074/jbc.M204827200; Chang Hung-Chun, 2007, Cell, V128, P212; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; DeLille J, 2000, P NATL ACAD SCI USA, V97, P1926, DOI 10.1073/pnas.030395197; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Falk S, 2010, J BIOL CHEM, V285, P5954, DOI 10.1074/jbc.M109.084996; FERSHT A, 1998, STRUCTURE MECH PROTE, P508; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; HACHIYA N, 1994, EMBO J, V13, P5146, DOI 10.1002/j.1460-2075.1994.tb06844.x; HACHIYA N, 1993, EMBO J, V12, P1579, DOI 10.1002/j.1460-2075.1993.tb05802.x; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Haslberger T, 2010, BIOCHEM CELL BIOL, V88, P63, DOI [10.1139/O09-118, 10.1139/o09-118]; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Jaru-Ampornpan P, 2010, NAT STRUCT MOL BIOL, V17, P696, DOI 10.1038/nsmb.1836; Kenniston JA, 2004, J STRUCT BIOL, V146, P130, DOI 10.1016/j.jsb.2003.10.023; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Murray AN, 2010, PROTEIN SCI, V19, P836, DOI 10.1002/pro.363; Nguyen TX, 2013, J BIOL CHEM, V288, P13420, DOI 10.1074/jbc.M113.462812; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Tang Yun-Chi, 2007, Cell, V128, P412; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027	34	14	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13431	13445		10.1074/jbc.M113.462861	http://dx.doi.org/10.1074/jbc.M113.462861			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23519468	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000318850300028
J	Yumoto, K; Thomas, PS; Lane, J; Matsuzaki, K; Inagaki, M; Ninomiya-Tsuji, J; Scott, GJ; Ray, MK; Ishii, M; Maxson, R; Mishina, Y; Kaartinen, V				Yumoto, Kenji; Thomas, Penny S.; Lane, Jamie; Matsuzaki, Kouichi; Inagaki, Maiko; Ninomiya-Tsuji, Jun; Scott, Gregory J.; Ray, Manas K.; Ishii, Mamoru; Maxson, Robert; Mishina, Yuji; Kaartinen, Vesa			TGF-beta-activated Kinase 1 (Tak1) Mediates Agonist-induced Smad Activation and Linker Region Phosphorylation in Embryonic Craniofacial Neural Crest-derived Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; CAUSES CLEFT-PALATE; SIGNAL-TRANSDUCTION; RECEPTOR KINASE; MICE; BMP; MOUSE; PATHWAYS; FUSION; FAMILY	Although the importance of TGF-beta superfamily signaling in craniofacial growth and patterning is well established, the precise details of its signaling mechanisms are still poorly understood. This is in part because of the concentration of studies on the role of the Smad-dependent (so-called "canonical") signaling pathways relative to the Smad-independent ones in many biological processes. Here, we have addressed the role of TGF-beta beta-activated kinase 1 (Tak1, Map3k7), one of the key mediators of Smad-independent (noncanonical) TGF-beta superfamily signaling in craniofacial development, by deleting Tak1 specifically in the neural crest lineage. Tak1-deficient mutants display a round skull, hypoplastic maxilla and mandible, and cleft palate resulting from a failure of palatal shelves to appropriately elevate and fuse. Our studies show that in neural crest-derived craniofacial ecto-mesenchymal cells, Tak1 is not only required for TGF-beta -and bone morphogenetic protein-induced p38 Mapk activation but also plays a role in agonist-induced C-terminal and linker region phosphorylation of the receptor-mediated R-Smads. Specifically, we demonstrate that the agonist-induced linker region phosphorylation of Smad2 at Thr-220, which has been shown to be critical for full transcriptional activity of Smad2, is dependent on Tak1 activity and that in palatal mesenchymal cells TGF beta RI and Tak1 kinases mediate both overlapping and distinct TGF-beta 2-induced transcriptional responses. To summarize, our results suggest that in neural crest-derived ecto-mesenchymal cells, Tak1 provides a critical point of intersection in a complex dialogue between the canonical and noncanonical arms of TGF-beta superfamily signaling required for normal craniofacial development.	[Yumoto, Kenji; Thomas, Penny S.; Lane, Jamie; Mishina, Yuji; Kaartinen, Vesa] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Matsuzaki, Kouichi] Kansai Med Univ, Dept Gastroenterol & Hepatol, Moriguchi, Osaka 5708506, Japan; [Inagaki, Maiko; Ninomiya-Tsuji, Jun] N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA; [Scott, Gregory J.; Ray, Manas K.] NIEHS, Lab Reprod & Dev Toxicol, NIH, Res Triangle Pk, NC 27709 USA; [Ishii, Mamoru; Maxson, Robert] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA	University of Michigan System; University of Michigan; Kansai Medical University; University of North Carolina; North Carolina State University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Southern California	Kaartinen, V (corresponding author), Univ Michigan, Dept Biol & Mat Sci, 1011 N Univ Ave, Ann Arbor, MI 48109 USA.	vesak@umich.edu	Kaartinen, Vesa/AAU-5396-2021	Kaartinen, Vesa/0000-0002-9432-510X; Ninomiya-Tsuji, Jun/0000-0002-5584-0176	National Institutes of Health [R01DE020843, ES071003-11, RO1 DE013085, HL074862, S10RR026475-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE020843 and ES071003-11 (to Y. M.), RO1 DE013085 and HL074862 (to V. K.), and S10RR026475-01 (to the University of Michigan mu CT Core Facility).	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Baek JA, 2011, DEV BIOL, V350, P520, DOI 10.1016/j.ydbio.2010.12.028; Bellusci S, 1997, DEVELOPMENT, V124, P53; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Cardoso S, 2012, J RECEPT SIG TRANSD, V32, P150, DOI 10.3109/10799893.2012.664553; Cohen-Solal KA, 2011, PIGM CELL MELANOMA R, V24, P512, DOI 10.1111/j.1755-148X.2011.00858.x; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Dudas M, 2004, DEV BIOL, V266, P96, DOI 10.1016/j.ydbio.2003.10.007; Dudas M, 2006, DEV BIOL, V296, P298, DOI 10.1016/j.ydbio.2006.05.030; Economou AD, 2012, NAT GENET, V44, P348, DOI 10.1038/ng.1090; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Han J, 2009, DEVELOPMENT, V136, P4225, DOI 10.1242/dev.036723; Harlow E., 1988, ANTIBODIES LAB MANUA, P481; Hilliard SA, 2005, J ANAT, V207, P655, DOI 10.1111/j.1469-7580.2005.00474.x; Hoffmann A, 2005, J BIOL CHEM, V280, P27271, DOI 10.1074/jbc.M503368200; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Hough C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042513; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Iwata J, 2012, J CLIN INVEST, V122, P873, DOI 10.1172/JCI61498; Iwata J, 2012, J BIOL CHEM, V287, P2353, DOI 10.1074/jbc.M111.280974; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Larsson J, 2001, EMBO J, V20, P1663, DOI 10.1093/emboj/20.7.1663; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Liu WJ, 2008, DEVELOPMENT, V135, P3959, DOI 10.1242/dev.025304; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Matsuzaki K, 2009, CANCER RES, V69, P5321, DOI 10.1158/0008-5472.CAN-08-4203; Nagy A, 2003, MANIPULATING MOUSE E, P687; Rice R, 2004, J CLIN INVEST, V113, P1692, DOI 10.1172/JCI200420384; Shim JH, 2009, EMBO J, V28, P2028, DOI 10.1038/emboj.2009.162; Song ZC, 2013, J BIOL CHEM, V288, P10440, DOI 10.1074/jbc.M112.432286; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Thomas PS, 2010, DEV BIOL, V340, P613, DOI 10.1016/j.ydbio.2010.02.021; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang GN, 2009, J BIOL CHEM, V284, P9663, DOI 10.1074/jbc.M809281200; Wtighton KH, 2008, CELL SIGNAL, V20, P1579, DOI 10.1016/j.cellsig.2008.02.003; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yu L, 2005, DEVELOPMENT, V132, P4397, DOI 10.1242/dev.02013; Zhang ZY, 2002, DEVELOPMENT, V129, P4135	47	55	58	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13467	13480		10.1074/jbc.M112.431775	http://dx.doi.org/10.1074/jbc.M112.431775			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23546880	Green Published, hybrid			2022-12-28	WOS:000318850300031
J	Chen, L; Bi, DL; Tian, LJ; McClafferty, H; Steeb, F; Ruth, P; Knaus, HG; Shipston, MJ				Chen, Lie; Bi, Danlei; Tian, Lijun; McClafferty, Heather; Steeb, Franziska; Ruth, Peter; Knaus, Hans Guenther; Shipston, Michael J.			Palmitoylation of the beta 4-Subunit Regulates Surface Expression of Large Conductance Calcium-activated Potassium Channel Splice Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT REGULATION; BETA-SUBUNITS; BK CHANNELS; MODULATION; FAMILY; ALPHA; SITE	Regulatory beta-subunits of large conductance calcium- and voltage-activated potassium (BK) channels play an important role in generating functional diversity and control of cell surface expression of the pore forming alpha-subunits. However, in contrast to alpha-subunits, the role of reversible post-translational modification of intracellular residues on beta-subunit function is largely unknown. Here we demonstrate that the human beta 4-subunit is S-acylated (palmitoylated) on a juxtamembrane cysteine residue (Cys-193) in the intracellular C terminus of the regulatory beta-subunit. beta 4-Subunit palmitoylation is important for cell surface expression and endoplasmic reticulum (ER) exit of the beta 4-subunit alone. Importantly, palmitoylated beta 4-subunits promote the ER exit and surface expression of the pore-forming alpha-subunit, whereas beta 4-subunits that cannot be palmitoylated do not increase ER exit or surface expression of alpha-subunits. Strikingly, however, this palmitoylation-and beta 4-dependent enhancement of alpha-subunit surface expression was only observed in alpha-subunits that contain a putative trafficking motif (... REVEDEC) at the very C terminus of the alpha-subunit. Engineering this trafficking motif to other C-terminal alpha-subunit splice variants results in alpha-subunits with reduced surface expression that can be rescued by palmitoylated, but not depalmitoylated, beta 4-subunits. Our data reveal a novel mechanism by which palmitoylated beta 4-subunit controls surface expression of BK channels through masking of a trafficking motif in the C terminus of the alpha-subunit. As palmitoylation is dynamic, this mechanism would allow precise control of specific splice variants to the cell surface. Our data provide new insights into how complex interplay between the repertoire of post-transcriptional and post-translational mechanisms controls cell surface expression of BK channels.	[Chen, Lie; Bi, Danlei; Tian, Lijun; McClafferty, Heather; Shipston, Michael J.] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Steeb, Franziska; Ruth, Peter] Med Univ Innsbruck, Div Mol & Cellular Pharmacol, A-6020 Innsbruck, Austria; [Knaus, Hans Guenther] Univ Tubingen, Inst Pharm, Div Pharmacol & Toxicol, D-72076 Tubingen, Germany	University of Edinburgh; Medical University of Innsbruck; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Shipston, MJ (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland.	mike.shipston@ed.ac.uk	Shipston, Michael/C-7309-2013	Shipston, Michael/0000-0001-7544-582X; Chen, Lie/0000-0001-9764-4299	Wellcome Trust program grant; British Heart Foundation [PG/12/57/29782] Funding Source: researchfish	Wellcome Trust program grant(Wellcome Trust); British Heart Foundation(British Heart Foundation)	This work was supported by a Wellcome Trust program grant (to M. J. S., H. G. K., and P. R.).	Abrami L, 2008, P NATL ACAD SCI USA, V105, P5384, DOI 10.1073/pnas.0710389105; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Burgoyne JR, 2012, FASEB J, V26, P832, DOI 10.1096/fj.11-189415; Chen L, 2005, J BIOL CHEM, V280, P33599, DOI 10.1074/jbc.M505383200; Chiu YH, 2010, MOL PHARMACOL, V77, P497, DOI 10.1124/mol.109.061929; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Grimm PR, 2009, P NATL ACAD SCI USA, V106, P11800, DOI 10.1073/pnas.0904635106; Holtzclaw JD, 2010, J AM SOC NEPHROL, V21, P634, DOI 10.1681/ASN.2009080817; Jeffries O, 2010, J BIOL CHEM, V285, P33307, DOI 10.1074/jbc.M110.153940; Jin P, 2002, J BIOL CHEM, V277, P10014, DOI 10.1074/jbc.M107682200; Jin P, 2002, J BIOL CHEM, V277, P43724, DOI 10.1074/jbc.M205795200; Kim EY, 2007, NEUROSCIENCE, V146, P1652, DOI 10.1016/j.neuroscience.2007.03.038; Kim EY, 2007, J NEUROPHYSIOL, V97, P3508, DOI 10.1152/jn.00009.2007; King JT, 2006, J NEUROPHYSIOL, V95, P2878, DOI 10.1152/jn.01352.2005; Lippiat JD, 2003, J MEMBRANE BIOL, V192, P141, DOI 10.1007/s00232-002-1070-0; Ma DH, 2007, FEBS LETT, V581, P1000, DOI 10.1016/j.febslet.2007.01.077; Martin GE, 2008, P NATL ACAD SCI USA, V105, P17543, DOI 10.1073/pnas.0801068105; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Nyholm TKM, 2007, BIOCHEMISTRY-US, V46, P1457, DOI 10.1021/bi061941c; Orio P, 2002, NEWS PHYSIOL SCI, V17, P156, DOI 10.1152/nips.01387.2002; Petrik D, 2007, NEUROSCIENCE, V149, P789, DOI 10.1016/j.neuroscience.2007.07.066; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Shruti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033429; Tian LJ, 2012, J BIOL CHEM, V287, P14718, DOI 10.1074/jbc.M111.335547; Tian LJ, 2010, J BIOL CHEM, V285, P23954, DOI 10.1074/jbc.M110.137802; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Wu RS, 2009, J NEUROSCI, V29, P8321, DOI 10.1523/JNEUROSCI.6191-08.2009; Yan JS, 2012, P NATL ACAD SCI USA, V109, P7917, DOI 10.1073/pnas.1205435109; Yang CT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006135	32	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13136	13144		10.1074/jbc.M113.461830	http://dx.doi.org/10.1074/jbc.M113.461830			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23504458	Green Published, hybrid			2022-12-28	WOS:000318555100063
J	Liu, XS; Chopp, M; Wang, XL; Zhang, L; Hozeska-Solgot, A; Tang, T; Kassis, H; Zhang, RL; Chen, C; Xu, J; Zhang, ZG				Liu, Xian Shuang; Chopp, Michael; Wang, Xin Li; Zhang, Li; Hozeska-Solgot, Ann; Tang, Tao; Kassis, Haifa; Zhang, Rui Lan; Chen, Charles; Xu, Jennifer; Zhang, Zheng Gang			MicroRNA-17-92 Cluster Mediates the Proliferation and Survival of Neural Progenitor Cells after Stroke	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SONIC HEDGEHOG PATHWAY; SUBVENTRICULAR ZONE; EPIGENETIC REGULATION; MIR-17-92 CLUSTER; NEWBORN NEURONS; ADULT-RAT; N-MYC; DIFFERENTIATION; PTEN; NEUROGENESIS	The role of microRNAs (miRNAs) in mediating adult neurogenesis after stroke has not been extensively studied. The present study investigated the function of the miR17-92 cluster in adult neural progenitor cells after experimental stroke. We found that stroke substantially up-regulated miR17-92 cluster expression in neural progenitor cells of the adult mouse. Overexpression of the miR17-92 cluster either in cultured ischemic neural progenitor cells or in the subventricular zone (SVZ) of ischemic animals significantly increased cell proliferation, whereas inhibition of individual members of the miR17-92 cluster, miR-18a and miR-19a, suppressed cell proliferation and increased cell death. The miR17-92 cluster mediated PTEN (phosphatase and tensin homolog) expression, which is a predicted target of the miR17-92 cluster. Addition of Sonic hedgehog (Shh) protein up-regulated miR17-92 expression and elevated c-Myc protein in ischemic neural progenitor cells, whereas blockade of the Shh signaling pathway down-regulated miR17-92 cluster expression and reduced c-Myc levels. Overexpression of c-Myc up-regulated miR17-92 cluster expression. Intraventricular infusion of Shh and a Shh receptor inhibitor, cyclopamine, to ischemic animals further elevated and suppressed, respectively, miR17-92 cluster expression in the SVZ. These data indicate that the miR17-92 cluster plays an important role in mediating neural progenitor cell function and that the Shh signaling pathway is involved in up-regulating miR17-92 cluster expression.	[Liu, Xian Shuang; Chopp, Michael; Wang, Xin Li; Zhang, Li; Hozeska-Solgot, Ann; Tang, Tao; Kassis, Haifa; Zhang, Rui Lan; Chen, Charles; Xu, Jennifer; Zhang, Zheng Gang] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI 48309 USA	Henry Ford Health System; Henry Ford Hospital; Oakland University	Liu, XS (corresponding author), Henry Ford Hosp, Dept Neurol, 2799 W Grand Blvd, Detroit, MI 48202 USA.	xsliu@neuro.hfh.edu	zhang, zheng/HCH-9684-2022	Kassis, Haifa/0000-0003-3546-2590	National Institutes of Health [RO1 AG037506, RO1 NS075156]; American Heart Association [10SDG2790012]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants RO1 AG037506 (to M. C.) and RO1 NS075156 (to Z. G. Z.) and American Heart Association Scientist Development Grant 10SDG2790012 (to X. S. L.).	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Brett JO, 2011, AGING-US, V3, P108, DOI 10.18632/aging.100285; Budde H, 2010, DEVELOPMENT, V137, P2127, DOI 10.1242/dev.050633; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; de Pontual L, 2011, NAT GENET, V43, P1026, DOI 10.1038/ng.915; Denli AM, 2009, NAT STRUCT MOL BIOL, V16, P346, DOI 10.1038/nsmb0409-346; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hatton BA, 2006, CANCER RES, V66, P8655, DOI 10.1158/0008-5472.CAN-06-1621; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Hong LX, 2010, CANCER RES, V70, P8547, DOI 10.1158/0008-5472.CAN-10-1938; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Li L, 2003, J CELL BIOCHEM, V88, P24, DOI 10.1002/jcb.10312; Li L, 2002, MOL CELL NEUROSCI, V20, P21, DOI 10.1006/mcne.2002.1115; Liu CM, 2010, CELL STEM CELL, V6, P433, DOI 10.1016/j.stem.2010.02.017; Liu CM, 2009, NEUROMOL MED, V11, P141, DOI 10.1007/s12017-009-8077-y; Liu XS, 2007, J CEREBR BLOOD F MET, V27, P564, DOI 10.1038/sj.jcbfm.9600371; Liu XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023461; Liu XS, 2009, J BIOL CHEM, V284, P22680, DOI 10.1074/jbc.M109.006551; Loven J, 2010, P NATL ACAD SCI USA, V107, P1553, DOI 10.1073/pnas.0913517107; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Marti E, 2002, TRENDS NEUROSCI, V25, P89, DOI 10.1016/S0166-2236(02)02062-3; Miwa K, 1998, NAT MED, V4, P1287, DOI 10.1038/3276; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Otaegi G, 2006, J CELL SCI, V119, P2739, DOI 10.1242/jcs.03012; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Sims JR, 2009, STROKE, V40, P3618, DOI 10.1161/STROKEAHA.109.561951; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Takakura S, 2008, CANCER SCI, V99, P1147, DOI 10.1111/j.1349-7006.2008.00800.x; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; Wang L, 2007, J BIOL CHEM, V282, P32462, DOI 10.1074/jbc.M706880200; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 2005, NEUROSCIENTIST, V11, P408, DOI 10.1177/1073858405278865; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Zhang RL, 2006, J CEREBR BLOOD F MET, V26, P857, DOI 10.1038/sj.jcbfm.9600237; Zhang ZG, 1997, J CEREBR BLOOD F MET, V17, P1081, DOI 10.1097/00004647-199710000-00010; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zhu GF, 1999, DEV BIOL, V215, P118, DOI 10.1006/dbio.1999.9431	52	103	114	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12478	12488		10.1074/jbc.M112.449025	http://dx.doi.org/10.1074/jbc.M112.449025			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23511639	hybrid, Green Published			2022-12-28	WOS:000318555100007
J	Minami, A; Shimono, Y; Mizutani, K; Nobutani, K; Momose, K; Azuma, T; Takai, Y				Minami, Akihiro; Shimono, Yohei; Mizutani, Kiyohito; Nobutani, Kentaro; Momose, Kenji; Azuma, Takeshi; Takai, Yoshimi			Reduction of the ST6 beta-Galactosamide alpha-2,6-Sialyltransferase 1 (ST6GAL1)-catalyzed Sialylation of Nectin-like Molecule 2/Cell Adhesion Molecule 1 and Enhancement of ErbB2/ErbB3 Signaling by MicroRNA-199a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; OVARIAN-CANCER CELLS; IMMUNOGLOBULIN SUPERFAMILY; HEPATOCELLULAR-CARCINOMA; PROTEIN GLYCOSYLATION; PROLIFERATION; EXPRESSION; GENE; SIALYLTRANSFERASE; TARGETS	Nectin-like molecule 2 (Necl-2)/cell adhesion molecule 1 (CADM1) is shown to be down-regulated by the promoter hypermethylation and/or loss of heterozygosity at chromosome 11q23.2 in many types of cancers, including lung and breast cancers, and is proposed to serve as a tumor suppressor. However, the incidence of these epigenetic and genetic abnormalities of Necl-2 is 30-60% in these cancers, and other mechanisms for the suppression of Necl-2 are presumed to be present. We previously showed that Necl-2 interacts in cis with ErbB3 and suppresses the heregulin (HRG)-induced ErbB2/ErbB3 signaling for cell movement and death. We studied here the relationship between Necl-2 and microRNA-199a (miR-199a) that is up-regulated or down-regulated in a variety of cancers. miR-199a did not directly target the Necl-2 mRNA or affect its mRNA level in human lung cancer A549 cells and human embryonic kidney HEK293 cells. Necl-2 was at least sialylated by the sialyltransferase ST6 beta-galactosamide alpha-2,6-sialyltransferase 1 (ST6GAL1). miR-199a targeted ST6GAL1 and reduced both the sialylation and the protein level of Necl-2. In addition, miR-199a enhanced the HRG-induced ErbB2/ErbB3 signaling. These results indicate that the suppressive role of Necl-2 in the HRG-induced ErbB2/ErbB3 signaling is regulated by miR-199a at least through the reduction of the ST6GAL1catalyzed sialylation of Necl-2 and/or through the reduction of the protein level of Necl-2 presumably by the protein degradation.	[Minami, Akihiro; Shimono, Yohei; Mizutani, Kiyohito; Nobutani, Kentaro; Momose, Kenji; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Minami, Akihiro; Nobutani, Kentaro; Momose, Kenji; Azuma, Takeshi] Kobe Univ, Grad Sch Med, Div Gastroenterol, Dept Internal Med,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Mizutani, Kiyohito; Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Pathogenet Signaling,Chuo Ku, Kobe, Hyogo 6500047, Japan	Kobe University; Kobe University; Kobe University	Takai, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ytakai@med.kobe-u.ac.jp	Mizutani, Kiyohito/L-8474-2019	Shimono, Yohei/0000-0002-6256-4704	Global Centers of Excellence Program "Global Center for Education and Research in Integrative Membrane Biology"; Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Society for the Promotion of Science; Core Research for Evolutional Science and Technology of the Japanese Science and Technology Agency; Naito Foundation; Sagawa Foundation; Yasuda Medical Foundation; Cell Science Research Foundation; Grants-in-Aid for Scientific Research [24790284, 23130510] Funding Source: KAKEN	Global Centers of Excellence Program "Global Center for Education and Research in Integrative Membrane Biology"; Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology of the Japanese Science and Technology Agency; Naito Foundation(Naito Memorial Foundation); Sagawa Foundation; Yasuda Medical Foundation; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Global Centers of Excellence Program "Global Center for Education and Research in Integrative Membrane Biology" and the Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology, Japan; by Grants-in-Aid from the Japan Society for the Promotion of Science; by Core Research for Evolutional Science and Technology of the Japanese Science and Technology Agency; and by grants from the Naito Foundation, the Sagawa Foundation, the Yasuda Medical Foundation, and the Cell Science Research Foundation.	Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Barker A, 2010, CURR OPIN PHARMACOL, V10, P655, DOI 10.1016/j.coph.2010.08.011; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Biederer T, 2006, GENOMICS, V87, P139, DOI 10.1016/j.ygeno.2005.08.017; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Dai L, 2012, MOL HUM REPROD, V18, P136, DOI 10.1093/molehr/gar066; Duan QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031518; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Gomyo H, 1999, GENOMICS, V62, P139, DOI 10.1006/geno.1999.6001; Hagen JW, 2008, CELL CYCLE, V7, P2327, DOI 10.4161/cc.6447; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Henry JC, 2010, BIOCHEM BIOPH RES CO, V403, P120, DOI 10.1016/j.bbrc.2010.10.130; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Huang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033762; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Kawano S, 2009, J BIOL CHEM, V284, P23793, DOI 10.1074/jbc.M109.025155; Kawashima N, 2009, J BIOL CHEM, V284, P6147, DOI 10.1074/jbc.M808171200; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Konishi A, 2003, J BIOL CHEM, V278, P35049, DOI 10.1074/jbc.M304913200; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Lee M, 2008, MOL CANCER RES, V6, P1316, DOI 10.1158/1541-7786.MCR-07-2209; LENNARZ W, 1983, METHOD ENZYMOL, V98, P91; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LIS H, 1993, EUR J BIOCHEM, V218, P1, DOI 10.1111/j.1432-1033.1993.tb18347.x; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Mascaux C, 2009, EUR RESPIR J, V33, P352, DOI 10.1183/09031936.00084108; Masuda M, 2002, J BIOL CHEM, V277, P31014, DOI 10.1074/jbc.M203620200; Maurel P, 2007, J CELL BIOL, V178, P861, DOI 10.1083/jcb.200705132; Momose K, 2013, GENES CELLS, V18, P195, DOI 10.1111/gtc.12027; Murakami Y, 2005, CANCER SCI, V96, P543, DOI 10.1111/j.1349-7006.2005.00089.x; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Santhakumar D, 2010, P NATL ACAD SCI USA, V107, P13830, DOI 10.1073/pnas.1008861107; Schraml P, 1999, CLIN CANCER RES, V5, P1966; Serino G, 2012, J AM SOC NEPHROL, V23, P814, DOI 10.1681/ASN.2011060567; Shatseva T, 2011, J CELL SCI, V124, P2826, DOI 10.1242/jcs.077529; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; SPIRO MJ, 1968, J BIOL CHEM, V243, P6520; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Tsukigi M, 2012, CANCER LETT, V315, P189, DOI 10.1016/j.canlet.2011.10.008; Urase K, 2001, NEUROREPORT, V12, P3217, DOI 10.1097/00001756-200110290-00015; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A, 2009, ESSENTIALS GLYCOBIOL, P617; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wakayama T, 2001, MOL REPROD DEV, V60, P158, DOI 10.1002/mrd.1072; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yin G, 2010, ONCOGENE, V29, P3545, DOI 10.1038/onc.2010.111; Yokoe S, 2007, CANCER RES, V67, P1935, DOI 10.1158/0008-5472.CAN-06-3023; Zhou FB, 2010, J BIOCHEM, V148, P273, DOI 10.1093/jb/mvq062	59	28	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11845	11853		10.1074/jbc.M112.405993	http://dx.doi.org/10.1074/jbc.M112.405993			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504322	Green Published, hybrid			2022-12-28	WOS:000318157600020
J	Shah, P; Fatehchand, K; Patel, H; Fang, HQ; Justiniano, SE; Mo, XK; Jarjoura, D; Tridandapani, S; Butchar, JP				Shah, Prexy; Fatehchand, Kavin; Patel, Hemal; Fang, Huiqing; Justiniano, Steven E.; Mo, Xiaokui; Jarjoura, David; Tridandapani, Susheela; Butchar, Jonathan P.			Toll-like Receptor 2 Ligands Regulate Monocyte Fc gamma Receptor Expression and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL PHOSPHATASE SHIP; CYTOKINE RESPONSE; IMMUNE-RESPONSES; MYELOID CELLS; TUMOR-CELLS; B-CELLS; IMMUNOTHERAPY; ACTIVATION; CANCER; TLR2	Fc gamma receptor (Fc gamma R) clustering on monocytes/macrophages results in phagocytosis and inflammatory cytokine production, which serve to eliminate antibody-opsonized targets and activate neighboring immune cells. Toll-like receptor 2 (TLR2), which recognizes a range of both bacterial and fungal components, elicits strong proinflammatory responses in these cells when stimulated by ligands, either natural or synthetic. Thus, we explored the possibility that TLR2 agonists could strengthen Fc gamma R activity within the context of antibody therapy. Human peripheral blood monocytes treated with the TLR2 agonist Pam2CSK4 showed significantly enhanced Fc gamma R-mediated cytokine production as well as phagocytic ability. An examination of the molecular mechanism behind this enhancement revealed increased expression of both Fc gamma RIIa and the common gamma subunit following Pam2CSK4 treatment. Interestingly however, expression of the inhibitory receptor Fc gamma RIIb was also modestly increased. Further investigation revealed that Pam2CSK4 also dramatically decreased the expression of SHIP, the major mediator of Fc gamma RIIb inhibitory activity. Using a murine Her2/neu solid tumor model of antibody therapy, we found that Pam2CSK4 significantly enhanced the ability of anti-Her2 antibody to reduce the rate of tumor growth. To verify that the Fc gamma R enhancement was not unique to the diacylated Pam2CSK4, we also tested Pam3CSK4, a related triacylated TLR2 agonist. Results showed significant enhancement in Fc gamma R function and expression. Taken together, these findings indicate that TLR2 activation can positively modulate Fc gamma R and suggest that TLR2 agonists should be considered for testing as adjuvants for antitumor antibody therapy.	[Shah, Prexy; Fatehchand, Kavin; Patel, Hemal; Fang, Huiqing; Justiniano, Steven E.; Tridandapani, Susheela; Butchar, Jonathan P.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Mo, Xiaokui; Jarjoura, David] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Tridandapani, Susheela; Butchar, Jonathan P.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Tridandapani, S (corresponding author), Ohio State Univ, Dept Internal Med, 415 DHLRI,473 W 12th Ave, Columbus, OH 43210 USA.	tridandapani.2@osu.edu; butchar.2@osu.edu	Butchar, Jonathan/E-2825-2011; Tridandapani, Susheela/E-4209-2011	Justiniano, Steven/0000-0003-1381-9309	National Institutes of Health [P01-CA095426, K12-CA133250, T32 60013191]; American Cancer Society [IRG-67-003-47]; NATIONAL CANCER INSTITUTE [P01CA095426, K12CA133250, P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-CA095426 (to S. T.) and K12-CA133250 (to J. P. B.) and National Institutes of Health Postdoctoral Fellowship T32 60013191 (to S. E. J.). This work was also supported by American Cancer Society Grant IRG-67-003-47 (to J. P. B.).	Butchar JP, 2010, CLIN CANCER RES, V16, P2065, DOI 10.1158/1078-0432.CCR-09-2591; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; Caproni E, 2012, J IMMUNOL, V188, P3088, DOI 10.4049/jimmunol.1101764; Charles PE, 2011, CRIT CARE, V15, DOI 10.1186/cc10330; Chtarbanova S, 2011, ARTERIOSCL THROM VAS, V31, P1734, DOI 10.1161/ATVBAHA.108.179523; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Costinean S, 2009, BLOOD, V114, P1374, DOI 10.1182/blood-2009-05-220814; Cremer TJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00073; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; Ha TZ, 2010, AM J PHYSIOL-HEART C, V298, pH984, DOI 10.1152/ajpheart.01109.2009; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Ho M, 2012, MABS-AUSTIN, V4, P562, DOI 10.4161/mabs.21521; Joshi T, 2006, MOL IMMUNOL, V43, P839, DOI 10.1016/j.molimm.2005.06.037; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Lu C, 2011, J IMMUNOL, V187, P1458, DOI 10.4049/jimmunol.1003428; Maresco DL, 1999, J IMMUNOL, V162, P6458; Nakamura K, 2000, J IMMUNOL, V164, P631, DOI 10.4049/jimmunol.164.2.631; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Oliveira-Nascimento L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00079; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Parihar R, 2002, J CLIN INVEST, V110, P983, DOI 10.1172/JCI200215950; Penichet ML, 1999, LAB ANIM SCI, V49, P179; Roda JM, 2007, CLIN CANCER RES, V13, P6419, DOI 10.1158/1078-0432.CCR-07-0865; Roda JM, 2006, J IMMUNOL, V177, P120, DOI 10.4049/jimmunol.177.1.120; Saber T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023540; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Tridandapani S, 2002, J BIOL CHEM, V277, P5082, DOI 10.1074/jbc.M110277200; Tridandapani S, 2002, J IMMUNOL, V169, P4370, DOI 10.4049/jimmunol.169.8.4370; Tridandapani S, 1999, J IMMUNOL, V162, P1408; Tsai YG, 2010, J IMMUNOL, V184, P7229, DOI 10.4049/jimmunol.1000083; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; Weiner LM, 2009, LANCET, V373, P1033, DOI 10.1016/S0140-6736(09)60251-8	37	16	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12345	12352		10.1074/jbc.M113.449983	http://dx.doi.org/10.1074/jbc.M113.449983			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504312	hybrid, Green Published			2022-12-28	WOS:000318157600065
J	Odell, AF; Odell, LR; Askham, JM; Alogheli, H; Ponnambalam, S; Hollstein, M				Odell, Adam F.; Odell, Luke R.; Askham, Jon M.; Alogheli, Hiba; Ponnambalam, Sreenivasan; Hollstein, Monica			A Novel p53 Mutant Found in Iatrogenic Urothelial Cancers Is Dysfunctional and Can Be Rescued by a Second-site Global Suppressor Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE EMBRYONIC FIBROBLASTS; ARISTOLOCHIC ACID; TP53 MUTATIONS; DNA-BINDING; WILD-TYPE; PATTERNS; ETIOLOGY; INSIGHTS; CELLS; GAIN	Exposure to herbal remedies containing the carcinogen aristolochic acid (AA) has been widespread in some regions of the world. Rare A -> T TP53 mutations were recently discovered in AA-associated urothelial cancers. The near absence of these mutations among all other sequenced human tumors suggests that they could be biologically silent. There are no cell banks with established lines derived from human tumors with which to explore the influence of the novel mutants on p53 function and cellular behavior. To investigate their impact, we generated isogenic mutant clones by integrase-mediated cassette exchange at the p53 locus of platform (null) murine embryonic fibroblasts and kidney epithelial cells. Common tumor mutants (R248W, R273C) were compared with the AA-associated mutants N131Y, R249W, and Q104L. Assays of cell proliferation, migration, growth in soft agar, apoptosis, senescence, and gene expression revealed contrasting outcomes on cellular behavior following introduction of N131Y or Q104L. The N131Y mutant demonstrated a phenotype akin to common tumor mutants, whereas Q104L clone behavior resembled that of cells with wild-type p53. Wild-type p53 responses were restored in double-mutant cells harboring N131Y and N239Y, a second-site rescue mutation, suggesting that pharmaceutical reactivation of p53 function in tumors expressing N131Y could have therapeutic benefit. N131Y is likely to contribute directly to tumor phenotype and is a promising candidate biomarker of AA exposure and disease. Rare mutations thus do not necessarily point to sites where amino acid exchanges are phenotypically neutral. Encounter with mutagenic insults targeting cryptic sites can reveal specific signature hotspots.	[Odell, Adam F.; Askham, Jon M.; Hollstein, Monica] Univ Leeds, Fac Med & Hlth, Leeds LS2 9JT, W Yorkshire, England; [Odell, Luke R.; Alogheli, Hiba] Uppsala Univ, Dept Med Chem, Div Organ Pharmaceut Chem, S-75123 Uppsala, Sweden; [Ponnambalam, Sreenivasan] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Hollstein, Monica] German Canc Res Ctr, Dept C016, D-69120 Heidelberg, Germany	University of Leeds; Uppsala University; University of Leeds; Helmholtz Association; German Cancer Research Center (DKFZ)	Odell, AF (corresponding author), Univ Leeds, LIGHT Lab, Fac Med & Hlth, Clarendon Way, Leeds LS2 9JT, W Yorkshire, England.	a.f.odell@leeds.ac.uk; m.hollstein@dkfz.de		Ponnambalam, Sreenivasan/0000-0002-4452-7619	Yorkshire Cancer Research Grant [L351]; White Rose University Consortium Grant; Deutsches Krebsforschungszentrum (German Cancer Research Center)	Yorkshire Cancer Research Grant; White Rose University Consortium Grant; Deutsches Krebsforschungszentrum (German Cancer Research Center)	This work was supported by Yorkshire Cancer Research Grant L351 (to M. H.), a White Rose University Consortium Grant (to A. F. O. and M. H.), and the Deutsches Krebsforschungszentrum (German Cancer Research Center).	Baroni TE, 2004, P NATL ACAD SCI USA, V101, P4930, DOI 10.1073/pnas.0401162101; Besaratinia A, 2010, FASEB J, V24, P2612, DOI 10.1096/fj.10-157263; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Chen CH, 2012, P NATL ACAD SCI USA, V109, P8241, DOI 10.1073/pnas.1119920109; Danziger SA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000498; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hainaut P., 2006, 25 YEARS P53 RES; Hollstein M., 2013, P53 CLIN, V2013, P95; Hollstein M., 2013, MUTAT RES; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; Joerger AC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000919; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Lai MN, 2010, JNCI-J NATL CANCER I, V102, P179, DOI 10.1093/jnci/djp467; Liu ZP, 2004, P NATL ACAD SCI USA, V101, P2963, DOI 10.1073/pnas.0308607101; Luo JL, 2001, ONCOGENE, V20, P320, DOI 10.1038/sj.onc.1204080; Mathew R, 2008, METHOD ENZYMOL, V446, P77, DOI 10.1016/S0076-6879(08)01605-4; Merabet A, 2010, BIOCHEM J, V427, P225, DOI 10.1042/BJ20091888; Nedelko T, 2009, INT J CANCER, V124, P987, DOI 10.1002/ijc.24006; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; Olivier M, 2012, NAT REV CANCER, V12, P503, DOI 10.1038/nrc3311; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Otsuka K, 2007, INT J CANCER, V121, P559, DOI 10.1002/ijc.22724; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Schetter AJ, 2012, P NATL ACAD SCI USA, V109, P7955, DOI 10.1073/pnas.1205457109; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wei QX, 2012, NAT PROTOC, V7, P1145, DOI 10.1038/nprot.2012.042; Wei QX, 2011, CELL CYCLE, V10, P1261, DOI 10.4161/cc.10.8.15303; Whibley C, 2010, J BIOL CHEM, V285, P11326, DOI 10.1074/jbc.M109.064444	32	10	12	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16704	16714		10.1074/jbc.M112.443168	http://dx.doi.org/10.1074/jbc.M112.443168			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23612969	Green Published, hybrid			2022-12-28	WOS:000320378900045
J	Lonic, A; Powell, JA; Kong, Y; Thomas, D; Holien, JK; Truong, N; Parker, MW; Guthridge, MA				Lonic, Ana; Powell, Jason A.; Kong, Yang; Thomas, Daniel; Holien, Jessica K.; Nhan Truong; Parker, Michael W.; Guthridge, Mark A.			Phosphorylation of Serine 779 in Fibroblast Growth Factor Receptor 1 and 2 by Protein Kinase C epsilon Regulates Ras/Mitogen-activated Protein Kinase Signaling and Neuronal Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELIMINATES PHOSPHATIDYLINOSITOL HYDROLYSIS; POINT MUTATION; NEURITE OUTGROWTH; CELL-SURVIVAL; PC12 CELLS; PATHWAYS; PKC; IDENTIFICATION; SPECIFICITY; INDUCTION	The FGF receptors (FGFRs) control a multitude of cellular processes both during development and in the adult through the initiation of signaling cascades that regulate proliferation, survival, and differentiation. Although FGFR tyrosine phosphorylation and the recruitment of Src homology 2 domain proteins have been widely described, we have previously shown that FGFR is also phosphorylated on Ser(779) in response to ligand and binds the 14-3-3 family of phosphoserine/threonine-binding adaptor/scaffold proteins. However, whether this receptor phosphoserine mode of signaling is able to regulate specific signaling pathways and biological responses is unclear. Using PC12 pheochromocytoma cells and primary mouse bone marrow stromal cells as models for growth factor-regulated neuronal differentiation, we show that Ser(779) in the cytoplasmic domains of FGFR1 and FGFR2 is required for the sustained activation of Ras and ERK but not for other FGFR phosphotyrosine pathways. The regulation of Ras and ERK signaling by Ser(779) was critical not only for neuronal differentiation but also for cell survival under limiting growth factor concentrations. PKC epsilon can phosphorylate Ser(779) in vitro, whereas overexpression of PKC epsilon results in constitutive Ser(779) phosphorylation and enhanced PC12 cell differentiation. Furthermore, siRNA knockdown of PKC epsilon reduces both growth factor-induced Ser(779) phosphorylation and neuronal differentiation. Our findings show that in addition to FGFR tyrosine phosphorylation, the phosphorylation of a conserved serine residue, Ser(779), can quantitatively control Ras/MAPK signaling to promote specific cellular responses.	[Lonic, Ana; Powell, Jason A.; Kong, Yang; Thomas, Daniel; Nhan Truong; Guthridge, Mark A.] South Australian SA Pathol, Cell Growth & Differentiat Lab, Div Human Immunol, Adelaide, SA 5000, Australia; [Holien, Jessica K.; Parker, Michael W.] St Vincents Inst Med Res, Biota Struct Biol Lab, Fitzroy, Vic 3065, Australia; [Holien, Jessica K.; Parker, Michael W.] St Vincents Inst Med Res, Australian Canc Res Fund ACRF Rat Drug Discovery, Fitzroy, Vic 3065, Australia; [Parker, Michael W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Guthridge, Mark A.] Monash Univ, Div Blood Canc, Australian Ctr Blood Dis, Alfred Med Res & Educ Precinct, Melbourne, Vic 3004, Australia	SA Pathology; St. Vincent's Institute of Medical Research; St. Vincent's Institute of Medical Research; University of Melbourne; Monash University	Guthridge, MA (corresponding author), Monash Univ, Div Blood Canc, Australian Ctr Blood Dis, 89 Commercial Rd, Melbourne, Vic 3004, Australia.	mark.guthridge@monash.edu	Parker, Michael W/F-9069-2013; Holien, Jess/V-7005-2019; guthridge, mark a/I-1889-2014	Parker, Michael W/0000-0002-3101-1138; Holien, Jess/0000-0002-8735-2871; guthridge, mark a/0000-0002-0536-3471; Lonic, Ana/0000-0003-4404-9095; Powell, jason/0000-0001-8493-9178	National Health and Medical Research Council of Australia; Victorian Government Operational Infrastructure Support Scheme	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government Operational Infrastructure Support Scheme	This work was supported by grants from the National Health and Medical Research Council of Australia and by funds from the Victorian Government Operational Infrastructure Support Scheme to St. Vincent's Institute.	Bae JH, 2009, CELL, V138, P514, DOI 10.1016/j.cell.2009.05.028; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Brodie C, 1999, CELL GROWTH DIFFER, V10, P183; Corbit KC, 1999, MOL CELL BIOL, V19, P4209; Cross MJ, 2002, MOL BIOL CELL, V13, P2881, DOI 10.1091/mbc.E02-02-0103; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Foehr ED, 2001, J BIOL CHEM, V276, P37529, DOI 10.1074/jbc.M103234200; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Guthridge MA, 2007, BIOCHEM SOC T, V35, P250, DOI 10.1042/BST0350250; Guthridge MA, 2000, MOL CELL, V6, P99, DOI 10.1016/S1097-2765(00)00011-3; Guthridge MA, 2004, BLOOD, V103, P820, DOI 10.1182/blood-2003-06-1999; Guthridge MA, 1996, ONCOGENE, V12, P1267; Hyde R, 2011, GENES BRAIN BEHAV, V10, P286, DOI 10.1111/j.1601-183X.2010.00667.x; Kissel H, 2000, EMBO J, V19, P1312, DOI 10.1093/emboj/19.6.1312; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Larsson H, 1999, J BIOL CHEM, V274, P25726, DOI 10.1074/jbc.274.36.25726; Lin HY, 1998, MOL CELL BIOL, V18, P3762, DOI 10.1128/MCB.18.7.3762; Lonic A, 2008, MOL CELL BIOL, V28, P3372, DOI 10.1128/MCB.01837-07; Maina F, 2001, MOL CELL, V7, P1293, DOI 10.1016/S1097-2765(01)00261-1; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; McNeil LK, 2005, P NATL ACAD SCI USA, V102, P13574, DOI 10.1073/pnas.0505110102; MOHAMMADI M, 1992, NATURE, V358, P681, DOI 10.1038/358681a0; Mohammadi M, 1996, MOL CELL BIOL, V16, P977; Molzan M, 2012, J MOL BIOL, V423, P486, DOI 10.1016/j.jmb.2012.08.009; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nelson TJ, 2009, TRENDS BIOCHEM SCI, V34, P136, DOI 10.1016/j.tibs.2008.11.006; Oksvold MP, 2004, FEBS LETT, V569, P207, DOI 10.1016/j.febslet.2004.05.068; Olayioye MA, 2003, J BIOL CHEM, V278, P32929, DOI 10.1074/jbc.M302910200; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Ortega S, 1998, P NATL ACAD SCI USA, V95, P5672, DOI 10.1073/pnas.95.10.5672; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Powell JA, 2009, BLOOD, V114, P4859, DOI 10.1182/blood-2009-02-204818; Raffioni S, 1999, P NATL ACAD SCI USA, V96, P7178, DOI 10.1073/pnas.96.13.7178; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Schuller AC, 2008, BIOCHEM J, V410, P205, DOI 10.1042/BJ20070859; Shirai Y, 2008, FEBS J, V275, P3988, DOI 10.1111/j.1742-4658.2008.06556.x; SPIVAKKROIZMAN T, 1994, J BIOL CHEM, V269, P14419; Sun MK, 2009, P NATL ACAD SCI USA, V106, P14676, DOI 10.1073/pnas.0907842106; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; WOOTEN MW, 1994, CELL GROWTH DIFFER, V5, P395; Yang HJ, 2008, J BIOL CHEM, V283, P5287, DOI 10.1074/jbc.M706917200; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Zheng Y, 2005, BLOOD, V105, P3648, DOI 10.1182/blood-2004-10-3916	51	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14874	14885		10.1074/jbc.M112.421669	http://dx.doi.org/10.1074/jbc.M112.421669			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23564461	Green Published, hybrid			2022-12-28	WOS:000319452100019
J	Xue, H; Xiao, ZC; Zhang, J; Wen, J; Wang, Y; Chang, Z; Zhao, J; Gao, X; Du, J; Chen, YG				Xue, Hua; Xiao, Zhicheng; Zhang, Jing; Wen, Jun; Wang, Yuan; Chang, Zai; Zhao, Jing; Gao, Xiang; Du, Jie; Chen, Ye-Guang			Disruption of the Dapper3 Gene Aggravates Ureteral Obstruction-mediated Renal Fibrosis by Amplifying Wnt/beta-catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTING DISHEVELLED DEGRADATION; BETA-CATENIN; INTERSTITIAL FIBROSIS; WNT; MICE; EXPRESSION; PATHWAY; TRANSDUCTION; NEPHROPATHY; PROGRESSION	Wnt/beta-catenin signaling plays key roles in embryonic development and tissue homeostasis. Dapper3/Dact3, one of the three members of the Dapper gene family, is transcriptionally repressed in colorectal cancer and may function as a negative regulator of Wnt/beta-catenin signaling. To investigate its physiological functions, we generated a mouse strain harboring conditional null alleles of Dapper3 (Dapper3(flox/flox)), and homozygous Dapper3-deficient (Dapper3(-)/(-)) mice were produced after crossing with EIIa-cre transgenic mice. We found that Dapper3 is not essential for mouse embryogenesis, postnatal survival, and reproduction. However, adult Dapper3(-)/(-) mice exhibited a mild reduction in body weight compared with their wild-type littermates, suggesting a functional role of Dapper3 in postnatal growth. To investigate the role of Dapper3 in renal fibrosis, we employed the unilateral ureteral obstruction model. Dapper3 mRNA expression was up-regulated in kidney after unilateral ureteral obstruction. Loss of the Dapper3 gene enhanced myofibroblast activation and extracellular matrix overproduction in the obstructed kidney. Moreover, this aggravated fibrotic phenotype was accompanied with accumulation of Dishevelled2 and beta-catenin proteins and activation of Wnt-targeted fibrotic genes. In primary renal tubular cells, Dapper3 inhibits Wnt-induced epithelial-to-mesenchymal transition. Consistently, Dapper3 interacted with and down-regulated Dishevelled2 protein and attenuated the Wnt-responsive Topflash reporter expression. These findings together suggest that Dapper3 antagonizes the fibrotic actions of Wnt signaling in kidney.	[Xue, Hua; Wen, Jun; Wang, Yuan; Chang, Zai; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Xiao, Zhicheng; Zhang, Jing; Du, Jie] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing An Zhen Hosp, Beijing 100029, Peoples R China; [Xiao, Zhicheng; Zhang, Jing; Du, Jie] Minist Educ, Key Lab Remodeling Related Cardiovasc Dis, Beijing 100029, Peoples R China; [Zhao, Jing; Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, Minist Educ, Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China	Tsinghua University; Capital Medical University; Nanjing University	Du, J (corresponding author), Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing An Zhen Hosp, Beijing 100029, Peoples R China.	jdu@bcm.edu; ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019; zhao, jing/B-3868-2019		National Natural Science Foundation of China [30930050, 31221064, 31090363]; 973 Program [2011CB943803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (30930050, 31221064, 31090363) and the 973 Program (2011CB943803).	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Chan DW, 2006, GASTROENTEROLOGY, V131, P1218, DOI 10.1053/j.gastro.2006.07.020; Cheng JZ, 2010, KIDNEY INT, V78, P668, DOI 10.1038/ki.2010.214; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Diamond JR, 1998, SEMIN NEPHROL, V18, P594; Fisher DA, 2006, DEV DYNAM, V235, P2620, DOI 10.1002/dvdy.20917; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gao X, 2008, J BIOL CHEM, V283, P35679, DOI 10.1074/jbc.M804088200; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; He WC, 2010, J BIOL CHEM, V285, P24665, DOI 10.1074/jbc.M109.091256; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Katoh M, 2003, INT J ONCOL, V22, P907; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; MACKENSENHAEN S, 1981, CLIN NEPHROL, V15, P167; Malbon CC, 2006, CURR TOP DEV BIOL, V72, P153, DOI 10.1016/S0070-2153(05)72002-0; Meng FW, 2008, J CELL SCI, V121, P2904, DOI 10.1242/jcs.032417; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Nelson PJ, 2011, EXPERT OPIN THER TAR, V15, P1073, DOI 10.1517/14728222.2011.588210; Nguyen HT, 1999, LAB INVEST, V79, P647; Risdon R., 1968, LANCET, V292, P363; Schainuck L I, 1970, Hum Pathol, V1, P631, DOI 10.1016/S0046-8177(70)80061-2; Shi Y, 2012, INT J INF TECH DECIS, V11, P1, DOI 10.1142/S0219622012010018; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Striker G E, 1970, Hum Pathol, V1, P615, DOI 10.1016/S0046-8177(70)80060-0; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Su Y, 2007, FASEB J, V21, P682, DOI 10.1096/fj.06-6246com; Surendran K, 2005, J AM SOC NEPHROL, V16, P2373, DOI 10.1681/ASN.2004110949; Surendran K, 2004, KIDNEY INT, V65, P2212, DOI 10.1111/j.1523-1755.2004.00641.x; Surendran K, 2002, AM J PHYSIOL-RENAL, V282, pF431, DOI 10.1152/ajprenal.0009.2001; Suriben R, 2009, NAT GENET, V41, P977, DOI 10.1038/ng.435; Waxman JS, 2004, DEVELOPMENT, V131, P5909, DOI 10.1242/dev.01520; Wen J, 2010, J BIOL CHEM, V285, P11023, DOI 10.1074/jbc.M109.085381; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Yau TO, 2005, ONCOGENE, V24, P1607, DOI 10.1038/sj.onc.1208340; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhang LX, 2004, SCIENCE, V306, P114, DOI 10.1126/science.1100569	42	18	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15006	15014		10.1074/jbc.M113.458448	http://dx.doi.org/10.1074/jbc.M113.458448			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23580654	Green Published, hybrid			2022-12-28	WOS:000319452100030
J	Halder, UC; Bhowmick, R; Mukherjee, TR; Nayak, MK; Chawla-Sarkar, M				Halder, Umesh Chandra; Bhowmick, Rahul; Mukherjee, Tapasi Roy; Nayak, Mukti Kant; Chawla-Sarkar, Mamta			Phosphorylation Drives an Apoptotic Protein to Activate Antiapoptotic Genes PARADIGM OF INFLUENZA A MATRIX 1 PROTEIN FUNCTION (Publication with Expression of Concern. See vol. 294, pg. 15120, 2019) (Withdrawn Publication. See vol. 295, pg. 13957, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							PROMYELOCYTIC-LEUKEMIA-PROTEIN; A VIRUS-INFECTION; NF-KAPPA-B; CELL-DEATH; HISTONE CHAPERONE; MATRIX PROTEIN; DAXX; P53; RELB; DNA	During infection, viral proteins target cellular pathways that regulate cellular innate immune responses and cell death. We demonstrate that influenza A virus matrix 1 protein (M1), an established proapoptotic protein, activates nuclear factor-kappa B member RelB-mediated survival genes (cIAP1, cIAP2, and cFLIP), a function that is linked with its nuclear translocation during early infection. Death domain-associated protein 6 (Daxx) is a transcription co-repressor of the RelB-responsive gene promoters. During influenza virus infection M1 binds to and stabilizes Daxx protein by preventing its ubiquitination and proteasomal degradation. Binding of M1 with Daxx through its Daxx binding motif prevents binding of RelB and Daxx, resulting in up-regulation of survival genes. This interaction also prevents promoter recruitment of DNA methyltransferases (Dnmt1 and Dnmt3a) and lowers CpG methylation of the survival gene promoters, leading to the activation of these genes. Thus, M1 prevents repressional function of Daxx during infection, thereby exerting a survival role. In addition to its nuclear localization signal, translocation of M1 to the nucleus depends on cellular kinase-mediated phosphorylation as the protein kinase C inhibitor calphostin C effectively down-regulates virus replication. The study reconciles the ambiguity of dual antagonistic function of viral protein and potentiates a possible target to limit virus infection.	[Chawla-Sarkar, Mamta] Natl Inst Cholera & Enter Dis, Div Virol, Scheme XM, Kolkata 700010, W Bengal, India; [Nayak, Mukti Kant] Univ Calcutta, Dept Zool, Kolkata 700019, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); University of Calcutta	Chawla-Sarkar, M (corresponding author), Natl Inst Cholera & Enter Dis, Div Virol, Scheme XM, P-33 CIT Rd, Kolkata 700010, W Bengal, India.	chawlam70@gmail.com			Indian Council of Medical Research (ICMR), India; ICMR; University Grants Commission, India; Council of Scientific and Industrial Research, India	Indian Council of Medical Research (ICMR), India(Indian Council of Medical Research (ICMR)); ICMR(Indian Council of Medical Research (ICMR)); University Grants Commission, India(University Grants Commission, India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by the Indian Council of Medical Research (ICMR), India.; Supported by a senior research fellowship from the Council of Scientific and Industrial Research, India.; Supported by the ICMR.; Supported by the University Grants Commission, India.	Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Bischof O, 2005, MOL CELL BIOL, V25, P1013, DOI 10.1128/MCB.25.3.1013-1024.2005; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Croxton R, 2006, CANCER RES, V66, P9026, DOI 10.1158/0008-5472.CAN-06-1047; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Ecsedy JA, 2003, MOL CELL BIOL, V23, P950, DOI 10.1128/MCB.23.3.950-960.2003; Elmore LW, 1997, P NATL ACAD SCI USA, V94, P14707, DOI 10.1073/pnas.94.26.14707; Elsasser SJ, 2012, NATURE, V491, P560, DOI 10.1038/nature11608; Escobar-Cabrera E, 2010, STRUCTURE, V18, P1642, DOI 10.1016/j.str.2010.09.016; Everett RD, 2001, ONCOGENE, V20, P7266, DOI 10.1038/sj.onc.1204759; Guccione E, 2004, ONCOGENE, V23, P4662, DOI 10.1038/sj.onc.1207631; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Halder UC, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.75; HENDERSON S, 1993, P NATL ACAD SCI USA, V90, P8479, DOI 10.1073/pnas.90.18.8479; Herzer K, 2005, CANCER RES, V65, P10830, DOI 10.1158/0008-5472.CAN-05-0880; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hollenbach AD, 2002, J CELL SCI, V115, P3319; Hoppe A, 2006, J VIROL, V80, P3042, DOI 10.1128/JVI.80.6.3042-3049.2006; HUPRIKAR J, 1980, J VIROL METHODS, V1, P117, DOI 10.1016/0166-0934(80)90020-8; Jabbour AM, 2002, CELL DEATH DIFFER, V9, P1311, DOI 10.1038/sj.cdd.4401135; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; JIANG D, 1993, ONCOGENE, V8, P2805; Josset L, 2008, J CLIN VIROL, V43, P381, DOI 10.1016/j.jcv.2008.08.017; Julkunen I, 2001, CYTOKINE GROWTH F R, V12, P171, DOI 10.1016/S1359-6101(00)00026-5; Khelifi AF, 2005, CELL DEATH DIFFER, V12, P724, DOI 10.1038/sj.cdd.4401559; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Lan KH, 2002, ONCOGENE, V21, P4801, DOI 10.1038/sj.onc.1205589; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Lilyestrom W, 2006, GENE DEV, V20, P2373, DOI 10.1101/gad.1456306; McNally BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002277; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MIURA M, 1995, P NATL ACAD SCI USA, V92, P8318, DOI 10.1073/pnas.92.18.8318; Muromoto R, 2004, J IMMUNOL, V172, P2985, DOI 10.4049/jimmunol.172.5.2985; Perez D, 2000, MOL CELL, V6, P53, DOI 10.1016/S1097-2765(00)00007-1; Puto LA, 2008, GENE DEV, V22, P998, DOI 10.1101/gad.1632208; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; Reinhardt J, 2000, VET MICROBIOL, V74, P87, DOI 10.1016/S0378-1135(00)00169-3; Rippo MR, 2004, ONCOGENE, V23, P7753, DOI 10.1038/sj.onc.1208051; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; Sarid R, 1997, NAT MED, V3, P293, DOI 10.1038/nm0397-293; Sato Y, 2003, VIROLOGY, V310, P29, DOI 10.1016/S0042-6822(03)00104-1; Sato Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000530; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Tavalai N, 2008, J VIROL, V82, P126, DOI 10.1128/JVI.01685-07; THOMAS M, 1995, ONCOGENE, V10, P261; Tsai K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002376; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; WHITTAKER G, 1995, J VIROL, V69, P439, DOI 10.1128/JVI.69.1.439-445.1995; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; YE ZP, 1995, J VIROL, V69, P1964, DOI 10.1128/JVI.69.3.1964-1970.1995; Zoog SJ, 2002, EMBO J, V21, P5130	64	15	15	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14554	14568		10.1074/jbc.M112.447086	http://dx.doi.org/10.1074/jbc.M112.447086			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23548901	Green Published, hybrid			2022-12-28	WOS:000319253500057
J	Sun, T; Yu, N; Zhai, LK; Li, N; Zhang, C; Zhou, L; Huang, Z; Jiang, XY; Shen, Y; Chen, ZY				Sun, Tao; Yu, Nuo; Zhai, Lu-Kai; Li, Na; Zhang, Chao; Zhou, Liang; Huang, Zhuo; Jiang, Xing-Yu; Shen, Ying; Chen, Zhe-Yu			c-Jun NH2-terminal Kinase (JNK)-interacting Protein-3 (JIP3) Regulates Neuronal Axon Elongation in a Kinesin- and JNK-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; IN-VIVO ELECTROPORATION; CENTRAL-NERVOUS-SYSTEM; SCAFFOLD PROTEIN; SIGNALING PATHWAY; CORTICAL-NEURONS; NEURITE OUTGROWTH; CELL-MIGRATION; TRANSPORT; GROWTH	The development of neuronal polarity is essential for the establishment of the accurate patterning of neuronal circuits in the brain. However, little is known about the underlying molecular mechanisms that control rapid axon elongation during neuronal development. Here, we report that c-Jun NH2-terminal kinase (JNK)-interacting protein-3 (JIP3) is highly expressed at axon tips during the critical period for axon development. Using gain- and loss-of-function approaches, immunofluorescence analysis, and in utero electroporation, we find that JIP3 can enhance axon elongation in primary hippocampal neurons and cortical neurons in vivo. We further demonstrate that JIP3 promotes axon elongation in a kinesin- and JNK-dependent manner using several deletion mutants of JIP3. Next, we demonstrate that the successful transportation of JIP3 to axon tips by kinesin is a prerequisite for enhancing JNK phosphorylation in this area and therefore promotes axon elongation, constituting a novel mechanism for coupling JIP3 anterograde transport with JNK signaling at the distal axons and axon elongation. Finally, our immunofluorescence data suggest that the activation of JNK at axon tips facilitates axon elongation by modulating cofilin activity and actin filament dynamics. These findings may have important implications for our understanding of neuronal axon elongation during development.	[Sun, Tao; Yu, Nuo; Zhai, Lu-Kai; Li, Na; Zhang, Chao; Chen, Zhe-Yu] Shandong Univ, Sch Med, Dept Neurobiol, Shandong Prov Key Lab Mental Disorders, Jinan 250012, Shandong, Peoples R China; [Zhou, Liang; Shen, Ying] Zhejiang Univ, Sch Med, Zhejiang Prov Key Lab Neurobiol, Key Lab Med Neurobiol,Minist Hlth,Dept Neurobiol, Hangzhou 310058, Zhejiang, Peoples R China; [Huang, Zhuo; Jiang, Xing-Yu] Chinese Acad Sci, Natl Ctr Nanosci & Technol, Key Lab Biol Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China	Shandong University; Zhejiang University; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China	Chen, ZY (corresponding author), Shandong Univ, Sch Med, Dept Neurobiol, Shandong Prov Key Lab Mental Disorders, 4 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	zheyuchen@sdu.edu.cn	jiang, xingyu/U-3976-2018; shen, ying/HHS-5635-2022	jiang, xingyu/0000-0002-5008-4703; Zhang, Chao/0000-0001-5930-3602	National Natural Science Foundation of China [31071254, 31130026, 51073045]; National 973 Basic Research Program of China [2012CB911000, 2009CB941403]; State Program of National Natural Science Foundation of China for Innovative Research Group Grant [81021001]; Independent Innovation Foundation of Shandong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Program of China(National Basic Research Program of China); State Program of National Natural Science Foundation of China for Innovative Research Group Grant; Independent Innovation Foundation of Shandong University	This work was supported by National Natural Science Foundation of China Grants 31071254, 31130026, and 51073045, National 973 Basic Research Program of China Grants 2012CB911000 and 2009CB941403, State Program of National Natural Science Foundation of China for Innovative Research Group Grant 81021001, and the Independent Innovation Foundation of Shandong University.	Akechi M, 2001, NEUROSCI RES, V39, P391, DOI 10.1016/S0168-0102(01)00194-8; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Barnat M, 2010, J NEUROSCI, V30, P7804, DOI 10.1523/JNEUROSCI.0372-10.2010; Bilimoria PM, 2010, J NEUROSCI, V30, P16766, DOI 10.1523/JNEUROSCI.1362-10.2010; Bjorkblom B, 2005, J NEUROSCI, V25, P6350, DOI 10.1523/JNEUROSCI.1517-05.2005; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Dajas-Ballador F, 2008, CURR BIOL, V18, P221, DOI 10.1016/j.cub.2008.01.025; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Fass Joseph, 2004, Anatomical Science International, V79, P173, DOI 10.1111/j.1447-073x.2004.00087.x; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079; Gehler S, 2004, J NEUROSCI, V24, P10741, DOI 10.1523/JNEUROSCI.2836-04.2004; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hammond JW, 2008, TRAFFIC, V9, P725, DOI 10.1111/j.1600-0854.2008.00722.x; Hatanaka Y, 2002, J COMP NEUROL, V454, P1, DOI 10.1002/cne.10421; Hatanaka Y, 2013, CEREB CORTEX, V23, P105, DOI 10.1093/cercor/bhr383; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Huang SH, 2011, J NEUROSCI, V31, P10602, DOI 10.1523/JNEUROSCI.0436-11.2011; Ito M, 1999, MOL CELL BIOL, V19, P7539; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; Kelkar N, 2003, P NATL ACAD SCI USA, V100, P9843, DOI 10.1073/pnas.1733944100; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Li Y, 2007, ANGEW CHEM INT EDIT, V46, P1094, DOI 10.1002/anie.200603844; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Matsuura H, 2002, J BIOL CHEM, V277, P40703, DOI 10.1074/jbc.M202004200; Meberg PJ, 2000, J NEUROSCI, V20, P2459; Ng JL, 2004, NEURON, V44, P779, DOI 10.1016/j.neuron.2004.11.014; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Oliva AA, 2006, J NEUROSCI, V26, P9462, DOI 10.1523/JNEUROSCI.2625-06.2006; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Sanyal S, 2002, NATURE, V416, P870, DOI 10.1038/416870a; Shmueli O, 2001, HUM MOL GENET, V10, P1061, DOI 10.1093/hmg/10.10.1061; Srahna M, 2006, PLOS BIOL, V4, P2076, DOI 10.1371/journal.pbio.0040348; Sun FN, 2011, EMBO J, V30, P3416, DOI 10.1038/emboj.2011.229; Suzuki A, 2010, FEBS LETT, V584, P2801, DOI 10.1016/j.febslet.2010.05.020; Tabata H, 2003, J NEUROSCI, V23, P9996; Tabata H, 2008, DEV GROWTH DIFFER, V50, P507, DOI [10.1111/j.1440-169x.2008.01043.x, 10.1111/j.1440-169X.2008.01043.x]; Takino T, 2005, J BIOL CHEM, V280, P37772, DOI 10.1074/jbc.M505241200; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Waetzig V, 2006, PROG NEUROBIOL, V80, P84, DOI 10.1016/j.pneurobio.2006.08.002; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Won KJ, 2008, J PHARMACOL SCI, V108, P372, DOI 10.1254/jphs.FP0072354; Xia CH, 2003, J CELL BIOL, V161, P55, DOI 10.1083/jcb.200301026; Xu H, 2010, J BIOL CHEM, V285, P3548, DOI 10.1074/jbc.M109.064113; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Zhao L, 2009, J CELL SCI, V122, P3123, DOI 10.1242/jcs.047712; Zheng W, 2012, CEREB CORTEX, V22, P2587, DOI 10.1093/cercor/bhr330	57	41	42	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14531	14543		10.1074/jbc.M113.464453	http://dx.doi.org/10.1074/jbc.M113.464453			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23576431	hybrid, Green Published			2022-12-28	WOS:000319253500055
J	Atsumi, Y; Inase, A; Osawa, T; Sugihara, E; Sakasai, R; Fujimori, H; Teraoka, H; Saya, H; Kanno, M; Tashiro, F; Nakagama, H; Masutani, M; Yoshioka, K				Atsumi, Yuko; Inase, Aki; Osawa, Tomoyuki; Sugihara, Eiji; Sakasai, Ryo; Fujimori, Hiroaki; Teraoka, Hirobumi; Saya, Hideyuki; Kanno, Masamoto; Tashiro, Fumio; Nakagama, Hitoshi; Masutani, Mitsuko; Yoshioka, Ken-ichi			The Arf/p53 Protein Module, Which Induces Apoptosis, Down-regulates Histone H2AX to Allow Normal Cells to Survive in the Presence of Anti-cancer Drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR SUPPRESSION; COLORECTAL-CANCER; DNA-DAMAGE; HOMOLOGOUS RECOMBINATION; TARGETED THERAPIES; CHEMOTHERAPY; P53; GAMMA-H2AX; POLY(ADP-RIBOSE); RECOGNITION	Anti-cancer drugs generally target cancer cells rather than normal somatic cells. However, the factors that determine this differential sensitivity are poorly understood. Here we show that Arf/p53-dependent down-regulation of H2AX induced the selective survival of normal cells after drug treatment, resulting in the preferential targeting of cancer cells. Treatment with camptothecin, a topoisomerase I inhibitor, caused normal cells to down-regulate H2AX and become quiescent, a process mediated by both Arf and p53. In contrast, transformed cells that harbor mutations in either Arf or p53 do not down-regulate H2AX and are more sensitive to drugs unless they have developed drug resistance. Such transformation-associated changes in H2AX expression rendered cancer cells more susceptible to drug-induced damage (by two orders of magnitude). Thus, the expression of H2AX and gamma H2AX (phosphorylated form of H2AX at Ser-139) is a critical factor that determines drug sensitivity and should be considered when administering chemotherapy.	[Atsumi, Yuko; Osawa, Tomoyuki; Fujimori, Hiroaki; Masutani, Mitsuko; Yoshioka, Ken-ichi] Natl Canc Ctr, Div Genome Stabil Res, Chuo Ku, Tokyo 1040045, Japan; [Inase, Aki; Nakagama, Hitoshi] Natl Canc Ctr, Div Canc Dev Syst, Chuo Ku, Tokyo 1040045, Japan; [Atsumi, Yuko] Kitasato Univ, Sch Sci, Dept Biosci, Minami Ku, Sagamihara, Kanagawa 2288555, Japan; [Osawa, Tomoyuki; Tashiro, Fumio] Tokyo Univ Sci, Katsushika Ku, Tokyo 1258585, Japan; [Sugihara, Eiji; Saya, Hideyuki] Keio Univ, Sch Med, Div Gene Regulat, Shinjuku Ku, Tokyo 1608582, Japan; [Sakasai, Ryo; Teraoka, Hirobumi] Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Biochem, Chiyoda Ku, Kandasurugadai, Tokyo 1010062, Japan; [Kanno, Masamoto] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Immunol, Minami Ku, Hiroshima 7348551, Japan	National Cancer Center - Japan; National Cancer Center - Japan; Kitasato University; Tokyo University of Science; Keio University; Tokyo Medical & Dental University (TMDU); Hiroshima University	Yoshioka, K (corresponding author), Natl Canc Ctr, Div Genome Stabil Res, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	kyoshiok@ncc.go.jp	Sugihara, Eiji/J-8058-2013; Saya, Hideyuki/J-4325-2013	Sugihara, Eiji/0000-0002-3233-1045; Saya, Hideyuki/0000-0001-6610-1902; Sakasai, Ryo/0000-0002-4495-5437	National Cancer Center Research and Development Fund [23-C-10]; MEXT KAKENHI [20770136]; Foundation for Promotion of Cancer Research; Grants-in-Aid for Scientific Research [23616003, 23501271] Funding Source: KAKEN	National Cancer Center Research and Development Fund(National Cancer Center - Japan); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Foundation for Promotion of Cancer Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by National Cancer Center Research and Development Fund Grant 23-C-10, by a grant-in-aid and the Third Term Comprehensive 10-Year Strategy for Cancer Control, and by Grants-in-Aid for Scientific Research MEXT KAKENHI Grant 20770136. This work was also supported by a research resident fellowship from the Foundation for Promotion of Cancer Research (to A. I.).	Atsumi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023432; Bassing CH, 2004, CELL CYCLE, V3, P149; Bernier J, 2005, NAT CLIN PRACT ONCOL, V2, P305, DOI 10.1038/ncponc0201; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Chaudhuri AR, 2012, NAT STRUCT MOL BIOL, V19, P417, DOI 10.1038/nsmb.2258; Dimitrova N, 2006, GENE DEV, V20, P3238, DOI 10.1101/gad.1496606; Ding HF, 1998, CRIT REV ONCOGENESIS, V9, P83, DOI 10.1615/CritRevOncog.v9.i1.60; Druker BJ, 2003, J CLIN ONCOL, V21, p239S, DOI 10.1200/JCO.2003.10.589; Folprecht G, 2005, NAT CLIN PRACT ONCOL, V2, P578, DOI 10.1038/ncponc0353; Fujimori H, 2012, J BIOL CHEM, V287, P36777, DOI 10.1074/jbc.M112.372557; Hochegger H, 2006, EMBO J, V25, P1305, DOI 10.1038/sj.emboj.7601015; Ichijima Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008821; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Liebermann DA, 2007, CELL CYCLE, V6, P166, DOI 10.4161/cc.6.2.3789; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lu C, 2009, APOPTOSIS, V14, P597, DOI 10.1007/s10495-009-0330-1; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Matheu A, 2008, CANCER RES, V68, P6031, DOI 10.1158/0008-5472.CAN-07-6851; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Midgley R, 2005, NAT CLIN PRACT ONCOL, V2, P364, DOI 10.1038/ncponc0228; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Rao VA, 2005, MOL CELL BIOL, V25, P8925, DOI 10.1128/MCB.25.20.8925-8937.2005; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Reni M, 2007, CANCER LETT, V256, P25, DOI 10.1016/j.canlet.2007.04.009; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sugimura K, 2008, J CELL BIOL, V183, P1203, DOI 10.1083/jcb.200806068; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Vincenzi B, 2008, NAT CLIN PRACT ONCOL, V5, P455, DOI 10.1038/ncponc1137; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Yoshioka K, 2012, INT J MOL SCI, V13, P6492, DOI 10.3390/ijms13056492; Zawacka-Pankau J, 2008, TOXICOL APPL PHARM, V232, P487, DOI 10.1016/j.taap.2008.07.012; Zhang YW, 2011, NUCLEIC ACIDS RES, V39, P3607, DOI 10.1093/nar/gkq1304; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	42	24	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13269	13277		10.1074/jbc.M112.402560	http://dx.doi.org/10.1074/jbc.M112.402560			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23536184	Green Published, hybrid			2022-12-28	WOS:000318850300013
J	Girvan, HM; Munro, AW				Girvan, Hazel M.; Munro, Andrew W.			Heme Sensor Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SOLUBLE GUANYLYL CYCLASE; REV-ERB-BETA; THIOL/DISULFIDE REDOX SWITCH; GAS-RESPONSIVE TRANSCRIPTION; IRON-DEPENDENT DEGRADATION; REGULATOR IRR PROTEIN; FACTOR 2-ALPHA KINASE; OXYGEN SENSOR; NITRIC-OXIDE; MYCOBACTERIUM-TUBERCULOSIS	Heme is a prosthetic group best known for roles in oxygen transport, oxidative catalysis, and respiratory electron transport. Recent years have seen the roles of heme extended to sensors of gases such as O-2 and NO and cell redox state, and as mediators of cellular responses to changes in intracellular levels of these gases. The importance of heme is further evident from identification of proteins that bind heme reversibly, using it as a signal, e. g. to regulate gene expression in circadian rhythm pathways and control heme synthesis itself. In this minireview, we explore the current knowledge of the diverse roles of heme sensor proteins.	[Girvan, Hazel M.; Munro, Andrew W.] Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England	University of Manchester	Munro, AW (corresponding author), Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England.	andrew.munro@manchester.ac.uk	Munro, Andrew/G-5639-2019	Munro, Andrew/0000-0002-4642-180X; Girvan, Hazel/0000-0003-2299-8644	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G008558/1, BB/K001884/1]; Biotechnology and Biological Sciences Research Council [BB/F014252/1, BB/G008558/1] Funding Source: researchfish; BBSRC [BB/F014252/1, BB/G008558/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grants BB/G008558/1 and BB/K001884/1 from the Biotechnology and Biological Sciences Research Council (BBSRC; to A. W. M. and supporting H. M. G.). This is the fifth article in the Thematic Minireview Series on Metals in Biology 2013.	Aicart-Ramos C, 2012, BIOCHEMISTRY-US, V51, P7403, DOI 10.1021/bi300848x; Aono S, 1998, J BIOL CHEM, V273, P25757, DOI 10.1074/jbc.273.40.25757; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Baker HM, 2003, P NATL ACAD SCI USA, V100, P3579, DOI 10.1073/pnas.0637295100; Barr I, 2012, P NATL ACAD SCI USA, V109, P1919, DOI 10.1073/pnas.1114514109; Barr I, 2011, J BIOL CHEM, V286, P16716, DOI 10.1074/jbc.M110.180844; BINDER R, 1994, EMBO J, V13, P1969, DOI 10.1002/j.1460-2075.1994.tb06466.x; Boon EM, 2005, NAT CHEM BIOL, V1, P53, DOI 10.1038/nchembio704; Borjigin M, 2007, ACTA CRYSTALLOGR D, V63, P282, DOI 10.1107/S0907444906051638; Chefalo PJ, 1998, EUR J BIOCHEM, V258, P820, DOI 10.1046/j.1432-1327.1998.2580820.x; Cho HY, 2009, J BIOL CHEM, V284, P13057, DOI 10.1074/jbc.M808905200; Clark RW, 2007, J BIOL INORG CHEM, V12, P139, DOI 10.1007/s00775-006-0168-8; Crumbley C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017290; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Dycke C, 2007, BIOCHEM J, V408, P429, DOI 10.1042/BJ20070983; Erbil WK, 2009, P NATL ACAD SCI USA, V106, P19753, DOI 10.1073/pnas.0911645106; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Farhana A, 2012, ANTIOXID REDOX SIGN, V17, P1232, DOI 10.1089/ars.2012.4613; Gadalla MM, 2010, J NEUROCHEM, V113, P14, DOI 10.1111/j.1471-4159.2010.06580.x; Gardner JD, 2010, J BIOL INORG CHEM, V15, P1117, DOI 10.1007/s00775-010-0672-8; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; GILLESGONZALEZ MA, 1995, BIOCHEMISTRY-US, V34, P232, DOI 10.1021/bi00001a027; Gong WM, 1998, P NATL ACAD SCI USA, V95, P15177, DOI 10.1073/pnas.95.26.15177; Green J, 2009, CURR OPIN MICROBIOL, V12, P145, DOI 10.1016/j.mib.2009.01.008; Gupta N, 2011, J BIOL CHEM, V286, P4392, DOI 10.1074/jbc.M110.193466; Hach A, 1999, MOL CELL BIOL, V19, P4324; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Han YC, 2007, MOL MICROBIOL, V64, P1090, DOI 10.1111/j.1365-2958.2007.05724.x; Hao B, 2002, BIOCHEMISTRY-US, V41, P12952, DOI 10.1021/bi020144l; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Ibrahim M, 2007, J INORG BIOCHEM, V101, P1776, DOI 10.1016/j.jinorgbio.2007.07.010; Ibrahim M, 2010, BIOCHEMISTRY-US, V49, P4864, DOI 10.1021/bi100506j; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Ioanoviciu A, 2007, BIOCHEMISTRY-US, V46, P4250, DOI 10.1021/bi602422p; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; Ishitsuka Y, 2008, BIOCHEMISTRY-US, V47, P8874, DOI 10.1021/bi800248c; Jaggar JH, 2005, CIRC RES, V97, P805, DOI 10.1161/01.RES.0000186180.47148.7b; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kang DK, 2003, J BIOL CHEM, V278, P14857, DOI 10.1074/jbc.M300616200; Koglin M, 2003, J BIOL CHEM, V278, P12590, DOI 10.1074/jbc.M212740200; Koglin M, 2001, J BIOL CHEM, V276, P30737, DOI 10.1074/jbc.M102549200; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; Lee JM, 2008, J BACTERIOL, V190, P6795, DOI 10.1128/JB.00401-08; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Martin E, 2012, BIOCHEMISTRY-US, V51, P2737, DOI 10.1021/bi300105s; Marvin KA, 2008, BIOCHEMISTRY-US, V47, P9016, DOI 10.1021/bi800486x; Marvin KA, 2009, BIOCHEMISTRY-US, V48, P7056, DOI 10.1021/bi900697c; McCoubrey WK, 1997, J BIOL CHEM, V272, P12568, DOI 10.1074/jbc.272.19.12568; Munakata H, 2004, J BIOCHEM, V136, P233, DOI 10.1093/jb/mvh112; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Pantopoulos K, 2012, BIOCHEMISTRY-US, V51, P5705, DOI 10.1021/bi300752r; Pardee KI, 2009, PLOS BIOL, V7, P384, DOI 10.1371/journal.pbio.1000043; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Puranik M, 2004, J BIOL CHEM, V279, P21096, DOI 10.1074/jbc.M400613200; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; RIDDLE RD, 1989, P NATL ACAD SCI USA, V86, P792, DOI 10.1073/pnas.86.3.792; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Roberts GP, 2001, PROG NUCLEIC ACID RE, V67, P35, DOI 10.1016/S0079-6603(01)67024-7; Rodgers KR, 2005, J INORG BIOCHEM, V99, P963, DOI 10.1016/j.jinorgbio.2005.02.016; Russwurm M, 2004, EMBO J, V23, P4443, DOI 10.1038/sj.emboj.7600422; Sasakura Y, 2006, ACCOUNTS CHEM RES, V39, P37, DOI 10.1021/ar0501525; Sciotti MA, 2003, J BACTERIOL, V185, P5639, DOI 10.1128/JB.185.18.5639-5642.2003; Shintani T, 2009, HEPATOLOGY, V49, P141, DOI 10.1002/hep.22604; Singh S, 2007, NAT PROD REP, V24, P631, DOI 10.1039/b604182p; Sousa EHS, 2007, BIOCHEMISTRY-US, V46, P6249, DOI 10.1021/bi7003334; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Tang XD, 2003, NATURE, V425, P531, DOI 10.1038/nature02003; Telezhkin V, 2011, PFLUG ARCH EUR J PHY, V461, P665, DOI 10.1007/s00424-011-0924-7; Trindade DM, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-57; Tsai AL, 2012, ANTIOXID REDOX SIGN, V17, P1246, DOI 10.1089/ars.2012.4564; Tuckerman JR, 2002, BIOCHEMISTRY-US, V41, P6170, DOI 10.1021/bi025628w; Tuckerman JR, 2001, J MOL BIOL, V308, P449, DOI 10.1006/jmbi.2001.4591; Uchida T, 2012, J INORG BIOCHEM, V108, P188, DOI 10.1016/j.jinorgbio.2011.12.005; Uma S, 2001, J BIOL CHEM, V276, P14875, DOI 10.1074/jbc.M011476200; Varfaj F, 2012, J BIOL CHEM, V287, P35181, DOI 10.1074/jbc.M112.378042; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wagner C, 2005, J BIOL CHEM, V280, P17687, DOI 10.1074/jbc.M412099200; Wang J, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-15; WEDEL B, 1994, P NATL ACAD SCI USA, V91, P2592, DOI 10.1073/pnas.91.7.2592; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Westberg JA, 2011, BIOCHEM BIOPH RES CO, V409, P266, DOI 10.1016/j.bbrc.2011.05.002; Williams SE, 2008, PFLUG ARCH EUR J PHY, V456, P561, DOI 10.1007/s00424-007-0439-4; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; Yang JH, 2005, J BIOL CHEM, V280, P7671, DOI 10.1074/jbc.M411664200; Yi L, 2010, J BIOL CHEM, V285, P20117, DOI 10.1074/jbc.M110.116483; Yi L, 2009, J BIOL CHEM, V284, P20556, DOI 10.1074/jbc.M109.015651; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yin L, 2012, J BIOL CHEM, V287, P13850, DOI 10.1074/jbc.M112.346494; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x; Zhong FF, 2011, J BIOL INORG CHEM, V16, P1227, DOI 10.1007/s00775-011-0811-x; ZITOMER RS, 1992, MICROBIOL REV, V56, P1	100	92	93	1	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13194	13203		10.1074/jbc.R112.422642	http://dx.doi.org/10.1074/jbc.R112.422642			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23539616	hybrid, Green Published			2022-12-28	WOS:000318850300006
J	Rothwell, PJ; Allen, WJ; Sisamakis, E; Kalinin, S; Felekyan, S; Widengren, J; Waksman, G; Seidel, CAM				Rothwell, Paul J.; Allen, William J.; Sisamakis, Evangelos; Kalinin, Stanislav; Felekyan, Suren; Widengren, Jerker; Waksman, Gabriel; Seidel, Claus A. M.			dNTP-dependent Conformational Transitions in the Fingers Subdomain of Klentaq1 DNA Polymerase INSIGHTS INTO THE ROLE OF THE "NUCLEOTIDE-BINDING" STATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-MOLECULE FRET; ENERGY-TRANSFER; CRYSTAL-STRUCTURES; LARGE FRAGMENT; INDUCED FIT; KINETIC MECHANISM; STRUCTURAL BASIS; FLUORESCENCE; FIDELITY; SELECTION	DNA polymerases are responsible for the accurate replication of DNA. Kinetic, single-molecule, and x-ray studies show that multiple conformational states are important for DNA polymerase fidelity. Using high precision FRET measurements, we show that Klentaq1 (the Klenow fragment of Thermus aquaticus DNA polymerase 1) is in equilibrium between three structurally distinct states. In the absence of nucleotide, the enzyme is mostly open, whereas in the presence of DNA and a correctly base-pairing dNTP, it re-equilibrates to a closed state. In the presence of a dNTP alone, with DNA and an incorrect dNTP, or in elevated MgCl2 concentrations, an intermediate state termed the "nucleotide-binding" state predominates. Photon distribution and hidden Markov modeling revealed fast dynamic and slow conformational processes occurring between all three states in a complex energy landscape suggesting a mechanism in which dNTP delivery is mediated by the nucleotide-binding state. After nucleotide binding, correct dNTPs are transported to the closed state, whereas incorrect dNTPs are delivered to the open state.	[Seidel, Claus A. M.] Univ Dusseldorf, Chair Mol Phys Chem, D-40225 Dusseldorf, Germany; [Allen, William J.; Waksman, Gabriel] Birkbeck & Univ Coll London, Inst Struct & Mol Biol, London WC1E 7HX, England; [Sisamakis, Evangelos; Widengren, Jerker] Royal Inst Technol, Albanova Univ Ctr, Dept Appl Phys, SE-10691 Stockholm, Sweden; [Allen, William J.; Waksman, Gabriel] UCL, Div Biosci, Inst Struct & Mol Biol, London WC1E 6BT, England	Heinrich Heine University Dusseldorf; University of London; Birkbeck University London; Royal Institute of Technology; University of London; Birkbeck University London; University College London		p.rothwell@mail.cryst.bbk.ac.uk; g.waksman@mail.cryst.bbk.ac.uk; cseidel@hhu.de	Seidel, Claus A.M./A-3682-2012	Seidel, Claus A.M./0000-0002-5171-149X; Widengren, Jerker/0000-0003-3200-0374	European Union Marie Curie Actions Research Training Network "DNA Enzymes"; Volkswagen Foundation [I/78 837]; Biological and Biotechnological Science Research Council; Swedish Foundation for International Cooperation in Research and Higher Education [IG2004-2032]	European Union Marie Curie Actions Research Training Network "DNA Enzymes"; Volkswagen Foundation(Volkswagen); Biological and Biotechnological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swedish Foundation for International Cooperation in Research and Higher Education	Supported by the European Union Marie Curie Actions Research Training Network "DNA Enzymes" and Volkswagen Foundation Grant I/78 837.; Supported by a studentship from the Biological and Biotechnological Science Research Council.; Supported by the Swedish Foundation for International Cooperation in Research and Higher Education Stipend IG2004-2032.	Allen WJ, 2008, PROTEIN SCI, V17, P401, DOI 10.1110/ps.073309208; Antonik M, 2006, J PHYS CHEM B, V110, P6970, DOI 10.1021/jp057257+; Berezhna SY, 2012, J AM CHEM SOC, V134, P11261, DOI 10.1021/ja3038273; Berg BJV, 2001, J BIOL CHEM, V276, P3408, DOI 10.1074/jbc.M002884200; Bermek O, 2011, J BIOL CHEM, V286, P3755, DOI 10.1074/jbc.M110.167593; Boukobza E, 2001, J PHYS CHEM B, V105, P12165, DOI 10.1021/jp012016x; Bucher D, 2011, BIOCHEMISTRY-US, V50, P10530, DOI 10.1021/bi201481a; Changeux Jean-Pierre, 2011, F1000 Biol Rep, V3, P19, DOI 10.3410/B3-19; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Eggeling C, 2006, J PHYS CHEM A, V110, P2979, DOI 10.1021/jp054581w; Eggeling C, 2001, J BIOTECHNOL, V86, P163, DOI 10.1016/S0168-1656(00)00412-0; Felekyan S, 2012, CHEMPHYSCHEM, V13, P1036, DOI 10.1002/cphc.201100897; Fries JR, 1998, J PHYS CHEM A, V102, P6601, DOI 10.1021/jp980965t; Gansen A, 2009, P NATL ACAD SCI USA, V106, P15308, DOI 10.1073/pnas.0903005106; Hanson JA, 2007, P NATL ACAD SCI USA, V104, P18055, DOI 10.1073/pnas.0708600104; Holzberger B, 2012, CHEMBIOCHEM, V13, P635, DOI 10.1002/cbic.201100802; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Kalinin S, 2008, J PHYS CHEM B, V112, P8361, DOI 10.1021/jp711942q; Kalinin S, 2007, J PHYS CHEM B, V111, P10253, DOI 10.1021/jp072293p; Kalinin S, 2012, NAT METHODS, V9, P1218, DOI [10.1038/nmeth.2222, 10.1038/NMETH.2222]; Kalinin S, 2010, J PHYS CHEM B, V114, P6197, DOI 10.1021/jp100025v; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kim SJ, 2003, J BIOL CHEM, V278, P5072, DOI 10.1074/jbc.M208472200; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; KOROLEV S, 1995, P NATL ACAD SCI USA, V92, P9264, DOI 10.1073/pnas.92.20.9264; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; KUCHTA RD, 1988, BIOCHEMISTRY-US, V27, P6716, DOI 10.1021/bi00418a012; Kumaran S, 2003, P NATL ACAD SCI USA, V100, P14828, DOI 10.1073/pnas.2432867100; Li Y, 1998, PROTEIN SCI, V7, P1116, DOI 10.1002/pro.5560070505; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Li Y, 2001, PROTEIN SCI, V10, P1225, DOI 10.1110/ps.250101; Liu Y, 2010, J PHYS CHEM B, V114, P5386, DOI 10.1021/jp9057669; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Muschielok A, 2008, NAT METHODS, V5, P965, DOI 10.1038/nmeth.1259; O'Connor D. V., 1984, TIME CORRELATED SING; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Orte A, 2006, ANAL CHEM, V78, P7707, DOI 10.1021/ac061122y; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Purohit V, 2003, BIOCHEMISTRY-US, V42, P10200, DOI 10.1021/bi0341206; Rasnik I, 2005, ACCOUNTS CHEM RES, V38, P542, DOI 10.1021/ar040138c; Rothwell PJ, 2007, J BIOL CHEM, V282, P28884, DOI 10.1074/jbc.M704824200; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Rothwell PJ, 2003, P NATL ACAD SCI USA, V100, P1655, DOI 10.1073/pnas.0434003100; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; Selvin P., 2008, SINGLE MOL TECHNIQUE; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Shah AM, 2003, BIOCHEMISTRY-US, V42, P10709, DOI 10.1021/bi034885d; Silva DA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002054; Sindbert S, 2011, J AM CHEM SOC, V133, P2463, DOI 10.1021/ja105725e; Sisamakis E, 2010, METHOD ENZYMOL, V475, P455, DOI 10.1016/S0076-6879(10)75018-7; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Torella JP, 2011, BIOPHYS J, V100, P1568, DOI 10.1016/j.bpj.2011.01.066; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; van der Meer B W, 2002, J Biotechnol, V82, P181, DOI 10.1016/S1389-0352(01)00037-X; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Wu EY, 2011, J BIOL CHEM, V286, P19758, DOI 10.1074/jbc.M110.191130; Zhong XJ, 1997, BIOCHEMISTRY-US, V36, P11891, DOI 10.1021/bi963181j	61	20	20	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13575	13591		10.1074/jbc.M112.432690	http://dx.doi.org/10.1074/jbc.M112.432690			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23525110	Green Published, hybrid			2022-12-28	WOS:000318850300040
J	La, P; Yang, G; Dennery, PA				La, Ping; Yang, Guang; Dennery, Phyllis A.			Mammalian Target of Rapamycin Complex 1 (mTORC1)-mediated Phosphorylation Stabilizes ISCU Protein IMPLICATIONS FOR IRON METABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOPROTEOMIC ANALYSIS; MTOR; SUBSTRATE; REVEALS; HYPOXIA	The scaffold protein ISCU facilitates the assembly of iron-sulfur clusters (ISCs), which are essential cofactors for many vital metabolic processes. The mTOR pathways are central to nutrient and energy-sensing networks. Here, we demonstrate that mTORC1 associates with ISCU and phosphorylates ISCU at serine 14. This phosphorylation stabilized ISCU protein. Insufficiency of ISCU triggered by mTORC1 inhibition prevented ISC assembly. Sustained ISCU protein levels enhanced by mTORC1 sensitized TSC2-null cells to iron deprivation due to constitutive ISC biogenesis-triggered iron demand, which outstrips supply. We conclude that the mTORC1 pathway serves to modulate iron metabolism and homeostasis, and we speculate that iron deprivation may be an adjunct in the treatment of cancers characterized by constitutive mTORC1 activation.	[La, Ping; Yang, Guang; Dennery, Phyllis A.] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA; [Dennery, Phyllis A.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	La, P (corresponding author), Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA.	lap@email.chop.edu; dennery@email.chop.edu	Dennery, Phyllis/GQG-9113-2022	Dennery, Phyllis/0000-0001-5745-1855	National Institutes of Health [R01-HL058752]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant R01-HL058752 (to P.A.D.).	BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chen Z, 2010, ONCOGENE, V29, P4362, DOI 10.1038/onc.2010.193; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Gauci S, 2009, ANAL CHEM, V81, P4493, DOI 10.1021/ac9004309; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Johnson C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005751; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Matouschek A, 1997, EMBO J, V16, P6727, DOI 10.1093/emboj/16.22.6727; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Nordin A, 2011, HUM GENET, V129, P371, DOI 10.1007/s00439-010-0931-3; Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Shor B, 2010, J BIOL CHEM, V285, P15380, DOI 10.1074/jbc.M109.071639; Sofroniadou S, 2011, DRUG SAFETY, V34, P97, DOI 10.2165/11585040-000000000-00000; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Ye H., 2010, ADV HEMATOL, V2010, DOI DOI 10.1155/2010/329394; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; YOSHIKURA H, 1974, J VIROL, V13, P1319, DOI 10.1128/JVI.13.6.1319-1325.1974; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhou T, 2012, DALTON T, V41, P6371, DOI 10.1039/c2dt12159j; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	30	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12901	12909		10.1074/jbc.M112.424499	http://dx.doi.org/10.1074/jbc.M112.424499			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23508953	hybrid, Green Published			2022-12-28	WOS:000318555100044
J	Walsh, AA; Szklarz, GD; Scott, EE				Walsh, Agnes A.; Szklarz, Grazyna D.; Scott, Emily E.			Human Cytochrome P450 1A1 Structure and Utility in Understanding Drug and Xenobiotic Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; P450 1A1; HUMAN LUNG; CATALYTIC-ACTIVITIES; SUBSTRATE-BINDING; ACTIVATION; EXPRESSION; OXIDATION; CYP1A1; 1B1	Cytochrome P450 (CYP) 1A1 is an extrahepatic monooxygenase involved in the metabolism of endogenous substrates and drugs, as well as the activation of certain toxins and environmental pollutants. CYP1A1 is particularly well known for its ability to biotransform polycyclic aromatic hydrocarbons, such as benzo[a] pyrene in tobacco smoke, into carcinogens. CYP1A1 possesses functional similarities and differences with human CYP1A2 and CYP1B1 enzymes, but the structural basis for this has been unclear. We determined a 2.6 angstrom structure of human CYP1A1 with the inhibitor alpha-naphthoflavone. alpha-Naphthoflavone binds within an enclosed active site, with the planar benzochromen-4-one core packed flat against the I helix that composes one wall of the active site, and the 2-phenyl substituent oriented toward the catalytic heme iron. Comparisons with previously determined structures of the related cytochrome P450 1A2 and 1B1 enzymes reveal distinct features among the active sites that may underlie the functional variability of these enzymes. Finally, docking studies probed the ability of CYP1A structures to assist in understanding their known in vitro interactions with several typical substrates and inhibitors.	[Walsh, Agnes A.; Scott, Emily E.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Szklarz, Grazyna D.] W Virginia Univ, Sch Pharm, Dept Basic Pharmaceut Sci, Morgantown, WV 26506 USA	University of Kansas; West Virginia University	Scott, EE (corresponding author), Univ Kansas, Dept Med Chem, 1251 Wescoe Hall Dr, Lawrence, KS 66045 USA.	eescott@ku.edu			National Institutes of Health [R01 GM076343, GM103393, RR001209, RR017708, GM103420]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708, P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103420, R01GM076343, P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM076343 (to E.E.S.), RR001209 (to the Stanford Synchrotron Radiation Lightsource), GM103393 and RR001209 (to the SSRL Structural Molecular Biology Program), and RR017708 and GM103420 (to the Protein Structure Laboratory at the University of Kansas).	Androutsopoulos VP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-187; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Arnold C, 2010, PHARMACOL REP, V62, P536, DOI 10.1016/S1734-1140(10)70311-X; BAUER E, 1995, CHEM RES TOXICOL, V8, P136, DOI 10.1021/tx00043a018; Chi AC, 2009, ORAL ONCOL, V45, P980, DOI 10.1016/j.oraloncology.2009.05.562; Chun YJ, 1999, BIOCHEM BIOPH RES CO, V262, P20, DOI 10.1006/bbrc.1999.1152; Chun YJ, 2001, DRUG METAB DISPOS, V29, P389; De Kerkhof EGV, 2008, DRUG METAB DISPOS, V36, P604, DOI 10.1124/dmd.107.018820; DeLano W.L, PYMOL MOL GRAPHICS S; DeVore NM, 2009, DRUG METAB DISPOS, V37, P1319, DOI 10.1124/dmd.109.026765; Doostdar H, 2000, TOXICOLOGY, V144, P31, DOI 10.1016/S0300-483X(99)00215-2; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ericksen SS, 2005, J BIOMOL STRUCT DYN, V23, P243, DOI 10.1080/07391102.2005.10507063; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hakkola J, 1996, BIOCHEM PHARMACOL, V52, P379, DOI 10.1016/0006-2952(96)00216-X; Hammons GJ, 1997, CARCINOGENESIS, V18, P851, DOI 10.1093/carcin/18.4.851; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Hayes CL, 1996, P NATL ACAD SCI USA, V93, P9776, DOI 10.1073/pnas.93.18.9776; Honma W, 2005, ARCH BIOCHEM BIOPHYS, V435, P157, DOI 10.1016/j.abb.2004.12.014; Huang QB, 2012, DRUG METAB DISPOS, V40, P2324, DOI 10.1124/dmd.112.047308; Huang QB, 2010, DRUG METAB DISPOS, V38, P1039, DOI 10.1124/dmd.109.030767; Iba MM, 2010, TOXICOLOGY, V273, P35, DOI 10.1016/j.tox.2010.04.012; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim D, 2005, ANNU REV PHARMACOL, V45, P27, DOI 10.1146/annurev.pharmtox.45.120403.100010; Kim JH, 2004, TOXICOL APPL PHARM, V199, P210, DOI 10.1016/j.taap.2003.11.015; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Lautraite S, 2002, MUTAGENESIS, V17, P45, DOI 10.1093/mutage/17.1.45; Lee AJ, 2003, ENDOCRINOLOGY, V144, P3382, DOI 10.1210/en.2003-0192; Leong CO, 2003, BRIT J CANCER, V88, P470, DOI 10.1038/sj.bjc.6600719; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Liu JG, 2004, ARCH BIOCHEM BIOPHYS, V424, P33, DOI 10.1016/j.abb.2003.12.040; Liu JG, 2003, DRUG METAB DISPOS, V31, P412, DOI 10.1124/dmd.31.4.412; Ma XC, 2005, DRUG METAB DISPOS, V33, P489, DOI 10.1124/dmd.104.002410; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nishimura M, 2003, YAKUGAKU ZASSHI, V123, P369; PAULSEN MD, 1992, J COMPUT AID MOL DES, V6, P449, DOI 10.1007/BF00130396; PAULSEN MD, 1991, PROTEINS, V11, P184, DOI 10.1002/prot.340110304; Piver B, 2004, BIOCHEM PHARMACOL, V68, P773, DOI 10.1016/j.bcp.2004.05.008; Porubsky PR, 2010, J BIOL CHEM, V285, P22282, DOI 10.1074/jbc.M110.109017; Reid JM, 1999, CLIN CANCER RES, V5, P2192; Rendic S, 2002, DRUG METAB REV, V34, P83, DOI 10.1081/DMR-120001392; Rendic S, 2012, CHEM RES TOXICOL, V25, P1316, DOI 10.1021/tx300132k; SANDHU P, 1994, ARCH BIOCHEM BIOPHYS, V309, P168, DOI 10.1006/abbi.1994.1099; Sansen S, 2007, J BIOL CHEM, V282, P14348, DOI 10.1074/jbc.M611692200; Schwarz D, 2004, BIOCHEM PHARMACOL, V67, P1445, DOI 10.1016/j.bcp.2003.12.023; Shah MB, 2012, BIOCHEMISTRY-US, V51, P7225, DOI 10.1021/bi300894z; Shimada T, 2004, CANCER SCI, V95, P1, DOI 10.1111/j.1349-7006.2004.tb03162.x; SHIMADA T, 1992, MOL PHARMACOL, V41, P856; Shimada T, 1998, ARCH BIOCHEM BIOPHYS, V357, P111, DOI 10.1006/abbi.1998.0808; Shimada T, 1997, DRUG METAB DISPOS, V25, P617; Shimada T, 1996, CANCER RES, V56, P2979; Shimada T, 2006, DRUG METAB PHARMACOK, V21, P257, DOI 10.2133/dmpk.21.257; Shimada T, 2010, CHEM RES TOXICOL, V23, P1921, DOI 10.1021/tx100286d; Suter M, 2010, METABOLISM, V59, P1481, DOI 10.1016/j.metabol.2010.01.013; Szklarz GD, 2002, J BIOMOL STRUCT DYN, V20, P155, DOI 10.1080/07391102.2002.10506831; Tu Y, 2008, DRUG METAB DISPOS, V36, P2371, DOI 10.1124/dmd.108.022640; Turesky RJ, 1998, CHEM RES TOXICOL, V11, P925, DOI 10.1021/tx980022n; Wang A, 2012, J BIOL CHEM, V287, P10834, DOI 10.1074/jbc.M111.307918; Wang A, 2011, J BIOL CHEM, V286, P5736, DOI 10.1074/jbc.M110.204420; Willey JC, 1997, AM J RESP CELL MOL, V17, P114, DOI 10.1165/ajrcmb.17.1.2783; Wogan GN, 2004, SEMIN CANCER BIOL, V14, P473, DOI 10.1016/j.semcancer.2004.06.010; Yengi LG, 2003, ANAL BIOCHEM, V316, P103, DOI 10.1016/S0003-2697(03)00042-3; Zhao YG, 2007, BIOCHEMISTRY-US, V46, P11559, DOI 10.1021/bi7011614; Zhou SF, 2009, AAPS J, V11, P481, DOI 10.1208/s12248-009-9127-y	66	187	193	5	59	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12932	12943		10.1074/jbc.M113.452953	http://dx.doi.org/10.1074/jbc.M113.452953			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23508959	hybrid, Green Published			2022-12-28	WOS:000318555100047
J	Waitkus, MS; Chandrasekharan, UM; Willard, B; Haque, SJ; DiCorleto, PE				Waitkus, Matthew S.; Chandrasekharan, Unni M.; Willard, Belinda; Haque, S. Jaharul; DiCorleto, Paul E.			STAT3-mediated Coincidence Detection Regulates Noncanonical Immediate Early Gene Induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; GLYCOGEN-SYNTHASE KINASE-3; FACTOR RECEPTOR TRANSACTIVATION; PROTEIN-COUPLED RECEPTORS; MONOCYTIC-CELL-ADHESION; TUMOR ENDOTHELIAL-CELLS; SUBSTRATE-SPECIFICITY; SIGNALING PATHWAYS; TYROSINE KINASE; ACTIVATION	Signaling pathways interact with one another to form dynamic networks in which the cellular response to one stimulus may depend on the presence, intensity, timing, or localization of other signals. In rare cases, two stimuli may be simultaneously required for cells to elicit a significant biological output. This phenomenon, generally termed "coincidence detection," requires a downstream signaling node that functions as a Boolean AND gate to restrict biological output from a network unless multiple stimuli are received within a specific window of time. Simultaneous activation of the EGF receptor (EGFR) and a thrombin receptor (protease-activated receptor-1, PAR-1) increases the expression of multiple immediate early genes (IEGs) associated with growth and angiogenesis. Using a bioinformatic comparison of IEG promoter regions, we identified STAT3 as a critical transcription factor for the detection of coincident EGFR/PAR-1 activation. EGFR activation induces classical STAT3 Tyr(705) phosphorylation but also initiates an inhibitory signal through the PI3K-AKT signaling axis that prevents STAT3 Ser(727) phosphorylation. Coincident PAR-1 signaling resolves these conflicting EGF-activated pathways by blocking AKT activation and permitting GSK-3 alpha/beta-dependent STAT3 Ser(727) phosphorylation and STAT3-dependent gene expression. Functionally, combinatorial EGFR/PAR-1 signaling suppresses EGF-induced proliferation and thrombin-induced leukocyte adhesion and triggers a STAT3-dependent increase in endothelial cell migration. This study reveals a novel signaling role for STAT3 in which the simultaneous presence of extracellular EGF and thrombin is detected at the level of STAT3 post-translational modifications. Collectively, our results describe a novel regulatory mechanism in which combinatorial EGFR/PAR-1 signaling regulates STAT3-dependent IEG induction and endothelial cell migration.	[Waitkus, Matthew S.; Chandrasekharan, Unni M.; DiCorleto, Paul E.] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Haque, S. Jaharul] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA; [Waitkus, Matthew S.; DiCorleto, Paul E.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44195 USA; [Willard, Belinda] Cleveland Clin, Lerner Res Inst, Mass Spectrometry Lab Prot Sequencing, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Cleveland Clinic Foundation	DiCorleto, PE (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.	dicorlp@ccf.org			National Institutes of Health [HL29582]; Graduate Assistance in Areas of National Need Predoctoral Fellowship; National Center for Advancing Translational Sciences, a component of the National Institutes of Health [UL1TR000439]; Roadmap for Medical Research, National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Graduate Assistance in Areas of National Need Predoctoral Fellowship; National Center for Advancing Translational Sciences, a component of the National Institutes of Health; Roadmap for Medical Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL29582 (to P. E. D.). This work was also supported by the Graduate Assistance in Areas of National Need Predoctoral Fellowship (to M. S. W.).; We thank Lisa Dechert, Emily Tillmaand, and Chad Braley for cell culture assistance and Joel Boerckel for constructive criticism of the manuscript. Human umbilical vein ECs were harvested by the Clinical and Translational Science Collaborative of Cleveland (supported by Grant UL1TR000439 from the National Center for Advancing Translational Sciences, a component of the National Institutes of Health and Roadmap for Medical Research, National Institutes of Health).	Aicher WK, 1999, RHEUMATOL INT, V18, P207, DOI 10.1007/s002960050086; Al-Ani B, 2010, HYPERTENSION, V55, P689, DOI 10.1161/HYPERTENSIONAHA.109.136333; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Almendro V, 2010, CURR DRUG TARGETS, V11, P1169, DOI 10.2174/138945010792006807; Amin DN, 2008, MICROVASC RES, V76, P15, DOI 10.1016/j.mvr.2008.01.002; Amin DN, 2006, CANCER RES, V66, P2173, DOI 10.1158/0008-5472.CAN-05-3387; Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; Arora S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r166; Baker CH, 2002, AM J PATHOL, V161, P929, DOI 10.1016/S0002-9440(10)64253-8; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Beurel E, 2009, CELL SIGNAL, V21, P978, DOI 10.1016/j.cellsig.2009.02.019; Beurel E, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-9; Chandrasekharan UM, 2004, J BIOL CHEM, V279, P46678, DOI 10.1074/jbc.M406441200; Chandrasekharan UM, 2010, ARTERIOSCL THROM VAS, V30, P1983, DOI 10.1161/ATVBAHA.110.212399; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Darmoul D, 2004, MOL CANCER RES, V2, P514; DAY ML, 1990, J BIOL CHEM, V265, P15253; De Luca A, 2008, J CELL PHYSIOL, V214, P559, DOI 10.1002/jcp.21260; DICORLETO PE, 1989, BIOCHEM J, V264, P71, DOI 10.1042/bj2640071; Dong JY, 1999, P NATL ACAD SCI USA, V96, P6235, DOI 10.1073/pnas.96.11.6235; Duan WR, 2002, MOL ENDOCRINOL, V16, P221, DOI 10.1210/me.16.2.221; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Gregg Jennifer, 2011, Genes Cancer, V2, P900, DOI 10.1177/1947601911431885; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Hirata A, 2004, CANCER SCI, V95, P614, DOI 10.1111/j.1349-7006.2004.tb02496.x; Hirata A, 2002, CANCER RES, V62, P2554; Hsieh HL, 2008, BBA-MOL CELL RES, V1783, P1563, DOI 10.1016/j.bbamcr.2008.03.016; Kaufmann K., 2002, J CELL BIOCHEM, V391, P15253; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kinney CM, 2008, AM J PHYSIOL-CELL PH, V294, pC241, DOI 10.1152/ajpcell.00187.2007; Kovacs KA, 2007, P NATL ACAD SCI USA, V104, P4700, DOI 10.1073/pnas.0607524104; Le Goff W, 2006, ARTERIOSCL THROM VAS, V26, P527, DOI 10.1161/01.ATV.0000201042.00725.84; Lee S, 2003, FASEB J, V17, pA326, DOI 10.1096/fj.02-0570fje; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Maretzky T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1232; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; Mehta VB, 2007, GROWTH FACTORS, V25, P253, DOI 10.1080/08977190701773070; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Pan JQ, 2011, NEUROPSYCHOPHARMACOL, V36, P1397, DOI 10.1038/npp.2011.24; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Pawson CT, 2010, NAT STRUCT MOL BIOL, V17, P653, DOI 10.1038/nsmb.1843; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Philip F, 2010, CURR BIOL, V20, P1327, DOI 10.1016/j.cub.2010.06.013; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; SAITO Y, 1994, BIOCHEM J, V303, P27, DOI 10.1042/bj3030027; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Schuringa JJ, 2001, FEBS LETT, V495, P71, DOI 10.1016/S0014-5793(01)02354-7; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; SHANKAR R, 1994, J BIOL CHEM, V269, P13936; Shin SY, 2001, J BIOL CHEM, V276, P7797, DOI 10.1074/jbc.M009465200; Sini P, 2005, CLIN CANCER RES, V11, P4521, DOI 10.1158/1078-0432.CCR-04-1954; Tsai JC, 2001, AM J PHYSIOL-GASTR L, V281, pG1271, DOI 10.1152/ajpgi.2001.281.5.G1271; Wang HZ, 2011, J IMMUNOL, V186, P5217, DOI 10.4049/jimmunol.1002513; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wu SQ, 2002, BLOOD, V100, P4454, DOI 10.1182/blood-2002-02-0415; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zwang YR, 2011, MOL CELL, V42, P524, DOI 10.1016/j.molcel.2011.04.017	65	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11988	12003		10.1074/jbc.M112.428516	http://dx.doi.org/10.1074/jbc.M112.428516			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504318	Green Published, hybrid			2022-12-28	WOS:000318157600033
J	Peng, H; Kang, N; Xu, J; Stanton, PK; Kang, J				Peng, Hong; Kang, Ning; Xu, Jun; Stanton, Patric K.; Kang, Jian			Two Distinct Modes of Exocytotic Fusion Pore Expansion in Large Astrocytic Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE SYNAPTIC VESICLES; PANCREATIC BETA-CELLS; YEAST VACUOLE DOCKING; VERTEX RING DOMAIN; MEMBRANE-FUSION; TRANSMITTER RELEASE; HIPPOCAMPAL SLICES; PATCH AMPEROMETRY; NEURONAL-ACTIVITY; CHROMAFFIN CELLS	Formation of the fusion pore is a central question for regulated exocytosis by which secretory cells release neurotransmitters or hormones. Here, by dynamically monitoring exocytosis of large vesicles (2-7 similar to m) in astrocytes with two-photon microscopy imaging, we found that the exocytotic fusion pore was generated from the SNARE-dependent fusion at a ring shape of the docked plasma-vesicular membrane and the movement of a fusion-produced membrane fragment. We observed two modes of fragment movements, 1) a shift fragment that shifted to expand the fusion pore and 2) a fall-in fragment that fell into the collapsed vesicle to expand the fusion pore. Shift and fall-in modes are associated with full and partial collapses of large vesicles, respectively. The astrocytic marker, sulforhodamine 101, stained the fusion-produced membrane fragment more brightly thanFM1-43. Sulforhodamine 101 imaging showed that double fusion pores could simultaneously occur in a single vesicle (16% of large vesicles) to accelerate discharge of vesicular contents. Electron microscopy of large astrocytic vesicles showed shift and fall-in membrane fragments. Two modes of fusion pore formation demonstrate a novel mechanism underlying fusion pore expansion and provide a new explanation for full and partial collapses of large secretory vesicles.	[Peng, Hong; Kang, Ning; Stanton, Patric K.; Kang, Jian] New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; [Xu, Jun] Tongji Univ, East Hosp, Sch Med, Shanghai 200120, Peoples R China	New York Medical College; Tongji University	Xu, J (corresponding author), Tongji Univ, East Hosp, Sch Med, Shanghai 200120, Peoples R China.	xunymc2000@yahoo.com; jian_kang@NYMC.edu		Peng, Hong/0000-0001-5522-072X	New York State Spinal Cord Injury [C020925]; United States Army Medical Research and Materiel Command (USAMRMC) [W81XWH 07254001]; Ministry of Science and Technology of China [2011CB966200, 2010CB945200]; National Natural Science Foundation of China [81271369]; National Natural Science Foundation of China (NSFC) [81070910]; Century Excellent Talents in University [NCET-10-0606]; Shanghai RisingStar program [11QA1407100]; International Cooperation and Exchanges NSFC [81261130318]; Fundamental Research Funds for the Central Universities	New York State Spinal Cord Injury; United States Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Century Excellent Talents in University; Shanghai RisingStar program; International Cooperation and Exchanges NSFC; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by New York State Spinal Cord Injury Grant C020925; United States Army Medical Research and Materiel Command (USAMRMC) Grant W81XWH 07254001; the Ministry of Science and Technology of China (Grants 2011CB966200 and 2010CB945200); the National Natural Science Foundation of China (Grant 81271369); the National Natural Science Foundation of China (NSFC) (Grant 81070910); New Century Excellent Talents in University (Grant NCET-10-0606); the Shanghai RisingStar program (Grant 11QA1407100); Projects of International Cooperation and Exchanges NSFC (Grant 81261130318); and the Fundamental Research Funds for the Central Universities.	Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; CHANDLER DE, 1980, J CELL BIOL, V86, P666, DOI 10.1083/jcb.86.2.666; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Cousin MA, 1999, J NEUROCHEM, V73, P2227, DOI 10.1046/j.1471-4159.1999.0732227.x; Crippa D, 2006, J PHYSIOL-LONDON, V570, P567, DOI 10.1113/jphysiol.2005.094052; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Duman JG, 2003, AM J PHYSIOL-CELL PH, V285, pC237, DOI 10.1152/ajpcell.00091.2003; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fellin T, 2006, J NEUROSCI, V26, P9312, DOI 10.1523/JNEUROSCI.2836-06.2006; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Finnegan JM, 1996, J NEUROCHEM, V66, P1914; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; HEUSER JE, 1981, J CELL BIOL, V88, P564, DOI 10.1083/jcb.88.3.564; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jiang M, 2009, J NEUROSCI, V29, P8063, DOI 10.1523/JNEUROSCI.6139-08.2009; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Jun Y, 2006, EMBO J, V25, P5260, DOI 10.1038/sj.emboj.7601413; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kang N, 2005, J NEUROPHYSIOL, V94, P4121, DOI 10.1152/jn.00448.2005; Kang N, 2013, NEUROSCIENCE, V240, P243, DOI 10.1016/j.neuroscience.2013.02.029; KEIFER J, 1992, J NEUROSCI, V12, P3187, DOI 10.1523/JNEUROSCI.12-08-03187.1992; KENNEDY RT, 1993, ANAL CHEM, V65, P1882, DOI 10.1021/ac00062a012; KJAERULFF O, 1994, J PHYSIOL-LONDON, V478, P265, DOI 10.1113/jphysiol.1994.sp020248; Larina O, 2007, MOL BIOL CELL, V18, P3502, DOI 10.1091/mbc.E07-01-0024; Liu QS, 2004, P NATL ACAD SCI USA, V101, P3172, DOI 10.1073/pnas.0306731101; Loson OC, 2011, J NEUROCHEM, V116, P909, DOI 10.1111/j.1471-4159.2010.07018.x; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; Min R, 2012, NAT NEUROSCI, V15, P746, DOI 10.1038/nn.3075; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Parri HR, 2001, NEUROREPORT, V12, P3897, DOI 10.1097/00001756-200112210-00008; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Pyle JL, 1999, NEURON, V24, P803, DOI 10.1016/S0896-6273(00)81028-4; Tabares L, 2003, BIOCHEM SOC T, V31, P837, DOI 10.1042/bst0310837; Takahashi N, 2002, SCIENCE, V297, P1349, DOI 10.1126/science.1073806; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Xu J, 2007, J BIOL CHEM, V282, P24185, DOI 10.1074/jbc.M700452200; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500	50	4	5	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16872	16881		10.1074/jbc.M113.468231	http://dx.doi.org/10.1074/jbc.M113.468231			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23620588	Green Published, hybrid			2022-12-28	WOS:000320378900060
J	Liu, YC; Miles, JJ; Neller, MA; Gostick, E; Price, DA; Purcell, AW; McCluskey, J; Burrows, SR; Rossjohn, J; Gras, S				Liu, Yu Chih; Miles, John J.; Neller, Michelle A.; Gostick, Emma; Price, David A.; Purcell, Anthony W.; McCluskey, James; Burrows, Scott R.; Rossjohn, Jamie; Gras, Stephanie			Highly Divergent T-cell Receptor Binding Modes Underlie Specific Recognition of a Bulged Viral Peptide bound to a Human Leukocyte Antigen Class I Molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; SELF-PEPTIDE; HLA MICROPOLYMORPHISM; STRUCTURAL BASIS; MHC RESTRICTION; ALLORECOGNITION; EPITOPE; IMPACT; REPERTOIRE; LONG	Human leukocyte antigen (HLA)-I molecules can present long peptides, yet the mechanisms by which T-cell receptors (TCRs) recognize featured pHLA-I landscapes are unclear. We compared the binding modes of three distinct human TCRs, CA5, SB27, and SB47, complexed with a "super-bulged" viral peptide (LPEPLPQGQLTAY) restricted by HLA-B*35:08. The CA5and SB27 TCRs engaged HLA-B*35:08LPEP similarly, straddling the central region of the peptide but making limited contacts with HLA-B* 35: 08. Remarkably, the the CA5TCR did not contact the alpha 1-helix of HLA-B* 35: 08. Differences in the CDR3 beta loop between the CA5 and SB27 TCRs caused altered fine specificities. Surprisingly, the SB47 TCR engaged HLA-B* 35: 08LPEP using a completely distinct binding mechanism, namely "bypassing" the bulged peptide and making extensive contacts with the extreme N-terminal end of HLA-B* 35: 08. This docking footprint included HLA-I residues not observed previously as TCR contact sites. The three TCRs exhibited differing patterns of alloreactivity toward closely related or distinct HLA-I allo-types. Thus, the human T-cell repertoire comprises a range of TCRs that can interact with "bulged" pHLA-I epitopes using unpredictable strategies, including the adoption of atypical footprints on the MHC-I.	[Liu, Yu Chih; Purcell, Anthony W.; Rossjohn, Jamie; Gras, Stephanie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Miles, John J.; Neller, Michelle A.; Burrows, Scott R.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Miles, John J.; Neller, Michelle A.; Burrows, Scott R.] Australian Ctr Vaccine Dev, Brisbane, Qld 4006, Australia; [Miles, John J.; Gostick, Emma; Price, David A.; Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales; [Price, David A.] NIADD, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [McCluskey, James] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia	Monash University; QIMR Berghofer Medical Research Institute; Cardiff University; National Institutes of Health (NIH) - USA; University of Melbourne	Gras, S (corresponding author), Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	stephanie.gras@monash.edu	Rossjohn, Jamie/F-9032-2013; McCluskey, James/A-1291-2007; Price, David A/C-7876-2013; gras, stephanie/C-8307-2013; Purcell, Anthony/AAH-1942-2019; Miles, John J/ABC-1105-2020; Burrows, Scott/G-2050-2011	Rossjohn, Jamie/0000-0002-2020-7522; McCluskey, James/0000-0002-8597-815X; Price, David A/0000-0001-9416-2737; Purcell, Anthony/0000-0003-0532-8331; Miles, John J/0000-0001-5506-6304; Burrows, Scott/0000-0002-1430-0472; gras, stephanie/0000-0001-7416-038X; Neller, Michelle/0000-0002-2457-1508	Australian Research Council (ARC) [DP110102078]; National Health and Medical Research Council of Australia (NHMRC) [APP1009326]; Wellcome Trust [100326/Z/12/Z] Funding Source: researchfish	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Australian Research Council (ARC) Grant DP110102078 and the National Health and Medical Research Council of Australia (NHMRC) Grant APP1009326.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Archbold JK, 2008, MOL IMMUNOL, V45, P583, DOI 10.1016/j.molimm.2006.05.018; Bade-Doding C, 2011, HAEMATOL-HEMATOL J, V96, P110, DOI 10.3324/haematol.2010.030924; Baker BM, 2001, J EXP MED, V193, P551, DOI 10.1084/jem.193.5.551; Baker BM, 2012, IMMUNOL REV, V250, P10, DOI 10.1111/j.1600-065X.2012.01165.x; Birnbaum ME, 2012, IMMUNOL REV, V250, P82, DOI 10.1111/imr.12006; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Bricogne G., 2011, BUSTER VERSION 2 10; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Burrows SR, 2006, TRENDS IMMUNOL, V27, P11, DOI 10.1016/j.it.2005.11.001; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; DeLano W.L, PYMOL MOL GRAPHICS S; Deng L, 2007, TRENDS BIOCHEM SCI, V32, P500, DOI 10.1016/j.tibs.2007.08.007; Ebert LM, 2009, CANCER RES, V69, P1046, DOI 10.1158/0008-5472.CAN-08-2926; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Gras S, 2012, IMMUNOL REV, V250, P61, DOI 10.1111/j.1600-065X.2012.01159.x; Gras S, 2012, J IMMUNOL, V188, P311, DOI 10.4049/jimmunol.1102686; Gras S, 2011, IMMUNOL CELL BIOL, V89, P388, DOI 10.1038/icb.2010.150; Gras S, 2010, J EXP MED, V207, P1555, DOI 10.1084/jem.20100603; Gras S, 2009, IMMUNITY, V30, P193, DOI 10.1016/j.immuni.2008.11.011; Green KJ, 2004, EUR J IMMUNOL, V34, P2510, DOI 10.1002/eji.200425193; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lefranc MP, 2005, NUCLEIC ACIDS RES, V33, pD593, DOI 10.1093/nar/gki065; Li YL, 2005, EMBO J, V24, P2968, DOI 10.1038/sj.emboj.7600771; Liu YC, 2012, J BIOL CHEM, V287, P12267, DOI 10.1074/jbc.M112.344689; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Miles JJ, 2006, J IMMUNOL, V177, P6804, DOI 10.4049/jimmunol.177.10.6804; Probst-Kepper M, 2004, J IMMUNOL, V173, P5610, DOI 10.4049/jimmunol.173.9.5610; Quigley M. F., 2011, CURR PROTOC IMMUNOL, V94, DOI DOI 10.33.1-10.33.6; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Speir JA, 2001, IMMUNITY, V14, P81, DOI 10.1016/S1074-7613(01)00091-7; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2005, J BIOL CHEM, V280, P23900, DOI 10.1074/jbc.M503060200; Tynan FE, 2005, J EXP MED, V202, P1249, DOI 10.1084/jem.20050864; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Viret C, 1999, Rev Immunogenet, V1, P91; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Wynn KK, 2008, BLOOD, V111, P4283, DOI 10.1182/blood-2007-11-122622; Yin L, 2012, IMMUNOL REV, V250, P49, DOI 10.1111/imr.12004; Yin YY, 2012, IMMUNOL REV, V250, P32, DOI 10.1111/imr.12002	49	31	31	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15442	15454		10.1074/jbc.M112.447185	http://dx.doi.org/10.1074/jbc.M112.447185			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23569211	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-28	WOS:000319822300003
J	Barker, MK; Rose, DR				Barker, Megan K.; Rose, David R.			Specificity of Processing alpha-Glucosidase I Is Guided by the Substrate Conformation CRYSTALLOGRAPHIC AND IN SILICO STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; PROTEIN GLYCOSYLATION; N-GLYCOSYLATION; PURIFICATION; OLIGOSACCHARIDE; GLYCOPROTEIN; BINDING; INHIBITION; RESIDUES; COMPLEX	Processing alpha-glucosidase I (GluI) is a key member of the eukaryotic N-glycosylation processing pathway, selectively catalyzing the first glycoprotein trimming step in the endoplasmic reticulum. Inhibition of GluI activity impacts the infectivity of enveloped viruses; however, despite interest in this protein from a structural, enzymatic, and therapeutic standpoint, little is known about its structure and enzymatic mechanism in catalysis of the unique glycan substrate Glc(3)Man(9)GlcNAc(2). The first structural model of eukaryotic GluI is here presented at 2-angstrom resolution. Two catalytic residues are proposed, mutations of which result in catalytically inactive, properly folded protein. Using Autodocking methods with the known substrate and inhibitors as ligands, including a novel inhibitor characterized in this work, the active site of GluI was mapped. From these results, a model of substrate binding has been formulated, which is most likely conserved in mammalian GluI.	Univ Toronto, Ontario Canc Inst, Princess Margaret Hosp, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Rose, David R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Waterloo	Barker, MK (corresponding author), 610 Univ Ave,Rm 7-411, Toronto, ON M5G 2M9, Canada.	megan.barker@utoronto.ca; david.rose@uwaterloo.ca			Canadian Institutes for Health Research [MOP111237]; Heart and Stroke Foundation [NA-6305]; Natural Science and Engineering Research Council of Canada (NSERC); United States Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; National Center for Research Resources [5P41RR007707]; National Institutes of Health from the NIGMS [8P41GM103543, GM103485]; National Science Foundation; National Institutes of Health NIGMS via National Science Foundation [DMR-0936384]; National Institutes of Health [GM-53163]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103543, R01GM053163, P41GM103485] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health NIGMS via National Science Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Canadian Institutes for Health Research Grant MOP111237, Heart and Stroke Foundation Grant NA-6305, and the Natural Science and Engineering Research Council of Canada (NSERC).; We acknowledge A. Chakrabartty and K. Popovic for assistance with circular dichroism and tryptophan fluorescence experiments; J. Holyoake and G. Li for helpful discussions regarding in silico experiments; and A. Beristain, for critical reading of the manuscript. C. Scaman provided the Cwh41p construct, and A. Fairbanks the tetrasaccharide substrate. Use of the Advanced Photon Source was supported by the United States Department of Energy, Basic Energy Sciences, Office of Science, under Contract No. DE-AC02-06CH11357. Use of the BioCARS Sector 14 was also supported by grants from the National Center for Research Resources Grant 5P41RR007707 and the National Institutes of Health Grant 8P41GM103543 from the NIGMS. The Cornell High Energy Synchrotron Source (CHESS) is supported by the National Science Foundation and National Institutes of Health NIGMS via National Science Foundation Grant DMR-0936384; the MacCHESS resource is supported by National Institutes of Health Grant GM103485 from the NIGMS. Development of the HKL2000 software package is supported by National Institutes of Health Grant GM-53163 (to Z. Otwinowski and W. Minor).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aleshin AE, 2003, J MOL BIOL, V327, P61, DOI 10.1016/S0022-2836(03)00084-6; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; ASANO N, 1994, J MED CHEM, V37, P3701, DOI 10.1021/jm00048a006; Barker MK, 2011, PROTEIN EXPRES PURIF, V79, P96, DOI 10.1016/j.pep.2011.05.015; BAUSE E, 1989, EUR J BIOCHEM, V183, P661, DOI 10.1111/j.1432-1033.1989.tb21096.x; BAUSE E, 1986, FEBS LETT, V206, P208, DOI 10.1016/0014-5793(86)80982-6; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boggon TJ, 2000, STRUCTURE, V8, pR143, DOI 10.1016/S0969-2126(00)00168-4; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Burda P, 1998, GLYCOBIOLOGY, V8, P455, DOI 10.1093/glycob/8.5.455; Carugo O, 1997, PROTEIN SCI, V6, P2261; Chapel C, 2007, J GEN VIROL, V88, P1133, DOI 10.1099/vir.0.82465-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; De Praeter CM, 2000, AM J HUM GENET, V66, P1744, DOI 10.1086/302948; Dell Anne, 2010, Int J Microbiol, V2010, P148178, DOI 10.1155/2010/148178; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; Dhanawansa R, 2002, GLYCOBIOLOGY, V12, P229, DOI 10.1093/glycob/12.3.229; Durantel D, 2007, CURR OPIN INVEST DR, V8, P125; Durrant C, 2002, BIOCHEM J, V365, P239, DOI 10.1042/BJ20011786; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faridmoayer A, 2005, GLYCOBIOLOGY, V15, P1341, DOI 10.1093/glycob/cwj009; Faridmoayer A, 2004, PROTEIN EXPRES PURIF, V33, P11, DOI 10.1016/j.pep.2003.09.013; Faridmoayer A, 2007, GLYCOCONJUGATE J, V24, P429, DOI 10.1007/s10719-007-9035-2; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Gibson RP, 2007, ANGEW CHEM INT EDIT, V46, P4115, DOI 10.1002/anie.200604825; Gloster TM, 2008, CHEM BIOL, V15, P1058, DOI 10.1016/j.chembiol.2008.09.005; Gohlke H, 2002, ANGEW CHEM INT EDIT, V41, P2645; HARRIS EMS, 1993, BIOCHEMISTRY-US, V32, P1618, DOI 10.1021/bi00057a028; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HETTKAMP H, 1984, EUR J BIOCHEM, V142, P85, DOI 10.1111/j.1432-1033.1984.tb08253.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jaskiewicz E, 1996, J BIOL CHEM, V271, P26395, DOI 10.1074/jbc.271.42.26395; Jo S, 2008, NUCLEIC ACIDS RES, V36, pW270, DOI 10.1093/nar/gkn314; Knezevic A, 2010, GLYCOBIOLOGY, V20, P959, DOI 10.1093/glycob/cwq051; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kurakata Y, 2008, J MOL BIOL, V381, P116, DOI 10.1016/j.jmb.2008.05.061; LAMMERS G, 1989, BIOCHEM J, V261, P389, DOI 10.1042/bj2610389; Lieberman RL, 2009, BIOCHEMISTRY-US, V48, P4816, DOI 10.1021/bi9002265; Mehta A, 1998, FEBS LETT, V430, P17, DOI 10.1016/S0014-5793(98)00525-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEVEROVA I, 1994, ANAL BIOCHEM, V222, P190, DOI 10.1006/abio.1994.1472; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Okuyama M, 2011, BIOSCI BIOTECH BIOCH, V75, P2269, DOI 10.1271/bbb.110610; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palcic MM, 1999, GLYCOCONJUGATE J, V16, P351, DOI 10.1023/A:1007096011392; Papandreou MJ, 2002, MOL PHARMACOL, V61, P186, DOI 10.1124/mol.61.1.186; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Plewczynski D, 2011, J COMPUT CHEM, V32, P742, DOI 10.1002/jcc.21643; PUKAZHENTHI BS, 1993, INDIAN J BIOCHEM BIO, V30, P333; QUIOCHO FA, 1989, PURE APPL CHEM, V61, P1293, DOI 10.1351/pac198961071293; Romaniouk A, 1997, GLYCOBIOLOGY, V7, P399, DOI 10.1093/glycob/7.3.399; Romero PA, 1997, GLYCOBIOLOGY, V7, P997, DOI 10.1093/glycob/7.7.997; Roth J, 2010, MOL CELLS, V30, P497, DOI 10.1007/s10059-010-0159-z; SCHWEDEN J, 1986, ARCH BIOCHEM BIOPHYS, V248, P335, DOI 10.1016/0003-9861(86)90429-7; SHAILUBHAI K, 1991, J BIOL CHEM, V266, P16587; SHAILUBHAI K, 1987, BIOCHEM J, V247, P555, DOI 10.1042/bj2470555; SPIRO MJ, 1991, J BIOL CHEM, V266, P5311; Spiro RG, 2000, J BIOL CHEM, V275, P35657, DOI 10.1074/jbc.R000022200; Stierand K, 2006, BIOINFORMATICS, V22, P1710, DOI 10.1093/bioinformatics/btl150; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Varki A, 2009, ESSENTIALS GLYCOBIOL, P281; Vekilov PG, 2003, METHOD ENZYMOL, V368, P84, DOI 10.1016/S0076-6879(03)68006-7; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zeng YC, 1998, ARCH BIOCHEM BIOPHYS, V355, P26, DOI 10.1006/abbi.1998.0717	67	53	54	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13563	13574		10.1074/jbc.M113.460436	http://dx.doi.org/10.1074/jbc.M113.460436			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23536181	Green Published, hybrid			2022-12-28	WOS:000318850300039
J	Bosch, B; Heipertz, EL; Drake, JR; Roche, PA				Bosch, Berta; Heipertz, Erica L.; Drake, James R.; Roche, Paul A.			Major Histocompatibility Complex (MHC) Class II-Peptide Complexes Arrive at the Plasma Membrane in Cholesterol-rich Microclusters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-ACTIVATION; DENDRITIC CELLS; LIPID RAFTS; RECEPTOR MICROCLUSTERS; IMMUNOLOGICAL SYNAPSE; MONOCLONAL-ANTIBODIES; ANTIGEN; TRANSPORT; MICRODOMAINS; MOLECULES	Dendritic cells (DCs) function by stimulating naive antigen-specific CD4 T cells to proliferate and secrete a variety of immunomodulatory factors. The ability to activate naive T cells comes from the capacity of DCs to internalize, degrade, and express peptide fragments of antigenic proteins on their surface bound to MHC class II molecules (MHC-II). Although DCs express tens of thousands of distinct MHC-II, very small amounts of specific peptide-MHC-II complexes are required to interact with and activate T cells. We now show that stimulatory MHC-II I-Ak-HEL(46-61) complexes that move from intracellular antigen-processing compartments to the plasma membrane are not randomly distributed on the DC surface. Confocal immunofluorescence microscopy and quantitative immunoelectron microscopy reveal that the majority of newly generated MHC-II I-Ak-HEL(46-61) complexes are expressed in sub-100-nm microclusters on the DC membrane. These microclusters are stabilized in cholesterol-containing microdomains, and cholesterol depletion inhibits the stability of these clusters as well as the ability of the DCs to function as antigen-presenting cells. These results demonstrate that specific cohorts of peptide-MHC-II complexes expressed on the DC surface are present in cholesterol-dependent microclusters and that cluster integrity is important for antigen-specific naive CD4 T cell activation by DCs.	[Bosch, Berta; Heipertz, Erica L.; Roche, Paul A.] NCI, NIH, Expt Immunol Branch, Bethesda, MD 20892 USA; [Drake, James R.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Albany Medical College	Roche, PA (corresponding author), NIH, Bldg 10,Rm 4B36, Bethesda, MD 20892 USA.	paul.roche@nih.gov		Roche, Paul/0000-0002-8949-9172	National Institutes of Health [AI-065773]; Intramural Research Program of the National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC009404, ZIABC011033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065773] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI-065773 (to J. R. D.) as well as the Intramural Research Program of the National Institutes of Health (to P. A. R.).	Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Caballero A, 2006, EUR J IMMUNOL, V36, P3131, DOI 10.1002/eji.200636447; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Dadaglio G, 1997, IMMUNITY, V6, P727, DOI 10.1016/S1074-7613(00)80448-3; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; Eren E, 2006, SCAND J IMMUNOL, V63, P7, DOI 10.1111/j.1365-3083.2006.01700.x; Fisher PJ, 2008, BLOOD, V112, P5037, DOI 10.1182/blood-2008-04-149526; Furuta K, 2012, P NATL ACAD SCI USA, V109, P19380, DOI 10.1073/pnas.1213868109; Gombos I, 2004, IMMUNOL LETT, V92, P117, DOI 10.1016/j.imlet.2003.11.022; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; Hiltbold EM, 2003, J IMMUNOL, V170, P1329, DOI 10.4049/jimmunol.170.3.1329; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; Kropshofer H, 2002, NAT IMMUNOL, V3, P61, DOI 10.1038/ni750; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Poloso NJ, 2004, J IMMUNOL, V173, P4539, DOI 10.4049/jimmunol.173.7.4539; Poloso NJ, 2004, CURR OPIN IMMUNOL, V16, P103, DOI 10.1016/j.coi.2003.11.009; Reay PA, 2000, J IMMUNOL, V164, P5626, DOI 10.4049/jimmunol.164.11.5626; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zhong GM, 1997, P NATL ACAD SCI USA, V94, P13856, DOI 10.1073/pnas.94.25.13856	29	37	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13236	13242		10.1074/jbc.M112.442640	http://dx.doi.org/10.1074/jbc.M112.442640			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23532855	Green Published, hybrid			2022-12-28	WOS:000318850300010
J	Li, B; Shi, YQ; Shu, JH; Gao, JL; Wu, P; Tang, SJ				Li, Bei; Shi, Yuqiang; Shu, Jianhong; Gao, Junling; Wu, Ping; Tang, Shao-Jun			Wingless-type Mammary Tumor Virus Integration Site Family, Member 5A (Wnt5a) Regulates Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Glycoprotein 120 (gp120)-induced Expression of Pro-Inflammatory Cytokines via the Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII) and c-Jun N-terminal Kinase (JNK) Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; COAT PROTEIN; MECHANICAL ALLODYNIA; FRIZZLED HOMOLOGS; PROINFLAMMATORY CYTOKINES; PAIN FACILITATION; ARACHIDONIC-ACID; NMDA RECEPTORS; DORSAL-HORN; STEM-CELLS	Chronic expression of pro-inflammatory cytokines critically contributes to the pathogenesis of HIV-associated neurological disorders (HANDs), but the host mechanism that regulates the HIV-induced cytokine expression in the CNS remains elusive. Here, we present evidence for a crucial role of Wnt5a signaling in the expression of pro-inflammatory cytokines in the spinal cord induced by a major HIV-envelope protein, gp120. Wnt5a is mainly expressed in spinal neurons, and rapidly up-regulated by intrathecal injection (i.t.) of gp120. We show that inhibition of Wnt5a by specific antagonists blocks gp120-induced up-regulation of IL-1 beta, IL-6, and TNF-alpha in the spinal cord. Conversely, injection (i.t.) of purified recombinant Wnt5a stimulates the expression of these cytokines. To elucidate the role of the Wnt5a-regulated signaling pathways in gp120-induced cytokine expression, we have focused on CaMKII and JNKs, the well characterized down-stream targets of Wnt5a signaling. We find that Wnt5a is required for gp120 to activate CaMKII and JNK signaling. Furthermore, we demonstrate that the Wnt5a/CaM-KII pathway is critical for the gp120-induced expression of IL-1 beta, whereas the Wnt5a/JNK pathway is for TNF-alpha expression. Meanwhile, the expression of IL-6 is co-regulated by both pathways. These results collectively suggest that Wnt5a signaling cascades play a crucial role in the regulation of gp120-induced expression of pro-inflammatory cytokines in the CNS.	[Li, Bei; Shi, Yuqiang; Shu, Jianhong; Gao, Junling; Wu, Ping; Tang, Shao-Jun] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Li, Bei] Hainan Prov Inst Drug Control, Haikou 570216, Hainan, Peoples R China; [Shu, Jianhong] Zhejiang Sci Tech Univ, Inst Biochem, Zhejiang Prov Key Lab Silkworm Bioreactor & Biome, Hangzhou 310018, Peoples R China	University of Texas System; University of Texas Medical Branch Galveston; Zhejiang Sci-Tech University	Tang, SJ (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	shtang@utmb.edu			National Institutes of Health [R01-NS079166]; University of Texas Medical Branch; Whitehall Foundation; John Dunn Foundation; TIRR Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Medical Branch; Whitehall Foundation; John Dunn Foundation; TIRR Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported, in whole or in part, by National Institutes of Health Grants R01-NS079166 (to S. J. T.), the University of Texas Medical Branch Start-up Funds, the Whitehall Foundation, and the John Dunn Foundation and TIRR Foundation (to P. W.).	ALOISI F, 1992, J IMMUNOL, V149, P2358; Barks JDE, 1997, NEUROSCIENCE, V76, P397, DOI 10.1016/S0306-4522(96)00373-9; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BERNARDO A, 1994, CELL MOL NEUROBIOL, V14, P159, DOI 10.1007/BF02090782; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Cerpa W, 2011, J NEUROSCI, V31, P9466, DOI 10.1523/JNEUROSCI.6311-10.2011; Christman MA, 2008, AM J PHYSIOL-HEART C, V294, pH2864, DOI 10.1152/ajpheart.00982.2007; Cuitino L, 2010, J NEUROSCI, V30, P8411, DOI 10.1523/JNEUROSCI.5736-09.2010; Dreyer EB, 1995, EUR J NEUROSCI, V7, P2502, DOI 10.1111/j.1460-9568.1995.tb01048.x; Endo M, 2012, J CELL SCI, V125, P2017, DOI 10.1242/jcs.097782; Gemignani A, 2000, EUR J NEUROSCI, V12, P2839, DOI 10.1046/j.1460-9568.2000.00172.x; George SJ, 2008, ARTERIOSCL THROM VAS, V28, P400, DOI 10.1161/ATVBAHA.107.160952; Giunta B, 2004, BRAIN RES BULL, V64, P165, DOI 10.1016/j.brainresbull.2004.06.008; Giunta B., 2008, HDB NEUROCHEMISTRY M, P407; Grovit-Ferbas K, 2010, IMMUNOL RES, V48, P40, DOI 10.1007/s12026-010-8166-x; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Holguin A, 2004, PAIN, V110, P517, DOI 10.1016/j.pain.2004.02.018; Hughes KR, 2011, INFLAMM BOWEL DIS, V17, P213, DOI 10.1002/ibd.21353; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Iskander S, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-7; Jenei V, 2009, P NATL ACAD SCI USA, V106, P19473, DOI 10.1073/pnas.0909409106; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Kraft-Terry SD, 2009, NEURON, V64, P133, DOI 10.1016/j.neuron.2009.09.042; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; Lee I, 2007, PAIN, V133, P9, DOI 10.1016/j.pain.2007.01.035; Li B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022920; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Liu XH, 2008, DIGEST LIVER DIS, V40, P560, DOI 10.1016/j.dld.2007.12.011; Loram LC, 2010, BRAIN BEHAV IMMUN, V24, P959, DOI 10.1016/j.bbi.2010.03.008; Louboutin JP, 2011, EUR J NEUROSCI, V34, P2015, DOI 10.1111/j.1460-9568.2011.07908.x; Louboutin JP, 2010, EXP NEUROL, V221, P231, DOI 10.1016/j.expneurol.2009.11.004; MERRILL JE, 1991, FASEB J, V5, P2391, DOI 10.1096/fasebj.5.10.2065887; Milligan ED, 2001, J NEUROSCI, V21, P2808, DOI 10.1523/JNEUROSCI.21-08-02808.2001; Nishita M, 2010, TRENDS CELL BIOL, V20, P346, DOI 10.1016/j.tcb.2010.03.001; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; PATRIZIO M, 1994, NEUROSCI LETT, V178, P184, DOI 10.1016/0304-3940(94)90755-2; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Pugh CR, 2000, BRAIN RES, V861, P8, DOI 10.1016/S0006-8993(99)02445-2; Rao JS, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-101; Reischl J, 2007, J INVEST DERMATOL, V127, P163, DOI 10.1038/sj.jid.5700488; SAWADA M, 1992, BRAIN RES, V583, P296, DOI 10.1016/S0006-8993(10)80037-X; Schoeniger-Skinner DK, 2007, BRAIN BEHAV IMMUN, V21, P660, DOI 10.1016/j.bbi.2006.10.010; Schwartz ES, 2009, J NEUROSCI, V29, P159, DOI 10.1523/JNEUROSCI.3792-08.2009; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Sen M, 2001, ARTHRITIS RHEUM, V44, P772, DOI 10.1002/1529-0131(200104)44:4<772::AID-ANR133>3.0.CO;2-L; Sen M, 2008, J IMMUNOL, V181, P4441, DOI 10.4049/jimmunol.181.7.4441; Shah A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021261; Shah A, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-96; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Shi YQ, 2012, J NEUROSCI, V32, P10833, DOI 10.1523/JNEUROSCI.5628-11.2012; Sugimura R, 2010, BIRTH DEFECTS RES C, V90, P243, DOI 10.1002/bdrc.20195; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316; Vallieres L, 1997, J NEUROCHEM, V69, P1668, DOI 10.1046/j.1471-4159.1997.69041668.x; Varela-Nallar L, 2010, P NATL ACAD SCI USA, V107, P21164, DOI 10.1073/pnas.1010011107; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wagner JA, 1996, J EXP MED, V183, P2417, DOI 10.1084/jem.183.6.2417; Wallace DR, 2006, SYNAPSE, V59, P51, DOI 10.1002/syn.20214; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250; Wu CY, 2009, GLIA, V57, P1775, DOI 10.1002/glia.20890; Xu HX, 2011, J NEUROSCI, V31, P17074, DOI 10.1523/JNEUROSCI.4072-11.2011; Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004	68	42	48	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13610	13619		10.1074/jbc.M112.381046	http://dx.doi.org/10.1074/jbc.M112.381046			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23539626	hybrid, Green Published			2022-12-28	WOS:000318850300043
J	Rodriguez, Y; Smerdon, MJ				Rodriguez, Yesenia; Smerdon, Michael J.			The Structural Location of DNA Lesions in Nucleosome Core Particles Determines Accessibility by Base Excision Repair Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; POLYMERASE-BETA; CROSS-LINKING; CATALYTIC MECHANISM; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURES; SEQUENCE CONTEXT; MAMMALIAN-CELLS; URACIL RESIDUES; GLYCOSYLASE	Packaging of DNA into chromatin affects accessibility of DNA regulatory factors involved in transcription, replication, and repair. Evidence suggests that even in the nucleosome core particle (NCP), accessibility to damaged DNA is hindered by the presence of the histone octamer. Base excision repair is the major pathway in mammalian cells responsible for correcting a large number of chemically modified bases. We have measured the repair of site-specific uracil and single nucleotide gaps along the surface of the NCP. Our results indicate that removal of DNA lesions is greatly dependent on their rotational and translational positioning in NCPs. Significantly, the rate of uracil removal with outwardly oriented DNA backbones is 2-10-fold higher than those with inwardly oriented backbones. In general, uracils with inwardly oriented backbones farther away from the dyad center of the NCP are more accessible than those near the dyad. The translational positioning of outwardly oriented gaps is the key factor driving gap filling activity. An outwardly oriented gap near the DNA ends exhibits a 3-fold increase in gap filling activity as compared with one near the dyad with the same rotational orientation. Near the dyad, uracil DNA glycosylase/APE1 removes an outwardly oriented uracil efficiently; however, polymerase beta activity is significantly inhibited at this site. These data suggest that the hindrance presented by the location of a DNA lesion is dependent on the structural requirements for enzyme catalysis. Therefore, remodeling at DNA damage sites in NCPs is critical for preventing accumulation of aborted intermediates and ensuring completion of base excision repair.	[Rodriguez, Yesenia] Washington State Univ, Sch Mol Biosci, Dept Pharmaceut Sci, Pullman, WA 99164 USA; [Smerdon, Michael J.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University; Washington State University	Smerdon, MJ (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	smerdon@wsu.edu			National Institutes of Health from the NIEHS [ES004106]; NIGMS [T32GM008336]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	National Institutes of Health from the NIEHS; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES004106 from the NIEHS (to M. J. S.) and Training Award T32GM008336 from NIGMS.	Anderson JD, 2000, J MOL BIOL, V296, P979, DOI 10.1006/jmbi.2000.3531; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; Baute J, 2008, CRIT REV BIOCHEM MOL, V43, P239, DOI 10.1080/10409230802309905 ; Beard BC, 2005, DNA REPAIR, V4, P203, DOI 10.1016/j.dnarep.2004.09.011; Beard BC, 2003, P NATL ACAD SCI USA, V100, P7465, DOI 10.1073/pnas.1330328100; Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; Berquist BR, 2008, J MOL BIOL, V379, P17, DOI 10.1016/j.jmb.2008.03.053; Cai Y, 2010, BIOCHEMISTRY-US, V49, P9943, DOI 10.1021/bi101560y; Chafin DR, 2000, EMBO J, V19, P5492, DOI 10.1093/emboj/19.20.5492; Cole HA, 2010, J BIOL CHEM, V285, P2876, DOI 10.1074/jbc.M109.073544; Dalal S, 2008, BIOCHEMISTRY-US, V47, P12118, DOI 10.1021/bi8011548; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Donigan KA, 2012, J BIOL CHEM, V287, P23830, DOI 10.1074/jbc.M111.324947; Donigan KA, 2009, MOL CARCINOGEN, V48, P362, DOI 10.1002/mc.20497; Donny W, 2004, J BIOL CHEM, V279, P25268, DOI 10.1074/jbc.M400804200; Duan MR, 2010, J BIOL CHEM, V285, P26295, DOI 10.1074/jbc.M110.140087; EFTEDAL I, 1993, NUCLEIC ACIDS RES, V21, P2095, DOI 10.1093/nar/21.9.2095; Fernandez AG, 2007, J MOL BIOL, V371, P649, DOI 10.1016/j.jmb.2007.05.090; Friedberg EC, 2005, DNA REPAIR MUTAGENES, P169; Fromme JC, 2004, ADV PROTEIN CHEM, V69, P1; Gansen A, 2009, J PHYS CHEM B, V113, P2604, DOI 10.1021/jp7114737; HAYES JJ, 1991, P NATL ACAD SCI USA, V88, P6829, DOI 10.1073/pnas.88.15.6829; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hinz JM, 2010, P NATL ACAD SCI USA, V107, P4646, DOI 10.1073/pnas.0914443107; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Huggins CF, 2002, MOL CELL, V10, P1201, DOI 10.1016/S1097-2765(02)00736-0; JACKSON V, 1978, CELL, V15, P945, DOI 10.1016/0092-8674(78)90278-7; Kosmoski JV, 1999, BIOCHEMISTRY-US, V38, P9485, DOI 10.1021/bi990297h; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Liu YA, 2007, J BIOL CHEM, V282, P13532, DOI 10.1074/jbc.M611295200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Menoni H, 2007, MOL CELL BIOL, V27, P5949, DOI 10.1128/MCB.00376-07; Mol CD, 2000, MUTAT RES-DNA REPAIR, V460, P211, DOI 10.1016/S0921-8777(00)00028-8; NILSEN H, 1995, FEBS LETT, V362, P205, DOI 10.1016/0014-5793(95)00244-4; Nilsen H, 2002, EMBO J, V21, P5943, DOI 10.1093/emboj/cdf581; Nilsen H, 2001, CARCINOGENESIS, V22, P987, DOI 10.1093/carcin/22.7.987; North JA, 2012, NUCLEIC ACIDS RES, V40, P10215, DOI 10.1093/nar/gks747; Odell ID, 2011, MOL CELL BIOL, V31, P4623, DOI 10.1128/MCB.05715-11; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Prasad A, 2007, MOL CELL BIOL, V27, P8442, DOI 10.1128/MCB.00791-07; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Prasad R, 2010, J BIOL CHEM, V285, P40479, DOI 10.1074/jbc.M110.155267; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Schroeder JC, 2003, CANCER RES, V63, P7530; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; Tan S, 2011, CURR OPIN STRUC BIOL, V21, P128, DOI 10.1016/j.sbi.2010.11.006; Thastrom A, 2004, METHODS, V33, P33, DOI 10.1016/j.ymeth.2003.10.018; Tims HS, 2007, METHODS, V41, P296, DOI 10.1016/j.ymeth.2007.01.001; Tims HS, 2011, J MOL BIOL, V411, P430, DOI 10.1016/j.jmb.2011.05.044; TULLIUS TD, 1991, FREE RADICAL RES COM, V12-3, P521; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67; Wei Q., 2007, DNA REPAIR GENETIC I, P376; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Wilson SH, 1998, MUTAT RES-DNA REPAIR, V407, P203, DOI 10.1016/S0921-8777(98)00002-0; Ye Y, 2012, BIOCHEMISTRY-US, V51, P6028, DOI 10.1021/bi3006412; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	67	66	66	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13863	13875		10.1074/jbc.M112.441444	http://dx.doi.org/10.1074/jbc.M112.441444			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23543741	Green Published, hybrid			2022-12-28	WOS:000318850300067
J	Carbe, C; Garg, A; Cai, ZG; Li, HG; Powers, A; Zhang, X				Carbe, Christian; Garg, Ankur; Cai, Zhigang; Li, Hongge; Powers, Andrea; Zhang, Xin			An Allelic Series at the Paired Box Gene 6 (Pax6) Locus Reveals the Functional Specificity of Pax Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACRIMAL GLAND DEVELOPMENT; RETINAL PROGENITOR CELLS; EYE DEVELOPMENT; BRAIN-DEVELOPMENT; DEVELOPING CORTEX; LENS DEVELOPMENT; DROSOPHILA EYE; MOUSE; DIFFERENTIATION; ANIRIDIA	The advent of the ocular and nervous system in metazoan evolution coincides with the diversification of a single ancestral paired box (Pax) gene into Pax6, Pax6(5a), and Pax2. To investigate the role of these Pax genes in neural development, we have generated an allelic series of knock-in models at the Pax6 locus. We showed that although Pax6(5a) and Pax2 could not replace Pax6 for its autoregulation in lens induction or for neural differentiation in retina, Pax6(5a) was sufficient for corneal-lenticular detachment. In brain development, cell proliferation in the cerebral cortex and dorsoventral patterning of the telencephalon and neural tube were partially rescued in either knock-in mutant. Contrary to the previous belief, our genetic studies showed that the Pax6 isoform Pax6(5a) could potentially play a role in neuronal differentiation in brain development. Importantly, Pax2 showed greater rescue efficiency than Pax6(5a) in the telencephalon even though the latter was identical to Pax6 outside the paired domain. In studying Ngn2, a Pax6 direct target gene in telencephalon, we showed that the level of Ngn2 expression correlated with the in vitro binding of Pax2, Pax6, and Pax6(5a) paired domain on its enhancer. Our results show that Pax6 is uniquely required for eye development, but in brain development, Pax6 can be functionally substituted by related Pax family genes that share a similar paired domain binding specificity.	[Zhang, Xin] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Zhang, X (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA.	xz4@iu.edu	Li, Hongge/G-7594-2015		National Institutes of Health [EY017061, EY018868]; NATIONAL EYE INSTITUTE [R01EY017061, R01EY018868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY017061 and EY018868 (to X. Z.).	Aota S, 2003, DEV BIOL, V257, P1, DOI 10.1016/S0012-1606(03)00058-7; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Azuma N, 2005, HUM MOL GENET, V14, P735, DOI 10.1093/hmg/ddi069; Baumer N, 2003, DEVELOPMENT, V130, P2903, DOI 10.1242/dev.00450; Berger J, 2007, DEVELOPMENT, V134, P1311, DOI 10.1242/dev.02809; Bharti K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002757; Bouchard M, 2000, DEVELOPMENT, V127, P3703; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Brown NL, 1998, DEVELOPMENT, V125, P4821; Brownell I, 2000, GENESIS, V27, P81, DOI 10.1002/1526-968X(200006)27:2<81::AID-GENE50>3.0.CO;2-N; Carbe C, 2012, DEV BIOL, V363, P320, DOI 10.1016/j.ydbio.2011.12.038; Caric D, 1997, DEVELOPMENT, V124, P5087; Chapouton P, 1999, DEVELOPMENT, V126, P5569; Dominguez M, 2004, NAT GENET, V36, P31, DOI 10.1038/ng1281; Donner AL, 2007, GENE EXPR PATTERNS, V7, P606, DOI 10.1016/j.modgep.2007.01.001; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Estivill-Torrus G, 2002, DEVELOPMENT, V129, P455; Favor J, 2001, GENETICS, V159, P1689; Fu WM, 1997, GENE DEV, V11, P2066, DOI 10.1101/gad.11.16.2066; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Haubst N, 2004, DEVELOPMENT, V131, P6131, DOI 10.1242/dev.01524; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Jang CC, 2003, DEVELOPMENT, V130, P2939, DOI 10.1242/dev.00522; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Kim AS, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-05-j0002.2001; Kozmik Z, 2005, CURR OPIN GENET DEV, V15, P430, DOI 10.1016/j.gde.2005.05.001; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Makarenkova HP, 2000, DEVELOPMENT, V127, P2563; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Mikkola I, 2001, J BIOL CHEM, V276, P4109, DOI 10.1074/jbc.M008882200; Nomura T, 2004, DEVELOPMENT, V131, P787, DOI 10.1242/dev.00984; Oron-Karni V, 2008, DEVELOPMENT, V135, P4037, DOI 10.1242/dev.028308; Pan Y, 2008, DEVELOPMENT, V135, P301, DOI 10.1242/dev.014829; Pan Y, 2006, DEVELOPMENT, V133, P4933, DOI 10.1242/dev.02679; Pan Y, 2010, DEVELOPMENT, V137, P1085, DOI 10.1242/dev.042820; Philips GT, 2005, DEV BIOL, V279, P308, DOI 10.1016/j.ydbio.2004.12.018; Punzo C, 2001, GENE DEV, V15, P1716, DOI 10.1101/gad.196401; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; Rowan S, 2010, GENE DEV, V24, P980, DOI 10.1101/gad.1890410; Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539; SCHMAHL W, 1993, ACTA NEUROPATHOL, V86, P126, DOI 10.1007/BF00334879; Schwarz M, 2000, DEVELOPMENT, V127, P4325; Shaham O, 2009, DEVELOPMENT, V136, P2567, DOI 10.1242/dev.032888; Singh S, 2002, P NATL ACAD SCI USA, V99, P6812, DOI 10.1073/pnas.102691299; Stoykova A, 1996, DEVELOPMENT, V122, P3453; Zhang X, 2002, GENE DEV, V16, P2097, DOI 10.1101/gad.1007602; Zhang X, 2006, DEV BIOL, V300, P748, DOI 10.1016/j.ydbio.2006.06.030	54	25	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12130	12141		10.1074/jbc.M112.436865	http://dx.doi.org/10.1074/jbc.M112.436865			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23515312	Green Published, hybrid			2022-12-28	WOS:000318157600045
J	Ma, B; Zhong, LL; van Blitterswijk, CA; Post, JN; Karperien, M				Ma, Bin; Zhong, Leilei; van Blitterswijk, Clemens A.; Post, Janine N.; Karperien, Marcel			T Cell Factor 4 Is a Pro-catabolic and Apoptotic Factor in Human Articular Chondrocytes by Potentiating Nuclear Factor kappa B Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-METALLOPROTEINASE 13; GENE-EXPRESSION; TRANSCRIPTION; ACTIVATION; KINASE; PHENOTYPE; CARTILAGE; PROMOTER; COLLAGEN; DOMAIN	T cell factor/lymphoid enhancer factor (TCF/LEF) transcription factors are downstream effectors of Wnt/beta-catenin signaling, which has been implicated in the development and progression of osteoarthritis (OA). This study aimed to investigate the role of TCF/LEF transcription factors in human articular chondrocytes. Primary human osteoarthritic cartilage predominantly expressed TCF4 and to a lesser extent, LEF1 and TCF3 mRNA. Overexpression of TCF4, but not of TCF3 or LEF1, induced MMP-1, -3, and -13 expression and generic MMP activity in human chondrocytes. This was due to potentiating NF-kappa B signaling by a protein-protein interaction between TCF4 and NF-kappa B p65 activating established NF-kappa B target genes such as MMPs and IL-6. LEF1 competed with TCF4 for binding to NF-kappa B p65. I kappa B-alpha was able to counteract the effect of TCF4 on NF-kappa B target gene expression. Finally, we showed that TCF4 mRNA expression was elevated in OA cartilage compared with healthy cartilage and induced chondrocyte apoptosis at least partly through activating caspase 3/7. Our findings suggest that increased TCF4 expression may contribute to cartilage degeneration in OA by augmenting NF-kappa B signaling.	[Ma, Bin; Zhong, Leilei; Post, Janine N.; Karperien, Marcel] Univ Twente, Dept Dev BioEngn, NL-7522 NB Enschede, Netherlands; [van Blitterswijk, Clemens A.] Univ Twente, Dept Tissue Regenerat, NL-7522 NB Enschede, Netherlands	University of Twente; University of Twente	Karperien, M (corresponding author), Univ Twente, Dept Dev BioEngn, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands.	b.j.karperien@utwente.nl	Ma, Bin/B-4239-2015; Post, Janine N./E-9983-2011; Karperien, Marcel/R-3270-2018	Ma, Bin/0000-0001-5744-9667; Post, Janine N./0000-0002-6645-6583; Karperien, Marcel/0000-0003-0751-0604; van Blitterswijk, Clemens/0000-0003-2371-4615	BioMedical Materials Institute [P2.02]; Dutch Ministry of Economic Affairs, Agriculture, and Innovation	BioMedical Materials Institute; Dutch Ministry of Economic Affairs, Agriculture, and Innovation	This work was supported by the Project P2.02 OAcontrol of the research program of the BioMedical Materials Institute, co-funded by the Dutch Ministry of Economic Affairs, Agriculture, and Innovation.	Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Furia B, 2002, J BIOL CHEM, V277, P4973, DOI 10.1074/jbc.M107848200; Hayashida M, 2009, ARTHRITIS RHEUM-US, V60, P708, DOI 10.1002/art.24332; Hecht A, 2003, J BIOL CHEM, V278, P3776, DOI 10.1074/jbc.M210081200; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Hurlstone A, 2002, EMBO J, V21, P2303, DOI 10.1093/emboj/21.10.2303; Hwang SG, 2004, J BIOL CHEM, V279, P26597, DOI 10.1074/jbc.M401401200; Ishiguro N, 1999, ARTHRITIS RHEUM, V42, P129, DOI 10.1002/1529-0131(199901)42:1<129::AID-ANR16>3.0.CO;2-4; Kim SJ, 2003, BIOCHEM BIOPH RES CO, V303, P206, DOI 10.1016/S0006-291X(03)00305-X; Kim SJ, 2002, J BIOL CHEM, V277, P33501, DOI 10.1074/jbc.M202862200; Kuhn K, 2001, ARTHRITIS RHEUM-US, V44, P1644, DOI 10.1002/1529-0131(200107)44:7<1644::AID-ART287>3.0.CO;2-S; Lark MW, 1997, J CLIN INVEST, V100, P93, DOI 10.1172/JCI119526; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Ma B, 2012, ARTHRITIS RHEUM-US, V64, P2589, DOI 10.1002/art.34425; Marr RA, 2004, J MOL NEUROSCI, V22, P5, DOI 10.1385/JMN:22:1-2:5; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nalesso G, 2011, J CELL BIOL, V193, P551, DOI 10.1083/jcb.201011051; Raymond L, 2007, OSTEOARTHR CARTILAGE, V15, P431, DOI 10.1016/j.joca.2006.09.011; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Valenta T, 2003, NUCLEIC ACIDS RES, V31, P2369, DOI 10.1093/nar/gkg346; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wan FY, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000067; Yuasa T, 2008, LAB INVEST, V88, P264, DOI 10.1038/labinvest.3700747; Yun K, 2007, BIOCHEM BIOPH RES CO, V364, P1009, DOI 10.1016/j.bbrc.2007.10.121; Yun K, 2007, BIOCHEM BIOPH RES CO, V357, P589, DOI 10.1016/j.bbrc.2007.03.170; Yun K, 2009, J IMMUNOL, V183, P5129, DOI 10.4049/jimmunol.0802744; Zhu M, 2009, J BONE MINER RES, V24, P12, DOI 10.1359/JBMR.080901	34	47	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17552	17558		10.1074/jbc.M113.453985	http://dx.doi.org/10.1074/jbc.M113.453985			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23603903	Green Published, hybrid			2022-12-28	WOS:000320380600046
J	Feigenbutz, M; Jones, R; Besong, TMD; Harding, SE; Mitchell, P				Feigenbutz, Monika; Jones, Rebecca; Besong, Tabot M. D.; Harding, Stephen E.; Mitchell, Phil			Assembly of the Yeast Exoribonuclease Rrp6 with Its Associated Cofactor Rrp47 Occurs in the Nucleus and Is Critical for the Controlled Expression of Rrp47	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; EXOSOME SUBUNIT RRP6P; HUMAN PM-SCL; RIBOSOMAL-RNA; SUBCELLULAR-LOCALIZATION; BIDIRECTIONAL PROMOTERS; POLY(A) POLYMERASE; GENE-EXPRESSION; DEGRADATION; TRANSCRIPTS	Rrp6 is a key catalytic subunit of the nuclear RNA exosome that plays a pivotal role in the processing, degradation, and quality control of a wide range of cellular RNAs. Here we report our findings on the assembly of the complex involving Rrp6 and its associated protein Rrp47, which is required for many Rrp6-mediated RNA processes. Recombinant Rrp47 is expressed as a non-globular homodimer. Analysis of the purified recombinant Rrp6.Rrp47 complex revealed a heterodimer, suggesting that Rrp47 undergoes a structural reconfiguration upon interaction with Rrp6. Studies using GFP fusion proteins show that Rrp6 and Rrp47 are localized to the yeast cell nucleus independently of one another. Consistent with this data, Rrp6, but not Rrp47, is found associated with the nuclear import adaptor protein Srp1. We show that the interaction with Rrp6 is critical for Rrp47 stability in vivo; in the absence of Rrp6, newly synthesized Rrp47 is rapidly degraded in a proteasome-dependent manner. These data resolve independent nuclear import routes for Rrp6 and Rrp47, reveal a structural reorganization of Rrp47 upon its interaction with Rrp6, and demonstrate a proteasome-dependent mechanism that efficiently suppresses the expression of Rrp47 in the absence of Rrp6.	[Feigenbutz, Monika; Jones, Rebecca; Mitchell, Phil] Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Besong, Tabot M. D.; Harding, Stephen E.] Univ Nottingham, Natl Ctr Macromol Hydrodynam, Loughborough LE12 5RD, Leics, England	University of Sheffield; University of Nottingham	Mitchell, P (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	p.j.mitchell@shef.ac.uk		Harding, Stephen E./0000-0002-7798-9692; Jones, Rebecca M/0000-0002-5310-8475; Mitchell, Phil/0000-0002-3178-0439	Wellcome Trust [08836/Z/09/Z, WT093134MA]; University of Sheffield; United Kingdom Engineering and Physical Sciences Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); University of Sheffield; United Kingdom Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Wellcome Trust Grants 08836/Z/09/Z (to P.M.) and WT093134MA (to the University of Sheffield light microscope facility).; Supported by a University of Sheffield Ph.D. studentship. Present address: School of Cancer Studies, University of Birmingham, Birmingham B15 2TT, United Kingdom.; Supported by a United Kingdom Engineering and Physical Sciences Research Council Dorothy Hodgkin studentship.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; AUKHIL I, 1993, J BIOL CHEM, V268, P2542; Belostotsky D, 2009, CURR OPIN CELL BIOL, V21, P352, DOI 10.1016/j.ceb.2009.04.011; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Butler JS, 2010, ADV EXP MED BIOL, V702, P91, DOI 10.1007/978-1-4419-7841-7_8; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Chekanova JA, 2007, CELL, V131, P1340, DOI 10.1016/j.cell.2007.10.056; Colfen H, 1997, EUR BIOPHYS J BIOPHY, V25, P333, DOI 10.1007/s002490050047; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Costello JL, 2011, J BIOL CHEM, V286, P4535, DOI 10.1074/jbc.M110.162826; Dam J, 2004, METHOD ENZYMOL, V384, P185; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Graham AC, 2006, MOL BIOL CELL, V17, P1399, DOI 10.1091/mbc.e05-08-0805; Graham AC, 2009, MOL BIOL CELL, V20, P2242, DOI 10.1091/mbc.E08-08-0825; Grzechnik P, 2008, MOL CELL, V32, P247, DOI 10.1016/j.molcel.2008.10.003; Gudipati RK, 2012, MOL CELL, V48, P409, DOI 10.1016/j.molcel.2012.08.018; Haile S, 2007, MOL BIOCHEM PARASIT, V151, P52, DOI 10.1016/j.molbiopara.2006.10.005; Harding SE, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P468; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lange H, 2008, MOL CELL BIOL, V28, P3038, DOI 10.1128/MCB.02064-07; Lardenois A, 2011, P NATL ACAD SCI USA, V108, P1058, DOI 10.1073/pnas.1016459108; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lejeune F, 2003, MOL CELL, V12, P675, DOI 10.1016/S1097-2765(03)00349-6; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Mateus C, 2000, YEAST, V16, P1313, DOI 10.1002/1097-0061(200010)16:14<1313::AID-YEA626>3.0.CO;2-O; Midtgaard SF, 2006, P NATL ACAD SCI USA, V103, P11898, DOI 10.1073/pnas.0604731103; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Mitchell P, 2010, BIOCHEM SOC T, V38, P1088, DOI 10.1042/BST0381088; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Motley AM, 2012, EMBO J, V31, P2852, DOI 10.1038/emboj.2012.151; Nehls P, 1998, NUCLEIC ACIDS RES, V26, P1160, DOI 10.1093/nar/26.5.1160; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Phillips S, 2003, RNA, V9, P1098, DOI 10.1261/rna.5560903; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rothbarth K, 1999, J CELL SCI, V112, P2223; Sattlegger E, 2011, J BIOL CHEM, V286, P10341, DOI 10.1074/jbc.M110.171587; Schilders G, 2007, NUCLEIC ACIDS RES, V35, P2564, DOI 10.1093/nar/gkm082; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider C, 2012, MOL CELL, V48, P422, DOI 10.1016/j.molcel.2012.08.013; Staub E, 2004, BIOESSAYS, V26, P567, DOI 10.1002/bies.20032; Stead JA, 2007, NUCLEIC ACIDS RES, V35, P5556, DOI 10.1093/nar/gkm614; Synowsky SA, 2006, MOL CELL PROTEOMICS, V5, P1581, DOI 10.1074/mcp.M600043-MCP200; Synowsky SA, 2009, J MOL BIOL, V385, P1300, DOI 10.1016/j.jmb.2008.11.011; TOLLERVEY D, 1987, EMBO J, V6, P469, DOI 10.1002/j.1460-2075.1987.tb04777.x; Tomecki R, 2010, CHEMBIOCHEM, V11, P938, DOI 10.1002/cbic.201000025; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Wasmuth EV, 2012, MOL CELL, V48, P133, DOI 10.1016/j.molcel.2012.07.012; Welter E, 2010, AUTOPHAGY, V6, P794, DOI 10.4161/auto.6.6.12348; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Wolin SL, 2012, TRENDS GENET, V28, P306, DOI 10.1016/j.tig.2012.03.005; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728	73	23	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15959	15970		10.1074/jbc.M112.445759	http://dx.doi.org/10.1074/jbc.M112.445759			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23580640	hybrid, Green Published			2022-12-28	WOS:000319822300048
J	Kurihara, S; Sakai, Y; Suzuki, H; Muth, A; Phanstiel, O; Rather, PN				Kurihara, Shin; Sakai, Yumi; Suzuki, Hideyuki; Muth, Aaron; Phanstiel, Otto; Rather, Philip N.			Putrescine Importer PlaP Contributes to Swarming Motility and Urothelial Cell Invasion in Proteus mirabilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; POLYAMINE TRANSPORT; UTILIZATION PATHWAY; BIOFILM FORMATION; GAMMA-AMINOBUTYRATE; EXPRESSION; GENE; DIFFERENTIATION; SPERMIDINE; BIOSYNTHESIS	Previously, we reported that the speA gene, encoding arginine decarboxylase, is required for swarming in the urinary tract pathogen Proteus mirabilis. In addition, this previous study suggested that putrescine may act as a cell-to-cell signaling molecule (Sturgill, G., and Rather, P. N. (2004) Mol. Microbiol. 51, 437-446). In this new study, PlaP, a putative putrescine importer, was characterized in P. mirabilis. In a wild-type background, a plaP null mutation resulted in a modest swarming defect and slightly decreased levels of intracellular putrescine. In a P. mirabilis speA mutant with greatly reduced levels of intracellular putrescine, plaP was required for the putrescine-dependent rescue of swarming motility. When a speA/plaP double mutant was grown in the presence of extracellular putrescine, the intracellular levels of putrescine were greatly reduced compared with the speA mutant alone, indicating that PlaP functioned as the primary putrescine importer. In urothelial cell invasion assays, a speA mutant exhibited a 50% reduction in invasion when compared with wild type, and this defect could be restored by putrescine in a PlaP-dependent manner. The putrescine analog Triamide-44 partially inhibited the uptake of putrescine by PlaP and decreased both putrescine stimulated swarming and urothelial cell invasion in a speA mutant.	[Kurihara, Shin; Suzuki, Hideyuki; Rather, Philip N.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Sakai, Yumi] Kyoto Inst Technol, Grad Sch Sci & Technol, Div Appl Biol, Sakyo Ku, Kyoto 6068585, Japan; [Muth, Aaron; Phanstiel, Otto] Univ Cent Florida, Dept Med Educ, Orlando, FL 32826 USA; [Rather, Philip N.] Vet Affairs Med Ctr, Res Serv, Decatur, GA 30033 USA	Emory University; Kyoto Institute of Technology; State University System of Florida; University of Central Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Kurihara, S (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	kurisin711@gmail.com			Japan Society for the Promotion of Science; Department of Veterans Affairs; Veterans Affairs [I01BX001725] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	Supported by a postdoctoral fellowship for research abroad from the Japan Society for the Promotion of Science. To whom correspondence should be addressed: Dept. of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322. Tel.: 404-728-5079; Fax: 404-728-4847; E-mail: kurisin711@gmail.com.; Supported by Merit Review and Research Career Scientist awards from the Department of Veterans Affairs.	Alamuri P, 2010, INFECT IMMUN, V78, P4882, DOI 10.1128/IAI.00718-10; ALLISON C, 1994, J INFECT DIS, V169, P1155, DOI 10.1093/infdis/169.5.1155; ALLISON C, 1992, MOL MICROBIOL, V6, P1583; APPLEBAUM D, 1975, BIOCHEMISTRY-US, V14, P3675, DOI 10.1021/bi00687a025; Armbruster CE, 2013, J BACTERIOL, V195, P1305, DOI 10.1128/JB.02136-12; BELAS R, 1994, J BACTERIOL, V176, P7169, DOI 10.1128/JB.176.23.7169-7181.1994; BOYLE SM, 1984, GENE, V30, P129, DOI 10.1016/0378-1119(84)90113-6; Burrell M, 2010, J BIOL CHEM, V285, P39224, DOI 10.1074/jbc.M110.163154; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; FARINHA MA, 1990, J BACTERIOL, V172, P3496, DOI 10.1128/jb.172.6.3496-3499.1990; Fraser GM, 2002, MICROBIOL-SGM, V148, P2191, DOI 10.1099/00221287-148-7-2191; FURUCHI T, 1991, J BIOL CHEM, V266, P20928; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Jelsbak L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036149; Jones BV, 2004, INFECT IMMUN, V72, P3941, DOI 10.1128/IAI.72.7.3941-3950.2004; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Karatan E, 2005, J BACTERIOL, V187, P7434, DOI 10.1128/JB.187.21.7434-7443.2005; KASHIWAGI K, 1990, J BIOL CHEM, V265, P20893; KASHIWAGI K, 1992, P NATL ACAD SCI USA, V89, P4529, DOI 10.1073/pnas.89.10.4529; Kaur N, 2008, J MED CHEM, V51, P1393, DOI 10.1021/jm070794t; Kolodkin-Gal I, 2012, CELL, V149, P684, DOI 10.1016/j.cell.2012.02.055; KUEHN GD, 1990, PLANT PHYSIOL, V94, P855, DOI 10.1104/pp.94.3.855; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kurihara S, 2006, FEMS MICROBIOL LETT, V256, P318, DOI 10.1111/j.1574-6968.2006.00137.x; Kurihara S, 2005, J BIOL CHEM, V280, P4602, DOI 10.1074/jbc.M411114200; Kurihara S, 2008, J BIOL CHEM, V283, P19981, DOI 10.1074/jbc.M800133200; Kurihara S, 2011, J BIOL CHEM, V286, P10185, DOI 10.1074/jbc.M110.176032; Kurihara S, 2010, J BACTERIOL, V192, P4582, DOI 10.1128/JB.00308-10; Kurihara S, 2009, J BACTERIOL, V191, P2776, DOI 10.1128/JB.01314-08; Kurihara S, 2009, FEMS MICROBIOL LETT, V294, P97, DOI 10.1111/j.1574-6968.2009.01552.x; Lee J, 2009, J BIOL CHEM, V284, P9899, DOI 10.1074/jbc.M900110200; MOBLEY HLT, 1995, TRENDS MICROBIOL, V3, P280, DOI 10.1016/S0966-842X(00)88945-3; MOBLEY HLT, 1987, J CLIN MICROBIOL, V25, P2216, DOI 10.1128/JCM.25.11.2216-2217.1987; Morgenstein RM, 2010, FEMS MICROBIOL REV, V34, P753, DOI 10.1111/j.1574-6976.2010.00229.x; Muth A. F., 2012, THESIS U CENTRAL FLO; Nasrallah GK, 2011, J BACTERIOL, V193, P4346, DOI 10.1128/JB.01506-10; Patel CN, 2006, J BACTERIOL, V188, P2355, DOI 10.1128/JB.188.7.2355-2363.2006; Pearson MM, 2008, J BACTERIOL, V190, P4027, DOI 10.1128/JB.01981-07; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; PISTOCCHI R, 1993, J BIOL CHEM, V268, P146; Rather PN, 2005, ENVIRON MICROBIOL, V7, P1065, DOI 10.1111/j.1462-2920.2005.00806.x; Sakamoto A, 2012, INT J BIOCHEM CELL B, V44, P1877, DOI 10.1016/j.biocel.2012.07.010; Samsonova NN, 2005, FEBS LETT, V579, P4107, DOI 10.1016/j.febslet.2005.06.038; Samsonova NN, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-2; Shah P, 2011, MICROBIOL-SGM, V157, P504, DOI 10.1099/mic.0.042564-0; Sturgill G, 2004, MOL MICROBIOL, V51, P437, DOI 10.1046/j.1365-2958.2003.03835.x; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; TABOR CW, 1987, J BIOL CHEM, V262, P16037; TABOR CW, 1986, P NATL ACAD SCI USA, V83, P6040, DOI 10.1073/pnas.83.16.6040; Terui Y, 2005, BIOCHEM J, V388, P427, DOI 10.1042/BJ20041778; Walker KE, 1999, MOL MICROBIOL, V32, P825, DOI 10.1046/j.1365-2958.1999.01401.x; Ware D, 2006, INFECT IMMUN, V74, P352, DOI 10.1128/IAI.74.1.352-361.2006	52	18	18	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15668	15676		10.1074/jbc.M113.454090	http://dx.doi.org/10.1074/jbc.M113.454090			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23572531	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000319822300023
J	Sobel, K; Menyhart, K; Killer, N; Renault, B; Bauer, Y; Studer, R; Steiner, B; Bolli, MH; Nayler, O; Gatfield, J				Sobel, Katrin; Menyhart, Katalin; Killer, Nina; Renault, Berengere; Bauer, Yasmina; Studer, Rolf; Steiner, Beat; Bolli, Martin H.; Nayler, Oliver; Gatfield, John			Sphingosine 1-Phosphate (S1P) Receptor Agonists Mediate Pro-fibrotic Responses in Normal Human Lung Fibroblasts via S1P(2) and S1P(3) Receptors and Smad-independent Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE GROWTH-FACTOR; IMMUNOMODULATOR FTY720; FACTOR-BETA; FIBROSIS; SPHINGOSINE-1-PHOSPHATE; DIFFERENTIATION; EXPRESSION; CASCADE	Synthetic sphingosine 1-phosphate receptor 1 modulators constitute a new class of drugs for the treatment of autoimmune diseases. Sphingosine 1-phosphate (S1P) signaling, however, is also involved in the development of fibrosis. Using normal human lung fibroblasts, we investigated the induction of fibrotic responses by the S1P receptor (S1PR) agonists S1P, FTY720-P, ponesimod, and SEW2871 and compared them with the responses induced by the known fibrotic mediator TGF-beta 1. In contrast to TGF-beta 1, S1PR agonists did not induce expression of the myofibroblast marker alpha-smooth muscle actin. However, TGF-beta 1, S1P, and FTY720-P caused robust stimulation of extracellular matrix (ECM) synthesis and increased pro-fibrotic marker gene expression including connective tissue growth factor. Ponesimod showed limited and SEW2871 showed no pro-fibrotic potential in these readouts. Analysis of pro-fibrotic signaling pathways showed that in contrast to TGF-beta 1, S1PR agonists did not activate Smad2/3 signaling but rather activated PI3K/Akt and ERK1/2 signaling to induce ECM synthesis. The strong induction of ECM synthesis by the nonselective agonists S1P and FTY720-P was due to the stimulation of S1P(2) and S1P(3) receptors, whereas the weaker induction of ECM synthesis at high concentrations of ponesimod was due to a low potency activation of S1P(3) receptors. Finally, in normal human lung fibroblast-derived myofibroblasts that were generated by TGF-beta 1 pretreatment, S1P and FTY720-P were effective stimulators of ECM synthesis, whereas ponesimod was inactive, because of the down-regulation of S1P(3)R expression in myofibroblasts. These data demonstrate that S1PR agonists are pro-fibrotic via S1P(2)R and S1P(3)R stimulation using Smad-independent pathways.	[Sobel, Katrin; Menyhart, Katalin; Killer, Nina; Renault, Berengere; Bauer, Yasmina; Studer, Rolf; Steiner, Beat; Bolli, Martin H.; Nayler, Oliver; Gatfield, John] Actel Pharmaceut Ltd, CH-4123 Allschwil, Switzerland	Actelion Pharmaceuticals Ltd	Gatfield, J (corresponding author), Actel Pharmaceut Ltd, Drug Discovery Biol Dept, Gewerbestr 16, CH-4123 Allschwil, Switzerland.	john.gatfield@actelion.com						Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Bolli MH, 2010, J MED CHEM, V53, P4198, DOI 10.1021/jm100181s; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Gellings Lowe N., 2009, CARDIOVASC RES, V82, P303, DOI DOI 10.1093/CVR/CVP056; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Gore-Hyer E, 2003, ARTHRITIS RHEUM-US, V48, P798, DOI 10.1002/art.10953; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Hardie WD, 2009, AM J PATHOL, V175, P3, DOI 10.2353/ajpath.2009.081170; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Keller CD, 2007, AM J PATHOL, V170, P281, DOI 10.2353/ajpath.2007.060485; Kono Y, 2007, AM J RESP CELL MOL, V37, P395, DOI 10.1165/rcmb.2007-0065OC; Leask A, 2009, J CELL COMMUN SIGNAL, V3, P89, DOI 10.1007/s12079-009-0037-7; Li CY, 2011, J HEPATOL, V54, P1205, DOI 10.1016/j.jhep.2010.08.028; Li CY, 2009, AM J PATHOL, V175, P1464, DOI 10.2353/ajpath.2009.090037; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Milara J, 2012, THORAX, V67, P147, DOI 10.1136/thoraxjnl-2011-200026; Morrison K, 2010, J PHARMACOL EXP THER, V335, P249, DOI 10.1124/jpet.110.169748; Murakami A, 2010, MOL PHARMACOL, V77, P704, DOI 10.1124/mol.109.061481; Nayler O, 2010, GPCR MOL PHARM DRUG, P252; Piali L, 2011, J PHARMACOL EXP THER, V337, P547, DOI 10.1124/jpet.110.176487; Pierce RA, 1995, CIBA F SYMP, V192, P199; Ponticos M, 2009, ARTHRITIS RHEUM-US, V60, P2142, DOI 10.1002/art.24620; Prasse A, 2009, RESPIROLOGY, V14, P788, DOI 10.1111/j.1440-1843.2009.01600.x; Rivera-Gil P, 2010, CYTOSKELETON, V67, P773, DOI 10.1002/cm.20486; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Sauer B, 2004, J BIOL CHEM, V279, P38471, DOI 10.1074/jbc.M313557200; Sonnylal S, 2010, ARTHRITIS RHEUM-US, V62, P1523, DOI 10.1002/art.27382; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Sweetwyne MT, 2012, MATRIX BIOL, V31, P178, DOI 10.1016/j.matbio.2012.01.006; Takuwa N, 2010, CARDIOVASC RES, V85, P484, DOI 10.1093/cvr/cvp312; Urata Yoshiko, 2005, Kobe Journal of Medical Sciences, V51, P17; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wetter JA, 2009, J BIOMOL SCREEN, V14, P1134, DOI 10.1177/1087057109343809; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Xin CY, 2006, BRIT J PHARMACOL, V147, P164, DOI 10.1038/sj.bjp.0706452; Xin CY, 2004, J BIOL CHEM, V279, P35255, DOI 10.1074/jbc.M312091200; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v	42	61	65	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14839	14851		10.1074/jbc.M112.426726	http://dx.doi.org/10.1074/jbc.M112.426726			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23589284	hybrid, Green Published			2022-12-28	WOS:000319452100016
J	Clark, KD; Strand, MR				Clark, Kevin D.; Strand, Michael R.			Hemolymph Melanization in the Silkmoth Bombyx mori Involves Formation of a High Molecular Mass Complex That Metabolizes Tyrosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-1,3-GLUCAN RECOGNITION PROTEIN; TENEBRIO-MOLITOR LARVAE; PRO-PHENOL OXIDASE; MANDUCA-SEXTA L; PROPHENOLOXIDASE ACTIVATION; IMMUNE-RESPONSES; TOBACCO HORNWORM; PSEUDOPLUSIA-INCLUDENS; PHENOLOXIDASE ACTIVITY; LEPIDOPTERAN INSECT	The phenoloxidase (PO) cascade regulates the melanization of blood (hemolymph) in insects and other arthropods. Most studies indicate that microbial elicitors activate the PO cascade, which results in processing of the zymogen PPO to PO. PO is then thought to oxidize tyrosine and o-diphenols to quinones, which leads to melanin. However, different lines of investigation raise questions as to whether these views are fully correct. Here we report that hemolymph from the silkmoth, Bombyx mori, rapidly melanizes after collection from a wound site. Prior studies indicated that in vitro activated PPO hydroxylates Tyr inefficiently. Measurement of in vivo substrate titers, however, suggested that Tyr was the only PO substrate initially present in B. mori plasma and that it is rapidly metabolized by PO. Fractionation of plasma by gel filtration chromatography followed by bioassays indicated that melanization activity was primarily associated with a high mass complex (similar to 670 kDa) that contained PO. The prophenoloxidase-activating protease inhibitor Egf1.0 blocked formation of this complex and Tyr metabolism, but the addition of phenylthiourea to plasma before fractionation enhanced complex formation and Tyr metabolism. Mass spectrometry analysis indicated that the complex contained PO plus other proteins. Taken together, our results indicate that wounding alone activates the PO cascade in B. mori. They also suggest that complex formation is required for efficient use of Tyr as a substrate.	[Clark, Kevin D.; Strand, Michael R.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Clark, KD (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	kclark@uga.edu; mrstrand@uga.edu	Clark, Kevin/GQA-9811-2022		National Science Foundation Grant [IOS-1121006]; United States Department of Agriculture Grant [2008-35320-18756]; Georgia Agricultural Experiment Station; Direct For Biological Sciences [1121006] Funding Source: National Science Foundation	National Science Foundation Grant(National Science Foundation (NSF)); United States Department of Agriculture Grant; Georgia Agricultural Experiment Station; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant IOS-1121006, United States Department of Agriculture Grant 2008-35320-18756, and the Georgia Agricultural Experiment Station.	Asada N, 1999, BIOCHEM GENET, V37, P149, DOI 10.1023/A:1018730404305; ASHIDA M, 1980, INSECT BIOCHEM, V10, P37, DOI 10.1016/0020-1790(80)90036-0; ASHIDA M, 1988, TISSUE CELL, V20, P599, DOI 10.1016/0040-8166(88)90061-4; ASHIDA M, 1981, INSECT BIOCHEM, V11, P57, DOI 10.1016/0020-1790(81)90041-X; ASHIDA M, 1988, INSECT BIOCHEM, V18, P11, DOI 10.1016/0020-1790(88)90031-5; ASO Y, 1985, INSECT BIOCHEM, V15, P9, DOI 10.1016/0020-1790(85)90038-1; Beck G, 1996, J BIOL CHEM, V271, P11035, DOI 10.1074/jbc.271.19.11035; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Chase MR, 2000, INSECT BIOCHEM MOLEC, V30, P953, DOI 10.1016/S0965-1748(00)00068-0; Christen JM, 2012, INSECT BIOCHEM MOLEC, V42, P946, DOI 10.1016/j.ibmb.2012.09.008; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Clark KD, 1997, J BIOL CHEM, V272, P23440, DOI 10.1074/jbc.272.37.23440; Clark KD, 2010, INSECT BIOCHEM MOLEC, V40, P460, DOI 10.1016/j.ibmb.2010.04.005; Dionex Corp, 2003, 150 DION CORP, P4; DOHKE K, 1973, ARCH BIOCHEM BIOPHYS, V157, P203, DOI 10.1016/0003-9861(73)90406-2; Gorman MJ, 2007, INSECT BIOCHEM MOLEC, V37, P1327, DOI 10.1016/j.ibmb.2007.08.006; HALL M, 1995, P NATL ACAD SCI USA, V92, P7764, DOI 10.1073/pnas.92.17.7764; Hopkins TL, 1998, ARCH INSECT BIOCHEM, V38, P193, DOI 10.1002/(SICI)1520-6327(1998)38:4&lt;193::AID-ARCH5&gt;3.0.CO;2-S; HOPKINS TL, 1984, INSECT BIOCHEM, V14, P533, DOI 10.1016/0020-1790(84)90008-8; Jaenicke E, 2003, BIOCHEM J, V371, P515, DOI 10.1042/BJ20021058; Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanost MR, 2008, INSECT IMMUNOLOGY, P69, DOI 10.1016/B978-012373976-6.50006-9; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; KAWABATA T, 1995, P NATL ACAD SCI USA, V92, P7774, DOI 10.1073/pnas.92.17.7774; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Kim MH, 2000, EUR J BIOCHEM, V267, P2599, DOI 10.1046/j.1432-1327.2000.01271.x; Kwon TH, 2000, EUR J BIOCHEM, V267, P6188, DOI 10.1046/j.1432-1327.2000.01695.x; Lee MH, 2004, J BIOL CHEM, V279, P3218, DOI 10.1074/jbc.M309821200; Lee SY, 2000, J BIOL CHEM, V275, P1337, DOI 10.1074/jbc.275.2.1337; Li YC, 2009, P NATL ACAD SCI USA, V106, P17002, DOI 10.1073/pnas.0906095106; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Liu C, 2010, P NATL ACAD SCI USA, V107, P12980, DOI 10.1073/pnas.1001725107; Lu Z, 2008, J BIOL CHEM, V283, P21325, DOI 10.1074/jbc.M801593200; Lu ZQ, 2010, INSECT BIOCHEM MOLEC, V40, P497, DOI 10.1016/j.ibmb.2010.04.009; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; MUNKIRS DD, 1990, J INVERTEBR PATHOL, V56, P267, DOI 10.1016/0022-2011(90)90110-R; Nappi A, 2009, ADV PARASIT, V70, P99, DOI 10.1016/S0065-308X(09)70004-1; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891; Sakamoto M, 2011, DEV COMP IMMUNOL, V35, P611, DOI 10.1016/j.dci.2011.01.003; Strand MR, 2010, INSECT VIROLOGY, P171; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Sugumaran M, 2000, ARCH BIOCHEM BIOPHYS, V379, P252, DOI 10.1006/abbi.2000.1884; Tsuchiya M, 1996, FEMS IMMUNOL MED MIC, V15, P129, DOI 10.1016/0928-8244(96)00053-3; Vavricka CJ, 2010, PROTEIN CELL, V1, P830, DOI 10.1007/s13238-010-0109-8; Wang Y, 2004, INSECT BIOCHEM MOLEC, V34, P731, DOI 10.1016/j.ibmb.2004.03.008; YASUHARA Y, 1995, ARCH BIOCHEM BIOPHYS, V320, P14, DOI 10.1006/abbi.1995.1337; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200; Zhang R, 2003, J BIOL CHEM, V278, P42072, DOI 10.1074/jbc.M307475200; Zhu Y, 2003, INSECT BIOCHEM MOLEC, V33, P541, DOI 10.1016/S0965-1748(03)00028-6	56	49	52	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14476	14487		10.1074/jbc.M113.459222	http://dx.doi.org/10.1074/jbc.M113.459222			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23553628	Green Published, hybrid			2022-12-28	WOS:000319253500050
J	Singh, A; Winterbottom, EF; Ji, YJ; Hwang, YS; Daar, IO				Singh, Arvinder; Winterbottom, Emily F.; Ji, Yon Ju; Hwang, Yoo-Seok; Daar, Ira O.			Abelson Interactor 1 (Abi1) and Its Interaction with Wiskott-Aldrich Syndrome Protein (Wasp) Are Critical for Proper Eye Formation in Xenopus Embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABL TRANSFORMING ACTIVITY; TYROSINE KINASE; FORMATION REQUIRE; BINDING-PROTEIN; CELL-ADHESION; RETINAL FATE; N-WASP; ACTIN; EPS8; PHOSPHORYLATION	Ab1 interactor 1 (Abi1) is a scaffold protein that plays a central role in the regulation of actin cytoskeleton dynamics as a constituent of several key protein complexes, and homozygous loss of this protein leads to embryonic lethality in mice. Because this scaffold protein has been shown in cultured cells to be a critical component of pathways controlling cell migration and actin regulation at cell-cell contacts, we were interested to investigate the in vivo role of Abi1 in morphogenesis during the development of Xenopus embryos. Using morpholino-mediated translation inhibition, we demonstrate that knockdown of Abi1 in the whole embryo, or specifically in eye field progenitor cells, leads to disruption of eye morphogenesis. Moreover, signaling through the Src homology 3 domain of Abi1 is critical for proper movement of retinal progenitor cells into the eye field and their appropriate differentiation, and this process is dependent upon an interaction with the nucleation-promoting factor Wasp (Wiskott-Aldrich syndrome protein). Collectively, our data demonstrate that the Abi1 scaffold protein is an essential regulator of cell movement processes required for normal eye development in Xenopus embryos and specifically requires an Src homology 3 domain-dependent interaction with Wasp to regulate this complex morphogenetic process.	[Singh, Arvinder; Winterbottom, Emily F.; Ji, Yon Ju; Hwang, Yoo-Seok; Daar, Ira O.] NCI, Lab Cell & Dev Signaling, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Daar, IO (corresponding author), NCI, Lab Cell & Dev Signaling, Frederick, MD 21702 USA.	daar@ncifcrf.gov		Daar, Ira/0000-0003-2657-526X	National Institutes of Health Intramural Research Program of the NCI; NATIONAL CANCER INSTITUTE [ZIABC010958] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program of the NCI.	Biesova Z, 1997, ONCOGENE, V14, P233, DOI 10.1038/sj.onc.1200822; Bong YS, 2004, BIOCHEM J, V377, P499, DOI 10.1042/BJ20031449; Cavodeassi F, 2005, NEURON, V47, P43, DOI 10.1016/j.neuron.2005.05.026; Chong LD, 2000, MOL CELL BIOL, V20, P724, DOI 10.1128/MCB.20.2.724-734.2000; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Courtney KD, 2000, MOL CELL NEUROSCI, V16, P244, DOI 10.1006/mcne.2000.0865; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; Derivery E, 2010, BIOESSAYS, V32, P119, DOI 10.1002/bies.200900123; Dubielecka PM, 2011, P NATL ACAD SCI USA, V108, P7022, DOI 10.1073/pnas.1016811108; Fuhrmann S, 2010, CURR TOP DEV BIOL, V93, P61, DOI [10.1016/B978-0-12-385044-7.00003-5, 10.1016/S0070-2153(10)93003-2]; Grove M, 2004, MOL CELL BIOL, V24, P10905, DOI 10.1128/MCB.24.24.10905-10922.2004; Hirsch N, 1997, J NEUROBIOL, V32, P45, DOI 10.1002/(SICI)1097-4695(199701)32:1<45::AID-NEU5>3.3.CO;2-V; HUANG S, 1993, J NEUROSCI, V13, P3193; Ikeguchi A, 2001, ONCOGENE, V20, P4926, DOI 10.1038/sj.onc.1204502; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Juang JL, 1999, ONCOGENE, V18, P5138, DOI 10.1038/sj.onc.1202911; Kenyon KL, 2001, DEV BIOL, V240, P77, DOI 10.1006/dbio.2001.0464; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Lee HS, 2006, NAT CELL BIOL, V8, P55, DOI 10.1038/ncb1344; Lee HS, 2009, MOL BIOL CELL, V20, P124, DOI 10.1091/mbc.E08-06-0662; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Li HS, 1997, DEVELOPMENT, V124, P603; Li YZ, 2007, J CELL SCI, V120, P1436, DOI 10.1242/jcs.03430; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Moore KB, 2004, DEV CELL, V6, P55, DOI 10.1016/S1534-5807(03)00395-2; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; REDDY BA, 1992, MECH DEVELOP, V39, P143, DOI 10.1016/0925-4773(92)90041-H; Ring C, 2011, P NATL ACAD SCI USA, V108, P149, DOI 10.1073/pnas.1012316108; Roffers-Agarwal J, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-36; Ryu JR, 2009, MOL CELL BIOL, V29, P1735, DOI 10.1128/MCB.01483-08; Saha MS, 1992, CURR OPIN GENET DEV, V2, P582, DOI 10.1016/S0959-437X(05)80176-5; Sato M, 2011, FEBS LETT, V585, P834, DOI 10.1016/j.febslet.2011.02.012; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Sible JC, 1997, DEV BIOL, V189, P335, DOI 10.1006/dbio.1997.8683; Sive H., 2000, EARLY DEV XENOPUS LE, P231; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Tani K, 2003, J BIOL CHEM, V278, P21685, DOI 10.1074/jbc.M301447200; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; Ziemnicka-Kotula D, 1998, J BIOL CHEM, V273, P13681, DOI 10.1074/jbc.273.22.13681	42	3	3	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14135	14146		10.1074/jbc.M112.445643	http://dx.doi.org/10.1074/jbc.M112.445643			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23558677	Green Published, hybrid			2022-12-28	WOS:000319253500018
J	Xue, XY; Raynard, S; Busygina, V; Singh, AK; Sung, P				Xue, Xiaoyu; Raynard, Steven; Busygina, Valeria; Singh, Akhilesh K.; Sung, Patrick			Role of Replication Protein A in Double Holliday Junction Dissolution Mediated by the BLM-Topo III alpha-RMI1-RMI2 Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-III-ALPHA; DOUBLE-STRAND BREAKS; DNA END-RESECTION; BLOOMS-SYNDROME HELICASE; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; GENOME STABILITY; ESSENTIAL COMPONENT; CROSSING-OVER; REPAIR	The conserved BTR complex, composed of the Bloom's syndrome helicase (BLM), topoisomerase III alpha, RMI1, and RMI2, regulates homologous recombination in favor of non-crossover formation via the dissolution of the double Holliday Junction (dHJ). Here we show enhancement of the BTR-mediated dHJ dissolution reaction by the heterotrimeric single-stranded DNA binding protein replication protein A (RPA). Our results suggest that RPA acts by sequestering a single-stranded DNA intermediate during dHJ dissolution. We provide evidence that RPA physically interacts with RMI1. The RPA interaction domain in RMI1 has been mapped, and RMI1 mutants impaired for RPA interaction have been generated. Examination of these mutants ascertains the significance of the RMI1-RPA interaction in dHJ dissolution. Our results thus implicate RPA as a cofactor of the BTR complex in dHJ dissolution.	[Xue, Xiaoyu; Raynard, Steven; Busygina, Valeria; Singh, Akhilesh K.; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Sung, P (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, C130 Sterling Hall Med,333 Cedar St, New Haven, CT 06520 USA.	patrick.sung@yale.edu			National Institutes of Health [RO1 ES015632, RO1 ES07061, RO1 GM57814]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015632, R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 ES015632, RO1 ES07061, and RO1 GM57814.	Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Bussen W, 2007, J BIOL CHEM, V282, P31484, DOI 10.1074/jbc.M706116200; Cejka P, 2012, MOL CELL, V47, P886, DOI 10.1016/j.molcel.2012.06.032; Cejka P, 2010, NAT STRUCT MOL BIOL, V17, P1377, DOI 10.1038/nsmb.1919; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Chen SH, 2012, J BIOL CHEM, V287, P19346, DOI 10.1074/jbc.M112.363044; Cheok CF, 2005, BIOCHEM SOC T, V33, P1456, DOI 10.1042/BST0331456; Deans AJ, 2009, MOL CELL, V36, P943, DOI 10.1016/j.molcel.2009.12.006; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; FU TJ, 1994, J MOL BIOL, V236, P91, DOI 10.1006/jmbi.1994.1121; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; KUHN EM, 1986, CANCER GENET CYTOGEN, V22, P1, DOI 10.1016/0165-4608(86)90132-9; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Plate I, 2008, J BIOL CHEM, V283, P29077, DOI 10.1074/jbc.M804881200; Raynard S, 2008, J BIOL CHEM, V283, P15701, DOI 10.1074/jbc.M802127200; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Singh TR, 2008, GENE DEV, V22, P2856, DOI 10.1101/gad.1725108; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tsubouchi H, 2000, MOL BIOL CELL, V11, P2221, DOI 10.1091/mbc.11.7.2221; Van Komen S, 2006, METHOD ENZYMOL, V408, P445, DOI 10.1016/S0076-6879(06)08028-1; Walther AP, 1999, BIOCHEMISTRY-US, V38, P3963, DOI 10.1021/bi982370u; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	35	28	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14221	14227		10.1074/jbc.M113.465609	http://dx.doi.org/10.1074/jbc.M113.465609			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23543748	hybrid, Green Published			2022-12-28	WOS:000319253500026
J	Nguyen, TX; Jaru-Ampornpan, P; Lam, VQ; Cao, PG; Piszkiewicz, S; Hess, S; Shan, SO				Nguyen, Thang X.; Jaru-Ampornpan, Peera; Lam, Vinh Q.; Cao, Peigen; Piszkiewicz, Samantha; Hess, Sonja; Shan, Shu-ou			Mechanism of an ATP-independent Protein Disaggregase I. STRUCTURE OF A MEMBRANE PROTEIN AGGREGATE REVEALS A MECHANISM OF RECOGNITION BY ITS CHAPERONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICLE; CHAPERONE; BINDING; HSP104; SUBSTRATE; PROTEOSTASIS; INSIGHTS; CYTOSOL; BODIES; HSP70	Protein aggregation is detrimental to the maintenance of proper protein homeostasis in all cells. To overcome this problem, cells have evolved a network of molecular chaperones to prevent protein aggregation and even reverse existing protein aggregates. The most extensively studied disaggregase systems are ATP-driven macromolecular machines. Recently, we reported an alternative disaggregase system in which the 38-kDa subunit of chloroplast signal recognition particle (cpSRP43) efficiently reverses the aggregation of its substrates, the light-harvesting chlorophyll a/b-binding (LHC) proteins, in the absence of external energy input. To understand the molecular mechanism of this novel activity, here we used biophysical and biochemical methods to characterize the structure and nature of LHC protein aggregates. We show that LHC proteins form micellar, disc-shaped aggregates that are kinetically stable and detergent-resistant. Despite the nonamyloidal nature, the LHC aggregates have a defined global organization, displaying the chaperone recognition motif on its solvent-accessible surface. These findings suggest an attractive mechanism for recognition of the LHC aggregate by cpSRP43 and provide important constraints to define the capability of this chaperone.	[Nguyen, Thang X.; Jaru-Ampornpan, Peera; Lam, Vinh Q.; Cao, Peigen; Piszkiewicz, Samantha; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Hess, Sonja] CALTECH, Beckman Inst, Div Biol, Proteome Explorat Lab, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	sshan@caltech.edu	Hess, Sonja/K-4842-2013; Cao, Peigen/F-5958-2012	Hess, Sonja/0000-0002-5904-9816; Piszkiewicz, Samantha/0000-0003-4391-776X	Betty and Gordon Moore Foundation; David and Lucile Packard Fellowship in science and engineering; Henry Dreyfus Teacher-Scholar Award; American Federation for Aging Research; Beckman Institute; United States Department of Energy [DE-FG03-01ER46175]	Betty and Gordon Moore Foundation(Gordon and Betty Moore Foundation); David and Lucile Packard Fellowship in science and engineering(The David & Lucile Packard Foundation); Henry Dreyfus Teacher-Scholar Award; American Federation for Aging Research; Beckman Institute; United States Department of Energy(United States Department of Energy (DOE))	Supported by a grant from the Betty and Gordon Moore Foundation.; Supported by the David and Lucile Packard Fellowship in science and engineering, the Henry Dreyfus Teacher-Scholar Award, and the Break-throughs in Gerontology award from the American Federation for Aging Research. To whom correspondence should be addressed: Division of Chemistry and Chemical Engineering, California Institute of Technology, 1200 E. California Blvd., Pasadena, CA 91125. Tel.: 626-395-3879; Fax: 626-568-9430; E-mail: sshan@caltech.edu.; We thank A. N. Murray and Dr. J. W. Kelly for recrystallized ThT and fibrilized A beta<INF>1-40</INF>, A. McDowall for EM analyses, members of the Proteome Exploration Laboratory for mass spectrometry assistance, and members of the Shan group for helpful comments on the manuscript. The Proteome Exploration Laboratory is supported by the Betty and Gordon Moore Foundation and the Beckman Institute. AFM studies were supported by United States Department of Energy Grant DE-FG03-01ER46175 (to J. Heath).	Abramoff M. D., 2004, J BIOPHOTONICS INT, V11, P36; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BREMS DN, 1988, P NATL ACAD SCI USA, V85, P3367, DOI 10.1073/pnas.85.10.3367; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Cain P, 2011, BIOCHEM J, V437, P149, DOI 10.1042/BJ20110270; Carrotta R, 2001, PROTEIN SCI, V10, P1312, DOI 10.1110/ps.42501; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; DeLille J, 2000, P NATL ACAD SCI USA, V97, P1926, DOI 10.1073/pnas.030395197; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Duennwald Martin L, 2012, PLoS Biol, V10, pe1001346, DOI 10.1371/journal.pbio.1001346; Falk S, 2010, J BIOL CHEM, V285, P21655, DOI 10.1074/jbc.C110.132746; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; Groenning M, 2007, J STRUCT BIOL, V158, P358, DOI 10.1016/j.jsb.2006.12.010; Groves MR, 2001, J BIOL CHEM, V276, P27778, DOI 10.1074/jbc.M103470200; HACHIYA N, 1994, EMBO J, V13, P5146, DOI 10.1002/j.1460-2075.1994.tb06844.x; HACHIYA N, 1993, EMBO J, V12, P1579, DOI 10.1002/j.1460-2075.1993.tb05802.x; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Henry RL, 2010, NAT STRUCT MOL BIOL, V17, P676, DOI 10.1038/nsmb0610-676; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Jaru-Ampornpan P, 2013, J BIOL CHEM, V288, P13431, DOI 10.1074/jbc.M113.462861; Jaru-Ampornpan P, 2010, NAT STRUCT MOL BIOL, V17, P696, DOI 10.1038/nsmb.1836; Kopito RR, 2000, EMBO REP, V1, P225, DOI 10.1093/embo-reports/kvd052; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Lam VQ, 2010, J CELL BIOL, V190, P623, DOI 10.1083/jcb.201004129; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Luheshi LM, 2009, FEBS LETT, V583, P2581, DOI 10.1016/j.febslet.2009.06.030; Lum R, 2008, J BIOL CHEM, V283, P30139, DOI 10.1074/jbc.M804849200; Mastrangelo IA, 2006, J MOL BIOL, V358, P106, DOI 10.1016/j.jmb.2006.01.042; MITRAKI A, 1987, EUR J BIOCHEM, V163, P29, DOI 10.1111/j.1432-1033.1987.tb10732.x; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; ROSEN CG, 1969, BIOCHEMISTRY-US, V8, P3915, DOI 10.1021/bi00838a006; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Speed MA, 1996, NAT BIOTECHNOL, V14, P1283, DOI 10.1038/nbt1096-1283; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; Tu CJ, 1999, J BIOL CHEM, V274, P27219, DOI 10.1074/jbc.274.38.27219; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; ZETTLMEISSL G, 1979, BIOCHEMISTRY-US, V18, P5567, DOI 10.1021/bi00592a007	45	9	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13420	13430		10.1074/jbc.M113.462812	http://dx.doi.org/10.1074/jbc.M113.462812			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23525109	Green Published, hybrid			2022-12-28	WOS:000318850300027
J	Yang, Y; Estacion, M; Dib-Hajj, SD; Waxman, SG				Yang, Yang; Estacion, Mark; Dib-Hajj, Sulayman D.; Waxman, Stephen G.			Molecular Architecture of a Sodium Channel S6 Helix RADIAL TUNING OF THE VOLTAGE-GATED SODIUM CHANNEL 1.7 ACTIVATION GATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSED-STATE INACTIVATION; EXTREME PAIN DISORDER; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; NA(V)1.7; MUTATION; SCN9A; PORE; DETERMINANTS; ARRANGEMENT	Voltage-gated sodium (Na-V) channels are membrane proteins that consist of 24 transmembrane segments organized into four homologous domains and are essential for action potential generation and propagation. Although the S6 helices of Na-V channels line the ion-conducting pore and participate in channel activation, their functional architecture is incompletely understood. Our recent studies show that a naturally occurring in-frame deletion mutation (Del-L955) of Na(V)1.7 channel, identified in individuals with a severe inherited pain syndrome (inherited erythromelalgia) causes a substantial hyperpolarizing shift of channel activation. Here we took advantage of this deletion mutation to understand the role of the S6 helix in the channel activation. Based on the recently published structure of a bacterial Na-V channel (Na(V)Ab), we modeled the WT and Del-L955 channel. Our structural model showed that Del-L955 twists the DII/S6 helix, shifting location and radial orientation of the activation gate residue (Phe(960)). Hypothesizing that these structural changes produce the shift of channel activation of Del-L955 channels, we restored a phenylalanine in wild-type orientation by mutating Ser(961) (Del-L955/S961F), correcting activation by similar to 10 mV. Correction of the displaced Phe960 (F960S) together with introduction of the rescuing activation gate residue (S961F) produced an additional similar to 6-mV restoration of activation of the mutant channel. A simple point mutation in the absence of a twist (L955A) did not produce a radial shift and did not hyperpolarize activation. Our results demonstrate the functional importance of radial tuning of the sodium channel S6 helix for the channel activation.	[Yang, Yang; Estacion, Mark; Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Yang, Yang; Estacion, Mark; Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Yale Univ, Sch Med, Ctr Neurosci & Regenerat Res, New Haven, CT 06510 USA; [Yang, Yang; Estacion, Mark; Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Vet Affairs Connecticut Healthcare Syst, Rehabil Res Ctr, West Haven, CT 06516 USA	Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Waxman, SG (corresponding author), VA Connecticut Healthcare Syst, Neurosci & Regenerat Res Ctr, 950 Campbell Ave,Bldg 34, West Haven, CT 06516 USA.	stephen.waxman@yale.edu	Estacion, Mark/H-2444-2011; Waxman, Stephen/Z-2507-2019; Yang, Yang/B-3440-2008	Estacion, Mark/0000-0002-7271-1165; Waxman, Stephen/0000-0001-5718-7177; Yang, Yang/0000-0001-6417-3654; Yang, Yang/0000-0003-4275-0515	Medical Research Service, Department of Veterans Affairs; Rehabilitation Research Service, Department of Veterans Affairs; Erythromelalgia Association	Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); Rehabilitation Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); Erythromelalgia Association	This work was supported by the Medical Research Service and Rehabilitation Research Service, Department of Veterans Affairs and the Erythromelalgia Association (to S. G. W. and S. D. D.-H.). The Center for Neuroscience and Regeneration Research is a Collaboration of the Paralyzed Veterans of America with Yale University.	Cheng XD, 2011, PROG MOL BIOL TRANSL, V101, P1, DOI 10.1016/B978-0-12-387685-0.00001-9; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins TR, 1998, J NEUROSCI, V18, P9607; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Dib-Hajj SD, 2005, BRAIN, V128, P1847, DOI 10.1093/brain/awh514; Dib-Hajj SD, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-37; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Dudley SC, 2000, J GEN PHYSIOL, V116, P679, DOI 10.1085/jgp.116.5.679; Estacion M, 2010, J PHYSIOL-LONDON, V588, P1915, DOI 10.1113/jphysiol.2009.186114; Estacion M, 2013, BIOCHEM BIOPH RES CO, V432, P99, DOI 10.1016/j.bbrc.2013.01.079; Faber CG, 2012, ANN NEUROL, V71, P26, DOI 10.1002/ana.22485; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Han C, 2012, NEUROLOGY, V78, P1635, DOI 10.1212/WNL.0b013e3182574f12; Han CY, 2012, BRAIN, V135, P2613, DOI 10.1093/brain/aws187; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Lampert A, 2008, J BIOL CHEM, V283, P24118, DOI 10.1074/jbc.M802900200; Li RA, 2001, J BIOL CHEM, V276, P11072, DOI 10.1074/jbc.M010862200; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; MCPHEE JC, 1994, P NATL ACAD SCI USA, V91, P12346, DOI 10.1073/pnas.91.25.12346; Minett MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1795; Muroi Y, 2010, NAT STRUCT MOL BIOL, V17, P230, DOI 10.1038/nsmb.1749; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Wang SY, 2003, BIOPHYS J, V85, P911, DOI 10.1016/S0006-3495(03)74530-5; Waxman SG, 2006, NATURE, V444, P831, DOI 10.1038/444831a; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; Yang Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2184; Yang Y, 2011, J BIOL CHEM, V286, P9298, DOI 10.1074/jbc.M110.195123; Yarov-Yarovoy V, 2001, J BIOL CHEM, V276, P20, DOI 10.1074/jbc.M006992200; Zarrabi T, 2010, J BIOL CHEM, V285, P39458, DOI 10.1074/jbc.M110.132886; Zhang J, 2011, STRUCTURE, V19, P1784, DOI 10.1016/j.str.2011.09.022; Zhang J, 2010, BIOINFORMATICS, V26, P3004, DOI 10.1093/bioinformatics/btq563; Zhang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015386; Zhang X, 2013, CELL RES, V23, P444, DOI 10.1038/cr.2012.158; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054	39	19	20	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13741	13747		10.1074/jbc.M113.462366	http://dx.doi.org/10.1074/jbc.M113.462366			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23536180	Green Published, hybrid			2022-12-28	WOS:000318850300056
J	Chung, IYW; Paetzel, M				Chung, Ivy Yeuk Wah; Paetzel, Mark			Crystal Structures of Yellowtail Ascites Virus VP4 Protease TRAPPING AN INTERNAL CLEAVAGE SITE TRANS ACYL-ENZYME COMPLEX IN A NATIVE SER/LYS DYAD ACTIVE SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC NECROSIS VIRUS; SER-LYS DYAD; SULFENIC ACIDS; CATALYTIC DYAD; SELF-CLEAVAGE; BIRNAVIRUS; AQUABIRNAVIRUS; IDENTIFICATION; AVIBIRNAVIRUS; REFINEMENT	Yellowtail ascites virus (YAV) is an aquabirnavirus that causes ascites in yellowtail, a fish often used in sushi. Segment A of the YAV genome codes for a polyprotein (pVP2-VP4-VP3), where processing by its own VP4 protease yields the capsid protein precursor pVP2, the ribonucleoprotein-forming VP3, and free VP4. VP4 protease utilizes the rarely observed serine-lysine catalytic dyad mechanism. Here we have confirmed the existence of an internal cleavage site, preceding the VP4/VP3 cleavage site. The resulting C-terminally truncated enzyme (ending at Ala(716)) is active, as shown by a trans full-length VP4 cleavage assay and a fluorometric peptide cleavage assay. We present a crystal structure of a native active site YAV VP4 with the internal cleavage site trapped as trans product complexes and trans acyl-enzyme complexes. The acyl-enzyme complexes confirm directly the role of Ser(633) as the nucleophile. A crystal structure of the lysine general base mutant (K674A) reveals the acyl-enzyme and empty binding site states of VP4, which allows for the observation of structural changes upon substrate or product binding. These snapshots of three different stages in the VP4 protease reaction mechanism will aid in the design of anti-birnavirus compounds, provide insight into previous site-directed mutagenesis results, and contribute to understanding of the serine-lysine dyad protease mechanism. In addition, we have discovered that this protease contains a channel that leads from the enzyme surface (adjacent to the substrate binding groove) to the active site and the deacylating water.	[Chung, Ivy Yeuk Wah; Paetzel, Mark] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Paetzel, M (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	mpaetzel@sfu.ca		Paetzel, Mark/0000-0002-7408-5487	National Science and Engineering Research Council; National Research Council; Canadian Institutes of Health Research; University of Saskatchewan; National Science and Engineering Research Council of Canada; Michael Smith Foundation for Health Research; Canadian Foundation of Innovation	National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Foundation of Innovation(Canada Foundation for Innovation)	We thank the staff at beam line 08ID-1 at the Canadian Light Source, Saskatoon, Canada (especially Shaunivan Labiuk) for technical assistance with data collection. The Canadian Light Source is supported by the National Science and Engineering Research Council, National Research Council, Canadian Institutes of Health Research, and University of Saskatchewan. We thank Dr. Syunichirou Oshima for providing the YAV cDNA.; This work was supported in part by the Canadian Institutes of Health Research (to M.P.), the National Science and Engineering Research Council of Canada (to M.P.), the Michael Smith Foundation for Health Research (to M.P.), and the Canadian Foundation of Innovation (to M.P.).	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Birghan C, 2000, EMBO J, V19, P114, DOI 10.1093/emboj/19.1.114; Botos I, 2004, J BIOL CHEM, V279, P8140, DOI 10.1074/jbc.M312243200; Casanas A, 2008, STRUCTURE, V16, P29, DOI 10.1016/j.str.2007.10.023; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Chung IYW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198812; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Da Costa B, 2002, J VIROL, V76, P2393, DOI 10.1128/JVI.76.5.2393-2402.2002; Da Costa B, 2003, J VIROL, V77, P719, DOI 10.1128/JVI.77.1.719-725.2003; DeLano WL, 2002, PYMOL USERS MANUAL; Delmas B, 2011, VIRUS TAXONOMY, P499; DOBOS P, 1979, J VIROL, V32, P593, DOI 10.1128/JVI.32.2.593-605.1979; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engh R. A., 2001, INT TABLES CRYSTALLO, VF, P382; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feldman AR, 2006, J MOL BIOL, V358, P1378, DOI 10.1016/j.jmb.2006.02.045; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Granzow H, 1997, J VIROL, V71, P8879, DOI 10.1128/JVI.71.11.8879-8885.1997; Hirayama T, 2007, MICROBIOL IMMUNOL, V51, P397, DOI 10.1111/j.1348-0421.2007.tb03927.x; Hjalmarsson A, 1999, J VIROL, V73, P3484, DOI 10.1128/JVI.73.4.3484-3490.1999; Hosono N, 1996, J FISH DIS, V19, P295, DOI 10.1111/j.1365-2761.1996.tb00707.x; Imajoh M, 2007, ARCH VIROL, V152, P1103, DOI 10.1007/s00705-007-0935-z; Immirzi A., 1966, CRYSTALLOGRAPHIC COM, P399; Kamakura M., 1995, AUT M JAP SOC FISH P, P14; Kettenhofen NJ, 2010, CHEM RES TOXICOL, V23, P1633, DOI 10.1021/tx100237w; Kim AC, 2008, J MOL BIOL, V376, P352, DOI 10.1016/j.jmb.2007.11.080; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Kusuda R., 1989, Suisan Zoshoku, V37, P115; Kusuda Riichi, 1994, Suisan Zoshoku, V42, P145; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JY, 2007, J BIOL CHEM, V282, P24928, DOI 10.1074/jbc.M701551200; Lejal N, 2000, J GEN VIROL, V81, P983, DOI 10.1099/0022-1317-81-4-983; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; LIEBECQ C, 1992, COMPENDIUM BIOCH NOM; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MURSHUDOV G, 1996, REFINEMENT PROTEIN S; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nobiron I, 2008, VIROLOGY, V371, P350, DOI 10.1016/j.virol.2007.09.022; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Paetzel M, 2002, J BIOL CHEM, V277, P9512, DOI 10.1074/jbc.M110983200; Paetzel M, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P3487, DOI 10.1016/B978-0-12-382219-2.00773-0; Petit S, 2000, J VIROL, V74, P2057, DOI 10.1128/JVI.74.5.2057-2066.2000; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; READ RJ, 1988, J APPL CRYSTALLOGR, V21, P490, DOI 10.1107/S002188988800562X; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Rodriguez-Lecompte JC, 2002, VIROLOGY, V292, P241, DOI 10.1006/viro.2001.1260; Savage DF, 2010, P NATL ACAD SCI USA, V107, P17164, DOI 10.1073/pnas.1009864107; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; Suzuki S, 1997, FISHERIES SCI, V63, P563, DOI 10.2331/fishsci.63.563; Suzuki S, 1998, FISHERIES SCI, V64, P342, DOI 10.2331/fishsci.64.342; Suzuki Satoru, 1998, Bulletin of Marine Sciences and Fisheries Kochi University, V18, P39; TENEYCK LF, 1973, ACTA CRYSTALLOGR A, VA 29, P183, DOI 10.1107/S0567739473000458; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; ZIMMERMAN M, 1977, ANAL BIOCHEM, V78, P47, DOI 10.1016/0003-2697(77)90006-9	61	2	2	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13068	13081		10.1074/jbc.M112.386953	http://dx.doi.org/10.1074/jbc.M112.386953			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23511637	Green Published, hybrid			2022-12-28	WOS:000318555100058
J	Small, JL; O'Donoghue, AJ; Boritsch, EC; Tsodikov, OV; Knudsen, GM; Vandal, O; Craik, CS; Ehrt, S				Small, Jennifer L.; O'Donoghue, Anthony J.; Boritsch, Eva C.; Tsodikov, Oleg V.; Knudsen, Giselle M.; Vandal, Omar; Craik, Charles S.; Ehrt, Sabine			Substrate Specificity of MarP, a Periplasmic Protease Required for Resistance to Acid and Oxidative Stress in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; ESCHERICHIA-COLI; QUALITY CONTROL; OUTER-MEMBRANE; CELL-ENVELOPE; HTRA FAMILY; PH; ADAPTATION; PHAGOSOME; IDENTIFICATION	The transmembrane serine protease MarP is important for pH homeostasis in Mycobacterium tuberculosis (Mtb). Previous structural studies revealed that MarP contains a chymotrypsin fold and a disulfide bond that stabilizes the protease active site in the substrate-bound conformation. Here, we determined that MarP is located in the Mtb periplasm and showed that this localization is essential for function. Using the recombinant protease domain of MarP, we identified its substrate specificity using two independent assays: positional-scanning synthetic combinatorial library profiling and multiplex substrate profiling by mass spectrometry. These methods revealed that MarP prefers bulky residues at P4, tryptophan or leucine at P2, arginine or hydrophobic residues at P1, and alanine or asparagine at P1'. Guided by these data, we designed fluorogenic peptide substrates and characterized the kinetic properties of MarP. Finally, we tested the impact of mutating MarP cysteine residues on the peptidolytic activity of recombinant MarP and its ability to complement phenotypes of Mtb Delta MarP. Taken together, our studies provide insight into the enzymatic properties of MarP, its substrate preference, and the importance of its transmembrane helices and disulfide bond.	[Small, Jennifer L.; Boritsch, Eva C.; Vandal, Omar; Ehrt, Sabine] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [O'Donoghue, Anthony J.; Knudsen, Giselle M.; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Tsodikov, Oleg V.] Univ Michigan, Coll Pharm, Dept Med Chem, Ann Arbor, MI 48109 USA	Cornell University; University of California System; University of California San Francisco; University of Michigan System; University of Michigan	Craik, CS (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	charles.craik@ucsf.edu; sae2004@med.cornell.edu	Ehrt, Sabine/AAU-6449-2020		Biomedical Technology Research Centers program of the NIGMS, National Institutes of Health [8P41GM103481]; National Institutes of Health [AI08172, P50 GM082250]; Sandler Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, P50GM082250, P41GM103481] Funding Source: NIH RePORTER	Biomedical Technology Research Centers program of the NIGMS, National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. B. Cravatt (Scripps Research Institute, La Jolla, CA) for fluorophosphonate-rhodamine. Mass spectrometry analysis was performed in the Bio-Organic Biomedical Mass Spectrometry Resource at the University of California, San Francisco (A. L. Burlingame, Director), which is supported by the Biomedical Technology Research Centers program of the NIGMS, National Institutes of Health, Grant 8P41GM103481.; This work was supported, in whole or in part, by National Institutes of Health Grants AI08172 (to S. E.) and P50 GM082250 (to C. S. C.). This work was also supported by the Sandler Center (to C. S. C.).	Abramovitch RB, 2011, MOL MICROBIOL, V80, P678, DOI 10.1111/j.1365-2958.2011.07601.x; [Anonymous], 2011, GLOB TUB CONTR; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Biswas T, 2010, STRUCTURE, V18, P1353, DOI 10.1016/j.str.2010.06.017; Braunstein M, 2000, J BACTERIOL, V182, P2732, DOI 10.1128/JB.182.10.2732-2740.2000; Buchmeier N, 2000, MOL MICROBIOL, V35, P1375, DOI 10.1046/j.1365-2958.2000.01797.x; Chalkley RJ, 2008, MOL CELL PROTEOMICS, V7, P2386, DOI 10.1074/mcp.M800021-MCP200; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Darby N., 1995, DISULFIDE BONDS PROT, P219; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Dutton RJ, 2010, P NATL ACAD SCI USA, V107, P297, DOI 10.1073/pnas.0912952107; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foster JW, 1999, CURR OPIN MICROBIOL, V2, P170, DOI 10.1016/S1369-5274(99)80030-7; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; Goldman BS, 1998, P NATL ACAD SCI USA, V95, P5003, DOI 10.1073/pnas.95.9.5003; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Huynh KK, 2007, MICROBIOL MOL BIOL R, V71, P452, DOI 10.1128/MMBR.00003-07; Ito K, 2008, CURR OPIN STRUC BIOL, V18, P450, DOI 10.1016/j.sbi.2008.02.002; Jabaiah AM, 2012, BIOL CHEM, V393, P933, DOI 10.1515/hsz-2012-0162; Kim DY, 2005, J BIOCHEM MOL BIOL, V38, P266; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Makinoshima H, 2005, NATURE, V436, P406, DOI 10.1038/nature03713; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; MohamedMohaideen NN, 2008, BIOCHEMISTRY-US, V47, P6092, DOI 10.1021/bi701929m; O'Donoghue AJ, 2012, NAT METHODS, V9, P1095, DOI [10.1038/NMETH.2182, 10.1038/nmeth.2182]; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Ohol YM, 2010, CELL HOST MICROBE, V7, P210, DOI 10.1016/j.chom.2010.02.006; Raju RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002511; Ribeiro-Guimaraes ML, 2007, MICROB PATHOGENESIS, V43, P173, DOI 10.1016/j.micpath.2007.05.010; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Sawa J, 2011, J BIOL CHEM, V286, P30680, DOI 10.1074/jbc.M111.243832; Schaible UE, 1998, J IMMUNOL, V160, P1290; SHERMAN DR, 1995, P NATL ACAD SCI USA, V92, P6625, DOI 10.1073/pnas.92.14.6625; Sklar JG, 2010, MOL MICROBIOL, V77, P605, DOI 10.1111/j.1365-2958.2010.07232.x; Skorko-Glonek J, 2003, BBA-PROTEINS PROTEOM, V1649, P171, DOI 10.1016/S1570-9639(03)00170-5; Skorko-Glonek J, 2006, ACTA BIOCHIM POL, V53, P585; Skorko-Glonek J, 2013, CURR PHARM DESIGN, V19, P977, DOI 10.2174/1381612811319060003; Sojka D, 2012, J BIOL CHEM, V287, P21152, DOI 10.1074/jbc.M112.347922; Song HH, 2011, MOL MICROBIOL, V80, P900, DOI 10.1111/j.1365-2958.2011.07619.x; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Vandal OH, 2009, J BACTERIOL, V191, P625, DOI 10.1128/JB.00932-08; Via LE, 1998, J CELL SCI, V111, P897; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P7032, DOI 10.1021/bi005111p; White MJ, 2010, J BACTERIOL, V192, P1498, DOI 10.1128/JB.01167-09; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	58	23	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12489	12499		10.1074/jbc.M113.456541	http://dx.doi.org/10.1074/jbc.M113.456541			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23504313	Green Published, hybrid			2022-12-28	WOS:000318555100008
J	Wu, CJ; Mannan, P; Lu, M; Udey, MC				Wu, Chuan-Jin; Mannan, Poonam; Lu, Michael; Udey, Mark C.			Epithelial Cell Adhesion Molecule (EpCAM) Regulates Claudin Dynamics and Tight Junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EP-CAM; BARRIER FUNCTION; COLORECTAL-CARCINOMA; TUMOR PROGRESSION; CANCER; ANTIGEN; PROTEINS; GENE; PERMEABILITY; METASTASIS	Epithelial cell adhesion molecule (EpCAM) (CD326) is a surface glycoprotein expressed by invasive carcinomas and some epithelia. Herein, we report that EpCAM regulates the composition and function of tight junctions (TJ). EpCAM accumulated on the lateral interfaces of human colon carcinoma and normal intestinal epithelial cells but did not co-localize with TJ. Knockdown of EpCAM in T84 and Caco-2 cells using shRNAs led to changes in morphology and adhesiveness. TJ formed readily after EpCAM knockdown; the acquisition of trans-epithelial electroresistance was enhanced, and TJ showed increased resistance to disruption by calcium chelation. Preparative immunoprecipitation demonstrated that EpCAM bound tightly to claudin-7. Co-immunoprecipitation documented associations of EpCAM with claudin-7 and claudin-1 but not claudin-2 or claudin-4. Claudin-1 associated with claudin-7 in co-transfection experiments, and claudin-7 was required for association of claudin-1 with EpCAM. EpCAM knockdown resulted in decreases in claudin-7 and claudin-1 proteins that were reversed with lysosome inhibitors. Immunofluorescence microscopy revealed that claudin-7 and claudin-1 continually trafficked into lysosomes. Although EpCAM knockdown decreased claudin-1 and claudin-7 protein levels overall, accumulations of claudin-1 and claudin-7 in TJ increased. Physical interactions between EpCAM and claudins were required for claudin stabilization. These findings suggest that EpCAM modulates adhesion and TJ function by regulating intracellular localization and degradation of selected claudins.	[Wu, Chuan-Jin; Lu, Michael; Udey, Mark C.] NCI, Dermatol Branch, NIH, Bethesda, MD 20892 USA; [Mannan, Poonam] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Udey, MC (corresponding author), NCI, Dermatol Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	udeym@mail.nih.gov			National Institutes of Health grant from the Intramural Research Program, Center for Cancer Research; National Institutes of Health grant from NCI; NATIONAL CANCER INSTITUTE [ZIABC010956] Funding Source: NIH RePORTER	National Institutes of Health grant from the Intramural Research Program, Center for Cancer Research; National Institutes of Health grant from NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health grants from the Intramural Research Program, Center for Cancer Research, and NCI.	Akita H, 2011, ONCOGENE, V30, P3468, DOI 10.1038/onc.2011.59; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Balzar M, 1998, MOL CELL BIOL, V18, P4833, DOI 10.1128/MCB.18.8.4833; Basak S, 1998, JNCI-J NATL CANCER I, V90, P691, DOI 10.1093/jnci/90.9.691; Blazar M, 2001, MOL CELL BIOL, V21, P2570, DOI 10.1128/MCB.21.7.2570-2580.2001; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Darido C, 2008, CANCER RES, V68, P4258, DOI 10.1158/0008-5472.CAN-07-5805; Ding L, 2012, GASTROENTEROLOGY, V142, P305, DOI 10.1053/j.gastro.2011.10.025; Dukes JD, 2011, MOL BIOL CELL, V22, P3192, DOI 10.1091/mbc.E11-04-0343; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Forster C, 2008, HISTOCHEM CELL BIOL, V130, P55, DOI 10.1007/s00418-008-0424-9; Fujita H, 2006, J HISTOCHEM CYTOCHEM, V54, P933, DOI 10.1369/jhc.6A6944.2006; Gelderman KA, 2002, EUR J IMMUNOL, V32, P128; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Guerra E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049302; Hewitt KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-186; Koch S, 2009, ANN NY ACAD SCI, V1165, P220, DOI 10.1111/j.1749-6632.2009.04025.x; Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527; Kuhn S, 2007, MOL CANCER RES, V5, P553, DOI 10.1158/1541-7786.MCR-06-0384; Ladwein M, 2005, EXP CELL RES, V309, P345, DOI 10.1016/j.yexcr.2005.06.013; Lei ZL, 2012, DEV BIOL, V371, P136, DOI 10.1016/j.ydbio.2012.07.005; LITVINOV SV, 1994, CELL ADHES COMMUN, V2, P417, DOI 10.3109/15419069409004452; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Lui WY, 2006, MOL CELL ENDOCRINOL, V250, P25, DOI 10.1016/j.mce.2005.12.021; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Maghzal N, 2010, J CELL BIOL, V191, P645, DOI 10.1083/jcb.201004074; Martin TA, 2011, FRONT BIOSCI-LANDMRK, V16, P898, DOI 10.2741/3726; Matsuda M, 2004, J CELL SCI, V117, P1247, DOI 10.1242/jcs.00972; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Nubel T, 2009, MOL CANCER RES, V7, P285, DOI 10.1158/1541-7786.MCR-08-0200; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Paris L, 2008, BBA-BIOMEMBRANES, V1778, P646, DOI 10.1016/j.bbamem.2007.08.004; Samarin SN, 2007, MOL BIOL CELL, V18, P3429, DOI 10.1091/mbc.E07-04-0315; Sivagnanam M, 2008, GASTROENTEROLOGY, V135, P429, DOI 10.1053/j.gastro.2008.05.036; Slanchev K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000563; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Takahashi S, 2009, J CELL SCI, V122, P985, DOI 10.1242/jcs.040055; Tirumalasetty PP, 2006, J PHARM PHARM SCI, V9, P32; Trzpis M, 2008, FRONT BIOSCI-LANDMRK, V13, P5050, DOI 10.2741/3063; Tunggal JA, 2005, EMBO J, V24, P1146, DOI 10.1038/sj.emboj.7600605; Utech M, 2006, METH MOL B, V341, P185; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Wilson AJ, 1997, CLIN SCI, V93, P97, DOI 10.1042/cs0930097; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yamazaki Y, 2011, MOL BIOL CELL, V22, P1495, DOI 10.1091/mbc.E10-12-1003; Zanna P, 2007, CANCER-AM CANCER SOC, V110, P452, DOI 10.1002/cncr.22785; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	48	87	90	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12253	12268		10.1074/jbc.M113.457499	http://dx.doi.org/10.1074/jbc.M113.457499			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486470	Green Published, hybrid			2022-12-28	WOS:000318157600057
J	Arvizo, RR; Moyano, DF; Saha, S; Thompson, MA; Bhattacharya, R; Rotello, VM; Prakash, YS; Mukherjee, P				Arvizo, Rochelle R.; Moyano, Daniel F.; Saha, Sounik; Thompson, Michael A.; Bhattacharya, Resham; Rotello, Vincent M.; Prakash, Y. S.; Mukherjee, Priyabrata			Probing Novel Roles of the Mitochondrial Uniporter in Ovarian Cancer Cells Using Nanoparticles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLD NANOPARTICLES; CALCIUM; PROTEIN; CA2+; BAX; ACTIVATION; MECHANISM; MEMBRANE; ANTIBODY; BCL-2	Nanoparticles provide a potent tool for targeting and understanding disease mechanisms. In this regard, cancer cells are surprisingly resistant to the expected toxic effects of positively charged gold nanoparticles ((+)AuNPs). Our investigations led to the identification of MICU1, regulator of mitochondrial calcium uniporter, as a key molecule conferring cancer cells with resistance to (+)AuNPs. The increase in cytosolic [Ca2+](cyto) in malignant cells induced by (+)AuNPs is counteracted by MICU1, preventing cell death. Pharmacological or siRNA-mediated inhibition of mitochondrial Ca+2 entry leads to endoplasmic reticulum stress and sensitizes cancer cells to +AuNP-induced cytotoxicity. Silencing MICU1 decreases Bcl-2 expression and increases caspase-3 activity and cytosolic cytochrome c levels, thus initiating the mitochondrial pathway for apoptosis: effects further enhanced by (+)AuNPs. This study highlights the potential of nanomaterials as a tool to broaden our understanding of cellular processes, establishes MICU1 as a novel regulator of the machinery in cancer cells that prevents apoptosis, and emphasizes the need to synergize nanoparticle design with understanding of mitochondrial machinery for enhancing targeted cellular toxicity.	[Arvizo, Rochelle R.; Saha, Sounik; Bhattacharya, Resham; Mukherjee, Priyabrata] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Thompson, Michael A.; Prakash, Y. S.] Mayo Clin, Coll Med, Dept Anesthesiol, Rochester, MN 55905 USA; [Prakash, Y. S.; Mukherjee, Priyabrata] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Mukherjee, Priyabrata] Mayo Clin, Coll Med, Ctr Canc, Rochester, MN 55905 USA; [Moyano, Daniel F.; Rotello, Vincent M.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Massachusetts System; University of Massachusetts Amherst	Prakash, YS (corresponding author), Mayo Clin, W Joseph St Marys Hosp 4 184, Coll Med, Dept Anesthesiol, 200 1st St SW, Rochester, MN 55905 USA.	prakash.ys@mayo.edu; Mukherjee.priyabrata@mayo.edu	Moyano, Daniel/A-7306-2012	Moyano, Daniel/0000-0002-9213-5660; Prakash, Y S/0000-0002-2968-224X	National Institutes of Health [CA135011, CA136494, GM077173, HL088029]; NATIONAL CANCER INSTITUTE [R01CA136494, R01CA135011] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA135011 and CA136494 (to P. M.), GM077173 (to V. M. R.), and HL088029 (to Y. S. P.).	Agasti SS, 2009, J AM CHEM SOC, V131, P5728, DOI 10.1021/ja900591t; Arvizo RR, 2011, NANOMED-NANOTECHNOL, V7, P580, DOI 10.1016/j.nano.2011.01.011; Arvizo RR, 2010, NANO LETT, V10, P2543, DOI 10.1021/nl101140t; Bhattacharyya S, 2012, ANGEW CHEM INT EDIT, V51, P1563, DOI 10.1002/anie.201105432; Bhattacharyya S, 2010, P NATL ACAD SCI USA, V107, P14541, DOI 10.1073/pnas.1006507107; Bhirde AA, 2009, ACS NANO, V3, P307, DOI 10.1021/nn800551s; Bianchi K, 2004, BBA-MOL CELL RES, V1742, P119, DOI 10.1016/j.bbamcr.2004.09.015; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Brust M., 1996, J CHEM SOC CHEM COMM, V7, P801; Chami M, 2004, J BIOL CHEM, V279, P54581, DOI 10.1074/jbc.M409663200; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Delmotte P, 2012, AM J PHYSIOL-CELL PH, V303, pC244, DOI 10.1152/ajpcell.00414.2011; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hostetler MJ, 1996, J AM CHEM SOC, V118, P4212, DOI 10.1021/ja960198g; Kilbride SM, 2013, ONCOGENE, V32, P2703, DOI 10.1038/onc.2012.348; Kim C, 2010, NAT CHEM, V2, P962, DOI [10.1038/nchem.858, 10.1038/NCHEM.858]; Kroemer G, 2006, ONCOGENE, V25, P4630, DOI 10.1038/sj.onc.1209589; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Massich MD, 2010, ACS NANO, V4, P5641, DOI 10.1021/nn102228s; Miranda OR, 2010, J AM CHEM SOC, V132, P5285, DOI 10.1021/ja1006756; Mukherjee P, 2005, CLIN CANCER RES, V11, P3530, DOI 10.1158/1078-0432.CCR-04-2482; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Prevarskaya N, 2010, TRENDS MOL MED, V16, P107, DOI 10.1016/j.molmed.2010.01.005; Rasola A, 2010, P NATL ACAD SCI USA, V107, P726, DOI 10.1073/pnas.0912742107; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Tait SWG, 2012, J CELL SCI, V125, P807, DOI 10.1242/jcs.099234; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Whelan RS, 2012, P NATL ACAD SCI USA, V109, P6566, DOI 10.1073/pnas.1201608109; You CC, 2007, NAT NANOTECHNOL, V2, P318, DOI 10.1038/nnano.2007.99; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhu ZJ, 2008, J AM CHEM SOC, V130, P14139, DOI 10.1021/ja805392f	38	29	29	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17610	17618		10.1074/jbc.M112.435206	http://dx.doi.org/10.1074/jbc.M112.435206			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23615904	hybrid, Green Published			2022-12-28	WOS:000320380600052
J	Gokulan, K; O'Leary, SE; Russell, WK; Russell, DH; Lalgondar, M; Begley, TP; Ioerger, TR; Sacchettini, JC				Gokulan, Kuppan; O'Leary, Sean E.; Russell, William K.; Russell, David H.; Lalgondar, Mallikarjun; Begley, Tadhg P.; Ioerger, Thomas R.; Sacchettini, James C.			Crystal Structure of Mycobacterium tuberculosis Polyketide Synthase 11 (PKS11) Reveals Intermediates in the Synthesis of Methyl-branched Alkylpyrones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STILBENE SYNTHASES; CHALCONE SYNTHASE; NEUROSPORA-CRASSA; PROTEIN CRYSTALS; ACID SYNTHESIS; BIOSYNTHESIS; LIPIDS; ACYLTRANSFERASES; INFECTION; VIRULENCE	PKS11 is one of three type III polyketide synthases (PKSs) identified in Mycobacterium tuberculosis. Although many PKSs in M. tuberculosis have been implicated in producing complex cell wall glycolipids, the biological function of PKS11 is unknown. PKS11 has previously been proposed to synthesize alkylpyrones from fatty acid substrates. We solved the crystal structure of M. tuberculosis PKS11 and found the overall fold to be similar to other type III PKSs. PKS11 has a deep hydrophobic tunnel proximal to the active site Cys-138 to accommodate substrates. We observed electron density in this tunnel from a co-purified molecule that was identified by mass spectrometry to be palmitate. Co-crystallization with malonyl-CoA (MCoA) or methylmalonyl-CoA (MMCoA) led to partial turnover of the substrate, resulting in trapped intermediates. Reconstitution of the reaction in solution confirmed that both co-factors are required for optimal activity, and kinetic analysis shows that MMCoA is incorporated first, then MCoA, followed by lactonization to produce methyl-branched alkylpyrones.	[Gokulan, Kuppan; Lalgondar, Mallikarjun; Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [O'Leary, Sean E.; Russell, William K.; Russell, David H.; Begley, Tadhg P.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Ioerger, Thomas R.] Texas A&M Univ, Dept Comp Sci & Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Sacchettini, JC (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	sacchett@tamu.edu	Russell, David H/C-3618-2015; Begley, Tadhg/B-5801-2015	Russell, David H/0000-0003-0830-3914; Gokulan, Kuppan/0000-0003-4045-5993	National Institutes of Health [P01AI095208]; Robert A. Welch Foundation [A-0034, A-0015]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI095208] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant P01AI095208 (to J. C. S.). This work was also supported by Robert A. Welch Foundation Grants A-0034 (to T. P. B.) and A-0015 to (J. C. S.). Use of the Advanced Photon Source (beamline 23ID) was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357.	Austin MB, 2004, J BIOL CHEM, V279, P45162, DOI 10.1074/jbc.M406567200; Austin MB, 2004, CHEM BIOL, V11, P1179, DOI 10.1016/j.chembiol.2004.05.024; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Bhatt K, 2007, MICROBIOL-SGM, V153, P513, DOI 10.1099/mic.0.2006/003103-0; Bloch K, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P1; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; de Jong A, 2007, CHEM BIOL, V14, P1232, DOI 10.1016/j.chembiol.2007.09.010; Domenech P, 2009, MICROBIOL-SGM, V155, P3532, DOI 10.1099/mic.0.029199-0; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Funa N, 2007, J BIOL CHEM, V282, P14476, DOI 10.1074/jbc.M701239200; Funabashi M, 2008, J BIOL CHEM, V283, P13983, DOI 10.1074/jbc.M710461200; Gokhale RS, 2007, CURR OPIN STRUC BIOL, V17, P736, DOI 10.1016/j.sbi.2007.08.021; Goyal A, 2008, J STRUCT BIOL, V162, P411, DOI 10.1016/j.jsb.2008.02.009; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Hatzios SK, 2009, J BIOL CHEM, V284, P12745, DOI 10.1074/jbc.M809088200; Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9; Huang WJ, 1998, EMBO J, V17, P1183, DOI 10.1093/emboj/17.5.1183; Jackson M, 2007, TUBERCULOSIS, V87, P78, DOI 10.1016/j.tube.2006.05.003; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kumar P, 2007, P NATL ACAD SCI USA, V104, P11221, DOI 10.1073/pnas.0611649104; Matsunaga I, 2004, J EXP MED, V200, P1559, DOI 10.1084/jem.20041429; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rubin-Pitel SB, 2008, CHEM BIOL, V15, P1079, DOI 10.1016/j.chembiol.2008.08.011; Sankaranarayanan R, 2004, NAT STRUCT MOL BIOL, V11, P894, DOI 10.1038/nsmb809; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Saxena P, 2003, J BIOL CHEM, V278, P44780, DOI 10.1074/jbc.M306714200; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; SHELDRICK GM, 1995, ACTA CRYSTALLOGR B, V51, P423, DOI 10.1107/S0108768195003661; Sirakova TD, 2001, J BIOL CHEM, V276, P16833, DOI 10.1074/jbc.M011468200; Suh DY, 2000, BIOCHEM J, V350, P229, DOI 10.1042/0264-6021:3500229; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Waddell SJ, 2005, LETT APPL MICROBIOL, V40, P201, DOI 10.1111/j.1472-765X.2005.01659.x	39	18	19	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16484	16494		10.1074/jbc.M113.468892	http://dx.doi.org/10.1074/jbc.M113.468892			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23615910	hybrid, Green Published			2022-12-28	WOS:000320378900025
J	Kunte, A; Zhang, W; Paduraru, C; Veerapen, N; Cox, LR; Besra, GS; Cresswell, P				Kunte, Amit; Zhang, Wei; Paduraru, Crina; Veerapen, Natacha; Cox, Liam R.; Besra, Gurdyal S.; Cresswell, Peter			Endoplasmic Reticulum Glycoprotein Quality Control Regulates CD1d Assembly and CD1d-mediated Antigen Presentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KILLER T-CELLS; TRIGLYCERIDE TRANSFER PROTEIN; CLASS-I MOLECULES; NKT CELLS; GLUCOSYLTRANSFERASE RECOGNIZES; ALPHA-GALACTOSYLCERAMIDE; COMPLEX STABILITY; LIPID ANTIGEN; HEAVY-CHAIN; CALRETICULIN	The non-classical major histocompatibility complex (MHC) homologue CD1d presents lipid antigens to innate-like lymphocytes called natural-killer T (NKT) cells. These cells, by virtue of their broad cytokine repertoire, shape innate and adaptive immune responses. Here, we have assessed the role of endoplasmic reticulum glycoprotein quality control in CD1d assembly and function, specifically the role of a key component of the quality control machinery, the enzyme UDP glucose glycoprotein glucosyltransferase (UGT1). We observe that in UGT1-deficient cells, CD1d associates prematurely with beta(2)-microglobulin (beta(2)m) and is able to rapidly exit the endoplasmic reticulum. At least some of these CD1d-beta(2)m heterodimers are shorter-lived and can be rescued by provision of a defined exogenous antigen, alpha-galactosylceramide. Importantly, we show that in UGT1-deficient cells the CD1d-beta(2)m heterodimers have altered antigenicity despite the fact that their cell surface levels are unchanged. We propose that UGT1 serves as a quality control checkpoint during CD1d assembly and further suggest that UGT1-mediated quality control can shape the lipid repertoire of newly synthesized CD1d. The quality control process may play a role in ensuring stability of exported CD1d-beta(2)m complexes, in facilitating presentation of low abundance high affinity antigens, or in preventing deleterious responses to self lipids.	[Kunte, Amit] Yale Univ Sch Med, Howard Hughes Med Inst, Dept Internal Med, Infect Dis Sect, New Haven, CT 06520 USA; [Zhang, Wei; Paduraru, Crina; Cresswell, Peter] Yale Univ Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06520 USA; [Veerapen, Natacha; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Cox, Liam R.] Univ Birmingham, Sch Chem, Birmingham B15 2TT, W Midlands, England	Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University; University of Birmingham; University of Birmingham	Cresswell, P (corresponding author), 300 Cedar St,TAC S669, New Haven, CT 06520 USA.	peter.cresswell@yale.edu	Cox, Liam/AAG-9351-2020	Cox, Liam/0000-0001-7018-3904; Besra, Gurdyal/0000-0002-5605-0395	Birmingham Science City Innovative; Advantage West Midlands; European Regional Development Fund; National Institutes of Health [R01-AI059167]; Howard Hughes Medical Institute; MRC [G1001750] Funding Source: UKRI; Medical Research Council [G1001750] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059167] Funding Source: NIH RePORTER	Birmingham Science City Innovative; Advantage West Midlands(General Electric); European Regional Development Fund(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Sebastian Joyce for hybridomas, Maurizio Molinari for cell lines, Yajuan Zhu for constructs, Ralf Leonhardt and Jelena Bezbradica for a critical review of the manuscript, and Nancy Dometios for help with manuscript preparation. The NMR spectrometers used in this research were funded in part through Birmingham Science City Innovative Uses for Advanced Materials in the Modern World (West Midlands Centre for Advanced Materials Project 2) with support from Advantage West Midlands and funded in part by the European Regional Development Fund.; This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI059167 (to P. C.). This work was also supported by the Howard Hughes Medical Institute (to P. C.).	BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Brigl M, 2010, SEMIN IMMUNOL, V22, P79, DOI 10.1016/j.smim.2009.10.006; Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043; Burdin N, 1998, J IMMUNOL, V161, P3271; Caramelo JJ, 2004, J BIOL CHEM, V279, P46280, DOI 10.1074/jbc.M408404200; Caramelo JJ, 2003, P NATL ACAD SCI USA, V100, P86, DOI 10.1073/pnas.262661199; CERUNDOLO V, 1991, EUR J IMMUNOL, V21, P2069, DOI 10.1002/eji.1830210915; De Libero G, 2012, TRENDS IMMUNOL, V33, P103, DOI 10.1016/j.it.2012.01.005; Dejgaard S, 2004, CURR ISSUES MOL BIOL, V6, P29; Dougan SK, 2005, J EXP MED, V202, P529, DOI 10.1084/jem.20050183; Dougan SK, 2007, J EXP MED, V204, P533, DOI 10.1084/jem.20062006; Florence WC, 2009, EMBO J, V28, P3579, DOI 10.1038/emboj.2009.286; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Gui M, 2001, J IMMUNOL, V167, P6239, DOI 10.4049/jimmunol.167.11.6239; Hayakawa Y, 2001, J IMMUNOL, V166, P6012, DOI 10.4049/jimmunol.166.10.6012; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Joyce S, 2011, J IMMUNOL, V187, P1081, DOI 10.4049/jimmunol.1001910; Kang SJ, 2004, NAT IMMUNOL, V5, P175, DOI 10.1038/ni1034; Kang SJ, 2002, J BIOL CHEM, V277, P44838, DOI 10.1074/jbc.M207831200; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Mallevaey T, 2012, IMMUNOLOGY, V136, P273, DOI 10.1111/j.1365-2567.2012.03580.x; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Odyniec AN, 2010, J BIOL CHEM, V285, P11937, DOI 10.1074/jbc.M109.077933; Paduraru C, 2006, J BIOL CHEM, V281, P40369, DOI 10.1074/jbc.M608518200; Park JJ, 2004, P NATL ACAD SCI USA, V101, P1022, DOI 10.1073/pnas.0307847100; Pearse BR, 2010, J CELL BIOL, V189, P829, DOI 10.1083/jcb.200912105; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Ritter C, 2005, EMBO J, V24, P1730, DOI 10.1038/sj.emboj.7600645; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Sagiv Y, 2007, J EXP MED, V204, P921, DOI 10.1084/jem.20061568; Salio M, 2010, CURR OPIN IMMUNOL, V22, P81, DOI 10.1016/j.coi.2009.12.008; Solda T, 2007, MOL CELL, V27, P238, DOI 10.1016/j.molcel.2007.05.032; Somnay-Wadgaonkar K, 1999, INT IMMUNOL, V11, P383, DOI 10.1093/intimm/11.3.383; Springer S, 1998, BIOCHEMISTRY-US, V37, P3001, DOI 10.1021/bi9717441; Sriram V, 2008, IMMUNOLOGY, V123, P272, DOI 10.1111/j.1365-2567.2007.02696.x; Tamura T, 2010, MOL MEMBR BIOL, V27, P412, DOI 10.3109/09687688.2010.495354; Terabe M, 2008, ADV CANCER RES, V101, P277, DOI 10.1016/S0065-230X(08)00408-9; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; vanderBurg SH, 1996, J IMMUNOL, V156, P3308; Wearsch PA, 2011, P NATL ACAD SCI USA, V108, P4950, DOI 10.1073/pnas.1102524108; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Yuan WM, 2009, J IMMUNOL, V182, P4784, DOI 10.4049/jimmunol.0803981; Zeissig S, 2012, NAT MED, V18, P1060, DOI 10.1038/nm.2811; Zhang W, 2011, P NATL ACAD SCI USA, V108, P4956, DOI 10.1073/pnas.1102527108; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009; Zhu YJ, 2010, J BIOL CHEM, V285, P38283, DOI 10.1074/jbc.M110.170530	51	6	6	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16391	16402		10.1074/jbc.M113.474221	http://dx.doi.org/10.1074/jbc.M113.474221			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23615906	Green Published, hybrid			2022-12-28	WOS:000320378900017
J	Sarkari, F; Wheaton, K; La Delfa, A; Mohamed, M; Shaikh, F; Khatun, R; Arrowsmith, CH; Frappier, L; Saridakis, V; Sheng, Y				Sarkari, Feroz; Wheaton, Keith; La Delfa, Anthony; Mohamed, Majda; Shaikh, Faryal; Khatun, Rahima; Arrowsmith, Cheryl H.; Frappier, Lori; Saridakis, Vivian; Sheng, Yi			Ubiquitin-specific Protease 7 Is a Regulator of Ubiquitin-conjugating Enzyme UbE2E1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H2B; HAUSP; P53; DOMAIN; USP7; DEUBIQUITINATION; LOCALIZATION; INHIBITION; ACTIVATION; EXPRESSION	Ubiquitin-specific protease 7 (USP7) is a deubiquitinating enzyme found in all eukaryotes that catalyzes the removal of ubiquitin from specific target proteins. Here, we report that UbE2E1, an E2 ubiquitin conjugation enzyme with a unique N-terminal extension, is a novel USP7-interacting protein. USP7 forms a complex with UbE2E1 in vitro and in vivo through the ASTSUSP7 binding motif within its N-terminal extension in an identical manner with other known USP7 binding proteins. We show that USP7 attenuates UbE2E1-mediated ubiquitination, an effect that requires the N-terminal ASTS sequence of UbE2E1 as well as the catalytic activity of USP7. Additionally, USP7 is critical in maintaining the steady state levels of UbE2E1 in cells. This study reveals a new cellular mechanism that couples the opposing activities of the ubiquitination machinery and a deubiquitinating enzyme to maintain and modulate the dynamic balance of the ubiquitin-proteasome system.	[Sarkari, Feroz; Wheaton, Keith; La Delfa, Anthony; Mohamed, Majda; Shaikh, Faryal; Khatun, Rahima; Saridakis, Vivian; Sheng, Yi] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; [Arrowsmith, Cheryl H.] Univ Hlth Network, Ontario Canc Inst, Div Canc Genom & Prote, Toronto, ON M5G 1L7, Canada; [Frappier, Lori] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	York University - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Saridakis, V (corresponding author), York Univ, Dept Biol, Life Sci Bldg,Rm 327A,4700 Keele St, Toronto, ON M3J 1P3, Canada.	vsaridak@yorku.ca; yisheng@yorku.ca	Wheaton, Keith/AAF-1561-2021	Arrowsmith, Cheryl/0000-0002-4971-3250	Canadian Institutes of Health Research (CIHR) [106583]; York University; Natural Science and Engineering Research Council of Canada Undergraduate Student Research Assistantship; York University James Wu Research Internship; Canada Foundation for Innovation (CFI) Leaders Opportunity Fund Program; Ontario Research Fund Research Infrastructure Program (ORF-RI); United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); York University; Natural Science and Engineering Research Council of Canada Undergraduate Student Research Assistantship(Natural Sciences and Engineering Research Council of Canada (NSERC)); York University James Wu Research Internship; Canada Foundation for Innovation (CFI) Leaders Opportunity Fund Program; Ontario Research Fund Research Infrastructure Program (ORF-RI); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was supported by Operating Grant 106583 from the Canadian Institutes of Health Research (CIHR) (to V. S. and Y. S.) as well as York University startup funds (to V. S. and Y. S.).; Supported by a Natural Science and Engineering Research Council of Canada Undergraduate Student Research Assistantship and a York University James Wu Research Internship.; We thank Dr. Bert Vogelstein for generously providing the HCT116 USP7<SUP>-/-</SUP> and the HCT116 parental cell lines. We thank Dr. Sirano Dhe-Paganon from Structural Genomics Consortium (SGC) Toronto for the HECT domain E3 ligase constructs (NEDD-4L and ITCH). Infrastructure was funded by the Canada Foundation for Innovation (CFI) Leaders Opportunity Fund Program and the Ontario Research Fund Research Infrastructure Program (ORF-RI). Results shown in this study are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. The Argonne National Laboratory is operated by the University of Chicago, Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; BANERJEE A, 1993, J BIOL CHEM, V268, P5668; Block K, 2005, CELL CYCLE, V4, P1421, DOI 10.4161/cc.4.10.2054; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Cummins JM, 2004, CELL CYCLE, V3, P689, DOI 10.4161/cc.3.6.924; David Y, 2010, J BIOL CHEM, V285, P8595, DOI 10.1074/jbc.M109.089003; Debonneville C, 2004, MOL CELL BIOL, V24, P2397, DOI 10.1128/MCB.24.6.2397-2409.2004; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Faustrup H, 2009, J CELL BIOL, V184, P13, DOI 10.1083/jcb.200807137; Fotia AB, 2006, INT J BIOCHEM CELL B, V38, P472, DOI 10.1016/j.biocel.2005.11.006; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Khoronenkova SV, 2013, NUCLEIC ACIDS RES, V41, P1750, DOI 10.1093/nar/gks1359; Lee HR, 2011, NAT STRUCT MOL BIOL, V18, P1336, DOI 10.1038/nsmb.2142; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; MEREDITH M, 1994, VIROLOGY, V200, P457, DOI 10.1006/viro.1994.1209; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nathan JA, 2008, TRAFFIC, V9, P1130, DOI 10.1111/j.1600-0854.2008.00747.x; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oh YM, 2007, BIOCHEM BIOPH RES CO, V357, P615, DOI 10.1016/j.bbrc.2007.03.193; Park YC, 2000, CELL, V101, P777, DOI 10.1016/S0092-8674(00)80889-2; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Plafker KS, 2009, BIOCHEMISTRY-US, V48, P3527, DOI 10.1021/bi801971m; Qing P, 2011, J CELL BIOCHEM, V112, P3856, DOI 10.1002/jcb.23317; Saridakis V, 2005, MOL CELL, V18, P25, DOI 10.1016/j.molcel.2005.02.029; Sarkari F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016598; Sarkari F, 2010, J MOL BIOL, V402, P825, DOI 10.1016/j.jmb.2010.08.017; Sarkari F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000624; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Summers MK, 2008, MOL CELL, V31, P544, DOI 10.1016/j.molcel.2008.07.014; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; van Wijk SJL, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.55; Yamanaka A, 2000, MOL BIOL CELL, V11, P2821, DOI 10.1091/mbc.11.8.2821; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	41	31	31	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16975	16985		10.1074/jbc.M113.469262	http://dx.doi.org/10.1074/jbc.M113.469262			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23603909	Green Published, hybrid			2022-12-28	WOS:000320378900069
J	Barrero, MJ; Sese, B; Marti, M; Belmonte, JCI				Barrero, Maria J.; Sese, Borja; Marti, Merce; Izpisua Belmonte, Juan Carlos			Macro Histone Variants Are Critical for the Differentiation of Human Pluripotent Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INACTIVE X-CHROMOSOME; STEM-CELLS; GENERATION; EFFICIENT; CHROMATIN; BINDING; DOMAIN	We have previously shown that macro histone variants (macroH2A) are expressed at low levels in stem cells and are up-regulated during differentiation. Here we show that the knockdown of macro histone variants impaired the in vitro and in vivo differentiation of human pluripotent cells, likely through defects in the silencing of pluripotency-related genes. ChIP experiments showed that during differentiation macro histone variants are recruited to the regulatory regions of pluripotency and developmental genes marked with H3K27me3 contributing to the silencing of these genes.	[Barrero, Maria J.; Sese, Borja; Marti, Merce; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; Salk Institute	Belmonte, JCI (corresponding author), Ctr Regenerat Med Barcelona, Barcelona 08003, Spain.	belmonte@salk.edu	Barrero, Maria J./Q-1785-2017	Barrero, Maria J./0000-0002-5990-7040; Sese, Borja/0000-0001-8554-897X	Ministerio de Ciencia e Innovacion of Spain (MICINN) [RYC-2007-01510, SAF2009-08588]; Ramon y Cajal program; Formacion de Personal Investigador (FPI); Ministerio de Ciencia e Innovacion of Spain (MICINN); G. Harold and Leila Y. Mathers Charitable Foundation; The Leona M. and Harry B. Helmsley Charitable Trust; ISCIII-TERCEL-MINECO; CIBER; Fundacion Cellex	Ministerio de Ciencia e Innovacion of Spain (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ramon y Cajal program(Spanish Government); Formacion de Personal Investigador (FPI)(Spanish Government); Ministerio de Ciencia e Innovacion of Spain (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); G. Harold and Leila Y. Mathers Charitable Foundation; The Leona M. and Harry B. Helmsley Charitable Trust; ISCIII-TERCEL-MINECO; CIBER; Fundacion Cellex(Foundation CELLEX)	This work was supported by Ministerio de Ciencia e Innovacion of Spain (MICINN) Grants RYC-2007-01510 and SAF2009-08588 (to M.J.B.).; 1 Supported in part by the Ramon y Cajal program.; 2 Recipient of a Formacion de Personal Investigador (FPI) predoctoral fellowship from Ministerio de Ciencia e Innovacion of Spain (MICINN).; 3 Work in the laboratory of J.C.I.B. was supported by the G. Harold and Leila Y. Mathers Charitable Foundation, The Leona M. and Harry B. Helmsley Charitable Trust, ISCIII-TERCEL-MINECO, CIBER, and Fundacion Cellex. To whom correspondence should be addressed. E-mail: belmonte@salk.edu.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Angelov D, 2003, MOL CELL, V11, P1033, DOI 10.1016/S1097-2765(03)00100-X; Barrero M. J., 2013, CELL REP, VS2211-1247, P00105; Barrero MJ, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/434529; Boue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012664; Buschbeck M, 2009, NAT STRUCT MOL BIOL, V16, P1074, DOI 10.1038/nsmb.1665; Chadwick BP, 2001, HUM MOL GENET, V10, P1101, DOI 10.1093/hmg/10.10.1101; Chakravarthy S, 2005, MOL CELL BIOL, V25, P7616, DOI 10.1128/MCB.25.17.7616-7624.2005; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Creppe C, 2012, MOL CELL BIOL, V32, P1442, DOI 10.1128/MCB.06323-11; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Faast R, 2001, CURR BIOL, V11, P1183, DOI 10.1016/S0960-9822(01)00329-3; Gamble MJ, 2010, CELL CYCLE, V9, P2568, DOI 10.4161/cc.9.13.12144; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pasque V, 2012, J CELL SCI, V125, P6094, DOI 10.1242/jcs.113019; Pasque V, 2011, EMBO J, V30, P2373, DOI 10.1038/emboj.2011.144; PEHRSON JR, 1992, SCIENCE, V257, P1398; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Raya A, 2008, COLD SH Q B, V73, P127, DOI 10.1101/sqb.2008.73.038; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; Terme JM, 2011, J BIOL CHEM, V286, P35347, DOI 10.1074/jbc.M111.281923	31	28	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16110	16116		10.1074/jbc.M113.466144	http://dx.doi.org/10.1074/jbc.M113.466144			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23595991	Green Published, hybrid			2022-12-28	WOS:000319822300061
J	Fukuda, R; Suico, MA; Koyama, K; Omachi, K; Kai, Y; Matsuyama, S; Mitsutake, K; Taura, M; Morino-Koga, S; Shuto, T; Kai, H				Fukuda, Ryosuke; Suico, Mary Ann; Koyama, Kosuke; Omachi, Kohei; Kai, Yukari; Matsuyama, Shingo; Mitsutake, Kazunori; Taura, Manabu; Morino-Koga, Saori; Shuto, Tsuyoshi; Kai, Hirofumi			Mild Electrical Stimulation at 0.1-ms Pulse Width Induces p53 Protein Phosphorylation and G(2) Arrest in Human Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DNA-DAMAGE; P53-DEPENDENT APOPTOSIS; INFLAMMATORY RESPONSE; CYCLE CHECKPOINTS; LIPID RAFTS; P38 MAPK; ACTIVATION; HYPERTHERMIA; SUPPRESSOR	Exogenous low-intensity electrical stimulation has been used for treatment of various intractable diseases despite the dearth of information on the molecular underpinnings of its effects. Our work and that of others have demonstrated that applied electrical stimulation at physiological strength or mild electrical stimulation (MES) activates the PI3K-Akt pathway, but whether MES activates other molecules remains unknown. Considering that MES is a form of physiological stress, we hypothesized that it can activate the tumor suppressor p53, which is a key modulator of the cell cycle and apoptosis in response to cell stresses. The potential response of p53 to an applied electrical current of low intensity has not been investigated. Here, we show that p53 was transiently phosphorylated at Ser-15 in epithelial cells treated with an imperceptible voltage (1 V/cm) and a 0.1-ms pulse width. MES-induced p53 phosphorylation was inhibited by pretreatment with a p38 MAPK inhibitor and transfection of dominant-negative mutants of p38, MKK3b, and MKK6b, implying the involvement of the p38 MAPK signaling pathway. Furthermore, MES treatment enhanced p53 transcriptional function and increased the expression of p53 target genes p21, BAX, PUMA, NOXA, and IRF9. Importantly, MES treatment triggered G(2) cell cycle arrest, but not cell apoptosis. MES treatment had no effect on the cell cycle in HCT116 p53(-/-) cells, suggesting a dependence on p53. These findings identify some molecular targets of electrical stimulation and incorporate the p38-p53 signaling pathway among the transduction pathways that MES affects.	[Fukuda, Ryosuke; Suico, Mary Ann; Koyama, Kosuke; Omachi, Kohei; Kai, Yukari; Matsuyama, Shingo; Taura, Manabu; Morino-Koga, Saori; Shuto, Tsuyoshi; Kai, Hirofumi] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, Kumamoto 8620973, Japan; [Mitsutake, Kazunori] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8620973, Japan	Kumamoto University; Kumamoto University	Kai, H (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Med, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	hirokai@gpo.kumamoto-u.ac.jp	Taura, Manabu/Y-6844-2019; Omachi, Kohei/ABB-2844-2020; Omachi, Kohei/GPX-9286-2022	Taura, Manabu/0000-0001-9577-8007; Shuto, Tsuyoshi/0000-0003-1275-4988; Suico, Mary Ann/0000-0002-6751-8352; Omachi, Kohei/0000-0002-0160-3271	Ministry of Education, Science, Sports, and Culture (MEXT) of Japan [22390015, 23590082]	Ministry of Education, Science, Sports, and Culture (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Science Research 22390015 (to H. K.) and 23590082 (to M. A. S.) from the Ministry of Education, Science, Sports, and Culture (MEXT) of Japan.	AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Ainsworth L, 2006, PAIN, V120, P182, DOI 10.1016/j.pain.2005.10.030; Balakatounis Konstantine C, 2008, Eplasty, V8, pe28; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; BASSETT CAL, 1993, J CELL BIOCHEM, V51, P387, DOI 10.1002/jcb.2400510402; Beebe SJ, 2003, FASEB J, V17, P1493, DOI 10.1096/fj.02-0859fje; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Cucullo L, 2005, GLIA, V51, P65, DOI 10.1002/glia.20188; Duan Y, 2008, P NATL ACAD SCI USA, V105, P11418, DOI 10.1073/pnas.0804954105; Feng LJ, 2006, CELL CYCLE, V5, P2812, DOI 10.4161/cc.5.23.3526; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Griffin Michelle, 2011, Eplasty, V11, pe34; Gu G, 2011, J INT MED RES, V39, P1783, DOI 10.1177/147323001103900521; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hoeferlin L Alexis, 2011, Genes Cancer, V2, P889, DOI 10.1177/1947601911432495; Kai H, 2009, INT J HYPERTHER, V25, P655, DOI 10.3109/02656730903039605; Kirson ED, 2004, CANCER RES, V64, P3288, DOI 10.1158/0008-5472.CAN-04-0083; Kirson ED, 2007, P NATL ACAD SCI USA, V104, P10152, DOI 10.1073/pnas.0702916104; Kishi H, 2001, J BIOL CHEM, V276, P39115, DOI 10.1074/jbc.M105134200; Koga T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043852; Komarova EA, 2005, FASEB J, V19, P1030, DOI 10.1096/fj.04-3213fje; Kondo T, 2013, NEUROREPORT, V24, P68, DOI 10.1097/WNR.0b013e32835c7df2; Kondo T, 2012, DIABETES, V61, P838, DOI 10.2337/db11-1098; Kondo T, 2010, OBES RES CLIN PRACT, V4, pE101, DOI 10.1016/j.orcp.2009.09.007; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lambert S, 2008, J CELL PHYSIOL, V217, P834, DOI 10.1002/jcp.21563; Liu G, 2009, J IMMUNOL, V182, P5063, DOI 10.4049/jimmunol.0803526; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Mayr M, 2002, FASEB J, V16, P1423, DOI 10.1096/fj.02-0042fje; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Miyakoda M, 2002, ONCOGENE, V21, P1090, DOI 10.1038/sj.onc.1205196; MIYASHITA T, 1995, CELL, V80, P293; Morino S, 2008, J PHARMACOL SCI, V108, P222, DOI 10.1254/jphs.08180SC; Morino S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004068; Morino-Koga S, 2013, J CELL PHYSIOL, V228, P439, DOI 10.1002/jcp.24149; Muller-Ladner U, 2000, ARTHRITIS RES, V2, P175, DOI 10.1186/ar84; Munoz-Fontela C, 2008, J EXP MED, V205, P1929, DOI 10.1084/jem.20080383; Murphy SH, 2011, P NATL ACAD SCI USA, V108, P17117, DOI 10.1073/pnas.1114420108; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nigro JM, 1997, CANCER RES, V57, P3635; Oba M, 2008, INT J ONCOL, V32, P1317; Oba M, 2010, J SURG RES, V162, P213, DOI 10.1016/j.jss.2009.03.093; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Saretzki G, 1999, ONCOGENE, V18, P5148, DOI 10.1038/sj.onc.1202898; Seegers JC, 2001, MED HYPOTHESES, V57, P224, DOI 10.1054/mehy.2001.1292; Sen N, 2012, TRANSCR-AUSTIN, V3, P119, DOI 10.4161/trns.20094; Sersa G, 2008, EJSO-EUR J SURG ONC, V34, P232, DOI 10.1016/j.ejso.2007.05.016; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Simelyte E, 2005, ARTHRITIS RHEUM-US, V52, P1876, DOI 10.1002/ART.21099; Suico MA, 2004, J BIOL CHEM, V279, P19091, DOI 10.1074/jbc.M312439200; Svirskis D, 2010, J CONTROL RELEASE, V146, P6, DOI 10.1016/j.jconrel.2010.03.023; Taura M, 2008, MOL CELL BIOL, V28, P6557, DOI 10.1128/MCB.01202-08; Taura M, 2011, NUCLEIC ACIDS RES, V39, P76, DOI 10.1093/nar/gkq762; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Yano S, 2011, J PHARMACOL SCI, V115, P94, DOI 10.1254/jphs.10185SC; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	66	14	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16117	16126		10.1074/jbc.M112.442442	http://dx.doi.org/10.1074/jbc.M112.442442			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23599430	hybrid, Green Published			2022-12-28	WOS:000319822300062
J	Khurana, SS; Riehl, TE; Moore, BD; Fassan, M; Rugge, M; Romero-Gallo, J; Noto, J; Peek, RM; Stenson, WF; Mills, JC				Khurana, Shradha S.; Riehl, Terrence E.; Moore, Benjamin D.; Fassan, Matteo; Rugge, Massimo; Romero-Gallo, Judith; Noto, Jennifer; Peek, Richard M., Jr.; Stenson, William F.; Mills, Jason C.			The Hyaluronic Acid Receptor CD44 Coordinates Normal and Metaplastic Gastric Epithelial Progenitor Cell Proliferation.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICOBACTER-PYLORI ERADICATION; POLYPEPTIDE-EXPRESSING METAPLASIA; ADHESION MOLECULE CD44; STEM-CELLS; IN-VITRO; SIGNAL TRANSDUCER; MOUSE STOMACH; CANCER; GROWTH; ACTIVATION	The stem cell in the isthmus of gastric units continually replenishes the epithelium. Atrophy of acid-secreting parietal cells (PCs) frequently occurs during infection with Helicobacter pylori, predisposing patients to cancer. Atrophy causes increased proliferation of stem cells, yet little is known about how this process is regulated. Here we show that CD44 labels a population of small, undifferentiated cells in the gastric unit isthmus where stem cells are known to reside. Loss of CD44 in vivo results in decreased proliferation of the gastric epithelium. When we induce PC atrophy by Helicobacter infection or tamoxifen treatment, this CD44(+) population expands from the isthmus toward the base of the unit. CD44 blockade during PC atrophy abrogates the expansion. We find that CD44 binds STAT3, and inhibition of either CD44 or STAT3 signaling causes decreased proliferation. Atrophy-induced CD44 expansion depends on pERK, which labels isthmal cells in mice and humans. Our studies delineate an in vivo signaling pathway, ERK -> CD44 -> STAT3, that regulates normal and atrophy-induced gastric stem/progenitor-cell proliferation. We further show that we can intervene pharmacologically at each signaling step in vivo to modulate proliferation.	[Khurana, Shradha S.; Riehl, Terrence E.; Moore, Benjamin D.; Stenson, William F.; Mills, Jason C.] Washington Univ, Sch Med, Dept Med, Div Gastroenterol, St Louis, MO 63110 USA; [Khurana, Shradha S.; Riehl, Terrence E.; Moore, Benjamin D.; Stenson, William F.; Mills, Jason C.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Khurana, Shradha S.; Riehl, Terrence E.; Moore, Benjamin D.; Stenson, William F.; Mills, Jason C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Fassan, Matteo; Rugge, Massimo] Univ Padua, Dept Med, Pathol & Cytopathol Unit, I-35126 Padua, Italy; [Romero-Gallo, Judith; Noto, Jennifer; Peek, Richard M., Jr.] Vanderbilt Univ, Sch Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37232 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Padua; Vanderbilt University	Mills, JC (corresponding author), Washington Univ, Sch Med, Dept Med, Div Gastroenterol, Box 8124,660 S Euclid Ave, St Louis, MO 63110 USA.	jmills@wustl.edu	Mills, Jason/AAA-6688-2021; Fassan, Matteo/F-5152-2012; Rugge, Massimo/K-7525-2016	Mills, Jason/0000-0002-0402-4662; Fassan, Matteo/0000-0001-6515-5482; 	National Institutes of Health [DK079798-3, DK079798-4, 2P30 DK052574-12, DK33165, DK55753, R01 DK58587, R01 CA 77955, F32 CA 153539, P01 116037, P30 DK 508404]; Alvin J. Siteman Cancer Center at Washington University School of Medicine; Barnes Jewish Hospital; Italian Association for Cancer Research (AIRC); American Chemical Society [DDC-115769]; Funderburg Research Scholar Award; Digestive Diseases Research Core Center; NATIONAL CANCER INSTITUTE [F32CA153539, R01CA077955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058587, R37DK033165, R01DK079798, P30DK052574, R01DK033165, R01DK094989, R01DK055753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alvin J. Siteman Cancer Center at Washington University School of Medicine; Barnes Jewish Hospital; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); American Chemical Society(American Chemical Society); Funderburg Research Scholar Award; Digestive Diseases Research Core Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK079798-3 and -4 and 2P30 DK052574-12 (to J.C.M.), DK33165 and DK55753 (to W. F. S.), R01 DK58587, R01 CA 77955, and P01 116037 (to R. M. P.), F32 CA 153539 (to J.N.), and P30 DK 508404 (to Vanderbilt Digestive Diseases Research Core Center).; 1 Supported in part by the Cancer Biology Pathway Program, Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes Jewish Hospital.; 2 Supported by Italian Association for Cancer Research (AIRC) Regional Grant 2008.; 3 Supported by American Chemical Society Grant DDC-115769 and Funderburg Research Scholar Award and the Digestive Diseases Research Core Center. To whom correspondence should be addressed: Division of Gastroenterology, Dept. of Medicine, Washington University School of Medicine, Box 8124, 660 S. Euclid Ave. St. Louis, MO 63110. Tel.: 314-362-4258; Fax: 314-362-2505; E-mail: jmills@wustl.edu.	Baines P, 2000, EUR J HAEMATOL, V64, P211, DOI 10.1034/j.1600-0609.2000.90139.x; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Bredemeyer AJ, 2009, DEV BIOL, V325, P211, DOI 10.1016/j.ydbio.2008.10.025; Bronte-Tinkew DM, 2009, CANCER RES, V69, P632, DOI 10.1158/0008-5472.CAN-08-1191; Chong JM, 1997, INT J CANCER, V74, P450, DOI 10.1002/(SICI)1097-0215(19970822)74:4<450::AID-IJC16>3.0.CO;2-D; Coffey RJ, 2007, J CLIN INVEST, V117, P70, DOI 10.1172/JCI30491; Collisson EA, 2012, CANCER DISCOV, V2, P685, DOI 10.1158/2159-8290.CD-11-0347; Correa P, 2007, GASTROENTEROLOGY, V133, P659, DOI 10.1053/j.gastro.2007.06.026; de Vries AC, 2009, AM J GASTROENTEROL, V104, P1342, DOI 10.1038/ajg.2008.15; Dhingra S, 2011, INT J CLIN EXP PATHO, V4, P733; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; El-Zimaity HMT, 2002, CANCER-AM CANCER SOC, V94, P1428, DOI 10.1002/cncr.10375; Fan XJ, 1996, GUT, V38, P507, DOI 10.1136/gut.38.4.507; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Fritz JM, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-76; Ghaffarzadehgan K, 2008, WORLD J GASTROENTERO, V14, P6376, DOI 10.3748/wjg.14.6376; Goldenring JR, 2010, PROG MOL BIOL TRANSL, V96, P117, DOI [10.1016/S1877-1173(10)96005-5, 10.1016/B978-0-12-381280-3.00005-1]; Goldenring JR, 2010, GASTROENTEROLOGY, V138, P2207, DOI 10.1053/j.gastro.2010.04.023; Goldenring JR, 1996, DIGEST DIS SCI, V41, P773, DOI 10.1007/BF02213134; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Graham DY, 2006, HELICOBACTER, V11, P139, DOI 10.1111/j.1523-5378.2006.00391.x; Grandi D, 2006, EUR J PHARMACOL, V538, P141, DOI 10.1016/j.ejphar.2006.03.049; Herrera V, 2009, CLIN MICROBIOL INFEC, V15, P971, DOI 10.1111/j.1469-0691.2009.03031.x; Higashikawa K, 1996, INT J CANCER, V66, P11, DOI 10.1002/(SICI)1097-0215(19960328)66:1<11::AID-IJC3>3.3.CO;2-L; Ho PL, 2012, CANCER RES, V72, P3135, DOI 10.1158/0008-5472.CAN-11-3195; Horst D, 2009, CANCER INVEST, V27, P844, DOI 10.1080/07357900902744502; Huh WJ, 2012, GASTROENTEROLOGY, V142, P21, DOI 10.1053/j.gastro.2011.09.050; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Ishimoto T, 2010, CANCER SCI, V101, P673, DOI 10.1111/j.1349-7006.2009.01430.x; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Jain RN, 2006, AM J PHYSIOL-GASTR L, V291, pG762, DOI 10.1152/ajpgi.00172.2006; Kanda N, 2004, ONCOGENE, V23, P4921, DOI 10.1038/sj.onc.1207606; KARAM SM, 1993, ANAT RECORD, V236, P280, DOI 10.1002/ar.1092360203; KARAM SM, 1993, ANAT REC, V236, P259, DOI 10.1002/ar.1092360202; Khavari TA, 2007, CELL CYCLE, V6, P2928, DOI 10.4161/cc.6.23.4998; Kikuchi M, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-65; Kobayashi T, 2000, J CLIN INVEST, V105, P1741, DOI 10.1172/JCI9441; Lee HJ, 2010, GASTROENTEROLOGY, V139, P213, DOI 10.1053/j.gastro.2010.04.008; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Lennerz JKM, 2010, AM J PATHOL, V177, P1514, DOI 10.2353/ajpath.2010.100328; LESLEY J, 1992, EUR J IMMUNOL, V22, P2719, DOI 10.1002/eji.1830221036; Leslie K, 2006, CANCER RES, V66, P2544, DOI 10.1158/0008-5472.CAN-05-2203; Li GH, 2010, INT J ONCOL, V37, P103, DOI 10.3892/ijo_00000658; Maegawa M, 2009, ANTICANCER RES, V29, P1111; Marampon F, 2009, MOL CANCER THER, V8, P543, DOI 10.1158/1535-7163.MCT-08-0570; Matkar SS, 2011, AM J CANCER RES, V1, P432; MAYER B, 1993, LANCET, V342, P1019, DOI 10.1016/0140-6736(93)92879-X; Mills JC, 2011, GASTROENTEROLOGY, V140, P412, DOI 10.1053/j.gastro.2010.12.001; Mills JC, 2002, P NATL ACAD SCI USA, V99, P14819, DOI 10.1073/pnas.192574799; Modlin Irvin M., 2003, Keio Journal of Medicine, V52, P134; Murai T, 2006, BIOCHEM J, V395, P65, DOI 10.1042/BJ20050582; Nakamura E, 2004, AM J PHYSIOL-GASTR L, V287, pG1053, DOI 10.1152/ajpgi.00353.2003; Nam KT, 2010, GASTROENTEROLOGY, V139, P2028, DOI 10.1053/j.gastro.2010.09.005; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Niv Y, 2008, HELICOBACTER, V13, P56, DOI 10.1111/j.1523-5378.2008.00571.x; Nomura S, 2004, GASTROENTEROLOGY, V127, P582, DOI 10.1053/j.gastro.2004.05.029; Nozaki K, 2008, GASTROENTEROLOGY, V134, P511, DOI 10.1053/j.gastro.2007.11.058; Osaki LH, 2011, CELL PROLIFERAT, V44, P174, DOI 10.1111/j.1365-2184.2011.00733.x; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Qiao XTT, 2011, J GASTROENTEROL, V46, P855, DOI 10.1007/s00535-011-0413-y; Quante M, 2012, CANCER CELL, V21, P36, DOI 10.1016/j.ccr.2011.12.004; Ramsey VG, 2007, DEVELOPMENT, V134, P211, DOI 10.1242/dev.02700; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Riehl TE, 2012, AM J PHYSIOL-GASTR L, V303, pG377, DOI 10.1152/ajpgi.00034.2012; Roder David M, 2002, Gastric Cancer, V5 Suppl 1, P5, DOI 10.1007/s10120-002-0203-6; Romero-Gallo J, 2008, LAB INVEST, V88, P328, DOI 10.1038/labinvest.3700719; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Sherry MM, 2009, STEM CELLS, V27, P2383, DOI 10.1002/stem.185; Shinohara M, 2010, GASTROENTEROLOGY, V139, P2050, DOI 10.1053/j.gastro.2010.08.052; Souza RF, 2004, AM J PHYSIOL-GASTR L, V287, pG743, DOI 10.1152/ajpgi.00144.2004; Syder AJ, 1999, MOL CELL, V3, P263, DOI 10.1016/S1097-2765(00)80454-2; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Tremblay E, 1997, GASTROENTEROLOGY, V112, P1188, DOI 10.1016/S0016-5085(97)70130-6; Wang TC, 2000, GASTROENTEROLOGY, V118, P36, DOI 10.1016/S0016-5085(00)70412-4; WASHINGTON K, 1994, HUM PATHOL, V25, P1043, DOI 10.1016/0046-8177(94)90063-9; Xiao C, 2010, GASTROENTEROLOGY, V138, P550, DOI 10.1053/j.gastro.2009.11.002; Yang JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021155	80	82	86	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16085	16097		10.1074/jbc.M112.445551	http://dx.doi.org/10.1074/jbc.M112.445551			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23589310	Green Published, hybrid			2022-12-28	WOS:000319822300059
J	Mansour, MK; Tam, JM; Khan, NS; Seward, M; Davids, PJ; Puranam, S; Sokolovska, A; Sykes, DB; Dagher, Z; Becker, C; Tanne, A; Reedy, JL; Stuart, LM; Vyas, JM				Mansour, Michael K.; Tam, Jenny M.; Khan, Nida S.; Seward, Michael; Davids, Peter J.; Puranam, Sravanthi; Sokolovska, Anna; Sykes, David B.; Dagher, Zeina; Becker, Christine; Tanne, Antoine; Reedy, Jennifer L.; Stuart, Lynda M.; Vyas, Jatin M.			Dectin-1 Activation Controls Maturation of beta-1,3-Glucan-containing Phagosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVASIVE FUNGAL-INFECTIONS; BETA-GLUCAN RECOGNITION; CANDIDA-ALBICANS; RECEPTOR DECTIN-1; LECTIN RECEPTORS; HOST-DEFENSE; SYK KINASE; MACROPHAGES; CARD9; EPIDEMIOLOGY	Elimination of fungal pathogens by phagocytes requires phagosome maturation, a process that involves the recruitment and fusion of intracellular proteins. The role of Dectin-1, a beta-1,3-glucan receptor, critical for fungal recognition and triggering of Th17 responses, to phagosomal maturation has not been defined. We show that GFP-Dectin-1 translocates to the fungal phagosome, but its signal decays after 2 h. Inhibition of acidification results in retention of GFP-Dectin-1 to phagosome membranes highlighting the requirement for an acidic pH. Following beta-1,3-glucan recognition, GFP-Dectin-1 undergoes tyrosine phosphorylation by Src kinases with subsequent Syk activation. Our results demonstrate that Syk is activated independently of intraphagosomal pH. Inhibition of Src or Syk results in prolonged retention of GFP-Dectin-1 to the phagosome signifying a link between Syk and intraphagosomal pH. beta-1,3-glucan phagosomes expressing a signaling incompetent Dectin-1 failed to mature as demonstrated by prolonged Dectin-1 retention, presence of Rab5B, failure to acquire LAMP-1 and inability to acidify. Phagosomes containing Candida albicans also require Dectin-1-dependent Syk activation for phagosomal maturation. Taken together, these results support a model where Dectin-1 not only controls internalization of beta-1,3-glucan containing cargo and triggers proinflammatory cytokines, but also acts as a master regulator for subsequent phagolysosomal maturation through Syk activation.	[Mansour, Michael K.; Tam, Jenny M.; Khan, Nida S.; Seward, Michael; Davids, Peter J.; Puranam, Sravanthi; Dagher, Zeina; Reedy, Jennifer L.; Vyas, Jatin M.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA; [Sokolovska, Anna; Becker, Christine; Tanne, Antoine; Stuart, Lynda M.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Sykes, David B.] Massachusetts Gen Hosp, Div Hematol & Oncol, Boston, MA 02114 USA; [Mansour, Michael K.; Tam, Jenny M.; Sykes, David B.; Reedy, Jennifer L.; Vyas, Jatin M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Davids, Peter J.] Bowdoin Coll, Brunswick, ME 04011 USA; [Puranam, Sravanthi] MIT, Cambridge, MA 02143 USA; [Stuart, Lynda M.] Broad Inst MIT & Harvard Univ, Cambridge, MA 02143 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Bowdoin College; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Vyas, JM (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Infect Dis, 55 Fruit St,Gray Jackson Bldg Room 504, Boston, MA 02114 USA.	jvyas@partners.org	Vyas, Jatin/Q-1627-2016	Vyas, Jatin/0000-0002-9985-9565; Seward, Michael/0000-0002-4813-6308	National Institutes of Health [NIAID T32-AI007061-35, NIAID R01AI079198, NIAID 1R01AI092084]; Leukemia & Lymphoma Society; Alex's Lemonade Stand Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079198, T32AI007061, R01AI092084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Alex's Lemonade Stand Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants NIAID T32-AI007061-35 (to M. K. M. and J. L. R.), NIAID R01AI079198 (to L. M. S.), and NIAID 1R01AI092084 (to J. M. V.).; Supported by The Leukemia & Lymphoma Society and Alex's Lemonade Stand Foundation.	Arendrup MC, 2010, CURR OPIN CRIT CARE, V16, P445, DOI 10.1097/MCC.0b013e32833e84d2; Artavanis-Tsakonas K, 2006, P NATL ACAD SCI USA, V103, P15945, DOI 10.1073/pnas.0607528103; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Brown J, 2007, PROTEIN SCI, V16, P1042, DOI 10.1110/ps.072791207; Carvalho A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00156; Carvalho A, 2012, CELL MOL IMMUNOL, V9, P276, DOI 10.1038/cmi.2012.1; Chai LYA, 2011, J INFECT DIS, V203, P736, DOI 10.1093/infdis/jiq102; De Luca A, 2012, J CLIN INVEST, V122, P1816, DOI 10.1172/JCI60862; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Dennehy KM, 2009, EUR J IMMUNOL, V39, P1379, DOI 10.1002/eji.200838543; Esteban A, 2011, P NATL ACAD SCI USA, V108, P14270, DOI 10.1073/pnas.1111415108; Fernandez-Arenas E, 2007, MOL CELL PROTEOMICS, V6, P460, DOI 10.1074/mcp.M600210-MCP200; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Heinsbroek SEM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000218; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Huang HB, 2012, J IMMUNOL, V189, P312, DOI 10.4049/jimmunol.1200603; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Kasperkovitz PV, 2010, J IMMUNOL, V185, P7614, DOI 10.4049/jimmunol.1002760; Kerrigan AM, 2010, IMMUNOL REV, V234, P335, DOI 10.1111/j.0105-2896.2009.00882.x; LeibundGut-Landmann S, 2012, CURR OPIN IMMUNOL, V24, P449, DOI 10.1016/j.coi.2012.04.007; Levitz SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000758; Ma J, 2012, J BIOL CHEM, V287, P34149, DOI 10.1074/jbc.M112.382812; Neofytos D, 2010, TRANSPL INFECT DIS, V12, P220, DOI 10.1111/j.1399-3062.2010.00492.x; Osorio F, 2008, EUR J IMMUNOL, V38, P3274, DOI 10.1002/eji.200838950; Pappas PG, 2010, CLIN INFECT DIS, V50, P1101, DOI 10.1086/651262; Rai MN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002863; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Skrzypek F, 2009, MICROBES INFECT, V11, P661, DOI 10.1016/j.micinf.2009.03.010; Strasser D, 2012, IMMUNITY, V36, P32, DOI 10.1016/j.immuni.2011.11.015; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; Tam JM, 2012, INTEGR BIOL-UK, V4, P220, DOI 10.1039/c2ib00089j; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wilkinson B, 2006, J BIOL CHEM, V281, P20842, DOI 10.1074/jbc.M600627200; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	46	57	58	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16043	16054		10.1074/jbc.M113.473223	http://dx.doi.org/10.1074/jbc.M113.473223			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23609446	Green Published, hybrid			2022-12-28	WOS:000319822300055
J	Nebel, M; Schwoerer, AP; Warszta, D; Siebrands, CC; Limbrock, AC; Swarbrick, JM; Fliegert, R; Weber, K; Bruhn, S; Hohenegger, M; Geisler, A; Herich, L; Schlegel, S; Carrier, L; Eschenhagen, T; Potter, BVL; Ehmke, H; Guse, AH				Nebel, Merle; Schwoerer, Alexander P.; Warszta, Dominik; Siebrands, Cornelia C.; Limbrock, Ann-Christin; Swarbrick, Joanna M.; Fliegert, Ralf; Weber, Karin; Bruhn, Soeren; Hohenegger, Martin; Geisler, Anne; Herich, Lena; Schlegel, Susan; Carrier, Lucie; Eschenhagen, Thomas; Potter, Barry V. L.; Ehmke, Heimo; Guse, Andreas H.			Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP)-mediated Calcium Signaling and Arrhythmias in the Heart Evoked by beta-Adrenergic Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; CARDIAC RYANODINE RECEPTOR; NAADP MOBILIZES CALCIUM; CA2+ RELEASE; SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; OPEN PROBABILITY; CADP-RIBOSE; C-EPSILON; STORE	Nicotinic acid adenine dinucleotide phosphate (NAADP) is the most potent Ca2+-releasing second messenger known to date. Here, we report a new role for NAADP in arrhythmogenic Ca2+ release in cardiac myocytes evoked by beta-adrenergic stimulation. Infusion of NAADP into intact cardiac myocytes induced global Ca2+ signals sensitive to inhibitors of both acidic Ca2+ stores and ryanodine receptors and to NAADP antagonist BZ194. Furthermore, in electrically paced cardiac myocytes BZ194 blocked spontaneous diastolic Ca2+ transients caused by high concentrations of the beta-adrenergic agonist isoproterenol. Ca2+ transients were recorded both as increases of the free cytosolic Ca2+ concentration and as decreases of the sarcoplasmic luminal Ca2+ concentration. Importantly, NAADP antagonist BZ194 largely ameliorated isoproterenol-induced arrhythmias in awake mice. We provide strong evidence that NAADP-mediated modulation of couplon activity plays a role for triggering spontaneous diastolic Ca2+ transients in isolated cardiac myocytes and arrhythmias in the intact animal. Thus, NAADP signaling appears an attractive novel target for antiarrhythmic therapy.	[Nebel, Merle; Warszta, Dominik; Siebrands, Cornelia C.; Fliegert, Ralf; Weber, Karin; Bruhn, Soeren; Schlegel, Susan; Guse, Andreas H.] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Signal Transduct, Calcium Signalling Grp, D-20246 Hamburg, Germany; [Schwoerer, Alexander P.; Limbrock, Ann-Christin; Ehmke, Heimo] Univ Med Ctr Hamburg Eppendorf, Dept Cellular & Integrat Physiol, Hamburg, Germany; [Geisler, Anne] Univ Med Ctr Hamburg Eppendorf, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Herich, Lena] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Carrier, Lucie; Eschenhagen, Thomas] Univ Med Ctr Hamburg Eppendorf, Dept Expt Pharmacol & Toxicol, Hamburg, Germany; [Guse, Andreas H.] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, D-20246 Hamburg, Germany; [Swarbrick, Joanna M.; Potter, Barry V. L.] Univ Bath, Dept Pharm & Pharmacol, Wolfson Lab Med Chem, Bath BA2 7AY, Avon, England; [Hohenegger, Martin] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria; [Carrier, Lucie] INSERM, U974, F-75013 Paris, France; [Carrier, Lucie] Univ Paris 06, Inst Myol, CNRS UMR7215, UMR S974,IFR14, F-75013 Paris, France	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bath; Medical University of Vienna; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Guse, AH (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Calcium Signalling Grp, Martinistr 52, D-20246 Hamburg, Germany.	guse@uke.de	Potter, Barry/AAX-4781-2020; Watt, Joanna M/F-2603-2010; Hohenegger, Martin/AAF-6479-2020	Watt, Joanna M/0000-0003-2854-6622; Hohenegger, Martin/0000-0001-6537-9574	Deutsche Forschungsgemeinschaft [FOR-604-GU 360/10-1, GU 360/10-2, FOR-604-IS 63/1-1, IS 63/1-2, FOR-604-EL 270/3-1, EL 270/3-2, FOR-604-CA 618/1-1, CA 618/1-2]; Forschergruppe of the Deutsche Forschungsgemeinschaft Signalling Pathways in the Healthy and Diseased Heart [FOR 604]; Herzfeldersche Familienstiftung; Wellcome Trust [084068, 082837]; FFM program of University Medical Centre Hamburg-Eppendorf; Austrian Science Fund (FWF) [P 22385] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschergruppe of the Deutsche Forschungsgemeinschaft Signalling Pathways in the Healthy and Diseased Heart(German Research Foundation (DFG)); Herzfeldersche Familienstiftung; Wellcome Trust(Wellcome TrustEuropean Commission); FFM program of University Medical Centre Hamburg-Eppendorf; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Deutsche Forschungsgemeinschaft Grants FOR-604-GU 360/10-1 and GU 360/10-2 (to A. H. G.), FOR-604-IS 63/1-1 and IS 63/1-2 (to H. E.), FOR-604-EL 270/3-1 and EL 270/3-2 (to T. E.), and FOR-604-CA 618/1-1 and CA 618/1-2 (to L. C.), all projects within Forschergruppe FOR 604 of the Deutsche Forschungsgemeinschaft Signalling Pathways in the Healthy and Diseased Heart, Herzfeldersche Familienstiftung (to M. H.), Wellcome Trust Grants 084068 (to B. V. L. P. and A. H. G.) and (to B. V. L. P.), and the FFM program of University Medical Centre Hamburg-Eppendorf (to M. N.).	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; Bak J, 2001, CURR BIOL, V11, P987, DOI 10.1016/S0960-9822(01)00269-X; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Copello JA, 2001, CELL CALCIUM, V30, P269, DOI 10.1054/ceca.2001.0235; Cordiglieri C, 2010, BRAIN, V133, P1930, DOI 10.1093/brain/awq135; Dammermann W, 2005, J BIOL CHEM, V280, P21394, DOI 10.1074/jbc.M413085200; Dammermann W, 2009, P NATL ACAD SCI USA, V106, P10678, DOI 10.1073/pnas.0809997106; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Freestone NS, 1999, N-S ARCH PHARMACOL, V360, P445, DOI 10.1007/s002109900075; Gasser A, 2006, J BIOL CHEM, V281, P16906, DOI 10.1074/jbc.M601347200; Gerasimenko JV, 2003, J CELL BIOL, V163, P271, DOI 10.1083/jcb.200306134; Gerasimenko JV, 2006, J CELL SCI, V119, P226, DOI 10.1242/jcs.02721; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guse AH, 2005, J BIOL CHEM, V280, P15952, DOI 10.1074/jbc.M414032200; Guse AH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002890; Higashida H, 1999, J BIOL CHEM, V274, P33348, DOI 10.1074/jbc.274.47.33348; Higashida H, 2000, BIOCHEM J, V352, P197, DOI 10.1042/0264-6021:3520197; Hohenegger M, 2002, BIOCHEM J, V367, P423, DOI 10.1042/BJ20020584; HOHENEGGER M, 1993, BIOCHEM J, V296, P303, DOI 10.1042/bj2960303; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; Klinger M, 1999, MOL PHARMACOL, V55, P462; Kominkova V., 2001, PFLUGERS ARCH, V441, P674; Kunerth S, 2003, CELL SIGNAL, V15, P783, DOI 10.1016/S0898-6568(03)00015-9; Langhorst MF, 2004, CELL SIGNAL, V16, P1283, DOI 10.1016/j.cellsig.2004.03.013; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lewis AM, 2012, BIOCHEM BIOPH RES CO, V427, P326, DOI 10.1016/j.bbrc.2012.09.054; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Oestreich EA, 2009, J BIOL CHEM, V284, P1514, DOI 10.1074/jbc.M806994200; Pohlmann L, 2007, CIRC RES, V101, P928, DOI 10.1161/CIRCRESAHA.107.158774; Proven A, 2006, J CELL SCI, V119, P3363, DOI 10.1242/jcs.03073; Rakovic S, 1999, J BIOL CHEM, V274, P17820, DOI 10.1074/jbc.274.25.17820; Soares S, 2007, AM J PHYSIOL-CELL PH, V292, pC227, DOI 10.1152/ajpcell.00638.2005; Steen M, 2007, J BIOL CHEM, V282, P18864, DOI 10.1074/jbc.M610925200; Venetucci LA, 2006, CIRC RES, V98, P1299, DOI 10.1161/01.RES.0000222000.35500.65; Venetucci LA, 2008, CARDIOVASC RES, V77, P285, DOI 10.1093/cvr/cvm009; Venetucci LA, 2007, CIRC RES, V100, P105, DOI 10.1161/01.RES.0000252828.17939.00; WALKER MJA, 1988, CARDIOVASC RES, V22, P447, DOI 10.1093/cvr/22.7.447; Walseth Timothy F, 2012, Messenger (Los Angel), V1, P86; Walseth TF, 2012, J BIOL CHEM, V287, P2308, DOI 10.1074/jbc.M111.306563; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Xiao BL, 2007, J BIOL CHEM, V282, P30256, DOI 10.1074/jbc.M703510200; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Yusufi ANK, 2001, BIOCHEM J, V353, P531, DOI 10.1042/0264-6021:3530531; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394	50	33	33	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16017	16030		10.1074/jbc.M112.441246	http://dx.doi.org/10.1074/jbc.M112.441246			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23564460	hybrid, Green Published			2022-12-28	WOS:000319822300053
J	Nsango, SE; Pompon, J; Xie, T; Rademacher, A; Fraiture, M; Thoma, M; Awono-Ambene, PH; Moyou, RS; Morlais, I; Levashina, EA				Nsango, Sandrine E.; Pompon, Julien; Xie, Ting; Rademacher, Annika; Fraiture, Malou; Thoma, Martine; Awono-Ambene, Parfait H.; Moyou, Roger S.; Morlais, Isabelle; Levashina, Elena A.			AP-1/Fos-TGase2 Axis Mediates Wounding-induced Plasmodium falciparum Killing in Anopheles gambiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA VECTOR; GENE FAMILIES; MOSQUITO; IMMUNITY; PROTEIN; EXPRESSION; INFECTION; MORPHOGENESIS; BACTERIAL; RESPONSES	Anopheline mosquitoes are the only vectors of human malaria worldwide. It is now widely accepted that mosquito immune responses play a crucial role in restricting Plasmodium development within the vector; therefore, further dissection of the molecular mechanisms underlying these processes should inform new vector control strategies urgently needed to roll back the disease. Here, using genome-wide transcriptional profiling, bioinformatics, and functional gene analysis, we identify a new axis of mosquito resistance to monoclonal Plasmodium falciparum infections that includes the AP-1 transcription factor Fos and the transglutaminase 2 (TGase2), a cross-linking enzyme with known roles in wound responses. We demonstrate that Fos regulates induction of TGase2 expression after wounding but does not affect expression of the components of the well characterized complement-like system. Silencing of Fos or of TGase2 aborts the wounding-induced mosquito killing of P. falciparum. These results reveal multiple signaling pathways that are required for efficient Plasmodium killing in Anopheles gambiae.	[Nsango, Sandrine E.; Pompon, Julien; Xie, Ting; Rademacher, Annika; Fraiture, Malou; Thoma, Martine; Levashina, Elena A.] Univ Strasbourg, INSERM 963, CNRS UPR 9022, F-67084 Strasbourg, France; [Nsango, Sandrine E.; Awono-Ambene, Parfait H.; Morlais, Isabelle] Org Coordinat Lutte Endemies Afr Cent, Lab Rech Paludisme, Yaounde, Cameroon; [Nsango, Sandrine E.; Morlais, Isabelle] Inst Rech Devt, UM1 CNRS 5290, IRD 224, UMR MIVEGEC, F-34394 Montpellier, France; [Moyou, Roger S.] Univ Yaounde I, Yaounde, Cameroon; [Levashina, Elena A.] Max Planck Inst Infect Biol, Dept Vector Biol, D-10117 Berlin, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Yaounde I; Max Planck Society	Levashina, EA (corresponding author), Max Planck Inst Infect Biol, Dept Vector Biol, Charitepl 1, D-10117 Berlin, Germany.	levashina@mpiib-berlin.mpg.de	Morlais, Isabelle/F-5078-2014; Pompon, Julien/AAA-4463-2021; Morlais, Isabelle/Q-2171-2019	Morlais, Isabelle/0000-0002-2962-7670; Pompon, Julien/0000-0003-1110-9039; Morlais, Isabelle/0000-0002-2962-7670; Levashina, Elena/0000-0003-4605-906X; XIE, Ting/0000-0002-2585-8578	CNRS [UPR 9022]; INSERM [U963]; l'Institut de Recherche pour le Developpement (IRD); EC [223601, 242095]; IRD-CNRS [6774.00]; Fondation pour la Recherche Medicale (FRM); DSFIRD scholarship; BIOMALPAR Ph.D. fellowship	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); l'Institut de Recherche pour le Developpement (IRD); EC(European CommissionEuropean Commission Joint Research Centre); IRD-CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); DSFIRD scholarship; BIOMALPAR Ph.D. fellowship	This work was supported by funds from CNRS (UPR 9022), INSERM (U963), and l'Institut de Recherche pour le Developpement (IRD); by grants from EC FP7 MALVECBLOK (grant agreement number 223601) and EVIMalar (grant agreement number 242095); by the IRD-CNRS collaboration (Convention 6774.00); by a fellowship from the Fondation pour la Recherche Medicale (FRM) (to J.P.); by a DSFIRD scholarship (to S.E.N.); and by a BIOMALPAR Ph.D. fellowship (to A. R.).	Abreu-Blanco Maria Teresa, 2011, Bioarchitecture, V1, P114; Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Annan Z, 2007, P NATL ACAD SCI USA, V104, P7987, DOI 10.1073/pnas.0702715104; BarillasMury C, 1996, EMBO J, V15, P4691, DOI 10.1002/j.1460-2075.1996.tb00846.x; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borenstein M., 2005, COMPREHENSIVE META A; Boudin C, 2005, AM J TROP MED HYG, V73, P1090, DOI 10.4269/ajtmh.2005.73.1090; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Burgoon LD, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni167; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; Dimopoulos G, 2002, P NATL ACAD SCI USA, V99, P8814, DOI 10.1073/pnas.092274999; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; Dong YM, 2009, J BIOL CHEM, V284, P9835, DOI 10.1074/jbc.M807084200; Dudoit S., 2004, MULTTEST RESAMPLING; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Ghosh D, 2000, NUCLEIC ACIDS RES, V28, P308, DOI 10.1093/nar/28.1.308; Kalinin A, 2001, J CELL SCI, V114, P3069; KOPACEK P, 1993, EUR J BIOCHEM, V213, P591, DOI 10.1111/j.1432-1033.1993.tb17798.x; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; LUSTIGMAN S, 1995, ANTIMICROB AGENTS CH, V39, P1913, DOI 10.1128/AAC.39.9.1913; MacDonald J. W., 2022, AFFYCORETOOLS FUNCTI; MARINOTTI O, 1990, INSECT BIOCHEM, V20, P619, DOI 10.1016/0020-1790(90)90074-5; Matsuda Y, 2007, J BIOL CHEM, V282, P37316, DOI 10.1074/jbc.M705731200; Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102; Michel K, 2005, INSECT BIOCHEM MOLEC, V35, P677, DOI 10.1016/j.ibmb.2005.02.009; Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006; Nsango SE, 2012, INT J PARASITOL, V42, P589, DOI 10.1016/j.ijpara.2012.03.008; Oduol F, 2000, P NATL ACAD SCI USA, V97, P11397, DOI 10.1073/pnas.180060997; Osaki T, 2004, CELL MOL LIFE SCI, V61, P1257, DOI 10.1007/s00018-004-3396-5; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramet M, 2002, DEV BIOL, V241, P145, DOI 10.1006/dbio.2001.0502; Ren N, 2005, GENETICS, V171, P625, DOI 10.1534/genetics.105.043687; Riehle MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003672; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Rogers DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000272; Rogers DW, 2008, P NATL ACAD SCI USA, V105, P19390, DOI 10.1073/pnas.0809723105; Scherfer C, 2006, DEV BIOL, V295, P156, DOI 10.1016/j.ydbio.2006.03.019; Schnitger AKD, 2007, J BIOL CHEM, V282, P21884, DOI 10.1074/jbc.M701635200; Schnorrer F, 2010, NATURE, V464, P287, DOI 10.1038/nature08799; Shibata T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013477; Stramer B, 2008, EMBO REP, V9, P465, DOI 10.1038/embor.2008.34; Suwanchaichinda C, 2009, GENE, V442, P47, DOI 10.1016/j.gene.2009.04.013; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Togawa T, 2007, INSECT BIOCHEM MOLEC, V37, P675, DOI 10.1016/j.ibmb.2007.03.011; Umehara M, 2010, MOL CELL BIOCHEM, V342, P223, DOI 10.1007/s11010-010-0487-5; Volz J, 2005, J BIOL CHEM, V280, P40161, DOI 10.1074/jbc.M506191200; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; Westfall P.H., 1993, RESAMPLING BASED MUL; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wood W, 2002, NAT CELL BIOL, V4, P907, DOI 10.1038/ncb875; Zeitlinger J, 1997, EMBO J, V16, P7393, DOI 10.1093/emboj/16.24.7393	67	19	20	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16145	16154		10.1074/jbc.M112.443267	http://dx.doi.org/10.1074/jbc.M112.443267			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23592781	hybrid, Green Published			2022-12-28	WOS:000319822300065
J	Carraher, CL; Schwarzbauer, JE				Carraher, Cara L.; Schwarzbauer, Jean E.			Regulation of Matrix Assembly through Rigidity-dependent Fibronectin Conformational Changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; EXTRACELLULAR-MATRIX; DIVALENT-CATIONS; ELASTIC-MODULUS; LYSOPHOSPHATIDIC ACID; SUBSTRATE FLEXIBILITY; INTEGRIN ACTIVATION; CELL-ADHESION; SYNERGY SITE; BINDING	Cells sense and respond to the mechanical properties of their microenvironment. We investigated whether these properties affect the ability of cells to assemble a fibrillar fibronectin (FN) matrix. Analysis of matrix assembled by cells grown on FN-coated polyacrylamide gels of varying stiffnesses showed that rigid substrates stimulate FN matrix assembly and activation of focal adhesion kinase (FAK) compared with the level of assembly and FAK signaling on softer substrates. Stimulating integrins with Mn2+ treatment increased FN assembly on softer gels, suggesting that integrin binding is deficient on soft substrates. Guanidine hydrochloride-induced extension of the substrate-bound FN rescued assembly on soft substrates to a degree similar to that of Mn2+ treatment and increased activation of FAK along with the initiation of assembly at FN matrix assembly sites. In contrast, increasing actin-mediated cell contractility did not rescue FN matrix assembly on soft substrates. Thus, rigidity-dependent FN matrix assembly is determined by extracellular events, namely the engagement of FN by cells and the induction of FN conformational changes. Extensibility of FN in response to substrate stiffness may serve as a mechanosensing mechanism whereby cells use pericellular FN to probe the stiffness of their environment.	[Carraher, Cara L.; Schwarzbauer, Jean E.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Schwarzbauer, JE (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	jschwarz@princeton.edu		Schwarzbauer, Jean/0000-0003-1012-7593	National Institutes of Health [GM059383, CA160611, 5T32GM007388]; NIGMS; NATIONAL CANCER INSTITUTE [R01CA160611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007388, R01GM059383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM059383, CA160611, and 5T32GM007388, a predoctoral training grant from the NIGMS.	AGUIRRE KM, 1994, J BIOL CHEM, V269, P27863; Antia M, 2008, FARADAY DISCUSS, V139, P229, DOI 10.1039/b718714a; AOTA S, 1994, J BIOL CHEM, V269, P24756; Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799; Baneyx G, 2001, P NATL ACAD SCI USA, V98, P14464, DOI 10.1073/pnas.251422998; Baugh L, 2004, J BIOMED MATER RES A, V69A, P525, DOI 10.1002/jbm.a.30026; Boudou T, 2006, BIORHEOLOGY, V43, P721; Chen F, 1996, J BIOL CHEM, V271, P9084, DOI 10.1074/jbc.271.15.9084; Christopher RA, 1997, J CELL SCI, V110, P569; DANEN EHJ, 1995, J BIOL CHEM, V270, P21612, DOI 10.1074/jbc.270.37.21612; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; ELICES MJ, 1991, J CELL BIOL, V112, P169, DOI 10.1083/jcb.112.1.169; Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; GAILIT J, 1988, J BIOL CHEM, V263, P12927; Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f; Gefen Amit, 2007, Technol Health Care, V15, P259; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Golji J, 2010, BIOPHYS J, V99, P1073, DOI 10.1016/j.bpj.2010.05.024; Guo HB, 2003, J BIOL CHEM, V278, P52412, DOI 10.1074/jbc.M308837200; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; HALLIDAY NL, 1995, EXP CELL RES, V217, P109, DOI 10.1006/excr.1995.1069; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Hynes R. O., 1990, FIBRONECTINS, P231; Hynes R. O., 2011, EXTRACELLULAR MATRIX, P1; Ilic D, 2004, J CELL SCI, V117, P177, DOI 10.1242/jcs.00845; Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Karuri NW, 2009, J BIOL CHEM, V284, P3445, DOI 10.1074/jbc.M805025200; KHAN MY, 1990, BIOCHEM J, V270, P33, DOI 10.1042/bj2700033; KISCHER CW, 1983, CELL TISSUE RES, V231, P29; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li SH, 2003, AM J PATHOL, V163, P1045, DOI 10.1016/S0002-9440(10)63464-5; Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166; Matsumoto T, 2002, PHYSIOL MEAS, V23, P635, DOI 10.1088/0967-3334/23/4/304; Maurer LM, 2012, J BIOL CHEM, V287, P13303, DOI 10.1074/jbc.M111.294041; MCKEOWNLONGO PJ, 1983, J CELL BIOL, V97, P466, DOI 10.1083/jcb.97.2.466; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Moshayedi P, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194114; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; Ohashi T, 2009, MATRIX BIOL, V28, P170, DOI 10.1016/j.matbio.2009.03.002; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Samani A, 2003, PHYS MED BIOL, V48, P2183, DOI 10.1088/0031-9155/48/14/310; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; Sechler JL, 1997, MOL BIOL CELL, V8, P2563, DOI 10.1091/mbc.8.12.2563; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Sottile J, 2007, AM J PHYSIOL-CELL PH, V293, pC1934, DOI 10.1152/ajpcell.00130.2007; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345, DOI 10.1152/ajpcell.2000.279.5.C1345; Wierzbicka-Patynowski I, 2002, J BIOL CHEM, V277, P19703, DOI 10.1074/jbc.M200270200; Williams CM, 2008, CANCER RES, V68, P3185, DOI 10.1158/0008-5472.CAN-07-2673; WILSON CL, 1992, J CELL BIOL, V119, P923, DOI 10.1083/jcb.119.4.923; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; Yeh WC, 2002, ULTRASOUND MED BIOL, V28, P467, DOI 10.1016/S0301-5629(02)00489-1; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yin M, 2007, CLIN GASTROENTEROL H, V5, P1207, DOI 10.1016/j.cgh.2007.06.012; Zhang QH, 1997, MOL BIOL CELL, V8, P1415, DOI 10.1091/mbc.8.8.1415; ZHANG QH, 1994, J CELL BIOL, V127, P1447, DOI 10.1083/jcb.127.5.1447; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	70	35	35	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14805	14814		10.1074/jbc.M112.435271	http://dx.doi.org/10.1074/jbc.M112.435271			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23589296	Green Published, hybrid			2022-12-28	WOS:000319452100013
J	Du, B; Luo, WJ; Li, RM; Tan, BH; Han, HH; Lu, XL; Li, DL; Qian, M; Zhang, DK; Zhao, YX; Liu, MY				Du, Bing; Luo, Weijia; Li, Ruimei; Tan, Binghe; Han, Honghui; Lu, Xiaoling; Li, Dali; Qian, Min; Zhang, Dekai; Zhao, Yongxiang; Liu, Mingyao			Lgr4/Gpr48 Negatively Regulates TLR2/4-associated Pattern Recognition and Innate Immunity by Targeting CD14 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; TOLL-LIKE RECEPTORS; LPS-BINDING-PROTEIN; SOLUBLE CD14; LIPOPOLYSACCHARIDE LPS; CELL-PROLIFERATION; GENE-EXPRESSION; DOWN-REGULATION; NULL MICE; KAPPA-B	The recognition of pathogen-associated molecular patterns by Toll-like receptors (TLRs) is pivotal in both innate and adaptive immune responses. Here we demonstrate that deletion of Lgr4/Gpr48 (G-protein-coupled receptor 48), a seven-transmembrane glycoprotein hormone receptor, potentiates TLR2/4-associated cytokine production and attenuates mouse resistance to septic shock. The expression of CD14, a co-receptor for TLR2/4-associated pathogen-associated molecular patterns, is increased significantly in Lgr4-deficient macrophages, which is consistent with the increased immune response, whereas the binding activity of cAMP-response element-binding protein is decreased significantly in Lgr4-deficient macrophages, which up-regulate the expression of CD14 at the transcriptional level. Together, our data demonstrate that Lgr4/Gpr48 plays a critical role in modulating the TLR2/4 signaling pathway and represents a useful therapeutic approach of targeting Lgr4/Gpr48 in TLR2/4-associated septic shock and autoimmune diseases.	[Du, Bing; Li, Ruimei; Tan, Binghe; Han, Honghui; Li, Dali; Qian, Min; Liu, Mingyao] E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Du, Bing; Li, Ruimei; Tan, Binghe; Han, Honghui; Li, Dali; Qian, Min; Liu, Mingyao] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Luo, Weijia; Zhang, Dekai; Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; [Luo, Weijia; Zhang, Dekai; Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Dept Mol & Cellular Med, Houston, TX 77030 USA; [Lu, Xiaoling; Zhao, Yongxiang] Guangxi Med Univ, Biol Targeting Diag & Therapy Res Ctr, Nanning 530021, Guangxi, Peoples R China	East China Normal University; East China Normal University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Guangxi Medical University	Zhao, YX (corresponding author), Guangxi Med Univ, Biol Targeting Diag & Therapy Res Ctr, 22 Shuang Yong Rd, Nanning 530021, Guangxi, Peoples R China.	yongxiang_zhao@126.com; ibms.ecnu@gmail.com	lu, xl/HDO-8340-2022	Liu, Mingyao/0000-0001-7339-5048; Du, Bing/0000-0002-5402-6527	National Institutes of Health Grant [R01CA134731]; National Basic Research Program of China Grant [2012CB910400]; National Natural Science Foundation of China [31000398, 81272369]; Science and Technology Commission of Shanghai Municipality [09JC1405200, 11DZ2260300]; NATIONAL CANCER INSTITUTE [R01CA134731] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Basic Research Program of China Grant(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA134731. This work was also supported by National Basic Research Program of China Grant 2012CB910400, National Natural Science Foundation of China Grants 31000398 and 81272369, and the Science and Technology Commission of Shanghai Municipality Grants 09JC1405200 and 11DZ2260300.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Borlikova G, 2009, MOL NEUROBIOL, V40, P73, DOI 10.1007/s12035-009-8072-1; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Cypess AM, 2011, ENDOCRINOLOGY, V152, P3680, DOI 10.1210/en.2011-1229; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dobroff AS, 2009, J BIOL CHEM, V284, P26194, DOI 10.1074/jbc.M109.019836; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Gao Yun, 2006, Hokkaido Igaku Zasshi, V81, P101; Gao Yun, 2009, Ai Zheng, V28, P104; GOYERT SM, 1988, SCIENCE, V239, P497, DOI 10.1126/science.2448876; GRIFFIN JD, 1981, J CLIN INVEST, V68, P932, DOI 10.1172/JCI110348; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Jin C, 2008, INVEST OPHTH VIS SCI, V49, P4245, DOI 10.1167/iovs.08-1860; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kato S, 2007, FEBS LETT, V581, P4685, DOI 10.1016/j.febslet.2007.08.064; Katsuno G, 2006, SHOCK, V25, P247, DOI 10.1097/01.shk.0000208803.50914.a2; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kerfoot SM, 2004, J IMMUNOL, V173, P7070, DOI 10.4049/jimmunol.173.11.7070; LANDMANN R, 1995, J INFECT DIS, V171, P639, DOI 10.1093/infdis/171.3.639; Lawn SD, 2000, CLIN EXP IMMUNOL, V120, P483, DOI 10.1046/j.1365-2249.2000.01246.x; Lei M, 2011, APPL MICROBIOL BIOT, V92, P115, DOI 10.1007/s00253-011-3371-7; Li XY, 2010, DEVELOPMENT, V137, P151, DOI 10.1242/dev.040659; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Loh ED, 2001, BIOCHEM BIOPH RES CO, V282, P757, DOI 10.1006/bbrc.2001.4625; Luo J, 2009, DEVELOPMENT, V136, P2747, DOI 10.1242/dev.033571; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Means TK, 1999, J IMMUNOL, V163, P6748; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Mohri Y, 2008, DEV DYNAM, V237, P2235, DOI 10.1002/dvdy.21639; Muroi M, 2002, J BIOL CHEM, V277, P42372, DOI 10.1074/jbc.M205966200; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Song HP, 2008, J BIOL CHEM, V283, P36687, DOI 10.1074/jbc.M800721200; Spek CA, 2003, J CLIN IMMUNOL, V23, P132, DOI 10.1023/A:1022528912387; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Sung B, 2007, MOL PHARMACOL, V71, P1703, DOI 10.1124/mol.107.034512; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Viriyakosol S, 1996, INFECT IMMUN, V64, P653, DOI 10.1128/IAI.64.2.653-656.1996; Wang J, 2012, J AM SOC NEPHROL, V23, P281, DOI 10.1681/ASN.2011040351; Wang ZL, 2010, FEBS LETT, V584, P4057, DOI 10.1016/j.febslet.2010.08.028; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; WURFEL MM, 1995, J EXP MED, V181, P1743, DOI 10.1084/jem.181.5.1743; Yamashita R, 2009, DEV DYNAM, V238, P993, DOI 10.1002/dvdy.21900; Zhao JS, 2007, GASTROENTEROLOGY, V132, P1331, DOI 10.1053/j.gastro.2007.02.001; Zhu N, 2008, CELL MOL IMMUNOL, V5, P153, DOI 10.1038/cmi.2008.19	53	38	42	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15131	15141		10.1074/jbc.M113.455535	http://dx.doi.org/10.1074/jbc.M113.455535			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23589304	Green Published, hybrid			2022-12-28	WOS:000319452100042
J	Rankin, CR; Hilgarth, RS; Leoni, G; Kwon, M; Den Beste, KA; Parkos, CA; Nusrat, A				Rankin, Carl R.; Hilgarth, Roland S.; Leoni, Giovanna; Kwon, Mike; Den Beste, Kyle A.; Parkos, Charles A.; Nusrat, Asma			Annexin A2 Regulates beta 1 Integrin Internalization and Intestinal Epithelial Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; LIPID RAFTS; TYROSINE PHOSPHORYLATION; INTEGRIN ACTIVATION; ENDOSOME BIOGENESIS; WOUND CLOSURE; ACTIN; ADHESION; BINDING; RECEPTOR	The gastrointestinal epithelium functions as an important barrier that separates luminal contents from the underlying tissue compartment and is vital in maintaining mucosal homeostasis. Mucosal wounds in inflammatory disorders compromise the critical epithelial barrier. In response to injury, intestinal epithelial cells (IECs) rapidly migrate to reseal wounds. We have previously observed that a membrane-associated, actin binding protein, annexin A2 (AnxA2), is up-regulated in migrating IECs and plays an important role in promoting wound closure. To identify the mechanisms by which AnxA2 promotes IEC movement and wound closure, we used a loss of function approach. AnxA2-specific shRNA was utilized to generate IECs with stable down-regulation of AnxA2. Loss of AnxA2 inhibited IEC migration while promoting enhanced cell-matrix adhesion. These functional effects were associated with increased levels of beta 1 integrin protein, which is reported to play an important role in mediating the cell-matrix adhesive properties of epithelial cells. Because cell migration requires dynamic turnover of integrin-based adhesions, we tested whether AnxA2 modulates internalization of cell surface beta 1 integrin required for forward cell movement. Indeed, pulse-chase biotinylation experiments in IECs lacking AnxA2 demonstrated a significant increase in cell surface beta 1 integrin that was accompanied by decreased beta 1 integrin internalization and degradation. These findings support an important role of AnxA2 in controlling dynamics of beta 1 integrin at the cell surface that in turn is required for the active turnover of cell-matrix associations, cell migration, and wound closure.	[Rankin, Carl R.; Hilgarth, Roland S.; Leoni, Giovanna; Kwon, Mike; Den Beste, Kyle A.; Parkos, Charles A.; Nusrat, Asma] Emory Univ, Dept Pathol & Lab Med, Epithelial Pathobiol & Mucosal Inflammat Res Unit, Atlanta, GA 30306 USA	Emory University	Nusrat, A (corresponding author), Emory Univ, Dept Pathol & Lab Med, Whitehead Res Bldg,Rm 105E,615 Michael St, Atlanta, GA 30322 USA.	anusrat@emory.edu		Den Beste, Kyle/0000-0003-1417-1882	National Institutes of Health [R01 DK072564, R01 DK061379, R01 DK079392, R01 DK055679, DK059888]; Morphology and Tissue Culture Support from Digestive Diseases Minicenter Grant [R24 DK064399]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059888, R01DK055679, R01DK061379, R01DK072564, R01DK079392, R24DK064399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Morphology and Tissue Culture Support from Digestive Diseases Minicenter Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK072564, R01 DK061379, and R01 DK079392 (to C. A. P.) and R01 DK055679 and DK059888 (to A. N.); and Morphology and Tissue Culture Support from Digestive Diseases Minicenter Grant R24 DK064399.	ALI SM, 1990, CELL SIGNAL, V2, P265, DOI 10.1016/0898-6568(90)90054-E; Babbin BA, 2007, AM J PATHOL, V170, P951, DOI 10.2353/ajpath.2007.060647; Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; Bellis SL, 1997, BIOCHEM J, V325, P375, DOI 10.1042/bj3250375; Biener Y, 1996, J BIOL CHEM, V271, P29489, DOI 10.1074/jbc.271.46.29489; BLACKWOOD RA, 1990, BIOCHEM J, V266, P195, DOI 10.1042/bj2660195; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; BRETSCHER MS, 1989, EMBO J, V8, P1341, DOI 10.1002/j.1460-2075.1989.tb03514.x; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chen P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006565; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Dukes JD, 2011, MOL BIOL CELL, V22, P3192, DOI 10.1091/mbc.E11-04-0343; EMANS N, 1993, J CELL BIOL, V120, P1357, DOI 10.1083/jcb.120.6.1357; GERKE V, 1984, EMBO J, V3, P227, DOI 10.1002/j.1460-2075.1984.tb01789.x; GLENNEY J, 1986, J BIOL CHEM, V261, P7247; Harder T, 1997, MOL BIOL CELL, V8, P533, DOI 10.1091/mbc.8.3.533; Harrist AV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005020; Hayashi H, 2012, J BIOL CHEM, V287, P15054, DOI 10.1074/jbc.M111.337931; Hayes MJ, 2006, EMBO J, V25, P1816, DOI 10.1038/sj.emboj.7601078; Huckaba TM, 2004, J CELL BIOL, V167, P519, DOI 10.1083/jcb.200404173; Ivaska J, 2002, EMBO J, V21, P3608, DOI 10.1093/emboj/cdf371; Jacob R, 2004, J BIOL CHEM, V279, P3680, DOI 10.1074/jbc.C300503200; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Law AL, 2009, MOL BIOL CELL, V20, P3896, DOI 10.1091/mbc.E08-12-1204; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000204; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotz MM, 1997, AM J PATHOL, V150, P747; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Mandell KJ, 2005, J BIOL CHEM, V280, P11665, DOI 10.1074/jbc.M412650200; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Morel E, 2009, DEV CELL, V16, P445, DOI 10.1016/j.devcel.2009.01.007; OUDINET JP, 1993, BIOCHEM J, V292, P63, DOI 10.1042/bj2920063; Presley JF, 1997, J BIOL CHEM, V272, P13929, DOI 10.1074/jbc.272.21.13929; RAUB TJ, 1989, EXP CELL RES, V184, P407, DOI 10.1016/0014-4827(89)90340-6; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; RUTTEN MJ, 1983, AM J PHYSIOL, V244, pG171, DOI 10.1152/ajpgi.1983.244.2.G171; SARAFIAN T, 1991, J CELL BIOL, V114, P1135, DOI 10.1083/jcb.114.6.1135; Severson EA, 2009, MOL BIOL CELL, V20, P1916, DOI 10.1091/mbc.E08-10-1014; Uittenbogaard A, 2002, J BIOL CHEM, V277, P4925, DOI 10.1074/jbc.M109278200; Upla P, 2004, MOL BIOL CELL, V15, P625, DOI 10.1091/mbc.E03-08-0588; Vassilieva EV, 2008, AM J PHYSIOL-GASTR L, V295, pG965, DOI 10.1152/ajpgi.00082.2008; Wang CR, 2010, J BIOL CHEM, V285, P29398, DOI 10.1074/jbc.M110.141440; Zibouche M, 2008, J BIOL CHEM, V283, P22121, DOI 10.1074/jbc.M801000200; Zobiack N, 2003, MOL BIOL CELL, V14, P4896, DOI 10.1091/mbc.E03-06-0387	50	37	37	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15229	15239		10.1074/jbc.M112.440909	http://dx.doi.org/10.1074/jbc.M112.440909			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23558678	Green Published, hybrid			2022-12-28	WOS:000319452100050
J	Choudhary, S; Kalita, M; Fang, L; Patel, KV; Tian, B; Zhao, YX; Edeh, CB; Brasier, AR				Choudhary, Sanjeev; Kalita, Mridul; Fang, Ling; Patel, Kershaw V.; Tian, Bing; Zhao, Yingxin; Edeh, Chukwudi B.; Brasier, Allan R.			Inducible Tumor Necrosis Factor (TNF) Receptor-associated Factor-1 Expression Couples the Canonical to the Non-canonical NF-kappa B Pathway in TNF Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; COMPLEX-FORMATION; KINASE-ALPHA; ACTIVATION; TRAF2; PHOSPHORYLATION; IDENTIFICATION; LYMPHOTOXIN; PROTEIN; CIAP2	The NF-kappa B transcription factor mediates the inflammatory response through distinct (canonical and non-canonical) signaling pathways. The mechanisms controlling utilization of either of these pathways are largely unknown. Here we observe that TNF stimulation induces delayed NF-kappa B2/p100 processing and investigate the coupling mechanism. TNF stimulation induces TNF-associated factor-1 (TRAF-1) that directly binds NF-kappa B-inducing kinase (NIK) and stabilizes it from degradation by disrupting its interaction with TRAF2.cIAP2 ubiquitin ligase complex. We show that TRAF1 depletion prevents TNF-induced NIK stabilization and reduces p52 production. To further examine the interactions of TRAF1 and NIK with NF-kappa B2/p100 processing, we mathematically modeled TRAF1.NIK as a coupling signaling complex and validated computational inference by siRNA knockdown to show non-canonical pathway activation is dependent not only on TRAF1 induction but also NIK stabilization by forming TRAF1.NIK complex. Thus, these integrated computational-experimental studies of TNF-induced TRAF1 expression identified TRAF1.NIK as a central complex linking canonical and non-canonical pathways by disrupting the TRAF2-cIAP2 ubiquitin ligase complex. This feed-forward kinase pathway is essential for the activation of non-canonical pathway.	[Choudhary, Sanjeev; Kalita, Mridul; Fang, Ling; Patel, Kershaw V.; Tian, Bing; Zhao, Yingxin; Edeh, Chukwudi B.; Brasier, Allan R.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Choudhary, Sanjeev; Zhao, Yingxin; Brasier, Allan R.] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Zhao, Yingxin; Brasier, Allan R.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Choudhary, S (corresponding author), Univ Texas Med Branch, MRB 8-138,301 Univ Blvd, Galveston, TX 77555 USA.	sachoudh@utmb.edu		Brasier, Allan/0000-0002-5012-4090; Choudhary, Sanjeev/0000-0001-8290-7420; , Kershaw/0000-0003-2002-4096	National Institutes of Health [AI062885]; National Institutes of Health (NHLBI) [HHSN268201000037C]; (National Institutes of Health) University of Texas Medical Branch Clinical and Translational Science Award [1U54RR02614]; National Institute of Diabetes and Digestive and Kidney Diseases [DK079053]; American Heart Association [0630100N]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); (National Institutes of Health) University of Texas Medical Branch Clinical and Translational Science Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI062885 (to A. R. B.), HHSN268201000037C (NHLBI; to A. R. B.), 1U54RR02614 (University of Texas Medical Branch Clinical and Translational Science Award; to A. R. B.), and National Institute of Diabetes and Digestive and Kidney Diseases DK079053 (to S. C.). This work was also supported by American Heart Association Grant 0630100N (to S. C.).	Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Brasier AR, 2011, J VIROL, V85, P11752, DOI 10.1128/JVI.05360-11; Choudhary S, 2005, J VIROL, V79, P8948, DOI 10.1128/JVI.79.14.8948-8959.2005; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He LS, 2004, J BIOL CHEM, V279, P55855, DOI 10.1074/jbc.M407284200; Kalita MK, 2011, J BIOL CHEM, V286, P37741, DOI 10.1074/jbc.M111.280925; Keshishian H, 2009, MOL CELL PROTEOMICS, V8, P2339, DOI 10.1074/mcp.M900140-MCP200; Kim JY, 2011, J CELL SCI, V124, P647, DOI 10.1242/jcs.075770; Lavorgna A, 2009, MOL IMMUNOL, V46, P3278, DOI 10.1016/j.molimm.2009.07.029; Lin X, 1998, MOL CELL BIOL, V18, P5899, DOI 10.1128/MCB.18.10.5899; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Liu P, 2008, J BIOL CHEM, V283, P23169, DOI 10.1074/jbc.M802729200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luftig MA, 2001, J BIOL CHEM, V276, P14602, DOI 10.1074/jbc.C100103200; Mordmuller B, 2003, EMBO REP, V4, P82, DOI 10.1038/embor710; Nowak DE, 2008, MOL CELL BIOL, V28, P3623, DOI 10.1128/MCB.01152-07; Qing GL, 2005, J BIOL CHEM, V280, P9765, DOI 10.1074/jbc.C400502200; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Starkey JM, 2006, DIABETES, V55, P1252, DOI 10.2337/db05-1554; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Tian B, 2002, J VIROL, V76, P6800, DOI 10.1128/JVI.76.13.6800-6814.2002; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhao Y., 2011, MOL CELL PROTEOMICS, V10; Zheng C, 2010, MOL CELL, V38, P101, DOI 10.1016/j.molcel.2010.03.009	34	32	35	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14612	14623		10.1074/jbc.M113.464081	http://dx.doi.org/10.1074/jbc.M113.464081			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23543740	hybrid, Green Published			2022-12-28	WOS:000319253500061
J	Fanjul-Fernandez, M; Folgueras, AR; Fueyo, A; Balbin, M; Suarez, MF; Fernandez-Garcia, MS; Shapiro, SD; Freije, JMP; Lopez-Otin, C				Fanjul-Fernandez, Miriam; Folgueras, Alicia R.; Fueyo, Antonio; Balbin, Milagros; Suarez, Maria F.; Soledad Fernandez-Garcia, M.; Shapiro, Steven D.; Freije, Jose M. P.; Lopez-Otin, Carlos			Matrix Metalloproteinase Mmp-1a Is Dispensable for Normal Growth and Fertility in Mice and Promotes Lung Cancer Progression by Modulating Inflammatory Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTECTIVE ROLE; TUMOR-GROWTH; FACTOR-BETA; METASTASIS; EXPRESSION; IDENTIFICATION; COLLAGENASE; INVASION; RECEPTOR; CELLS	Human MMP-1 is a matrix metalloproteinase repeatedly associated with many pathological conditions, including cancer. Thus, MMP1 overexpression is a poor prognosis marker in a variety of advanced cancers, including colorectal, breast, and lung carcinomas. Moreover, MMP-1 plays a key role in the metastatic behavior of melanoma, breast, and prostate cancer cells. However, functional and mechanistic studies on the relevance of MMP-1 in cancer have been hampered by the absence of an in vivo model. In this work, we have generated mice deficient in Mmp1a, the murine ortholog of human MMP1. Mmp1a(-/-) mice are viable and fertile and do not exhibit obvious abnormalities, which has facilitated studies of cancer susceptibility. These studies have shown a decreased susceptibility to develop lung carcinomas induced by chemical carcinogens in Mmp1a(-/-) mice. Histopathological analysis indicated that tumors generated in Mmp1a(-/-) mice are smaller than those of wild-type mice, consistently with the idea that the absence of Mmp-1a hampers tumor progression. Proteomic analysis revealed decreased levels of chitinase-3-like 3 and accumulation of the receptor for advanced glycation end-products and its ligand S100A8 in lung samples from Mmp1a(-/-) mice compared with those from wild-type. These findings suggest that Mmp-1a could play a role in tumor progression by modulating the polarization of a Th1/Th2 inflammatory response to chemical carcinogens. On the basis of these results, we propose that Mmp1a knock-out mice provide an excellent in vivo model for the functional analysis of human MMP-1 in both physiological and pathological conditions.	[Fanjul-Fernandez, Miriam; Folgueras, Alicia R.; Suarez, Maria F.; Freije, Jose M. P.; Lopez-Otin, Carlos] Univ Oviedo, Fac Med, Dept Bioquim & Biol Mol, Inst Univ Oncol, E-33006 Oviedo, Spain; [Fueyo, Antonio] Univ Oviedo, Fac Med, Dept Biol Func, Inst Univ Oncol, E-33006 Oviedo, Spain; [Balbin, Milagros] Hosp Univ Cent Asturias, Med Oncol Serv, Oviedo 33006, Spain; [Soledad Fernandez-Garcia, M.] Hosp Univ Cent Asturias, Oviedo 33006, Spain; [Shapiro, Steven D.] Univ Pittsburgh, Dept Med, Sch Med, Pittsburgh, PA 15261 USA	University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Oviedo; Central University Hospital Asturias; Central University Hospital Asturias; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lopez-Otin, C (corresponding author), Univ Oviedo, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.	clo@uniovi.es	Folgueras, Alicia/B-3281-2017; Balbín, Milagros/I-4206-2015; Freije, José M.P./A-6535-2008; López-Otín, Carlos/AAB-2106-2020; Suárez, María Fernanda Valencia/F-8200-2019; Fueyo, Antonio/ABH-3243-2020	Folgueras, Alicia/0000-0003-3426-9502; Balbín, Milagros/0000-0001-5325-0407; Freije, José M.P./0000-0002-4688-8266; López-Otín, Carlos/0000-0001-6964-1904; Suárez, María Fernanda Valencia/0000-0001-8987-8431; Fueyo, Antonio/0000-0002-7121-9398; Miriam, Fanjul Fernandez/0000-0002-0074-2325	Ministerio de Economia y Competitividad-Spain; Fundacion Botin; Obra Social Cajastur-Asturias, Spain	Ministerio de Economia y Competitividad-Spain; Fundacion Botin; Obra Social Cajastur-Asturias, Spain	This work was supported by grants from Ministerio de Economia y Competitividad-Spain and Fundacion Botin. The Instituto Universitario de Oncologia is supported by Obra Social Cajastur-Asturias, Spain.	Agarwal A, 2010, CANCER RES, V70, P5880, DOI 10.1158/0008-5472.CAN-09-4341; Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Balbin M, 1998, J BIOL CHEM, V273, P23959, DOI 10.1074/jbc.273.37.23959; Balbin M, 2001, J BIOL CHEM, V276, P10253, DOI 10.1074/jbc.M009586200; Blackburn JS, 2007, CANCER RES, V67, P10849, DOI 10.1158/0008-5472.CAN-07-1791; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Cai YP, 2009, J IMMUNOL, V182, P5393, DOI 10.4049/jimmunol.0803874; Chen YL, 2008, J IMMUNOL, V181, P4272, DOI 10.4049/jimmunol.181.6.4272; Chizzolini C, 2000, J IMMUNOL, V164, P5952, DOI 10.4049/jimmunol.164.11.5952; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; Foley CJ, 2012, J BIOL CHEM, V287, P24330, DOI 10.1074/jbc.M112.356303; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; Garcia-Prieto E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013242; Garg P, 2010, CANCER RES, V70, P792, DOI 10.1158/0008-5472.CAN-09-3166; Godefroy E, 2011, CANCER CELL, V19, P333, DOI 10.1016/j.ccr.2011.01.037; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; Greenlee KJ, 2006, J IMMUNOL, V177, P7312, DOI 10.4049/jimmunol.177.10.7312; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Gutierrez-Fernandez A, 2008, CANCER RES, V68, P2755, DOI 10.1158/0008-5472.CAN-07-5154; Iida J, 2007, MELANOMA RES, V17, P205, DOI 10.1097/CMR.0b013e3282a660ad; Im YH, 2001, CANCER RES, V61, P6665; Jawad MU, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014250; Jost M, 2006, CANCER RES, V66, P5234, DOI 10.1158/0008-5472.CAN-05-4315; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Korpi JT, 2008, BRIT J CANCER, V98, P766, DOI 10.1038/sj.bjc.6604239; LIOTTA LA, 1990, CANCER METAST REV, V9, P285, DOI 10.1007/BF00049519; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Lopez-Otin C, 2009, CELL CYCLE, V8, P3657, DOI 10.4161/cc.8.22.9956; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Marshall NA, 2012, CANCER RES, V72, P581, DOI 10.1158/0008-5472.CAN-11-0307; Masset A, 2011, INT J CANCER, V128, P283, DOI 10.1002/ijc.25326; McCawley LJ, 2004, CANCER RES, V64, P6965, DOI 10.1158/0008-5472.CAN-04-0910; Murray GI, 1996, NAT MED, V2, P461, DOI 10.1038/nm0496461; Nabeshima Y, 2006, BIOCHEM BIOPH RES CO, V346, P658, DOI 10.1016/j.bbrc.2006.05.183; Nielsen BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002959; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Poola I, 2005, NAT MED, V11, P481, DOI 10.1038/nm1243; Pulukuri SMK, 2008, INT J ONCOL, V32, P757; RudolphOwen LA, 1997, ENDOCRINOLOGY, V138, P4902, DOI 10.1210/en.138.11.4902; Sandler NG, 2003, J IMMUNOL, V171, P3655, DOI 10.4049/jimmunol.171.7.3655; Sauter W, 2008, CANCER EPIDEM BIOMAR, V17, P1127, DOI 10.1158/1055-9965.EPI-07-2840; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; Van Lint P, 2007, J LEUKOCYTE BIOL, V82, P1375, DOI 10.1189/jlb.0607338; Wang HW, 2010, CELL CYCLE, V9, P4824, DOI 10.4161/cc.9.24.14322; Wyatt CA, 2005, CANCER RES, V65, P11101, DOI 10.1158/0008-5472.CAN-05-2446; Yu Q, 2000, GENE DEV, V14, P163	50	39	39	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14647	14656		10.1074/jbc.M112.439893	http://dx.doi.org/10.1074/jbc.M112.439893			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23548910	hybrid, Green Published			2022-12-28	WOS:000319253500064
J	Balasubramaniyan, N; Luo, YH; Sun, AQ; Suchy, FJ				Balasubramaniyan, Natarajan; Luo, Yuhuan; Sun, An-Qiang; Suchy, Frederick J.			SUMOylation of the Farnesoid X Receptor (FXR) Regulates the Expression of FXR Target Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO-INTERACTING MOTIF; BILE-ACID TRANSPORTER; CHROMATIN IMMUNOPRECIPITATION; MECHANISMS; ACTIVATION; ALPHA; BETA; TRANSCRIPTION; METHYLATION; CHOLESTASIS	The farnesoid X receptor (FXR) belongs to a family of ligand-activated transcription factors that regulate many aspects of metabolism including bile acid homeostasis. Here we show that FXR is covalently modified by the small ubiquitin-like modifier (Sumo1), an important regulator of cell signaling and transcription. Well conserved consensus sites at lysine 122 and 275 in the AF-1 and ligand binding domains, respectively, of FXR were subject to SUMOylation in vitro and in vivo. Chromatin immunoprecipitation (ChIP) analysis showed that Sumo1 was recruited to the bile salt export pump (BSEP), the small heterodimer partner (SHP), and the OST alpha-OST beta organic solute transporter loci in a ligand-dependent fashion. Sequential chromatin immunoprecipitation (ChIP-ReChIP) verified the concurrent binding of FXR and Sumo1 to the BSEP and SHP promoters. Overexpression of Sumo1 markedly decreased binding and/or recruitment of FXR to the BSEP and SHP promoters on ChIP-ReChIP. SUMOylation did not have an apparent effect on nuclear localization of FXR. Expression of Sumo1 markedly inhibited the ligand-dependent, transactivation of BSEP and SHP promoters by FXR/retinoid X receptor alpha (RXR alpha) in HepG2 cells. In contrast, mutations that abolished SUMOylation of FXR or siRNA knockdown of Sumo1 expression augmented the transactivation of BSEP and SHP promoters by FXR. Pathways for SUMOylation were significantly altered during obstructive cholestasis with differential Sumo1 recruitment to the promoters of FXR target genes. In conclusion, FXR is subject to SUMOylation that regulates its capacity to transactivate its target genes in normal liver and during obstructive cholestasis.	Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; Univ Colorado, Sch Med, Childrens Hosp, Colorado Res Inst, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Suchy, FJ (corresponding author), 13123 E 16th Ave,B065, Aurora, CO 80045 USA.	frederick.suchy@childrenscolorado.org			National Institutes of Health from the NIDDK [DK-084434]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084434] Funding Source: NIH RePORTER	National Institutes of Health from the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-084434 from the NIDDK (to F. J. S.).	Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200; Ananthanarayanan M, 2004, J BIOL CHEM, V279, P54348, DOI 10.1074/jbc.M410021200; Ananthanarayanan M, 2011, AM J PHYSIOL-GASTR L, V300, pG771, DOI 10.1152/ajpgi.00499.2010; Andreou Artemisia M., 2009, Biotechnology Journal, V4, P1740, DOI 10.1002/biot.200900219; Balasubramaniyan N, 2012, AM J PHYSIOL-GASTR L, V302, pG937, DOI 10.1152/ajpgi.00441.2011; Chaya D, 2004, METHOD ENZYMOL, V376, P361; Choi SJ, 2006, J BIOL CHEM, V281, P30669, DOI 10.1074/jbc.M604033200; Das PM, 2004, BIOTECHNIQUES, V37, P961, DOI 10.2144/04376RV01; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geier A, 2006, NAT CLIN PRACT GASTR, V3, P574, DOI 10.1038/ncpgasthep0602; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kolesar P, 2012, NUCLEIC ACIDS RES, V40, P7831, DOI 10.1093/nar/gks484; Kotaja N, 2002, J BIOL CHEM, V277, P30283, DOI 10.1074/jbc.M204768200; Lee JH, 2009, MOL CELL, V35, P806, DOI 10.1016/j.molcel.2009.07.021; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Paddibhatla I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001234; Picard N, 2012, MOL CELL BIOL, V32, P2709, DOI 10.1128/MCB.06624-11; Pichler Andrea, 2008, V446, P131, DOI 10.1007/978-1-60327-084-7_9; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rosonina E, 2010, GENE DEV, V24, P1242, DOI 10.1101/gad.1917910; Rytinki MM, 2009, J BIOL CHEM, V284, P26184, DOI 10.1074/jbc.M109.038943; Schwartz D, 2012, ESSAYS BIOCHEM, V52, P165, DOI [10.1042/bse0520165, 10.1042/BSE0520165]; Soroka CJ, 2010, SEMIN LIVER DIS, V30, P178, DOI 10.1055/s-0030-1253226; Sun AQ, 2004, J BIOL CHEM, V279, P16295, DOI 10.1074/jbc.M312838200; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Teng SL, 2012, AMINO ACIDS, V43, P447, DOI 10.1007/s00726-011-1100-2; Treuter E, 2011, BBA-MOL BASIS DIS, V1812, P909, DOI 10.1016/j.bbadis.2010.12.008; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Wang YG, 2009, J CELL SCI, V122, P4249, DOI 10.1242/jcs.050542; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Winter S, 2010, ESSAYS BIOCHEM, V48, P45, DOI [10.1042/bse0480045, 10.1042/BSE0480045]; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Yang Y, 2011, ONCOGENE, V30, P2207, DOI 10.1038/onc.2010.600; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhou WL, 2012, J CELL SCI, V125, P3630, DOI 10.1242/jcs.102889; Zollner G, 2006, MOL PHARMACEUT, V3, P231, DOI 10.1021/mp060010s; Zollner G, 2008, CLIN LIVER DIS, V12, P1, DOI 10.1016/j.cld.2007.11.010	38	42	45	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13850	13862		10.1074/jbc.M112.443937	http://dx.doi.org/10.1074/jbc.M112.443937			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23546875	Green Published, hybrid			2022-12-28	WOS:000318850300066
J	Alvares, K; Stern, PH; Veis, A				Alvares, Keith; Stern, Paula H.; Veis, Arthur			Dentin Phosphoprotein Binds Annexin 2 and Is Involved in Calcium Transport in Rat Kidney Ureteric Bud Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASES; BONE SIALOPROTEIN; SIBLING PROTEINS; INCISOR DENTIN; II TETRAMER; EXPRESSION; PHOSPHOPHORYN; SIALOPHOSPHOPROTEIN; COMPLEX; MINERALIZATION	Dentin phosphoprotein (DPP) is the most abundant noncollagenous protein in the dentin, where it plays a major role in the mineralization of dentin. However, we and others have shown that in addition to being present in the dentin, DPP is also present in nonmineralizing tissues like the kidney, lung, and salivary glands, where it conceivably has other functions such as in calcium transport. Because annexins have been implicated as calcium transporters, we examined the relationships between DPP and annexins. In this report, we show that DPP binds to annexin 2 and 6 present in a rat ureteric bud cell line (RUB1). Immunofluorescence studies show that annexin 2 and DPP colocalize in these cells. In addition, DPP and annexin 2 colocalize in the ureteric bud branches of embryonic metanephric kidney. In the RUB1 cells and ureteric bud branches of embryonic kidney, colocalization was restricted to the cell membrane. Studies on calcium influx into RUB cells show that in the presence of anti-DPP, there was a 40% reduction of calcium influx into these cells. We postulate that DPP has different functions in the kidney as compared with the odontoblasts. In the odontoblasts, its primary function is in the extracellular mineralization of dentin, whereas in the kidney it may participate in calcium transport.	[Alvares, Keith; Veis, Arthur] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Stern, Paula H.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Alvares, K (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	k-alvares@northwestern.edu		Alvares, Keith/0000-0003-3710-4367	National Institutes of Health [DE001374]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE001374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE001374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE001374 (to A.V.).	Alvares K, 2006, DEV DYNAM, V235, P2980, DOI 10.1002/dvdy.20935; Boros S, 2009, PFLUG ARCH EUR J PHY, V458, P99, DOI 10.1007/s00424-008-0602-6; Borthwick LA, 2008, CELL CALCIUM, V44, P147, DOI 10.1016/j.ceca.2007.11.001; Burn SF, 2011, DEV BIOL, V352, P288, DOI 10.1016/j.ydbio.2011.01.033; Butler WT, 2002, CONNECT TISSUE RES, V43, P301, DOI 10.1080/03008200290000682; Chaplet M, 2006, INT J CANCER, V118, P850, DOI 10.1002/ijc.21442; Chen S, 2008, J BIOL CHEM, V283, P19359, DOI 10.1074/jbc.M709492200; CHUNG CY, 1994, J CELL BIOL, V126, P539, DOI 10.1083/jcb.126.2.539; DIMUZIO MT, 1978, CALC TISS RES, V25, P169, DOI 10.1007/BF02010765; DIMUZIO MT, 1978, J BIOL CHEM, V253, P6845; Fedarko NS, 2004, FASEB J, V18, P734, DOI 10.1096/fj.03-0966fje; Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Fitzpatrick SL, 2000, BIOCHEMISTRY-US, V39, P1021, DOI 10.1021/bi991411z; George A, 1999, CONNECT TISSUE RES, V40, P49, DOI 10.3109/03008209909005277; Gilbert T, 2011, BIOCHIMIE, V93, P2126, DOI 10.1016/j.biochi.2011.07.007; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; Gu K, 2000, EUR J ORAL SCI, V108, P35, DOI 10.1034/j.1600-0722.2000.00765.x; Hao JJ, 2009, J HISTOCHEM CYTOCHEM, V57, P227, DOI 10.1369/jhc.2008.952119; Jadlowiec J, 2004, J BIOL CHEM, V279, P53323, DOI 10.1074/jbc.M404934200; Jadlowiec JA, 2006, J BIOL CHEM, V281, P5341, DOI 10.1074/jbc.M506158200; Jain A, 2002, J BIOL CHEM, V277, P13700, DOI 10.1074/jbc.M110757200; Kirsch T, 2000, J BIOL CHEM, V275, P35577, DOI 10.1074/jbc.M005648200; Kirsch T, 1997, J CELL BIOL, V137, P1149, DOI 10.1083/jcb.137.5.1149; LEE SL, 1977, BIOCHEMISTRY-US, V16, P2971, DOI 10.1021/bi00632a026; Lewit-Bentley A, 2000, CELL BIOL INT, V24, P799, DOI 10.1006/cbir.2000.0629; Ma KY, 2000, J BIOL CHEM, V275, P15541, DOI 10.1074/jbc.275.20.15541; MACDOUGALL M, 1985, BIOCHEM J, V232, P493, DOI 10.1042/bj2320493; Mai JX, 2000, BBA-PROTEIN STRUCT M, V1477, P215, DOI 10.1016/S0167-4838(99)00274-5; Ogbureke KUE, 2005, KIDNEY INT, V68, P155, DOI 10.1111/j.1523-1755.2005.00389.x; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Prasad M, 2011, J HISTOCHEM CYTOCHEM, V59, P1009, DOI 10.1369/0022155411423406; RAHIMA M, 1988, CALCIFIED TISSUE INT, V42, P104, DOI 10.1007/BF02556342; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Riminucci M, 2003, CALCIFIED TISSUE INT, V73, P281, DOI 10.1007/s00223-002-2134-y; Ritchie HH, 2000, BBA-GENE STRUCT EXPR, V1493, P27, DOI 10.1016/S0167-4781(00)00150-0; Saito T, 2004, ARCH ORAL BIOL, V49, P239, DOI 10.1016/j.archoralbio.2003.08.003; STETLERSTEVENSON WG, 1983, BIOCHEMISTRY-US, V22, P4326, DOI 10.1021/bi00287a025; THIEL C, 1992, J CELL SCI, V103, P733; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; VEIS A, 1988, CIBA F SYMP, V136, P161; VEIS A, 1967, BIOCHEMISTRY-US, V6, P2409, DOI 10.1021/bi00860a017; Veis A., 1982, BIOMINERALIZATION BI, P273; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; Wang W, 2002, J CELL BIOL, V157, P1061, DOI 10.1083/jcb.200203014; ZANETTI M, 1981, EUR J BIOCHEM, V113, P541, DOI 10.1111/j.1432-1033.1981.tb05096.x; ZENG FY, 1993, INT J BIOCHEM, V25, P1019, DOI 10.1016/0020-711X(93)90116-V	48	7	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13036	13045		10.1074/jbc.M112.389627	http://dx.doi.org/10.1074/jbc.M112.389627			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23525114	hybrid, Green Published			2022-12-28	WOS:000318555100055
J	Wu, M; Beckham, GT; Larsson, AM; Ishida, T; Kim, S; Payne, CM; Himmel, ME; Crowley, MF; Horn, SJ; Westereng, B; Igarashi, K; Samejima, M; Stahlberg, J; Eijsink, VGH; Sandgren, M				Wu, Miao; Beckham, Gregg T.; Larsson, Anna M.; Ishida, Takuya; Kim, Seonah; Payne, Christina M.; Himmel, Michael E.; Crowley, Michael F.; Horn, Svein J.; Westereng, Bjorge; Igarashi, Kiyohiko; Samejima, Masahiro; Stahlberg, Jerry; Eijsink, Vincent G. H.; Sandgren, Mats			Crystal Structure and Computational Characterization of the Lytic Polysaccharide Monooxygenase GH61D from the Basidiomycota Fungus Phanerochaete chrysosporium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULE; GLYCOSIDE HYDROLASE FAMILY; CELLOBIOSE DEHYDROGENASE; LIGNOCELLULOSIC BIOMASS; SERRATIA-MARCESCENS; CELLULOSE; ENZYMES; DEGRADATION; RESOLUTION; SEQUENCE	Carbohydrate structures are modified and degraded in the biosphere by a myriad of mostly hydrolytic enzymes. Recently, lytic polysaccharide mono-oxygenases (LPMOs) were discovered as a new class of enzymes for cleavage of recalcitrant polysaccharides that instead employ an oxidative mechanism. LPMOs employ copper as the catalytic metal and are dependent on oxygen and reducing agents for activity. LPMOs are found in many fungi and bacteria, but to date no basidiomycete LPMO has been structurally characterized. Here we present the three-dimensional crystal structure of the basidiomycete Phanerochaete chrysosporium GH61D LPMO, and, for the first time, measure the product distribution ofLPMOaction on a lignocellulosic substrate. The structure reveals a copper-bound active site common to LPMOs, a collection of aromatic and polar residues near the binding surface that may be responsible for regioselectivity, and substantial differences in loop structures near the binding face compared with other LPMO structures. The activity assays indicate that this LPMO primarily produces aldonic acids. Last, molecular simulations reveal conformational changes, including the binding of several regions to the cellulose surface, leading to alignment of three tyrosine residues on the binding face of the enzyme with individual cellulose chains, similar to what has been observed for family 1 carbohydrate-binding modules. A calculated potential energy surface for surface translation indicates that P. chrysosporium GH61D exhibits energy wells whose spacing seems adapted to the spacing of cellobiose units along a cellulose chain.	[Wu, Miao; Larsson, Anna M.; Stahlberg, Jerry; Sandgren, Mats] Swedish Univ Agr Sci, Dept Mol Biol, SE-75007 Uppsala, Sweden; [Beckham, Gregg T.; Kim, Seonah] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Payne, Christina M.; Himmel, Michael E.; Crowley, Michael F.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Beckham, Gregg T.] Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA; [Ishida, Takuya; Igarashi, Kiyohiko; Samejima, Masahiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Payne, Christina M.] Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA; [Horn, Svein J.; Westereng, Bjorge] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway	Swedish University of Agricultural Sciences; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Colorado School of Mines; University of Tokyo; University of Kentucky; Norwegian University of Life Sciences	Beckham, GT (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, 1617 Cole Blvd, Golden, CO 80401 USA.	gregg.beckham@nrel.gov; mats.sandgren@slu.se	crowley, michael F/A-4852-2013; Payne, Christina/ABE-8330-2020; Horn, Svein Jarle/C-6258-2008; Westereng, Bjørge/A-1688-2013; Payne, Christina M/C-7338-2011; Igarashi, Kiyohiko/E-6799-2016; Stahlberg, Jerry/D-4163-2013	crowley, michael F/0000-0001-5163-9398; Payne, Christina/0000-0001-5264-0964; Horn, Svein Jarle/0000-0002-1590-9001; Westereng, Bjørge/0000-0002-5141-7231; Payne, Christina M/0000-0001-5264-0964; Igarashi, Kiyohiko/0000-0001-5152-7177; Sandgren, Mats/0000-0002-2358-4534; Stahlberg, Jerry/0000-0003-4059-8580	Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences through the research program MicroDrivE; Japan Society for the Promotion of Science (JSPS); Department of Energy Office of the Biomass Program; Norwegian Research Council [218425, 193817, 196885, 214613]; Advanced Low Carbon Technology Research and Development Program of the Japan Science and Technology Agency	Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences through the research program MicroDrivE; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Department of Energy Office of the Biomass Program(United States Department of Energy (DOE)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Advanced Low Carbon Technology Research and Development Program of the Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported in part by the Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences through the research program MicroDrivE and by the Japan Society for the Promotion of Science (JSPS) through a fellowship (to T.I.).; Supported by the Department of Energy Office of the Biomass Program.; Supported by Norwegian Research Council Grant 218425.; Supported in part by Norwegian Research Council Grants 193817, 196885, and 214613.; Supported by the Advanced Low Carbon Technology Research and Development Program of the Japan Science and Technology Agency.	Aachmann FL, 2012, P NATL ACAD SCI USA, V109, P18779, DOI 10.1073/pnas.1208822109; Adav SS, 2012, J PROTEOMICS, V75, P1493, DOI 10.1016/j.jprot.2011.11.020; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beckham GT, 2011, J PHYS CHEM B, V115, P4516, DOI 10.1021/jp200912q; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bey M., 2012, APPL ENVIRON MICROB, V287, P3147; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Bu LT, 2009, J PHYS CHEM B, V113, P10994, DOI 10.1021/jp904003z; Cannella D, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-26; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Dimarogona M, 2012, BIORESOURCE TECHNOL, V110, P480, DOI 10.1016/j.biortech.2012.01.116; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Evrard GX, 2007, ACTA CRYSTALLOGR D, V63, P108, DOI 10.1107/S0907444906023389; Fernandez-Fueyo E, 2012, P NATL ACAD SCI USA, V109, P5458, DOI 10.1073/pnas.1119912109; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Habu N, 1997, BIOTECHNOL APPL BIOC, V26, P97; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Henriksson G, 1999, EUR J BIOCHEM, V259, P88, DOI 10.1046/j.1432-1327.1999.00011.x; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hori C, 2011, FEMS MICROBIOL LETT, V321, P14, DOI 10.1111/j.1574-6968.2011.02307.x; Horn SJ, 2011, BIOMASS BIOENERG, V35, P4879, DOI 10.1016/j.biombioe.2011.10.013; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Igarashi K, 2008, APPL ENVIRON MICROB, V74, P5628, DOI 10.1128/AEM.00812-08; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karkehabadi S, 2008, J MOL BIOL, V383, P144, DOI 10.1016/j.jmb.2008.08.016; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kawai R, 2006, BIOTECHNOL LETT, V28, P365, DOI 10.1007/s10529-005-6179-7; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kleywegt GJ, 1997, J MOL BIOL, V273, P371, DOI 10.1006/jmbi.1997.1309; Klinman JP, 1996, CHEM REV, V96, P2541, DOI 10.1021/cr950047g; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Matthews JF, 2012, J CHEM THEORY COMPUT, V8, P735, DOI 10.1021/ct2007692; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCCRACKEN J, 1987, J AM CHEM SOC, V109, P4064, DOI 10.1021/ja00247a037; MURSHUDOV G, 1996, REFINEMENT PROTEIN S; Nimlos MR, 2012, J BIOL CHEM, V287, P20603, DOI 10.1074/jbc.M112.358184; Olson A, 2012, NEW PHYTOL, V194, P1001, DOI 10.1111/j.1469-8137.2012.04128.x; Pannu NS, 1996, ACTA CRYSTALLOGR A, V52, P659, DOI 10.1107/S0108767396004370; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Tsukada T, 2006, APPL MICROBIOL BIOT, V73, P807, DOI 10.1007/s00253-006-0526-z; UZCATEGUI E, 1991, J BIOTECHNOL, V19, P271, DOI 10.1016/0168-1656(91)90064-3; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vaaje-Kolstad G, 2012, J MOL BIOL, V416, P239, DOI 10.1016/j.jmb.2011.12.033; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vanden Wymelenberg A, 2006, FUNGAL GENET BIOL, V43, P343, DOI 10.1016/j.fgb.2006.01.003; Vanden Wymelenberg A, 2009, APPL ENVIRON MICROB, V75, P4058, DOI 10.1128/AEM.00314-09; Westereng B, 2013, J CHROMATOGR A, V1271, P144, DOI 10.1016/j.chroma.2012.11.048; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; Wong E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002373; WOOD TM, 1971, BIOCHEM J, V121, P353, DOI 10.1042/bj1210353	73	132	138	4	131	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12828	12839		10.1074/jbc.M113.459396	http://dx.doi.org/10.1074/jbc.M113.459396			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23525113	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000318555100038
J	Pastor, JM; Bernal, V; Salvador, M; Argandona, M; Vargas, C; Csonka, L; Sevilla, A; Iborra, JL; Nieto, JJ; Canovas, M				Pastor, Jose M.; Bernal, Vicente; Salvador, Manuel; Argandona, Montserrat; Vargas, Carmen; Csonka, Laszlo; Sevilla, Angel; Iborra, Jose L.; Nieto, Joaquin J.; Canovas, Manuel			Role of Central Metabolism in the Osmoadaptation of the Halophilic Bacterium Chromohalobacter salexigens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; HALOMONAS-ELONGATA; CORYNEBACTERIUM-GLUTAMICUM; TRANSCRIPTIONAL REGULATION; GLUCOSE CATABOLISM; GENOME SEQUENCE; CARBON-SOURCES; SP NOV.; PATHWAYS; EXPRESSION	Bacterial osmoadaptation involves the cytoplasmic accumulation of compatible solutes to counteract extracellular osmolarity. The halophilic and highly halotolerant bacterium Chromohalobacter salexigens is able to grow up to 3 M NaCl in a minimal medium due to the de novo synthesis of ectoines. This is an osmoregulated pathway that burdens central metabolic routes by quantitatively drawing off TCA cycle intermediaries. Consequently, metabolism in C. salexigens has adapted to support this biosynthetic route. Metabolism of C. salexigens is more efficient at high salinity than at low salinity, as reflected by lower glucose consumption, lower metabolite overflow, and higher biomass yield. At low salinity, by-products (mainly gluconate, pyruvate, and acetate) accumulate extracellularly. Using [1-C-13]-, [2-C-13]-, [6-C-13]-, and [U-C-13(6)] glucose as carbon sources, we were able to determine the main central metabolic pathways involved in ectoines biosynthesis from glucose. C. salexigens uses the Entner-Doudoroff pathway rather than the standard glycolytic pathway for glucose catabolism, and anaplerotic activity is high to replenish the TCA cycle with the intermediaries withdrawn for ectoines biosynthesis. Metabolic flux ratios at low and high salinity were similar, revealing a certain metabolic rigidity, probably due to its specialization to support high biosynthetic fluxes and partially explaining why metabolic yields are so highly affected by salinity. This work represents an important contribution to the elucidation of specific metabolic adaptations in compatible solute-accumulating halophilic bacteria.	[Pastor, Jose M.; Bernal, Vicente; Sevilla, Angel; Iborra, Jose L.; Canovas, Manuel] Univ Murcia, Fac Quim, Dept Bioquim & Biol Mol & Inmunol B, E-30100 Murcia, Spain; [Salvador, Manuel; Argandona, Montserrat; Vargas, Carmen; Nieto, Joaquin J.] Univ Seville, Dept Microbiol & Parasitol, E-41012 Seville, Spain; [Csonka, Laszlo] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	University of Murcia; University of Sevilla; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Bernal, V (corresponding author), Ctr Tecnol Repsol, Direcc Tecnol, Grp Bioenergia, Carretera A-5,Km 18, Mostoles Madrid 28935, Spain.	vbernal@um.es; mcanovas@um.es	Argandoña, Montserrat/H-5531-2015; Iborra, JL JL/K-4165-2014; Bernal, Vicente/M-4119-2014; Canovas, Manuel/K-3860-2014; Salvador de Lara, Manuel/H-2960-2015; Hernández, José María Pastor/R-9164-2019; Vargas, Carmen/A-6283-2018; Gutiérrez, Joaquín José Nieto/K-9974-2014	Iborra, JL JL/0000-0003-0936-2465; Bernal, Vicente/0000-0003-2482-3477; Canovas, Manuel/0000-0003-3254-1736; Salvador de Lara, Manuel/0000-0002-1966-2480; Vargas, Carmen/0000-0002-4094-4319; Gutiérrez, Joaquín José Nieto/0000-0001-8879-819X; Argandona, Montserrat/0000-0002-2635-1023; PASTOR, JOSE MARIA/0000-0003-4813-1125	Ministerio de Ciencia e Innovacion (Spain) [BIO2008-04502-01, BIO2011-29233-C02-01, BIO2011-22833]; Junta de Andalucia (Spain) [P08-CVI-03724]; Spanish National Network on Extremophilic Microorganisms Grant [BIO2011-12879-E]; MICINN (Spain); Universidad de Murcia (Programa Propio); Junta de Andalucia; National Science Foundation [IOS-1054977]; Programa Juan de la Cierva (Spain); Fondo Europeo de Desarrollo Regional funds	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia (Spain)(Junta de AndaluciaEuropean Commission); Spanish National Network on Extremophilic Microorganisms Grant; MICINN (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Universidad de Murcia (Programa Propio); Junta de Andalucia(Junta de Andalucia); National Science Foundation(National Science Foundation (NSF)); Programa Juan de la Cierva (Spain); Fondo Europeo de Desarrollo Regional funds	This work was supported in part by Fondo Europeo de Desarrollo Regional funds, Ministerio de Ciencia e Innovacion (Spain) Projects BIO2008-04502-01, BIO2011-29233-C02-01, and BIO2011-22833, Junta de Andalucia (Spain) Grant P08-CVI-03724, and Spanish National Network on Extremophilic Microorganisms Grant BIO2011-12879-E.; Recipient of Formacion de Profesorado Universitario and Formacion de Personal Investigador fellowships from MICINN (Spain).; Recipient of a post-doctoral contract from Universidad de Murcia (Programa Propio). To whom correspondence may be addressed: Grupo de Bioenergia, Direccion de Tecnologia, Centro de Tecnologia de Repsol, Carretera A-5, Km 18, 28935 Mostoles-Madrid, Spain. Tel.: 34-868-887393; Fax: 34-868-884148; E- mail: vbernal@um.es.; Recipient of a post-doctoral contract from Junta de Andalucia.; Supported by National Science Foundation Award IOS-1054977.; Recipient of a post-doctoral contract from the Programa Juan de la Cierva (Spain).	Ahmed H, 2004, BIOCHEM SOC T, V32, P303, DOI 10.1042/BST0320303; Aoshima M, 2003, BIOTECHNOL BIOENG, V84, P732, DOI 10.1002/bit.10832; Arahal DR, 2001, INT J SYST EVOL MICR, V51, P1443, DOI 10.1099/00207713-51-4-1443; Argandona M, 2010, APPL ENVIRON MICROB, V76, P3575, DOI 10.1128/AEM.03136-09; Ates O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-12; Buch A, 2008, RES MICROBIOL, V159, P635, DOI 10.1016/j.resmic.2008.09.012; Buch A, 2010, BIORESOURCE TECHNOL, V101, P679, DOI 10.1016/j.biortech.2009.08.075; Canovas D, 1996, J BACTERIOL, V178, P7221, DOI 10.1128/jb.178.24.7221-7226.1996; Canovas D, 1999, APPL ENVIRON MICROB, V65, P3774; Canovas D, 1997, J BIOL CHEM, V272, P25794, DOI 10.1074/jbc.272.41.25794; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Castano-Cerezo S, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-54; Cayol JL, 2000, INT J SYST EVOL MICR, V50, P559, DOI 10.1099/00207713-50-2-559; CONWAY T, 1992, FEMS MICROBIOL LETT, V103, P1; Copeland A, 2011, STAND GENOMIC SCI, V5, P379, DOI 10.4056/sigs.2285059; Csonka LN, 2005, CELL ORIGIN LIFE EXT, V9, P267; Dauner M, 2001, J BACTERIOL, V183, P7308, DOI 10.1128/JB.183.24.7308-7317.2001; del Castillo T, 2007, J BACTERIOL, V189, P5142, DOI 10.1128/JB.00203-07; ENTNER N, 1952, J BIOL CHEM, V196, P853; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; Garcia-Estepa R, 2006, J BACTERIOL, V188, P3774, DOI 10.1128/JB.00136-06; Goss TJ, 2001, J BACTERIOL, V183, P6607, DOI 10.1128/JB.183.22.6607-6619.2001; HOMMES RWJ, 1989, ARCH MICROBIOL, V151, P261, DOI 10.1007/BF00413140; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KEMP RG, 1993, J BACTERIOL, V175, P5723, DOI 10.1128/JB.175.17.5723-5724.1993; Klapa MI, 1999, BIOTECHNOL BIOENG, V62, P375, DOI 10.1002/(SICI)1097-0290(19990220)62:4<375::AID-BIT1>3.3.CO;2-F; Kretzschmar U, 2008, ARCH MICROBIOL, V190, P151, DOI 10.1007/s00203-008-0381-7; LESSIE TG, 1984, ANNU REV MICROBIOL, V38, P359, DOI 10.1146/annurev.mi.38.100184.002043; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Netzer R, 2004, ARCH MICROBIOL, V182, P354, DOI 10.1007/s00203-004-0710-4; Nicolas C, 2007, FEBS LETT, V581, P3771, DOI 10.1016/j.febslet.2007.06.066; Oren A, 2003, FEMS MICROBIOL LETT, V223, P83, DOI 10.1016/S0378-1097(03)00345-8; Oren A, 2002, EXTREMOPHILES, V6, P491, DOI 10.1007/s00792-002-0286-3; Oren A, 1999, MICROBIOL MOL BIOL R, V63, P334, DOI 10.1128/MMBR.63.2.334-348.1999; Oren A, 2011, ENVIRON MICROBIOL, V13, P1908, DOI 10.1111/j.1462-2920.2010.02365.x; Pastor JM, 2010, BIOTECHNOL ADV, V28, P782, DOI 10.1016/j.biotechadv.2010.06.005; Peng L, 2003, APPL MICROBIOL BIOT, V61, P163, DOI 10.1007/s00253-002-1202-6; PETERS P, 1990, FEMS MICROBIOL LETT, V71, P157; Prabhu J, 2004, APPL ENVIRON MICROB, V70, P3130, DOI 10.1128/AEM.70.5.3130-3132.2004; Renilla S, 2012, APPL MICROBIOL BIOT, V93, P2109, DOI 10.1007/s00253-011-3536-4; Reshetnikov AS, 2008, FEMS MICROBIOL LETT, V288, P202, DOI 10.1111/j.1574-6968.2008.01366.x; Roberts MF, 2004, FRONT BIOSCI-LANDMRK, V9, P1999, DOI 10.2741/1366; Rojo F, 2010, FEMS MICROBIOL REV, V34, P658, DOI 10.1111/j.1574-6976.2010.00218.x; SAKAMOTO N, 1975, J BACTERIOL, V124, P775, DOI 10.1128/JB.124.2.775-783.1975; SAWYER MH, 1977, ARCH MICROBIOL, V112, P169, DOI 10.1007/BF00429331; Schwibbert K, 2011, ENVIRON MICROBIOL, V13, P1973, DOI 10.1111/j.1462-2920.2010.02336.x; Seo JS, 2005, NAT BIOTECHNOL, V23, P63, DOI 10.1038/nbt1045; SEVERIN J, 1992, J GEN MICROBIOL, V138, P1629, DOI 10.1099/00221287-138-8-1629; Tang KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007233; Tesch M, 1999, APPL ENVIRON MICROB, V65, P1099; TIWARI NP, 1969, BIOCHIM BIOPHYS ACTA, V192, P395, DOI 10.1016/0304-4165(69)90388-2; Trotsenko Iu A, 2002, Mikrobiologiia, V71, P149; VanderWerf MJ, 1997, ARCH MICROBIOL, V167, P332; Varela CA, 2004, APPL ENVIRON MICROB, V70, P4222, DOI 10.1128/AEM.70.7.4222-4229.2004; Vargas C, 1997, SYST APPL MICROBIOL, V20, P173, DOI 10.1016/S0723-2020(97)80063-X; Vargas Carmen, 2008, Saline Syst, V4, P14, DOI 10.1186/1746-1448-4-14; Vemuri GN, 2006, APPL ENVIRON MICROB, V72, P3653, DOI 10.1128/AEM.72.5.3653-3661.2006; Wendisch VF, 2000, J BACTERIOL, V182, P3088, DOI 10.1128/JB.182.11.3088-3096.2000; Werner S, 2010, J MOL EVOL, V71, P346, DOI 10.1007/s00239-010-9389-0; YAGI T, 1976, FEBS LETT, V61, P34, DOI 10.1016/0014-5793(76)80165-2; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW6, DOI 10.1093/nar/gkl164	61	42	42	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17769	17781		10.1074/jbc.M113.470567	http://dx.doi.org/10.1074/jbc.M113.470567			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23615905	Green Published, hybrid			2022-12-28	WOS:000320380600066
J	Schiefner, A; Sinz, Q; Neumaier, I; Schwab, W; Skerra, A				Schiefner, Andre; Sinz, Quirin; Neumaier, Irmgard; Schwab, Wilfried; Skerra, Arne			Structural Basis for the Enzymatic Formation of the Key Strawberry Flavor Compound 4-Hydroxy-2,5-dimethyl-3(2H)-furanone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUINONE OXIDOREDUCTASE; 2,5-DIMETHYL-4-HYDROXY-3(2H)-FURANONE; SEQUENCES; CLONING; NADPH	The last step in the biosynthetic route to the key strawberry flavor compound 4-hydroxy-2,5-dimethyl-3(2H)-furanone (HDMF) is catalyzed by Fragaria x ananassa enone oxidoreductase (FaEO), earlier putatively assigned as quinone oxidoreductase (FaQR). The ripening-induced enzyme catalyzes the reduction of the exocyclic double bond of the highly reactive precursor 4-hydroxy-5-methyl-2-methylene-3(2H)-furanone (HMMF) in a NAD(P) H-dependent manner. To elucidate the molecular mechanism of this peculiar reaction, we determined the crystal structure of FaEO in six different states or complexes at resolutions of <= 1.6 angstrom, including those with HDMF as well as three distinct substrate analogs. Our crystallographic analysis revealed a monomeric enzyme whose active site is largely determined by the bound NAD(P) H cofactor, which is embedded in a Rossmann-fold. Considering that the quasi-symmetric enolic reaction product HDMF is prone to extensive tautomerization, whereas its precursor HMMF is chemically labile in aqueous solution, we used the asymmetric and more stable surrogate product 2-ethyl-4-hydroxy-5-methyl-3(2H)-furanone (EHMF) and the corresponding substrate (2E)-ethylidene-4-hydroxy-5-methyl-3(2H)-furanone (EDHMF) to study their enzyme complexes as well. Together with deuterium-labeling experiments of EDHMF reduction by [4R-H-2]NADH and chiral-phase analysis of the reaction product EHMF, our data show that the 4R-hydride of NAD(P) H is transferred to the unsaturated exocyclic C6 carbon of HMMF, resulting in a cyclic achiral enolate intermediate that subsequently becomes protonated, eventually leading to HDMF. Apart from elucidating this important reaction of the plant secondary metabolism our study provides a foundation for protein engineering of enone oxidoreductases and their application in biocatalytic processes.	[Schiefner, Andre; Neumaier, Irmgard; Skerra, Arne] Tech Univ Munich, CIPS M, D-85350 Freising Weihenstephan, Germany; [Schiefner, Andre; Neumaier, Irmgard; Skerra, Arne] Tech Univ Munich, Lehrstuhl Biol Chem, D-85350 Freising Weihenstephan, Germany; [Sinz, Quirin; Schwab, Wilfried] Tech Univ Munich, D-85350 Freising Weihenstephan, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich	Schwab, W (corresponding author), Tech Univ Munich, D-85350 Freising Weihenstephan, Germany.	schwab@wzw.tum.de	Skerra, Arne/A-2269-2013	Schiefner, Andre/0000-0001-5215-4122; Skerra, Arne/0000-0002-5717-498X				BRUCHE G, 1991, Z LEBENSM UNTERS FOR, V193, P115, DOI 10.1007/BF01193358; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Durchschein K, 2012, EUR J ORG CHEM, V2012, P4963, DOI 10.1002/ejoc.201200776; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fay LB, 1997, J AGR FOOD CHEM, V45, P4057, DOI 10.1021/jf9702306; Hauck T, 2002, CARBOHYD RES, V337, P1185, DOI 10.1016/S0008-6215(02)00121-0; Hodge JE, 1963, AM SOC BREW CHEM P, V83, P84; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klein D, 2007, J AGR FOOD CHEM, V55, P6705, DOI 10.1021/jf071055o; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mano J, 2002, PLANT CELL PHYSIOL, V43, P1445, DOI 10.1093/pcp/pcf187; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monde K, 2009, CHIRALITY, V21, pE110, DOI 10.1002/chir.20788; MOSANDL A, 1990, HRC-J HIGH RES CHROM, V13, P660; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ohloff G., 1969, FORTSCHRITTE CHEMISC, V12, P185; OTTOLINA G, 1989, BIOCHIM BIOPHYS ACTA, V998, P173, DOI 10.1016/0167-4838(89)90270-7; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Persson B, 2008, CELL MOL LIFE SCI, V65, P3879, DOI 10.1007/s00018-008-8587-z; Raab T, 2006, PLANT CELL, V18, P1023, DOI 10.1105/tpc.105.039784; Raab T, 2003, CHIRALITY, V15, P573, DOI 10.1002/chir.10247; Raab T, 2003, CHROMATOGRAPHIA, V57, P501, DOI 10.1007/BF02492548; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; RODIN JO, 1965, J FOOD SCI, V30, P280, DOI 10.1111/j.1365-2621.1965.tb00302.x; Roscher R, 1997, J AGR FOOD CHEM, V45, P3202, DOI 10.1021/jf9700945; Roscher R, 1998, J AGR FOOD CHEM, V46, P1488, DOI 10.1021/jf970659x; Roscher R, 1996, PHYTOCHEMISTRY, V43, P155, DOI 10.1016/0031-9422(96)00216-6; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schieberle P, 1997, J AGR FOOD CHEM, V45, P227, DOI 10.1021/jf960366o; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Schwab W., 1997, Recent Research Developments in Phytochemistry, V1, P643; Schwab W, 1998, J AGR FOOD CHEM, V46, P2266, DOI 10.1021/jf9710037; Shimomura Y, 2003, J BACTERIOL, V185, P4211, DOI 10.1128/JB.185.14.4211-4218.2003; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; SKERRA A, 1992, NUCLEIC ACIDS RES, V20, P3551, DOI 10.1093/nar/20.14.3551; SKERRA A, 1994, GENE, V151, P131, DOI 10.1016/0378-1119(94)90643-2; Wein M, 2002, PLANT J, V31, P755, DOI 10.1046/j.1365-313X.2002.01396.x; Wein M, 2001, J AGR FOOD CHEM, V49, P2427, DOI 10.1021/jf010072p; Yamauchi Y, 2011, J BIOL CHEM, V286, P6999, DOI 10.1074/jbc.M110.202226; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Youn B, 2006, J BIOL CHEM, V281, P40076, DOI 10.1074/jbc.M605900200	43	22	24	4	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16815	16826		10.1074/jbc.M113.453852	http://dx.doi.org/10.1074/jbc.M113.453852			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23589283	Green Published, hybrid			2022-12-28	WOS:000320378900054
J	Xu, JX; Xu, TT; Wu, B; Ye, YH; You, XJ; Shu, XD; Pei, DQ; Liu, JS				Xu, Jinxin; Xu, Tingting; Wu, Bin; Ye, Yinghua; You, Xiaojuan; Shu, Xiaodong; Pei, Duanqing; Liu, Jinsong			Structure of Sorting Nexin 11 (SNX11) Reveals a Novel Extended Phox Homology (PX) Domain Critical for Inhibition of SNX10-induced Vacuolation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; RETROMER; ASSOCIATION; TRANSPORT; PROTEINS; ROLES	Sorting nexins are phox homology (PX) domain-containing proteins involved in diverse intracellular endosomal trafficking pathways. The PX domain binds to certain phosphatidylinositols and is recruited to vesicles rich in these lipids. The structure of the PX domain is highly conserved, containing a three-stranded beta-sheet, followed by three alpha-helices. Here, we report the crystal structures of truncated human SNX11 (sorting nexin 11). The structures reveal that SNX11 contains a novel PX domain, hereby named the extended PX (PXe) domain, with two additional alpha-helices at the C terminus. We demonstrate that these alpha-helices are indispensible for the in vitro functions of SNX11. We propose that this PXe domain is present in SNX10 and is responsible for the vacuolation activity of SNX10. Thus, this novel PXe domain constitutes a structurally and functionally important PX domain subfamily.	[Xu, Jinxin; Xu, Tingting; You, Xiaojuan; Liu, Jinsong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China; [Xu, Jinxin; Xu, Tingting; Liu, Jinsong] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Wu, Bin; Ye, Yinghua; Shu, Xiaodong; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510530, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Liu, JS (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China.	liu_jinsong@gibh.ac.cn	Wu, Bin/E-7238-2016		National Basic Research Program of China 973 Program [2012CB917200, 2009CB941102]; National Natural Science Foundation of China [30870496, 30871404]; National Science Fund for Distinguished Young Scholars Grant [30725012]; One Hundred Person Project of the Chinese Academy of Sciences	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars Grant(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); One Hundred Person Project of the Chinese Academy of Sciences	The work was supported in part by National Basic Research Program of China 973 Program Grants 2012CB917200 and 2009CB941102, National Natural Science Foundation of China Grants 30870496 and 30871404, National Science Fund for Distinguished Young Scholars Grant 30725012, and the One Hundred Person Project of the Chinese Academy of Sciences (to X. S. and J. L.).	Aker M, 2012, J MED GENET, V49, P221, DOI 10.1136/jmedgenet-2011-100520; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Chen YQ, 2012, CELL RES, V22, P333, DOI 10.1038/cr.2011.134; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cozier GE, 2002, J BIOL CHEM, V277, P48730, DOI 10.1074/jbc.M206986200; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Harterink M, 2011, NAT CELL BIOL, V13, P914, DOI 10.1038/ncb2281; Hong Z, 2009, CELL RES, V19, P1334, DOI 10.1038/cr.2009.130; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Qin BM, 2006, J BIOL CHEM, V281, P36891, DOI 10.1074/jbc.M608884200; Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; Rojas R, 2007, MOL CELL BIOL, V27, P1112, DOI 10.1128/MCB.00156-06; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Song JK, 2007, PROTEIN SCI, V16, P807, DOI 10.1110/ps.072752407; Teasdale RD, 2012, BIOCHEM J, V441, P39, DOI 10.1042/BJ20111226; van Weering JRT, 2012, TRAFFIC, V13, P94, DOI 10.1111/j.1600-0854.2011.01297.x; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016; Yao D, 2009, CHINESE SCI BULL, V54, P3965, DOI 10.1007/s11434-009-0529-0; Zhang P, 2011, CELL RES, V21, P1677, DOI 10.1038/cr.2011.167; Zhou CZ, 2003, J BIOL CHEM, V278, P50371, DOI 10.1074/jbc.M304392200; Zhu C, 2012, J CELL BIOCHEM, V113, P1608, DOI 10.1002/jcb.24029	30	13	17	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16598	16605		10.1074/jbc.M112.449306	http://dx.doi.org/10.1074/jbc.M112.449306			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23615901	hybrid, Green Published			2022-12-28	WOS:000320378900036
J	Xue, Y; Ha, Y				Xue, Yi; Ha, Ya			Large Lateral Movement of Transmembrane Helix S5 Is Not Required for Substrate Access to the Active Site of Rhomboid Intramembrane Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE PROTEASES; CRYSTAL-STRUCTURE; MOLECULAR RULERS; STRUCTURAL BASIS; GLPG; FAMILY; PROTEOLYSIS; MECHANISM; ACTIVATION; MEMBRANE	Rhomboids represent an evolutionarily ancient protease family. Unlike most other proteases, they are polytopic membrane proteins and specialize in cleaving transmembrane protein substrates. The polar active site of rhomboid protease is embedded in the membrane and normally closed. For the bacterial rhomboid GlpG, it has been proposed that one of the transmembrane helices (S5) of the protease can rotate to open a lateral gate, enabling substrate to enter the protease from inside the membrane. Here, we studied the conformational change in GlpG by solving the cocrystal structure of the protease with a mechanism-based inhibitor. We also examined the lateral gating model by cross-linking S5 to a neighboring helix (S2). The crystal structure shows that inhibitor binding displaces a capping loop (L5) from the active site but causes only minor shifts in the transmembrane helices. Cross-linking S5 and S2, which not only restricts the lateral movement of S5 but also prevents substrate from passing between the two helices, does not hinder the ability of the protease to cleave a membrane protein substrate in detergent solution and in reconstituted membrane vesicles. Taken together, these data suggest that a large lateral movement of the S5 helix is not required for substrate access to the active site of rhomboid protease.	[Xue, Yi; Ha, Ya] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Ha, Y (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	ya.ha@yale.edu			National Institutes of Health Grant [GM082839]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082839] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM082839 (to Y. H.).	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Adrain C, 2011, EMBO REP, V12, P421, DOI 10.1038/embor.2011.50; Baker RP, 2007, P NATL ACAD SCI USA, V104, P8257, DOI 10.1073/pnas.0700814104; Baker RP, 2006, PLOS PATHOG, V2, P922, DOI 10.1371/journal.ppat.0020113; Baker RP, 2012, NAT CHEM BIOL, V8, P759, DOI [10.1038/NCHEMBIO.1021, 10.1038/nchembio.1021]; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Brooks CL, 2011, J MOL BIOL, V407, P687, DOI 10.1016/j.jmb.2011.01.046; Buguliskis JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000858; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Ha Y, 2009, SEMIN CELL DEV BIOL, V20, P240, DOI 10.1016/j.semcdb.2008.11.006; Koonin EV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r19; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Maegawa S, 2005, BIOCHEMISTRY-US, V44, P13543, DOI 10.1021/bi051363k; Maegawa S, 2007, MOL MICROBIOL, V64, P435, DOI 10.1111/j.1365-2958.2007.05679.x; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SAEZ R, 1985, FEBS LETT, V179, P311, DOI 10.1016/0014-5793(85)80541-X; Santos JM, 2011, SCIENCE, V331, P473, DOI 10.1126/science.1199284; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Vinothkumar KR, 2010, EMBO J, V29, P3797, DOI 10.1038/emboj.2010.243; Wang YC, 2007, J MOL BIOL, V374, P1104, DOI 10.1016/j.jmb.2007.10.014; Wang YC, 2007, P NATL ACAD SCI USA, V104, P2098, DOI 10.1073/pnas.0611080104; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Xue Y, 2012, BIOCHEMISTRY-US, V51, P3723, DOI 10.1021/bi300368b; Xue Y, 2012, J BIOL CHEM, V287, P3099, DOI 10.1074/jbc.M111.310482; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047	40	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16645	16654		10.1074/jbc.M112.438127	http://dx.doi.org/10.1074/jbc.M112.438127			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23609444	Green Published, hybrid			2022-12-28	WOS:000320378900040
J	Yar, S; Chowdhury, SAK; Davis, RT; Kobayashi, M; Monasky, MM; Rajan, S; Wolska, BM; Gaponenko, V; Kobayashi, T; Wieczorek, DF; Solaro, RJ				Yar, Sumeyye; Chowdhury, Shamim A. K.; Davis, Robert T., III; Kobayashi, Minae; Monasky, Michelle M.; Rajan, Sudarsan; Wolska, Beata M.; Gaponenko, Vadim; Kobayashi, Tomoyoshi; Wieczorek, David F.; Solaro, R. John			Conserved Asp-137 Is Important for both Structure and Regulatory Functions of Cardiac alpha-Tropomyosin (alpha-TM) in a Novel Transgenic Mouse Model Expressing alpha-TM-D137L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE THIN-FILAMENTS; LIGHT-CHAIN PHOSPHORYLATION; COILED-COIL; TROPONIN-I; DILATED CARDIOMYOPATHY; REDUCTIVE ALKYLATION; BETA-TROPOMYOSIN; LYSINE RESIDUES; STRIATED-MUSCLE; MOLECULAR-BASIS	alpha-Tropomyosin (alpha-TM) has a conserved, charged Asp-137 residue located in the hydrophobic core of its coiled-coil structure, which is unusual in that the residue is found at a position typically occupied by a hydrophobic residue. Asp-137 is thought to destabilize the coiled-coil and so impart structural flexibility to the molecule, which is believed to be crucial for its function in the heart. Aprevious in vitro study indicated that the conversion of Asp-137 to a more typical canonical Leu alters flexibility of TM and affects its in vitro regulatory functions. However, the physiological importance of the residue Asp-137 and altered TM flexibility is unknown. In this study, we further analyzed structural properties of the alpha-TM-D137L variant and addressed the physiological importance of TM flexibility in cardiac function in studies with a novel transgenic mouse model expressing alpha-TM-D137L in the heart. Our NMR spectroscopy data indicated that the presence of D137L introduced long range rearrangements in TM structure. Differential scanning calorimetry measurements demonstrated that alpha-TM-D137L has higher thermal stability compared with alpha-TM, which correlated with decreased flexibility. Hearts of transgenic mice expressing alpha-TM-D137L showed systolic and diastolic dysfunction with decreased myofilament Ca2(+) sensitivity and cardiomyocyte contractility without changes in intracellular Ca2(+) transients or post-translational modifications of major myofilament proteins. Weconclude that conversion of the highly conserved Asp137 to Leu results in loss of flexibility of TM that is important for its regulatory functions in mouse hearts. Thus, our results provide insight into the link between flexibility of TM and its function in ejecting hearts.	[Yar, Sumeyye; Gaponenko, Vadim] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA; [Yar, Sumeyye; Chowdhury, Shamim A. K.; Davis, Robert T., III; Kobayashi, Minae; Monasky, Michelle M.; Wolska, Beata M.; Kobayashi, Tomoyoshi; Solaro, R. John] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Wolska, Beata M.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Wolska, Beata M.; Kobayashi, Tomoyoshi; Solaro, R. John] Univ Illinois, Cardiovasc Res Ctr, Chicago, IL 60612 USA; [Rajan, Sudarsan; Wieczorek, David F.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University System of Ohio; University of Cincinnati	Solaro, RJ (corresponding author), Univ Illinois, Dept Physiol & Biophys, 835 S Wolcott Ave,M-C 901, Chicago, IL 60612 USA.	solarorj@uic.edu	Yar, Sumeyye/F-4992-2015; Monasky, Michelle/B-4273-2009; Gaponenko, Vadim/K-9729-2019	Yar, Sumeyye/0000-0002-1592-2361; Monasky, Michelle/0000-0003-3205-2254; Gaponenko, Vadim/0000-0002-7891-9223	National Institutes of Health [PO1 HL62426, R01 CA135341, RO1 HL081680]; American Heart Association Predoctoral Fellowship [12PRE9260034]; NATIONAL CANCER INSTITUTE [R01CA135341] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081680, T32HL007692, P01HL062426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL62426 (Project 1) (to R.J.S.), R01 CA135341 (to V.G.), and RO1 HL081680 (to D.F.W.). This work was also supported by American Heart Association Predoctoral Fellowship 12PRE9260034 (to S.Y.).	BRANDT PW, 1990, J MOL BIOL, V212, P473, DOI 10.1016/0022-2836(90)90326-H; Chen YD, 2004, BIOCHEMISTRY-US, V43, P11491, DOI 10.1021/bi049186v; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dubois E, 2011, EUR HEART J, V32, P115, DOI 10.1093/eurheartj/ehq108; FABIATO A, 1988, METHODS ENZYMOL, V157, P378; Gaffin RD, 2011, J MOL CELL CARDIOL, V51, P812, DOI 10.1016/j.yjmcc.2011.07.026; GERKEN TA, 1982, J BIOL CHEM, V257, P2894; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GODT RE, 1982, J GEN PHYSIOL, V80, P279, DOI 10.1085/jgp.80.2.279; HASELGROVE JC, 1973, COLD SPRING HARB SYM, V37, P341, DOI 10.1101/SQB.1973.037.01.044; Heller MJ, 2003, J BIOL CHEM, V278, P41742, DOI 10.1074/jbc.M303408200; James J, 2011, J BIOL CHEM, V286, P9913, DOI 10.1074/jbc.R110.171801; Kirk JA, 2009, CIRC RES, V105, P1232, DOI 10.1161/CIRCRESAHA.109.205427; Kobayashi T, 2009, J BIOL CHEM, V284, P20052, DOI 10.1074/jbc.M109.001396; Korte FS, 2005, AM J PHYSIOL-HEART C, V289, pH801, DOI 10.1152/ajpheart.01227.2004; Kremneva E, 2004, BIOPHYS J, V87, P3922, DOI 10.1529/biophysj.104.048793; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Kurinov IV, 2000, BIOCHEM BIOPH RES CO, V275, P549, DOI 10.1006/bbrc.2000.3329; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lehman W, 2000, J MOL BIOL, V302, P593, DOI 10.1006/jmbi.2000.4080; Loong CKP, 2012, FEBS LETT, V586, P3503, DOI 10.1016/j.febslet.2012.08.005; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MEANS GE, 1968, BIOCHEMISTRY-US, V7, P2192, DOI 10.1021/bi00846a023; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Mudalige WAKA, 2009, J MOL BIOL, V389, P575, DOI 10.1016/j.jmb.2009.04.027; Muthuchamy M, 1995, J BIOL CHEM, V270, P30593, DOI 10.1074/jbc.270.51.30593; NADALGINARD B, 1989, J CLIN INVEST, V84, P1693, DOI 10.1172/JCI114351; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Nevzorov IA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209353; Nitanai Y, 2007, ADV EXP MED BIOL, V592, P137; Nixon BR, 2013, ARCH BIOCHEM BIOPHYS, V535, P30, DOI 10.1016/j.abb.2012.11.010; PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5; POTEKHIN SA, 1982, J MOL BIOL, V159, P519, DOI 10.1016/0022-2836(82)90299-6; Rajan S, 2007, CIRC RES, V101, P205, DOI 10.1161/CIRCRESAHA.107.148379; Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; Schulz EM, 2012, J BIOL CHEM, V287, P44478, DOI 10.1074/jbc.M112.402040; Scruggs SB, 2011, ARCH BIOCHEM BIOPHYS, V510, P129, DOI 10.1016/j.abb.2011.02.013; Scruggs SB, 2009, J BIOL CHEM, V284, P5097, DOI 10.1074/jbc.M807414200; Singh A, 2006, STRUCTURE, V14, P43, DOI 10.1016/j.str.2005.09.016; Singh A, 2003, BIOCHEMISTRY-US, V42, P14114, DOI 10.1021/bi0348462; Solaro RJ, 2013, CIRC RES, V112, P355, DOI 10.1161/CIRCRESAHA.112.268672; Solaro RJ, 2009, J PHYSIOL-LONDON, V587, P3, DOI 10.1113/jphysiol.2008.166751; Straussman R, 2007, J MOL BIOL, V366, P1232, DOI 10.1016/j.jmb.2006.11.083; STURTEVANT JM, 1991, BIOPOLYMERS, V31, P489, DOI 10.1002/bip.360310504; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Sumida JP, 2008, J BIOL CHEM, V283, P6728, DOI 10.1074/jbc.M707485200; Sun YB, 2010, J MOL CELL CARDIOL, V48, P859, DOI 10.1016/j.yjmcc.2009.11.019; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Warren CM, 2008, PROTEOMICS, V8, P100, DOI 10.1002/pmic.200700772; Warren CM, 2003, ANAL BIOCHEM, V320, P149, DOI 10.1016/S0003-2697(03)00350-6; Wider G, 1999, CURR OPIN STRUC BIOL, V9, P594, DOI 10.1016/S0959-440X(99)00011-1; WILLIAMS DL, 1981, BIOCHEMISTRY-US, V20, P3856, DOI 10.1021/bi00516a029; Wolska BM, 1996, AM J PHYSIOL-HEART C, V271, pH1250, DOI 10.1152/ajpheart.1996.271.3.H1250; Wolska BM, 1998, CIRCULATION, V98, P465; Yuan C, 2008, AM J PHYSIOL-HEART C, V295, pH647, DOI 10.1152/ajpheart.00357.2008	56	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16235	16246		10.1074/jbc.M113.458695	http://dx.doi.org/10.1074/jbc.M113.458695			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23609439	hybrid, Green Published			2022-12-28	WOS:000320378900004
J	Franklin, JM; Carrasco, GA				Franklin, Jade M.; Carrasco, Gonzalo A.			G-protein Receptor Kinase 5 Regulates the Cannabinoid Receptor 2-induced Up-regulation of Serotonin 2A Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTOR; CB2 RECEPTORS; SIGNALING PATHWAY; BETA-ARRESTINS; MENTAL-HEALTH; ACTIVATION; 5-HT2A; AGONISTS; BRAIN; PHOSPHORYLATION	We have recently reported that cannabinoid agonists can up-regulate and enhance the activity of serotonin 2A (5-HT2A) receptors in the prefrontal cortex (PFCx). Increased expression and activity of cortical 5-HT2A receptors has been associated with neuropsychiatric disorders, such as anxiety and schizophrenia. Here we report that repeated CP55940 exposure selectively up-regulates GRK5 proteins in rat PFCx and in a neuronal cell culture model. We sought to examine the mechanism underlying the regulation of GRK5 and to identify the role of GRK5 in the cannabinoid agonist-induced up-regulation and enhanced activity of 5-HT2A receptors. Interestingly, we found that cannabinoid agonist-induced up-regulation of GRK5 involves CB2 receptors, beta-arrestin 2, and ERK1/2 signaling because treatment with CB2 shRNA lentiviral particles, beta-arrestin 2 shRNA lentiviral particles, or ERK1/2 inhibitor prevented the cannabinoid agonist-induced up-regulation of GRK5. Most importantly, we found that GRK5 shRNA lentiviral particle treatment prevented the cannabinoid agonist-induced up-regulation and enhanced 5-HT2A receptor-mediated calcium release. Repeated cannabinoid exposure was also associated with enhanced phosphorylation of CB2 receptors and increased interaction between beta-arrestin 2 and ERK1/2. These latter phenomena were also significantly inhibited by GRK5 shRNA lentiviral treatment. Our results suggest that sustained activation of CB2 receptors, which up-regulates 5-HT2A receptor signaling, enhances GRK5 expression; the phosphorylation of CB2 receptors; and the beta-arrestin 2/ERK interactions. These data could provide a rationale for some of the adverse effects associated with repeated cannabinoid agonist exposure.	[Franklin, Jade M.; Carrasco, Gonzalo A.] Univ Kansas, Sch Pharm, Dept Pharmacol & Toxicol, Lawrence, KS 66045 USA	University of Kansas	Carrasco, GA (corresponding author), Univ Kansas, Sch Pharm, Dept Pharmacol & Toxicol, 1251 Wescoe Hall Dr,3050 Malott Hall, Lawrence, KS 66045 USA.	carrasco@ku.edu	Carrasco, Gonzalo/R-7523-2019	Carrasco, Gonzalo/0000-0001-5553-4251	National Institutes of Health, NIDA [DA024329, DA034315]; University of Kansas [2301421, 2302213]; University of Kansas; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA024329] Funding Source: NIH RePORTER	National Institutes of Health, NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); University of Kansas; University of Kansas; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health, NIDA, Grants DA024329 and DA034315. This work was also supported by University of Kansas General Research Fund 2301421 and New Faculty General Research Fund 2302213 awards and University of Kansas startup funds.	Abood ME, 1996, INT REV NEUROBIOL, V39, P197, DOI 10.1016/S0074-7742(08)60667-4; Aksamitiene E, 2010, CELL SIGNAL, V22, P1369, DOI 10.1016/j.cellsig.2010.05.006; Atwood BK, 2012, MOL PHARMACOL, V81, P250, DOI 10.1124/mol.111.074013; Bouaboula M, 1996, EUR J BIOCHEM, V237, P704, DOI 10.1111/j.1432-1033.1996.0704p.x; Bouaboula M, 1999, J BIOL CHEM, V274, P20397, DOI 10.1074/jbc.274.29.20397; Brusco A, 2008, ANN NY ACAD SCI, V1139, P450, DOI 10.1196/annals.1432.037; Carrasco GA, 2003, EUR J PHARMACOL, V463, P235, DOI 10.1016/S0014-2999(03)01285-8; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Ciruela A, 2003, BRIT J PHARMACOL, V138, P751, DOI 10.1038/sj.bjp.0705103; Clough AR, 2005, AUST NZ J PSYCHIAT, V39, P612, DOI 10.1111/j.1440-1614.2005.01634.x; Dai Y, 2011, PSYCHOPHARMACOLOGY, V213, P403, DOI 10.1007/s00213-010-1984-7; Dalton GD, 2012, BRIT J PHARMACOL, V165, P2497, DOI 10.1111/j.1476-5381.2011.01455.x; den Boon FS, 2012, P NATL ACAD SCI USA, V109, P3534, DOI 10.1073/pnas.1118167109; Felder CC, 2006, MOL INTERV, V6, P149, DOI 10.1124/mi.6.3.6; Franklin J. M., 2012, EUR NEUROPS IN PRESS, DOI DOI 10.1016/J.EUR0NEUR0.2012.06.012; Franklin JM, 2013, SYNAPSE, V67, P145, DOI 10.1002/syn.21626; Franklin JM, 2013, PHARMACOL RES, V68, P46, DOI 10.1016/j.phrs.2012.11.002; Franklin JM, 2012, J PSYCHOPHARMACOL, V26, P1333, DOI 10.1177/0269881112450786; Fu J, 2005, J BIOL CHEM, V280, P3178, DOI 10.1074/jbc.M410044200; Garcia-Gutierrez MS, 2012, BRIT J PHARMACOL, V165, P951, DOI 10.1111/j.1476-5381.2011.01625.x; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Gorantla S, 2010, J NEUROIMMUNE PHARM, V5, P456, DOI 10.1007/s11481-010-9225-8; Guindon J, 2008, BRIT J PHARMACOL, V153, P319, DOI 10.1038/sj.bjp.0707531; Henquet C, 2005, SCHIZOPHRENIA BULL, V31, P608, DOI 10.1093/schbul/sbi027; Hillard CJ, 1999, J PHARMACOL EXP THER, V289, P1427; Howlett A. C., 2005, HDB EXP PHARM, P53; Ichikawa J, 2001, J NEUROCHEM, V76, P1521, DOI 10.1046/j.1471-4159.2001.00154.x; Islam KN, 2012, J BIOL CHEM, V287, P12771, DOI 10.1074/jbc.M111.324566; Jones BW, 2007, J BIOL CHEM, V282, P12893, DOI 10.1074/jbc.M610854200; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Kuepper R, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d738; Large M, 2011, ARCH GEN PSYCHIAT, V68, P555, DOI 10.1001/archgenpsychiatry.2011.5; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Magalhaes AC, 2010, NAT NEUROSCI, V13, P622, DOI 10.1038/nn.2529; Metaye T, 2005, CELL SIGNAL, V17, P917, DOI 10.1016/j.cellsig.2005.01.002; Morales M, 2012, NAT MED, V18, P504, DOI 10.1038/nm.2722; O'Shea M, 2004, J PSYCHOPHARMACOL, V18, P502, DOI 10.1177/0269881104047277; O'Shea M, 2006, J PSYCHOPHARMACOL, V20, P611, DOI 10.1177/0269881106065188; Oien Derek B, 2011, J Amino Acids, V2011, P721094, DOI 10.4061/2011/721094; Onaivi ES, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001640; Patton GC, 2002, BMJ-BRIT MED J, V325, P1195, DOI 10.1136/bmj.325.7374.1195; Pelletier JP, 2003, ARTHRITIS RHEUM-US, V48, P1582, DOI 10.1002/art.11014; Pronin AN, 1998, J BIOL CHEM, V273, P31510, DOI 10.1074/jbc.273.47.31510; Reilly D, 1998, ADDICTION, V93, P837, DOI 10.1046/j.1360-0443.1998.9368375.x; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Roth BL, 2011, NEUROPHARMACOLOGY, V61, P348, DOI 10.1016/j.neuropharm.2011.01.012; Rubino T, 2006, MOL NEUROBIOL, V33, P199, DOI 10.1385/MN:33:3:199; Sagredo O, 2009, GLIA, V57, P1154, DOI 10.1002/glia.20838; Seitz PK, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-25; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Singh RK, 2010, J PSYCHOPHARMACOL, V24, P1079, DOI 10.1177/0269881109103090; Thomas BF, 1998, J PHARMACOL EXP THER, V285, P285; Troisi A, 1998, ADDICTION, V93, P487, DOI 10.1046/j.1360-0443.1998.9344874.x; Yaniv SP, 2010, EUR J CELL BIOL, V89, P712, DOI 10.1016/j.ejcb.2010.05.002; Yiangou Y, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-12; Zarruk JG, 2012, STROKE, V43, P211, DOI 10.1161/STROKEAHA.111.631044; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157	60	24	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15712	15724		10.1074/jbc.M113.454843	http://dx.doi.org/10.1074/jbc.M113.454843			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23592773	Green Published, hybrid			2022-12-28	WOS:000319822300027
J	Kundumani-Sridharan, V; Dyukova, E; Hansen, DE; Rao, GN				Kundumani-Sridharan, Venkatesh; Dyukova, Elena; Hansen, Dale E., III; Rao, Gadiparthi N.			12/15-Lipoxygenase Mediates High-fat Diet-induced Endothelial Tight Junction Disruption and Monocyte Transmigration A NEW ROLE FOR 15(S)-HYDROXYEICOSATETRAENOIC ACID IN ENDOTHELIAL CELL DYSFUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; CELL-JUNCTIONS; ATHEROSCLEROTIC LESIONS; PROTEIN; 15-LIPOXYGENASE; LIPOXYGENASE; EXPRESSION; OCCLUDIN; ZO-1; INFLAMMATION	A convincing body of evidence suggests that 12/15-lipoxygenase (12/15-LO) plays a role in atherosclerosis. However, the mechanisms of its involvement in the pathogenesis of this disease are not clear. Therefore, the purpose of this study is to understand the mechanisms by which 12/15-LO mediates endothelial dysfunction. 15(S)-Hydroxyeicosatetraenoic acid (15(S)-HETE), the major 12/15-LO metabolite of arachidonic acid (AA), induced endothelial barrier permeability via Src and Pyk2-dependent zonula occluden (ZO)-2 tyrosine phosphorylation and its dissociation from the tight junction complexes. 15(S)-HETE also stimulated macrophage adhesion to the endothelial monolayer in Src and Pyk2-dependent manner. Ex vivo studies revealed that exposure of arteries from WT mice to AA or 15(S)-HETE led to Src-Pyk2-dependent ZO-2 tyrosine phosphorylation, tight junction disruption, and macrophage adhesion, whereas the arteries from 12/15-LO knock-out mice are protected from these effects of AA. Feeding WT mice with a high-fat diet induced the expression of 12/15-LO in the arteries leading to tight junction disruption and macrophage adhesion and deletion of the 12/15-LO gene disallowed these effects. Thus, the findings of this study provide the first evidence of the role of 12/15-LO and its AA metabolite, 15(S)-HETE, in high-fat diet-induced endothelial tight junction disruption and macrophage adhesion, the crucial events underlying the pathogenesis of atherosclerosis.	[Kundumani-Sridharan, Venkatesh; Dyukova, Elena; Hansen, Dale E., III; Rao, Gadiparthi N.] Univ Tennessee Hlth Sci Ctr, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Rao, GN (corresponding author), 894 Union Ave, Memphis, TN 38163 USA.	rgadipar@uthsc.edu	Kundumani-Sridharan, Venkatesh/AAB-4535-2020; Kundumani-Sridharan, Venkatesh/I-4799-2016; Kundumani-Sridharan, Venkatesh/ABD-9613-2021	Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371	National Institutes of Health from the NHLBI [HL074860]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074860] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL074860 from the NHLBI (to G. N. R.).	Aggarwal NT, 2008, ARTERIOSCL THROM VAS, V28, P2209, DOI 10.1161/ATVBAHA.108.177113; Bajpai AK, 2007, INVEST OPHTH VIS SCI, V48, P4930, DOI 10.1167/iovs.07-0617; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; BERKNER KL, 1988, BIOTECHNIQUES, V6, P616; Block ER, 2010, J BIOL CHEM, V285, P13372, DOI 10.1074/jbc.M109.083089; Bolick DT, 2005, ARTERIOSCL THROM VAS, V25, P2301, DOI 10.1161/01.ATV.0000186181.19909.a6; Buckbinder L, 2007, P NATL ACAD SCI USA, V104, P10619, DOI 10.1073/pnas.0701421104; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; CATHCART MK, 1991, J LIPID RES, V32, P63; Cavallaro U, 2011, NAT REV MOL CELL BIO, V12, P189, DOI 10.1038/nrm3068; Cheranov SY, 2008, BLOOD, V111, P5581, DOI 10.1182/blood-2007-11-126680; Cines DB, 1998, BLOOD, V91, P3527; Collins NT, 2006, ARTERIOSCL THROM VAS, V26, P62, DOI 10.1161/01.ATV.0000194097.92824.b3; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Cyrus T, 2001, CIRCULATION, V103, P2277; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Elias BC, 2009, J BIOL CHEM, V284, P1559, DOI 10.1074/jbc.M804783200; Fernandez-Martin L, 2012, ARTERIOSCL THROM VAS, V32, pE90, DOI 10.1161/ATVBAHA.112.252080; Fruchart JC, 2004, CIRCULATION, V109, P15, DOI 10.1161/01.CIR.0000131513.33892.5b; Funk CD, 2006, ARTERIOSCL THROM VAS, V26, P1204, DOI 10.1161/01.ATV.0000222960.43792.ff; Gadepalli R, 2012, ARTERIOSCL THROM VAS, V32, P2652, DOI 10.1161/ATVBAHA.112.253112; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harats D, 2000, ARTERIOSCL THROM VAS, V20, P2100, DOI 10.1161/01.ATV.20.9.2100; Hatley ME, 2003, J BIOL CHEM, V278, P25369, DOI 10.1074/jbc.M301175200; HENRIKSSON P, 1985, BIOCHIM BIOPHYS ACTA, V834, P272, DOI 10.1016/0005-2760(85)90166-3; HILTUNEN T, 1995, CIRCULATION, V92, P3297, DOI 10.1161/01.CIR.92.11.3297; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; ITOH M, 1993, J CELL BIOL, V121, P491, DOI 10.1083/jcb.121.3.491; KIM JA, 1995, ARTERIOSCL THROM VAS, V15, P942, DOI 10.1161/01.ATV.15.7.942; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1169, P80, DOI 10.1016/0005-2760(93)90085-N; Lessner SM, 2002, AM J PATHOL, V160, P2145, DOI 10.1016/S0002-9440(10)61163-7; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Naikawadi RP, 2012, CIRC RES, V111, P1517, DOI 10.1161/CIRCRESAHA.112.273078; Nunemaker CS, 2008, AM J PHYSIOL-ENDOC M, V295, pE1065, DOI 10.1152/ajpendo.90371.2008; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; ROSS R, 1973, SCIENCE, V180, P1332, DOI 10.1126/science.180.4093.1332; ROSS R, 1976, SCIENCE, V193, P1094, DOI 10.1126/science.822515; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Sendobry SM, 1997, BRIT J PHARMACOL, V120, P1199, DOI 10.1038/sj.bjp.0701007; Seth A, 2007, J BIOL CHEM, V282, P11487, DOI 10.1074/jbc.M610597200; Sigari F, 1997, ARTERIOSCL THROM VAS, V17, P3639, DOI 10.1161/01.ATV.17.12.3639; Song L, 2004, MICROVASC RES, V67, P78, DOI 10.1016/j.mvr.2003.07.001; Sonobe Y, 2009, J BIOL CHEM, V284, P31834, DOI 10.1074/jbc.M109.025940; Tang X, 2006, ARTERIOSCL THROM VAS, V26, P78, DOI 10.1161/01.ATV.0000191640.73313.ad; Wegmann F, 2006, J EXP MED, V203, P1671, DOI 10.1084/jem.20060565; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499; YLAHERTTUALA S, 1995, J CLIN INVEST, V95, P2692, DOI 10.1172/JCI117971; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271; Yoshida H, 2004, CLIN CHIM ACTA, V345, P161, DOI 10.1016/j.cccn.2004.03.018; Zhu H, 2003, J BIOL CHEM, V278, P13350, DOI 10.1074/jbc.M212104200	60	40	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15830	15842		10.1074/jbc.M113.453290	http://dx.doi.org/10.1074/jbc.M113.453290			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23589307	Green Published, hybrid			2022-12-28	WOS:000319822300037
J	Mialki, RK; Zhao, J; Wei, JX; Mallampalli, DF; Zhao, YT				Mialki, Rachel K.; Zhao, Jing; Wei, Jianxin; Mallampalli, Daniel F.; Zhao, Yutong			Overexpression of USP14 Protease Reduces I-kappa B Protein Levels and Increases Cytokine Release in Lung Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN; PHOSPHORYLATION; EXPRESSION; CANCER	The ubiquitin-proteasome system is the major pathway of non-lysosomal intracellular protein degradation, playing an important role in a variety of cellular responses including cell division, proliferation, and apoptosis. Ubiquitin-specific protease 14 (USP14) is a component of proteasome regulatory subunit 19 S that regulates deubiquitinated proteins entering inside the proteasome core 20 S. The role of USP14 in protein degradation is still controversial. Several studies suggest that USP14 plays an inhibitory role in protein degradation. Here, in contrast, overexpression of USP14 induced I-kappa B degradation, which increased cytokine release in lung epithelial cells. Overexpression of HA-tagged USP14 (HA-USP14) reduced I-kappa Bprotein levels by increasing the I-kappa B degradation rate in mouse lung epithelial cells (MLE12). I-kappa B polyubiquitination was reduced in HA-USP14-overexpressed MLE12 cells, suggesting that USP14 regulates I-kappa B degradation by removing its ubiquitin chain, thus promoting the deubiquitinated I-kappa B degradation within the proteasome. Interestingly, we found that USP14 was associated with RelA, a binding partner of I-kappa B, suggesting that RelA is the linker between USP14 and I-kappa B. Lipopolysaccharide (LPS) treatment induced serine phosphorylation of USP14 as well as further reducing I-kappa B levels in HA-USP14-overexpressed MLE12 cells as compared with empty vector transfected cells. Further, overexpression of HA-USP14 increased the LPS-, TNF alpha-, or Escherichia coli-induced IL-8 release in human lung epithelial cells. This study suggests that USP14 removes the ubiquitin chain of I-kappa B, therefore inducing I-kappa B degradation and increasing cytokine release in lung epithelial cells.	[Zhao, Yutong] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhao, YT (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, 3459 5th Ave,NW 628 MUH, Pittsburgh, PA 15213 USA.	zhaoy3@upmc.edu	Wei, Jianxin/P-5431-2016		National Institutes of Health [RO1 HL091916, HL112791]; American Heart Association Award [12SDG9050005]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112791, R01HL091916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Award(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL091916 and HL112791 (to Y.Z.). This work was also supported by American Heart Association Award 12SDG9050005 (to J.Z.).	Adams J, 2003, CANCER TREAT REV, V29, P3, DOI 10.1016/S0305-7372(03)00081-1; Chen PC, 2009, J NEUROSCI, V29, P10909, DOI 10.1523/JNEUROSCI.2635-09.2009; Crimmins S, 2006, J NEUROSCI, V26, P11423, DOI 10.1523/JNEUROSCI.3600-06.2006; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; Djakovic SN, 2012, J NEUROSCI, V32, P5126, DOI 10.1523/JNEUROSCI.4427-11.2012; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Kim HM, 2011, BBA-GENE REGUL MECH, V1809, P67, DOI 10.1016/j.bbagrm.2010.08.008; Lappe-Siefke C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000631; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003871; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Mines MA, 2009, J BIOL CHEM, V284, P5742, DOI 10.1074/jbc.M808507200; Nagai A, 2009, BIOCHEM BIOPH RES CO, V379, P995, DOI 10.1016/j.bbrc.2008.12.182; Perry JW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002783; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rivett AJ, 2001, BIOCHIMIE, V83, P363; Saeki Y, 2012, METHODS MOL BIOL, V832, P315, DOI 10.1007/978-1-61779-474-2_22; SCHWARTZ AL, 1992, AM J RESP CELL MOL, V7, P463, DOI 10.1165/ajrcmb/7.5.463; Shinji S, 2006, ONCOL REP, V15, P539; Sun WJ, 2010, CELL SIGNAL, V22, P386, DOI 10.1016/j.cellsig.2009.10.008; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; UGAI S, 1993, J BIOCHEM, V113, P754, DOI 10.1093/oxfordjournals.jbchem.a124116; Zhang L, 2012, NAT CELL BIOL, V14, P717, DOI 10.1038/ncb2522	26	50	55	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15437	15441		10.1074/jbc.C112.446682	http://dx.doi.org/10.1074/jbc.C112.446682			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23615914	Green Published, hybrid			2022-12-28	WOS:000319822300002
J	Tao, SC; Yamazaki, D; Komazaki, S; Zhao, CZ; Iida, T; Kakizawa, S; Imaizumi, Y; Takeshima, H				Tao, Shengchen; Yamazaki, Daiju; Komazaki, Shinji; Zhao, Chengzhu; Iida, Tsunaki; Kakizawa, Sho; Imaizumi, Yuji; Takeshima, Hiroshi			Facilitated Hyperpolarization Signaling in Vascular Smooth Muscle-overexpressing TRIC-A Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; SARCOPLASMIC-RETICULUM; RYANODINE RECEPTOR; CALCIUM-RELEASE; CA2+ RELEASE; CELLS; ION; K+; ACTIVATION; TYPE-1	The TRIC channel subtypes, namely TRIC-A and TRIC-B, are intracellular monovalent cation-specific channels and likely mediate counterion movements to support efficient Ca2+ release from the sarco/endoplasmic reticulum. Vascular smooth muscle cells (VSMCs) contain both TRIC subtypes and two Ca2+ release mechanisms; incidental opening of ryanodine receptors (RyRs) generates local Ca2+ sparks to induce hyperpolarization and relaxation, whereas agonist-induced activation of inositol trisphosphate receptors produces global Ca2+ transients causing contraction. Tric-a knock-out mice develop hypertension due to insufficient RyR-mediated Ca2+ sparks in VSMCs. Here we describe transgenic mice overexpressing TRIC-A channels under the control of a smooth muscle cell-specific promoter. The transgenic mice developed congenital hypotension. In Tric-a-overexpressing VSMCs from the transgenic mice, the resting membrane potential decreased because RyR-mediated Ca2+ sparks were facilitated and cell surface Ca2+-dependent K+ channels were hyperactivated. Under such hyperpolarized conditions, L-type Ca2+ channels were inactivated, and thus, the resting intracellular Ca2+ levels were reduced in Tric-a-overexpressing VSMCs. Moreover, Tric-a overexpression impaired inositol trisphosphate-sensitive stores to diminish agonist-induced Ca2+ signaling in VSMCs. These altered features likely reduced vascular tonus leading to the hypotensive phenotype. Our Tric-a-transgenic mice together with Tric-a knock-out mice indicate that TRIC-A channel density in VSMCs is responsible for controlling basal blood pressure at the whole-animal level.	[Tao, Shengchen; Yamazaki, Daiju; Zhao, Chengzhu; Iida, Tsunaki; Kakizawa, Sho; Takeshima, Hiroshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Yamazaki, Daiju; Takeshima, Hiroshi] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Kyoto 6068501, Japan; [Komazaki, Shinji] Saitama Med Univ, Saitama 3500495, Japan; [Imaizumi, Yuji] Nagoya City Univ, Grad Sch Pharmaceut Sci, Nagoya 4678603, Aichi, Japan	Kyoto University; Kyoto University; Saitama Medical University; Nagoya City University	Takeshima, H (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto 6068501, Japan.	takeshim@pharm.kyoto-u.ac.jp	Imaizumi, Yuji/AAF-6585-2020	Takeshima, Hiroshi/0000-0003-4525-3725	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labour and Welfare; Vehicle Racing Commemorative Foundation; Astellas Foundation; Suzuken Memorial Foundation; Kanae Foundation; Japan Foundation for Applied Enzymology; Takeda Science Foundation; Ono Medical Research Foundation; Kowa Life Science Foundation; Grants-in-Aid for Scientific Research [23240055, 23390020] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Vehicle Racing Commemorative Foundation; Astellas Foundation(Astellas Pharmaceuticals); Suzuken Memorial Foundation; Kanae Foundation; Japan Foundation for Applied Enzymology; Takeda Science Foundation(Takeda Science Foundation (TSF)); Ono Medical Research Foundation; Kowa Life Science Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grants-in-Aid for Scientific Research and Platform for Drug Design, Discovery, and Development), the Ministry of Health, Labour and Welfare, the Vehicle Racing Commemorative Foundation, the Astellas Foundation, the Suzuken Memorial Foundation, the Kanae Foundation, the Japan Foundation for Applied Enzymology, the Takeda Science Foundation, the Ono Medical Research Foundation, and the Kowa Life Science Foundation.	Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; BEZPROZVANNY I, 1995, J MEMBRANE BIOL, V145, P205; Bolton TB, 1999, ANNU REV PHYSIOL, V61, P85, DOI 10.1146/annurev.physiol.61.1.85; CORONADO R, 1980, NATURE, V288, P495, DOI 10.1038/288495a0; DEVINE CE, 1972, J CELL BIOL, V52, P690, DOI 10.1083/jcb.52.3.690; Fink RHA, 1996, ACTA PHYSIOL SCAND, V156, P387, DOI 10.1046/j.1365-201X.1996.212000.x; Gillespie D, 2012, CELL CALCIUM, V51, P427, DOI 10.1016/j.ceca.2012.02.001; Hotta S, 2007, J PHYSIOL-LONDON, V582, P489, DOI 10.1113/jphysiol.2007.130302; IDE T, 1991, BIOCHEM BIOPH RES CO, V176, P38, DOI 10.1016/0006-291X(91)90886-C; IINO M, 1990, JPN J PHARMACOL, V54, P345, DOI 10.1254/jjp.54.345; Iino M, 2000, JPN J PHARMACOL, V82, P15, DOI 10.1254/jjp.82.15; Ikemoto T, 1998, PFLUG ARCH EUR J PHY, V437, P43, DOI 10.1007/s004240050744; Iwamoto T, 2004, NAT MED, V10, P1193, DOI 10.1038/nm1118; Kamp F, 1998, BIOPHYS J, V74, P290, DOI 10.1016/S0006-3495(98)77786-0; Kiyoshi H, 2006, AM J PHYSIOL-HEART C, V291, pH2723, DOI 10.1152/ajpheart.00894.2005; Koshita Makoto, 2007, Journal of Smooth Muscle Research, V43, P219, DOI 10.1540/jsmr.43.219; Laurent S, 2012, LANCET, V380, P591, DOI 10.1016/S0140-6736(12)60825-3; Lesh RE, 1998, CIRC RES, V82, P175; MEISSNER G, 1983, MOL CELL BIOCHEM, V55, P65; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Moore ED, 2004, BIOPHYS J, V87, P1836, DOI 10.1529/biophysj.104.044123; NAKANO Y, 1991, GENE, V99, P285; Ohi Y, 2001, J PHYSIOL-LONDON, V534, P313, DOI 10.1111/j.1469-7793.2001.t01-3-00313.x; PATHAK RK, 1986, J CELL BIOL, V102, P2158, DOI 10.1083/jcb.102.6.2158; Pitt SJ, 2010, BIOPHYS J, V99, P417, DOI 10.1016/j.bpj.2010.04.051; SMITH OA, 1974, ANNU REV PHYSIOL, V36, P93, DOI 10.1146/annurev.ph.36.030174.000521; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; SOMLYO AV, 1981, J CELL BIOL, V90, P577, DOI 10.1083/jcb.90.3.577; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Takeshima H, 1998, EMBO J, V17, P3309, DOI 10.1093/emboj/17.12.3309; Tasker PN, 1999, CIRC RES, V84, P536, DOI 10.1161/01.RES.84.5.536; Venturi E., 2013, PFLUGERS AR IN PRESS; Venturi E, 2013, PFLUG ARCH EUR J PHY, V465, P187, DOI 10.1007/s00424-012-1197-5; Vermassen E, 2003, J CELL SCI, V116, P1269, DOI 10.1242/jcs.00354; Wellman GC, 2003, CELL CALCIUM, V34, P211, DOI 10.1016/S0143-4160(03)00124-6; Yamazaki D, 2011, CELL METAB, V14, P231, DOI 10.1016/j.cmet.2011.05.011; Yamazaki D, 2009, DEVELOPMENT, V136, P2355, DOI 10.1242/dev.036798; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928; Zhao XL, 2010, J BIOL CHEM, V285, P37370, DOI 10.1074/jbc.M110.170084	40	14	14	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15581	15589		10.1074/jbc.M112.435396	http://dx.doi.org/10.1074/jbc.M112.435396			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23592776	hybrid, Green Published			2022-12-28	WOS:000319822300016
J	Ward, T; Wang, M; Liu, X; Wang, ZK; Xia, P; Chu, YJ; Wang, XW; Liu, LF; Jiang, K; Yu, HJ; Yan, MM; Wang, JY; Hill, DL; Huang, YJ; Zhu, TG; Yao, XB				Ward, Tarsha; Wang, Ming; Liu, Xing; Wang, Zhikai; Xia, Peng; Chu, Youjun; Wang, Xiwei; Liu, Lifang; Jiang, Kai; Yu, Huijuan; Yan, Maomao; Wang, Jianyu; Hill, Donald L.; Huang, Yuejia; Zhu, Tongge; Yao, Xuebiao			Regulation of a Dynamic Interaction between Two Microtubule-binding Proteins, EB1 and TIP150, by the Mitotic p300/CBP-associated Factor (PCAF) Orchestrates Kinetochore Microtubule Plasticity and Chromosome Stability during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLUS-END TRACKING; SPINDLE; PHOSPHORYLATION; ACETYLATION; SEGREGATION; ATTACHMENT; FORMS; PRC1; LINK; KMN	The microtubule cytoskeleton network orchestrates cellular dynamics and chromosome stability in mitosis. Although tubulin acetylation is essential for cellular plasticity, it has remained elusive how kinetochore microtubule plus-end dynamics are regulated by p300/CBP-associated factor (PCAF) acetylation in mitosis. Here, we demonstrate that the plus-end tracking protein, TIP150, regulates dynamic kinetochore-microtubule attachments by promoting the stability of spindle microtubule plus-ends. Suppression of TIP150 by siRNA results in metaphase alignment delays and perturbations in chromosome biorientation. TIP150 is a tetramer that binds an end-binding protein (EB1) dimer through the C-terminal domains, and overexpression of the C-terminal TIP150 or disruption of the TIP150-EB1 interface by a membrane-permeable peptide perturbs chromosome segregation. Acetylation of EB1-PCAF regulates the TIP150 interaction, and persistent acetylation perturbs EB1-TIP150 interaction and accurate metaphase alignment, resulting in spindle checkpoint activation. Suppression of the mitotic checkpoint serine/threonine protein kinase, BubR1, overrides mitotic arrest induced by impaired EB1-TIP150 interaction, but cells exhibit whole chromosome aneuploidy. Thus, the results identify a mechanism by which the TIP150-EB1 interaction governs kinetochore microtubule plus-end plasticity and establish that the temporal control of the TIP150-EB1 interaction by PCAF acetylation ensures chromosome stability in mitosis.	[Ward, Tarsha; Wang, Ming; Liu, Xing; Wang, Zhikai; Xia, Peng; Chu, Youjun; Wang, Xiwei; Liu, Lifang; Jiang, Kai; Yu, Huijuan; Yan, Maomao; Wang, Jianyu; Hill, Donald L.; Huang, Yuejia; Zhu, Tongge; Yao, Xuebiao] Anhui Key Lab Cellular Dynam & Chem Biol, Anhui MSM Joint Res Grp Cellular Dynam, Hefei 230026, Anhui, Peoples R China; [Ward, Tarsha; Wang, Ming; Liu, Xing; Wang, Zhikai; Xia, Peng; Chu, Youjun; Wang, Xiwei; Liu, Lifang; Jiang, Kai; Yu, Huijuan; Yan, Maomao; Wang, Jianyu; Hill, Donald L.; Huang, Yuejia; Zhu, Tongge; Yao, Xuebiao] Univ Sci & Technol China, Hefei 230026, Anhui, Peoples R China; [Ward, Tarsha; Liu, Xing; Wang, Zhikai; Chu, Youjun; Wang, Xiwei; Jiang, Kai; Yu, Huijuan; Yan, Maomao; Hill, Donald L.; Huang, Yuejia; Zhu, Tongge; Yao, Xuebiao] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA; [Ward, Tarsha; Liu, Xing; Wang, Zhikai; Chu, Youjun; Wang, Xiwei; Jiang, Kai; Yu, Huijuan; Yan, Maomao; Hill, Donald L.; Huang, Yuejia; Zhu, Tongge; Yao, Xuebiao] Morehouse Sch Med, Mol Imaging Core, Atlanta, GA 30310 USA; [Liu, Lifang] Airforce Gen Hosp, Beijing 100036, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; Morehouse School of Medicine	Yao, XB (corresponding author), Anhui Key Lab Cellular Dynam & Chem Biol, Anhui MSM Joint Res Grp Cellular Dynam, Hefei 230026, Anhui, Peoples R China.	yaoxb@ustc.edu.cn	Yao, Xuebiao/P-5771-2014; liu, li/HGC-0900-2022; Liu, Xing/H-2989-2018	Liu, Xing/0000-0002-7480-5085; Wang, Ming/0000-0002-7000-1063; Xia, Peng/0000-0002-5419-7756	National Institutes of Health [DK56292, CA164133, G12RR03034, UL1RR025008, CA132389]; Chinese 973 Project [2010CB912103, 2012CB917204, 2012CB945002, 2002CB713700]; Chinese Academy of Science [KSCX2-YW-H-10]; Anhui Province Key Project Grant [08040102005]; International Collaboration Grant [2009DFA31010]; Chinese Natural Science Foundation [90508002, 91129714, 31071184, 81270466, 90913016, MOE20113402130010]; Chinese Postdoctoral Fellowship [2012M510210]; Fundamental Research Funds for Central Universities Grants [WK2060190018, WK2340000021]; NATIONAL CANCER INSTITUTE [R01CA164133, P20CA132389] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008, G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 Project(National Basic Research Program of China); Chinese Academy of Science(Chinese Academy of Sciences); Anhui Province Key Project Grant; International Collaboration Grant; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Fellowship; Fundamental Research Funds for Central Universities Grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56292, CA164133, G12RR03034, UL1RR025008, and CA132389. This work was also supported by Chinese 973 Project Grants 2010CB912103, 2012CB917204, 2012CB945002, and 2002CB713700; Chinese Academy of Science Grant KSCX2-YW-H-10; Anhui Province Key Project Grant 08040102005; International Collaboration Grant 2009DFA31010; Chinese Natural Science Foundation Grants 90508002, 91129714, 31071184, 81270466, 90913016, and MOE20113402130010, Chinese Postdoctoral Fellowship 2012M510210; and Fundamental Research Funds for Central Universities Grants WK2060190018 and WK2340000021.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; [Anonymous], CELL, V112, P407; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Choi E, 2009, EMBO J, V28, P2077, DOI 10.1038/emboj.2009.123; Chu LL, 2012, J MOL CELL BIOL, V4, P331, DOI 10.1093/jmcb/mjs023; Chu YJ, 2011, J MOL CELL BIOL, V3, P260, DOI 10.1093/jmcb/mjq037; Dixit R, 2010, METHOD CELL BIOL, V95, P543, DOI 10.1016/S0091-679X(10)95027-9; Du J, 2008, ONCOGENE, V27, P4107, DOI 10.1038/onc.2008.34; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Fu CH, 2007, CELL RES, V17, P449, DOI 10.1038/cr.2007.32; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Huang YJ, 2012, J BIOL CHEM, V287, P1500, DOI 10.1074/jbc.M111.277194; Jiang K, 2009, EMBO REP, V10, P857, DOI 10.1038/embor.2009.94; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kops GJPL, 2009, BIOCHEM SOC T, V37, P971, DOI 10.1042/BST0370971; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Liu J, 2009, J BIOL CHEM, V284, P23059, DOI 10.1074/jbc.M109.009670; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; Nakamura T, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120117; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Siegel JJ, 2012, ANNU REV CELL DEV BI, V28, P189, DOI 10.1146/annurev-cellbio-101011-155807; SU LK, 1995, CANCER RES, V55, P2972; Wang HM, 2004, J BIOL CHEM, V279, P54590, DOI 10.1074/jbc.M407588200; Wang XW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.406652; Xia P, 2012, P NATL ACAD SCI USA, V109, P16564, DOI 10.1073/pnas.1202639109; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 2009, CELL RES, V19, P152, DOI 10.1038/cr.2009.7; Zhang LY, 2011, J BIOL CHEM, V286, P3033, DOI 10.1074/jbc.M110.165340; Zhao LL, 2010, J BIOL CHEM, V285, P2488, DOI 10.1074/jbc.M109.042614; Zhou RH, 2003, MOL BIOL CELL, V14, P1097, DOI 10.1091/mbc.E02-07-0425	33	23	25	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15771	15785		10.1074/jbc.M112.448886	http://dx.doi.org/10.1074/jbc.M112.448886			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23595990	hybrid, Green Published			2022-12-28	WOS:000319822300032
J	Wu, MH; Tao, Y; Liu, XT; Zang, JY				Wu, Minhao; Tao, Yue; Liu, Xiaotian; Zang, Jianye			Structural Basis for Phosphorylated Autoinducer-2 Modulation of the Oligomerization State of the Global Transcription Regulator LsrR from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUORUM; LUXS; REPRESSOR; BINDING; COMMUNICATION; EXPRESSION; SEQUENCE; INDUCER; SYSTEM; AI-2	Quorum-sensing systems are widely used by bacteria to control behavior in response to fluctuations in cell density. Several small diffusible molecules called autoinducers act as signaling molecules in quorum-sensing processes through interplay with sensors. Autoinducers modulate vital physiological functions such as nutrient acquisition, gene transcription, and virulence factor production. In Escherichia coli, LsrR serves as a global transcription regulator that responds to autoinducer-2 to regulate the expression of a variety of genes, including the lsr operon and the lsrR gene. Here, we report the crystal structure of full-length LsrR from E. coli, which has an N-terminal DNA-binding domain and a C-terminal ligand-binding domain connected by a beta-strand. Although only two molecules are found in one asymmetric unit, two neighboring dimers pack to form a tetramer that is consistent with the oligomerization state of LsrR in solution. Mutagenesis experiments and gel shift assays indicated that Gln-33 and Tyr-26 might be involved in interactions between LsrR and DNA. The LsrR-binding site for phosphorylated autoinducer-2 was predicted by structural comparisons of LsrR with CggR and SorC. Cross-linking, size exclusion chromatography, and gel shift assays determined that phosphorylated autoinducer-2 triggered the disassembly of the LsrR tetramer into dimers and reduced the DNA binding ability of LsrR. Our findings reveal a mechanism for the change in the oligomerization state of LsrR in the presence of phosphorylated autoinducer-2. Based on these observations, we propose that phosphorylated autoinducer-2 triggers the disassembly of the LsrR tetramer to activate the transcription of its target genes.	[Zang, Jianye] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Zang, Jianye] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zang, JY (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, 96 Jinzhai Rd, Hefei 230026, Anhui, Peoples R China.	zangjy@ustc.edu.cn	Zang, Jianye/E-5228-2013		Chinese Ministry of Science and Technology [2009CB825502, 2012CB917202]; National Natural Science Foundation of China [31171241, 30970576]; Ph.D. Programs Foundation of Ministry of Education of China [20113402110033]; "100 Talents Program" of the Chinese Academy of Sciences	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); "100 Talents Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported Chinese Ministry of Science and Technology Grants 2009CB825502 and 2012CB917202, National Natural Science Foundation of China Grants 31171241 and 30970576, the Ph.D. Programs Foundation of Ministry of Education of China Grant 20113402110033, and "100 Talents Program" of the Chinese Academy of Sciences (to J. Z.).	Antunes LCM, 2009, CRIT REV MICROBIOL, V35, P69, DOI 10.1080/10408410902733946; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Byrd CM, 2009, CELL RES, V19, P1229, DOI 10.1038/cr.2009.122; Chung WSO, 2001, J BACTERIOL, V183, P3903, DOI 10.1128/JB.183.13.3903-3909.2001; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Sanctis D, 2009, J MOL BIOL, V387, P759, DOI 10.1016/j.jmb.2009.02.017; DeLano W.L, PYMOL MOL GRAPHICS S; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Federle MJ, 2009, CONTRIB MICROBIOL, V16, P18, DOI 10.1159/000219371; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li J, 2007, J BACTERIOL, V189, P6011, DOI 10.1128/JB.00014-07; Liu XT, 2010, ACTA CRYSTALLOGR F, V66, P913, DOI 10.1107/S1744309110020695; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Ohtani K, 2009, J BACTERIOL, V191, P3919, DOI 10.1128/JB.01455-08; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rezacova P, 2008, MOL MICROBIOL, V69, P895, DOI 10.1111/j.1365-2958.2008.06318.x; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Taga ME, 2001, MOL MICROBIOL, V42, P777, DOI 10.1046/j.1365-2958.2001.02669.x; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Xavier KB, 2007, ACS CHEM BIOL, V2, P128, DOI 10.1021/cb600444h; Xavier KB, 2005, J BACTERIOL, V187, P238, DOI 10.1128/JB.187.1.238-248.2005; Xue T, 2009, CELL RES, V19, P1258, DOI 10.1038/cr.2009.91; Zorrilla S, 2007, BIOCHEMISTRY-US, V46, P14996, DOI 10.1021/bi701805e; Zorrilla S, 2007, BIOPHYS J, V92, P3215, DOI 10.1529/biophysj.106.095109	35	12	12	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					15878	15887		10.1074/jbc.M112.417634	http://dx.doi.org/10.1074/jbc.M112.417634			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23589368	Green Published, hybrid			2022-12-28	WOS:000319822300041
J	Dokladny, K; Zuhl, MN; Mandell, M; Bhattacharya, D; Schneider, S; Deretic, V; Moseley, PL				Dokladny, Karol; Zuhl, Micah Nathaniel; Mandell, Michael; Bhattacharya, Dhruva; Schneider, Suzanne; Deretic, Vojo; Moseley, Pope Lloyd			Regulatory Coordination between Two Major Intracellular Homeostatic Systems HEAT SHOCK RESPONSE AND AUTOPHAGY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; MOLECULAR CHAPERONES; CELL-DEATH; AMINO-ACIDS; ER STRESS; IN-VITRO; INDUCTION; INCREASES; INHIBITION	The eukaryotic cell depends on multitiered homeostatic systems ensuring maintenance of proteostasis, organellar integrity, function and turnover, and overall cellular viability. At the two opposite ends of the homeostatic system spectrum are heat shock response and autophagy. Here, we tested whether there are interactions between these homeostatic systems, one universally operational in all prokaryotic and eukaryotic cells, and the other one (autophagy) is limited to eukaryotes. We found that heat shock response regulates autophagy. The interaction between the two systems was demonstrated by testing the role of HSF-1, the central regulator of heat shock gene expression. Knockdown of HSF-1 increased the LC3 lipidation associated with formation of autophagosomal organelles, whereas depletion of HSF-1 potentiated both starvation- and rapamycin-induced autophagy. HSP70 expression but not expression of its ATPase mutant inhibited starvation or rapamycin-induced autophagy. We also show that exercise induces autophagy in humans. As predicted by our in vitro studies, glutamine supplementation as a conditioning stimulus prior to exercise significantly increased HSP70 protein expression and prevented the expected exercise induction of autophagy. Our data demonstrate for the first time that heat shock response, from the top of its regulatory cascade (HSF-1) down to the execution stages delivered by HSP70, controls autophagy thus connecting and coordinating the two extreme ends of the homeostatic systems in the eukaryotic cell.	[Moseley, Pope Lloyd] Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Albuquerque, NM 87131 USA; [Zuhl, Micah Nathaniel; Schneider, Suzanne] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Mandell, Michael; Bhattacharya, Dhruva; Deretic, Vojo] Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Moseley, Pope Lloyd] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; Technical University of Denmark	Moseley, PL (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, MSC 10-5550, Albuquerque, NM 87131 USA.	pmoseley@salud.unm.edu	Mandell, Michael/AAP-3462-2021	Moseley, Pope/0000-0002-3723-9950; Mandell, Michael/0000-0002-5773-2806; Deretic, Vojo/0000-0002-3624-5208	National Institutes of Health [RM-07-007]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RM-07-007.	Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Atwal RS, 2008, AUTOPHAGY, V4, P91, DOI 10.4161/auto.5201; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bolt AM, 2012, TOXICOL APPL PHARM, V264, P255, DOI 10.1016/j.taap.2012.08.006; Chu EK, 1997, CRIT CARE MED, V25, P1727, DOI 10.1097/00003246-199710000-00025; CRAIG EA, 1994, CELL, V78, P365, DOI 10.1016/0092-8674(94)90416-2; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Dokladny K, 2006, AM J PHYSIOL-GASTR L, V290, pG204, DOI 10.1152/ajpgi.00401.2005; Dokladny K, 2001, AM J PHYSIOL-REG I, V280, pR338, DOI 10.1152/ajpregu.2001.280.2.R338; Dokladny K, 2008, J APPL TOXICOL, V28, P885, DOI 10.1002/jat.1352; Dokladny K, 2008, AM J PATHOL, V172, P659, DOI 10.2353/ajpath.2008.070522; Dokladny K, 2006, CELL STRESS CHAPERON, V11, P268, DOI 10.1379/CSC-194R.1; Dokladny K, 2010, CELL STRESS CHAPERON, V15, P153, DOI 10.1007/s12192-009-0129-6; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Gupta S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000410; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; He CC, 2012, AUTOPHAGY, V8, P1548, DOI 10.4161/auto.21327; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; HOTCHKISS R, 1993, AM J PHYSIOL, V265, pR1447, DOI 10.1152/ajpregu.1993.265.6.R1447; Jardon MA, 2012, BIOTECHNOL BIOENG, V109, P1228, DOI 10.1002/bit.24393; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kluger MJ, 1997, AM J PHYSIOL-REG I, V273, pR858, DOI 10.1152/ajpregu.1997.273.3.R858; Ko YH, 2011, CANCER BIOL THER, V12, P1085, DOI 10.4161/cbt.12.12.18671; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Koren J, 2010, J BIOL CHEM, V285, P2498, DOI 10.1074/jbc.M109.057208; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kwon WY, 2010, BRIT J NUTR, V103, P890, DOI 10.1017/S0007114509992509; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Li QS, 2011, IMMUNITY, V34, P541, DOI 10.1016/j.immuni.2011.04.006; Liang C, 2010, CELL DEATH DIFFER, V17, P1807, DOI 10.1038/cdd.2010.115; Liang P, 1997, J CELL SCI, V110, P1431; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Machado-Neto JA, 2011, BBA-MOL CELL RES, V1813, P1404, DOI 10.1016/j.bbamcr.2011.04.002; MAILHOS C, 1993, NEUROSCIENCE, V55, P621, DOI 10.1016/0306-4522(93)90428-I; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Merksamer PI, 2010, J CELL SCI, V123, P1003, DOI 10.1242/jcs.035832; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0; Moseley PL, 1998, ANN NY ACAD SCI, V856, P206, DOI 10.1111/j.1749-6632.1998.tb08327.x; MOSELEY PL, 1994, AM J PHYSIOL, V267, pC425, DOI 10.1152/ajpcell.1994.267.2.C425; MOSSER DD, 1992, J CELL PHYSIOL, V151, P561, DOI 10.1002/jcp.1041510316; Murata M, 1999, J CELL PHYSIOL, V180, P105, DOI 10.1002/(SICI)1097-4652(199907)180:1<105::AID-JCP12>3.0.CO;2-5; Musch MW, 1996, AM J PHYSIOL-CELL PH, V270, pC429, DOI 10.1152/ajpcell.1996.270.2.C429; Mustafi SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008719; Ogier-Denis E, 2000, J BIOL CHEM, V275, P39090, DOI 10.1074/jbc.M006198200; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Park MA, 2008, MOL PHARMACOL, V73, P1168, DOI 10.1124/mol.107.042697; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Pattingre S, 2003, J BIOL CHEM, V278, P16667, DOI 10.1074/jbc.M210998200; Pereira C, 2004, J MOL NEUROSCI, V23, P97, DOI 10.1385/JMN:23:1-2:097; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; POSO AR, 1982, J BIOL CHEM, V257, P2114; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Qin L, 2010, AUTOPHAGY, V6, P239, DOI 10.4161/auto.6.2.11062; Ravikumar B, 2009, J CELL SCI, V122, P1707, DOI 10.1242/jcs.031773; Reijonen S, 2008, EXP CELL RES, V314, P950, DOI 10.1016/j.yexcr.2007.12.025; Ren Y, 2009, BMB REP, V42, P599, DOI 10.5483/BMBRep.2009.42.9.599; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; RYAN AJ, 1992, J APPL PHYSIOL, V73, P1517, DOI 10.1152/jappl.1992.73.4.1517; Sakiyama T, 2009, GASTROENTEROLOGY, V136, P924, DOI 10.1053/j.gastro.2008.12.002; Salmond RJ, 2011, EUR J IMMUNOL, V41, P2137, DOI 10.1002/eji.201141523; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Scriven P, 2007, J MOL MED, V85, P331, DOI 10.1007/s00109-006-0150-5; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; van der Vos KE, 2012, NAT CELL BIOL, V14, P829, DOI 10.1038/ncb2536; Vergne I, 2009, EMBO J, V28, P2244, DOI 10.1038/emboj.2009.159; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021415; Zhang Y, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-81; Zhou J, 2004, J BIOL CHEM, V279, P13506, DOI 10.1074/jbc.M310164200	91	106	110	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14959	14972		10.1074/jbc.M113.462408	http://dx.doi.org/10.1074/jbc.M113.462408			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23576438	hybrid, Green Published			2022-12-28	WOS:000319452100026
J	Midgley, AC; Rogers, M; Hallett, MB; Clayton, A; Bowen, T; Phillips, AO; Steadman, R				Midgley, Adam C.; Rogers, Mathew; Hallett, Maurice B.; Clayton, Aled; Bowen, Timothy; Phillips, Aled O.; Steadman, Robert			Transforming Growth Factor-beta 1 (TGF-beta 1)-stimulated Fibroblast to Myofibroblast Differentiation Is Mediated by Hyaluronan (HA)-facilitated Epidermal Growth Factor Receptor (EGFR) and CD44 Co-localization in Lipid Rafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; CANCER-CELLS; EXTRACELLULAR-MATRIX; KIDNEY FIBROSIS; BREAST-CANCER; FACTOR-BETA; TGF-BETA; EXPRESSION; MIGRATION; KINASE	Fibroblast to myofibroblast differentiation drives effective wound healing and is largely regulated by the cytokine transforming growth factor-beta 1 (TGF-beta 1). Myofibroblasts express alpha-smooth muscle actin and are present in granulation tissue, where they are responsible for wound contraction. Our previous studies show that fibroblast differentiation in response to TGF-beta 1 is dependent on and mediated by the linear polysaccharide hyaluronan (HA). Both the HA receptor, CD44, and the epidermal growth factor receptor (EGFR) are involved in this differentiation response. The aim of this study was to understand the mechanisms linking HA-, CD44-, and EGFR-regulated TGF-beta 1-dependent differentiation. CD44 and EGFR co-localization within membrane-bound lipid rafts was necessary for differentiation, and this triggered downstream mitogen-activated protein kinase (MAPK/ERK) and Ca2+/calmodulin kinase II (CaMKII) activation. We also found that ERK phosphorylation was upstream of CaMKII phosphorylation, that ERK activation was necessary for CaMKII signaling, and that both kinases were essential for differentiation. In addition, HA synthase-2 (HAS2) siRNA attenuated both ERK and CaMKII signaling and sequestration of CD44 into lipid rafts, preventing differentiation. In summary, the data suggest that HAS2-dependent production of HA facilitates TGF-beta 1-dependent fibroblast differentiation through promoting CD44 interaction with EGFR held within membrane-bound lipid rafts. This induces MAPK/ERK, followed by CaMKII activation, leading to differentiation. This pathway is synergistic with the classical TGF-beta 1-dependent SMAD-signaling pathway and may provide a novel opportunity for intervention in wound healing.	[Midgley, Adam C.; Rogers, Mathew; Bowen, Timothy; Phillips, Aled O.; Steadman, Robert] Cardiff Univ, Inst Nephrol, Cardiff CF14 4XN, S Glam, Wales; [Hallett, Maurice B.] Cardiff Univ, Neutrophil Signalling Grp, Inst Mol & Expt Med, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Hallett, Maurice B.] Cardiff Univ, Cardiff Inst Tissue Engn & Repair, Cardiff CF14 4XN, S Glam, Wales; [Clayton, Aled] Cardiff Univ, Inst Canc & Genet, Sch Med, Velindre Canc Ctr, Cardiff CF14 2TL, S Glam, Wales	Cardiff University; Cardiff University; Cardiff University; Cardiff University; Velindre Cancer Centre	Steadman, R (corresponding author), Cardiff Univ, Inst Nephrol, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	steadmanr@cf.ac.uk	Midgley, Adam C./P-8108-2019; Hallett, Maurice/I-6866-2012; Steadman, Robert/O-1614-2016	Midgley, Adam C./0000-0002-7622-0275; Hallett, Maurice/0000-0001-8197-834X; Steadman, Robert/0000-0002-1303-2496; Phillips, Aled/0000-0001-9744-7113	Research into Aging/Age UK [358]; Kidney Wales Foundation	Research into Aging/Age UK; Kidney Wales Foundation	This work was supported in part by a studentship from Research into Aging/Age UK (Grant 358) (to A. M. and R. S.). This work was also supported by the Kidney Wales Foundation.	Akhmetshina A, 2008, ARTHRITIS RHEUM-US, V58, P2553, DOI 10.1002/art.23677; alKhateeb T, 1997, J PERIODONTOL, V68, P1063, DOI 10.1902/jop.1997.68.11.1063; ANSCHER MS, 1993, NEW ENGL J MED, V328, P1592, DOI 10.1056/NEJM199306033282203; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; BORDER WA, 1995, J CLIN INVEST, V96, P655, DOI 10.1172/JCI118107; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Border WA, 1997, KIDNEY INT, V51, P1388, DOI 10.1038/ki.1997.190; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; BRECHT M, 1986, BIOCHEM J, V239, P445, DOI 10.1042/bj2390445; Deng ZY, 2009, CHINESE MED J-PEKING, V122, P1449, DOI 10.3760/cma.j.issn.0366-6999.2009.12.018; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF1202, DOI 10.1152/ajprenal.00406.2005; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Ellis IR, 2007, EXP CELL RES, V313, P732, DOI 10.1016/j.yexcr.2006.11.016; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Hardie WD, 2008, AM J PHYSIOL-LUNG C, V294, pL1217, DOI 10.1152/ajplung.00020.2008; Hinz B, 2003, THROMB HAEMOSTASIS, V90, P993, DOI 10.1160/TH03-05-0328; Irwin ME, 2011, J CELL PHYSIOL, V226, P2316, DOI 10.1002/jcp.22570; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Ito T, 2004, J BIOL CHEM, V279, P25326, DOI 10.1074/jbc.M403135200; Ito T, 2004, KIDNEY INT, V65, P823, DOI 10.1111/j.1523-1755.2004.00457.x; Jenkins RH, 2004, J BIOL CHEM, V279, P41453, DOI 10.1074/jbc.M401678200; Knudson CB, 2004, CLIN ORTHOP RELAT R, pS152, DOI 10.1097/01.blo.0000143804.26638.82; Kosaki R, 1999, CANCER RES, V59, P1141; Krieg T, 1989, Recenti Prog Med, V80, P594; Lambert S, 2006, J INVEST DERMATOL, V126, P954, DOI 10.1038/sj.jid.5700168; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Liu Y, 2007, MOL MEMBR BIOL, V24, P91, DOI 10.1080/10929080600990500; Ma Frank Y, 2009, Front Biosci (Schol Ed), V1, P171, DOI 10.2741/s17; Meran S, 2008, J BIOL CHEM, V283, P6530, DOI 10.1074/jbc.M704819200; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; Meran S, 2011, J BIOL CHEM, V286, P17618, DOI 10.1074/jbc.M111.226563; Nylander N, 1998, IN VITRO CELL DEV-AN, V34, P182; Palyi-Krekk Z, 2008, CANCER LETT, V263, P231, DOI 10.1016/j.canlet.2008.01.014; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P10315, DOI 10.1021/bi025943i; Poumay Yves, 2009, Folia Med (Plovdiv), V51, P5; Roepstorff K, 2002, J BIOL CHEM, V277, P18954, DOI 10.1074/jbc.M201422200; Samarakoon R, 2008, J MOL CELL CARDIOL, V44, P527, DOI 10.1016/j.yjmcc.2007.12.006; Simpson RML, 2010, AM J PATHOL, V176, P1215, DOI 10.2353/ajpath.2010.090802; Simpson RML, 2009, AM J PATHOL, V175, P1915, DOI 10.2353/ajpath.2009.090045; Singer HA, 2012, J PHYSIOL-LONDON, V590, P1349, DOI 10.1113/jphysiol.2011.222232; Spicer AP, 1999, BIOCHEM SOC T, V27, P109, DOI 10.1042/bst0270109; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; Stephens P, 2001, BRIT J DERMATOL, V144, P229, DOI 10.1046/j.1365-2133.2001.04006.x; Thankamony SP, 2006, J BIOL CHEM, V281, P34601, DOI 10.1074/jbc.M601530200; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Wang SJ, 2006, ARCH OTOLARYNGOL, V132, P771, DOI 10.1001/archotol.132.7.771; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675; Zhai H, 2005, EUR J PHARMACOL, V516, P112, DOI 10.1016/j.ejphar.2005.04.035; Zhuang LY, 2002, CANCER RES, V62, P2227	60	183	188	1	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14824	14838		10.1074/jbc.M113.451336	http://dx.doi.org/10.1074/jbc.M113.451336			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23589287	Green Published, hybrid			2022-12-28	WOS:000319452100015
J	Yu, WL; Jiang, YL; Pikis, A; Cheng, W; Bai, XH; Ren, YM; Thompson, J; Zhou, CZ; Chen, YX				Yu, Wei-Li; Jiang, Yong-Liang; Pikis, Andreas; Cheng, Wang; Bai, Xiao-Hui; Ren, Yan-Min; Thompson, John; Zhou, Cong-Zhao; Chen, Yuxing			Structural Insights into the Substrate Specificity of a 6-Phospho-beta-glucosidase BglA-2 from Streptococcus pneumoniae TIGR4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; BINDING CASSETTE TRANSPORTERS; GLYCOSYL HYDROLASES; BETA-GLUCOSIDASE; PHOSPHOTRANSFERASE SYSTEM; LACTOCOCCUS-LACTIS; CRYSTAL-STRUCTURE; MECHANISM; PROTEINS; BACTERIA	The 6-phospho-beta-glucosidase BglA-2 (EC 3.2.1.86) from glycoside hydrolase family 1 (GH-1) catalyzes the hydrolysis of beta-1,4-linked cellobiose 6-phosphate (cellobiose-6'P) to yield glucose and glucose 6-phosphate. Both reaction products are further metabolized by the energy-generating glycolytic pathway. Here, we present the first crystal structures of the apo and complex forms of BglA-2 with thiocellobiose-6'P (a non-metabolizable analog of cellobiose-6'P) at 2.0 and 2.4 angstrom resolution, respectively. Similar to other GH-1 enzymes, the overall structure of BglA-2 from Streptococcus pneumoniae adopts a typical (beta/alpha)(8) TIM-barrel, with the active site located at the center of the convex surface of the beta-barrel. Structural analyses, in combination with enzymatic data obtained from site-directed mutant proteins, suggest that three aromatic residues, Tyr(126), Tyr(303), and Trp(338), at subsite +1 of BglA-2 determine substrate specificity with respect to 1,4-linked 6-phospho-beta-glucosides. Moreover, three additional residues, Ser(424), Lys(430), and Tyr(432) of BglA-2, were found to play important roles in the hydrolytic selectivity toward phosphorylated rather than non-phosphorylated compounds. Comparative structural analysis suggests that a tryptophan versus a methionine/alanine residue at subsite -1 may contribute to the catalytic and substrate selectivity with respect to structurally similar 6-phospho-beta-galactosidases and 6-phospho-beta-glucosidases assigned to the GH-1 family.	[Yu, Wei-Li; Jiang, Yong-Liang; Cheng, Wang; Bai, Xiao-Hui; Ren, Yan-Min; Zhou, Cong-Zhao; Chen, Yuxing] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Yu, Wei-Li; Jiang, Yong-Liang; Cheng, Wang; Bai, Xiao-Hui; Ren, Yan-Min; Zhou, Cong-Zhao; Chen, Yuxing] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Pikis, Andreas; Thompson, John] NIDCR, Microbial Biochem & Genet Sect, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA; [Pikis, Andreas] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); US Food & Drug Administration (FDA)	Zhou, CZ (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.	zcz@ustc.edu.cn; cyxing@ustc.edu.cn	Chen, Yuxing/P-4156-2014; PIKIS, ANDREAS/AFU-1192-2022; Zhou, Cong-Zhao/E-9174-2011	Chen, Yuxing/0000-0002-7560-1922; Zhou, Cong-Zhao/0000-0002-6881-7151; Jiang, YongLiang/0000-0001-5441-4936	National Institutes of Health, NIDCR, Intramural Research Program; Ministry of Science and Technology of China [2009CB918800]; National Natural Science Foundation of China [31270781]; Research Fund for the Doctoral Program of Higher Education of China [20123402110004]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000341] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR, Intramural Research Program; Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the National Institutes of Health, NIDCR, Intramural Research Program. This work was also supported by Ministry of Science and Technology of China Grant 2009CB918800, National Natural Science Foundation of China Grant 31270781, and Research Fund for the Doctoral Program of Higher Education of China Grant 20123402110004.	Ajdic D, 2007, J BACTERIOL, V189, P5049, DOI 10.1128/JB.00338-07; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; Cartwright K, 2002, EUR J PEDIATR, V161, P188, DOI 10.1007/s00431-001-0907-3; Cote CK, 2000, MICROBIOL-UK, V146, P1555, DOI 10.1099/00221287-146-7-1555; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Davidson AL, 2002, J BACTERIOL, V184, P1225, DOI 10.1128/JB.184.5.1225-1233.2002; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HENDERSON PJF, 1992, INT REV CYTOL, V137A, P149; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; HONDA S, 1989, ANAL BIOCHEM, V180, P351, DOI 10.1016/0003-2697(89)90444-2; Jiang YL, 2011, J BIOL CHEM, V286, P43004, DOI 10.1074/jbc.M111.256578; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; KUNDIG W, 1964, P NATL ACAD SCI USA, V52, P1067, DOI 10.1073/pnas.52.4.1067; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; McKessar SJ, 2007, J BACTERIOL, V189, P1342, DOI 10.1128/JB.01170-06; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Patzlaff JS, 2003, J BIOL CHEM, V278, P29546, DOI 10.1074/jbc.M304796200; Poolman B, 1996, MOL MICROBIOL, V19, P911, DOI 10.1046/j.1365-2958.1996.397949.x; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Prag G, 2000, J MOL BIOL, V300, P611, DOI 10.1006/jmbi.2000.3906; Puri V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-334; REIZER J, 1988, CRC CR REV MICROBIOL, V15, P297, DOI 10.3109/10408418809104461; ROSEMAN S, 1989, FEMS MICROBIOL LETT, V63, P3, DOI 10.1016/0168-6445(89)90003-X; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; Sanz-Aparicio J, 1998, J MOL BIOL, V275, P491, DOI 10.1006/jmbi.1997.1467; STEINFORT C, 1989, INFECT IMMUN, V57, P2006, DOI 10.1128/IAI.57.7.2006-2013.1989; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Thompson J, 1998, J BIOL CHEM, V273, P27347, DOI 10.1074/jbc.273.42.27347; Thompson J, 2002, J BIOL CHEM, V277, P34310, DOI 10.1074/jbc.M206397200; Thompson J, 1997, J BACTERIOL, V179, P1636, DOI 10.1128/jb.179.5.1636-1645.1997; Tribolo S, 2007, J MOL BIOL, V370, P964, DOI 10.1016/j.jmb.2007.05.034; WIESMANN C, 1995, STRUCTURE, V3, P961, DOI 10.1016/S0969-2126(01)00230-1; Wiesmann C, 1997, J MOL BIOL, V269, P851, DOI 10.1006/jmbi.1997.1084; Yang XB, 2005, ANAL SCI, V21, P1177, DOI 10.2116/analsci.21.1177; Yip V. L. Y., 2006, ANGEW CHEM INT EDIT, V45, P1; Yip VLY, 2004, J AM CHEM SOC, V126, P8354, DOI 10.1021/ja047632w	43	16	17	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					14949	14958		10.1074/jbc.M113.454751	http://dx.doi.org/10.1074/jbc.M113.454751			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23580646	Green Published, hybrid			2022-12-28	WOS:000319452100025
J	Chen, L; Wei, TY; Si, XX; Wang, QQ; Li, Y; Leng, Y; Deng, AM; Chen, J; Wang, GY; Zhu, SC; Kang, JH				Chen, Long; Wei, Tingyi; Si, Xiaoxing; Wang, Qianqian; Li, Yan; Leng, Ye; Deng, Anmei; Chen, Jie; Wang, Guiying; Zhu, Songcheng; Kang, Jiuhong			Lysine Acetyltransferase GCN5 Potentiates the Growth of Non-small Cell Lung Cancer via Promotion of E2F1, Cyclin D1, and Cyclin E1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; SMALL-MOLECULE INHIBITORS; P53-MDM2 INTERACTION; MESANGIAL CELLS; COLON-CANCER; GENE; TRANSCRIPTION; ACETYLATION; PROTEIN; PCAF	The lysine acetyltransferases play crucial but complex roles in cancer development. GCN5 is a lysine acetyltransferase that generally regulates gene expression, but its role in cancer development remains largely unknown. In this study, we report that GCN5 is highly expressed in non-small cell lung cancer tissues and that its expression correlates with tumor size. We found that the expression of GCN5 promotes cell growth and the G(1)/S phase transition in multiple lung cancer cell lines. Further study revealed that GCN5 regulates the expression of E2F1, cyclin D1, and cyclin E1. Our reporter assays indicated that the expression of GCN5 enhances the activities of the E2F1, cyclin D1, and cyclin E1 promoters. ChIP experiments suggested that GCN5 binds directly to these promoters and increases the extent of histone acetylation within these regions. Mechanistic studies suggested that GCN5 interacts with E2F1 and is recruited by E2F1 to the E2F1, cyclin D1, and cyclin E1 promoters. The function of GCN5 in lung cancer cells is abrogated by the knockdown of E2F1. Finally, we confirmed that GCN5 regulates the expression of E2F1, cyclin D1, and cyclin E1 and potentiates lung cancer cell growth in a mouse tumor model. Taken together, our results demonstrate that GCN5 specifically potentiates lung cancer growth by directly promoting the expression of E2F1, cyclin D1, and cyclin E1 in an E2F1-dependent manner. Our study identifies a specific and novel function of GCN5 in lung cancer development and suggests that the GCN5-E2F1 interaction represents a potential target for lung cancer treatment.	[Chen, Long; Wei, Tingyi; Si, Xiaoxing; Li, Yan; Leng, Ye; Wang, Guiying; Zhu, Songcheng; Kang, Jiuhong] Tongji Univ, Shanghai Matern & Infant Hlth Hosp 1, Shanghai Key Lab Signaling & Dis Res, Sch Life Sci & Technol,Clin & Translat Res Ctr, Shanghai 200092, Peoples R China; [Wang, Qianqian; Deng, Anmei; Chen, Jie] Second Mil Med Univ, Changhai Hosp, Dept Hematol & Lab Med, Shanghai 200433, Peoples R China	Tongji University; Naval Medical University	Zhu, SC (corresponding author), Tongji Univ, Shanghai Matern & Infant Hlth Hosp 1, Shanghai Key Lab Signaling & Dis Res, Sch Life Sci & Technol,Clin & Translat Res Ctr, 1239 Si Ping Rd, Shanghai 200092, Peoples R China.	zhusongcheng@tongji.edu.cn; jhkang@tongji.edu.cn			Ministry of Science and Technology [2011CB965100, 2010CB944902, 2011CBA01106, 2011DFA30480, 2010CB945000, 2012CB966603]; National Natural Science Foundation of China [91219305, 31171432, 31101061, 31210103905, 30971451, 31071306, 31000378, 81170499]; Science and Technology Commission of Shanghai Municipality Grant [11ZR1438500, 11XD1405300]; Ministry of Education from "Chen Guang" Project from Shanghai Municipal Education Commission [IRT1168, 20110072110039]; Shanghai Education Development Foundation Grant [12CG19]; Fundamental Research Funds for the Central Universities	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality Grant(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Education from "Chen Guang" Project from Shanghai Municipal Education Commission; Shanghai Education Development Foundation Grant; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by Ministry of Science and Technology Grants 2011CB965100, 2010CB944902, 2011CBA01106, 2011DFA30480, 2010CB945000, and 2012CB966603; National Natural Science Foundation of China Grants 91219305, 31171432, 31101061, 31210103905, 30971451, 31071306, 31000378, and 81170499; Science and Technology Commission of Shanghai Municipality Grant 11ZR1438500 and 11XD1405300; Ministry of Education Grants IRT1168 and 20110072110039 from "Chen Guang" Project from Shanghai Municipal Education Commission; Shanghai Education Development Foundation Grant 12CG19, and the Fundamental Research Funds for the Central Universities.	Ahmad M, 2012, DNA CELL BIOL, V31, pS62, DOI 10.1089/dna.2011.1575; Akil A, 2012, CANCER EPIDEMIOL, V36, pE300, DOI 10.1016/j.canep.2012.05.011; Al Dayel Fouad, 2012, J Infect Public Health, V5 Suppl 1, pS31, DOI 10.1016/j.jiph.2012.09.008; Alla V, 2010, JNCI-J NATL CANCER I, V102, P127, DOI 10.1093/jnci/djp458; Armas-Pineda C, 2007, J EXP CLIN CANC RES, V26, P269; Banerjee D, 2000, CANCER RES, V60, P2365; Cagle PT, 2012, ARCH PATHOL LAB MED, V136, P1482, DOI 10.5858/arpa.2012-0508-RA; Cartier J, 2011, J BIOL CHEM, V286, P26406, DOI 10.1074/jbc.M110.191239; Chen JK, 2010, MOL CELL BIOL, V30, P5621, DOI 10.1128/MCB.00465-10; Coffey K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045539; Engelmann D, 2012, CANCER RES, V72, P571, DOI 10.1158/0008-5472.CAN-11-2575; Fantin VR, 2007, CLIN CANCER RES, V13, P7237, DOI 10.1158/1078-0432.CCR-07-2114; Geng Y, 1996, ONCOGENE, V12, P1173; Germaniuk-Kurowska A, 2007, CANCER RES, V67, P11789, DOI 10.1158/0008-5472.CAN-07-2721; Giannini G, 2012, FUTURE MED CHEM, V4, P1439, DOI [10.4155/FMC.12.80, 10.4155/fmc.12.80]; Guo RF, 2011, NUCLEIC ACIDS RES, V39, P1390, DOI 10.1093/nar/gkq983; Halkidou K, 2003, ONCOGENE, V22, P2466, DOI 10.1038/sj.onc.1206342; Hayakawa T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/129383; Icardi L, 2012, CYTOKINE GROWTH F R, V23, P283, DOI 10.1016/j.cytogfr.2012.08.002; Inoshita S, 1999, KIDNEY INT, V56, P1238, DOI 10.1046/j.1523-1755.1999.00705.x; Iwamoto M, 2004, CANCER BIOL THER, V3, P395, DOI 10.4161/cbt.3.4.733; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kishimoto M, 2005, CLIN CANCER RES, V11, P512; Komatsu N, 2006, ONCOL REP, V15, P187; Lee JH, 2012, ADV CANCER RES, V116, P39, DOI 10.1016/B978-0-12-394387-3.00002-1; Li J, 2011, J BIOMOL SCREEN, V16, P450, DOI 10.1177/1087057111399191; Li SS, 2009, J BIOL CHEM, V284, P9411, DOI 10.1074/jbc.M809617200; Liu Y, 2013, CANCER RES, V73, P1308, DOI 10.1158/0008-5472.CAN-12-2489; Ma JA, 2010, CARCINOGENESIS, V31, P1552, DOI 10.1093/carcin/bgq140; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; NEUMAN E, 1994, MOL CELL BIOL, V14, P6607, DOI 10.1128/MCB.14.10.6607; Okumura K, 2006, J BIOL CHEM, V281, P26562, DOI 10.1074/jbc.M605391200; Park WJ, 2012, MOLECULES, V17, P13116, DOI 10.3390/molecules171113116; Ramsey MR, 2011, CANCER RES, V71, P4373, DOI 10.1158/0008-5472.CAN-11-0046; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Shiota M, 2010, CANCER SCI, V101, P1797, DOI 10.1111/j.1349-7006.2010.01598.x; Son JW, 2012, TUBERC RESPIR DIS, V73, P137, DOI 10.4046/trd.2012.73.3.137; Suzuki J, 2009, CLIN CANCER RES, V15, P3163, DOI 10.1158/1078-0432.CCR-08-2319; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Udayakumar T, 2010, SEMIN RADIAT ONCOL, V20, P258, DOI 10.1016/j.semradonc.2010.05.007; Vu BT, 2011, CURR TOP MICROBIOL, V348, P151, DOI 10.1007/82_2010_110; Wang F., 2013, CELL MOL LI IN PRESS; Watanabe N, 2012, CURR DRUG TARGETS, V13, P1654, DOI 10.2174/138945012803530035; Xu QB, 2009, MOL BIOL CELL, V20, P10, DOI 10.1091/mbc.E08-03-0324; Yan HL, 2012, CELL SIGNAL, V24, P961, DOI 10.1016/j.cellsig.2011.12.019; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Yuan H, 2013, AM J PHYSIOL-RENAL, V304, pF601, DOI 10.1152/ajprenal.00523.2012; Zhong S, 2007, ONCOGENE, V26, P2621, DOI 10.1038/sj.onc.1210041; Zhu SC, 2007, J BIOL CHEM, V282, P18327, DOI 10.1074/jbc.M700636200	50	100	104	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14510	14521		10.1074/jbc.M113.458737	http://dx.doi.org/10.1074/jbc.M113.458737			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23543735	hybrid, Green Published			2022-12-28	WOS:000319253500053
J	Gao, GZ; Wu, XY; Zhou, JQ; He, MF; He, JJ; Guo, DY				Gao, Guozhen; Wu, Xiaoyun; Zhou, Jieqiong; He, Mingfeng; He, Johnny J.; Guo, Deyin			Inhibition of HIV-1 Transcription and Replication by a Newly Identified Cyclin T1 Splice Variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; LONG TERMINAL REPEAT; P-TEFB KINASE; IN-VIVO; TAR RNA; DEPENDENT TRANSCRIPTION; ELONGATION COMPLEX; 7SK SNRNP; PROTEIN; ACTIVATION	A variety of cellular factors participates in the HIV-1 life cycle. Among them is the well characterized cyclin T1 (CYCT1). CycT1 binds to cyclin-dependent kinase 9 (CDK9) and forms the positive transcription elongation factor-b (P-TEFb). P-TEFb is then recruited by HIV-1 TAT to the HIV-1 long terminal repeat (LTR) promoter and subsequently leads to phosphorylation of the C-terminal domain of RNA polymerase II (pol II), enhanced processivity of pol II, and transcription of a full-length HIV-1 RNA. In this study, we report the identification of a new CYCT1 splice variant, designated as CYCT1b, and accordingly we renamed CYCT1 as CYCT1a. CYCT1b was detected in several cell lines, including primary human CD4 T cells, and its expression was subject to cell cycle regulation. Similar to CYCT1a, CYCT1b was primarily localized in the nucleus. CYCT1b expression was found to be inversely correlated with HIV-1 gene expression and replication. This inverse correlation appeared to involve TAT transactivation, CDK9 binding, and subsequent recruitment of P-TEFb to the HIV-1 LTR promoter and pol II C-terminal domain phosphorylation. In agreement with these findings, CYCT1b expression led to direct inhibition of TAT-transactivated transcription of the HIV-1 LTR promoter. Taken together, these results show that the newly identified CYCT1b splice variant inhibits HIV-1 transcription and may provide new clues for the development of anti-HIV strategies.	[Gao, Guozhen; Wu, Xiaoyun; Zhou, Jieqiong; Guo, Deyin] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Gao, Guozhen; Wu, Xiaoyun; Zhou, Jieqiong; Guo, Deyin] Wuhan Univ, Coll Life Sci, Modern Virol Res Ctr, Wuhan 430072, Peoples R China; [Gao, Guozhen; He, Mingfeng; He, Johnny J.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [He, Johnny J.] Indiana Univ Sch Med, Ctr AIDS Res, Indianapolis, IN 46202 USA; [He, Johnny J.] Univ N Texas, Hlth Sci Ctr, Ft Worth, TX 76107 USA; [Guo, Deyin] Wuhan Univ, Sch Med, Inst Med Virol, Wuhan 430071, Peoples R China	Wuhan University; Wuhan University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of North Texas System; University of North Texas Health Science Center; Wuhan University	He, JJ (corresponding author), Univ N Texas, Hlth Sci Ctr, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	johnny.he@unthsc.edu; dguo@whu.edu.cn	Gao, Guozhen/U-1554-2019	Gao, Guozhen/0000-0002-9510-1474	National Institutes of Health [R01NS065785, R01MH092673]; National Natural Science Foundation, China [31028002/C010803]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS065785 and R01MH092673 (to J. J. H.). This work was also supported by Grant 31028002/C010803 (to D. G.) from the National Natural Science Foundation, China.	Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Benedikt A, 2011, LEUKEMIA, V25, P135, DOI 10.1038/leu.2010.249; Bevec D, 1996, SCIENCE, V271, P1858, DOI 10.1126/science.271.5257.1858; Bogerd HP, 1998, J VIROL, V72, P8627, DOI 10.1128/JVI.72.11.8627-8635.1998; Brady J, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-69; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chou S, 2013, P NATL ACAD SCI USA, V110, pE123, DOI 10.1073/pnas.1216971110; Dhillon S, 2010, J VIROL, V84, P5494, DOI 10.1128/JVI.02153-09; Dong CS, 2009, J VIROL, V83, P3518, DOI 10.1128/JVI.02665-08; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; Fang JH, 2004, VIROLOGY, V330, P471, DOI 10.1016/j.virol.2004.09.039; Fraldi A, 2001, J CELL BIOCHEM, P247; Friedrich BM, 2011, VIRUS RES, V161, P101, DOI 10.1016/j.virusres.2011.08.001; Fu TJ, 1999, J BIOL CHEM, V274, P34527, DOI 10.1074/jbc.274.49.34527; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Garriga J, 1998, ONCOGENE, V17, P3093, DOI 10.1038/sj.onc.1202548; Garriga J, 2010, J CELL PHYSIOL, V222, P200, DOI 10.1002/jcp.21938; Gold MO, 1998, J VIROL, V72, P4448, DOI 10.1128/JVI.72.5.4448-4453.1998; He JL, 1997, P NATL ACAD SCI USA, V94, P3954, DOI 10.1073/pnas.94.8.3954; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; He N, 2008, MOL CELL, V29, P588, DOI 10.1016/j.molcel.2008.01.003; Henao-Mejia J, 2009, MOL CELL, V33, P87, DOI 10.1016/j.molcel.2008.11.024; Herrmann CH, 1998, J VIROL, V72, P9881, DOI 10.1128/JVI.72.12.9881-9888.1998; Hiscott J, 2001, J CLIN INVEST, V107, P143, DOI 10.1172/JCI11918; Ivanov D, 1999, J MOL BIOL, V288, P41, DOI 10.1006/jmbi.1999.2663; Jablonski JA, 2009, J VIROL, V83, P981, DOI 10.1128/JVI.01801-08; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lee CS, 2008, NUCLEIC ACIDS RES, V36, P4708, DOI 10.1093/nar/gkn454; Lee DK, 2001, J BIOL CHEM, V276, P9978, DOI 10.1074/jbc.M002285200; Li JL, 2002, J VIROL, V76, P8374, DOI 10.1128/JVI.76.16.8374-8382.2002; Li ZY, 2005, FEBS LETT, V579, P3100, DOI 10.1016/j.febslet.2005.04.074; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Liou LY, 2006, J LEUKOCYTE BIOL, V79, P388, DOI 10.1189/jlb.0805429; Liou LY, 2002, J VIROL, V76, P10579, DOI 10.1128/JVI.76.21.10579-10587.2002; Liu JF, 2011, J NEUROIMMUNE PHARM, V6, P308, DOI 10.1007/s11481-011-9265-8; Liu Y, 2002, J BIOL CHEM, V277, P23854, DOI 10.1074/jbc.M200773200; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Marcello A, 2001, J BIOL CHEM, V276, P39220, DOI 10.1074/jbc.M104830200; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Montanuy I, 2008, J BIOL CHEM, V283, P7368, DOI 10.1074/jbc.M706243200; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Napolitano G, 1999, AIDS, V13, P1453, DOI 10.1097/00002030-199908200-00003; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Ramakrishnan R, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-90; Ramakrishnan Rajesh, 2011, BMC Res Notes, V4, P260, DOI 10.1186/1756-0500-4-260; Rato S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009276; Rohr O, 2003, J LEUKOCYTE BIOL, V74, P736, DOI 10.1189/jlb.0403180; Schulte A, 2005, J BIOL CHEM, V280, P24968, DOI 10.1074/jbc.M501431200; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Shilatifard A, 1997, P NATL ACAD SCI USA, V94, P3639, DOI 10.1073/pnas.94.8.3639; Shore SM, 2003, GENE, V307, P175, DOI 10.1016/S0378-1119(03)00466-9; Simone C, 2002, ONCOGENE, V21, P4137, DOI 10.1038/sj.onc.1205493; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Sung TL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000263; Tian YN, 2003, J BIOL CHEM, V278, P44041, DOI 10.1074/jbc.M306443200; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wimmer J, 1999, VIROLOGY, V255, P182, DOI 10.1006/viro.1998.9589; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Yedavalli VSRK, 2003, J BIOL CHEM, V278, P6404, DOI 10.1074/jbc.M209162200; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	74	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14297	14309		10.1074/jbc.M112.438465	http://dx.doi.org/10.1074/jbc.M112.438465			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23569210	Green Published, hybrid			2022-12-28	WOS:000319253500034
J	Brachvogel, B; Zaucke, F; Dave, K; Norris, EL; Stermann, J; Dayakli, M; Koch, M; Gorman, JJ; Bateman, JF; Wilson, R				Brachvogel, Bent; Zaucke, Frank; Dave, Keyur; Norris, Emma L.; Stermann, Jacek; Dayakli, Muenire; Koch, Manuel; Gorman, Jeffrey J.; Bateman, John F.; Wilson, Richard			Comparative Proteomic Analysis of Normal and Collagen IX Null Mouse Cartilage Reveals Altered Extracellular Matrix Composition and Novel Components of the Collagen IX Interactome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE EPIPHYSEAL DYSPLASIA; ARTICULAR-CARTILAGE; XII COLLAGEN; BETA-IG-H3 INTERACTS; STATISTICAL-MODEL; GROWTH-PLATE; MURINE MODEL; PROTEIN; MICE; PSEUDOACHONDROPLASIA	The cartilage extracellular matrix is essential for endochondral bone development and joint function. In addition to the major aggrecan/collagen II framework, the interacting complex of collagen IX, matrilin-3, and cartilage oligomeric matrix protein (COMP) is essential for cartilage matrix stability, as mutations in Col9a1, Col9a2, Col9a3, Comp, and Matn3 genes cause multiple epiphyseal dysplasia, in which patients develop early onset osteoarthritis. In mice, collagen IX ablation results in severely disturbed growth plate organization, hypocellular regions, and abnormal chondrocyte shape. This abnormal differentiation is likely to involve altered cell-matrix interactions but the mechanism is not known. To investigate the molecular basis of the collagen IX null phenotype we analyzed global differences in protein abundance between wild-type and knockout femoral head cartilage by capillary HPLC tandem mass spectrometry. We identified 297 proteins in 3-day cartilage and 397 proteins in 21-day cartilage. Components that were differentially abundant between wild-type and collagen IX-deficient cartilage included 15 extracellular matrix proteins. Collagen IX ablation was associated with dramatically reduced COMP and matrilin-3, consistent with known interactions. Matrilin-1, matrilin-4, epiphycan, and thrombospondin-4 levels were reduced in collagen IX null cartilage, providing the first in vivo evidence for these proteins belonging to the collagen IX interactome. Thrombospondin-4 expression was reduced at the mRNA level, whereas matrilin-4 was verified as a novel collagen IX-binding protein. Furthermore, changes in TGF beta-induced protein beta ig-h3 and fibronectin abundance were found in the collagen IX knock-out but not associated with COMP ablation, indicating specific involvement in the abnormal collagen IX null cartilage. In addition, the more widespread expression of collagen XII in the collagen IX-deficient cartilage suggests an attempted compensatory response to the absence of collagen IX. Our differential proteomic analysis of cartilage is a novel approach to identify candidate matrix protein interactions in vivo, underpinning further analysis of mutant cartilage lacking other matrix components or harboring disease-causing mutations.	[Brachvogel, Bent; Zaucke, Frank; Stermann, Jacek; Dayakli, Muenire; Koch, Manuel] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Brachvogel, Bent; Koch, Manuel; Bateman, John F.; Wilson, Richard] CMMC, D-50931 Cologne, Germany; [Dave, Keyur; Norris, Emma L.; Gorman, Jeffrey J.] Queensland Inst Med Res, Prot Discovery Ctr, Herston, Qld 4029, Australia; [Koch, Manuel] Univ Cologne, Fac Med, Inst Dent Res & Oral Musculoskeletal Biol, D-50931 Cologne, Germany; [Bateman, John F.; Wilson, Richard] Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [Wilson, Richard] Univ Tasmania, Cent Sci Lab, Hobart, Tas 7001, Australia	University of Cologne; University of Cologne; QIMR Berghofer Medical Research Institute; University of Cologne; Murdoch Children's Research Institute; University of Tasmania	Bateman, JF (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia.	john.bateman@mcri.edu.au; richard.wilson@utas.edu.au	Zaucke, Frank/E-2077-2012; Koch, Manuel/AAG-9914-2021; Zaucke, Frank/AAT-2688-2021; Wilson, Richard/H-8429-2012; Dave, Keyur/L-2862-2016	Koch, Manuel/0000-0002-2962-7814; Wilson, Richard/0000-0003-0152-4394; Dave, Keyur/0000-0002-6476-8399; Brachvogel, Bent/0000-0002-3923-0554; Bateman, John/0000-0001-8542-0730	National Health and Medical Research Council of Australia; Murdoch Childrens Research Institute; Victorian Government's Operational Infrastructure Support Program; Deutsche Forschungsgemeinschaft [BR2304/5-1, BR2304/7-1, ZA561/2-1]; Bioplatforms Australia; Queensland State Government	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Murdoch Childrens Research Institute; Victorian Government's Operational Infrastructure Support Program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bioplatforms Australia; Queensland State Government	This work was supported by grants from the National Health and Medical Research Council of Australia, the Murdoch Childrens Research Institute, the Victorian Government's Operational Infrastructure Support Program, and Deutsche Forschungsgemeinschaft Grants BR2304/5-1, BR2304/7-1, and ZA561/2-1.; We thank Mats Paulsson for critical reading of this manuscript and Paul O'Donnell (Bio21 institute, University of Melbourne) for assistance in analyzing excised proteins by mass spectrometry. Access to proteomic infrastructure funding in the QIMR Protein Discovery Centre was made possible through the Australian Government National Collaborative Infrastructure Scheme (NCRIS) provided via Bioplatforms Australia and the Queensland State Government.	Agarwal P, 2012, J BIOL CHEM, V287, P22549, DOI 10.1074/jbc.M111.335935; Aszodi A, 2000, CELL STRUCT FUNCT, V25, P73, DOI 10.1247/csf.25.73; Billings PC, 2002, J BIOL CHEM, V277, P28003, DOI 10.1074/jbc.M106837200; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; Blumbach K, 2008, MATRIX BIOL, V27, P306, DOI 10.1016/j.matbio.2007.11.007; Bonnemann CG, 2000, P NATL ACAD SCI USA, V97, P1212, DOI 10.1073/pnas.97.3.1212; Briggs MD, 2002, HUM MUTAT, V19, P465, DOI 10.1002/humu.10066; Brown RJ, 2011, PROTEOMICS, V11, P4660, DOI 10.1002/pmic.201100058; Budde B, 2005, MOL CELL BIOL, V25, P10465, DOI 10.1128/MCB.25.23.10465-10478.2005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dreier R, 2008, MATRIX BIOL, V27, P319, DOI 10.1016/j.matbio.2008.01.006; Eyre DR, 2006, EUR CELLS MATER, V12, P57, DOI 10.22203/eCM.v012a07; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; Font B, 1996, MATRIX BIOL, V15, P341, DOI 10.1016/S0945-053X(96)90137-7; Fresquet M, 2010, J BIOL CHEM, V285, P34048, DOI 10.1074/jbc.M110.154443; GORDON MK, 1990, ANN NY ACAD SCI, V580, P8, DOI 10.1111/j.1749-6632.1990.tb17913.x; GORDON MK, 1989, J BIOL CHEM, V264, P19772; Gregory KE, 2001, J BONE MINER RES, V16, P2005, DOI 10.1359/jbmr.2001.16.11.2005; Groma G, 2011, MATRIX BIOL, V30, P275, DOI 10.1016/j.matbio.2011.04.002; Hagg R, 1997, J BIOL CHEM, V272, P20650, DOI 10.1074/jbc.272.33.20650; Hanssen E, 2003, J BIOL CHEM, V278, P24334, DOI 10.1074/jbc.M303455200; Hashimoto K, 1997, BBA-MOL CELL RES, V1355, P303, DOI 10.1016/S0167-4889(96)00147-4; Holden P, 2001, J BIOL CHEM, V276, P6046, DOI 10.1074/jbc.M009507200; Izu Y, 2011, J CELL BIOL, V193, P1115, DOI 10.1083/jcb.201010010; Johnson HJ, 1997, J BIOL CHEM, V272, P18709, DOI 10.1074/jbc.272.30.18709; Kall L, 2009, BIOINFORMATICS, V25, P964, DOI 10.1093/bioinformatics/btp021; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim DS, 2012, J NEUROSCI, V32, P8977, DOI 10.1523/JNEUROSCI.6494-11.2012; Klatt AR, 2001, J BIOL CHEM, V276, P17267, DOI 10.1074/jbc.M100587200; Kutsuna T, 2011, INT J MOL MED, V28, P829, DOI 10.3892/ijmm.2011.766; Leighton MP, 2007, HUM MOL GENET, V16, P1728, DOI 10.1093/hmg/ddm121; NAKATA K, 1993, P NATL ACAD SCI USA, V90, P2870, DOI 10.1073/pnas.90.7.2870; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Newman B, 2003, CLIN GENET, V63, P241, DOI 10.1034/j.1399-0004.2003.00046.x; Nuka S, 2010, OSTEOARTHR CARTILAGE, V18, P88, DOI 10.1016/j.joca.2009.11.006; Ohno S, 2005, CONNECT TISSUE RES, V46, P227, DOI 10.1080/03008200500346111; Ohno S, 2002, BBA-GEN SUBJECTS, V1572, P114, DOI 10.1016/S0304-4165(02)00286-6; Parsons P, 2011, J BIOL CHEM, V286, P34986, DOI 10.1074/jbc.M111.238188; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pham TV, 2010, BIOINFORMATICS, V26, P363, DOI 10.1093/bioinformatics/btp677; Pirog-Garcia KA, 2007, HUM MOL GENET, V16, P2072, DOI 10.1093/hmg/ddm155; Posey KL, 2008, AM J PATHOL, V172, P1664, DOI 10.2353/ajpath.2008.071094; Reinboth B, 2006, J BIOL CHEM, V281, P7816, DOI 10.1074/jbc.M511316200; Schmitz M, 2006, J BIOL CHEM, V281, P32587, DOI 10.1074/jbc.M601976200; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; Svensson L, 2002, MOL CELL BIOL, V22, P4366, DOI 10.1128/MCB.22.12.4366-4371.2002; Takeda H, 2010, INT J MOL MED, V25, P593, DOI 10.3892/ijmm_00000381; Tillgren V, 2009, J BIOL CHEM, V284, P28543, DOI 10.1074/jbc.M109.047076; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Ween MP, 2011, INT J CANCER, V128, P1570, DOI 10.1002/ijc.25494; Wilson R., 2012, MOL CELL PROTEOMICS, V11.1, DOI DOI 10.1074/MCP.M111.014159; Wilson R, 2008, METHODS, V45, P22, DOI 10.1016/j.ymeth.2008.01.008; Wilson R, 2010, MOL CELL PROTEOMICS, V9, P1296, DOI 10.1074/mcp.M000014-MCP201; Wilson R, 2008, MATRIX BIOL, V27, P709, DOI 10.1016/j.matbio.2008.07.007; Yoshimi Masayuki, 2005, Journal of Medical and Dental Sciences, V52, P203	56	39	39	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13481	13492		10.1074/jbc.M112.444810	http://dx.doi.org/10.1074/jbc.M112.444810			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23530037	Green Published, hybrid			2022-12-28	WOS:000318850300032
J	Heim, KP; Crowley, PJ; Brady, LJ				Heim, Kyle P.; Crowley, Paula J.; Brady, L. Jeannine			An Intramolecular Interaction Involving the N Terminus of a Streptococcal Adhesin Affects Its Conformation and Adhesive Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE PROTEIN ANTIGEN; CIRCULAR-DICHROISM SPECTRA; SALIVARY AGGLUTININ; BACTERIA-BINDING; MUTANS P1; MONOCLONAL-ANTIBODIES; SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; ISOPEPTIDE BONDS; ADHERENCE	The adhesin P1 is localized on the surface of the oral pathogen Streptococcus mutans and facilitates an interaction with the glycoprotein complex salivary agglutinin that is comprised primarily of the scavenger receptor gp340. Recent crystal structures of P1 display an unusual structure in which the protein folds back upon itself to form an elongated hybrid helical stalk with a globular head at the apex and a globular C-terminal region at the base. The N terminus of P1 has not yet been characterized. In this report we describe the contribution of an interaction between the N-terminal and C-terminal portions of the protein that is required for proper function of P1 on the surface of S. mutans. Utilizing recombinant N-terminal and C-terminal fragments, we employed isothermal titration calorimetry and native gel electrophoresis to demonstrate that these fragments form a high affinity and stable complex in solution. Furthermore, circular dichroism and surface plasmon resonance measurements indicated that the N-terminal fragment contributes to the folding and increases the functionality of the C-terminal fragment in trans. Finally, we utilized circular dichroism, surface plasmon resonance, and differential scanning calorimetry to show that an N-terminal 106-amino acid segment within P1 contributes to the proper folding and function of the full-length recombinant molecule and increases the stability of its elongated hybrid helical stalk.	[Heim, Kyle P.; Crowley, Paula J.; Brady, L. Jeannine] Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Brady, LJ (corresponding author), Univ Florida, Dept Oral Biol, 1395 Ctr Dr,D4-22, Gainesville, FL 32610 USA.	jbrady@dental.ufl.edu	Brady, L. Jeannine/P-5059-2019		National Institutes of Health [R01DE08007, R01DE21789]; University of Florida Alumni Fellowship; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE008007, R01DE021789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida Alumni Fellowship(University of Florida); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE08007 and R01DE21789 (NIDCR). This work was also supported by a University of Florida Alumni Fellowship.	AYAKAWA GY, 1987, INFECT IMMUN, V55, P2759, DOI 10.1128/IAI.55.11.2759-2767.1987; Balakrishnan M, 2000, AUST DENT J, V45, P235, DOI 10.1111/j.1834-7819.2000.tb00257.x; Bikker FJ, 2004, J BIOL CHEM, V279, P47699, DOI 10.1074/jbc.M406095200; Bikker FJ, 2002, J BIOL CHEM, V277, P32109, DOI 10.1074/jbc.M203788200; BLEIWEIS AS, 1992, ADV EXP MED BIOL, V327, P229; BLEIWEIS AS, 1990, ARCH ORAL BIOL, V35, pS15, DOI 10.1016/0003-9969(90)90126-U; BOWEN WH, 1991, INFECT IMMUN, V59, P4606, DOI 10.1128/IAI.59.12.4606-4609.1991; BRADY LJ, 1992, INFECT IMMUN, V60, P1008, DOI 10.1128/IAI.60.3.1008-1017.1992; Brady LJ, 1998, INFECT IMMUN, V66, P4274; BRADY LJ, 1991, INFECT IMMUN, V59, P1803, DOI 10.1128/IAI.59.5.1803-1810.1991; BRADY LJ, 1991, INFECT IMMUN, V59, P4425, DOI 10.1128/IAI.59.12.4425-4435.1991; BUCKLEY ND, 1995, J BACTERIOL, V177, P5028, DOI 10.1128/jb.177.17.5028-5034.1995; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Crowley PJ, 2008, INFECT IMMUN, V76, P2456, DOI 10.1128/IAI.01315-07; CROWLEY PJ, 1993, INFECT IMMUN, V61, P1547, DOI 10.1128/IAI.61.4.1547-1552.1993; Crowley PJ, 1999, INFECT IMMUN, V67, P1201, DOI 10.1128/IAI.67.3.1201-1206.1999; ERICSON T, 1983, EUR J BIOCHEM, V133, P255, DOI 10.1111/j.1432-1033.1983.tb07456.x; Forsgren N, 2010, J MOL BIOL, V397, P740, DOI 10.1016/j.jmb.2010.01.065; GOMEZ J, 1995, PROTEINS, V22, P404, DOI 10.1002/prot.340220410; GOMEZ J, 1995, J MOL BIOL, V252, P337, DOI 10.1006/jmbi.1995.0501; Guzman-Armstrong Sandra, 2005, J Sch Nurs, V21, P272; HAJISHENGALLIS G, 1992, INFECT IMMUN, V60, P5057, DOI 10.1128/IAI.60.12.5057-5064.1992; HAJISHENGALLIS G, 1994, J DENT RES, V73, P1493, DOI 10.1177/00220345940730090301; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; HENNESSEY JP, 1981, BIOCHEMISTRY-US, V20, P1085, DOI 10.1021/bi00508a007; Holdgate G, 2010, METHODS MOL BIOL, V572, P101, DOI 10.1007/978-1-60761-244-5_7; Hu XQ, 2011, J AM CHEM SOC, V133, P478, DOI 10.1021/ja107513t; Jakubovics NS, 2005, MOL MICROBIOL, V55, P1591, DOI 10.1111/j.1365-2958.2005.04495.x; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; KELLY C, 1990, ARCH ORAL BIOL, V35, pS33, DOI 10.1016/0003-9969(90)90128-W; KISHIMOTO E, 1989, INFECT IMMUN, V57, P3702, DOI 10.1128/IAI.57.12.3702-3707.1989; KOGA T, 1986, J GEN MICROBIOL, V132, P2873; KOGA T, 1990, INFECT IMMUN, V58, P289, DOI 10.1128/IAI.58.2.289-296.1990; Larson MR, 2011, J BIOL CHEM, V286, P21657, DOI 10.1074/jbc.M111.231100; Larson MR, 2010, P NATL ACAD SCI USA, V107, P5983, DOI 10.1073/pnas.0912293107; Lee SF, 2003, INFECT IMMUN, V71, P676, DOI 10.1128/IAI.71.2.676-681.2003; LEE SF, 1989, INFECT IMMUN, V57, P3306, DOI 10.1128/IAI.57.11.3306-3313.1989; Leito JTD, 2008, BIOL CHEM, V389, P1193, DOI 10.1515/BC.2008.135; Lewis Edwin A., 2005, V305, P1; LIVINGSTONE JR, 1991, BIOCHEMISTRY-US, V30, P4237, DOI 10.1021/bi00231a019; Loimaranta V, 2005, INFECT IMMUN, V73, P2245, DOI 10.1128/IAI.73.4.2245-2252.2005; Lopez Maria M, 2002, Methods Mol Biol, V173, P121; Ma BY, 2000, PROTEIN ENG, V13, P617, DOI 10.1093/protein/13.9.617; Madsen J, 2010, INNATE IMMUN-LONDON, V16, P160, DOI 10.1177/1753425910368447; McArthur WP, 2007, FEMS IMMUNOL MED MIC, V50, P342, DOI 10.1111/j.1574-695X.2007.00260.x; Mosci F, 1990, Minerva Stomatol, V39, P413; MUNRO GH, 1993, INFECT IMMUN, V61, P4590, DOI 10.1128/IAI.61.11.4590-4598.1993; MURPHY KP, 1992, J MOL BIOL, V227, P293, DOI 10.1016/0022-2836(92)90699-K; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Nylander A, 2011, ACTA CRYSTALLOGR F, V67, P23, DOI 10.1107/S174430911004443X; Oho T, 1998, INFECT IMMUN, V66, P115, DOI 10.1128/IAI.66.1.115-121.1998; Oli MW, 2012, MICROBIOL-SGM, V158, P2903, DOI 10.1099/mic.0.060855-0; Oli MW, 2006, J MICROBIOL METH, V65, P503, DOI 10.1016/j.mimet.2005.09.011; PERRY D, 1989, INFECT IMMUN, V57, P805, DOI 10.1128/IAI.57.3.805-809.1989; Pointon JA, 2010, J BIOL CHEM, V285, P33858, DOI 10.1074/jbc.M110.149385; Rhodin NR, 2004, INFECT IMMUN, V72, P4680, DOI 10.1128/IAI.72.8.4680-4688.2004; Rhodin NR, 2004, INFECT IMMUN, V72, P13, DOI 10.1128/IAI.72.1.13-21.2004; Robinette RA, 2009, J IMMUNOL, V183, P4628, DOI 10.4049/jimmunol.0803300; RUSSELL MW, 1980, INFECT IMMUN, V28, P486; RUSSELL MW, 1989, ORAL MICROBIOL IMMUN, V4, P106, DOI 10.1111/j.1399-302X.1989.tb00107.x; RUSSELL RRB, 1979, J GEN MICROBIOL, V114, P109, DOI 10.1099/00221287-114-1-109; Seifert TB, 2004, INFECT IMMUN, V72, P4699, DOI 10.1128/IAI.72.8.4699-4706.2004; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; SPOLAR RS, 1992, BIOCHEMISTRY-US, V31, P3947, DOI 10.1021/bi00131a009; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Tsai CJ, 2001, CRIT REV BIOCHEM MOL, V36, P399, DOI 10.1080/20014091074228; van Dolleweerd CJ, 2004, J BIOL CHEM, V279, P22198, DOI 10.1074/jbc.M400820200; Velazquez-Campoy Adrian, 2004, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1708s23; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Zucca M, 1990, G Batteriol Virol Immunol, V83, P108	74	9	9	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13762	13774		10.1074/jbc.M113.459974	http://dx.doi.org/10.1074/jbc.M113.459974			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23539625	Green Published, hybrid			2022-12-28	WOS:000318850300058
J	Kerzerho, J; Schneider, A; Favry, E; Castelli, FA; Maillere, B				Kerzerho, Jerome; Schneider, Aurelie; Favry, Emmanuel; Castelli, Florence Anne; Maillere, Bernard			The Signal Peptide of the Tumor-shared Antigen Midkine Hosts CD4(+) T Cell Epitopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING GROWTH-FACTOR; CATHEPSIN-D; REPERTOIRE; CANCER; EXPRESSION; MICE; SPECIFICITY; GENERATION; CARCINOMAS; FREQUENCY	Because of the key role of CD4 T cell response in immunity to tumors, we investigated the CD4(+) T cell response to the recently identified tumor antigen Midkine (MDK). By weekly stimulations of T lymphocytes harvested from seven HLA-DR-typed healthy donors, we derived CD4(+) T cell lines specific for eight MDK peptides. Most of the T cell lines reacted with the peptides 9-23 and 14-28, located in and overlapping the MDK signal peptide, respectively. Accordingly, the MDK signal peptide appeared to be rich in good binders to common HLA-DR molecules. The peptide 9-23-specific T cell lines were specifically stimulated by autologous dendritic cells loaded with lysates of MDK-transfected cells or with lysates of tumor cells naturally expressing the MDK protein. One T cell line was stimulated by HLA-compatible MDK-transfected tumor cells. By contrast, the peptide 14-28-specific T cell lines were not stimulated in any of these conditions. Our data demonstrate that CD4(+) T cell epitopes present in the signal peptide can be accessible to recognition by CD4(+) T cells and may therefore contribute to tumor immunity, whereas a peptide overlapping the junction between the signal peptide and the mature protein is not.	[Kerzerho, Jerome; Schneider, Aurelie; Favry, Emmanuel; Castelli, Florence Anne; Maillere, Bernard] CEA, IBiTecS, Serv Ingn Mol Prot SIMOPRO, Labex LERMIT,Labex VRI, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay	Maillere, B (corresponding author), CEA, IBiTecS, Serv Ingn Mol Prot SIMOPRO, F-91191 Gif Sur Yvette, France.	bernard.maillere@cea.fr			Commissariat a l'Energie Atomique	Commissariat a l'Energie Atomique(French Atomic Energy Commission)	This work was supported by the Commissariat a l'Energie Atomique.	Assarsson E, 2007, J IMMUNOL, V178, P7890, DOI 10.4049/jimmunol.178.12.7890; Assudani DP, 2007, CANCER IMMUNOL IMMUN, V56, P70, DOI 10.1007/s00262-006-0154-6; Borbosa MDF, 2007, DRUG DISCOV TODAY, V12, P674, DOI 10.1016/j.drudis.2007.06.005; Castelli FA, 2002, J IMMUNOL, V169, P6928, DOI 10.4049/jimmunol.169.12.6928; Castelli FA, 2008, EUR J IMMUNOL, V38, P2821, DOI 10.1002/eji.200738072; Castelli FA, 2007, EUR J IMMUNOL, V37, P1513, DOI 10.1002/eji.200636783; Choudhuri R, 1997, CANCER RES, V57, P1814; Delluc S, 2011, FASEB J, V25, P2040, DOI 10.1096/fj.10-173872; Delluc S, 2010, BLOOD, V116, P4542, DOI 10.1182/blood-2010-04-280875; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Egilmez NK, 2002, CANCER RES, V62, P2611; El Hage F, 2008, P NATL ACAD SCI USA, V105, P10119, DOI 10.1073/pnas.0802753105; Haynes L, 2001, Prog Brain Res, V132, P313; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Hewitt EW, 1997, J IMMUNOL, V159, P4693; Hobo A, 2009, J CLIN INVEST, V119, P1616, DOI 10.1172/JCI37249; Horiba M, 2006, CIRCULATION, V114, P1713, DOI 10.1161/CIRCULATIONAHA.106.632273; Ikematsu S, 2000, BRIT J CANCER, V83, P701, DOI 10.1054/bjoc.2000.1339; Ikematsu S, 2008, CANCER SCI, V99, P2070, DOI 10.1111/j.1349-7006.2008.00957.x; Ishiguro H, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00027; Kerzerho J, 2010, J IMMUNOL, V185, P418, DOI 10.4049/jimmunol.0901014; Koide N, 1999, HEPATO-GASTROENTEROL, V46, P3189; Kovjazin R, 2011, VACCINE, V29, P4676, DOI 10.1016/j.vaccine.2011.04.103; Kwok WW, 2012, J IMMUNOL, V188, P2537, DOI 10.4049/jimmunol.1102190; Maeda S, 2007, BRIT J CANCER, V97, P405, DOI 10.1038/sj.bjc.6603879; Martoglio B, 2003, BIOCHEM SOC T, V31, P1243; Maruyama K, 2004, ARTHRITIS RHEUM-US, V50, P1420, DOI 10.1002/art.20175; Mitchell MS, 2007, CANCER IMMUNOL IMMUN, V56, P287, DOI 10.1007/s00262-006-0191-1; MIZUOCHI T, 1994, IMMUNOL LETT, V43, P189, DOI 10.1016/0165-2478(94)90221-6; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; MURAMATSU H, 1991, BIOCHEM BIOPH RES CO, V177, P652, DOI 10.1016/0006-291X(91)91838-4; Muramatsu T, 2011, CURR PHARM DESIGN, V17, P410, DOI 10.2174/138161211795164167; Musson JA, 2010, INFECT IMMUN, V78, P4356, DOI 10.1128/IAI.00195-10; OBrien T, 1996, CANCER RES, V56, P2515; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Sato W, 2001, J IMMUNOL, V167, P3463, DOI 10.4049/jimmunol.167.6.3463; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Takei Y, 2001, CANCER RES, V61, P8486; Takenaka H, 2009, AM J PHYSIOL-HEART C, V296, pH462, DOI 10.1152/ajpheart.00733.2008; Texier C, 2000, J IMMUNOL, V164, P3177, DOI 10.4049/jimmunol.164.6.3177; Texier C, 2001, EUR J IMMUNOL, V31, P1837, DOI 10.1002/1521-4141(200106)31:6&lt;1837::AID-IMMU1837&gt;3.0.CO;2-H; Thomas WD, 1998, INT J CANCER, V75, P384; Wang QL, 2007, J BIOMED SCI, V14, P783, DOI 10.1007/s11373-007-9192-0; Wang XF, 2008, J IMMUNOL, V181, P431, DOI 10.4049/jimmunol.181.1.431; Wang XF, 2007, CANCER IMMUNOL IMMUN, V56, P807, DOI 10.1007/s00262-006-0230-y; Wolfel C, 2000, INT J CANCER, V88, P432; Ye C, 1999, BRIT J CANCER, V79, P179, DOI 10.1038/sj.bjc.6690030; Zarour HM, 2002, CANCER RES, V62, P213; Zhang Y, 2005, J IMMUNOL, V174, P2404, DOI 10.4049/jimmunol.174.4.2404	49	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13370	13377		10.1074/jbc.M112.427302	http://dx.doi.org/10.1074/jbc.M112.427302			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23553629	Green Published, hybrid			2022-12-28	WOS:000318850300022
J	Minor, EA; Court, BL; Young, JI; Wang, GF				Minor, Emily A.; Court, Brenda L.; Young, Juan I.; Wang, Gaofeng			Ascorbate Induces Ten-Eleven Translocation (Tet) Methylcytosine Dioxygenase-mediated Generation of 5-Hydroxymethylcytosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; VITAMIN-C; DNA DEMETHYLATION; 5-METHYLCYTOSINE; BRAIN; SPECIFICATION; HYDROXYLATION; CONVERSION; TRANSPORT; PROTEINS	Ascorbate (vitamin C) is best known for its role in scurvy, in which the hydroxylation of collagen catalyzed by dioxygenases is incomplete due to ascorbate deficiency. Here, we report a novel function of ascorbate in the hydroxylation of 5-methylcytosine (5-mC) to 5-hydroxymethylcytosine (5-hmC) in DNA catalyzed by Tet (ten-eleven translocation) methylcytosine dioxygenase. The content of 5-hmC is extremely low in mouse embryonic fibroblasts cultured in ascorbate-free medium. Additions of ascorbate dose-and time-dependently enhance the generation of 5-hmC, without any effects on the expression of Tet genes. Treatment with another reducer glutathione (GSH) does not change the level of 5-hmC. Further, blocking ascorbate entry into cells by phloretin and knocking down Tet (Tet1, Tet2, and Tet3) expression by short interference RNAs (siRNA) significantly inhibit the effect of ascorbate on 5-hmC. These results suggest that ascorbate enhances 5-hmC generation, most likely by acting as a co-factor for Tet methylcytosine dioxygenase to hydroxylate 5-mC. Thus, we have uncovered a novel role for ascorbate in modulating the epigenetic control of genome activity.	[Minor, Emily A.; Court, Brenda L.; Young, Juan I.; Wang, Gaofeng] Univ Miami, Miller Sch Med, Dept Human Genet, Dr John T Macdonald Fdn,John P Hussman Inst Human, Miami, FL 33136 USA	University of Miami	Wang, GF (corresponding author), Univ Miami, Miller Sch Med, Biomed Res Bldg,Rm 525,1501 NW 10th Ave, Miami, FL 33136 USA.	gwang@med.miami.edu			James and Esther King Biomedical Research Program award [3KN08]; BrightFocus Foundation [M2012048]	James and Esther King Biomedical Research Program award; BrightFocus Foundation(BrightFocus Foundation)	This research was supported, in part, by a James and Esther King Biomedical Research Program award (3KN08) and a BrightFocus Foundation grant (M2012048) (to G. W.)	Chung TL, 2010, STEM CELLS, V28, P1848, DOI 10.1002/stem.493; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Khare T, 2012, NAT STRUCT MOL BIOL, V19, P1037, DOI 10.1038/nsmb.2372; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; May JM, 2005, ARCH BIOCHEM BIOPHYS, V434, P178, DOI 10.1016/j.abb.2004.10.023; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Tsao C. S., 1997, J NUTR, V117, P291; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Wilson JX, 2005, ANNU REV NUTR, V25, P105, DOI 10.1146/annurev.nutr.25.050304.092647; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	22	274	284	7	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13669	13674		10.1074/jbc.C113.464800	http://dx.doi.org/10.1074/jbc.C113.464800			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23548903	hybrid, Green Published			2022-12-28	WOS:000318850300050
J	Pan, WW; Zhou, JJ; Liu, XM; Xu, Y; Guo, LJ; Yu, C; Shi, QH; Fan, HY				Pan, Wei-Wei; Zhou, Jian-Jie; Liu, Xiao-Man; Xu, Ying; Guo, Lian-Jun; Yu, Chao; Shi, Qing-Hua; Fan, Heng-Yu			Death Domain-associated Protein DAXX Promotes Ovarian Cancer Development and Chemoresistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PML NUCLEAR-BODIES; SURFACE EPITHELIAL-CELLS; INHIBITORY PROTEIN; APOPTOSIS; REPRESSION; CHK2; UBIQUITINATION; EXPRESSION; BINDING; ATR	Understanding the genes involved in apoptosis and DNA damage responses may improve therapeutic strategies for ovarian cancer. The death domain-associated protein DAXX can be either a pro-apoptotic or an anti-apoptotic factor, depending on the cell type and context. In this study, we found that DAXX was highly expressed in human ovarian surface epithelial tumors but not in granulosa cell tumors. In cultured ovarian cancer cells, DAXX interacted with promyelocytic leukemia protein (PML) and localized to subnuclear domains (so-called PML nuclear bodies). A role for DAXX in ovarian cancer cell proliferation, metastasis, and radio/chemoresistance was examined. Overexpression of DAXX enhanced multiple ovarian cancer cell lines' proliferation, colony formation, and migration, whereas Daxx depletion by RNA interference had the opposite effects. When transplanted into nude mice, ovarian cancer cells that overexpressed DAXX displayed enhanced tumorigenesis capability in vivo, whereas Daxx depletion inhibited tumor development. Importantly, Daxx induced tumorigenic transformation of normal ovarian surface epithelial cells. Daxx also protected ovarian cancer cells against x-irradiation-and chemotherapy-induced DNA damage by interacting with PML. Taken together, our results suggest that DAXX is a novel ovarian cancer oncogene that promotes ovarian cancer cell proliferation and chemoresistance in ovarian cancer cells. Thus, modulating DAXX-PML nuclear body activity may be an effective strategy for preventing the recurrence and chemoresistance of ovarian cancers.	[Pan, Wei-Wei; Zhou, Jian-Jie; Liu, Xiao-Man; Guo, Lian-Jun; Yu, Chao; Fan, Heng-Yu] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Pan, Wei-Wei; Xu, Ying] Jiaxing Univ, Sch Med, Jiaxing 314001, Peoples R China; [Shi, Qing-Hua] Univ Sci & Technol China, Sch Life Sci, Hefei 230022, Peoples R China	Zhejiang University; Jiaxing University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Fan, HY (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	hyfan@zju.edu.cn	Shi, Qinghua/N-2950-2013; Xu, Ying/A-3009-2013; Xu, Ying/AAF-3081-2019	Xu, Ying/0000-0002-6689-7768; Xu, Ying/0000-0002-6689-7768	National Natural Science Foundation of China [81172473]; National Basic Research Program of China [2011CB944504, 2012CB944403]; Natural Science Foundation of Zhejiang Province [R2100145, Y2110873]; Science and Technology Bureau Project of Jiaxing [2011AY1048-6]; Zhejiang University [2011QN81001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Science and Technology Bureau Project of Jiaxing; Zhejiang University	This work was supported by National Natural Science Foundation of China Grant 81172473, National Basic Research Program of China Grants 2011CB944504 and 2012CB944403, Natural Science Foundation of Zhejiang Province Grants R2100145 and Y2110873, Science and Technology Bureau Project of Jiaxing Grant 2011AY1048-6, and Basic Scientific Research Funding of Zhejiang University Grant 2011QN81001.	Abedini MR, 2010, ONCOGENE, V29, P11, DOI 10.1038/onc.2009.300; Abedini MR, 2008, CANCER RES, V68, P4511, DOI 10.1158/0008-5472.CAN-08-0673; Abedini MR, 2004, ONCOGENE, V23, P6997, DOI 10.1038/sj.onc.1207925; Bernardi R, 2008, ONCOGENE, V27, P6299, DOI 10.1038/onc.2008.305; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Bischof O, 2002, EMBO J, V21, P3358, DOI 10.1093/emboj/cdf341; Block GJ, 2006, MOL CELL BIOL, V26, P8814, DOI 10.1128/MCB.00636-06; Chang CC, 2005, J BIOL CHEM, V280, P10164, DOI 10.1074/jbc.M409161200; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Chauhan SC, 2009, CANCER RES, V69, P765, DOI 10.1158/0008-5472.CAN-08-0587; Chen LY, 2003, MOL CELL BIOL, V23, P7108, DOI 10.1128/MCB.23.20.7108-7121.2003; Dellaire G, 2006, J CELL SCI, V119, P1026, DOI 10.1242/jcs.02816; Dellaire G, 2006, J CELL BIOL, V175, P55, DOI 10.1083/jcb.200604009; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Hofmann TG, 2003, CELL DEATH DIFFER, V10, P1290, DOI 10.1038/sj.cdd.4401313; Huang YS, 2012, CELL CYCLE, V11, P99, DOI 10.4161/cc.11.1.18430; Joe YS, 2006, J BIOL CHEM, V281, P28764, DOI 10.1074/jbc.M604392200; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin DY, 2003, J BIOL CHEM, V278, P15958, DOI 10.1074/jbc.M300387200; Lindsay CR, 2008, FRONT BIOSCI-LANDMRK, V13, P7132, DOI 10.2741/3216; Lv L, 2012, CELL CYCLE, V11, P2864, DOI 10.4161/cc.21196; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Morozov VM, 2008, ONCOGENE, V27, P2177, DOI 10.1038/sj.onc.1210865; Mullany LK, 2011, ONCOGENE, V30, P3522, DOI 10.1038/onc.2011.70; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; Takahashi Y, 2004, ONCOGENE, V23, P2819, DOI 10.1038/sj.onc.1207533; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; TVEIT KM, 1989, ANTICANCER RES, V9, P1577; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; Wethkamp N, 2009, J BIOL CHEM, V284, P28783, DOI 10.1074/jbc.M109.041186; Yang ST, 2006, J BIOL CHEM, V281, P26645, DOI 10.1074/jbc.M604391200; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Yeurl PL, 2008, J CELL BIOCHEM, V103, P456, DOI 10.1002/jcb.21408	34	39	41	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13620	13630		10.1074/jbc.M112.446369	http://dx.doi.org/10.1074/jbc.M112.446369			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23539629	Green Published, hybrid			2022-12-28	WOS:000318850300044
J	Huang, WQ; Bei, L; Eklund, EA				Huang, Weiqi; Bei, Ling; Eklund, Elizabeth A.			Fas-associated Phosphatase 1 (Fap1) Influences beta Catenin Activity in Myeloid Progenitor Cells Expressing the Bcr-abl Oncogene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-BINDING-PROTEIN; TYROSINE-PHOSPHATASE; CONSTITUTIVE ACTIVATION; PTPN13 GENE; PDZ DOMAIN; ICSBP; GP91(PHOX); PU.1; MICE; TRANSCRIPTION	Increased beta catenin activity correlates with leukemia stem cell expansion and disease progression in chronic myeloid leukemia (CML). We found previously that expression of the CML-related Bcr-abl oncoprotein in myeloid progenitor cells increases expression of Fas-associated phosphatase 1 (Fap1). This resulted in Fap1-dependent resistance to Fas-induced apoptosis in these cells. Fap1 also interacts with the adenomatous polyposis coli (Apc) protein, but the functional significance of this interaction is unknown. Apc participates in a complex that includes glycogen synthase kinase beta (Gsk3 beta) and beta catenin. Assembly of this complex results in phosphorylation of beta catenin by Gsk3 beta, which facilitates beta catenin ubiquitination and degradation by the proteasome. In this study, we found increased association of Fap1 with the Apc complex in Bcr-abl(+) myeloid progenitor cells. We also found Fap1-dependent inactivation of Gsk3 beta and consequent stabilization of beta catenin in these cells. Consistent with this, Bcr-abl(+) cells exhibited a Fap1-dependent increase in beta catenin activity. Our studies identified Fap1-dependent Gsk3 beta inactivation as a molecular mechanism for increased beta catenin activity in CML.	[Huang, Weiqi; Bei, Ling; Eklund, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Huang, Weiqi; Bei, Ling; Eklund, Elizabeth A.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Eklund, Elizabeth A.] Jesse Brown Vet Hlth Adm Hosp, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch, Dept Med, 303 E Chicago Ave, Lurie 5-105, Chicago, IL 60611 USA.	e-eklund@northwestern.edu			NATIONAL CANCER INSTITUTE [R01CA174205] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002067] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA174205] Funding Source: Medline; BLRD VA [I01 BX002067] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BLRD VA		Abrahamsson AE, 2009, P NATL ACAD SCI USA, V106, P3925, DOI 10.1073/pnas.0900189106; Barker N, 2000, ADV CANCER RES, V77, P1; Benetti R, 2005, J BIOL CHEM, V280, P22070, DOI 10.1074/jbc.M501810200; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; Eklund EA, 1999, J IMMUNOL, V163, P6095; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Hao SX, 2000, MOL CELL BIOL, V20, P1149, DOI 10.1128/MCB.20.4.1149-1161.2000; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Huang WQ, 2008, J BIOL CHEM, V283, P7921, DOI 10.1074/jbc.M706710200; Huang WQ, 2013, LEUKEMIA LYMPHOMA, V54, P619, DOI 10.3109/10428194.2012.720979; Huang WQ, 2012, J BIOL CHEM, V287, P8110, DOI 10.1074/jbc.M111.294884; Huang WQ, 2010, MOL CELL BIOL, V30, P4575, DOI 10.1128/MCB.01595-09; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kautz B, 2001, J BIOL CHEM, V276, P37868; Kim K, 2000, MOL BIOL CELL, V11, P3509, DOI 10.1091/mbc.11.10.3509; Konieczna I, 2008, J CLIN INVEST, V118, P853, DOI 10.1172/JCI33742; Kozlov G, 2002, J MOL BIOL, V320, P813, DOI 10.1016/S0022-2836(02)00544-2; LARRICK JW, 1980, J IMMUNOL, V125, P6; Minami Y, 2008, P NATL ACAD SCI USA, V105, P17967, DOI 10.1073/pnas.0808303105; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Saras J, 1997, J BIOL CHEM, V272, P20979, DOI 10.1074/jbc.272.34.20979; SARAS J, 1994, J BIOL CHEM, V269, P24082; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; Simon M, 2005, ONCOGENE, V24, P2410, DOI 10.1038/sj.onc.1208431; Yanagisawa J, 1997, J BIOL CHEM, V272, P8539, DOI 10.1074/jbc.272.13.8539; Zhang J, 2010, BIOCHEMISTRY-US, V49, P9280, DOI 10.1021/bi101131f; Zhang XW, 1998, BLOOD, V92, P3829, DOI 10.1182/blood.V92.10.3829; Zhu CL, 2004, J BIOL CHEM, V279, P50874, DOI 10.1074/jbc.M405736200	28	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12766	12776		10.1074/jbc.M112.429696	http://dx.doi.org/10.1074/jbc.M112.429696			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23519466	Green Published, hybrid			2022-12-28	WOS:000318555100033
J	Saraiva, N; Prole, DL; Carrara, G; de Motes, CM; Johnson, BF; Byrne, B; Taylor, CW; Smith, GL				Saraiva, Nuno; Prole, David L.; Carrara, Guia; de Motes, Carlos Maluquer; Johnson, Benjamin F.; Byrne, Bernadette; Taylor, Colin W.; Smith, Geoffrey L.			Human and Viral Golgi Anti-apoptotic Proteins (GAAPs) Oligomerize via Different Mechanisms and Monomeric GAAP Inhibits Apoptosis and Modulates Calcium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BAX INHIBITOR-1; ENDOPLASMIC-RETICULUM; VACCINIA VIRUS; CROSS-LINKING; PH REGULATION; FAMILY; CHANNEL; GENE; TRAFFICKING; HOMEOSTASIS	Golgi anti-apoptotic proteins (GAAPs) are hydrophobic proteins resident in membranes of the Golgi complex. They protect cells from a range of apoptotic stimuli, reduce the Ca2+ content of intracellular stores, and regulate Ca2+ fluxes. GAAP was discovered in camelpox virus, but it is highly conserved throughout evolution and encoded by all eukaryote genomes examined. GAAPs are part of the transmembrane Bax inhibitor-containing motif (TMBIM) family that also includes other anti-apoptotic and Ca2+-modulating membrane proteins. Most TMBIM members show multiple bands when analyzed by SDS-PAGE, suggesting that they may be oligomeric. However, the molecular mechanisms of oligomerization, the native state of GAAPs in living cells and the functional significance of oligomerization have not been addressed. TMBIM members are thought to have evolved from an ancestral GAAP. Two different GAAPs, human (h) and viral (v) GAAP were therefore selected as models to examine oligomerization of TMBIM family members. We show that both hGAAP and vGAAP in their native states form oligomers and that oligomerization is pH-dependent. Surprisingly, hGAAP and vGAAP do not share the same oligomerization mechanism. Oligomerization of hGAAP is independent of cysteines, but oligomerization of vGAAP depends on cysteines 9 and 60. Amutant vGAAP that is unable to oligomerize revealed that monomeric vGAAP retains both its anti-apoptotic function and its effect on intracellular Ca2+ stores. In conclusion, GAAP can oligomerize in a pH-regulated manner, and monomeric GAAP is functional.	[Saraiva, Nuno; Carrara, Guia; de Motes, Carlos Maluquer; Smith, Geoffrey L.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Saraiva, Nuno; Carrara, Guia; de Motes, Carlos Maluquer; Johnson, Benjamin F.; Smith, Geoffrey L.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Virol Sect, London W2 1PG, England; [Prole, David L.; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Byrne, Bernadette] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England	University of Cambridge; Imperial College London; University of Cambridge; Imperial College London	Smith, GL (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	gls37@cam.ac.uk	Smith, Geoffrey L/G-2894-2012; de Motes, Carlos Maluquer/AAF-8092-2021; Saraiva, Nuno/I-9299-2019; Taylor, Colin/G-2447-2010	de Motes, Carlos Maluquer/0000-0003-4712-4601; Saraiva, Nuno/0000-0003-1333-9137; Johnson, Benjamin/0000-0001-5991-7612; Prole, David/0000-0003-2782-6665; Taylor, Colin/0000-0001-7771-1044; Byrne, Bernadette/0000-0001-9598-9832; Smith, Geoffrey L/0000-0002-3730-9955	UK Medical Research Council [G0900224]; Wellcome Trust [085295]; Portuguese Foundation for Science and Technology; St. John's College (Cambridge, UK); Medical Research Council [G0900224] Funding Source: researchfish; MRC [G0900224] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); St. John's College (Cambridge, UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the UK Medical Research Council (G0900224) and The Wellcome Trust (085295).; Supported by the Portuguese Foundation for Science and Technology.; Supported in part by a Meres Research associateship from St. John's College (Cambridge, UK).	Ahn T, 2010, CELL CALCIUM, V47, P387, DOI 10.1016/j.ceca.2010.02.003; Ahn T, 2009, FEBS J, V276, P2285, DOI 10.1111/j.1742-4658.2009.06956.x; Balasubramanian S, 2004, J BIOL CHEM, V279, P18840, DOI 10.1074/jbc.M313470200; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Bultynck G, 2012, J BIOL CHEM, V287, P2544, DOI 10.1074/jbc.M111.275354; Capasso M, 2011, TRENDS CELL BIOL, V21, P20, DOI 10.1016/j.tcb.2010.09.006; Carrara G, 2012, J BIOL CHEM, V287, P15896, DOI 10.1074/jbc.M111.336149; de Mattia F, 2009, MOL BIOL CELL, V20, P3638, DOI 10.1091/mbc.E09-05-0385; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; Fatmi MQ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000994; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; GRODEN DL, 1991, CELL CALCIUM, V12, P279, DOI 10.1016/0143-4160(91)90002-V; Gubser C, 2007, PLOS PATHOG, V3, P246, DOI 10.1371/journal.ppat.0030017; Hu L, 2009, APOPTOSIS, V14, P1255, DOI 10.1007/s10495-009-0402-2; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Karasawa A, 2010, BIOCHEM J, V426, P99, DOI 10.1042/BJ20091339; Kew J. N., 2010, ION CHANNELS STRUCTU, P172; Kim HR, 2008, J BIOL CHEM, V283, P15946, DOI 10.1074/jbc.M800075200; KORNBLATT JA, 1980, CAN J BIOCHEM CELL B, V58, P219, DOI 10.1139/o80-030; Lee S, 2007, J BIOCHEM MOL BIOL, V40, P226; Neri D, 2011, NAT REV DRUG DISCOV, V10, P767, DOI 10.1038/nrd3554; Opi S, 2006, J VIROL, V80, P4673, DOI 10.1128/JVI.80.10.4673-4682.2006; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; PARKINSON JE, 1994, VIROLOGY, V204, P376, DOI 10.1006/viro.1994.1542; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Reimers K, 2008, CURR MOL MED, V8, P148, DOI 10.2174/156652408783769562; Rojas-Rivera D, 2012, CELL DEATH DIFFER, V19, P1013, DOI 10.1038/cdd.2011.189; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Woolf PJ, 2003, BIOPHYS CHEM, V104, P217, DOI 10.1016/S0301-4622(02)00369-1; Xu CY, 2008, J BIOL CHEM, V283, P11477, DOI 10.1074/jbc.M708385200; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Zhou JH, 2008, COMPUT BIOL CHEM, V32, P159, DOI 10.1016/j.compbiolchem.2008.01.002	35	25	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					13057	13067		10.1074/jbc.M112.414367	http://dx.doi.org/10.1074/jbc.M112.414367			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23508950	hybrid, Green Published			2022-12-28	WOS:000318555100057
J	Fujimoto, Z; Jackson, A; Michikawa, M; Maehara, T; Momma, M; Henrissat, B; Gilbert, HJ; Kaneko, S				Fujimoto, Zui; Jackson, Adam; Michikawa, Mari; Maehara, Tomoko; Momma, Mitsuru; Henrissat, Bernard; Gilbert, Harry J.; Kaneko, Satoshi			The Structure of a Streptomyces avermitilis alpha-L-Rhamnosidase Reveals a Novel Carbohydrate-binding Module CBM67 within the Six-domain Arrangement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; HYDROLASE; FAMILY; HYDROLYSIS; MECHANISM; LECTIN; DEGRADATION	alpha-L-Rhamnosidases hydrolyze alpha-linked L-rhamnosides from oligosaccharides or polysaccharides. We determined the crystal structure of the glycoside hydrolase family 78 Streptomyces avermitilis alpha-L-rhamnosidase (SaRha78A) in its free and L-rhamnose complexed forms, which revealed the presence of six domains N, D, E, F, A, and C. In the ligand complex, L-rhamnose was bound in the proposed active site of the catalytic module, revealing the likely catalytic mechanism of SaRha78A. Glu(636) is predicted to donate protons to the glycosidic oxygen, and Glu(895) is the likely catalytic general base, activating the nucleophilic water, indicating that the enzyme operates through an inverting mechanism. Replacement of Glu(636) and Glu(895) resulted in significant loss of alpha-rhamnosidase activity. Domain D also bound L-rhamnose in a calcium-dependent manner, with a K-D of 135 mu M. Domain D is thus a non-catalytic carbohydrate binding module (designated SaCBM67). Mutagenesis and structural data identified the amino acids in SaCBM67 that target the features of L-rhamnose that distinguishes it from the other major sugars present in plant cell walls. Inactivation of SaCBM67 caused a substantial reduction in the activity of SaRha78A against the polysaccharide composite gum arabic, but not against aryl rhamnosides, indicating that SaCBM67 contributes to enzyme function against insoluble substrates.	[Fujimoto, Zui; Momma, Mitsuru] Natl Inst Agrobiol Sci, Biomol Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Jackson, Adam; Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Michikawa, Mari; Maehara, Tomoko; Kaneko, Satoshi] Natl Food Res Inst, Food Biotechnol Div, Tsukuba, Ibaraki 3058642, Japan; [Henrissat, Bernard] Aix Marseille Univ, CNRS, UMR 7257, Lab Architecture & Fonct Macromol Biol, F-13288 Marseille 9, France	National Institute of Agrobiological Sciences - Japan; Newcastle University - UK; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Fujimoto, Z (corresponding author), Natl Inst Agrobiol Sci, Biomol Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	zui@affrc.go.jp; harry.gilbert@newcastle.ac.uk; sakaneko@affrc.go.jp	Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Fujimoto, Zui/0000-0002-3551-6854	JSPS KAKENHI [22580110]; Grants-in-Aid for Scientific Research [22580110] Funding Source: KAKEN; BBSRC [BB/G016224/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G016224/1] Funding Source: researchfish	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in part, by JSPS KAKENHI Grant 22580110.	Barker IJ, 2010, J PHYS CHEM B, V114, P15389, DOI 10.1021/jp107886e; Bonanno Jeffrey B., 2005, Journal of Structural and Functional Genomics, V6, P225, DOI 10.1007/s10969-005-6827-0; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cui Z, 2007, J MOL BIOL, V374, P384, DOI 10.1016/j.jmb.2007.09.003; Cuskin F, 2012, P NATL ACAD SCI USA, V109, P20889, DOI 10.1073/pnas.1212034109; DEFAYE J, 1986, CARBOHYD RES, V150, P221, DOI 10.1016/0008-6215(86)80018-0; Drewnowski A, 1997, AM J CLIN NUTR, V66, P391, DOI 10.1093/ajcn/66.2.391; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ficko-Blean E, 2008, P NATL ACAD SCI USA, V105, P6560, DOI 10.1073/pnas.0711491105; Guerin DMA, 2002, J MOL BIOL, V316, P1061, DOI 10.1006/jmbi.2001.5404; HALL J, 1995, BIOCHEM J, V309, P749, DOI 10.1042/bj3090749; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Ichinose H, 2013, BIOSCI BIOTECH BIOCH, V77, P213, DOI 10.1271/bbb.120735; Ichinose H, 2009, J BIOL CHEM, V284, P25097, DOI 10.1074/jbc.M109.022723; Jamal-Talabani S, 2004, STRUCTURE, V12, P1177, DOI 10.1016/j.str.2004.04.022; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ly HD, 1999, ANNU REV BIOCHEM, V68, P487, DOI 10.1146/annurev.biochem.68.1.487; Montanier C, 2010, J BIOL CHEM, V285, P31742, DOI 10.1074/jbc.M110.142133; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mutter M, 1998, CARBOHYD RES, V311, P155, DOI 10.1016/S0008-6215(98)00188-8; OCHSNER UA, 1994, J BIOL CHEM, V269, P19787; Oguri S, 1996, J BACTERIOL, V178, P5692, DOI 10.1128/jb.178.19.5692-5698.1996; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petersen L, 2009, J PHYS CHEM B, V113, P7331, DOI 10.1021/jp811470d; Shirai T, 2009, J MOL BIOL, V391, P390, DOI 10.1016/j.jmb.2009.06.027; Sidhu G, 1999, BIOCHEMISTRY-US, V38, P5346, DOI 10.1021/bi982946f; Sumisa F, 2004, J BIOSCI BIOENG, V98, P257, DOI 10.1016/S1389-1723(04)00278-6; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Vakonakis I, 2008, STRUCTURE, V16, P944, DOI 10.1016/j.str.2008.02.020; Vila-Real Helder, 2011, Enzyme Res, V2011, P692618, DOI 10.4061/2011/692618; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang H, 2006, FOOD SCI TECHNOL RES, V12, P43, DOI 10.3136/fstr.12.43; Yazawa R, 2011, BIOSCI BIOTECH BIOCH, V75, P379, DOI 10.1271/bbb.100730; Zverlov VV, 2000, MOL MICROBIOL, V35, P173, DOI 10.1046/j.1365-2958.2000.01691.x	43	48	56	6	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12376	12385		10.1074/jbc.M113.460097	http://dx.doi.org/10.1074/jbc.M113.460097			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486481	hybrid, Green Published			2022-12-28	WOS:000318157600068
J	Gillis, J; Schipper-Krom, S; Juenemann, K; Gruber, A; Coolen, S; van den Nieuwendijk, R; van Veen, H; Overkleeft, H; Goedhart, J; Kampinga, HH; Reits, EA				Gillis, Judith; Schipper-Krom, Sabine; Juenemann, Katrin; Gruber, Anna; Coolen, Silvia; van den Nieuwendijk, Rian; van Veen, Henk; Overkleeft, Hermen; Goedhart, Joachim; Kampinga, Harm H.; Reits, Eric A.			The DNAJB6 and DNAJB8 Protein Chaperones Prevent Intracellular Aggregation of Polyglutamine Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFETIME IMAGING MICROSCOPY; BULBAR MUSCULAR-ATROPHY; HEAT-SHOCK PROTEINS; EXPANDED POLYGLUTAMINE; MOLECULAR CHAPERONES; ANDROGEN RECEPTOR; PROTEOLYTIC CLEAVAGE; NUCLEAR INCLUSIONS; MUTANT HUNTINGTIN; MAMMALIAN-CELLS	Fragments of proteins containing an expanded polyglutamine (polyQ) tract are thought to initiate aggregation and toxicity in at least nine neurodegenerative diseases, including Huntington's disease. Because proteasomes appear unable to digest the polyQ tract, which can initiate intracellular protein aggregation, preventing polyQ peptide aggregation by chaperones should greatly improve polyQ clearance and prevent aggregate formation. Here we expressed polyQ peptides in cells and show that their intracellular aggregation is prevented by DNAJB6 and DNAJB8, members of the DNAJ (Hsp40) chaperone family. In contrast, HSPA/Hsp70 and DNAJB1, also members of the DNAJ chaperone family, did not prevent peptide-initiated aggregation. Intriguingly, DNAJB6 and DNAJB8 also affected the soluble levels of polyQ peptides, indicating that DNAJB6 and DNAJB8 inhibit polyQ peptide aggregation directly. Together with recent data showing that purified DNAJB6 can suppress fibrillation of polyQ peptides far more efficiently than polyQ expanded protein fragments in vitro, we conclude that the mechanism of DNAJB6 and DNAJB8 is suppression of polyQ protein aggregation by directly binding the polyQ tract.	[Gillis, Judith; Schipper-Krom, Sabine; Juenemann, Katrin; Gruber, Anna; Coolen, Silvia; van Veen, Henk; Reits, Eric A.] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [van den Nieuwendijk, Rian; Overkleeft, Hermen] Leiden Univ, Dept Bioorgan Synth, NL-2333 CC Leiden, Netherlands; [Goedhart, Joachim] Leiden Univ, Swammerdam Inst Life Sci, NL-1090 GE Leiden, Netherlands; [Kampinga, Harm H.] Univ Med Ctr Groningen, Dept Cell Biol, NL-9713 AV Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; University of Groningen	Reits, EA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	e.a.reits@amc.uva.nl	Coolen, Silvia/ABD-4352-2020	Coolen, Silvia/0000-0003-1902-5227; Goedhart, Joachim/0000-0002-0630-3825; Kampinga, Harm/0000-0002-8966-8466; Overkleeft, Herman/0000-0001-6976-7005	VENI Grant [91646038]; VIDI Grant from NWO-Zon-MW [91796315]; Hersenstichting; Agentschap.nl Grant [IOP IGE07004]	VENI Grant; VIDI Grant from NWO-Zon-MW; Hersenstichting; Agentschap.nl Grant	This work was supported by VENI Grant 91646038 and VIDI Grant 91796315 from NWO-Zon-MW and by a grant from the Hersenstichting (to E. R.), and by Agentschap.nl Grant IOP IGE07004 (to H. H. K.).	Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Chai YH, 2002, P NATL ACAD SCI USA, V99, P9310, DOI 10.1073/pnas.152101299; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chuang JZ, 2002, J BIOL CHEM, V277, P19831, DOI 10.1074/jbc.M109613200; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Durrenberger PF, 2009, J NEUROSCI RES, V87, P238, DOI 10.1002/jnr.21819; Ellerby LM, 1999, J NEUROCHEM, V72, P185, DOI 10.1046/j.1471-4159.1999.0720185.x; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Haacke A, 2006, HUM MOL GENET, V15, P555, DOI 10.1093/hmg/ddi472; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Iwata A, 2009, J BIOL CHEM, V284, P9796, DOI 10.1074/jbc.M809739200; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; KAMPINGA HH, 1993, J CELL SCI, V104, P11; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Nollen EAA, 1999, MOL CELL BIOL, V19, P2069; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Raspe M, 2009, J CELL SCI, V122, P3262, DOI 10.1242/jcs.045567; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Rousseau E, 2009, J BIOL CHEM, V284, P1917, DOI 10.1074/jbc.M806256200; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Suhr ST, 2001, J CELL BIOL, V153, P283, DOI 10.1083/jcb.153.2.283; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; van Munster EB, 2005, ADV BIOCHEM ENG BIOT, V95, P143; Van Munster EB, 2004, J MICROSC-OXFORD, V213, P29, DOI 10.1111/j.1365-2818.2004.01249.x; van Munster EB, 2004, CYTOM PART A, V58A, P185, DOI 10.1002/cyto.a.20013; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Wilburn B, NEURON, V70, P427; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Young JE, 2007, J BIOL CHEM, V282, P30150, DOI 10.1074/jbc.M705265200	55	83	85	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17225	17237		10.1074/jbc.M112.421685	http://dx.doi.org/10.1074/jbc.M112.421685			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23612975	Green Published, hybrid			2022-12-28	WOS:000320380600019
J	Tao, GZ; Lehwald, N; Jang, KY; Baek, J; Xu, BH; Omary, MB; Sylvester, KG				Tao, Guo-Zhong; Lehwald, Nadja; Jang, Kyu Yun; Baek, Joy; Xu, Baohui; Omary, M. Bishr; Sylvester, Karl G.			Wnt/beta-Catenin Signaling Protects Mouse Liver against Oxidative Stress-induced Apoptosis through the Inhibition of Forkhead Transcription Factor FoxO3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; CELL-SURVIVAL; COLON-CANCER; INJURY; EXPRESSION; MICE; GROWTH; REGENERATION; HEPATOCYTES; HOMEOSTASIS	Numerous liver diseases are associated with extensive oxidative tissue damage. It is well established that Wnt/beta-catenin signaling directs multiple hepatocellular processes, including development, proliferation, regeneration, nutrient homeostasis, and carcinogenesis. It remains unexplored whether Wnt/beta-catenin signaling provides hepatocyte protection against hepatotoxin-induced apoptosis. Conditional, liver-specific beta-catenin knockdown (KD) mice and their wild-type littermates were challenged by feeding with a hepatotoxin 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet to induce chronic oxidative liver injury. Following the DDC diet, mice with beta-catenin-deficient hepatocytes demonstrate increased liver injury, indicating an important role of beta-catenin signaling for liver protection against oxidative stress. This finding was further confirmed in AML12 hepatocytes with beta-catenin signaling manipulation in vitro using paraquat, a known oxidative stress inducer. Immunofluorescence staining revealed an intense nuclear FoxO3 staining in beta-catenin-deficient livers, suggesting active FoxO3 signaling in response to DDC-induced liver injury when compared with wild-type controls. Consistently, FoxO3 target genes p27 and Bim were significantly induced in beta-catenin KD livers. Conversely, SGK1, a beta-catenin target gene, was significantly impaired in beta-catenin KD hepatocytes that failed to inactivate FoxO3. Furthermore, shRNA-mediated deletion of FoxO3 increased hepatocyte resistance to oxidative stress-induced apoptosis, confirming a proapoptotic role of FoxO3 in the stressed liver. Our findings suggest that Wnt/beta-catenin signaling is required for hepatocyte protection against oxidative stress-induced apoptosis. The inhibition of FoxO through its phosphorylation by beta-catenin-induced SGK1 expression reduces the apoptotic function of FoxO3, resulting in increased hepatocyte survival. These findings have relevance for future therapies directed at hepatocyte protection, regeneration, and anti-cancer treatment.	[Tao, Guo-Zhong; Lehwald, Nadja; Jang, Kyu Yun; Baek, Joy; Xu, Baohui; Sylvester, Karl G.] Stanford Univ, Dept Surg, Sch Med, Stanford, CA 94305 USA; [Lehwald, Nadja] Univ Dusseldorf, Sch Med, Dept Surg, D-40545 Dusseldorf, Germany; [Jang, Kyu Yun] Chonbuk Natl Univ, Sch Med, Dept Pathol, Jeonju 561180, South Korea; [Jang, Kyu Yun] Chonbuk Natl Univ, Sch Med, Res Inst Clin Med, Jeonju 561180, South Korea; [Omary, M. Bishr] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Sylvester, Karl G.] Lucile Packard Childrens Hosp, Stanford, CA 94304 USA	Stanford University; Heinrich Heine University Dusseldorf; Jeonbuk National University; Jeonbuk National University; University of Michigan System; University of Michigan; Lucile Packard Children's Hospital (LPCH)	Sylvester, KG (corresponding author), Stanford Univ, Dept Surg, Div Pediat Surg, Sch Med,Hagey Lab Regenerat Med, 257 Campus Dr, Stanford, CA 94305 USA.	sylvester@stanford.edu		Xu, Baohui/0000-0002-2857-7464; Baek, Han Bit/0000-0001-6597-7216; Sylvester, Karl G./0000-0002-8559-0155; Omary, Bishr/0000-0002-8624-2347	National Institutes of Health, NIDDK, Pilot Grant [DK56339]; National Institutes of Health Grant [DK47918]; Children's Surgical Research Program Fund; Transplantation and Tissue Engineering Center, Packard Foundation for Children's Health; YAEL Foundation; German Research Foundation (Deutsche Forschungsgemeinschaft Grant [NL 2509/2-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339, R01DK047918] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK, Pilot Grant; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Surgical Research Program Fund; Transplantation and Tissue Engineering Center, Packard Foundation for Children's Health; YAEL Foundation; German Research Foundation (Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Pilot Grant DK56339 (Digestive Disease Center at Stanford) (to K. G. S.) and National Institutes of Health Grant DK47918 (to M. B. O.). This work was also supported by grants from the Children's Surgical Research Program Fund and the Transplantation and Tissue Engineering Center, Packard Foundation for Children's Health (to K. G. S.) and the YAEL Foundation and the German Research Foundation (Deutsche Forschungsgemeinschaft Grant NL 2509/2-1) (to N. L.).	Behari J, 2010, AM J PATHOL, V176, P744, DOI 10.2353/ajpath.2010.090667; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Czaja MJ, 2007, SEMIN LIVER DIS, V27, P378, DOI 10.1055/s-2007-991514; Dehner M, 2008, J BIOL CHEM, V283, P19201, DOI 10.1074/jbc.M710366200; Dey A, 2006, HEPATOLOGY, V43, pS63, DOI 10.1002/hep.20957; Diesen DL, 2010, J SURG RES, V162, P95, DOI 10.1016/j.jss.2009.09.019; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Habtezion A, 2011, P NATL ACAD SCI USA, V108, P1445, DOI 10.1073/pnas.1010833108; Hanada S, 2010, GASTROENTEROLOGY, V138, P1607, DOI 10.1053/j.gastro.2009.12.055; Hoogeboom D, 2008, J BIOL CHEM, V283, P9224, DOI 10.1074/jbc.M706638200; Hoogeboom D, 2009, BBA-REV CANCER, V1796, P63, DOI 10.1016/j.bbcan.2009.02.002; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kamo N, 2013, HEPATOLOGY, V57, P289, DOI 10.1002/hep.25958; Kaplowitz N, 2000, J HEPATOL, V32, P39, DOI 10.1016/S0168-8278(00)80414-6; Khatri S, 2010, J BIOL CHEM, V285, P15960, DOI 10.1074/jbc.M110.121871; Kim PJ, 2003, LANCET, V362, P205, DOI 10.1016/S0140-6736(03)13910-4; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Lehwald N, 2012, GASTROENTEROLOGY, V143, P754, DOI 10.1053/j.gastro.2012.05.048; Lehwald N, 2011, GASTROENTEROLOGY, V141, P707, DOI 10.1053/j.gastro.2011.04.051; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Loguercio C, 2003, FREE RADICAL BIO MED, V34, P1, DOI 10.1016/S0891-5849(02)01167-X; Monga SPS, 2011, INT J BIOCHEM CELL B, V43, P1021, DOI 10.1016/j.biocel.2009.09.001; Nejak-Bowen K, 2013, HEPATOLOGY, V57, P763, DOI 10.1002/hep.26042; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Schwartz DR, 2003, CANCER RES, V63, P2913; Shin I, 2001, MOL BIOL CELL, V12, P3328, DOI 10.1091/mbc.12.11.3328; Snider NT, 2011, J CELL BIOL, V195, P217, DOI 10.1083/jcb.201102142; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Strnad R, 2008, BBA-MOL BASIS DIS, V1782, P764, DOI 10.1016/j.bbadis.2008.08.008; Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042; Tan XP, 2005, GASTROENTEROLOGY, V129, P285, DOI 10.1053/j.gastro.2005.04.013; Tao GZ, 2008, J PATHOL, V215, P164, DOI 10.1002/path.2344; Tao GZ, 2009, J CELL SCI, V122, P3851, DOI 10.1242/jcs.051862; Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061; Tapia JC, 2006, P NATL ACAD SCI USA, V103, P15079, DOI 10.1073/pnas.0606845103; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Weerasinghe SVW, 2011, HEPATOLOGY, V53, P1323, DOI 10.1002/hep.24203; Wilk A, 2012, CELL CYCLE, V11, P2660, DOI 10.4161/cc.21015; Xie XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024469; Yan YB, 2012, NAT MED, V18, P854, DOI 10.1038/nm.2799; Zatloukal K, 2007, EXP CELL RES, V313, P2033, DOI 10.1016/j.yexcr.2007.04.024; Zhang KB, 2012, ENDOCRINOLOGY, V153, P631, DOI 10.1210/en.2011-1527	52	92	98	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17214	17224		10.1074/jbc.M112.445965	http://dx.doi.org/10.1074/jbc.M112.445965			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23620592	hybrid, Green Published			2022-12-28	WOS:000320380600018
J	Seki, M; Takeda, Y; Iwai, K; Tanaka, K				Seki, Mineaki; Takeda, Yukiko; Iwai, Kazuhiro; Tanaka, Kiyoji			IOP1 Protein Is an External Component of the Human Cytosolic Iron-Sulfur Cluster Assembly (CIA) Machinery and Functions in the MMS19 Protein-dependent CIA Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCISION-REPAIR; DNA-REPAIR; FANCONI-ANEMIA; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; HELICASE BRIP1; TFIIH; TRANSCRIPTION; YEAST; XPD	The emerging link between iron metabolism and genome integrity is increasingly clear. Recent studies have revealed that MMS19 and cytosolic iron-sulfur cluster assembly (CIA) factors form a complex and have central roles in CIA pathway. However, the composition of the CIA complex, particularly the involvement of the Fe-S protein IOP1, is still unclear. The roles of each component are also largely unknown. Here, we show that MMS19, MIP18, and CIAO1 form a tight "core" complex and that IOP1 is an "external" component of this complex. Although IOP1 and the core complex form a complex both in vivo and in vitro, IOP1 behaves differently in vivo. A deficiency in any core component leads to down-regulation of all of the components. In contrast, IOP1 knockdown does not affect the level of any core component. In MMS19-overproducing cells, other core components are also up-regulated, but the protein level of IOP1 remains unchanged. IOP1 behaves like a target protein in the CIA reaction, like other Fe-S helicases, and the core complex may participate in the maturation process of IOP1. Alternatively, the core complex may catch and hold IOP1 when it becomes mature to prevent its degradation. In any case, IOP1 functions in the MMS19-dependent CIA pathway. We also reveal that MMS19 interacts with target proteins. MIP18 has a role to bridge MMS19 and CIAO1. CIAO1 also binds IOP1. Based on our in vivo and in vitro data, new models of the CIA machinery are proposed.	[Seki, Mineaki; Takeda, Yukiko; Iwai, Kazuhiro; Tanaka, Kiyoji] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Iwai, Kazuhiro] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan	Osaka University; Kyoto University	Seki, M (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan.	mseki@fbs.osaka-u.ac.jp; ktanaka@fbs.osaka-u.ac.jp	IWAI, KAZUHIRO/GSN-7385-2022	Iwai, Kazuhiro/0000-0001-5620-5951	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [22510061]; Health and Labor Sciences Research Grants for Research on Intractable Diseases; Grants-in-Aid for Scientific Research [22131009] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labor Sciences Research Grants for Research on Intractable Diseases; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research (C) 22510061 (to M. S.) and a Grant-in-aid for Scientific Research on Innovative Areas (to K. T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) and by Health and Labor Sciences Research Grants for Research on Intractable Diseases (to K. T.).	ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Araujo SJ, 2000, GENE DEV, V14, P349; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; de Winter JP, 2009, MUTAT RES-FUND MOL M, V668, P11, DOI 10.1016/j.mrfmmm.2008.11.004; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Gari K, 2012, SCIENCE, V337, P243, DOI 10.1126/science.1219664; Ito S, 2010, MOL CELL, V39, P632, DOI 10.1016/j.molcel.2010.07.029; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kou HP, 2008, P NATL ACAD SCI USA, V105, P15714, DOI 10.1073/pnas.0710736105; Lauder S, 1996, MOL CELL BIOL, V16, P6783; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; Lombaerts M, 1997, NUCLEIC ACIDS RES, V25, P3974, DOI 10.1093/nar/25.20.3974; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Parish JL, 2006, J CELL SCI, V119, P4857, DOI 10.1242/jcs.03262; Peng M, 2007, EMBO J, V26, P3238, DOI 10.1038/sj.emboj.7601754; Porello SL, 1998, BIOCHEMISTRY-US, V37, P6465, DOI 10.1021/bi972433t; PRAKASH L, 1977, GENETICS, V86, P33; Queimado L, 2001, NUCLEIC ACIDS RES, V29, P1884, DOI 10.1093/nar/29.9.1884; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Seroz T, 2000, NUCLEIC ACIDS RES, V28, P4506, DOI 10.1093/nar/28.22.4506; Song DS, 2008, J BIOL CHEM, V283, P9231, DOI 10.1074/jbc.M708077200; Song DS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201731; Sonoda E, 2003, EMBO J, V22, P3188, DOI 10.1093/emboj/cdg308; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723; Takedachi A, 2010, MOL CELL BIOL, V30, P2708, DOI 10.1128/MCB.01460-09; Urzica E, 2009, BIOCHEMISTRY-US, V48, P4946, DOI 10.1021/bi900312x; van Wietmarschen N, 2012, J BIOL CHEM, V287, P43351, DOI 10.1074/jbc.M112.431270; WANG ZG, 1994, NATURE, V368, P74, DOI 10.1038/368074a0; Wolski SC, 2008, PLOS BIOL, V6, P1332, DOI 10.1371/journal.pbio.0060149; Wu YL, 2012, NUCLEIC ACIDS RES, V40, P4247, DOI 10.1093/nar/gks039; Wu YL, 2009, CURR MOL MED, V9, P470, DOI 10.2174/156652409788167159	38	30	31	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16680	16689		10.1074/jbc.M112.416602	http://dx.doi.org/10.1074/jbc.M112.416602			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23585563	Green Published, hybrid			2022-12-28	WOS:000320378900043
J	Ramanagoudr-Bhojappa, R; Chib, S; Byrd, AK; Aarattuthodiyil, S; Pandey, M; Patel, SS; Raney, KD				Ramanagoudr-Bhojappa, Ramanagouda; Chib, Shubeena; Byrd, Alicia K.; Aarattuthodiyil, Suja; Pandey, Manjula; Patel, Smita S.; Raney, Kevin D.			Yeast Pif1 Helicase Exhibits a One-base-pair Stepping Mechanism for Unwinding Duplex DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; REPLICATION FORK PROGRESSION; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL-DNA; FUNCTIONAL INTERACTION; TURNOVER KINETICS; BINDING-PROTEIN; PCRA HELICASE; TRANSLOCATION; PROCESSIVITY	Kinetic analysis of the DNA unwinding and translocation activities of helicases is necessary for characterization of the biochemical mechanism(s) for this class of enzymes. Saccharomyces cerevisiae Pif1 helicase was characterized using presteady state kinetics to determine rates of DNA unwinding, displacement of streptavidin from biotinylated DNA, translocation on single-stranded DNA (ssDNA), and ATP hydrolysis activities. Unwinding of substrates containing varying duplex lengths was fit globally to a model for stepwise unwinding and resulted in an unwinding rate of similar to 75 bp/s and a kinetic step size of 1 base pair. Pif1 is capable of displacing streptavidin from biotinylated oligonucleotides with a linear increase in the rates as the length of the oligonucleotides increased. The rate of translocation on ssDNA was determined by measuring dissociation from varying lengths of ssDNA and is essentially the same as the rate of unwinding of dsDNA, making Pif1 an active helicase. The ATPase activity of Pif1 on ssDNA was determined using fluorescently labeled phosphate-binding protein to measure the rate of phosphate release. The quantity of phosphate released corresponds to a chemical efficiency of 0.84 ATP/nucleotides translocated. Hence, when all of the kinetic data are considered, Pif1 appears to move along DNA in single nucleotide or base pair steps, powered by hydrolysis of 1 molecule of ATP.	[Ramanagoudr-Bhojappa, Ramanagouda; Chib, Shubeena; Byrd, Alicia K.; Aarattuthodiyil, Suja; Raney, Kevin D.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Pandey, Manjula; Patel, Smita S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	University of Arkansas System; University of Arkansas Medical Sciences; Rutgers State University New Brunswick; Rutgers State University Medical Center	Raney, KD (corresponding author), 4301 W Markham St,Slot 516, Little Rock, AR 72205 USA.	raneykevind@uams.edu	Aarattuthodiyil, Suja/W-2167-2019; Ramanagoudr Bhojappa, Ramanagouda/ABG-3444-2021	Ramanagoudr Bhojappa, Ramanagouda/0000-0002-3122-3827; Byrd, Alicia/0000-0001-5484-0759	National Institutes of Health [R01 GM098922]; Translational Research Institute (TRI) [UL1TR000039]; NIH National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences (NCATS);  [GM51966]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051966, R01GM098922, R37GM051966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Translational Research Institute (TRI); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM098922 (to K. D. R.), Translational Research Institute (TRI) grant UL1TR000039 through the NIH National Center for Research Resources (NCRR) and National Center for Advancing Translational Sciences (NCATS), and GM51966 (to S. S. P.).	Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Barranco-Medina S, 2010, BIOCHEMISTRY-US, V49, P8445, DOI 10.1021/bi100984j; Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Byrd AK, 2012, J MOL BIOL, V420, P141, DOI 10.1016/j.jmb.2012.04.007; Cheng X, 2007, MITOCHONDRION, V7, P211, DOI 10.1016/j.mito.2006.11.023; Cheng X, 2010, EUR J CELL BIOL, V89, P742, DOI 10.1016/j.ejcb.2010.06.008; Dhakal S, 2013, NUCLEIC ACIDS RES, V41, P3915, DOI 10.1093/nar/gkt038; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Eoff RL, 2006, NAT STRUCT MOL BIOL, V13, P242, DOI 10.1038/nsmb1055; Eoff RL, 2010, BIOCHEMISTRY-US, V49, P4543, DOI 10.1021/bi100061v; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; FOURY F, 1983, P NATL ACAD SCI-BIOL, V80, P5345, DOI 10.1073/pnas.80.17.5345; FOURY F, 1985, EMBO J, V4, P3525, DOI 10.1002/j.1460-2075.1985.tb04112.x; Galletto R, 2013, NUCLEIC ACIDS RES, V41, P4613, DOI 10.1093/nar/gkt117; He XP, 2012, STRUCTURE, V20, P1189, DOI 10.1016/j.str.2012.04.013; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Ivessa AS, 2002, GENE DEV, V16, P1383, DOI 10.1101/gad.982902; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; LAHAYE A, 1993, J BIOL CHEM, V268, P26155; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Lucius AL, 2004, J MOL BIOL, V339, P731, DOI 10.1016/j.jmb.2004.04.009; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Lucius AL, 2002, J MOL BIOL, V324, P409, DOI 10.1016/S0022-2836(02)01067-7; Manosas M, 2010, NUCLEIC ACIDS RES, V38, P5518, DOI 10.1093/nar/gkq273; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Noirot-Gros MF, 2002, MOL GENET GENOMICS, V267, P391, DOI 10.1007/s00438-002-0670-9; O'Rourke TW, 2002, MOL CELL BIOL, V22, P4086, DOI 10.1128/MCB.22.12.4086-4093.2002; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Rad B, 2012, P NATL ACAD SCI USA, V109, P1443, DOI 10.1073/pnas.1119952109; Rajagopal V, 2010, J BIOL CHEM, V285, P17821, DOI 10.1074/jbc.M110.114785; Ramanagoudr-Bhojappa R, 2013, NUCLEIC ACIDS RES, V41, P1029, DOI 10.1093/nar/gks1088; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; ROMAN LJ, 1992, J BIOL CHEM, V267, P4207; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Saikrishnan K, 2009, CELL, V137, P849, DOI 10.1016/j.cell.2009.03.036; Salins LLE, 2004, SENSOR ACTUAT B-CHEM, V97, P81, DOI 10.1016/j.snb.2003.07.019; Sarlos K, 2012, P NATL ACAD SCI USA, V109, P9804, DOI 10.1073/pnas.1114468109; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Sikora B, 2006, J BIOL CHEM, V281, P36110, DOI 10.1074/jbc.M604412200; Soultanas P, 1999, NUCLEIC ACIDS RES, V27, P1421, DOI 10.1093/nar/27.6.1421; Tackett AJ, 2001, BIOCHEMISTRY-US, V40, P543, DOI 10.1021/bi002122+; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wang QX, 2010, NUCLEIC ACIDS RES, V38, P1312, DOI 10.1093/nar/gkp1118; Yang Y, 2008, NUCLEIC ACIDS RES, V36, P1976, DOI 10.1093/nar/gkm1174; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771	56	42	46	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 31	2013	288	22					16185	16195		10.1074/jbc.M113.470013	http://dx.doi.org/10.1074/jbc.M113.470013			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	156LA	23596008	Green Published, hybrid			2022-12-28	WOS:000319822300069
J	Gyoneva, S; Traynelis, SF				Gyoneva, Stefka; Traynelis, Stephen F.			Norepinephrine Modulates the Motility of Resting and Activated Microglia via Different Adrenergic Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-COERULEUS; BETA(2)-ADRENERGIC RECEPTOR; GENE-EXPRESSION; SENILE DEMENTIA; G-PROTEINS; NORADRENALINE; CELLS; BRAIN; NEURONS; PHOSPHORYLATION	Microglia, the resident immune cells of the central nervous system (CNS), monitor the brain for disturbances of tissue homeostasis by constantly moving their fine processes. Microglia respond to tissue damage through activation of ATP/ADP receptors followed by directional process extension to the damaged area. A common feature of several neurodegenerative diseases is the loss of norepinephrine, which might contribute to the associated neuroinflammation. We carried out a high resolution analysis of the effects of norepinephrine (NE) on microglial process dynamics in acute brain slices from mice that exhibit microglia-specific enhanced green fluorescent protein expression. Bath application of NE to the slices resulted in significant process retraction in microglia. Analysis of adrenergic receptor expression with quantitative PCR indicated that resting microglia primarily express beta(2) receptors but switch expression to alpha(2A) receptors under proinflammatory conditions modeled by LPS treatment. Despite the differential receptor expression, NE caused process retraction in both resting and LPS-activated microglia cultured in the gelatinous substrate Matrigel in vitro. The use of subtype-selective receptor agonists and antagonists confirmed the involvement of beta(2) receptors in mediating microglial process dynamics in resting cells and alpha(2A) receptors in activated cells. Co-application of NE with ATP to resting microglia blocked the ATP-induced process extension and migration in isolated microglia, and beta(2) receptor antagonists prolonged ATP effects in brain slice tissues, suggesting the presence of cross-talk between adrenergic and purinergic signaling in microglia. These data show that the neurotransmitter NE can modulate microglial motility, which could affect microglial functions in pathogenic situations of either elevated or reduced NE levels.	[Gyoneva, Stefka; Traynelis, Stephen F.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Gyoneva, S (corresponding author), Emory Univ, Sch Med, Rollins Res Ctr, Dept Pharmacol, Rm 5062,1510 Clifton Rd NE, Atlanta, GA 30322 USA.	stefka.gyoneva@gmail.com			National Institutes of Health [1F31NS076215]; NINDS [5T32ES12870]; NIEHS [T32GM008602]; Udall Parkinson's Disease Research Center at Emory University;  [P50-NS071669]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES012870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS076215, P50NS071669] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Udall Parkinson's Disease Research Center at Emory University; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1F31NS076215, a NINDS National Research Service Award (to S. G.); 5T32ES12870, an NIEHS toxicology institutional training grant (to S. G.); T32GM008602, a pharmacological sciences institutional training grant (to S. G.); and P50-NS071669, a NINDS internal pilot grant from the Udall Parkinson's Disease Research Center at Emory University (to S. F. T).	ATKINSON BN, 1991, J NEUROCHEM, V56, P587, DOI 10.1111/j.1471-4159.1991.tb08190.x; Avignone E, 2008, J NEUROSCI, V28, P9133, DOI 10.1523/JNEUROSCI.1820-08.2008; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bianco F, 2005, BRAIN RES REV, V48, P144, DOI 10.1016/j.brainresrev.2004.12.004; Bohm SK, 1997, BIOCHEM J, V322, P1; CHANPALAY V, 1989, J COMP NEUROL, V287, P373, DOI 10.1002/cne.902870308; Colton CA, 1996, NEUROCHEM INT, V29, P43, DOI 10.1016/0197-0186(95)00139-5; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174, DOI 10.2174/187152710791012053; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; EASON MG, 1992, J BIOL CHEM, V267, P15795; Farber K, 2005, MOL CELL NEUROSCI, V29, P128, DOI 10.1016/j.mcn.2005.01.003; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; Feinstein DL, 2002, NEUROCHEM INT, V41, P357, DOI 10.1016/S0197-0186(02)00049-9; Fornai F, 1997, J PHARMACOL EXP THER, V283, P100; Fujita H, 1998, NEUROSCI LETT, V242, P37, DOI 10.1016/S0304-3940(98)00003-2; GERMAN DC, 1992, ANN NEUROL, V32, P667, DOI 10.1002/ana.410320510; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gyoneva S, 2009, PARKINSONISM RELAT D, V15, pS195, DOI 10.1016/S1353-8020(09)70813-2; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Heneka MT, 2010, P NATL ACAD SCI USA, V107, P6058, DOI 10.1073/pnas.0909586107; Heneka MT, 2002, J NEUROSCI, V22, P2434, DOI 10.1523/JNEUROSCI.22-07-02434.2002; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; IVERSEN LL, 1983, NEUROSCI LETT, V39, P95, DOI 10.1016/0304-3940(83)90171-4; Jardanhazi-Kurutz D, 2011, NEUROSCIENCE, V176, P396, DOI 10.1016/j.neuroscience.2010.11.052; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; KALARIA RN, 1989, NEUROSCI LETT, V97, P203, DOI 10.1016/0304-3940(89)90164-X; Kandasamy K, 2005, J BIOL CHEM, V280, P1931, DOI 10.1074/jbc.M405937200; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Kong Y, 2010, J NEUROSCI, V30, P11848, DOI 10.1523/JNEUROSCI.2985-10.2010; Kvetnansky R, 2009, PHYSIOL REV, V89, P535, DOI 10.1152/physrev.00042.2006; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Lee SH, 2012, GLIA, V60, P1366, DOI 10.1002/glia.22355; Leverenz JB, 2001, NEUROBIOL AGING, V22, P555, DOI 10.1016/S0197-4580(01)00221-4; Li DJ, 2011, J BIOL CHEM, V286, P3805, DOI 10.1074/jbc.M110.118018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOHSE MJ, 1993, BIOCHIM BIOPHYS ACTA, V1179, P171, DOI 10.1016/0167-4889(93)90139-G; LOUGHLIN AJ, 1993, IMMUNOLOGY, V79, P125; MANN DMA, 1980, BRIT J PSYCHIAT, V136, P533, DOI 10.1192/bjp.136.6.533; Mori K, 2002, NEUROPHARMACOLOGY, V43, P1026, DOI 10.1016/S0028-3908(02)00211-3; Morioka N, 2009, NEUROCHEM INT, V55, P226, DOI 10.1016/j.neuint.2009.03.004; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Orr AG, 2009, NAT NEUROSCI, V12, P872, DOI 10.1038/nn.2341; Paspalas CD, 1998, BRAIN RES BULL, V45, P247, DOI 10.1016/S0361-9230(97)00327-4; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pocock JM, 2007, TRENDS NEUROSCI, V30, P527, DOI 10.1016/j.tins.2007.07.007; Prinz M, 2001, BRAIN RES, V899, P264, DOI 10.1016/S0006-8993(01)02174-6; Rommelfanger KS, 2007, P NATL ACAD SCI USA, V104, P13804, DOI 10.1073/pnas.0702753104; Rommelfanger KS, 2007, BIOCHEM PHARMACOL, V74, P177, DOI 10.1016/j.bcp.2007.01.036; Rommelfanger KS, 2004, J NEUROCHEM, V91, P1116, DOI 10.1111/j.1471-4159.2004.02785.x; Scheffel J, 2012, GLIA, V60, P1930, DOI 10.1002/glia.22409; Schutsky K, 2011, J NEUROSCI, V31, P14172, DOI 10.1523/JNEUROSCI.2122-11.2011; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Sperlagh B, 2007, PURINERG SIGNAL, V3, P117, DOI 10.1007/s11302-006-9043-x; Stanford SC, 1995, PHARMACOL THERAPEUT, V68, P297, DOI 10.1016/0163-7258(95)02010-1; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Tanaka KF, 2002, J NEUROSCI RES, V70, P232, DOI 10.1002/jnr.10399; Tha KK, 2000, BRAIN RES, V885, P25, DOI 10.1016/S0006-8993(00)02883-3; Tholanikunnel BG, 2010, J BIOL CHEM, V285, P33816, DOI 10.1074/jbc.M110.168229; Vazquez-Prado J, 2003, CELL SIGNAL, V15, P549, DOI 10.1016/S0898-6568(02)00151-1; Zhang WP, 2004, NEUROPHARMACOLOGY, V47, P438, DOI 10.1016/j.neuropharm.2004.04.017	64	115	115	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 24	2013	288	21					15291	15302		10.1074/jbc.M113.458901	http://dx.doi.org/10.1074/jbc.M113.458901			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	151HU	23548902	Green Published, hybrid			2022-12-28	WOS:000319452100055
J	Nagel, ZD; Cun, SJ; Klinman, JP				Nagel, Zachary D.; Cun, Shujian; Klinman, Judith P.			Identification of a Long-range Protein Network That Modulates Active Site Dynamics in Extremophilic Alcohol Dehydrogenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL FLEXIBILITY; DIHYDROFOLATE-REDUCTASE; ENZYME DYNAMICS; TEMPERATURE; ADAPTATION; CATALYSIS; FLUCTUATIONS; PARAMETERS; STABILITY; COMPLEX	A tetrameric thermophilic alcohol dehydrogenase from Bacillus stearothermophilus (ht-ADH) has been mutated at an aromatic side chain in the active site (Trp-87). The ht-W87A mutation results in a loss of the Arrhenius break seen at 30 degrees C for the wild-type enzyme and an increase in cold lability that is attributed to destabilization of the active tetrameric form. Kinetic isotope effects (KIEs) are nearly temperature-independent over the experimental temperature range, and similar in magnitude to those measured above 30 degrees C for the wild-type enzyme. This suggests that the rigidification in the wild-type enzyme below 30 degrees C does not occur for ht-W87A. A mutation at the dimer-dimer interface in a thermolabile psychrophilic homologue of ht-ADH, ps-A25Y, leads to a more thermostable enzyme and a change in the rate-determining step at low temperature. The reciprocal mutation in ht-ADH, ht-Y25A, results in kinetic behavior similar to that of W87A. Collectively, the results indicate that flexibility at the active site is intimately connected to a subunit interaction 20 angstrom away. The convex Arrhenius curves previously reported for ht-ADH (Kohen, A., Cannio, R., Bartolucci, S., and Klinman, J. P. (1999) Nature 399, 496499) are proposed to arise, at least in part, from a change in subunit interactions that rigidifies the substrate-binding domain below 30 degrees C, and impedes the ability of the enzyme to sample the catalytically relevant conformational landscape. These results implicate an evolutionarily conserved, long-range network of dynamical communication that controls C-H activation in the prokaryotic alcohol dehydrogenases.	[Nagel, Zachary D.; Cun, Shujian; Klinman, Judith P.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Klinman, Judith P.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Cun, Shujian; Klinman, Judith P.] Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Klinman, JP (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	klinman@berkeley.edu			National Institutes of Health [GM025765, GM008295]; National Science Foundation [MCB0446395]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025765, R01GM025765, T32GM008295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM025765 (to J. P. K.) and GM008295 (to Z. D. N.) and the National Science Foundation Grant MCB0446395 (to J. P. K.).	Anandarajah K, 2008, Z PHYS CHEM, V222, P1333, DOI 10.1524/zpch.2008.5391; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Ceccarelli C, 2004, BIOCHEMISTRY-US, V43, P5266, DOI 10.1021/bi049736p; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; EKLUND H, 1981, J MOL BIOL, V146, P561, DOI 10.1016/0022-2836(81)90047-4; Fan F, 2007, BIOCHEMISTRY-US, V46, P6402, DOI 10.1021/bi700255v; Feller G, 2007, EXTREMOPHILES, V11, P211, DOI 10.1007/s00792-006-0050-1; Feller G, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/32/323101; Fields PA, 1998, P NATL ACAD SCI USA, V95, P11476, DOI 10.1073/pnas.95.19.11476; Forst, 1973, THEORY UNIMOLECULAR; Glowacki DR, 2012, NAT CHEM, V4, P169, DOI [10.1038/NCHEM.1244, 10.1038/nchem.1244]; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Heyes DJ, 2011, J BIOL CHEM, V286, P11849, DOI 10.1074/jbc.M111.219626; Klinman JP, 2009, CHEM PHYS LETT, V471, P179, DOI 10.1016/j.cplett.2009.01.038; Kohen A, 2000, J AM CHEM SOC, V122, P10738, DOI 10.1021/ja002229k; Kohen A, 1999, NATURE, V399, P496, DOI 10.1038/20981; Lam SY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001027; Liang ZX, 2004, BIOCHEMISTRY-US, V43, P14676, DOI 10.1021/bi049004x; Liang ZX, 2004, J AM CHEM SOC, V126, P9500, DOI 10.1021/ja047087z; Liang ZX, 2004, P NATL ACAD SCI USA, V101, P9556, DOI 10.1073/pnas.0403337101; Limbach HH, 2006, PHILOS T R SOC B, V361, P1399, DOI 10.1098/rstb.2006.1872; Lonhienne T, 2000, BBA-PROTEIN STRUCT M, V1543, P1, DOI 10.1016/S0167-4838(00)00210-7; Loveridge EJ, 2009, BIOCHEMISTRY-US, V48, P5922, DOI 10.1021/bi900411a; MASSEY V, 1966, J BIOL CHEM, V241, P2347; Merkley ED, 2010, PROTEIN ENG DES SEL, V23, P327, DOI 10.1093/protein/gzp090; Nagel ZD, 2006, CHEM REV, V106, P3095, DOI 10.1021/cr050301x; Nagel ZD, 2012, BIOCHEMISTRY-US, V51, P4147, DOI 10.1021/bi3001352; Nagel ZD, 2011, P NATL ACAD SCI USA, V108, P10520, DOI 10.1073/pnas.1104989108; Nagel ZD, 2009, NAT CHEM BIOL, V5, P543, DOI 10.1038/nchembio.204; Nanda V, 2000, PROTEINS, V40, P112, DOI 10.1002/(SICI)1097-0134(20000701)40:1<112::AID-PROT130>3.0.CO;2-C; Oyeyemi OA, 2011, BIOCHEMISTRY-US, V50, P8251, DOI 10.1021/bi200640s; Pudney CR, 2009, J AM CHEM SOC, V131, P17072, DOI 10.1021/ja908469m; Schramm VL, 2011, ANNU REV BIOCHEM, V80, P703, DOI 10.1146/annurev-biochem-061809-100742; SOMERO GN, 1978, ANNU REV ECOL SYST, V9, P1, DOI 10.1146/annurev.es.09.110178.000245; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; Stojkovic V, 2012, J AM CHEM SOC, V134, P1738, DOI 10.1021/ja209425w; Tang KES, 1998, J BIOMOL STRUCT DYN, V16, P397, DOI 10.1080/07391102.1998.10508256; Truhlar DG, 2001, P NATL ACAD SCI USA, V98, P848, DOI 10.1073/pnas.98.3.848; Tsigos I, 1998, EUR J BIOCHEM, V254, P356, DOI 10.1046/j.1432-1327.1998.2540356.x; Tzeng SR, 2011, CURR OPIN STRUC BIOL, V21, P62, DOI 10.1016/j.sbi.2010.10.007; VARLEY PG, 1991, J MOL BIOL, V220, P531, DOI 10.1016/0022-2836(91)90028-5; VIHINEN M, 1987, PROTEIN ENG, V1, P477, DOI 10.1093/protein/1.6.477; WEBER G, 1995, J PHYS CHEM-US, V99, P1052, DOI 10.1021/j100003a031; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406	48	36	36	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2013	288	20					14087	14097		10.1074/jbc.M113.453951	http://dx.doi.org/10.1074/jbc.M113.453951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	148OB	23525111	hybrid, Green Published			2022-12-28	WOS:000319253500014
J	Ali, SS; Whitney, JC; Stevenson, J; Robinson, H; Howell, PL; Navarre, WW				Ali, Sabrina S.; Whitney, John C.; Stevenson, James; Robinson, Howard; Howell, P. Lynne; Navarre, William Wiley			Structural Insights into the Regulation of Foreign Genes in Salmonella by the Hha/H-NS Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORIZONTALLY ACQUIRED GENES; PROTEIN H-NS; ESCHERICHIA-COLI; NUCLEOID-PROTEIN; DIMERIZATION DOMAIN; BACTERIAL GENOMES; CRYSTAL-STRUCTURE; DNA; BINDING; OLIGOMERIZATION	The bacterial nucleoid-associated proteins Hha and H-NS jointly repress horizontally acquired genes in Salmonella, including essential virulence loci encoded within Salmonella pathogenicity islands. Hha is known to interact with the N-terminal dimerization domain of H-NS; however, the manner in which this interaction enhances transcriptional silencing is not understood. To further understand this process, we solved the x-ray crystal structure of Hha in complex with the N-terminal dimerization domain of H-NS (H-NS(1-46)) to 3.2 angstrom resolution. Two monomers of Hha bind to symmetrical sites on either side of the H-NS(1-46) dimer. Disruption of the Hha/H-NS interaction by the H-NS site-specific mutation I11A results in increased expression of the Hha/H-NS co-regulated gene hilA without affecting the expression levels of proV, a target gene repressed by H-NS in an Hha-independent fashion. Examination of the structure revealed a cluster of conserved basic amino acids that protrude from the surface of Hha on the opposite side of the Hha/H-NS(1-46) interface. Hha mutants with a diminished positively charged surface maintain the ability to interact with H-NS but can no longer regulate hilA. Increased expression of the hilA locus did not correspond to significant depletion of H-NS at the promoter region in chromatin immunoprecipitation assays. However, in vitro, we find Hha improves H-NS binding to target DNA fragments. Taken together, our results show for the first time how Hha and H-NS interact to direct transcriptional repression and reveal that a positively charged surface of Hha enhances the silencing activity of H-NS nucleoprotein filaments.	[Ali, Sabrina S.; Stevenson, James; Navarre, William Wiley] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Whitney, John C.; Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Whitney, John C.; Howell, P. Lynne] Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); United States Department of Energy (DOE); Brookhaven National Laboratory	Navarre, WW (corresponding author), Univ Toronto, Fac Med, Dept Mol Genet, Rm 4379,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	william.navarre@utoronto.ca		Navarre, William/0000-0002-9293-9220	Canada Institutes for Health Research (CIHR) [MOP-86683, MSH-87729]; Natural Sciences and Engineering Research Council of Canada [RGPIN 386286-10]; CIHR [13337]; Natural Science and Engineering Research Council of Canada; Cystic Fibrosis Canada; Ontario Graduate Scholarship Program; Ontario Student Opportunities Trust Fund; Hospital for Sick Children Foundation Student Scholarship Program	Canada Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); CIHR(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cystic Fibrosis Canada; Ontario Graduate Scholarship Program(Ontario Graduate Scholarship); Ontario Student Opportunities Trust Fund; Hospital for Sick Children Foundation Student Scholarship Program	The Navarre laboratory is supported by an Operating Grant and New Investigator Award from the Canada Institutes for Health Research (CIHR) (MOP-86683 and MSH-87729) and a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (RGPIN 386286-10). This work was also supported by CIHR Grant 13337 (to P. L. H.). The National Synchrotron Light Source Beam line X29 is supported by the United States Department of Energy Office of Biological and Environmental Research and the National Institutes of Health National Center for Research Resources.; Supported in part by graduate scholarships from the Natural Science and Engineering Research Council of Canada, Cystic Fibrosis Canada, the Ontario Graduate Scholarship Program, the Ontario Student Opportunities Trust Fund, and the Hospital for Sick Children Foundation Student Scholarship Program.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ali SS, 2011, J BACTERIOL, V193, P4881, DOI 10.1128/JB.05198-11; Arold ST, 2010, P NATL ACAD SCI USA, V107, P15728, DOI 10.1073/pnas.1006966107; Badaut C, 2002, J BIOL CHEM, V277, P41657, DOI 10.1074/jbc.M206037200; Bae SH, 2008, BIOCHEMISTRY-US, V47, P1993, DOI 10.1021/bi701914t; Banos RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000513; Bloch V, 2003, NAT STRUCT BIOL, V10, P212, DOI 10.1038/nsb904; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; Castang S, 2008, P NATL ACAD SCI USA, V105, P18947, DOI 10.1073/pnas.0808215105; Cerdan R, 2003, J MOL BIOL, V334, P179, DOI 10.1016/j.jmb.2003.09.051; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coombes BK, 2005, P NATL ACAD SCI USA, V102, P17460, DOI 10.1073/pnas.0505401102; Dame RT, 2008, BIOCHEM SOC T, V36, P732, DOI 10.1042/BST0360732; Dame RT, 2005, J BACTERIOL, V187, P1845, DOI 10.1128/JB.187.5.1845-1848.2005; Dame RT, 2000, NUCLEIC ACIDS RES, V28, P3504, DOI 10.1093/nar/28.18.3504; Dame RT, 2002, J BIOL CHEM, V277, P2146, DOI 10.1074/jbc.C100603200; Dame RT, 2001, BIOCHIMIE, V83, P231; Daubin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r57; Ekhnovich IN, 2007, J BACTERIOL, V189, P6882, DOI 10.1128/JB.00905-07; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esposito D, 2002, J MOL BIOL, V324, P841, DOI 10.1016/S0022-2836(02)01141-5; Fahlen TF, 2001, J BACTERIOL, V183, P6620, DOI 10.1128/JB.183.22.6620-6629.2001; de Alba CF, 2011, FEBS LETT, V585, P1765, DOI 10.1016/j.febslet.2011.05.024; Garcia J, 2005, BIOCHEM J, V388, P755, DOI 10.1042/BJ20050002; Garcia J, 2006, J MOL BIOL, V359, P679, DOI 10.1016/j.jmb.2006.03.059; Garcia J, 2009, FEBS LETT, V583, P2911, DOI 10.1016/j.febslet.2009.07.054; Gordon BRG, 2008, J BACTERIOL, V190, P7052, DOI 10.1128/JB.00733-08; Gordon BRG, 2011, P NATL ACAD SCI USA, V108, P10690, DOI 10.1073/pnas.1102544108; Grainger DC, 2006, NUCLEIC ACIDS RES, V34, P4642, DOI 10.1093/nar/gkl542; Groisman EA, 1996, CELL, V87, P791, DOI 10.1016/S0092-8674(00)81985-6; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; Navarre WW, 2007, GENE DEV, V21, P1456, DOI 10.1101/gad.1543107; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Nieto JM, 2000, MOL GEN GENET, V263, P349, DOI 10.1007/s004380051178; Nieto JM, 2002, J BACTERIOL, V184, P629, DOI 10.1128/JB.184.3.629-635.2002; Olekhnovich IN, 2006, J MOL BIOL, V357, P373, DOI 10.1016/j.jmb.2006.01.007; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Paytubi S, 2004, MOL MICROBIOL, V54, P251, DOI 10.1111/j.1365-2958.2004.04268.x; Perez JC, 2008, J BIOL CHEM, V283, P10773, DOI 10.1074/jbc.M709843200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pons JI, 2004, PROTEIN EXPRES PURIF, V35, P293, DOI 10.1016/j.pep.2004.02.018; Sharma VK, 2004, J BACTERIOL, V186, P7290, DOI 10.1128/JB.186.21.7290-7301.2004; Shindo H, 1999, FEBS LETT, V455, P63, DOI 10.1016/S0014-5793(99)00862-5; Silphaduang U, 2007, J BACTERIOL, V189, P3669, DOI 10.1128/JB.00002-07; Smyth CP, 2000, MOL MICROBIOL, V36, P962, DOI 10.1046/j.1365-2958.2000.01917.x; Spurio R, 1997, EMBO J, V16, P1795, DOI 10.1093/emboj/16.7.1795; Stella S, 2005, EMBO J, V24, P2896, DOI 10.1038/sj.emboj.7600754; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Takagi S, 2009, BRIT J HAEMATOL, V147, P543, DOI 10.1111/j.1365-2141.2009.07863.x; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Ueguchi C, 1996, J MOL BIOL, V263, P149, DOI 10.1006/jmbi.1996.0566; UEGUCHI C, 1993, MOL GEN GENET, V236, P171, DOI 10.1007/BF00277109; Vivero A, 2008, J BACTERIOL, V190, P1152, DOI 10.1128/JB.01206-07; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yee A, 2002, P NATL ACAD SCI USA, V99, P1825, DOI 10.1073/pnas.042684599; Yun SH, 2012, MOL CELLS, V33, P211, DOI 10.1007/s10059-012-0006-5; Zhou YN, 2006, J BACTERIOL, V188, P7022, DOI 10.1128/JB.00687-06	62	50	53	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13356	13369		10.1074/jbc.M113.455378	http://dx.doi.org/10.1074/jbc.M113.455378			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23515315	Green Published, hybrid			2022-12-28	WOS:000318850300021
J	Xin, H; Lu, RZ; Lee, H; Zhang, W; Zhang, CY; Deng, JH; Liu, Y; Shen, SD; Wagner, KU; Forman, S; Jove, R; Yu, H				Xin, Hong; Lu, Rongze; Lee, Heehyoung; Zhang, Wang; Zhang, Chunyan; Deng, Jiehui; Liu, Yong; Shen, Shudan; Wagner, Kay-Uwe; Forman, Stephen; Jove, Richard; Yu, Hua			G-protein-coupled Receptor Agonist BV8/Prokineticin-2 and STAT3 Protein Form a Feed-forward Loop in Both Normal and Malignant Myeloid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR ANGIOGENESIS; BV8; IDENTIFICATION; ACTIVATION; EXPRESSION; HOMOLOG; CROSSTALK; APOPTOSIS; SYSTEM; CANCER	An important role of BV8 in mobilization of myeloid cells and myeloid cell-dependent angiogenesis has been established. Recently, it has also been shown that granulocyte colony-stimulating factor (G-CSF)-induced BV8 expression is STAT3 dependent in CD11b(+)Gr1(+) myeloid cells. However, the BV8 downstream signaling pathway(s) intrinsic to myeloid cells crucial for angiogenesis, and potentially also for development of cancers of myeloid origin, remains largely unknown. Here we show that BV8 activates STAT3, which is critical for regulating genes important for both tumor cell proliferation/survival and tumor angiogenesis, in both normal and malignant myeloid cells. Further, BV8-induced STAT3 activation requires Janus-activated kinase 2 (JAK2) activity as shown by both genetic and pharmacologic inhibition. Knocking down BV8 in human myeloid leukemia cells inhibits STAT3 activity and expression of STAT3 downstream angiogenic and pro-proliferation/survival genes, leading to a decrease in tumor cell viability. BV8 shRNA expressing leukemia cells exhibit reduced STAT3 activity and tumor growth in vivo. Taken together, we have delineated a signaling pathway downstream of BV8 that plays critical roles in both the tumor microenvironment and malignant myeloid cells for angiogenesis and tumor cell proliferation/survival.	[Xin, Hong; Lee, Heehyoung; Zhang, Wang; Zhang, Chunyan; Deng, Jiehui; Liu, Yong; Shen, Shudan; Yu, Hua] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, Duarte, CA 91010 USA; [Lu, Rongze] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA 91010 USA; [Jove, Richard] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Forman, Stephen] City Hope Natl Med Ctr, Dept Hematol Hematopoiet Cell Transplantat, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; University of Nebraska System; University of Nebraska Medical Center; City of Hope	Yu, H (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Immunotherapeut & Tumor Immunol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	hyu@coh.org	Lu, Rongze/R-2149-2016	Deng, Jiehui/0000-0001-7986-8643; Wagner, Kay-Uwe/0000-0002-5081-0226; YU, Hua/0000-0003-0931-1000	Tim Nesvig Fund at the City of Hope Comprehensive Cancer Center; National Institutes of Health [R01 CA122976, U54 CA163117, P50 CA107399, R01CA146092, P30 CA033572]; V Foundation Translational Research Grant; HEADstrong Foundation	Tim Nesvig Fund at the City of Hope Comprehensive Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation Translational Research Grant; HEADstrong Foundation	This study was supported by the Tim Nesvig Fund at the City of Hope Comprehensive Cancer Center, the National Institutes of Health (Grants R01 CA122976, U54 CA163117, P50 CA107399, and R01CA146092 to H. Y. and P30 CA033572 to the City of Hope Cancer Center, the V Foundation Translational Research Grant, and the HEADstrong Foundation, in memory of Nicholas E. Colleluori.	Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; De Toni F, 2006, ONCOGENE, V25, P3113, DOI 10.1038/sj.onc.1209346; Giannini E, 2009, P NATL ACAD SCI USA, V106, P14646, DOI 10.1073/pnas.0903720106; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Krempler A, 2004, GENESIS, V40, P52, DOI 10.1002/gene.20063; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; LeCouter J, 2004, P NATL ACAD SCI USA, V101, P16813, DOI 10.1073/pnas.0407697101; LeCouter J, 2003, P NATL ACAD SCI USA, V100, P2685, DOI 10.1073/pnas.0337667100; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Li M, 2001, MOL PHARMACOL, V59, P692, DOI 10.1124/mol.59.4.692; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Lu RZ, 2012, CANCER RES, V72, P2239, DOI 10.1158/0008-5472.CAN-11-3016; Masuda Y, 2002, BIOCHEM BIOPH RES CO, V293, P396, DOI 10.1016/S0006-291X(02)00239-5; Melchiorri D, 2001, EUR J NEUROSCI, V13, P1694, DOI 10.1046/j.1460-9568.2001.01549.x; Mollay C, 1999, EUR J PHARMACOL, V374, P189, DOI 10.1016/S0014-2999(99)00229-0; Qu XP, 2012, J BIOL CHEM, V287, P19574, DOI 10.1074/jbc.M111.326801; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Tamburini J, 2007, BLOOD, V110, P1025, DOI 10.1182/blood-2006-12-061283; Wu JH, 2004, CANCER RES, V64, P6461, DOI 10.1158/0008-5472.CAN-04-0866; Xin H, 2011, CANCER RES, V71, P6601, DOI 10.1158/0008-5472.CAN-11-1217; Xin H, 2009, CANCER RES, V69, P2506, DOI 10.1158/0008-5472.CAN-08-4323; Yang F, 2012, CANCER BIOL THER, V13, P534, DOI 10.4161/cbt.19603; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995	31	48	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2013	288	19					13842	13849		10.1074/jbc.M113.450049	http://dx.doi.org/10.1074/jbc.M113.450049			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	143EV	23548897	hybrid, Green Published			2022-12-28	WOS:000318850300065
J	Darnell, JE				Darnell, James E., Jr.			Joys and Surprises of a Career Studying Eukaryotic Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYADENYLIC ACID SEQUENCES; MESSENGER-RIBONUCLEIC-ACID; INFECTED HELA-CELLS; ENRICHED TRANSCRIPTION FACTOR; GAMMA SIGNAL-TRANSDUCTION; LABELED POLYRIBOSOMAL RNA; PROTEIN-TYROSINE KINASES; MAMMARY-TUMOR VIRUS; INTERFERON-ALPHA; NUCLEAR-RNA	In this Reflections, I review a few early and very lucky events that gave me a running start for the rest of a long and wonderfully enjoyable career. For the main part, a discussion is provided of what I recall as the main illuminating results that my many dozens of students and postdoctoral fellows (approximately 140 in all) provided to our biochemical/molecular biological world.	Rockefeller Univ, Mol Cell Biol Lab, New York, NY 10065 USA	Rockefeller University	Darnell, JE (corresponding author), Rockefeller Univ, Mol Cell Biol Lab, New York, NY 10065 USA.	darnell@mail.rockefeller.edu						AUGUST JT, 1962, J BIOL CHEM, V237, P3786; BACHENHEIMER S, 1975, P NATL ACAD SCI USA, V72, P4445, DOI 10.1073/pnas.72.11.4445; BENJAMIN TL, 1966, J MOL BIOL, V16, P359, DOI 10.1016/S0022-2836(66)80179-1; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; BERNHARDT D, 1969, J MOL BIOL, V42, P43, DOI 10.1016/0022-2836(69)90485-9; BOEYE A, 1959, VIROLOGY, V9, P691, DOI 10.1016/0042-6822(59)90158-8; BRENNER S, 1961, NATURE, V190, P576, DOI 10.1038/190576a0; BRENNER S, 1961, COLD SPRING HARB SYM, V26, P101, DOI 10.1101/SQB.1961.026.01.015; BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529; BRITTEN RJ, 1971, Q REV BIOL, V46, P111, DOI 10.1086/406830; Carlson E. A., 2004, MENDELS LEGACY, V43; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; CLAYTON DF, 1985, MOL CELL BIOL, V5, P2623, DOI 10.1128/MCB.5.10.2623; CLAYTON DF, 1983, MOL CELL BIOL, V3, P1552, DOI 10.1128/MCB.3.9.1552; DALES S, 1973, BACTERIOL REV, V37, P103, DOI 10.1128/MMBR.37.2.103-135.1973; Darnell J., 2011, RNA LIFES INDISPENSA; Darnell J.E., 1978, COLD SPRING HARB SYM, V42, P515; DARNELL JE, 1961, VIROLOGY, V13, P271, DOI 10.1016/0042-6822(61)90145-3; DARNELL JE, 1971, P NATL ACAD SCI USA, V68, P1321, DOI 10.1073/pnas.68.6.1321; DARNELL JE, 1955, J CLIN INVEST, V34, P1237, DOI 10.1172/JCI103169; DARNELL JE, 1958, J EXP MED, V107, P633, DOI 10.1084/jem.107.5.633; DARNELL JE, 1971, SCIENCE, V174, P507, DOI 10.1126/science.174.4008.507; DARNELL JE, 1962, COLD SPRING HARB SYM, V27, P149, DOI 10.1101/SQB.1962.027.001.017; DARNELL JE, 1960, J BIOL CHEM, V235, P74; DERMAN E, 1981, CELL, V23, P731, DOI 10.1016/0092-8674(81)90436-0; EAGLE H, 1959, J BIOL CHEM, V234, P592; EAGLE H, 1955, SCIENCE, V122, P501, DOI 10.1126/science.122.3168.501; EAGLE H, 1956, J EXP MED, V104, P271, DOI 10.1084/jem.104.2.271; EDMONDS M, 1971, P NATL ACAD SCI USA, V68, P1336, DOI 10.1073/pnas.68.6.1336; EDMONDS M, 1960, J BIOL CHEM, V235, P1142; FIRMBACHKRAFT I, 1990, ONCOGENE, V5, P1329; FU XY, 1992, P NATL ACAD SCI USA, V89, P7840, DOI 10.1073/pnas.89.16.7840; FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555; GIERER A, 1956, NATURE, V177, P702, DOI 10.1038/177702a0; GLASER RJ, 1956, J EXP MED, V103, P173, DOI 10.1084/jem.103.1.173; GOLDBERG S, 1977, CELL, V10, P617, DOI 10.1016/0092-8674(77)90094-0; GOLDBERG S, 1978, J VIROL, V25, P806, DOI 10.1128/JVI.25.3.806-810.1978; GROS F, 1961, NATURE, V190, P581, DOI 10.1038/190581a0; HACKETT PB, 1974, NATURE, V251, P639, DOI 10.1038/251639a0; HACKETT PB, 1975, J MOL BIOL, V91, P235, DOI 10.1016/0022-2836(75)90378-2; HADJIVAS.A, 1966, J MOL BIOL, V20, P1, DOI 10.1016/0022-2836(66)90112-4; HARRIS H, 1963, NATURE, V200, P227, DOI 10.1038/200227a0; HARRIS H, 1959, BIOCHEM J, V73, P362, DOI 10.1042/bj0730362; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; JELINEK W, 1973, J MOL BIOL, V75, P515, DOI 10.1016/0022-2836(73)90458-0; JOHNSON JC, 1969, ANNU REV MED, V20, P315, DOI 10.1146/annurev.me.20.020169.001531; KNIGHT E, 1979, P NATL ACAD SCI USA, V76, P1824, DOI 10.1073/pnas.76.4.1824; LAI E, 1990, GENE DEV, V4, P1427, DOI 10.1101/gad.4.8.1427; LAI E, 1991, GENE DEV, V5, P416, DOI 10.1101/gad.5.3.416; LARNER AC, 1984, P NATL ACAD SCI-BIOL, V81, P6733, DOI 10.1073/pnas.81.21.6733; LARNER AC, 1986, J BIOL CHEM, V261, P453; LEE SY, 1971, P NATL ACAD SCI USA, V68, P1331, DOI 10.1073/pnas.68.6.1331; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; LEVY D, 1986, P NATL ACAD SCI USA, V83, P8929, DOI 10.1073/pnas.83.23.8929; LINDBERG U, 1970, P NATL ACAD SCI USA, V65, P1089, DOI 10.1073/pnas.65.4.1089; MENDECKI J, 1972, BIOCHEMISTRY-US, V11, P792, DOI 10.1021/bi00755a018; MESELSON M, 1957, P NATL ACAD SCI USA, V43, P581, DOI 10.1073/pnas.43.7.581; MOLLOY GR, 1973, BIOCHEMISTRY-US, V12, P2324, DOI 10.1021/bi00736a022; MORSE SI, 1954, P SOC EXP BIOL MED, V87, P582, DOI 10.3181/00379727-87-21451; MOWSHOWITZ DB, 1970, J MOL BIOL, V50, P143, DOI 10.1016/0022-2836(70)90111-7; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; NAKAZATO H, 1973, J BIOL CHEM, V248, P1472; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; PENMAN S, 1963, P NATL ACAD SCI USA, V49, P654, DOI 10.1073/pnas.49.5.654; Penman S, 1966, SCIENCE, V154, P786; PHILIPSON L, 1971, P NATL ACAD SCI USA, V68, P2806, DOI 10.1073/pnas.68.11.2806; Philipson L, 1975, Cold Spring Harb Symp Quant Biol, V39 Pt 1, P447; POWELL DJ, 1984, J MOL BIOL, V179, P21, DOI 10.1016/0022-2836(84)90304-8; REICH N, 1987, P NATL ACAD SCI USA, V84, P6394, DOI 10.1073/pnas.84.18.6394; RICH A, 1963, SCIENCE, V142, P1658, DOI 10.1126/science.142.3600.1658; RINGOLD GM, 1977, P NATL ACAD SCI USA, V74, P2879, DOI 10.1073/pnas.74.7.2879; ROEDER RG, 1969, NATURE, V224, P234, DOI 10.1038/224234a0; SAMBROOK J, 1968, P NATL ACAD SCI USA, V60, P1288, DOI 10.1073/pnas.60.4.1288; SCHERRER K, 1963, P NATL ACAD SCI USA, V49, P240, DOI 10.1073/pnas.49.2.240; SCHERRER K, 1962, BIOCHEM BIOPH RES CO, V7, P486, DOI 10.1016/0006-291X(62)90341-8; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Sharp P A, 1975, Cold Spring Harb Symp Quant Biol, V39 Pt 1, P457; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; SOEIRO R, 1966, J MOL BIOL, V19, P362; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; STEWART SE, 1958, J NATL CANCER I, V20, P1223, DOI 10.1093/jnci/20.6.1223; TIBBETTS C, 1974, J MOL BIOL, V88, P767, DOI 10.1016/0022-2836(74)90398-2; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; WALL R, 1972, VIROLOGY, V50, P27, DOI 10.1016/0042-6822(72)90342-X; WARNER J, 1963, VIROLOGY, V19, P393, DOI 10.1016/0042-6822(63)90079-5; Warner Jonathan R., 2002, Trends in Biochemical Sciences, V27, P376, DOI 10.1016/S0968-0004(02)02126-6; WARNER JR, 1963, P NATL ACAD SCI USA, V49, P122, DOI 10.1073/pnas.49.1.122; Watson JD, 2006, RNA WORLD, pxv; WEBER J, 1977, CELL, V10, P611, DOI 10.1016/0092-8674(77)90093-9; WILKS AF, 1991, MOL CELL BIOL, V11, P2057, DOI 10.1128/MCB.11.4.2057; WILKS AF, 1989, P NATL ACAD SCI USA, V86, P1603, DOI 10.1073/pnas.86.5.1603; YOUNG HA, 1977, J VIROL, V21, P139, DOI 10.1128/JVI.21.1.139-146.1977	95	3	3	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12957	12966		10.1074/jbc.X113.471722	http://dx.doi.org/10.1074/jbc.X113.471722			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23525107	Green Published, hybrid			2022-12-28	WOS:000318555100049
J	Crevenna, AH; Naredi-Rainer, N; Schonichen, A; Dzubiella, J; Barber, DL; Lamb, DC; Wedlich-Soldner, R				Crevenna, Alvaro H.; Naredi-Rainer, Nikolaus; Schoenichen, Andre; Dzubiella, Joachim; Barber, Diane L.; Lamb, Don C.; Wedlich-Soeldner, Roland			Electrostatics Control Actin Filament Nucleation and Elongation Kinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; NA+/H+ EXCHANGER; BARBED END; PH; POLYMERIZATION; IDENTIFICATION; CYTOSKELETON; ASSOCIATION; ACTIVATION; MECHANISM	The actin cytoskeleton is a central mediator of cellular morphogenesis, and rapid actin reorganization drives essential processes such as cell migration and cell division. Whereas several actin-binding proteins are known to be regulated by changes in intracellular pH, detailed information regarding the effect of pH on the actin dynamics itself is still lacking. Here, we combine bulk assays, total internal reflection fluorescence microscopy, fluorescence fluctuation spectroscopy techniques, and theory to comprehensively characterize the effect of pH on actin polymerization. We show that both nucleation and elongation are strongly enhanced at acidic pH, with a maximum close to the pI of actin. Monomer association rates are similarly affected by pH at both ends, although dissociation rates are differentially affected. This indicates that electrostatics control the diffusional encounter but not the dissociation rate, which is critical for the establishment of actin filament asymmetry. A generic model of protein-protein interaction, including electrostatics, explains the observed pH sensitivity as a consequence of charge repulsion. The observed pH effect on actin in vitro agrees with measurements of Listeria propulsion in pH-controlled cells. pH regulation should therefore be considered as a modulator of actin dynamics in a cellular environment.	[Crevenna, Alvaro H.; Wedlich-Soeldner, Roland] Max Planck Inst Biochem, AG Cellular Dynam & Cell Patterning, D-82152 Martinsried, Germany; [Crevenna, Alvaro H.; Naredi-Rainer, Nikolaus; Lamb, Don C.] Univ Munich, Dept Chem & Biochem, D-81377 Munich, Germany; [Crevenna, Alvaro H.; Naredi-Rainer, Nikolaus; Lamb, Don C.] Univ Munich, Ctr Nanosci, D-81377 Munich, Germany; [Schoenichen, Andre; Barber, Diane L.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Dzubiella, Joachim] Helmholtz Zentrum Berlin, D-14109 Berlin, Germany; [Dzubiella, Joachim] Humboldt Univ, Inst Phys, D-12489 Berlin, Germany; [Lamb, Don C.] Univ Munich, Munich Ctr Integrated Prot Sci, D-81377 Munich, Germany; [Lamb, Don C.] Univ Illinois, Dept Phys, Urbana, IL 61801 USA	Max Planck Society; University of Munich; University of Munich; University of California System; University of California San Francisco; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Humboldt University of Berlin; University of Munich; University of Illinois System; University of Illinois Urbana-Champaign	Crevenna, AH (corresponding author), Univ Munich, Dept Chem & Biochem, Butenandtstr 5-13,Haus E, D-81377 Munich, Germany.	alvaro.crevenna@cup.uni-muenchen.de; don.lamb@cup.uni-muenchen.de; wedlich@biochem.mpg.de	Dzubiella, Joachim/K-8886-2012; Lamb, Don C/G-9501-2014; Crevenna, Alvaro/Q-4476-2019; Crevenna, Alvaro/E-9125-2016	Lamb, Don C/0000-0002-0232-1903; Crevenna, Alvaro/0000-0002-5580-3711; Crevenna, Alvaro/0000-0002-5580-3711	National Institutes of Health [GM58642]; Deutsche Forschungsgemeinschaft [SFB 863, SPP 1464]; Emmy-Noether Programm; Ludwig-Maximilians-Universitat Munchen (LMUInnovativBio-Imaging Network); Nanosystems Initiative Munich; Max Planck Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Emmy-Noether Programm(German Research Foundation (DFG)); Ludwig-Maximilians-Universitat Munchen (LMUInnovativBio-Imaging Network); Nanosystems Initiative Munich; Max Planck Society(Max Planck Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM58642. This work was also supported by Deutsche Forschungsgemeinschaft Grants SFB 863 and SPP 1464 and Emmy-Noether Programm (to J. D.), the Ludwig-Maximilians-Universitat Munchen (LMUInnovativBio-Imaging Network), the Nanosystems Initiative Munich, and the Max Planck Society.	Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Barrat J.-L., 2003, BASIC CONCEPTS SIMPL; BEGG DA, 1979, J CELL BIOL, V83, P241, DOI 10.1083/jcb.83.1.241; Breitsprecher D, 2009, METHODS MOL BIOL, V571, P401, DOI 10.1007/978-1-60761-198-1_27; Brooks C, 2005, AM J PHYSIOL-RENAL, V289, pF410, DOI 10.1152/ajprenal.00440.2004; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Debye P., 1942, T ELECTROCHEM SOC, V82, P265, DOI [10.1149/1.3071413, DOI 10.1149/1.3071413]; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Denker SP, 2002, CURR OPIN CELL BIOL, V14, P214, DOI 10.1016/S0955-0674(02)00304-6; DRENCKHAHN D, 1986, J BIOL CHEM, V261, P2754; Elson EL, 2011, BIOPHYS J, V101, P2855, DOI 10.1016/j.bpj.2011.11.012; FEI W, 1989, BIOPHYS J, V55, P293, DOI 10.1016/S0006-3495(89)82804-8; Footer MJ, 2007, P NATL ACAD SCI USA, V104, P2181, DOI 10.1073/pnas.0607052104; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; FRIEDEN C, 1983, P NATL ACAD SCI-BIOL, V80, P6513, DOI 10.1073/pnas.80.21.6513; Gillies RJ, 2002, J MAGN RESON IMAGING, V16, P430, DOI 10.1002/jmri.10181; Haglund CM, 2011, J CELL BIOL, V195, P7, DOI 10.1083/jcb.201103148; Ivanchenko S, 2011, SUPRAMOLECULAR STRUCTURE AND FUNCTION 10, P1, DOI 10.1007/978-94-007-0893-8_1; Jegou A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001161; Kang HR, 2012, P NATL ACAD SCI USA, V109, P16923, DOI 10.1073/pnas.1211078109; Kohler S, 2012, CELL REP, V2, P433, DOI 10.1016/j.celrep.2012.08.014; Kovar DR, 2004, P NATL ACAD SCI USA, V101, P14725, DOI 10.1073/pnas.0405902101; Krichevsky O, 2002, REP PROG PHYS, V65, P251, DOI 10.1088/0034-4885/65/2/203; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Muller JD, 2000, BIOPHYS J, V78, P474, DOI 10.1016/S0006-3495(00)76610-0; Narita A, 2011, EMBO J, V30, P1230, DOI 10.1038/emboj.2011.48; Niedermayer T, 2012, P NATL ACAD SCI USA, V109, P10769, DOI 10.1073/pnas.1121381109; Oda T, 2001, BIOPHYS J, V80, P841, DOI 10.1016/S0006-3495(01)76063-8; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; OOSAWA F, 1959, J POLYM SCI, V37, P323, DOI 10.1002/pol.1959.1203713202; POUYSSEGUR J, 1985, FEBS LETT, V190, P115, DOI 10.1016/0014-5793(85)80439-7; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; Qin S, 2011, STRUCTURE, V19, P1744, DOI 10.1016/j.str.2011.10.015; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Schmoller KM, 2012, SOFT MATTER, V8, P9685, DOI 10.1039/c2sm25969a; Schwarz US, 2012, J CELL SCI, V125, P3051, DOI 10.1242/jcs.093716; Sept D, 1999, J MOL BIOL, V294, P1181, DOI 10.1006/jmbi.1999.3332; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; Shetron-Rama LM, 2002, INFECT IMMUN, V70, P1087, DOI 10.1128/IAI.70.3.1087-1096.2002; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Srivastava J, 2008, P NATL ACAD SCI USA, V105, P14436, DOI 10.1073/pnas.0805163105; STEINER RF, 1952, J POLYM SCI, V8, P23, DOI 10.1002/pol.1952.120080102; Stock C, 2006, ACTA PHYSIOL, V187, P149, DOI 10.1111/j.1748-1716.2006.01543.x; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; TILNEY LG, 1978, J CELL BIOL, V77, P536, DOI 10.1083/jcb.77.2.536; Tominaga T, 1998, EMBO J, V17, P4712, DOI 10.1093/emboj/17.16.4712; von Smoluchowski M, 1916, PHYS Z, V17, P557; VOYNOYASENETSKAYA T, 1994, J BIOL CHEM, V269, P4721; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Zhou HX, 2010, Q REV BIOPHYS, V43, P219, DOI 10.1017/S0033583510000120; ZIMMERLE CT, 1988, BIOCHEMISTRY-US, V27, P7766, DOI 10.1021/bi00420a027	57	34	35	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12102	12113		10.1074/jbc.M113.456327	http://dx.doi.org/10.1074/jbc.M113.456327			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486468	Green Published, hybrid			2022-12-28	WOS:000318157600043
J	Slupe, AM; Merrill, RA; Flippo, KH; Lobas, MA; Houtman, JCD; Strack, S				Slupe, Andrew M.; Merrill, Ronald A.; Flippo, Kyle H.; Lobas, Mark A.; Houtman, Jon C. D.; Strack, Stefan			A Calcineurin Docking Motif (LXVP) in Dynamin-related Protein 1 Contributes to Mitochondrial Fragmentation and Ischemic Neuronal Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERAPEUTIC TIME WINDOW; CEREBRAL-ISCHEMIA; REGULATES TRANSLOCATION; TACROLIMUS FK506; PLASMA-MEMBRANE; DRP1; FISSION; DEPHOSPHORYLATION; PHOSPHORYLATION; PHOSPHATASE	Fission and fusion events dynamically control the shape and function of mitochondria. The activity of the mitochondrial fission enzyme dynamin-related protein 1 (Drp1) is finely tuned by several post-translational modifications. Phosphorylation of Ser-656 by cAMP-dependent protein kinase (PKA) inhibits Drp1, whereas dephosphorylation by a mitochondrial protein phosphatase 2A isoform and the calcium-calmodulin-dependent phosphatase calcineurin (CaN) activates Drp1. Here, we identify a conserved CaN docking site on Drp1, an LXVP motif, which mediates the interaction between the phosphatase and mechanoenzyme. We mutated the LXVP motif in Drp1 to either increase or decrease similarity to the prototypical LXVP motif in the transcription factor NFAT, and assessed stability of the mutant Drp1-CaN complexes by affinity precipitation and isothermal titration calorimetry. Furthermore, we quantified effects of LXVP mutations on Drp1 dephosphorylation kinetics in vitro and in intact cells. With tools for bidirectional control of the CaN-Drp1 signaling axis in hand, we demonstrate that the Drp1 LXVP motif shapes mitochondria in neuronal and non-neuronal cells, and that CaN-mediated Drp1 dephosphorylation promotes neuronal death following oxygen-glucose deprivation. These results point to the CaN-Drp1 complex as a potential target for neuroprotective therapy of ischemic stroke.	[Slupe, Andrew M.; Merrill, Ronald A.; Flippo, Kyle H.; Strack, Stefan] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA; [Lobas, Mark A.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Houtman, Jon C. D.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Strack, S (corresponding author), 2-432 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	stefan-strack@uiowa.edu		Flippo, Kyle/0000-0001-9667-7056; Houtman, Jon/0000-0002-5307-9854; Strack, Stefan/0000-0002-6175-7280; Merrill, Ronald/0000-0002-5276-4163	National Institutes of Health [NS056244, NS057714, CA136729, F31 NS077563]; NATIONAL CANCER INSTITUTE [R01CA136729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067795, T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS056244, R01NS056244, R01NS057714, T32NS045549, F31NS077563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS056244 and NS057714 (to S. S.) and CA136729 (to J. C. D. H.) and Predoctoral Fellowship F31 NS077563 (to A. M. S.).	Ankarcrona M, 1996, FEBS LETT, V394, P321, DOI 10.1016/0014-5793(96)00959-3; Arnoult D, 2005, CURR BIOL, V15, P2112, DOI 10.1016/j.cub.2005.10.041; Asai A, 1999, J BIOL CHEM, V274, P34450, DOI 10.1074/jbc.274.48.34450; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; BLUMENTHAL DK, 1986, J BIOL CHEM, V261, P8140; Bochelen D, 1999, J PHARMACOL EXP THER, V288, P653; Brustovetsky T, 2009, CELL CALCIUM, V46, P18, DOI 10.1016/j.ceca.2009.03.017; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Cho SG, 2010, AM J PHYSIOL-RENAL, V299, pF199, DOI 10.1152/ajprenal.00716.2009; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Cribbs JT, 2009, METHOD ENZYMOL, V457, P231, DOI 10.1016/S0076-6879(09)05013-7; Dagda RK, 2008, J BIOL CHEM, V283, P36241, DOI 10.1074/jbc.M800989200; Dickey AS, 2011, J NEUROSCI, V31, P15716, DOI 10.1523/JNEUROSCI.3159-11.2011; Dougherty MK, 2009, MOL CELL, V34, P652, DOI 10.1016/j.molcel.2009.06.001; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frieden M, 2004, J BIOL CHEM, V279, P22704, DOI 10.1074/jbc.M312366200; Furuichi Y, 2003, J CEREBR BLOOD F MET, V23, P1183, DOI 10.1097/01.WCB.0000088761.02615.EB; Furuichi Y, 2003, BRAIN RES, V965, P137, DOI 10.1016/S0006-8993(02)04151-3; Furuichi Y, 2007, EXP NEUROL, V204, P138, DOI 10.1016/j.expneurol.2006.10.003; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Greenwood SM, 2007, J BIOL CHEM, V282, P26235, DOI 10.1074/jbc.M704488200; Jahani-Asl A, 2011, J BIOL CHEM, V286, P4772, DOI 10.1074/jbc.M110.167155; KLEE CB, 1988, ADV ENZYMOL RAMB, V61, P149; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Liu WT, 2012, J NEUROSCI RES, V90, P1183, DOI 10.1002/jnr.23016; Martin BL, 1999, BIOCHEMISTRY-US, V38, P3386, DOI 10.1021/bi981748l; Martinez-Martinez S, 2006, J BIOL CHEM, V281, P6227, DOI 10.1074/jbc.M513885200; McAvoy T., 2010, CURR PROTOC MOL BOL, V92; Mehta S, 2009, MOL CELL BIOL, V29, P2777, DOI 10.1128/MCB.01197-08; Merrill RA, 2013, FEBS J, V280, P662, DOI 10.1111/j.1742-4658.2012.08631.x; Merrill RA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000612; Misonou H, 2005, J NEUROSCI, V25, P11184, DOI 10.1523/JNEUROSCI.3370-05.2005; Mondragon A, 1997, BIOCHEMISTRY-US, V36, P4934, DOI 10.1021/bi9631935; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Moy LY, 2004, J BIOL CHEM, V279, P54487, DOI 10.1074/jbc.M406636200; Nicholls DG, 2008, ANN NY ACAD SCI, V1147, P53, DOI 10.1196/annals.1427.002; O'Donnell SE, 2011, PROTEINS, V79, P765, DOI 10.1002/prot.22917; Ogata T, 2009, MECH AGEING DEV, V130, P328, DOI 10.1016/j.mad.2009.02.001; Oliveria SF, 2012, J NEUROSCI, V32, P15328, DOI 10.1523/JNEUROSCI.2302-12.2012; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; PEDIGO S, 1995, BIOCHEMISTRY-US, V34, P1179, DOI 10.1021/bi00004a011; Pivovarova NB, 2004, J NEUROSCI, V24, P5611, DOI 10.1523/JNEUROSCI.0531-04.2004; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rintoul GL, 2003, J NEUROSCI, V23, P7881; RODBARD D, 1974, CLIN CHEM, V20, P1255; Rodriguez A, 2009, MOL CELL, V33, P616, DOI 10.1016/j.molcel.2009.01.030; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; Sanderson JL, 2012, J NEUROSCI, V32, P15036, DOI 10.1523/JNEUROSCI.3326-12.2012; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Shalbuyeva N, 2006, J BIOL CHEM, V281, P37547, DOI 10.1074/jbc.M607263200; Sharifi ZN, 2012, STROKE RES TREAT, V2012, DOI DOI 10.1155/2012/809417; SHARKEY J, 1994, NATURE, V371, P336, DOI 10.1038/371336a0; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Strack S., 2011, ENZYME RES, V2011, DOI DOI 10.4061/2011/398751; Strack S, 2012, J BIOL CHEM, V287, P10990, DOI 10.1074/jbc.M112.342105; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang JX, 2011, NAT MED, V17, P71, DOI 10.1038/nm.2282; Wilson TJ, 2013, NEUROBIOL DIS, V51, P13, DOI 10.1016/j.nbd.2012.01.009; Wood AM, 1998, J NEUROCHEM, V70, P677; Ye QL, 2008, PROTEINS, V73, P19, DOI 10.1002/prot.22032; Young KW, 2010, J BIOCHEM MOL TOXIC, V24, P335, DOI 10.1002/jbt.20343	73	53	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12353	12365		10.1074/jbc.M113.459677	http://dx.doi.org/10.1074/jbc.M113.459677			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486469	Green Published, hybrid			2022-12-28	WOS:000318157600066
J	Wei, H; Bera, TK; Wayne, AS; Xiang, LM; Colantonio, S; Chertov, O; Pastan, I				Wei, Hui; Bera, Tapan K.; Wayne, Alan S.; Xiang, Laiman; Colantonio, Simona; Chertov, Oleg; Pastan, Ira			A Modified Form of Diphthamide Causes Immunotoxin Resistance in a Lymphoma Cell Line with a Deletion of the WDR85 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOLOGIC MALIGNANCIES; RECOMBINANT IMMUNOTOXIN; OVCA1; BIOSYNTHESIS	HA22 is a recombinant immunotoxin that kills CD22-expressing cells by ADP-ribosylating and inactivating elongation factor-2 (EF2). HA22 is composed of an Fv that binds to CD22 fused to a portion of Pseudomonas exotoxin A. HA22 is very active in drug-resistant hairy cell leukemia but is less active in children with acute lymphoblastic leukemia. To understand why some patients do not respond to HA22, we isolated an HA22-resistant lymphoma cell line and showed that resistance was due to the inability of HA22 to ADP-ribosylate and inactivate EF2. We analyzed the diphthamide synthesis genes and found that the WDR85 gene was deleted. We show that WDR85 knockdown conferred HA22 resistance to sensitive cells and that sensitivity was restored by introduction of a WDR85 cDNA into resistant cells. Analysis of EF2 in the mutant cells revealed a novel form of diphthamide with an additional methyl group that prevented ADP-ribosylation and inactivation of EF2. The abnormal methylation appeared to be catalyzed by DPH5. Inactivation of the WDR85 gene could be a mechanism of immunotoxin resistance in patients undergoing immunotoxin therapy.	[Wei, Hui; Bera, Tapan K.; Wayne, Alan S.; Xiang, Laiman; Pastan, Ira] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Wayne, Alan S.] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Colantonio, Simona; Chertov, Oleg] SAIC Frederick Inc, Frederick Natl Lab Canc Res, Adv Technol Program, Prot Chem Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Pastan, I (corresponding author), NCI, Mol Biol Lab, Rm 5106,37 Convent Dr, Bethesda, MD 20892 USA.	pastani@mail.nih.gov	pastan, ira/P-9319-2019	pastan, ira/0000-0002-9223-0270; Chertov, Oleg/0000-0002-0426-2521	Center for Cancer Research, NCI, National Institutes of Health; NCI, National Institutes of Health [HHSN261200800001E]; MedImmune, LLC.; NATIONAL CANCER INSTITUTE [ZIABC008753] Funding Source: NIH RePORTER	Center for Cancer Research, NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MedImmune, LLC.(AstraZenecaMedimmune); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health, in part with federal funds from NCI, National Institutes of Health, under Contract HHSN261200800001E and under a Cooperative Research and Development Agreement with MedImmune, LLC. Dr. Pastan is an inventor of patents on immunotoxins that have all been assigned to the National Institutes of Health.	Bachner D, 2002, FEBS LETT, V526, P124, DOI 10.1016/S0014-5793(02)03115-0; Baylin SB, 2011, NAT MED, V17, P288, DOI 10.1038/nm0311-288; Bruening W, 1999, CANCER RES, V59, P4973; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; CHAUDHARY VK, 1989, NATURE, V339, P394, DOI 10.1038/339394a0; Chen CM, 2004, GENE DEV, V18, P320, DOI 10.1101/gad.1162204; Du X, 2008, CANCER RES, V68, P6300, DOI 10.1158/0008-5472.CAN-08-0461; Du X, 2010, MOL CELL BIOL, V30, P3444, DOI 10.1128/MCB.00813-09; Fei ZL, 2011, J BIOL CHEM, V286, P27761, DOI 10.1074/jbc.M111.248435; FitzGerald DJ, 2011, CANCER RES, V71, P6300, DOI 10.1158/0008-5472.CAN-11-1374; Francke F, 2005, BIOCHEM BIOPH RES CO, V334, P1292, DOI 10.1016/j.bbrc.2005.07.027; Greganova E, 2011, FEBS J, V278, P2613, DOI 10.1111/j.1742-4658.2011.08199.x; Howlader N, 2011, SEER CANC STAT REV 1; Jensen MR, 2004, GENE DEV, V18, P245, DOI 10.1101/gad.1184004; Kreitman RJ, 2012, J CLIN ONCOL, V30, P1822, DOI 10.1200/JCO.2011.38.1756; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; MAGRATH IT, 1980, J NATL CANCER I, V64, P477; MATTHEAKIS LC, 1992, MOL CELL BIOL, V12, P4026, DOI 10.1128/MCB.12.9.4026; Nowak NJ, 2010, CANCER GENET CYTOGEN, V199, P15, DOI 10.1016/j.cancergencyto.2010.01.014; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Pastan Ira, 2004, Methods Mol Biol, V248, P503; PHILLIPS N, 1993, INT J CANCER, V54, P85, DOI 10.1002/ijc.2910540115; Phillips NJ, 1996, CANCER LETT, V102, P85, DOI 10.1016/0304-3835(96)04169-9; Ries L. A. G., 1999, NIH PUB, V99-4649, P1; Salvatore G, 2002, CLIN CANCER RES, V8, P995; Stewart DR, 2007, AM J MED GENET C, V145C, P383, DOI 10.1002/ajmg.c.30148; Su XY, 2012, J AM CHEM SOC, V134, P773, DOI 10.1021/ja208870a; Wayne AS, 2008, JNCI-J NATL CANCER I, V100, P1271, DOI 10.1093/jnci/djn306; Wayne AS, 2011, BLOOD, V118, P113, DOI 10.1182/blood.V118.21.248.248; Wayne AS, 2010, CLIN CANCER RES, V16, P1894, DOI 10.1158/1078-0432.CCR-09-2980; Wei H, 2012, P NATL ACAD SCI USA, V109, P6898, DOI 10.1073/pnas.1204523109; Zhang Y, 2010, NATURE, V465, P891, DOI 10.1038/nature09138; Zhang YJ, 2010, CANCER RES, V70, P1082, DOI 10.1158/0008-5472.CAN-09-2405	34	25	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12305	12312		10.1074/jbc.M113.461343	http://dx.doi.org/10.1074/jbc.M113.461343			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23486472	Green Published, hybrid			2022-12-28	WOS:000318157600061
J	Zhang, YH; Wang, NN; Raab, RW; McKown, RL; Irwin, JA; Kwon, I; van Kuppevelt, TH; Laurie, GW				Zhang, Yinghui; Wang, Ningning; Raab, Ronald W.; McKown, Robert L.; Irwin, Jacob A.; Kwon, Inchan; van Kuppevelt, Toin H.; Laurie, Gordon W.			Targeting of Heparanase-modified Syndecan-1 by Prosecretory Mitogen Lacritin Requires Conserved Core GAGAL plus Heparan and Chondroitin Sulfate as a Novel Hybrid Binding Site That Enhances Selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; DRY EYE; EXTRACELLULAR DOMAIN; INTEGRIN ACTIVATION; CRYSTAL-STRUCTURE; LACRIMAL GLAND; EXPRESSION; GROWTH; IDENTIFICATION; PROTEOGLYCANS	Cell surface heparan sulfate (HS) proteoglycans shape organogenesis and homeostasis by capture and release of morphogens through mechanisms largely thought to exclude the core protein domain. Nevertheless, heparanase deglycanation of the N-terminal HS-rich domain of syndecan-1 (SDC1), but not SDC2 or -4, is a prerequisite for binding of the prosecretory mitogen lacritin (Ma, P., Beck, S. L., Raab, R. W., McKown, R. L., Coffman, G. L., Utani, A., Chirico, W. J., Rapraeger, A. C., and Laurie, G. W. (2006) Heparanase deglycanation of syndecan-1 is required for binding of the epithelial-restricted prosecretory mitogen lacritin. J. Cell Biol. 174, 1097-1106). We now report that the conserved and hydrophobic GAGAL domain in SDC1, adjacent to predicted HS substitution sites, is necessary to ligate and substantially enhance the alpha-helicity of the amphipathic C terminus of lacritin. Swapping out GAGAL for GADED in SDC2 or for GDLDD in SDC4 (both less hydrophobic) abrogated binding. HS and chondroitin sulfate are also essential. Both are detected in the N terminus, and when incubated with antibodies HS4C3 (anti-HS) or IO3H10 (anti-chondroitin sulfate), binding was absent, as occurred when all three N-terminal glycosaminoglycan substitution sites were mutated to alanine or when cells were treated with 4-methylumbelliferyl-beta-D-xylopyranoside or chlorate to suppress glycosaminoglycan substitution or sulfation, respectively. SDC1 interacts with the hydrophobic face of lacritin via Leu-108/Leu-109/Phe-112 as well as with Glu-103/Lys-107 and Lys-111 of the largely cationic face. Carving a hybrid hydrophobic/electrostatic docking site out of SDC1 in a manner dependent on endogenous heparanase is a dynamic process appropriate for subtle or broad epithelial regulation in morphogenesis, health, and disease.	[Zhang, Yinghui; Wang, Ningning; Laurie, Gordon W.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA; [Laurie, Gordon W.] Univ Virginia, Dept Ophthalmol, Charlottesville, VA 22908 USA; [Irwin, Jacob A.; Kwon, Inchan] Univ Virginia, Dept Chem Engn, Charlottesville, VA 22908 USA; [Raab, Ronald W.; McKown, Robert L.] James Madison Univ, Dept Integrated Sci & Technol, Harrisonburg, VA 22807 USA; [van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6500 HB Nijmegen, Netherlands	University of Virginia; University of Virginia; University of Virginia; James Madison University; Radboud University Nijmegen	Laurie, GW (corresponding author), Univ Virginia, Dept Cell Biol, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	glaurie@virginia.edu	van Kuppevelt, A.H.M.S.M./L-4463-2015; Laurie, Gordon W/A-5244-2008	Laurie, Gordon W/0000-0002-5311-2650	National Institutes of Health [RO1 EY013143, EY018222]; NATIONAL EYE INSTITUTE [R01EY013143, R01EY018222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 EY013143 and EY018222 (to G. W. L.).	Adams JC, 2001, J CELL BIOL, V152, P1169, DOI 10.1083/jcb.152.6.1169; Barden JA, 1997, J BIOL CHEM, V272, P29572, DOI 10.1074/jbc.272.47.29572; Beauvais DM, 2010, J CELL SCI, V123, P3796, DOI 10.1242/jcs.067645; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Capurro MI, 2005, CANCER RES, V65, P6245, DOI 10.1158/0008-5472.CAN-04-4244; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Dahlback M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191510; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Dore JM, 1998, FEBS LETT, V426, P67, DOI 10.1016/S0014-5793(98)00310-X; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Khan S, 2011, J BIOL CHEM, V286, P24842, DOI 10.1074/jbc.M111.226027; Kirkpatrick CA, 2006, DEV BIOL, V300, P570, DOI 10.1016/j.ydbio.2006.09.011; KOKENYESI R, 1994, J BIOL CHEM, V269, P12304; Koo BS, 2005, J PROTEOME RES, V4, P719, DOI 10.1021/pr0498133; Landgraf P, 2008, J BIOL CHEM, V283, P25036, DOI 10.1074/jbc.M800963200; Langford JK, 2005, J BIOL CHEM, V280, P3467, DOI 10.1074/jbc.M412451200; Langford JK, 1998, J BIOL CHEM, V273, P29965, DOI 10.1074/jbc.273.45.29965; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Lin PY, 2005, INVEST OPHTH VIS SCI, V46, P1593, DOI 10.1167/iovs.04-0864; LOHMANDER LS, 1979, J BIOL CHEM, V254, P551; LUGEMWA FN, 1991, J BIOL CHEM, V266, P6674; Ma PS, 2006, J CELL BIOL, V174, P1097, DOI 10.1083/jcb.200511134; Mantelli F, 2009, INVEST OPHTH VIS SCI, V50, P2666, DOI 10.1167/iovs.08-2734; McFall AJ, 1998, J BIOL CHEM, V273, P28270, DOI 10.1074/jbc.273.43.28270; McKown RL, 2013, INVEST OPHTH VIS SCI, V54, P1979, DOI 10.1167/iovs.12-10740; McKown RL, 2009, EXP EYE RES, V88, P848, DOI 10.1016/j.exer.2008.09.002; Nichols JJ, 2009, CORNEA, V28, P1109, DOI 10.1097/ICO.0b013e3181a2ad81; Ori A, 2011, J BIOL CHEM, V286, P19892, DOI 10.1074/jbc.M111.228114; PARALKAR VM, 1991, P NATL ACAD SCI USA, V88, P3397, DOI 10.1073/pnas.88.8.3397; Park H, 2002, J BIOL CHEM, V277, P29730, DOI 10.1074/jbc.M202435200; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Peterson SB, 2010, J BIOL CHEM, V285, P14504, DOI 10.1074/jbc.M110.104166; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2009, J BIOL CHEM, V284, P28382, DOI 10.1074/jbc.M109.022905; Porter D, 2003, P NATL ACAD SCI USA, V100, P10931, DOI 10.1073/pnas.1932980100; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Rawson JM, 2005, CURR BIOL, V15, P833, DOI 10.1016/j.cub.2005.03.039; Rubin JB, 2002, DEVELOPMENT, V129, P2223; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Samudre S, 2011, INVEST OPHTH VIS SCI, V52, P6265, DOI 10.1167/iovs.10-6220; Sanghi S, 2001, J MOL BIOL, V310, P127, DOI 10.1006/jmbi.2001.4748; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Shafat I, 2006, J BIOL CHEM, V281, P23804, DOI 10.1074/jbc.M602762200; Srinivasan S, 2012, INVEST OPHTH VIS SCI, V53, P5052, DOI 10.1167/iovs.11-9022; ten Dam GB, 2006, J BIOL CHEM, V281, P4654, DOI 10.1074/jbc.M506357200; TSUTSUI J, 1991, BIOCHEM BIOPH RES CO, V176, P792, DOI 10.1016/S0006-291X(05)80255-4; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Velez VF, 2013, INVEST OPHTH VIS SCI, V54, P2123, DOI 10.1167/iovs.12-11488; Wang JH, 2006, J CELL BIOL, V174, P689, DOI 10.1083/jcb.200605140; Weigelt B, 2003, J CANCER RES CLIN, V129, P735, DOI 10.1007/s00432-003-0514-y; Whiteford JR, 2007, EXP CELL RES, V313, P3902, DOI 10.1016/j.yexcr.2007.08.002; Yan D, 2010, DEVELOPMENT, V137, P2033, DOI 10.1242/dev.045740; Yan D, 2009, DEV CELL, V17, P470, DOI 10.1016/j.devcel.2009.09.001; Zhong M, 2004, BIOCHEMISTRY-US, V43, P3490, DOI 10.1021/bi035899m; Zhou L, 2009, J PROTEOME RES, V8, P4889, DOI 10.1021/pr900686s	62	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12090	12101		10.1074/jbc.M112.422717	http://dx.doi.org/10.1074/jbc.M112.422717			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23504321	Green Published, hybrid			2022-12-28	WOS:000318157600042
